PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Kim, S; Connaughton, DP				Kim, Sungwon; Connaughton, Daniel P.			Soccer, concussions, and safety: Perceptions of parents of youth soccer participants	JOURNAL OF SAFETY RESEARCH			English	Article						Attitudes; Injury prevention; Youth sport; Head injury; Coaches; Heading	STATES HIGH-SCHOOL; FOR-DISEASE-CONTROL; COACHES; HEADS; EPIDEMIOLOGY; KNOWLEDGE; EDUCATION; SPORTS	Introduction: The rate of concussions in youth soccer is among the highest of all youth sports. Parents play an important role in caring for their children and making decisions regarding whether they should participate in a sport, such as soccer, where concussions are well known. This study examined parental perceptions regarding: (a) coaches' role in concussion management, (b) heading restriction policies, and (c) overall concussion risk and participation issues. Method: Online surveys were completed by 419 parents of youth soccer players who participated in the largest U.S. youth soccer programs nationwide. Results: Findings indicated 44.5% of the respondents had considered keeping their children from playing organized soccer and 47.2% were concerned about a potential decline in youth soccer participation due to concussions. Nearly 69% of responding parents agreed that heading should be banned for participants 10 years old or younger, while 56.5% thought heading should not be limited for participants 13 or older. Only 35% of parents were very confident about their child's coach's ability to properly identify concussions and remove those suspected of a concussion from play. Parents' socioeconomic status (SES), soccer coaching and playing experience, and previous history of concussion(s) were key predictors of greater perceived risk about concussions. Conclusions: Findings from this study shed light on parents' perceptions about concussions and related safety issues in youth soccer. Understanding what parents believe about concussions is vital to preserve youth soccer participation and can be used to strengthen education and policies that promote a safer environment for youth sport participants. Practical Applications: Youth soccer coaches can benefit from stronger, comprehensive educational efforts at the league/club level. Additionally, parents of youth athletes who are in the lower SES communities should be targeted to receive concussion safety information and/or interventions that would improve their knowledge, attitude, and practices regarding concussion safety. (c) 2021 National Safety Council and Elsevier Ltd. All rights reserved.	[Kim, Sungwon] St Johns Univ, 8000 Utopia Pkwy, Queens, NY 11439 USA; [Connaughton, Daniel P.] Univ Florida, POB 118208, Gainesville, FL 32611 USA		Kim, S (corresponding author), St Johns Univ, 8000 Utopia Pkwy, Queens, NY 11439 USA.	kims1@stjohns.edu; danc@hhp.ufl.edu		Connaughton, Daniel/0000-0001-7421-3138; Kim, Sungwon/0000-0003-2136-7613			Anderson SJ, 2000, PEDIATRICS, V105, P659, DOI 10.1542/peds.105.3.640; Aspen Institute/espnW, 2014, PROJ PLAY SURV PAR Y; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Brussoni M, 2013, AM J MENS HEALTH, V7, P77, DOI 10.1177/1557988312462739; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Daugherty J, 2019, HEALTH EDUC J, V78, P784, DOI 10.1177/0017896919846185; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Gessel LM, 2007, J ATHL TRAINING, V42, P495; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Lee JGL, 2020, HEALTH PROMOT PRACT, V21, p157S, DOI 10.1177/1524839919879923; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; National Conference of State Legislatures,, 2015, TRAUMATIC BRAIN INJU; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; OConnor P. A, 2014, WALL STR J; Parker EM, 2015, J HEAD TRAUMA REHAB, V30, P198, DOI 10.1097/HTR.0000000000000097; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sarmiento K, 2019, J SAFETY RES, V69, P217, DOI 10.1016/j.jsr.2019.01.005; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; SGB Media, 2019, SFIA SPORTS IND FAC; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Sports & Fitness Industry Association, 2018, SPORTS FITN LEIS ACT; Statistics Brain, 2019, YOUTH SPORTS PROGR S; US Youth Soccer,, 2016, US YOUTH SOCC ANN RE; Watson A, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2759; Whitehill JM, 2020, J ADOLESCENT HEALTH, V66, P247, DOI 10.1016/j.jadohealth.2019.08.024; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	33	0	0	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	JUN	2021	77						255	262		10.1016/j.jsr.2021.03.008			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	SO4VT	WOS:000658972700026	34092316				2022-02-07	
J	Komoltsev, IG; Frankevich, SO; Shirobokova, NI; Volkova, AA; Onufriev, MV; Moiseeva, JV; Novikova, MR; Gulyaeva, NV				Komoltsev, Ilia G.; Frankevich, Stepan O.; Shirobokova, Natalia I.; Volkova, Aleksandra A.; Onufriev, Mikhail V.; Moiseeva, Julia V.; Novikova, Margarita R.; Gulyaeva, Natalia V.			Neuroinflammation and Neuronal Loss in the Hippocampus Are Associated with Immediate Posttraumatic Seizures and Corticosterone Elevation in Rats	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						neuroinflammation; neurodegeneration; hippocampus; corticosterone; seizures; traumatic brain injury; epileptogenesis	TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION INJURY; CELL-DEATH; EPILEPSY; NEUROGENESIS; MECHANISMS; PATHOPHYSIOLOGY; VULNERABILITY; EPIDEMIOLOGY; STRESS	Hippocampal damage after traumatic brain injury (TBI) is associated with late posttraumatic conditions, such as depression, cognitive decline and epilepsy. Mechanisms of selective hippocampal damage after TBI are not well understood. In this study, using rat TBI model (lateral fluid percussion cortical injury), we assessed potential association of immediate posttraumatic seizures and changes in corticosterone (CS) levels with neuroinflammation and neuronal cell loss in the hippocampus. Indices of distant hippocampal damage (neurodegeneration and neuroinflammation) were assessed using histological analysis (Nissl staining, Iba-1 immunohistochemical staining) and ELISA (IL-1 beta and CS) 1, 3, 7 and 14 days after TBI or sham operation in male Wistar rats (n = 146). IL-1 beta was elevated only in the ipsilateral hippocampus on day 1 after trauma. CS peak was detected on day 3 in blood, the ipsilateral and contralateral hippocampus. Neuronal cell loss in the hippocampus was demonstrated bilaterally; in the ipsilateral hippocampus it started earlier than in the contralateral. Microglial activation was evident in the hippocampus bilaterally on day 7 after TBI. The duration of immediate seizures correlated with CS elevation, levels of IL-1 beta and neuronal loss in the hippocampus. The data suggest potential association of immediate post-traumatic seizures with CS-dependent neuroinflammation-mediated distant hippocampal damage.	[Komoltsev, Ilia G.; Frankevich, Stepan O.; Shirobokova, Natalia I.; Volkova, Aleksandra A.; Onufriev, Mikhail V.; Moiseeva, Julia V.; Novikova, Margarita R.; Gulyaeva, Natalia V.] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Lab Funct Biochem Nervous Syst, 5A Butlerov Str, Moscow 117485, Russia; [Komoltsev, Ilia G.; Gulyaeva, Natalia V.] Res & Clin Ctr Neuropsychiat, Moscow Healthcare Dept, 43 Donskaya Str, Moscow 115419, Russia		Gulyaeva, NV (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Lab Funct Biochem Nervous Syst, 5A Butlerov Str, Moscow 117485, Russia.; Gulyaeva, NV (corresponding author), Res & Clin Ctr Neuropsychiat, Moscow Healthcare Dept, 43 Donskaya Str, Moscow 115419, Russia.	komoltsev.ilia@ihna.ru; stepan.frankevich@yandex.ru; mr.brightside144@mail.ru; aleksandra.al.volkova@gmail.com; mikeonuf@ihna.ru; jumois@ihna.ru; mrnovikova@ihna.ru; nata_gul@ihna.ru	Novikova, Margarita/AAC-2331-2022		Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [19-015-00258]	This research was funded by Russian Foundation for Basic Research grant #19-015-00258.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Aronica E, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P139, DOI 10.1016/B978-0-12-804066-9.00011-0; Ben Assayag E, 2017, PSYCHONEUROENDOCRINO, V82, P133, DOI 10.1016/j.psyneuen.2017.05.013; Beniczky S, 2016, EPILEPSIA, V57, P1363, DOI 10.1111/epi.13472; Bolshakov AP, 2021, BIOCHEMISTRY-MOSCOW+, V86, P156, DOI [10.1134/S0006297921020048, 10.31857/S0320972521020044]; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dampney RAL, 2016, ADV PHYSIOL EDUC, V40, P283, DOI 10.1152/advan.00027.2016; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; [Гуляева Н.В. Gulyaeva N.V.], 2021, [Российский физиологический журнал им. И.М. Сеченова, Russian Journal of Physiology, Rossiiskii fiziologicheskii zhurnal im. I.M. Sechenova], V107, P518, DOI 10.31857/S0869813921040099; Gulyaeva NV, 2019, BIOCHEMISTRY-MOSCOW+, V84, P1306, DOI 10.1134/S0006297919110087; Gulyaeva NV, 2015, NEUROCHEM J+, V9, P85, DOI 10.1134/S1819712415020075; Gulyaeva NV, 2010, NEUROCHEM J+, V4, P84, DOI 10.1134/S1819712410020029; Gulyaeva NV, 2021, BIOCHEMISTRY-MOSCOW+, V86, P641, DOI 10.1134/S0006297921060031; Gulyaeva NV, 2019, NEUROCHEM RES, V44, P1306, DOI 10.1007/s11064-018-2662-0; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Hamer HM, 2003, BRAIN, V126, P547, DOI 10.1093/brain/awg051; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jefferys J.G.R., 2012, JASPERS BASIC MECH E, P1; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim YK, 2016, PROG NEURO-PSYCHOPH, V64, P277, DOI 10.1016/j.pnpbp.2015.06.008; Komol'tsev IG, 2018, NEUROCHEM J+, V12, P256, DOI 10.1134/S1819712418030054; Komoltsev IG, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10090570; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu J, 2005, ACT NEUR S, V95, P281; Lu XCM, 2020, J NEUROTRAUM, V37, P236, DOI 10.1089/neu.2019.6573; Mattson MP, 2019, HBK STRESS SER, V3, P125, DOI 10.1016/B978-0-12-813146-6.00011-4; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Noachtar S, 2009, EPILEPSY BEHAV, V15, P2, DOI 10.1016/j.yebeh.2009.02.029; Parent JM, 2010, EPILEPSIA, V51, P45, DOI 10.1111/j.1528-1167.2010.02831.x; Pitkanen A, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P661, DOI 10.1016/B978-0-12-804066-9.00046-8; Prager EM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286re5; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; RINK A, 1995, AM J PATHOL, V147, P1575; Roberts AJ, 1995, PSYCHONEUROENDOCRINO, V20, P891, DOI 10.1016/0306-4530(95)00016-X; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; RUTH RE, 1982, EXP NEUROL, V76, P508, DOI 10.1016/0014-4886(82)90120-0; Shivacharan RS, 2019, EXP NEUROL, V317, P119, DOI 10.1016/j.expneurol.2019.02.005; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith D, 2018, EPILEPSY RES, V147, P87, DOI 10.1016/j.eplepsyres.2018.09.005; Sorrells SF, 2014, NEUROENDOCRINOLOGY, V100, P129, DOI 10.1159/000367849; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Tas YC, 2019, CURR NEUROPHARMACOL, V17, P151, DOI 10.2174/1570159X15666170915160707; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; TUPPER DE, 1980, ACTA NEUROBIOL EXP, V40, P999; Van Erum J, 2019, EPILEPSY BEHAV, V95, P51, DOI 10.1016/j.yebeh.2019.02.029; Vezzani Annamaria, 2012, Handb Clin Neurol, V107, P163, DOI 10.1016/B978-0-444-52898-8.00010-0; VIRGIN CE, 1991, J NEUROCHEM, V57, P1422, DOI 10.1111/j.1471-4159.1991.tb08309.x	61	0	0	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2021	22	11							5883	10.3390/ijms22115883			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	SQ1ZL	WOS:000660157800001	34070933	Green Published, gold			2022-02-07	
J	Li, B; Yuan, HG; Li, HB; Luo, BC; Yu, XP; Wang, YH; Liu, W				Li, Bin; Yuan, Honggang; Li, Huibing; Luo, Baochang; Yu, Xiaoping; Wang, Yanhua; Liu, Wen			Mechanism of Aquaporin-4 Up-Regulation After Traumatic Brain Injury and Preventative Action of Astragalus Polysaccharides in Mice	JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING			English	Article						Aquaporin-4; Traumatic Brain Injury; Astragalus Polysaccharides	NF-KAPPA-B; AQP4 EXPRESSION; P38 MAPK; SIGNALING PATHWAY; RAT MODEL; EDEMA; GROWTH; ACTIVATION; ISCHEMIA; CELLS	Here, we aimed to clarify the anti-inflammatory function of Astragalus Polysaccharides (APS), a chemical compound derived from Astragalus membranaceus, and the action of AQP4 on brain injury. We hypothesized that APS could improve the traumatic brain injury (TBI) outcome via inhibiting expression of AQP4 in astrocytes. The present study elucidated that AQP4 was up-regulated and was effectively blocked by APS in mice with severe controlled cortical impact (CCI). Pre-treatment with APS effectively inhibited the up-regulation of AQP4 and diminished the neurological deficits in mice. Additionally, primary astrocytes treated with mechanically-injured astrocyte supernatant, to mimic TBI in vitro, showed a significant up-regulation in swelling. We confirmed various signal molecules (NF-kappa B, MAPKs, and ERK) to have a role in astrocyte swelling, after activation in trauma, and to be involved in the up-regulation of AQP4. These signal molecules also significantly decreased with APS treatment. In conclusion, our study suggests that APS attenuated neurological deficits and brain edema by decreasing AQP4 up-regulation in astrocytes following TBI in mice, via reducing NF-kappa B, MAPKs, and the ERK signal molecules.	[Li, Bin; Yuan, Honggang; Li, Huibing; Luo, Baochang; Yu, Xiaoping; Wang, Yanhua; Liu, Wen] Peoples Hosp Hanchuan, Dept Neurosurg, Xiaogan 431600, Hubei, Peoples R China		Li, HB (corresponding author), Peoples Hosp Hanchuan, Dept Neurosurg, Xiaogan 431600, Hubei, Peoples R China.				People's Hospital of Hanchuan	This work was supported by People's Hospital of Hanchuan.	Chen YQ, 2017, J CELL BIOCHEM, V118, P4905, DOI 10.1002/jcb.26176; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Dibas A, 2008, MOL VIS, V14, P1770; Fu XM, 2007, GLIA, V55, P935, DOI 10.1002/glia.20515; Guan Y, 2020, EXP THER MED, V19, P2029, DOI 10.3892/etm.2020.8456; Guo O, 2005, J NEUROTRAUM, V22, P1185; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Li ZP, 2017, J FUNCT FOODS, V39, P152, DOI 10.1016/j.jff.2017.10.004; Manley G. T., 2005, J. Neurochem., V94, P983; Maroli N, 2019, J CHEM INF MODEL, V59, P4942, DOI 10.1021/acs.jcim.9b00711; Perez-Monter C, 2015, J HEPATOL, V62, pS332, DOI 10.1016/S0168-8278(15)30307-X; Qi LL, 2011, LIFE SCI, V88, P50, DOI 10.1016/j.lfs.2010.10.025; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Shi WZ, 2012, NEUROSCI BULL, V28, P680, DOI 10.1007/s12264-012-1281-z; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tait MJ, 2010, NEUROSCIENCE, V167, P60, DOI 10.1016/j.neuroscience.2010.01.053; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Wang XR, 2017, J STROKE CEREBROVASC, V26, P2199, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.002; Winkler C, 2017, DEV COMP IMMUNOL, V73, P124, DOI 10.1016/j.dci.2017.03.017; Yang M, 2014, CYTOKINE, V70, P81, DOI 10.1016/j.cyto.2014.07.250; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zhang YM, 2019, J CELL BIOCHEM, V120, P17584, DOI 10.1002/jcb.29025; Zheng J, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0224-8; Zhou LJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44822; Zhou X, 2018, INT J BIOL MACROMOL, V106, P596, DOI 10.1016/j.ijbiomac.2017.08.054; Zhu HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/280493	27	0	0	2	4	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2157-9083	2157-9091		J BIOMATER TISS ENG	J. Biomater. Tissue Eng.	JUN	2021	11	6					1037	1045		10.1166/jbt.2021.2502			9	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	SV2CK	WOS:000663632500002					2022-02-07	
J	Li, QF; Gao, YL; Shen, J; Mu, XY; Wang, JY; Ouyang, LF; Chen, K; He, H; Pei, JH; Ren, QJ; Sun, S; Liu, HL; Zhou, L; Sun, YM; Long, W; Zhang, JN; Zhang, XD				Li, Qifeng; Gao, Yalong; Shen, Jun; Mu, Xiaoyu; Wang, Junying; Ouyang, Lufei; Chen, Ke; He, Hua; Pei, Jiahui; Ren, Qinjuan; Sun, Si; Liu, Haile; Zhou, Lei; Sun, Yuanming; Long, Wei; Zhang, Jianning; Zhang, Xiao-Dong			Catalase-like quantum dots of L-lysine polymerization as free radical scavengers for hypoxic brain injury	MATERIALS TODAY COMMUNICATIONS			English	Article						Quantum dots; Traumatic brain injury; Hypoxemia; Catalase-mimic; Reactive oxygen and nitrogen species	CARBON DOTS; OXIDATIVE STRESS; GREEN SYNTHESIS; NANOPARTICLES; ANTIOXIDANT; PROTECT; FRAGMENTATION; MECHANISMS; NANOZYMES; INCREASE	Hypoxemia as one of the most common symptoms of traumatic brain injury (TBI) can significantly exacerbate the development of secondary damage, which further contributes to generating large numbers of neurotoxic factors such as reactive oxygen and nitrogen species (RONS), pro-inflammatory cytokine and chemokine. Here, we developed a kind of quantum dots as catalase-mimic and multiple free radical scavengers by means of the microwave heating polymerization of L-lysine. Hydrogen peroxide as overproduced radicals can be decomposed to supply oxygen, contributing to improving the hypoxic condition in brain. Simultaneously, other traditional RONS such as O-2(center dot-), (OH)-O-center dot, NO and ONOO- can be eliminated by the quantum dots. The total ROS level is back to normal after the quantum dots treatment, promoting the H2O2/LPS-stimulated cell survival in vitro. Oxidative stress induced by hypoxic brain injury is restored by the quantum dots intravenous injection, leading to the protection of neural cells in vivo. Additionally, the quantum dots can improve the spatial learning and memory of TBI mice by water maze test. This work provides a new perspective for the therapy of hypoxic brain injury.	[Li, Qifeng; Gao, Yalong; Shen, Jun; Zhou, Lei; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Li, Qifeng; Gao, Yalong; Shen, Jun; Zhou, Lei; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Key Lab Posttrauma Neuro Repair & Regenerat Cent, Tianjin 300052, Peoples R China; [Mu, Xiaoyu; Zhang, Xiao-Dong] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin Key Lab Brain Sci & Neuroengn, Tianjin 300072, Peoples R China; [Mu, Xiaoyu; Wang, Junying; Ouyang, Lufei; Chen, Ke; Pei, Jiahui; Ren, Qinjuan; Sun, Si; Liu, Haile; Zhang, Xiao-Dong] Tianjin Univ, Sch Sci, Tianjin Key Lab Low Dimens Mat Phys & Preparing T, Tianjin 300350, Peoples R China; [He, Hua] China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao 266580, Peoples R China; [He, Hua] China Univ Petr East China, Ctr Bioengn & Biotechnol, Qingdao 266580, Peoples R China; [Sun, Yuanming; Long, Wei] Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Mol Nucl Med, 238 Baidi Rd, Tianjin 300192, Peoples R China; [Shen, Jun] Wannan Med Coll, Dept Neurosurg, Yijishan Hosp, Wuhu 241001, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Key Lab Posttrauma Neuro Repair & Regenerat Cent, Tianjin 300052, Peoples R China.; Mu, XY; Zhang, XD (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Tianjin Key Lab Brain Sci & Neuroengn, Tianjin 300072, Peoples R China.	muxiaoyu@tju.edu.cn; jianningzhang@hotmail.com; xiaodongzhang@tju.edu.cn	Zhang, Xiaodong/F-4665-2015	Zhang, Xiaodong/0000-0002-7212-0138; yalong, Gao/0000-0002-7162-5433	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 91859101, 81801234, 81971744, U1932107, 82001952, 81471786]; National Natural Science Foundation of Tianjin [19JCZDJC34000]; Innovation Foundation of Tianjin University	This work was financially supported by the National Natural Science Foundation of China (Grant Nos. 81330029, 91859101, 81801234, 81971744, U1932107, 82001952 and 81471786) and National Natural Science Foundation of Tianjin (No. 19JCZDJC34000), the Innovation Foundation of Tianjin University.	CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Cormode DP, 2018, TRENDS BIOTECHNOL, V36, P15, DOI 10.1016/j.tibtech.2017.09.006; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dohi K, 2007, ANTIOXID REDOX SIGN, V9, P281, DOI 10.1089/ars.2007.9.281; Dowding JM, 2014, CELL DEATH DIFFER, V21, P1622, DOI 10.1038/cdd.2014.72; El-Hnayn R, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10010104; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Gedda G, 2016, SENSOR ACTUAT B-CHEM, V224, P396, DOI 10.1016/j.snb.2015.09.065; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Huang XT, 2017, YONSEI MED J, V58, P1012, DOI 10.3349/ymj.2017.58.5.1012; Huang YY, 2019, CHEM REV, V119, P4357, DOI 10.1021/acs.chemrev.8b00672; Huang YY, 2016, ANGEW CHEM INT EDIT, V55, P6646, DOI 10.1002/anie.201600868; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kang C, 2017, ACS NANO, V11, P6194, DOI 10.1021/acsnano.7b02308; Kim CK, 2012, ANGEW CHEM INT EDIT, V51, P11039, DOI 10.1002/anie.201203780; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Li LB, 2018, J MATER CHEM C, V6, P7944, DOI 10.1039/c7tc05878k; Liu YL, 2017, J AM CHEM SOC, V139, P856, DOI 10.1021/jacs.6b11013; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meiling T.T., 2016, SCI REP-UK, V6, P315; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Mu XY, 2019, NANO LETT, V19, P4527, DOI 10.1021/acs.nanolett.9b01333; Mu XY, 2019, ACS NANO, V13, P1870, DOI 10.1021/acsnano.8b08045; Nih LR, 2018, NAT MATER, V17, P642, DOI 10.1038/s41563-018-0083-8; Ouyang LF, 2020, J MATER CHEM B, V8, P2321, DOI 10.1039/c9tb02447f; Penn DL, 2018, NEUROSURGERY, V82, pN9, DOI 10.1093/neuros/nyx539; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Qiu Y, 2014, NANOSCALE, V6, P11744, DOI 10.1039/c4nr03275f; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Singh N, 2017, ANGEW CHEM INT EDIT, V56, P14267, DOI 10.1002/anie.201708573; Smith KA, 2017, REDOX BIOL, V13, P228, DOI 10.1016/j.redox.2017.05.020; Soh M, 2017, ANGEW CHEM INT EDIT, V56, P11399, DOI 10.1002/anie.201704904; Sun HJ, 2018, ANGEW CHEM INT EDIT, V57, P9224, DOI 10.1002/anie.201712469; Tortella FC, 2015, SHOCK, V44, P17, DOI 10.1097/SHK.0000000000000380; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Wang XY, 2016, INORG CHEM FRONT, V3, P41, DOI 10.1039/c5qi00240k; Wei H, 2013, CHEM SOC REV, V42, P6060, DOI 10.1039/c3cs35486e; Wu JJX, 2019, CHEM SOC REV, V48, P1004, DOI 10.1039/c8cs00457a; Xu C, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.88; Yan RJ, 2019, ACS NANO, V13, P11552, DOI 10.1021/acsnano.9b05075; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Zhang W, 2016, J AM CHEM SOC, V138, P5860, DOI 10.1021/jacs.5b12070; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhao L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09290-y; Zhao SJ, 2015, ACS APPL MATER INTER, V7, P17054, DOI 10.1021/acsami.5b03228; Zhou YB, 2017, BIOCONJUGATE CHEM, V28, P2903, DOI 10.1021/acs.bioconjchem.7b00673	52	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2352-4928		MATER TODAY COMMUN	Mater. Today Commun.	JUN	2021	27								102286	10.1016/j.mtcomm.2021.102286			10	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	TX3WT	WOS:000683021300007					2022-02-07	
J	Liang, Y; Chen, LL; Cao, QL; Lin, W; Guo, QH; Wang, YH				Liang, Y.; Chen, Lele; Cao, Qilong; Lin, Wei; Guo, Qihao; Wang, Yuhai			Depression in patients with traumatic brain injury-Prevalence and association with cognitive and physical function	CURRENT PSYCHOLOGY			English	Article						Traumatic brain injury; Depression; Cognition; Activity of daily living	DISORDERS; PREDICTORS; DEFICITS; OUTCOMES; SLEEP; MILD; ADL	Depression is the most commonly diagnosed disorder among patients with traumatic brain injury (TBI). Understanding the association between the depression and the cognitive and physical function has important clinical implications in promoting the quality of life. Although evidences existed that patients with TBI experienced depression, cognitive impairment, and reduction in physical function. However, the relationship among these three conditions was not well understood. In the current study, we used the Hamilton Depression Scale, Montreal Cognitive Assessment-Basic Scale, and Activity of Daily Living Scale to assess the conditions of depression, cognition, and activities of daily living (ADL) among 145 TBI patients. To better understand the relationship between depression, cognition, and ADL, the data was analyzed using binary logistic regression. The Odds Ratio (OR) was computed to explore the risk of cognitive impairment and low-activities of daily living with depression. A total of 62.9% (n = 90/145) of patients lived with depression. The risk of cognitive impairment was 2.30 times higher for patients with depression than patients without depression (OR = 2.30, 95% confidence interval [CI] 1.08, 4.90), and the risk of low-activities of daily living was 5.14 times higher for patients with depression than patients without depression (OR = 5.14, 95% CI 2.17, 12.14). Compared to patients without depression, patients with depression scored worse on tests of language and visual-spatial perception, and were slower on tests of executive functioning. In summary, this study provides initial evidence that depression significantly affects the cognition and ADL of TBI patients.	[Liang, Y.] Wenzhou Med Univ, Affiliated Kangning Hosp, Wenzhou 325035, Peoples R China; [Chen, Lele; Cao, Qilong] Nanjing Univ, Sch Social & Behav Sci, Dept Social Work & Social Policy, Nanjing, Jiangsu, Peoples R China; [Lin, Wei; Wang, Yuhai] 101st Hosp Chinese Peoples Liberat Army, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China; [Guo, Qihao] Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China		Lin, W (corresponding author), 101st Hosp Chinese Peoples Liberat Army, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China.; Guo, QH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	smithlinwx@aliyun.com; dr.guoqihao@126.com					Bin Abdullah MFIL, 2018, ASIAN J PSYCHIATR, V37, P67, DOI 10.1016/j.ajp.2018.08.017; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brailovskaia J., 2017, CURR PSYCHOL, P1, DOI DOI 10.1007/S12144-017-9627-3; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Canham R., 2000, EUR C 2000 P 26; Chen KL, 2016, J AM GERIATR SOC, V64, pE285, DOI 10.1111/jgs.14530; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P11, DOI 10.1017/S1355617717000595; ENDICOTT J, 1981, ARCH GEN PSYCHIAT, V38, P98; Eto F, 1992, Nihon Ronen Igakkai Zasshi, V29, P841; Failla MD, 2016, J HEAD TRAUMA REHAB, V31, pE62, DOI 10.1097/HTR.0000000000000214; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Garcia Sarah, 2011, Cardiovasc Psychiatry Neurol, V2011, P368324, DOI 10.1155/2011/368324; Holroyd S, 2005, NEUROLOGY, V64, P2134, DOI 10.1212/01.WNL.0000165958.12724.0D; Hurst FG, 2020, DISABIL REHABIL, V42, P651, DOI 10.1080/09638288.2018.1504993; Julayanont P, 2015, J AM GERIATR SOC, V63, P2550, DOI 10.1111/jgs.13820; Kaplan E., 2001, BOSTON NAMING TEST; Kos C, 2016, NEUROSCI BIOBEHAV R, V69, P381, DOI 10.1016/j.neubiorev.2016.08.012; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee NY, 2015, J PHYS THER SCI, V27, P145, DOI 10.1589/jpts.27.145; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Liu BY, 2015, CHIN J TRAUMATOL, V18, P135, DOI 10.1016/j.cjtee.2015.04.002; Mayberg H. S, 2002, SEM CLIN NEUR; Mioni G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00269; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schmidt M., 1996, REY AUDITORY VERBAL; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shirai M, 2021, CURR PSYCHOL, V40, P895, DOI 10.1007/s12144-018-0010-9; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wada T, 2004, ARCH GERONTOL GERIAT, V39, P15, DOI 10.1016/j.archger.2003.12.003; Webb CA, 2018, CLIN GERONTOLOGIST, V41, P172, DOI 10.1080/07317115.2017.1408733; ZHENG YP, 1988, BRIT J PSYCHIAT, V152, P660, DOI 10.1192/bjp.152.5.660	34	0	0	3	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1046-1310	1936-4733		CURR PSYCHOL	Curr. Psychol.	JUN	2021	40	6					3058	3064		10.1007/s12144-019-00243-8			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	SL4MS	WOS:000656893700048					2022-02-07	
J	Long, D; Polinder, S; Bonsel, GJ; Haagsma, JA				Long, Di; Polinder, Suzanne; Bonsel, Gouke J.; Haagsma, Juanita A.			Test-retest reliability of the EQ-5D-5L and the reworded QOLIBRI-OS in the general population of Italy, the Netherlands, and the United Kingdom	QUALITY OF LIFE RESEARCH			English	Article						Test-retest reliability; Web-based; EQ-5D-5L; Reworded QOLIBRI-OS	QUALITY-OF-LIFE; CORRELATION-COEFFICIENT; INTERRATER RELIABILITY; SCALE; DESIGN; HRQOL; KAPPA	Purpose To assess the test-retest reliability of the EQ-5D-5L and the reworded Quality of Life After Traumatic Brain Injury Overall Scale (QOLIBRI-OS) for the general population of Italy, the Netherlands, and the United Kingdom (UK). Methods The sample contains 1864 members of the general population (aged 18-75 years) of Italy, the Netherlands, and the UK who completed a web-based questionnaire at two consecutive time points. The survey included items on gender, age, level of education, occupational status, household annual income, chronic health status, and the EQ-5D-5L and reworded QOLIBRI-OS instrument. Test-retest reliability of the EQ-5D-5L dimensions, EQ-5D-5L summary index, EQ VAS, reworded QOLIBRI-OS dimensions and reworded QOLIBRI-OS level sum score was examined by Gwet's Agreement Coefficient (Gwet's AC) and Intraclass Correlation Coefficient (ICC). Results Gwet's AC ranged from 0.64 to 0.97 for EQ-5D-5L dimensions. The ICC ranged from 0.73 to 0.84 for the EQ-5D-5L summary index and 0.61 to 0.68 for EQ VAS in the three countries. Gwet's AC ranged from 0.35 to 0.55 for reworded QOLIBRI-OS dimensions in the three countries. The ICC ranged from 0.69 to 0.77 for reworded QOLIBRI-OS level sum score. Conclusion Test-retest reliability of the EQ-5D-5L administered via a web-based questionnaire was substantial to almost perfect for the EQ-5D-5L dimensions, good for EQ-5D-5L summary index, and moderate for the EQ VAS. However, test-retest reliability was less satisfactory for the reworded QOLIBRI-OS. This indicates that the web-based EQ-5D-5L is a reliable instrument for the general population, but further research of the reworded QOLIBRI-OS is required.	[Long, Di; Polinder, Suzanne; Bonsel, Gouke J.; Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Bonsel, Gouke J.] EuroQol Grp Execut Off, Rotterdam, Netherlands		Long, D (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	d.long@erasmusmc.nl		Long, Di/0000-0001-6493-9314	EuroQol Research Foundation [141-2020RA]	This study was funded by the EuroQol Research Foundation, Grant Number 141-2020RA.	Bobak CA, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0550-6; Bowker, 1998, P SURV METH SECT; Buchholz I, 2018, PHARMACOECONOMICS, V36, P645, DOI 10.1007/s40273-018-0642-5; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Coughlin S.S., 2011, SURVEY PRACTICE, V4, P1, DOI [10.29115/SP-2011-0004, DOI 10.29115/SP-2011-0004]; Couper MP, 2001, PUBLIC OPIN QUART, V65, P230, DOI 10.1086/322199; Cramer D., 1988, FUNDAMENTAL STAT SOC; Devlin N., 2020, METHODS ANAL REPORTI, P102; Devlin NJ, 2017, APPL HEALTH ECON HEA, V15, P127, DOI 10.1007/s40258-017-0310-5; Frost MH, 2007, VALUE HEALTH, V10, pS94, DOI 10.1111/j.1524-4733.2007.00272.x; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Gwet KL, 2014, HDB INTERRATER RELIA, V4; Heiberg G, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1101-9; Jia HM, 2009, PUBLIC HEALTH REP, V124, P692, DOI 10.1177/003335490912400511; Kim TH, 2013, QUAL LIFE RES, V22, P2245, DOI 10.1007/s11136-012-0331-3; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Machin D, 2013, QUALITY LIFE ASSESSM; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mehta S, 2018, STAT MED, V37, P2734, DOI 10.1002/sim.7679; Peterson R., 1992, J ACADEMY MARKETING, V20, P61, DOI DOI 10.1007/BF02723476; Petrolia DR, 2009, PUBLIC OPIN QUART, V73, P537, DOI 10.1093/poq/nfp038; Purba FD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197098; ROBINSON R, 1993, BMJ-BRIT MED J, V307, P994, DOI 10.1136/bmj.307.6910.994; Romero M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-664; Schleyer TKL, 2000, J AM MED INFORM ASSN, V7, P416, DOI 10.1136/jamia.2000.0070416; Scholtes VA, 2011, INJURY, V42, P236, DOI 10.1016/j.injury.2010.11.042; Stahl M. J., 2003, ENCY HLTH CARE MANAG; Streiner DL., 2015, HLTH MEASUREMENT SCA, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001]; Tran D, 2020, COMMUN STAT-SIMUL C, V49, P989, DOI 10.1080/03610918.2018.1490428; Tukey JW., 1977, EXPLORATORY DATA ANA, V2, P131; Turk T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194239; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wong GKC, 2014, J CLIN NEUROSCI, V21, P954, DOI 10.1016/j.jocn.2013.09.010; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10; Wu YJ, 2021, VALUE HEALTH, V24, P1319, DOI 10.1016/j.jval.2021.04.1282; Wyatt JC, 2000, J AM MED INFORM ASSN, V7, P426, DOI 10.1136/jamia.2000.0070426; Yin SM, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0091-3	41	0	0	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2021	30	10					2961	2971		10.1007/s11136-021-02893-3		JUN 2021	11	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	UY9AB	WOS:000656783500001	34075530	Green Published, hybrid			2022-02-07	
J	Mansour, NO; Shama, MA; Werida, RH				Mansour, Noha O.; Shama, Mohamed A.; Werida, Rehab H.			The effect of doxycycline on neuron-specific enolase in patients with traumatic brain injury: a randomized controlled trial	THERAPEUTIC ADVANCES IN CHRONIC DISEASE			English	Article						brain injury biomarkers; doxycycline; neuron specific enolase; secondary brain injury; traumatic brain injury	GLASGOW-COMA-SCALE; PROGNOSTIC VALUE; MINOCYCLINE; NEUROINFLAMMATION; NEUROPROTECTION; ERYTHROPOIETIN; INFLAMMATION; CYTOKINES; ISCHEMIA; OUTCOMES	Objective: We aimed to examine the effect of doxycycline on serum levels of neuron-specific enolase (NSE), a marker of neuronal damage in traumatic brain injury (TBI) patients. Methods: Patients were randomly assigned into two groups (n = 25 each) to receive either placebo or doxycycline (200 mg daily), with their standard management for 7 days. Results: NSE serum levels in the doxycycline and control groups on day 3 were 14.66 +/- 1.78 versus 18.09 +/- 4.38 ng/mL, respectively (p = 0.008), and on day 7 were 12.3 +/- 2.0 versus 16.43 +/- 3.85 ng/mL, respectively (p = 0.003). Glasgow Coma Scale (GCS) on day 7 was 11.90 +/- 2.83 versus 9.65 +/- 3.44 in the doxycycline and control groups, respectively (p = 0.031). NSE serum levels and GCS scores were negatively correlated (r = -0.569, p < 0.001). Conclusion: Adjunctive early use of doxycycline might be a novel option that halts the ongoing secondary brain injury in patients with moderate to severe TBI. Future larger clinical trials are warranted to confirm these findings.	[Mansour, Noha O.] Mansoura Univ, Fac Pharm, Clin Pharm & Pharm Practice Dept, Mansoura, Egypt; [Shama, Mohamed A.] Tanta Univ, Fac Med, Emergency Med & Traumatol Dept, Tanta, Egypt; [Werida, Rehab H.] Damanhour Univ, Clin Pharm & Pharm Practice Dept, Fac Pharm, Elchorniash St, Elbehairah 31527, Egypt		Werida, RH (corresponding author), Damanhour Univ, Clin Pharm & Pharm Practice Dept, Fac Pharm, Elchorniash St, Elbehairah 31527, Egypt.	rehabwrieda@pharm.dmu.edu.eg	Mansour, Noha O./AAF-6254-2020	Mansour, Noha O./0000-0002-4448-994X; Werida, Rehab/0000-0002-5983-3993			Angelucci F, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1494-4; Balducci C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00738; Balducci C, 2018, NEUROBIOL AGING, V70, P128, DOI 10.1016/j.neurobiolaging.2018.06.002; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Covington NV, 2021, AM J SPEECH-LANG PAT, V30, P974, DOI 10.1044/2020_AJSLP-20-00081; Dik B, 2019, PAK J PHARM SCI, V32, P391; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Elvers KT, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035677; Ergun R, 1998, NEUROL RES, V20, P418; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Haque A, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020033; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Jantzie LL, 2010, J PSYCHIATR NEUROSCI, V35, P20, DOI 10.1503/jpn.090061; Koulaeinejad N, 2019, IRAN J PHARM RES, V18, P1086, DOI 10.22037/ijpr.2019.1100677; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Krakauer T, 2003, ANTIMICROB AGENTS CH, V47, P3630, DOI 10.1128/AAC.47.11.3630-3633.2003; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Mahmoodpoor A, 2018, J CRIT CARE, V45, P128, DOI 10.1016/j.jcrc.2018.01.029; Malek AJ, 2020, J TRAUMA ACUTE CARE, V89, P435, DOI 10.1097/TA.0000000000002801; Meli DN, 2006, INFECT IMMUN, V74, P3890, DOI 10.1128/IAI.01949-05; Mercier Eric, 2016, CMAJ Open, V4, pE371; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Minagar A, 2008, ARCH NEUROL-CHICAGO, V65, P199, DOI 10.1001/archneurol.2007.41; Mokhtari M, 2018, J CLIN PHARMACOL, V58, P42, DOI 10.1002/jcph.980; Naeimi ZS, 2006, BRAIN INJURY, V20, P463, DOI 10.1080/02699050600664418; Nau R, 2010, CLIN MICROBIOL REV, V23, P858, DOI 10.1128/CMR.00007-10; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Obrenovich M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8050784; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rana A, 2020, BRAIN INJURY, V34, P1039, DOI 10.1080/02699052.2020.1772508; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Rigor RR, 2012, AM J PHYSIOL-CELL PH, V302, pC1513, DOI 10.1152/ajpcell.00371.2011; Santa-Cecilia FV, 2019, NEUROTOX RES, V35, P981, DOI 10.1007/s12640-019-00015-z; Skrifvars MB, 2017, J TRAUMA ACUTE CARE, V83, P449, DOI 10.1097/TA.0000000000001594; Smith K, 2005, CLIN THER, V27, P1329, DOI 10.1016/j.clinthera.2005.09.005; Stagg HW, 2013, J TRAUMA ACUTE CARE, V75, P1040, DOI 10.1097/TA.0b013e3182aa9c79; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yu RJ, 2016, NEUROPHARMACOLOGY, V103, P1, DOI 10.1016/j.neuropharm.2015.11.032; Zaheer S, 2013, ANN INDIAN ACAD NEUR, V16, P504, DOI 10.4103/0972-2327.120442; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	46	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2040-6223	2040-6231		THER ADV CHRONIC DIS	Ther. Adv. Chronic Dis.	JUN	2021	12								20406223211024362	10.1177/20406223211024362			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UF2SC	WOS:000688427700001	34262678	Green Published, gold			2022-02-07	
J	Marcynyszyn, LA; McCarty, CA; Rivara, FP; Johnson, AM; Wang, J; Zatzick, DF				Marcynyszyn, Lyscha A.; McCarty, Carolyn A.; Rivara, Frederick P.; Johnson, Ashleigh M.; Wang, Jin; Zatzick, Douglas F.			Parent Traumatic Events and Adolescent Internalizing Symptoms: The Mediating Role of Parental Depression Among Youth with Persistent Post-concussive Symptoms	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						adolescents; anxiety; concussion; depression; mediation; parent psychosocial functioning	ADVERSE CHILDHOOD EXPERIENCES; POSTTRAUMATIC-STRESS-DISORDER; CHILDREN; HEALTH; TRANSMISSION; RISK; PSYCHOPATHOLOGY; PREVENTION; SEVERITY; OUTCOMES	Objective Research has demonstrated associations between parental depression (PD) and negative psychological outcomes among their children. However, little is known about the pathways through which lifetime parent traumatic events (PTEs) influence their adolescents' internalizing symptoms. Our study examined whether PD mediates the association between PTE and adolescent depressive and anxious symptoms among youth with persistent postconcussive symptoms (PPCS). Methods We used baseline data from a randomized effectiveness trial of collaborative care for treatment of persistent postconcussive symptoms among sports-injured adolescents aged 11-18 years. Parent-adolescent dyads were recruited from pediatric clinics throughout western Washington. Eligible adolescents had three or more PPCS that lasted for at least 1 month but <9 months and spoke English. Of 1,870 potentially eligible adolescents, 1,480 (79%) were excluded for not meeting the inclusion criteria. Of the eligible 390 adolescents, 189 (49%) declined to participate/consent. Participants included 200 parent-adolescent dyads (adolescent M-age = 14.7 years, SD = 1.7). Parent respondents were mostly female (83%) and mothers (81%). Adolescents reported on their depressive (Patient Health Questionnaire-9; PHQ-9) and anxious symptoms (Revised Child Anxiety and Depression Scale-Short Version [anxiety subscale]) and parents reported on their depressive symptoms (M = 3.7, SD = 3.7; PHQ-9). Results Mediation analyses revealed two (out of four) significant indirect effects of PTE on both adolescent and parent report of depressive symptoms, but not anxiety. Conclusions This study elucidates one pathway (PD) through which PTE history influences adolescent depressive symptoms, supporting a two-generation approach to pediatric patient care for youth experiencing PPCS.	[Marcynyszyn, Lyscha A.; McCarty, Carolyn A.; Rivara, Frederick P.; Johnson, Ashleigh M.] Univ Washington, Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [McCarty, Carolyn A.; Rivara, Frederick P.; Wang, Jin] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.; Wang, Jin; Zatzick, Douglas F.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Zatzick, Douglas F.] Univ Washington, Psychiat & Behav Sci, Seattle, WA 98195 USA		Marcynyszyn, LA (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Bldg Cure M-S CURE 3,1920 Terry Ave, Seattle, WA 98101 USA.	lyscha.marcynyszyn@seattlechildrens.org	Johnson, Ashleigh/ABG-6095-2021	Johnson, Ashleigh/0000-0001-6638-9352	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD090230-01]	This work was supported by the National Institute of Child Health and Human Development, Grant number 1R01HD090230-01.	Beardslee WR, 2011, J AM ACAD CHILD PSY, V50, P1098, DOI 10.1016/j.jaac.2011.07.020; Bhatta S, 2018, J PEDIATR NURS, V38, P8, DOI 10.1016/j.pedn.2017.10.001; Booker James, 2019, Br J Neurosurg, V33, P367, DOI 10.1080/02688697.2019.1598542; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chandler GE, 2015, J AM PSYCHIAT NURSES, V21, P406, DOI 10.1177/1078390315620609; Cooke JE, 2019, CHILD ABUSE NEGLECT, V93, P27, DOI 10.1016/j.chiabu.2019.04.011; Copley M, 2020, J RACIAL ETHN HEALTH, V7, P571, DOI 10.1007/s40615-019-00686-6; Diamond G, 2016, FAM PROCESS, V55, P595, DOI 10.1111/famp.12241; Ebesutani C, 2012, PSYCHOL ASSESSMENT, V24, P833, DOI 10.1037/a0027283; Felitti VJ, 2019, AM J PREV MED, V56, P774, DOI 10.1016/j.amepre.2019.04.001; Folger AT, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2826; Garber J, 2010, DEV PSYCHOPATHOL, V22, P819, DOI 10.1017/S0954579410000489; Garber J, 2009, JAMA-J AM MED ASSOC, V301, P2215, DOI 10.1001/jama.2009.788; Gladstone T., 2019, HARVARD REV PSYCHIAT, V27, P1, DOI [10.1097/HRP, DOI 10.1097/HRP]; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lambert JE, 2014, J TRAUMA STRESS, V27, P9, DOI 10.1002/jts.21891; Leen-Feldner EW, 2013, CLIN PSYCHOL REV, V33, P1106, DOI 10.1016/j.cpr.2013.09.001; Leen-Feldner EW, 2011, J ANXIETY DISORD, V25, P169, DOI 10.1016/j.janxdis.2010.08.017; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Marsac ML, 2016, JAMA PEDIATR, V170, P70, DOI 10.1001/jamapediatrics.2015.2206; Martin SR, 2020, J PEDIATR PSYCHOL, V45, P359, DOI 10.1093/jpepsy/jsz098; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McCarty CA, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3662-3; McDonald SW, 2019, PREV MED, V118, P286, DOI 10.1016/j.ypmed.2018.11.013; Milan S, 2017, J ABNORM CHILD PSYCH, V45, P171, DOI 10.1007/s10802-016-0156-6; Natl Acad Natl Res Council & Inst Med, 2009, DEPRESSION IN PARENTS, PARENTING, AND CHILDREN: OPPORTUNITIES TO IMPROVE IDENTIFICATION, TREATMENT, AND PREVENTION, P1; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Plant DT, 2018, CLIN CHILD PSYCHOL P, V23, P483, DOI 10.1177/1359104517742186; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; SAS Institute, 2014, VERS 9 4; Schickedanz A, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0023; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; StataCorp, 2019, STATA STAT SOFTWARE; Sweeney S, 2016, J AFFECT DISORDERS, V205, P44, DOI 10.1016/j.jad.2016.05.073; Szilagyi M, 2016, ACAD PEDIATR, V16, P668, DOI 10.1016/j.acap.2016.04.013; van Ee E, 2016, TRAUMA VIOLENCE ABUS, V17, P186, DOI 10.1177/1524838015584355; Vickerstaff V, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0754-4; Weissman MM, 2006, AM J PSYCHIAT, V163, P1001, DOI 10.1176/appi.ajp.163.6.1001; Wiesner M, 2004, J ADOLESCENCE, V27, P485, DOI 10.1016/j.adolescence.2004.03.002; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	48	0	0	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JUN	2021	46	5					547	556		10.1093/jpepsy/jsaa128			10	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	TF9GZ	WOS:000671024200007	33411915	Green Published			2022-02-07	
J	McMillan, TM; Aslam, H; Crowe, E; Seddon, E; Barry, SJE				McMillan, Tom M.; Aslam, Hira; Crowe, Eimear; Seddon, Eleanor; Barry, Sarah J. E.			Associations between significant head injury and persisting disability and violent crime in women in prison in Scotland, UK: a cross-sectional study	LANCET PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; NORMATIVE DATA; HEALTH; RELIABILITY; VALIDATION; TBI	Background The prevalence of head injury is estimated to be as high as 55% in women in prison and might be a risk factor for violent offending, but evidence is equivocal. The extent of persisting disability is unknown, making decisions about service needs difficult. The UN recognises vulnerabilities in women in prison, but does not include head injury. This study aimed to investigate relationships among head injury, comorbidities, disability, and offending in women in prison. Methods In this cross-sectional study, women were recruited between Feb 2, 2018, and Sept 30, 2019, from four prisons across Scotland, UK: Her Majesty's Prison (HMP) Cornton Vale, Her Majesty's Young Offenders Institute Polmont, HMP Edinburgh, and HMP Greenock (detaining approximately 355 individuals at the time of recruitment). Women were included if they were aged older than 16 years, fluent in English, able to participate in face-to-face assessment and provide informed consent, and did not have a severe acute disorder of cognition or communication. Head injury, cognition, disability, mental health, and history of abuse and problematic substance use were assessed by interview. History of head injury was assessed with the Ohio State University Traumatic Brain Injury Identification method and disability was assessed with the Glasgow Outcome at Discharge Scale. Comparisons were made between women with and without a history of significant head injury. Findings We recruited 109 (31%) of the 355 women in these prisons. The sample was demographically representative of the approximately 400 individuals in women's prisons in Scotland. Significant head injury (SHI) was found in 85 (78%) of 109 women, of whom 34 (40%) had associated disability. Repeat head injury was reported in 71 (84%) of the 85 women with SHI and, in most cases, this resulted from domestic abuse that had occurred over many years. Women with a history of SHI were significantly more likely to have a history of violent offences than those without a history of SHI (66 [79%] of 85 women in the SHI group vs 13 [54%] of 24 women in the no-SHI group had committed a violent offence; odds ratio [OR] 3 & middot;1, 95% CI 1 & middot;2-8 & middot;1). This effect remained significant after adjusting for current factors (3 & middot;1, 1 & middot;1-9 & middot;0), including comorbidities associated with post-traumatic stress disorder, and was no longer statistically significant after adjusting for historical factors (3 & middot;3, 1 & middot;0-10 & middot;9), such as abuse as a child or adult. Women with SHI had spent longer in prison than women without SHI after adjustment for current (rate ratio 3 & middot;4, 1 & middot;3-8 & middot;4) or historical (3 & middot;5, 1 & middot;3-9 & middot;2) risk factors. Interpretation It is recognised that women in prison are vulnerable because of histories of abuse and problematic substance use; however, history of SHI needs to be included when developing criminal justice policy, interventions to reduce mental health morbidity, and assessment and management of risk of violent offending. Funding The Scottish Government. Copyright (c) 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.	[McMillan, Tom M.; Aslam, Hira; Crowe, Eimear; Seddon, Eleanor] Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland; [Barry, Sarah J. E.] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland.	thomas.mcmillan@glasgow.ac.uk		Barry, Sarah J.E./0000-0003-3039-8729	Scottish Government	The Scottish Government.	Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; Binswanger IA, 2010, AM J PUBLIC HEALTH, V100, P476, DOI 10.2105/AJPH.2008.149591; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Franke I, 2019, CURR OPIN PSYCHIATR, V32, P342, DOI 10.1097/YCO.0000000000000504; Greco T, 2019, EXP NEUROL, V317, P206, DOI 10.1016/j.expneurol.2019.01.012; Green P., 2003, WORD MEMORY TEST WIN; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hollows S. E., 1985, ADULT MEMORY INFORM; Hughes N, 2020, LANCET CHILD ADOLESC, V4, P151, DOI 10.1016/S2352-4642(19)30347-5; Kiely KM, 2014, ARCH CLIN NEUROPSYCH, V29, P767, DOI 10.1093/arclin/acu055; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; MacDonald M, 2013, INT J LAW PSYCHIAT, V36, P293, DOI 10.1016/j.ijlp.2013.04.014; McGinley A, 2019, BRAIN INJURY, V33, P1581, DOI 10.1080/02699052.2019.1658223; McMillan TM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210427; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; Monahan K, 2018, J NEUROL NEUROMEDICI, V3, P36; National Health Service Scotland, 2016, BRAIN INJ OFF; Nicholls T.L., 2015, APA HDB FORENSIC PSY, P79; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; O'Sullivan M, 2015, AGGRESS VIOLENT BEH, V25, P54, DOI 10.1016/j.avb.2015.07.006; Prison Reform Trust, 2017, DOM AB DRIV WOM OFF; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Scottish Government, INTR SCOTT IND MULT; Scottish Government, 2020, SCOTT PRIS POP STAT; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Stoddard SA, 2011, PEDIATRICS, V127, P1074, DOI 10.1542/peds.2010-2453; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; UN Office on Drugs and Crime, 2014, HDB WOM IMPR; van den Bergh BJ, 2011, B WORLD HEALTH ORGAN, V89, P689, DOI 10.2471/BLT.10.082842; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; World Prison Brief Institute for Criminal Policy Research Birkbeck University of London, 2017, WORLD FEMALE IMPRISO; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	0	0	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2215-0374			LANCET PSYCHIAT	Lancet Psychiatry	JUN	2021	8	6					512	520		10.1016/S2215-0366(21)00082-1			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	SH7AR	WOS:000654287100021	33992149	Green Accepted, hybrid, Green Published			2022-02-07	
J	Menacho, S; Hawryluk, G				Menacho, Sarah; Hawryluk, Gregory			Failure of an effective physiologic threshold compliance tool to demonstrate benefit in a clinical trial of traumatic brain injury patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Threshold; Neuromonitoring; Intracranial pressure; Compliance; Head injury; Traumatic brain injury; Neurocritical care; Technology; Trial; Failure	SPINAL-CORD INJURIES; ACUTE CERVICAL-SPINE; PRESSURE MANAGEMENT; TRANSFUSION; GUIDELINES; BEDSIDE	Background: Better physiologic threshold compliance holds promise for improving outcomes in neurocritical care patients. Methods: Our group developed a threshold compliance tool. This software computes and displays the proportion of values out of range in real time. We captured intracranial pressure (ICP) measures in our patients before and after implementation of this technology. Ten months after the threshold compliance tool was introduced we initiated a randomized controlled trial involving acute traumatic brain injury (TBI) patients to assess whether the tool was effective at reducing out-of-range ICP values. Results: A total of 54 patients with ICP monitors were included in our analysis, 42 of whom sustained a TBI. Implementation of the threshold compliance tool was associated with an 85.3% reduction in ICP values exceeding 22 mmHg in neurocritical care patients (p = 0.004) and a 76.8% reduction in patients with TBI (p = 0.043). Out-of-range values in an area-under-the-curve analysis were reduced by 78.8% in all patients (p = 0.009) and in TBI patients by 77.9% (p = 0.051). Out-of-range values were not further reduced during our randomized controlled trial examining the threshold compliance tool, and a difference between treatment groups was not suggested. Conclusions: Implementation of a threshold compliance tool was associated with a marked and significant reduction in out-of-range ICP values. Benefit was, however, not evident in a randomized controlled trial. Our analysis provides a unique perspective on our failure to detect an apparent true difference and may provide insights into other neurotrauma trial failures. (c) 2021 Elsevier Ltd. All rights reserved.	[Menacho, Sarah] Univ Utah, Dept Neurosurg, Clin Neurosci Ctr, Salt Lake City, UT 84112 USA; [Hawryluk, Gregory] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Hawryluk, Gregory] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Hawryluk, G (corresponding author), Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada.; Hawryluk, G (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	neuropub@hsc.utah.edu; ghawryluk@hsc.mb.ca			Neurosurgery Research and Education Foundation (NREF); University of Utah Hospital	This work was supported by a Neurosurgery Research and Education Foundation (NREF) award to Dr. Sarah Menacho. It was also supported by an Imagine Perfect Care grant from the University of Utah Hospital to Drs. Menacho and Hawryluk.	[Anonymous], 2000, J Neurotrauma, V17, P507; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charry JD, 2019, NEUROL NEUROCHIR POL, V53, P55, DOI 10.5603/PJNNS.a2018.0003; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; De Bonis P, 2013, NEW ENGL J MED, V368, P1749, DOI 10.1056/NEJMc1301076; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Hadley M, 2002, NEUROSURGERY, V50, pS58; Hadley MN, 2002, NEUROSURGERY, V50, pS1; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Hawryluk GWJ, 2020, JAMA NEUROL, V77, P1150, DOI 10.1001/jamaneurol.2020.1310; Hirschi R, 2020, WORLD NEUROSURG, V134, P654, DOI 10.1016/j.wneu.2019.12.040; Hirschi R, 2019, J NEUROSURG, V131, P1216, DOI 10.3171/2018.4.JNS172604; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nourallah B, 2018, ACTA NEUROCHIR, V160, P1315, DOI 10.1007/s00701-018-3555-3; Ratanalert S, 2004, SURG NEUROL, V61, P429, DOI 10.1016/S0090-3019(03)00579-2; Reddy GD, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0379-9; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Smielewski P, 2005, ACT NEUR S, V95, P43; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P493, DOI DOI 10.1089/NEU.2000.17.493; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Volovici V, 2019, J NEUROTRAUM, V36, P3183, DOI 10.1089/neu.2019.6474; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752; Zeiler FA, 2020, BRIT J ANAESTH, V124, P440, DOI 10.1016/j.bja.2019.11.031	36	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2021	88						113	119		10.1016/j.jocn.2021.03.025			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SD5ZM	WOS:000651455000020	33992169				2022-02-07	
J	Mirsky, N; Kim, M; Plotsker, E; Thaller, SR				Mirsky, Nicholas; Kim, Minji; Plotsker, Ethan; Thaller, Seth R.			Craniofacial Injuries From Personal Watercraft Accidents	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial; head injuries; injuries; Jet-Ski; maxillofacial; personal watercraft; trauma; traumatic brain injuries	PATTERNS; TRAUMA; IMPACT	Personal watercraft (PWC) use is a popular leisure activity. Although injuries associated with PWCs have been examined broadly, there is a lack of investigation into craniofacial injuries within this setting. This paper reviews the literature discussing PWC incidents and PWC-related craniofacial injuries. A comprehensive literature search of the MEDLINE, EMBASE, Google Scholar, and National Library of Medicine databases was conducted for studies published through January 2021. Articles were selected if they contained information on PWC accidents and related craniofacial injuries. We also examined 3 patient cases of PWC-related craniofacial injuries. Overall, our review suggests that over the past 20 years, injuries and accidents have decreased significantly whereas fatalities have decreased to a lesser extent. Most PWC-related craniofacial injuries result from blunt trauma and a notable number of deaths and traumatic brain injuries occur in adolescents. Given the increasing number of PWC sales, PWC-related craniofacial injuries may be more prevalent, which prompts improved regulations and protective gears. Existing state laws on PWCs vary dramatically. As of now, there is no uniform policy that requires protective equipment use like helmets or instruction before PWC use. There also should be limitations on alcohol consumption as well as age of the riders. Overall, our review indicates that more research is needed to reduce the number of craniofacial injuries among PWC riders.	[Mirsky, Nicholas; Kim, Minji; Plotsker, Ethan] Univ Miami, Miller Sch Med, 1600 NW 10th Ave 1140, Miami, FL 33136 USA; [Thaller, Seth R.] Univ Miami, Div Plast Aesthet & Reconstruct Surg, Miami, FL USA		Mirsky, N (corresponding author), Univ Miami, Miller Sch Med, 1600 NW 10th Ave 1140, Miami, FL 33136 USA.	nmirsky@med.miami.edu					[Anonymous], 2020, PERSONAL WATERCRAFT; [Anonymous], 2007, STATE BOATING LAWS; BACHULIS BL, 1988, AM J SURG, V155, P708, DOI 10.1016/S0002-9610(88)80151-X; Beierle EA, 2002, AM SURGEON, V68, P535; Branche CM, 1997, JAMA-J AM MED ASSOC, V278, P663, DOI 10.1001/jama.278.8.663; CARR WP, 1981, MINN MED, V64, P521; Donnally CJ, 2018, ORTHOP TRAUMATOL-SUR, V104, P267, DOI 10.1016/j.otsr.2018.01.004; Freeman MD, 2013, J FORENSIC SCI, V58, P237, DOI 10.1111/j.1556-4029.2012.02250.x; Garri JI, 1999, PLAST RECONSTR SURG, V104, P922, DOI 10.1097/00006534-199909040-00005; Gill R., 2012, J TRAUMA TREATMENT, V1, P1; Guard USC, 2019, RECR BOAT STAT; Haan JM, 2002, AM SURGEON, V68, P624; HAMMAN BL, 1993, J PEDIATR SURG, V28, P920, DOI 10.1016/0022-3468(93)90697-J; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; Jones CS, 2000, ACCIDENT ANAL PREV, V32, P373, DOI 10.1016/S0001-4575(99)00091-3; Kim CW, 2003, J ORTHOP TRAUMA, V17, P571, DOI 10.1097/00005131-200309000-00005; Laraque D, 2000, PEDIATRICS, V105, P452, DOI 10.1542/peds.105.2.452; Lin MR, 2003, ANN EMERG MED, V41, P783, DOI 10.1067/mem.2003.186; McKnight AJ, 2007, ACCIDENT ANAL PREV, V39, P398, DOI 10.1016/j.aap.2006.09.004; National Transportation Safety Board, 1998, NTSBSS9801PB98917002; Rubin LE, 2003, J PEDIATR SURG, V38, P1525, DOI 10.1016/S0022-3468(03)00507-4; Shin SH, 2017, AM SURGEON, V83, pE485; Sung KM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1849134; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson DC, 2000, COCHRANE DB SYST REV, V2; VERNBERG D, 1989, JAMA-J AM MED ASSOC, V261, P1883, DOI 10.1001/jama.1989.03420130045021; Webster SK., 2016, COAST GUARD J SAFETY, V73, P59; White MW, 1999, AM SURGEON, V65, P865; Woodyard C, 2020, EVERYONE IS BUYING B	30	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1621	1625		10.1097/SCS.0000000000007774			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100123	34015801				2022-02-07	
J	Moro, N; Ghavim, SS; Sutton, RL				Moro, Nobuhiro; Ghavim, Sima S.; Sutton, Richard L.			Massive efflux of adenosine triphosphate into the extracellular space immediately after experimental traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						adenosine triphosphate; gliotransmitter; microdialysis; rat; traumatic brain injury	INVOLVEMENT	The aim of the current study was to determine effects of mild traumatic brain injury (TBI), with or without blockade of purinergic ATP Y1 (P2Y1) receptors or store-operated calcium channels, on extracellular levels of ATP, glutamate, glucose and lactate. Concentrations of ATP, glutamate, glucose and lactate were measured in cerebral microdialysis samples obtained from the ipsilateral cortex and underlying hippocampus of rats with mild unilateral controlled cortical impact (CCI) or sham injury. Immediately after CCI, a large release of ATP was observed in the cortex (3.53-fold increase of pre-injury value) and hippocampus (2.97-fold increase of pre-injury value), with ATP returning to the baseline levels within 20 min post-injury and remaining stable for during the 3-h sampling period. In agreement with the results of previous studies, there was a significant increase in glutamate 20 min after CCI, which was concomitant with a decrease in extracellular glucose (20 min) and an increase in lactate (40-60 min) in both brain regions after CCI. Addition of a selective P2Y1 receptor blocker (MRS2179 ammonium salt hydrate) to the microdialysis perfusate significantly lowered pre-injury ATP and glutamate levels, and eliminated the post-CCI peaks. Addition of a blocker of store-operated calcium channels [2-aminoethoxy diphenylborinate (2-APB)] to the microdialysis perfusate significantly lowered pre-injury ATP in the hippocampus, and attenuated the post-CCI peak in both the cortex and hippocampus. 2-APB treatment significantly increased baseline glutamate levels, but the values post-injury did not differ from those in the sham group. Pre-injury glucose levels, but not lactate levels, were increased by MRS2179 and decreased by 2-APB. However, none of these treatments substantially altered the CCI-induced reduction in glucose and increase in lactate in the cortex. In conclusion, the results of the present study demonstrated that a short although extensive release of ATP immediately after experimental TBI can be significantly attenuated by blockade of P2Y1 receptors or store-operated calcium channels.	[Moro, Nobuhiro; Ghavim, Sima S.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Moro, Nobuhiro] Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo 1738610, Japan		Moro, N (corresponding author), Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, 30-1 Oyaguchikamicho, Tokyo 1738610, Japan.	moro.nobuhiro@nihon-u.ac.jp			UCLA Brain Injury Research Center	The current study was supported by the UCLA Brain Injury Research Center.	Alberini CM, 2018, GLIA, V66, P1244, DOI 10.1002/glia.23250; Asadollahi M, 2019, BRAIN RES, V1704, P11, DOI 10.1016/j.brainres.2018.09.028; Bazargani N, 2017, NEURON, V94, P228, DOI 10.1016/j.neuron.2017.03.035; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cai CS, 2019, JOVE-J VIS EXP, DOI 10.3791/59286; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; CHARLES AC, 1993, GLIA, V7, P134, DOI 10.1002/glia.440070203; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Pitta M, 2016, NEUROSCIENCE, V323, P43, DOI 10.1016/j.neuroscience.2015.04.001; Diniz CRAF, 2017, BRAIN RES, V1676, P19, DOI 10.1016/j.brainres.2017.09.011; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Fields RD, 2011, SEMIN CELL DEV BIOL, V22, P214, DOI 10.1016/j.semcdb.2011.02.009; Gonzalez-Sanchez P, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00363; Guo H, 2018, MOL MED REP, V17, P1819, DOI 10.3892/mmr.2017.8072; Harada K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00499; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heinke B, 2007, NEUROPHARMACOLOGY, V52, P1015, DOI 10.1016/j.neuropharm.2006.10.020; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Illes P, 2019, TRENDS NEUROSCI, V42, P885, DOI 10.1016/j.tins.2019.09.006; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jones DA, 2000, J NEUROCHEM, V75, P1703, DOI 10.1046/j.1471-4159.2000.0751703.x; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kawamura M, 2004, J NEUROSCI, V24, P10835, DOI 10.1523/JNEUROSCI.3028-04.2004; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Koss DJ, 2009, CELL CALCIUM, V46, P39, DOI 10.1016/j.ceca.2009.04.001; Lalo U, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00242; Lerchundi R, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00080; Li JH, 2013, NEUROCHEM RES, V38, P2216, DOI 10.1007/s11064-013-1130-0; Loiola EC, 2011, NEUROCHEM INT, V58, P414, DOI 10.1016/j.neuint.2010.12.019; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Molnar T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-96; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Muller MS, 2017, J NEUROCHEM, V142, P876, DOI 10.1111/jnc.14119; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Olianas MC, 2014, BBA-MOL CELL RES, V1843, P3004, DOI 10.1016/j.bbamcr.2014.09.012; Papanikolaou M, 2017, BRAIN STRUCT FUNCT, V222, P2993, DOI 10.1007/s00429-017-1380-8; Parri R, 2007, NAT NEUROSCI, V10, P271, DOI 10.1038/nn0307-271; Prebil M, 2011, BIOCHEM BIOPH RES CO, V405, P308, DOI 10.1016/j.bbrc.2011.01.035; Rose CR, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00451; Sakuragi S, 2017, BIOCHEM BIOPH RES CO, V486, P879, DOI 10.1016/j.bbrc.2017.03.096; Schwarz Y, 2017, NAT NEUROSCI, V20, P1529, DOI 10.1038/nn.4647; Shijo K, 2017, NEUROCHEM INT, V102, P66, DOI 10.1016/j.neuint.2016.11.014; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; Svobodova I, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00192; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tanaka M, 2007, NEUROCHEM RES, V32, P988, DOI 10.1007/s11064-006-9259-8; Taylor AN, 2018, J NEUROTRAUM, V35, P630, DOI 10.1089/neu.2017.5238; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wellmann M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00446; Winkler U, 2017, J NEUROSCI RES, V95, P2172, DOI 10.1002/jnr.24020; Xu ZK, 2016, CHEM-BIOL INTERACT, V254, P63, DOI 10.1016/j.cbi.2016.05.025; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2	59	0	0	1	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2021	21	6							575	10.3892/etm.2021.10007			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	RK3NH	WOS:000638205800001	33850547	Green Published, gold			2022-02-07	
J	Mughal, A; Sackheim, AM; Sancho, M; Longden, TA; Russell, S; Lockette, W; Nelson, MT; Freeman, K				Mughal, Amreen; Sackheim, Adrian M.; Sancho, Maria; Longden, Thomas A.; Russell, Sheila; Lockette, Warren; Nelson, Mark T.; Freeman, Kalev			Impaired capillary-to-arteriolar electrical signaling after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral blood flow; capillary endothelial cells; functional hyperemia; inward rectifier K+ channels (Kir2; 1); traumatic brain injury	CEREBRAL-BLOOD-FLOW; CORTICAL IMPACT INJURY; HEAD-INJURY; NITRIC-OXIDE; SPREADING DEPRESSION; RAT-BRAIN; ISOFLURANE; AUTOREGULATION; DYSFUNCTION; ANESTHESIA	Traumatic brain injury (TBI) acutely impairs dynamic regulation of local cerebral blood flow, but long-term (>72 h) effects on functional hyperemia are unknown. Functional hyperemia depends on capillary endothelial cell inward rectifier potassium channels (Kir2.1) responding to potassium (K+) released during neuronal activity to produce a regenerative, hyperpolarizing electrical signal that propagates from capillaries to dilate upstream penetrating arterioles. We hypothesized that TBI causes widespread disruption of electrical signaling from capillaries-to-arterioles through impairment of Kir2.1 channel function. We randomized mice to TBI or control groups and allowed them to recover for 4 to 7 days post-injury. We measured in vivo cerebral hemodynamics and arteriolar responses to local stimulation of capillaries with 10 mM K+ using multiphoton laser scanning microscopy through a cranial window under urethane and alpha-chloralose anesthesia. Capillary angio-architecture was not significantly affected following injury. However, K+-induced hyperemia was significantly impaired. Electrophysiology recordings in freshly isolated capillary endothelial cells revealed diminished Ba2+-sensitive Kir2.1 currents, consistent with a reduction in channel function. In pressurized cerebral arteries isolated from TBI mice, K+ failed to elicit the vasodilation seen in controls. We conclude that disruption of endothelial Kir2.1 channel function impairs capillary-to-arteriole electrical signaling, contributing to altered cerebral hemodynamics after TBI.	[Mughal, Amreen; Sancho, Maria; Nelson, Mark T.; Freeman, Kalev] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Sackheim, Adrian M.; Russell, Sheila; Freeman, Kalev] Univ Vermont, Dept Surg, Given E301,89 Beaumont Ave, Burlington, VT 05405 USA; [Longden, Thomas A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Lockette, Warren] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Nelson, Mark T.] Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England		Freeman, K (corresponding author), Univ Vermont, Dept Surg, Given E301,89 Beaumont Ave, Burlington, VT 05405 USA.	kalev.freeman@uvm.edu	Mughal, Amreen/ABE-9059-2020	Mughal, Amreen/0000-0002-0046-2286; Sancho, Maria/0000-0003-4750-1040	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R35 HL140027] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37 DK053832] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM123010] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110656] Funding Source: Medline		Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abrahamson EE, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113257; Aksenov DP, 2015, J CEREBR BLOOD F MET, V35, P1819, DOI 10.1038/jcbfm.2015.130; Balbi M, 2017, J CEREBR BLOOD F MET, V37, P3625, DOI 10.1177/0271678X16686595; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; Dawes GS, 1941, J PHYSIOL-LONDON, V99, P224, DOI 10.1113/jphysiol.1941.sp003895; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; EKELUND L, 1974, NEURORADIOLOGY, V7, P209, DOI 10.1007/BF00342700; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Fernandez-Klettl F, 2015, J CEREBR BLOOD F MET, V35, P883, DOI 10.1038/jcbfm.2015.60; Gao YR, 2017, NEUROIMAGE, V153, P382, DOI 10.1016/j.neuroimage.2016.11.069; Gargiulo S, 2012, ILAR J, V53, pE55, DOI 10.1093/ilar.53.1.55; Golding EA, 2003, J CEREBR BLOOD F MET, V23, P210, DOI 10.1097/01.WCB.0000044739.64940.B5; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Haber M, 2018, J NEUROTRAUM, V35, P2250, DOI 10.1089/neu.2018.5684; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Harraz OF, 2018, ELIFE, V7, DOI 10.7554/eLife.38689; Harraz OF, 2018, P NATL ACAD SCI USA, V115, pE3569, DOI 10.1073/pnas.1800201115; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; HOLADAY DA, 1975, ANESTHESIOLOGY, V43, P325, DOI 10.1097/00000542-197509000-00009; Huang L, 2017, PEDIATR NEUROL, V67, P59, DOI 10.1016/j.pediatrneurol.2016.10.010; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kehl F, 2002, ANESTHESIOLOGY, V97, P1528, DOI 10.1097/00000542-200212000-00027; LANGFITT TW, 1977, ANN SURG, V186, P411, DOI 10.1097/00000658-197710000-00002; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Leithner C, 2010, J CEREBR BLOOD F MET, V30, P311, DOI 10.1038/jcbfm.2009.211; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Longden TA, 2017, NAT NEUROSCI, V20, P717, DOI 10.1038/nn.4533; Longden TA, 2016, J CEREBR BLOOD F MET, V36, P492, DOI 10.1177/0271678X15616138; Longden TA, 2014, P NATL ACAD SCI USA, V111, P7462, DOI 10.1073/pnas.1401811111; Lyons DG, 2016, ELIFE, V5, DOI 10.7554/eLife.12024; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; MCCARRON JG, 1990, AM J PHYSIOL, V259, pH902, DOI 10.1152/ajpheart.1990.259.3.H902; Montoya-Zegarra JA, 2019, ANGIOGENESIS, V22, P223, DOI 10.1007/s10456-018-9652-3; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; Nakahata K, 2006, ANESTH ANALG, V102, P571, DOI 10.1213/01.ane.0000194303.00844.5e; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Okamoto H, 1997, ANESTHESIOLOGY, V86, P875, DOI 10.1097/00000542-199704000-00018; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Pappas AC, 2015, J NEUROSCI, V35, P13375, DOI 10.1523/JNEUROSCI.1551-15.2015; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pickett BP, 1996, ARCH OTOLARYNGOL, V122, P565; Povlsen GK, 2016, J CEREBR BLOOD F MET, V36, P1195, DOI 10.1177/0271678X16638350; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sackheim AM, 2017, J SURG RES, V213, P100, DOI 10.1016/j.jss.2017.02.016; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Sigurdardottir S, 2020, J INT NEUROPSYCH SOC, V26, P654, DOI 10.1017/S1355617720000193; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sonner JM, 2007, ANESTHESIOLOGY, V106, P107, DOI 10.1097/00000542-200701000-00019; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Vadlamani A, 2020, J HEAD TRAUMA REHAB, V35, pE436, DOI 10.1097/HTR.0000000000000561; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Wei HS, 2016, NEURON, V91, P851, DOI 10.1016/j.neuron.2016.07.016; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	89	0	0	2	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2021	41	6					1313	1327		10.1177/0271678X20962594			15	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	SF2XN	WOS:000652624200012	33050826	Green Published			2022-02-07	
J	Nafiisah; Faniyah, F; Pratama, YM				Nafiisah; Faniyah, Falah; Pratama, Yoga Mulia			Anti-Inflammatory Effect of Centella asiatica (L.) Extract by Decreasing TNF-alpha Serum Levels in Rat Model of Traumatic Brain Injury	MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL			English	Article						Centella asiatica (L.) extract; TNF-alpha; traumatic brain injury		Centella asiatica (L.) has many active ingredients with many important roles, including as antioxidant, anti-inflamation and neuroprotectant. Centella asiatica (L.) can reduce inflammatory reactions by inhibiting the activity of TNF-alpha. Thus, Centella asiatica (L.) is a potential alternative therapy for traumatic brain injury by reducing inflammation via TNF-alpha expression modulation. This study aimed to determine the effect of Centella asiatica (L.) on serum TNF-alpha levels in rat model of traumatic brain injury. This study was conducted during the period of July 3-17, 2020 at the LPPT Unit IV, Gajah Mada University. This was a true experimental with post-test only control group study on 35 male wistar rats as the experimental animals. The rats were divided into 5 groups: P1, P2, and traumatic brain injury groups that received Centella asiatica (L.) treatment at 150, 300, and 600 mg/kgBW/d doses, respectively. Blood samples were collected after the experimental animals were terminated to assess serum TNF-alpha levels. Mean TNF-alpha levels were 60,980 +/- 4,057, 76,931 +/- 0,698, P3=75,889 +/- 0,948, P4=75,868 +/- 1,163, and 74,508 +/- 1,126 for P1, P2, P3, P4, and PS, respectively. The Kruskal Wallis test results showed a statistically different between groups (p=0.005). This study shows that Centella asiatica (L.) can decrease serum TNF-alpha level in rat model of traumatic brain injury.	[Nafiisah] Jenderal Soedirman Univ, Histol Dept, Fac Med, Jalan Dr Gumbreg 1 Mersi, Purwokerto 53112, Central Java, Indonesia; [Faniyah, Falah] Jenderal Soedirman Univ, Fac Med, Dept Pediat, Purwokerto, Central Java, Indonesia; [Pratama, Yoga Mulia] Jenderal Soedirman Univ, Fac Med, Dept Internal Med, Purwokerto, Central Java, Indonesia		Nafiisah (corresponding author), Jenderal Soedirman Univ, Histol Dept, Fac Med, Jalan Dr Gumbreg 1 Mersi, Purwokerto 53112, Central Java, Indonesia.	dr.nafiisah@unsoed.ac.id					Andrzejowski J, 2010, BRIT J ANAESTH, V105, P704; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Chen H, 2017, INT J OPHTHALMOL-CHI, V10, P179, DOI 10.18240/ijo.2017.02.01; Chong NJ, 2011, RES J PHARM BIOL CHE, V2, P445; Faul M, 2010, TRAUMATIC BRAIN INJU; Freire MAM, 2012, W INDIAN MED J, V61, P751; George M, 2009, AFR J TRADIT COMPLEM, V6, P554; Jazmi AF, 2017, INDONESIAN J CANC CH, V6, P105; Kementerian Kesehatan RI Badan Penelitian dan Pengembangan, 2018, HAS UT RIS KES DAS HAS UT RIS KES DAS; Khotimah H, 2009, LAPORAN HIBAH PENELI, P1; Lumbessy M, 2013, JURNAL MIPA, V2, P50; Maleki SJ, 2019, FOOD CHEM, V299, DOI 10.1016/j.foodchem.2019.125124; Prasetyo BH, 2017, JURNAL KEDOKTERAN BR, V29, P287; Rochmah MA, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2649281; Sari LM, 2018, CAKRADONYA DENT J, V10, P65; Sharma S, 2011, J NAT SC BIOL MED, pS117; Wan JY, 2013, PHYTOTHER RES, V27, P1136, DOI 10.1002/ptr.4838	17	0	0	0	0	UNIV PADJADJARAN, FAKULTAS KEDOKTERAN, GEDUNG RUMAH SAKIT PENDIDIKAN	BANDUNG	RUANG MAJALAH KEDOKTERAN BANDUNG LANTAI 3, JL PROF DR EIJKMAN NO 38, BANDUNG, 40161, INDONESIA	0126-074X	2338-6223		MAJ KEDOKT BDG-MKB	Maj. Kedokt. Bdg.-MKB	JUN	2021	53	2					63	66		10.15395/mkb.v53n2.2222			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TP3AH	WOS:000677465800001		gold			2022-02-07	
J	Nahas, JV; Choi, MJ; Wolfe, EM; Pierrot, RG; Slavin, BR; Plotsker, EL; Mathew, PJ; Thaller, SR				Nahas, John V.; Choi, Melinda J.; Wolfe, Erin M.; Pierrot, Randall G.; Slavin, Benjamin R.; Plotsker, Ethan L.; Mathew, Prakash J.; Thaller, Seth R.			Kick Start to an Epidemiological Report of Soccer-Related Craniofacial Trauma Analysis	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial trauma; sideline management; soccer; sports medicine	INJURIES	Introduction: Soccer is a global sport played by millions annually with an increasing popularity in the United States. Game is played by a wide range of participants from all ages and levels of competition. This scenario leads to a potential disparity in the injury profile based on quantifiable demographics. As the game continues to grow, injury detection and side-line assessment must change as well. Methods: Utilizing a national injury database, a retrospective cohort study was conducted using 10 years of data collected from randomly selected emergency departments across the United States. Patient demographics, injury sites, and diagnosis were recorded. Diagnoses examined included concussion, contusion or abrasion, dental injury, fracture, hematoma, hemorrhage, internal injury, and laceration. Results: Highest percentage of craniofacial injuries was observed in soccer players between the ages of 12 and 18. In ages 6 to 11 the most common injuries were contusions and dental injuries, with a significantly low number of fractures. Within the age group of 12 to 18 the highest percentage of injuries was concussions. Finally, the highest percentage of injury in the ages of 19 to 34 were fractures and lacerations. Discussion: There is a shift in injury profile as the age of soccer players increases and the level of play becomes faster-paced. In youth players, there is a higher percentage of soft tissue injury. Older players are more likely to suffer a higher degree of injury including fractures, concussions, and lacerations. This suggests a great utility for a layperson-friendly educational intervention initiative applicable to all demographics for the sport of soccer.	[Nahas, John V.; Choi, Melinda J.; Wolfe, Erin M.; Pierrot, Randall G.; Slavin, Benjamin R.; Plotsker, Ethan L.; Mathew, Prakash J.; Thaller, Seth R.] Univ Miami, Miller Sch Med, Dept Surg, Div Plast Surg, Miami, FL 33136 USA		Thaller, SR (corresponding author), Div Plast Aesthet & Reconstruct Surg, 1120 NW 14th St,4th Floor, Miami, FL 33136 USA.	sthaller@med.miami.edu		Slavin, Benjamin/0000-0002-6755-2358			[Anonymous], 2018, NAT EL INJ SURV SYST; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cusimano MD, 2017, JAMA-J AM MED ASSOC, V317, P2548, DOI 10.1001/jama.2017.6204; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Herrero H, 2014, AM J SPORT MED, V42, P78, DOI 10.1177/0363546513507767; Honsik KA, 2004, PHYSICIAN SPORTSMED, V32, P23, DOI 10.3810/psm.2004.09.550; IBM, 2019, SPSS STAT COMP PROGR; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; MLS Soccer Staff, 2020, MLS EXP NEW TIM REL; Sprau AC, 2021, J CRANIOFAC SURG, V32, P1557, DOI 10.1097/SCS.0000000000007221; Wu BW, 2020, J ORAL MAXIL SURG, V78, P588, DOI 10.1016/j.joms.2019.11.031	11	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1584	1586		10.1097/SCS.0000000000007639			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100112	33741876				2022-02-07	
J	Ou, QF; Wu, PF; Zhou, ZB; Lei, Z; Pan, D; Tang, JY				Ou, Qifeng; Wu, Panfeng; Zhou, Zhengbing; Lei, Zeng; Pan, Ding; Tang, Ju-yu			Algorithm for covering circumferential wound on limbs with ALTP or/and DIEP flaps based on chain-linked design and combined transplantation	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Circumferential wound; Perforator skin flap; Flap design; Upper extremity; Lower extremity; Degloving injury	SOFT-TISSUE RECONSTRUCTION; FREE ANTEROLATERAL THIGH; DEGLOVING INJURIES; PERFORATOR FLAPS; UPPER EXTREMITY; DEFECTS; HEAD; ANGIOGRAPHY; COVERAGE; TIME	Introduction: Coverage of circumferential wounds on limbs is a challenging reconstructive job. Here, we propose a skin flap-based algorithm to reconstruct circumferential wound with the chain-linked design and combined transplantation of ALTP and DIEP flap, which could achieve full-coverage and simultaneously primary donor-site closure.& nbsp; Patient and methods: From December 2007 to December 2018, 14 patients with circumferential would on upper or lower limbs underwent reconstruction with ALTP or DIEP flap, by the technique of combined transplantation or chain-linked design, or both. The wound was classified into five different types according to the width compared to the donor site (overall magnitudes and regularity), which was separately reconstructed by five different wound decomposition and corresponding flap design. Flap survivorship, complication on recipient or donor site and any secondary surgeries have been recorded.& nbsp; Results: 14 patients were successfully treated with 22 flaps, including seven patients reconstructed with one flap (4 bi-pedicled, 2 tri-pedicled), 6 patients reconstructed with two flaps (1 in mono-pedicled, 5 in multi-pedicled), one with 3 flaps and skin grafts. Only one donor site was not directly closed, and one experienced dehiscence but finally healed. All flaps survived uneventfully but three had minor edge necrosis and later treated with skin graft.& nbsp; Conclusion: The algorithm is practical in circumferential wound resurfacing on limbs for allowing flexible design, sufficient coverage, and low donor site morbidity.& nbsp; (c) 2020 Elsevier Ltd. All rights reserved.	[Ou, Qifeng; Wu, Panfeng; Zhou, Zhengbing; Lei, Zeng; Pan, Ding; Tang, Ju-yu] Cent South Univ, Xiangya Hosp, Dept Orthoped Hand & Microsurg, 87 XiangYa Rd, Changsha 410008, Hunan, Peoples R China		Tang, JY (corresponding author), Cent South Univ, Xiangya Hosp, Dept Orthoped Hand & Microsurg, 87 XiangYa Rd, Changsha 410008, Hunan, Peoples R China.	tangjuyu@csu.edu.cn		wu, panfeng/0000-0003-1106-4045	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81472104]	This publication was funded in part by the National Natural Science Foundation of China (81472104) . Thanks to JingJie Peng for polishing the English text of this manuscript.	Abdelfattah U, 2019, PLAST RECONSTR SURG, V144, P1202, DOI 10.1097/PRS.0000000000006167; Cho EH, 2018, PLAST RECONSTR SURG, V141, P191, DOI 10.1097/PRS.0000000000003927; Ciudad P, 2019, MICROSURG, V39, P316, DOI 10.1002/micr.30413; Dibbs R, 2019, SEMIN PLAST SURG, V33, P17, DOI 10.1055/s-0039-1677702; Hakim S, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0093-2; Hendrickson SA, 2017, ARCH PLAST SURG-APS, V44, P564, DOI 10.5999/aps.2017.01368; Hocaoglu E, 2017, CLIN PLAST SURG, V44, P143, DOI 10.1016/j.cps.2016.08.011; Horn D, 2014, J CRANIO MAXILL SURG, V42, P1551, DOI 10.1016/j.jcms.2013.11.017; Janis JE, 2011, PLAST RECONSTR SURG, V127, p205S, DOI 10.1097/PRS.0b013e318201271c; Kovar A, 2020, J RECONSTR MICROSURG, V36, P197, DOI 10.1055/s-0039-1698469; Laungani AT, 2017, J RECONSTR MICROSURG, V33, P49, DOI 10.1055/s-0036-1588017; Lee YJ, 2020, MICROSURG, V40, P440, DOI 10.1002/micr.30549; Lee ZH, 2019, PLAST RECONSTR SURG, V144, P759, DOI 10.1097/PRS.0000000000005955; Lo S, 2013, INJURY, V44, P331, DOI 10.1016/j.injury.2013.01.025; Loja MN, 2017, J TRAUMA ACUTE CARE, V82, P518, DOI 10.1097/TA.0000000000001339; Luo ZH, 2019, ANN PLAS SURG, V82, P64, DOI 10.1097/SAP.0000000000001659; Maccauro G, 2015, BMC MUSCULOSKEL DIS, P16; Mahajan AL, 2016, J PLAST RECONSTR AES, V69, P920, DOI 10.1016/j.bjps.2016.03.015; Marsh DJ, 2010, J PLAST RECONSTR AES, V63, P120, DOI 10.1016/j.bjps.2008.08.022; Maruccia M, 2018, MICROSURG, V38, P26, DOI 10.1002/micr.30141; Ng ZY, 2017, ARCH PLAST SURG-APS, V44, P117, DOI 10.5999/aps.2017.44.2.117; Pau M, 2019, J CRANIO MAXILL SURG, V47, P1617, DOI 10.1016/j.jcms.2019.07.021; Philandrianos C, 2018, J RECONSTR MICROSURG, V34, P121, DOI 10.1055/s-0037-1607323; Prokuski V, 2020, HAND CLIN, V36, P369, DOI 10.1016/j.hcl.2020.03.011; Qing LM, 2019, MICROSURG, V39, P190, DOI 10.1002/micr.30407; Qing LM, 2019, J PLAST RECONSTR AES, V72, P1909, DOI 10.1016/j.bjps.2019.08.004; Radtke C, 2016, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00303; Razek AAKA, 2014, INT J ORAL MAX SURG, V43, P811, DOI 10.1016/j.ijom.2014.03.014; Razek AAKA, 2013, EUR J RADIOL, V82, P1885, DOI 10.1016/j.ejrad.2013.07.007; Sabino JM, 2016, ADV WOUND CARE, V5, P403, DOI 10.1089/wound.2015.0656; Shachar Y, 2016, J PLAST RECONSTR AES, V69, P1676, DOI 10.1016/j.bjps.2016.08.024; Sultan SM, 2020, J RECONSTR MICROSURG, V36, P346, DOI 10.1055/s-0040-1701209; Tang JY, 2013, MICROSURG, V33, P612, DOI 10.1002/micr.22127; Tatar R., 2020, INJURY; Venkatadass K, 2017, INJURY, V48, P2509, DOI 10.1016/j.injury.2017.09.010; Wang CM, 2017, CLIN PLAST SURG, V44, P13, DOI 10.1016/j.cps.2016.09.007; Yoshimatsu H, 2018, MICROSURG, V38, P89, DOI 10.1002/micr.30202; Zeltzer AA, 2012, J PLAST RECONSTR AES, V65, pE42, DOI 10.1016/j.bjps.2011.09.046	38	0	0	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUN	2021	52	6					1356	1362		10.1016/j.injury.2020.10.031			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	SJ0XL	WOS:000655253400019	33051078				2022-02-07	
J	Parker, BM; Menaker, J; Berry, CD; Tesoreiero, RB; O'Connor, JV; Stein, DM; Scalea, TM				Parker, Brandon M.; Menaker, Jay; Berry, Cherisse D.; Tesoreiero, Ronald B.; O'Connor, James V.; Stein, Deborah M.; Scalea, Thomas M.			Single Center Experience With Veno-Venous Extracorporeal Membrane Oxygenation in Patients With Traumatic Brain Injury	AMERICAN SURGEON			English	Article						traumatic brain injury; extracorporeal membrane oxygenation	RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; LIFE-SUPPORT; IMPROVES SURVIVAL; MORTALITY; FAILURE; ARDS; BLUNT; ECMO	Veno-venous extracorporeal membrane oxygenation (VV-ECMO) use in patients following traumatic injury continues to increase. Some consider traumatic brain injury (TBI) as an absolute contraindication for VV-ECMO because of the concern for systemic anticoagulation (A/C) worsening intracranial injury. We evaluated outcomes and complications in patients with TBI treated with VV-ECMO. Methods We retrospectively reviewed TBI patients >= 18 years of age treated with VV-ECMO. The primary outcome was survival to discharge. Secondary outcomes included progression of intracranial hemorrhage, bleeding complications, and episodes of oxygenator thrombosis requiring exchange. Medians and interquartile ranges were reported where appropriate. Results 13 TBI patients received VV-ECMO support during the study period. The median age was 28 years (Interquartile range (IQR) 25-37.5) and 85% were men. Median admission Glasgow coma scale was 5 (IQR 3-13.5). Median injury severity score (ISS) was 48 (IQR 33.5-66). Median pre-ECMO PaO2:FiO2 ratio was 58 (IQR 47-74.5). Five (38.4%) patients survived to discharge. Six patients (46%) received systemic A/C while on ECMO. No patient had worsening of intracranial hemorrhage on computed tomography imaging. There were two bleeding complications in patients on A/C, neither was related to TBI. Four patients required an oxygenator change; 2 in patients on A/C. Conclusion VV-ECMO appears safe with TBI. We have demonstrated that A/C can be withheld without increased complications. Traumatic brain injury should not be considered an absolute contraindication to the use of VV-ECMO for severe respiratory failure and should be decided on a case by case basis. Additional research is needed to confirm these preliminary findings.	[Parker, Brandon M.] Univ Miami, Miller Sch Med, Dept Surg, 1800 NW 10th Ave,T215, Miami, FL 33136 USA; [Menaker, Jay; O'Connor, James V.; Scalea, Thomas M.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD USA; [Berry, Cherisse D.] NYU, Sch Med, Dept Surg, New York, NY USA; [Tesoreiero, Ronald B.; Stein, Deborah M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA		Parker, BM (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, 1800 NW 10th Ave,T215, Miami, FL 33136 USA.	bmp55@med.miami.edu					Ahmad SB, 2017, J TRAUMA ACUTE CARE, V82, P587, DOI 10.1097/TA.0000000000001352; Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Bedeir K, 2017, J TRAUMA ACUTE CARE, V82, P400, DOI 10.1097/TA.0000000000001292; Biderman P, 2013, J TRAUMA ACUTE CARE, V75, P907, DOI 10.1097/TA.0b013e3182a8334f; Biscotti M, 2015, PERFUSION-UK, V30, P407, DOI 10.1177/0267659114554327; Bosarge PL, 2016, J TRAUMA ACUTE CARE, V81, P236, DOI 10.1097/TA.0000000000001068; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Deatrick KB, 2020, PERFUSION-UK, V35, P13, DOI 10.1177/0267659119850024; Firstenberg MS, 2012, CASE REP SURG, V2012, DOI 10.1155/2012/897184; Galvagno SM, 2019, PERFUSION-UK, V34, P523, DOI 10.1177/0267659119826828; Guirand DM, 2014, J TRAUMA ACUTE CARE, V76, P1275, DOI 10.1097/TA.0000000000000213; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Messing JA, 2014, ASAIO J, V60, P597, DOI 10.1097/MAT.0000000000000103; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Munoz-Bendix C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1088-1; Navarrete-Navarro P, 2001, J CRIT CARE, V16, P47, DOI 10.1053/jcrc.2001.25230; Peek GJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-163; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Ried M, 2013, CRIT CARE, V17, DOI 10.1186/cc12782; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; Ventetuolo CE, 2014, AM J RESP CRIT CARE, V190, P497, DOI 10.1164/rccm.201404-0736CI; Zhou R, 2015, PERFUSION-UK, V30, P403, DOI 10.1177/0267659114554326	33	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JUN	2021	87	6					949	953		10.1177/0003134820956360			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UH1YF	WOS:000689734900017	33295187				2022-02-07	
J	Payr, S; Schuller, A; Dangl, T; Scheider, P; Sator, T; Chocholka, B; Jaindl, M; Schwendenwein, E; Tiefenboeck, TM				Payr, Stephan; Schuller, Andrea; Dangl, Theresia; Scheider, Philipp; Sator, Thomas; Chocholka, Britta; Jaindl, Manuela; Schwendenwein, Elisabeth; Tiefenboeck, Thomas M.			Maintaining Medical Resources to Treat Paediatric Injuries during COVID-19 Lockdown Is Essential-An Epidemiological Analysis of a Level 1 Trauma Centre in Central Europe	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						paediatric trauma; fractures; traumatic brain injury; COVID-19; pandemic		Background: This study examined the effect of the COVID-19 pandemic and the resulting decrease in the incidence of various categories of injuries, with the main focus on fractures and mild traumatic brain injuries in a paediatric population. Methods: This retrospective cohort study evaluated all children from 0 to 18 years of age presenting with an injury at the level 1 trauma centre of the University Clinic of Orthopaedics and Trauma Surgery in Vienna during the lockdown from 16 March to 29 May 2020 compared to records over the same timeframe from 2015 to 2019. Results: In total, 14,707 patients with injuries were included. The lockdown did not lead to a significant decrease in fractures but, instead, yielded a highly significant increase in mild traumatic brain injuries when compared to all injuries that occurred (p = 0.082 and p = 0.0001) as well as acute injuries (excluding contusions, distortions and miscellaneous non-acute injuries) (p = 0.309 and p = 0.034). Conclusions: The percentage of paediatric fractures did not decrease at the level 1 trauma centre, and a highly significant proportional increase in paediatric patients with mild traumatic brain injuries was observed during the COVID-19 lockdown. Therefore, medical resources should be maintained to treat paediatric trauma patients and provide neurological monitoring during pandemic lockdowns.	[Payr, Stephan; Schuller, Andrea; Dangl, Theresia; Scheider, Philipp; Sator, Thomas; Chocholka, Britta; Jaindl, Manuela; Schwendenwein, Elisabeth; Tiefenboeck, Thomas M.] Med Univ Vienna, Univ Clin Orthopaed & Trauma Surg, Dept Trauma Surg, A-1090 Vienna, Austria		Tiefenboeck, TM (corresponding author), Med Univ Vienna, Univ Clin Orthopaed & Trauma Surg, Dept Trauma Surg, A-1090 Vienna, Austria.	stephan.payr@meduniwien.ac.at; n1617891@students.meduniwien.ac.at; theresia.dangl@meduniwien.ac.at; philipp.scheider@meduniwien.ac.at; n1447277@students.meduniwien.ac.at; britta.chocholka@meduniwien.ac.at; manuela.jaindl@meduniwien.ac.at; elisabeth.schwendenwein@meduniwien.ac.at; thomas.tiefenboeck@meduniwien.ac.at		Tiefenboeck, Thomas/0000-0002-8698-8341			Baxter Ian, 2020, Bone Jt Open, V1, P424, DOI 10.1302/2633-1462.17.BJO-2020-0086.R1; Bram JT, 2020, J PEDIATR ORTHOPED, V40, P373, DOI 10.1097/BPO.0000000000001600; Buki A, 2015, ADV TECH STAND NEURO, V42, P147, DOI 10.1007/978-3-319-09066-5_8; Del Boca D, 2020, REV ECON HOUSEHOLD, V18, P1001, DOI 10.1007/s11150-020-09502-1; Federal Ministry of Social Affairs H., 982020 BGBL FED MIN; Gilmartin S, 2021, IRISH J MED SCI, DOI 10.1007/s11845-021-02593-4; Greco T, 2019, EXP NEUROL, V317, P206, DOI 10.1016/j.expneurol.2019.01.012; Hernigou J, 2020, INT ORTHOP, V44, P1473, DOI 10.1007/s00264-020-04619-5; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Keays G, 2020, HEALTH PROMOT CHRON, V40, P336, DOI 10.24095/hpcdp.40.11/12.02; Memeo Antonio, 2020, Minerva Pediatr, DOI 10.23736/S0026-4946.20.05910-1; Nabian MH, 2020, INJURY, V51, P2811, DOI 10.1016/j.injury.2020.09.015; Pollak M., CHRONOLOGIE CORONA 1; Pollak M.K.N., CHRONOLOGIE CORONA 2; Raitio A, 2021, SCAND J SURG, V110, P254, DOI 10.1177/1457496920968014; Simma B, 2013, AM J EMERG MED, V31, P1133, DOI 10.1016/j.ajem.2013.04.007; Sugand K, 2020, ACTA ORTHOP, V91, P633, DOI 10.1080/17453674.2020.1807092; Toniolo-Barrios M, 2021, BUS HORIZONS, V64, P189, DOI 10.1016/j.bushor.2020.09.004; Turgut A, 2020, ACTA ORTHOP TRAUMATO, V54, P355, DOI 10.5152/j.aott.2020.20209; Williams N, 2020, ANZ J SURG, V90, P1863, DOI 10.1111/ans.16277; Wong FL, 2020, J CHILD ORTHOP, V14, P245, DOI 10.1302/1863-2548.14.200140	21	0	0	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUN	2021	18	11							5829	10.3390/ijerph18115829			11	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	SP9LP	WOS:000659984600001	34071610	Green Published			2022-02-07	
J	Peng, Y; Kan, SF; Ren, WJ; Li, ZX; Yin, G; Yu, B; Lin, HD				Peng, Ying; Kan, Shi-Feng; Ren, Wei-Jie; Li, Zhuo-Xuan; Yin, Gang; Yu, Bo; Lin, Hao-Dong			Contralateral S1 nerve root transfer for motor function recovery in the lower extremity among patients with central nervous system injury: study protocol for a randomized controlled trial	ANNALS OF PALLIATIVE MEDICINE			English	Article						Nerve transfer; motor function reconstruction; stroke; traumatic brain injury; randomized controlled trial	TRAUMATIC BRAIN-INJURY; STROKE; REORGANIZATION; REHABILITATION; THERAPY; PLEXUS; CORTEX	Background: Central nervous system injury (CNSI) comprises a series of common diseases that severely affect patients' motor function and quality of life and is associated with high disability and mortality rates. Previous studies have shown that contralateral lumbosacral nerve root transfer significantly improved the function of the paralyzed limb in rat models of CNSI. These studies showed that severing the sacral 1 nerve root (S1) did not damage the function of the ipsilateral lower extremity. Thus, we speculate that contralateral S1 nerve root transfer can improve the recovery of a paralyzed limb. Because no associated rigorously designed randomized controlled trial has evaluated the effectiveness of contralateral S1 nerve transfer thus far, we designed this clinical trial to compare the effects of this new treatment approach with those of traditional treatments in paralyzed patients after chronic CNSI. Methods: This is a single-center, prospective, randomized controlled trial. Forty patients, who meet the inclusion criteria and have hemiplegia caused by chronic CNSI, will be randomly divided into the surgical or non-surgical group. The treatment effect in the 2 groups will be assessed before and 3, 6, 9, 12, 18, and 24 months after intervention by using numerous scales and resting-state functional magnetic resonance imaging. The primary outcome will be the Fugl-Meyer score for the lower limbs 24 months after treatment. The secondary outcomes include the modified Ashworth spasm scale, the modified Barthel scale, 10-m walking speed measurement results, three-dimensional gait analysis, muscle strength testing, electromyography, and resting-state functional magnetic resonance imaging findings. Safety outcomes and adverse events will be observed simultaneously. Discussion: We expect that the surgery will improve the sensorimotor functions of the paralyzed limb, and the results of this trial will provide high-quality clinical evidence for a new efficient treatment strategy for disability after CNSI.	[Peng, Ying; Li, Zhuo-Xuan; Yin, Gang; Lin, Hao-Dong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Trauma Ctr, 100 Haining Rd, Shanghai 200080, Peoples R China; [Kan, Shi-Feng; Yu, Bo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Rehabil, 100 Haining Rd, Shanghai 200080, Peoples R China; [Ren, Wei-Jie] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Radiol, Shanghai, Peoples R China		Lin, HD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Trauma Ctr, 100 Haining Rd, Shanghai 200080, Peoples R China.; Yu, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Rehabil, 100 Haining Rd, Shanghai 200080, Peoples R China.	boyujtu@163.com; haodonglin@hotmail.com			Clinical Research Plan of SHDC [SHDC2020CR4024]; Medical Innovation Research Project of Shanghai Science and Technology Commission [20Y11913100]; Research Physician Project of Shanghai Jiao Tong University School of Medicine	This work was supported by the Clinical Research Plan of SHDC (grant number: SHDC2020CR4024), the Medical Innovation Research Project of Shanghai Science and Technology Commission (grant number: 20Y11913100), and the Research Physician Project of Shanghai Jiao Tong University School of Medicine.	Arpin DJ, 2013, RES DEV DISABIL, V34, P1134, DOI 10.1016/j.ridd.2012.12.014; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Gu YD, 1998, J RECONSTR MICROSURG, V14, P57, DOI 10.1055/s-2007-1006902; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Heitsch LE, 2013, CLIN GERIATR MED, V29, P231, DOI 10.1016/j.cger.2012.10.001; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang S, 2010, MICROSURG, V30, P314, DOI 10.1002/micr.20747; Lambert C, 2016, MOL NEUROBIOL, V53, P2297, DOI 10.1007/s12035-015-9138-x; Langerak NG, 2011, J REHABIL MED, V43, P330, DOI 10.2340/16501977-0669; Lee DH, 2013, CHILD NERV SYST, V29, P403, DOI 10.1007/s00381-012-1969-4; Lin HD, 2013, MUSCLE NERVE, V47, P241, DOI 10.1002/mus.23507; Lin HD, 2012, NEUROSURGERY, V70, P170, DOI 10.1227/NEU.0b013e31822c4b39; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Mir O, 2013, EXPERT REV NEUROTHER, V13, P119, DOI [10.1586/ERN.12.164, 10.1586/ern.12.164]; Moschovakis AK, 1998, J NEUROSCI, V18, P10219; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Romero JR, 2006, BEHAV NEUROL, V17, P17, DOI 10.1155/2006/137532; Sauser K, 2014, ANN EMERG MED, V64, P235, DOI 10.1016/j.annemergmed.2014.01.034; Steinle Brad, 2011, Mo Med, V108, P284; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Thieme H, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008449.pub3; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Wang R, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00951; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Zheng MX, 2018, NEW ENGL J MED, V378, P22, DOI 10.1056/NEJMoa1615208; Zong HY, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160412	31	0	0	3	3	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	JUN	2021	10	6					6900	6908		10.21037/apm-21-183			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	TB0PG	WOS:000667644500019	34237987	gold			2022-02-07	
J	Pierrot, RG; Weber, LE; Wolfe, EM; Slavin, BR; Eidelson, SA; Plotsker, E; Mathew, PJ; Thaller, SR				Pierrot, Randall G.; Weber, Lee E.; Wolfe, Erin M.; Slavin, Benjamin R.; Eidelson, Sarah A.; Plotsker, Ethan; Mathew, Prakash J.; Thaller, Seth R.			Skating on Thin Ice: Craniofacial Injuries in Amateur Ice Hockey	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial injuries; facial trauma; hockey	PLAYERS; SPORTS	Introduction: Hockey is a sport of high speeds, projectiles, and slick surfaces. A scenario is ripe for craniofacial injuries. Annually, over 1 million Americans, with many more abroad participate in organized hockey. This number continues to grow at youth, amateur and professional levels. Following the characterization of groups with the highest incidence of hockey-related craniofacial injuries, our goal is to propose guidelines for the acute management of hockey-related craniofacial injuries in amateur settings. Methods: This study follows a 10-year retrospective cohort design, examining hockey-related craniofacial injury data derived from the National Electronic Injury Surveillance System database. Within the NEISS data, patients were stratified by age, gender, and ethnicity to allow for analysis and comparison between groups. Results: Sample data consisted of 2,544 hockey-related craniofacial injuries treated in US emergency departments between 2010 and 2019. Majority of the injuries included in this analysis involved patients within the 12-18-year-old age group (53.8%). Of the diagnoses, concussion was the most frequent hockey-related craniofacial injury (39.9%). Dental injuries represented the least (1%). In the 12 to 18 age group, the diagnoses concussion, fracture, and laceration differed significantly from the null hypothesis of equality of proportions across all injury types (P < 0.05). Similarly, within the 19 to 34 age group, the diagnoses of concussion, fracture, laceration, and internal injury differed significantly from the null hypothesis of assumed equality of proportion (P < 0.05). Conclusions: High incidence of hockey-related craniofacial injury among patients 12 to 18 years of age signals a need for continued interventions targeted towards this age group. Increased sideline personnel training and education, as well as promoting a stricter adherence to established guidelines are integral parts of a greater strategy towards reducing injury incidence. Working towards reducing injuries and making participation in hockey safer, should be a goal as the sport continues to experience a historic rise in interest and participation.	[Pierrot, Randall G.; Weber, Lee E.; Wolfe, Erin M.; Slavin, Benjamin R.; Eidelson, Sarah A.; Plotsker, Ethan; Mathew, Prakash J.; Thaller, Seth R.] Univ Miami, Miller Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Miami, FL 33136 USA		Thaller, SR (corresponding author), Div Plast Aesthet & Reconstruct Surg, 1120 NW 14th St,4th Floor, Miami, FL 33136 USA.	sthaller@med.miami.edu		Slavin, Benjamin/0000-0002-6755-2358			Agel J, 2007, J ATHL TRAINING, V42, P241; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Bernstein R., 2006, CODE UNWRITTEN RULES; Bynum AB, 2003, TELEMED J E-HEALTH, V9, P361, DOI 10.1089/153056203772744680; COLBURN K, 1985, CAN J SOCIOL, V10, P153; Deady B, 1996, J Emerg Med, V14, P645, DOI 10.1016/S0736-4679(96)00134-5; Deady B, 1999, J EMERG MED, V17, P459, DOI 10.1016/S0736-4679(99)00006-2; Donskov AS, 2019, SPORTS, V7, DOI 10.3390/sports7110227; Dube TV, 2007, J SPORT SCI MED, V6, P393; Goldschmied N, 2013, SPORTS HEALTH, V5, P458, DOI 10.1177/1941738113491711; Hawn KL, 2002, J ATHL TRAINING, V37, P204; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; Jang ES, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120951413; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kichloo Asim, 2020, Fam Med Community Health, V8, DOI 10.1136/fmch-2020-000530; Kwon D, 2007, AM J SURG, V193, P417, DOI 10.1016/j.amjsurg.2006.11.009; Light J., 2016, MATH IN INDUST CASE, V7, P7; McCaw S T, 1999, Tex Med, V95, P66; Merkel DL, 2012, INT J SPORTS PHYS TH, V7, P242; Moslener MD, 2010, CURR SPORT MED REP, V9, P134, DOI 10.1249/JSR.0b013e3181dfccd9; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sprau AC, 2021, J CRANIOFAC SURG, V32, P1557, DOI 10.1097/SCS.0000000000007221	24	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1573	1576		10.1097/SCS.0000000000007584			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100109	33710063				2022-02-07	
J	Pistoia, F; Shiel, A; Ornello, R; Saporito, G; Gentili, L; Carolei, A; Marini, C; Sacco, S; Marinangeli, F				Pistoia, Francesca; Shiel, Agnes; Ornello, Raffaele; Saporito, Gennaro; Gentili, Luca; Carolei, Antonio; Marini, Carmine; Sacco, Simona; Marinangeli, Franco			Translation and Transcultural Adaptation of the Wessex Head Injury Matrix, Italian Version: A Preliminary Report	BRAIN SCIENCES			English	Article						coma; vegetative state; minimally conscious states; consciousness	MINIMALLY CONSCIOUS STATES; CLINICAL COMPLEXITY; COMA SCALE; DISORDERS; RECOVERY; COMORBIDITIES; VALIDATION	Background: Patients who are in a coma, a vegetative state or a minimally conscious state present a clinical challenge for neurological assessment, which is a prerequisite for establishing a prognosis and planning management. Several scales have been developed to evaluate these patients. The Wessex Head Injury Matrix is a comprehensive tool but is currently available only in the French and English languages. The aim of this study was to translate and evaluate the reliability of the Italian version of the scale. Methods: The original scale was translated according to a standard protocol: three separate translations were made, and a selected version was back-translated to check for any errors in order to obtain the most accurate Italian translation. A final back translation of the agreed version was made as a further check. The final version was then administered blind to a consecutive series of patients with severe acquired brain injury by two examiners. Inter-rater and test-retest reliability were assessed using a weighted Cohen's kappa (Kw). Concurrent validity of the WHIM was evaluated by rho Spearman's correlation coefficient using the Glasgow Coma Scale (GCS) and the Coma Recovery Scale Revised (CRS-R) as the available gold standard. Results: Twenty-four patients (12 males and 12 females; mean age 59.9 +/- 20.1; mean duration from index event 17.7 +/- 20.0 days) with stroke (n = 15), traumatic brain injury (n = 7) and anoxic encephalopathy (n = 2) were included. Inter-rater [Kw 0.80 (95% CI 0.75-0.84)] and test-retest reliability [Kw 0.77 (95% CI 0.72-0.81)] showed good values. WHIM total scores correlated significantly with total scores on the GCS (rho = 0.776; p < 0.001) and the CRS-R (rho = 0.881; p < 0.001) demonstrating concurrent validity; Conclusion: The Italian version of the scale is now available for clinical practice and research.	[Pistoia, Francesca; Ornello, Raffaele; Saporito, Gennaro; Carolei, Antonio; Sacco, Simona] Univ LAquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Shiel, Agnes] Natl Univ Ireland, Sch Hlth Sci, Galway H91 TK33, Ireland; [Gentili, Luca; Marini, Carmine; Marinangeli, Franco] Univ LAquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy		Pistoia, F (corresponding author), Univ LAquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	francesca.pistoia@univaq.it; agnes.shiel@nuigalway.ie; raffaele.ornello@univaq.it; gennaro.saporito@graduate.univaq.it; luca.gentili@graduate.univaq.it; antonio.carolei@univaq.it; carmine.marini@univaq.it; simona.sacco@univaq.it; franco.marinangeli@univaq.it	Sacco, Simona/I-5253-2012	Sacco, Simona/0000-0003-0651-1939; PISTOIA, Francesca/0000-0003-0790-4240			Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Dhamapurkar SK, 2018, BRAIN INJURY, V32, P1103, DOI 10.1080/02699052.2018.1484165; Di Stefano C, 2012, BRAIN INJURY, V26, P1250, DOI 10.3109/02699052.2012.667588; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Estraneo A, 2021, BRAIN INJURY, V35, P1, DOI 10.1080/02699052.2020.1861652; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Majerus S, 2000, NEUROPSYCHOL REHABIL, V10, P167, DOI 10.1080/096020100389237; Pignat JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156882; Pincherle A, 2019, ANN NEUROL, V85, P443, DOI 10.1002/ana.25417; Pistoia F, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01042; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Pistoia F, 2013, BRAIN INJURY, V27, P1330, DOI 10.3109/02699052.2013.809554; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Sara M, 2010, J NEUROTRAUM, V27, P771, DOI [10.1089/neu.2008.0804, 10.1089/neu.2008-0804]; Scarponi F, 2019, EUR J PHYS REHAB MED, V55, P191, DOI 10.23736/S1973-9087.18.05342-X; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2005, NEUROPSYCHOL REHABIL, V15, P381, DOI 10.1080/09602010443000524; Schnakers C, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120930; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; TEASDALE G, 1974, LANCET, V2, P81; Turner-Stokes L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006051; Wheatley-Smith L, 2013, DISABIL REHABIL, V35, P1006, DOI 10.3109/09638288.2012.720355; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Wilson FC, 2009, NEUROPSYCHOL REHABIL, V19, P754, DOI 10.1080/09602010902805318	28	0	0	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUN	2021	11	6							810	10.3390/brainsci11060810			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SX9NL	WOS:000665523600001	34207277	gold, Green Published			2022-02-07	
J	Plotsker, EL; Mathew, P; Wolfe, EM; Thaller, S				Plotsker, Ethan L.; Mathew, Prakash; Wolfe, Erin M.; Thaller, Seth			Craniofacial Injuries in Lacrosse: A Novel Algorithm for Injury Assessment	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Concussion; craniofacial injury; lacrosse	WOMENS LACROSSE; HEAD	Introduction: Lacrosse is played widely across the United States, as evidenced by growing participation in the sport. The rapid increase in participation suggests that many of the new players are inexperienced. Many coaches might be ill-equipped to deal with player trauma. There are several crucial differences in the way the sports are played between males and females, altering the experience of the game and the injury profiles that may arise. Methods: A query of the National Electronic Injury Surveillance System database was performed to study the types of craniofacial injuries incurred from lacrosse. Results: Concussions were the most common injury type, and players between 10 and 14 years old were found to be at greater risk of contusions relative to older players. Players between 15 and 19 years old were at a greater risk of sustaining lacerations. In terms of gender, females were more likely to experience concussions than males, and were at increased risk of head injuries relative to face injuries. Discussion: The finding that females are at increased risk of concussion might be subsequent to a lack of adequate training by coaches. Female athletes tend to experience worse outcomes following concussions incurred secondary to playing sports. Recent work has suggested that this may be a consequence of female anatomy; women tend to have shorter neck dimensions, which predisposes them to more deleterious head-neck accelerations, and thus concussions. These results may inform a layperson-friendly algorithm for the workup of craniofacial injuries sustained from lacrosse.	[Plotsker, Ethan L.; Mathew, Prakash; Wolfe, Erin M.; Thaller, Seth] Univ Miami Hosp, Div Plast & Reconstruct Surg, Miami, FL USA		Plotsker, EL (corresponding author), Univ Miami Hosp, 1120 NW 14th St,Suite 410, Miami, FL 33136 USA.	eplotsker@med.miami.edu					Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Goldenberg Michael S., 1995, Journal of Athletic Training, V30, P37; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P6, DOI 10.1186/s40621-017-0104-0; Mathew PJ., 2015, J AM COLL SURG, V221; Ristolainen L, 2009, J SPORT SCI MED, V8, P443; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Scheffler P, 2019, INT J PEDIATR OTORHI, V121, P6, DOI 10.1016/j.ijporl.2019.02.036; Schroeder T., 2001, NEISS SAMPLE DESIGN; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Vincent HK, 2015, SPORTS HEALTH, V7, P448, DOI 10.1177/1941738114552990; Warner K, 2018, J ATHL TRAINING, V53, P1049, DOI 10.4085/1062-6050-312-17	13	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1571	1573		10.1097/SCS.0000000000007574			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100108	33654036				2022-02-07	
J	Puolakkainen, T; Murros, OJ; Abio, A; Thoren, H; Virtanen, K; Snall, J				Puolakkainen, Tero; Murros, Olli-Jussi; Abio, Anne; Thoren, Hanna; Virtanen, Kaisa; Snall, Johanna			Associated Injuries Are Common Among Patients With Bicycle-Related Craniofacial Fractures	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							BRAIN-INJURY; HELMETS; EPIDEMIOLOGY	Purpose: Ample evidence exists on the relationship between bicycle injuries and craniofacial fractures. However, as the mechanism behind these injuries is often multifactorial, the presence of associated injuries (AIs) in this study population requires further examination. We hypothesized that patients with craniofacial fracture injured in bicycle accidents are at high risk of sustaining severe AIs, especially those of the head and neck region. Patients and Methods: The investigators performed a retrospective study on all patients with bicyclerelated craniofacial fracture admitted to a tertiary trauma centre during 2013 to 2018. The predictor variable was defined as any type of craniofacial fracture. The outcome variable was defined as any kind of AI. Other study variables included demographic and injury-related parameters. Variables were analyzed using bivariate and Firth's logistic regression analyses. Results: A total of 407 patients were included in the analysis. Our results revealed that AIs were present in 150 (36.9%) patients; there were multiple AIs in 47 cases. Traumatic brain injuries followed by upper limb injuries were the most frequent AIs. Severe head and neck injuries were present in 20.1% of all patients with craniofacial fracture. AIs were observed in 57.4% of patients with combined midfacial fractures (P < .001). Helmet use had a protective effect against traumatic brain injuries (P < .001). Conclusions: Our results suggest that AIs are relatively common in this specific patient population. Close co-operation in multidisciplinary trauma centers allowing comprehensive evaluation and treatment can be recommended for patients with bicycle-related craniofacial fracture. (C) 2021 American Association of Oral and Maxillofacial Surgeons.	[Puolakkainen, Tero; Murros, Olli-Jussi; Snall, Johanna] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Puolakkainen, Tero; Murros, Olli-Jussi; Virtanen, Kaisa; Snall, Johanna] Helsinki Univ Hosp, Helsinki, Finland; [Abio, Anne] Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neurosci, Injury Epidemiol & Prevent Res Grp, Turku, Finland; [Abio, Anne] Univ Turku, Turku, Finland; [Abio, Anne] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany; [Thoren, Hanna] Univ Turku, Inst Dent, Dept Oral & Maxillofacial Surg, Turku, Finland; [Thoren, Hanna] Turku Univ Hosp, Dept Oral & Maxillofacial Dis, Turku, Finland; [Virtanen, Kaisa] Univ Helsinki, Dept Orthoped & Traumatol, Helsinki, Finland		Puolakkainen, T (corresponding author), Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland.	Tlmpuo@utu.fi					Airaksinen N., 2010, ANN ADV AUTOMOTIVE M, V54, P267; Alfrey EJ, 2021, J SURG RES, V257, P593, DOI 10.1016/j.jss.2020.08.009; Baschera D, 2019, WORLD NEUROSURG, V126, pE1023, DOI 10.1016/j.wneu.2019.03.032; Benjamin T, 2019, JAMA OTOLARYNGOL, V145, P140, DOI 10.1001/jamaoto.2018.3351; Boffano P, 2013, OR SURG OR MED OR PA, V116, P275, DOI 10.1016/j.oooo.2013.03.004; Chu MW, 2016, J SURG RES, V206, P386, DOI 10.1016/j.jss.2016.08.019; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; Din-Lovinescu C, 2020, J ORAL MAXIL SURG, V78, DOI 10.1016/j.joms.2019.08.006; Dinh MM, 2015, EMERG MED AUSTRALAS, V27, P323, DOI 10.1111/1742-6723.12407; Farkkila EM, 2019, J ORAL MAXIL SURG, V77, P109, DOI 10.1016/j.joms.2018.07.032; Fergus KB, 2019, TRAFFIC INJ PREV, V20, P550, DOI 10.1080/15389588.2019.1620219; Joseph B, 2017, AM J SURG, V213, P413, DOI 10.1016/j.amjsurg.2016.05.021; Kim YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181362; Kurt M, 2017, ANN BIOMED ENG, V45, P1148, DOI 10.1007/s10439-016-1732-1; LINDQVIST C, 1986, INT J ORAL MAX SURG, V15, P12, DOI 10.1016/S0300-9785(86)80005-9; Mundinger GS, 2013, J ORAL MAXIL SURG, V71, P2092, DOI 10.1016/j.joms.2013.07.005; Page PS, 2020, BRIT J NEUROSURG, V34, P276, DOI 10.1080/02688697.2020.1731425; Puolakkainen T, 2020, INT J ORAL MAX SURG; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Stier R, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.30011; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Toivari M, 2019, J ORAL MAXIL SURG, V77, P565, DOI 10.1016/j.joms.2018.10.020; Toivari M, 2016, J ORAL MAXIL SURG, V74, P1403, DOI 10.1016/j.joms.2016.02.001; Tveita Ingrid Aune, 2017, J Med Case Rep, V11, P148, DOI 10.1186/s13256-017-1316-1; Varjonen EA, 2018, J ORAL MAXIL SURG, V76, DOI 10.1016/j.joms.2018.03.035; White A, 2015, ALCOHOL CLIN EXP RES, V39, P1712, DOI 10.1111/acer.12815; Yamamoto K, 2011, J ORAL MAXIL SURG, V69, pE155, DOI 10.1016/j.joms.2010.12.028	28	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JUN	2021	79	6					1319	1326		10.1016/j.joms.2021.01.011			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	SL1ZA	WOS:000656718200022	33607009				2022-02-07	
J	Rahman, RAA; Hanapiah, FA; Nikmat, AW; Ismail, NA; Manaf, H				Rahman, Rabiatul Adawiah Abdul; Hanapiah, Fazah Akhtar; Nikmat, Azlina Wati; Ismail, Nor Azira; Manaf, Haidzir			Effects of Concurrent Tasks on Gait Performance in Children With Traumatic Brain Injury Versus Children With Typical Development	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Attention; Child; Gait; Traumatic brain injuries	WALKING PERFORMANCE; BALANCE ABILITIES; RECOVERY; MOTOR; ATTENTION	Objective To investigate how gait parameters in children with traumatic brain injury (TBI) versus typically developing (TD) children are influenced by secondary concurrent tasks and examine the correlations between gait parameters and attention and balance in children with TBI. Methods Sixteen children with TBI (mean age, 11.63 +/- 1.89 years) and 22 TD controls (mean age, 11.41 +/- 2.24 years) participated in this case-control study. Attention and functional balance were measured using the Children's Color Trail Test (CCTT) and Pediatric Balance Scale (PBS). All participants first walked without concurrent tasks and then with concurrent motor and cognitive tasks. The APDM Mobility Lab was used to measure gait parameters, including gait velocity, stride length, stride duration, cadence, and double support time. Repeated-measures analysis of variance and Spearman correlation coefficient were used for the analysis. Results Children with TBI showed significantly more deterioration in gait performance than TD children (p<0.05). Concurrent tasks (motor and cognitive) significantly decreased gait velocity and cadence and increased stride time; the differences were more obvious during the concurrent cognitive task. A moderate correlation was found between gait parameters (gait velocity and stride length) and CCTT-2 and PBS scores in children with TBI. Conclusion Gait performance may be affected by task complexity following TBI. Attention and balance deficits caused deterioration in gait performance under the concurrent task condition in children with TBI. This study illustrates the crucial role of task demand and complexity in dual-task interference.	[Rahman, Rabiatul Adawiah Abdul] Univ Teknol MARA, Physiotherapy Programme, Fac Hlth Sci, Bertam Campus, George Town, Malaysia; [Hanapiah, Fazah Akhtar] Univ Teknol MARA, Dept Rehabil Med, Fac Med, Sungai Buloh Campus, Shah Alam, Selangor, Malaysia; [Hanapiah, Fazah Akhtar; Ismail, Nor Azira] Daehan Rehabil Hosp Putrajaya, Putrajaya, Malaysia; [Nikmat, Azlina Wati] Univ Teknol MARA, Dept Psychiat, Fac Med, Sungai Buloh Campus, Shah Alam, Selangor, Malaysia; [Manaf, Haidzir] Univ Teknol MARA, Clin & Rehabil Exercise Res Grp, Fac Hlth Sci, Puncak Alam Campus, Puncak Alam 42300, Selangor, Malaysia		Manaf, H (corresponding author), Univ Teknol MARA, Clin & Rehabil Exercise Res Grp, Fac Hlth Sci, Puncak Alam Campus, Puncak Alam 42300, Selangor, Malaysia.	haidzir5894@uitm.edu.my	Hanapiah, Fazah/AAW-8811-2021; Manaf, Haidzir/O-1463-2013	Manaf, Haidzir/0000-0003-0342-8136; ISMAIL, NOR AZIRA/0000-0002-5017-0759	Ministry of Higher Education MalaysiaMinistry of Education, Malaysia [600-RMI/NRGS 5/3 [11/2013]]	This work was funded by the Ministry of Higher Education Malaysia through the Niche Research Grant Scheme (No. 600-RMI/NRGS 5/3 [11/2013]).	Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Beretta E, 2009, BRAIN INJURY, V23, P751, DOI 10.1080/02699050903133988; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Cherng RJ, 2007, GAIT POSTURE, V26, P231, DOI 10.1016/j.gaitpost.2006.09.004; Cherng RJ, 2009, GAIT POSTURE, V29, P204, DOI 10.1016/j.gaitpost.2008.08.003; Franjoine Mary Rose, 2003, Pediatr Phys Ther, V15, P114, DOI 10.1097/01.PEP.0000068117.48023.18; Gianarris WJ, 2001, CLIN PSYCHOL REV, V21, P1061, DOI 10.1016/S0272-7358(00)00085-4; Hagmann-von Arx P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00352; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Huang Hsiang-Ju, 2003, Pediatr Phys Ther, V15, P105, DOI 10.1097/01.PEP.0000067886.96352.6B; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2011, NEUROREHABILITATION, V29, P45, DOI 10.3233/NRE-2011-0676; Katz-Leurer M, 2011, BRAIN INJURY, V25, P581, DOI 10.3109/02699052.2011.572943; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Katz-Leurer M, 2009, GAIT POSTURE, V29, P154, DOI 10.1016/j.gaitpost.2008.06.013; Kohler MJ, 2020, COGN BEHAV NEUROL, V33, P233, DOI 10.1097/WNN.0000000000000236; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Llorente AM, 2000, CLIN NEUROPSYCHOL, V14, P162, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT162; Llorente AM, 2009, CLIN NEUROPSYCHOL, V23, P645, DOI 10.1080/13854040802427795; Manaf H, 2015, PM&R, V7, P1159, DOI 10.1016/j.pmrj.2015.05.007; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Poreh A., 2012, ARCH ASSESSMENT PSYC, V2, P57; Rahman RAA, 2018, REHABIL RES PRACT, V2018, DOI 10.1155/2018/2071726; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	35	0	0	1	2	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	JUN	2021	45	3					186	196		10.5535/arm.21004			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	TE0VV	WOS:000669736700004	34126668	gold, Green Published			2022-02-07	
J	Raj, SP; Schmidt, MM; Moscato, EL; Guzman-Gomez, A; Rodriguez, B; Seid, CS; Wade, SL				Raj, Stacey P.; Schmidt, Matthew M.; Moscato, Emily L.; Guzman-Gomez, Amalia; Rodriguez, Beatriz; Seid, Claire S.; Wade, Shari L.			Road-to-Recovery-TBI: Pilot Trial of an eHealth Intervention for Caregivers After Pediatric Brain Injury	CLINICAL PRACTICE IN PEDIATRIC PSYCHOLOGY			English	Article						caregiver targeted interventions; pediatric traumatic brain injury; eHealth	MENTAL-HEALTH; BEHAVIOR PROBLEMS; FAMILY BURDEN; CHILDREN; PARENT; OUTCOMES; METAANALYSIS; ADOLESCENTS; EXPERIENCES; INSULT	Objective: Traumatic brain injury (TBI) is a leading cause of acquired disability in childhood, impacting long-term health and functioning. Caregivers of children with TBI report worsening psychological health-and caregiver functioning and behaviors directly impact child recovery and outcomes. We developed and pilot tested road-to-recovery-TBI (R2R-TBI), a self-guided, eHealth intervention to support caregivers during the acute phase following pediatric TBI and equip families with skills to promote a positive path to recovery. Method: Caregivers of children hospitalized for moderate-to-severe TBI were recruited within 3 months postinjury. Twenty primary caregivers completed measures assessing caregiver psychological functioning, family functioning, and child behavior prior to accessing the intervention and at follow-up 1 month later. Caregivers also completed postintervention satisfaction and usability surveys. Results: Thirty of 42 eligible caregivers consented to participate. Caregivers were diverse with regard to race/ethnicity (45% non-White), income (65% receiving public assistance), and child age (1 month to 15 years). All caregivers rated the intervention as helpful and 90% reported making positive changes. While average scores were in the nonclinical range at baseline and follow-up, percentages of caregivers reporting clinically elevated challenges across all measures (15% to 50%) were higher than instrument norms. There were no significant changes in caregiver, family, or child outcomes from baseline to follow-up. Conclusions: Given challenges that caregivers experience accessing in-office interventions that target their well-being and/or parenting, the R2R-TBI program may be a cost-effective and accessible approach to supporting families during a challenging phase of recovery. Further research is needed to examine the efficacy of the intervention.	[Raj, Stacey P.; Guzman-Gomez, Amalia; Rodriguez, Beatriz] Xavier Univ, Sch Psychol, Cincinnati, OH 45207 USA; [Raj, Stacey P.; Moscato, Emily L.; Seid, Claire S.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Rehabil Med, Cincinnati, OH 45229 USA; [Schmidt, Matthew M.] Univ Florida, Coll Educ, Gainesville, FL 32611 USA; [Moscato, Emily L.; Wade, Shari L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Wade, Shari L.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Rehabil Med, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org		Guzman-Gomez, Amalia/0000-0003-3419-6462; Raj, Stacey/0000-0002-3500-4402; Schmidt, Matthew/0000-0002-8110-4367	Ohio Emergency Medical Services	This pilot trial was funded by a grant from the Ohio Emergency Medical Services.	Abidin R, 1995, PERCEIVED STRESS IND, V3rd; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; American Psychological Association, CONSTR ID STRESSF AS; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Boothroyd RA, 1997, PRELIMINARY MANUAL C; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1002/HBM.20701; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Canter KS, 2019, J CLIN PSYCHOL MED S, V26, P68, DOI 10.1007/s10880-018-9565-8; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cohen-Zimerman S, 2019, NEUROPSYCHOLOGIA, V124, P1, DOI 10.1016/j.neuropsychologia.2019.01.001; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Derogatis L. R, 2001, BRIEF SYMPTOMS INVEN; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fitzpatrick M., 2019, CHILD CARE PRACTICE, V25, P129, DOI [10.1080/13575279.2018.1446906, DOI 10.1080/13575279.2018.1446906]; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gordon WA, 2017, J HEAD TRAUMA REHAB, V32, P393, DOI 10.1097/HTR.0000000000000274; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kurowski BG, 2018, CONT CLIN TRIAL COMM, V10, P111, DOI 10.1016/j.conctc.2018.04.001; Law EF, 2014, J PEDIATR PSYCHOL, V39, P866, DOI 10.1093/jpepsy/jsu032; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Linardon J, 2019, WORLD PSYCHIATRY, V18, P325, DOI 10.1002/wps.20673; Luxton DD, 2011, PROF PSYCHOL-RES PR, V42, P505, DOI 10.1037/a0024485; Mandolesi L, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7219461; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McIntyre A., 2007, PARTICIPATORY ACTION; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Mullins LL, 2015, FAM RELAT, V64, P176, DOI 10.1111/fare.12104; Narad ME, 2019, J DEV BEHAV PEDIATR, V40, P451, DOI 10.1097/DBP.0000000000000681; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Pew Research Center, 2019, MOB TECHN HOM BROADB; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2018, J HEAD TRAUMA REHAB, V33, pE19, DOI 10.1097/HTR.0000000000000388; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Sahler OJZ, 2013, J CLIN ONCOL, V31, P1329, DOI 10.1200/JCO.2011.39.1870; Santiago CD, 2013, J CLIN PSYCHOL, V69, P115, DOI 10.1002/jclp.21951; Schmidt M, 2020, J FORMATIVE DES LEAR, V4, P88, DOI 10.1007/s41686-020-00049-z; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tyerman E, 2017, BRAIN INJURY, V31, P1553, DOI 10.1080/02699052.2017.1341999; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Woods D., 2014, SOCIAL CARE NEURODIS, V5, P51, DOI [10.1108/SCN-01-2013-0002, DOI 10.1108/SCN-01-2013-0002]; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	55	0	0	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	2169-4826	2169-4834		CLIN PRACT PEDIAT PS	Clin. Pract. Pediatr. Psychol.	JUN	2021	9	2					167	179		10.1037/cpp0000398			13	Psychology, Clinical; Psychology, Developmental	Emerging Sources Citation Index (ESCI)	Psychology	UB1TV	WOS:000685634500007					2022-02-07	
J	Ridley, EJ; Davies, AR; Bernard, S; McArthur, C; Murray, L; Paul, E; Trapani, A; Cooper, DJ				Ridley, Emma J.; Davies, Andrew R.; Bernard, Stephen; McArthur, Colin; Murray, Lynne; Paul, Eldho; Trapani, Antony; Cooper, D. James		ANZICS Clinical Trials Grp	Measured energy expenditure in mildly hypothermic critically ill patients with traumatic brain injury: A sub-study of a randomized controlled trial	CLINICAL NUTRITION			English	Article						Critical illness; Enteral nutrition; Prophylactic hypothermia; Energy expenditure; Metabolism; Traumatic brain injury	CRITICAL-CARE MEDICINE; ENTERAL NUTRITION; GUIDELINES; MANAGEMENT; TEMPERATURE; MODERATE; VOLUME	Background & aims: Prophylactic hypothermia, often used in critically ill patients with traumatic brain injury, reduces energy expenditure and may affect energy delivered by nutrition therapy. The primary objective of this study was to measure energy expenditure in hypothermic patients over the first 3 days after traumatic brain injury (TBI). Secondary objectives included comparison of measured energy expenditure and nutrition delivery to day 7. Methods: A prospective sub-study of a randomized controlled trial conducted in patients with severe TBI, investigating prophylactic hypothermia (33-35 degrees C) as a neuroprotective therapy. In two centers, indirect calorimetry was initiated within 24 h of randomization and repeated up to twice daily to day 7. Data are presented as n (%), mean (standard deviation (SD)), median [interquartile range (IQR)], and mean difference (95% confidence interval (CI)). Results: Forty patients were included (20 in each group), with 17 patients in the hypothermic and 16 in the normothermic group having an indirect calorimetry measurement in the first 3 days. Over the first 3 days, the mean temperature in the hypothermic and normothermic groups was 33.5 (0.6) degrees C (n = 17) and 37 (0.5) degrees C (n = 16), p < 0.0001, and the mean measured energy expenditure, was 21 (5) and 27 (4) kcal/ kg, p 1/4 0.002, representing a mean difference of 5 (95% CI: 2-8) kcal/kg. Energy expenditure was 20% (95% CI: 9.5-29%) less in hypothermia patients compared to normothermia patients. Hypothermia patients also had higher gastric residual volumes across the 7 day study period (438 (237) mls vs 184 (103) mls, p < 0.0001) and higher use of metoclopramide and erythromycin as prokinetics. Despite enteral nutrition intolerance, hypothermia patients received 93% of measured energy expenditure over 7 days. Conclusion: In TBI patients, energy expenditure was 20% less when receiving prophylactic hypothermia compared to normothermia. Greater gastric residual volumes, use of prokinetics and energy delivery that approximated measured energy expenditure was also observed in hypothermia patients. Trial registry number: POLAR-RCT: clinicaltrials.gov Identifier: NCT00987688; Anzctr.org.au Identifier: ACTRN12609000764235. This sub-study was not registered separately. (c) 2021 Published by Elsevier Ltd.	[Ridley, Emma J.; Davies, Andrew R.; Murray, Lynne; Paul, Eldho; Trapani, Antony; Cooper, D. James] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Preventat Med, St Kilda Rd, Melbourne, Vic 3004, Australia; [Ridley, Emma J.] Alfred Hosp, Nutr Dept, Commercial Rd, Melbourne, Vic 3004, Australia; [Bernard, Stephen; Cooper, D. James] Alfred Hosp, Intens Care Unit, Commercial Rd, Melbourne, Vic 3004, Australia; [McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Pk Rd, Auckland, New Zealand		Ridley, EJ (corresponding author), Level 3,553 St Kilda Rd, Melbourne, Vic 3031, Australia.	emma.ridley@monash.edu	Ridley, Emma J./H-2864-2019	Ridley, Emma J./0000-0002-7922-5717; Trapani, Tony/0000-0001-7771-3760	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [545,901, 1,121,037]; Victorian Neurotrauma Initiative [VNI D162]; Alfred Foundation; Australasian Society of Parenteral and Enteral Nutrition	In Australia and New Zealand the POLAR-RCT was supported by the grants from the National Health and Medical Research Council of Australia (545,901 and 1,121,037); the Victorian Neurotrauma Initiative (VNI for the Transport Accident Commission, Victoria, Australia) (VNI D162). This sub-study gratefully received funding from The Alfred Foundation and the Australasian Society of Parenteral and Enteral Nutrition.	Arrich J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub4; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Bardutzky J, 2004, INTENS CARE MED, V30, P151, DOI 10.1007/s00134-003-1988-4; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brain Trauma F American Association of Neurological S Congress of Neurological S, 2007, J NEUROTRAUM, V24, pS1, DOI DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Holzinger U, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0856-2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McClave SA, 2003, JPEN-PARENTER ENTER, V27, P16, DOI 10.1177/014860710302700116; Montejo JC, 2010, INTENS CARE MED, V36, P1386, DOI 10.1007/s00134-010-1856-y; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Rehal MS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1232-6; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Ridley EJ, 2018, JPEN-PARENTER ENTER, V42, P1349, DOI 10.1002/jpen.1163; Saur J, 2008, IN VIVO, V22, P143; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013	22	0	0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	JUN	2021	40	6					3875	3882		10.1016/j.clnu.2021.05.012			8	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	TC6OE	WOS:000668759900027	34130035				2022-02-07	
J	Sandev, R; Shukla, Y; Rao, A				Sandev, Ravinder; Shukla, Yashasvi; Rao, Akhilesh			Audit of Computed Tomography (Brain) Referrals from the Accident and Emergency Department in a Tertiary Care Hospital	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Clinical audit; Glasgow coma scale; Head Injury; Noncontrast computed tomography; National institute for health and care excellence guidelines	HEAD-INJURY; CT	Introduction: Non-contrast Computerised Tomography (NCCT) Brain is a common referral made from the Accident and Emergency (A&E) department both for traumatic and non traumatic causes. Aim: To evaluate the veracity of the referrals made by the Accident and Emergency Department clinicians for non-contrast computed tomography Head. Materials and Methods: This was the Retrospective evaluation of diagnostic yield of head Computed Tomography (CT) referrals made from A&E Department of a tertiary care hospital located in northern-central India over three year period between January 2015 to December 2017. CT reports were first grouped into two major group's trauma and non trauma referrals with further subdivision into positive and negative scan on the basis of presence of abnormality. Subsequently, the positive trauma reports were classified into Major findings (three subgroups extra-axial haemorrhage, brain contusions and other miscellaneous findings) and minor findings like undisplaced fractures of the skull or facial bones with or without subgaleal haematoma. Distribution of trauma cases as per National Institute for Health and Care Excellence (NICE) criteria was then tabulated. Non-trauma reports were also further classified in to the two major clinically important findings of haemorrhage and infarct as well as non-specific minor findings. Results: Of the total data of 2185 head CT (980 trauma cases and 1205 in non trauma cases) referrals done by A&E Department during the study period. The 144 (58.5%) out of trauma cases and 328 (27.2%) out of non trauma cases were with major findings. 788 (80.4%) of trauma cases and 965 (80.1%) out of non trauma cases were referred by Medical Officer (MO)/ Resident as revealed from the audit. Positivity percentages for traumatic and non traumatic causes were 25.1% and 27.2%, respectively. Conclusion: Due to non adherence to existing guidelines or due to poor clinical knowledge, there is poor diagnostic yield of CT referrals made from A&E department. Thus clinical Audit is essential at Department of Radiodiagnosis to streamline the referring protocols and improves the overall efficiency of the healthcare system.	[Sandev, Ravinder] MH Secund Erabad, Dept Radiodiag, Hyderabad, Telangana, India; [Shukla, Yashasvi] TSM Med Coll, Dept Radiodiag, Lucknow, Uttar Pradesh, India; [Rao, Akhilesh] CHAF, Dept Radiodiag, Bangalore, Karnataka, India		Shukla, Y (corresponding author), 901 D1 Akash Enclave, Lucknow, Uttar Pradesh, India.	shukla_yashasvi@yahoo.in					Baloescu C, 2018, ANN EMERG MED, V72, P637, DOI 10.1016/j.annemergmed.2018.06.034; Hentel KD, 2011, EMERGEN MED, V43, P06; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Ismail MS, 2008, J EMERG MED TRAUMA A, V8, P151; Kelly AM, 2000, EMERG MED AUSTRALASI, V12, P50, DOI 10.1046/j.1442-2026.2000.00083.x23; Lee CI, 2012, AM J ROENTGENOL, V199, P1054, DOI 10.2214/AJR.11.8303; Lolli V, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150849; Maharjan S, 2017, ASIAN J MED SCI, V8, P76, DOI [10.3126/ajms.v8i2.16205, DOI 10.3126/AJMS.V8I2.16205]; Mohsin SN., 2018, J TRAUMA CRIT CARE, V2, P03; National Institute for Clinical Excellence Triage, 2014, ASS INV EARL MAN HEA; Nawaz Muhammad, 2009, J Ayub Med Coll Abbottabad, V21, P91; Prevedello LM, 2012, AM J MED, V125, P356, DOI 10.1016/j.amjmed.2011.06.023; Puri S, 2012, AM J ROENTGENOL, V199, P1328, DOI 10.2214/AJR.12.8581; Remedios D, 2014, INSIGHTS IMAGING, V5, P9, DOI 10.1007/s13244-013-0299-8; Sinclair Douglas E., 1993, Journal of Emergency Medicine, V11, P643, DOI 10.1016/0736-4679(93)90325-2; Swartzberg K, 2018, SAMJ S AFR MED J, V108, P230, DOI [10.7196/SAMJ.2018.v108i3.12635, 10.7196/samj.2018.v108i3.12635]; Waganekar A, 2018, J EMERG TRAUMA SHOCK, V11, P25, DOI 10.4103/JETS.JETS_112_17	17	0	0	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	JUN	2021	15	6								10.7860/JCDR/2021/46166.14970			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SV1GB	WOS:000663572600004		gold			2022-02-07	
J	Scheiman, M; Grady, MF; Jenewein, E; Shoge, R; Podolak, OE; Howell, DH; Master, CL				Scheiman, Mitchell; Grady, Matthew F.; Jenewein, Erin; Shoge, Ruth; Podolak, Olivia E.; Howell, David H.; Master, Christina L.			Frequency of oculomotor disorders in adolescents 11 to 17 years of age with concussion, 4 to 12 weeks post injury	VISION RESEARCH			English	Article						Concussion; Concussion-related vision disorders; Convergence insufficiency; Accommodative insufficiency; Saccadic dysfunction	SYMPTOMATIC CONVERGENCE INSUFFICIENCY; RANDOMIZED CLINICAL-TRIAL; FOOTBALL PLAYERS; VISUAL FUNCTION; VISION THERAPY; HIGH-SCHOOL; RECOVERY; CHILDREN; DYSFUNCTIONS; RELIABILITY	The purpose of the study was to determine the frequency of vision diagnoses after concussion in adolescents and evaluate the sensitivity and specificity of physician-administered screening for detecting convergence and accommodative disorders post-concussion. We enrolled participants 11 to 17 years old, assessed 4 to 12 weeks following a diagnosed concussion. During the initial concussion examination, a sports medicine physician measured the near point of convergence (NPC), monocular accommodative amplitude (AA), and symptoms using the Convergence Insufficiency Symptom Survey (CISS). A comprehensive oculomotor evaluation was performed by an optometrist. One hundred and thirteen adolescents were enrolled, with a mean age of 15.2 years. Seventy-nine of the 113 (70%) participants had at least one oculomotor diagnosis after concussion, with the most common problems being vergence disorders (60%) and accommodative disorders (57%). The most common vergence disorder was convergence insufficiency (35%). Among accommodative disorders, the most common problem was accommodative insufficiency (35%). In all, 47% of the participants had more than one oculomotor diagnosis following concussion. The sensitivity of physician screening using measures of NPC, AA, and CISS for detecting convergence and accommodative insufficiency was 63%, 43%, 48%, respectively. The results of this study provide additional evidence that vision problems are common in adolescents with persistent concussion symptoms in the sub-acute phase 4 to 12 weeks post-concussion, and current physician screening methods using the NPC, AA, or the CISS underperform. Thus, it is prudent that adolescents with post-concussion symptoms lasting more than 4 weeks post injury receive a comprehensive oculomotor examination.	[Scheiman, Mitchell; Jenewein, Erin; Shoge, Ruth] Salus Univ, Penn Coll Optometry, Elkins Pk, PA USA; [Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Div Orthoped, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Div Gen Pediat, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Grady, Matthew F.; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grady, Matthew F.; Podolak, Olivia E.; Master, Christina L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Howell, David H.] Univ Colorado, Sch Med, Dept Orthoped Aurora, Childrens Hosp Colorado,Sports Med Ctr, Aurora, CO USA		Scheiman, M (corresponding author), Salus Univ, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	mscheiman@salus.edu		Scheiman, Mitchell/0000-0002-9274-5696			Aletaha M, 2018, J OPHTHAL VIS RES, V13, P307, DOI 10.4103/jovr.jovr_99_17; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; CITT-ART Investigator Grp, 2019, OPTOMETRY VISION SCI, V96, P825, DOI 10.1097/OPX.0000000000001443; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Clark TY, 2017, J AAPOS, V21, P452, DOI 10.1016/j.jaapos.2017.06.019; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin D. J., 2020, AM J EMERGENCY MED, V38; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Davis AL, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6963976; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Horan Lindsay A, 2015, Am Orthopt J, V65, P99, DOI 10.3368/aoj.65.1.99; Horwood AM, 2014, BRIT J OPHTHALMOL, V98, P679, DOI 10.1136/bjophthalmol-2013-304533; Howell DR, 2018, J CHILD NEUROL, V33, P794, DOI 10.1177/0883073818789320; Hussaindeen JR, 2017, CLIN EXP OPTOM, V100, P642, DOI 10.1111/cxo.12496; Hussein M., 1997, J OPTOM VIS DEV, V28, P91; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Master CL, 2018, ANN INTERN MED, V169, pITC1, DOI 10.7326/AITC201807030; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Momeni-Moghaddam H, 2015, MIDDLE EAST AFR J OP, V22, P97, DOI 10.4103/0974-9233.148357; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Rouse M. W., 1997, Investigative Ophthalmology and Visual Science, V38, pS975; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Rouse MW, 1998, OPTOMETRY VISION SCI, V75, P88, DOI 10.1097/00006324-199802000-00012; Scheiman M, 2005, BRIT J OPHTHALMOL, V89, P1318, DOI 10.1136/bjo.2005.068197; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Scheiman M., 2019, CLIN MANAGEMENT BINO, V5th; Scheiman M, 2008, ARCH OPHTHALMOL-CHIC, V126, P1336, DOI 10.1001/archopht.126.10.1336; Scheiman MM, 2016, OPTOMETRY VISION SCI, V93, P1457; Schneider J, 2007, DEV NEUROREHABIL, V10, P282; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Trieu L., 2016, AM ACAD OPTOME; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Wajuihian Samuel Otabor, 2016, J Optom, V9, P246, DOI 10.1016/j.optom.2015.10.006; Zasler N, 2019, J HEAD TRAUMA REHAB, V34, P409, DOI 10.1097/HTR.0000000000000524	61	0	0	2	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	JUN	2021	183						73	80		10.1016/j.visres.2020.09.011			8	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	RN5SM	WOS:000640411800007	33735759				2022-02-07	
J	Shah, SA; Gautam, R; Lowder, R; Mauer, EA; Carullo, RB; Parlatore, DE; Gerber, LM; Schiff, ND; Traube, C				Shah, Sudhin A.; Gautam, Richa; Lowder, Ryan; Mauer, Elizabeth A.; Carullo, Renata B.; Parlatore, Dorin E.; Gerber, Linda M.; Schiff, Nicholas D.; Traube, Chani			Quantitative Electroencephalographic Markers of Delirium in the Pediatric Intensive Care Unit: Insights From a Heterogenous Convenience Sample	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; EEG; SLEEP; RECOVERY	Objective: Little is known about the underlying neurophysiology of pediatric delirium. In adult patients, the sensitivity of EEG to clinical symptoms of delirium has been noted, with a slowing of background activity (alpha) and an increase in slow-wave activity (delta-theta). In this pilot study, the authors extended this investigation to a pediatric cohort. Methods: In a convenience sample, 23 critically ill children were screened for delirium, using the Cornell Assessment for Pediatric Delirium (CAPD), every 12 hours throughout their pediatric intensive care unit stay as part of standard intensive care unit procedure, and EEGs were performed as part of their clinical care. After hospital discharge, EEGs were reviewed using quantitative analysis, and the maximum delta-alpha ratio (DAR; eyes closed) was derived for each 12-hour period. DAR values were compared between delirious and nondelirious episodes, and the linear relationship between DAR and CAPD was assessed. Results: Higher DARs were associated with episodes of delirium. The DAR also positively correlated with CAPD assessments, with higher DARs relating to higher delirium scores. Conclusions: Future prospective studies may further investigate this relationship in a more homogeneous and larger sample, and the DAR should be considered to track delirium and assess the effectiveness of therapeutic interventions.	[Shah, Sudhin A.; Lowder, Ryan] Cornell Univ, Dept Rehabil Med, Joan & Sanford I Weill Med Coll, New York, NY 10021 USA; [Traube, Chani] Cornell Univ, Dept Pediat, Joan & Sanford I Weill Med Coll, New York, NY 10021 USA; [Mauer, Elizabeth A.; Gerber, Linda M.] Cornell Univ, Dept Populat Hlth Sci, Joan & Sanford I Weill Med Coll, New York, NY 10021 USA; [Gautam, Richa] Cornell Univ, Joan & Sanford I Weill Med Coll, Clin & Translat Sci Ctr, New York, NY 10021 USA; [Carullo, Renata B.; Parlatore, Dorin E.; Traube, Chani] New York Presbyterian Hosp, Dept Pediat, New York, NY USA; [Shah, Sudhin A.; Schiff, Nicholas D.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Schiff, Nicholas D.] Weill Cornell Med, Dept Neurol, New York, NY USA; [Schiff, Nicholas D.] Rockefeller Univ Hosp, 1230 York Ave, New York, NY 10021 USA		Shah, SA (corresponding author), Cornell Univ, Dept Rehabil Med, Joan & Sanford I Weill Med Coll, New York, NY 10021 USA.; Shah, SA (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.	sut2006@med.cornell.edu			NIH National Center for Advancing Translational Science [UL1TR002384]; Clinical Translational Science Center at Weill Cornell Medical College [UL1-TR000457-06]	Supported by the NIH National Center for Advancing Translational Science (award UL1TR002384) and the Clinical Translational Science Center at Weill Cornell Medical College (grant UL1-TR000457-06).	[Anonymous], 2013, DIAGN STAT MAN MENT; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; ENGEL G L, 1959, J Chronic Dis, V9, P260, DOI 10.1016/0021-9681(59)90165-1; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; Hatherill S, 2010, J PSYCHOSOM RES, V68, P337, DOI 10.1016/j.jpsychores.2009.10.011; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; JACOBSON SA, 1993, J NEUROL NEUROSUR PS, V56, P153, DOI 10.1136/jnnp.56.2.153; Kerson AG, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0189-5; KOPONEN H, 1989, J NEUROL NEUROSUR PS, V52, P980, DOI 10.1136/jnnp.52.8.980; Maldonado JR, 2018, INT J GERIATR PSYCH, V33, P1428, DOI 10.1002/gps.4823; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Mitra P, 2007, OBSERVED BRAIN DYNAM; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Nunez P. L., 2006, ELECT FIELDS BRAIN N; Palanca BJA, 2017, BRIT J ANAESTH, V119, P294, DOI 10.1093/bja/aew475; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ribary U, 2019, MAGNETOENCEPHALOGRAP; Romano J, 1944, ARCH NEURO PSYCHIATR, V51, P356, DOI 10.1001/archneurpsyc.1944.02290280054003; Shah SA, 2017, J NEUROTRAUM, V34, P2691, DOI 10.1089/neu.2016.4911; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thomas C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-86; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Traube C, 2017, CRIT CARE MED, V45, P584, DOI 10.1097/CCM.0000000000002250; Traube C, 2014, CRIT CARE MED, V42, P656, DOI 10.1097/CCM.0b013e3182a66b76; van der Kooi AW, 2015, CHEST, V147, P94, DOI 10.1378/chest.13-3050; van der Kooi AW, 2012, J NEUROPSYCH CLIN N, V24, P472, DOI 10.1176/appi.neuropsych.11110347; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009	37	0	0	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2021	33	3					219	224		10.1176/appi.neuropsych.20070184			6	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	TN0BE	WOS:000675909300007	33757305				2022-02-07	
J	Shan, YC; Li, YH; Xu, XX; Feng, JF; Wu, X; Gao, GY				Shan, Yingchi; Li, Yihua; Xu, Xuxu; Feng, Junfeng; Wu, Xiang; Gao, Guoyi			Evaluation of Intracranial Hypertension in Traumatic Brain Injury Patient: A Noninvasive Approach Based on Cranial Computed Tomography Features	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; computed tomography; intracranial pressure; noninvasive intracranial pressure evaluation	CT FINDINGS; PRESSURE; MARSHALL; STANDARD; MODERATE	Background: Our purpose was to establish a noninvasive quantitative method for assessing intracranial pressure (ICP) levels in patients with traumatic brain injury (TBI) through investigating the Hounsfield unit (HU) features of computed tomography (CT) images. Methods: In this retrospective study, 47 patients with a closed TBI were recruited. Hounsfield unit features from the last cranial CT and the initial ICP value were collected. Three models were established to predict intracranial hypertension with Hounsfield unit (HU model), midline shift (MLS model), and clinical expertise (CE model) features. Results: The HU model had the highest ability to predict intracranial hypertension. In 34 patients with unilateral injury, the HU model displayed the highest performance. In three classifications of intracranial hypertension (ICP <= 22, 23-29, and >= 30 mmHg), the HU model achieved the highest F1 score. Conclusions: This radiological feature-based noninvasive quantitative approach showed better performance compared with conventional methods, such as the degree of midline shift and clinical expertise. The results show its potential in clinical practice and further research.	[Shan, Yingchi; Li, Yihua; Wu, Xiang; Gao, Guoyi] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Neurosurg, Shanghai 201600, Peoples R China; [Xu, Xuxu; Feng, Junfeng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 201600, Peoples R China		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Neurosurg, Shanghai 201600, Peoples R China.	18301965008@163.com; liyihuamail2020@163.com; 18326936939@163.com; fengjfmail@163.com; drwuxiang@163.com; gao3@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671198, 81971699]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant [20152212]; Shanghai Shenkang clinical research plan of SHDC [16CR3011A]	The study was supported by the National Natural Science Foundation of China (Grant Nos. 81671198 and 81971699), the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (20152212), and the Shanghai Shenkang clinical research plan of SHDC (16CR3011A).	Alali AS, 2019, J NEUROSURG, V131, P612, DOI 10.3171/2018.4.JNS173166; Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; Cardim D, 2021, J NEUROSURG SCI, V65, P383, DOI 10.23736/S0390-5616.19.04604-6; Delic J, 2016, RADIOLOGY, V279, P859, DOI 10.1148/radiol.2015151388; Eide PK, 2003, ACTA NEUROCHIR, V145, P171, DOI 10.1007/s00701-002-1062-y; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Harary M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020465; Inaba K, 2007, AM SURGEON, V73, P1023; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kanazawa T, 2020, J CLIN NEUROSCI, V71, P144, DOI 10.1016/j.jocn.2019.08.098; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P135, DOI 10.2147/OAEM.S179090; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Moore NA, 2013, BRIT J NEUROSURG, V27, P340, DOI 10.3109/02688697.2012.754402; Nag DS, 2019, WORLD J CLIN CASES, V7, P1535, DOI 10.12998/wjcc.v7.i13.1535; Nagesh M, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19527; Narayan V, 2018, WORLD NEUROSURG, V114, P293, DOI 10.1016/j.wneu.2018.02.159; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Oliveira RAG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00044; Pappu S, 2016, J NEUROIMAGING, V26, P37, DOI 10.1111/jon.12289; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shen QJ, 2018, EUR RADIOL, V28, P4389, DOI 10.1007/s00330-018-5364-8; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	28	0	0	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUN	2021	10	11							2524	10.3390/jcm10112524			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SQ2IG	WOS:000660180800001	34200228	gold, Green Published			2022-02-07	
J	Shepherd-Banigan, M; Pogoda, TK; McKenna, K; Sperber, N; Van Houtven, CH				Shepherd-Banigan, Megan; Pogoda, Terri K.; McKenna, Kevin; Sperber, Nina; Van Houtven, Courtney H.			Experiences of VA Vocational and Education Training and Assistance Services: Facilitators and Barriers Reported by Veterans With Disabilities	PSYCHIATRIC REHABILITATION JOURNAL			English	Article						US Department of Veterans Affairs; vocational rehabilitation; family caregiver	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; SUPPORTED EMPLOYMENT; REINTEGRATION; PARTICIPATION; COMPENSATION; ASSOCIATIONS; UNEMPLOYMENT; SYMPTOMS; OUTCOMES	Objective: To understand the experiences of veterans with disabilities and caregiving needs who use Department of Veterans Affairs (VA) vocational and education services, including Supported Employment, the Post-9/11 GI Bill, and Vocational Rehabilitation and Employment. Method: We conducted 26 joint semistructured interviews with post-9/11 veterans who had used at least one of three vocational and education services, and their family members who were enrolled in a VA Caregiver Support Program. Results: VA vocational and education services helped veterans with disabilities transition from the military into civilian life by providing skills and incremental exposure to engaging in everyday life tasks. Veteran motivation, caregiver support, and engaged staff at VA and academic institutions were key drivers of veteran success. Veterans who experienced challenges cited the following barriers: health problems, concerns about benefits loss if they became employed, and VA and academic programs that did not accommodate the needs of nontraditional veteran learners. Conclusions and Implications for Practice: There is a need to bolster VA vocational and educational services for veterans with disabilities in several domains, including modifying the roles of frontline staff and increasing communication between vocational counselors and health care teams to better accommodate the veteran's health-related limitations. Providing a vocational rehabilitation navigator to help veterans identify opportunities within VA and work/educational settings that are a good match for the veteran's goals and abilities could also be beneficial across vocational and educational services.	[Shepherd-Banigan, Megan; Sperber, Nina; Van Houtven, Courtney H.] VA Durham Healthcare Syst, Durham Vet Affairs Hlth Serv Res & Dev HSR&D, Ctr Innovat Accelerate Discovery & Practice Trans, 508 Fulton St, Durham, NC 27705 USA; [Shepherd-Banigan, Megan; McKenna, Kevin; Sperber, Nina; Van Houtven, Courtney H.] Duke Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA		Shepherd-Banigan, M (corresponding author), VA Durham Healthcare Syst, Durham Vet Affairs Hlth Serv Res & Dev HSR&D, Ctr Innovat Accelerate Discovery & Practice Trans, 508 Fulton St, Durham, NC 27705 USA.	megan.shepherd-banigan@va.gov		Van Houtven, Courtney/0000-0002-0783-1611; McKenna, Kevin/0000-0003-3983-1306	Robert Wood Johnson Foundation through the Systems for Action National Coordinating Center [74941]; Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT) at the Durham Veterans Affairs Health Care System [CIN 13-410]; Department of Veterans Affairs, Caregiver Support ProgramUS Department of Veterans Affairs; Quality Enhancement Research Initiative [PEC 14-272]	Support for this publication was provided by the Robert Wood Johnson Foundation through the Systems for Action National Coordinating Center (ID 74941). Additional support comes from the Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT; CIN 13-410) at the Durham Veterans Affairs Health Care System and the Department of Veterans Affairs, Caregiver Support Program, and Quality Enhancement Research Initiative (PEC 14-272). We acknowledge the efforts of Karen Stechuchak who compiled the recruitment list and Emilie Travis who recruited all participants.	Bell G. L., 2015, THESIS U WASHINGTON; Browning L. T. R., 2015, FAILURE IS NOT OPTIO; Burton A.K., 2006, IS WORK GOOD YOUR HL; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cate C. A., 2011, THESIS U CALIFORNIA; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cotner BA, 2018, TOP SPINAL CORD INJ, V24, P325, DOI 10.1310/sci17-00046; Davis LL, 2018, JAMA PSYCHIAT, V75, P316, DOI 10.1001/jamapsychiatry.2017.4472; Davis LL, 2012, PSYCHIAT SERV, V63, P464, DOI 10.1176/appi.ps.201100340; Defense and Veterans Brain Injury Center, 2019, DOD WORLD TBI; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; Drake R., 2012, INDIVIDUAL PLACEMENT, DOI [10.1093/acprof:oso/9780199734016.001.0001, DOI 10.1093/ACPROF:OSO/9780199734016.001.0001]; Drew D, 2001, PSYCHIATR SERV, V52, P1479, DOI 10.1176/appi.ps.52.11.1479; Elbogen EB, 2020, J AFFECT DISORDERS, V260, P703, DOI 10.1016/j.jad.2019.09.062; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Erbes CR, 2011, J REHABIL RES DEV, V48, P1159, DOI 10.1682/JRRD.2010.11.0212; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gregg B.T., 2016, AM J OCCUP THER, V70, P1, DOI [https://doi.org/10.5014/ajot.2016.021030, DOI 10.5014/AJOT.2016.021030]; Guest G., 2012, APPL THEMATIC ANAL; Hamilton AB, 2015, MED CARE, V53, pS32, DOI 10.1097/MLR.0000000000000297; Kukla M, 2018, PSYCHIATR REHABIL J, V41, P103, DOI 10.1037/prj0000297; Kukla M, 2016, PSYCHIAT SERV, V67, P412, DOI 10.1176/appi.ps.201500108; Meshberg-Cohen S, 2014, ADDICT BEHAV, V39, P445, DOI 10.1016/j.addbeh.2013.09.005; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Niv N, 2017, PSYCHIAT SERV, V68, P636, DOI 10.1176/appi.ps.201600065; Pogoda TK, 2017, BRAIN INJURY, V31, P1220, DOI 10.1080/02699052.2016.1274777; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Reddy L Felice, 2014, Schizophr Res Cogn, V1, P144, DOI 10.1016/j.scog.2014.09.004; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Ruderman L, 2016, DEPRESS ANXIETY, V33, P606, DOI 10.1002/da.22494; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Shepherd-Banigan M, 2020, NURS OUTLOOK, V68, P184, DOI 10.1016/j.outlook.2019.08.006; Sripada RK, 2018, PSYCHOL TRAUMA-US, V10, P140, DOI 10.1037/tra0000241; Steele J. L., 2011, SERVICE SCH MILITARY; Tanielian T.L., 2008, INVISIBLE WOUNDS WAR, V1; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; U.S. Department of Labor, 2019, OCT 2019 JOB REP VET; U.S. Department of Veterans Affairs, 2019, VA CAR SUPP; U.S. Department of Veterans Affairs, 2019, 911 US DEP VET AFF; U.S. Department of Veterans Affairs, 2019, PSYCH REH REC SERV V; U.S. Department of Veterans Affairs, 2019, VOC REH EMPL VR E; van der Noordt M, 2014, OCCUP ENVIRON MED, V71, P730, DOI 10.1136/oemed-2013-101891; Van Houtven CH, 2019, MED CARE RES REV, V76, P89, DOI 10.1177/1077558717697015; Waszak DL, 2017, WORKPLACE HEALTH SAF, V65, P430, DOI 10.1177/2165079916682524; Wyse JJ, 2020, PSYCHOL SERV, V17, P65, DOI 10.1037/ser0000283	46	0	0	2	7	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1095-158X	1559-3126		PSYCHIATR REHABIL J	Psychiatr. Rehabil. J.	JUN	2021	44	2					148	156		10.1037/prj0000437			9	Psychiatry; Rehabilitation	Social Science Citation Index (SSCI)	Psychiatry; Rehabilitation	SM0JG	WOS:000657298500007	32597666	Bronze			2022-02-07	
J	Shibahashi, K; Hoda, H; Ishida, T; Sugiyama, K; Okura, Y; Hamabe, Y				Shibahashi, Keita; Hoda, Hidenori; Ishida, Takuto; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hamabe, Yuichi			Older Adults with Traumatic Brain Injury in the Most Aged and Most Rapidly Aging Country: An Analysis of the Nationwide Trauma Registry of Japan	WORLD NEUROSURGERY			English	Article						Aging society; Descriptive analysis; Epidemiology; Predictive accuracy; Traumatic brain injury	ELDERLY-PATIENTS	BACKGROUND: Despite the increasing numbers of older adults with traumatic brain injury (TBI), minimal data are available to support the development of treatment strategies. We aimed to comprehensively describe the incidence, characteristics, outcomes, and predictive accuracy of the severity indicators among older adults with TBI. METHODS: Using the Japan Trauma Data Bank, we identified patients aged >= 18 years with TBI from 2004 to 2019. The patients were grouped according to age, and their baseline characteristics, radiological findings, severity, complications, and in-hospital mortality were assessed. Receiver operating characteristic curves were used to assess the accuracy of severity indicators for predicting in-hospital mortality. RESULTS: Of the 94,180 patients who met the inclusion criteria, 50,990 (54.1%) were older adults (aged >= 65 years). Their proportion had increased at 2.1% annually, which exceeded the 0.5% annual increase in the general population. The proportion of women and the prevalence of comorbidities increased significantly with age. Traffic accidents were the leading cause of TBI among young adults, and falling at ground level was the leading cause for those aged >= 75 years. The radiological findings were significantly different among the age groups. The proportion of acute epidural hemorrhage, skull fracture, and diffuse axonal injury decreased and that of acute subdural hemorrhage increased with age. The predictive accuracy of the Glasgow coma scale, revised trauma score, and injury severity score decreased with increasing age. CONCLUSIONS: The proportion of older patients with TBI increased more quickly than did the proportion of older people in the general population. The characteristics and predictive accuracy of the severity indicators differed significantly among the different age groups. TBI studies that focus on older patients are necessary.	[Shibahashi, Keita; Hoda, Hidenori; Ishida, Takuto; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Hoda, Hidenori/0000-0002-4283-4412; Ishida, Takuto/0000-0001-7038-8459			BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kojima M, 2019, ANN EMERG MED, V73, P281, DOI 10.1016/j.annemergmed.2018.09.034; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Statistics Bureau of Japan, POP EST; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; United Nations, WORLD POPULATION PRO; World Health Organization, VIOL INJ PREV DIS VI	17	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2021	150						E570	E576		10.1016/j.wneu.2021.03.059			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SM8GR	WOS:000657837500059	33746100				2022-02-07	
J	Shiels, T; Kenny, N; Shiels, R; Mannix-McNamara, P				Shiels, Teresa; Kenny, Neil; Shiels, Roy; Mannix-McNamara, Patricia			Incivility in Higher Education: Challenges of Inclusion for Neurodiverse Students with Traumatic Brain Injury in Ireland	SOCIETIES			English	Article						incivility; students with traumatic brain injury; higher education; power	WORKPLACE; SELF; PEOPLE	This paper explores the lived experience of incivility for neurodiverse students with traumatic brain injury (TBI) in Ireland. The higher education (HE) environment can be challenging for students with TBI. Incivility is common in higher education, and students with disabilities such as TBI are often marginalized within academia, making them more vulnerable to incivility. For this paper, data are drawn from the first author's autoethnographic study, and is supplemented with semi-structured interviews from a sample of HE seven students also with TBI. Results revealed that participants' experiences of incivility were common and were linked to the organizational culture of higher education. Our experiences point to a need for better responsiveness when interactions are frequently uncivil, despite there being policies that recognize diversity and equality. This is the first paper of its kind to explore this particular experience in Ireland and the purpose of this paper is to raise awareness of the challenges of neurodiverse students and how they are exacerbated by organizational and interpersonal incivility.	[Shiels, Teresa; Mannix-McNamara, Patricia] Univ Limerick, Sch Educ, Limerick V94 H58H, Ireland; [Kenny, Neil] Dublin City Univ, Sch Inclus & Special Educ, Dublin 9, Ireland; [Shiels, Roy] Univ Limerick, Student Affairs, Limerick V94 H58H, Ireland		Shiels, T (corresponding author), Univ Limerick, Sch Educ, Limerick V94 H58H, Ireland.	teresa.shiels@ul.ie; neil.kenny@dcu.ie; roy.shiels@ul.ie; patricia.m.mcnamara@ul.ie	Mannix-McNamara, Patricia/AAY-5739-2021	Mannix-McNamara, Patricia/0000-0002-3011-0177			Andersson LM, 1999, ACAD MANAGE REV, V24, P452, DOI 10.2307/259136; [Anonymous], 2011, RATIO JURIS INT J JU, V24, P49, DOI [DOI 10.1111/J.1467-9337.2010.00473X, 10.1111/j.1467-9337.2010.00473.x, DOI 10.1111/J.1467-9337.2010.00473.X]; Atewologun D., 2018, RES REPORT; Barr JJ, 2015, CURR PSYCHOL, V34, P223, DOI 10.1007/s12144-014-9253-2; Bochner P. Arthur, 2006, COMMUNICATION PERSPE, P13; Bourdieu P., 1979, CRIT ANTHROPOL, V4, P77, DOI DOI 10.1177/0308275X7900401307; Bratton J., 2007, WORK ORG BEHAV; Brookfield SD, 2017, BECOMING CRITICALLY; Brown B, 2006, FAM SOC, V87, P43, DOI 10.1606/1044-3894.3483; Buber Martin, 1970, I THOU; Burke S, 2020, HEALTH POLICY, V124, P225, DOI 10.1016/j.healthpol.2019.12.018; Burnier D, 2006, J CONTEMP ETHNOGR, V35, P410, DOI 10.1177/0891241606286982; Burstow B, 2003, VIOLENCE AGAINST WOM, V9, P1293, DOI 10.1177/1077801203255555; Chang, 2008, AUTOETHNOGRAPHY METH; Chatham-Carpenter A., 2009, IOWA J COMMUN, V41, P125; Cortina LM, 2008, ACAD MANAGE REV, V33, P55; Ellis C., 1996, COMPOSING ETHNOGRAPH; Ellis Carolyn, 2004, ETHNOGRAPHIC; Falvo D., 2013, MED PSYCHOSOCIAL ASP; Foucault M., 1988, TECHNOLOGIES SELF SE, P16, DOI DOI 10.1080/09518398.2013.786849; Foucault M., 1990, HIST SEXUALITY INTRO, V1; Foucault M., 1995, DISCIPLINE PUNISH BI; Freire P, 1973, ED CRITICAL CONSCIOU, V1; Freire P., 2000, PEDAGOGY OPPRESSED; Freire P, 1973, ED CRITICAL CONSCIOU; Giddens A., 1984, CONSTITUTION SOC OUT; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Heidegger Martin, 1962, BEING TIME, P437; Hodgins M, 2019, SAGE OPEN, V9, DOI 10.1177/2158244019894278; Hodgins M, 2017, QUAL RES ORGAN MANAG, V12, P190, DOI 10.1108/QROM-03-2017-1508; Hollis LP, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015589997; Hunt C.S., 2000, REHABILITATION ED, V14, P269; Hyland NE, 2010, TEACH TEACH EDUC, V26, P821, DOI 10.1016/j.tate.2009.10.019; Keeling R., 2014, J COLL CHARACTER, V15, P141, DOI 10.1515/jcc-2014-0018; Kumar S, 2006, PERS INDIV DIFFER, V40, P147, DOI 10.1016/j.paid.2005.05.014; Lai CK, 2013, SOC PERSONAL PSYCHOL, V7, P315, DOI 10.1111/spc3.12023; Linden MA, 2007, ARCH CLIN NEUROPSYCH, V22, P665, DOI 10.1016/j.acn.2007.04.009; Linton Simi, 1998, CLAIMING DISABILITY; Marchiondo K, 2010, J NURS EDUC, V49, P608, DOI 10.3928/01484834-20100524-05; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mendez M, 2013, COLOMB APPL LINGUIST, V15, P279; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Oppong, 2014, PSYCHOL THOUGHT, V7, P111, DOI [10.5964/psyct.v7i2.104, DOI 10.5964/PSYCT.V7I2.104]; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Passeron Jean-Claude., 1990, REPROD ED SOC CULTUR; Pearson CM, 2000, ORGAN DYN, V29, P123, DOI 10.1016/S0090-2616(00)00019-X; Reid K, 2005, PSYCHOLOGIST, V18, P20; Rohrer J, 2010, AAUP J ACAD FREEDOM, V10, P1; Smith F.L., 2018, 1 AMENDMENT STUDIES, V52, P96, DOI [https://doi.org/10.1080/21689725.2018.1495094, DOI 10.1080/21689725.2018.1495094]; Stixrud WR, 2012, J MANAG EDUC, V36, P135, DOI 10.1177/1052562911430317; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33; Thomas C., 1999, FEMALE FORMS EXPERIE; Voynova R., 2017, INT J CROSS DISCIP S, V8, P3140, DOI [10.20533/ijcdse.2042.6364.2017.0422, DOI 10.20533/IJCDSE.2042.6364.2017.0422]; Wolbring G., 2008, DEVELOPMENT, V51, P252, DOI DOI 10.1057/DEV.2008.17; Youssef CM, 2007, J MANAGE, V33, P774, DOI 10.1177/0149206307305562	55	0	0	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4698		SOCIETIES	Societies	JUN	2021	11	2							60	10.3390/soc11020060			14	Sociology	Emerging Sources Citation Index (ESCI)	Sociology	SX8YH	WOS:000665483000001		Green Published, gold			2022-02-07	
J	Shimoni, Z; Danilov, V; Hadar, S; Froom, P				Shimoni, Zvi; Danilov, Vendi; Hadar, Shoshana; Froom, Paul			Head Computed Tomography Scans in Elderly Patients with Low Velocity Head trauma after a Fall	ISRAEL MEDICAL ASSOCIATION JOURNAL			English	Article						computed tomography (CT) brain imaging; elderly; facial fracture; intracranial hemorrhage; traumatic brain injury (TBI)	EMERGENCY-DEPARTMENT; INJURY; CT	Background: Recommendations for a head computed tomography (CT) scan in elderly patients without a toss of consciousness after a traumatic brain injury and without neurological findings on admission and who are not taking oral anticoagulant therapy, are discordant. Objectives: To determine variables associated with intracranial hemorrhage (ICH) and the need for neurosurgery in elderly patients after low velocity head trauma Methods: In a regional hospital, we retrospectively selected 206 consecutive patients aged >= 65 years with head CT scans ordered in the emergency department because of low velocity head trauma. Outcome variables were an ICH and neurological surgery. Independent variables included age, sex, disability, neurological findings, facial fractures, mental status, headache, head sutures, toss of consciousness, and anticoagulation therapy. Results: Fourteen patients presented with ICH (6.8%, 3.811.1%) and three (1.5%, 0.3-4.2%) with a neurosurgical procedure. One patient with a coma (0.5, 0.0-2.7) died 2 hours after presentation. All patients who required surgery or died had neurological findings. Reducing head CT scans by 97.1% (93.8-98.9%) would not have missed any patient with possible surgical utility. Twelve of the 14 patients (85.7%) with an ICH had neurological findings, post-trauma loss of consciousness or a facial fracture were not present in 83.5% (95% confidence interval 77.7-88.3) of the cohort. Conclusions: None of our patients with neurological findings required neurosurgery. Careful palpation of the facial bones to identify facial fractures might aid in the decision whether to perform a head CT scan.	[Shimoni, Zvi] Laniado Hosp, Dept Internal Med B, Netanya, Israel; [Danilov, Vendi; Hadar, Shoshana] Laniado Hosp, Dept Neurol, Netanya, Israel; [Froom, Paul] Laniado Hosp, Dept Clin Util, IL-42150 Netanya, Israel; [Shimoni, Zvi] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Froom, Paul] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel		Froom, P (corresponding author), Laniado Hosp, Dept Clin Util, IL-42150 Netanya, Israel.	froomp@gmail.com					Bennett JM, 2014, BR J MED MED RES, V6, P342; Campiglio L, 2017, NEUROL-CLIN PRACT, V7, P296, DOI 10.1212/CPJ.0000000000000375; Davey K, 2018, ANN EMERG MED, V72, P342, DOI 10.1016/j.annemergmed.2018.03.034; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Dusenberry MW, 2017, AM J EMERG MED, V35, P260, DOI 10.1016/j.ajem.2016.10.065; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Ferorelli D, 2020, RADIOL MED, V125, P595, DOI 10.1007/s11547-020-01143-9; Firsching R, 2017, J NEUROL SURG PART A, V78, P478, DOI 10.1055/s-0037-1599239; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; Gardner RL, 2007, AM J EMERG MED, V25, P643, DOI 10.1016/j.ajem.2006.11.037; Jeanmonod R, 2019, AM J EMERG MED, V37, P1470, DOI 10.1016/j.ajem.2018.10.049; Klang E, 2017, J AM COLL RADIOL, V14, P171, DOI 10.1016/j.jacr.2016.08.032; Lampart A, 2020, J AM GERIATR SOC, V68, P977, DOI 10.1111/jgs.16400; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; Morley C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203316; Pages PJ, 2020, J NEURORADIOLOGY, V47, P54, DOI 10.1016/j.neurad.2019.03.004; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Solomon D, 2019, ISR MED ASSOC J, V21, P779; Timashpolsky A, 2016, PLAST SURG-CHIR PLAS, V24, P73, DOI 10.1177/229255031602400203	21	0	0	0	0	ISRAEL MEDICAL ASSOC JOURNAL	RAMAT GAN	2 TWIN TOWERS, 11TH FL, 35 JABOTINSKY ST, PO BOX 3604, RAMAT GAN 52136, ISRAEL	1565-1088			ISR MED ASSOC J	Isr. Med. Assoc. J.	JUN	2021	23	6					359	363					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD5XJ	WOS:000669399200008	34155849				2022-02-07	
J	Siwicka-Gieroba, D; Robba, C; Poleszczuk, J; Debowska, M; Waniewski, J; Badenes, R; Jaroszynski, A; Piasek, E; Kotfis, K; Biernawska, J; Dabrowski, W				Siwicka-Gieroba, Dorota; Robba, Chiara; Poleszczuk, Jan; Debowska, Malgorzata; Waniewski, Jacek; Badenes, Rafael; Jaroszynski, Andrzej; Piasek, Ewa; Kotfis, Katarzyna; Biernawska, Jowita; Dabrowski, Wojciech			Changes in Subendocardial Viability Ratio in Traumatic Brain Injury Patients	BRAIN CONNECTIVITY			English	Article						brain-heart cross-talk; decompressive craniectomy; myocardial perfusion; subendocardial viability ratio; traumatic brain injury	CARDIAC DYSFUNCTION; BLOOD-PRESSURE; ASSOCIATION; MORTALITY	Background: Traumatic brain injury (TBI) is often associated with cardiac dysfunction, which is a consequence of the brain-heart cross talk. The subendocardial viability ratio (SEVR) is an estimate of myocardial perfusion. The aim of this study was to analyze changes in the SEVR in patients with severe TBI without previous cardiac diseases. Methods: Adult patients treated for severe TBI with a Glasgow coma score <8 were studied. Pressure waveforms were obtained by a high-fidelity tonometer in the radial artery for SEVR calculation at five time points: immediately after admission to the intensive care unit and 24, 48, 72, and 96 h after admission. SEVRs and other clinically important parameters were analyzed in patients who survived and did not survive after 28 days of treatment, as well as in patients who underwent decompressive craniectomy (DC). Results: A total of 64 patients (16 females and 48 males) aged 18-64 years were included. Fifty patients survived and 14 died. DC was performed in 23 patients. SEVRs decreased 24 h after admission in nonsurvivors (p < 0.05) and after 48 h in survivors (p < 0.01) and its values were significantly lower in nonsurvivors than in survivors at 24, 72, and 96 h from admission (p < 0.05). The SEVR increased following DC (p < 0.05). Conclusions: A decreased SEVR is observed in TBI patients. Surgical decompression increases the SEVR, indicating improvement in coronary microvascular perfusion. The results of our study seem to confirm that brain injury affects myocardium function.	[Siwicka-Gieroba, Dorota; Piasek, Ewa; Dabrowski, Wojciech] Med Univ Lublin, Dept Anaesthesiol & Intens Care, Jaczewskiego 8, PL-20954 Lublin, Poland; [Robba, Chiara] Osped Policlin San Martino, Dept Anaesthesia & Intens Care, Genoa, Italy; [Poleszczuk, Jan; Debowska, Malgorzata; Waniewski, Jacek] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Dept Math Modeling Physiol Proc, Warsaw, Poland; [Badenes, Rafael] Univ Valencia, Hosp Clin Univ Valencia, Dept Anesthesiol & Intens Care, Valencia, Spain; [Jaroszynski, Andrzej] Jan Kochanowski Univ Humanities & Sci, Coll Med, Dept Nephrol, Kielce, Poland; [Kotfis, Katarzyna] Pomeranian Med Univ, Dept Anaesthesiol Intens Therapy & Acute Intoxica, Szczecin, Poland; [Biernawska, Jowita] Pomeranian Med Univ, Dept Anaesthesiol & Intens Therapy, Szczecin, Poland		Siwicka-Gieroba, D; Dabrowski, W (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Care, Jaczewskiego 8, PL-20954 Lublin, Poland.	dsiw@wp.pl; w.dabrowski5@yahoo.com	Kotfis, Katarzyna/O-4355-2014; Debowska, Malgorzata/F-3035-2015	Kotfis, Katarzyna/0000-0001-8430-1369; Jacek, Waniewski/0000-0002-2705-504X; Poleszczuk, Jan/0000-0001-8758-7200; Debowska, Malgorzata/0000-0001-8741-7930; Dabrowski, Wojciech/0000-0003-0449-2375; Siwicka-Gieroba, Dorota/0000-0002-1001-0080; Jaroszynski, Andrzej/0000-0001-8194-1723; Badenes, Rafael/0000-0001-7017-0150	National Science Centre, PolandNational Science Centre, Poland [2018/31/D/ST7/03472]	This study was supported by the National Science Centre, Poland (project no 2018/31/D/ST7/03472).	Anyfanti P, 2019, AM J HYPERTENS, V32, P557, DOI 10.1093/ajh/hpz039; Aslanger E, 2017, ANATOL J CARDIOL, V17, P37, DOI 10.14744/AnatolJCardiol.2016.7009; Bahloul M, 2006, AM J CRIT CARE, V15, P462; Battaglini D, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02885-8; Biso Sylvia, 2017, Cardiovasc Psychiatry Neurol, V2017, P5842182, DOI 10.1155/2017/5842182; BUCKBERG GD, 1972, CIRC RES, V30, P67, DOI 10.1161/01.RES.30.1.67; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; Dabrowski W, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228653; Dabrowski W, 2018, J ELECTROCARDIOL, V51, P499, DOI 10.1016/j.jelectrocard.2017.12.038; Ekart R, 2019, CARDIORENAL MED, V9, P41, DOI 10.1159/000493512; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; HOFFMAN JIE, 1975, BRIT MED J, V1, P76, DOI 10.1136/bmj.1.5949.76; Hoffman JIE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000285; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Katsanos AH, 2013, INT J CARDIOL, V167, P328, DOI 10.1016/j.ijcard.2012.06.107; Kenigsberg BB, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0999-7; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Kuck K, 2018, J ELECTROCARDIOL, V51, P768, DOI 10.1016/j.jelectrocard.2018.05.011; Mashaly HA., 2008, CLEVE CLIN J MED, V75, P26, DOI DOI 10.3949/CCJM.75.SUPPL_2.S26; Milewska A, 2009, J ELECTROCARDIOL, V42, P420, DOI 10.1016/j.jelectrocard.2009.04.001; Mowery NT, 2008, J TRAUMA, V65, P621, DOI 10.1097/TA.0b013e3181837980; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Osteraas ND, 2017, HAND CLINIC, V140, P49, DOI 10.1016/B978-0-444-63600-3.00004-0; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Poleszczuk J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006417; Rimaz S., 2019, ANESTH PAIN MED, V9, pE90858; Scandale G, 2018, J CLIN HYPERTENS, V20, P478, DOI 10.1111/jch.13213; Schultz MG, 2013, AM J HYPERTENS, V26, P557, DOI 10.1093/ajh/hps077; Sijercic Selma, 2018, Med Arch, V72, P316, DOI 10.5455/medarh.2018.72.316-318; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Sinski M, 2016, ARCH MED SCI, V12, P992, DOI 10.5114/aoms.2015.49038; Steinberg C, 2018, CURR OPIN CARDIOL, V33, P31, DOI 10.1097/HCO.0000000000000465; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Tsiachris D, 2012, J HUM HYPERTENS, V26, P64, DOI 10.1038/jhh.2010.127; Venkata C, 2018, CLIN MED RES, V16, P57, DOI 10.3121/cmr.2018.1437; Wijesurendra RS, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009218; Wu X, 2011, J TRAUMA, V71, P820, DOI 10.1097/TA.0b013e3182277b69	40	0	0	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	JUN 1	2021	11	5					349	358		10.1089/brain.2020.0850			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SO2SJ	WOS:000658826700003	33559521				2022-02-07	
J	Slavin, BR; Pierrot, RG; Sprau, AC; Wolfe, EM; Mathew, PJ; Chopra, K; Thaller, SR				Slavin, Benjamin R.; Pierrot, Randall G.; Sprau, Annelise C.; Wolfe, Erin M.; Mathew, Prakash J.; Chopra, Karan; Thaller, Seth R.			Heads Up Play: Acute Assessment and Management of Basketball-Related Craniofacial Injuries by On-Court Personnel	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Basketball; craniofacial injuries; facial trauma; sideline management	SURVEILLANCE DESCRIPTIVE EPIDEMIOLOGY; 1ST DECADE; SPORTS; CONCUSSION	Introduction: With a following of over 825 million people, basketball currently ranks amongst the world's most popular sports. Despite a number of concussion awareness and player safety protocols that have been implemented at the professional level of organized play, a standardized, layperson-friendly algorithm for the acute management of basketball-related craniofacial injuries does not appear to presently exist. Methods: This 10-year retrospective cohort study was conducted using the National Electronic Injury Surveillance System database to examine basketball-related craniofacial injuries from 2010 to 2019. Within the National Electronic Injury Surveillance System dataset, factors including patient age, gender, diagnosis, injury type, and injury location were included in our analysis. Results: Overall, 22,529 basketball-related craniofacial injuries occurred between 2010 and 2019 in players ages 5 to 49 years old. Adolescent (12-18-year-old) and young adult (19-34-year-old) age groups had the highest incidence of craniofacial injuries. The adolescent cohort experienced a significantly greater proportion of concussions and lower proportion of both facial lacerations and fractures compared with the within group null hypothesis of equal proportions (P < 0.05). The young adult cohort experienced a significantly greater proportion of facial lacerations and fractures and lower proportion of concussions, contusions/abrasions, hematomas, and internal injuries compared to this cohort's null hypothesis (P < 0.05). Males experienced a significantly greater proportion of fractures, lacerations, and dental injuries and lower proportion of concussions, contusions/abrasions, and internal injuries compared to the hypothesized equality of proportions (P < 0.05). Females experienced a significantly greater proportion of concussions, contusions/abrasions, and internal injuries and lower proportion of fractures, lacerations, and dental injuries compared to the hypothesized equality of proportions (P < 0.05). Conclusions: Although several steps have already been taken at the professional level to try to promote player safety, particularly with concussion protocols and prevention of lower extremity injuries, there remains a paucity of resources to guide management of other types of acute craniofacial injury. The role of layperson-friendly educational interventions remains intriguing as a potential means of improving outcomes regardless of socioeconomic status or health literacy. Additional studies still need to be completed to determine efficacy and best future direction.	[Slavin, Benjamin R.; Pierrot, Randall G.; Wolfe, Erin M.; Mathew, Prakash J.; Thaller, Seth R.] Univ Miami, Miller Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Miami, FL 33136 USA; [Sprau, Annelise C.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Chopra, Karan] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA		Thaller, SR (corresponding author), Div Plast Aesthet & Reconstruct Surg, 1120 NW 14th St,4th Floor, Miami, FL 33136 USA.	sthaller@med.miami.edu		Slavin, Benjamin/0000-0002-6755-2358			Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Clifton DR, 2018, J ATHL TRAINING, V53, P1037, DOI 10.4085/1062-6050-150-17; Clifton DR, 2018, J ATHL TRAINING, V53, P1025, DOI 10.4085/1062-6050-148-17; DiFiori JP, 2018, SPORTS MED, V48, P2053, DOI 10.1007/s40279-018-0950-0; Fletcher EN, 2014, J ATHL TRAINING, V49, P381, DOI 10.4085/1062-6050-49.3.09; Gopfert A, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000346; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Lesic N, 2011, COLLEGIUM ANTROPOL, V35, P347; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; Monroe KW, 2011, CLIN PEDIATR, V50, P17, DOI 10.1177/0009922810378735; Othman S, 2019, CRANIOMAX TRAUM REC, V12, P266, DOI 10.1055/s-0039-1679930; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; SANE J, 1988, AM J SPORT MED, V16, P647, DOI 10.1177/036354658801600616; Shvili J., 2020, WORLDATLAS      1016; Sprau AC, 2021, J CRANIOFAC SURG, V32, P1557, DOI 10.1097/SCS.0000000000007221; Vriend I, 2017, SPORTS MED, V47, P2027, DOI 10.1007/s40279-017-0718-y	16	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1580	1584		10.1097/SCS.0000000000007588			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100111	33654038				2022-02-07	
J	Somekh, J				Somekh, Judith			Model-based pathway enrichment analysis applied to the TGF-beta regulation of autophagy in autism	JOURNAL OF BIOMEDICAL INFORMATICS			English	Article						Pathway enrichment analysis; Differential gene expression; Petri nets; Gene expression; Autophagy; TGF-beta; Autism	TRAUMATIC BRAIN-INJURY; SIGNAL-TRANSDUCTION; KINASE ACTIVATION; EXPRESSION; GROWTH; TAK1; APOPTOSIS; PREDICTION; TGF-BETA-1; NETWORKS	To differentiate between conditions of health and disease, current pathway enrichment analysis methods detect the differential expression of distinct biological pathways. System-level model-driven approaches, however, are lacking. Here we present a new methodology that uses a dynamic model to suggest a unified subsystem to better differentiate between diseased and healthy conditions. Our methodology includes the following steps: 1) detecting connections between relevant differentially expressed pathways; 2) construction of a unified in silico model, a stochastic Petri net model that links these distinct pathways; 3) model execution to predict subsystem activation; and 4) enrichment analysis of the predicted subsystem. We apply our approach to the TGF-beta regulation of the autophagy system implicated in autism. Our model was constructed manually, based on the literature, to predict, using model simulation, the TGF-beta-to-autophagy active subsystem and downstream gene expression changes associated with TGF-beta, which go beyond the individual findings derived from literature. We evaluated the in silico predicted subsystem and found it to be co-expressed in the normative whole blood human gene expression data. Finally, we show our subsystem's gene set to be significantly differentially expressed in two independent datasets of blood samples of ASD (autistic spectrum disorders) individuals as opposed to controls. Our study demonstrates that dynamic pathway unification can define a new refined subsystem that can significantly differentiate between disease conditions.	[Somekh, Judith] Univ Haifa, Dept Informat Syst, IL-3498838 Haifa, Israel		Somekh, J (corresponding author), Univ Haifa, Dept Informat Syst, IL-3498838 Haifa, Israel.	judith_somekh@is.haifa.ac.il					Amadoz A, 2019, BRIEF BIOINFORM, V20, P1655, DOI 10.1093/bib/bby040; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blatke M.A., 2015, ALGEBRAIC DISCRETE M, P141, DOI DOI 10.1016/B978-0-12-801213-0.00007-1; Dai L, 2012, IUBMB LIFE, V64, P825, DOI 10.1002/iub.1078; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Ding Y, 2014, SEMIN NEPHROL, V34, P62, DOI 10.1016/j.semnephrol.2013.11.009; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Freudlsperger C, 2013, ONCOGENE, V32, P1549, DOI 10.1038/onc.2012.171; Ghavami S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.36; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goines PE, 2013, NEUROTOXICOL TERATOL, V36, P67, DOI 10.1016/j.ntt.2012.07.006; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heiner M, 2015, LECT NOTES COMPUT SC, V9115, P200, DOI 10.1007/978-3-319-19488-2_10; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hong MY, 2012, CHINESE MED J-PEKING, V125, P2019, DOI 10.3760/cma.j.issn.0366-6999.2012.11.032; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Hung Jui-Hung, 2013, Methods Mol Biol, V939, P201, DOI 10.1007/978-1-62703-107-3_13; Ihnatova I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191154; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Kajdaniuk D, 2013, ENDOKRYNOL POL, V64, P384, DOI 10.5603/EP.2013.0022; *KEGG, KYOTO ENCY GENES GEN; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Kleeff J, 1998, J BIOL CHEM, V273, P7495, DOI 10.1074/jbc.273.13.7495; Koch I, 2011, COMPUT BIOL SER, V16, P3, DOI 10.1007/978-1-84996-474-6_1; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Korcsmaros T, 2017, INTEGR BIOL-UK, V9, P97, DOI 10.1039/c6ib00215c; Lee Kyung-Min, 2013, Exp Neurobiol, V22, P133, DOI 10.5607/en.2013.22.3.133; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moustakas A, 2013, TGF HUMAN DIS; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Okada K, 2007, PROG NEURO-PSYCHOPH, V31, P187, DOI 10.1016/j.pnpbp.2006.08.020; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Peleg M, 2005, J AM MED INFORM ASSN, V12, P181, DOI 10.1197/jamia.M1637; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Pramparo T, 2015, JAMA PSYCHIAT, V72, P386, DOI 10.1001/jamapsychiatry.2014.3008; Rohr C, 2010, BIOINFORMATICS, V26, P974, DOI 10.1093/bioinformatics/btq050; Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4; Rzhetsky A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003518; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Simillion C, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1571-6; Somekh J, 2016, J BIOMED INFORM, V63, P366, DOI 10.1016/j.jbi.2016.08.008; Somekh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051430; Steggles LJ, 2007, BIOINFORMATICS, V23, P336, DOI 10.1093/bioinformatics/btl596; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-161; Suzuki HI, 2010, AUTOPHAGY, V6, P645, DOI 10.4161/auto.6.5.12046; Szczepanska A., 2011, INT STAT REV, V79, P491, DOI [10.1111/j.1751-5823.2011.00159_12.x, 10.1111/j.1751-5823.2011.00159 _ 12.x]; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Thomas PD, 2019, NAT GENET, V51, P1429, DOI 10.1038/s41588-019-0500-1; Till A, 2013, AUTOPHAGY, V9, P1256, DOI 10.4161/auto.25483; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wu H, 2009, MECH DEVELOP, V126, P624, DOI 10.1016/j.mod.2009.06.1082; Xu NG, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/531518; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Xu YF, 2012, INT J MOL MED, V29, P781, DOI 10.3892/ijmm.2012.911; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Yu JW, 2014, J MOL CELL BIOL, V6, P349, DOI 10.1093/jmcb/mju030; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zou X, 2012, J NUTR BIOCHEM, V23, P994, DOI 10.1016/j.jnutbio.2011.05.006	76	0	0	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1532-0464	1532-0480		J BIOMED INFORM	J. Biomed. Inform.	JUN	2021	118								103781	10.1016/j.jbi.2021.103781			11	Computer Science, Interdisciplinary Applications; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Medical Informatics	SV1QU	WOS:000663600500002	33839306				2022-02-07	
J	Standiford, L; O'Daniel, M; Hysell, M; Trigger, C				Standiford, Louis; O'Daniel, Michael; Hysell, Matthew; Trigger, Christopher			A randomized cohort study of the efficacy of PO magnesium in the treatment of acute concussions in adolescents	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SULFATE; NEUROPROTECTION; THERAPY	Introduction/study objective: Concussions are becoming a growing concern in society today with one out of every five adolescents being affected. This accounts for 1.6 to 3.8 million emergency department visits annually. The current standard of care involves an initial period of mental rest with symptomatic care and symptom-based return to daily activities/sports. High dose IV magnesium has been proven to be neuroprotective in severe TBI. We hypothesized that oral magnesium replacement following a concussion will decrease the overall symptomatic period allowing a quicker return to functional baseline. Methods: We used a randomized cohort study involving patients aged 12-18 who presented within 48 h after a concussion. Our study design had a treatment arm including acetaminophen, ondansetron, and magnesium PO and a placebo arm of acetaminophen and ondansetron. We then utilized the Post- Concussion Severity Score (PCSS) to evaluate the extent of the patient's symptoms. This score was collected immediately prior to obtaining medications, 1 h, 48 h, and 120 h after starting the study. The study relied on outpatient follow up through phone conversations, and a Sports Medicine clinic locally. Results: Our data shows that there was a statistically significant decrease in the PCSS at 48 h (p = 0.016) in the magnesium group relative to the placebo treatment arm. This study does imply that magnesium supplementation has potential benefit in treatment of concussions acutely. Conclusion: Oral magnesium replacement decreases symptoms acutely following a concussion and should be provided with symptomatic management following a concussion in the emergency setting. (C) 2020 Elsevier Inc. All rights reserved.	[Standiford, Louis; O'Daniel, Michael; Hysell, Matthew; Trigger, Christopher] Spectrum Hlth, Dept Emergency Med, St Joseph, MI 49085 USA		Standiford, L (corresponding author), Spectrum Hlth, Dept Emergency Med, St Joseph, MI 49085 USA.	louis.standiford@lakelandhealth.org					Agrawal Shruti, 2016, World J Crit Care Med, V5, P36, DOI 10.5492/wjccm.v5.i1.36; Arango MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005400.pub3; Busingye DS, 2016, CNS NEUROSCI THER, V22, P854, DOI 10.1111/cns.12591; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1570, DOI 10.1212/01.CON.0000458973.71142.7d; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grober U, 2015, NUTRIENTS, V7, P8199, DOI 10.3390/nu7095388; Halstead ME, 2016, SPORTS HEALTH, V8, P50, DOI 10.1177/1941738115622158; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1999, J CLIN NEUROSCI, V6, P505, DOI 10.1016/S0967-5868(99)90011-5; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Li W, 2015, J CRANIOFAC SURG, V26, P393, DOI 10.1097/SCS.0000000000001339; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Petrelli T, 2017, PAED CHILD HEALT-CAN, V22, P2, DOI 10.1093/pch/pxw011; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Vollmer BL., 2017, CLIN PEDIATR, DOI [10.1177/0009922817693300000992281769330, DOI 10.1177/0009922817693300000992281769330]; Zhao L, 2016, THER CLIN RISK MANAG, V12, DOI 10.2147/TCRM.S109482	26	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2021	44						419	422		10.1016/j.ajem.2020.05.010			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SP0HO	WOS:000659354100010	33243533				2022-02-07	
J	Steinberg, J				Steinberg, Jonathan			THE FALSE PROMISE OF MDL BELLWETHER REFORM: HOW MANDATORY BELLWETHER TRIAL CONSENT WOULD FURTHER MIRE MULTIDISTRICT LITIGATION	NEW YORK UNIVERSITY LAW REVIEW			English	Article							REPEAT PLAYERS	Over one third of all pending cases in the federal court system are part of a Multidistrict Litigation (MDL) proceeding. Previous and ongoing MDLs include claims stemming from the opioid epidemic, the Deepwater Horizon oil spill, the National Football League concussion cases, and a myriad of pharmaceutical and medical products liability suits. Both the percentage and sheer number of cases utilizing this form of aggregate litigation have dramatically increased in recent years. Bellwether trials, designed to test the facts and legal theories underpinning many of the consolidated cases, are a key feature of MDLs in facilitating resolution. This Note examines the role of MDL bellwether trials and the potential impact of proposed reforms. Part I surveys the functions of bellwether trials as well as current judicial limitations imposed on the practice. Part II examines proposals that would further restrict the use of MDL bellwether trials: first, a bill from the 115th Congress and second, proposed amendments to the Federal Rules of Civil Procedure. These proposals would require the consent of all parties for an MDL bellwether to ensue. Finally, Part III explores the potential effects of these proposed reforms as well as the discrepancies between their purported aims and the likely impact of their enactment. These proposals would exacerbate the MDL "black hole," result in less informed settlements, and create more opacity in the MDL process. Principally, they are an attempt to wrest power over procedure to cement defendants' structural advantage over the MDL.	[Steinberg, Jonathan] NYU, Sch Law, New York, NY 10003 USA		Steinberg, J (corresponding author), NYU, Sch Law, New York, NY 10003 USA.						[Anonymous], 2017, COMMUNICATION; [Anonymous], 2017, FICALA FIX LIT AB; [Anonymous], 2020, AG M ADV COMM CIV RU, P40; [Anonymous], 2019, MDL STAT PEND MDL DO; Barash Martina, 2019, BLOOMBERG L     1115; Bone Robert G., 2019, REV LITIG, V38, P211; Bone Robert G., 2019, REV LITIG, V38, P233; Bradt AD, 2019, GEORGETOWN LAW J, V108, P73; Bradt AD, 2018, FORDHAM LAW REV, V87, P87; Bradt AD, 2017, U PENN LAW REV, V165, P831; Bradt AD, 2012, NOTRE DAME LAW REV, V88, P759; Bradt Andrew D., 2019, GA L REV, V53, P1377; Bradt Andrew D., 2019, GA L REV, V53, P1375; Bradt Andrew D., 2018, B C L REV, V59, P1256; Bradt Andrew D., 2018, BOSTON COLL LAW REV, V59, P1251; Brown Loren H., 2014, AKRON L REV, V47, P667; Brown Loren H., 2014, AKRON L REV, V47, P663; Burbank SB, 1996, J LEGAL EDUC, V46, P513; Burch EC, 2017, CORNELL LAW REV, V102, P1445; Burch EC, 2017, VANDERBILT LAW REV, V70, P67; Burch Elizabeth Chamblee, 2017, VANDERBILT LAW REV, V70, P71; Caulfield Christine, 2007, LAW360; Cohen P., 2020, NEW YORK TIMES; Curley Mike, 2020, LAW360; Dodge Jaime, 2014, EMORY LJ, V64, P329; Dodge Jaime, 2014, EMORY LJ, V64, P378; Dooley LG, 2008, NEW YORK U LAW REV, V83, P411; Dooley Laura G., 2008, NEW YORK U LAW REV, V83, P437; Estoppel Collateral, 2019, BLACKS LAW DICT; Fallon Eldon, 2008, TUL L REV, V82, P2330; Fallon Eldon E., 2008, TUL L REV, V82, P2354; Faulk Richard O., 1998, TEX TECH L REV, V29, P779; Faulk Richard O., 1998, TEX TECH L REV, V29, P800; Field Emily, 2017, LAW360; Fleming George M., 2014, S TEX L REV, V56, P83; Fleming George M., 2014, S TEX L REV, V56, P71; FOR CIV. JUST, 2018, MDL PRACTICES NEED F; Glover JM, 2018, FORDHAM LAW REV, V86, P2113; Glover J. Maria, 2014, J TORT L, V5, P3; Glover J. Maria, 2014, J TORT L, V5, P20; Gluck AR, 2017, U PENN LAW REV, V165, P1669; Gluck Abbe R., 2017, U PENN LAW REV, V165, P1673; Hensler Deborah, 2001, SETON HALL L REV, V31, P883; Hensler Deborah R., 2001, SETON HALL L REV, V31, P894; HERR DAVID F., 2020, MULTIDISTRICT LITIGA, V5, P18; Hoffman J., 2019, NEW YORK TIMES; Jeopardy Double, 2019, BLACKS LAW DICT, V11th; JUD. CONF. OF THE UNITED STATES, 2018, AG M ADV COMM CI RUL, P155; JUD. CONF. OF THE UNITED STATES, 2019, SUMM REP JUD C COMM, P17; JUD. CONF. OF THE UNITED STATES, 2020, AG M ADV COMM CIV RU, P47; Kennedy John, 2017, LAW360; Lahav AD, 2008, GEORGE WASH LAW REV, V76, P576; Lahav Alexandra D., 2008, GEORGE WASH LAW REV, V76, P584; Lahav Alexandra D., 2018, REV LITIG, V37, P187; Lahav Alexandra D., 2018, REV LITIG, V37, P185; LAWS. FOR CIV. JUST, 2017, ALL CIV ACT P CALL B, P1; LAWS. FOR CIV. JUST, 2018, MAJ IN CURR AG, P1; Lidgett Adam, 2020, LAW360; Margaret S.Thomas, 2014, EMORY LJ, V63, P1339; MCGOVERN FE, 1995, TEX LAW REV, V73, P1821; McKenzie TA, 2012, NEW YORK U LAW REV, V87, P960; Mueller Christopher B., 2017, U KAN L REV, V65, P531; Mueller Christopher B., 2017, U KAN L REV, V65, P535; Mullenix LS, 2013, NORTHWEST U LAW REV, V107, P511; Mullenix LS, 2011, U CINCI LAW REV, V80, P389; Mullenix Linda S., 2011, U CIN L REV, V80, P426; Mullenix Linda S., 2013, NORTHWEST U LAW REV, V107, P554; Mullenix Linda S., 2011, U CIN L REV, V80, P424; Mullenix Linda S., 2018, REV LITIG, V37, P129; Mullenix Linda S., 2018, REV LITIG, V37, P146; NAGAREDA RICHARD A., 2007, MASS TORTS WORLD SET, P223; NAGAREDA RICHARD A., 2013, LAW CLASS ACTIONS OT, P586; Noll DL, 2019, MICH LAW REV, V118, P403; Overley Jeff, 2019, LAW360; Overley Jeff, 2020, LAW360; Plumer Brad, 2015, VOX             0511; Pollis AS, 2011, FORDHAM LAW REV, V79, P1643; Redish MH, 2015, BOSTON U LAW REV, V95, P109; Redish Martin H., 2015, BU L REV, V95, P113; ROTHSTEIN BARBARA J., 2011, MANAGING MULTIDISTRI, P3; SAACK AL, 2017, LEWIS CLARK L REV, V21, P847; Saack Amy L., 2017, LEWIS CLARK L REV, V21, P848; Savage ZB, 2013, NEW YORK U LAW REV, V88, P439; Savage Zachary B., 2013, NEW YORK U LAW REV, V88, P457; SCH DUKE L., 2018, GUID BEST PRACT LARG, Vvii; Sekula T, 2019, TEX LAW REV, V97, P859; Sekula Thomas, 2019, TEX LAW REV, V97, P863; Seyedfarshi Amir, 2016, W MICH U COOLEY J PR, V17, P295; Seyedfarshi Amir, 2016, TM COOLEY J PRAC CLI, V17, P301; Sherman Edward F., 2008, TUL L REV, V82, P2205; Sherman Edward F., 2008, TUL L REV, V82, P2215; Silver C, 2010, VANDERBILT LAW REV, V63, P107; Silver Charles, 2010, VANDERBILT LAW REV, V63, P123; Silver Charles, 1997, WAKE FOREST L REV, V32, P733; Silver Charles, 1997, WAKE FOREST L REV, V32, P746; Silver Courtney E., 2009, OHIO ST L J, V70, P461; Silver Courtney E., 2009, OHIO ST L J, V70, P455; Smyth Julie Carr, 2019, ASS PRESS; Teter M, 2008, CATHOL U LAW REV, V58, P153; Thomas Margaret S., 2014, EMORY LJ, V63, P1367; Tidmarsh Jay, 2019, CONN L REV, V51, P792; Tidmarsh Jay, 2019, CONN LAW REV, V51, P769; Troy A.McKenzie, 2012, NEW YORK U LAW REV, V87, P994; WHITNEY MELISSA J., 2019, BELLWETHER TRIALS MD, P4	104	0	0	0	0	NEW YORK UNIV SCHOOL LAW	NEW YORK	110 WEST THIRD ST, NEW YORK, NY 10012 USA	0028-7881			NEW YORK U LAW REV	N. Y. Univ. Law Rev.	JUN	2021	96	3					809	855					47	Law	Social Science Citation Index (SSCI)	Government & Law	SP2AL	WOS:000659474400004					2022-02-07	
J	Tarkenton, T; Caze, IT; Silver, CH; Hynan, LS; Didehbani, N; Miller, S; Batjer, H; Bell, K; Cullum, CM				Tarkenton, Tahnae; Caze, Todd, II; Silver, Cheryl H.; Hynan, Linda S.; Didehbani, Nyaz; Miller, Shane; Batjer, Hunt; Bell, Kathleen; Cullum, C. Munro			Differences in Adolescent Symptom Reporting Following Motor Vehicle Accident Versus Sport-Related Concussion	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Mild traumatic brain injury; Motor vehicle accident; Sport-related concussion; Rehabilitation; Pediatrics	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION SYNDROME; HIGH-SCHOOL; EPIDEMIOLOGY; CHILDREN	Objective: To characterize potential differences in youth concussion sustained in motor vehicle accident (MVA) versus sport-related concussion (SRC), hypothesizing that youth who sustain concussion in a MVA would endorse higher initial and persistent symptom scores compared to those with SRC, despite similar injury severity levels. Methods: Participants age 12-18 who sustained a concussion (i.e., Glasgow Coma Scale = 13-15) in a MVA (n = 35) were matched with SRC participants (n = 35) by sex, age, and days since injury. ANCOVA comparing initial postconcussion total symptom scores between the MVA and SRC groups were performed. Chi-square analysis with injury group by recovery time was used to determine whether youth who sustained concussion from MVA were more likely to endorse symptoms persisting >30 days at 3 months postinjury, and ANCOVA compared 3-month total symptom scores. Results: On average, the MVA group reported significantly higher initial postconcussion and more frequent persistent symptom scores compared to the SRC group. Conclusions: This is the first known study to examine context of injury in youth concussion while matching for injury severity, age, sex, and days since injury. Findings suggest the context of injury is an important clinical variable related to initial reporting of symptoms and endorsement of symptoms lasting more than 30 days. Tailored interventions that consider the context of injury may facilitate symptom resolution.	[Tarkenton, Tahnae; Caze, Todd, II; Silver, Cheryl H.; Hynan, Linda S.; Didehbani, Nyaz; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Hynan, Linda S.] Univ Texas Southwestern Med Ctr Dallas, Dept Populat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Hynan, Linda S.] Univ Texas Southwestern Med Ctr Dallas, Dept Data Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Miller, Shane] Univ Texas Southwestern Med Ctr Dallas, Dept Orthoped Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Miller, Shane] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Didehbani, Nyaz; Bell, Kathleen] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neumtherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Batjer, Hunt; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neuml Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Miller, Shane] Scottish Rite Children Orthoped & Sports Med Ctr, 5700 Dallas Pkwy, Frisco, TX 75034 USA		Cullum, CM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Psychol Div, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Munro.Cullum@UTSouthwestern.edu			Texas Institute for Brain Injury and Repair; Peter O'Donnell Brain Institute at UT Southwestern Medical Center	Funding was provided by the Texas Institute for Brain Injury and Repair and the Peter O'Donnell Brain Institute at UT Southwestern Medical Center.	Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; Agyemang, 2017, J MULTIDISCIPLINARY, V9, P45; [Anonymous], 2013, Br J Sports Med, V47, P263; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arnett P. A., 2019, NEUROPSYCHOLOGY SPOR, P71; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Cullum CM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-032345; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Donlon K, 2015, CHILD NEUROPSYCHOL, V21, P803, DOI 10.1080/09297049.2014.944491; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Landolt MA, 2003, J CHILD PSYCHOL PSYC, V44, P1199, DOI 10.1111/1469-7610.00201; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Misch MR, 2020, EMERG MED CLIN N AM, V38, P207, DOI 10.1016/j.emc.2019.09.010; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Peden M., 2008, World report on child injury prevention; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Van Pelt KL, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-018-0178-3; Varriano B, 2018, CAN J NEUROL SCI, V45, P636, DOI 10.1017/cjn.2018.322; Wilmoth K, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519830421; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	42	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2021	36	4					554	560		10.1093/arclin/acaa086			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	XT7SO	WOS:000733782900010	33067613				2022-02-07	
J	Tatum, S; Smith, ZZ; Taylor, JA; Poulsen, DJ; Dudek, FE; Barth, DS				Tatum, Sean; Smith, Zachariah Z.; Taylor, Jeremy A.; Poulsen, David J.; Dudek, F. Edward; Barth, Daniel S.			Sensitivity of unilateral- versus bilateral-onset spike-wave discharges to ethosuximide and carbamazepine in the fluid percussion injury rat model of traumatic brain injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						SWD; PTE; absence; seizure; epilepsy	ACUTE NONCONVULSIVE SEIZURES; GENETIC ABSENCE EPILEPSY; SPRAGUE-DAWLEY RATS; ANTIEPILEPTIC DRUGS; ANIMAL-MODELS; STRASBOURG; COMMON	Unilateral-onset spike-wave discharges (SWDs) following fluid percussion injury (FPI) in rats have been used for nearly two decades as a model for complex partial seizures in human posttraumatic epilepsy (PTE). This study determined if SWDs with a unilateral versus bilateral cortical onset differed. In this experiment, 2-mo-old rats received severe FPI (3 atm) or sham surgery and were instrumented for chronic video-electrocorticography (ECoG) recording (up to 9 mo). The antiseizure drug, carbamazepine (CBZ), and the antiabsence drug, ethosuximide (ETX), were administered separately to determine if they selectively suppressed unilateral- versus bilateral-onset SWDs, respectively. SWDs did not significantly differ between FPI and sham rats on any measured parameter (wave-shape, frequency spectrum, duration, or age-related progression), including unilateral H7%) versus bilateral (similar to 83%) onsets. SWDs with a unilateral onset preferentially originated ipsilateral to the craniotomy in both FPI and sham rats, suggesting that the unilateral-onset SWDs were related to surgical injury and not specifically to FPI. ETX profoundly suppressed SWDs with either unilateral or bilateral onsets, and CBZ had no effect on either type of SWD. These results suggest that SWDs with either a unilateral or bilateral onset have a pharmacosensitivity similar to absence seizures and are very different from the complex partial seizures of PTE. Therefore, SWDs with a unilateral onset after FPI are not a model of the complex partial seizures that occur in PTE, and their use for finding new treatments for PTE could be counterproductive, particularly if their close similarity to normal brain oscillations is not acknowledged. NEW & NOTEWORTHY Unilateral-onset spike-wave discharges (SWDs) in rats have been used to model complex partial seizures in human posttraumatic epilepsy (PTE), compared to bilateral-onset SWDs thought to reflect human absence seizures. Here, we show that both unilateral- and bilateral-onset SWDs following traumatic brain injury are suppressed by the antiabsence drug ethosuximide and are unaffected by the antiseizure drug carbamazepine. We propose that unilateral-onset SWDs are not useful for studying mechanisms of, or treatments for, PTE.	[Tatum, Sean; Smith, Zachariah Z.; Taylor, Jeremy A.; Barth, Daniel S.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Poulsen, David J.] Univ Buffalo, Dept Neurosurg, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Dudek, F. Edward] Univ Utah, Dept Neurosurg, Sch Med, Salt Lake City, UT USA		Barth, DS (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	daniel.barth@colorado.edu		BARTH, DANIEL/0000-0001-5474-1320; Poulsen, David/0000-0002-7793-2813	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [PR100040, EP150033]; Citizens United for Research in Epilepsy CURE [7153]	This work was supported by the U.S. Army Medical Research and Material Command (Grants PR100040 and EP150033) and by Citizens United for Research in Epilepsy CURE (Grant 7153) .	Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bercum FM, 2015, J NEUROSCI, V35, P15894, DOI 10.1523/JNEUROSCI.2803-15.2015; Coenen AML, 2003, BEHAV GENET, V33, P635, DOI 10.1023/A:1026179013847; COENEN AML, 1987, EPILEPSY RES, V1, P297, DOI 10.1016/0920-1211(87)90005-2; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2003, J NEUROTRAUM, V20, P1059; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; DEFEO MR, 1995, PHARMACOL RES, V31, P109, DOI 10.1016/1043-6618(95)80055-7; Depaulis A, 2016, J NEUROSCI METH, V260, P159, DOI 10.1016/j.jneumeth.2015.05.022; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Eastman CL, 2015, EXP NEUROL, V264, P150, DOI 10.1016/j.expneurol.2014.12.010; Eastman CL, 2010, EXP NEUROL, V224, P369, DOI 10.1016/j.expneurol.2010.04.013; Glauser TA, 2010, NEW ENGL J MED, V362, P790, DOI 10.1056/NEJMoa0902014; Goldenberg Marvin M, 2010, P T, V35, P392; Goren MZ, 2007, CNS DRUG REV, V13, P224, DOI 10.1111/j.1527-3458.2007.00009.x; Grabenstatter HL, 2019, EPILEPSIA, V60, P636, DOI 10.1111/epi.14680; HONACK D, 1989, NEUROPHARMACOLOGY, V28, P599, DOI 10.1016/0028-3908(89)90139-1; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; KAPLAN BJ, 1985, EXP NEUROL, V88, P425, DOI 10.1016/0014-4886(85)90204-3; Kelly KM, 2006, EXP NEUROL, V201, P495, DOI 10.1016/j.expneurol.2006.05.006; Kelly Kevin M, 2004, Epilepsy Curr, V4, P176, DOI 10.1111/j.1535-7597.2004.04503.x; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Loscher W, 2016, EPILEPSY RES, V126, P157, DOI 10.1016/j.eplepsyres.2016.05.016; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Mifsud J, 2001, BIOPHARM DRUG DISPOS, V22, P83, DOI 10.1002/bdd.266; Mountney A, 2013, J NEUROTRAUM, V30, P1973, DOI 10.1089/neu.2013.3001; Nissinen J, 2007, EPILEPSY RES, V73, P181, DOI 10.1016/j.eplepsyres.2006.10.003; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Shaw FZ, 2007, J NEUROPHYSIOL, V97, P238, DOI 10.1152/jn.00340.2006; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Smith D, 2018, EPILEPSY RES, V147, P87, DOI 10.1016/j.eplepsyres.2018.09.005; Smith MD, 2007, EPILEPSY RES, V74, P97, DOI 10.1016/j.eplepsyres.2007.02.001; Smith ZZ, 2018, J NEUROPHYSIOL, V119, P1818, DOI 10.1152/jn.00721.2017; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Taylor JA, 2019, J NEUROSCI, V39, P4829, DOI 10.1523/JNEUROSCI.1167-18.2019; Taylor JA, 2017, J NEUROSCI, V37, P5861, DOI 10.1523/JNEUROSCI.3235-16.2017; Terzioglu B, 2006, J PHARMACOL SCI, V100, P227, DOI 10.1254/jphs.FP0050691; Twele Friederike, 2016, Epilepsia Open, V1, P45, DOI 10.1002/epi4.2; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999	50	0	0	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JUN	2021	125	6					2166	2177		10.1152/jn.00098.2021			12	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	SQ4AI	WOS:000660300600014	33949882				2022-02-07	
J	Theodorou, CM; Nuno, M; Yamashiro, KJ; Brown, EG				Theodorou, Christina M.; Nuno, Miriam; Yamashiro, Kaeli J.; Brown, Erin G.			Increased mortality in very young children with traumatic brain injury due to abuse: A nationwide analysis of 10,965 patients	JOURNAL OF PEDIATRIC SURGERY			English	Article						Child abuse; Traumatic brain injury; Accidental head injury; Mortality	HEAD TRAUMA; ICISS	Background: Traumatic brain injury (TBI) is the leading cause of death and disability in young children; however, the impact of mechanism on outcomes has not been fully evaluated. We hypothesized that children with TBI due to abuse would have a higher mortality than children with accidental TBI due to motor vehicle collisions (MVC). Methods: We performed a retrospective review of the National Kids' Inpatient (KID) hospitalizations database of children < 2 years old with TBI due to abuse or MVC (20 0 0-2016). The primary outcome was mortality. Secondary outcomes were length of stay (LOS) and hospital charges. We investigated predictors of mortality with multivariable regression. Results: Of 10,965 children with TBI, 65.2% were due to abuse. Overall mortality was 9.8% ( n = 1074). Abused children had longer LOS (5.7 vs 1.6 days, p < 0.0 0 01) and higher hospital charges ($34,314 vs $19,360, p < 0.0 0 01) than children with TBI due to MVC. The odds of mortality were 42% higher in children with abusive head trauma (OR 1.42, 95% CI 1.10-1.83, p = 0.007) compared to MVCs after adjusting for age, race, sex, neurosurgical intervention, injury severity, and insurance. Conclusion: Children with abusive traumatic brain injury have increased risk of mortality, longer LOS, and higher hospital charges compared to children with TBI due to motor vehicle collision after adjusting for relevant confounders. Resources must be directed at prevention and early identification of abuse. (c) 2021 Elsevier Inc. All rights reserved.	[Theodorou, Christina M.; Yamashiro, Kaeli J.; Brown, Erin G.] Univ Calif Davis, Med Ctr, Dept Pediat Gen Thorac & Fetal Surg, Sacramento, CA 95817 USA; [Nuno, Miriam] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Sacramento, CA 95817 USA		Theodorou, CM (corresponding author), Univ Calif Davis, Med Ctr, Dept Pediat Gen Thorac & Fetal Surg, Sacramento, CA 95817 USA.	ctheodorou@ucdavis.edu		Theodorou, Christina/0000-0002-0365-3053; Brown, Erin/0000-0003-4381-1850	National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001860]	The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR001860 for authors C.M.T. and E.G.B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; Allen CJ, 2016, PEDIATR SURG INT, V32, P657, DOI 10.1007/s00383-016-3900-7; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI, DOI [10.1080/02699052.2017.1312145, DOI 10.1080/02699052.2017.1312145]; Davies F, 2020, EMERG MED J, V37, P118, DOI 10.1136/emermed-2019-209280; O'Meara AMI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00118; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Larimer EL, 2013, J PEDIATR SURG, V48, P1357, DOI 10.1016/j.jpedsurg.2013.03.035; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Lee Michael Jr, 2017, Hosp Pediatr, V7, P572, DOI 10.1542/hpeds.2017-0027; Livingston JK, 2019, PEDIATR SURG INT, V35, P779, DOI 10.1007/s00383-019-04482-5; Meredith JW, 2003, J TRAUMA, V55, P924, DOI 10.1097/01.TA.0000085645.62482.87; Nuno M, 2020, CHILD ABUSE NEGLECT, V104, DOI 10.1016/j.chiabu.2020.104488; Nuno M, 2019, J TRAUMA ACUTE CARE, V87, P827, DOI 10.1097/TA.0000000000002255; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Powers E, 2019, J EMERG MED, V56, P592, DOI 10.1016/j.jemermed.2019.01.030; Rosenfeld EH, 2020, J PEDIATR SURG, V55, P693, DOI 10.1016/j.jpedsurg.2019.03.024; Shahi N, 2020, J PEDIATR SURG, V55, P335, DOI 10.1016/j.jpedsurg.2019.10.024; Tepas JJ, 2008, J TRAUMA, V65, P1258, DOI 10.1097/TA.0b013e31818cac29; Vadivelu S, 2015, WORLD NEUROSURG, V84, P1340, DOI 10.1016/j.wneu.2015.06.023	21	0	0	2	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	JUN	2021	56	6					1174	1179		10.1016/j.jpedsurg.2021.02.044			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Surgery	SC9ER	WOS:000650965100014	33752910				2022-02-07	
J	Tsur, N; Haller, CS				Tsur, Noga; Haller, Chiara S.			Self-Rated Health Among Patients With Severe Traumatic Brain Injury and Their Close Relatives: The Role of Posttraumatic Stress Symptoms	PSYCHOSOMATIC MEDICINE			English	Article						TRAST-MI; severe traumatic brain injury; posttraumatic stress symptoms; patients; relatives; self-rated health; AIS = Abbreviated Injury Scale; GCS = Glasgow Coma Scale; HAIS = Abbreviated Injury Scale of the head region; HRQoL = health-related quality of life; PEBITA = Patient-relevant Endpoints after Brain Injury from Traumatic Accidents; PTS = posttraumatic stress; PTSD = Posttraumatic stress disorder; SSS-PTSD = The Short Screening Scale for Statistical Manual of Mental Disorders; Fourth Edition PTSD; sTBI = severe Traumatic Brain Injury; TBI = traumatic brain injury; TRAST-MI = Trajectories of Recovery After Severe Traumatic brain injury-Matters In families	SHORT SCREENING SCALE; QUALITY-OF-LIFE; SINGLE-ITEM; SECONDARY TRAUMATIZATION; POSTCONCUSSIVE SYMPTOMS; DISORDER SYMPTOMS; PHYSICAL HEALTH; COMBAT VETERANS; EX-PRISONERS; OLDER-ADULTS	Objective Severe traumatic brain injury (sTBI) is accompanied by significant declines in self-rated health (SRH). Although such deteriorations in SRH are related to various consequences of sTBI, the effect of posttraumatic reactions (i.e., posttraumatic stress [PTS] symptoms) has been tested insufficiently to date, especially among civilians. The present investigation is based on Trajectories of Recovery After Severe Traumatic brain injury-Matters In families (TRAST-MI), a unique study among civilians with sTBI and their families. Previous research revealed that civilian sTBI has effects beyond the injured patient, influencing their close relatives as well. The aim of this study was to assess the association between PTS symptoms and SRH among patients with civilian sTBI and their close relatives. Methods Patients with sTBI (assessed by an Abbreviated Injury Scale of the head region score >3) and their close relatives participated in TRAST-MI. One hundred twenty-six patient-relative dyads were assessed at 3, 6, and 12 months after the injury. Results Multilevel modeling revealed that patients' PTS symptoms were associated with consequent SRH (slope = 0.42; p < .001), and relatives' PTS symptoms were associated with their respective SRH (slope = 0.2; p = .012). Conclusions The findings of this study reveal that SRH of both patients with sTBI and their relatives are negatively affected by their own PTS symptoms. These findings underline the understanding that sTBI is not merely a medical trauma but rather a comprehensive psychosocial trauma, which has consequences for the whole family system.	[Tsur, Noga] Tel Aviv Univ, Bob Shapell Sch Social Work, Tel Aviv, Israel; [Haller, Chiara S.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Haller, Chiara S.] Harvard Med Sch, Div Publ Psychiat, Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA; [Haller, Chiara S.] Cognicreate LLC, Cambridge, MA USA		Tsur, N (corresponding author), Tel Aviv Univ, Sch Social Work, Tel Aviv, Israel.	nogatsur@tauex.tau.ac.il; haller@fas.harvard.edu			PEBITA	All authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The senior author received a grant from PEBITA as a principal investigator of TRAST-MI in 2017 for her continuous commitment to investigations in patients with brain disorders. Neither her nor any of the other authors received any financial support for the research, authorship, and/or publication of this article.	Acierno R, 2006, AM J GERIAT PSYCHIAT, V14, P1051, DOI 10.1097/01.JGP.0000221327.97904.b0; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Averill PM, 2000, J ANXIETY DISORD, V14, P133, DOI 10.1016/S0887-6185(99)00045-6; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Benyamini Y, 2005, SOC SCI MED, V61, P1267, DOI 10.1016/j.socscimed.2005.01.023; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Benyamini Y., 2016, ASSESSMENT HLTH PSYC, P175; Benyamini Y, 2011, PSYCHOL HEALTH, V26, P1407, DOI 10.1080/08870446.2011.621703; Bohnert KM, 2011, INT J METH PSYCH RES, V20, pE1, DOI 10.1002/mpr.331; Bosma CM, 2018, ARCH PHYS MED REHAB, V99, P1576, DOI 10.1016/j.apmr.2018.02.008; Boynton-Jarrett R, 2008, PEDIATRICS, V122, P961, DOI 10.1542/peds.2007-3063; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Delahanty DL, 2003, J ANXIETY DISORD, V17, P149, DOI 10.1016/S0887-6185(02)00185-8; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Durai UNB, 2011, J AM GERIATR SOC, V59, P1087, DOI 10.1111/j.1532-5415.2011.03407.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Figley CR., 1997, BURNOUT FAMILIES SYS; Gad AM., 2017, INT J STAT DISTRIBUT, V3, P72, DOI DOI 10.11648/J.IJSD.20170304.13; Gardner DG, 1998, EDUC PSYCHOL MEAS, V58, P898, DOI 10.1177/0013164498058006003; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Ginzburg K, 2014, J BEHAV MED, V37, P564, DOI 10.1007/s10865-013-9514-9; Haller CS, 2017, BRAIN INJURY, V31, P1903, DOI 10.1080/02699052.2017.1346295; Haller CS, 2017, J PERS, V85, P481, DOI 10.1111/jopy.12254; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Haller CS, 2017, QUAL LIFE RES, V26, P893, DOI 10.1007/s11136-016-1416-1; Hawkley LC, 2006, PSYCHOL AGING, V21, P152, DOI 10.1037/0882-7974.21.1.152; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kimerling R, 2000, J TRAUMA STRESS, V13, P115, DOI 10.1023/A:1007729116133; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Krause N, 2004, PSYCHOL AGING, V19, P637, DOI 10.1037/0882-7974.19.4.637; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lahav Y, 2017, J TRAUMA STRESS, V30, P399, DOI 10.1002/jts.22204; Lahav Y, 2016, J PSYCHOSOM RES, V89, P61, DOI 10.1016/j.jpsychores.2016.08.008; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin Y, 2016, J FAM PSYCHOL, V30, P72, DOI 10.1037/fam0000170; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Lopez-Martinez AE, 2014, EUR J PAIN, V18, P1129, DOI 10.1002/j.1532-2149.2014.00459.x; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Maercker A, 1998, DIAGNOSTICA, V44, P130; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Manor O, 2001, INT J EPIDEMIOL, V30, P600, DOI 10.1093/ije/30.3.600; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; Messina N, 2006, AM J PUBLIC HEALTH, V96, P1842, DOI 10.2105/AJPH.2005.082016; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pielmaier L, 2013, J LOSS TRAUMA, V18, P521, DOI 10.1080/15325024.2012.719342; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Pinheiro J., 2018, NLME LINEAR NONLINEA; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Rogers C., 1961, C ROGERS READER, P409; Rolland JS, 2017, FAM PROCESS, V56, P799, DOI 10.1111/famp.12316; SHIELDS SA, 1989, J PERS ASSESS, V53, P802, DOI 10.1207/s15327752jpa5304_16; Siegrist P., 2010, TRAUMA GEWALT, V3, P208; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tsur N., 2019, FAM PROCESS; Tsur N, 2020, CHILD ABUSE NEGLECT, V104, DOI 10.1016/j.chiabu.2020.104469; Tsur N, 2019, SOC SCI MED, V234, DOI 10.1016/j.socscimed.2019.112373; Tsur N, 2017, PSYCHOSOM MED, V79, P655, DOI 10.1097/PSY.0000000000000461; van Buuren S, 2010, EUR ASSOC METHODOL S, P173; Van der Kolk B, 2014, BODY KEEPS SCORE; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; Weiss Daniel S., 1997, P399; Wolitzky-Taylor KB, 2010, DEPRESS ANXIETY, V27, P190, DOI 10.1002/da.20653; Wu SQ, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-320, 10.1186/1471-2458-13-636]; Zerach G, 2015, J HEALTH PSYCHOL, V20, P222, DOI 10.1177/1359105313502563; Zhang SR, 2009, J REHABIL MED, V41, P1062, DOI 10.2340/16501977-0462; Zinzow HM, 2011, J AM COLL HEALTH, V59, P588, DOI 10.1080/07448481.2010.520175; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	82	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	JUN	2021	83	5					449	456		10.1097/PSY.0000000000000946			8	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	TD6KE	WOS:000669432500007	33883538				2022-02-07	
J	Velasco, R; Moore, CM; Deiratany, S; D'Elia, F; Tourteau, LB; Zuiani, C; Bognar, Z; Erdelyi, K; Fadgyas, B; Fejes, M; Teksam, O; Mirzeyev, Y; Esmeray, P; Fernandez, SM; Ricondo, A; Da Dalt, L; Bressan, S; Priante, E; Snoeck, E; Broers, M; Castman-Berrevoets, CE; Fernandes, RM; Borges, J; Obieta, A; Alcalde, M; Pinol, S; Gonzalez, J; Azzali, A; Gioe, D; La Spina, L; Bianconi, M; Arribas, M; Parri, N				Velasco, Roberto; Moore, Carmel M.; Deiratany, Samir; D'Elia, Federica; Bertrand Tourteau, Laetitia; Zuiani, Chiara; Bognar, Zsolt; Erdelyi, Katalin; Fadgyas, Balazs; Fejes, Marianna; Teksam, Ozlem; Mirzeyev, Yalcin; Esmeray, Pelin; Fernandez, Santiago M.; Ricondo, Amaia; Da Dalt, Liviana; Bressan, Silvia; Priante, Elena; Snoeck, Eveline; Broers, Merel; Castman-Berrevoets, Coriene E.; Fernandes, Ricardo M.; Borges, Joana; Obieta, Anaida; Alcalde, Maider; Pinol, Sergio; Gonzalez, Javier; Azzali, Annachiara; Gioe, Daniela; La Spina, Luisa; Bianconi, Martina; Arribas, Marta; Parri, Niccolo			Variability in the management and imaging use in paediatric minor head trauma in European emergency departments. A Research in European Pediatric Emergency Medicine study	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						computed tomography; clinical prediction rules; emergency department; minor head trauma; paediatrics; traumatic brain injury	COMPUTED-TOMOGRAPHY; UNITED-STATES; INJURY; CHILDREN; GUIDELINES; PECARN	Objective The objective of the study was to assess the variability in the management of paediatric MHT in European emergency departments (EDs). Methods This was a multicentre retrospective study of children <= 18 years old with minor head trauma (MHT) (Glasgow Coma Scale >= 14) who presented to 15 European EDs between 1 January 2013 and 31 December 31. Data on clinical characteristics, imaging tests, and disposition of included patients were collected at each hospital over a 3-year period. Results We included 11 212 patients. Skull radiography was performed in 3416 (30.5%) patients, range 0.4-92.3%. A computed tomography (CT) was obtained in 696 (6.2%) patients, range 1.6-42.8%. The rate of admission varied from 0 to 48.2%. Conclusion We found great variability in terms of the type of imaging and rate of CT scan obtained. Our study suggests opportunity for improvement in the area of paediatric head injury and the need for targeted individualised ED interventions to improve management of MHT.	[Velasco, Roberto] Rio Hortega Univ Hosp, Pediat Emergency Unit, Dulzaina 2, Valladolid 47012, Spain		Velasco, R (corresponding author), Rio Hortega Univ Hosp, Pediat Emergency Unit, Dulzaina 2, Valladolid 47012, Spain.	robertovelascozuniga@gmail.com	La Spina, Luisa/AAC-5832-2022; VELASCO, ROBERTO/H-5885-2011; Fernandes, Ricardo M/C-7501-2015	La Spina, Luisa/0000-0003-1218-6407; VELASCO, ROBERTO/0000-0003-0073-2650; Fernandes, Ricardo M/0000-0002-7253-6475; Borges, Joana/0000-0001-9421-5237	Research in European Pediatric Emergency Medicine (REPEM) Network	We gratefully acknowledge the Research in European Pediatric Emergency Medicine (REPEM) Network for supporting this project, Santiago Mintegi from the Cruces University Hospital, Biocruces Health Research Institute, Bilbao, Spain, for his advice and contribution to this study. We also acknowledge Dr. Giulio Andreatta for his support and assistance with data collection at the Emergency Department of Padova,	Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bergman DA, 1999, PEDIATRICS, V104, P1407; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Bressan S, 2017, EUR J EMERG MED, V24, P308, DOI 10.1097/MEJ.0000000000000459; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Lumba-Brown A., REPORT PEDIAT MILD T; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Marin JR, 2015, J PEDIATR-US, V167, P897, DOI 10.1016/j.jpeds.2015.06.052; Mintegi S, 2014, EUR J EMERG MED, V21, P24, DOI 10.1097/MEJ.0b013e328364d807; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Parri N, 2018, J PEDIATR-US, V196, P230, DOI 10.1016/j.jpeds.2017.12.057; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reed MJ, 2005, ARCH DIS CHILD, V90, P859, DOI 10.1136/adc.2004.053603; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Velasco R, 2015, AN PEDIATR, V83, P166, DOI 10.1016/j.anpedi.2014.10.012	24	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	JUN	2021	28	3					196	201		10.1097/MEJ.0000000000000763			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RV7OL	WOS:000646017200010	33079737				2022-02-07	
J	Viezel-Mathieu, A; Galli, R; Lessard, L				Viezel-Mathieu, Alex; Galli, Rafael; Lessard, Lucie			A Review of Frontal Orbital and Frontal Sinus Fractures and Associated Ocular Injuries-Level I Trauma Center-University Hospital Experience	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial trauma; facial fractures; frontal sinus	MANAGEMENT	Background: Traumatic frontal fractures result from high force injuries and can result in significant morbidity and mortality. The purpose of the current study is to evaluate our Montreal General Hospital (MGH) experience with frontal bone fractures. Methods: A comprehensive review of our trauma database was performed. All adult patients (>18 years) presenting with a diagnosis of frontal sinus fracture were identified. A thorough retrospective electronic medical records search was performed and relevant data extracted. Specifically, all cases of ocular injury or sequelae were identified and an in-depth review was performed. Results: Between 2008 and 2014, 10,189 trauma patients presented to the MUHC Level 1 trauma center. A total of 1277 patients presented with a facial fracture and 140 had a frontal sinus fracture. The mean age was 43.5 years, 90% were male and the mean hospitalization time was 16.2 days. A significant proportion of patients suffered concomitant craniomaxillofacial fractures including orbital (79%), maxillary (66%), nasal (64%), zygomaticomaxillary complex (34%), nasoorbitoethmoid (31%), Lefort types I-III (18%), and mandibular (8%). Associated cervical spine injuries were documented in 16% of patients. Ocular injuries were present in 30% of subjects. 26% of patients had some form of permanent sequelae from their trauma, mainly neurological. Conclusions: Due to the intimate association of the frontal bones with the brain and the orbits, frontal sinus fractures demand a sophisticated multidisciplinary craniofacial surgical approach. Given the high rate of ocular injury of 30% as well as severe systemic injuries, the authors propose a modified treatment algorithm for these complex cases.	[Viezel-Mathieu, Alex; Galli, Rafael; Lessard, Lucie] McGill Univ, Div Plast & Reconstruct Surg, Montreal, PQ, Canada		Lessard, L (corresponding author), McGill Univ, Div Plast & Reconstruct Surg, Montreal, PQ, Canada.; Lessard, L (corresponding author), McGill Univ, Surg, 1650 Cedar Ave,D6-269, Montreal, PQ H3G 1A4, Canada.; Lessard, L (corresponding author), McGill Univ, Hlth Ctr MUHC, 1650 Cedar Ave,D6-269, Montreal, PQ H3G 1A4, Canada.; Lessard, L (corresponding author), McGill Univ, 1650 Cedar Ave,D6-269, Montreal, PQ H3G 1A4, Canada.; Lessard, L (corresponding author), Int ICOPLAST, Educ Comm, 1650 Cedar Ave,D6-269, Montreal, PQ H3G 1A4, Canada.	drlessard@gmail.com					Azzi AJ, 2019, J CRANIOFAC SURG, V30, pE228, DOI 10.1097/SCS.0000000000005186; Draf W, 2005, FRONTAL SINUS, P219, DOI 10.1007/3-540-27607-6_24; Ehrenfeld M, 2012, PRINCIPLES INTERNAL; Gerbino G, 2000, J CRANIO MAXILL SURG, V28, P133, DOI 10.1054/jcms.2000.0134; Kountakis SE, 2007, RHINOLOGIC SLEEP APN; Lauder A, 2010, LARYNGOSCOPE, V120, P1940, DOI 10.1002/lary.21081; Lee J, 2013, J CRANIOFAC SURG, V24, P34, DOI 10.1097/SCS.0b013e3182799098; LUCE EA, 1987, PLAST RECONSTR SURG, V80, P500, DOI 10.1097/00006534-198710000-00003; Malekpour M, 2016, J CRANIOFAC SURG, V27, P1677, DOI 10.1097/SCS.0000000000002724; Manson PN, 2009, PLAST RECONSTR SURG, V124, P2096, DOI 10.1097/PRS.0b013e3181bf8394; McCarthy JG., 1990, PLASTIC SURG GEN PRI, V1; McCarty JC, 2020, J CRANIOFAC SURG, V31, P1182, DOI 10.1097/SCS.0000000000006379; Metzinger SE, 2009, CRANIOMAX TRAUM REC, V2, P27, DOI 10.1055/s-0029-1202597; Moore L, 2017, ANN SURG, V265, P212, DOI 10.1097/SLA.0000000000001614; MUNRO IR, 1994, PLAST RECONSTR SURG, V93, P185, DOI 10.1097/00006534-199401000-00031; ONISHI K, 1989, J CRANIO MAXILL SURG, V17, P58, DOI 10.1016/S1010-5182(89)80046-0; Pappachan B, 2012, J MAXILLOFAC ORAL SU, V11, P224, DOI 10.1007/s12663-011-0289-7; Poon A, 1999, J TRAUMA, V46, P494, DOI 10.1097/00005373-199903000-00027; Rodriguez ED, 2008, PLAST RECONSTR SURG, V122, P1850, DOI 10.1097/PRS.0b013e31818d58ba; ROHRICH RJ, 1992, CLIN PLAST SURG, V19, P219; Thaller SR., 2004, FACIAL TRAUMA MANAGE; WALLIS A, 1988, LARYNGOSCOPE, V98, P593; Yavuzer R, 2005, PLAST RECONSTR SURG, V115, p79E, DOI 10.1097/01.PRS.0000161988.06847.6A; Young Craig C, 2002, Curr Sports Med Rep, V1, P306	24	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1615	1618		10.1097/SCS.0000000000007422			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100121	33741886				2022-02-07	
J	Wahlquist, VE; Kaminski, TW				Wahlquist, Victoria E.; Kaminski, Thomas W.			Analysis of Head Impact Biomechanics in Youth Female Soccer Players Following the Get aHEAD Safely in Soccer (TM) Heading Intervention	SENSORS			English	Article						repetitive head impacts; football; concussion; wearable sensors	CHRONIC TRAUMATIC ENCEPHALOPATHY; POSTURAL CONTROL; NEUROCOGNITIVE PERFORMANCE; BALANCE; ACCELERATION; SCENARIO	The effects of repetitive head impacts associated with soccer heading, especially in the youth population, are unknown. The purpose of this study was to examine balance, neurocognitive function, and head impact biomechanics after an acute bout of heading before and after the Get aHEAD Safely in Soccer (TM) program intervention. Twelve youth female soccer players wore a Triax SIM-G head impact sensor during two bouts of heading, using a lightweight soccer ball, one before and one after completion of the Get aHEAD Safely in Soccer (TM) program intervention. Participants completed balance (BESS and SWAY) and neurocognitive function (ImPACT) tests at baseline and after each bout of heading. There were no significant changes in head impact biomechanics, BESS, or ImPACT scores pre- to post-season. Deficits in three of the five SWAY positions were observed from baseline to post-season. Although we expected to see beneficial changes in head impact biomechanics following the intervention, the coaches and researchers observed an improvement in heading technique/form. Lightweight soccer balls would be a beneficial addition to header drills during training as they are safe and help build confidence in youth soccer players.	[Wahlquist, Victoria E.; Kaminski, Thomas W.] Univ Delaware, Athlet Training Res Lab, Newark, DE 19716 USA		Kaminski, TW (corresponding author), Univ Delaware, Athlet Training Res Lab, Newark, DE 19716 USA.	vwahlq@udel.edu; kaminski@udel.edu		Kaminski, Thomas/0000-0003-0924-0978			Alosco M.L., 2019, NEUROPSYCHOLOGY SPOR, P151; Alsalaheen B, 2016, BRAIN INJURY, V30, P914, DOI 10.3109/02699052.2016.1146965; Anderson SL, 2019, CLIN J SPORT MED, V29, P413, DOI 10.1097/JSM.0000000000000545; Ashton J, 2021, SCI MED FOOTBALL, V5, P181, DOI 10.1080/24733938.2020.1846769; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bonke EM, 2021, J SCI MED SPORT, V24, P247, DOI 10.1016/j.jsams.2020.09.003; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Caccese JB, 2021, CLIN J SPORT MED, V31, P266, DOI 10.1097/JSM.0000000000000709; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Caccese JB, 2016, J SPORT REHABIL, V25, P133, DOI 10.1123/jsr.2014-0281; FIFA, 2007, FIFA MAGAZINE, P10; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harriss A, 2019, MUSCULOSKEL SCI PRAC, V40, P53, DOI 10.1016/j.msksp.2019.01.009; Hosseini-Farid M, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25020021; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kaminski TW, 2020, SCI MED FOOTBALL, V4, P93, DOI 10.1080/24733938.2019.1677937; Kaminski TW, 2020, RES SPORTS MED, V28, P217, DOI 10.1080/15438627.2019.1635130; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Peek K, 2020, J SCI MED SPORT, V23, P453, DOI 10.1016/j.jsams.2019.11.004; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Viel S, 2009, MOTOR CONTROL, V13, P25, DOI 10.1123/mcj.13.1.25; Wahlquist VE, 2019, SCI MED FOOTBALL, V3, P115, DOI 10.1080/24733938.2018.1532104	31	0	0	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	JUN	2021	21	11							3859	10.3390/s21113859			9	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	SQ9LT	WOS:000660670100001	34204896	gold, Green Published			2022-02-07	
J	Wang, CY; Shao, CJ; Zhang, L; Siedlak, SL; Meabon, JS; Peskind, ER; Lu, YB; Wang, WZ; Perry, G; Cook, DG; Zhu, XW				Wang, Chunyu; Shao, Changjuan; Zhang, Li; Siedlak, Sandra L.; Meabon, James S.; Peskind, Elaine R.; Lu, Yubing; Wang, Wenzhang; Perry, George; Cook, David G.; Zhu, Xiongwei			Oxidative Stress Signaling in Blast TBI-Induced Tau Phosphorylation	ANTIOXIDANTS			English	Article						blast; traumatic brain injury; tau phosphorylation; oxidative stress; ERK; JNK; p38; GSK3 beta	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RATS INVOLVEMENT; AXONAL INJURY; ANIMAL-MODEL; EXPOSURE; ENCEPHALOPATHY; INFLAMMATION; DYSFUNCTION; PERSISTENT	Traumatic brain injury caused by blast is associated with long-term neuropathological changes including tau phosphorylation and pathology. In this study, we aimed to determine changes in initial tau phosphorylation after exposure to a single mild blast and the potential contribution of oxidative stress response pathways. C57BL/6 mice were exposed to a single blast overpressure (BOP) generated by a compressed gas-driven shock tube that recapitulates battlefield-relevant open-field BOP, and cortical tissues were harvested at different time points up to 24 h after blast for Western blot analysis. We found that BOP caused elevated tau phosphorylation at Ser202/Thr205 detected by the AT8 antibody at 1 h post-blast followed by tau phosphorylation at additional sites (Ser262 and Ser396/Ser404 detected by PHF1 antibody) and conformational changes detected by Alz50 antibody. BOP also induced acute oxidative damage at 1 h post-blast and gradually declined overtime. Interestingly, Extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) were acutely activated in a similar temporal pattern as the rise and fall in oxidative stress after blast, with p38 showing a similar trend. However, glycogen synthase kinase-3 beta (GSK3 beta) was inhibited at 1 h and remained inhibited for 24 h post blast. These results suggested that mitogen-activated protein kinases (MAPKs) but not GSK3 beta are likely involved in mediating the effects of oxidative stress on the initial increase of tau phosphorylation following a single mild blast.	[Wang, Chunyu] Cent South Univ, Second Xiangya Hosp, Dept Neurol, Changsha 410083, Peoples R China; [Wang, Chunyu; Shao, Changjuan; Zhang, Li; Siedlak, Sandra L.; Lu, Yubing; Wang, Wenzhang; Zhu, Xiongwei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Zhang, Li] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200240, Peoples R China; [Meabon, James S.; Peskind, Elaine R.; Cook, David G.] VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Meabon, James S.; Peskind, Elaine R.; Cook, David G.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98115 USA; [Perry, George] Univ Texas San Antonio, Dept Biol, Coll Sci, San Antonio, TX 78229 USA; [Cook, David G.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA		Zhu, XW (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	wangchunyu@csu.edu.cn; cxs708@case.edu; lenzhangli@hotmail.com; sls7@case.edu; James64@uw.edu; peskind@uw.edu; yubing.lu@case.edu; wenzhang.wang@case.edu; George.Perry@utsa.edu; dgcook@uw.edu; xiongwei.zhu@case.edu	; Zhu, Xiongwei/A-9629-2009; Perry, George/A-8611-2009	Meabon, James/0000-0002-0225-1546; Zhu, Xiongwei/0000-0003-2092-6508; Perry, George/0000-0002-6547-0172	Robert M. Kohrman Memorial Fund, National Institute of Health [AG049479]; VA Biomedical Laboratory Research and Development Service from the U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01BX002311]; Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B77421]; University of Washington Friends of Alzheimer's Research; Department of Veterans Affairs Biomedical Laboratory Research and Development Service Merit Review GrantsUS Department of Veterans Affairs [BX004896-01A2]	This research was supported in part by the Robert M. Kohrman Memorial Fund, National Institute of Health (AG049479 to X.Z.), VA Biomedical Laboratory Research and Development Service from the U.S. Department of Veterans Affairs I01BX002311 (D.G.C.); Veterans Affairs Rehabilitation Research and Development Service #B77421 (E.R.P.); University of Washington Friends of Alzheimer's Research (D.G.C. and E.R.P.); Department of Veterans Affairs Biomedical Laboratory Research and Development Service Merit Review Grants #BX004896-01A2 (J.S.M.).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Aldag M, 2017, J NEUROTRAUM, V34, pS26, DOI 10.1089/neu.2017.5218; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Chen ST, 2018, J ALZHEIMERS DIS, V65, P79, DOI 10.3233/JAD-171152; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Katz DI, 2021, NEUROLOGY, V96, P848, DOI 10.1212/WNL.0000000000011850; Kornblith E, 2020, NEUROLOGY, V95, pE1768, DOI 10.1212/WNL.0000000000010617; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu Q, 2005, FREE RADICAL BIO MED, V38, P746, DOI 10.1016/j.freeradbiomed.2004.11.005; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McKee AC, 2020, SEMIN NEUROL, V40, P359, DOI 10.1055/s-0040-1713632; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Miller BE, 1999, LIFE SCI, V65, P2215, DOI 10.1016/S0024-3205(99)00486-5; Murphy EK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74296-2; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Peng JHF, 2006, ANN CLIN LAB SCI, V36, P151; Rana P, 2020, METABOLOMICS, V16, DOI 10.1007/s11306-020-1649-4; Rashedinia M, 2015, ACTA NEUROBIOL EXP, V75, P208; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Shi QX, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147038; Shi QX, 2020, BRAIN RES BULL, V157, P149, DOI 10.1016/j.brainresbull.2020.02.002; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Su B, 2010, NEUROSCI LETT, V468, P267, DOI 10.1016/j.neulet.2009.11.010; Takeda A, 2000, J NEUROCHEM, V75, P1234, DOI 10.1046/j.1471-4159.2000.0751234.x; Tripathy A, 2019, J ALZHEIMERS DIS, V67, P1277, DOI 10.3233/JAD-181039; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wang L, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00189-z; Wang WZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00376-6; Wang YS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00413; Yang Y, 2018, J ALZHEIMERS DIS, V62, P1305, DOI 10.3233/JAD-170788; Zhu XW, 2005, MOL NEUROBIOL, V31, P205, DOI 10.1385/MN:31:1-3:205; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	43	0	0	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	JUN	2021	10	6							955	10.3390/antiox10060955			12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	SX8DO	WOS:000665428600001	34203583	gold, Green Published			2022-02-07	
J	Weymann, KB; Rourke, JM				Weymann, Kris B.; Rourke, Jennifer M.			Sleep after Traumatic Brain Injury	NURSING CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Sleep; Sleep-wake disorders; Insomnia; Fatigue	POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; WAKE DISTURBANCES; AMERICAN ACADEMY; UNITED-STATES; RISK-FACTORS; DISORDERS; INSOMNIA; FATIGUE; REHABILITATION	remain poorly understood. Four of 6 viable theories of sleep function reviewed by Krueger and colleagues4 focus on brain health-promoting neural connectivity, restoring neural networks to maintain cognitive and behavioral performance, allowing for the flushing of substances from the brain tissue, and restoring brain energy stores. The role of sleep in brain recovery from traumatic brain injury (TBI) may be important, but it is not understood. TBI is defined as altered brain function from an external force, rated as mild-such as concussion-or moderate or severe, usually determined by score on the Glasgow Coma Scale. Although each TBI is unique, there are some common problems that arise from this heterogeneous disorder. Sleep problems are among the most common complaints after TBI of all levels of	[Weymann, Kris B.; Rourke, Jennifer M.] VA Portland Hlth Care Syst, P2IESD,3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA; [Weymann, Kris B.] Oregon Hlth & Sci Univ, Sch Nursing, SN-6S,3455 Southwest US Vet Hosp Rd, Portland, OR 97239 USA		Weymann, KB (corresponding author), Oregon Hlth & Sci Univ, Sch Nursing, SN-6S,3455 Southwest US Vet Hosp Rd, Portland, OR 97239 USA.	weymannk@ohsu.edu					Aoun R, 2019, NAT SCI SLEEP, V11, P131, DOI 10.2147/NSS.S182158; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bhatnagar S, 2016, BRAIN RES, V1640, P164, DOI 10.1016/j.brainres.2016.01.021; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chang VTA, 2020, NEUROCRIT CARE, V32, P596, DOI 10.1007/s12028-019-00795-4; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; Collen JF, 2012, J CLIN SLEEP MED, V8, P667, DOI 10.5664/jcsm.2260; Crichton T, 2020, BRAIN INJURY, V34, P1525, DOI 10.1080/02699052.2020.1810316; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Draganich C, 2019, BRAIN INJURY, V33, P1194, DOI 10.1080/02699052.2019.1631484; Driver S, 2018, NEUROREHABILITATION, V43, P347, DOI 10.3233/NRE-182536; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Fleming MK, 2020, NEUROREHAB NEURAL RE, V34, P661, DOI 10.1177/1545968320929669; Grimm J, 2020, CRIT CARE NURSE, V40, pE16, DOI 10.4037/ccn2020939; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Jaffe M., 2019, PRACT NEUROL; Jaussent I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01547-0; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; Krause AJ, 2017, NAT REV NEUROSCI, V18, P404, DOI 10.1038/nrn.2017.55; Krueger JM, 2016, SLEEP MED REV, V28, P46, DOI 10.1016/j.smrv.2015.08.005; Lettieri CJ, 2020, SLEEP MED CLIN, V15, P227, DOI 10.1016/j.jsmc.2020.02.009; Li X, 2020, J NURS RES, V28, DOI 10.1097/jnr.0000000000000384; Lowe A, 2020, DISABIL REHABIL, V42, P1041, DOI 10.1080/09638288.2018.1516819; Makley MJ, 2020, NEUROREHAB NEURAL RE, V34, P111, DOI 10.1177/1545968319895478; Maneewong J, 2017, NEUROPSYCH DIS TREAT, V13, DOI 10.2147/NDT.S128138; Martindale SL, 2017, REHABIL PSYCHOL, V62, P563, DOI 10.1037/rep0000159; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Monderer R, 2020, SLEEP MED CLIN, V15, P155, DOI 10.1016/j.jsmc.2020.02.004; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Patil SP, 2019, J CLIN SLEEP MED, V15, P301, DOI 10.5664/jcsm.7638; Peterson AB, 2020, MMWR-MORBID MORTAL W, V69, P225, DOI 10.15585/mmwr.mm6909a2; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Poulsen I, 2021, AUST CRIT CARE, V34, P76, DOI 10.1016/j.aucc.2020.05.006; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Sheng P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081802; Shimura A, 2020, SLEEP HEALTH, V6, P288, DOI 10.1016/j.sleh.2020.02.001; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Suzuki Y, 2017, SLEEP MED, V33, P36, DOI 10.1016/j.sleep.2016.06.033; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van der Zweerde T, 2020, SLEEP MED CLIN, V15, P117, DOI 10.1016/j.jsmc.2020.02.001; Wang YJ, 2021, NEUROPSYCHOL REHABIL, V31, P211, DOI 10.1080/09602011.2019.1682622; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Zalai DM, 2020, CMAJ OPEN, V8, P7; Zhou Y, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8120223; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	64	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0029-6465	1558-1357		NURS CLIN N AM	Nurs. Clin. North Am.	JUN	2021	56	2					275	286		10.1016/j.cnur.2021.02.006			12	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	SN2KK	WOS:000658122900010	34023121				2022-02-07	
J	Wu, CH; Tsai, YC; Tsai, TH; Kuo, KL; Su, YF; Chang, CH; Lin, CL				Wu, Chieh-Hsin; Tsai, Yi-Cheng; Tsai, Tai-Hsin; Kuo, Keng-Liang; Su, Yu-Feng; Chang, Chih-Hui; Lin, Chih-Lung			Valproic Acid Reduces Vasospasm through Modulation of Akt Phosphorylation and Attenuates Neuronal Apoptosis in Subarachnoid Hemorrhage Rats	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						apoptosis; Akt; endothelial nitric oxide synthase (eNOs); ERK; subarachnoid hemorrhage (SAH); valproic acid (VPA); vasospasm	GLYCOGEN-SYNTHASE KINASE-3-BETA; SIGNAL-REGULATED KINASE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; CASPASE INHIBITORS; CELL-DEATH; ERK-MAPK; MODEL; ACTIVATION	Aneurysmal subarachnoid hemorrhage (SAH) is a devastating emergent event associated with high mortality and morbidity. Survivors usually experience functional neurological sequelae caused by vasospasm-related delayed ischemia. In this study, male Sprague-Dawley rats were randomly assigned to five groups: sham (non-SAH) group, SAH group, and three groups with SAH treated with different doses of valproic acid (VPA) (10, 20, 40 mg/kg, once-daily, for 7 days). The severity of vasospasm was determined by the ratio of cross-sectional areas to intima-media thickness of the basilar arteries (BA) on the seventh day after SAH. The BA showed decreased expression of phospho-Akt proteins. The dentate gyrus showed increased expression of cleaved caspase-3 and Bax proteins and decreased expression of Bcl-2, phospho-ERK 1/2, phospho-Akt and acetyl-histone H3 proteins. The incidence of SAH-induced vasospasm was significantly lower in the SAH group treated with VPA 40 mg/kg (p < 0.001). Moreover, all groups treated with VPA showed reversal of the above-mentioned protein expression in BA and the dentate gyrus. Treatment with VPA upregulated histone H3 acetylation and conferred anti-vasospastic and neuro-protective effects by enhancing Akt and/or ERK phosphorylation. This study demonstrated that VPA could alleviate delayed cerebral vasospasm induced neuro-apoptosis after SAH.	[Wu, Chieh-Hsin; Tsai, Tai-Hsin; Kuo, Keng-Liang; Su, Yu-Feng; Chang, Chih-Hui; Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Div Neurosurg, Dept Surg, Kaohsiung 80756, Taiwan; [Wu, Chieh-Hsin; Tsai, Tai-Hsin; Su, Yu-Feng; Lin, Chih-Lung] Kaohsiung Med Univ, Sch Med, Dept Surg, Coll Med, Kaohsiung 80756, Taiwan; [Tsai, Yi-Cheng; Tsai, Tai-Hsin; Kuo, Keng-Liang; Chang, Chih-Hui; Lin, Chih-Lung] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80756, Taiwan		Lin, CL (corresponding author), Kaohsiung Med Univ Hosp, Div Neurosurg, Dept Surg, Kaohsiung 80756, Taiwan.; Lin, CL (corresponding author), Kaohsiung Med Univ, Sch Med, Dept Surg, Coll Med, Kaohsiung 80756, Taiwan.; Lin, CL (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80756, Taiwan.	wujoeys@gmail.com; iiidns11@hotmail.com; Teishin8@hotmail.com; geet810224@yahoo.com.tw; suyufeng2000@gmail.com; chchang20@gmail.com; chihlung1@yahoo.com			Taiwan Ministry of Science and Technology [MOST103-2314-B-037-044-MY2]; Kaohsiung Medical University Hospital [KMUH 103-3R17]	This work was funded by grants from the Taiwan Ministry of Science and Technology (MOST103-2314-B-037-044-MY2), and Kaohsiung Medical University Hospital (KMUH 103-3R17).	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Aoki K, 2002, J CLIN NEUROSCI, V9, P672, DOI 10.1054/jocn.2002.1088; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Bertelsen F, 2018, BRAIN RES, V1680, P110, DOI 10.1016/j.brainres.2017.12.018; BONITA R, 1985, STROKE, V16, P591, DOI 10.1161/01.STR.16.4.591; Bowden CL, 2006, AUST NZ J PSYCHIAT, V40, P386, DOI 10.1111/j.1440-1614.2006.01815.x; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Cahill J, 2006, STROKE, V37, P1868, DOI 10.1161/01.STR.0000226995.27230.96; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Chang CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/207616; Chang CZ, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0074-3; Chatpun S, 2011, J TRAUMA, V70, P787, DOI [10.1097/TA.0b013e3181e7954f, 10.1155/2010/479364]; Chi JH, 2017, EUR J PHARMACOL, V796, P101, DOI 10.1016/j.ejphar.2016.12.026; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; CONRAD CD, 1995, HIPPOCAMPUS, V5, P1, DOI 10.1002/hipo.450050103; COOK DA, 1995, PHARMACOL THERAPEUT, V66, P259, DOI 10.1016/0163-7258(94)00080-M; Dankbaar JW, 2009, NEURORADIOLOGY, V51, P813, DOI 10.1007/s00234-009-0575-y; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dubois F, 2009, MOL BIOCHEM PARASIT, V168, P7, DOI 10.1016/j.molbiopara.2009.06.001; Dudhani RV, 2013, JOVE-J VIS EXP, DOI 10.3791/4157; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; Emmez H, 2017, TURK NEUROSURG, V27, P374, DOI 10.5137/1019-5149.JTN.16101-15.1; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Gao C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-7; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Hamming AM, 2017, STROKE, V48, P452, DOI 10.1161/STROKEAHA.116.014738; Hara A, 1998, NEUROL RES, V20, P127; Kamat PK, 2019, ARCH BIOCHEM BIOPHYS, V676, DOI 10.1016/j.abb.2019.108117; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kautu BB, 2013, NEUROSCI LETT, V541, P116, DOI 10.1016/j.neulet.2013.02.026; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kondo S, 1998, STROKE, V29, P181, DOI 10.1161/01.STR.29.1.181; Kostrouchova M, 2007, FOLIA BIOL-PRAGUE, V53, P37; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Kuboyama T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08535-4; Lin CL, 2006, ACTA NEUROCHIR, V148, P873, DOI 10.1007/s00701-006-0793-6; Lin CL, 2007, J NEUROSURG, V106, P436, DOI 10.3171/jns.2007.106.3.436; Lin CL, 2009, J NEUROSURG, V110, P457, DOI 10.3171/2008.6.17622; Lin CL, 2003, J NEUROSCI METH, V123, P89, DOI 10.1016/S0165-0270(02)00344-8; Lin XP, 2014, INT J DEV NEUROSCI, V38, P17, DOI 10.1016/j.ijdevneu.2014.07.004; Liu YZ, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-21; Macdonald R.L., 2014, FUNCT REHABIL NEUROS, V120, P81; Matz P, 1996, STROKE, V27, P504, DOI 10.1161/01.STR.27.3.504; Meguro T, 2001, NEUROL RES, V23, P761, DOI 10.1179/016164101101199144; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Michaelis M, 2006, CELL DEATH DIFFER, V13, P446, DOI 10.1038/sj.cdd.4401759; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Mora A, 1999, EUR J BIOCHEM, V266, P886, DOI 10.1046/j.1432-1327.1999.00919.x; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nau R, 2002, BRAIN PATHOL, V12, P329; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Piao Y, 2013, J TOXICOL PATHOL, V26, P29, DOI 10.1293/tox.26.29; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shen Junjun, 2014, Zhonghua Yi Xue Za Zhi, V94, P2123; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Suzuki H, 1999, J CLIN INVEST, V104, P59, DOI 10.1172/JCI5357; Tibbs R, 2000, J NEUROSURG, V93, P1041, DOI 10.3171/jns.2000.93.6.1041; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yuksel S, 2012, TURK NEUROSURG, V22, P529, DOI 10.5137/1019-5149.JTN.5731-12.1; Zhang C, 2014, BRAIN RES, V1555, P1, DOI 10.1016/j.brainres.2014.01.051; Zhou CM, 2005, J CEREBR BLOOD F MET, V25, P572, DOI 10.1038/sj.jcbfm.9600069; Zhou CM, 2004, J CEREBR BLOOD F MET, V24, P419, DOI 10.1097/00004647-200404000-00007; Zoerle T, 2012, J CEREBR BLOOD F MET, V32, P1645, DOI 10.1038/jcbfm.2012.57	82	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2021	22	11							5975	10.3390/ijms22115975			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	SQ2PR	WOS:000660200100001	34205883	Green Published, gold			2022-02-07	
J	Yang, X; Shen, Y; Ding, ZF; Tian, Y; Hu, JJ; Guo, QL; Huang, CS				Yang, Xin; Shen, Yu; Ding, Zhuofeng; Tian, Ying; Hu, Jiajia; Guo, Qulian; Huang, Changsheng			Circulating Level of Myelin Basic Protein Predicts Postherpetic Neuralgia A Prospective Study	CLINICAL JOURNAL OF PAIN			English	Article						biomarkers; myelin basic protein; neuralgia; postherpetic; plasma; risk factors	TRAUMATIC BRAIN-INJURY; HERPES-ZOSTER; CEREBROSPINAL-FLUID; NEUROPATHIC PAIN; MITOCHONDRIAL-DNA; RISK-FACTORS; RAT MODEL; BIOMARKERS; PATHOGENESIS; EXPRESSION	Objectives: Patients with herpes zoster (HZ) would benefit from accurate prediction of whether they are likely to develop postherpetic neuralgia (PHN). We investigated whether a circulating biomarker of neuronal damage could be a predictor of PHN in this nonmatched prospective, nested, case-control study. Materials and Methods: We included patients with HZ who were within 90 days after rash onset. Volunteers without a history of HZ were recruited as controls. We evaluated epidemiologic factors and circulating neuronal damage biomarkers, including cell-free DNA, myelin basic protein (MBP), and soluble protein-100B (S100B). We conducted logistic regression analyses to develop a prediction model of PHN. Results: We found that cell-free DNA and MBP levels were higher in patients with HZ (n=71) than in controls (n=37). However, only MBP level was higher in patients who developed PHN (n=25), in comparison with those who did not (n=46). MBP level and 3 clinical factors, age, acute pain severity, and response to treatment drugs were identified as independent predictors of PHN. Receiver operating characteristic (ROC) curve analysis showed that the prediction made using a combination of MBP level and clinical factors had an area under ROC curve of 0.853 (95% confidence interval: 0.764 to 0.943), which was better than prediction using clinical factors alone (area under ROC curve: 0.823, 95% confidence interval: 0.728 to 0.917). Discussion: Our results indicate that circulating MBP level in patients with HZ is a predictor for PHN. The combination of clinical predictors and MBP level enhanced the prediction performance.	[Yang, Xin; Shen, Yu; Ding, Zhuofeng; Tian, Ying; Hu, Jiajia; Guo, Qulian; Huang, Changsheng] Cent South Univ, Dept Anesthesiol, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Guo, Qulian; Huang, Changsheng] Cent South Univ, Natl Clin Res Ctr Geriatr Disorders, Xiangya Hosp, Changsha, Peoples R China		Huang, CS (corresponding author), Cent South Univ, Dept Anesthesiol, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	changsheng.huang@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771207, 81873733, 81571081]; Big Data Project of Central South University: Safety and Quality of Anesthesia (Central South University, Changsha, China)	Supported by the National Natural Science Foundation of China (grant numbers 81771207, 81873733, 81571081) and Big Data Project of Central South University: Safety and Quality of Anesthesia (Central South University, Changsha, China).	Aarthy R, 2015, MOL DIAGN THER, V19, P339, DOI 10.1007/s40291-015-0167-y; BALFOUR HH, 1988, AM J MED, V85, P68; Baron R, 1997, PAIN, V73, P231, DOI 10.1016/S0304-3959(97)00105-X; Baron R, 1995, NEUROLOGY, V45, pS63, DOI 10.1212/WNL.45.12_Suppl_8.S63; BENNETT GJ, 1994, ANN NEUROL, V35, pS38, DOI 10.1002/ana.410350712; Celikbilek A, 2014, NEUROSCI LETT, V558, P53, DOI 10.1016/j.neulet.2013.10.067; Cho SI, 2014, J PAIN, V15, P149, DOI 10.1016/j.jpain.2013.10.006; Delaney A, 2009, NEUROTHERAPEUTICS, V6, P630, DOI 10.1016/j.nurt.2009.07.005; Derkus B, 2017, BIOSENS BIOELECTRON, V89, P781, DOI 10.1016/j.bios.2016.10.019; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Ding ZF, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00341; Drolet M, 2010, J PAIN, V11, P1211, DOI 10.1016/j.jpain.2010.02.020; Forbes HJ, 2016, PAIN, V157, P30, DOI 10.1097/j.pain.0000000000000307; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Gonzalez-Martinez T, 2003, MICROSC RES TECHNIQ, V60, P633, DOI 10.1002/jemt.10304; He RC, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00305; Hou XR, 2018, NEUROSCIENCE, V377, P138, DOI 10.1016/j.neuroscience.2018.02.026; Huang Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005997; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Johnson RW, 2014, NEW ENGL J MED, V371, P1526, DOI 10.1056/NEJMcp1403062; Jung BF, 2004, NEUROLOGY, V62, P1545, DOI 10.1212/01.WNL.0000123261.00004.29; Klompas M, 2011, MAYO CLIN PROC, V86, P1146, DOI 10.4065/mcp.2011.0305; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Lim ET, 2004, MULT SCLER J, V10, P261, DOI 10.1191/1352458504ms1020oa; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Oaklander AL, 1998, ANN NEUROL, V44, P789, DOI 10.1002/ana.410440513; Opstelten W, 2007, PAIN, V132, pS52, DOI 10.1016/j.pain.2007.02.004; Park J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030323; Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887; Rauck RL, 2013, J PAIN SYMPTOM MANAG, V46, P219, DOI 10.1016/j.jpainsymman.2012.07.011; ROWBOTHAM MC, 1989, PAIN, V39, P129, DOI 10.1016/0304-3959(89)90001-8; Rowbotham MC, 1996, BRAIN, V119, P347, DOI 10.1093/brain/119.2.347; Sommer C, 2017, J PAIN SYMPTOM MANAG, V53, P614, DOI 10.1016/j.jpainsymman.2016.09.015; Sorci Guglielmo, 2013, World J Biol Chem, V4, P1, DOI 10.4331/wjbc.v4.i1.1; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; THOMAS DGT, 1977, LANCET, V1, P113; Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018; Varhaug KN, 2017, MITOCHONDRION, V34, P32, DOI 10.1016/j.mito.2016.12.003; Volpi A, 2008, J MED VIROL, V80, P1646, DOI 10.1002/jmv.21254; Wang TT, 2020, J PROTEOMICS, V225, DOI 10.1016/j.jprot.2020.103879; Wen YY, 2015, PAIN PRACT, V15, P530, DOI 10.1111/papr.12206; WHITAKER JN, 1980, ANN NEUROL, V7, P58, DOI 10.1002/ana.410070111; Whitaker JN, 1998, MULT SCLER J, V4, P16, DOI 10.1191/135245898678909123; Wilhelm IR, 2010, EUR J ANAESTH, V27, P169, DOI 10.1097/EJA.0b013e328330e989; Xu M, 2018, MOL PAIN, V14, DOI 10.1177/1744806918767549; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091454; Zhou HC, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00240; Zou Y, 2018, BRIT J ANAESTH, V121, P973, DOI 10.1016/j.bja.2018.03.036; Zou Y, 2016, MOL PAIN, V12, DOI 10.1177/1744806916681566	52	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-8047	1536-5409		CLIN J PAIN	Clin. J. Pain	JUN	2021	37	6					429	436		10.1097/AJP.0000000000000937			8	Anesthesiology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	SK4OR	WOS:000656197400005	33883415				2022-02-07	
J	Yaramothu, C; Morris, CJ; d'Antonio-Bertagnolli, JV; Alvarez, TL				Yaramothu, Chang; Morris, Christopher J.; d'Antonio-Bertagnolli, John Vito; Alvarez, Tara L.			OculoMotor Assessment Tool Test Procedure and Normative Data	OPTOMETRY AND VISION SCIENCE			English	Article							POST-CONCUSSION SYMPTOMS; SCREENING VOMS TOOL; FUSIONAL VERGENCE; EYE-MOVEMENTS; BRAIN-INJURY; VISION; CONVERGENCE; RELIABILITY; REHABILITATION; COMMON	SIGNIFICANCE This study establishes normative data and a testing procedure for the oculomotor assessment tool. The oculomotor assessment tool standardizes visual targets for the Vestibular/OculoMotor Screening assessment and provides additional metrics that may aid in the differentiation between those with normal and those with abnormal oculomotor function potentially caused by a concussion. PURPOSE This study aimed to assess the oculomotor endurance of healthy participants with no self-reported history of concussions using the oculomotor assessment tool. METHODS Healthy participants (n = 376, average age of 20.4 years, range of 11 to 34 years, with no self-reported history of concussions) were recruited to perform the following three tasks for 60 seconds each: (1) horizontal saccades, (2) vertical saccades, and (3) vergence jumps. The participants were instructed to alternate visual fixation between two targets for each of the tasks as fast as they could without overshooting or undershooting the visual target. The differences in the number of eye movements between the initial and latter 30 seconds of the 1-minute test were analyzed. RESULTS A statistical difference (P < .001) was observed in the number of eye movements for all three tasks (horizontal saccades [70 +/- 15 for initial 30 seconds, 63 +/- 13 for latter 30 seconds], vertical saccades [68 +/- 14, 63 +/- 13], and vergence jumps [43 +/- 11, 39 +/- 10]) between the initial and latter 30 seconds. No significant differences were identified in the number of eye movements or the change in eye movements between the initial and latter 30 seconds based on sex. CONCLUSIONS These results establish a normative database for various eye movements. These data could potentially be used to compare different patient populations who have binocular endurance dysfunctions potentially due to traumatic brain injury, such as patients with concussion(s).	[Yaramothu, Chang; Morris, Christopher J.; d'Antonio-Bertagnolli, John Vito; Alvarez, Tara L.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Yaramothu, Chang] New Jersey Inst Technol, Sch Appl Engn & Technol, Newark, NJ 07102 USA		Yaramothu, C; Alvarez, TL (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.; Yaramothu, C (corresponding author), New Jersey Inst Technol, Sch Appl Engn & Technol, Newark, NJ 07102 USA.	chang.yaramothu@njit.edu; cjm64@njit.edu; john.vito@njit.edu; tara.l.alvarez@njit.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EY023261]; New Jersey Institute of Technology (faculty seed grant)	Foundation for the National Institutes of Health (R01EY023261; to TLA) and New Jersey Institute of Technology (faculty seed grant; to TLA).	Abraham Neethu G, 2015, Oman J Ophthalmol, V8, P14, DOI 10.4103/0974-620X.149856; Akhand O, 2019, CURR OPIN NEUROL, V32, P68, DOI 10.1097/WCO.0000000000000654; Alvarez CP, 2006, GRAEF ARCH CLIN EXP, V244, P821, DOI 10.1007/s00417-005-0166-5; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Alvarez TL, 1998, J NEUROPHYSIOL, V79, P37, DOI 10.1152/jn.1998.79.1.37; Bijvank JAN, 2019, J NEUROL SCI, V402, P167, DOI 10.1016/j.jns.2019.05.024; Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Burns D., 2014, OPTOMETRY PRACTICE, V15, P75; Chen YF, 2010, J MED BIOL ENG, V30, P1; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2017, Concussion, V2, pCNC36, DOI 10.2217/cnc-2016-0029; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Craton N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7090119; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; HUNG GK, 1986, IEEE T BIO-MED ENG, V33, P1021, DOI 10.1109/TBME.1986.325868; Ireland D., 2010, J VISUAL-JAPAN, V9, P276; Iverson GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218997; JONES R, 1980, AM J OPTOM PHYS OPT, V57, P640; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2019, ARCH CLIN NEUROPSYCH, V34, P762, DOI 10.1093/arclin/acz026.32; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marandi RZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31577-1; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Moran RN, 2019, J NEUROSURG-PEDIATR, V23, P465, DOI 10.3171/2018.10.PEDS18425; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pillai C, 2017, SEMIN OPHTHALMOL, V32, P144, DOI 10.1080/08820538.2016.1228412; Rouse MW, 2002, OPTOMETRY VISION SCI, V79, P254, DOI 10.1097/00006324-200204000-00012; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Samadani Uzma, 2016, Concussion, V1, pCNC2, DOI 10.2217/cnc.15.2; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Santo AL, 2020, J SPORT REHABIL, V29, P1179, DOI 10.1123/jsr.2019-0428; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 1996, J Am Optom Assoc, V67, P193; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Spano M, 2019, SPORTS, V7, DOI 10.3390/sports7020053; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Wajuihian Samuel Otabor, 2016, J Optom, V9, P246, DOI 10.1016/j.optom.2015.10.006; Watson J, 2020, ARCH CLIN NEUROPSYCH, V35, P469, DOI 10.1093/arclin/acaa015; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Yaramothu C, 2019, J NEUROTRAUM, V36, P2200, DOI 10.1089/neu.2018.6075; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Yuan WH, 2000, VISION RES, V40, P3089, DOI 10.1016/S0042-6989(00)00162-0	57	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JUN	2021	98	6					636	643		10.1097/OPX.0000000000001698			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	TA5EP	WOS:000667272000014	34039908				2022-02-07	
J	Yuan, JW; Boniello, MR; Fuller, DA				Yuan, Jinghong Wesley; Boniello, Michael R.; Fuller, David A.			Diagnosis and treatment of a closed and inverted metacarpal head fracture	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						avascular necrosis of the metacarpal bone; flipped metacarpal head fracture; inverted; metacarpal head fracture; metacarpal head fracture; open reduction; polytrauma		This case report documents a rare inversion of a closed metacarpal head fracture in the setting of polytrauma. Although rare, hemispherical articular bones can fracture and rotate 180 degrees. Because of the symmetry of the bone and the rarity of an inverted, metacarpal head fracture, a delay in diagnosis and subsequent treatment can occur, which can lead to a poor outcome. This is particularly true in the setting of polytrauma. A 38-year-old male, polytrauma patient presented to the emergency department (ED) after falling off a bridge and being struck by an oncoming vehicle. He presented with multiple surgical fractures of the upper and lower extremities as well as his pelvis. Three days after he was brought to the ED, x-rays were performed of his painful left hand, which revealed an extra-articular third metacarpal head fracture, for which he underwent open reduction of the closed fracture. Both collateral ligaments were intact and the head fragment had inverted within the constraints of these ligaments. Some of the ligament and capsular tissue remained attached to the head fragment along the radial and ulnar margins but was otherwise entirely covered with cartilage. The reduction maneuver was difficult but after the reduction was achieved, the fracture appeared stable and no internal fixation was used. Post reduction, the injury was splinted for 2 weeks and then early motion was allowed. The fracture has since healed, and the patient has attained near-full function of the finger and joint.	[Yuan, Jinghong Wesley] Rowan Univ, Cooper Med Sch, Camden, NJ 08103 USA; [Boniello, Michael R.; Fuller, David A.] Cooper Univ Hosp, Dept Orthopaed Surg, Camden, NJ USA		Yuan, JW (corresponding author), Rowan Univ, Cooper Med Sch, Camden, NJ 08103 USA.	yuanji35@rowan.edu			JACEP Open policy	By JACEP Open policy, all authors are required to disclose any and all commercial, financial, and other relationships in anyway related to the subject of this article as per ICMJEconflict of interest guidelines (see www.icmje.org).The authors have stated that no such relationships exist.	Kollitz Kathleen M, 2014, Hand (N Y), V9, P16, DOI 10.1007/s11552-013-9562-1; Mellick LB, 2011, ANN EMERG MED, V58, P310, DOI 10.1016/j.annemergmed.2011.01.015; Pfeifer R, 2008, PATIENT SAF SURG, V2, DOI 10.1186/1754-9493-2-20; Robbins MM, 2015, RADIOL CASE REP, V3, P193; Steffens K, 1994, Handchir Mikrochir Plast Chir, V26, P12	5	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	JUN	2021	2	3							e12428	10.1002/emp2.12428			3	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	TD7UO	WOS:000669527200043	34136879	gold, Green Published			2022-02-07	
J	Zanier, ER; Barzago, MM; Vegliante, G; Romeo, M; Restelli, E; Bertani, I; Natale, C; Colnaghi, L; Colombo, L; Russo, L; Micotti, E; Fioriti, L; Chiesa, R; Diomede, L				Zanier, Elisa R.; Barzago, Maria Monica; Vegliante, Gloria; Romeo, Margherita; Restelli, Elena; Bertani, Ilaria; Natale, Carmina; Colnaghi, Luca; Colombo, Laura; Russo, Luca; Micotti, Edoardo; Fioriti, Luana; Chiesa, Roberto; Diomede, Luisa			C. elegans detects toxicity of traumatic brain injury generated tau	NEUROBIOLOGY OF DISEASE			English	Article						Tau; Tauopathy; Traumatic brain injury; Caenorhabditis elegans		Traumatic brain injury (TBI) is associated with widespread tau pathology in about 30% of patients surviving late after injury. We previously found that TBI in mice induces the formation of an abnormal form of tau (tauTBI) which progressively spreads from the site of injury to remote brain regions. Intracerebral inoculation of TBI brain homogenates into na?ve mice induced progressive tau pathology, synaptic loss and late cognitive decline, suggesting a pivotal role of tauTBI in post-TBI neurodegeneration. However, the possibility that tauTBI was a marker of TBI-associated neurodegeneration rather than a toxic driver of functional decline could not be excluded. Here we employed the nematode C. elegans as a biosensor to test the pathogenic role of TBI generated tau. The motility of this nematode depends on efficient neuromuscular transmission and is exceptionally sensitive to the toxicity of amyloidogenic proteins, providing a tractable model for our tests. We found that worms exposed to brain homogenates from chronic but not acute TBI mice, or from mice in which tauTBI had been transmitted by intracerebral inoculation, had impaired motility and neuromuscular synaptic transmission. Results were similar when worms were given brain homogenates from transgenic mice overexpressing tau P301L, a tauopathy mouse model, suggesting that TBI-induced and mutant tau have similar toxic properties. P301L brain homogenate toxicity was similar in wild-type and ptl-1 knock-out worms, indicating that the nematode tau homolog protein PTL-1 was not required to mediate the toxic effect. Harsh protease digestion to eliminate the protein component of the homogenates, pre-incubation with anti-tau antibodies or tau depletion by immunoprecipitation, abolished the toxicity. Homogenates of chronic TBI brains from tau knock-out mice were not toxic to C. elegans, whereas oligomeric recombinant tau was sufficient to impair their motility. This study indicates that tauTBI impairs motor activity and synaptic transmission in C. elegans and supports a pathogenic role of tauTBI in the long-term consequences of TBI. It also sets the groundwork for the development of a C. elegans-based platform for screening anti-tau compounds.	[Zanier, Elisa R.; Vegliante, Gloria; Restelli, Elena; Bertani, Ilaria; Natale, Carmina; Colnaghi, Luca; Micotti, Edoardo; Fioriti, Luana; Chiesa, Roberto] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Via Mario Negri 2, I-20156 Milan, Italy; [Barzago, Maria Monica; Romeo, Margherita; Natale, Carmina; Colnaghi, Luca; Colombo, Laura; Russo, Luca; Diomede, Luisa] Ist Ric Farmacol Mario Negri IRCCS, Dept Mol Biochem & Pharmacol, Via Mario Negri 2, I-20156 Milan, Italy		Zanier, ER; Chiesa, R (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Via Mario Negri 2, I-20156 Milan, Italy.; Diomede, L (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Mol Biochem & Pharmacol, Via Mario Negri 2, I-20156 Milan, Italy.	elisa.zanier@marionegri.it; roberto.chiesa@marionegri.it; luisa.diomede@marionegri.it	Chiesa, Roberto/Q-4295-2019; Colnaghi, Luca/W-4192-2019; Fioriti, Luana/AAN-7207-2021; Natale, Carmina/ABE-4340-2021; Vegliante, Gloria/ABF-9054-2021; Russo, Luca/AAS-9387-2021	Chiesa, Roberto/0000-0002-3842-3733; Colnaghi, Luca/0000-0002-9699-5318; Natale, Carmina/0000-0001-8552-9875; Vegliante, Gloria/0000-0002-7563-0889; Russo, Luca/0000-0002-3690-1877; Barzago, Maria Monica/0000-0002-6952-0069; Romeo, Margherita/0000-0002-3020-8545	Fondazione Regionale per la Ricerca Biomedica [Care4NeuroRare CP_20/2018]; Alzheimer's AssociationAlzheimer's Association [AARG-17-532633, AARG-17-505136]; Fondazione TelethonFondazione TelethonEuropean Commission [TCP15011]; BrightFocus awardBrightFocus Foundation [A2019296F]; Fondo di Beneficenza - Gruppo Intesa Sanpaolo; NIH Office Research Infrastructure ProgramsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P40 OD010440]	This work was supported by Fondazione Regionale per la Ricerca Biomedica (Care4NeuroRare CP_20/2018) to LD; the Alzheimer's Association (AARG-17-532633 to ERZ and RC, AARG-17-505136 to LF); Fondazione Telethon (Telethon Career Award TCP15011) to LF. LC is the recipient of the BrightFocus award (A2019296F) and the Fondo di Beneficenza -Gruppo Intesa Sanpaolo. C. elegans and OP50 E. coli were provided by the GCG, which is funded by NIH Office Research Infrastructure Programs (P40 OD010440). RB809 strain was provided by the C. elegans Gene Knockout Project at the Oklahoma Medical Research Foundation, which was part of the International C. elegans Gene Knockout Consortium. The authors would like to thank Prof David K Menon for numerous useful discussions.	Benilova I, 2020, P NATL ACAD SCI USA, V117, P23815, DOI 10.1073/pnas.2007406117; Bouybayoune I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004796; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Brandt R, 2009, NEUROBIOL AGING, V30, P22, DOI 10.1016/j.neurobiolaging.2007.05.011; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Diomede L, 2014, BLOOD, V123, P3543, DOI 10.1182/blood-2013-10-525634; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Drisaldi B, 2015, CELL REP, V11, P1694, DOI 10.1016/j.celrep.2015.04.061; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fatouros C, 2012, HUM MOL GENET, V21, P3587, DOI 10.1093/hmg/dds190; Giorgino T, 2019, BBA-MOL BASIS DIS, V1865, P648, DOI 10.1016/j.bbadis.2019.01.010; Goedert M, 1996, J CELL SCI, V109, P2661; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Hashi Y, 2016, BIOSCI BIOTECH BIOCH, V80, P1107, DOI 10.1080/09168451.2016.1141038; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Kraemer B, 2007, INT REV NEUROBIOL, V77, P219, DOI 10.1016/S0074-7742(06)77007-6; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu KP, 2016, JAMA NEUROL, V73, P1356, DOI 10.1001/jamaneurol.2016.2027; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Morelli F, 2018, NEUROBIOL DIS, V117, P226, DOI 10.1016/j.nbd.2018.06.018; Mulcahy B, 2013, J EXP BIOL, V216, P492, DOI 10.1242/jeb.068734; Natale C, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110838; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nussbaum-Krammer CI, 2014, DIS MODEL MECH, V7, P31, DOI 10.1242/dmm.013011; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Rossi G, 2014, NEUROBIOL AGING, V35, P408, DOI 10.1016/j.neurobiolaging.2013.08.004; Rubenstein R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00124; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sengupta P, 2009, CURR OPIN NEUROBIOL, V19, P637, DOI 10.1016/j.conb.2009.09.009; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stravalaci M, 2016, J ALZHEIMERS DIS, V53, P1485, DOI 10.3233/JAD-150882; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Takahata K, 2019, BRAIN, V142, P3265, DOI 10.1093/brain/awz238; Tan XL, 2019, J NEUROTRAUM, V36, P87, DOI 10.1089/neu.2017.5491; van Hummel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163236; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350; Wechalekar AD, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.26; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zeinolabediny Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10875-0	56	0	0	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUN	2021	153								105330	10.1016/j.nbd.2021.105330			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RH8KI	WOS:000636459900003	33711491	Green Published, gold			2022-02-07	
J	Zhang, B; O'Brien, K; Won, W; Li, S				Zhang, Bei; O'Brien, Katherine; Won, William; Li, Sheng			A Retrospective Analysis on Clinical Practice-Based Approaches Using Zolpidem and Lorazepam in Disorders of Consciousness	BRAIN SCIENCES			English	Article						disorders of consciousness; zolpidem; lorazepam; traumatic brain injury; anoxic brain injury	ANOXIC BRAIN-INJURY; STATE; PATIENT; AROUSAL	This is a retrospective study to investigate the results of using zolpidem and lorazepam in persons with disorders of consciousness (DoC) and to provide practical information for clinical application and further studies. The cohort included 146 patients (11 hemorrhagic stroke, 87 traumatic brain injury (TBI), 48 anoxic brain injury (ABI)) admitted to a specialized DoC rehabilitation program. A positive trial indicated a patient responded to either zolpidem or lorazepam with prominent functional improvements necessitating routine use of the medication. Non-responders had equivocal or negative (i.e., went to sleep) responses. Eleven patients with a stroke who had either medication were all non-responders. Of the remaining 135 patients, 95 received at least one medication trial. The overall positive rate was 11.6% (11/95), with 6.3% (5/79) for zolpidem and 14.0% (6/43) for lorazepam. Among TBI patients, the positive rate of the zolpidem trial (10.2%, 5/49) was slightly higher than that of the lorazepam trial (6.9%, 2/29; p > 0.05). Among ABI patients, the positive rate of the lorazepam trial (28.6%, 4/14) was significantly higher than that of the zolpidem trial (0%, 0/30; p = 0.007). Following a positive trial, most patients were continued on the medications on a regular basis before eventual discontinuation. Our results suggested the etiology of DoC, considering traumatic vs. anoxic injuries, may serve in guiding the clinical application of these medications in the treatment of DoC and in future prospective studies. We advocate for screening all patients with DoC using zolpidem and/or lorazepam.	[Zhang, Bei; Won, William; Li, Sheng] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Zhang, Bei; O'Brien, Katherine; Li, Sheng] TIRR Mem Hermann Hosp, TIRR Disorders Consciousness Program, Houston, TX 77030 USA; [O'Brien, Katherine] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA		Li, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Phys Med & Rehabil, Houston, TX 77030 USA.; Li, S (corresponding author), TIRR Mem Hermann Hosp, TIRR Disorders Consciousness Program, Houston, TX 77030 USA.	Bei.Zhang@uth.tmc.edu; Katherine.O'Brien@memorialhermann.org; William.W.Won@uth.tmc.edu; Sheng.Li@uth.tmc.edu	Li, Sheng/ABC-5392-2021				Arnts H, 2020, CORTEX, V132, P135, DOI 10.1016/j.cortex.2020.08.011; Bomalaski MN, 2017, JAMA NEUROL, V74, P1130, DOI 10.1001/jamaneurol.2017.1133; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Clauss RP, 2000, S AFR MED J, V90, P68; Cohen L, 2004, NEW ENGL J MED, V350, P949, DOI 10.1056/NEJM200402263500922; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Du B, 2014, AM J MED SCI, V347, P178, DOI 10.1097/MAJ.0b013e318287c79c; Edlow BL, 2021, NAT REV NEUROL, V17, P135, DOI 10.1038/s41582-020-00428-x; Giacino JT, 2020, ARCH PHYS MED REHAB, V101, P1072, DOI 10.1016/j.apmr.2020.01.013; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hahm MH, 2019, CLIN PSYCHOPHARM NEU, V17, P453, DOI 10.9758/cpn.2019.17.3.453; Interlandi J., 2011, NEW YORK TIMES MAGAZ; Kothari S., 2019, NEUROPALLIATIVE CARE, V1st, P37; Luz J., 2014, PM&R, V6, pS309; Machado C, 2014, CURR PHARM DESIGN, V20, P4185; Mancuso CE, 2004, PHARMACOTHERAPY, V24, P1177, DOI 10.1592/phco.24.13.1177.38089; Nutt D, 2006, J CLIN SLEEP MED, V2, pS7; Pignat JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156882; Sayadnasiri M, 2019, CLIN NEUROPHARMACOL, V42, P186, DOI 10.1097/WNF.0000000000000362; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Sienaert P, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00181; Sutton JA, 2017, BRAIN INJURY, V31, P1019, DOI 10.1080/02699052.2017.1300836; Thonnard M, 2013, FUNCT NEUROL, V28, P259, DOI 10.11138/FNeur/2013.28.4.259; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157; Zhang B, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11050608; Zhang B, 2021, PM&R, V13, P657, DOI 10.1002/pmrj.12458	30	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUN	2021	11	6							726	10.3390/brainsci11060726			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TA6TB	WOS:000667379800001	34072336	gold, Green Published			2022-02-07	
J	Ashendorf, L; Clark, EL; Humphreys, CT				Ashendorf, Lee; Clark, Erika L.; Humphreys, Clare T.			The Rey 15-Item Memory Test in US veterans	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Performance validity test; Rey-15; veterans; malingering; effort	PERFORMANCE VALIDITY; RECOGNITION TRIAL; CLINICAL-SAMPLE; DIGIT SPAN	Introduction: The Rey 15-item Test is a public-domain, memory-based performance validity test, frequently used in clinical settings. Various efforts have been made to modify the test to make it more sensitive and more robust to effects of lower education and intelligence. The most promising of these is the addition of a recognition trial to the existing free recall paradigm. Method: The present study explored the use of the Rey-15 + Recognition Trial in a sample of 155 younger U.S. military veterans seen for evaluation of mild traumatic brain injury or attention deficit hyperactivity disorder (50 cases classified as invalid, 105 classified as valid). Results: Optimal classification accuracy was obtained on the Combination index (cutoff <= 23, sensitivity = 50%, specificity = 95%) and the Recognition Hits score (cutoff <= 11, sensitivity = 52%, specificity = 93%). The Free Recall score had somewhat lower sensitivity when a similar 95% specificity threshold was set (cutoff <= 11, 38% sensitivity). A qualitative error score used in previous studies did not improve classification accuracy. Conclusions: The Rey-15 + Recognition Trial proved to be effective, with particular advantage bestowed by the recognition trial. Implications of these findings in the context of the study's clinical sample of military veterans and in the broader literature are discussed.	[Ashendorf, Lee] VA Cent Western Massachusetts, Mental Hlth Serv Line, Worcester, MA USA; [Ashendorf, Lee; Clark, Erika L.; Humphreys, Clare T.] Univ Massachusetts, Dept Psychiat, Worcester, MA 01605 USA		Ashendorf, L (corresponding author), Worcester Lake Ave VA Clin, 55 North Lake Ave, Worcester, MA 01655 USA.	Lee.Ashendorf@va.gov					ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Assistant Secretary of Defense, 2015, TRAUMATIC BRAIN INJU; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Back C., 1996, ASSESSMENT, V3, P449, DOI [https://doi.org/10.1177/107319119600300411, DOI 10.1177/107319119600300411]; Bailey KC, 2018, CLIN NEUROPSYCHOL, V32, P119, DOI 10.1080/13854046.2017.1333151; Barkley R.A., 2011, BARKLEY ADULT ADHD R; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; DiCarlo MA, 1997, ARCH CLIN NEUROPSYCH, V12, P309, DOI 10.1093/arclin/12.4.309; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Flaherty JM, 2015, BRAIN INJURY, V29, P1630, DOI 10.3109/02699052.2015.1075249; Frederick R.I., 2003, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n03_01, DOI 10.1300/J151V02N03_01, https://doi.org/10.1300/J151v02n03_01]; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2020, ARCH CLIN NEUROPSYCH, V35, P717, DOI 10.1093/arclin/acaa017; McCaul C, 2018, CLIN NEUROPSYCHOL, V32, P1054, DOI 10.1080/13854046.2018.1425481; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; Rey A, 1958, LEXAMEN CLINIQUE PSY; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sugarman MA, 2016, APPL NEUROPSYCH-ADUL, V23, P105, DOI 10.1080/23279095.2015.1014557; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Weathers FW., 2013, PTSD CHECKLIST DSM 5; WechslerD, 2001, WECHSLER TEST ADULT; White DJ, 2020, J CLIN EXP NEUROPSYC, V42, P459, DOI 10.1080/13803395.2020.1758634; Whitney KA, 2008, APPL NEUROPSYCHOL, V15, P287, DOI 10.1080/09084280802325215; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	43	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 16	2021	43	3					324	331		10.1080/13803395.2021.1932761		MAY 2021	8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	SY2NR	WOS:000657544700001	34078219				2022-02-07	
J	Kelley, AM; Bernhardt, K; Hass, N; Rooks, T				Kelley, Amanda M.; Bernhardt, Kyle; Hass, Norah; Rooks, Tyler			Detecting functional deficits following sub-concussive head impacts: the relationship between head impact kinematics and visual-vestibular balance performance	BRAIN INJURY			English	Article						Concussion; balance; sensors; performance; functional deficits	TRAUMATIC BRAIN-INJURY	Introduction: Mild traumatic brain injury (mTBI) continues to be a significant issue facing the US military. While TBI cases in deployed environments are of significant concern, an estimated 80% of diagnoses occur in garrison settings (e.g., military training). Objective: With the aim of improving the detection of potentially concussive exposures, the objective of this study was to evaluate the relationships between head impact kinematics and performance on a visual-vestibular balance task. Methods: Participants (n = 51) were enrolled in the Basic Airborne Training Course. Two sensors to measure head impacts sustained were worn. Performance was measured at four time points: baseline and at the end of each week of the course. Results: Visual-vestibular balance task performance tended to decrease over the course of airborne training for our participants, however, limited to the most challenging levels of the task. Also, head impact kinematic measures correlated with performance outcomes to suggest that worse performance was associated with greater number of impacts and greater linear and rotational acceleration and rotational velocity. Discussion: Our findings suggest that visual-vestibular balance task performance may be a useful measure for detection of sub-concussive impacts and that wearable sensors may provide useful data on head impact kinematics that relates directly to functionally relevant performance.	[Kelley, Amanda M.; Bernhardt, Kyle; Hass, Norah; Rooks, Tyler] US Army Aeromed Res Lab, POB 620577, Ft Rucker, AL 36362 USA; [Bernhardt, Kyle; Hass, Norah] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA		Kelley, AM (corresponding author), US Army Aeromed Res Lab, POB 620577, Ft Rucker, AL 36362 USA.	Amanda.m.kelley.civ@mail.mil			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	This study was funded by the US Army Medical Research and Materiel Command.	[Anonymous], 2010, PORT FIELD BAS DEV E; [Anonymous], 2015, 16513 HQDA EXORD DEP; [Anonymous], 2013, C EXP ACT TRAUM BRAI; [Anonymous], 2012, 649011 DODI; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barker J. M., 2007, Journal of Medical Engineering & Technology, V31, P161, DOI 10.1080/03091900500272781; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Cap?-Aponte JE., 2013, SPINE, V4, P1; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Forde NJ, 2014, NEUROIMAGE, V90, P280, DOI 10.1016/j.neuroimage.2013.12.050; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hults Kathryn N, 2006, J Neurosci Nurs, V38, P447; IBM SPSS Statistics for Windows, 2010, IBM SPSS STAT WIND V; Institute of Medicine (US), 2014, COMM GULF WAR HLTH L; King AT., 1976, PROPOSED KING DEVICK; Kosoris N, 2016, PROCEEDINGS I3D 2016: 20TH ACM SIGGRAPH SYMPOSIUM ON INTERACTIVE 3D GRAPHICS AND GAMES, P207, DOI 10.1145/2856400.2876009; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MATLAB, 2016, VERS 9 1 R2016B SOFT; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Messa A., 2016, E MAIL TYLER ROOKS; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; R Development Core Team, 2008, R LANG ENV STAT COMP; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Traumatic Brain Injury Center of Excellence, 2011, DOD WORLDW NUMB TBI; Walsh DV, 2016, J NEUROL SCI, V370, P305, DOI 10.1016/j.jns.2016.09.014; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zoroya G., 2017, CHOSEN FEW CO PARATR	33	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					812	820		10.1080/02699052.2021.1927182		MAY 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000656058800001	34053379				2022-02-07	
J	Shepherd-Banigan, M; Smith, VA; Stechuchak, KM; Van Houtven, CH				Shepherd-Banigan, Megan; Smith, Valerie A.; Stechuchak, Karen M.; Van Houtven, Courtney H.			Informal Caregiver Support Policies Change Use of Vocational Assistance Services for Individuals With Disabilities	MEDICAL CARE RESEARCH AND REVIEW			English	Article; Early Access						veterans; vocational rehabilitation; war-related injury; caregivers; government programs	TRAUMATIC BRAIN-INJURY; NONVOCATIONAL OUTCOMES; EMPLOYMENT; VETERANS; REHABILITATION; WORK	Support policies for caregivers improves care-recipient access to care and effects may generalize to nonhealth services. Using administrative data from the U.S. Department of Veterans Affairs (VA) for veterans <55 years, we assessed the association between enrollment in a VA caregiver support program and veteran use of vocational assistance services: the post-9/11 GI Bill, VA vocational rehabilitation and employment (VR&E), and supported employment. We applied instrumental variables to Cox proportional hazards models. Caregiver enrollment in the program increased veteran supported employment use (hazard ratio = 1.35, 95% confidence interval [1.14, 1.53]), decreased VR&E use (hazard ratio = 0.84, 95% confidence interval [0.76, 0.92]), and had no effect on the post-9/11 GI Bill. Caregiver support policies could increase access to some vocational assistance for individuals with disabilities, particularly supported employment, which is integrated into health care. Limited coordination between health and employment sectors and misaligned incentives may have inhibited effects for the post-9/11 GI Bill and VR&E.	[Shepherd-Banigan, Megan; Smith, Valerie A.; Stechuchak, Karen M.; Van Houtven, Courtney H.] Durham VA Hlth Care Syst, Durham, NC USA; [Shepherd-Banigan, Megan; Smith, Valerie A.; Van Houtven, Courtney H.] Duke Univ, Durham, NC USA; [Shepherd-Banigan, Megan; Van Houtven, Courtney H.] Duke Margolis Ctr Hlth Policy, Durham, NC USA		Shepherd-Banigan, M (corresponding author), Durham VA Hlth Care Syst, Ctr Innovat Accelerate Discovery & Practice Trans, Durham VA Hlth Serv Res & Dev HSR&D, 508 Fulton St, Durham, NC 27705 USA.	mes86@duke.edu		Smith, Valerie/0000-0001-5170-9819; Van Houtven, Courtney/0000-0002-0783-1611	Robert Wood Johnson Foundation through the Systems for Action National Coordinating Center [74941]; Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT) at the Durham VA Health Care System [CIN 13-410]; Department of Veterans Affairs, Caregiver Support ProgramUS Department of Veterans Affairs; Department of Veterans Affairs, Quality Enhancement Research InitiativeUS Department of Veterans Affairs [PEC 14-272]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Robert Wood Johnson Foundation through the Systems for Action National Coordinating Center, ID 74941. The sponsor had no role in the study design; the collection, analysis, interpretation of the data; the writing of the report; or in the decision to submit the article for publication. Additional support comes from the Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT) (CIN 13-410) at the Durham VA Health Care System and the Department of Veterans Affairs, Caregiver Support Program, and Quality Enhancement Research Initiative (PEC 14-272).	Al-Janabi H, 2016, HEALTH ECON, V25, P1529, DOI 10.1002/hec.3259; Angrist JD, 2011, AM ECON J-APPL ECON, V3, P96, DOI 10.1257/app.3.2.96; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Barr A, 2015, J HUM RESOUR, V50, P580, DOI 10.3368/jhr.50.3.580; Barzallo DP, 2018, APPL HEALTH ECON HEA, V16, P347, DOI 10.1007/s40258-018-0391-9; Becker G., 1991, TREATISE FAMILY, DOI 10.4159/9780674020665; BECKER GS, 1992, KYKLOS, V45, P327, DOI 10.1111/j.1467-6435.1992.tb02119.x; Bond GR, 2014, ADM POLICY MENT HLTH, V41, P69, DOI 10.1007/s10488-012-0444-6; Bond GR, 2001, J CONSULT CLIN PSYCH, V69, P489, DOI 10.1037//0022-006X.69.3.489; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Crowther R, 1800, Cochrane Database Syst Rev, pCD003080, DOI 10.1002/14651858.CD003080; Davis LL, 2012, PSYCHIAT SERV, V63, P464, DOI 10.1176/appi.ps.201100340; Duggan Mark, 2014, LABOR MARKET EFFECTS, p[1, 2]; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Jackson Y, 2009, WORK, V33, P381, DOI 10.3233/WOR-2009-0886; Kukla M, 2012, J NERV MENT DIS, V200, P214, DOI 10.1097/NMD.0b013e318247cb29; Martinez-Camblor P, 2019, BIOSTATISTICS, V20, P80, DOI 10.1093/biostatistics/kxx062; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Ramchand R., 2014, HIDDEN HEROES AM MIL; Resnick SG, 2008, J REHABIL RES DEV, V45, P427, DOI 10.1682/JRRD.2007.06.0093; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; ROSS CE, 1995, J HEALTH SOC BEHAV, V36, P230, DOI 10.2307/2137340; Rutledge M.S, 2014, WHY SSI SNAP ENROLLM; Shepherd-Banigan M, 2020, NURS OUTLOOK, V68, P184, DOI 10.1016/j.outlook.2019.08.006; Sperber NR, 2021, J HEALTH SERV RES PO, V26, P180, DOI 10.1177/1355819620983371; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Steele J.L., 2011, SERVICE MEMBERS SCH; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; U.S. Department of Veterans Affairs, 2019, VOC REH EMPL VR E; Van Houtven CH, 2004, J HEALTH ECON, V23, P1159, DOI 10.1016/j.jhealeco.2004.04.008; Van Houtven CH, 2019, MED CARE RES REV, V76, P89, DOI 10.1177/1077558717697015; Wagner TH, 2016, HEALTH SERV RES, V51, P2002, DOI 10.1111/1475-6773.12454; Wewiorski NJ, 2018, PSYCHOL SERV, V15, P191, DOI 10.1037/ser0000177; Wolff JL, 2016, NEW ENGL J MED, V375, P2513, DOI 10.1056/NEJMp1612351; Zhang L, 2018, EDUC EVAL POLICY AN, V40, P82, DOI 10.3102/0162373717724002	36	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1077-5587	1552-6801		MED CARE RES REV	Med. Care Res. Rev.											10775587211018548	10.1177/10775587211018548		MAY 2021	15	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	SM8UY	WOS:000657875300001	34053345				2022-02-07	
J	Stillo, D; Danielli, E; Ho, RA; DeMatteo, C; Hall, GB; Bock, NA; Connolly, JF; Noseworthy, MD				Stillo, David; Danielli, Ethan; Ho, Rachelle A.; DeMatteo, Carol; Hall, Geoffrey B.; Bock, Nicholas A.; Connolly, John F.; Noseworthy, Michael D.			Localization and Identification of Brain Microstructural Abnormalities in Paediatric Concussion	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						concussion; diffusion tensor imaging (DTI); paediatric; MRI; personalized	WHITE-MATTER INTEGRITY; DIFFUSION; INJURY; ROBUST; OPTIMIZATION; REGISTRATION; TRACTOGRAPHY; ACCURATE; MAPS	In the United States, approximately 2.53 million people sustain a concussion each year. Relative to adults, youth show greater cognitive deficits following concussion and a longer recovery. An accurate and reliable imaging method is needed to determine injury severity and symptom resolution. The primary objective of this study was to characterize concussions with diffusion tensor imaging (DTI). This was performed through a normative Z-scoring analysis of DTI metrics, fractional anisotropy (FA), axial diffusivity (AD), and radial diffusivity (RD), to quantify patient-specific injuries and identify commonly damaged brain regions in paediatric concussion patients relative to healthy controls. It was hypothesized that personalizing the detection analysis through normative Z-scoring would provide an understanding of trauma-induced microstructural damage. Concussion patients were volunteers recruited from the Emergency Department of the McMaster Children's Hospital with a recent concussion (n = 26), 9 males and 17 females, mean age 14.22 +/- 2.64, while healthy paediatric brain DTI datasets (25 males and 24 females, mean age 13.52 +/- 1.03) were obtained from an MRI data repository. Significant abnormalities were commonly found in the longitudinal fasciculus, fronto-occipital fasciculus, and corticospinal tract, while unique abnormalities were localized in a number of other areas reflecting the individuality of each child's injury. Total injury burden, determined by the number of regions containing outliers per DTI metric per patient, was used as the metric to quantify the overall injury severity of each patient. The primary outcome of this analysis found that younger patients experienced a significantly greater injury burden when measured using fractional anisotropy (p < 0.001). These results show that DTI was able to detect microstructural changes caused by concussion, on a per-person basis, and has the potential to be a useful tool for improving diagnostic accuracy and prognosis of a concussion.	[Stillo, David; Danielli, Ethan; Hall, Geoffrey B.; Noseworthy, Michael D.] St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada; [Stillo, David; Danielli, Ethan; Connolly, John F.; Noseworthy, Michael D.] McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada; [Ho, Rachelle A.; DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Ho, Rachelle A.; Hall, Geoffrey B.; Bock, Nicholas A.; Connolly, John F.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [DeMatteo, Carol; Connolly, John F.; Noseworthy, Michael D.] McMaster Univ, ARiEAL Res Ctr, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Dept Linguist, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Radiol, Hamilton, ON, Canada		Noseworthy, MD (corresponding author), St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, ARiEAL Res Ctr, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Radiol, Hamilton, ON, Canada.	nosewor@mcmaster.ca		Connolly, John/0000-0001-8869-5369; Danielli, Ethan/0000-0001-9963-9565	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [133527]	This project was supported by the Canadian Institutes of Health Research (CIHR; http://www.cihr-irsc.gc.ca) in a research operating grant entitled "Safely Returning Children and Youth to Activity After Concussion'' (CIHR MOP#133527).	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Center for Disease Control and Prevention, 2020, TRAUMATIC BRAIN INJU; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Danielli Ethan, 2020, Critical Reviews in Biomedical Engineering, V48, P261, DOI 10.1615/CritRevBiomedEng.2020034991; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Filippi M, 2016, HAND CLINIC, V136, P1065, DOI 10.1016/B978-0-444-53486-6.00056-9; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jakab A, 2017, NEUROIMAGE-CLIN, V15, P601, DOI 10.1016/j.nicl.2017.06.013; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Montgomery D.C., 2010, APPL STAT PROBABILIT, P351; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mori S, 2005, MRI ATLAS HUMAN WHIT; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Rivkin M.J., 2016, NIH NATL DATABASE AU; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	35	0	0	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 31	2021	15								657374	10.3389/fnhum.2021.657374			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SR5VE	WOS:000661109500001	34135741	gold, Green Published			2022-02-07	
J	Alkhaibary, A; Alshalawi, A; Althaqafi, RM; Alghuraybi, AA; Basalamah, A; Shammaa, AM; Altalhy, AA; Abdelrahman, TM				Alkhaibary, Ali; Alshalawi, Abdulaziz; Althaqafi, Raad M.; Alghuraybi, Abdullah A.; Basalamah, Ali; Shammaa, Ahmed M.; Altalhy, Ali A.; Abdelrahman, Tamer M.			Traumatic Brain Injury: A Perspective on the Silent Epidemic	CUREUS			English	Article						collision; coma; head; injury; traffic	COMA SCALE SCORE; HEAD-INJURY; CARE; DEFINITION; DEATH	Background: Epidemiological data regarding the causes, patterns, severity, and outcomes of traumatic brain injury (TBI) are essential to plan for preventive strategies addressing this public health epidemic. The main aim of this study is to explore the patterns and causes of traumatic brain injury at two trauma centers. Methods: A retrospective cohort study was conducted using a pre-tested validated data collection sheet. Data were collected from the medical records and electronic database of patients who presented to the emergency department with head trauma. Variables including the mechanisms, patterns of the injury, accompanying injuries, level of consciousness, and hospitalization duration were investigated for any possible association. Results: A total of 269 patients (78% males, 22% females) who satisfied our study criteria were included in the final analysis. Motor vehicle collisions were the most common reason for traumatic brain injury (57.6%) followed by falls (28.3%). There was a statistically significant association observed between type of hemorrhage and Glasgow coma scale at initial presentation (P < 0.05). Conclusion: The most common cause of traumatic brain injury is motor vehicle collisions, followed by falls. The public should be made aware of the importance of using safety and precautionary measures to minimize the impact of traumatic brain injuries. Educational programs for neurotrauma prevention can be developed and utilized as a blueprint for local hospitals and officials in the country.	[Alkhaibary, Ali] Minist Natl Guard Hlth Affairs, Div Neurosurg, Dept Surg, King Abdulaziz Med City, Riyadh, Saudi Arabia; [Alkhaibary, Ali] King Abdullah Int Med Res Ctr, Neurosurg, Riyadh, Saudi Arabia; [Alkhaibary, Ali] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia; [Alshalawi, Abdulaziz; Althaqafi, Raad M.; Alghuraybi, Abdullah A.; Abdelrahman, Tamer M.] Taif Univ, Coll Med, Dept Surg, At Taif, Saudi Arabia; [Basalamah, Ali] King Saud Univ Med City, Dept Neurosurg, King Khalid Univ Hosp, Riyadh, Saudi Arabia; [Shammaa, Ahmed M.] Med Univ Warsaw, Coll Med, Dept Surg, Warsaw, Poland; [Altalhy, Ali A.] King Faisal Med Complex, Dept Neurosurg, At Taif, Saudi Arabia		Alkhaibary, A (corresponding author), Minist Natl Guard Hlth Affairs, Div Neurosurg, Dept Surg, King Abdulaziz Med City, Riyadh, Saudi Arabia.; Alkhaibary, A (corresponding author), King Abdullah Int Med Res Ctr, Neurosurg, Riyadh, Saudi Arabia.; Alkhaibary, A (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia.	alkhaibarya@hotmail.com	Alkhaibary, Ali/ABB-4332-2021	basalamah, Ali/0000-0001-9812-5503; Althaqafi, Raad M.M./0000-0001-9162-7754			Al-Habib A, 2012, J TRAUMA ACUTE CARE, V72, P1356, DOI 10.1097/TA.0b013e318250b537; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Al-Naami MY, 2010, ANN SAUDI MED, V30, P50, DOI [10.5144/0256-4947.59374, 10.4103/0256-4947.59374]; Aldwsari Omar Mufi, 2018, J Family Med Prim Care, V7, P1548, DOI 10.4103/jfmpc.jfmpc_101_18; [Anonymous], 2002, TRAUMATIC BRAIN INJU; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Coburn K, 1992, AACN Clin Issues Crit Care Nurs, V3, P9; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ohwaki K, 2008, NEUROCRIT CARE, V8, P271, DOI 10.1007/s12028-007-9007-1; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pavlova V, 2018, ENDOCR METAB IMMUNE, V18, P502, DOI 10.2174/1871530318666180423121833; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Popescu C, 2015, J Med Life, V8, P272; Sadaka F, 2018, AM J EMERG MED, V36, P1624, DOI 10.1016/j.ajem.2018.01.051; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116	28	0	0	1	2	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAY 29	2021	13	5							e15318	10.7759/cureus.15318			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SK5JQ	WOS:000656251900008	34221767	Green Published, gold			2022-02-07	
J	Beidler, PG; Novokhodko, A; Prolo, LM; Browd, S; Lutz, BR				Beidler, Peter G.; Novokhodko, Alexander; Prolo, Laura M.; Browd, Samuel; Lutz, Barry R.			Fluidic Considerations of Measuring Intracranial Pressure Using an Open External Ventricular Drain	CUREUS			English	Article						external ventricular drain; cerebrospinal fluid; intracranial hypertension; continuous measurement; traumatic brain injury; catheter; bioengineering; neuro-surgery; neuro-monitoring; neurology and critical care	CEREBROSPINAL-FLUID; MANAGEMENT; CATHETERS	Measurement of intracranial pressure (ICP) during cerebrospinal fluid (CSF) drainage with an external ventricular drain (EVD) typically requires stopping the flow during measurement. However, there may be benefits to simultaneous ICP measurement and CSF drainage. Several studies have evaluated whether accurate ICP measurements can be obtained while the EVD is open. They report differing outcomes when it comes to error, and hypothesize several sources of error. This study presents an investigation into the fluidic sources of error for ICP measurement with concurrent drainage in an EVD. Our experiments and analytical model both show that the error in pressure measurement increases linearly with flow rate and is not clinically significant, regardless of drip chamber height. At physiologically relevant flow rates (40 mL/hr) and ICP set points (13.6 - 31.3 cmH(2)O or 10 - 23 mmHg), our model predicts an underestimation of 0.767 cmH(2)O (0.56 mmHg) with no observed data point showing error greater than 1.09 cmH(2)O (0.8 mmHg) in our experiment. We extrapolate our model to predict a realistic worst-case clinical scenario where we expect to see a mean maximum error of 1.06 cmH(2)O (0.78 mmHg) arising from fluidic effects within the drainage system for the most resistive catheter. Compared to other sources of error in current ICP monitoring, error in pressure measurement due to drainage flow is small and does not prohibit clinical use. However, other effects such as ventricular collapse or catheter obstruction could affect ICP measurement under continuous drainage and are not investigated in this study.	[Beidler, Peter G.; Novokhodko, Alexander; Browd, Samuel; Lutz, Barry R.] Univ Washington, Bioengn, Seattle, WA 98195 USA; [Novokhodko, Alexander] Univ Washington, Mech Engn, Seattle, WA 98195 USA; [Prolo, Laura M.] Stanford Univ, Sch Med, Neurosurg, Stanford, CA 94305 USA; [Prolo, Laura M.] VA Palo Alto Hlth Care Syst, Surg Serv, Palo Alto, CA USA; [Browd, Samuel] Seattle Childrens Hosp, Neurosurg, Seattle, WA USA; [Browd, Samuel] Univ Washington, Neurol Surg, Seattle, WA 98195 USA		Lutz, BR (corresponding author), Univ Washington, Bioengn, Seattle, WA 98195 USA.	blutz@uw.edu					[Anonymous], 2021, DUET EDMS SYSTEM IND; Birch AA, 2006, NEUROCRIT CARE, V5, P51, DOI 10.1385/NCC:5:1:51; Bisnaire D, 1997, J Neurosci Nurs, V29, P261; Bloomfield IG, 1998, PEDIATR NEUROSURG, V28, P246, DOI 10.1159/000028659; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; BRYDON HL, 1995, BRIT J NEUROSURG, V9, P639, DOI 10.1080/02688699550040927; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 2003, NEUROSURGERY, V52, P619, DOI 10.1227/01.NEU.0000049956.11888.6D; Elixmann IM, 2011, AT-AUTOM, V59, P613, DOI 10.1524/auto.2011.0954; Galarza M, 2014, CHILD NERV SYST, V30, P105, DOI 10.1007/s00381-013-2226-1; Hockel K, 2018, ACTA NEUROCHIR SUPPL, V126, P281, DOI 10.1007/978-3-319-65798-1_55; Iencean SM, 2009, INTRACRANIAL HYPERTE; Javed K, 2021, NEUROANATOMY CHOROID; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kwon Young Sub, 2016, Korean J Neurotrauma, V12, P28, DOI 10.13004/kjnt.2016.12.1.28; Lui ACP, 1998, CAN J ANAESTH, V45, P297, DOI 10.1007/BF03012018; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; Nag DS, 2019, WORLD J CLIN CASES, V7, P1535, DOI 10.12998/wjcc.v7.i13.1535; OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8; RUBIN RC, 1966, J NEUROSURG, V25, P430, DOI 10.3171/jns.1966.25.4.0430; Seaver CE., 2018, THESIS U TENNESSEE K; Sunderland NE, 2016, J NEUROSCI NURS, V48, P274, DOI 10.1097/JNN.0000000000000255; Telano LN, 2021, PHYSL CEREBRAL SPINA; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Welty J. R., 2008, FUNDAMENTALS MOMENTU; WILKINSON HA, 1989, NEUROSURGERY, V24, P348, DOI 10.1227/00006123-198903000-00007; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9	28	0	0	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAY 29	2021	13	5							e15324	10.7759/cureus.15324			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SK5JQ	WOS:000656251900014	34221772	Green Published, gold			2022-02-07	
J	Bottari, SA; Lamb, DG; Murphy, AJ; Porges, EC; Rieke, JD; Harciarek, M; Datta, S; Williamson, JB				Bottari, Sarah A.; Lamb, Damon G.; Murphy, Aidan J.; Porges, Eric C.; Rieke, Jake D.; Harciarek, Michal; Datta, Somnath; Williamson, John B.			Hyperarousal symptoms and decreased right hemispheric frontolimbic white matter integrity predict poorer sleep quality in combat-exposed veterans	BRAIN INJURY			English	Article						Mild traumatic brain injury; ptsd; hyperarousal; sleep disturbance; white matter injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; OEF/OIF VETERANS; PTSD CHECKLIST; MILITARY; DISTURBANCES; INSOMNIA; IRAQ; DEPLOYMENT; ASYMMETRY	Objective Disrupted sleep is common following combat deployment. Contributors to risk include posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI); however, the mechanisms linking PTSD, mTBI, and sleep are unclear. Both PTSD and mTBI affect frontolimbic white matter tracts, such as the uncinate fasciculus. The current study examined the relationship between PTSD symptom presentation, lateralized uncinate fasciculus integrity, and sleep quality. Method Participants include 42 combat veterans with and without PTSD and mTBI. Freesurfer and Tracula were used to establish specific white matter ROI integrity via 3-T MRI. The Pittsburgh Sleep Quality Index and PTSD Checklist were used to assess sleep quality and PTSD symptoms. Results Decreased fractional anisotropy in the right uncinate fasciculus (beta = -1.11, SE = 0.47, p < .05) and increased hyperarousal symptom severity (beta = 3.50, SE = 0.86, p < .001) were associated with poorer sleep quality. Conclusion Both right uncinate integrity and hyperarousal symptom severity are associated withsleep quality in combat veterans. The right uncinate is a key regulator of limbic behavior and sympathetic nervous system reactivity, a core component of hyperarousal. Damage to this pathway may be one mechanism by which mTBI and/or PTSD could create vulnerability for sleep problems following combat deployment.	[Bottari, Sarah A.; Lamb, Damon G.; Williamson, John B.] Univ Florida, Dept Psychiat, Ctr OCD Anxiety & Related Disorders, Gainesville, FL 32611 USA; [Bottari, Sarah A.; Porges, Eric C.; Williamson, John B.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Lamb, Damon G.; Rieke, Jake D.; Williamson, John B.] Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA; [Lamb, Damon G.; Murphy, Aidan J.; Porges, Eric C.; Williamson, John B.] Univ Florida, Ctr Cognit Aging & Memory, McKnight Brain Inst, Gainesville, FL USA; [Harciarek, Michal] Univ Gdansk, Inst Psychol, Div Clin Psychol & Neuropsychol, Dept Social Sci, Gdansk, Poland; [Datta, Somnath] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA		Williamson, JB (corresponding author), Univ Florida, Dept Psychiat, McKnight Brain Inst L4 100, Gainesville, FL 32610 USA.	john.williamson@ufl.edu	Harciarek, Michal/AAS-5103-2021	Harciarek, Michal/0000-0001-8289-8878	Department of Veterans AffairsUS Department of Veterans Affairs [IK2RX000707]	This work was supported by the Department of Veterans Affairs [IK2RX000707].	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander M, 2016, SLEEP, V39, P1399, DOI 10.5665/sleep.5972; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 2011, FRONT NEUROINFORM, P5; Antonow-Schlorke I, 2009, OBSTET GYNECOL, V113, P142, DOI 10.1097/AOG.0b013e3181924d3b; Averill Christopher L, 2018, Mol Neuropsychiatry, V4, P75, DOI 10.1159/000490464; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Bhatia K, 2017, NEUROPSYCHOBIOLOGY, V75, P132, DOI 10.1159/000485111; Burtis DB, 2014, BIOL PSYCHOL, V100, P79, DOI 10.1016/j.biopsycho.2014.05.006; Buysse D J, 1989, Psychiatry Res, V28, P193; Caldwell JA, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz112; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; Davidson RJ., 1996, BRAIN ASYMMETRY; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fink AM, 2018, CLIN AUTON RES, V28, P509, DOI 10.1007/s10286-018-0560-9; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gelis LA, 2010, MIL MED, V175, P567, DOI 10.7205/MILMED-D-09-00123; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gottesmann Claude, 2011, Front Neurol, V2, P81, DOI 10.3389/fneur.2011.00081; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Harnett NG, 2020, BRAIN IMAGING BEHAV, V14, P1012, DOI 10.1007/s11682-018-9995-9; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; HEILMAN KM, 1978, NEUROLOGY, V28, P229, DOI 10.1212/WNL.28.3.229; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Kalmbach DA, 2018, NAT SCI SLEEP, V10, P193, DOI 10.2147/NSS.S138823; King PR, 2017, J PSYCHOSOM RES, V96, P60, DOI 10.1016/j.jpsychores.2017.03.012; Klimova A, 2019, BIOL PSYCHIAT-COGN N, V4, P81, DOI 10.1016/j.bpsc.2018.10.004; Koch SBJ, 2017, J PSYCHIATR NEUROSCI, V42, P331, DOI 10.1503/jpn.160129; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Lamb DG, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00124; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; Li SM, 2016, RADIOLOGY, V280, P520, DOI 10.1148/radiol.2016152038; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McGinley JJ, 2015, PSYCHOPHYSIOLOGY, V52, P416, DOI 10.1111/psyp.12332; MELLMAN TA, 1995, BIOL PSYCHIAT, V38, P174, DOI 10.1016/0006-3223(94)00238-X; Mellman TA, 2001, J TRAUMA STRESS, V14, P241, DOI 10.1023/A:1007812321136; Mincic AM, 2015, NEUROPSYCHOLOGIA, V77, P97, DOI 10.1016/j.neuropsychologia.2015.08.007; Mitchell HA, 2010, BIOCHEM PHARMACOL, V79, P801, DOI 10.1016/j.bcp.2009.10.004; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Donnell T, 2004, NEUROPSYCHOBIOLOGY, V50, P273, DOI 10.1159/000080952; Oppenheimer S, 2001, ANN NEUROL, V49, P555, DOI 10.1002/ana.1038.abs; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Pace-Schott EF, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0018-9; Pena EA, 2006, J AM STAT ASSOC, V101, P341, DOI 10.1198/016214505000000637; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Raikes AC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00468; Roine T, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00028; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Santhanam P, 2019, J NEUROTRAUM, V36, P1093, DOI 10.1089/neu.2017.5541; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sexton CE, 2017, HUM BRAIN MAPP, V38, P5465, DOI 10.1002/hbm.23739; Shen YC, 2009, MIL MED, V174, P217, DOI 10.7205/MILMED-D-03-4307; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Short NA, 2014, J AFFECT DISORDERS, V165, P159, DOI 10.1016/j.jad.2014.04.069; Spiegelhalder K, 2014, HUM BRAIN MAPP, V35, P3431, DOI 10.1002/hbm.22412; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; UNO H, 1994, HORM BEHAV, V28, P336, DOI 10.1006/hbeh.1994.1030; van Wyk M, 2016, PSYCHOL TRAUMA-US, V8, P688, DOI 10.1037/tra0000115; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Williams JL, 2011, J PSYCHOPATHOL BEHAV, V33, P514, DOI 10.1007/s10862-011-9248-3; Williamson JB, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01571; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wilson MA, 2019, STRESS, V22, P530, DOI 10.1080/10253890.2019.1621283; Wittling W, 1998, NEUROPSYCHOLOGIA, V36, P461, DOI 10.1016/S0028-3932(97)00129-2; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Yamada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112411; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zoccoli G, 2020, CURR OPIN PHYSIOL, V15, P128, DOI 10.1016/j.cophys.2020.01.002	100	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					922	933		10.1080/02699052.2021.1927186		MAY 2021	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000656063500001	34053386	hybrid			2022-02-07	
J	Asim, M; El-Menyar, A; Parchani, A; Nabir, S; Ahmed, MN; Ahmed, Z; Ramzee, AF; Al-Thani, A; Al-Abdulmalek, A; Al-Thani, H				Asim, Mohammad; El-Menyar, Ayman; Parchani, Ashok; Nabir, Syed; Ahmed, Mohamed Nadeem; Ahmed, Zahoor; Ramzee, Ahmed Faidh; Al-Thani, Abdulaziz; Al-Abdulmalek, Abdulrahman; Al-Thani, Hassan			Rotterdam and Marshall Scores for Prediction of in-hospital Mortality in Patients with Traumatic Brain Injury: An observational study	BRAIN INJURY			English	Article						Traumatic brain injury; head CT scan; Rotterdam and Marshall scores; prognostic value; outcomes	GLASGOW COMA SCALE; HEAD-INJURY; CT SCORES; CLASSIFICATION	Background: We aimed to assess the prognostic value of Rotterdam and Marshall scoring systems to predict in-hospital mortality in patients with traumatic brain injury (TBI). Methods: A retrospective analysis was conducted for patients with TBI who underwent head computerized tomography (CT) scan at a Level I trauma center between 2011 and 2018. Receiver operating characteristic (ROC) curves were used to determine the cutoff values for predicting in-hospital mortality. Results: A total of 1035 patients with TBI were included with a mean age of 30 years. The mean Rotterdam and Marshall scores were higher among non-survivors (p = .001). Patients with higher Rotterdam (>3) or Marshall (>2) CT scores were older, had higher injury severity scores and in-hospital mortality and had lower GCS and blood ethanol levels than those with lower scores. The cutoff point of Rotterdam score was 3.5 (sensitivity, 61.2%; specificity, 85.6%) and Marshall score was 2.5 (74.3% sensitivity and 76.3% specificity). Multivariable logistic regression analyses showed that Marshall and Rotterdam scoring systems were independent predictors of mortality (odds ratio 8.4; 95% confidence interval 4.95-14.17 and odds ratio 4.4; 95% confidence interval 2.36-9.39, respectively). Conclusion: Rotterdam and Marshall CT scores have independent prognostic values in patients with TBI even in alcoholic patients.	[Asim, Mohammad; El-Menyar, Ayman] Hamad Gen Hosp HGH, Clin Res, Trauma & Vasc Surg Sect, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Clin Med, Doha, Qatar; [Parchani, Ashok; Al-Thani, Hassan] Hamad Gen Hosp HGH, Trauma Surg Sect, Dept Surg, Doha, Qatar; [Nabir, Syed; Ahmed, Mohamed Nadeem; Ahmed, Zahoor] Hamad Gen Hosp HGH, Dept Radiol, Doha, Qatar; [Ramzee, Ahmed Faidh] Hamad Gen Hosp HGH, Dept Surg, Doha, Qatar; [Al-Thani, Abdulaziz; Al-Abdulmalek, Abdulrahman] Hamad Gen Hosp HGH, Dept Med, Doha, Qatar		El-Menyar, A (corresponding author), Weill Cornell Med Coll, Clin Med, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015; Ramzee, Ahmed Faidh/ABA-5322-2021	El-Menyar, Ayman/0000-0003-2584-953X; Ramzee, Ahmed Faidh/0000-0002-7049-6115			Al-Thani H, 2020, PREHOSP DISASTER MED, V35, P508, DOI 10.1017/S1049023X20000904; [Anonymous], 2019, ASS ADVANCEMENT AUTO; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; Charry JD, 2017, J NEUROSCI RURAL PRA, V8, P23, DOI 10.4103/jnrp.jnrp_434_16; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; El-Menyar A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243658; El-Menyar A, 2019, BRAIN INJURY, V33, P419, DOI 10.1080/02699052.2018.1553065; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; Helmy TA., 2015, JAMA-J AM MED ASSOC, V3, P69; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Jovanovic B, 2016, MED PRIN PRACT, V25, P435, DOI 10.1159/000447566; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Mohammadifard M, 2018, EUR J TRANSL MYOL, V28, P265, DOI 10.4081/ejtm.2018.7542; Munakomi S, 2016, CHIN J TRAUMATOL, V19, P25, DOI 10.1016/j.cjtee.2015.12.005; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Settervall Cristina Helena Costanti, 2011, Rev. Latino-Am. Enfermagem, V19, P1337; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wesson HKH, 2015, CURR TRAUMA REP, V1, P147, DOI 10.1007/s40719-015-0017-8; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	28	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					803	811		10.1080/02699052.2021.1927181		MAY 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000657221800001	34076543				2022-02-07	
J	Cao, XY; Qian, X; Liu, GD; Wang, YH				Cao, Xin-yi; Qian, Xiao; Liu, Guo-dong; Wang, Yu-hai			Bioinformatics-based Identification of Key Pathways and Hub Genes of Traumatic Brain Injury in a Rat Model	CURRENT MEDICAL SCIENCE			English	Article						traumatic brain injury; bioinformatics analysis; differentially expressed gene; hub gene; signal pathway	CEREBRAL-CORTEX; NEUROINFLAMMATION; INFLAMMATION; CONTRIBUTES; EXPRESSION; BARRIER; PATHOPHYSIOLOGY; ACTIVATION; MANAGEMENT; NETWORKS	Traumatic brain injury (TBI) is a common injury caused by external forces that lead to damaged brain function or pathological changes in the brain tissue. To explore the molecular mechanism and the hub genes of TBI, we downloaded gene expression profiles of the TBI model of rat and the sham control for the subsequent gene set enrichment analysis, pathway analysis and protein-protein interactions analysis. The results of Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis indicated that multiple biological pathways, including immune response, inflammatory response and cellular response to interleukin-1, as well as signaling pathways, such as tumor necrosis factor signaling pathway, chemokine signaling pathway, cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway and nuclear factor kappa B signaling pathway were implicated in the TBI. In conclusion, this study provides insights into the molecular mechanism of TBI by screening the differentially expressed genes and hub genes that can be used as biomarkers and therapeutic targets.	[Cao, Xin-yi; Qian, Xiao; Liu, Guo-dong; Wang, Yu-hai] Anhui Med Univ, Wuxi Clin Coll, 904th Hosp Joint Logist Support Force Chinese Peo, Wuxi 214000, Jiangsu, Peoples R China		Wang, YH (corresponding author), Anhui Med Univ, Wuxi Clin Coll, 904th Hosp Joint Logist Support Force Chinese Peo, Wuxi 214000, Jiangsu, Peoples R China.	caoxinyi322@163.com; wangyuhai67@126.com			Military Logistics Scientific Research Project [CLB20J027]	This work was supported by the Military Logistics Scientific Research Project (No. CLB20J027).	Abou El Fadl MH, 2018, NEUROSURG CLIN N AM, V29, P213, DOI 10.1016/j.nec.2017.11.002; Godoy DA, 2018, NEUROSURG CLIN N AM, V29, P195, DOI 10.1016/j.nec.2017.12.001; Anghinah R, 2018, ARQ NEURO-PSIQUIAT, V76, P100, DOI [10.1590/0004-282X20170196, 10.1590/0004-282x20170196]; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Feldman N, 2015, AGEING RES REV, V24, P29, DOI 10.1016/j.arr.2015.01.003; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hui JL, 2020, PEERJ, V8, DOI 10.7717/peerj.8653; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kotera M, 2012, METHODS MOL BIOL, V802, P19, DOI 10.1007/978-1-61779-400-1_2; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lucas K, 2013, MOL NEUROBIOL, V48, P190, DOI 10.1007/s12035-013-8425-7; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miao M, 2020, EXPERT OPIN DRUG MET, V16, P11, DOI 10.1080/17425255.2020.1711884; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Nikolian VC, 2018, CRIT CARE MED, V46, pE59, DOI 10.1097/CCM.0000000000002800; Pachter JS, 2003, J NEUROPATH EXP NEUR, V62, P593, DOI 10.1093/jnen/62.6.593; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; SEBIRE G, 1993, RES VIROLOGY, V144, P47, DOI 10.1016/S0923-2516(06)80011-7; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Shojo H, 2017, CELL TRANSPLANT, V26, P1301, DOI 10.1177/0963689717715169; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; van Dam S, 2015, NUCLEIC ACIDS RES, V43, pD1124, DOI 10.1093/nar/gku1042; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Woodcock TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188305; Yu NZ, 2018, TRANSL NEUROSCI, V9, P175, DOI 10.1515/tnsci-2018-0026; Yu ZQ, 2012, ANN CLIN LAB SCI, V42, P26; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	48	0	0	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2096-5230	2523-899X		CURR MED SCI	Curr. Med. Sci.	JUN	2021	41	3					610	617		10.1007/s11596-021-2365-7		MAY 2021	8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	TH0OJ	WOS:000655805800005	34047944				2022-02-07	
J	Demirkiran, H; Kilic, M; Tomak, Y; Dalkiran, T; Yurttutan, S; Basaranoglu, M; Tuncer, O; Derme, T; Tekeli, AE; Bahar, I; Keskin, S; Oksuz, H				Demirkiran, Hilmi; Kilic, Mehmet; Tomak, Yakup; Dalkiran, Tahir; Yurttutan, Sadik; Basaranoglu, Murat; Tuncer, Oguz; Derme, Turan; Tekeli, Arzu Esen; Bahar, Ilhan; Keskin, Siddik; Oksuz, Hafize			Evaluation of the incidence, characteristics, and outcomes of pediatric chronic critical illness	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; LONG-STAY PATIENTS; PROLONGED MECHANICAL VENTILATION; QUALITY-OF-LIFE; ILL PATIENTS; EPIDEMIOLOGY; CHILDREN; PROFILE	Our aim was to determine characteristics of children with chronic critical illness (CCI) admitted to the pediatric intensive care unit (PICU) of a tertiary care children's hospital in Turkey. The current study was a multicenter retrospective cohort study that was done from 2014 to 2017. It involved three university hospitals PICUs in which multiple criteria were set to identify pediatric CCIs. Pediatric patients staying in the ICU for at least 14 days and having at least one additional criterion, including prolonged mechanical ventilation, tracheostomy, sepsis, severe wound (burn) or trauma, encephalopathy, traumatic brain injury, status epilepticus, being postoperative, and neuromuscular disease, was accepted as CCI. In order to identify the newborn as a chronic critical patient, a stay in the intensive care unit for at least 30 days in addition to prematurity was required. Eight hundred eighty seven (11.14%) of the patients who were admitted to the PICU met the definition of CCI and 775 of them (87.3%) were discharged to their home. Of CCI patients, 289 (32.6%) were premature and 678 (76.4%) had prolonged mechanical ventilation. The total cost values for 2017 were statistically higher than the other years. As the length of ICU stay increased, the costs also increased. Interestingly, high incidence rates were observed for PCCI in our hospitals and these patients occupied 38.01% of the intensive care bed capacity. In conclusion, we observed that prematurity and prolonged mechanical ventilation increase the length of ICU stay, which also increased the costs. More work is needed to better understand PCCI.	[Demirkiran, Hilmi; Tekeli, Arzu Esen] Van Yuzuncu Yil Univ, Dept Anesthesiol & Reanimat, Fac Med, Van, Turkey; [Kilic, Mehmet] Hisar Intercontinental Hosp, Dept Pediat, Istanbul, Turkey; [Tomak, Yakup] Sakarya Univ, Anesthesiol & Intens Care Unit, Fac Med, Sakarya, Turkey; [Dalkiran, Tahir] Necip Fazil City Hosp, Pediat Intens Care Unit, Kahramanmaras, Turkey; [Yurttutan, Sadik] Kahramanmaras Sutcu Imam Univ, Div Neonatol, Dept Pediat, Fac Med, Kahramanmaras, Turkey; [Basaranoglu, Murat; Tuncer, Oguz] Van Yuzuncu Yil Univ, Div Neonatol, Dept Pediat, Fac Med, Van, Turkey; [Derme, Turan] Univ Hlth Sci, Dept Pediat, Div Neonatol, Minist Hlth Ankara City Hosp, Ankara, Turkey; [Bahar, Ilhan] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Internal Med Crit Care Unit, Izmir, Turkey; [Keskin, Siddik] Van Yuzuncu Yil Univ, Dept Biostat, Fac Med, Van, Turkey; [Oksuz, Hafize] Kahramanmaras Sutcu Imam Univ, Dept Anesthesiol & Reanimat, Fac Med, Kahramanmaras, Turkey		Demirkiran, H (corresponding author), Van Yuzuncu Yil Univ, Dept Anesthesiol & Reanimat, Fac Med, Van, Turkey.	h.dkiran@hotmail.com		Demirkiran, Hilmi/0000-0001-8116-3933			Bagshaw SM, 2014, CAN MED ASSOC J, V186, pE95, DOI 10.1503/cmaj.130639; Carson SS, 2006, CURR OPIN CRIT CARE, V12, P405, DOI 10.1097/01.ccx.0000244118.08753.dc; Carson SS, 2012, RESP CARE, V57, P848, DOI 10.4187/respcare.01736; Chalom R, 1999, CRIT CARE MED, V27, P2079, DOI 10.1097/00003246-199910000-00001; Conlon NP, 2009, PEDIATR CRIT CARE ME, V10, P41, DOI 10.1097/PCC.0b013e31819371f6; Donohue PK, 2018, J PALLIAT MED, V21, P940, DOI 10.1089/jpm.2017.0397; Feudtner C, 2000, PEDIATRICS, V106, P205; Hardelid P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005331; Hirschfeld RS, 2019, PEDIATR CRIT CARE ME, V20, pE546, DOI 10.1097/PCC.0000000000002150; Hsu Benson S, 2015, S D Med, V68, P341; Ishihara T, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000499; Iwashyna TJ, 2015, CRIT CARE RESUSC, V17, P215; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kirk AHP, 2018, J PEDIATR INTENSIVE, V7, P1, DOI 10.1055/s-0037-1601337; Lone NI, 2011, CRIT CARE, V15, DOI 10.1186/cc10117; Loss Sergio Henrique, 2017, Rev. bras. ter. intensiva, V29, P87, DOI [10.5935/0103-507X.20170013, 10.5935/0103-507x.20170013]; MacIntyre NR, 2012, RESP CARE, V57, P1021, DOI 10.4187/respcare.01768; Marcin JP, 2001, CRIT CARE MED, V29, P652, DOI 10.1097/00003246-200103000-00035; Naghib S, 2010, INTENS CARE MED, V36, P131, DOI 10.1007/s00134-009-1693-z; Namachivayam P, 2012, PEDIATR CRIT CARE ME, V13, P520, DOI 10.1097/PCC.0b013e31824fb989; Namachivayam SP, 2015, CRIT CARE MED, V43, P1978, DOI 10.1097/CCM.0000000000001076; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Pearson G, 2001, INTENS CARE MED, V27, P1670, DOI 10.1007/s001340101072; Peltoniemi OM, 2016, PEDIATR CRIT CARE ME, V17, pE43, DOI 10.1097/PCC.0000000000000587; Peterson-Carmichael SL, 2012, RESP CARE, V57, P993, DOI 10.4187/respcare.01738; Rennick JE, 2015, PEDIATRICS, V135, pE289, DOI 10.1542/peds.2014-2174; Rose Louise, 2019, Crit Care Explor, V1, pe0005, DOI 10.1097/CCE.0000000000000005; Rose L, 2014, CAN RESPIR J, V21, P287, DOI 10.1155/2014/484835; Sauthier M, 2017, RESP CARE, V62, P49, DOI 10.4187/respcare.04881; Shapiro Miriam C, 2017, Hosp Pediatr, V7, P236, DOI 10.1542/hpeds.2016-0107; van der Heide P, 2004, ACTA PAEDIATR, V93, P1070, DOI 10.1080/08035250410027580; Walter JK, 2013, PEDIATRICS, V131, pS90, DOI 10.1542/peds.2012-1427k; Wiencek C, 2010, AACN ADV CRIT CARE, V21, P44, DOI 10.1097/NCI.0b013e3181c6a162	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0248883	10.1371/journal.pone.0248883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	WOS:000664636100004	34048449	gold, Green Published			2022-02-07	
J	Huang, BY; Wang, HK; Zhong, DD; Meng, J; Li, M; Yang, BX; Ran, JH				Huang, Boyue; Wang, Hongkai; Zhong, Dandan; Meng, Jia; Li, Min; Yang, Baoxue; Ran, Jianhua			Expression of Urea Transporter B in Normal and Injured Brain	FRONTIERS IN NEUROANATOMY			English	Article						ScRNA-seq; distribution; neuron; TBI; urea transporter B	SINGLE-CELL GENOMICS; TISSUE DISTRIBUTION; MESSENGER-RNA; UT-B; RAT; AQUAPORIN-4; METABOLISM; PROTEIN; FAMILY	Urea transporter B (UT-B) is a membrane channel protein widely distributed in mammals, and plays a significant physiological role by regulating urea and water transportation in different tissues. More and more studies have found that UT-B is related to neurological diseases, including myelinopathy and depression. When urea accumulates in the brains of UT-B knockout mice, the synaptic plasticity of neurons is reduced, and the morphology and function of glial cells are also changed. However, the distribution and expression change of UT-B remain unclear. The purpose of this study is to determine the expression characteristics of UT-B in the brain. Through single-cell RNA sequencing, UT-B was found to express universally and substantially throughout the various cells in the central nervous system except for endothelial and smooth muscle cells. UT-B was detected in the third cerebral ventricular wall, granule cell layer of the dentate gyrus, and other parts of the hippocampal, cerebral cortex, substantia nigra, habenular, and lateral hypothalamic nucleus by immunohistochemistry. Compared with the membrane expression of UT-B in glial cells, the subcellular localization of UT-B is in the Golgi apparatus of neurons. Further, the expression of UT-B was regulated by osmotic pressure in vitro. In the experimental traumatic brain injury model (TBI), the number of UT-B positive neurons near the ipsilateral cerebral cortex increased first and then decreased over time, peaking at the 24 h. We inferred that change in UT-B expression after the TBI was an adaptation to changed urea levels. The experimental data suggest that the UT-B may be a potential target for the treatment of TBI and white matter edema.	[Huang, Boyue; Wang, Hongkai; Ran, Jianhua] Chongqing Med Univ, Dept Anat, Basic Med Coll, Lab Neurosci & Tissue Engn, Chongqing, Peoples R China; [Huang, Boyue; Wang, Hongkai; Zhong, Dandan; Meng, Jia; Li, Min; Yang, Baoxue] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China		Ran, JH (corresponding author), Chongqing Med Univ, Dept Anat, Basic Med Coll, Lab Neurosci & Tissue Engn, Chongqing, Peoples R China.; Yang, BX (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China.	baoxue@bjmu.edu.cn; ranjianhua@cqmu.edu.cn	huang, arial/AAV-3651-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81620108029, 81770738, 81330074, 81974083]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7172113]	This work was supported by the National Natural Science Foundation of China Grants Nos. 81620108029, 81770738, 81330074, and 81974083, the Beijing Natural Science Foundation Grant No. 7172113.	Bagnasco SM, 2003, AM J PHYSIOL-RENAL, V284, pF3, DOI 10.1152/ajprenal.00260.2002; Berger UV, 1998, ANAT EMBRYOL, V197, P405, DOI 10.1007/s004290050152; BOLKENIUS FN, 1986, INT J DEV NEUROSCI, V4, P217, DOI 10.1016/0736-5748(86)90061-4; Couriaud C, 1996, BBA-GENE STRUCT EXPR, V1309, P197, DOI 10.1016/S0167-4781(96)00172-8; Desai M, 2018, J NEUROSURG SCI, V62, P563, DOI 10.23736/S0390-5616.18.04476-4; Doran JJ, 2006, AM J PHYSIOL-REG I, V290, pR1446, DOI 10.1152/ajpregu.00352.2004; DORNAY M, 1986, EXP NEUROL, V92, P665, DOI 10.1016/0014-4886(86)90307-9; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Homayoon N, 2019, MOVEMENT DISORD, V34, P129, DOI 10.1002/mds.27549; Huang Boyue, 2017, Adv Exp Med Biol, V969, P251, DOI 10.1007/978-94-024-1057-0_17; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Li X, 2012, J MOL NEUROSCI, V46, P362, DOI 10.1007/s12031-011-9594-3; Morris SM, 2004, CURR OPIN CLIN NUTR, V7, P45, DOI 10.1097/00075197-200401000-00009; PALLONE TL, 1994, AM J PHYSIOL, V267, pR260, DOI 10.1152/ajpregu.1994.267.1.R260; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Rao VLR, 1998, BRAIN RES, V783, P163, DOI 10.1016/S0006-8993(97)01301-2; RATNER S, 1960, ARCH BIOCHEM BIOPHYS, V91, P280, DOI 10.1016/0003-9861(60)90502-6; Sands Jeff M, 2014, Subcell Biochem, V73, P45, DOI 10.1007/978-94-017-9343-8_4; Sands JM, 1999, NEWS PHYSIOL SCI, V14, P46; SANDS JM, 1991, J CLIN INVEST, V88, P137, DOI 10.1172/JCI115269; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Shayakul C, 2013, MOL ASPECTS MED, V34, P313, DOI 10.1016/j.mam.2012.12.003; Stewart G, 2011, BRIT J PHARMACOL, V164, P1780, DOI 10.1111/j.1476-5381.2011.01377.x; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Timothy J, 1996, J NEUROL NEUROSUR PS, V61, P209, DOI 10.1136/jnnp.61.2.209; Trinh-Trang-Tan MM, 2002, AM J PHYSIOL-RENAL, V283, pF912, DOI 10.1152/ajprenal.00359.2001; Wagner L, 2002, AM J PHYSIOL-RENAL, V283, pF578, DOI 10.1152/ajprenal.00355.2001; Wang HK, 2019, EBIOMEDICINE, V48, P478, DOI 10.1016/j.ebiom.2019.09.049; Wang Hongkai, 2014, Subcell Biochem, V73, P7, DOI 10.1007/978-94-017-9343-8_2; Yang B, 2002, J BIOL CHEM, V277, P10633, DOI 10.1074/jbc.M200207200; Yang B., 2014, BIOCHEM B, V73, P127, DOI [10.1007/978-94-017-9343-8_8, DOI 10.1007/978-94-017-9343-8_8]; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang Baoxue, 2014, Subcell Biochem, V73, P153, DOI 10.1007/978-94-017-9343-8_10; Yang BX, 1998, J BIOL CHEM, V273, P9369, DOI 10.1074/jbc.273.16.9369; Yang BX, 2002, J BIOL CHEM, V277, P36782, DOI 10.1074/jbc.M206948200; Yang LM, 2014, BRAIN RES BULL, V100, P22, DOI 10.1016/j.brainresbull.2013.10.007; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zhang H, 2018, NAT CHEM BIOL, V14, P575, DOI 10.1038/s41589-018-0038-z	41	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5129			FRONT NEUROANAT	Front. Neuroanat.	MAY 28	2021	15								591726	10.3389/fnana.2021.591726			11	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	SQ1BF	WOS:000660094300001	34122018	Green Published, gold			2022-02-07	
J	Randhi, R; Damon, M; Dixon, KJ				Randhi, Rajasa; Damon, Melissa; Dixon, Kirsty J.			Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice	BMC GASTROENTEROLOGY			English	Article						Acute pancreatitis; Cerulein; Mice; Inflammation; Cytokines; TNF; TNFR1; Neuropathic pain	TUMOR-NECROSIS-FACTOR; INDUCED ACUTE-PANCREATITIS; TRAUMATIC BRAIN-INJURY; FACTOR-ALPHA; NECROTIZING PANCREATITIS; PROTEASE INHIBITORS; NEUROPATHIC PAIN; THERAPY; INTERLEUKIN-1; DECREASES	Background Symptoms associated with acute pancreatitis can be debilitating, and treatment remains a challenge. This study aimed to investigate the efficacy of selectively inhibiting the soluble form of TNF (solTNF) using the biologic XPro1595 in a mouse model of acute pancreatitis. Methods Acute pancreatitis was induced in adult male C57Bl/6J mice by administering cerulein (8 injections of 50 mu g/kg I.P., spaced an hour apart), with XPro1595 (10 mg/kg, S.C.) or vehicle being administered approximately 18 h after the last injection. Serum was collected 6 or 18 h after the last cerulein injection, pancreatic tissue was collected 2 and 7 days post-induction, and brain hippocampal tissue was collected at 7 days post-induction. The animal's pain level was assessed 3, 5 and 7 days post-induction. Results The induction of acute pancreatitis promoted a strong increase in serum amylase levels, which had receded back to baseline levels by the next morning. XPro1595 treatment began after amylase levels had subsided at 18 h, and prevented pancreatic immune cell infiltration, that subsequently prevented tissue disruption and acinar cell death. These improvements in pathology were associated with a significant reduction in mechanical hypersensitivity (neuropathic pain). XPro1595 treatment also prevented an increase in hippocampal astrocyte reactivity, that may be associated with the prevention of neuropathic pain in this mouse model. Conclusion Overall, we observed that selectively inhibiting solTNF using XPro1595 improved the pathophysiological and neurological sequelae of cerulein-induced pancreatitis in mice, which provides support of its use in patients with pancreatitis.	[Randhi, Rajasa; Damon, Melissa; Dixon, Kirsty J.] Virginia Commonwealth Univ, Dept Surg, 1101 E Marshall St, Richmond, VA 23298 USA		Dixon, KJ (corresponding author), Virginia Commonwealth Univ, Dept Surg, 1101 E Marshall St, Richmond, VA 23298 USA.	kirsty.dixon@vcuhealth.org			Virginia Commonwealth Neurotrauma Initiative [FP00001476]; Virginia Commonwealth University Department of Surgery	We gratefully acknowledge the grant support from the Virginia Commonwealth Neurotrauma Initiative funding to KJD (FP00001476), and Virginia Commonwealth University Department of Surgery pilot funding to KJD. Funding bodies did not contribute to the design of study or collection, analysis, interpretation of data or writing of the manuscript.	Akinosoglou K, 2014, WORLD J GASTROENTERO, V20, P15200, DOI 10.3748/wjg.v20.i41.15200; Atretkhany KSN, 2018, P NATL ACAD SCI USA, V115, P13051, DOI 10.1073/pnas.1807499115; Ban LQ, 2008, P NATL ACAD SCI USA, V105, P13644, DOI 10.1073/pnas.0803429105; Bell A, 2018, VET J, V237, P55, DOI 10.1016/j.tvjl.2018.05.004; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Bugiantella W, 2016, INT J SURG, V28, pS163, DOI 10.1016/j.ijsu.2015.12.038; Cardoso-Cruz H, 2013, J NEUROSCI, V33, P2465, DOI 10.1523/JNEUROSCI.5197-12.2013; Cattaruzza F, 2013, AM J PHYSIOL-GASTR L, V304, pG1002, DOI 10.1152/ajpgi.00005.2013; Cavanagh C, 2016, NEUROBIOL AGING, V47, P41, DOI 10.1016/j.neurobiolaging.2016.07.009; Chao KC, 2006, BRIT J SURG, V93, P332, DOI 10.1002/bjs.5251; Chen CC, 2007, J PANCREAS, V8, P488; Clausen BH, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0203-6; Clayton H, 2013, DERMATOLOGY, V227, P193, DOI 10.1159/000351714; De Logu Francesco, 2019, Handb Exp Pharmacol, V260, P161, DOI 10.1007/164_2019_336; Dellarole A, 2014, BRAIN BEHAV IMMUN, V41, P65, DOI 10.1016/j.bbi.2014.04.003; Denham W, 1997, GASTROENTEROLOGY, V113, P1741, DOI 10.1053/gast.1997.v113.pm9352880; Dixon KJ, 2016, STEM CELL RES, V17, P504, DOI 10.1016/j.scr.2016.09.029; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Dumont M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00270; Fischer R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06993-4; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Geisz A, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129717; Gerard E, 2015, PAIN, V156, P1320, DOI 10.1097/j.pain.0000000000000181; Grau GE, 1997, NAT MED, V3, P1193, DOI 10.1038/nm1197-1193; GREWAL HP, 1994, SURGERY, V115, P213; Gunawan F, 2019, J COMMUNITY HOSP INT, V9, P147, DOI 10.1080/20009666.2019.1593783; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Hausmann S, 2016, AM J PATHOL, V186, P24, DOI 10.1016/j.ajpath.2015.09.022; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; HUGHES CB, 1995, SURGERY, V117, P201, DOI 10.1016/S0039-6060(05)80086-8; Hughes CB, 1996, AM J SURG, V171, P274, DOI 10.1016/S0002-9610(97)89568-2; Ignatowski TA, 1999, BRAIN RES, V841, P70, DOI 10.1016/S0006-8993(99)01782-5; INmuneBioInc, INMUNE BIOANN FIN PH; INmuneBioInc, INMUNE BIOR POS PREL; Irie Y, 2017, J NEUROIMMUNE PHARM, V12, P693, DOI 10.1007/s11481-017-9757-2; ISRCTN, REG PHAS IIB RAND DO; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Junger H, 2000, PAIN, V85, P145, DOI 10.1016/S0304-3959(99)00262-6; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kruse P, 1999, J SURG RES, V85, P294, DOI 10.1006/jsre.1999.5609; Le Bars D, 2002, ANN FR ANESTH, V21, P315, DOI 10.1016/S0750-7658(02)00592-0; LEONHARDT U, 1993, PANCREAS, V8, P98, DOI 10.1097/00006676-199301000-00017; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; MacPherson KP, 2017, NEUROBIOL DIS, V102, P81, DOI 10.1016/j.nbd.2017.02.010; Magerl W, 1999, PAIN, V82, P127, DOI 10.1016/S0304-3959(99)00061-5; Majidi S, 2017, SOUTH MED J, V110, P727, DOI 10.14423/SMJ.0000000000000727; Malleo G, 2007, SHOCK, V28, P130, DOI 10.1097/shk.0b013e3180487ba1; Martuscello RT, 2012, PAIN, V153, P1871, DOI 10.1016/j.pain.2012.05.028; Mutso AA, 2014, J NEUROPHYSIOL, V111, P1065, DOI 10.1152/jn.00611.2013; NIH, RAND TREATM AC PANCR; NORMAN J, 1995, SURGERY, V117, P648, DOI 10.1016/S0039-6060(95)80008-5; NORMAN JG, 1995, ARCH SURG-CHICAGO, V130, P966; Okubo Y, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.43; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Osman MO, 1998, GUT, V43, P232, DOI 10.1136/gut.43.2.232; Paszkowski AS, 2002, ANN SURG, V235, P68, DOI 10.1097/00000658-200201000-00009; de Macedo FHP, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0538-0; Qiu P, 2013, CRIT CARE MED, V41, P2419, DOI 10.1097/CCM.0b013e3182982add; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Sahu KKL., 2019, QJM-INT J MED, V113, P2; Sama DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038170; Seta T, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-102; Stobaugh DJ, 2014, ANN PHARMACOTHER, V48, P1282, DOI 10.1177/1060028014540869; Stumpf F, 2016, PANCREAS, V45, P572, DOI 10.1097/MPA.0000000000000483; Tekin SO, 2015, BRATISL MED J, V116, P167, DOI 10.4149/BLL_2015_034; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; TRAUB RJ, 1988, J NEUROPHYSIOL, V59, P41, DOI 10.1152/jn.1988.59.1.41; Triantafillidis JK, 2000, AM J GASTROENTEROL, V95, P3334; Wajant H, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00091; Watanabe T, 2016, MUCOSAL IMMUNOL, V9, P1234, DOI 10.1038/mi.2015.144; Weitz JR, 2020, DIABETES, V69, P1206, DOI 10.2337/db19-0687; Weitz JR, 2018, DIABETOLOGIA, V61, P182, DOI 10.1007/s00125-017-4416-y; Werlang ME, 2017, ACG CASE REP J, V4, DOI 10.14309/crj.2017.103; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yang SH, 2016, CANCER IMMUNOL RES, V4, P520, DOI 10.1158/2326-6066.CIR-15-0235; Zhang K, 2018, EUR J PHARMACOL, V833, P63, DOI 10.1016/j.ejphar.2018.05.034; Zhang LP, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-66; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	79	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-230X		BMC GASTROENTEROL	BMC Gastroenterol.	MAY 28	2021	21	1							243	10.1186/s12876-021-01827-0			10	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	SO6PJ	WOS:000659093100002	34049483	gold, Green Published			2022-02-07	
J	Seelig, J; Heller, RA; Haubruck, P; Sun, Q; Klingenberg, GJ; Hackler, J; Crowell, HL; Daniel, V; Moghaddam, A; Schomburg, L; Biglari, B				Seelig, Julian; Heller, Raban Arved; Haubruck, Patrick; Sun, Qian; Klingenberg, Georg Jochen; Hackler, Julian; Crowell, Helena Lucia; Daniel, Volker; Moghaddam, Arash; Schomburg, Lutz; Biglari, Bahram			Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury	FRONTIERS IN NEUROSCIENCE			English	Article						diagnostic biomarker; in vitro diagnostic test; trace element; neuroregeneration; neurotrauma	INTRASPINAL PRESSURE; ZINC; SELENOPROTEINS; HIF-1-ALPHA; EXPRESSION; MARKER; CANCER; SERUM; FLUID; RISK	Introduction: Traumatic spinal cord injury (TSCI) presents a diagnostic challenge as it may have dramatic consequences for the affected patient. Additional biomarkers are needed for improved care and personalized therapy. Objective: Serum selenium binding protein 1 (SELENBP1) has been detected in myocardial infarction, reflecting hypoxic tissue damage and recovery odds. As SELENBP1 is usually not detected in the serum of healthy subjects, we tested the hypothesis that it may become detectable in TSCI and indicate tissue damage and regeneration odds. Methods: In this prospective observational study, patients with comparable injuries were allocated to three groups; vertebral body fractures without neurological impairment (control "C"), TSCI without remission ("G0"), and TSCI with signs of remission ("G1"). Consecutive serum samples were available from different time points and analyzed for SELENBP1 by sandwich immunoassay, for trace elements by X-ray fluorescence and for cytokines by multiplex immunoassays. Results: Serum SELENBP1 was elevated at admission in relation to the degree of neurological impairment [graded as A, B, C, or D according to the American Spinal Injury Association (AISA) impairment scale (AIS)]. Patients with the most severe neurological impairment (classified as AIS A) exhibited the highest SELENBP1 concentrations (p = 0.011). During the first 3 days, SELENBP1 levels differed between G0 and G1 (p = 0.019), and dynamics of SELENBP1 correlated to monocyte chemoattractant protein 1, chemokine ligand 3 and zinc concentrations. Conclusion: Circulating SELENBP1 concentrations are related to the degree of neurological impairment in TSCI and provide remission odds information. The tight correlation of SELENBP1 with CCL2 levels provides a novel link between Se metabolism and immune cell activation, with potential relevance for neurological damage and regeneration processes, respectively.	[Seelig, Julian; Heller, Raban Arved; Sun, Qian; Klingenberg, Georg Jochen; Hackler, Julian; Schomburg, Lutz] Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany; [Seelig, Julian; Heller, Raban Arved; Sun, Qian; Klingenberg, Georg Jochen; Hackler, Julian; Schomburg, Lutz] Free Univ Berlin, Berlin, Germany; [Seelig, Julian; Heller, Raban Arved; Sun, Qian; Klingenberg, Georg Jochen; Hackler, Julian; Schomburg, Lutz] Humboldt Univ, Berlin Inst Hlth, Berlin, Germany; [Heller, Raban Arved; Haubruck, Patrick] Heidelberg Univ Hosp, Ctr Orthopaed Trauma Surg & Spinal Cord Injury, Dept Trauma & Reconstruct Surg, Heidelberg Trauma Res Grp, Heidelberg, Germany; [Heller, Raban Arved] Heidelberg Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Haubruck, Patrick] Univ Sydney, Kolling Inst Med Res, Inst Bone & Joint Res, Raymond Purees Bone & Joint Res Labs, St Leonardo, NSW, Australia; [Crowell, Helena Lucia] Univ Zurich, SIB Swiss Inst Bioinformat, Zurich, Switzerland; [Crowell, Helena Lucia] Swiss Fed Inst Technol, Life Sci Zurich Grad Sch, Syst Biol PhD Program, Zurich, Switzerland; [Crowell, Helena Lucia] Univ Zurich, Zurich, Switzerland; [Daniel, Volker] Heidelberg Univ Hosp, Inst Immunol, Transplantat Immunol, Heidelberg, Germany; [Moghaddam, Arash] Hosp Aschaffenburg Alzenau, Aschaffenburg Trauma & Orthopaed Res Grp, Ctr Orthopaed Trauma Surg & Sports Med, Aschaffenburg, Germany; [Biglari, Bahram] BG Trauma Ctr Ludwigshafen, Dept Paraplegiol, Ludwigshafen, Germany		Schomburg, L (corresponding author), Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany.; Schomburg, L (corresponding author), Free Univ Berlin, Berlin, Germany.; Schomburg, L (corresponding author), Humboldt Univ, Berlin Inst Hlth, Berlin, Germany.; Biglari, B (corresponding author), BG Trauma Ctr Ludwigshafen, Dept Paraplegiol, Ludwigshafen, Germany.	lutz.schomburg@charite.de; bahram.biglari@bgu-ludwigshafen.de	Seelig, Julian/AAU-6678-2021; Crowell, Helena/ABF-9547-2021; Heller, Raban/K-7018-2016	Crowell, Helena/0000-0002-4801-1767; Heller, Raban/0000-0001-8006-9742; Schomburg, Lutz/0000-0001-9445-1555	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [FOR2558, Scho 849/6-2, CRC/TR 296]; Oskar-Helene-Heim Foundation, Berlin, Germany; Charite-Universitatsmedizin Berlin	This specific project received no particular grant from any funding agency in the public, commercial, or not-for-profit sectors. Analyses in the lab of LS are supported by the Deutsche Forschungsgemeinschaft (DFG), Research Unit FOR2558 "TraceAge" (Scho 849/6-2), and CRC/TR 296 "Local control of TH action" (LocoTact, P17). We gratefully acknowledge the funding received toward the doctoral thesis of RH from the Oskar-Helene-Heim Foundation, Berlin, Germany, and the financial support by the Open Access Publication Fund of Charite-Universitatsmedizin Berlin.	Auguie B., 2017, MISCELLANEOUS FUNCTI; Avery JC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091203; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Besold AN, 2016, J BIOL INORG CHEM, V21, P137, DOI 10.1007/s00775-016-1335-1; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Casha S, 2011, J NEUROTRAUM, V28, P1479, DOI 10.1089/neu.2009.1156; Chen SL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00493; Diamond AM, 2015, NUTRIENTS, V7, P3938, DOI 10.3390/nu7053938; Elhodaky M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113437; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Hackler J, 2020, J TRACE ELEM MED BIO, V58, DOI 10.1016/j.jtemb.2019.126437; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Heller RA, 2017, SPINAL CORD, V55, P1002, DOI 10.1038/sc.2017.69; Heller RA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050421; Heller RA, 2019, J TRACE ELEM MED BIO, V51, P141, DOI 10.1016/j.jtemb.2018.10.006; Huang C, 2012, CLIN CANCER RES, V18, P3042, DOI 10.1158/1078-0432.CCR-12-0183; Hughes DJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111812; Hughes DJ, 2016, AM J CLIN NUTR, V104, P406, DOI 10.3945/ajcn.116.131672; Hybsier S, 2017, REDOX BIOL, V11, P403, DOI 10.1016/j.redox.2016.12.025; Jeong JY, 2014, BMB REP, V47, P411, DOI 10.5483/BMBRep.2014.47.7.104; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Kielczykowska M, 2018, ADV CLIN EXP MED, V27, P245, DOI 10.17219/acem/67222; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Kuhn EC, 2019, J TRACE ELEM MED BIO, V52, P247, DOI 10.1016/j.jtemb.2019.01.005; Kuhn-Heid ECD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092005; Kurita T, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00443-6; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon BK, 2015, EXP NEUROL, V269, P154, DOI 10.1016/j.expneurol.2015.04.008; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Levenson CW, 2005, NUTR REV, V63, P122, DOI 10.1111/j.1753-4887.2005.tb00130.x; Lewandowski L, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13036; Ma EY, 2018, NEUROTOXICOLOGY, V69, P141, DOI 10.1016/j.neuro.2018.10.002; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Moghaddam A, 2015, INT J MOL SCI, V16, P7900, DOI 10.3390/ijms16047900; Mohammadi A, 2018, PSYCHIAT RES, V265, P25, DOI 10.1016/j.psychres.2018.04.036; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Pol A, 2018, NAT GENET, V50, P120, DOI 10.1038/s41588-017-0006-7; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Saadoun S, 2020, NEUROTHERAPEUTICS, V17, P511, DOI 10.1007/s13311-019-00820-6; Schott Mandy, 2018, Oncotarget, V9, P10445, DOI 10.18632/oncotarget.23853; Seelig J, 2020, J TRACE ELEM MED BIO, V57, P124, DOI 10.1016/j.jtemb.2019.126415; Shadgan B, 2019, J NEUROTRAUM, V36, P3034, DOI 10.1089/neu.2018.6208; Sperl A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110509; Spinal Cord Injury (SCI), 2016, FACTS FIG GLANC; Steinbrenner H, 2019, REDOX BIOL, V20, P489, DOI 10.1016/j.redox.2018.11.004; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yan J, 1998, J NEUROSCI, V18, P8682; Zhang ZH, 2021, ANTIOXID REDOX SIGN, V35, P863, DOI 10.1089/ars.2019.7990	55	0	0	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 28	2021	15								680240	10.3389/fnins.2021.680240			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SS2NT	WOS:000661578800001	34140879	Green Published, gold			2022-02-07	
J	Abd El-kader, M; Hamza, E; El-Gamal, R; Eladl, ASR; El Nashar, EM; Alghamdi, MA; Erfan, OS				Abd El-kader, Marwa; Hamza, Eman; El-Gamal, Randa; Eladl, Amira Sobhy Rashed; El Nashar, Eman Mohamad; Alghamdi, Mansour A.; Erfan, Omnia S.			Modulation of vigabatrin induced cerebellar injury: the role of caspase-3 and RIPK1/RIPK3-regulated cell death pathways	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Vigabatrin; Apoptosis; Necroptosis; RIPK1; RIPK3; Omega-3	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; TAURINE-DEFICIENCY; INDUCED NECROPTOSIS; OMEGA-3; PROTEIN; GABA; INHIBITION; APOPTOSIS; SYMPTOMS	Vigabatrin is the drug of choice in resistant epilepsy and infantile spasms. Ataxia, tremors, and abnormal gait have been frequently reported following its use indicating cerebellar involvement. This study aimed, for the first time, to investigate the involvement of necroptosis and apoptosis in the VG-induced cerebellar cell loss and the possible protective role of combined omega-3 and vitamin B12 supplementation. Fifty Sprague-Dawley adult male rats (160-200 g) were divided into equal five groups: the control group received normal saline, VG200 and VG400 groups received VG (200 mg or 400 mg/kg, respectively), VG200 + OB and VG400 + OB groups received combined VG (200 mg or 400 mg/kg, respectively), vitamin B12 (1 mg/kg), and omega-3 (1 g/kg). All medications were given daily by gavage for four weeks. Histopathological changes were examined in H&E and luxol fast blue (LFB) stained sections. Immunohistochemical staining for caspase-3 and receptor-interacting serine/threonine-protein kinase-1 (RIPK1) as well as quantitative real-time polymerase chain reaction (qRT-PCR) for myelin basic protein (MBP), caspase-3, and receptor-interacting serine/threonine-protein kinase-3 (RIPK3) genes were performed. VG caused a decrease in the granular layer thickness and Purkinje cell number, vacuolations, demyelination, suppression of MBP gene expression, and induction of caspases-3, RIPK1, and RIPK3 in a dose-related manner. Combined supplementation with B12 and omega-3 improved the cerebellar histology, increased MBP, and decreased apoptotic and necroptotic markers. In conclusion, VG-induced neuronal cell loss is dose-dependent and related to both apoptosis and necroptosis. This could either be ameliorated (in low-dose VG) or reduced (in high-dose VG) by combined supplementation with B12 and omega-3.	[Abd El-kader, Marwa; Erfan, Omnia S.] Mansoura Univ, Fac Med, Dept Anat, Mansoura 35516, Egypt; [Hamza, Eman; El-Gamal, Randa] Mansoura Univ, Fac Med, Dept Med Biochem, Mansoura, Egypt; [Eladl, Amira Sobhy Rashed] Mansoura Univ, Fac Med, Dept Pharmacol, Mansoura, Egypt; [El Nashar, Eman Mohamad] Benha Univ, Dept Histol & Cell Biol, Fac Med, Banha, Egypt; [El Nashar, Eman Mohamad; Alghamdi, Mansour A.] King Khalid Univ, Dept Anat, Coll Med, Abha, Saudi Arabia; [Alghamdi, Mansour A.] King Khalid Univ, Coll Med, Genom & Personalized Med Unit, Abha, Saudi Arabia		Abd El-kader, M (corresponding author), Mansoura Univ, Fac Med, Dept Anat, Mansoura 35516, Egypt.	dr.marwa5566@yahoo.com; emanhamza2010@yahoo.com; drrandaelgamal@yahoo.com; dr_amiraeladl@mans.edu.eg; enshar@kku.edu.sa; m.alghamdi@kku.edu.sa; omnia.sameer@gmail.com	Alghamdi, Mansour/AAL-8430-2021; Abd El-Kader, Marwa/D-9676-2019; Nashar, ُEman El/AAC-5855-2022; Erfan, Omnia S./AAD-1200-2022; Hamza, Eman Hamza/AAZ-2692-2021	Alghamdi, Mansour/0000-0002-6613-1498; Nashar, ُEman El/0000-0002-2883-6761; Erfan, Omnia S./0000-0002-3766-0913; Hamza, Eman Hamza/0000-0003-0064-7835	Deanship of Scientific Research at King Khalid University [R.G.P. 2/31/40]	The authors would like to extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this project through the research group program under grant number (R.G.P. 2/31/40).	Adhikari S, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-43; Calderon-Ospina CA, 2020, CNS NEUROSCI THER, V26, P5, DOI 10.1111/cns.13207; Anitha P., 2020, THESIS; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Belizario J, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/128076; Ben-Menachem E, 2011, ACTA NEUROL SCAND, V124, P5, DOI 10.1111/j.1600-0404.2011.01596.x; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Boscia F, 2016, GLIA, V64, P1677, DOI 10.1002/glia.23030; Carmant L, 2011, ACTA NEUROL SCAND, V124, P36, DOI 10.1111/j.1600-0404.2011.01599.x; Chan K, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.17; Chen XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1345-8; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Choi ME, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128834; de Almagro MC, 2015, SEMIN CELL DEV BIOL, V39, P56, DOI 10.1016/j.semcdb.2015.02.002; de Queiroz KB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01763-y; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Farias JG, 2017, EXP BIOL MED, V242, P1104, DOI 10.1177/1535370216649263; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gamble, 2002, HEMATOXYLIN EOSIN, P125; Gemelli T, 2018, MOL NEUROBIOL, V55, P5101, DOI 10.1007/s12035-017-0711-3; Gomez-Meda BC, 2016, MUTAT RES-GEN TOX EN, V797, P1, DOI 10.1016/j.mrgentox.2015.12.003; Grober U, 2013, NUTRIENTS, V5, P5031, DOI 10.3390/nu5125031; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Heckmann BL, 2019, CELL DEATH DIFFER, V26, P41, DOI 10.1038/s41418-018-0195-3; Hernandez-Benitez R, 2014, CELL PHYSIOL BIOCHEM, V34, P2038, DOI 10.1159/000366399; Huang GR, 2018, TOXICOLOGY, V406, P33, DOI 10.1016/j.tox.2018.05.015; Huang TL, 2020, MAR DRUGS, V18, DOI 10.3390/md18020083; Jakaria M, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101223; Jammoul F, 2009, ANN NEUROL, V65, P98, DOI 10.1002/ana.21526; Jantzie LL, 2015, PEDIATR RES, V77, P554, DOI 10.1038/pr.2015.9; Jong CJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080795; Kishino A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235896; Lee KH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091057; Linnebank M, 2011, ANN NEUROL, V69, P352, DOI 10.1002/ana.22229; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohamed EA, 2018, ARCH MED SCI, V14, P1450, DOI 10.5114/aoms.2018.79008; Moosavirad SA, 2016, RES PHARM SCI, V11, P390, DOI 10.4103/1735-5362.192490; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nelson GR, 2015, TRANSL PEDIATR, V4, P260, DOI 10.3978/j.issn.2224-4336.2015.09.01; Niu XL, 2018, MOL MED REP, V18, P4516, DOI 10.3892/mmr.2018.9465; Okada K, 2010, EXP NEUROL, V222, P191, DOI 10.1016/j.expneurol.2009.12.017; Pacheco FJ, 2014, INFLAMM RES, V63, P859, DOI 10.1007/s00011-014-0760-2; Padmanabhan S, 2019, NUTR CANCER, V71, P100, DOI 10.1080/01635581.2018.1513047; Parviz M, 2014, J PEDIATR EPILEPSY, V3, P217, DOI 10.3233/PEP-14097; Preece NE, 2004, SYNAPSE, V53, P36, DOI 10.1002/syn.20038; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Qiao M, 2000, EPILEPSIA, V41, P655, DOI 10.1111/j.1528-1157.2000.tb00225.x; Rathod R, 2014, BRAIN DEV-JPN, V36, P853, DOI 10.1016/j.braindev.2013.12.007; Rodrigues C, 2019, EPILEPSY RES, V150, P38, DOI 10.1016/j.eplepsyres.2019.01.002; Sable P, 2011, NEUROSCIENCE, V190, P127, DOI 10.1016/j.neuroscience.2011.05.010; Scalabrino G, 2003, CLIN CHEM LAB MED, V41, P1435, DOI 10.1515/CCLM.2003.220; Schlanger S, 2002, EPILEPSIA, V43, P103, DOI 10.1046/j.1528-1157.2002.13601.x; Schonstedt V, 2015, NEURORADIOL J, V28, P515, DOI 10.1177/1971400915598082; Singh D, 2018, J ANAT SOC INDIA, V67, P158, DOI 10.1016/j.jasi.2018.09.001; Singh D, 2014, J ANAT SOC INDIA, V63, P156, DOI 10.1016/j.jasi.2014.11.008; Singh D, 2013, J CLIN DIAGN RES, V7, P2555, DOI 10.7860/JCDR/2013/6187.3610; Sommerfeld A, 2015, CELL PHYSIOL BIOCHEM, V36, P866, DOI 10.1159/000430262; Sun GY, 2018, PROSTAG LEUKOTR ESS, V136, P3, DOI 10.1016/j.plefa.2017.03.006; Tan A, 2018, PROSTAG LEUKOTR ESS, V132, P23, DOI 10.1016/j.plefa.2018.03.010; Tao Y, 2016, CELL PHYSIOL BIOCHEM, V40, P831, DOI 10.1159/000453143; Tillman L, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8941046; Tomi M, 2008, BBA-BIOMEMBRANES, V1778, P2138, DOI 10.1016/j.bbamem.2008.04.012; Tummers B, 2017, IMMUNOL REV, V277, P76, DOI 10.1111/imr.12541; Vargas RA, 2018, INT J CLIN PHARM PHA, V3, P142, DOI 10.15344/2456-3501/2018/142.; Vinogradova LV, 2005, EPILEPSIA, V46, P800, DOI 10.1111/j.1528-1167.2005.52604.x; Vogel KR, 2017, PEDIATR NEUROL, V66, P44, DOI 10.1016/j.pediatrneurol.2016.09.016; Vogel KR, 2013, J INHERIT METAB DIS, V36, P401, DOI 10.1007/s10545-012-9499-5; Walters DC, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.456; Wang JY, 2014, NEUROBIOL DIS, V68, P91, DOI 10.1016/j.nbd.2014.04.014; Wu FF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00406; Yu Y, 2018, J MOL NEUROSCI, V64, P449, DOI 10.1007/s12031-018-1043-0; Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1; Yuan SQ, 2020, BIOMED PHARMACOTHER, V126, DOI 10.1016/j.biopha.2020.110102; Zhang S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.286; Zhang XW, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030627; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057503; Zhu W, 2018, INFLAMMATION, V41, P1182, DOI 10.1007/s10753-018-0765-z; Zirpoli H, 2020, ANNU REV NUTR, V40, P161, DOI 10.1146/annurev-nutr-082018-124539	80	0	0	0	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	AUG	2021	52	4					781	798		10.1007/s10735-021-09984-y		MAY 2021	18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	TS5ZZ	WOS:000655575000001	34046766				2022-02-07	
J	MacGregor, AJ; Shannon, KB; Dougherty, AL				MacGregor, Andrew J.; Shannon, Kaeley B.; Dougherty, Amber L.			Time Since Injury as a Factor in Post-Concussion Symptom Reporting among Military Service Members with Blast-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						combat; concussion; mild traumatic brain injury; military; post-concussion symptoms	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; POSTCONCUSSION SYMPTOMS; DEPLOYMENT; IRAQ; PERSISTENT; PSYCHOGENESIS; PHYSIOGENESIS; AFGHANISTAN	Over the last decade, much research has been devoted to concussion among military personnel. Post-concussion symptoms after blast-related concussion are common, but it is unknown whether symptom reporting differs over time. This study's objective was to assess the relationship between time since injury and post-concussion symptom reporting. We conducted a retrospective review of existing records to identify service members who experienced blast-related concussion during deployment between 2007 and 2012 and who responded to a Post-Deployment Health Assessment (PDHA). The study population included 3690 military personnel grouped by time between injury and PDHA completion: 1-90 days (45.3%, n = 1,673), 91-180 days (33.0%, n = 1,216), or 181-365 days (21.7%, n = 801). Post-concussion symptoms assessed on the PDHA included headache, tinnitus, memory problems, concentration problems, difficulty making decisions, irritability, dizziness, and sleep problems. All post-concussion symptoms were higher for 91-180 days and 181-365 days after injury relative to 1-90 days, with the exception of dizziness. After adjustment for loss of consciousness, mental health comorbidity, and other covariates, the odds of reporting three or more post-concussion symptoms were significantly higher in those who completed the PDHA 91-180 days (odds ratio: 1.29; 95% confidence interval: 1.09-1.51) or 181-365 days after injury (odds ratio: 1.33; 95% confidence interval: 1.09-1.61), compared with the 1-90 days group. These findings suggest that refinements to in-theater medical care may be needed to reduce post-concussion symptom burden and improve the prospect of concussion recovery.	[MacGregor, Andrew J.; Shannon, Kaeley B.; Dougherty, Amber L.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Shannon, Kaeley B.] Axiom Resource Management Inc, San Diego, CA USA; [Dougherty, Amber L.] Leidos Inc, San Diego, CA USA		MacGregor, AJ (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	andrewmacgregor@protonmail.com		MacGregor, Andrew/0000-0003-1020-7390	US Navy Bureau of Medicine and Surgery [60808]	This report was supported by the US Navy Bureau of Medicine and Surgery under work unit no. 60808.	Agimi Y, 2018, AM J PUBLIC HEALTH, V108, P683, DOI 10.2105/AJPH.2018.304347; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cogan AM, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.027599; Commission on Professional Hospital Activities, 1977, INT CLASS DIS; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Ferdosi H, 2019, AM J EPIDEMIOL, V188, P77, DOI 10.1093/aje/kwy199; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Galarneau A.J, 2011, N ATL TREAT ORG M ME; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Greer N, 2016, PREVALENCE EPIDEMIOL; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoot MR, 2018, BRAIN INJURY, V32, P1169, DOI 10.1080/02699052.2018.1482427; Institute of Medicine, 2009, GULF WAR HLTH LONG T; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lawson BD, 2016, MIL MED, V181, P887, DOI 10.7205/MILMED-D-15-00184; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Office of the Under Secretary of Defense for Personnel and Readiness, 2019, DEP DEF INSTR 6490 0; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Psychological Health Center of Excellence, 2021, POSTD HLTH ASS; Rona RJ, 2020, J HEAD TRAUMA REHAB, V35, P46, DOI 10.1097/HTR.0000000000000497; Schneiderman A.I, 2008, AM J EPIDEMIOL, V23, P17; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scofield DE, 2017, J NEUROTRAUM, V34, P3249, DOI 10.1089/neu.2017.5101; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spooner SP, 2014, MIL MED, V179, P1319, DOI 10.7205/MILMED-D-14-00191; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tschiffely AE, 2018, MIL MED, V183, pE140, DOI 10.1093/milmed/usx036; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112	49	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2447	2453		10.1089/neu.2020.7334		MAY 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000655206400001	33906380				2022-02-07	
J	Caplan, HW; Prabhakara, KS; Furman, NET; Zorofchian, S; Martin, C; Xue, HS; Olson, SD; Cox, CS				Caplan, Henry W.; Prabhakara, Karthik S.; Furman, Naama E. Toledano; Zorofchian, Soheil; Martin, Cecilia; Xue, Hasen; Olson, Scott D.; Cox, Charles S., Jr.			Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model	PLOS ONE			English	Article							REGULATORY T-CELLS; MESENCHYMAL STEM-CELLS; STROMAL CELLS; AMPHIREGULIN; DELIVERY	Traumatic brain injury (TBI) causes both physical disruption of the blood brain barrier (BBB) and altered immune responses that can lead to significant secondary brain injury and chronic inflammation within the central nervous system (CNS). Cell therapies, including mesenchymal stromal cells (MSC), have been shown to restore BBB integrity and augment endogenous splenic regulatory T cells (Treg), a subset of CD4+ T cells that function to regulate immune responses and prevent autoimmunity. We have recently shown that infusion of human cord blood-derived Treg decreased neuroinflammation after TBI in vivo and in vitro. However, while both cells have demonstrated anti-inflammatory and regenerative potential, they likely utilize differing, although potentially overlapping, mechanisms. Furthermore, studies investigating these two cell types together, as a combination therapy, are lacking. In this study, we compared the ability of Treg+MSC combination therapy, as well as MSC and Treg monotherapies, to improve BBB permeability in vivo and suppress inflammation in vitro. While Treg+MSC combination did not significantly augment potency in vivo, our in vitro data demonstrates that combination therapy may augment therapeutic potency and immunosuppressive potential compared to Treg or MSC monotherapy.	[Caplan, Henry W.; Prabhakara, Karthik S.; Furman, Naama E. Toledano; Zorofchian, Soheil; Martin, Cecilia; Xue, Hasen; Olson, Scott D.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX 77030 USA		Olson, SD; Cox, CS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX 77030 USA.	scott.d.olson@uth.tmc.edu; charles.s.cox@uth.tmc.edu		Martin, Cecilia/0000-0001-7096-986X	NIH NIGMS 2T32 grant [GM0879201-11A1]	This study was supported by the NIH NIGMS 2T32 grant GM0879201-11A1 (CSC and supporting HWC), www.nigms.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Caplan H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01645; Caplan HW, 2020, STEM CELL TRANSL MED, V9, P903, DOI 10.1002/sctm.19-0444; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Engela AU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00126; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; George MJ, 2018, STEM CELL TRANSL MED, V7, P731, DOI 10.1002/sctm.18-0015; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Ko JH, 2020, CELL REP, V30, P3806, DOI 10.1016/j.celrep.2020.02.062; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Le Blanc K, 2015, IMMUNOL LETT, V168, P140, DOI 10.1016/j.imlet.2015.05.004; Lee ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138846; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ma OKF, 2016, WORLD J STEM CELLS, V8, P268, DOI 10.4252/wjsc.v8.i9.268; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meng HL, 2019, P NATL ACAD SCI USA, V116, P5558, DOI 10.1073/pnas.1814394116; Negi N, 2020, STEM CELLS, V38, P596, DOI 10.1002/stem.3151; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Prabhakara KS, 2018, MOL THER, V26, P2152, DOI 10.1016/j.ymthe.2018.06.022; Prevention CfDCa, 2015, REPORT C TRAUMATIC B; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rodriguez-Perea AL, 2016, CLIN EXP IMMUNOL, V185, P281, DOI 10.1111/cei.12804; Sanchez-Fueyo A, 2020, AM J TRANSPLANT, V20, P1125, DOI 10.1111/ajt.15700; Schiavon V, 2019, P NATL ACAD SCI USA, V116, P6298, DOI 10.1073/pnas.1812471116; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Takahashi T, 2014, STEM CELL TRANSL MED, V3, P1484, DOI 10.5966/sctm.2014-0012; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Zaiss DM, 2019, IMMUNOLOGY, V157, P190, DOI 10.1111/imm.13057; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zhou YF, 2014, J THORAC CARDIOV SUR, V148, P1131, DOI 10.1016/j.jtcvs.2014.06.029	38	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251601	10.1371/journal.pone.0251601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	WOS:000664633500026	34038436	gold, Green Published			2022-02-07	
J	Cristofori, I; Zhong, WT; Cohen-Zimerman, S; Bulbulia, J; Gordon, B; Krueger, F; Grafman, J				Cristofori, Irene; Zhong, Wanting; Cohen-Zimerman, Shira; Bulbulia, Joseph; Gordon, Barry; Krueger, Frank; Grafman, Jordan			Brain networks involved in the influence of religion on empathy in male Vietnam War veterans	SCIENTIFIC REPORTS			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; NEURAL BASES; MIND; BEHAVIOR; GOD; SPIRITUALITY; ADOLESCENCE; PERSPECTIVE; VIOLENCE; THOUGHTS	Humans all over the world believe in spirits and deities, yet how the brain supports religious cognition remains unclear. Drawing on a unique sample of patients with penetrating traumatic brain injuries (pTBI) and matched healthy controls (HCs) we investigate dependencies of religious cognition on neural networks that represent (1) others agents' intentions (Theory of Mind, ToM) and (2) other agents' feelings (Empathy). Extending previous observations that ToM networks are recruited during prayer, we find that people with vmPFC damage report higher scores on the personal relationship with God inventory even when they are not praying. This result offers evidence that it is the modulation of ToM networks that support beliefs in supernatural agents. With respect to empathetic processing, we observed that vmPFC and pSTS/TPJ lesions mediated by the strength of the personal relationship with God affect empathetic responses. We suggest that the neurological networks underpinning God representations amplify human empathetic responses. The cultural evolutionary study of religion has argued that supernatural beliefs evoke pro-social responses because people fear the wrath of Gods. Our findings imply greater attention should be paid to the mechanisms by which religious cognition may regulate empathetic responses to others.	[Cristofori, Irene] Inst Cognit Sci Marc Jeannerod CNRS, UMR 5229, 67 Blvd Pinel, F-69675 Bron, France; [Cristofori, Irene] Univ Lyon, Etab 1, Villeurbanne, France; [Zhong, Wanting; Cohen-Zimerman, Shira; Grafman, Jordan] Shirley Ryan AbilityLab, Cognit Neurosci Lab, Brain Injury Res, Chicago, IL USA; [Zhong, Wanting; Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Bulbulia, Joseph] Victoria Univ Wellington, Fac Sci, Sch Psychol, Wellington, New Zealand; [Bulbulia, Joseph] Max Plank Inst Sci Human Hist, Jena, Germany; [Gordon, Barry] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gordon, Barry] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Grafman, Jordan] Feinberg Sch Med, Dept Neurol, Chicago, IL USA; [Grafman, Jordan] Feinberg Sch Med, Dept Psychiat, Chicago, IL USA; [Grafman, Jordan] Feinberg Sch Med, Dept Cognit Neurol & Alzheimers Dis, Chicago, IL USA; [Grafman, Jordan] Northwestern Univ, Dept Psychol, Chicago, IL 60611 USA		Cristofori, I (corresponding author), Inst Cognit Sci Marc Jeannerod CNRS, UMR 5229, 67 Blvd Pinel, F-69675 Bron, France.; Cristofori, I (corresponding author), Univ Lyon, Etab 1, Villeurbanne, France.	icristofori@isc.cnrs.fr			Therapeutic Cognitive Neuroscience Fund; Smart Family Foundation of New York; Templeton Religion Trust [TRT0196]	This research was supported by the Therapeutic Cognitive Neuroscience Fund (B. Gordon), the Smart Family Foundation of New York (J. Grafman), and a Templeton Religion Trust TRT0196 grant (J. Bulbulia). The funders played no role in the design of this study or the interpretation of its results. The authors thank all of the Vietnam veterans who participated in this study. Without their long-term commitment to improving the health care of veterans, this study could not have been completed.	[Anonymous], 2019, NW 1615 L ST WASHING; Argyle Michael, 2013, SOCIAL PSYCHOL RELIG; Asp E, 2012, NEUROPSYCHOLOGY, V26, P414, DOI 10.1037/a0028526; Atran S, 2004, BEHAV BRAIN SCI, V27, P713, DOI 10.1017/S0140525X04000172; Baldner C, 2014, MOTIV EMOTION, V38, P727, DOI 10.1007/s11031-014-9417-2; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BATSON CD, 1981, J PERS SOC PSYCHOL, V40, P511, DOI 10.1037/0022-3514.40.3.511; Batson CD, 1999, EUR J SOC PSYCHOL, V29, P909, DOI 10.1002/(SICI)1099-0992(199911)29:7<909::AID-EJSP965>3.0.CO;2-L; BATSON CD, 1983, J PERS SOC PSYCHOL, V45, P1380, DOI 10.1037/0022-3514.45.6.1380; Beadle JN, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00288; Bloom P, 2012, ANNU REV PSYCHOL, V63, P179, DOI 10.1146/annurev-psych-120710-100334; Boyer P, 2008, ANNU REV ANTHROPOL, V37, P111, DOI 10.1146/annurev.anthro.37.081407.085201; Boyer P, 2008, NATURE, V455, P1038, DOI 10.1038/4551038a; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bruck M, 1999, ANNU REV PSYCHOL, V50, P419, DOI 10.1146/annurev.psych.50.1.419; Bulbulia J., 2009, CURR ANTHROPOL, V50, P772; Bushman BJ, 2007, PSYCHOL SCI, V18, P204, DOI 10.1111/j.1467-9280.2007.01873.x; Cohen-Zimerman S, 2020, COGN AFFECT BEHAV NE, V20, P575, DOI 10.3758/s13415-020-00787-4; Cristofori I, 2015, SOC COGN AFFECT NEUR, V10, P1038, DOI 10.1093/scan/nsu155; Dang TP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41544-z; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Delis DC., 2001, DELIS KAPLAN EXECUTI; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gervais WM, 2013, PERSPECT PSYCHOL SCI, V8, P380, DOI 10.1177/1745691613489836; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grafman J, 2020, CURR DIR PSYCHOL SCI, V29, P126, DOI 10.1177/0963721419898183; Hanks RA, 2020, REHABIL PSYCHOL, V65, P347, DOI 10.1037/rep0000304; Hayes, 2018, INTRO MEDIATION MODE; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; HYER L, 1991, J CLIN PSYCHOL, V47, P510, DOI 10.1002/1097-4679(199107)47:4<510::AID-JCLP2270470407>3.0.CO;2-F; Janowski V, 2013, SOC COGN AFFECT NEUR, V8, P201, DOI 10.1093/scan/nsr086; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Jeffreys S.H., 1998, THEORY PROBABILITY, V3; Johnson MK, 2012, PSYCHOL RELIG SPIRIT, V4, P154, DOI 10.1037/a0025107; Jung D, 2018, SCI REP-UK, V8, P1; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Lawrence RT, 1997, J PSYCHOL THEOL, V25, P214, DOI 10.1177/009164719702500206; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Love J, 2019, J STAT SOFTW, V88, P1, DOI 10.18637/jss.v088.i02; Lowicki P, 2020, PERS INDIV DIFFER, V161, DOI 10.1016/j.paid.2020.109976; Lowicki P, 2020, INT J PSYCHOL RELIG, V30, P128, DOI 10.1080/10508619.2019.1672486; Markstrom CA, 2010, YOUTH SOC, V42, P59, DOI 10.1177/0044118X09333644; Mazzarella E, 2013, SOC NEUROSCI-UK, V8, P248, DOI 10.1080/17470919.2012.761160; McNeil M., 1994, REVISED TOKEN TEST; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Norenzayan A, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X14001356; Norenzayan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036880; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paradiso S, 2016, J CLIN EXP NEUROPSYC, V38, P887, DOI 10.1080/13803395.2016.1172558; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Power EA, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0057; Preston JL, 2014, RELIGION, PERSONALITY, AND SOCIAL BEHAVIOR, P149; Purzycki BG, 2016, NATURE, V530, P327, DOI 10.1038/nature16980; Pyysiainen I, 2010, TRENDS COGN SCI, V14, P104, DOI 10.1016/j.tics.2009.12.007; R Core Team, 2020, R LANG ENV STAT COMP; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Saleam J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01149; Saroglou V, 2009, INT J PSYCHOL RELIG, V19, P143, DOI 10.1080/10508610902880063; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Shariff AF, 2016, CURR BIOL, V26, pR699, DOI 10.1016/j.cub.2016.06.031; Soler M, 2012, EVOL HUM BEHAV, V33, P346, DOI 10.1016/j.evolhumbehav.2011.11.004; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spilka Bernard, 2003, PSYCHOL RELIG EMPIRI, V3rd; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Ments Laila, 2018, Comput Soc Netw, V5, P1, DOI 10.1186/s40649-017-0049-z; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; Westfall PH, 1997, BIOMETRIKA, V84, P419, DOI 10.1093/biomet/84.2.419; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willard AK, 2013, COGNITION, V129, P379, DOI 10.1016/j.cognition.2013.07.016; Zhong WT, 2017, NEUROPSYCHOLOGIA, V100, P18, DOI 10.1016/j.neuropsychologia.2017.04.009	89	0	0	2	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 26	2021	11	1							11047	10.1038/s41598-021-90481-3			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SO7IO	WOS:000659148400039	34040097	gold, Green Published			2022-02-07	
J	Lindner, AM; Hawkins, DN				Lindner, Andrew M.; Hawkins, Daniel N.			Education, Political Party, and Football Viewership Predict Americans' Attention to News About Concussions in Sports	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						concussions; sport; news attention; football; polarization	UNITED-STATES; SCIENCE	News outlets, sports coverage, and even Hollywood movies have highlighted the growing body of research documenting the long-term negative consequences of traumatic injury in athletics, particularly, (sports-related) concussions. Despite so much media coverage, little is known about how much attention members of the American public pay to sports concussion news. Disparities in attention to concussion news among sociodemographic groups may contribute to further inequalities in rates of concussions that stem from participation in collision sports. In this study, using a 2017 nationally representative survey of US residents (n = 964), we examine the social, political, and demographic correlates of individuals' attention to news about concussions in sports. Regression results indicate that older, more educated, Democratic-leaning respondents reported that they pay more attention to news about concussions. Additionally, respondents with a greater past competitive athletic participation and those who regularly watch baseball and football reported higher levels of attention to concussion news. These findings are consistent with previous research showing higher levels of news consumption and trust in science among the highly educated and Democrats. The increased levels among football viewers may be in response to the inclusion of concussion news in game coverage.</p>	[Lindner, Andrew M.] Skidmore Coll, Dept Sociol, Saratoga Springs, NY 12866 USA; [Hawkins, Daniel N.] Univ Nebraska, Coll Arts & Sci, Dept Sociol & Anthropol, Omaha, NE 68182 USA		Lindner, AM (corresponding author), Skidmore Coll, Dept Sociol, Saratoga Springs, NY 12866 USA.	alindner@skidmore.edu	Lindner, Andrew/U-3898-2019	Lindner, Andrew/0000-0003-4347-8787	Faculty Research Initiative Grant by Skidmore College's Faculty Development Committee	The collection of survey data was supported by a Faculty Research Initiative Grant provided by Skidmore College's Faculty Development Committee.	Abramowitz A, 2019, ANN AM ACAD POLIT SS, V681, P137, DOI 10.1177/0002716218811309; Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Allison R, 2021, SOCCER SOC, V22, P457, DOI 10.1080/14660970.2020.1827231; Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Bachynski K.E., 2019, NO GAME BOYS PLAY HI, DOI [10.5149/northcarolina/9781469653709.001.0001, DOI 10.5149/NORTHCAROLINA/9781469653709.001.0001]; Binney Z.O., 2019, WHY ATTACK FOOTBALL; Binney ZO, 2019, NEUROLOGY, V92, P43, DOI 10.1212/WNL.0000000000006699; Boufous S, 2004, AUST NZ J PUBL HEAL, V28, P482, DOI 10.1111/j.1467-842X.2004.tb00032.x; Concussion Legacy Foundation, 2021, MED PROJ; Erikson E.H., 1997, LIFE CYCLE COMPLETED; Fainaru-Wada M., 2014, LEAGUE DENIAL NFL CO; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Gordon A., 2013, ESPN CHEERED VIOLENC; Kalman-Lamb Nathan., 2018, GAME MISCONDUCT INJU; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Lindner A.M., 2021, TIME OUT NATL PERSPE, P169; Lindner AM, 2012, SOCIOL QUART, V53, P68, DOI 10.1111/j.1533-8525.2011.01226.x; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Malcolm D., 2020, CONCUSSION CRISIS SP, DOI [10.4324/9780429292408, DOI 10.4324/9780429292408]; Martin L.L., 2015, WHITE SPORTS BLACK S; McGlynn J, 2020, J SPORT SOC ISSUES, V44, P261, DOI 10.1177/0193723520903226; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nisbet EC, 2015, ANN AM ACAD POLIT SS, V658, P36, DOI 10.1177/0002716214555474; Perry, 2020, SOCIUS, DOI [10.1177/2378023120977727, DOI 10.1177/2378023120977727]; Rotolo T, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113491; Semuels A., 2019, ATLANTIC; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Strandbu A, 2020, SPORT EDUC SOC, V25, P931, DOI 10.1080/13573322.2019.1676221; Stroud NJ, 2017, POLIT COMMUN, V34, P479, DOI 10.1080/10584609.2017.1330077; Veldkamp CLS, 2017, ACCOUNT RES, V24, P127, DOI 10.1080/08989621.2016.1268922; Whalen L., 2019, THESIS	33	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	MAY 26	2021	3								655890	10.3389/fspor.2021.655890			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WF0WU	WOS:000706036500001	34124656	Green Published, gold			2022-02-07	
J	Singh, A; Singh, K; Sahu, A; Prasad, RS; Pandey, N; Dhar, S				Singh, Ashvamedh; Singh, Kulwant; Sahu, Anurag; Prasad, R. S.; Pandey, N.; Dhar, Sambuddha			Serum Concentration of Myelin Basic Protein as a Prognostic Marker in Mild-to-moderate Head Injury Patients: A Prospective Study in a Tertiary Care Center	INDIAN JOURNAL OF NEUROSURGERY			English	Article; Early Access						MBP; serum biomarker; myelin basic protein; traumatic brain injury; serum biomarker in TBI	TRAUMATIC BRAIN-INJURY; DIAGNOSIS; ASSAY; INDIA	Objective To estimate the level of myelin basic protein (MBP) and look for its validity in outcome prediction among mild-to-moderate head injury patients. Materials and Methods It was a prospective study done at the Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University from Jan 2018 to July 2019. All patients who presented to us within 48 hours of injury with mild-to-moderate head injury with apparently normal CT brain were include in the study. The serum sample were collected on the day of admission and 48 hours later, and patients were treated with standard protocols and observed 6 months postdischarge. Results Of the 32 patients enrolled, we observed mean MBP level was higher for severity of brain damage, but not associated with age, mode of injury, and radiological diagnosis. Mean MBP levels were not statistically associated with Glasgow coma scale (GCS) score at admission but was correlated to outcome with p < 0.05, with sensitivity of 50% and specificity 72%, that is, patients with good outcome have lower mean MBP levels. Conclusion MBP as per our analysis can be used as a prognostic marker in patients with head injury. It is not the absolute value rather a trend showing rise in serum MBP levels, which carries a significant value in outcome prediction.	[Singh, Ashvamedh; Singh, Kulwant; Sahu, Anurag; Prasad, R. S.; Pandey, N.; Dhar, Sambuddha] Banaras Hindu Univ, Inst Med Sci IMS, Dept Neurosurg, Varanasi, Uttar Pradesh, India		Sahu, A (corresponding author), IMS BHU, Dept Neurosurg, Varanasi 221005, Uttar Pradesh, India.	anuragsahu25@rediffmail.com		Singh, Ashvamedh/0000-0002-6477-1387			Agrawal Amit, 2016, Int J Crit Illn Inj Sci, V6, P65, DOI 10.4103/2229-5151.183025; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2017, NEUROL INDIA, V65, P257, DOI 10.4103/0028-3886.201848; Mao Q, 1995, Hua Xi Yi Ke Da Xue Xue Bao, V26, P135; Nath HD, 2011, INDIAN J NEUROTRAUM, V8, P11, DOI 10.1016/S0973-0508(11)80018-3; NOSEWORTHY TW, 1985, CRIT CARE MED, V13, P743, DOI 10.1097/00003246-198509000-00010; Saxena MK, 2010, INDIAN J NEUROTRAUM, V7, P129, DOI 10.1016/S0973-0508(10)80027-9; Su E, 2012, NEUROCRIT CARE, V17, P401, DOI 10.1007/s12028-012-9767-0; THOMAS DGT, 1977, LANCET, V1, P113; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	15	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.												10.1055/s-0040-1716936		MAY 2021	5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	SH1MY	WOS:000653901100003		gold			2022-02-07	
J	Singh, R; Prasad, RS; Singh, K; Sahu, A; Pandey, N				Singh, Rahul; Prasad, Ravi Shankar; Singh, Kulwant; Sahu, Anurag; Pandey, Nityanand			Clinical, Surgical and Outcome Predictive Factor Analysis of Operated Acute Subdural Hematoma Cases: A Retrospective Study of 114 Operated Cases at Tertiary Centre	INDIAN JOURNAL OF NEUROSURGERY			English	Article; Early Access						Acute subdural hematoma; outcome predictive factors; operated acute SDH; Glasgow outcome score	TRAUMATIC BRAIN-INJURY; FUNCTIONAL OUTCOMES; MORTALITY; IMPACT	Objective To analyze clinical, surgical and outcome predictive factors of operated acute subdural hematoma (SDH) cases for prognostication and surgical outcome prediction. Material and Methods This retrospective study includes 114 patients operated for acute SDH in the Department of Neurosurgery of IMS BHU, Varanasi, India, a tertiary care center, between 1 August 2018 and 1 November 2019. Each patient was evaluated for age, sex, mode of injury, localization of hematoma, clinical presentation, comorbidity, severity of injury, best motor response, CT findings, and Glasgow outcome scale (GOS) at discharge. The outcome was also evaluated by further making a dichotomized group using GOS in death/dependent (1-3) versus independent (4-5). Statistical tests were done using the GraphPad Prism version 8.3.0. Results The most common age group operated upon in this study was the 40 to 60 years age group (n = 45, 39.48%). Males were 78% with male to female ratio of 3.56:1. The most common clinical presentation was altered sensorium (98.25%). The most common comorbidity was hypertension ( n = 32, 28.07%). GCS at admission, severity of injury, pupillary changes, and best motor response (p < 0.0001) were significantly associated with surgical outcome. Conclusion GCS at admission, severity of injury, pupillary changes, and best motor response were significantly (p < 0.05) associated with surgical outcome. Age and gender of patients were not found to be significantly associated.	[Singh, Rahul; Prasad, Ravi Shankar; Singh, Kulwant; Sahu, Anurag; Pandey, Nityanand] Banaras Hindu Univ IMS BHU, Inst Med Sci, Dept Neurosurg, Varanasi, Uttar Pradesh, India		Prasad, RS (corresponding author), Banaras Hindu Univ IMS BHU, Inst Med Sci, Dept Neurosurg, Varanasi, Uttar Pradesh, India.	rsprasadbhuhodneurosurgery@gmail.com					Basmaci M, 2012, INDIAN J CRIT CARE M, V16, P222, DOI 10.4103/0972-5229.106508; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fryburg Karsten, 2011, Surg Neurol Int, V2, P44, DOI 10.4103/2152-7806.79759; Hanif S, 2009, Ir Med J, V102, P255; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Jeffree RL, 2009, J CLIN NEUROSCI, V16, P882, DOI 10.1016/j.jocn.2008.10.004; Kameyama M., 2013, NEUROTRAUMATOLOGY, V36, P10; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Marbacher S, 2010, ACTA NEUROCHIR, V152, P501, DOI 10.1007/s00701-009-0521-0; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Mulligan P, 2013, J NEUROSCI RURAL PRA, V4, P250, DOI 10.4103/0976-3147.118760; Oh CH, 2008, J KOREAN NEUROSURG S, V44, P211, DOI 10.3340/jkns.2008.44.4.211; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Sawauchi S, 2007, NEUROL SURG TOKYO, V35, P43; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SEELIG JM, 1981, J NEUROSURG, V55, P516, DOI 10.3171/jns.1981.55.4.0516; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shima Katsuji, 2010, Asian J Neurosurg, V5, P15; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; TOMINAGA, 2008, NEUROTRAUMATOLOGY, V31, P49; Umezawa K., 2011, NEUROTRAUMATOLOGY, V34, P132; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Youmans J., 2017, YOUMANS WINN NEUROLO, V7th	34	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.												10.1055/s-0040-1719201		MAY 2021	8	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	SH1MY	WOS:000653901100004		gold			2022-02-07	
J	Song, D; Zhu, MT; Chi, SY; Xia, L; Li, Z; Liu, ZH				Song, Dan; Zhu, Mengting; Chi, Siyu; Xia, Lan; Li, Zhen; Liu, Zhihong			Sensitizing the Luminescence of Lanthanide-Doped Nanoparticles over 1500 nm for High-Contrast and Deep Imaging of Brain Injury	ANALYTICAL CHEMISTRY			English	Article							AG2SE QUANTUM DOTS; UP-CONVERSION; IN-VIVO; FLUORESCENCE; WINDOW; STROKE	Real-time and in situ visualization of cerebrovascular dysfunction is significant for studying brain injury, which however, is restricted by the complex brain structure and limited imaging strategies. Luminescence imaging in NIR-IIb region (1500-1700 nm) is a promising tool owing to its merits including deep penetration, high resolution, and fast data acquisition. Unfortunately, a luminescent material in this region with sufficient brightness and biocompatibility is scarce. Herein, Ag2Se quantum dot-sensitized lanthanide-doped nanocrystals (QDs-LnNCs) with emission beyond 1500 nm were fabricated to image the cerebrovascular structure and hemodynamics in ischemic stroke and traumatic brain injury. The sensitization by QDs provided an over 100-fold enhanced brightness of LnNCs and a remarkable penetration depth of 11 mm. Dynamic information of blood perfusion and flow rates were acquired and the damage of the blood-brain barrier in the two injury models was investigated. Our results proved QDs-LnNCs as a kind of competent nanomaterial for noninvasive brain imaging.	[Song, Dan; Chi, Siyu; Xia, Lan; Liu, Zhihong] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China; [Zhu, Mengting; Li, Zhen; Liu, Zhihong] Hubei Univ, Coll Chem & Chem Engn, Wuhan 430062, Peoples R China		Liu, ZH (corresponding author), Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China.; Li, Z; Liu, ZH (corresponding author), Hubei Univ, Coll Chem & Chem Engn, Wuhan 430062, Peoples R China.	zhenli@hubu.edu.cn; zhhliu@whu.edu.cn		Li, Zhen/0000-0002-7427-6777	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21625503, 21807028]	This work was financially supported by the National Natural Science Foundation of China (no. 21625503 and 21807028).	Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; Chen GY, 2015, NANO LETT, V15, P7400, DOI 10.1021/acs.nanolett.5b02830; Diao S, 2015, ANGEW CHEM INT EDIT, V54, P14758, DOI 10.1002/anie.201507473; Ding F, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201900260; Fan Y, 2019, ADV OPT MATER, V7, DOI 10.1002/adom.201801417; Franke D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12749; Garfield DJ, 2018, NAT PHOTONICS, V12, P402, DOI 10.1038/s41566-018-0156-x; Gu YP, 2012, J AM CHEM SOC, V134, P79, DOI 10.1021/ja2089553; He SQ, 2018, CHEM SOC REV, V47, P4258, DOI 10.1039/c8cs00234g; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hong GS, 2014, NAT PHOTONICS, V8, P723, DOI [10.1038/nphoton.2014.166, 10.1038/NPHOTON.2014.166]; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Li YB, 2019, ACS NANO, V13, P248, DOI 10.1021/acsnano.8b05431; Luo Y, 2015, BRAIN RES, V1597, P86, DOI 10.1016/j.brainres.2014.12.005; Ren F, 2020, NANO TODAY, V34, DOI 10.1016/j.nantod.2020.100905; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Saba L, 2010, NEURORADIOLOGY, V52, P75, DOI 10.1007/s00234-009-0589-5; Shao W, 2016, J AM CHEM SOC, V138, P16192, DOI 10.1021/jacs.6b08973; Shi LJ, 2016, RSC ADV, V6, P38183, DOI 10.1039/c6ra04987g; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Song XR, 2019, ANGEW CHEM INT EDIT, V58, P18981, DOI 10.1002/anie.201909416; Tan LJ, 2014, ACS APPL MATER INTER, V6, P6217, DOI 10.1021/am5015088; Tian R, 2020, ADV MATER, V32, DOI 10.1002/adma.201907365; Wang X, 2018, ADV OPT MATER, V6, DOI 10.1002/adom.201800690; Wehrenberg BL, 2002, J PHYS CHEM B, V106, P10634, DOI 10.1021/jp021187e; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wu X, 2016, ACS NANO, V10, P1060, DOI 10.1021/acsnano.5b06383; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu JT, 2017, ACS NANO, V11, P4133, DOI 10.1021/acsnano.7b00944; Xue ZL, 2018, BIOMATERIALS, V171, P153, DOI 10.1016/j.biomaterials.2018.04.037; Zhang WM, 2020, ANAL CHEM, V92, P6094, DOI 10.1021/acs.analchem.0c00529; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zheng KZ, 2019, NANO TODAY, V29, DOI 10.1016/j.nantod.2019.100797; Zhong YT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00917-6; Zhu CN, 2013, ACS APPL MATER INTER, V5, P1186, DOI 10.1021/am303110x; Zou WQ, 2012, NAT PHOTONICS, V6, P560, DOI 10.1038/nphoton.2012.158	40	0	0	18	33	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	JUN 8	2021	93	22					7949	7957		10.1021/acs.analchem.1c00731		MAY 2021	9	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	SS0XF	WOS:000661465300023	34032404				2022-02-07	
J	Tang, ZJ; Yang, RJ; Zhang, JS; Huang, QL; Zhou, XP; Wei, WJ; Jiang, QH				Tang, Zhiji; Yang, Ruijin; Zhang, Jinshi; Huang, Qianliang; Zhou, Xiaoping; Wei, Wenjin; Jiang, Qiuhua			Outcomes of Traumatic Brain-Injured Patients With Glasgow Coma Scale < 5 and Bilateral Dilated Pupils Undergoing Decompressive Craniectomy	FRONTIERS IN NEUROLOGY			English	Article						decompressive craniectomy; bilateral dilated pupils; GCS; mortality; traumatic brain injury	PROGRESSIVE HEMORRHAGIC INJURY; MANAGEMENT; SCORE	Objective: Decompressive craniectomy (DC) plays an important role in the treatment of patients with severe traumatic brain injury (sTBI) with mass lesions and intractably elevated intracranial hypertension (ICP). However, whether DC should be performed in patients with bilateral dilated pupils and a low Glasgow Coma Scale (GCS) score is still controversial. This retrospective study explored the clinical outcomes and risk factors for an unfavorable prognosis in sTBI patients undergoing emergency DC with bilateral dilated pupils and a GCS score Methods: The authors reviewed the data from patients who underwent emergency DC from January 2012 to March 2019 in a medical center in China. All data, such as patient demographics, radiological findings, clinical parameters, and preoperative laboratory variables, were extracted. Multivariate logistic regression analysis was performed to determine the factors associated with 30-day mortality and 6-month negative neurological outcome {defined as death or vegetative state [Glasgow Outcome Scale (GOS) score 1-2]}. Results: A total of 94 sTBI patients with bilateral dilated pupils and a GCS score lower than five who underwent emergency DC were enrolled. In total, 74 patients (78.7%) died within 30 days, and 84 (89.4%) had a poor 6-month outcome (GOS 1-2). In multivariate analysis, advanced age (OR: 7.741, CI: 2.288-26.189), prolonged preoperative activated partial thromboplastin time (aPTT) (OR: 7.263, CI: 1.323-39.890), and low GCS (OR: 6.162, CI: 1.478-25.684) were associated with a higher risk of 30-day mortality, while advanced age (OR: 8.812, CI: 1.817-42.729) was the only independent predictor of a poor 6-month prognosis in patients undergoing DC with preoperative bilateral dilated pupils and a GCS score Conclusions: The mortality and disability rates are extremely high in severe TBI patients undergoing emergency DC with bilateral fixed pupils and a GCS score <5. DC is more valuable for younger patients.	[Tang, Zhiji; Yang, Ruijin; Zhang, Jinshi; Huang, Qianliang; Zhou, Xiaoping; Wei, Wenjin; Jiang, Qiuhua] Ganzhou Peoples Hosp, Dept Neurosurg, Ganzhou, Peoples R China		Jiang, QH (corresponding author), Ganzhou Peoples Hosp, Dept Neurosurg, Ganzhou, Peoples R China.	jiangqh1968@126.com			Science and Technology Department of Jiangxi Province [20203BBGL73174]	This work was part of the Key Research and Development Program funded by Science and Technology Department of Jiangxi Province, grant number: 20203BBGL73174.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Chu SY, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0330-5; Fotakopoulos George, 2016, Surg Neurol Int, V7, P19, DOI 10.4103/2152-7806.176671; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Grindlinger GA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3251-9; Honeybul S, 2018, CURR OPIN CRIT CARE, V24, P97, DOI 10.1097/MCC.0000000000000481; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Huang YH, 2016, WORLD NEUROSURG, V88, P59, DOI 10.1016/j.wneu.2015.12.041; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jamous M, 2010, EUR J TRAUMA EMERG S, V36, P465, DOI 10.1007/s00068-010-0002-4; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Khalili Hosseinali, 2017, Bull Emerg Trauma, V5, P190; Khan Farid, 2018, Asian J Neurosurg, V13, P730, DOI 10.4103/ajns.AJNS_6_18; Manuel Vinas-Rios Juan, 2015, Asian J Neurosurg, V10, P190, DOI 10.4103/1793-5482.161171; Mao X, 2015, THER CLIN RISK MANAG, V11, P1627, DOI 10.2147/TCRM.S89820; Nourallah B, 2018, NEUROCRIT CARE, V29, P203, DOI 10.1007/s12028-018-0526-8; Park Jun-Hee, 2014, Korean J Neurotrauma, V10, P112, DOI 10.13004/kjnt.2014.10.2.112; Potts MB, 2008, ACTA NEUROCHIR SUPPL, V102, P109, DOI 10.1007/978-3-211-85578-2_22; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Scotter J, 2015, EMERG MED J, V32, P654, DOI 10.1136/emermed-2014-204260; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Townshend J, 2018, FAM J, V26, P77, DOI 10.1177/1066480717752905; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	34	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 25	2021	12								656369	10.3389/fneur.2021.656369			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SO0IX	WOS:000658666600001	34113309	gold, Green Published			2022-02-07	
J	Ali, MFA; Ghoul, AMF; Refaat, MI				Ali, Mohammed F. A.; Ghoul, Ahmed M. F.; Refaat, Mohamed, I			The effect of serum D-dimer levels on the cognitive outcome of patients with moderate traumatic brain injury	EGYPTIAN JOURNAL OF NEUROSURGERY			English	Article						D-dimer; Cognitive outcome; Traumatic brain injury; Serum biological markers; Montreal cognitive assessment-Basic	MANAGEMENT; MARKERS	Background Cognitive impairment after traumatic brain injury (TBI) is a main source of morbidity for affected individuals, their family members, and their community. There are numerous serum biomarkers, which are elevated after TBI; one of these is D-dimer. Several studies have related that trauma-related coagulopathy, marked by elevated D-dimer levels, is associated with poor prognosis. Objective The aim of this study was to find if there is a correlation between elevated serum levels of D-dimer and impairment of final cognitive outcome in case suffering of Moderate TBI. Patients and method This is a prospective cohort study with a random sample of 87 patients suffering from moderate TBI. Serum level of D-dimer was requested for all cases after confirming the diagnosis of moderate TBI with post-traumatic GCS 9-12. Head trauma treatment protocols were followed according to each case diagnosis and then at the time of discharge cognitive outcome was assessed for all cases. Neurocognition was assessed by Montreal cognitive assessment-Basic (MoCA-B). Results Eighty-seven cases were included in this trial with a mean age 28 years. 48.3% of cases were treated conservatively while the remaining 51.7% needed surgical interventions for different pathologies. Seventy-five cases had elevated levels of serum D-dimer (86.2%) whereas only 12 cases have within normal levels (13.8%). A twofold increase in the serum D-dimer level was found in 41% of cases, while 34.5% of cases had three- to sixfold increases, and 10% of cases had more than sixfold increase. The mean MoCA-B score was 24 points (range 13-27). Correlating the D-dimer levels statistically with the MoCA scores, age, admission and discharge GCS, and durations of hospital stay did not show any statistical significance with any of these variables. Conclusion The role played by D-dimer in the pathophysiology of cognitive deficits and its correlation with post moderate TBI cognitive outcome was not proven.	[Ali, Mohammed F. A.; Ghoul, Ahmed M. F.; Refaat, Mohamed, I] Cairo Univ, Fac Med, Dept Neurosurg, 6 Sray El Manial, Cairo, Egypt		Ali, MFA (corresponding author), Cairo Univ, Fac Med, Dept Neurosurg, 6 Sray El Manial, Cairo, Egypt.	dr.mohamedfathy2006@gmail.com					Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Grigorakos L., 2016, J NEUROSCI CLIN RES, V1, P1; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; JENNETT B, 1975, LANCET, V1, P480; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Montaser T., 2013, SCAND J TRAUMA RESUS, V21, pA4, DOI [10.1186/1757-7241-21-S2-A4, DOI 10.1186/1757-7241-21-S2-A4]; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Naseri M., 2005, IRAN J RADIOL, V2, P3; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Sugimoto K, 2017, J NEUROTRAUM, V34, P3245, DOI 10.1089/neu.2017.5240	17	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2520-8225		EGYPT J NEUROSURG	Egypt. J. Neurosurg.	MAY 24	2021	36	1							10	10.1186/s41984-021-00097-y			5	Clinical Neurology; Surgery	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Surgery	WC9WV	WOS:000704601300001		gold			2022-02-07	
J	Gonzalez, AC; Kim, M; Keser, Z; Ibrahim, L; Singh, SK; Ahmad, MJ; Hasan, O; Kamali, A; Hasan, KM; Schulz, PE				Gonzalez, Angelica C.; Kim, Minseon; Keser, Zafer; Ibrahim, Lamya; Singh, Sonia K.; Ahmad, Mohammed J.; Hasan, Omar; Kamali, Arash; Hasan, Khader M.; Schulz, Paul E.			Diffusion Tensor Imaging Correlates of Concussion Related Cognitive Impairment	FRONTIERS IN NEUROLOGY			English	Article						diffusion tensor imaging; concussion; mild traumatic brain injury; cognitive impairment; prognosis	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; ACTIVATION	Introduction: Cognitive impairment after concussion has been widely reported, but there is no reliable imaging biomarker that predicts the severity of cognitive decline post-concussion. This study tests the hypothesis that patients with a history of concussion and persistent cognitive impairment have fractional anisotropy (FA) and mean diffusivity (MD) values from diffusion tensor imaging (DTI) that are specifically associated with poor performance on the Montreal Cognitive Assessment (MoCA). Methods: Fifty-three subjects (19 females) with concussions and persistent cognitive symptoms had MR imaging and the MoCA. Imaging was analyzed by atlas-based, whole-brain DTI segmentation and FLAIR lesion segmentation. Then, we conducted a random forest-based recursive feature elimination (RFE) with 10-fold cross-validation on the entire dataset, and with partial correlation adjustment for age and lesion load. Results: RFE showed that 11 DTI variables were found to be important predictors of MoCA scores. Partial correlation analyses, corrected for age and lesion load, showed significant correlations between MoCA scores and right fronto-temporal regions: inferior temporal gyrus MD (r = -0.62, p = 0.00001), middle temporal gyrus MD (r = -0.54, p = 0.0001), angular gyrus MD (r = -0.48, p = 0.0008), and inferior frontal gyrus FA (r = 0.44, p = 0.002). Discussion: This is the first study to demonstrate a correlation between MoCA scores and DTI variables in patients with a history of concussion and persistent cognitive impairment. This kind of research will significantly increase our understanding of why certain persons have persistent cognitive changes after concussion which, in turn, may allow us to predict persistent impairment after concussion and suggest new interventions.	[Gonzalez, Angelica C.; Kim, Minseon; Keser, Zafer; Ibrahim, Lamya; Singh, Sonia K.; Ahmad, Mohammed J.; Hasan, Omar; Schulz, Paul E.] Univ Texas Houston, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA; [Kamali, Arash; Hasan, Khader M.] Univ Texas Houston, McGovern Med Sch, Dept Diagnost & Intervent Radiol, Houston, TX USA		Schulz, PE (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA.	paul.e.schulz@uth.tmc.edu					Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Baker CM, 2018, OPER NEUROSURG, V15, pS245, DOI 10.1093/ons/opy260; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Cornejo AC, 2020, ANN NEUROL, V88, pS262; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hasan KM, 2007, NEUROIMAGE, V34, P1497, DOI 10.1016/j.neuroimage.2006.10.029; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Knierim JJ, 2015, CURR BIOL, V25, pR1116, DOI 10.1016/j.cub.2015.10.049; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Maillard P, 2015, NEUROBIOL AGING, V36, P1670, DOI 10.1016/j.neurobiolaging.2015.01.007; Manjon JV, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00030; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mori S, 2016, COMPUT SCI ENG, V18, P21, DOI 10.1109/MCSE.2016.93; Panwar N, 2019, ASIAN J PSYCHIATR, V41, P60, DOI 10.1016/j.ajp.2018.08.007; Patel A, 2020, NEUROANATOMY TEMPORA; Peterson AB, 2014, SURVEILLANCE REPORT; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Schmidt R, 2007, STROKE, V38, P2619, DOI 10.1161/STROKEAHA.107.489112; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wikipedia contributors, 2021, FEAT SEL WIK FREE EN	42	0	0	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 24	2021	12								639179	10.3389/fneur.2021.639179			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SN5AM	WOS:000658302300001	34108926	gold, Green Published			2022-02-07	
J	Gutova, M; Cheng, JP; Adhikarla, V; Tsaturyan, L; Barish, ME; Rockne, RC; Moschonas, EH; Bondi, CO; Kline, AE				Gutova, Margarita; Cheng, Jeffrey P.; Adhikarla, Vikram; Tsaturyan, Lusine; Barish, Michael E.; Rockne, Russell C.; Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.			Intranasally Administered L-Myc-Immortalized Human Neural Stem Cells Migrate to Primary and Distal Sites of Damage after Cortical Impact and Enhance Spatial Learning	STEM CELLS INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; ABBREVIATED ENVIRONMENTAL ENRICHMENT; HISTOLOGICAL BENEFITS; COGNITIVE DEFICITS; CLINICAL-TRIALS; RECOVERY; THERAPY; MODEL; TRANSPLANTATION; RATS	As the success of stem cell-based therapies is contingent on efficient cell delivery to damaged areas, neural stem cells (NSCs) have promising therapeutic potential because they inherently migrate to sites of central nervous system (CNS) damage. To explore the possibility of NSC-based therapy after traumatic brain injury (TBI), isoflurane-anesthetized adult male rats received a controlled cortical impact (CCI) of moderate severity (2.8mm deformation at 4m/s) or sham injury (i.e., no cortical impact). Beginning 1-week post-injury, the rats were immunosuppressed and 1x106 human NSCs (LM-NS008.GFP.fLuc) or vehicle (VEH) (2% human serum albumen) were administered intranasally (IN) on post-operative days 7, 9, 11, 13, 15, and 17. To evaluate the spatial distributions of the LM-NSC008 cells, half of the rats were euthanized on day 25, one day after completion of the cognitive task, and the other half were euthanized on day 46. 1mm thick brain sections were optically cleared (CLARITY), and volumes were imaged by confocal microscopy. In addition, LM-NSC008 cell migration to the TBI site by immunohistochemistry for human-specific Nestin was observed at day 39. Acquisition of spatial learning was assessed in a well-established Morris water maze task on six successive days beginning on post-injury day 18. IN administration of LM-NSC008 cells after TBI (TBI+NSC) significantly facilitated spatial learning relative to TBI+VEH rats (p<0.05) and had no effect on sham+NSC rats. Overall, these data indicate that IN-administered LM-NSC008 cells migrate to sites of TBI damage and that their presence correlates with cognitive improvement. Future studies will expand on these preliminary findings by evaluating other LM-NSC008 cell dosing paradigms and evaluating mechanisms by which LM-NSC008 cells contribute to cognitive recovery.	[Gutova, Margarita; Tsaturyan, Lusine; Barish, Michael E.] City Hope Natl Med Ctr, Dept Dev & Stem Cell Biol, Beckman Res Inst, Duarte, CA 91010 USA; [Cheng, Jeffrey P.; Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Cheng, Jeffrey P.; Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Adhikarla, Vikram; Rockne, Russell C.] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, Div Math Oncol, Beckman Res Inst, Duarte, CA USA; [Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15260 USA		Gutova, M (corresponding author), City Hope Natl Med Ctr, Dept Dev & Stem Cell Biol, Beckman Res Inst, Duarte, CA 91010 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15260 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15260 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15260 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Psychol, Pittsburgh, PA 15260 USA.	mgutova@coh.org; klinae@upmc.edu	Rockne, Russell/T-1549-2017	Rockne, Russell/0000-0002-1557-159X; Kline, PhD, Anthony E./0000-0002-7218-3454	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30CA033572, R03 CA216142-01, HD069620, NS099674, NS084967, NS113810, NS094950, NS099683, NS110609]; Albert & Bettie Sacchi Foundation; UMPC Rehabilitation Institute; National Cancer Institute of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA033572]	This work was supported by the National Institutes of Health (grants P30CA033572 and R03 CA216142-01 (MG); HD069620, NS099674, NS084967, and NS113810 (AEK); and NS094950, NS099683, and NS110609 (COB)); the Albert & Bettie Sacchi Foundation (MG); and the UMPC Rehabilitation Institute (COB). Research reported in this publication includes work performed in the City of Hope Pathology Core supported by the National Cancer Institute of the NIH under grant number P30CA033572. The authors acknowledge the technical expertise of the City of Hope Pathology Core and the Light Microscopy Core, including Brian Armstrong and Loren Quintanar.	Aboody KS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005365; Arlotta P, 2019, CURR OPIN NEUROBIOL, V56, P194, DOI 10.1016/j.conb.2019.03.001; Ballini A, 2019, EUR REV MED PHARMACO, V23, P1626, DOI 10.26355/eurrev_201902_17122; Balyasnikova IV, 2014, MOL THER, V22, P140, DOI 10.1038/mt.2013.199; Barish ME, 2017, STEM CELL TRANSL MED, V6, P1522, DOI 10.1002/sctm.16-0397; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bleimeister IH, 2019, BRAIN RES, V1714, P227, DOI 10.1016/j.brainres.2019.03.007; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bondi CO, 2014, BIOL PSYCHIAT, V75, P38, DOI 10.1016/j.biopsych.2013.06.007; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; Czerniecki SM, 2018, CELL STEM CELL, V22, P929, DOI 10.1016/j.stem.2018.04.022; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dekkers JF, 2019, NAT PROTOC, V14, P1756, DOI 10.1038/s41596-019-0160-8; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Duncan K, 2015, BRAIN RES, V1623, P160, DOI 10.1016/j.brainres.2015.03.007; Faul M, 2010, TRAUMATIC BRAIN INJU; Gage FH, 2003, SCI AM, V289, P46, DOI 10.1038/scientificamerican0903-46; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111; GAGE FH, 1994, NEUROBIOL AGING, V15, pS191; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Gutova M, 2013, GENE THER, V20, P143, DOI 10.1038/gt.2012.12; Gutova M, 2013, STEM CELL TRANSL MED, V2, P766, DOI 10.5966/sctm.2013-0049; Hamed SA, 2017, EXPERT REV CLIN PHAR, V10, P409, DOI 10.1080/17512433.2017.1293521; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Karch CM, 2019, STEM CELL REP, V13, P939, DOI 10.1016/j.stemcr.2019.09.006; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Lajud N, 2019, J NEUROTRAUM, V36, P756, DOI 10.1089/neu.2018.5866; Li ZQ, 2016, STEM CELL REP, V7, P483, DOI 10.1016/j.stemcr.2016.07.013; Loebinger MR, 2009, CANCER RES, V69, P8862, DOI 10.1158/0008-5472.CAN-09-1912; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lopez-Tobon A, 2019, STEM CELL REP, V13, P847, DOI 10.1016/j.stemcr.2019.09.005; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Margarita G., 2015, ENLIVEN J STEM CELL, V2, DOI [10.18650/2379-5751.23006, DOI 10.18650/2379-5751.23006]; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mohan SP, 2020, J PHARM BIOALLIED SC, V12, P60, DOI 10.4103/jpbs.JPBS_229_20; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Nudi ET, 2015, J NEUROTRAUM, V32, P1117, DOI 10.1089/neu.2014.3618; Ohnuki M, 2014, P NATL ACAD SCI USA, V111, P12426, DOI 10.1073/pnas.1413299111; Parton A, 2005, CURR OPIN NEUROL, V18, P675, DOI 10.1097/01.wco.0000189872.54245.13; Pasca SP, 2019, NAT MED, V25, P1655, DOI 10.1038/s41591-019-0621-1; Penney J, 2020, MOL PSYCHIATR, V25, P148, DOI 10.1038/s41380-019-0468-3; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Rafiee F, 2020, INT J NEUROSCI, V130, P107, DOI 10.1080/00207454.2019.1664518; Rice HE, 2007, AM J ROENTGENOL, V188, P1101, DOI 10.2214/AJR.06.0663; Rockne RC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199967; Rolfe A., 2015, STEM CELL THERAPY BR; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P139, DOI 10.4137/GRSB.S13204; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Simon C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030568; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Taylor DN, 2017, J CHIROPR MED, V16, P19, DOI 10.1016/j.jcm.2016.10.005; Tirughana R, 2018, MOL THER-METH CLIN D, V10, P48, DOI 10.1016/j.omtm.2018.05.006; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; Valverde Y, 2018, J ENDODONT, V44, P1121, DOI 10.1016/j.joen.2018.03.015; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zahr SK, 2019, CELL DEATH DIFFER, V26, P2495, DOI 10.1038/s41418-019-0411-9; Zibara K, 2019, NEUROPHARMACOLOGY, V145, P177, DOI 10.1016/j.neuropharm.2018.09.032	83	0	0	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-966X	1687-9678		STEM CELLS INT	Stem Cells Int.	MAY 24	2021	2021									10.1155/2021/5549381			11	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ST1FY	WOS:000662197100002	34122556	gold, Green Published			2022-02-07	
J	Gvion, A; Shahaf, G				Gvion, Aviah; Shahaf, Goded			Real-time monitoring of barriers to patient engagement for improved rehabilitation: a protocol and representative case reports	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article; Early Access						rehabilitation; engagement; monitor; barriers; cognitive; affective	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; ATTENTION; STROKE; IMPAIRMENT; DISORDER; THERAPY	Purpose There is ample evidence that patient engagement is of major clinical importance in rehabilitation, and it seems this engagement is based upon effective allocation of attention to the tasks during the rehabilitation session. It is possible to discern two types of barriers which hinder attentive engagement: (1) dysfunctional affective coping and (2) limited cognitive recruitment and specifically attention deficit. These barriers might be general for a given patient, due to pre-morbid or co-morbid dysfunctions. But more often they are evoked by tasks or challenges during the rehabilitation session which might be too complicated or stressing for the specific patient who copes with potentially grave impairments. These barriers hinder rehabilitation progress and should be monitored and overcome, by the therapist, throughout the session. Methods We have developed an easy-to-use tool for monitoring a patient's attentive engagement in real-time throughout a rehabilitation session based on analysing the electrophysiological signal sampled from a simple headset. The tool then analyzes the dynamics of the marker over time to identify cognitive and affective barriers during the session. It enables the therapist to insert feedback regarding the patient's functional performance and to combine it with the analysed barriers, in order to derive automatic recommendations for overcoming the cognitive and affective barriers (if identified) for significant enhancement of the rehabilitation session. Results and conclusions In this work we present the principles of the tool as well as three detailed case reports to demonstrate its potential usefulness.	[Gvion, Aviah] Reuth Rehabil Ctr, Tel Aviv, Israel; [Gvion, Aviah] Ono Acad Coll, Kiryat Ono, Israel; [Shahaf, Goded] Rambam Hlth Care Campus, IL-31999 Haifa, Israel		Shahaf, G (corresponding author), Rambam Hlth Care Campus, IL-31999 Haifa, Israel.	godeds@gmail.com		Shahaf, Goded/0000-0003-2674-3585			Askim T, 2009, NEUROREHAB NEURAL RE, V23, P295, DOI 10.1177/1545968308322840; Bartur G, 2020, DISABIL REHABIL-ASSI, V15, P471, DOI 10.1080/17483107.2019.1680749; Bartur G, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9071568; Biran M., 2004, SHEMESH NAMING 100 O; Colombo R, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-3; Conte A, 2007, EXP BRAIN RES, V182, P109, DOI 10.1007/s00221-007-0975-3; Danzl Megan M, 2012, J Allied Health, V41, P35; Friedmann N., 2007, TILTAN KTIVA BATTERY; Friedmann N., 2003, BLIP BATTERY ASSESSM; Friedmann N., 2015, PILPEL WORD PICTURE; Friedmann N., 1998, BAFLA FRIEDMANN BATT; Glenn D, 2013, J CONSULT CLIN PSYCH, V81, P639, DOI 10.1037/a0033403; Gvion A, 2021, APHASIOLOGY, V35, P1519, DOI 10.1080/02687038.2020.1822988; Harvey PO, 2004, J PSYCHIATR RES, V38, P567, DOI 10.1016/j.jpsychires.2004.03.003; Horton S, 2011, DISABIL REHABIL, V33, P270, DOI 10.3109/09638288.2010.524270; Isserles M, 2018, J ECT, V34, P274, DOI 10.1097/YCT.0000000000000551; Karpin H., 2020, DISABIL REHABIL ASSI, V2020, P1; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim S, 2013, BRAIN INJURY, V27, P209, DOI 10.3109/02699052.2012.729292; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Lequerica AH, 2009, DISABIL REHABIL, V31, P753, DOI 10.1080/09638280802309095; Lincoln M, 2014, INT J TELEREHABILITA, V6, P65, DOI 10.5195/IJT.2014.6155; Loo SK, 2012, NEUROTHERAPEUTICS, V9, P569, DOI 10.1007/s13311-012-0131-z; O'Sullivan M, 2015, AGING NEUROPSYCHOL C, V22, P280, DOI 10.1080/13825585.2014.927818; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; Paolucci S, 2012, EUR J PHYS REHAB MED, V48, P455; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Pyoria O, 2007, DISABIL REHABIL, V29, P503, DOI 10.1080/09638280600902497; Raggi VL, 2006, CLIN CHILD FAM PSYCH, V9, P85, DOI 10.1007/s10567-006-0006-0; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Shahaf G, 2015, J NEUROSCI METH, V239, P183, DOI 10.1016/j.jneumeth.2014.10.016; Shahaf G, 2019, PSYCHIAT QUART, V90, P793, DOI 10.1007/s11126-019-09664-x; Shahaf G, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18113918; Shahaf G, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00032; Shahaf G, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00128; Shahaf G, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00094; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Wallace AC, 2010, CLIN REHABIL, V24, P471, DOI 10.1177/0269215509358944; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632	39	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.												10.1080/17483107.2021.1929513		MAY 2021	13	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	SH3UP	WOS:000654062600001	34033726				2022-02-07	
J	Pin, E; Petricoin, EF; Cortes, N; Bowman, TG; Andersson, E; Uhlen, M; Nilsson, P; Caswell, SV				Pin, Elisa; Petricoin, Emanuel F.; Cortes, Nelson; Bowman, Thomas G.; Andersson, Eni; Uhlen, Mathias; Nilsson, Peter; Caswell, Shane V.			Immunoglobulin A Autoreactivity toward Brain Enriched and Apoptosis-Regulating Proteins in Saliva of Athletes after Acute Concussion and Subconcussive Impacts	JOURNAL OF NEUROTRAUMA			English	Article						antigen microarray; autoantibodies; concussion; saliva; traumatic brain injury	VIDEO INCIDENT ANALYSIS; AUTOANTIBODIES; ACTIVATION; INJURY	The diagnosis and management of concussion is hindered by its diverse clinical presentation and assessment tools reliant on subjectively experienced symptoms. The biomechanical threshold of concussion is also not well understood, and asymptomatic concussion or "subconcussive impacts" of variable magnitudes are common in contact sports. Concerns have risen because athletes returning to activity too soon have an increased risk of prolonged recovery or long-term adverse health consequences. To date, little is understood on a molecular level regarding concussion and subconcussive impacts. Recent research suggests that neuroinflammatory mechanisms may serve an important role subsequent to concussion and possibly to subconcussive impacts. These studies suggest that autoantibodies may be a valuable tool for detection of acute concussion and monitoring for changes caused by cumulative exposure to subconcussive impacts. Hence, we aimed to profile the immunoglobulin (Ig)A autoantibody repertoire in saliva by screening a unique sport-related head trauma biobank. Saliva samples (n = 167) were donated by male and female participants enrolled in either the concussion (24-48 h post-injury) or subconcussion (non-concussed participants having moderate or high cumulative subconcussive impact exposure) cohorts. Study design included discovery and verification phases. Discovery aimed to identify new candidate autoimmune targets of IgA. Verification tested whether concussion and subconcussion cohorts increased IgA reactivity and whether cohorts showed similarities. The results show a significant increase in the prevalence of IgA toward protein fragments representing 5-hydroxytryptamine receptor 1A (HTR1A), serine/arginine repetitive matrix 4 (SRRM4) and FAS (tumor necrosis factor receptor superfamily member 6) after concussion and subconcussion. These results may suggest that concussion and subconcussion induce similar physiological effects, especially in terms of immune response. Our study demonstrates that saliva is a potential biofluid for autoantibody detection in concussion and subconcussion. After rigorous confirmation in much larger independent study sets, a validated salivary autoantibody assay could provide a non-subjective quantitative means of assessing concussive and subconcussive events.	[Pin, Elisa; Andersson, Eni; Nilsson, Peter] KTH Royal Inst Technol, SciLifeLab, Dept Prot Sci, Div Affin Prote, Stockholm, Sweden; [Uhlen, Mathias] KTH Royal Inst Technol, SciLifeLab, Dept Prot Sci, Div Syst Biol, Stockholm, Sweden; [Petricoin, Emanuel F.] George Mason Univ, Sch Kinesiol, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Petricoin, Emanuel F.; Cortes, Nelson; Caswell, Shane V.] George Mason Univ, Sch Kinesiol, Inst BioHlth Innovat, Manassas, VA USA; [Cortes, Nelson; Caswell, Shane V.] George Mason Univ, Sch Kinesiol, Sports Med Assessment Res & Testing Lab, Manassas, VA USA; [Bowman, Thomas G.] Univ Lynchburg, Dept Athlet Training, Lynchburg, VA USA		Caswell, SV (corresponding author), George Mason Univ, Sch Kinesiol, Katherine Johnson Hall 221,MSN 4E5, Manassas, VA 20110 USA.	scaswell@gmu.edu	Uhlen, Mathias/AAV-8746-2021	Cortes, Nelson/0000-0001-8762-3144			Adam DJ, 1999, J VASC SURG, V30, P229, DOI 10.1016/S0741-5214(99)70132-1; Agaton C, 2003, MOL CELL PROTEOMICS, V2, P405, DOI 10.1074/mcp.M300022-MCP200; Ayoglu B, 2016, BIOANALYSIS, V8, P1105, DOI 10.4155/bio.16.31; Ayoglu B, 2016, P NATL ACAD SCI USA, V113, P2188, DOI 10.1073/pnas.1518553113; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Brandtzaeg P, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20401; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Covassin T, 2018, AM J SPORT MED, V46, P2270, DOI 10.1177/0363546518780225; Di Battista AP, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-0339-3; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grosjean MB, 2007, HISTOL HISTOPATHOL, V22, P235, DOI 10.14670/HH-22.235; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Haggmark-Manberg A, 2016, AUTOIMMUNITY, V49, P421, DOI 10.1080/08916934.2016.1183655; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Ikuno N, 2001, J GASTROEN HEPATOL, V16, P1390, DOI 10.1046/j.1440-1746.2001.02624.x; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Javidi E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00686; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Lee YH, 2009, AM J DENT, V22, P241; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Markopoulos AK, 1997, DIABETES RES CLIN PR, V38, P169, DOI 10.1016/S0168-8227(97)00078-8; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072; O'Connor KL, 2017, ANN BIOMED ENG, V45, P1985, DOI 10.1007/s10439-017-1843-3; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Pin E, 2017, J PROTEOME RES, V16, P204, DOI 10.1021/acs.jproteome.6b00620; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; Raad M, 2014, NEUROSCIENCE, V281, P16, DOI 10.1016/j.neuroscience.2014.08.045; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Staron J, 2018, EXPERT OPIN THER PAT, V28, P679, DOI 10.1080/13543776.2018.1514011; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; Tengvall K, 2019, P NATL ACAD SCI USA, V116, P16955, DOI 10.1073/pnas.1902623116; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wang XQ, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0863-4; Wu CC, 2014, CANCER EPIDEM BIOMAR, V23, P1569, DOI 10.1158/1055-9965.EPI-13-1269; Zhang CZ, 2016, INT J ORAL SCI, V8, P133, DOI 10.1038/ijos.2016.38; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	51	0	0	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2373	2383		10.1089/neu.2020.7375		MAY 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000653489300001	33858214				2022-02-07	
J	Nguyen, JV; Yaw, T; Gratton, H				Nguyen, Jerika, V; Yaw, Tian; Gratton, Holly			Incidence of neurobehavioral side effects associated with levetiracetam compared to phenytoin in traumatic brain injury patients	BRAIN INJURY			English	Article						Phenytoin; levetiracetam; seizure prophylaxis; traumatic brain injury; neurobehavioral effects	EPILEPSY; GUIDELINES	Background: Phenytoin is recommended for seizure prophylaxis in traumatic brain injury (TBI). Levetiracetam has been proposed as an alternative agent. The purpose of this study was to determine whether there is a difference in the incidence of neurobehavioral side effects in patients with TBI receiving levetiracetam compared to those receiving phenytoin for seizure prophylaxis. Methods: This was a retrospective cohort study conducted at a level 1 trauma center from June 2008 to April 2014. Patients with TBI aged 16 years and older who received levetiracetam or phenytoin for seizure prophylaxis were evaluated and incidence of neurobehavioral side effects were compared for the two groups. Results: Of the 200 patients who met inclusion criteria, 95 (47.5%) received phenytoin and 105 (52.5%) received levetiracetam. Incidence of neurobehavioral side effects was not statistically different between groups (76 [80%] vs. 75 [71.4%], p = .189). The two groups were well matched. Conclusion: In patients with TBI, receipt of levetiracetam for seizure prophylaxis did not appear to be associated with increased neurobehavioral side effects compared to receipt of phenytoin.	[Nguyen, Jerika, V; Yaw, Tian; Gratton, Holly] Oregon Hlth & Sci Univ Hosp, Dept Pharm Serv, Portland, OR USA		Nguyen, JV (corresponding author), Oregon Hlth & Sci Univ Hosp, Portland, OR 97239 USA.	jerika.nguyen@philips.com	Nguyen, Jerika/AAU-1366-2021	Nguyen, Jerika/0000-0002-2990-6426; Yaw, Tian/0000-0002-5820-8045			Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; Halma E, 2014, SEIZURE-EUR J EPILEP, V23, P685, DOI 10.1016/j.seizure.2014.06.004; Khan NR, 2016, NEUROSURGERY, V79, P775, DOI 10.1227/NEU.0000000000001445; Levetiracetam, 2017, LEXICOMP; Marson AG., 2020, COCHRANE DB SYST REV, V2020, DOI DOI 10.1002/14651858.CD001901.PUB3; Mbizvo GK, 2014, INT J NEUROSCI, V124, P627, DOI 10.3109/00207454.2013.866951; Phenytoin, 2017, LEX DRUGS; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468	13	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					902	906		10.1080/02699052.2021.1927184		MAY 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000653003600001	34027761				2022-02-07	
J	Schonegg, D; Ferrari, R; Ebner, J; Blumer, M; Lanzer, M; Gander, T				Schoenegg, Daphne; Ferrari, Raphael; Ebner, Julian; Blumer, Michael; Lanzer, Martin; Gander, Thomas			Proximity of the middle meningeal artery and maxillary artery to the mandibular head and mandibular neck as revealed by three-dimensional time-of-flight magnetic resonance angiography	ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG			English	Article; Early Access						Maxillary artery; Middle meningeal artery; Mandibular condylar process; Topographic relationship	FORAMEN SPINOSUM; TEMPOROMANDIBULAR-JOINT; INFRATEMPORAL FOSSA; CONDYLAR PROCESS; FRACTURES; ANATOMY; RAMUS; EMBOLIZATION; ANKYLOSIS; SHAPE	Purpose The close topographic relationship between vascular and osseous structures in the condylar and subcondylar region and marked variability in the arterial course has been revealed by both imaging and cadaveric studies. This study aimed to verify the previously published information in a large sample and to determine a safe surgical region. Methods We analyzed the three-dimensional time-of-flight magnetic resonance angiography images of 300 individuals. Results The mean distance between the middle meningeal artery and the apex of the condyle or the most medial point of the condyle was 18.8 mm (range: 11.2-25.9 mm) or 14.5 mm (range: 8.8-22.9 mm) respectively. The course of the maxillary artery relative to the lateral pterygoid muscle was medial in 45.7% of cases and lateral in 54.3%. An asymmetric course was evident in 66 patients (22%). The mean distance between the maxillary artery and condylar process at the deepest point of the mandibular notch was 6.2 mm in sides exhibiting a medial course (range: 3.7-9.8 mm) and 6.6 mm in sides exhibiting a lateral course (range: 3.9-10.4 mm). The distances were significantly influenced by age, gender, and the course of the maxillary artery. Conclusion Our study emphasizes the marked inter- and intra-individual variability of the maxillary and middle meningeal arterial courses. We confirmed the proximity of the arteries to the condylar process. Extensive surgical experience and thorough preparation for each individual case are essential to prevent iatrogenic vascular injury.	[Schoenegg, Daphne; Ferrari, Raphael; Ebner, Julian; Blumer, Michael; Lanzer, Martin; Gander, Thomas] Univ Hosp Zurich, Dept Oral & Maxillofacial Surg, Frauenklinikstr 24, CH-8091 Zurich, Switzerland		Gander, T (corresponding author), Univ Hosp Zurich, Dept Oral & Maxillofacial Surg, Frauenklinikstr 24, CH-8091 Zurich, Switzerland.	Thomas.Gander@usz.ch			Universitat Zurich	Open Access funding provided by Universitat Zurich.	Akiyama O, 2018, CLIN ANAT, V31, P724, DOI 10.1002/ca.22926; Al-Moraissi EA, 2015, J ORAL MAXIL SURG, V73, P482, DOI 10.1016/j.joms.2014.09.027; Aland RC, 2016, ANAT SCI INT, V91, P207, DOI 10.1007/s12565-015-0289-7; Alderazi YJ, 2017, WORLD NEUROSURG, V101, P254, DOI 10.1016/j.wneu.2017.01.086; Alvernia JE, 2017, ACTA NEUROCHIR, V159, P655, DOI 10.1007/s00701-017-3092-5; Arimoto S, 2015, INT J ORAL MAX SURG, V44, P977, DOI 10.1016/j.ijom.2015.04.007; Balcioglu Huseyin Avni, 2010, Eur J Dent, V4, P166; Baur DA, 2014, J ORAL MAXIL SURG, V72, P1125, DOI 10.1016/j.joms.2013.12.030; Bendrihem R, 2017, SURG RADIOL ANAT, V39, P23, DOI 10.1007/s00276-016-1697-7; Berner T, 2015, J CRANIO MAXILL SURG, V43, P1404, DOI 10.1016/j.jcms.2015.07.027; Blume M, 2019, J ORAL MAXIL SURG, V77, DOI 10.1016/j.joms.2018.08.013; Blumer M, 2020, J ORAL MAXIL SURG, V78, P1151, DOI 10.1016/j.joms.2020.02.024; Cuccia AM, 2013, IMAGNG SCI DENT, V43, P37, DOI 10.5624/isd.2013.43.1.37; Cvetko E, 2014, FOLIA MORPHOL, V73, P87, DOI 10.5603/FM.2014.0013; da Silva TH, 2013, J NEUROL SURG PART B, V74, P108, DOI 10.1055/s-0033-1333615; Dennison J, 2009, ORAL SURG ORAL MED O, V108, pE26, DOI 10.1016/j.tripleo.2009.07.029; Ellwanger JH, 2013, J NEUROL SURG REP, V74, P73, DOI 10.1055/s-0033-1347901; Ganugapanta VR, 2017, J CLIN DIAGN RES, V11, pZC29, DOI 10.7860/JCDR/2017/21678.9328; Gulses A, 2012, J CRANIOFAC SURG, V23, P1465, DOI 10.1097/SCS.0b013e3182575793; Guo YX, 2014, J CRANIO MAXILL SURG, V42, P206, DOI 10.1016/j.jcms.2013.05.001; Hara S, 2014, J ORAL MAXIL SURG, V72, P1373, DOI 10.1016/j.joms.2013.12.012; Hoffman D, 2015, ORAL MAXIL SURG CLIN, V27, P109, DOI 10.1016/j.coms.2014.09.008; Hossameldin RH, 2017, BRIT J ORAL MAX SURG, V55, P584, DOI 10.1016/j.bjoms.2017.03.001; Hussain A, 2008, ORAL SURG ORAL MED O, V105, P32, DOI 10.1016/j.tripleo.2007.04.010; Huumonen S, 2010, J ORAL REHABIL, V37, P34, DOI 10.1111/j.1365-2842.2009.02022.x; Hwang SH, 2014, CLIN ANAT, V27, P691, DOI 10.1002/ca.22329; Isolan GR, 2007, SKULL BASE-INTERD AP, V17, P285, DOI 10.1055/s-2007-985193; Iwai T, 2013, J CRANIOFAC SURG, V24, P534, DOI 10.1097/SCS.0b013e3182646b0b; Joo W, 2013, CLIN ANAT, V26, P455, DOI 10.1002/ca.22202; Kornieieva M, 2015, J NEUROL SURG PART B, V76, P451, DOI 10.1055/s-0035-1554902; Krayenbuhl N, 2008, NEUROSURG REV, V31, P397, DOI 10.1007/s10143-008-0152-6; Lepic T, 2019, J CLIN ULTRASOUND, V47, P405, DOI 10.1002/jcu.22712; Maeda S, 2012, ANAT SCI INT, V87, P187, DOI 10.1007/s12565-012-0146-x; Orbay H, 2007, PLAST RECONSTR SURG, V120, P1865, DOI 10.1097/01.prs.0000287137.72674.3c; Otake Ippei, 2011, Okajimas Folia Anatomica Japonica, V87, P155; Pandyan DA, 2014, J ORAL MAXIL SURG, V72, DOI 10.1016/j.joms.2013.11.009; Polev GA, 2019, J CRANIOFAC SURG, V30, P137, DOI 10.1097/SCS.0000000000004981; Saccucci M, 2012, HEAD FACE MED, V8, DOI 10.1186/1746-160X-8-15; Safi AF, 2018, J CRANIOFAC SURG, V29, P510, DOI 10.1097/SCS.0000000000004137; Sairam V, 2018, CONTEMP CLIN DENT, V9, P49, DOI 10.4103/ccd.ccd_704_17; Siniscalchi EN, 2016, CASE REP MED, V2016, DOI 10.1155/2016/9168429; Tanoue S, 2013, RADIOGRAPHICS, V33, pE209, DOI 10.1148/rg.337125173; Toure G, 2018, PLAST RECONSTR SURG, V141, p718E, DOI 10.1097/PRS.0000000000004295; Uysal II, 2011, INT J MORPHOL, V29, P1274, DOI 10.4067/S0717-95022011000400034; Vuksanovic-Bozaric A, 2019, SURG RADIOL ANAT, V41, P161, DOI 10.1007/s00276-018-2136-8; Walker Cameron J, 2017, Atlas Oral Maxillofac Surg Clin North Am, V25, P11, DOI 10.1016/j.cxom.2016.10.002; Wang L, 2018, WORLD NEUROSURG, V113, P320, DOI 10.1016/j.wneu.2018.02.158; Wysocki J, 2012, J CRANIO MAXILL SURG, V40, P112, DOI 10.1016/j.jcms.2011.03.017; Yagmurlu K, 2017, WORLD NEUROSURG, V100, P540, DOI 10.1016/j.wneu.2016.12.130; Yalcin ED, 2019, J CRANIOFAC SURG, V30, P2621, DOI 10.1097/SCS.0000000000005699	50	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1865-1550	1865-1569		ORAL MAXILLOFAC SURG	Oral Maxillofac. Surg.-Heidelb.												10.1007/s10006-021-00960-0		MAY 2021	8	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	SF7NV	WOS:000652938700001	34024006	hybrid			2022-02-07	
J	Bakalkin, G; Nosova, O; Sarkisyan, D; Hallberg, M; Zhang, ML; Schouenborg, J; Marklund, N; Watanabe, H				Bakalkin, Georgy; Nosova, Olga; Sarkisyan, Daniil; Hallberg, Mathias; Zhang, Mengliang; Schouenborg, Jens; Marklund, Niklas; Watanabe, Hiroyuki			Unilateral traumatic brain injury of the left and right hemisphere produces the left hindlimb response in rats	EXPERIMENTAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Stroke; Ipsilateral response; Contralateral response; Postural asymmetry	CONTROLLED CORTICAL IMPACT; MOTOR CORTEX; PATHOPHYSIOLOGY; DYNORPHIN; NECK; NEURODEGENERATION; IMPAIRMENT; LOCOMOTION; MOVEMENTS; RECOVERY	Traumatic brain injury and stroke result in hemiplegia, hemiparesis, and asymmetry in posture. The effects are mostly contralateral; however, ipsilesional deficits may also develop. We here examined whether ablation brain injury and controlled cortical impact (CCI), a rat model of clinical focal traumatic brain injury, both centered over the left or right sensorimotor cortex, induced hindlimb postural asymmetry (HL-PA) with contralesional or ipsilesional limb flexion. The contralesional hindlimb was flexed after left or right side ablation injury. In contrast, both the left and right CCI unexpectedly produced HL-PA with flexion on left side. The flexion persisted after complete spinal cord transection suggesting that CCI triggered neuroplastic processes in lumbar neural circuits enabling asymmetric muscle contraction. Left limb flexion was exhibited under pentobarbital anesthesia. However, under ketamine anesthesia, the body of the left and right CCI rats bent laterally in the coronal plane to the ipsilesional side suggesting that the left and right injury engaged mirror-symmetrical motor pathways. Thus, the effects of the left and right CCI on HL-PA were not mirror-symmetrical in contrast to those of the ablation brain injury, and to the left and right CCI produced body bending. Ipsilateral effects of the left CCI on HL-PA may be mediated by a lateralized motor pathway that is not affected by the left ablation injury. Alternatively, the left-side-specific neurohormonal mechanism that signals from injured brain to spinal cord may be activated by both the left and right CCI but not by ablation injury.	[Bakalkin, Georgy; Nosova, Olga; Sarkisyan, Daniil; Hallberg, Mathias; Watanabe, Hiroyuki] Uppsala Univ, Dept Pharmaceut Biosci, Husargatan 3,Box 591, S-75124 Uppsala, Sweden; [Zhang, Mengliang] Univ Southern Denmark, Dept Mol Med, Odense, Denmark; [Zhang, Mengliang; Schouenborg, Jens] Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, Lund, Sweden; [Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg, Lund, Sweden		Bakalkin, G (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Husargatan 3,Box 591, S-75124 Uppsala, Sweden.	Georgy.Bakalkin@farmbio.uu.se		Hallberg, Mathias/0000-0002-9835-870X; Marklund, Niklas/0000-0002-9797-5626; Sarkisyan, Daniil/0000-0002-2451-4386; Bakalkin, Georgy/0000-0002-8074-9833; Schouenborg, Jens/0000-0002-2815-6918; Zhang, Mengliang/0000-0001-5945-6625	Uppsala University; Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2014-62X-12190-19-5, 2019-01771-3]; L. Hiertas Minne foundation; P.O. Zetterling foundation	Open access funding provided by Uppsala University. The study was supported by the Swedish Research Council (Grants K2014-62X-12190-19-5 and 2019-01771-3) to G.B., L. Hiertas Minne foundation, and P.O. Zetterling foundation to O.N., Uppsala University to G.B.	Bakalkin G., 2020, 056937 BIORXIV, DOI [10.1101/2020.04.23.056937, DOI 10.1101/2020.04.23.056937]; BAKALKIN GY, 1986, PEPTIDES, V7, P551, DOI 10.1016/0196-9781(86)90025-2; BAKALKIN GY, 1989, INT J NEUROSCI, V47, P217, DOI 10.3109/00207458908987436; BAKALKIN GY, 1989, BRAIN RES, V480, P277, DOI 10.1016/0006-8993(89)90193-5; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Carpenter BL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06351-4; Caudle RM, 2000, PAIN, V87, P235, DOI 10.1016/S0304-3959(00)00360-2; CHAMBERLAIN TJ, 1963, J NEUROPHYSIOL, V26, P662, DOI 10.1152/jn.1963.26.4.662; CHAZOV EI, 1981, EXPERIENTIA, V37, P887, DOI 10.1007/BF01985696; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Coelho DB, 2019, J STROKE CEREBROVASC, V28, P954, DOI 10.1016/j.jstrokecerebrovasdis.2018.12.021; Cregg JM, 2020, NAT NEUROSCI, V23, P730, DOI 10.1038/s41593-020-0633-7; Silva FPD, 2018, J MOTOR BEHAV, V50, P104, DOI 10.1080/00222895.2017.1306479; Deliagina TG, 2000, J NEUROPHYSIOL, V84, P1673, DOI 10.1152/jn.2000.84.3.1673; DREW T, 1990, J NEUROPHYSIOL, V64, P767, DOI 10.1152/jn.1990.64.3.767; Ellis MD, 2012, J NEUROPHYSIOL, V108, P3096, DOI 10.1152/jn.01030.2011; Fernandes CA, 2018, HUM MOVEMENT SCI, V57, P374, DOI 10.1016/j.humov.2017.09.015; Gonzalez CLR, 2004, EUR J NEUROSCI, V20, P3442, DOI 10.1111/j.1460-9568.2004.03751.x; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hanna-Pladdy B, 2002, J NEUROL NEUROSUR PS, V73, P574, DOI 10.1136/jnnp.73.5.574; Harris JE, 2006, NEUROREHAB NEURAL RE, V20, P380, DOI 10.1177/1545968305284528; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; HETZLER BE, 1985, PHARMACOL BIOCHEM BE, V22, P653, DOI 10.1016/0091-3057(85)90291-6; HULTBORN H, 1983, ACTA PHYSIOL SCAND, V119, P423, DOI 10.1111/j.1748-1716.1983.tb07358.x; Hussain ZM, 2012, J NEUROTRAUM, V29, P1785, DOI 10.1089/neu.2011.2286; Knebel D, 2018, CURR BIOL, V28, pR1290, DOI 10.1016/j.cub.2018.09.063; Lacalle-Aurioles M, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.594304; Lorentzen J, 2018, CLIN NEUROPHYSIOL, V129, P89, DOI 10.1016/j.clinph.2017.10.023; Maenza C, 2020, NEUROREHAB NEURAL RE, V34, P39, DOI 10.1177/1545968319875951; Mani S, 2013, BRAIN, V136, P1288, DOI 10.1093/brain/aws283; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; Maximyuk O, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.39; McCall AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00112; McElreath R, 2019, STAT RETHINKING BAYE; McPherson JG, 2018, J PHYSIOL-LONDON, V596, P1211, DOI 10.1113/JP274968; Nation KM, 2018, PAIN, V159, P919, DOI 10.1097/j.pain.0000000000001167; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nusbaum MP, 2017, NAT REV NEUROSCI, V18, P389, DOI 10.1038/nrn.2017.56; Phelps CE, 2019, PAIN, V160, P1614, DOI 10.1097/j.pain.0000000000001553; Purves D, 2012, NEUROSCIENCE; Quessy S, 2004, EXP BRAIN RES, V156, P342, DOI 10.1007/s00221-003-1787-8; ROBINSON RG, 1979, SCIENCE, V205, P707, DOI 10.1126/science.462179; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Sainburg RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01092; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Sheean G, 2009, PM&R, V1, P827, DOI 10.1016/j.pmrj.2009.08.002; Shevell M, 2009, NEUROLOGY, V72, P850, DOI 10.1212/01.wnl.0000343961.35429.09; Smeets CJLM, 2015, BRAIN, V138, P2537, DOI 10.1093/brain/awv195; Stan Development Team, 2019, STAN MOD LANG US GUI; Stancher G, 2018, PROG BRAIN RES, V238, P33, DOI 10.1016/bs.pbr.2018.06.002; Tandon S, 2008, EUR J NEUROSCI, V27, P228, DOI 10.1111/j.1460-9568.2007.05997.x; Varghese R, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01340; VARLINSKAYA E I, 1984, Byulleten' Eksperimental'noi Biologii i Meditsiny, V98, P281; Watanabe H, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0548-20.2021; Watanabe H, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa208; WINTERS WD, 1986, NEUROPHARMACOLOGY, V25, P1095, DOI 10.1016/0028-3908(86)90156-5; Zhang ML, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa055	61	0	0	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JUL	2021	239	7					2221	2232		10.1007/s00221-021-06118-4		MAY 2021	12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TK8LI	WOS:000652984000001	34021800	hybrid, Green Published			2022-02-07	
J	Chu, SA; Chen, TY; Chen, PY; Tzeng, WJ; Liang, CL; Lu, K; Chen, HJ; Wu, CC; Chen, JH; Tsai, CC; Wang, HK				Chu, Shao-Ang; Chen, Te-Yuan; Chen, Po-Yuan; Tzeng, Wei-Jie; Liang, Cheng-Loong; Lu, Kang; Chen, Han-Jung; Wu, Cheng-Chun; Chen, Jian-Han; Tsai, Chin-Chuan; Wang, Hao-Kuang			Acupuncture May Decrease the Incidence of Post-stroke Dementia: A Taiwan Nationwide Retrospective Cohort Study	FRONTIERS IN NEUROLOGY			English	Article						acupuncture; dementia; stroke; incidence; outcome	TRANSIENT ISCHEMIC ATTACK; TRAUMATIC BRAIN-INJURY; STROKE; MECHANISMS; RISK	Background: Post-stroke dementia may affect up to one-third of stroke survivors. Acupuncture as a complementary treatment for stroke has been shown to be beneficial for subsequent post-stroke rehabilitation. The purpose of this retrospective cohort study was to investigate the potential effect of acupuncture to protect stroke patients from dementia. Methods: We included 9,547 patients receiving ambulatory or hospital care for stroke and 9.547 non-stroke patients; patients were matched for sex, age, and Charlson Comorbidity Index. Each individual was traced for the subsequent development of dementia. Two thousand four hundred and forty-nine stroke patients received acupuncture treatment and 7,098 residue stroke patients without acupuncture treatment served as control groups. This is a 3-year follow-up cohorts study: the incidence and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) of post- stroke dementia in the Cox proportional hazard regression. Results: During the 3-year follow-up, 1,403 patients with stroke (14.70%) and 427 patients without stroke (4.47%) developed dementia. The adjusted HRs of development of dementia among stroke patients were 3.64-times (range, 3.27-4.06), and the incidence of dementia was higher in male. Stroke patients receiving acupuncture treatment had a lower probability of dementia than those without acupuncture during the follow-up period, the adjusted HRs was 0.49 (95% CI, 0.42-0.58; p < 0.001). Conclusions: The association between stroke and dementia existed in both sexes, more prominent in male. Patients with stroke receiving acupuncture treatments showed decreased risk of dementia. Care must be taken evaluating these results because this study was limited to lack of information regarding lifestyles, stroke severities, and acupuncture methods that were used in treatments.	[Chu, Shao-Ang; Chen, Te-Yuan; Chen, Po-Yuan; Tzeng, Wei-Jie; Liang, Cheng-Loong; Lu, Kang; Chen, Han-Jung; Wu, Cheng-Chun; Wang, Hao-Kuang] E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Chu, Shao-Ang; Chen, Te-Yuan; Chen, Po-Yuan; Tzeng, Wei-Jie; Liang, Cheng-Loong; Lu, Kang; Chen, Han-Jung; Wu, Cheng-Chun; Chen, Jian-Han; Wang, Hao-Kuang] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Chen, Jian-Han] E Da Hosp, Dept Gen Surg, Kaohsiung, Taiwan; [Tsai, Chin-Chuan] E Da Hosp, Chinese Med Dept, Kaohsiung, Taiwan; [Tsai, Chin-Chuan] I Shou Univ, Sch Chinese Med Post Baccalaureates, Kaohsiung, Taiwan		Wang, HK (corresponding author), E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan.; Chen, JH; Wang, HK (corresponding author), I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.; Chen, JH (corresponding author), E Da Hosp, Dept Gen Surg, Kaohsiung, Taiwan.; Tsai, CC (corresponding author), E Da Hosp, Chinese Med Dept, Kaohsiung, Taiwan.; Tsai, CC (corresponding author), I Shou Univ, Sch Chinese Med Post Baccalaureates, Kaohsiung, Taiwan.	jamihan1981@gmail.com; ed103622@edah.org.tw; ed101393@gmail.com			E-Da Hospital, Kaohsiung, Taiwan; Center for Database Research, E-Da Healthcare Group	This study was supported in part by grants from the E-Da Hospital, Kaohsiung, Taiwan (EDAD2015) and supported by Center for Database Research, E-Da Healthcare Group.	Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Cai W, 2017, AGEING RES REV, V34, P77, DOI 10.1016/j.arr.2016.09.006; Chon TY, 2013, MAYO CLIN PROC, V88, P1141, DOI 10.1016/j.mayocp.2013.06.009; Douiri A, 2013, CIRCULATION, V128, P1341, DOI 10.1161/CIRCULATIONAHA.113.002236; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gorelick PB, 2015, JAMA-J AM MED ASSOC, V314, P29, DOI 10.1001/jama.2015.7149; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Henon H, 2006, CEREBROVASC DIS, V22, P61, DOI 10.1159/000092923; Huang W, 2009, SLEEP MED REV, V13, P73, DOI 10.1016/j.smrv.2008.04.002; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Li CH, 2019, GERIATR GERONTOL INT, V19, P815, DOI 10.1111/ggi.13725; Lin CK, 2021, RISK MANAG HEALTHC P, V14, P177, DOI 10.2147/RMHP.S290964; Lu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19521; Mijajlovic MD, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0779-7; Pasquier F, 1999, REV NEUROL, V155, P749; Pendlebury ST, 2019, LANCET NEUROL, V18, P248, DOI 10.1016/S1474-4422(18)30442-3; Pendlebury ST, 2012, INT J STROKE, V7, P570, DOI 10.1111/j.1747-4949.2012.00837.x; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Prince M, 2015, EPIDEMIOLOGY IMPACT; Seitz RJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00238; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Shi Guang-Xia, 2015, ScientificWorldJournal, V2015, P161439, DOI 10.1155/2015/161439; Shi GX, 2014, CHIN J INTEGR MED, V20, P661, DOI 10.1007/s11655-013-1323-4; Shih CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089208; van Rooij FG, 2016, CEREBROVASC DIS, V42, P1, DOI 10.1159/000444282; Venkat P, 2015, EXP NEUROL, V272, P97, DOI 10.1016/j.expneurol.2015.05.006; Wang HK, 2020, STROKE, V51, P1248, DOI 10.1161/STROKEAHA.119.027012; Woods B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005562.pub2; Wu P, 2010, STROKE, V41, pE171, DOI 10.1161/STROKEAHA.109.573576; Yang ZR, 2020, J ALZHEIMERS DIS, V77, P1157, DOI 10.3233/JAD-200536; Ye Y, 2017, NEUROCHEM INT, V107, P204, DOI 10.1016/j.neuint.2016.12.001; Ye Y, 2017, STROKE, V48, P1044, DOI 10.1161/STROKEAHA.116.014696; Zhang JH, 2014, NEUROEPIDEMIOLOGY, V42, P50, DOI 10.1159/000355435; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004	36	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 21	2021	12								657048	10.3389/fneur.2021.657048			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SM5NY	WOS:000657653200001	34093405	gold, Green Published			2022-02-07	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Insular Connectivity Is Associated With Self-Appraisal of Cognitive Function After a Concussion	FRONTIERS IN NEUROLOGY			English	Article						concussion; mild TBI; self-appraisal; insula; fMRI; DTI	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; ANTERIOR CINGULATE CORTEX; INDUCED SICKNESS BEHAVIOR; MIDCINGULATE CORTEX; SYMPTOM SEVERITY; BLOOD-FLOW; ANOSOGNOSIA; AWARENESS; RELIABILITY	Concussion is associated with acute cognitive impairments, with declines in processing speed and reaction time being common. In the clinical setting, these issues are identified via symptom assessments and neurocognitive test (NCT) batteries. Practice guidelines recommend integrating both symptoms and NCTs into clinical decision-making, but correlations between these measures are often poor. This suggests that many patients experience difficulties in the self-appraisal of cognitive issues. It is presently unclear what neural mechanisms give rise to appraisal mismatch after a concussion. One promising target is the insula, which regulates aspects of cognition, particularly interoception and self-monitoring. The present study tested the hypothesis that appraisal mismatch is due to altered functional connectivity of the insula to frontal and midline structures, with hypo-connectivity leading to under-reporting of cognitive issues and hyper-connectivity leading to over-reporting. Data were collected from 59 acutely concussed individuals and 136 normative controls, including symptom assessments, NCTs and magnetic resonance imaging (MRI) data. Analysis of resting-state functional MRI supported the hypothesis, identifying insular networks that were associated with appraisal mismatch in concussed athletes that included frontal, sensorimotor, and cingulate connections. Subsequent analysis of diffusion tensor imaging also determined that symptom over-reporting was associated with reduced fractional anisotropy and increased mean diffusivity of posterior white matter. These findings provide new insights into the mechanisms of cognitive appraisal mismatch after a concussion. They are of particular interest given the central role of symptom assessments in the diagnosis and clinical management of concussion.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.	nchurchill.research@gmail.com			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN356342 - 401065, RN294001-367456]; Canadian Institute for Military and Veterans Health Research (CIMVHR) [W7714-145967]; Siemens Healthineers Canada	This work was supported by the Canadian Institutes of Health Research (CIHR) [grant numbers RN356342 - 401065, RN294001-367456]; the Canadian Institute for Military and Veterans Health Research (CIMVHR) [grant number W7714-145967]; and Siemens Healthineers Canada.	Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bernstein JP., 2018, APPL NEUROPSYCH-ADUL, V2018, P1, DOI [10.1080/23279095.2017.1416471, DOI 10.1080/23279095.2017.1416471]; Bro R, 1996, J CHEMOMETR, V10, P47, DOI 10.1002/(SICI)1099-128X(199601)10:1<47::AID-CEM400>3.0.CO;2-C; Brown BM, 1996, J AM STAT ASSOC, V91, P1668, DOI 10.2307/2291594; Caseras X, 2013, HUM BRAIN MAPP, V34, P1220, DOI 10.1002/hbm.21503; Cerliani L, 2012, HUM BRAIN MAPP, V33, P2005, DOI 10.1002/hbm.21338; Churchill NW, 2020, HUM BRAIN MAPP, V41, P2567, DOI 10.1002/hbm.24962; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Churchill NW, 2013, NEUROIMAGE, V82, P306, DOI 10.1016/j.neuroimage.2013.05.102; Cloutman LL, 2012, NEUROIMAGE, V59, P3514, DOI 10.1016/j.neuroimage.2011.11.016; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gerretsen P, 2017, J CLIN PSYCHIAT, V78, pE1187, DOI 10.4088/JCP.16m11367; Goulden N, 2014, NEUROIMAGE, V99, P180, DOI 10.1016/j.neuroimage.2014.05.052; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Heilman KM, 1998, PHILOS T R SOC B, V353, P1903, DOI 10.1098/rstb.1998.0342; Hoffstaedter F, 2014, HUM BRAIN MAPP, V35, P2741, DOI 10.1002/hbm.22363; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Klumpp H, 2012, BIOL PSYCHOL, V89, P273, DOI 10.1016/j.biopsycho.2011.10.010; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Moritz AR, 1943, ANN SURG, V117, P562, DOI 10.1097/00000658-194304000-00006; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nakata H, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01489; Namkung H, 2017, TRENDS NEUROSCI, V40, P200, DOI 10.1016/j.tins.2017.02.002; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; REED BR, 1993, J CLIN EXP NEUROPSYC, V15, P231, DOI 10.1080/01688639308402560; Ries ML, 2007, J INT NEUROPSYCH SOC, V13, P450, DOI 10.1017/S1355617707070488; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Simmons WK, 2013, HUM BRAIN MAPP, V34, P2944, DOI 10.1002/hbm.22113; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Tabert MH, 2002, NEUROLOGY, V58, P758, DOI 10.1212/WNL.58.5.758; Tarlochan F., 2013, INT, V2, P17; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Uddin LQ, 2017, J CLIN NEUROPHYSIOL, V34, P300, DOI 10.1097/WNP.0000000000000377; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vogel A, 2005, INT J GERIATR PSYCH, V20, P238, DOI 10.1002/gps.1272; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Wright CI, 2003, BIOL PSYCHIAT, V54, P1067, DOI 10.1016/S0006-3223(03)00548-1	83	0	0	5	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 21	2021	12								653442	10.3389/fneur.2021.653442			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	SM3GN	WOS:000657498300001	34093401	Green Published, gold			2022-02-07	
J	Fryc, AM; Raudales, AM; Nelson-Aguiar, RR; Risi, MM; Weiss, NH				Fryc, Aleksandra M.; Raudales, Alexa M.; Nelson-Aguiar, Rebecca R.; Risi, Megan M.; Weiss, Nicole H.			The Role of Presumed Head and Neck Injuries in Emotion Dysregulation Among Community Women With a History of Physical Intimate Partner Violence	VIOLENCE AGAINST WOMEN			English	Article						intimate partner violence; presumed head and neck injuries; emotion dysregulation	TRAUMATIC BRAIN-INJURY; HETEROSEXUAL PARTNERS; INITIAL VALIDATION; DOMESTIC VIOLENCE; MECHANICAL TURK; SEX-DIFFERENCES; SELF-HARM; DIFFICULTIES; BEHAVIOR; AMYGDALA	Intimate partner violence (IPV) is prevalent among women and associated with negative outcomes, including emotion dysregulation. Limited research has examined factors that contribute to emotion dysregulation in this population. This study explores the potential influence of presumed head and neck injuries from IPV on five dimensions of emotion dysregulation. Participants were 352 community women who responded to an online survey. Results of a path analysis indicated that presumed head and neck injuries from IPV were significantly associated with lack of emotional clarity and difficulties engaging in goal-directed behaviors when experiencing emotions. Findings suggest an association between presumed head and neck injuries from IPV and emotion dysregulation, underscoring the potential need for considering both neurological and psychological factors in the assessment and treatment of emotion dysregulation in this population.	[Fryc, Aleksandra M.] Albert Einstein Coll Med, Biomed Sci Grad Program, The Bronx, NY USA; [Raudales, Alexa M.] Univ Rhode Isl, Kingston, RI 02881 USA; [Risi, Megan M.] Univ Rhode Isl, Behav Sci Program, Kingston, RI 02881 USA; [Weiss, Nicole H.] Univ Rhode Isl, Clin Psychol, Kingston, RI 02881 USA; [Nelson-Aguiar, Rebecca R.] Augusta Univ, East Cent Reg Hosp, Augusta, GA USA		Fryc, AM (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, The Bronx, NY 10461 USA.	aleksandra.fryc@einsteinmed.org		Nelson, Rebecca/0000-0002-5837-7893	University of Rhode Island Undergraduate Research and Innovation Committee; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K23DA039327]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research described here was supported by a grant awarded to the first author from the University of Rhode Island Undergraduate Research and Innovation Committee. Work on this paper by the last author (NHW) was supported by National Institute on Drug Abuse Grant K23DA039327.	Alexander WH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21407-9; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Archer J, 2000, PSYCHOL BULL, V126, P651, DOI 10.1037//0033-2909.126.5.651; Archer J, 2002, AGGRESS VIOLENT BEH, V7, P313, DOI 10.1016/S1359-1789(01)00061-1; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Bjureberg J, 2016, J PSYCHOPATHOL BEHAV, V38, P284, DOI 10.1007/s10862-015-9514-x; Black M C., 2011, NATL INTIMATE PARTNE; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CDC, 2015, NAT INT PARTN SEX VI; Centers for Disease Control and Prevention (CDC, 2011, NAT INT PARTN SEX VI; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Cloitre M, 2005, BEHAV THER, V36, P119, DOI 10.1016/S0005-7894(05)80060-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Davis TS, 2014, J ABNORM PSYCHOL, V123, P499, DOI 10.1037/a0036962; Devries K, 2011, SOC SCI MED, V73, P79, DOI 10.1016/j.socscimed.2011.05.006; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Dolezal T., 2009, HIDDEN COSTS HLTH CA; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Folkman S., 1984, STRESS; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Gratz K. L., 2010, ASSESSING MINDFULNES, P107, DOI DOI 10.1037/A0022144; Gratz KL, 2006, J ABNORM PSYCHOL, V115, P850, DOI 10.1037/0021-843X.115.4.850; Gratz Kim L., 2008, Cognitive Behaviour Therapy, V37, P14, DOI 10.1080/16506070701819524; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gross JJ, 2015, PSYCHOL INQ, V26, P1, DOI 10.1080/1047840X.2014.940781; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ireland S., 1994, NIDA RES MONOGR, V141, P159; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kraut R, 2004, AM PSYCHOL, V59, P105, DOI 10.1037/0003-066X.59.2.105; Lagdon S, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.24794; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee Bruce, 2005, NeuroRx, V2, P372; Lilly MM, 2013, J CLIN PSYCHOL, V69, P737, DOI 10.1002/jclp.21934; Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085; Mennin DS, 2005, BEHAV RES THER, V43, P1281, DOI 10.1016/j.brat.2004.08.008; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mishra S, 2017, INT GAMBL STUD, V17, P125, DOI 10.1080/14459795.2017.1284250; Mohammadi A., 2018, INT J BODY MIND CULT, V5, P14; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Ownsworth T., 2014, SELF IDENTITY BRAIN; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Silva E, 2017, J APPL DEV PSYCHOL, V50, P36, DOI 10.1016/j.appdev.2017.04.001; Smith S. G., 2018, NATL INTIMATE PARTNE; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Thurman DJ., 1995, GUIDELINES SURVEILLA; Troy AS, 2018, EMOTION, V18, P58, DOI 10.1037/emo0000371; Tull MT, 2007, BEHAV THER, V38, P303, DOI 10.1016/j.beth.2006.10.001; Tull MT, 2015, CURR OPIN PSYCHOL, V3, pIV, DOI 10.1016/j.copsyc.2015.03.009; Vajda A, 2014, PROCD SOC BEHV, V131, P386, DOI 10.1016/j.sbspro.2014.04.135; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; Vasilev CA, 2009, J CHILD PSYCHOL PSYC, V50, P1357, DOI 10.1111/j.1469-7610.2009.02172.x; Wang YM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01921; Weiss NH, 2019, J CLIN PSYCHOL, V75, P1267, DOI 10.1002/jclp.22768; Weiss NH, 2018, J TRAUMA STRESS, V31, P775, DOI 10.1002/jts.22330; Weiss NH, 2015, CURR OPIN PSYCHOL, V3, P22, DOI 10.1016/j.copsyc.2015.01.013; Weiss NH, 2015, BEHAV MODIF, V39, P431, DOI 10.1177/0145445514566504; Weiss NH, 2012, J ANXIETY DISORD, V26, P453, DOI 10.1016/j.janxdis.2012.01.007; Welborn BL, 2009, SOC COGN AFFECT NEUR, V4, P328, DOI 10.1093/scan/nsp028; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503	84	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1077-8012	1552-8448		VIOLENCE AGAINST WOM	Violence Against Women	FEB	2022	28	2					417	442	10778012211005568	10.1177/10778012211005568		MAY 2021	26	Women's Studies	Social Science Citation Index (SSCI)	Women's Studies	XV5PI	WOS:000652867500001	34018422				2022-02-07	
J	Gabbatore, I; Longobardi, C; Bosco, FM				Gabbatore, Ilaria; Longobardi, Claudio; Bosco, Francesca M.			Improvement of Communicative-pragmatic Ability in Adolescents with Autism Spectrum Disorder: The Adapted Version of the Cognitive Pragmatic Treatment	LANGUAGE LEARNING AND DEVELOPMENT			English	Article; Early Access							HIGH-FUNCTIONING CHILDREN; TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; SOCIAL COMMUNICATION; SKILLS GROUP; MIND; LANGUAGE; INTERVENTION; SCHIZOPHRENIA; INDIVIDUALS	Autism spectrum disorder (ASD) is a complex pathology that includes impaired social interaction abilities. Insufficient attention has been paid to programs specifically devoted to improving communicative-pragmatic skills. Moreover, the majority of studies have focused on children, while programs specifically developed for the adolescents are lacking. The present study aims to test the feasibility and acceptability of the adapted version of the Cognitive Pragmatic Treatment for adolescents (A-CPT), a 15-session group training, as well as its ability to improve the communicative-pragmatic performance of adolescents with ASD. Twenty-one verbally fluent adolescents with ASD took part in the training; they were assessed in three phases, i.e., before, after and at three-month follow-up, using the equivalent forms of the Assessment Battery for Communication (ABaCo), a tool for testing a wide range of pragmatic phenomena, such as direct and indirect speech acts, irony, deceit and violation of Grice's maxims, expressed through linguistic, non-verbal, i.e., gestures, or paralinguistic expressive means. Furthermore, Theory of Mind (ToM) tasks and tests investigating the main cognitive domains, for example, Executive Functions (planning, shifting, working memory) and long-term memory, were administered. The results showed an improvement in participants' performance in all the four scales of the ABaCo, i.e., linguistic, extralinguistic, paralinguistic and context scale; this improvement was maintained at follow-up assessment three months after the end of the program. No improvement was observed in the cognitive and ToM domains investigated, with the only exception of expressive vocabulary task. Despite the lack of a control group, the high degree of feasibility of the CPT, highlight the importance of more work needed in this research line.	[Gabbatore, Ilaria; Longobardi, Claudio; Bosco, Francesca M.] Univ Turin, Dept Psychol, GIPSI Res Grp Inferential Proc Social Interact, Turin, Italy; [Gabbatore, Ilaria] Univ Oulu, Child Language Res Ctr, Oulu, Finland; [Bosco, Francesca M.] Inst Neurosci Turin, Turin, Italy		Bosco, FM (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	francesca.bosco@unito.it	BOSCO, Francesca Marina/B-6746-2013; Longobardi, claudio/E-8296-2013	BOSCO, Francesca Marina/0000-0001-6101-8587; Longobardi, claudio/0000-0002-8457-6554; GABBATORE, ILARIA/0000-0002-9724-8066			Adams C, 2002, J CHILD PSYCHOL PSYC, V43, P973, DOI 10.1111/1469-7610.00226; Adams C, 2012, INT J LANG COMM DIS, V47, P233, DOI 10.1111/j.1460-6984.2011.00146.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2016, MINERVA PSICH, V57, P93; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; Baixauli-Fortea I, 2019, APPL NEUROPSYCH-CHIL, V8, P101, DOI 10.1080/21622965.2017.1392861; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Bara Bruno, 2010, COGNITIVE PRAGMATICS; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2001, INT REV RES MENT RET, V23, P169; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barry TD, 2003, J AUTISM DEV DISORD, V33, P685, DOI 10.1023/B:JADD.0000006004.86556.e0; Bisiacchi P.S., 2005, BVN 5 11 BATTERIA VA; Bosco FM, 2018, J COMMUN DISORD, V75, P102, DOI 10.1016/j.jcomdis.2018.05.002; Bosco FM, 2018, ARCH CLIN NEUROPSYCH, V33, P875, DOI 10.1093/arclin/acy041; Bosco FM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00827; Bosco FM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01453; Bosco FM, 2017, CORTEX, V94, P73, DOI 10.1016/j.cortex.2017.06.010; Bosco FM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00021; Bosco FM, 2017, APPL PSYCHOLINGUIST, V38, P57, DOI 10.1017/S0142716416000047; Bosco FM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00166; Bosco FM, 2014, CONSCIOUS COGN, V24, P84, DOI 10.1016/j.concog.2014.01.003; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Bosco FM, 2009, CONSCIOUS COGN, V18, P306, DOI 10.1016/j.concog.2008.06.006; Brizio A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01011; Brizzolara D., 1993, APPRENDIMENTO PATOLO, P124; Chung YS, 2014, SCHIZOPHRENIA BULL, V40, P602, DOI 10.1093/schbul/sbt048; Colgan SE, 2006, CHILD NEUROPSYCHOL, V12, P307, DOI 10.1080/09297040600701360; Cotugno AJ, 2009, J AUTISM DEV DISORD, V39, P1268, DOI 10.1007/s10803-009-0741-4; Cummings L., 2014, CAMBRIDGE HDB COMMUN, P559; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Fletcher-Watson S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008785.pub2; Gabbatore I, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1612078; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Gugliotta M., 2009, BVN 12 18 BATTERIA V; Hampton LH, 2016, J INTELL DISABIL RES, V60, P444, DOI 10.1111/jir.12283; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Holland A., 1999, COMMUNICATION ACTIVI; Hyter YD, 2017, PERSP PRAGMAT PHILO, V11, P493, DOI 10.1007/978-3-319-47489-2_19; Jolliffe T, 2000, PSYCHOL MED, V30, P1169, DOI 10.1017/S003329179900241X; Kasari C, 2010, J AUTISM DEV DISORD, V40, P1045, DOI 10.1007/s10803-010-0955-5; Laghi F, 2014, BRIT J PSYCHOL, V105, P509, DOI 10.1111/bjop.12054; Laugeson EA, 2012, J AUTISM DEV DISORD, V42, P1025, DOI 10.1007/s10803-011-1339-1; Levinson SC, 1983, PRAGMATICS CAMBRIDGE; Lopata C, 2010, J AUTISM DEV DISORD, V40, P1297, DOI 10.1007/s10803-010-0989-8; Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446; Loukusa S, 2009, RES AUTISM SPECT DIS, V3, P890, DOI 10.1016/j.rasd.2009.05.002; Marini A, 2011, APHASIOLOGY, V25, P1372, DOI 10.1080/02687038.2011.584690; Marraffa C, 2016, J PAEDIATR CHILD H, V52, P461, DOI 10.1111/jpc.13178; Matthews D, 2018, LANG LEARN DEV, V14, P186, DOI 10.1080/15475441.2018.1455584; McConnell SR, 2002, J AUTISM DEV DISORD, V32, P351, DOI 10.1023/A:1020537805154; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morett LM, 2016, J AUTISM DEV DISORD, V46, P998, DOI 10.1007/s10803-015-2645-9; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; OZONOFF S, 1995, J AUTISM DEV DISORD, V25, P415, DOI 10.1007/BF02179376; Parola A, 2019, J NEUROLINGUIST, V51, P53, DOI 10.1016/j.jneuroling.2018.12.003; Parola A, 2018, PSYCHIAT RES, V260, P144, DOI 10.1016/j.psychres.2017.11.051; Parsons L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172242; Picone L, 2017, BPA APPL PSYCHOL B, V65, P70; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; RAPAPORT D, 1968, DIAGNOSTIC PSYCHOL T; Raven J. C., 1938, PROGR MATRICES; Saban-Bezalel R, 2017, J COGN PSYCHOL, V29, P809, DOI 10.1080/20445911.2017.1325893; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shukla-Mehta S, 2010, FOCUS AUTISM DEV DIS, V25, P23, DOI 10.1177/1088357609352901; Silverman LB, 2010, COGNITION, V115, P380, DOI 10.1016/j.cognition.2010.01.002; Solomon M, 2011, SCHIZOPHR RES, V131, P146, DOI 10.1016/j.schres.2011.03.005; Soorya LV, 2015, J AM ACAD CHILD PSY, V54, P208, DOI 10.1016/j.jaac.2014.12.005; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Spinnler H, 1987, STANDARDIZZAZIONE TA; Tager-Flusberg H., 2005, WHY LANGUAGE MATTERS, P298, DOI [10.1093/acprof:oso/9780195159912.003.0014, DOI 10.1093/ACPROF:OSO/9780195159912.003.0014, DOI 10.1093/ACPROF:0S0/9780195159912.003.0014]; Thomeer ML, 2015, J AUTISM DEV DISORD, V45, P2115, DOI 10.1007/s10803-015-2374-0; Tirassa M, 2006, COGN SYST RES, V7, P128, DOI 10.1016/j.cogsys.2006.01.002; Tirassa M, 2008, EMERG COMMUN-STUD NE, V10, P81; Volden J., 2002, J SPEECH LANGUAGE PA, V26, P138; Volden J, 2010, AM J SPEECH-LANG PAT, V19, P204, DOI 10.1044/1058-0360(2010/09-0011); Watkins L, 2017, INDIAN J PEDIATR, V84, P68, DOI 10.1007/s12098-015-1938-5; White SW, 2007, J AUTISM DEV DISORD, V37, P1858, DOI 10.1007/s10803-006-0320-x; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P511, DOI 10.1080/13682820802708098; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Winner M.G., 2009, PERSPECT LANG LEARN, V16, P62, DOI [DOI 10.1044/LLE16.2.62, 10.1044/lle16.2.62]	85	0	0	5	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1547-5441	1547-3341		LANG LEARN DEV	Lang. Learn. Dev.												10.1080/15475441.2021.1924177		MAY 2021	18	Psychology, Developmental; Linguistics; Language & Linguistics; Psychology, Experimental	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Psychology; Linguistics	SV2JR	WOS:000663651500001		Green Submitted			2022-02-07	
J	Guerrette, MC; McKerral, M				Guerrette, Marie-Claude; McKerral, Michelle			Validation of the Mayo-Portland Adaptability Inventory-4 (MPAI-4) and reference norms in a French-Canadian population with traumatic brain injury receiving rehabilitation	DISABILITY AND REHABILITATION			English	Article; Early Access						Traumatic brain injury; rehabilitation; outcome assessment; social participation; psychometrics; validation study	COMMUNITY-BASED REHABILITATION; CROSS-CULTURAL ADAPTATION; POST-ACUTE REHABILITATION; COMMON OUTCOME MEASURES; INTERNATIONAL CLASSIFICATION; CEREBROVASCULAR ACCIDENT; PARTICIPATION; RECOMMENDATIONS; INSTRUMENTS; DISABILITY	Purpose Validate the factor structure and establish internal consistency reliability of the French-Canadian version of the Mayo-Portland Adaptability Inventory (MPAI-4), using a Canadian sample of adults with traumatic brain injury (TBI) receiving post-acute rehabilitation services. Materials and methods Psychometric analysis of French-Canadian MPAI-4 data from TBI adults (N = 1012) who received rehabilitation interventions and for whom a first French-Canadian MPAI-4 measure was completed between 2016 and 2020. Results Exploratory factor analysis was used to evaluate the factor structure of the French-Canadian MPAI-4. The final and best solution revealed three factors, which accounted for 48.68% of the variance. Using Cronbach's alpha, all subscales showed good internal consistency (all 0.70 <= alpha <= 0.89). Reference norms for the TBI sample are provided, as well as descriptive raw data according to sex, age, TBI severity and rehabilitation setting. Conclusions The French-Canadian MPAI-4 factor structure is validated. The three factors extracted are similar to the three subscales of the original MPAI-4. The questionnaire shows good psychometric properties and represents a suitable tool for TBI adults receiving rehabilitation services in a French-Canadian context. The provided reference norms will also help guide the clinical use of the MPAI-4 in French-Canadian TBI populations.	[Guerrette, Marie-Claude; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Guerrette, Marie-Claude; McKerral, Michelle] Ctr Interdisciplinary Res Rehabil Greater Montrea, Lindsay Pavil,6363 Hudson Rd, Montreal, PQ H3S 1M9, Canada		McKerral, M (corresponding author), Ctr Interdisciplinary Res Rehabil Greater Montrea, Lindsay Pavil,6363 Hudson Rd, Montreal, PQ H3S 1M9, Canada.	michelle.mckerral@umontreal.ca			Fonds de recherche du Quebec - Sante (FRQS)Fonds de la Recherche en Sante du Quebec; (Fonds de recherche du Quebec - Sante FRQS) [254599]	This research was supported by a graduate scholarship from the Fonds de recherche du Quebec - Sante (FRQS) to Marie-Claude Guerrette and by a research grant from the Fonds de recherche du Quebec - Sante FRQS) to Michelle McKerral [grant number 254599].	Altman IM, 2013, ARCH PHYS MED REHAB, V94, P1837, DOI 10.1016/j.apmr.2013.02.014; Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; [Anonymous], 2015, REPORT C TRAUMATIC B; Ashley JG, 2018, BRAIN INJURY, V32, P600, DOI 10.1080/02699052.2018.1432896; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bennett S., 2000, AUST OCCUP THER J, V47, P171, DOI DOI 10.1046/J.1440-1630.2000.00237.X; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Cattelani R, 2009, EUR J PHYS REHAB MED, V45, P513; Chen PY, 2015, SLEEP MED, V16, P598, DOI 10.1016/j.sleep.2014.11.016; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Curran C, 2015, BRAIN INJURY, V29, P25, DOI 10.3109/02699052.2014.948067; Dharm-Datta Shreshth, 2015, J Trauma Acute Care Surg, V79, pS197, DOI 10.1097/TA.0000000000000721; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Ford CEL, 2016, NEUROREHABILITATION, V39, P65, DOI 10.3233/NRE-161339; Gaskin CJ, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0309-5; Gjersing L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-13; Granger C., 2008, RASCH MEAS T, V21, P1122; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hamed R, 2012, INT J REHABIL RES, V35, P243, DOI 10.1097/MRR.0b013e3283544c9f; Hux K, 2019, BRAIN INJURY, V33, P1332, DOI 10.1080/02699052.2019.1641745; Jackson D, 2017, BRAIN INJURY, V31, P1405, DOI 10.1080/02699052.2017.1350998; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Kline P, 2000, HDB PSYCHOL TESTING, V2nd; Kline R. B., 2016, PRINCIPLES PRACTICE, VFourth; Lamontagne ME., 2016, INESSS ONF CLIN PRAC; Lewis FD., 2017, INT J PHYS MED REHAB, V5, P1; Lexell J, 2012, J REHABIL MED, V44, P65, DOI 10.2340/16501977-0897; Lezak, 2008, MANUAL MAYO PORTLAND; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2016, J NEUROTRAUM, V33, P1371, DOI 10.1089/neu.2015.4080; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McKerral M., 2014, MANUEL MPAI 4 VERSIO; McKerral M., 2014, MPAI 4 VERSION CANAD; Pituch K., 2015, APPL MULTIVARIATE ST, V6th; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Wampold BE., 1999, RASCH MEAS T, V13, P695; Wang WL, 2006, WESTERN J NURS RES, V28, P310, DOI 10.1177/0193945905284712; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	52	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1924882		MAY 2021	7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	SF8JZ	WOS:000652996300001	34027749	Green Submitted			2022-02-07	
J	Inoue, K; Morimoto, H; Ohgidani, M; Ueki, T				Inoue, Koichi; Morimoto, Hiroyuki; Ohgidani, Masahiro; Ueki, Takatoshi			Modulation of inflammatory responses by fractalkine signaling in microglia	PLOS ONE			English	Article							NITRIC-OXIDE; MEDIATED PHOSPHORYLATION; TRAUMATIC BRAIN; SPINAL-CORD; ACTIVATION; CX3CR1; INJURY; NEUROTOXICITY; EXPRESSION; ALPHA	Reactive microglia are suggested to be involved in neurological disorders, and the mechanisms underlying microglial activity may provide insights into therapeutic strategies for neurological diseases. Microglia produce immunological responses to various stimuli, which include fractalkine (FKN or CX3CL1). CX3CR1, a FKN receptor, is present in microglial cells, and when FKN is applied before lipopolysaccharide (LPS) administration, LPS-induced inflammatory responses are inhibited, suggesting that the activation of the FKN signal is beneficial. Considering the practical administration for treatment, we investigated the influence of FKN on immunoreactive microglia using murine primary microglia and BV-2, a microglial cell line. The administration of LPS leads to nitric oxide (NO) production. NO was reduced when FKN was administered 4 h after LPS administration without a change in inducible nitric oxide synthase expression. In contrast, morphological changes, migratory activity, and proliferation were not altered by delayed FKN treatment. LPS decreases the CX3CR1 mRNA concentration, and the overexpression of CX3CR1 restores the FKN-mediated decrease in NO. CX3CR1 overexpression decreased the NO production that is mediated by LPS even without the application of FKN. ATP and ethanol also reduced CX3CR1 mRNA concentrations. In conclusion, the delayed FKN administration modified the LPS-induced microglial activation. The FKN signals were attenuated by a reduction in CX3CR1 by some inflammatory stimuli, and this modulated the inflammatory response of microglial cells, at least partially.	[Inoue, Koichi; Morimoto, Hiroyuki; Ohgidani, Masahiro; Ueki, Takatoshi] Nagoya City Univ, Grad Sch Med Sci, Dept Integrat Anat, Nagoya, Aichi, Japan		Inoue, K; Ueki, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Integrat Anat, Nagoya, Aichi, Japan.	ino-k@umin.ac.jp; ueki@med.nagoya-cu.ac.jp			Salt Science Research Foundation [1721]; Nagoya City University [2013004]; KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16H06404]	This work was supported by a Salt Science Research Foundation Grant 1721 (K.I.), Grant-in-Aid for Research in Nagoya City University Grant (2013004) (K.I.) and a KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas "Willdynamics" (16H06404) (K.I. and T.U.)."The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Hayato, 2018, Int J Physiol Pathophysiol Pharmacol, V10, P115; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cederblad L, 2016, BIOCHEM J, V473, P641, DOI 10.1042/BJ20150520; Chen X, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01882-6; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Dheen ST, 2005, GLIA, V50, P21, DOI 10.1002/glia.20153; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Fan Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00309; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Gresa-Arribas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045227; Gunner G, 2019, NAT NEUROSCI, V22, P1075, DOI 10.1038/s41593-019-0419-y; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hao F, 2013, NEUROCHEM RES, V38, P1002, DOI 10.1007/s11064-013-1010-7; Hausel P, 2006, ONCOGENE, V25, P198, DOI 10.1038/sj.onc.1209030; Hellwig S, 2016, BRAIN BEHAV IMMUN, V55, P126, DOI 10.1016/j.bbi.2015.11.008; Ho CY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01857-7; Inoue K, 2020, NEUROREPORT, V31, P571, DOI 10.1097/WNR.0000000000001449; Inoue K, 2012, J BIOL CHEM, V287, P20839, DOI 10.1074/jbc.M111.319418; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Lauro C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00414; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee M, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e5; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Liang Y, 2018, J CANCER, V9, P3603, DOI 10.7150/jca.26497; Liu WM, 2019, ONCOL REP, V41, P1911, DOI 10.3892/or.2019.6957; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Maciejewski-Lenoir D, 1999, J IMMUNOL, V163, P1628; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Pandur E, 2019, CELL MOL NEUROBIOL, V39, P985, DOI 10.1007/s10571-019-00694-4; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Sheridan GK, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130181; Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272; Tanaka A, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0223-y; TODA KI, 1990, CANCER RES, V50, P5526; Winkler Z, 2017, BEHAV BRAIN RES, V334, P119, DOI 10.1016/j.bbr.2017.07.023; Wynne AM, 2010, BRAIN BEHAV IMMUN, V24, P1190, DOI 10.1016/j.bbi.2010.05.011; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Zhang SZ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1439-x; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	46	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252118	10.1371/journal.pone.0252118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	WOS:000664632300054	34019594	gold, Green Published			2022-02-07	
J	Jitsu, M; Niwa, K; Suzuki, G; Obara, T; Iwama, Y; Hagisawa, K; Takahashi, Y; Matsushita, Y; Takeuchi, S; Nawashiro, H; Sato, S; Kawauchi, S				Jitsu, Motoyuki; Niwa, Katsuki; Suzuki, Go; Obara, Takeyuki; Iwama, Yukiko; Hagisawa, Kohsuke; Takahashi, Yukihiro; Matsushita, Yoshitaro; Takeuchi, Satoru; Nawashiro, Hiroshi; Sato, Shunichi; Kawauchi, Satoko			Behavioral and Histopathological Impairments Caused by Topical Exposure of the Rat Brain to Mild-Impulse Laser-Induced Shock Waves: Impulse Dependency	FRONTIERS IN NEUROLOGY			English	Article						diffuse axonal injury; elevated plus maze test; forced swimming test; spontaneous motor activity; blast-induced traumatic brain injury; laser-induced shock wave	ELEVATED PLUS-MAZE; BLAST EXPOSURE; INJURY; MODEL; DEPRESSION; ANXIETY; TBI	Although an enormous number of animal studies on blast-induced traumatic brain injury (bTBI) have been conducted, there still remain many uncertain issues in its neuropathology and mechanisms. This is partially due to the complex and hence difficult experimental environment settings, e.g., to minimize the effects of blast winds (tertiary mechanism) and to separate the effects of brain exposure and torso exposure. Since a laser-induced shock wave (LISW) is free from dynamic pressure and its energy is spatially well confined, the effects of pure shock wave exposure (primary mechanism) solely on the brain can be examined by using an LISW. In this study, we applied a set of four LISWs in the impulse range of 15-71 Pa.s to the rat brain through the intact scalp and skull; the interval between each exposure was similar to 5 s. For the rats, we conducted locomotor activity, elevated plus maze and forced swimming tests. Axonal injury in the brain was also examined by histological analysis using Bodian silver staining. Only the rats with exposure at higher impulses of 54 and 71 Pa.s showed significantly lower spontaneous movements at 1 and 2 days post-exposure by the locomotor activity test, but after 3 days post-exposure, they had recovered. At 7 days post-exposure, however, these rats (54 and 71 Pa.s) showed significantly higher levels of anxiety-related and depression-like behaviors by the elevated plus maze test and forced swimming test, respectively. To the best of the authors' knowledge, there have been few studies in which a rat model showed both anxiety-related and depression-like behaviors caused by blast or shock wave exposure. At that time point (7 days post-exposure), histological analysis showed significant decreases in axonal density in the cingulum bundle and corpus callosum in impulse-dependent manners; axons in the cingulum bundle were found to be more affected by a shock wave. Correlation analysis showed a statistically significant correlation between the depression like-behavior and axonal density reduction in the cingulum bundle. The results demonstrated the dependence of behavior deficits and axonal injury on the shock wave impulse loaded on the brain.	[Jitsu, Motoyuki; Niwa, Katsuki; Suzuki, Go; Obara, Takeyuki; Iwama, Yukiko; Hagisawa, Kohsuke; Takahashi, Yukihiro; Matsushita, Yoshitaro] Japan Ground Self Def Force, Mil Med Res Unit, Tokyo, Japan; [Takeuchi, Satoru; Nawashiro, Hiroshi] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama, Japan; [Sato, Shunichi; Kawauchi, Satoko] Natl Def Med Coll Res Inst, Div Bioinformat & Therapeut Syst, Tokorozawa, Saitama, Japan		Kawauchi, S (corresponding author), Natl Def Med Coll Res Inst, Div Bioinformat & Therapeut Syst, Tokorozawa, Saitama, Japan.	satok-bits@ndmc.ac.jp		Jitsu, Motoyuki/0000-0003-1605-9405	Research Promotion Program for Defense Medicine under the Ministry of Defense	This work was partially supported by the Research Promotion Program for Defense Medicine under the Ministry of Defense.	Aitman T, 2016, DIS MODEL MECH, V9, P1069, DOI 10.1242/dmm.027706; Alley M., 2009, THESIS PURDUE U W LA; Ando T, 2009, APPL SURF SCI, V255, P9898, DOI 10.1016/j.apsusc.2009.04.115; [Anonymous], 2020, UA ARMY ASIA PACIFIC; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Blaze J, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00160; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cernak Ibolja, 2017, Concussion, V2, pCNC42, DOI 10.2217/cnc-2017-0006; Cernak I, 2017, BRAIN INJURY, V31, P1168, DOI 10.1080/02699052.2016.1274779; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Good CH, 2020, NEUROPSYCHOPHARMACOL, V45, P176, DOI 10.1038/s41386-019-0431-7; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kawauchi S, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.3.035005; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maekawa T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230774; Magnus D, 2018, DEF TECHNOL, V14, P469, DOI 10.1016/j.dt.2018.07.014; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Masuo Y, 1997, BRAIN RES PROTOC, V1, P321, DOI 10.1016/S1385-299X(97)00005-6; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Miyata S, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00131; Nelson NW., 2015, BRAIN NEUROTRAUMA MO, P6; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Schmitt U, 1998, PHARMACOL BIOCHEM BE, V59, P807, DOI 10.1016/S0091-3057(97)00502-9; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Swiergiel AH, 2008, BEHAV BRAIN RES, V186, P32, DOI 10.1016/j.bbr.2007.07.018; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Yamada K, 2013, PHARMACOL BIOCHEM BE, V114, P23, DOI 10.1016/j.pbb.2013.10.022; Yamamoto S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020245	47	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 21	2021	12								621546	10.3389/fneur.2021.621546			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SM5LF	WOS:000657646100001	34093390	gold, Green Published			2022-02-07	
J	Chen, AM; Azar, SS; Harris, A; Brecha, NC; Muller, LPD				Chen, Ashley M.; Azar, Shaghauyegh S.; Harris, Alexander; Brecha, Nicholas C.; Perez de Sevilla Mueller, Luis			PTEN Expression Regulates Gap Junction Connectivity in the Retina	FRONTIERS IN NEUROANATOMY			English	Article						connexin (Cx36); PTEN (phosphatase and tensin homolog deleted on chromosome 10); retinal ganglion cells; degeneration; retina; gap junction (connexin)	ALPHA-GANGLION-CELLS; AII-AMACRINE CELLS; RD10 MOUSE MODEL; AXON REGENERATION; VISUAL SIGNALS; RABBIT RETINA; X-CELL; CONNEXIN36; MODULATION; PROTEIN	Manipulation of the phosphatase and tensin homolog (PTEN) pathway has been suggested as a therapeutic approach to treat or prevent vision loss due to retinal disease. In this study, we investigated the effects of deleting one copy of Pten in a well-characterized class of retinal ganglion cells called alpha-ganglion cells in the mouse retina. In Pten(+/-) retinas, alpha-ganglion cells did not exhibit major changes in their dendritic structure, although most cells developed a few, unusual loop-forming dendrites. By contrast, alpha-ganglion cells exhibited a significant decrease in heterologous and homologous gap junction mediated cell coupling with other retinal ganglion and amacrine cells. Additionally, the majority of OFF alpha-ganglion cells (12/18 cells) formed novel coupling to displaced amacrine cells. The number of connexin36 puncta, the predominant connexin that mediates gap junction communication at electrical synapses, was decreased by at least 50% on OFF alpha-ganglion cells. Reduced and incorrect gap junction connectivity of alpha-ganglion cells will affect their functional properties and alter visual image processing in the retina. The anomalous connectivity of retinal ganglion cells would potentially limit future therapeutic approaches involving manipulation of the Pten pathway for treating ganglion cell degeneration in diseases like glaucoma, traumatic brain injury, Parkinson's, and Alzheimer's diseases.	[Chen, Ashley M.; Azar, Shaghauyegh S.; Harris, Alexander; Brecha, Nicholas C.; Perez de Sevilla Mueller, Luis] Univ Calif Los Angeles, David Geffen Sch Med Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med Los Angeles, Stein Eye Inst, Los Angeles, CA USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med Los Angeles, CURE Digest Dis Res Ctr, Los Angeles, CA USA; [Brecha, Nicholas C.] Vet Adm Greater Angeles Hlth Syst, Los Angeles, CA USA		Muller, LPD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	luisperez@mednet.ucla.edu			VA Merit ReviewUS Department of Veterans Affairs [5I01BX000764]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EY04067]; NIDDDK [P30 DK41301]; Career Scientist Award from the United States Department of Veterans AffairsUS Department of Veterans Affairs [14F-RCS-004]	Support for these studies is from VA Merit Review (5I01BX000764; NB), NIH R01 EY04067 (NB), and NIDDDK P30 DK41301 (UCLA Cure Center Core). This work was supported in part by Career Scientist Award (14F-RCS-004) from the United States Department of Veterans Affairs. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. NB is a VA Senior Career Research Scientist.	Abbasian Mohammad, 2012, Iranian Biomedical Journal, V16, P127, DOI 10.6091/ibj.1099.2012; Akopian A, 2019, J COMP NEUROL, V527, P159, DOI 10.1002/cne.24074; Akopian A, 2014, J NEUROSCI, V34, P10582, DOI 10.1523/JNEUROSCI.1912-14.2014; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ARNETT D, 1981, J PHYSIOL-LONDON, V317, P29, DOI 10.1113/jphysiol.1981.sp013812; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Baohan A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12829; Bleckert A, 2014, CURR BIOL, V24, P310, DOI 10.1016/j.cub.2013.12.020; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Cantrup R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032795; CASINI G, 1995, J COMP NEUROL, V356, P132, DOI 10.1002/cne.903560109; Chen YS, 2015, EUR J PHARM BIOPHARM, V95, P182, DOI 10.1016/j.ejpb.2015.01.031; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; Cuenca N, 2014, PROG RETIN EYE RES, V43, P17, DOI 10.1016/j.preteyeres.2014.07.001; Danesh-Meyer HV, 2012, BRAIN, V135, P506, DOI 10.1093/brain/awr338; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Garcia-Junco-Clemente P, 2013, P NATL ACAD SCI USA, V110, P18297, DOI 10.1073/pnas.1309207110; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gonzalez-Sanchez A, 2016, ONCOTARGET, V7, P49819, DOI 10.18632/oncotarget.10454; Grimes WN, 2009, NAT NEUROSCI, V12, P585, DOI 10.1038/nn.2302; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Guldenagel M, 2000, J COMP NEUROL, V425, P193; Guzman-Aranguez A, 2013, BRIT J PHARMACOL, V170, P730, DOI 10.1111/bph.12330; Hartveit E, 2012, BRAIN RES, V1487, P160, DOI 10.1016/j.brainres.2012.05.060; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2009, NEUROSCIENCE, V160, P126, DOI 10.1016/j.neuroscience.2009.01.081; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu EH, 2003, J NEUROSCI, V23, P6768; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jo HS, 2012, EMBO J, V31, P817, DOI 10.1038/emboj.2011.443; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Kang TH, 2004, CELL TISSUE RES, V317, P109, DOI 10.1007/s00441-004-0907-5; Keeley PW, 2018, VISUAL NEUROSCI, V35, DOI 10.1017/S0952523817000347; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kim TJ, 2006, INVEST OPHTH VIS SCI, V47, P2757, DOI 10.1167/iovs.05-1442; Krieger B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180091; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Leibinger M, 2012, NEUROBIOL DIS, V46, P314, DOI 10.1016/j.nbd.2012.01.004; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li Y, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00633; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Massey SC, 1999, J COMP NEUROL, V411, P3; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Mills SL, 2001, J COMP NEUROL, V436, P336; Muller LPD, 2007, J COMP NEUROL, V505, P177, DOI 10.1002/cne.21487; Muller LPD, 2019, J COMP NEUROL, V527, P133, DOI 10.1002/cne.24234; Muller LPD, 2013, J COMP NEUROL, V521, P2486, DOI 10.1002/cne.23294; Muller LPD, 2010, VISUAL NEUROSCI, V27, P91, DOI 10.1017/S0952523810000131; Muller LPD, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00039; Muller LPD, 2010, J COMP NEUROL, V518, P4813, DOI 10.1002/cne.22490; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Norsworthy MW, 2017, NEURON, V94, P1112, DOI 10.1016/j.neuron.2017.05.035; O'Brien J, 2014, CURR OPIN NEUROBIOL, V29, P64, DOI 10.1016/j.conb.2014.05.011; Ogino M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060954; Pan F, 2010, J COMP NEUROL, V518, P911, DOI 10.1002/cne.22254; Pang JJ, 2012, J PHYSIOL-LONDON, V590, P223, DOI 10.1113/jphysiol.2011.222141; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; POURCHO RG, 1985, BRAIN RES, V348, P339, DOI 10.1016/0006-8993(85)90453-6; Preiss S, 2007, CARDIOVASC RES, V73, P833, DOI 10.1016/j.cardiores.2006.12.019; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Sakagami K, 2012, MOL CELL NEUROSCI, V49, P171, DOI 10.1016/j.mcn.2011.11.007; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Sawant A, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108858; SCHNITZER J, 1984, J NEUROSCI, V4, P2948; Schubert T, 2005, J COMP NEUROL, V485, P191, DOI 10.1002/cne.20510; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tachibana N, 2016, J NEUROSCI, V36, P9454, DOI 10.1523/JNEUROSCI.0936-16.2016; Tanimoto N, 2012, J NEUROSCI, V32, P4861, DOI 10.1523/JNEUROSCI.4654-11.2012; Tran NM, 2019, NEURON, V104, P1039, DOI 10.1016/j.neuron.2019.11.006; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Van Hook MJ, 2019, PROG RETIN EYE RES, V72, DOI 10.1016/j.preteyeres.2019.05.001; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Vaney DI, 1998, J NEUROSCI, V18, P10594; Varadarajan SG, 2018, CURR OPIN NEUROBIOL, V53, P198, DOI 10.1016/j.conb.2018.10.001; Volgyi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069426; Volgyi B, 2013, PROG RETIN EYE RES, V34, P1, DOI 10.1016/j.preteyeres.2012.12.002; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Vuong HE, 2015, NEUROSCIENCE, V307, P319, DOI 10.1016/j.neuroscience.2015.08.060; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Wang GY, 1998, J NEUROPHYSIOL, V79, P151, DOI 10.1152/jn.1998.79.1.151; Wang XW, 2018, CELL REP, V24, P2540, DOI 10.1016/j.celrep.2018.07.105; WASSLE H, 1995, J COMP NEUROL, V361, P537, DOI 10.1002/cne.903610315; Xia XB, 2004, VISUAL NEUROSCI, V21, P791, DOI 10.1017/S0952523804215127; Xiong QJ, 2012, J NEUROSCI, V32, P1643, DOI 10.1523/JNEUROSCI.4480-11.2012; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	111	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5129			FRONT NEUROANAT	Front. Neuroanat.	MAY 20	2021	15								629244	10.3389/fnana.2021.629244			15	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	SL7WX	WOS:000657126500001	34093139	Green Published, gold			2022-02-07	
J	Littlejohn, EL; DeSana, AJ; Williams, HC; Chapman, RT; Joseph, B; Juras, JA; Saatman, KE				Littlejohn, Erica L.; DeSana, Anthony J.; Williams, Hannah C.; Chapman, Rudy T.; Joseph, Binoy; Juras, Jelena A.; Saatman, Kathryn E.			IGF1-Stimulated Posttraumatic Hippocampal Remodeling Is Not Dependent on mTOR	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						traumatic brain injury; insulin-like growth factor-1; mTOR; neurogenesis; rapamycin; neuronal differentiation; pS6; dendritic outgrowth	TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR-I; NEURAL STEM-CELL; MAMMALIAN TARGET; IGF-I; DENTATE GYRUS; NEURONAL DIFFERENTIATION; RAPAMYCIN PROTECTS; PROGENITOR CELLS; SEIZURE ACTIVITY	Adult hippocampal neurogenesis is stimulated acutely following traumatic brain injury (TBI). However, many hippocampal neurons born after injury develop abnormally and the number that survive long-term is debated. In experimental TBI, insulin-like growth factor-1 (IGF1) promotes hippocampal neuronal differentiation, improves immature neuron dendritic arbor morphology, increases long-term survival of neurons born after TBI, and improves cognitive function. One potential downstream mediator of the neurogenic effects of IGF1 is mammalian target of rapamycin (mTOR), which regulates proliferation as well as axonal and dendritic growth in the CNS. Excessive mTOR activation is posited to contribute to aberrant plasticity related to posttraumatic epilepsy, spurring preclinical studies of mTOR inhibitors as therapeutics for TBI. The degree to which pro-neurogenic effects of IGF1 depend upon upregulation of mTOR activity is currently unknown. Using immunostaining for phosphorylated ribosomal protein S6, a commonly used surrogate for mTOR activation, we show that controlled cortical impact TBI triggers mTOR activation in the dentate gyrus in a time-, region-, and injury severity-dependent manner. Posttraumatic mTOR activation in the granule cell layer (GCL) and dentate hilus was amplified in mice with conditional overexpression of IGF1. In contrast, delayed astrocytic activation of mTOR signaling within the dentate gyrus molecular layer, closely associated with proliferation, was not affected by IGF1 overexpression. To determine whether mTOR activation is necessary for IGF1-mediated stimulation of posttraumatic hippocampal neurogenesis, wildtype and IGF1 transgenic mice received the mTOR inhibitor rapamycin daily beginning at 3 days after TBI, following pulse labeling with bromodeoxyuridine. Compared to wildtype mice, IGF1 overexpressing mice exhibited increased posttraumatic neurogenesis, with a higher density of posttrauma-born GCL neurons at 10 days after injury. Inhibition of mTOR did not abrogate IGF1-stimulated enhancement of posttraumatic neurogenesis. Rather, rapamycin treatment in IGF1 transgenic mice, but not in WT mice, increased numbers of cells labeled with BrdU at 3 days after injury that survived to 10 days, and enhanced the proportion of posttrauma-born cells that differentiated into neurons. Because beneficial effects of IGF1 on hippocampal neurogenesis were maintained or even enhanced with delayed inhibition of mTOR, combination therapy approaches may hold promise for TBI.	[Littlejohn, Erica L.; DeSana, Anthony J.; Williams, Hannah C.; Chapman, Rudy T.; Joseph, Binoy; Juras, Jelena A.; Saatman, Kathryn E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Dept Physiol, Lexington, KY 40506 USA		Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Dept Physiol, Lexington, KY 40506 USA.	k.saatman@uky.edu		LITTLEJOHN, ERICA/0000-0003-3255-8546	National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS072302, NS092552, NS077889]; Kentucky Spinal Cord and Head Injury Research Trust [KSCHIRT 14-12A, 19-5A]	This work was supported by the grants from the National Institutes of Health National Institute of Neurological Disorders and Stroke (NS072302, NS092552 and NS077889) and the Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT 14-12A and 19-5A).	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Arsenijevic Y, 1998, J NEUROSCI, V18, P2118; Bekinschtein P, 2014, HIPPOCAMPUS, V24, P905, DOI 10.1002/hipo.22304; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/JCI34739, 10.1172/jCI34739]; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Chen ST, 2020, NEURAL REGEN RES, V15, P2335, DOI 10.4103/1673-5374.285002; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; de Souza JS, 2017, HUM MOL GENET, V26, P270, DOI 10.1093/hmg/ddw384; Dempsey RJ, 2003, J NEUROCHEM, V87, P586, DOI 10.1046/j.1471-4159.2003.02022.x; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Getz SA, 2016, NEUROBIOL DIS, V93, P12, DOI 10.1016/j.nbd.2016.03.010; Gibb SL, 2015, STEM CELLS, V33, P3530, DOI 10.1002/stem.2189; Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hartman NW, 2013, CELL REP, V5, P433, DOI 10.1016/j.celrep.2013.09.017; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; He ML, 2019, EXP NEUROL, V311, P15, DOI 10.1016/j.expneurol.2018.09.006; Hester MS, 2016, EXP NEUROL, V280, P1, DOI 10.1016/j.expneurol.2016.03.015; Hurtado-Chong A, 2009, EUR J NEUROSCI, V30, P742, DOI 10.1111/j.1460-9568.2009.06870.x; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Jiang GH, 2015, CLIN SCI, V129, P1047, DOI 10.1042/CS20150312; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018812; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Littlejohn EL, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00925-6; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; McCurdy RD, 2005, EUR J NEUROSCI, V22, P1581, DOI 10.1111/j.1460-9568.2005.04355.x; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Millan O, 2019, THER DRUG MONIT, V41, P160, DOI 10.1097/FTD.0000000000000616; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Nieto-Estevez V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00052; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Orhan N, 2016, BRAIN RES, V1631, P113, DOI 10.1016/j.brainres.2015.11.038; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Paliouras GN, 2012, J NEUROSCI, V32, P15012, DOI 10.1523/JNEUROSCI.2248-12.2012; Parent JM, 1997, J NEUROSCI, V17, P3727; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Peters AJ, 2018, ANESTHESIOLOGY, V129, P278, DOI 10.1097/ALN.0000000000002197; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rozas NS, 2015, J NEUROTRAUM, V32, P149, DOI 10.1089/neu.2014.3469; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schultheiss C, 2013, HIPPOCAMPUS, V23, P1345, DOI 10.1002/hipo.22180; Shahror RA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6422; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Shi J, 2007, EUR J NEUROSCI, V25, P3499, DOI 10.1111/j.1460-9568.2007.05624.x; Skalecka A, 2016, DEV NEUROBIOL, V76, P1308, DOI 10.1002/dneu.22392; Song Q, 2015, MOL MED REP, V12, P7203, DOI 10.3892/mmr.2015.4407; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tensaouti Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229240; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718; Wang XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0162-16.2016; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Yu MM, 2019, MAGN RESON IMAGING, V62, P1, DOI 10.1016/j.mri.2019.01.017; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113801; Zhou MO, 2013, NEURON, V77, P647, DOI 10.1016/j.neuron.2012.12.033; Zhu G, 2012, DEVELOPMENT, V139, P3422, DOI 10.1242/dev.083154; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	101	0	0	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	MAY 20	2021	9								663456	10.3389/fcell.2021.663456			18	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	SM1VQ	WOS:000657399800001	34095131	gold, Green Published			2022-02-07	
J	Tillmann, BW; Nathens, AB; Scales, DC; Haas, B				Tillmann, Bourke W.; Nathens, Avery B.; Scales, Damon C.; Haas, Barbara			Association Between Intoxication and Urgent Neurosurgical Procedures in Severe Traumatic Brain Injury: Results From the American College of Surgeons Trauma Quality Improvement Program	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						craniocerebral trauma; neurosurgical procedures; quality improvement; healthcare disparities; registries	HOMELESS ADULTS; RISK-FACTORS; HEAD-INJURY; MANAGEMENT; OUTCOMES; MORTALITY; ALCOHOL; CARE; DISPARITIES; GUIDELINES	Background: The probability of undergoing surgery after severe traumatic brain injury (TBI) varies significantly across studies and centers. However, causes of this variability are poorly understood. We hypothesized that intoxication may impact the probability of receiving an urgent neurosurgical procedure among patients with severe TBI. Methods: We performed a retrospective cohort study of adult patients admitted to a Level I or II trauma center in the United States or Canada with an isolated severe TBI (2012-2016). Data were derived from the Trauma Quality Improvement Program dataset. An urgent neurosurgical procedure was defined as a procedure that occurred within 24 hours of admission. Multivariable logistic regression was utilized to examine the independent effect of intoxication on a patient's likelihood of undergoing an urgent procedure, as well as the timing of the procedure. Results: Of the 33,646 patients with an isolated severe TBI, 11,313 (33.6%) were intoxicated. An urgent neurosurgical procedure was performed in 8,255 (24.5%) cases. Overall, there was no difference in the probability of undergoing an urgent procedure between patients who were and were not intoxicated (OR 0.99; 95% CI 0.94-1.06). While intoxication status had no impact on the probability of surgery among patients with the most severe TBI (head AIS 5: OR 1.06 [95% CI 0.98-1.15]), intoxicated patients on the lower spectrum of injury had lower odds of undergoing an urgent procedure (AIS 3: OR 0.80 [95% CI 0.66-0.97]). Among patients who underwent an urgent procedure, intoxication had no impact on timing. Conclusion: Intoxication status was not associated with differences in the probability of undergoing an urgent neurosurgical procedure among all patients with a severe TBI. However, in patients with less severe TBI, intoxication status was associated with decreased likelihood of receiving an urgent intervention. This finding underscores the challenge in the management of intoxicated patients with TBI.	[Tillmann, Bourke W.; Scales, Damon C.; Haas, Barbara] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Tillmann, Bourke W.; Scales, Damon C.; Haas, Barbara] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,Room D108, Toronto, ON M4N, Canada; [Tillmann, Bourke W.; Nathens, Avery B.; Scales, Damon C.; Haas, Barbara] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Nathens, Avery B.; Haas, Barbara] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Nathens, Avery B.; Scales, Damon C.; Haas, Barbara] Sunnybrook Res Inst, Toronto, ON, Canada; [Scales, Damon C.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Scales, Damon C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada		Tillmann, BW (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,Room D108, Toronto, ON M4N, Canada.	Bourke.tillmann@sunnybrook.ca	Tillmann, Bourke/ABC-6001-2021	Tillmann, Bourke/0000-0002-7815-5972	research ethics board of the Sunnybrook Research Institute [252-2017]	The data supporting the findings of this study are held by the American College of Surgeons Trauma Quality Improvement Program. Restrictions apply to the availability of the data such that the authors are not able to make the data publicly available. Access to the data may be requested at https://www.facs.org/quality-programs/trauma/tqp/center-programs/tqip/collaboratives.This study was approved by the research ethics board of the Sunnybrook Research Institute, project number 252-2017. All data were obtained from a pre-existing trauma registry and additional consent to participate was not required. This paper was accepted for oral presentation at the Trauma Association of Canada Annual Meeting and Conference, March 26-27, 2020, in Halifax, Nova Scotia, Canada. Due to the Covid-19 pandemic the meeting was canceled, and the presentation was delayed to virtual pre-conference in November 2020.	Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; American College of Surgeons, 2017, NAT TRAUM DAT STAND; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Canadian Institute for Health Information, 2010, CIHI DAT QUAL STUD 2; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Dasenbrock HH, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0864-8; Dickman SL, 2016, HEALTH AFFAIR, V35, P1189, DOI 10.1377/hlthaff.2015.1024; Dimick JB, 2004, HLTH AFF MILLWOOD S; Dimick J, 2013, HEALTH AFFAIR, V32, P1046, DOI 10.1377/hlthaff.2011.1365; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Government of Canada, 2019, CAN HLTH CAR SYST; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; HAFNEREATON C, 1993, JAMA-J AM MED ASSOC, V269, P787, DOI 10.1001/jama.269.6.787; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hernan MA, 2009, AM J EPIDEMIOL, V170, P959, DOI 10.1093/aje/kwp293; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; Hornor MA, 2018, CURR TRAUMA REP, V4, P160, DOI 10.1007/s40719-018-0127-1; Hwang SW, 1998, ARCH INTERN MED, V158, P1454, DOI 10.1001/archinte.158.13.1454; Juurlink D, 2006, CANADIAN I HLTH INFO; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Khormi YH, 2018, J NEUROTRAUM, V35, P1407, DOI 10.1089/neu.2017.5345; Lane PL, 2000, CAN J SURG, V43, P442; LOWENFELS AB, 1984, ANN EMERG MED, V13, P1056, DOI 10.1016/S0196-0644(84)80070-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marion DW, 2006, NEUROSURGERY, V58, P655; McCredie VA, 2018, CRIT CARE MED, V46, P1139, DOI 10.1097/CCM.0000000000003149; Mohan D, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5416; Mohan D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-103; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; O'Connell JJ, 2005, J PUBLIC HEALTH MAN, V11, P311; Osborne NH, 2009, J VASC SURG, V50, P709, DOI 10.1016/j.jvs.2009.05.020; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; RUTHERFORD WH, 1977, LANCET, V1, P1021; Schoenfeld AJ, 2019, ANN SURG, V269, P459, DOI 10.1097/SLA.0000000000002695; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; van den Berk-Clark C, 2014, J HEALTH CARE POOR U, V25, P1278, DOI 10.1353/hpu.2014.0115; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z	52	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	MAR	2022	37	3					373	384	08850666211017497	10.1177/08850666211017497		MAY 2021	12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ5EZ	WOS:000652872300001	34013826	hybrid, Green Accepted			2022-02-07	
J	You, CY; Lu, SW; Fu, YQ; Xu, F				You, Cheng-Yan; Lu, Si-Wei; Fu, Yue-Qiang; Xu, Feng			Relationship between admission coagulopathy and prognosis in children with traumatic brain injury: a retrospective study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Children; Activated partial thromboplastin time; Fibrinogen; Prognosis; Traumatic brain injury	HEMORRHAGIC PROGRESSION; COAGULATION; MORTALITY; PREDICTOR	Background Coagulopathy in adult patients with traumatic brain injury (TBI) is strongly associated with unfavorable outcomes. However, few reports focus on pediatric TBI-associated coagulopathy. Methods We retrospectively identified children with Glasgow Coma Scale <= 13 in a tertiary pediatric hospital from April 2012 to December 2019 to evaluate the impact of admission coagulopathy on their prognosis. A classification and regression tree (CART) analysis using coagulation parameters was performed to stratify the death risk among patients. The importance of these parameters was examined by multivariate logistic regression analysis. Results A total of 281 children with moderate to severe TBI were enrolled. A receiver operating characteristic curve showed that activated partial thromboplastin time (APTT) and fibrinogen were effective predictors of in-hospital mortality. According to the CART analysis, APTT of 39.2 s was identified as the best discriminator, while 120 mg/dL fibrinogen was the second split in the subgroup of APTT <= 39.2 s. Patients were stratified into three groups, in which mortality was as follows: 4.5 % (APTT <= 39.2 s, fibrinogen > 120 mg/dL), 20.5 % (APTT <= 39.2 s and fibrinogen <= 120 mg/dL) and 60.8 % (APTT > 39.2 s). Furthermore, length-of-stay in the ICU and duration of mechanical ventilation were significantly prolonged in patients with deteriorated APTT or fibrinogen values. Multiple logistic regression analysis showed that APTT > 39.2 s and fibrinogen <= 120 mg/dL was independently associated with mortality in children with moderate to severe TBI. Conclusions We concluded that admission APTT > 39.2 s and fibrinogen <= 120 mg/dL were independently associated with mortality in children with moderate to severe TBI. Early identification and intervention of abnormal APTT and fibrinogen in pediatric TBI patients may be beneficial to their prognosis.	[You, Cheng-Yan; Lu, Si-Wei; Fu, Yue-Qiang; Xu, Feng] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, 136 Zhongshan Er Rd, Chongqing 400014, Peoples R China; [You, Cheng-Yan; Lu, Si-Wei; Fu, Yue-Qiang; Xu, Feng] Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China; [You, Cheng-Yan; Lu, Si-Wei; Fu, Yue-Qiang; Xu, Feng] Natl Clin Res Ctr Child Hlth & Disorders, Chongqing 400014, Peoples R China; [You, Cheng-Yan; Lu, Si-Wei; Fu, Yue-Qiang; Xu, Feng] China Int Sci & Technol Cooperat Base Child Dev &, Chongqing 400014, Peoples R China; [You, Cheng-Yan; Lu, Si-Wei; Fu, Yue-Qiang; Xu, Feng] Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China		Fu, YQ (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, 136 Zhongshan Er Rd, Chongqing 400014, Peoples R China.; Fu, YQ (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China.; Fu, YQ (corresponding author), Natl Clin Res Ctr Child Hlth & Disorders, Chongqing 400014, Peoples R China.; Fu, YQ (corresponding author), China Int Sci & Technol Cooperat Base Child Dev &, Chongqing 400014, Peoples R China.; Fu, YQ (corresponding author), Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China.	480887@hospital.cqmu.edu.cn			Natural Science Foundation Project of Chongqing of China [cstc2020jcyj-msxmX1087]	This study was supported by Natural Science Foundation Project of Chongqing of China (No. cstc2020jcyj-msxmX1087).	Abdelmalik PA., 2015, NEUROCRIT CARE, V24, P1; Albert Venencia, 2019, Hematol Oncol Stem Cell Ther, V12, P32, DOI 10.1016/j.hemonc.2018.09.005; [Anonymous], 2012, HLTH INT J PUBLIC HL, V1, P14; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Dekker SE, 2016, J SURG RES, V205, P147, DOI 10.1016/j.jss.2016.06.023; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dwivedi Ashish Kumar, 2018, Asian J Neurosurg, V13, P1123, DOI 10.4103/ajns.AJNS_16_17; Fair KA, 2021, J NEUROTRAUM, V38, P960, DOI 10.1089/neu.2018.6234; Fu YQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222591; Hayakawa M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1811-1; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Shrestha Ajit, 2017, Asian J Neurosurg, V12, P648, DOI 10.4103/ajns.AJNS_192_14; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	27	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAY 20	2021	29	1							67	10.1186/s13049-021-00884-4			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SF2PX	WOS:000652604400001	34016132	Green Published, gold			2022-02-07	
J	Beidler, E; Schmitt, AJ; Matta, M; Griger, C				Beidler, Erica; Schmitt, Ara J.; Matta, Michael; Griger, Cassondra			Diagnosed and Nondisclosed Sport-Related Concussion: An Exploratory Comparison Study by ADHD Status in Collegiate Athletes	JOURNAL OF ATTENTION DISORDERS			English	Article						sport-related concussion; ADHD; collegiate athletes	SELF-REPORTED CONCUSSIONS; MULTIPLE IMPUTATION; CHAINED EQUATIONS; KNOWLEDGE; SYMPTOMS; CHILDREN	Objective: To determine if ADHD status in collegiate athletes was associated with differences in the number of diagnosed and nondisclosed sport-related concussions, and reasons why suspected concussive injuries were not reported. Method: A cross-sectional survey was completed by 858 collegiate athletes (65 with ADHD; 793 without ADHD). The survey included self-report items regarding ADHD status and histories of diagnosed and nondisclosed sport-related concussions. Groups were matched for gender, age, and sport with a ratio of one participant with ADHD to four without ADHD. Results: Collegiate athletes with ADHD reported significantly more diagnosed sport-related concussions and were more likely to have a history of diagnosis compared to those without ADHD. There were no significant differences between groups regarding sport-related concussion nondisclosure history. Conclusion: Collegiate athletes with ADHD have an increased prevalence rate of diagnosed sport-related concussions compared to those without ADHD; however, this developmental disorder may not influence injury nondisclosure decisions.	[Beidler, Erica] Duquesne Univ, Athlet Training, Pittsburgh, PA 15219 USA; [Schmitt, Ara J.] Duquesne Univ, Sch Psychol, Pittsburgh, PA 15219 USA; [Griger, Cassondra] Duquesne Univ, Sch Psychol Program, Pittsburgh, PA 15219 USA; [Matta, Michael] Univ Houston, Sch Psychol, Houston, TX USA		Beidler, E (corresponding author), Duquesne Univ, Dept Athlet Training, 600 Forbes Ave, Pittsburgh, PA 15282 USA.	johnsone1@duq.edu	Matta, Michael/AAK-8442-2021	Matta, Michael/0000-0003-4266-0130; Beidler, Erica/0000-0002-0179-5074			Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barkley RA, 2015, ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS AND CHILDREN, P53; BERGANDI TA, 1988, INT J SPORT PSYCHOL, V19, P226; Clendenin Aaron A, 2005, J Atten Disord, V8, P79, DOI 10.1177/1087054705277166; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Enders C. K., 2010, APPL MISSING DATA AN; FARMER JE, 1995, HEALTH PSYCHOL, V14, P325, DOI 10.1037/0278-6133.14.4.325; Gormley MJ, 2019, J ATTEN DISORD, V23, P1766, DOI 10.1177/1087054715623046; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Ho DE, 2011, J STAT SOFTW, V42, p[8, 1], DOI DOI 10.18637/JSS.V042.I08; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Kuhn AW, 2017, NEUROSURGERY, V64, P211, DOI 10.1093/neuros/nyx294; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; McAllister-Deitrick J, 2022, CLIN J SPORT MED, V32, P56, DOI 10.1097/JSM.0000000000000833; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; RStudio Team, 2015, RSTUDIO INT DEV R; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; van Buuren S, 2011, J STAT SOFTW, V45, P1; Venables W.N., 2002, MODERN APPL STAT S, V4th edn; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Weyandt L.L., 2013, COLL STUDENTS ADHD C; White R., 2013, SPORTS HEALTH, V6, P149; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	34	0	0	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.	FEB	2022	26	4					606	615	10870547211015432	10.1177/10870547211015432		MAY 2021	10	Psychology, Developmental; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	YK8YK	WOS:000652854500001	34009041				2022-02-07	
J	Emery, CA; Eliason, P; Warriyar, V; Palacios-Derflingher, L; Black, AM; Krolikowski, M; Spencer, N; Sick, S; Kozak, S; Schneider, KJ; Babul, S; Mrazik, M; Lebrun, C; Goulet, C; Macpherson, A; Hagel, BE				Emery, Carolyn A.; Eliason, Paul; Warriyar, Vineetha; Palacios-Derflingher, Luz; Black, Amanda Marie; Krolikowski, Maciek; Spencer, Nicole; Sick, Stacy; Kozak, Stacy; Schneider, Kathryn J.; Babul, Shelina; Mrazik, Martin; Lebrun, Constance; Goulet, Claude; Macpherson, Alison; Hagel, Brent E.			Body checking in non-elite adolescent ice hockey leagues: it is never too late for policy change aiming to protect the health of adolescents	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						injury prevention; concussion; adolescent; ice hockey; sporting injuries	CONSENSUS STATEMENT; PHYSICAL-ACTIVITY; RISK-FACTORS; YOUTH; CONCUSSION; INJURY; SCHOOL; PARTICIPATION; RECOVERY; SPORTS	Objectives The objective of this study is to evaluate the effect of policy change disallowing body checking in adolescent ice hockey leagues (ages 15-17) on reducing rates of injury and concussion. Methods This is a prospective cohort study. Players 15-17 years-old were recruited from teams in non-elite divisions of play (lower 40%-70% by division of play depending on year and city of play in leagues where policy permits or prohibit body checking in Alberta and British Columbia, Canada (2015-18). A validated injury surveillance methodology supported baseline, exposure-hours and injury data collection. Any player with a suspected concussion was referred to a study physician. Primary outcomes include game-related injuries, game-related injuries (>7 days time loss), game-related concussions and game-related concussions (>10 days time loss). Results 44 teams (453 player-seasons) from non-body checking and 52 teams (674 player-seasons) from body checking leagues participated. In body checking leagues there were 213 injuries (69 concussions) and in non-body checking leagues 40 injuries (18 concussions) during games. Based on multiple multilevel mixed-effects Poisson regression analyses, policy prohibiting body checking was associated with a lower rate of injury (incidence rate ratio (IRR): 0.38 (95% CI 0.24 to 0.6)) and concussion (IRR: 0.49; 95% CI 0.26 to 0.89). This translates to an absolute rate reduction of 7.82 injuries/1000 game-hours (95% CI 2.74 to 12.9) and the prevention of 7326 injuries (95% CI 2570 to 12083) in Canada annually. Conclusions The rate of injury was 62% lower (concussion 51% lower) in leagues not permitting body checking in non-elite 15-17 years old leagues highlighting the potential public health impact of policy prohibiting body checking in older adolescent ice hockey players.	[Emery, Carolyn A.; Eliason, Paul; Warriyar, Vineetha; Palacios-Derflingher, Luz; Black, Amanda Marie; Krolikowski, Maciek; Spencer, Nicole; Sick, Stacy; Kozak, Stacy; Schneider, Kathryn J.; Hagel, Brent E.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.; Hagel, Brent E.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Babul, Shelina] Univ British Columbia, Fac Med, Dept Pediat, Vancouver, BC, Canada; [Babul, Shelina] British Columbia Childrens Hosp, British Columbia Injury Res & Prevent Unit, Vancouver, BC, Canada; [Mrazik, Martin] Univ Alberta, Dept Educ Psychol, Edmonton, AB, Canada; [Lebrun, Constance] Univ Alberta, Fac Med & Dent, Glen Sather Sports Med Clin, Edmonton, AB, Canada; [Lebrun, Constance] Univ Alberta, Fac Med & Dent, Dept Family Med, Edmonton, AB, Canada; [Goulet, Claude] Laval Univ, Dept Phys Educ, Quebec City, PQ, Canada; [Macpherson, Alison] York Univ, Fac Hlth, Sch Kinesiol & Hlth SCi, Toronto, ON, Canada		Emery, CA (corresponding author), Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada.	caemery@ucalgary.ca	Eliason, Paul/ABC-7702-2021	Emery, Carolyn Ann/0000-0002-9499-6691	Alberta Innovates Health Solutions (Collaborative Research and Innovation Opportunities Program) [3685]; Canadian Institutes of Health Research (Institute of Neuroscience, Mental Health and Addictions)Canadian Institutes of Health Research (CIHR) [293332]; Hotchkiss Brain Institute (University of Calgary)	This study was funded by Alberta Innovates Health Solutions (Collaborative Research and Innovation Opportunities Program Grant #3685), Canadian Institutes of Health Research (Institute of Neuroscience, Mental Health and Addictions Grant #293332), and the Hotchkiss Brain Institute (University of Calgary).	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Fox CK, 2010, J SCHOOL HEALTH, V80, P31, DOI 10.1111/j.1746-1561.2009.00454.x; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Hockey Canada, TEACH CHECK BOD CHEC; Hockey Canada, 2019, ANN REP 2018 2019; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Kang J, 2014, INJURY PREV, V20, P177, DOI 10.1136/injuryprev-2012-040537; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Lacny S, 2014, BRIT J SPORT MED, V48, P1299, DOI 10.1136/bjsports-2014-093493; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; R Core Team, 2021, R LANG ENV STAT COMP; Schneider KJ, 2021, CLIN J SPORT MED, V31, P70, DOI 10.1097/JSM.0000000000000673; Slutzky CB, 2009, PSYCHOL SPORT EXERC, V10, P381, DOI 10.1016/j.psychsport.2008.09.006; StataCorp, 2017, STATA STAT SOFTWARE; Taliaferro LA, 2008, J SCHOOL HEALTH, V78, P545, DOI 10.1111/j.1746-1561.2008.00342.x; Turcotte K., 2013, CONCUSSION CHILDREN; van Buuren S, 2011, J STAT SOFTW, V45, P1; Warriyar, 2019, CLIN J SPORT MED, V29, pe49	31	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2022	56	1					12	+		10.1136/bjsports-2020-103757		MAY 2021	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	XU7GG	WOS:000726919000001	34016603				2022-02-07	
J	Greenberg, JK; Otun, A; Nasraddin, A; Brownson, RC; Kuppermann, N; Limbrick, DD; Yen, PY; Foraker, RE				Greenberg, Jacob K.; Otun, Ayodamola; Nasraddin, Azzah; Brownson, Ross C.; Kuppermann, Nathan; Limbrick, David D.; Yen, Po-Yin; Foraker, Randi E.			Electronic clinical decision support for children with minor head trauma and intracranial injuries: a sociotechnical analysis	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article						Sociotechnical analysis; Traumatic brain injury; Head trauma; Electronic clinical decision support; Implementation science; Health information technology	PRACTITIONER PERFORMANCE; PATIENT OUTCOMES; PEDIATRIC TRAUMA; TRANSFERS; IMPROVE; RULES; CARE; EXPERIENCE; ADMISSION; SYSTEMS	Background Current management of children with minor head trauma (MHT) and intracranial injuries is not evidence-based and may place some children at risk of harm. Evidence-based electronic clinical decision support (CDS) for management of these children may improve patient safety and decrease resource use. To guide these efforts, we evaluated the sociotechnical environment impacting the implementation of electronic CDS, including workflow and communication, institutional culture, and hardware and software infrastructure, among other factors. Methods Between March and May, 2020 semi-structured qualitative focus group interviews were conducted to identify sociotechnical influences on CDS implementation. Physicians from neurosurgery, emergency medicine, critical care, and pediatric general surgery were included, along with information technology specialists. Participants were recruited from nine health centers in the United States. Focus group transcripts were coded and analyzed using thematic analysis. The final themes were then cross-referenced with previously defined sociotechnical dimensions. Results We included 28 physicians and four information technology specialists in seven focus groups (median five participants per group). Five physicians were trainees and 10 had administrative leadership positions. Through inductive thematic analysis, we identified five primary themes: (1) clinical impact; (2) stakeholders and users; (3) tool content; (4) clinical practice integration; and (5) post-implementation evaluation measures. Participants generally supported using CDS to determine an appropriate level-of-care for these children. However, some had mixed feelings regarding how the tool could best be used by different specialties (e.g. use by neurosurgeons versus non-neurosurgeons). Feedback from the interviews helped refine the tool content and also highlighted potential technical and workflow barriers to address prior to implementation. Conclusions We identified key factors impacting the implementation of electronic CDS for children with MHT and intracranial injuries. These results have informed our implementation strategy and may also serve as a template for future efforts to implement health information technology in a multidisciplinary, emergency setting.	[Greenberg, Jacob K.; Otun, Ayodamola; Limbrick, David D.] Washington Univ, Sch Med, Dept Neurol Surg, 660 S Euclid Ave,Box 8057, St Louis, MO 63110 USA; [Nasraddin, Azzah; Brownson, Ross C.] Washington Univ, Sch Med, Brown Sch Social Work, St Louis, MO USA; [Yen, Po-Yin; Foraker, Randi E.] Washington Univ, Sch Med, Inst Informat, St Louis, MO USA; [Kuppermann, Nathan] Univ Calif Davis, Dept Emergency Med, Davis, CA 95616 USA		Greenberg, JK (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, 660 S Euclid Ave,Box 8057, St Louis, MO 63110 USA.	jacobgreenberg@wustl.edu		Greenberg, Jacob/0000-0003-2675-5658	Thrasher Research Fund; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality	This study was supported by the Thrasher Research Fund and by the Agency for Healthcare Research and Quality. While feedback from these funding bodies influenced the early study design, the funders had no role in the data collection, analysis, or interpretation of the data, or in the decision to submit the manuscript for publication.	Acosta CD, 2010, ACAD EMERG MED, V17, P1364, DOI 10.1111/j.1553-2712.2010.00926.x; Ahmed AK, 2018, J NEUROSURG-PEDIATR, V21, P434, DOI 10.3171/2017.9.PEDS17436; Ash JS, 2007, J AM MED INFORM ASSN, V14, P415, DOI 10.1197/jamia.M2373; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Ballard DW, 2016, APPL CLIN INFORM, V7, P883, DOI 10.4338/ACI-2016-05-RA-0073; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Beerlage-de Jong N, 2017, AM J INFECT CONTROL, V45, P365, DOI 10.1016/j.ajic.2016.12.001; Coleman JJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-111; Colville Gillian, 2009, Intensive Crit Care Nurs, V25, P72, DOI 10.1016/j.iccn.2008.10.002; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Dayan PS, 2017, PEDIATRICS, V139; Ekstrom Heidi L, 2019, EGEMS (Wash DC), V7, P15, DOI 10.5334/egems.282; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Green SM, 2013, ANN EMERG MED, V62, P132, DOI 10.1016/j.annemergmed.2013.02.006; Greenberg JK, 2019, J NEUROSURG-PEDIATR, V23, P227, DOI 10.3171/2018.7.PEDS18263; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Hartman M, 2008, PEDIATRICS, V122, pE172, DOI 10.1542/peds.2007-3399; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; Holmgren AJ, 2021, JAMA INTERN MED, V181, P251, DOI 10.1001/jamainternmed.2020.7071; Horng S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174708; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; Kirkovits T, 2016, JMIR CANCER, V2, P2, DOI 10.2196/cancer.5132; Kuo WC, 2019, P NATL ACAD SCI USA, V116, P22737, DOI 10.1073/pnas.1908021116; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee H, 2019, NAT BIOMED ENG, V3, P173, DOI 10.1038/s41551-018-0324-9; Li J, 2012, PEDIATRICS, V130, P83, DOI 10.1542/peds.2011-1819; Liberati EG, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0644-2; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McKinstry CJ, 2018, J HLTH CARE FINANCE; Melnick Edward R, 2015, EGEMS (Wash DC), V3, P1136, DOI 10.13063/2327-9214.1136; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Olakotan OO, 2020, J BIOMED INFORM, V106, DOI 10.1016/j.jbi.2020.103453; Patterson BW, 2019, ANN EMERG MED, V74, P285, DOI 10.1016/j.annemergmed.2018.10.034; Press Anne, 2016, Evid Based Med, V21, P203, DOI 10.1136/ebmed-2016-110440; Schnipper JL, 2008, J AM MED INFORM ASSN, V15, P513, DOI 10.1197/jamia.M2501; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Sittig DF, 2010, QUAL SAF HEALTH CARE, V19, pI68, DOI 10.1136/qshc.2010.042085; Sorin V, 2020, J AM COLL RADIOL; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Tallapragada K, 2018, ANZ J SURG, V88, P202, DOI 10.1111/ans.14175; Van de Velde S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0772-3; Varghese P, 2016, HEALTH INFORM SER, P227, DOI 10.1007/978-3-319-31913-1_13; Wang HE, 2012, ANN EMERG MED, V60, P632, DOI 10.1016/j.annemergmed.2012.02.020; Wright A, 2008, J BIOMED INFORM, V41, P982, DOI 10.1016/j.jbi.2008.03.009; Yen Po-Yin, 2017, JMIR Med Inform, V5, pe28, DOI 10.2196/medinform.7476	49	0	1	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	MAY 19	2021	21	1							161	10.1186/s12911-021-01522-w			11	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Medical Informatics	SE6SK	WOS:000652201500001	34011315	Green Published, Green Submitted, gold			2022-02-07	
J	Huang, XF; Lu, YL; Li, L; Sun, TJ; Jiang, XH; Li, M; Zhang, TX; Yu, AY				Huang, Xiaofei; Lu, Yuanlan; Li, Lie; Sun, Tianjing; Jiang, Xuheng; Li, Mo; Zhang, Tianxi; Yu, Anyong			Protective effect of acute splenic irradiation in rats with traumatic brain injury	NEUROREPORT			English	Article						microglia; traumatic brain injury; Tuftsin; X-rays		Objective To explore the protective effect of acute splenic irradiation against traumatic brain injury (TBI) in rats. Methods A rat model of TBI was established according to Feeney's method. Splenic irradiation was performed by the reverse intensity-modulated radiation therapy (IMRT) source-axis distance (SAD) irradiation technique. Rat brain tissue samples were collected, the water content of the rat brain tissue was determined and the abundance of microglia was detected by immunofluorescence. Spleens were collected to measure the spleen index. Lung, liver, small intestine and kidney tissues were taken for hematoxylin and eosin staining to observe whether there was radiation-induced pathological damage. Peripheral blood was collected to detect tuftsin and the inflammatory factors IL-6 and IL-10. Results Compared with the nonirradiated TBI rat group, the 4-h spleen irradiation TBI rat group showed (1) increased behavioral scores at 3 days after TBI (P < 0.05), (2) reduced water content of the ipsilateral hemisphere at 3 days after TBI, (3) reduced spleen index at 3 and 7 days after TBI, (4) reduced number of microglia cells infiltrating around the lesion at 7 days after TBI, (5) reduced IL-6 levels at 3 days after TBI, (6) increased IL-10 levels at 3 and 5days after TBI and (7) Compared with the nonirradiated TBI rat group, the 8-h spleen irradiation TBI rat group showed reduced tuftsin levels at 3 and 7days after TBI. Conclusions Acute splenic irradiation had a protective effect in rats with TBI.	[Huang, Xiaofei; Lu, Yuanlan; Sun, Tianjing; Jiang, Xuheng; Li, Mo; Zhang, Tianxi; Yu, Anyong] Zunyi Med Univ, Affiliated Hosp, Dept Emergency, Zunyi, Guizhou, Peoples R China; [Li, Lie] Zunyi Med Univ, Affiliated Hosp, Canc Hosp, Zunyi, Guizhou, Peoples R China		Zhang, TX; Yu, AY (corresponding author), Dept Emergency, 149 Dalian Rd, Zunyi, Guizhou, Peoples R China.	92150@sina.com; anyongyu@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81760233]; Technology Project of Guizhou Province [(2020)]4Y149020, (2019)5661]	This work was supported by grants from the National Natural Science Foundation of China (81760233) and the Technology Project of Guizhou Province [(2020)]4Y149020 and (2019)5661] to Anyong Yu.	Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Chen HY, 2019, BIOCHEM BIOPH RES CO, V510, P156, DOI 10.1016/j.bbrc.2019.01.071; Chin AL, 2018, ADV RADIAT ONCOL, V3, P297, DOI 10.1016/j.adro.2018.02.005; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16725; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Helbig G, 2019, MED ONCOL, V36, DOI 10.1007/s12032-019-1245-5; Hughes RT, 2019, J RADIOSURGERY SBRT, V6, P161; Kim E, 2014, J CEREBR BLOOD F MET, V34, P1411, DOI 10.1038/jcbfm.2014.101; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madry C, 2015, J BIOL CHEM, V290, P12443, DOI 10.1074/jbc.R115.637157; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; NAJJAR VA, 1970, NATURE, V228, P672, DOI 10.1038/228672a0; Oliveira LC, 2018, ECANCERMEDICALSCIENC, V12, DOI 10.3332/ecancer.2018.887; Orandi BJ, 2016, AM J TRANSPLANT, V16, P3041, DOI 10.1111/ajt.13882; Ostrowski RP, 2012, TRANSL STROKE RES, V3, P473, DOI 10.1007/s12975-012-0206-5; Puukila S, 2019, INT J RADIAT BIOL, V95, P1072, DOI 10.1080/09553002.2019.1625459; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Song KH, 2017, TOXICOL APPL PHARM, V333, P17, DOI 10.1016/j.taap.2017.08.008; Weinmann M, 2001, STRAHLENTHER ONKOL, V177, P105, DOI 10.1007/PL00002384; Xiao X, 2016, Metabolomics (Los Angel), V6, P1; Yang L, 2017, METAB BRAIN DIS, V32, P1395, DOI 10.1007/s11011-017-9991-6; Zaorsky NG, 2017, CANCER TREAT REV, V53, P47, DOI 10.1016/j.ctrv.2016.11.016; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354	28	0	0	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAY 19	2021	32	8					711	720		10.1097/WNR.0000000000001650			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RW2KL	WOS:000646354200009	33876783	hybrid			2022-02-07	
J	Ramanathan, P; Liu, R; Chen, MH; Kennedy, MRT				Ramanathan, Pradeep; Liu, Ran; Chen, Ming-Hui; Kennedy, Mary R. T.			Memory and Executive Functions Subserving Judgments of Learning: Cognitive Reorganization After Traumatic Brain Injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Memory; executive functions; metamemory; judgments of learning; traumatic brain injury	STANDARD ERRORS; METAMEMORY; ACCURACY; RECALL; PREDICTIONS; CUE; JOL; REGRESSION; RETURN	We investigated relationships between psychometric measures of memory, executive functions (EFs), and task-based measures of Judgments of Learning (JOLs) in individuals with and without Traumatic Brain Injury (TBI), to study functional reorganization after TBI. We hypothesized that, in controls, accuracy of immediate JOLs would be associated with short-term memory and EFs (but not long-term memory, LTM), while accuracy of delayed JOLs would be associated primarily with LTM. We hypothesized that those with good recovery from TBI would demonstrate functional reorganization of the relationships between memory, EFs, and JOLs. Eighteen individuals with TBI and 18 matched controls completed eight neuropsychological tests of memory and EFs. They studied word-pairs, made immediate and delayed JOLs, and took a cued-recall test for the studied word-pairs. Stepwise regression and Lasso analyses generated a predictive model of JOL accuracy for each group. Accuracy of immediate JOLs in controls was predicted by short-term memory, inhibition, switching, and cognitive fluency, while accuracy of delayed JOLs was predicted by verbal recall. In individuals with TBI, inhibition predicted immediate JOL accuracy and switching predicted delayed JOL accuracy. Cognitive reorganization in those with good long-term recovery from TBI may account for the ability to make JOLs with accuracy similar to controls.	[Ramanathan, Pradeep] Calif State Univ Hayward, Dept Speech Language & Hearing Sci, 25800 Carlos Bee Blvd, Hayward, CA 94542 USA; [Liu, Ran] Takeda Pharmaceut Co Ltd, Stat, Cambridge, MA USA; [Chen, Ming-Hui] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Kennedy, Mary R. T.] Chapman Univ, Dept Commun Sci & Disorders, Irvine, CA USA		Ramanathan, P (corresponding author), Calif State Univ Hayward, Dept Speech Language & Hearing Sci, 25800 Carlos Bee Blvd, Hayward, CA 94542 USA.	pradeep.ramanathan@csueastbay.edu		Ramanathan, Pradeep/0000-0003-1950-0171	University of MinnesotaUniversity of Minnesota System; Minnesota Speech-Language-Hearing Association; University of Connecticut; California State University, East Bay	This research was supported in part by grants from the University of Minnesota, the Minnesota Speech-Language-Hearing Association, the University of Connecticut, and California State University, East Bay.	Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Cohen J., 1983, APPL MULTIPLE REGRES; Crawford JR, 2008, J INT NEUROPSYCH SOC, V14, P1069, DOI 10.1017/S1355617708081228; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DUNLOSKY J, 1992, MEM COGNITION, V20, P374, DOI 10.3758/BF03210921; Dunlosky J, 1997, J MEM LANG, V36, P34, DOI 10.1006/jmla.1996.2476; Dunlosky J., 2008, METACOGNITION; Dunlosky J., 2014, REMEMBERING, P70, DOI [10.4324/9781315752808-12, DOI 10.4324/9781315752808-12]; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Haugrud N, 2010, AGING NEUROPSYCHOL C, V17, P220, DOI 10.1080/13825580903042700; HOLM S, 1979, SCAND J STAT, V6, P65; Kennedy MRT, 2004, NEUROPSYCHOL REHABIL, V14, P449, DOI 10.1080/09602010443000038; Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kertesz A., 2007, WAB R W APHASIA BATT; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Kuera H., 1967, COMPUTATIONAL ANAL P; Kyung M, 2010, BAYESIAN ANAL, V5, P369, DOI 10.1214/10-BA607; Laham D., 1998, LATENT SEMANTIC ANAL; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Metcalfe J, 2008, PSYCHON B REV, V15, P174, DOI 10.3758/PBR.15.1.174; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Nelson TO, 2004, PSYCHOL METHODS, V9, P53, DOI 10.1037/1082-989X.9.1.53; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Osborne J.W., 2004, PRACT ASSESSMENT RES, V9, P8, DOI DOI 10.7275/KTZQ-JQ66; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ramanathan P, 2014, J SPEECH LANG HEAR R, V57, P1817, DOI 10.1044/2014_JSLHR-L-13-0204; Rhodes MG, 2011, PSYCHOL BULL, V137, P131, DOI 10.1037/a0021705; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; SAS Institute Inc, 2016, SAS 94 SQL PROC US G, V4th; Schneider W., 2002, E PRIME REFERENCE GU; Shaked D, 2014, NEUROPSYCHOLOGY, V28, P695, DOI 10.1037/neu0000078; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Son LK, 2005, MEM COGNITION, V33, P1116, DOI 10.3758/BF03193217; Souchay C, 2004, EXP AGING RES, V30, P47, DOI 10.1080/03610730490251478; SPELLMAN BA, 1992, PSYCHOL SCI, V3, P315, DOI 10.1111/j.1467-9280.1992.tb00680.x; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tabachnick B.G., 2001, USING MULTIVARIATE S; Thorndike E. L., 1944, TEACHERS WORD BOOK 3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Wechsler D, 1987, MEMORY SCALE REVISED; Zhou LQ, 2017, J ADULT DEV, V24, P48, DOI 10.1007/s10804-016-9246-5	51	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1929345		MAY 2021	24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SE6CG	WOS:000652157700001	34006181				2022-02-07	
J	Zimering, MB; Delic, V; Citron, BA				Zimering, Mark B.; Delic, Vedad; Citron, Bruce A.			Gene Expression Changes in a Model Neuron Cell Line Exposed to Autoantibodies from Patients with Traumatic Brain Injury and/or Type 2 Diabetes	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Neurodegeneration; Autoantibodies; Neurites; Cell death; RNAseq; Gene expression	SEROTONIN 5-HT2A RECEPTOR; DYSFUNCTION	Traumatic brain injury and adult type 2 diabetes mellitus are each associated with the late occurrence of accelerated cognitive decline and Parkinson's disease through unknown mechanisms. Previously, we reported increased circulating agonist autoantibodies targeting the 5-hydroxytryptamine 2A receptor in plasma from subsets of Parkinson's disease, dementia, and diabetic patients suffering with microvascular complications. Here, we use a model neuron, mouse neuroblastoma (N2A) cell line, to test messenger RNA expression changes following brief exposure to traumatic brain injury and/or type 2 diabetes mellitus plasma harboring agonist 5-hydroxytryptamine 2A receptor autoantibodies. We now report involvement of the mitochondrial dysfunction pathway and Parkinson's disease pathways in autoantibody-induced gene expression changes occurring in neuroblastoma cells. Functional gene categories upregulated significantly included cell death, cytoskeleton-microtubule function, actin polymerization or depolymerization, regulation of cell oxidative stress, mitochondrial function, immune function, protein metabolism, and vesicle function. Gene categories significantly downregulated included microtubule function, cell adhesion, neurotransmitter release, dopamine metabolism synaptic plasticity, maintenance of neuronal differentiation, mitochondrial function, and cell signaling. Taken together, these results suggest that agonist 5-hydroxytryptamine receptor autoantibodies (which increase in Parkinson's disease and other forms of neurodegeneration) mediate a coordinating program of gene expression changes in a model neuron which predispose to neuro-apoptosis and are linked to human neurodegenerative diseases pathways.	[Zimering, Mark B.] VA New Jersey Healthcare Syst, Endocrine & Diabet Sect, Med Serv, 385 Tremt Ave, E Orange, NJ 07018 USA; [Zimering, Mark B.] Univ Med & Dent New Jersey, New Brunswick, NJ 08903 USA; [Delic, Vedad; Citron, Bruce A.] VA New Jersey Hlth Care Syst Res & Dev, Lab Mol Biol, Mailstop 15,385 Tremt Ave, E Orange, NJ 07018 USA; [Citron, Bruce A.] Rutgers State Univ, New Jersey Med Sch, Pharmacol Physiol & Neurosci, Newark, NJ USA		Zimering, MB (corresponding author), VA New Jersey Healthcare Syst, Endocrine & Diabet Sect, Med Serv, 385 Tremt Ave, E Orange, NJ 07018 USA.; Zimering, MB (corresponding author), Univ Med & Dent New Jersey, New Brunswick, NJ 08903 USA.	mark.zimering@va.gov			Biomedical Laboratory Research and Development/Technology Transfer Program; New Jersey Commission on Brain Injury Research [CBIRPIL007, TTP-001-20S]; Congressionally Directed Gulf War Illness Research Program [W81XWH-16-1-0626]; Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation/Biomedical Laboratory Research and Development)US Department of Veterans Affairs [RX001520, RX003253, BX005015]; Veterans Bio-Medical Research Institute	This study was supported by the Biomedical Laboratory Research and Development/Technology Transfer Program and the New Jersey Commission on Brain Injury Research (CBIRPIL007) to MBZ (TTP-001-20S), Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program (W81XWH-16-1-0626), the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation/Biomedical Laboratory Research and Development (RX001520, RX003253, BX005015), and the Veterans Bio-Medical Research Institute.	Aikiyo S, 2021, DIGESTION, V102, P516, DOI 10.1159/000509209; Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Chen YZ, 2012, J CELL MOL MED, V16, P2583, DOI 10.1111/j.1582-4934.2012.01604.x; COOK EH, 1994, J NEUROCHEM, V63, P465; Delic V, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00924-7; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dintica CS, 2019, NEUROLOGY, V92, pe700, DOI 10.1212/WNL.0000000000006919; DiProspero NA, 2004, J NEUROCYTOL, V33, P517, DOI 10.1007/s11068-004-0514-8; Friel DD, 2000, CELL CALCIUM, V28, P307, DOI 10.1054/ceca.2000.0172; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Lopez-Gimenez JF, 2018, CURR TOP BEHAV NEURO, V36, P45, DOI 10.1007/7854_2017_478; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Nayak SV, 2000, NEUROPHARMACOLOGY, V39, P2681, DOI 10.1016/S0028-3908(00)00109-X; PARRUTI G, 1993, BIOCHEM BIOPH RES CO, V190, P475, DOI 10.1006/bbrc.1993.1072; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Repici M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091377; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Williams David R, 2013, Continuum (Minneap Minn), V19, P1189, DOI 10.1212/01.CON.0000436152.24038.e0; Xu TJ, 2000, BRAIN RES BULL, V51, P499, DOI 10.1016/S0361-9230(99)00278-6; Zimering, 2019, ENDOCRINOL DIABETES, V3, P118; Zimering Mark B, 2020, J Endocrinol Diabetes, V7, P1; Zimering Mark B, 1800, J Endocrinol Diabetes, V6, DOI 10.15226/2374-6890/6/3/001137; Zimering Mark B, 1800, J Endocrinol Diabetes, V5, DOI 10.15226/2374-6890/5/2/01102; Zimering Mark B, 1800, J Endocrinol Diabetes, V4, DOI 10.15226/2374-6890/4/4/00184; Zimering MB, 2009, J CLIN ENDOCR METAB, V94, P2171, DOI 10.1210/jc.2008-2354	33	0	0	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-021-02428-4		MAY 2021	11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SE6FK	WOS:000652165900001	34013450	hybrid, Green Published			2022-02-07	
J	Bland, ML; Rowson, S				Bland, Megan L.; Rowson, Steven			A price-performance analysis of the protective capabilities of wholesale bicycle helmets	TRAFFIC INJURY PREVENTION			English	Article						Cycling; impact; biomechanics; injury risk; concussion; head acceleration	REAL-WORLD	Objective Although bicycle helmets are an effective countermeasure against head injury, many cyclists do not wear one. One avenue for facilitating widespread helmet use is through community-driven helmet safety initiatives, which often give away or subsidize wholesale helmet models that are manufactured at a low price point. However, the impact performance of such helmets during real-world accident conditions has yet to be explored. The present study seeks to investigate trends between wholesale bicycle helmet price and protective capabilities. Methods Nine common wholesale helmet models (price range $3.65-$12.95) were evaluated according to the bicycle Summation of Tests for the Analysis of Risk (STAR) methodology, which analyzes helmet performance in 24 oblique impact tests reflecting common cyclist head impact conditions. Resulting head peak linear acceleration (PLA) and peak rotational velocity (PRV) were collected and used to predict risk of concussion. Concussion risks were then combined using the STAR algorithm in order to summarize each model's risks into a single, weighted metric. Results Large ranges in kinematic results led to large variations in concussion risks between helmets, and in turn, large variations in STAR values (13.5-26.2). Wholesale helmet price was not significantly associated with STAR, although incorporating 30 previous bicycle helmet STAR results produced a weak negative correlation between price and STAR overall. Nonetheless, the best-performing wholesale helmet produced one of the lowest overall STAR values for a price of $6.45. Helmet style was instead a superior predictor of STAR, with multi-sport style helmets producing significantly higher linear accelerations and resulting STAR values than bike style helmets. Conclusions These results show that the impact performance of wholesale helmets ranges considerably despite their low price-points. Results can also guide helmet safety promotion organizers toward distributing wholesale bicycle helmet models associated with lower overall concussion risks.	[Bland, Megan L.; Rowson, Steven] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA		Bland, ML (corresponding author), 120 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	mbland27@vt.edu			Insurance Institute for Highway Safety; Virginia Tech Institute for Critical Technology and Applied Science	The authors would like to thank the Insurance Institute for Highway Safety and the Virginia Tech Institute for Critical Technology and Applied Science for their funding and support.	Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; Cobb BR, 2018, P I MECH ENG P-J SPO, V232, P176, DOI 10.1177/1754337117708092; [CPSC] United States Consumer Product Safety Commission, 1998, SAF STAND BIC HELM F, P11711; [ECE] United Nations Economic Commission for Europe, 1999, R2205 UN EC COMM EUR; Gaither TW, 2018, INJURY PREV, V24, P135, DOI 10.1136/injuryprev-2016-042281; Haileyesus T, 2007, INJURY PREV, V13, P202, DOI 10.1136/ip.2006.014019; [IIHS] Insurance Institute for Highway Safety, 2019, PED BIC BIC HELM; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Nelson TS, 2010, TRAFFIC INJ PREV, V11, P309, DOI 10.1080/15389581003614870; Olivier J, 2017, TRAFFIC INJ PREV, V18, P755, DOI 10.1080/15389588.2017.1298748; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sanford T, 2015, JAMA-J AM MED ASSOC, V314, P947, DOI 10.1001/jama.2015.8295; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Thibault L., 1971, P 15 STAPP CAR CRASH; Verschueren, 2009, THESIS KATHOLIEKE U; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5	19	0	0	2	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	AUG 18	2021	22	6					478	482		10.1080/15389588.2021.1929943		MAY 2021	5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	TM0FO	WOS:000662856900001	34138652				2022-02-07	
J	Corallo, F; Tarda, D; Coppola, V; Bonanno, L; Lo Buono, V; Palmeri, R; De Cola, MC; Di Cara, M; Romeo, L; Raciti, L; Todaro, A; Logiudice, AL; Bramanti, P; Marino, S; Formica, C				Corallo, Francesco; Tarda, Dominique; Coppola, Valentina; Bonanno, Lilla; Lo Buono, Viviana; Palmeri, Rosanna; De Cola, Maria Cristina; Di Cara, Marcella; Romeo, Laura; Raciti, Loredana; Todaro, Antonino; Logiudice, Anna Lisa; Bramanti, Placido; Marino, Silvia; Formica, Caterina			The relationship between body image and emotional and cognitive impairment after brain damage: A preliminary study	BRAIN AND BEHAVIOR			English	Article						anxiety; body image; depression; mood; self&#8208; perception	STROKE; DEPRESSION; ANXIETY; FREQUENCY; INVENTORY; SYMPTOMS; PATTERNS; SELF	Introduction The image of one's own body derives from experimentation of one's own body pattern. The emotional experience can lead to a real or distorted self-representation. After brain damage, a disorder of body image is frequent. The purpose of this study was to investigate the role of body image following acquired brain injury (ABI). Methods Forty-six hospitalized patients were enrolled and subdivided into two groups depending on the etiology of the damage: traumatic or vascular. For each group, we considered their cognitive level and mood. Patients underwent a broad battery of tests to investigate different domains: Montreal Cognitive Assessment (MoCA); Beck's Depression Inventory (BDI-II); Hamilton Rating Scale for Anxiety (HAM-A); Clinical Insight Rating Scale (CIRS); Body Image Scale (BIS); Human Figure Drawing (HFD). The latter was used to assess the implicit body image of each patient. Results Both groups showed a significant relationship between BDI-II and BIS. A positive correlation was found between BIS and HAM-A, but only in the traumatic group. We showed a positive correlation between MoCA and HFD. In addition, we observed some subitems of MoCA as predictive variables in HFD, which differ in the two groups. In a traumatic group, the visuospatial domain is predictive in HFD, as well as age of patients' and education. In the vascular groups, orientation, naming, abstraction, and language domains are instead predictive. Conclusions The results confirm the crucial role of the cognitive level and mood on self-perception.	[Corallo, Francesco; Tarda, Dominique; Coppola, Valentina; Bonanno, Lilla; Lo Buono, Viviana; Palmeri, Rosanna; De Cola, Maria Cristina; Di Cara, Marcella; Romeo, Laura; Raciti, Loredana; Todaro, Antonino; Logiudice, Anna Lisa; Bramanti, Placido; Marino, Silvia; Formica, Caterina] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy		De Cola, MC (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo SS, 113 Via Palermo, I-98124 Messina, Italy.	mariacristina.decola@irccsme.it	corallo, francesco/K-5932-2016	corallo, francesco/0000-0003-4862-3832; De Cola, Maria Cristina/0000-0002-7509-3833			Anderson G.L., 1951, INTRO PROJECTIVE TEC; ANDERSON RJ, 1992, REHABIL COUNS BULL, V35, P240; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Bartuccio M., 2012, VISUAL DIAGNOSIS CAR, DOI [10.1097/OPX.0b013e31828591f8, DOI 10.1097/OPX.0B013E31828591F8]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Broomfield NM, 2015, INT J STROKE, V10, P897, DOI 10.1111/ijs.12109; Burton CAC, 2013, INT J STROKE, V8, P545, DOI 10.1111/j.1747-4949.2012.00906.x; Corbett A., 1996, BRIT J OCCUP THER, V59, P325, DOI [10.1177/030802269605900709, DOI 10.1177/030802269605900709]; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; House A, 1996, J NEUROPSYCH CLIN N, V8, P453; Jourard SM., 1953, J CONSULT PSYCHOL, V17, P343, DOI 10.1037/h0060689; KINSELLA G, 1980, MED J AUSTRALIA, V2, P663; LANGER KG, 1994, J GERIATR PSYCH NEUR, V7, P121, DOI 10.1177/089198879400700208; Lenzi GL, 2008, REV NEUROL-FRANCE, V164, P837, DOI 10.1016/j.neurol.2008.07.010; Llorensa R, 2017, NEUROPSYCHOLOGIA, V96, P61, DOI 10.1016/j.neuropsychologia.2017.01.007; Maaijwee NAMM, 2016, EUR J NEUROL, V23, P1262, DOI 10.1111/ene.13009; Maresca G, 2020, PSYCHOL HEALTH MED, V25, P10, DOI 10.1080/13548506.2019.1597977; Martella F., 2016, PSICOTER COGN COMPOR, V22, P65, DOI [10.13140/RG.2.2.20830.64328, DOI 10.13140/RG.2.2.20830.64328]; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OTT BR, 1992, INT J GERIATR PSYCH, V7, P899, DOI 10.1002/gps.930071209; Razmus M, 2017, COGN PROCESS, V18, P359, DOI 10.1007/s10339-017-0831-8; Schottke H, 2015, INT PSYCHOGERIATR, V27, P1805, DOI 10.1017/S1041610215000988; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007	31	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JUN	2021	11	6							e02181	10.1002/brb3.2181		MAY 2021	7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	SU4OA	WOS:000651489800001	34002955	gold, Green Published			2022-02-07	
J	Lambrinakos-Raymond, K; Dubrovsky, AS; Gagnon, I; Zemek, R; Burstein, B				Lambrinakos-Raymond, Kristen; Dubrovsky, Alexander Sasha; Gagnon, Isabelle; Zemek, Roger; Burstein, Brett		Pediatr Emergency Res Canada	Management of Pediatric Post-Concussion Headaches: National Survey of Abortive Therapies Used in the Emergency Department	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						concussion; mild traumatic brain injury; post-concussion syndrome; post-traumatic headache; treatment	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HEADACHES; POSTCONCUSSION SYNDROME; CHILDREN; INTERVENTIONS; ADOLESCENTS; SYMPTOMS; MIGRAINE; PAIN	Children frequently present to an Emergency Department (ED) after concussion, and headache is the most commonly associated symptom. Recent guidelines emphasize the importance of analgesia for post-concussion headache (PCH), yet evidence to inform treatment is lacking. We sought to characterize abortive therapies used to manage refractory PCH in the pediatric ED and factors associated with treatment. A scenario-based survey was distributed to ED physicians at all 15 Canadian tertiary pediatric centers. Participants were asked questions regarding ED treatment of acute (48 h) and persistent (1 month) PCH refractory to appropriate doses of acetaminophen/ibuprofen. Logistic regression was used to assess factors associated with treatment. Response rate was 63% (137/219). Nearly all physicians (128/137, 93%) endorsed treatment in the ED for acute PCH of severe intensity, with most selecting intravenous treatments (116/137, 84.7%). Treatments were similar for acute and persistent PCH. The most common treatments were metoclopramide (72%), physiologic saline (47%), and nonsteroidal anti-inflammatory agents (NSAIDS; 35%). Second-line ED treatments were more variable. For acute PCH of moderate intensity, overall treatment was lower (102/137, 74%; p < 0.0001), and NSAIDS (48%) were most frequently selected. In multi-variable regression analyses, no physician- or ED-level factor was associated with receiving treatment, or treatment using metoclopramide specifically. Treatment for refractory PCH in the pediatric ED is highly variable. Importantly, patients with severe PCH are most likely to receive intravenous therapies, often with metoclopramide, despite a paucity of evidence supporting these choices. Further research is urgently needed to establish the comparative effectiveness of pharmacotherapeutic treatments for children with refractory PCH.	[Lambrinakos-Raymond, Kristen; Dubrovsky, Alexander Sasha; Gagnon, Isabelle; Burstein, Brett] McGill Univ, Montreal Childrens Hosp, Div Pediat Emergency Med, Dept Pediat,Hlth Ctr, Montreal, PQ, Canada; [Lambrinakos-Raymond, Kristen; Dubrovsky, Alexander Sasha] UP Ctr Pediat Emergencies, Brossard, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Dept Emergency Med, Ottawa, ON, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Burstein, Brett] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada		Burstein, B (corresponding author), Montreal Childrens Hosp, Div Pediat Emergency Med, 1001 Decarie Blvd,Suite BS1-4336, Montreal, PQ H4A 3J1, Canada.	brett.burstein@mail.mcgill.ca					Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Blume HK, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0516-x; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bresee N, 2018, AM J EMERG MED, V36, P2225, DOI 10.1016/j.ajem.2018.04.007; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Burstein Brett, 2016, Hosp Pediatr, V6, P226, DOI 10.1542/hpeds.2015-0195; Centers for Disease Control and Prevention, 2018, REPORT C MANAGEMENT; Chan S, 2015, AM J EMERG MED, V33, P635, DOI 10.1016/j.ajem.2015.01.053; Choe MC, 2016, J CHILD NEUROL, V31, P76, DOI 10.1177/0883073814568152; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Dillman DA., 2007, MAIL INTERNET SURVEY; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Fein JA, 2012, PEDIATRICS, V130, pE1391, DOI 10.1542/peds.2012-2536; Friedman BW, 2018, AM J EMERG MED, V36, P285, DOI 10.1016/j.ajem.2017.10.034; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Kacperski J, 2016, HEADACHE, V56, P36, DOI 10.1111/head.12737; Kapadia M, 2019, CURR REV MUSCULOSKE, V12, P57, DOI 10.1007/s12178-019-09533-x; Kinnaman K.A., Management strategies and medication use for treating paediatric patients with concussions. Acta Paediatr, V102, pE424; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lambrinakos-Raymond K, 2019, J PEDIATR-US, V210, P20, DOI 10.1016/j.jpeds.2019.02.035; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lumba-Brown A, 2014, PEDIATR EMERG CARE, V30, P139, DOI 10.1097/PEC.0000000000000084; Mannix R, 2019, J NEUROTRAUM, V36, P2886, DOI 10.1089/neu.2018.6290; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Oskoui M, 2019, HEADACHE, V59, P1158, DOI 10.1111/head.13628; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Petrelli T, 2017, PAED CHILD HEALT-CAN, V22, P2, DOI 10.1093/pch/pxw011; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Reed N., 2020, ONTARIO NEUROTRAUMA; Rome HP, 2000, PAIN MED, V1, P7, DOI 10.1046/j.1526-4637.2000.99105.x; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Seifert T, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0568-6; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Worthington I, 2013, CAN J NEUROL SCI, V40, pS33; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	41	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7508		MAY 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SE2EZ	WOS:000651887500001	33787343				2022-02-07	
J	Brown, SSG; Dams-O'Connor, K; Watson, E; Balchandani, P; Feldman, RE				Brown, Stephanie S. G.; Dams-O'Connor, Kristen; Watson, Eric; Balchandani, Priti; Feldman, Rebecca E.			Case Report: An MRI Traumatic Brain Injury Longitudinal Case Study at 7 Tesla: Pre- and Post-injury Structural Network and Volumetric Reorganization and Recovery	FRONTIERS IN NEUROLOGY			English	Article						7T MRI; diffusion MRI; traumatic brain injury; structural connectivity; case study	DIFFUSION MRI; SEGMENTATION; CONNECTIVITY; SYSTEM	Importance: A significant limitation of many neuroimaging studies examining mild traumatic brain injury (mTBI) is the unavailability of pre-injury data. Objective: We therefore aimed to utilize pre-injury ultra-high field brain MRI and compare a collection of neuroimaging metrics pre- and post-injury to determine mTBI related changes and evaluate the enhanced sensitivity of high-resolution MRI. Design: In the present case study, we leveraged multi-modal 7 Tesla MRI data acquired at two timepoints prior to mTBI (23 and 12 months prior to injury), and at two timepoints post-injury (2 weeks and 8 months after injury) to examine how a right parietal bone impact affects gross brain structure, subcortical volumetrics, microstructural order, and connectivity. Setting: This research was carried out as a case investigation at a single primary care site. Participants: The case participant was a 38-year-old female selected for inclusion based on a mTBI where a right parietal impact was sustained. Main outcomes: The main outcome measurements of this investigation were high spatial resolution structural brain metrics including volumetric assessment and connection density of the white matter connectome. Results: At the first scan timepoint post-injury, the cortical gray matter and cerebral white matter in both hemispheres appeared to be volumetrically reduced compared to the pre-injury and subsequent post-injury scans. Connectomes produced from whole-brain diffusion-weighted probabilistic tractography showed a widespread decrease in connectivity after trauma when comparing mean post-injury and mean pre-injury connection densities. Findings of reduced fractional anisotropy in the cerebral white matter of both hemispheres at post-injury time point 1 supports reduced connection density at a microstructural level. Trauma-related alterations to whole-brain connection density were markedly reduced at the final scan timepoint, consistent with symptom resolution. Conclusions and Relevance: This case study investigates the structural effects of traumatic brain injury for the first time using pre-injury and post-injury 7 Tesla MRI longitudinal data. We report findings of initial volumetric changes, decreased structural connectivity and reduced microstructural order that appear to return to baseline 8 months post-injury, demonstrating in-depth metrics of physiological recovery. Default mode, salience, occipital, and executive function network alterations reflect patient-reported hypersomnolence, reduced cognitive processing speed and dizziness.	[Brown, Stephanie S. G.] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England; [Dams-O'Connor, Kristen; Watson, Eric] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, Brain Injury Res Ctr, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Balchandani, Priti] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY 10029 USA; [Feldman, Rebecca E.] Univ British Columbia, Dept Comp Sci Math Phys & Stat, Kelowna, BC, Canada		Brown, SSG (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Cambridge, England.	sb2403@medschl.cam.ac.uk		Watson, Eric/0000-0003-2072-9213	DOD-IDA [W81XWH-19-1-0616]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH109544]	This work was funded by DOD-IDA W81XWH-19-1-0616 and NIH R01 MH109544.	Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Biagianti B, 2020, J AFFECT DISORDERS, V262, P71, DOI 10.1016/j.jad.2019.10.058; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Iglesias JE, 2015, NEUROIMAGE, V115, P117, DOI 10.1016/j.neuroimage.2015.04.042; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Goriely A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.138001; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Jang SH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014306; Jang SH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013315; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Li L, 2019, BRAIN RES, V1717, P127, DOI 10.1016/j.brainres.2019.04.020; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Pearson, 2009, ADV CLIN SOLUTIONS W; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Saygin ZM, 2017, NEUROIMAGE, V155, P370, DOI 10.1016/j.neuroimage.2017.04.046; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Seeley WW, 2019, J NEUROSCI, V39, P9878, DOI 10.1523/JNEUROSCI.1138-17.2019; Smith RE, 2015, NEUROIMAGE, V119, P338, DOI 10.1016/j.neuroimage.2015.06.092; Smith RE, 2015, NEUROIMAGE, V104, P253, DOI 10.1016/j.neuroimage.2014.10.004; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Sotiropoulos SN, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3752; Tournier J.D., 2010, P INT SOC MAGNETIC R, P1670; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Warntges S, 2014, OPHTHALMIC RES, V51, P37, DOI 10.1159/000355464; Zaretskaya N, 2018, NEUROIMAGE, V165, P11, DOI 10.1016/j.neuroimage.2017.09.060	35	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 17	2021	12								631330	10.3389/fneur.2021.631330			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SK2KT	WOS:000656049300001	34079509	Green Published, gold			2022-02-07	
J	Kazempour, M; Kazempour, A; Baniassadi, M; Remond, Y; Baghani, M				Kazempour, Morteza; Kazempour, Amin; Baniassadi, Majid; Remond, Yves; Baghani, Mostafa			Numerical Investigation of Axonal Damage for Regular and Irregular Axonal Distributions	FRONTIERS IN MECHANICAL ENGINEERING-SWITZERLAND			English	Article						visco-hyperelastic; traumatic brain injury (TBI); diffuse axonal injury (DAI); FEM; axonal damage	BRAIN WHITE-MATTER; MECHANICAL-PROPERTIES; COMPUTATIONAL APPROACH; CONSTITUTIVE MODEL; IN-VIVO; TISSUE; ELEMENT; BEHAVIOR	Recently, various researches have revealed the importance of the investigations performed for evaluating mechanical properties and damages of the brain tissues while dealing with the production of surgical ligaments and helmets. Therefore, it is vital to study the structure of the brain both experimentally and numerically. By experimental tests, despite being costly, it is almost impossible to establish stress distribution in micro scale, which causes injury. Micromechanical predictions are effective ways to assess brain behavior. They can be applied to compensate for some experimental test limitations. In this work, a numerical study of the axonal injury in different heterogeneous porcine brain parts with different axon distributions under quasi-static loading is provided. In order to produce a heterogeneous structure, axons are distributed in regular, semi-regular, and irregular patterns inside the representative volume element. To accurately examine the brain tissue time-dependent behavior, a visco-hyperelastic constitutive model is developed. Also, axonal damage is studied under different conditions by applying different levels of load and rate. Because of geometrical complexities, a self-consistent method was applied to study the damage in higher volume fractions of the axon. The results reveal that the regions of the brain enjoying a regular axon distribution would have higher strength. In addition, among the two influential load and loading rate parameters, the brain tissue in all regions shows more sensitivity toward the applying load.	[Kazempour, Morteza; Baniassadi, Majid; Baghani, Mostafa] Univ Tehran, Coll Engn, Sch Mech Engn, Tehran, Iran; [Kazempour, Amin] Univ Mohaghegh Ardabili, Sch Comp Sci, Ardebil, Iran; [Baniassadi, Majid; Remond, Yves] Univ Strasbourg, ICube CNRS, Alsace, France		Baghani, M (corresponding author), Univ Tehran, Coll Engn, Sch Mech Engn, Tehran, Iran.	baghani@ut.ac.ir	Baghani, Mostafa/U-2864-2018; Baniassadi, Majid/U-2890-2018	Baghani, Mostafa/0000-0001-6695-3128; Baniassadi, Majid/0000-0002-4434-082X			Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; Anderson AT, 2016, J MECH BEHAV BIOMED, V59, P538, DOI 10.1016/j.jmbbm.2016.03.005; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bergstrom JS, 1998, J MECH PHYS SOLIDS, V46, P931, DOI 10.1016/S0022-5096(97)00075-6; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; CAFFREY JM, 1992, BRAIN RES, V592, P283, DOI 10.1016/0006-8993(92)91687-A; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavoshnejad P, 2018, P I MECH ENG H, V232, P673, DOI 10.1177/0954411918783782; Chavoshnejad P, 2020, EXTREME MECH LETT, V36, DOI 10.1016/j.eml.2020.100647; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Faul M., 2002, INJ PREV S1, V16, pA268; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fereidoonnezhad B, 2020, J BIOMECH, V111, DOI 10.1016/j.jbiomech.2020.110006; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; HASHIN Z, 1983, J APPL MECH-T ASME, V50, P481, DOI 10.1115/1.3167081; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Horgan CO, 2009, INT J SOLIDS STRUCT, V46, P3078, DOI 10.1016/j.ijsolstr.2009.04.007; Javid S, 2014, J MECH BEHAV BIOMED, V30, P290, DOI 10.1016/j.jmbbm.2013.11.010; Kanit T, 2003, INT J SOLIDS STRUCT, V40, P3647, DOI 10.1016/S0020-7683(03)00143-4; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Karami G., 2011, SIMULIA CUST C, P1, DOI 10.21236/ada548703; Kazempour M., 2018, STEM CELLS REGENERAT; Kazempour M, 2019, BIOMECH MODEL MECHAN, V18, P969, DOI 10.1007/s10237-019-01124-6; Labus KM, 2016, J MECH BEHAV BIOMED, V62, P195, DOI 10.1016/j.jmbbm.2016.05.003; Langlois J. A., 2006, TRAUMATIC BRAIN INJU, DOI [10.1037/e721222007-001, DOI 10.1037/E721222007-001]; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Miller R.T., 1998, STAPP CAR CRASH C SA, DOI [10.4271/983154, DOI 10.4271/983154]; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Samadi-Dooki A, 2018, J MECH BEHAV BIOMED, V77, P24, DOI 10.1016/j.jmbbm.2017.08.037; SCHMIDSCHONBEIN GW, 1981, BIOPHYS J, V36, P243, DOI 10.1016/S0006-3495(81)84726-1; Schmidt JL, 2018, J MECH BEHAV BIOMED, V79, P30, DOI 10.1016/j.jmbbm.2017.11.045; Sheidaei A, 2019, MATH MECH SOLIDS, V24, P3027, DOI 10.1177/1081286519828418; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Tanielian T., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/MG720.1, DOI 10.7249/MG720.1]; Testu J, 2017, J MECH BEHAV BIOMED, V74, P333, DOI 10.1016/j.jmbbm.2017.06.027; Voyiadjis GZ, 2018, J MECH BEHAV BIOMED, V83, P63, DOI 10.1016/j.jmbbm.2018.04.011; WANG HC, 1972, J BIOMECH, V5, P431, DOI 10.1016/0021-9290(72)90002-4; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V77, P702, DOI 10.1016/j.jmbbm.2017.08.029; Whitford C, 2018, BIOMECH MODEL MECHAN, V17, P19, DOI 10.1007/s10237-017-0942-2; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yousefsani SA, 2018, J MECH BEHAV BIOMED, V80, P194, DOI 10.1016/j.jmbbm.2018.02.002; Zhang MG, 2014, BIOMECH MODEL MECHAN, V13, P1, DOI 10.1007/s10237-013-0481-4	51	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2297-3079		FRONT MECH ENG-SWITZ	Front. Mech. Eng.-Switzerland	MAY 17	2021	7								685519	10.3389/fmech.2021.685519			17	Engineering, Mechanical; Mechanics	Emerging Sources Citation Index (ESCI)	Engineering; Mechanics	SN7XD	WOS:000658499800001		Green Published, gold			2022-02-07	
J	MacGillivray, S; Wynn, G; Ogle, M; Shore, J; Carey, JP; Dennison, CR				MacGillivray, Samantha; Wynn, Gabriella; Ogle, Megan; Shore, Julia; Carey, Jason P.; Dennison, Christopher R.			Repeatability and Biofidelity of a Physical Surrogate Neck Model Fit to a Hybrid III Head	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Test dummies; Impact; Head kinematics; Brain injury; Helmet assessment; Concussions	TRAUMATIC BRAIN-INJURY; UNITED-STATES; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; IMPACTS; CONCUSSIONS; SPORT; EPIDEMIOLOGY; LOCATION	In helmet impact testing, parameters including acceleration and velocity are measured using instrumented head-neck models that are meant to be mechanically realistic (i.e. biofidelic) stand-ins, or surrogates, for humans. Currently available models of the human neck are designed primarily for application in automotive crash testing, and their applicability in assessment of helmets is often questioned. The object of the present work is to document the mechanical design, repeatability, and biofidelity in low speed impact of a new neck model that we apply with a Hybrid III head. Focusing on Hybrid III head kinematics measured during impacts at 2 to 6 m/s, the co-efficient of variance of repeated measures of kinematics was generally less than 10%. Differences in kinematics between identical copies of the neck was less than 20% when tested with helmets, and less than 7% when the head was not helmeted. In parallel testing using a Hybrid III head-neck, the co-efficient of variance in repeated measures was less than 4% and the kinematics significantly differed from those measured using the new neck. CORAplus scores for the new neck were approximately 0.70 when compared against data for human subjects with passive neck muscles experiencing impact at 2 m/s.	[MacGillivray, Samantha; Ogle, Megan; Shore, Julia; Carey, Jason P.] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada; [Wynn, Gabriella; Dennison, Christopher R.] Univ Alberta, Mech Engn, Biomed Instrumentat Lab, Edmonton, AB, Canada		Wynn, G (corresponding author), Univ Alberta, Mech Engn, Biomed Instrumentat Lab, Edmonton, AB, Canada.	wynn@ualberta.ca		Wynn, Gabriella/0000-0001-5855-9462	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Canada Research Chairs ProgramCanada Research Chairs; Faculty of Engineering at the University of AlbertaUniversity of Alberta	Financial support for the following is gratefully acknowledged from several sources: The Natural Sciences and Engineering Research Council of Canada (Discovery and Engage Grants); The Canada Foundation for Innovation; The Canada Research Chairs Program; and the Faculty of Engineering at the University of Alberta.	[Anonymous], 2013, 1583012013 ISO; [Anonymous], 2005, BIOM RESP REQ THOR N; [Anonymous], 2007, F104507 ASTM; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Been Bernard, 2004, Stapp Car Crash J, V48, P431; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Centers for Disease Control and Prevention, SURV REP TRAUM BRAIN; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cohen J, 2013, STAT POWER ANAL BEHA, P24; Cohen J, 2013, STAT POWER ANAL BEHA, P284; Crandall JR, 2011, CLIN ANAT, V24, P362, DOI 10.1002/ca.21152; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Foster J., 1977, SAE T, V86, P3268; Gehre C, 2011, ASSESSMENT DUMMY MOD; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Henry YY, 2017, JOVE-J VIS EXP, V127; Hodgson LM, 1972, HEAD MODEL IMPACT, DOI [10.4271/720969, DOI 10.4271/720969]; Hynd D, 2013, TRAFFIC INJ PREV, V14, pS95, DOI 10.1080/15389588.2013.806987; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Nelson TS, 2010, TRAFFIC INJ PREV, V11, P309, DOI 10.1080/15389581003614870; Newman J.A., 2000, STAPP CAR CRASH J; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Parent Daniel, 2017, Stapp Car Crash J, V61, P227; Parent J, 2013, THORACIC BIOFIDELITY; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Reynier KA, 2020, ANN BIOMED ENG, V48, P2751, DOI 10.1007/s10439-020-02609-7; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Saari A, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024822; Sances A, 1998, BIOM HLTH R, V21, P147; Sances A Jr, 2001, Biomed Sci Instrum, V37, P423; Scherer R. D., 2001, DESIGN EVALUATION WO; Society of Automotive Engineers, 2014, J211 SAE; Sosin DM, 1996, BRAIN INJURY, V10, P47; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thunert, 2012, CORA RELEASE 3 6 USE; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Wiklund, 2002, TRAFFIC INJ PREV, V3, P167, DOI [10.1080/15389580211995, DOI 10.1080/15389580211995]; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; Xu L., 2000, SAE T, V109, P284; Yu HY, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4040944	53	0	0	3	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2957	2972		10.1007/s10439-021-02786-z		MAY 2021	16	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000651367100004	33999296				2022-02-07	
J	Albanese, BJ; Preston, TJ; Bedford, C; Macatee, RJ; Schmidt, NB				Albanese, Brian J.; Preston, Thomas J.; Bedford, Carter; Macatee, Richard J.; Schmidt, Norman B.			Distress Intolerance Prospectively Predicts Traumatic Intrusions Following an Experimental Trauma in a Non-clinical Sample	COGNITIVE THERAPY AND RESEARCH			English	Article						Distress intolerance; Traumatic intrusions; Analogue trauma; Multi-level model; Posttraumatic stress disorder; PTSD	POSTTRAUMATIC-STRESS-DISORDER; PTSD SYMPTOM SEVERITY; ANXIETY SENSITIVITY; TOLERANCE ASSOCIATIONS; FILM PARADIGM; DEPRESSION; EMOTION; IDEATION; VALIDITY; SCALES	Background Distress intolerance (DI) is a well-established cognitive-affective factor that reflects the inability to tolerate negative emotional experiences. DI has been consistently linked with post-traumatic stress disorder (PTSD) but no research to date has demonstrated whether DI confers pre-existing risk for PTSD-like symptoms following an analogue trauma. Methods Participants (n = 70) were recruited based on either a history of traumatic brain injury (TBI) or elevations on a related emotional vulnerability. After completing self-report measures, participants watched a film depicting life-threatening car accidents and then monitored the occurrence of intrusions. Ambulatory assessments of film-related traumatic intrusions were then reported 3x/day for 7 days. Results As hypothesized, greater DI predicted a poorer ability to volitionally suppress intrusions during the lab-based monitoring period. DI also predicted greater naturalistic intrusions on average throughout the subsequent week, and this difference was largest at the beginning of the follow-up period. Unexpectedly, DI did not predict the trajectory (i.e., slope) of naturalistic intrusions during the follow-up period. TBI status was also not related to intrusions during the follow-up period. Conclusions These findings provide critical support for DI as a pre-existing risk factor for the development of intrusive thoughts following an analogue trauma. Future research should seek to extend these findings to a clinical sample.	[Albanese, Brian J.; Preston, Thomas J.; Macatee, Richard J.] Auburn Univ, Dept Psychol Sci, 226 Thach Hall, Auburn, AL 36849 USA; [Bedford, Carter; Schmidt, Norman B.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA		Albanese, BJ (corresponding author), Auburn Univ, Dept Psychol Sci, 226 Thach Hall, Auburn, AL 36849 USA.	albanese@auburn.edu			National Institute of Health Integrated Clinical Neuroscience Training for Translational Research [4T32MH093311-05]	This work was also in part supported by the National Institute of Health Integrated Clinical Neuroscience Training for Translational Research (Grant No. 4T32MH093311-05). Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the National Institute of Health.	Albanese BJ, 2019, BIOL PSYCHIAT-COGN N, V4, P902, DOI 10.1016/j.bpsc.2019.05.015; Albanese BJ, 2019, J AFFECT DISORDERS, V257, P536, DOI 10.1016/j.jad.2019.07.014; Albanese BJ, 2018, PSYCHIATRY, V81, P71, DOI 10.1080/00332747.2017.1309867; Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Allan NP, 2018, J ANXIETY DISORD, V53, P91, DOI 10.1016/j.janxdis.2017.08.002; Almeida DM, 2002, ASSESSMENT, V9, P41, DOI 10.1177/1073191102009001006; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anestis MD, 2011, J PSYCHIATR RES, V45, P603, DOI 10.1016/j.jpsychires.2010.10.013; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Banducci AN, 2017, J ANXIETY DISORD, V47, P99, DOI 10.1016/j.janxdis.2017.01.004; Bates D., 2007, LME4 PACKAGE R PACKA, V2, P74, DOI DOI 10.18637/JSS.V067.I01; Baum A., 2011, HDB STRESS SCI BIOL, P583; Boffa JW, 2019, BEHAV RES THER, V113, P39, DOI 10.1016/j.brat.2018.12.007; Boffa JW, 2018, PSYCHIAT RES, V267, P400, DOI 10.1016/j.psychres.2018.03.085; Boffa JW, 2016, BEHAV THER, V47, P367, DOI 10.1016/j.beth.2016.02.006; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bryant RA, 2017, JAMA PSYCHIAT, V74, P135, DOI 10.1001/jamapsychiatry.2016.3470; Clark IA, 2015, COGNITION EMOTION, V29, P702, DOI 10.1080/02699931.2014.926861; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Delahanty DL, 2006, ANN NY ACAD SCI, V1071, P27, DOI 10.1196/annals.1364.003; First M., 2015, STRUCTURED CLIN INTE; Galatzer-Levy IR, 2013, DEPRESS ANXIETY, V30, P489, DOI 10.1002/da.22048; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Holmes EA, 2004, J EXP PSYCHOL GEN, V133, P3, DOI 10.1037/0096-3445.133.1.3; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Ingram RE, 2001, VULNERABILITY TO PSYCHOPATHOLOGY, P3; Iyadurai L, 2019, CLIN PSYCHOL REV, V69, P67, DOI 10.1016/j.cpr.2018.08.005; James EL, 2016, CLIN PSYCHOL REV, V47, P106, DOI 10.1016/j.cpr.2016.04.010; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kraemer HC, 1997, ARCH GEN PSYCHIAT, V54, P337; Kraemer KM, 2013, ANXIETY STRESS COPIN, V26, P330, DOI 10.1080/10615806.2012.693604; Kratovic L, 2021, J AGGRESS MALTREAT T, V30, P82, DOI 10.1080/10926771.2019.1709594; Law KC, 2015, CURR OPIN PSYCHOL, V3, P30, DOI 10.1016/j.copsyc.2015.01.014; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Leyro TM, 2010, PSYCHOL BULL, V136, P576, DOI 10.1037/a0019712; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Macatee RJ, 2018, PSYCHOL ADDICT BEHAV, V32, P944, DOI 10.1037/adb0000418; Macatee RJ, 2018, J ABNORM PSYCHOL, V127, P12, DOI 10.1037/abn0000323; Macatee RJ, 2017, BEHAV RES THER, V90, P96, DOI 10.1016/j.brat.2016.12.013; Macatee RJ, 2016, J AFFECT DISORDERS, V206, P125, DOI 10.1016/j.jad.2016.07.035; Macatee RJ, 2015, J BEHAV THER EXP PSY, V48, P33, DOI 10.1016/j.jbtep.2015.01.007; Macatee RJ, 2013, J PSYCHIATR RES, V47, P1462, DOI 10.1016/j.jpsychires.2013.06.019; Marshall-Berenz EC, 2010, J TRAUMA STRESS, V23, P623, DOI 10.1002/jts.20568; May J, 2004, MEMORY, V12, P447, DOI 10.1080/09658210444000061; McDermott KA, 2019, COGNITIVE THER RES, V43, P561, DOI 10.1007/s10608-018-9960-3; McGrew SJ, 2020, PSYCHOL TRAUMA-US, V12, P306, DOI 10.1037/tra0000516; McHugh RK, 2012, BEHAV THER, V43, P641, DOI 10.1016/j.beth.2011.12.001; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Norr AM, 2016, PERS INDIV DIFFER, V90, P210, DOI 10.1016/j.paid.2015.11.014; Norris F.H., 2002, GENDER PTSD, P3; Olatunji BO, 2018, J BEHAV THER EXP PSY, V61, P113, DOI 10.1016/j.jbtep.2018.07.001; Olatunji BO, 2015, J ANXIETY DISORD, V34, P76, DOI 10.1016/j.janxdis.2015.06.002; Pettit JW, 2009, DEPRESS ANXIETY, V26, P758, DOI 10.1002/da.20512; R Core Team, 2018, R FDN STAT COMPUTING; Rahman N, 2019, ANXIETY STRESS COPIN, V32, P202, DOI 10.1080/10615806.2019.1566532; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Ridout M, 2001, BIOMETRICS, V57, P219, DOI 10.1111/j.0006-341X.2001.00219.x; Sayed S, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0612-y; Schmidt NB, 2017, J CONSULT CLIN PSYCH, V85, P596, DOI 10.1037/ccp0000195; Schweizer T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190360; Short NA, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.12909; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; STRONG DR, 2003, COMPUTERIZED MIRROR; Vujanovic A. A., 2020, EMOTION POSTTRAUMATI, P343, DOI [DOI 10.1016/B978-0-12-816022-0.00012-0, 10.1016/B978-0-12-816022-0.00012-0]; Vujanovic AA, 2018, PSYCHOL ADDICT BEHAV, V32, P264, DOI 10.1037/adb0000362; Vujanovic AA, 2017, J ANXIETY DISORD, V48, P45, DOI 10.1016/j.janxdis.2016.08.005; Vujanovic AA, 2016, BEHAV MODIF, V40, P120, DOI 10.1177/0145445515621490; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; Zvolensky MJ, 2010, CURR DIR PSYCHOL SCI, V19, P406, DOI 10.1177/0963721410388642	73	0	0	2	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0147-5916	1573-2819		COGNITIVE THER RES	Cogn. Ther. Res.	DEC	2021	45	6					1202	1212		10.1007/s10608-021-10228-2		MAY 2021	11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	WO1ZA	WOS:000650807200001					2022-02-07	
J	Basch, CH; Kollia, B; MacLean, SA; Ahn, S				Basch, Corey H.; Kollia, Betty; MacLean, Sarah A.; Ahn, Soomin			Concussion Knowledge, Beliefs, and Behaviors among University Students: Implications for Faculty and Staff	JOURNAL OF PUBLIC HEALTH-HEIDELBERG			English	Article; Early Access						Concussion; College students; Knowledge; Behaviors; Cognitive communication disorders	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; TRENDS	Introduction Concussion affects one's ability to function in everyday life, and many students who suffer from related symptoms have difficulty adjusting to the academic and social demands of college. The purpose of this study was to examine college students' knowledge, beliefs, and behaviors regarding concussion. Methods This cross-sectional study took place at a suburban university in the northeastern United States during fall semester 2019, in a public health elective core curriculum course. Results A total of 416 students responded (response rate 85%). Regarding having a close experience with concussion, 59.1% of participants had a family member or friend who had sustained a concussion, and 20.7% had a personal history of concussion. Students who reported ever playing a sport were more likely to report a personal history of concussion (p<0.001). Students with a personal or family history of concussion were more likely to report currently playing and having ever played a sport (p <= 0.003). Female participants were less likely to report that they engage in contact sports (p<0.001) and more likely to report always being careful with physical activities so as to avoid head injuries (p=0.003). Many students reported never wearing a helmet when engaging in high-risk behaviors, but most students reported they would seek medical treatment for a suspected concussion. Conclusions Universities would benefit on many levels from an active education and prevention campaign, removing the possible peer stigma associated with admitting to a concussion, and seeking appropriate cognitive, linguistic, and communication treatments and academic accommodations to facilitate ongoing learning.	[Basch, Corey H.; Ahn, Soomin] William Paterson Univ, Dept Publ Hlth, Univ Hall, Wayne, NJ 07470 USA; [Kollia, Betty] William Paterson Univ, Dept Commun Disorders & Sci, Wayne, NJ 07470 USA; [MacLean, Sarah A.] Icahn Sch Med Mt Sinai, 1 Gustave L Levy Pl, New York, NY 10029 USA		Basch, CH (corresponding author), William Paterson Univ, Dept Publ Hlth, Univ Hall, Wayne, NJ 07470 USA.	baschc@wpunj.edu					Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bey T, 2009, WEST J EMERG MED, V10, P6; Breck J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17626; Centers for Disease Control and Prevention, HEADS; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention, 2019, TRAUMATIC BRAIN INJU; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; Duff MC., 2009, ASHA LEADER, V14, P10, DOI [10.1044/leader.FTR1.14092009.10, DOI 10.1044/LEADER.FTR1.14092009.10]; Gurusamy J, 2019, BMC NURS, V18, DOI 10.1186/s12912-019-0388-1; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Kollia B, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_265_17; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea MA, 2021, JAMA NEUROL, V78, P346, DOI 10.1001/jamaneurol.2020.5193; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Meske S., 2018, J HEAD TRAUMA REHABI, V34, P1; Mokris RL, 2019, J CONCUSSION, DOI [10.1177/2059700219870920, DOI 10.1177/2059700219870920]; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Patricios J, 2015, BRIT J SPORT MED, V49, P492, DOI 10.1136/bjsports-2014-094284; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Schellinger SK, 2018, BRAIN INJURY, V32, P1377, DOI 10.1080/02699052.2018.1492737; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Vreeland K, 2017, THESIS, P748; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	31	0	0	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2198-1833	1613-2238		J PUBLIC HEALTH-HEID	J. Public Health-Heidelberg												10.1007/s10389-021-01594-y		MAY 2021	8	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	SC6ZA	WOS:000650815200004					2022-02-07	
J	Pearce, AJ; King, DA; White, AJ; Suter, CM				Pearce, Alan J.; King, Doug A.; White, Adam J.; Suter, Catherine M.			Effects of Stricter Management Guidelines on Return-to-Competition Timeframes Following Concussion in Professional Australian Rules Football: An Exploratory Analysis	SPORTS MEDICINE			English	Article							INJURY; ELITE; PLAY; INCREASES; SPORT	Background Management of concussion remains a serious issue for professional sports, particularly with the growing knowledge on the consequences of repetitive concussion. One primary concern is the subjective assessment of recovery that dictates the time until a concussed athlete is returned-to-competition. In response to this concern, the Australian Football League (AFL) changed its policy in 2020 such that medical clearance for return-to-competition was extended from 1 day, to a minimum of 5 days, prior to the next scheduled match. Objective We sought to explore the impact of the AFL policy change by asking whether time to return-to-competition after concussion was increased in the 2020 season relative to previous years. Methods Retrospective data on injury and return-to-competition were sourced from publicly available tables published by the AFL. Our primary exploration compared the number of matches missed and the number of days missed in concussed players across 2017-2020 inclusive, with secondary exploration analysing the proportion of players returning to play 12 days or longer. Results Analysis of data from 166 concussed players revealed no increase in the number of matches missed in 2020 relative to previous years as would have been expected from an extended recovery protocol. Comparing 2020 relative to 2017-2019, we found that there was an overall moderate reduction in median time to return-to-competition (RTC) in 2020 (10 vs 13 days, respectively d = - 0.345) and a significant reduction in players taking more than 12 days to RTC (p = 0.046). Conclusion This exploratory study demonstrates that clubs may not have followed policy change around concussion management designed to increase time to RTC. Ongoing auditing is required to ensure player clearance meets policy goals, highlighting the need for objective measures for RTC after concussion.	[Pearce, Alan J.] La Trobe Univ, Coll Sci Hlth & Engn, Kingsbury Dr, Melbourne, Vic, Australia; [King, Doug A.] Auckland Univ Technol, Sports Performance Res Inst New Zealand SPRINZ, Fac Hlth & Environm Sci, Auckland, New Zealand; [White, Adam J.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Sport Hlth Sci & Social Work, Oxford, England; [Suter, Catherine M.] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia		Pearce, AJ (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Kingsbury Dr, Melbourne, Vic, Australia.	alan.pearce@latrobe.edu.au		White, Adam/0000-0002-6865-8197; King, Doug/0000-0003-0135-0937	Australian Sports Brain Bank; Sports Health Check charity (Australia); Erasmus+ strategic partnerships program [2019-1-IE01-KA202-051555]	CMS is supported by the Australian Sports Brain Bank. AJP is funded in part by Sports Health Check charity (Australia) and Erasmus+ strategic partnerships program (2019-1-IE01-KA202-051555. No author has any conflict of interest in this work.	Australian Football League, 2020, STAT 2019 AFL INJ RE; Australian Football League, 2021, AFL STAT UPD CONC GU; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Chadwick T, 2020, 7 NEWS; Cohen J, 1988, STAT POWER ANAL BEHA; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; Davis GA, 2020, NEUROSURGERY, V87, P418, DOI 10.1093/neuros/nyaa057; Dijkstra HP, 2017, BRIT J SPORT MED, V51, P419, DOI 10.1136/bjsports-2016-096209; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; Kelly K, 2017, J CLIN EXP NEUROPSYC, V39, P587, DOI 10.1080/13803395.2016.1250870; King D, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117162; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; McClure S, 2020, AGE; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Twomey C, 2021, AUSTR FOOTBALL LEAGU; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217	22	0	0	1	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	DEC	2021	51	12					2647	2654		10.1007/s40279-021-01484-z		MAY 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WW5XS	WOS:000650804500001	33991315	hybrid, Green Published			2022-02-07	
J	Sakamoto, MS; Merritt, VC; Jurick, SM; Crocker, LD; Hoffman, SN; Jak, AJ				Sakamoto, McKenna S.; Merritt, Victoria C.; Jurick, Sarah M.; Crocker, Laura D.; Hoffman, Samantha N.; Jak, Amy J.			Self-efficacy and coping style in Iraq and Afghanistan-era veterans with and without mild traumatic brain injury and posttraumatic stress disorder	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						coping; mild traumatic brain injury; posttraumatic stress disorder; self&#8208; efficacy; veteran	QUALITY-OF-LIFE; PTSD; WAR; ASSOCIATIONS; DEPRESSION; STRATEGIES; OUTCOMES; PERFORMANCE; RESILIENCE; COMPLAINTS	Objective To examine self-efficacy and coping style in combat-exposed Veterans with and without mild traumatic brain injury (mTBI) history and posttraumatic stress disorder (PTSD). Methods Veterans (N = 81) were categorized into four groups: comorbid mTBI and PTSD (n = 23), PTSD-only (n = 16), mTBI-only (n = 25), and combat-exposed controls (n = 17). Outcomes included the Self-Efficacy for Symptom Management Scale and the Brief Coping Orientation to Problems Experienced. Results Significant group effects were found on self-efficacy and coping style, even when adjusting for total mTBIs and psychiatric comorbidities. Post-hoc analyses revealed that the comorbid and PTSD-only groups generally had lower self-efficacy than the mTBI-only and control groups and that the PTSD-only group used less action-focused coping than the mTBI-only and control groups. Conclusion Our results suggest that self-efficacy and coping style vary as a function of mTBI history and PTSD status and that it may be important to integrate these malleable factors into interventions for this population.	[Sakamoto, McKenna S.; Merritt, Victoria C.; Jurick, Sarah M.; Crocker, Laura D.; Jak, Amy J.] VA San Diego Healthcare Syst VASDHS, Res & Psychol Serv, San Diego, CA USA; [Merritt, Victoria C.; Jurick, Sarah M.; Jak, Amy J.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA; [Merritt, Victoria C.; Jurick, Sarah M.; Crocker, Laura D.; Jak, Amy J.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Hoffman, Samantha N.] San Diego State Univ Univ Calif San Diego SDSU UC, Joint Doctoral Program JDP Clin Psychol, San Diego, CA USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	ajak@health.ucsd.edu		Hoffman, Samantha/0000-0002-2792-8576; Merritt, Victoria/0000-0001-5683-4168	VA Rehabilitation Research & Development Service [IK2 RX002459]; VA Clinical Science Research & Development Service [IK2 CX001952]; U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01 CX001135]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095]	VA Rehabilitation Research & Development Service, Grant/Award Number: IK2 RX002459; VA Clinical Science Research & Development Service, Grant/Award Number: IK2 CX001952; U.S. Department of Veterans Affairs, Grant/Award Number: I01 CX001135; U.S. Department of Defense, Grant/Award Number: W81XWH-13-2-0095	Anderson JFI, 2020, NEUROPSYCHOL REHABIL, V30, P1115, DOI 10.1080/09602011.2018.1556706; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Badour CL, 2012, BEHAV RES THER, V50, P610, DOI 10.1016/j.brat.2012.06.006; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; BANDURA A, 1989, DEV PSYCHOL, V25, P729, DOI 10.1037/0012-1649.25.5.729; Bandura A., 1995, SELF EFFICACY CHANGI; Belanger HG, 2020, NEUROPSYCHOL REHABIL, V30, P1190, DOI 10.1080/09602011.2019.1575245; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Billings A G, 1981, J Behav Med, V4, P139, DOI 10.1007/BF00844267; Blackburn L, 2015, J CLIN PSYCHOL, V71, P219, DOI 10.1002/jclp.22133; Boden MT, 2014, J SUBST ABUSE TREAT, V47, P160, DOI 10.1016/j.jsat.2014.03.006; Boden MT, 2012, J PSYCHOPATHOL BEHAV, V34, P433, DOI 10.1007/s10862-012-9293-6; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carver C.S., 2011, HDB STRESS SCI BIOL, P221; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cifu DX, 2018, BRAIN INJURY, V32, P1149, DOI 10.1080/02699052.2018.1496274; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Douglas JM, 2019, NEUROPSYCHOL REHABIL, V29, P73, DOI 10.1080/09602011.2016.1259114; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; FAIRBANK JA, 1991, J CONSULT CLIN PSYCH, V59, P274, DOI 10.1037/0022-006X.59.2.274; Fischer, 2015, 75700 RS22452 C RES; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gallagher MW, 2020, J CLIN PSYCHOL, V76, P329, DOI 10.1002/jclp.22882; Ginzburg K, 2003, PERS INDIV DIFFER, V34, P463, DOI 10.1016/S0191-8869(02)00066-1; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Karstoft KI, 2015, J ANXIETY DISORD, V32, P89, DOI 10.1016/j.janxdis.2015.03.007; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Martindale SL, 2016, REHABIL PSYCHOL, V61, P231, DOI 10.1037/rep0000076; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rodrigues CS, 2010, J ANXIETY DISORD, V24, P694, DOI 10.1016/j.janxdis.2010.04.013; Sasse N, 2014, DISABIL REHABIL, V36, P2152, DOI 10.3109/09638288.2014.893029; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; SOLOMON Z, 1989, BRIT J CLIN PSYCHOL, V28, P131, DOI 10.1111/j.2044-8260.1989.tb00823.x; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tyrrell CJ, 2019, CLIN GERONTOLOGIST, V42, P398, DOI 10.1080/07317115.2019.1569189; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Yehene E, 2020, APPL NEUROPSYCH-ADUL, V27, P468, DOI 10.1080/23279095.2019.1569523	58	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	OCT	2021	77	10					2306	2322		10.1002/jclp.23154		MAY 2021	17	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UQ4AI	WOS:000650691400001	33991109				2022-02-07	
J	Lasry, O; Dendukuri, N; Marcoux, J; Buckeridge, DL				Lasry, Oliver; Dendukuri, Nandini; Marcoux, Judith; Buckeridge, David L.			Recurrent Traumatic Brain Injury Surveillance Using Administrative Health Data: A Bayesian Latent Class Analysis	FRONTIERS IN NEUROLOGY			English	Article						surveillance; traumatic brain injury; recurrence; recurrent traumatic brain injury; Bayesian analysis; latent class analysis	DISEASE PREVALENCE; FOOTBALL PLAYERS; DIAGNOSTIC-TESTS; POPULATION; CONCUSSION; RISK; EPIDEMIOLOGY; ASSOCIATION; CHILDREN; SUICIDE	Background: The initial injury burden from incident TBI is significantly amplified by recurrent TBI (rTBI). Unfortunately, research assessing the accuracy to conduct rTBI surveillance is not available. Accurate surveillance information on recurrent injuries is needed to justify the allocation of resources to rTBI prevention and to conduct high quality epidemiological research on interventions that mitigate this injury burden. This study evaluates the accuracy of administrative health data (AHD) surveillance case definitions for rTBI and estimates the 1-year rTBI incidence adjusted for measurement error. Methods: A 25% random sample of AHD for Montreal residents from 2000 to 2014 was used in this study. Four widely used TBI surveillance case definitions, based on the International Classification of Disease and on radiological exams of the head, were applied to ascertain suspected rTBI cases. Bayesian latent class models were used to estimate the accuracy of each case definition and the 1-year rTBI measurement-error-adjusted incidence without relying on a gold standard rTBI definition that does not exist, across children (<18 years), adults (18-64 years), and elderly (> =65 years). Results: The adjusted 1-year rTBI incidence was 4.48 (95% CrI 3.42, 6.20) per 100 person-years across all age groups, as opposed to a crude estimate of 8.03 (95% CrI 7.86, 8.21) per 100 person-years. Patients with higher severity index TBI had a significantly higher incidence of rTBI compared to patients with lower severity index TBI. The case definition that identified patients undergoing a radiological examination of the head in the context of any traumatic injury was the most sensitive across children [0.46 (95% CrI 0.33, 0.61)], adults [0.79 (95% CrI 0.64, 0.94)], and elderly [0.87 (95% CrI 0.78, 0.95)]. The most specific case definition was the discharge abstract database in children [0.99 (95% CrI 0.99, 1.00)], and emergency room visits claims in adults/elderly [0.99 (95% CrI 0.99, 0.99)]. Median time to rTBI was the shortest in adults (75 days) and the longest in children (120 days). Conclusion: Conducting accurate surveillance and valid epidemiological research for rTBI using AHD is feasible when measurement error is accounted for.	[Lasry, Oliver; Dendukuri, Nandini; Buckeridge, David L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Lasry, Oliver; Marcoux, Judith] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada		Lasry, O (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Lasry, O (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	oliver.lasry@mcgill.ca			Vanier Canada Graduate Scholarship from the Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	OL was supported by a Vanier Canada Graduate Scholarship from the Canadian Institutes for Health Research.	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Barker-Collo S, 2016, NEUROEPIDEMIOLOGY, V47, P46, DOI 10.1159/000448403; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1814, DOI 10.1093/rheumatology/kem233; Bernatsky S, 2005, STAT MED, V24, P2365, DOI 10.1002/sim.2116; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1373/clinchem.2015.246280, 10.1136/bmj.h5527, 10.1148/radiol.2015151516]; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Centers for Disease Control and Prevention, 1997, MMWR MORB MORTAL WKL, V46, P224; Chung H, 2004, AM STAT, V58, P152, DOI 10.1198/0003130043286; Dendukuri N, 2009, STAT MED, V28, P441, DOI 10.1002/sim.3470; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Garrett ES, 2000, BIOMETRICS, V56, P1055, DOI 10.1111/j.0006-341X.2000.01055.x; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gelman A, 1996, STAT SINICA, V6, P733; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Izadi M., 2013, P 27 M AAAI, P35; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; KLONOFF H, 1971, AM J PUBLIC HEALTH N, V61, P2405, DOI 10.2105/AJPH.61.12.2405; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lasry O., 2016, Health Promot Chronic Dis Prev Can., V36, P268; Lasry O, 2018, EPIDEMIOLOGY, V29, P876, DOI [10.1097/ede.0000000000000888, 10.1097/EDE.0000000000000888]; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCutcheon AL, 1987, LATENT CLASS ANAL, P96; McGraw M, 2019, CAN J EMERG MED, V21, P120, DOI 10.1017/cem.2018.444; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pepe MS, 2007, BIOSTATISTICS, V8, P474, DOI 10.1093/biostatistics/kxl038; Richard YF, 2015, AM J EPIDEMIOL, V182, P177, DOI 10.1093/aje/kwv014; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; WALTER SD, 1988, J CLIN EPIDEMIOL, V41, P923, DOI 10.1016/0895-4356(88)90110-2; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397	49	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 14	2021	12								664631	10.3389/fneur.2021.664631			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SJ4CR	WOS:000655480000001	34054707	gold, Green Published			2022-02-07	
J	Lloyd, O; Ownsworth, T; Zimmer-Gembeck, MJ; Fleming, J; Shum, DHK				Lloyd, Owen; Ownsworth, Tamara; Zimmer-Gembeck, Melanie J.; Fleming, Jennifer; Shum, David H. K.			Measuring domain-specific deficits in self-awareness in children and adolescents with acquired brain injury: Component analysis of the Paediatric Awareness Questionnaire	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Acquired brain injury; Self-awareness; Metacognition; Children; Adolescents	COMPETENCE RATING-SCALE; IMPAIRED AWARENESS; PATIENT; CHILDHOOD; REHABILITATION; UNAWARENESS; VALIDATION; FEEDBACK; PEOPLE	Self-awareness has been found to vary across different functional domains for adults with acquired brain injury (ABI); however, domain-specific self-awareness is yet to be investigated following paediatric ABI. This study aimed to validate the Paediatric Awareness Questionnaire (PAQ) as a multi-domain measure of self-awareness and to investigate domain-specific self-awareness in children with ABI. One hundred and ninety-seven children and adolescents (8-16 years, M = 12.44, SD = 2.62) with mixed causes of ABI (70% with traumatic brain injury) and their parents (n = 197) were recruited through consecutive rehabilitation appointments and completed the PAQ. The 37 items of the parent version of the PAQ were subjected to a principal component analysis with varimax rotation. A five-component solution (29 items) explained 64% of the variance in the PAQ items. Components revealed five domains of self-awareness: socio-emotional functioning, activities of daily living (ADLs), cognition, physical functioning, and communication. Internal consistency of the components ranged from acceptable to excellent (alpha = .70-.95). The analysis identified that children had poorer self-awareness of cognitive functioning than socio-emotional functioning, ADLs, and communication skills. Overall, the findings identify five components (i.e., functional domains) of self-awareness and provide some support that self-awareness varies across domains following paediatric ABI.	[Lloyd, Owen; Ownsworth, Tamara; Zimmer-Gembeck, Melanie J.] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Lloyd, Owen; Ownsworth, Tamara; Zimmer-Gembeck, Melanie J.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Lloyd, Owen] Childrens Hlth Queensland, Queensland Paediat Rehabil Serv, Queensland Childrens Hosp, Brisbane, Qld, Australia; [Lloyd, Owen] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Shum, David H. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Peoples R China		Lloyd, O (corresponding author), Childrens Hlth Queensland, Queensland Paediat Rehabil Serv, Queensland Childrens Hosp, 501 Stanley St, South Brisbane 4101, Australia.	owen.lloyd@griffithuni.edu.au	Ownsworth, Tamara/ABB-6961-2021; Shum, David H. K./A-3914-2008; Zimmer-Gembeck, Melanie/H-3031-2015	Ownsworth, Tamara/0000-0003-1835-7094; Shum, David H. K./0000-0002-4810-9262; Zimmer-Gembeck, Melanie/0000-0001-9100-010X; Lloyd, Owen/0000-0001-7410-8135; Fleming, Jennifer/0000-0002-5603-2410			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V., 2018, DEV NEUROPSYCHOLOGY, V2nd Ed., DOI [10.4324/9780203799123, DOI 10.4324/9780203799123]; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Crowther JE, 2011, J HEAD TRAUMA REHAB, V26, P192, DOI 10.1097/HTR.0b013e318218dd22; Damon W, 1988, SELF UNDERSTANDING C; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1996, BRAIN INJURY, V10, P1; Geurten M, 2017, CHILD NEUROPSYCHOL, V23, P67, DOI 10.1080/09297049.2015.1077945; Geurten M, 2016, CLIN NEUROPSYCHOL, V30, P558, DOI 10.1080/13854046.2016.1178331; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Harter S., 2012, HDB SELF IDENTITY, P680; Hellebrekers D, 2017, BRAIN INJURY, V31, P1469, DOI 10.1080/02699052.2017.1377350; Hendry K, 2020, CHILD NEUROPSYCHOL, V26, P1005, DOI 10.1080/09297049.2020.1750577; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Hurst FG, 2020, DISABIL REHABIL, V42, P651, DOI 10.1080/09638288.2018.1504993; Josman N, 2000, OCCUP THER J RES, V20, P241, DOI 10.1177/153944920002000402; Josman Naomi, 2000, Physical and Occupational Therapy in Pediatrics, V19, P39, DOI 10.1300/J006v19n03_04; Krasny-Pacini A, 2015, DISABIL REHABIL, V37, P2092, DOI 10.3109/09638288.2014.998783; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lloyd O, 2021, J NEUROTRAUM, V38, P616, DOI 10.1089/neu.2020.7191; Lloyd O, 2018, CHILD NEUROPSYCHOL, V24, P702, DOI 10.1080/09297049.2017.1332173; Lloyd O, 2015, J HEAD TRAUMA REHAB, V30, P311, DOI 10.1097/HTR.0000000000000113; Markova IS, 2006, NEUROPSYCHOL REHABIL, V16, P439, DOI 10.1080/09602010500373396; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M., 2019, TXB TRAUMATIC BRAIN, P269; Sherer M., 2014, HDB NEUROPSYCHOLOGY, P233, DOI [10.1007/978-1-4939-0784-7_12, DOI 10.1007/978-1-4939-0784-7_12]; SIMPSON D, 1982, LANCET, V2, P450; Sveen U, 2015, DISABIL REHABIL, V37, P239, DOI 10.3109/09638288.2014.913706; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Warner M., 1991, HERDERS WARRIORS TRA, P3, DOI DOI 10.4095/134069; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060	54	0	0	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1926290		MAY 2021	21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SC1TZ	WOS:000650464100001	33980136				2022-02-07	
J	Osier, ND; Bramlett, HM; Shear, DA; Mondello, S; Carlson, SW; Dietrich, WD; Deng-Bryant, Y; Wang, KKW; Hayes, RL; Yang, ZH; Empey, PE; Poloyac, SM; Lafrenaye, AD; Povlishock, JT; Gilsdorf, JS; Kochanek, PM; Dixon, CE				Osier, Nicole D.; Bramlett, Helen M.; Shear, Deborah A.; Mondello, Stefania; Carlson, Shaun W.; Dietrich, W. Dalton; Deng-Bryant, Ying; Wang, Kevin K. W.; Hayes, Ronald L.; Yang, Zhihui; Empey, Philip E.; Poloyac, Samuel M.; Lafrenaye, Audrey D.; Povlishock, John T.; Gilsdorf, Janice S.; Kochanek, Patrick M.; Dixon, C. Edward			Kollidon VA64 Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; consortium; controlled cortical impact; fluid percussion injury; neuroprotection; penetrating ballistic-like brain injury; rat; therapy	CONTROLLED CORTICAL IMPACT; LEVETIRACETAM TREATMENT; MODEL; MILD; BIOMARKERS; MOTOR; RATS	Loss of plasmalemmal integrity may mediate cell death after traumatic brain injury (TBI). Prior studies in controlled cortical impact (CCI) indicated that the membrane resealing agent Kollidon VA64 improved histopathological and functional outcomes. Kollidon VA64 was therefore selected as the seventh therapy tested by the Operation Brain Trauma Therapy consortium, across three pre-clinical TBI rat models: parasagittal fluid percussion injury (FPI), CCI, and penetrating ballistic-like brain injury (PBBI). In each model, rats were randomized to one of four exposures (7-15/group): (1) sham; (2) TBI+vehicle; (3) TBI+Kollidon VA64 low-dose (0.4 g/kg); and (4) TBI+Kollidon VA64 high-dose (0.8 g/kg). A single intravenous VA64 bolus was given 15 min post-injury. Behavioral, histopathological, and serum biomarker outcomes were assessed over 21 days generating a 22-point scoring matrix per model. In FPI, low-dose VA64 produced zero points across behavior and histopathology. High-dose VA64 worsened motor performance compared with TBI-vehicle, producing -2.5 points. In CCI, low-dose VA64 produced intermediate benefit on beam balance and the Morris water maze (MWM), generating +3.5 points, whereas high-dose VA64 showed no effects on behavior or histopathology. In PBBI, neither dose altered behavior or histopathology. Regarding biomarkers, significant increases in glial fibrillary acidic protein (GFAP) levels were seen in TBI versus sham at 4 h and 24 h across models. Benefit of low-dose VA64 on GFAP was seen at 24 h only in FPI. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) was increased in TBI compared with vehicle across models at 4 h but not at 24 h, without treatment effects. Overall, low dose VA64 generated +4.5 points (+3.5 in CCI) whereas high dose generated -2.0 points. The modest/inconsistent benefit observed reduced enthusiasm to pursue further testing.	[Osier, Nicole D.] Univ Texas Austin, Sch Nursing, Holist Adult Hlth Div, Austin, TX 78712 USA; [Osier, Nicole D.] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA; [Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA; [Shear, Deborah A.; Deng-Bryant, Ying; Gilsdorf, Janice S.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Program, Silver Spring, MD USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Carlson, Shaun W.; Dixon, C. Edward] Univ Pittsburgh, Sch Med, Brain Trauma Res Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wang, Kevin K. W.; Yang, Zhihui] Univ Florida, McKnight Brain Inst, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med, Gainesville, FL USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Ctr Prote & Biomarkers Res, Ctr Innovat Res, Alachua, FL USA; [Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Pharm & Therapeut, Pittsburgh, PA USA; [Poloyac, Samuel M.] Univ Texas Austin, Sch Pharm, Austin, TX 78712 USA; [Lafrenaye, Audrey D.; Povlishock, John T.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Clin & Translat Sci, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15261 USA; [Dixon, C. Edward] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA		Kochanek, PM (corresponding author), UPMC Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Crit Care Med, 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA.	kochanekpm@pitt.edu	Empey, Philip/L-9604-2019; Mondello, Stefania/A-1813-2012	Empey, Philip/0000-0001-7474-2339; Mondello, Stefania/0000-0002-8587-3614	United States Department of DefenseUnited States Department of Defense [W81XWH-10-1-0623, WH81XWH-14-2-0018]	This study was supported by the United States Department of Defense Grants W81XWH-10-1-0623 and WH81XWH-14-2-0018.	Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; DIXON CE, 1991, J NEUROSCI METH, V39, P253; du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI [10.1111/bph.15193, 10.1177/0271678X20943823]; Fang F, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/24/245502; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Hernandez ML, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01238; Jha RM, 2021, J NEUROTRAUM, V38, P628, DOI 10.1089/neu.2020.7421; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Katayama Y, 1998, ACT NEUR S, V71, P289; Kochanek PM, 2020, J NEUROTRAUM, V37, P2353, DOI 10.1089/neu.2018.6203; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Lafrenaye A, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.586958; Lafrenaye AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70266-w; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Lithgow GJ, 2017, NATURE, V548, P387, DOI 10.1038/548387a; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; Mellert W, 2004, FOOD CHEM TOXICOL, V42, P1573, DOI 10.1016/j.fct.2004.05.003; Miller BF, 2014, J CEREBR BLOOD F MET, V34, P1347, DOI 10.1038/jcbfm.2014.89; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; National Research Council, 2010, GUIDE CARE USE LAB A, V8th ed.; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Zhang ZQ, 2011, TRANSL STROKE RES, V2, P455, DOI 10.1007/s12975-011-0137-6; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	43	0	0	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2454	2472		10.1089/neu.2021.0089		MAY 2021	19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000650333300001	33843262				2022-02-07	
J	Sadrameli, SS; Davidov, V; Sulhan, S; Vaziri, S; Hartman, CJ; Hooten, KG; Murad, GJA				Sadrameli, Saeed S.; Davidov, Vitaliy; Sulhan, Suraj; Vaziri, Sasha; Hartman, Cory J.; Hooten, Kristopher G.; Murad, Gregory J. A.			The utility of routine post-hospitalization CT imaging in patients with non-operative mild to moderate traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; INTRACRANIAL HEMORRHAGE; FOLLOW-UP; MANAGEMENT; STATES; SCANS	Primary Objective: The purpose of this study was to determine the utility of CT imaging in patients with non-operative mild-moderate TBI with respect to changes in management. Methods: We conducted a retrospective analysis for 191 patients over a 5-year interval to examine whether follow-up CT initiated a change in management. We created a logistic regression model to incorporate different variables contributing to change in management. Results: Of 191 patients, 31 (16.2%) underwent a change in management. Change in management was associated with older age (65 yo vs. 55 yo, p = .011), diagnosis of subdural hematoma (p = .041), antiplatelet/anticoagulant therapy (p = .009), imaging performed (p = .16), and increased blood products on CT (p = <0.0001). For patients on antiplatelet/anticoagulant therapy, only those with worsening findings on CT required a change in management (p = .0002, 0.039). Surgical intervention was indicated in two patients. Conclusions: Limited clinical value exists in repeat CT scans for patients with mild TBI. Most patients with traumatic SAH, contusions, or asymptomatic patients should not have repeat imaging, as our study revealed only 2% of patients with positive CT finding and 0.6% requiring surgical intervention.	[Sadrameli, Saeed S.; Sulhan, Suraj] Houston Methodist Neurol Inst, Dept Neurosurg, Houston, TX 77030 USA; [Davidov, Vitaliy] Texas A&M, Coll Med, Bryan, TX USA; [Vaziri, Sasha; Hartman, Cory J.; Hooten, Kristopher G.; Murad, Gregory J. A.] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Hooten, Kristopher G.] Tripler Army Med Ctr, Dept Neurosurg, Honolulu, HI 96859 USA		Sadrameli, SS (corresponding author), Houston Methodist Neurol Inst, Dept Neurosurg, Houston, TX 77030 USA.	ssadrameli@houstonmethodist.org		Davidov, Vitaliy/0000-0002-2449-6165			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Befeler AR, 2016, J NEUROSURG, V124, P703, DOI 10.3171/2015.4.JNS141257; Camins M B, 1996, Bull Am Coll Surg, V81, P16; Camins MB, 1996, B AM COLL SURG, V81, P47; Campiglio L, 2017, NEUROL-CLIN PRACT, V7, P296, DOI 10.1212/CPJ.0000000000000375; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease C Prevention, 2006, MMWR-MORBID MORTAL W, V55, P201; Coronado VG, 2006, JAMA-J AM MED ASSOC, V295, P1764; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Faul M, 2010, CORONADO V TRAUMATIC; Frechon P, 2020, CLIN NEUROL NEUROSUR, V191, DOI 10.1016/j.clineuro.2020.105682; Ling G, 2009, EXPLOSIVE BLAST NEUR; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; Nagesh M, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19527; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Rubino S, 2014, J NEUROSURG, V121, P944, DOI 10.3171/2014.6.JNS132204; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE G, 1974, LANCET, V2, P81; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Zasler N. D., 2012, BRAIN INJURY MED PRI	27	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					778	782		10.1080/02699052.2021.1910999		MAY 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000650974600001	33998357				2022-02-07	
J	Schellenberg, M; Benjamin, E; Cowan, S; Owattanapanich, N; Wong, MD; Inaba, K; Demetriades, D				Schellenberg, Morgan; Benjamin, Elizabeth; Cowan, Shaun; Owattanapanich, Natthida; Wong, Monica D.; Inaba, Kenji; Demetriades, Demetrios			The impact of delayed time to first CT head on functional outcomes after blunt head trauma with moderately depressed GCS	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Traumatic brain injury; Time to intervention; Computed tomography of the head; Undertriage; Glasgow Coma Scale score	MANAGEMENT; DIAGNOSIS	Purpose Recent work suggests patients with moderately depressed Glasgow Coma Scale (GCS) score in the Emergency Department (ED) who do not undergo immediate head CT (CTH) have delayed neurosurgical intervention and longer ED stay. The present study objective was to determine the impact of time to first CTH on functional neurologic outcomes in this patient population. Methods Blunt trauma patients presenting to our Level I trauma center (11/2015-10/2019) with first ED GCS 9-12 were retrospectively identified and included. Transfers and those with extracranial AIS >= 3 were excluded. The study population was stratified into Immediate (<= 1 h) and Delayed (1-6 h) CTH groups based on time from ED arrival to first CTH. Outcomes included functional outcomes at hospital discharge based on the Modified Rankin Scale (mRS). Results After exclusions, 564 patients were included: 414 (73%) with Immediate CTH and 150 (27%) Delayed CTH. Both groups arrived with median GCS 11 and alcohol/drug intoxication did not differ (p > 0.05). AIS Head/Neck was comparable (3[3-4] vs. 3[3-3], p = 0.349). Time to ED disposition decision and ED exit were significantly shorter after Immediate CTH (2.8[1.5-5.3] vs. 5.2[3.6-7.5]h, p < 0.001 and 5.5[3.3-8.9] vs. 8.1[5.2-11.7]h, p < 0.001). Functional outcomes were slightly worse after Immediate CTH (mRS 2[1-4] vs. 2[1-3], p = 0.002). Subgroup analysis of patients requiring neurosurgical intervention demonstrated a greater proportion of moderately disabled patients with a lower proportion of severely disabled or dead patients after Immediate CTH as compared to Delayed CTH (51 vs. 20%, p = 0.063 and 35 vs. 60%, p = 0.122). Conclusions Immediate CTH shortened time to disposition decision out of the ED and ED exit. Patients requiring neurosurgical intervention after Immediate CTH had improved functional outcomes when compared to those undergoing Delayed CTH. These differences did not reach statistical significance in this single-center study and, therefore, a large, multicenter study is the next step in demonstrating the potential functional outcomes benefit of Immediate CTH after blunt head trauma.	[Schellenberg, Morgan; Benjamin, Elizabeth; Cowan, Shaun; Owattanapanich, Natthida; Wong, Monica D.; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, LAC USC Med Ctr, Div Trauma & Surg Crit Care, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA		Schellenberg, M (corresponding author), Univ Southern Calif, LAC USC Med Ctr, Div Trauma & Surg Crit Care, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	morgan.schellenberg@med.usc.edu					American College of Surgeons, 2014, RESOURCES OPTIMAL CA, V6; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bardes JM, 2019, J EMERG MED, V57, P151, DOI 10.1016/j.jemermed.2019.04.003; Benjamin ER, 2018, J EMERG MED, V55, P278, DOI 10.1016/j.jemermed.2018.02.001; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Gempeler A, 2020, NEUROCRIT CARE, V33, P718, DOI 10.1007/s12028-020-00955-x; Hoffmann M, 2012, J TRAUMA ACUTE CARE, V73, P1607, DOI 10.1097/TA.0b013e318270d572; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Marshall SA, 2012, MIL MED, V177, P76, DOI 10.7205/MILMED-D-12-00142; Polites SF, 2018, AM J SURG, V216, P813, DOI 10.1016/j.amjsurg.2018.07.061; Roberts BW, 2018, CIRCULATION, V137, P2114, DOI 10.1161/CIRCULATIONAHA.117.032054; Schellenberg M, 2021, EUR J TRAUMA EMERG S, V47, P1511, DOI 10.1007/s00068-020-01421-1; Schellenberg M, 2019, J TRAUMA ACUTE CARE, V87, P865, DOI 10.1097/TA.0000000000002393; Soon C. Y., 2007, SMJ Singapore Medical Journal, V48, P131; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P287, DOI 10.1097/TA.0000000000001745; van Dijck JTJM, 2020, ACTA NEUROCHIR, V162, P1607, DOI 10.1007/s00701-020-04384-9; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991	18	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01677-1		MAY 2021	6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SC2UI	WOS:000650532600001	33990862	Green Published, Bronze			2022-02-07	
J	Al-Jehani, H; Al-Sharydah, A; Alabbas, F; Ajlan, A; Al Issawi, W; Baeesa, S				Al-Jehani, Hosam; Al-Sharydah, Abdulaziz; Alabbas, Faisal; Ajlan, Abdulrazag; Al Issawi, Wisam; Baeesa, Saleh			The utility of decompressive craniectomy in severe traumatic brain injury in Saudi Arabia trauma centers	BRAIN INJURY			English	Article						Decompressive craniectomy; head injury; traumatic brain injury	HEAD-INJURY; CRANIOPLASTY; EPIDEMIOLOGY; MANAGEMENT	Background: Decompressive craniectomy (DC) represents an effective method for intracranial pressure (ICP) reduction in cases of severe traumatic brain injury (TBI). However, little is known regarding the attitude of practicing neurosurgeons toward decompressive craniectomy (DC) in Saudi Arabia. Objective: We aimed to explore the perspective on DC among neurosurgeons in Saudi Arabia. Methods: An electronic survey was distributed via e-mail to members of the Saudi Association of Neurological Surgery (SANS). Results: A total of 52 neurosurgeons participated in this survey. The majority of these neurosurgeons practice in a governmental (95.2%), tertiary hospital (75.5%) with academic affiliations (77.6%). Most surgeons (71.4%) agreed that the DC approach for managing refractory ICP is supported by evidence-based medicine. The majority of the participants choose to perform DC on a unilateral basis (80%). Interestingly, DC followed by duraplasty was performed by only 71% of these surgeons, with 29% of the respondents not performing expansive duraplasty. Conclusion: In Saudi Arabia, the utility of DC in cases of TBI with refractory intracranial hypertension has not been clearly defined among practicing neurosurgeons. The development of appropriate, widely adopted TBI guidelines should thus be a priority in Saudi Arabia to reduce variability among TBI care practices. In addition, a national TBI registry should be established for documenting different practices and longitudinal outcomes.	[Al-Jehani, Hosam; Al-Sharydah, Abdulaziz; Alabbas, Faisal; Al Issawi, Wisam] Imam Abdulrahman Bin Faisal Univ King Fahd Hosp U, Neurosurg, Al Khobar, Saudi Arabia; [Al-Jehani, Hosam] McGill Univ, Fac Med, Neurol & Neurosurg, Montreal, PQ, Canada; [Ajlan, Abdulrazag] King Saud Univ, Surg, Riyadh, Saudi Arabia; [Baeesa, Saleh] King Abdulaziz Univ, Surg, Jeddah, Saudi Arabia		Al-Jehani, H (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, 3801 Univ St Montreal,Room 109 Quebec, Montreal, PQ H3A 2B4, Canada.	hosam.aljehani@gmail.com	Baeesa, Saleh Salem/G-5519-2011	Baeesa, Saleh Salem/0000-0002-3053-7912; Al-Jehani, Hosam/0000-0002-3830-9789			Al-Habib A, 2013, ANN SAUDI MED, V33, P351, DOI 10.5144/0256-4947.2013.351; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Alhabdan S, 2013, ANN SAUDI MED, V33, P52, DOI 10.5144/0256-4947.2013.52; Ansari S, 2000, PUBLIC HEALTH, V114, P37, DOI 10.1016/S0033-3506(00)00306-1; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Bouvier D, 2012, ANN BIOL CLIN-PARIS, V70, P269, DOI 10.1684/abc.2012.0701; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Faul M, 2010, TRAUMATIC BRAIN INJU; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Marcelo M., 2012, INNOVATIVE TECHNIQUE, P227; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; TEASDALE G, 1974, LANCET, V2, P81; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050	24	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					798	802		10.1080/02699052.2021.1920051		MAY 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000649120300001	33974453				2022-02-07	
J	Amyot, F; Lynch, CE; Ollinger, J; Werner, JK; Silverman, E; Moore, C; Davis, C; Turtzo, LC; Diaz-Arrastia, R; Kenney, K				Amyot, Franck; Lynch, Cillian E.; Ollinger, John; Werner, J. Kent; Silverman, E.; Moore, Carol; Davis, Cora; Turtzo, L. Christine; Diaz-Arrastia, Ramon; Kenney, Kimbra			Cerebrovascular Reactivity Measures Are Associated With Post-traumatic Headache Severity in Chronic TBI; A Retrospective Analysis	FRONTIERS IN PHYSIOLOGY			English	Article						cerebrovascular reactivity; migraine; chronic; traumatic brain injury; post-traumatic headache	DISEASE; SIMVASTATIN	Objective: To characterize the relationship between persistent post-traumatic headache (pPTH) and traumatic cerebrovascular injury (TCVI) in chronic traumatic brain injury (TBI). Cerebrovascular reactivity (CVR), a measure of the cerebral microvasculature and endothelial cell function, is altered both in individuals with chronic TBI and migraine headache disorder (Amyot et al., 2017; Lee et al., 2019b). The pathophysiologies of pPTH and migraine are believed to be associated with chronic microvascular dysfunction. We therefore hypothesize that TCVI may contribute to the underlying migraine-like mechanism(s) of pPTH. Materials and Methods: 22 moderate/severe TBI participants in the chronic stage (>6 months) underwent anatomic and functional magnetic resonance imaging (fMRI) scanning with hypercapnia gas challenge to measure CVR as well as the change in CVR (Delta CVR) after single-dose treatment of a specific phosphodiesterase-5 (PDE-5) inhibitor, sildenafil, which potentiates vasodilation in response to hypercapnia in impaired endothelium, as part of a Phase2a RCT of sildenafil in chronic TBI (NCT01762475). CVR and Delta CVR measures of each participant were compared with the individual's pPTH severity measured by the headache impact test-6 (HIT-6) survey. Results: There was a moderate correlation between HIT-6 and both CVR and Delta CVR scores [Spearman's correlation = -0.50 (p = 0.018) and = 0.46 (p = 0.03), respectively], indicating that a higher headache burden is associated with decreased endothelial function in our chronic TBI population. Conclusion: There is a correlation between PTH and CVR in chronic moderate-severe TBI. This relationship suggests that chronic TCVI may underlie the pathobiology of pPTH. Further, our results suggest that novel treatment strategies that target endothelial function and vascular health may be beneficial in refractory pPTH.	[Amyot, Franck; Ollinger, John; Davis, Cora; Kenney, Kimbra] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA; [Lynch, Cillian E.; Silverman, E.; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Werner, J. Kent; Moore, Carol; Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Turtzo, L. Christine] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD USA		Kenney, K (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA.; Kenney, K (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	kimbra.kenney@usuhs.edu			Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD; Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS; Intramural Research Program of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086090, DoD W81XWH14-2-0176, W81XWH-19-2-0002]	This work was supported by the Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD, by the Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS, and by the Intramural Research Program of the National Institutes of Health. This work was also funded by the NINDS U01 NS086090, DoD W81XWH14-2-0176, and W81XWH-19-2-0002.	Accession Medical Standards Analysis and Research Activity, 2019, DISABILITY EVALUATIO; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; [Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Barnes JN, 2013, J APPL PHYSIOL, V114, P1383, DOI 10.1152/japplphysiol.01258.2012; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Christensen CE, 2021, PAIN, V162, P176, DOI 10.1097/j.pain.0000000000002008; Christensen CE, 2019, CEPHALALGIA, V39, P264, DOI 10.1177/0333102418787336; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Haber M, 2018, J NEUROTRAUM, V35, P2250, DOI 10.1089/neu.2018.5684; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Hwang JY, 2018, EXP BRAIN RES, V236, P1421, DOI 10.1007/s00221-018-5230-6; Kansagara D., 2013, COMPLICATIONS MILD T; Kassner Andrea, 2004, Top Magn Reson Imaging, V15, P58, DOI 10.1097/00002142-200402000-00006; Kenney K, 2018, ANN CLIN TRANSL NEUR, V5, P418, DOI 10.1002/acn3.541; Kruuse C, 2003, BRAIN, V126, P241, DOI 10.1093/brain/awg009; Lee MJ, 2019, J NEUROL SCI, V398, P204, DOI 10.1016/j.jns.2019.01.039; Lee MJ, 2019, NEUROLOGY, V92, pE342, DOI 10.1212/WNL.0000000000006822; Lin Guan-Yu, 2014, Can Urol Assoc J, V8, pE378, DOI 10.5489/cuaj.1736; Lu HZ, 2014, JOVE-J VIS EXP, DOI 10.3791/52306; Mascalchi M, 2017, J NEUROIMAGING, V27, P85, DOI 10.1111/jon.12374; Mason BN, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00233; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Metti A, 2020, NEUROLOGY, V94, pE1137, DOI 10.1212/WNL.0000000000008935; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Sam K, 2016, ANN NEUROL, V80, P277, DOI 10.1002/ana.24712; Shafi R, 2021, J NEUROTRAUM, V38, P1036, DOI 10.1089/neu.2020.7272; Soljanlahti S, 2007, ACTA RADIOL, V48, P894, DOI 10.1080/02841850701468891; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Tong XK, 2015, J CEREBR BLOOD F MET, V35, P512, DOI 10.1038/jcbfm.2014.226; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Wilson Julie C, 2020, J Clin Transl Res, V5, P161; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890	37	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	MAY 13	2021	12								649901	10.3389/fphys.2021.649901			8	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	SI6ZW	WOS:000654977300001	34054569	gold, Green Published			2022-02-07	
J	McInnis, C; Garcia, MJS; Widjaja, E; Frndova, H; Van Huyse, J; Guerguerian, AM; Oyefiade, A; Laughlin, S; Raybaud, C; Miller, E; Tay, K; Bigler, ED; Dennis, M; Fraser, DD; Campbell, C; Choong, K; Dhanani, S; Lacroix, J; Farrell, C; Beauchamp, MH; Schachar, R; Hutchison, JS; Wheeler, AL				McInnis, Carter; Garcia, Maria Jose Solana; Widjaja, Elysa; Frndova, Helena; Van Huyse, Judith; Guerguerian, Anne-Marie; Oyefiade, Adeoye; Laughlin, Suzanne; Raybaud, Charles; Miller, Elka; Tay, Keng; Bigler, Erin D.; Dennis, Maureen; Fraser, Douglas D.; Campbell, Craig; Choong, Karen; Dhanani, Sonny; Lacroix, Jacques; Farrell, Catherine; Beauchamp, Miriam H.; Schachar, Russell; Hutchison, James S.; Wheeler, Anne L.		Attention Traumatic Brain Injury A; Canadian Critical Care Trials Grp; Canadian TBI Res Consortium	Magnetic Resonance Imaging Findings Are Associated with Long-Term Global Neurological Function or Death after Traumatic Brain Injury in Critically Ill Children	JOURNAL OF NEUROTRAUMA			English	Article						functional outcomes; magnetic resonance imaging; pediatrics; prediction models; traumatic brain injury	PEDIATRIC TBI; AXONAL INJURY; DTI FINDINGS; BIOMARKERS; OUTCOMES; COGNITION; LESIONS; MRI	The identification of children with traumatic brain injury (TBI) who are at risk of death or poor global neurological functional outcome remains a challenge. Magnetic resonance imaging (MRI) can detect several brain pathologies that are a result of TBI; however, the types and locations of pathology that are the most predictive remain to be determined. Forty-two critically ill children with TBI were recruited prospectively from pediatric intensive care units at five Canadian children's hospitals. Pathologies detected on subacute phase MRIs included cerebral hematoma, herniation, cerebral laceration, cerebral edema, midline shift, and the presence and location of cerebral contusion or diffuse axonal injury (DAI) in 28 regions of interest were assessed. Global functional outcome or death more than 12 months post-injury was assessed using the Pediatric Cerebral Performance Category score. Linear modeling was employed to evaluate the utility of an MRI composite score for predicting long-term global neurological function or death after injury, and nonlinear Random Forest modeling was used to identify which MRI features have the most predictive utility. A linear predictive model of favorable versus unfavorable long-term outcomes was significantly improved when an MRI composite score was added to clinical variables. Nonlinear Random Forest modeling identified five MRI variables as stable predictors of poor outcomes: presence of herniation, DAI in the parietal lobe, DAI in the subcortical white matter, DAI in the posterior corpus callosum, and cerebral contusion in the anterior temporal lobe. Clinical MRI has prognostic value to identify children with TBI at risk of long-term unfavorable outcomes.	[McInnis, Carter] Queens Univ, Fac Hlth Sci, Kingston, ON, Canada; [McInnis, Carter; Garcia, Maria Jose Solana; Widjaja, Elysa; Van Huyse, Judith; Guerguerian, Anne-Marie; Oyefiade, Adeoye; Dennis, Maureen; Schachar, Russell; Hutchison, James S.; Wheeler, Anne L.] Hosp Sick Children, Neurosci & Mental Hlth Res Program, Toronto, ON, Canada; [Widjaja, Elysa; Laughlin, Suzanne; Raybaud, Charles] Hosp Sick Children, Dept Diagnost Imaging, Div Neuroradiol, Toronto, ON, Canada; [Frndova, Helena; Guerguerian, Anne-Marie; Hutchison, James S.] Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada; [Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada; [Guerguerian, Anne-Marie; Hutchison, James S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Guerguerian, Anne-Marie; Hutchison, James S.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Oyefiade, Adeoye; Dennis, Maureen] Univ Toronto, Div Hematol Oncol, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Wheeler, Anne L.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Laughlin, Suzanne; Miller, Elka] Childrens Hosp Eastern Ontario, Dept Med Imaging, Ottawa, ON, Canada; [Dhanani, Sonny] Childrens Hosp Eastern Ontario, Dept Pediat, Div Pediat Intens Care, Ottawa, ON, Canada; [Tay, Keng] London Hlth Sci Ctr, Dept Radiol, London, ON, Canada; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol Sci, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Fraser, Douglas D.] Univ Western Ontario, Childrens Hosp, London Hlth Sci Ctr, Div Pediat Crit Care Med,Dept Pediat,Schulich Sch, London, ON, Canada; [Fraser, Douglas D.] Lawson Res Inst, London, ON, Canada; [Campbell, Craig] Univ Western Ontario, London Hlth Sci Ctr, Childrens Hosp, Div Neurol, London, ON, Canada; [Campbell, Craig] Univ Western Ontario, Dept Pediat Epidemiol & Clin Neurol Sci, Schulich Sch Med, London, ON, Canada; [Choong, Karen] McMaster Childrens Hosp, Hamilton Hlth Sci, Dept Pediat, Div Pediat Intens Care, Hamilton, ON, Canada; [Lacroix, Jacques; Farrell, Catherine; Beauchamp, Miriam H.] Univ Montreal, CHU St Justine, Div Pediat Crit Care, Montreal, PQ, Canada; [Lacroix, Jacques; Farrell, Catherine; Beauchamp, Miriam H.] CHU St Justine, Ctr Rech, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada		Hutchison, JS; Wheeler, AL (corresponding author), Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Peter Gilgan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G 0A4, Canada.	jamie.hutchison@sickkids.ca; anne.wheeler@sickkids.ca	Choong, Karen/ABB-7867-2021	Choong, Karen/0000-0002-4608-4508; McInnis, Carter/0000-0001-9383-3340	Ontario Neurotrauma Foundation [2006-ABI-COMOR-440]; Catalyst Scholarship for TBI Research - FedEx; Sick Kids Foundation; Ruth Taylor Studentship Fund at Queen's University School of Medicine	This study was funded by a peer reviewed grant (2006-ABI-COMOR-440) from the Ontario Neurotrauma Foundation. ALW is supported by a Catalyst Scholarship for TBI Research funded by FedEx and the Sick Kids Foundation. CM was supported by the Ruth Taylor Studentship Fund at Queen's University School of Medicine.	Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; GENTRY LR, 1994, RADIOLOGY, V191, P1; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Nowicki M, 2019, BRAIN INJURY, V33, P916, DOI 10.1080/02699052.2019.1565893; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Oyefiade A, 2019, J NEURO-ONCOL, V142, P39, DOI 10.1007/s11060-018-03083-x; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Stojanovski S, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102102; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Wald M.M., 2021, TRAUMATIC BRAIN INJU; Wilkinson A.A., 2017, CHILD NEUROL OPEN, V4; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Wilkinson AA, 2016, PEDIATR CRIT CARE ME, V17, P638, DOI 10.1097/PCC.0000000000000752; Yue JK, 2018, NEUROL RES, V40, P972, DOI 10.1080/01616412.2018.1505416; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	42	0	0	3	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2407	2418		10.1089/neu.2020.7514		MAY 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000649839500001	33787327				2022-02-07	
J	Meng, FW; Yu, JT; Chen, JY; Yang, PF				Meng, Fan-Wei; Yu, Jun-Tao; Chen, Jin-Yuan; Yang, Peng-Fei			New lymphatic cell formation is associated with damaged brain tissue clearance after penetrating traumatic brain injury	SCIENTIFIC REPORTS			English	Article							LYMPHANGIOGENESIS; PATHOPHYSIOLOGY	We characterized the tissue repair response after penetrating traumatic brain injury (pTBI) in this study. Seventy specific pathogen-free Kunming mice were randomly divided into the following groups: normal control, 1, 3, 7, 15, 21, and 30 days after pTBI. Hematoxylin and eosin (H&E) staining, immunohistochemistry, and immunofluorescence were performed to examine and monitor brain tissue morphology, and the distribution and expression of lymphatic-specific markers lymphatic vessel endothelial receptor-1 (LYVE-1), hematopoietic precursor cluster of differentiation 34 (CD34) antigen, and Prospero-related homeobox-1 (PROX1) protein. H&E staining revealed that damaged and necrotic tissues observed on day 1 at and around the injury site disappeared on day 7, and there was gradual shrinkage and disappearance of the lesion on day 30, suggesting a clearance mechanism. We explored the possibility of lymphangiogenesis causing this clearance as part of the post-injury response. Notably, expression of lymphangiogenesis markers LYVE-1, CD34, and PROX1 was detected in damaged mouse brain tissue but not in normal tissue. Moreover, new lymphatic cells and colocalization of LYVE-1/CD34 and LYVE-1/PROX1 were also observed. Our findings of the formation of new lymphatic cells following pTBI provide preliminary insights into a post-injury clearance mechanism in the brain. Although we showed that lymphatic cells are implicated in brain tissue repair, further research is required to clarify the origin of these cells.	[Meng, Fan-Wei; Yu, Jun-Tao; Chen, Jin-Yuan; Yang, Peng-Fei] Shandong Coll Tradit Chinese Med, Dept Anat & Physiol, 508 Binhaidonglu, Yantai 264199, Shandong, Peoples R China		Meng, FW (corresponding author), Shandong Coll Tradit Chinese Med, Dept Anat & Physiol, 508 Binhaidonglu, Yantai 264199, Shandong, Peoples R China.	13853573075@163.com					Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00209; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Dempsey L., 2015, NAT IMMUNOL, V16, P688; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jha SK, 2018, ANN ANAT, V219, P25, DOI 10.1016/j.aanat.2018.05.003; Kaser-Eichberger A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00023; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meng FW, 2020, J ANAT, V237, P933, DOI 10.1111/joa.13247; Meng FW, 2020, NEUROPATHOLOGY, V40, P215, DOI 10.1111/neup.12625; Mortimer PS, 2014, J CLIN INVEST, V124, P915, DOI 10.1172/JCI71608; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Noe Francesco M, 2019, Epilepsia Open, V4, P30, DOI 10.1002/epi4.12302; Raper D, 2016, TRENDS NEUROSCI, V39, P581, DOI 10.1016/j.tins.2016.07.001; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sandrone S, 2019, NAT MED, V25, P538, DOI 10.1038/s41591-019-0417-3; Srinivasan RS, 2011, GENE DEV, V25, P2187, DOI 10.1101/gad.16974811; Vaahtomeri K, 2017, GENE DEV, V31, P1615, DOI 10.1101/gad.303776.117; Varricchi G, 2018, CURR OPIN IMMUNOL, V53, P152, DOI 10.1016/j.coi.2018.05.002; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	23	0	0	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 13	2021	11	1							10193	10.1038/s41598-021-89616-3			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL5EP	WOS:000656941100032	33986371	Green Published, gold			2022-02-07	
J	Ronning, P; Helseth, E; Skaansar, O; Tverdal, C; Andelic, N; Bhatnagar, R; Melberg, M; Skaga, NO; Aarhus, M; Halvorsen, S; Helseth, R				Ronning, Pal; Helseth, Eirik; Skaansar, Ola; Tverdal, Cathrine; Andelic, Nada; Bhatnagar, Rahul; Melberg, Mathias; Skaga, Nils Oddvar; Aarhus, Mads; Halvorsen, Sigrun; Helseth, Ragnhild			Impact of Preinjury Antithrombotic Therapy on 30-Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; antithrombotic therapy; antiplatelet therapy; anticoagulant therapy; elderly; mortality	ANTIPLATELET THERAPY; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; TRANEXAMIC ACID; ESC GUIDELINES; HEAD-INJURIES; MANAGEMENT; ASSOCIATION; HEMORRHAGE; AGENTS	Objective: Elderly patients are frequently in need of antithrombotic therapy for reducing thrombotic events. The association between antithrombotic drugs and survival after traumatic brain injury (TBI) is, nevertheless, unclear. Methods: This retrospective study included patients >= 65 years admitted to a Norwegian Level 1 trauma center with TBI identified on cerebral computed tomography (cerebral-CT) during 2014-2019. Preinjury use of antiplatelets and anticoagulants was compared to the prescription rate in the general Norwegian population. The primary outcome was 30-day mortality. Uni- and multivariate logistic regression analyses estimated the association between the use of antithrombotic drugs and mortality. Results: The study includes 832 consecutive TBI patients >= 65 years. The median age was 76 years, 58% were males, 51% had moderate or severe TBI, and 39% had multiple traumas. Preinjury use of antithrombotics was registered in 471/832 (55.6%) patients; antiplatelet therapy alone in 268, anticoagulant therapy alone in 172, and combined antiplatelet and anticoagulant therapy in 31. Antiplatelet use did not differ between the study cohort and the general Norwegian population >= 65 years (31 vs. 31%, p = 0.87). Anticoagulant therapy was used more commonly in the study cohort than in the general Norwegian population (24 vs. 19%, p = 0.04). Combined use of antiplatelet and anticoagulant therapy was significantly associated with 30-day mortality, while preinjury antiplatelet or anticoagulation treatment alone was not. No difference in 30-day mortality between patients using VKA, DOACs, or LMWH was encountered. Conclusions: In this cohort, neither antiplatelet nor anticoagulant therapy alone was associated with increased 30-day mortality. Anticoagulant use was more prevalent among TBI patients than the general population, suggesting that anticoagulation might contribute to the initiation of intracranial bleeding after blunt head trauma. Combined antiplatelet and anticoagulant therapy posed increased risk of 30-day mortality.	[Ronning, Pal; Helseth, Eirik; Skaansar, Ola; Tverdal, Cathrine; Aarhus, Mads] Oslo Univ Hosp Ulleval, Dept Neurosurg, Oslo, Norway; [Helseth, Eirik; Tverdal, Cathrine; Andelic, Nada; Halvorsen, Sigrun] Univ Oslo, Fac Med, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Bhatnagar, Rahul; Halvorsen, Sigrun; Helseth, Ragnhild] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway; [Melberg, Mathias] Oslo Univ Hosp Ulleval, Dept Pulmonol, Oslo, Norway; [Skaga, Nils Oddvar] Oslo Univ Hosp, Dept Anesthesiol, Oslo, Norway		Helseth, R (corresponding author), Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway.	ragnhild.helseth@gmail.com		Tverdal, Cathrine/0000-0002-1094-3825	OUH	The work has been financed by OUH.	Apostolaki-Hansson T, 2021, STROKE, V52, P966, DOI 10.1161/STROKEAHA.120.030930; Apostolaki-Hansson T, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00760; Arnett DK, 2019, J AM COLL CARDIOL, V74, pE177, DOI 10.1016/j.jacc.2019.03.010; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Becattini C, 2020, BLOOD, V135, P305, DOI 10.1182/blood.2019001881; Brain Trauma Foundation, 2016, GUIDELINES MANAGEMEN, V4th; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Cuker A, 2019, AM J HEMATOL, V94, P697, DOI 10.1002/ajh.25475; Dunham CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109473; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Gulati S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202575; Huang WY, 2018, JAMA NEUROL, V75, P1511, DOI 10.1001/jamaneurol.2018.2215; Inohara T, 2018, JAMA-J AM MED ASSOC, V319, P463, DOI 10.1001/jama.2017.21917; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Johnston SC, 2018, NEW ENGL J MED, V379, P215, DOI 10.1056/NEJMoa1800410; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Konstantinides SV, 2019, EUR HEART J, V40, P3453, DOI 10.1093/eurheartj/ehz726; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mathieu F, 2020, J NEUROTRAUM, V37, P2069, DOI 10.1089/neu.2019.6911; Narum S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0094-1; Norwegian Institute of Public Health, 2019, NAT PRESCR DAT; Probst MA, 2020, ANN EMERG MED, V75, P354, DOI 10.1016/j.annemergmed.2019.10.004; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Rutherford OCW, 2020, EUR HEART J-CARD PHA, V6, P75, DOI 10.1093/ehjcvp/pvz086; Schaefer JK, 2019, JAMA INTERN MED, V179, P533, DOI 10.1001/jamainternmed.2018.7816; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Tillman H, 2019, JAMA NEUROL, V76, P774, DOI 10.1001/jamaneurol.2019.0932; Tollefsen MH, 2018, WORLD NEUROSURG, V114, pE209, DOI 10.1016/j.wneu.2018.02.167; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Tverdal C, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00269-8; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Veltkamp R, 2013, SEMIN THROMB HEMOST, V39, P963, DOI 10.1055/s-0033-1357506; Watson VL, 2017, NEUROSURGERY, V81, P899, DOI 10.1093/neuros/nyx072; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Xian Y, 2019, JAMA NEUROL, V76, P1192, DOI 10.1001/jamaneurol.2019.2099; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003725; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995; Zehtabchi S, 2015, AM J EMERG MED, V33, P458, DOI 10.1016/j.ajem.2014.11.009; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	48	0	0	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 13	2021	12								650695	10.3389/fneur.2021.650695			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SI6ZA	WOS:000654975100001	34054695	gold, Green Published			2022-02-07	
J	Sengupta, D; Bindra, A; Kumar, N; Goyal, K; Singh, PK; Chaturvedi, A; Malhotra, R; Mishra, AK				Sengupta, Deep; Bindra, Ashish; Kumar, Niraj; Goyal, Keshav; Singh, Pankaj Kumar; Chaturvedi, Arvind; Malhotra, Rajesh; Mishra, Ashwani Kumar			Respiratory morbidity and mortality of traumatic cervical spinal cord injury at a level I trauma center in India	SPINAL CORD SERIES AND CASES			English	Article							CARE; REHABILITATION; COMPLICATIONS; CHALLENGES; MANAGEMENT; OUTCOMES; BURDEN	Study design Descriptive retrospective. Objectives To evaluate the burden of respiratory morbidity in terms of ventilator dependence (VD) days and length of stay in neurotrauma ICU (NICU) and hospital, and to determine mortality in patients with traumatic cervical spinal cord injury (CSCI) in a low middle-income country (LMIC). Setting Jai Prakash Narayan Apex Trauma Center (JPNATC), All India Institute of Medical Sciences (AIIMS), New Delhi, India. Methods A total of 135 patients admitted with CSCI in the NICU between January 2017 to December 2018 were screened. Information regarding age, gender, American Spinal Injury Association (ASIA) impairment scale (AIS), level of injury, duration of VD, length of NICU, hospital stay, and outcome in terms of mortality or discharge from the hospital were obtained from the medical records. Results A total of 106 CSCI patients were analyzed. The mean (SD) age of patients was 40 (+/- 16) years and male: female ratio was 5:1. The duration of VD, duration of NICU, and hospital stay was a median of 8 days (IQR 1127), 6 days (IQR 1118), and 15 days (IQR 3127) respectively. Mortality was 19% (20/106). The mortality was significantly associated with poorer AIS score, VD, and duration of ICU and hospital stay. All patients were discharged to home only after they became ventilator-free. Conclusions The ventilator burden, hospital stay, and mortality are high in patients with CSCI in LMICs. Poor AIS scores, prolonged VD, ICU and hospital stay are associated with mortality. There is a need for comprehensive CSCI rehabilitation programs in LMICs to improve outcome.	[Sengupta, Deep; Bindra, Ashish; Kumar, Niraj; Goyal, Keshav; Chaturvedi, Arvind] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Neuroanaesthesiol & Crit Care, New Delhi, India; [Singh, Pankaj Kumar] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Neurosurg, New Delhi, India; [Malhotra, Rajesh] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, New Delhi, India; [Mishra, Ashwani Kumar] All India Inst Med Sci, Natl Drug Dependence Treatment Ctr, Biostat, New Delhi, India		Bindra, A (corresponding author), All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Neuroanaesthesiol & Crit Care, New Delhi, India.	dr_ashi2208@yahoo.com		Goyal, Keshav/0000-0001-9139-0689			Aleem IS, 2017, GLOB SPINE J, V7, P325, DOI 10.1177/2192568217694362; Bank M, 2018, GERIATR ORTHOP SURG, V9, DOI 10.1177/2151459318770882; Berlowitz DJ, 2016, BREATHE, V12, P329, DOI 10.1183/20734735.012616; Chamberlain JD, 2015, NEUROEPIDEMIOLOGY, V44, P182, DOI 10.1159/000382079; Chhabra HS, 2018, SPINAL CORD, V56, P71, DOI 10.1038/sc.2017.102; Conradsson D, 2019, SPINAL CORD, V57, P763, DOI 10.1038/s41393-019-0286-0; Franceschini M, 2020, SPINAL CORD, V58, P768, DOI 10.1038/s41393-020-0421-y; Fussenich W, 2018, SPINAL CORD, V56, P461, DOI 10.1038/s41393-017-0055-x; Vazquez RG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/168757; Galvagno Samuel M Jr, 2019, Anesthesiol Clin, V37, P13, DOI 10.1016/j.anclin.2018.09.009; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Lalwani S, 2014, INDIAN J MED RES, V140, P40; Liebscher T, 2015, J SPINAL CORD MED, V38, P607, DOI 10.1179/2045772314Y.0000000254; Loss Sérgio Henrique, 2015, Rev. bras. ter. intensiva, V27, P26, DOI 10.5935/0103-507X.20150006; MINAMINO M, 2018, LIFE SCI ALLIANCE, V1; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Neumann CR, 2009, J TRAUMA, V67, P67, DOI 10.1097/TA.0b013e3181aa63f3; Oderud T, 2014, AFR J DISABIL, V3, DOI 10.4102/ajod.v3i2.80; Parent S, 2011, J NEUROTRAUM, V28, P1363, DOI 10.1089/neu.2009.1151; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Renaud R, 2018, J REHABIL MED, V50, P402, DOI 10.2340/16501977-2323; Rinkaewkan P, 2015, SPINAL CORD, V53, P591, DOI 10.1038/sc.2015.8; Shao J, 2011, J SPINAL CORD MED, V34, P555, DOI 10.1179/2045772311Y.0000000024; Shavelle RM, 2006, J SPINAL CORD MED, V29, P511, DOI 10.1080/10790268.2006.11753901; Singh R, 2008, INT J REHABIL RES, V31, P247, DOI 10.1097/MRR.0b013e3282fb7d25; Soni KD, 2018, J EMERG TRAUMA SHOCK, V11, P189, DOI 10.4103/JETS.JETS_132_17; Spiegel DA, 2008, J BONE JOINT SURG AM, V90A, P915, DOI 10.2106/JBJS.G.00637; Wang HC, 2020, SPINE, V45, pE515, DOI 10.1097/BRS.0000000000003302; Zakrasek EC, 2017, SPINAL CORD, V55, P559, DOI 10.1038/sc.2017.10; Zheng Y, 2020, NEURAL REGEN RES, V15, P1437, DOI 10.4103/1673-5374.274332	30	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2058-6124			SPINAL CORD SER CASE	Spinal Cord Ser. Cases	MAY 13	2021	7	1							36	10.1038/s41394-020-00371-5			8	Clinical Neurology; Rehabilitation	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Rehabilitation	SD6EI	WOS:000651468000003	33986249	Green Published, Bronze			2022-02-07	
J	Williams, ET; Bubu, OM; Seixas, A; Sarpong, DF; Jean-Louis, G				Williams, Ellita T.; Bubu, Omonigho M.; Seixas, Azizi; Sarpong, Daniel F.; Jean-Louis, Girardin			Ambient Stimuli Perpetuate Nighttime Sleep Disturbances in Hospital Patients With TBI	BIOLOGICAL RESEARCH FOR NURSING			English	Article						noise; nocturnal awakenings; sleep; environment; TBI	TRAUMATIC BRAIN-INJURY; NOCTURNAL AWAKENINGS; ACUTE-PHASE; CARE; QUALITY; REHABILITATION; ENVIRONMENT; SYMPTOMS; RECOVERY; UNIT	Background and Objectives: The effect of the ambient environment, sound, light, and movement, on the nighttime rest-activity of patients hospitalized with moderate-severe traumatic brain injury (TBI) is poorly understood. The purpose of this study was to examine how sound, light, and movement in these patients' hospital rooms may contribute to nighttime awakenings. Methods: An observational design was used with 18 adult participants on a neuroscience step-down unit diagnosed with moderate-severe TBI. For up to five consecutive nights, actigraphy was used to capture nighttime awakenings while a custom-made multisensory device captured sound, light, and movement exposures in the participant's room. Results: Participants were awake for 24% (or about 3 hr) of the time during the designated nighttime period of 8 pm to 8 am. Average nighttime exposures of sound was 52 dB, light was nine lumens, and movement, measured as a proportion, was 0.28% or 28%. With each stimuli exposure set at its average, there was a 20% probability of participant nighttime awakenings. Clinically meaningful reductions of movement in and out the participant's room and elevated sound significantly decreases the participant's probability of nighttime awakenings (p < .05), but reductions in light did not. Conclusion: The ambient environment seems to impede restful sleep in immediate post-injury phase of patients with moderate-severe TBI.	[Williams, Ellita T.; Bubu, Omonigho M.; Seixas, Azizi; Jean-Louis, Girardin] NYU Langone Hlth, Dept Populat Hlth, Grossman Sch Med, 180 Madison Ave, New York, NY 10016 USA; [Bubu, Omonigho M.; Seixas, Azizi; Jean-Louis, Girardin] NYU Langone Hlth, Dept Psychiat, Grossman Sch Med, New York, NY 10016 USA; [Sarpong, Daniel F.] Xavier Univ Louisiana, Coll Pharm, Div Clin & Adm Sci, New Orleans, LA 70125 USA		Williams, ET (corresponding author), NYU Langone Hlth, Dept Populat Hlth, Grossman Sch Med, 180 Madison Ave, New York, NY 10016 USA.	ellita.williams@nyulangone.org		BUBU, OMONIGHO/0000-0001-7438-2628; Seixas, Azizi/0000-0003-0843-2679; Jean-Louis, Girardin/0000-0001-6777-2724	NIH/NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [5TL1TR000422]; NIH/NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR015715, T32NR009759]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R25NS094093-04, 5T32HL129 953-04]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded, in part, by the following grants awarded to Dr. Williams: NIH/NCATS 5TL1TR000422, NIH/NINR F31NR015715, NIH/NINR T32NR009759, NIH 5R25NS094093-04, and 5T32HL129 953-04.	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Anafi RC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-362; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernhofer EI, 2014, J ADV NURS, V70, P1164, DOI 10.1111/jan.12282; Buchanan DT, 2017, J CLIN SLEEP MED, V13, P11, DOI 10.5664/jcsm.6376; Burgess HJ, 2014, PHOTOCHEM PHOTOBIOL, V90, P723, DOI 10.1111/php.12241; Busch-Vishniac IJ, 2005, J ACOUST SOC AM, V118, P3629, DOI 10.1121/1.2118327; Busch-Vishniac Ilene, 2015, Biomed Instrum Technol, V49, P280, DOI 10.2345/0899-8205-49.4.280; Buxton O, 2012, ANN INTERN MED, V3, P170; Callahan ML, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0867-x; Chiu HY, 2014, INT J NURS STUD, V51, P892, DOI 10.1016/j.ijnurstu.2013.10.020; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Desjardins France, 2008, Nurs Leadersh (Tor Ont), V21, P26; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Duclos C, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0709-x; Fanfulla F, 2011, SLEEP, V34, P355, DOI 10.1093/sleep/34.3.355; Gabor JY, 2003, AM J RESP CRIT CARE, V167, P708, DOI 10.1164/rccm.2201090; Gathecha E, 2016, J HOSP MED, V11, P467, DOI 10.1002/jhm.2578; Gooley JJ, 2011, J CLIN ENDOCR METAB, V96, pE463, DOI 10.1210/jc.2010-2098; Hagen C., 1997, RANCHO AMIGOS COGNIT; Hagen C, 1972, RANCHO AMIGOS LEVELS; Hill A, 2007, DATA ANAL USING REGR; Inouye SK, 2013, JAMA INTERN MED, V173, P1555, DOI 10.1001/jamainternmed.2013.7809; JENNETT B, 1977, LANCET, V1, P878; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; Linder LA, 2012, ONCOL NURS FORUM, V39, P553, DOI 10.1188/12.ONF.553-561; Lorah J, 2019, BEHAV RES METHODS, V51, P440, DOI 10.3758/s13428-018-1188-3; Malkmus P., 1974, LEVELS COGNITIVE FUN; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morgenthaler TI, 2015, J CLIN SLEEP MED, V11, P279, DOI 10.5664/jcsm.4548; Nazem S, 2016, J HEAD TRAUMA REHAB, V31, P136, DOI 10.1097/HTR.0000000000000225; Neitzel RL, 2011, ANN OCCUP HYG, V55, P906, DOI 10.1093/annhyg/mer050; Nelson J, 2015, J NEUROSCI NURS, V47, pE9, DOI 10.1097/JNN.0000000000000136; Ohayon MM, 2010, J PSYCHOSOM RES, V69, P565, DOI 10.1016/j.jpsychores.2010.03.010; Ohayon MM, 2008, J PSYCHIATR RES, V43, P48, DOI 10.1016/j.jpsychires.2008.02.001; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Park Marn Joon, 2014, Environ Health Toxicol, V29, pe2014006, DOI 10.5620/eht.2014.29.e2014006; Pellicane AJ, 2014, REHABIL NURS, V39, P305, DOI 10.1002/rnj.169; Ren DX, 2017, J HEAD TRAUMA REHAB, V32, pE29, DOI 10.1097/HTR.0000000000000294; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas KP, 2012, J HOSP MED, V7, P508, DOI 10.1002/jhm.1934; Ugras GA, 2015, J NEUROSCI NURS, V47, P104, DOI 10.1097/JNN.0000000000000122; van Enkhuizen J, 2014, BEHAV BRAIN RES, V261, P40, DOI 10.1016/j.bbr.2013.12.003; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; WHO, 2018, ENV NOIS GUID EUR RE; WHO, 2009, NIGHT NOIS GUID EUR; Williams E. T., 2016, TESTING REFINING SOU; Williams ET, 2019, J NEUROSCI NURS, V51, P134, DOI 10.1097/JNN.0000000000000441; Williams ET, 2017, J NURSING DOCTORAL S, V7, P48; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697; Yoder JC, 2013, JAMA INTERN MED, V173, P1554, DOI 10.1001/jamainternmed.2013.7791	54	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	OCT	2021	23	4					637	645	10998004211016060	10.1177/10998004211016060		MAY 2021	9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	WA2RN	WOS:000651181800001	33982620				2022-02-07	
J	Cripe, CT; Cooper, R; Mikulecky, P; Huang, JH; Hack, DC				Cripe, Curtis T.; Cooper, Rebecca; Mikulecky, Peter; Huang, Jason H.; Hack, Dallas C.			Improved Mild Closed Head Traumatic Brain Injury Outcomes With a Brain-Computer Interface Amplified Cognitive Remediation Training	CUREUS			English	Article						cognitive remediation training; brain computer interface; bci; quantitative electroencephalography; qeeg; traumatic brain injury; mtbi; executive cognitive control	MEMORY; FMRI; TBI	This study is a retrospective chart review of 200 clients who participated in a non-verbal restorative cognitive remediation training (rCRT) program between 2012 and 2020. Each client participated in the program for about. 16 weeks, and the study as a whole occurred over a five-year period. The program was applied to effect proper neural functional remodeling needed to support resilient, flexible, and adaptable behaviors after encountering a mild closed head traumatic brain injury (mTBI). The rCRT program focused on improving functional performance in executive cognitive control networks as defined by IMR1 studies. All rCRT activities were delivered in a semi-game-like manner, incorporating a brain-computer interface (BCI) that provided in-the-moment neural network performance integrity metrics (nPIMs) used to adjust the level of play required to properly engage long-term potentiation (LTP) and long-term depression (LTD) network learning rules. This study reports on t-test and Reliable Change Index (RCI) changes found within individual cognitive abilities' performance metrics derived from the Woodcock-Johnson Cognitive Abilities III Test. We compared pre- and post-scores from seven cognitive abilities considered dependent on executive cognitive control networks against seven non-executive control abilities. We observed significant improvements (p < 10(4)) with large Cohen's d effect sizes (0.78-1.20) across 13 of 14 cognitive ability domains with a medium effect size (0.49) on the remaining one. The mean percent change for the pooled trained domain was double that observed for the pooled untrained domain, al 17.2% versus 8.3%, respectively. lb further adjust for practice effects, practice effect RCI values were computed and further supported the effectiveness of the rCRT (trained RCI 1.4-4.8; untrained RCI 0.08-0.75).	[Cripe, Curtis T.] Fordham Univ, Grad Sch Social Serv, New York, NY USA; [Cripe, Curtis T.; Cooper, Rebecca] NTLGrp Inc, Behav Med NeuroEngn, Scottsdale, AZ USA; [Mikulecky, Peter; Hack, Dallas C.] Neurol Inc, Brain Mapping & Optimizat, Newport Beach, CA 92660 USA; [Huang, Jason H.] Baylor Scott & White Med Ctr, Neurosurg, Temple, TX USA		Mikulecky, P (corresponding author), Neurol Inc, Brain Mapping & Optimizat, Newport Beach, CA 92660 USA.	peter@neurologics.com					[Anonymous], 2015, REPORT C MILD TRAUMA; Bathelt J, 2019, TRENDS NEUROSCI EDUC, V15, P38, DOI 10.1016/j.tine.2019.02.004; Blazer DG., PROGR UNDERSTANDING; Braboszcz C, 2011, NEUROIMAGE, V54, P3040, DOI 10.1016/j.neuroimage.2010.10.008; Cai WD, 2016, CEREB CORTEX, V26, P2140, DOI 10.1093/cercor/bhv046; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chen TW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002469; Chiaravalloti ND, 2015, J HEAD TRAUMA REHAB, V30, P261, DOI 10.1097/HTR.0000000000000164; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Cripe C., 2014, PSYCHOL NEW DESIGN S, P100; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Gordon EM, 2018, CELL REP, V24, P1687, DOI 10.1016/j.celrep.2018.07.050; Gratton G, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13038; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Roitsch J, 2019, J HEAD TRAUMA REHAB, V34, pE42, DOI 10.1097/HTR.0000000000000444; Santarnecchi E, 2017, INTELLIGENCE, V63, P9, DOI 10.1016/j.intell.2017.04.008; Sha ZQ, 2019, BIOL PSYCHIAT, V85, P379, DOI 10.1016/j.biopsych.2018.11.011; Siemann J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20049-1; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vinogradov S, 2012, NEUROPSYCHOPHARMACOL, V37, P43, DOI 10.1038/npp.2011.251; Woodcock R.W, 2001, WOODCOCK JOHNSON 3 A; Wykes T, 2002, BRIT J PSYCHIAT, V181, P144	31	0	0	2	3	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAY 12	2021	13	5							e14996	10.7759/cureus.14996			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SC8VH	WOS:000650940700021	34007777	gold, Green Published			2022-02-07	
J	Fedele, B; McKenzie, D; Williams, G; Giles, R; Olver, J				Fedele, Bianca; McKenzie, Dean; Williams, Gavin; Giles, Robert; Olver, John			Assessing Sleep Architecture With Polysomnography During Posttraumatic Amnesia After Traumatic Brain Injury: A Pilot Study	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						brain injuries; traumatic; sleep; posttraumatic amnesia; polysomnography; melatonin; rehabilitation	WAKE DISTURBANCES; AMERICAN-ACADEMY; ACUTE-PHASE; MELATONIN; APNEA; DIAGNOSIS; RECOMMENDATIONS; REHABILITATION; METAANALYSIS; GUIDELINES	Background Early-onset sleep disturbance is common following moderate to severe traumatic brain injury (TBI) and often emerges while patients are in posttraumatic amnesia (PTA). However, sleep disruptions during this subacute recovery phase are not well-defined, and research often utilizes indirect measures (actigraphy) that quantify sleep based on activity. This study aims to examine sleep macro-architecture and sleep quality directly with ambulatory polysomnography (PSG) and measure endogenous salivary melatonin levels for patients experiencing PTA following moderate to severe TBI. Method Participants were recruited from an inpatient TBI rehabilitation unit. Nighttime PSG was administered at the patient's bedside. Two saliva specimens were collected for melatonin testing on a separate evening (24:00 and 06:00 hours) using melatonin hormone profile test kits. Results Of 27 patients in whom PSG was recorded, the minimum required monitoring time occurred in n =17 (adherence: 63%) at a median of 37.0 days (quartile 1 [Q1] to quartile 3 [Q3]: 21.5-50.5) postinjury. Median non-rapid eye movement (NREM) and REM sleep proportions were similar to normal estimates. Slow-wave sleep was reduced and absent in 35.3% of patients. Sleep periods appeared fragmented, and median sleep efficiency was reduced (63.4%; Q1-Q3: 55.1-69.2). Median melatonin levels at both timepoints were outside the normal range of values specified for this test (from Australian Clinical Labs). Conclusion This study reports that ambulatory PSG and salivary melatonin assessment are feasible for patients experiencing PTA and offers new insight into the extent of sleep disturbance. Further research is necessary to understand associations between PTA and sleep disturbance.	[Fedele, Bianca; McKenzie, Dean; Williams, Gavin; Giles, Robert; Olver, John] Epworth HealthCare, Melbourne, Vic, Australia; [Fedele, Bianca; Williams, Gavin; Olver, John] Epworth Monash Rehabil Med EMReM Unit, Melbourne, Vic, Australia; [Fedele, Bianca; McKenzie, Dean; Olver, John] Monash Univ, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Melbourne, Vic, Australia		Fedele, B (corresponding author), Epworth HealthCare, Dept Rehabil, 89 Bridge Rd, Melbourne, Vic 3121, Australia.	bianca.fedele@epworth.org.au		Fedele, Bianca/0000-0003-4302-2480; Olver, John/0000-0001-7069-1191	Epworth Research Institute (ERI)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Professor Jack Cade AM Intensivist Major Development Grant from the Epworth Research Institute (ERI).	American Association of Sleep Technologists, SLEEP TECHN TECHN GU; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Benloucif S, 2005, J BIOL RHYTHM, V20, P178, DOI 10.1177/0748730404273983; Benloucif S, 2008, J CLIN SLEEP MED, V4, P66; Berry RB, 2016, AASM MANUAL SCORING; Carskadon M. A., 2017, PRINCIPLES PRACTICE; Chokroverty S., 2017, SLEEP DISORDERS MED, P5, DOI DOI 10.1007/978-1-4939-6578-62; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Colten HR, 2006, SLEEP DISORDERS SLEE, P34; Curran-Everett D, 2013, ADV PHYSIOL EDUC, V37, P213, DOI 10.1152/advan.00053.2013; de Almeida EA, 2011, CHILD NERV SYST, V27, P879, DOI 10.1007/s00381-010-1278-8; Dijk Derk-Jan, 2009, J Clin Sleep Med, V5, pS6; Douglas JA, 2017, SLEEP MED, V36, pS2, DOI 10.1016/j.sleep.2017.03.019; Driver S, 2016, BRAIN IMPAIR, V17, P55, DOI 10.1017/BrImp.2015.20; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duclos C, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz191; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Efron B., 1993, INTRO BOOTSTRAP; ENGLISH J, 1993, ANN CLIN BIOCHEM, V30, P415, DOI 10.1177/000456329303000414; Fares Auda, 2011, J Cardiovasc Dis Res, V2, P153, DOI 10.4103/0975-3583.85261; Fedele B, 2020, BRAIN INJURY, V34, P316, DOI 10.1080/02699052.2019.1695288; Flemons WW, 2003, CHEST, V124, P1543, DOI 10.1378/chest.124.4.1543; George CFP, 1996, CAN MED ASSOC J, V155, P1673; Gosselin N, 2017, PRINCIPLES PRACTICE, P260; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Hirshkowitz M, 2004, MED CLIN N AM, V88, P551, DOI 10.1016/j.mcna.2004.01.001; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kryger M., 2017, PRINCIPLES PRACTICE; Leger D, 2018, SLEEP MED REV, V41, P113, DOI 10.1016/j.smrv.2018.01.008; Makley MJ, 2018, NEUROREHABILITATION, V43, P277, DOI 10.3233/NRE-182537; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mantua J, 2018, SLEEP MED REV, V41, P61, DOI 10.1016/j.smrv.2018.01.004; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matsuo M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00110; MERICA H, 1985, SLEEP, V8, P261, DOI 10.1093/sleep/8.3.261; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Ohayon M, 2017, SLEEP HEALTH, V3, P6, DOI 10.1016/j.sleh.2016.11.006; Olver J., 2012, PRACTICAL MANAGEMENT, P231; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Portier F, 2000, AM J RESP CRIT CARE, V162, P814, DOI 10.1164/ajrccm.162.3.9908002; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Sewalt CA, 2020, BRIT J SURG, V107, P373, DOI 10.1002/bjs.11304; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Smith MT, 2018, J CLIN SLEEP MED, V14, P1209, DOI 10.5664/jcsm.7228; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Walker JM, 2007, J CLIN SLEEP MED, V3, P455; Wang D, 2007, SLEEP MED REV, V11, P35, DOI 10.1016/j.smrv.2006.03.006; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697; Zeitzer JM, 2020, PM&R, V12, P1205, DOI 10.1002/pmrj.12353; Zisapel N, 2018, BRIT J PHARMACOL, V175, P3190, DOI 10.1111/bph.14116	63	0	0	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUL	2021	35	7					622	633	15459683211011241	10.1177/15459683211011241		MAY 2021	12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	SY4KH	WOS:000651175200001	33978535				2022-02-07	
J	Gribbell, M; Hsu, J; Krech, L; Pounders, S; Koestner, A; Haverkamp, J; Burns, K; Gawel, J; Kwazneski, D; Iskander, G; Gibson, C; Chapman, A				Gribbell, Mikalah; Hsu, Justin; Krech, Laura; Pounders, Steffen; Koestner, Amy; Haverkamp, Jennifer; Burns, Kelly; Gawel, Jeffrey; Kwazneski, Douglas; Iskander, Gaby; Gibson, Charles; Chapman, Alistair			Step up to the Brain Injury Guidelines league: Adoption of Brain Injury Guidelines at a Level III trauma center, A pilot study	TRAUMA-ENGLAND			English	Article; Early Access						Trauma; traumatic brain injury; Brain Injury Guidelines; acute care surgery	HEAD COMPUTED-TOMOGRAPHY	Introduction: The Brain Injury Guidelines (BIG) direct surgeons to implement risk-stratified treatment plans for patients with traumatic brain injury (TBI). BIG categorize patients into one of three severity categories, from lowest to highest risk (BIG 1, BIG 2, and BIG 3). BIG empowers physicians to implement standardized treatment plans that limit unnecessary hospitalizations, repeat imaging, and neurosurgical consultation. These guidelines have been studied in Level I trauma centers, but their clinical application has never been studied in a Level III trauma center. In this pilot study, we sought to determine if the BIG can be implemented in a regional trauma center where patients with less severe brain injuries are locally evaluated and treated. Methods: All TBI patients at a Level III trauma center were stratified using the BIG criteria, where BIG 1 and BIG 2 patients were managed locally and BIG 3 patients were transferred to a Level I trauma center. We conducted a retrospective review using the local trauma database and electronic medical records over a 1-year period when BIG were first protocolized. The primary endpoint included deaths, complications, readmissions, and length of stay. Results: There were 6 (12.2%) BIG 1, 5 (10.2%) BIG 2, and 38 (77.6%) BIG 3 patients evaluated at the Level III trauma center. All BIG 1 and BIG 2 patients remained at the Level III trauma center, and 33 of the 38 BIG 3 patients were transferred. There were no complications, readmissions, or unexpected transfers within the BIG 1 or BIG 2 patient cohorts. Conclusion: The BIG criteria can be successfully implemented in a Level III trauma center. A collaborative transfer agreement with a Level I trauma center reduces unnecessary transfers without negatively affecting patient care. The BIG criteria should be considered for well-developed regional trauma systems.	[Gribbell, Mikalah] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA; [Hsu, Justin] Michigan State Univ, Spectrum Hlth, Coll Human Med, Gen Surg Residency, 100 Michigan NE,Suite A501, Grand Rapids, MI 49503 USA; [Krech, Laura; Pounders, Steffen; Chapman, Alistair] Spectrum Hlth Trauma Res Inst, Grand Rapids, MI USA; [Pounders, Steffen] Spectrum Hlth Off Res, Grand Rapids, MI USA; [Koestner, Amy; Haverkamp, Jennifer; Burns, Kelly; Gawel, Jeffrey; Kwazneski, Douglas; Iskander, Gaby; Gibson, Charles; Chapman, Alistair] Spectrum Hlth Acute Care Surg & Gen Surg, Grand Rapids, MI USA		Hsu, J (corresponding author), Michigan State Univ, Spectrum Hlth, Coll Human Med, Gen Surg Residency, 100 Michigan NE,Suite A501, Grand Rapids, MI 49503 USA.	Justin.Hsu@Spectrumhealth.org		Hsu, Justin/0000-0001-9850-3869			Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Brito A, 2019, J SURG RES, V244, P332, DOI 10.1016/j.jss.2019.06.071; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Martin GE, 2018, J TRAUMA ACUTE CARE, V84, P483, DOI 10.1097/TA.0000000000001767; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Reljic T, 2014, J NEUROTRAUM, V31, P78, DOI 10.1089/neu.2013.2873; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129	11	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma											14604086211017374	10.1177/14604086211017374		MAY 2021	7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	SD1YY	WOS:000651164800001					2022-02-07	
J	Hummel, R; Lang, M; Walderbach, S; Wang, Y; Tegeder, I; Golz, C; Schafer, MKE				Hummel, Regina; Lang, Manuel; Walderbach, Simona; Wang, Yong; Tegeder, Irmgard; Goelz, Christina; Schaefer, Michael K. E.			Single intracerebroventricular progranulin injection adversely affects the blood-brain barrier in experimental traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						blood-brain barrier; neuroinflammation; neuroprotection; progranulin; traumatic brain injury	CEREBRAL ISCHEMIA-REPERFUSION; HIPPOCAMPAL NEUROGENESIS; FRONTOTEMPORAL DEMENTIA; BREAKDOWN PRODUCTS; INFLAMMATION; RESPONSES; PROTECTS; INVOLVEMENT; SUPPRESSION; DYSFUNCTION	Progranulin (PGRN) is a neurotrophic and anti-inflammatory factor with protective effects in animal models of ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury (TBI). Administration of recombinant (r) PGRN prevents exaggerated brain pathology after TBI in Grn-deficient mice, suggesting that local injection of recombinant progranulin (rPGRN) provides therapeutic benefit in the acute phase of TBI. To test this hypothesis, we subjected adult male C57Bl/6N mice to the controlled cortical impact model of TBI, administered a single dose of rPGRN intracerebroventricularly (ICV) shortly before the injury, and examined behavioral and biological effects up to 5 days post injury (dpi). The anti-inflammatory bioactivity of rPGRN was confirmed by its capability to inhibit the inflammation-induced hypertrophy of murine primary microglia and astrocytes in vitro. In C57Bl/6N mice, however, ICV administration of rPGRN failed to attenuate behavioral deficits over the 5-day observation period. (Immuno)histological gene and protein expression analyses at 5 dpi did not reveal a therapeutic benefit in terms of brain injury size, brain inflammation, glia activation, cell numbers in neurogenic niches, and neuronal damage. Instead, we observed a failure of TBI-induced mRNA upregulation of the tight junction protein occludin and increased extravasation of serum immunoglobulin G into the brain parenchyma at 5 dpi. In conclusion, single ICV administration of rPGRN had not the expected protective effects in the acute phase of murine TBI, but appeared to cause an aggravation of blood-brain barrier disruption. The data raise questions about putative PGRN-boosting approaches in other types of brain injuries and disease.	[Hummel, Regina; Lang, Manuel; Walderbach, Simona; Wang, Yong; Goelz, Christina; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany; [Tegeder, Irmgard] Goethe Univ Frankfurt, Inst Clin Pharmacol, Med Fac, Frankfurt, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Mainz, Germany		Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany.; Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci, Langenbeckstr 1,Bldg 505, D-55131 Mainz, Germany.	Michael.Schaefer@unimedizin-mainz.de		Schafer, Michael K.E./0000-0001-6055-6244; wang, yong/0000-0001-6134-9079; Tegeder, Irmgard/0000-0001-7524-8025	Mainz Research School of Translational Biomedicine (TransMed) of the University Medical Center, Johannes Gutenberg-University Mainz, Germany; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SCHA1261/4-3, CRC1080]	This study was supported by the Mainz Research School of Translational Biomedicine (TransMed) of the University Medical Center, Johannes Gutenberg-University Mainz, Germany, and by the Deutsche Forschungsgemeinschaft (SCHA1261/4-3 to MKES and CRC1080, C02 to IT).	Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Altmann C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0132-1; Amado DA, 2019, MOL THER, V27, P465, DOI 10.1016/j.ymthe.2018.11.013; Asakura R, 2011, NEUROREPORT, V22, P881, DOI 10.1097/WNR.0b013e32834bf4ca; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 2018, METHODS MOL BIOL, V1806, P3, DOI 10.1007/978-1-4939-8559-3_1; Cash A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093344; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Chiba Y, 2018, AM J PHYSIOL-LUNG C, V314, pL215, DOI 10.1152/ajplung.00575.2016; Chitramuthu BP, 2017, BRAIN, V140, P3081, DOI 10.1093/brain/awx198; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; De Reuck J, 2012, EUR J NEUROL, V19, P1355, DOI 10.1111/j.1468-1331.2012.03776.x; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Gass J, 2012, BRAIN RES, V1462, P118, DOI 10.1016/j.brainres.2012.01.047; Golz C, 2019, J NEUROCHEM, V150, P173, DOI 10.1111/jnc.14678; Griemert EV, 2019, ANN NEUROL, V85, P667, DOI 10.1002/ana.25458; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Horinokita I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205210; Hsiung G.Y.R., 1993, GENEREVIEWS R; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Hummel R, 2020, BRIT J PHARMACOL, V177, P5208, DOI 10.1111/bph.15259; Jackman K, 2013, J NEUROSCI, V33, P19579, DOI 10.1523/JNEUROSCI.4318-13.2013; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Kanazawa M, 2015, BRAIN, V138, P1932, DOI 10.1093/brain/awv079; Kao AW, 2017, NAT REV NEUROSCI, V18, P325, DOI 10.1038/nrn.2017.36; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Lau TT, 2016, J BIOMED MATER RES A, V104, P2968, DOI 10.1002/jbm.a.35845; Li B, 2015, CRIT CARE MED, V43, pE304, DOI 10.1097/CCM.0000000000001096; Li XG, 2020, BIOCHEM BIOPH RES CO, V521, P569, DOI 10.1016/j.bbrc.2019.09.111; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Ma YB, 2017, MOL NEUROBIOL, V54, P3717, DOI 10.1007/s12035-016-9939-6; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Paushter DH, 2018, ACTA NEUROPATHOL, V136, P1, DOI 10.1007/s00401-018-1861-8; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Salazar DA, 2015, J NEUROSCI, V35, P9315, DOI 10.1523/JNEUROSCI.4808-14.2015; Schafer MKE, 2018, MATRIX BIOL, V68-69, P571, DOI 10.1016/j.matbio.2017.10.002; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Staib-Lasarzik I, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0531-7; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0078-x; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tao J, 2012, BRAIN RES, V1436, P130, DOI 10.1016/j.brainres.2011.11.063; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tian QY, 2014, FRONT BIOSCI-LANDMRK, V19, P1176, DOI 10.2741/4274; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Wang C, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1630-1; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Zheng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021023; Zhou CH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0415-4; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	72	0	0	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2021	158	2					342	357		10.1111/jnc.15375		MAY 2021	16	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	TJ2BR	WOS:000649581300001	33899947	hybrid			2022-02-07	
J	Ignacy, T; Post, A; Gardner, AJ; Gilchrist, MD; Hoshizaki, TB				Ignacy, Talia; Post, Andrew; Gardner, Andrew J.; Gilchrist, Michael D.; Hoshizaki, Thomas Blaine			Comparison of dynamic response and maximum principal strain of diagnosed concussion in professional men's rugby league	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article; Early Access						Head injury; impact reconstructions; finite element analysis; biomechanics	VIDEO ANALYSIS; CONTACT SPORTS; INJURY; RECONSTRUCTION; ACCELERATION; HEADGEAR; FOOTBALL; IMPACTS; PERFORMANCE; PREDICTORS	Rugby league has been identified as a contact sport with a high incidence of concussion. Research has been conducted to describe incidence and mechanisms of concussion in rugby league, however the risks associated with injury events (shoulder, hip, head to head) are unknown. The purpose of this study was to describe the common injury events leading to concussion in the National Rugby League and compare these events through analysis of dynamic response and brain tissue deformation. Twenty-seven impact videos of concussive injuries were physically reconstructed to obtain linear and rotational accelerations of the head. Dynamic response data were input into the University College Dublin Brain Trauma Model (UCDBTM) to calculate maximum principal strain (MPS). Head-to-head events produced a short duration event with an average peak linear and peak rotational acceleration of 205g and 15,890 rad/s(2), respectively, which were significantly greater than the longer duration hip-to-head (24.7g and 2650 rad/s(2)) and shoulder-to-head (24.2g and 3280 rad/s(2)) impacts. There were no differences in MPS between events. These results suggest that risk of strain to the brain may be produced by short and long duration acceleration events. Thus, both of these accelerations need to be accounted for in the development of improved head and body protection in rugby. In addition, this data demonstrates that these events cause a risk of concussion requiring efforts to limit or modify how energy is transferred to the head.	[Ignacy, Talia; Post, Andrew; Hoshizaki, Thomas Blaine] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Mech & Mat Engn, Dublin, Ireland; [Gardner, Andrew J.] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Gardner, Andrew J.] John Hunter Hosp, Hunter New England Local Hlth Dist, Sports Concuss Program, New Lambton Hts, NSW, Australia		Post, A (corresponding author), Univ Ottawa, Fac Hlth Sci, Neurotrauma Impact Sci Lab, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552; Gardner, Andrew/0000-0001-5031-5586			Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Clark JM, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1599062; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gennarelli TA, 2015, INT RES COUNCIL BIOM; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Ho J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/36/365601; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T.B., 2014, J NEUROL NEUROPHYS, V5, P1, DOI [10.4172/2155-9562.1000181, DOI 10.4172/2155-9562.1000181]; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Ignacy T., 2017, HUMAN KINETICS; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kendall M, 2013, INT RES COUNCIL BIOM; Kendall M., 2016, HUMAN KINETICS; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knouse CL, 2003, J ATHL TRAINING, V38, P330; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Nahum A, 1977, 21 STAPP CAR CRASH C; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A., 2019, 42 CAN MED BIOL ENG; Post A, 2021, TRAUMA, V23, P24, DOI 10.1177/1460408620916578; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Rock BB, 2016, HUMAN KINETICS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Savage J, 2013, J SPORTS MED, V2013; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; WINTER DA, 1990, BIOMECHANICS MOTOR C, P56; Yang J., 2011, INVESTIGATION BRAIN, P9; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	59	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.											17543371211016596	10.1177/17543371211016596		MAY 2021	11	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	SD7QF	WOS:000651567600001					2022-02-07	
J	Mishra, SK; Khushu, S; Gangenahalli, G				Kumar Mishra, Sushanta; Khushu, Subash; Gangenahalli, Gurudutta			Neuroprotective response and efficacy of intravenous administration of mesenchymal stem cells in traumatic brain injury mice	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						fluorescence in situ hybridisation; magnetic resonance imaging; mesenchymal stem cells; neuronal differentiation; traumatic brain injury	COGNITIVE RECOVERY; CELLULAR-THERAPY; STROMAL CELLS; NEUROGENESIS; PROLIFERATION; TRANSPLANTATION; RATS	Cellular transplantation of stem cells can be a beneficial treatment approach for neurodegenerative diseases such as traumatic brain injury (TBI). In this study, we investigated the proliferation and differentiation potential of infused mesenchymal stem cells (MSCs) after localisation at the injury site. We evaluated the appropriate homing of infused MSCs through immunohistochemistry, followed by Y-chromosome-specific polymerase chain reaction and fluorescent in situ hybridisation analyses. The proliferation and differentiation of infused MSCs were analysed using exogenous cell tracer 5 '-bromo-2 '-deoxyuridine (BrdU) labelling and neuronal specific markers, respectively. Structural and functional recovery in TBI mice were examined by performing magnetic resonance imaging and different behavioural assessments, respectively. Results demonstrated a significantly high number of BrdU-positive cells in the lesion region in the MSC-infused group compared with control and TBI groups. Infused MSCs were well differentiated into neural-like cells and expressed significantly more neural markers (neuronal nuclear antigen [NeuN], microtubule-associated protein 2 [MAP2] and glial fibrillary acid protein [GFAP]). Improved tissue abnormalities as well as functional behaviours were observed in MSC-infused TBI mice, implying the substantial proliferation and differentiation of infused MSCs. Our findings support the neuroprotective response and efficacy of MSCs after transplantation in TBI mice, and MSCs may serve as potential therapeutic candidates in regenerative medicine.	[Kumar Mishra, Sushanta; Khushu, Subash] Inst Nucl Med & Allied Sci INMAS, MRI Res Grp, DRDO, Delhi, India; [Kumar Mishra, Sushanta; Gangenahalli, Gurudutta] Inst Nucl Med & Allied Sci INMAS, Div Stem Cell & Gene Therapy Res, DRDO, Delhi, India		Khushu, S (corresponding author), Inst Nucl Med & Allied Sci INMAS, MRI Res Grp, DRDO, Delhi, India.; Gangenahalli, G (corresponding author), Inst Nucl Med & Allied Sci INMAS, Div Stem Cell & Gene Therapy Res, DRDO, Delhi, India.	skhushu@yahoo.com; gangenahalligurudutta@gmail.com			Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of IndiaDefence Research & Development Organisation (DRDO) [INM-311, 4.1/1.6]; Indian Council of Medical ResearchIndian Council of Medical Research (ICMR) [ICMR-25070/2014]	We wish to thank the Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of India for providing S & T project (INM-311, 4.1/1.6). The authors would like to acknowledge Dr. Kailash Manda, Division of Behavioural Neuroscience, INMAS, Delhi for his unconditional support in the behavioural study. We would like to thank Abhishek Thakkar, Northwestern University and Lal PathLabs, Delhi for their assistance in the statistical analysis and histological analysis, respectively. Our sincere thanks to the Indian Council of Medical Research (ICMR-25070/2014) for providing a research fellowship to Sushanta Kumar Mishra in support of the project.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Anbari F, 2014, NEURAL REGEN RES, V9, P919, DOI 10.4103/1673-5374.133133; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; Dantuma E, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt37; Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gutierrez-Fernandez M, 2011, NEUROSCIENCE, V175, P394, DOI 10.1016/j.neuroscience.2010.11.054; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Lim JY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt79; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mishra SK, 2020, METHODS MOL BIOL, V2150, P93, DOI 10.1007/7651_2019_277; Mishra SK, 2018, STEM CELL REV REP, V14, P888, DOI 10.1007/s12015-018-9828-7; Mishra SK, 2017, STEM CELL TRANSL MED, V6, P316, DOI 10.5966/sctm.2016-0087; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Mishra SK, 2015, EXP CELL RES, V339, P427, DOI 10.1016/j.yexcr.2015.11.010; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Willing AE, 2020, CNS NEUROSCI THER, V26, P616, DOI 10.1111/cns.13300; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Ye Y, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00183; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Yu Q, 2015, CELL J, V16, P440; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zibara K, 2019, NEUROPHARMACOLOGY, V145, P177, DOI 10.1016/j.neuropharm.2018.09.032	46	0	0	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2021	54	1					4392	4407		10.1111/ejn.15261		MAY 2021	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TK7MV	WOS:000649407700001	33932318				2022-02-07	
J	Penttila, N; Korpijaakko-Huuhka, AM; Bona, J				Penttila, Nelly; Korpijaakko-Huuhka, Anna-Maija; Bona, Judit			Disfluency clusters in typical and atypical finnish adult speech. A pilot study	CLINICAL LINGUISTICS & PHONETICS			English	Article						Disfluencies; disfluency clusters; Fluency; traumatic brain injury; typical speakers	FLUENCY; COHERENCE; WORDS; TIME; AGE	This study first aimed to investigate disfluency clusters in typical and atypical Finnish adult speakers. Secondly, it aimed to observe possible fluency strategies in speakers representing different fluency levels. In addition to individual disfluency types, we examined different characteristics of disfluency clusters produced by 23 speakers in a fluency continuum. Three adult speaker groups participated in this study: typical speakers with high disfluency frequencies (GA), typical and atypical speakers with very high disfluency frequencies (GB) and atypical speakers with the highest disfluency frequencies (GC). Data were based on a narrative speech task, and disfluency clusters were analysed with both traditional methods and alternative methods. Two statistically significant differences between the speaker groups were found: 1) the length of the clusters was highest in GC compared to other groups, and 2) speakers in GC formulated their utterances more than other groups. Other results, although nonsignificant, were that 3) speakers in GA revised utterances more often than interrupted them compared to GB and GC speakers, and 4) clusters using repetitive words and phrases to maintain fluency were found in GA and GB only. In this study, different fluency levels revealed different strategies in both the production of single disfluencies and in disfluency clusters. It seems that more fluent speakers formulate their messages differently than less fluent speakers, and repetitions can be used to maintain fluency and possibly prevent difficult clusters, as noted with more fluent speakers.	[Penttila, Nelly; Korpijaakko-Huuhka, Anna-Maija] Tampere Univ, Fac Social Sci, Kalevantie 5 Linna Bldg,Room 4062, Tampere 33100, Finland; [Bona, Judit] Eotvos Lorand Univ, Dept Appl Linguist & Phonet, Budapest, Hungary		Penttila, N (corresponding author), Tampere Univ, Fac Social Sci, Kalevantie 5 Linna Bldg,Room 4062, Tampere 33100, Finland.	nelly.penttila@tuni.fi	; Bona, Judit/H-3050-2017	Penttila, Nelly/0000-0002-6086-2310; Bona, Judit/0000-0003-2369-1636			ALLWOOD J, 1990, NORD J LINGUIST, V13, P3, DOI DOI 10.1017/S0332586500002092; Ambrose NG, 1999, J SPEECH LANG HEAR R, V42, P895, DOI 10.1044/jslhr.4204.895; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Andrade Claudia Regina Furquim de, 2010, Pro Fono, V22, P13, DOI 10.1590/S0104-56872010000100004; Arnold JE, 2003, J PSYCHOLINGUIST RES, V32, P25, DOI 10.1023/A:1021980931292; B?na J., 2018, BESZ DKUTATAS, V2018, P221; Barr DJ, 2002, J MEM LANG, V46, P391, DOI 10.1006/jmla.2001.2815; Bona J, 2019, CLIN LINGUIST PHONET, V33, P393, DOI 10.1080/02699206.2018.1513075; Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101; Clark HH, 1998, COGNITIVE PSYCHOL, V37, P201, DOI 10.1006/cogp.1998.0693; COLBURN N, 1985, J FLUENCY DISORD, V10, P51, DOI 10.1016/0094-730X(85)90005-1; Coppens-Hofman MC, 2013, J COMMUN DISORD, V46, P484, DOI 10.1016/j.jcomdis.2013.08.001; Cutler A., 1983, J SEMANT, V2, P205, DOI [10.1093/semant/2.2.205, DOI 10.1093/SEMANT/2.2.205]; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Duckworth, 1996, ADV CLIN PHONETICS S, P171; Eklund R., 2001, P DISS 01 DISFL SPON, P5; Faragasso, 2008, BULGARIAN J COMMUNIC, V2, P10; De Andrade CRF, 2007, CLIN LINGUIST PHONET, V21, P771, DOI 10.1080/02699200701502161; Goberman AM, 2010, J NEUROLINGUIST, V23, P470, DOI 10.1016/j.jneuroling.2008.11.001; Habash, 2012, AAAI FALL S ART INT; Heeman P., 1997, THESIS U ROCHESTER C; Hokkanen T., 2001, THESIS FINNISH LIT S, V10; Horvath V, 2010, ACTA LINGUIST HUNGAR, V57, P288, DOI 10.1556/ALing.57.2010.2-3.6; Jankovics J., P DISS 2019 9 WORKSH, P79; Jokel R, 2007, J MED SPEECH-LANG PA, V15, P243; Juste FS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199054; Juste FS, 2011, FOLIA PHONIATR LOGO, V63, P57, DOI 10.1159/000319913; Kent R, 2018, PUHE JA KIELI, V38, P153, DOI [10.23997/pk.77384, DOI 10.23997/PK.77384]; Korpijaakko-Huuhka AM, 2012, J INTERACT RES COM D, V3, P47, DOI 10.1558/jircd.v3i1.47; Lake JK, 2011, PSYCHON B REV, V18, P135, DOI 10.3758/s13423-010-0037-x; LaSalle L., 2015, J SPEECH LANG HEAR R, V18, P64, DOI [10.1179/2050572814Y.0000000049, DOI 10.1179/2050572814Y.0000000049]; Launonen, 2008, COMMUNICATION DISORD, P9; Levelt W.J.M., 1989, SPEAKING INTENTION A; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Lickley RJ, 2015, BLACKW HBK LINGUIST, P445; M?cke, 2014, P 10 INT SEM SPEECH, P29; McDonald S., 2014, SOCIAL COMMUNICATION, P48; McDougall K, 2017, SPEECH COMMUN, V95, P16, DOI 10.1016/j.specom.2017.10.001; Myers FL, 2012, J FLUENCY DISORD, V37, P9, DOI 10.1016/j.jfludis.2011.10.001; Patterson J., 2017, APHASIA REHABILITATI, P173; Peltonen P., 2020, THESIS U TURKU; Peltonen P, 2016, EUR J APPL LINGUIST, V4, P209, DOI 10.1515/eujal-2014-0018; Penttil?, 2019, MITEN PUHE SUJUU TYY; Penttil? N., 2019, PHONETICIAN J INT SO, V27, P28; Penttila N, 2019, J FLUENCY DISORD, V59, P33, DOI 10.1016/j.jfludis.2019.01.001; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Prins R, 2004, APHASIOLOGY, V18, P1075, DOI 10.1080/02687030444000534; Raukola-Lindblom M, 2020, NEUROREHABILITATION, V47, P55, DOI 10.3233/NRE-203083; Robb MP, 2009, LOGOP PHONIATR VOCO, V34, P36, DOI 10.1080/14015430902748519; Roberts PM, 2009, J COMMUN DISORD, V42, P414, DOI 10.1016/j.jcomdis.2009.06.001; Rossi NF, 2011, RES DEV DISABIL, V32, P2957, DOI 10.1016/j.ridd.2011.05.006; Sawyer J, 2010, J SPEECH LANG HEAR R, V53, P1191, DOI 10.1044/1092-4388(2010/09-0067); Segalowitz N., 2010, COGNITIVE BASES 2 LA, DOI 10.4324/9780203851357; Shriberg, 2005, P EUR C SPEECH COMM, P1781; Shriberg E., 1999, P 14 INT C PHON SCI; Shriberg E. E., 1994, THESIS; TETNOWSKI JA, 2010, HDB LANGUAGE SPEECH, P431; Tree JEF, 1995, J MEM LANG, V34, P709, DOI 10.1006/jmla.1995.1032; Wiklund M, 2019, CLIN LINGUIST PHONET, V33, P654, DOI 10.1080/02699206.2019.1578415; Wir?n M., 2010, P FONETIK 2010 2 4 J, P23; Yaruss JS, 1998, AM J SPEECH-LANG PAT, V7, P25, DOI 10.1044/1058-0360.0702.25	61	0	0	3	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	JAN 2	2022	36	1					1	16		10.1080/02699206.2021.1924861		MAY 2021	16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	XW6FR	WOS:000649355600001	33971787	hybrid			2022-02-07	
J	Ramstrom, T; Bunketorp-Kall, L; Wangdell, J				Ramstrom, Therese; Bunketorp-Kall, Lina; Wangdell, Johanna			Arm activity measure (ArmA): psychometric evaluation of the Swedish version	JOURNAL OF PATIENT-REPORTED OUTCOMES			English	Article						Central nervous system; spasticity; patient reported outcome measures; Spinal cord injury; Stroke traumatic brain injury; Rehabilitation; Upper limb	MODIFIED ASHWORTH SCALE; SPASTICITY; RELIABILITY; PREVALENCE; INJURY; STROKE	Background Patient Reported Outcomes Measure (PROM) are commonly used in research and essential to understand the patient experience when receiving treatment. Arm Activity Measure (ArmA) is a valid and reliable self-report questionnaire for assessing passive (section A) and active (section B) real-life arm function in patients with disabling spasticity. The original English version of ArmA has been psychometrically tested and translated into Thai. Aims Translate and cross-culturally adapt ArmA to Swedish language and context. Further, to evaluate the reliability, validity and sensitivity of the Swedish version of the questionnaire (ArmA-S) in patients with disabling upper limb spasticity caused by injuries to the central nervous system (CNS). Materials and methods ArmA was translated and cross-culturally adapted according to established guidelines. Validity and reliability were evaluated in 61 patients with disabling spasticity. Face and content validity was evaluated by expert opinions from clinicians and feedback from patients with upper limb spasticity. Internal consistency reliability was assessed with Cronbach's alpha and test-retest reliability was assessed using the quadratic weighted kappa. Results ArmA-S was shown to be clinically feasible, with good face and content validity and no floor or ceiling effects. Internal consistency of ArmA-S was high and equivalent to ArmA; with Chronbach ' s alpha coefficients values of 0.94 and 0.93 for section A and B, respectively. Test-retest reliability was good, with kappa values of 0.86 and 0.83 for section A and B, respectively. Some layout modifications of ArmA-S were made to further increase the user-friendliness, test-retest reliability, and responsiveness. Conclusion ArmA-S was shown to be a reliable and valid self-report questionnaire for use in clinical practice and research to assess improvements in passive and active upper limb function in patients with disabling spasticity.	[Ramstrom, Therese; Bunketorp-Kall, Lina; Wangdell, Johanna] Sahlgrenska Univ Hosp Molndal, Ctr Adv Reconstruct Extrem, House U1,Level 6, SE-43180 Molndal, Sweden; [Ramstrom, Therese; Wangdell, Johanna] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Hand Surg, Gothenburg, Sweden; [Bunketorp-Kall, Lina] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Hlth & Rehabil, Gothenburg, Sweden		Ramstrom, T (corresponding author), Sahlgrenska Univ Hosp Molndal, Ctr Adv Reconstruct Extrem, House U1,Level 6, SE-43180 Molndal, Sweden.; Ramstrom, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Hand Surg, Gothenburg, Sweden.	therese.ramstrom@vgregion.se		Wangdell, Johanna/0000-0001-5065-0501; Ramstrom, Therese/0000-0003-0893-6615	Local Research and Development Board for Gothenburg and Sodra Bohuslan; Swedish government [725241]; Swedish county councils (ALF) [725241]; University of Gothenburg	This study was supported by research grants from The Local Research and Development Board for Gothenburg and Sodra Bohuslan and the Swedish state under the agreement between the Swedish government and the county councils (the ALF-agreement, 725241). Open Access funding provided by University of Gothenburg.	Ansari NN, 2007, INT J THER REHABIL, V14, P63, DOI 10.12968/ijtr.2007.14.2.23516; Ansari Noureddin Nakhostin, 2008, Physiotherapy Theory and Practice, V24, P205, DOI 10.1080/09593980701523802; Ashford S, 2016, DISABIL REHABIL, V38, P384, DOI 10.3109/09638288.2015.1041613; Ashford S, 2013, DISABIL REHABIL, V35, P1513, DOI 10.3109/09638288.2012.743602; Ashford S, 2013, CLIN REHABIL, V27, P728, DOI 10.1177/0269215512474942; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bergfeldt U, 2020, J HAND SURG-EUR VOL, V45, P807, DOI 10.1177/1753193420918743; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Buntragulpoontawee M, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0971-2; Draak THP, 2019, EUR J NEUROL, V26, P850, DOI 10.1111/ene.13941; Holtz KA, 2017, ARCH PHYS MED REHAB, V98, P1132, DOI 10.1016/j.apmr.2016.09.124; Hudak PL, 1996, AM J IND MED, V30, P372; Ibuki A, 2007, INT J THER REHABIL, V14, P391, DOI 10.12968/ijtr.2007.14.9.24579; Lewek MD, 2019, J NEUROL PHYS THER, V43, P122, DOI 10.1097/NPT.0000000000000257; Machin D, 2007, QUALITY LIFE ASSESSM, DOI [10.1002/9780470024522, DOI 10.1002/9780470024522]; MAYNARD FM, 1990, ARCH PHYS MED REHAB, V71, P566; Naghdi S, 2014, NEUROREHABILITATION, V34, P177, DOI 10.3233/NRE-131016; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Pendleton HM, 2018, PEDRETTIS OCCUPATION, P8; Priebe MM, 1996, ARCH PHYS MED REHAB, V77, P713, DOI 10.1016/S0003-9993(96)90014-3; Ramstrom T., 2021, J SURG, DOI [10.29011/2575-9760.001363, DOI 10.29011/2575-9760.001363]; Sommerfeld DK, 2012, AM J PHYS MED REHAB, V91, P814, DOI 10.1097/PHM.0b013e31825f13a3; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thibaut A, 2013, BRAIN INJURY, V27, P1093, DOI 10.3109/02699052.2013.804202; Voerman GE, 2010, DISABIL REHABIL, V32, P775, DOI 10.3109/09638280903304490; Waljee JF, 2018, HAND CLIN, V34, P473, DOI 10.1016/j.hcl.2018.06.005; Wamper KE, 2010, ACTA ORTHOP, V81, P703, DOI 10.3109/17453674.2010.537808; Wedekind C, 2005, BRAIN INJURY, V19, P681, DOI 10.1080/02699050400025182; WITZ K, 1990, J EDUC STAT, V15, P84; WUOLLE KS, 1994, J HAND SURG-AM, V19A, P209, DOI 10.1016/0363-5023(94)90008-6; Zorowitz RD, 2013, NEUROLOGY, V80, pS45, DOI 10.1212/WNL.0b013e3182764c86	32	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2509-8020		J PATIENT-REP OUTCOM	J. Patient-Rep. Outcomes	MAY 12	2021	5	1							39	10.1186/s41687-021-00310-4			11	Health Care Sciences & Services; Health Policy & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	SD5SI	WOS:000651435100002	33982227	gold, Green Submitted, Green Published			2022-02-07	
J	Dietzel, M; Scherer, S; Esser, M; Kirschner, HJ; Fuchs, J; Lieber, J				Dietzel, Markus; Scherer, Simon; Esser, Michael; Kirschner, Hans-Joachim; Fuchs, Joerg; Lieber, Justus			Fractures of the proximal radius in children: management and results of 100 consecutive cases	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article; Early Access						Pediatric trauma; Radial neck fracture; Proximal radius fracture; ESIN; Elastic stable intramedullary nailing; Pseudarthrosis	NECK FRACTURES; CLOSED REDUCTION; GROWTH-BEHAVIOR; HEAD; CLASSIFICATION; FIXATION; SYSTEMS; FOREARM	Introduction Pediatric radial neck and head fractures are rare, accounting for only 1% of all fractures in children. The aim of this study is to describe the management and results of the respective fracture types and different injury characteristics. Materials and methods This study performs a retrospective data analysis of 100 consecutive patients with a fracture of the proximal radius treated in a single high-volume pediatric trauma center. Results One hundred patients [mean age 7.5 years (1-15)] were documented with a fracture of the proximal radius between 3/2011 and 12/2019. The gender distribution was 62 girls and 38 boys. Twenty-seven patients had concomitant injuries. Conservative treatment was performed in 63 patients (Judet I = 27; II = 30; III = 6; Mason I = 2) using an above-the-elbow cast for 21 days (6-35). Surgical treatment was performed in 37 patients (Judet II = 3; III = 22; IV = 5; V = 7) using elastic stable intramedullary nailing (ESIN). Open reduction was necessary in five cases, and additional immobilization was performed in 32 cases. Six complications occurred: loss of implant stability (n = 2), healing in malalignment, pseudarthrosis, radioulnar synostosis, and a persisting hypoesthesia at the thumb. As a result, two ESIN osteosynthesis were revised, and one radial head resection was performed. Loss of movement was seen in 11% of cases, overall Mayo elbow performance index (MEPI) was 99.8 (90-100), and none of the patients experienced negative impacts on activities of daily life. Conclusions Proximal radial fractures occur predominately without dislocation. Good results are obtained with conservative treatment throughout. In cases with displacement exceeding growth-related correction, ESIN is the undisputed treatment of choice. Open surgery and long immobilization periods should be avoided whenever possible.	[Dietzel, Markus; Scherer, Simon; Kirschner, Hans-Joachim; Fuchs, Joerg; Lieber, Justus] Univ Childrens Hosp, Dept Pediat Surg & Pediat Urol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany; [Esser, Michael] Univ Hosp, Dept Diagnost Radiol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany		Dietzel, M (corresponding author), Univ Childrens Hosp, Dept Pediat Surg & Pediat Urol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	markus.dietzel@med.uni-tuebingen.de; simon.scherer@med.uni-tuebingen.de; michael.essser@med.uni-tuebingen.de; hans-joachim.kirschner@med.uni-tuebingen.de; joerg.fuchs@med.uni-tuebingen.de; justus.lieber@med.uni-tuebingen.de		Dietzel, Markus/0000-0001-9439-0203	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. This study was not supported by any grants.	Adrian M, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0912-x; Badoi A, 2016, EUR J PEDIATR SURG, V26, P514, DOI 10.1055/s-0035-1566108; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P232; Eberl R, 2010, EUR J PEDIATR SURG, V20, P250, DOI 10.1055/s-0030-1249104; Fekete K, 2002, ORTHOP TRAUMATOL, V10, P289; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; Fuller CB, 2016, J PEDIATR ORTHOPED, V36, P793, DOI 10.1097/BPO.0000000000000576; Gutierrez-de la Iglesia D, 2017, J PEDIATR ORTHOPED, V37, P159, DOI 10.1097/BPO.0000000000000617; Hell AK, 2014, UNFALLCHIRURG, V117, P1085, DOI 10.1007/s00113-014-2632-1; JUDET J, 1962, Ann Chir, V16, P1377; Kang S, 2015, J ORTHOP TRAUMA, V29, pE253, DOI 10.1097/BOT.0000000000000322; Keller Patrick R, 2018, Case Rep Orthop, V2018, P5131639, DOI 10.1155/2018/5131639; Koerner D, 2020, ARCH ORTHOP TRAUM SU, V140, P887, DOI 10.1007/s00402-019-03321-5; Kruppa C, 2015, INJURY, V46, pS10, DOI 10.1016/S0020-1383(15)30013-9; Landin LA, 1997, J PEDIATR ORTHOP B, V6, P79, DOI 10.1097/01202412-199704000-00002; Lieber J, 2014, UNFALLCHIRURG, V117, P1092, DOI 10.1007/s00113-014-2633-0; Longo UG, 2008, BRIT MED BULL, V87, P131, DOI 10.1093/bmb/ldn023; Malmvik J, 2003, J PEDIATR ORTHOP B, V12, P63, DOI 10.1097/00009957-200301000-00012; Monson R, 2009, J PEDIATR ORTHOPED, V29, P243, DOI 10.1097/BPO.0b013e3181990745; Nicholson LT, 2019, J AM ACAD ORTHOP SUR, V27, pE876, DOI 10.5435/JAAOS-D-18-00204; Qiao F, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2947-8; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; Sheps DM, 2009, CAN J SURG, V52, P277; Sinikumpu JJ, 2013, SCAND J SURG, V102, P258, DOI 10.1177/1457496913490459; Su YX, 2016, J PEDIATR ORTHOPED, V36, P797, DOI 10.1097/BPO.0000000000000572; Vocke AK, 1998, J PEDIATR ORTHOP B, V7, P217, DOI 10.1097/01202412-199807000-00007; Waters PM, 2001, J PEDIATR ORTHOPED, V21, P570, DOI 10.1097/00004694-200109000-00003; Yallapragada RK, 2020, J ORTHOP, V17, P127, DOI 10.1016/j.jor.2019.06.001; Zimmerman RM, 2013, J BONE JOINT SURG AM, V95A, P1825, DOI 10.2106/JBJS.L.01130	30	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.												10.1007/s00402-021-03917-w		MAY 2021	8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	SA3QG	WOS:000649212500001	33974141	hybrid			2022-02-07	
J	Feller, CN; Awad, AJ; Nelson, MES; Ketchum, N; Pahapill, PA				Feller, Christina N.; Awad, Ahmed J.; Nelson, Mary Elizabeth S.; Ketchum, Nicholas; Pahapill, Peter A.			Low Rate of Intrathecal Baclofen Pump Catheter-Related Complications: Long-Term Study in Over 100 Adult Patients Associated With Reinforced Catheter	NEUROMODULATION			English	Article						Catheter&#8208; related complications; intrathecal baclofen pump; retrospective study; spasticity	SPASTICITY; DELIVERY; THERAPY; RECOMMENDATIONS	Objectives Intrathecal baclofen (ITB) is a cost-effective therapy for patients with severe spasticity. The most common complications are catheter-related complications (CRCs) including kinking/occlusion, blockage, migration, fracture, disconnection, and CSF leak. Our objective was to determine the CRC rate in a large cohort of adults with newly implanted ITB pump systems with polymer reinforced silicone catheters. Materials and Methods This is a retrospective study of a prospectively maintained database consisting of patients who had undergone implantation of ITB pump systems with Ascenda (Medtronic, Minneapolis) catheters from 2013 to 2020. Over this seven-year period, 141 patients underwent ITB pump system implantations; 126 of which had a minimum of one-year follow-up. Results The 126 patients with a minimum of one year follow-up (average 43 month; range 12-89), had an average age of 51 years (63% male). Severe spasticity was due to spinal cord injury (38%), traumatic brain injury (15%), cerebral palsy (13%), multiple sclerosis (11%), stroke (10%), and other (13%). Nine (7.1%) CRCs occurred in 7 (5.6%) patients (median 6 mo. post-implant): 5 intrathecal catheter occlusions (range 3-52 months post-implant), two fractures in one patient (6 months), one disconnection at the catheter pump interface (2 months), and one due to kinking at 84 months No migrations occurred. Conclusions Reported CRCs have been high for ITB pump systems. Ours is the first large cohort, long-term study of CRCs related to reinforced catheters; additionally, our low CRC rate compares favorably to previously published data. Thus, implantation of reinforced catheters may be associated with a low CRC rate.	[Feller, Christina N.; Awad, Ahmed J.; Pahapill, Peter A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Awad, Ahmed J.] An Najah Natl Univ, Fac Med & Hlth Sci, Nablus, Palestine; [Nelson, Mary Elizabeth S.; Ketchum, Nicholas] Med Coll Wisconsin, Dept Phys Med & Rehabil, Milwaukee, WI 53226 USA; [Pahapill, Peter A.] US Dept Vet Affairs Med Ctr, Neurosurg, Milwaukee, WI USA		Pahapill, PA (corresponding author), Froedtert Hosp, Dept Neurosurg, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.; Pahapill, PA (corresponding author), Med Coll Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	ppahapill@mcw.edu					Arocho-Quinones EV, 2019, WORLD NEUROSURG, V128, pE87, DOI 10.1016/j.wneu.2019.04.003; Awaad Yasser, 2012, ISRN Neurol, V2012, P575168, DOI 10.5402/2012/575168; Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; Deer TR, 2017, NEUROMODULATION, V20, P155, DOI 10.1111/ner.12579; Deer TR, 2017, NEUROMODULATION, V20, P31, DOI 10.1111/ner.12565; Konrad PE, 2016, NEUROMODULATION, V19, P848, DOI 10.1111/ner.12524; Lake W, 2019, NEUROSURG CLIN N AM, V30, P203, DOI 10.1016/j.nec.2018.12.002; Santin-Amo JM, 2019, NEUROCIRUGIA, V30, P288, DOI 10.1016/j.neucir.2019.05.001; Motta F, 2016, J NEUROSURG-PEDIATR, V18, P493, DOI 10.3171/2016.4.PEDS15646; Nelson MES, 2019, NEUROMODULATION, V22, P839, DOI 10.1111/ner.12974; Ordia JI, 1996, J NEUROSURG, V85, P452, DOI 10.3171/jns.1996.85.3.0452; Pucks-Faes E, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.965; Saulino M, 2016, NEUROMODULATION, V19, P632, DOI 10.1111/ner.12467; Saulino M, 2015, NEUROMODULATION, V18, P141, DOI 10.1111/ner.12220; Servi, 2010, PM R S, V2, pS157S; Stetkarova I, 2015, PAIN PHYSICIAN, V18, pE633; Taira T, 2013, NEUROMODULATION, V16, P266, DOI 10.1111/ner.12010; Thibaut A, 2013, BRAIN INJURY, V27, P1093, DOI 10.3109/02699052.2013.804202; Yablon SA, 2004, AM J PHYS MED REHAB, V83, pS10, DOI 10.1097/01.PHM.0000141126.11008.7D	19	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	OCT	2021	24	7					1176	1180		10.1111/ner.13412		MAY 2021	5	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	WK7OV	WOS:000649022300001	33974333				2022-02-07	
J	Jacob, US; Pillay, J; Oyefeso, EO				Jacob, Udeme Samuel; Pillay, Jace; Oyefeso, Esther Olufunke			Attention Span of Children With Mild Intellectual Disability: Does Music Therapy and Pictorial Illustration Play Any Significant Role?	FRONTIERS IN PSYCHOLOGY			English	Article						attention span; children; mild intellectual disability; music therapy; pictorial illustration	TRAUMATIC BRAIN-INJURY; SEDUCTIVE DETAILS; SOCIAL-SKILLS; RATING-SCALE; AUTISM	This study investigated the effects of music therapy and pictorial illustration on the attention span of children with mild intellectual difficulties. A pre-test, post-test and control group quasi-experimental research design was used with a sample of children diagnosed with mild intellectual disability from three special schools in Ibadan, Nigeria. Fifty children were randomly selected and assigned to one of three groups: music therapy, pictorial illustration, or control (N = 50, male = 25, female = 25, mean age = 11.6 years). Twenty-four sessions of music therapy and pictorial illustration classes were held with the experimental group only. The Moss Attention Rating Scale was used before and after the intervention to collect data on participants' attention span. Analysis of Covariance indicated that there was a significant statistical difference between pre-test and post-test results of the two groups. The estimated marginal means of post-attention span by treatment indicated that pictorial illustration had the highest post-attention span score, followed by music therapy, while post-attention span score for the control group was the least. Based on the findings, it is recommended that teachers, caregivers, and parents of children with mild intellectual disability adopt pictorial illustration and music therapy as teaching strategies to enhance their attention span.	[Jacob, Udeme Samuel; Pillay, Jace] Univ Johannesburg, Fac Educ, South African Res Chair Educ & Care Childhood, Johannesburg, South Africa; [Jacob, Udeme Samuel; Oyefeso, Esther Olufunke] Univ Ibadan, Fac Educ, Dept Special Educ, Ibadan, Nigeria		Jacob, US; Pillay, J (corresponding author), Univ Johannesburg, Fac Educ, South African Res Chair Educ & Care Childhood, Johannesburg, South Africa.; Jacob, US; Oyefeso, EO (corresponding author), Univ Ibadan, Fac Educ, Dept Special Educ, Ibadan, Nigeria.	udeme01@gmail.com; jacep@uj.ac.za; estheroyefeso@gmail.com	Jacob, Udeme/AAW-1672-2021	Jacob, Udeme/0000-0002-3234-8226	South African Research Chairs Initiative of the Department of Science and Innovation; National Research Foundation of South AfricaNational Research Foundation - South Africa; South African Research Chair in Education and Care in Childhood, Faculty of Education, University of Johannesburg, South Africa [87300]	This work was supported by the South African Research Chairs Initiative of the Department of Science and Innovation and National Research Foundation of South Africa, South African Research Chair in Education and Care in Childhood, Faculty of Education, University of Johannesburg, South Africa (grant number: 87300, 2017).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson SA, 2010, SCHOOL PSYCHOL QUART, V25, P178, DOI 10.1037/a0021213; Baker F, 2008, NORD J MUSIC THER, V17, P105, DOI 10.1080/08098130809478203; Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001; Brooks BA, 2015, J INTELL DISABIL RES, V59, P678, DOI 10.1111/jir.12171; Bruscia K.E., 2014, DEFINING MUSIC THERA; Butcher K., 2007, P ANN M COGN SCI SOI; Carnahan C., 2009, EDUC TREAT CHILD, V32, P37, DOI [10.1353/etc.0.0047, DOI 10.1353/ETC.0.0047]; Christiansen H, 2015, HEALTH EDUC, V115, P285, DOI 10.1108/HE-03-2014-0040; Cole EM., 2000, CHILD ADOLESC SOC WO, V17, P305, DOI [10.1023/A:1007550124043, DOI 10.1023/A:1007550124043]; Commodari E, 2012, CURR PSYCHOL, V31, P17, DOI 10.1007/s12144-012-9128-3; Constanti F.A., 2015, J PLUS ED, V12A, P178; Dean S., 2006, UNDERSTANDING ACHIEV; Deutsch CK, 2008, DEV DISABIL RES REV, V14, P285, DOI 10.1002/ddrr.42; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Dieringer ST, 2017, ADAPT PHYS ACT Q, V34, P217, DOI 10.1123/apaq.2015-0033; Ekins C, 2019, PALAESTRA, V33, P16; Erbay F, 2013, KURAM UYGUL EGIT BIL, V13, P422; Eren B, 2013, KURAM UYGUL EGIT BIL, V13, P1877; Gardner-Neblett N, 2014, J APPL DEV PSYCHOL, V35, P457, DOI 10.1016/j.appdev.2014.09.003; Golos DB, 2012, EARLY CHILD EDUC J, V40, P239, DOI 10.1007/s10643-012-0506-0; Gooding LF, 2011, J MUSIC THER, V48, P440, DOI 10.1093/jmt/48.4.440; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Guvendi B., 2017, J HUM SCI, V14, P3879, DOI [10.14687/jhs.v14i4.4812, DOI 10.14687/JHS.V14I4.4812]; Harp SF, 1998, J EDUC PSYCHOL, V90, P414, DOI 10.1037/0022-0663.90.3.414; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Hart T, 2009, NEUROPSYCHOLOGY, V23, P729, DOI 10.1037/a0016153; Hedges JH, 2013, ANN NY ACAD SCI, V1292, P1, DOI 10.1111/nyas.12154; Hill D.A., 2003, DEV MAT LANGUAGE TEA, P174; Iwasaki B, 2013, READ TEACH, V67, P137, DOI 10.1002/TRTR.1203; Johnels JA, 2016, NORD J MUSIC THER, V25, P118, DOI 10.1080/08098131.2016.1180210; Kern P, 2007, J AUTISM DEV DISORD, V37, P1264, DOI 10.1007/s10803-006-0272-1; Klein N, 2016, CURR PROB PEDIATR AD, V46, P195, DOI 10.1016/j.cppeds.2015.12.004; Koss M.D., 2015, J CHILDRENS LIT, V41, P32; Kruschke JK, 2005, STUD COGN, P113; Laureys S, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P1; Male A., 2007, ILLUSTRATION THEORET; Markworth L., 2014, QUALITATIVE INQUIRIE; Mayer RE, 2009, MULTIMEDIA LEARNING, 2ND EDITION, P1, DOI 10.1017/CBO9780511811678; Mayer RE, 1997, EDUC PSYCHOL-US, V32, P1, DOI 10.1207/s15326985ep3201_1; Moreno R, 1999, J EDUC PSYCHOL, V91, P358, DOI 10.1037/0022-0663.91.2.358; Nguyen A., 2014, UNDERGRADUATE RES PO, V57, P15; Ostrosky MichaeleneM., 2015, YOUNG EXCEPTIONAL CH, V18, P30, DOI [10.1177/1096250613512666, DOI 10.1177/1096250613512666]; Ozdemir F.E., 2007, THESIS MIDDLE E TU A; Register D, 2007, J MUSIC THER, V44, P23, DOI 10.1093/jmt/44.1.23; Roslina, 2017, ADV LANG LIT STUD, V8, P213, DOI [10.7575/aiac.alls.v.8n.2p.213, DOI 10.7575/AIAC.ALLS.V.8N.2P.213]; Sanchez CA, 2006, MEM COGNITION, V34, P344, DOI 10.3758/BF03193412; Schnotz W, 2003, LEARN INSTR, V13, P141, DOI 10.1016/S0959-4752(02)00017-8; Schnotz W., 2005, CAMBRIDGE HDB MULTIM, P49, DOI [DOI 10.1017/CBO9780511816819.005, 10.1017/CBO9780511816819.005]; Schweizer K, 2010, SPRINGER SER HUM EXC, P247, DOI 10.1007/978-1-4419-1210-7_15; Shelton J., 2008, PSYCHE, V14, P1; Sigmon ML, 2016, READ TEACH, V70, P111, DOI 10.1002/trtr.1473; Sorel S., 2010, QUAL INQUIRIES MUSIC, V5, P173; Sze S., 2006, ACAD ED LEADERSHIP J, V10, P113; Sze S., 2004, ED BENEFITS MUSIC IN; Titus S., 2012, USING MUSIC DECREASE; Whyte J, 2003, ARCH PHYS MED REHAB, V84, P268, DOI 10.1053/apmr.2003.50108; Yilmaz A, 2018, EDUC SCI, V8, DOI 10.3390/educsci8020089	58	0	0	12	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 11	2021	12								677703	10.3389/fpsyg.2021.677703			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	SG9TV	WOS:000653783300001	34046000	gold, Green Published			2022-02-07	
J	Ma, HP; Ong, JR; Ou, JC; Chiang, YH; Lian, SY				Ma, Hon-Ping; Ong, Jiann Ruey; Ou, Ju-Chi; Chiang, Yung-Hsiao; Lian, Shoou-Yang			Comparison of Dizziness Factors for Mild Traumatic Brain Injury Patients with and without Dizziness: A Factor Analysis and Propensity Score Model Study	COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE			English	Article							SLEEP QUALITY INDEX; HANDICAP INVENTORY; NEUROPSYCHIATRIC FEATURES; CHINESE VERSION; DEMENTIA; EPIDEMIOLOGY; ASSOCIATION; TRANSLATION; PREVALENCE; VALIDATION	Traumatic brain injury (TBI) causes major socioeconomic problems worldwide. In the United States, nearly three-quarters of patients with TBI have mild TBI (mTBI). 32% of these patients may develop dizziness. In this study, we analyzed the factor structure of the traditional Chinese version of the DHI and evaluate the differences in DHI factors between dizziness and nondizziness groups. In total, 315 patients with mTBI, comprising 158 with self-reported dizziness and 157 without dizziness, were recruited from three hospitals. The responses for Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Epworth Sleepiness Scale (ESS), and Pittsburgh Sleep Quality Index (PSQI) demonstrated between-group differences. The Chinese DHI had internal validity and had four factors that differed from the English version (3 aspects). The group effects for the physical subscale remained significantly different even after adjustments in the propensity score model. For the Chinese version, two of four factors remained significantly different in the effects between self-reported dizziness and nondizziness groups. The factors of our Chinese DHI differed from those of the original English version of DHI. After adjustments using the propensity score model, the physical subscale demonstrated significant differences between the self-reported dizziness and nondizziness groups. Only two factors from our Chinese DHI were significantly different; moreover, it contained only three physical, five functional, and three emotional items.	[Ma, Hon-Ping; Ong, Jiann Ruey; Ou, Ju-Chi] Taipei Med Univ, Shuang Ho Hosp, Emergency Dept, Taipei, Taiwan; [Ma, Hon-Ping; Ong, Jiann Ruey] Taipei Med Univ, Sch Med, Emergency Dept, Taipei, Taiwan; [Ma, Hon-Ping] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Neurosci Res Ctr, Taipei, Taiwan; [Lian, Shoou-Yang] Yuans Gen Hosp, Dept Emergency, Kaohsiung, Taiwan		Lian, SY (corresponding author), Yuans Gen Hosp, Dept Emergency, Kaohsiung, Taiwan.	acls2000@tmu.edu.tw; malsia95@gmail.com; juchi@tmu.edu.tw; ychiang@tmu.edu.tw; shoouyanglian@gmail.com		Ou, Ju-Chi/0000-0003-3549-7283	Department of Emergency, Yuan's General Hospital [106YGH-TMU-07]	This research was supported through grants from the Department of Emergency, Yuan's General Hospital (106YGH-TMU-07).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Asmundson GJG, 1999, J VESTIBUL RES-EQUIL, V9, P63; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Che H.H., 2006, FORMOSAN J MED, V10, P451; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Goto F, 2011, ACTA OTO-LARYNGOL, V131, P817, DOI 10.3109/00016489.2011.565423; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Herrschaft H, 2012, J PSYCHIATR RES, V46, P716, DOI 10.1016/j.jpsychires.2012.03.003; Huang TY, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/378726; Ihl R, 2011, INT J GERIATR PSYCH, V26, P1186, DOI 10.1002/gps.2662; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kurre A, 2010, BMC EAR NOSE THROAT, V10, DOI 10.1186/1472-6815-10-3; Kurre A, 2009, OTOL NEUROTOL, V30, P359, DOI 10.1097/MAO.0b013e3181977e09; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mueller M, 2014, EUR J PUBLIC HEALTH, V24, P802, DOI 10.1093/eurpub/ckt171; Napryeyenko O, 2007, ARZNEIMITTELFORSCH, V57, P4; Nikolova G., 2013, BULGARIAN NEUROLOGY, V14, P139; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez N, 2001, ACTA OTO-LARYNGOL, P145; Poon DMY, 2004, ANN OTO RHINOL LARYN, V113, P1006, DOI 10.1177/000348940411301212; Rawlings AM, 2018, NEUROLOGY, V91, pE759, DOI 10.1212/WNL.0000000000006027; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schneider Lon S., 2005, Current Alzheimer Research, V2, P541, DOI 10.2174/156720505774932287; Szczupak M, 2016, HAND CLINIC, V137, P295, DOI 10.1016/B978-0-444-63437-5.00021-2; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tuunainen E, 2012, AURIS NASUS LARYNX, V39, P577, DOI 10.1016/j.anl.2011.12.004; Velicer WF, 1998, PSYCHOL METHODS, V3, P231, DOI 10.1037/1082-989X.3.2.231; Vereeck L, 2007, ACTA OTO-LARYNGOL, V127, P788, DOI 10.1080/00016480601075464; [王振 WANG Zhen], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P476; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	45	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1748-670X	1748-6718		COMPUT MATH METHOD M	Comput. Math. Method Med.	MAY 11	2021	2021								5571319	10.1155/2021/5571319			8	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	SX3EH	WOS:000665091300003	34055038	gold, Green Published			2022-02-07	
J	Ruzinak, R; Bittsansky, M; Martinikova, M; Nosal, V; Kantorova, E; Ballova, J; Koprusakova, MT; Hnilicova, P; Grendar, M; Dusenka, R; Kolarovszki, B; Zelenak, K; Kurca, E; Sivak, S				Ruzinak, Robert; Bittsansky, Michal; Martinikova, Martina; Nosal, Vladimir; Kantorova, Ema; Ballova, Jana; Koprusakova, Monika Turcanova; Hnilicova, Petra; Grendar, Marian; Dusenka, Robert; Kolarovszki, Branislav; Zelenak, Kamil; Kurca, Egon; Sivak, Stefan			Proton magnetic resonance spectroscopy changes in the brainstem in patients after mild traumatic brain injury with loss of consciousness	BIOMEDICAL PAPERS-OLOMOUC			English	Article; Early Access						mild traumatic brain injury; concussion; loss of consciousness; magnetic resonance spectroscopy	MR SPECTROSCOPY; CONCUSSION; DAMAGE	Introduction. Loss of consciousness (LOC) is used as a diagnostic feature of mild traumatic brain injury (MTBI). However, only 10% of concussions result in LOC. There are only a limited number of in-vivo studies dealing with unconsciousness and structural and functional integrity of the brainstem in patients with MTBI. The aim of our pilot study was to assess the sensitivity of proton magnetic resonance spectroscopy (1H-MRS) to detect metabolic changes in the brainstem in patients after MTBI with unconscioussness. Methods. Twenty-four patients (12 with LOC, and 12 without LOC) within 3 days of MTBI and 19 healthy controls were examined. All subjects underwent single-voxel 1H-MRS examination of the upper brainstem. Spectra were evaluated using LCModel software. Ratios of total N-acetylaspartate (tNAA), total choline-containing compounds (tCho) and glutamate plus glutamine (Glx) to total creatine (tCre) were used for calculations. Results. We found a significant decrease in tNAA/tCre and tCho/tCre ratios in the patient group with LOC when compared with the control group of healthy volunteers (P=0.002 and P=0.041, respectively), and a significant decrease in the tNAA/tCre ratio in the LOC group when compared with patients without LOC (P=0.04). Other metabolite ratios in the brainstem did not show any significant group differences. Conclusion. Our findings indicate that decrease of tNAA/tCre ratio in the upper brainstem using single-voxel 1H-MRS may provide a potential biomarker for MTBI associated with LOC.	[Ruzinak, Robert; Nosal, Vladimir; Kantorova, Ema; Ballova, Jana; Koprusakova, Monika Turcanova; Kurca, Egon; Sivak, Stefan] Comenius Univ, Jessenius Fac Med Martin, Clin Neurol, Bratislava, Slovakia; [Bittsansky, Michal; Hnilicova, Petra; Grendar, Marian] Comenius Univ Bratilava, Jessenius Fac Med Martin, Biomed Ctr Martin, Bratislava, Slovakia; [Martinikova, Martina] FD Roosevelt Hosp, Dept Neurol, Banska Bystrica, Slovakia; [Dusenka, Robert] Comenius Univ, Jessenius Fac Med Martin, Clin Urol, Bratislava, Slovakia; [Kolarovszki, Branislav] Comenius Univ, Jessenius Fac Med, Clin Neurosurg, Bratislava, Slovakia; [Zelenak, Kamil] Comenius Univ, Jessenius Fac Med Martin, Clin Radiol, Bratislava, Slovakia		Sivak, S (corresponding author), Comenius Univ, Jessenius Fac Med Martin, Clin Neurol, Bratislava, Slovakia.	sivakste@gmail.com			VEGAVedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission [1/0301/19]	The authors are extremely grateful to the patients and healthy volunteers for their collabora-tion. This work was supported by the VEGA grant No. 1/0301/19.	BROWN WJ, 1972, AM J PATHOL, V67, P41; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cartwright PE, 2019, UNDERSEA HYPERBAR M, V46, P291; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Edlow BL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0375-y; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002628; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; MITCHELL DE, 1973, LANCET, V2, P215; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Plum F, 1982, DIAGNOSIS STUPOR COM, V3rd, P3; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; R Core Team, R LANG ENV STAT COMP; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Snider SB, 2019, NEUROLOGY, V93, pE1281, DOI 10.1212/WNL.0000000000008163; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Veeramuthu V, 2018, ACAD RADIOL, V25, P1167, DOI 10.1016/j.acra.2018.01.005; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4	30	0	0	0	0	PALACKY UNIV, MEDICAL FAC	OLOMOUC	CENTRAL LIBRARY, HNEVOTINSKA 3, OLOMOUC, 00000, CZECH REPUBLIC	1213-8118	1804-7521		BIOMED PAP	Biomed. Pap-Olomouc												10.5507/bp.2021.029		MAY 2021	7	Engineering, Biomedical; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Research & Experimental Medicine	XQ1VV	WOS:000731341400001	33976431	gold			2022-02-07	
J	Kristensson, J; Longoni, F; Ostberg, P; Ake, S; Smith, SR; Saldert, C				Kristensson, Joana; Longoni, Francesca; Ostberg, Per; Ake, Sabina; Rodseth Smith, Signe; Saldert, Charlotta			Evaluation of treatment effects of semantic feature analysis on mild anomia in multiple sclerosis	APHASIOLOGY			English	Article; Early Access						Multiple sclerosis; mild anomia; word retrieval; semantic feature analysis	QUANTITATIVE SYNTHESIS; COGNITIVE IMPAIRMENT; LANGUAGE; RETRIEVAL; SWEDISH; COMMUNICATION; PERFORMANCE; DISORDERS; DISCOURSE; SPEECH	Background: Multiple sclerosis (MS) commonly includes anomia and other communicative deficits that affect communicative participation and quality of life. Anomia treatment in MS is currently unexplored. Owing to the degenerative nature of MS, compensatory treatment might be preferable to restorative treatment. Semantic feature analysis (SFA) has been reported to have a treatment effect in aphasia and traumatic brain injury, and it can also be used as a compensatory word-finding strategy. SFA might therefore be effective on anomia in MS. Aims: The aim of this study was to evaluate the treatment effects of SFA on mild anomia in MS. Hypotheses were that, if used as a strategy, SFA may improve word-retrieval ability in connected speech, reduce self-perceived word-finding difficulties and increase communicative participation. Methods & Procedures: Two participants (one with relapsing-remitting MS, one with progressive MS) experiencing anomia and reduced communicative participation took part in this early-phase study with a single-case experimental design (SCED). Outcome measures included accuracy and speed in confrontation naming of treated items, correct information units (CIUs) in a re-telling task, self-reported strategy use in everyday communication, self-reported occurrence of anomia and related nuisance, and self-reported communicative participation. Measurements were carried out before treatment, at the beginning of every third treatment session, once directly after treatment, repeatedly during a maintenance phase, and once at a follow-up session ten weeks after treatment. Outcomes & Results: No treatment effects on confrontation-naming ability, re-telling ability or self-reported measures were evident in either participant after treatment with SFA. Effects of repeated measures appeared as reduced response time in confrontation naming. Conclusions: SFA as the sole element of treatment may not be sufficient to obtain treatment effects on mild anomia in MS. Further research is warranted.	[Kristensson, Joana; Longoni, Francesca; Ake, Sabina; Rodseth Smith, Signe; Saldert, Charlotta] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Speech & Language Pathol Unit,Dept Hlth & Rehabil, Gothenburg, Sweden; [Ostberg, Per] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Speech & Language Pathol, Stockholm, Sweden; [Ostberg, Per] Karolinska Univ Hosp, Med Unit Speech & Language Pathol, Stockholm, Sweden		Kristensson, J (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Dept Hlth & Rehabil, Box 452, SE-40530 Gothenburg, Sweden.	joana.kristensson@gu.se		Kristensson, Joana/0000-0003-3633-9009; Longoni, Francesca/0000-0002-1539-241X; Saldert, Charlotta/0000-0001-8808-3610; Ake, Sabina/0000-0002-3925-9162	Swedish Research Council for Health, Working Life and Welfare (FORTE) [2015-00503]; Swedish Research Council (VR)Swedish Research Council [2016-01275]	This work was supported by the Swedish Research Council for Health, Working Life and Welfare (FORTE) [2015-00503] and the Swedish Research Council (VR) [2016-01275].	Arnott WL, 1997, APHASIOLOGY, V11, P969, DOI 10.1080/02687039708249422; Arrondo G., 2010, EUROPEAN NEUROLOGICA, V2, P1; Bauer M, 2020, APHASIOLOGY, V34, P1471, DOI 10.1080/02687038.2019.1676393; Baylor C, 2013, J SPEECH LANG HEAR R, V56, P1190, DOI 10.1044/1092-4388(2012/12-0140); Benedict RHB, 2017, J INT NEUROPSYCH SOC, V23, P832, DOI 10.1017/S1355617717000959; Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; Boyle M, 2004, AM J SPEECH-LANG PAT, V13, P236, DOI 10.1044/1058-0360(2004/025); Boyle M., 1995, AM J SPEECH-LANG PAT, V4, P94, DOI [DOI 10.1044/1058-0360.0404.94, 10.1044/1058-0360.0404.94]; Carotenuto A, 2018, ARCH CLIN NEUROPSYCH, V33, P194, DOI 10.1093/arclin/acx061; Cavandoli O, 2007, LINEA DVD QUIPOS JUS; De Dios Perez B., 2017, THESIS U MANCHESTER; De Geer S., NEUROSCIENCE P UNPUB; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DeLuca J, 2020, NAT REV NEUROL, V16, P319, DOI 10.1038/s41582-020-0355-1; DeSousa Eduardo Adonias, 2002, Am J Alzheimers Dis Other Demen, V17, P23, DOI 10.1177/153331750201700104; Druks J., 2000, OBJECT ACTION NAMING; Eckerstrom M, 2013, INT PSYCHOGERIATR, V25, P420, DOI 10.1017/S1041610212001846; Efstratiadou EA, 2018, J SPEECH LANG HEAR R, V61, P1261, DOI 10.1044/2018_JSLHR-L-16-0330; El-Wahsh S, 2020, MULT SCLER RELAT DIS, V39, DOI 10.1016/j.msard.2019.101896; Fergadiotis G, 2016, APHASIOLOGY, V30, P364, DOI 10.1080/02687038.2015.1067288; Friend KB, 1999, CLIN NEUROPSYCHOL, V13, P78, DOI 10.1076/clin.13.1.78.1979; Galletta EE, 2018, AM J SPEECH-LANG PAT, V27, P477, DOI 10.1044/2017_AJSLP-16-0168; Hartelius LD., 2015, DYSARTRI BEDOMNING I DYSARTRI BEDOMNING I; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1166, DOI 10.1016/j.neuropsychologia.2005.10.006; Johansson K, 2021, FOLIA PHONIATR LOGO, V73, P50, DOI 10.1159/000505063; Kambanaros M, 2017, APHASIOLOGY, V31, P49, DOI 10.1080/02687038.2016.1154498; Kaplan E, 1983, BOSTON NAMING TEST; Klugman TM, 2002, FOLIA PHONIATR LOGO, V54, P201, DOI 10.1159/000063194; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laakso K, 2000, CLIN LINGUIST PHONET, V14, P329, DOI 10.1080/02699200050051065; Lethlean JB, 1997, APHASIOLOGY, V11, P39, DOI 10.1080/02687039708248454; Lublin FD, 2014, EUR NEUROL, V72, P1, DOI 10.1159/000367614; Magnin E, 2015, EUR NEUROL, V74, P243, DOI 10.1159/000442348; Maloni H, 2018, JNP-J NURSE PRACT, V14, P172, DOI 10.1016/j.nurpra.2017.11.018; MASSARO M, 1994, CLIN APHASIOL, V22, P245; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Noffs G, 2018, AUTOIMMUN REV, V17, P1202, DOI 10.1016/j.autrev.2018.06.010; Papunet, 2018, KEHITYSVAMMALIITTO F; Pashek GV, 2002, APHASIOLOGY, V16, P261, DOI 10.1080/02687040143000573; Perez BD, 2020, APHASIOLOGY, V34, P195, DOI 10.1080/02687038.2019.1642999; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Renauld S, 2016, MULT SCLER RELAT DIS, V10, P103, DOI 10.1016/j.msard.2016.09.005; SCRUGGS TE, 1988, J SPEC EDUC, V22, P259, DOI 10.1177/002246698802200301; SCRUGGS TE, 1987, REM SPEC EDUC, V8, P24, DOI 10.1177/074193258700800206; Semel E., 2003, CLIN EVALUATION LANG; Sepulcre J, 2011, J CLIN EXP NEUROPSYC, V33, P169, DOI 10.1080/13803395.2010.499354; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Tallberg IM, 2009, APHASIOLOGY, V23, P1184, DOI 10.1080/02687030802436884; Tallberg IM, 2005, BRAIN LANG, V94, P19, DOI 10.1016/j.bandl.2004.11.004; Theodoros D, 2000, SPEECH LANGUAGE DISO; Vlaar AMM, 2003, CLIN REHABIL, V17, P756, DOI 10.1191/0269215503cr674oa; Wambaugh JL, 2007, J REHABIL RES DEV, V44, P381, DOI 10.1682/JRRD.2006.05.0038; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574; Yorkston KM, 2014, J COMMUN DISORD, V52, P196, DOI 10.1016/j.jcomdis.2014.05.005	54	0	0	3	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology												10.1080/02687038.2021.1900535		MAY 2021	25	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	SA2YA	WOS:000649164700001		hybrid, Green Submitted			2022-02-07	
J	Yi, M; Wang, DS; Chen, YY; Xu, X; Dai, XP				Yi, Min; Wang, Dongsheng; Chen, Yanyi; Xu, Xia; Dai, Xingping			beta-Asarone suppresses TNF-alpha expression through DNA methylation and c-Jun-mediated transcription modulation in scratch-injured neuronal cells	JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY			English	Article						DNA methylation; traumatic brain injury; tumor necrosis factor&#8208; &#945; &#946; &#8208; asarone	PROTECTS; ACTIVATION	This study aimed to investigate the role and possible mechanism of beta-asarone in regulating neuronal apoptosis and axonal regeneration. A scratch injury was applied to cell cultures of mouse primary cortical neurons to mimic neuronal injury. The neuronal apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling staining and western blot analysis of apoptosis-related proteins. The axonal regeneration was assessed by immunofluorescent staining of beta-tubulin III and western blot analysis of axonal markers. In the results, beta-asarone inhibited neuronal apoptosis and promoted axonal regeneration by suppressing tumor necrosis factor-alpha (TNF-alpha) expression in scratch-injured mouse neuronal cells. Research investigating the molecular mechanisms by which beta-asarone inhibited TNF-alpha expression showed that, on the one hand, beta-asarone suppressed the JNK/c-Jun pathway and thus transcriptionally inhibited TNF-alpha expression; on the other hand, beta-asarone induced expression of UHRF1 that recruited DNMT1 to induce TNF-alpha promoter methylation and subsequently decreased the messenger RNA expression of TNF-alpha. In conclusion, beta-asarone suppresses TNF-alpha expression through DNA methylation and c-Jun-mediated transcription modulation in scratch-injured neuronal cells.	[Yi, Min] Cent South Univ, Xiangya Hosp 2, Dept Integrated Tradit Chinese & Western Med, Changsha, Hunan, Peoples R China; [Wang, Dongsheng; Chen, Yanyi; Xu, Xia; Dai, Xingping] Cent South Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, 87 Xiangya Rd, Changsha 410078, Hunan, Peoples R China		Dai, XP (corresponding author), Cent South Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, 87 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	xingpingdai@csu.edu.cn			Key project of 2020 Hunan Province Natural Fund [2020JJ4872]; Key Projects of Hunan Provincial Administration of traditional Chinese medicine in 2020 [202010]; National renowned expert in traditional Chinese Medicine Professor Li Jiabang inheritance studio, State Administration of Traditional Chinese Medicine letter [(2018) 134]; Hunan Science and technology Major projects sub project [2020SK1014]	Key project of 2020 Hunan Province Natural Fund, Grant/Award Number: 2020JJ4872; Key Projects of Hunan Provincial Administration of traditional Chinese medicine in 2020, Grant/Award Number: 202010; National renowned expert in traditional Chinese Medicine Professor Li Jiabang inheritance studio, State Administration of Traditional Chinese Medicine letter, Grant/Award Number: (2018) 134; Hunan Science and technology Major projects sub project, Grant/Award Number: 2020SK1014	An HM, 2014, PHARMAZIE, V69, P391, DOI 10.1691/ph.2014.3662; Chang WG, 2018, DRUG DES DEV THER, V12, P455, DOI 10.2147/DDDT.S155567; Chang WG, 2015, INT J CLIN EXP MED, V8, P20658; Dai XP, 2019, BIOL CHEM, V400, P753, DOI 10.1515/hsz-2018-0340; Dong HY, 2019, EXP THER MED, V18, P3767, DOI 10.3892/etm.2019.8018; Dong HY, 2014, MOLECULES, V19, P5634, DOI 10.3390/molecules19055634; Huang LP, 2017, BIOMED PHARMACOTHER, V94, P666, DOI 10.1016/j.biopha.2017.07.125; Huang TQ, 2018, NEUROREPORT, V29, P661, DOI [10.1097/WNR.0000000000001015, 10.1097/wnr.0000000000001015]; Huang ZJ, 2020, CNS NEUROSCI THER, V26, P698, DOI 10.1111/cns.13298; Lam KYC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179077; Lin C, 2014, J CHANGCHUN U TRADIT, V30, P230; Liu SJ, 2016, DRUG DES DEV THER, V10, P1461, DOI 10.2147/DDDT.S93559; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; de Amorim VCM, 2020, N-S ARCH PHARMACOL, V393, P1921, DOI 10.1007/s00210-020-01905-2; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; Nanbu W., 2019, FRONT PHARMACOL, V10, P1529; Qi SS, 2019, J IMMUNOL, V203, P3045, DOI 10.4049/jimmunol.1900467; Rajan TS, 2017, INT J IMMUNOPATH PH, V30, P383, DOI 10.1177/0394632017740976; Su CM, 2019, J CELL PHYSIOL, V234, P9793, DOI 10.1002/jcp.27665; Walker LJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22540; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; Xie XM, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00383; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yen CY, 2016, CANCER LETT, V373, P185, DOI 10.1016/j.canlet.2016.01.036; Yi MN, 2016, NEUROSCI LETT, V624, P62, DOI 10.1016/j.neulet.2016.05.004; Zhang QS, 2016, BIOMED PHARMACOTHER, V83, P153, DOI 10.1016/j.biopha.2016.06.017	27	0	0	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1095-6670	1099-0461		J BIOCHEM MOL TOXIC	J. Biochem. Mol. Toxicol.	JUL	2021	35	7							e22798	10.1002/jbt.22798		MAY 2021	11	Biochemistry & Molecular Biology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Toxicology	TT1BE	WOS:000648484400001	33969572				2022-02-07	
J	Ivanisevic, M; Eloi, J; Roth, RM; Tayim, FM; Flashman, LA; McDonald, BC; McAllister, TW				Ivanisevic, Mirjana; Eloi, Janelle; Roth, Robert M.; Tayim, Fadi M.; Flashman, Laura A.; McDonald, Brenna C.; McAllister, Thomas W.			Self-Rated Executive Functions in Mild Traumatic Brain Injury	PSYCHOLOGICAL INJURY & LAW			English	Article						Executive function; Traumatic brain injury; Outcome; Mood	WORKING-MEMORY; NEUROPSYCHOLOGICAL OUTCOMES; CONCUSSION; ACTIVATION; RECOVERY; IMPACT	Prior research has found that individuals with a pre-injury psychiatric history report greater difficulty with executive functioning after mild traumatic brain injury (mTBI). The present study examined self-rated executive functioning after the acute phase of recovery in individuals with mTBI having no prior psychiatric history. Participants included 59 individuals with mTBI and 27 healthy comparison subjects (HC). They completed the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) and Beck Depression Inventory-II. Participants had no prior history of psychiatric diagnosis based on semi-structured interview. In those with a valid BRIEF-A, the mTBI group (n = 54; days since injury: M = 465.04, SD = 146.92, range = 315-1144) endorsed poorer executive functioning than the HC group (n = 24) on several BRIEF-A scales. Only the Working Memory and Inhibit scales remained significant after adjusting for group differences in education and depression score, but they did not survive adjustment for multiple comparisons. The mean standardized scores for the mTBI group were well within normal limits across scales. Furthermore, there were no group differences on any BRIEF-A scales for percentage of participants with clinically elevated scores. Individuals with mTBI and no prior psychiatric history did not endorse significant executive dysfunction. Our findings support previous literature indicating that self-rated executive dysfunction in those with mTBI after the acute phase of recovery is likely due to factors other than brain injury, such as subclinical symptoms of depression.	[Ivanisevic, Mirjana] VA Boston Healthcare Syst, Dept Psychol, Boston, MA 02130 USA; [Eloi, Janelle; Roth, Robert M.] DHMC Geisel Sch Med Dartmouth, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Tayim, Fadi M.] Premier Hlth Clin Neurosci Inst, Dayton, OH 45409 USA; [Flashman, Laura A.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27157 USA; [McDonald, Brenna C.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Roth, RM (corresponding author), DHMC Geisel Sch Med Dartmouth, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Robert.M.Roth@Hitchcock.org					Aase DM, 2021, ARCH CLIN NEUROPSYCH, V36, P424, DOI 10.1093/arclin/acaa053; Abeare K, 2021, PSYCHOL INJ LAW, V14, P2, DOI 10.1007/s12207-021-09402-4; Airaksinen E, 2004, PSYCHOL MED, V34, P83, DOI 10.1017/S0033291703008559; [Anonymous], STRUCTURED CLIN INTE; Arciniega H, 2019, ATTEN PERCEPT PSYCHO, V81, P2597, DOI 10.3758/s13414-019-01774-9; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bertisch H, 2019, J HEAD TRAUMA REHAB, V34, P36, DOI 10.1097/HTR.0000000000000399; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Brevik EJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00309; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carroll EL, 2020, J NEUROL, V267, P3223, DOI 10.1007/s00415-020-09979-x; Centers for Disease Control and Prevention, 2006, US CLASS DIS FUNCT D; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Cole WR., 2016, TRANSLATIONAL RES TR, DOI DOI 10.1201/B18959-20; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Dotson VM, 2020, NEUROPSYCHOL REV, V30, P461, DOI 10.1007/s11065-020-09436-6; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Gaasedelen OJ, 2019, CLIN NEUROPSYCHOL, V33, P1467, DOI 10.1080/13854046.2019.1612947; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Isquith PK, 2013, APPL NEUROPSYCH-CHIL, V2, P125, DOI 10.1080/21622965.2013.748389; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Korgaonkar MS, 2021, NEUROBIOL STRESS, V14, DOI 10.1016/j.ynstr.2021.100308; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McAllister TW., 2002, J NEUROPSYCHIATRY CL, V14, P116; McCrea M., 2008, MILD TRAUMATIC BRAIN; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Menatti ARR, 2020, J HEAD TRAUMA REHAB, V35, pE36, DOI 10.1097/HTR.0000000000000467; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Roth RM, 2015, CHILD NEUROPSYCHOL, V21, P225, DOI 10.1080/09297049.2014.897318; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sabelli AG, 2021, PSYCHOL INJ LAW, V14, P17, DOI 10.1007/s12207-021-09400-6; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stillman AM, 2020, J NEUROTRAUM, V37, P305, DOI 10.1089/neu.2018.5925; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y	52	0	0	3	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2021	14	2					144	150		10.1007/s12207-021-09411-3		MAY 2021	7	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	SP9OZ	WOS:000648378000001					2022-02-07	
J	Virani, S; Barton, A; Goodyear, BG; Yeates, KO; Brooks, BL				Virani, Shane; Barton, Alexander; Goodyear, Bradley G.; Yeates, Keith Owen; Brooks, Brian L.			Susceptibility-Weighted Magnetic Resonance Imaging (MRI) of Microbleeds in Pediatric Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; adolescence; pediatric; long-term; susceptibility-weighted imaging; microbleeds	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; RISK-FACTORS; RELIABILITY	Objective: The long-term consequences of pediatric concussion on brain structure are poorly understood. This study aimed to evaluate the presence and clinical significance of cerebral microbleeds several years after pediatric concussion. Methods: Children and adolescents 8-19 years of age with either a history of concussion (n = 35), or orthopedic injury (n = 20) participated. Mean time since injury for the sample was 30.4 months (SD = 19.6). Participants underwent susceptibility-weighted imaging, rated their depression and postconcussion symptoms, and completed cognitive testing. Parents of participants also completed symptom ratings for their child. Hypointensities in susceptibility-weighted images indicative of cerebral microbleeds were calculated as a measure of hypointensity burden. Results: Hypointensity burden did not differ significantly between participants with a history of concussion and those with a history of orthopedic injury. Depression ratings (self and parent report), postconcussion symptom ratings (self and parent report), and cognitive performance did not significantly correlate with hypointensity burden in the concussion group. Conclusions: These findings suggest that at approximately 2.5 years postinjury, children and adolescents with prior concussion do not have a greater amount of cerebral microbleeds compared to those with orthopedic injury. Future research should use longitudinal study designs and investigate children with persistent postconcussive symptoms to gain better insight into the long-term effects of concussion on cerebral microbleeds.	[Virani, Shane] Univ Calgary, Fac Kinesiol, Dept Pediat, Calgary, AB, Canada; [Virani, Shane; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Dept Pediat, Neurosci Program, Calgary, AB, Canada; [Barton, Alexander; Goodyear, Bradley G.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Goodyear, Bradley G.] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Goodyear, Bradley G.; Yeates, Keith Owen; Brooks, Brian L.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Goodyear, Bradley G.; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca			Shaikh Family Research Award; Ronald and Irene Ward Chair in Pediatric Brain Injury; Vi Riddell Children's Pain and Rehabilitation Program; Integrated Concussion Research Program; Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR)	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study ("NEURO-detect") was funded by the Shaikh Family Research Award (distributed by the Alberta Children's Hospital Research Institute) awarded to Brian Brooks, with additional support from the Ronald and Irene Ward Chair in Pediatric Brain Injury (awarded to Keith Yeates). Shane Virani acknowledges salary funding by the Vi Riddell Children's Pain and Rehabilitation Program and the Integrated Concussion Research Program. Brian Brooks acknowledges salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award.	Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohland JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007200; Brooks BL, 2019, BRAIN INJURY, V33, P233, DOI 10.1080/02699052.2018.1540798; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Charidimou Andreas, 2012, Front Neurol, V3, P133; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kirov II, 2018, NEUROIMAG CLIN N AM, V28, P91, DOI 10.1016/j.nic.2017.09.007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; MacMaster FP, 2020, J HEAD TRAUMA REHAB, V35, pE127, DOI 10.1097/HTR.0000000000000535; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martini DN, 2017, AM J SPORT MED, V45, P1420, DOI 10.1177/0363546516686785; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Moore RD, 2018, INT J PSYCHOPHYSIOL, V132, P14, DOI 10.1016/j.ijpsycho.2018.04.003; Plourde V, 2020, ARCH CLIN NEUROPSYCH, V35, P302, DOI 10.1093/arclin/acz073; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Reynolds CR, 2004, BASC; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Sohn MN, 2020, J INT NEUROPSYCH SOC, V26, P763, DOI 10.1017/S1355617720000223; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Tseng Ying-Chi, 2015, J NEUROL NEUROPHYSIO, V6, P1; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zivanovic N, 2021, J CHILD NEUROL, V36, P186, DOI 10.1177/0883073820962930	42	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	SEP	2021	36	10					867	874	08830738211002946	10.1177/08830738211002946		MAY 2021	8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	UP8AG	WOS:000651175000001	33966537	hybrid, Green Published			2022-02-07	
J	Grovola, MR; Paleologos, N; Brown, DP; Tran, N; Wofford, KL; Harris, JP; Browne, KD; Shewokis, PA; Wolf, JA; Cullen, DK; Duda, JE				Grovola, Michael R.; Paleologos, Nicholas; Brown, Daniel P.; Tran, Nathan; Wofford, Kathryn L.; Harris, James P.; Browne, Kevin D.; Shewokis, Patricia A.; Wolf, John A.; Cullen, D. Kacy; Duda, John E.			Diverse changes in microglia morphology and axonal pathology during the course of 1 year after mild traumatic brain injury in pigs	BRAIN PATHOLOGY			English	Article						axonal pathology; concussion; microglia; mild traumatic brain injury; skeletal analysis	CELLS; NEUROPROTECTION; MACROPHAGES; DISRUPTION; NEURONS; MEMORY	Over 2.8 million people experience mild traumatic brain injury (TBI) in the United States each year, which may lead to long-term neurological dysfunction. The mechanical forces that are caused by TBI propagate through the brain to produce diffuse axonal injury (DAI) and trigger secondary neuroinflammatory cascades. The cascades may persist from acute to chronic time points after injury, altering the homeostasis of the brain. However, the relationship between the hallmark axonal pathology of diffuse TBI and potential changes in glial cell activation or morphology have not been established in a clinically relevant large animal model at chronic time points. In this study, we assessed the tissue from pigs subjected to rapid head rotation in the coronal plane to generate mild TBI. Neuropathological assessments for axonal pathology, microglial morphological changes, and astrocyte reactivity were conducted in specimens out to 1-year post-injury. We detected an increase in overall amyloid precursor protein pathology, as well as periventricular white matter and fimbria/fornix pathology after a single mild TBI. We did not detect the changes in corpus callosum integrity or astrocyte reactivity. However, detailed microglial skeletal analysis revealed changes in morphology, most notably increases in the number of microglial branches, junctions, and endpoints. These subtle changes were most evident in periventricular white matter and certain hippocampal subfields, and were observed out to 1-year post-injury in some cases. These ongoing morphological alterations suggest persistent change in neuroimmune homeostasis. Additional studies are needed to characterize the underlying molecular and neurophysiological alterations, as well as potential contributions to neurological deficits.	[Grovola, Michael R.; Paleologos, Nicholas; Brown, Daniel P.; Tran, Nathan; Wofford, Kathryn L.; Harris, James P.; Browne, Kevin D.; Wolf, John A.; Cullen, D. Kacy; Duda, John E.] Corporal Michael J Crescenz VA Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, PADRECC Mail Stop 127,3900 Woodland Ave, Philadelphia, PA 19104 USA; [Grovola, Michael R.; Paleologos, Nicholas; Brown, Daniel P.; Wofford, Kathryn L.; Harris, James P.; Browne, Kevin D.; Wolf, John A.; Cullen, D. Kacy] Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA; [Shewokis, Patricia A.] Drexel Univ, Coll Nursing & Hlth Profess, Dept Nutr Sci, Philadelphia, PA 19104 USA; [Shewokis, Patricia A.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Cullen, D. Kacy] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Duda, John E.] Corporal Michael J Crescenz VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, Philadelphia, PA 19104 USA; [Duda, John E.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA		Duda, JE (corresponding author), Corporal Michael J Crescenz VA Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, PADRECC Mail Stop 127,3900 Woodland Ave, Philadelphia, PA 19104 USA.; Cullen, DK (corresponding author), Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA.	dkacy@pennmedicine.upenn.edu; John.Duda@va.gov		Paleologos, Nicholas/0000-0002-5110-9378; Cullen, D. Kacy/0000-0002-5355-5216; Grovola, Michael/0000-0003-4125-9329	Department of Veterans AffairsUS Department of Veterans Affairs [I01-RX001097, I01-BX003748, IK2-RX001479]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R03-NS116301, NINDS R01-NS101108, NINDS T32-NS043126, NINDS F32-NS116205]; CURE Foundation; US Department of Defense [ERP CDMRP] [W81XWH-16-1-0675]	This work was made possible through financial support provided by the Department of Veterans Affairs [RR&D Merit Review I01-RX001097 (Duda), BLR&D Merit Review I01-BX003748 (Cullen), and RR&D Career Development Award IK2-RX001479 (Wolf)], the National Institutes of Health [NINDS R03-NS116301 (Cullen), NINDS R01-NS101108 (Wolf), NINDS T32-NS043126 (Harris), NINDS F32-NS116205 (Wofford)], the CURE Foundation [Taking Flight Award (Wolf)], and the US Department of Defense [ERP CDMRP #W81XWH-16-1-0675 (Wolf)]. None of the funding sources aided in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication	Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Benusa SD., 2020, NEUROIMMUNOL NEUROIN, V2020, P1; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Debels H, 2013, TISSUE ENG PT A, V19, P2615, DOI [10.1089/ten.tea.2013.0071, 10.1089/ten.TEA.2013.0071]; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Gorse KM., 2018, FRONT NEUROL, V9, P1; Grovola MR., 2020, J NEUROINFLAMMATION, V17, P1; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Helmchen F., 2005, Neuroforum, V11, P95; Holdeman TC, 2009, PSYCHIAT SERV, V60, P273, DOI 10.1176/appi.ps.60.2.273; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Khokhar BR, 2021, MIL MED, V186, pE293, DOI 10.1093/milmed/usaa249; Koliatsos VE, 2019, CURR OPIN NEUROL, V32, P786, DOI 10.1097/WCO.0000000000000763; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mac Donald CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6676; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soltys Z, 2005, J NEUROSCI METH, V146, P50, DOI 10.1016/j.jneumeth.2005.01.009; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Walker WC, 2018, BRAIN INJURY, V32, P1156, DOI 10.1080/02699052.2018.1483529; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Wes PD, 2016, GLIA, V64, P197, DOI 10.1002/glia.22866; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	66	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	SEP	2021	31	5							e12953	10.1111/bpa.12953		MAY 2021	19	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	UE6VV	WOS:000647864300001	33960556	gold, Green Published			2022-02-07	
J	Idriss-Hassan, A; Berube, M; Belcaid, A; Clement, J; Bourgeois, G; Rizzo, C; Neveu, X; Soltana, K; Thakore, J; Moore, L				Idriss-Hassan, Abakar; Berube, Melanie; Belcaid, Amina; Clement, Julien; Bourgeois, Gilles; Rizzo, Christine; Neveu, Xavier; Soltana, Kahina; Thakore, Jaimini; Moore, Lynne			Derivation and validation of actionable quality indicators targeting reductions in complications for injury admissions	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Trauma system; Benchmarking; Quality indicators; Complications	IN-HOSPITAL COMPLICATIONS; TRAUMATIC BRAIN-INJURY; PROGNOSTIC MODELS; OF-CARE; MORTALITY; DETERMINANTS; CONSENSUS; OUTCOMES; BINARY; SYSTEM	Purpose Approximately, one out of five patients hospitalized following injury will develop at least one hospital complication, more than three times that observed for general admissions. We currently lack actionable Quality Indicators (QI) targeting specific complications in this population. We aimed to derive and validate QI targeting hospital complications for injury admissions and develop algorithms to identify patient charts to review. Methods We conducted a retrospective cohort study including patients with major trauma admitted to any level I or II adult trauma center an integrated Canadian trauma system (2014-2019). We used the trauma registry to develop five QI targeting deep vein thrombosis/pulmonary embolism (DVT/PE), decubitus ulcers, delirium, pneumonia and urinary tract infection (UTI). We developed algorithms to identify patient charts to revise on consultation with a group of clinical experts. Results The study population included 14,592 patients of whom 5.3% developed DVT or PE, 2.7% developed a decubitus ulcer, 8.6% developed delirium, 14.7% developed pneumonia and 7.3% developed UTI. The indicators demonstrated excellent predictive performance (Area Under the Curve 0.81-0.87). We identified 4 hospitals with a higher than average incidence of at least one of the targeted complications. The algorithms identified on average 50 and 20 charts to be reviewed per year for level I and II centers, respectively. Conclusion In line with initiatives to improve the quality of trauma care, we propose QI targeting reductions in hospital complications for injury admissions and algorithms to generate case lists to facilitate the review of patient charts.	[Idriss-Hassan, Abakar; Berube, Melanie; Belcaid, Amina; Neveu, Xavier; Soltana, Kahina; Moore, Lynne] Univ Laval, Axe Sante Populat & Prat Optimales Sante,CHU Queb, Populat Hlth & Optimal Hlth Practices Res Unit,Ct, Traumatol Urgence Soins Intensifs,Trauma Emergenc, Quebec City, PQ, Canada; [Idriss-Hassan, Abakar] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Berube, Melanie] Univ Laval, Fac Nursing, Quebec City, PQ, Canada; [Belcaid, Amina; Clement, Julien] Inst Natl Excellence Sante & Serv Sociaux, Quebec City, PQ, Canada; [Clement, Julien] Univ Laval, Dept Surg, Quebec City, PQ, Canada; [Bourgeois, Gilles] Urgences Sante, Montreal, PQ, Canada; [Rizzo, Christine] Univ Laval, CHU Quebec, Ctr Rech, Hop Enfant Jesus, Quebec City, PQ, Canada; [Thakore, Jaimini] Trauma Serv BC, Data Evaluat & Analyt, Vancouver, BC, Canada; [Moore, Lynne] Univ Laval, Dept Social & Preventat Med, 2325 Rue Univ, Quebec City, PQ G1V 0A6, Canada		Moore, L (corresponding author), Univ Laval, Axe Sante Populat & Prat Optimales Sante,CHU Queb, Populat Hlth & Optimal Hlth Practices Res Unit,Ct, Traumatol Urgence Soins Intensifs,Trauma Emergenc, Quebec City, PQ, Canada.	idriss-hassan.abakar.1@ulaval.ca; melanie.berube@fsi.ulaval.ca; amina.belcaid@chudequebec.ca; julienclement@hotmail.com; Gillesbourgeois1954@gmail.com; christine.rizzo@chudequebec.ca; xavier.neveu@crchudequebec.ulaval.ca; kahina.soltana@crchudequebec.ulaval.ca; Jaimini.Thakore@phsa.ca; lynne.moore@fmed.ulaval.ca					Bustillo RA, 2020, EUR J TRAUMA EMERG S, V46, P903, DOI 10.1007/s00068-018-1057-x; [Anonymous], PERFORMANCE COMP INF; Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Canadian Institute for Health Information, 2018, CAN COD STAND VERS 2; Centers for Disease Control and Prevention, 2019, COST INJ VIOL US; Cox J, 2011, AM J CRIT CARE, V20, P364, DOI 10.4037/ajcc2011934; de Jongh MAC, 2011, BRIT J SURG, V98, P790, DOI 10.1002/bjs.7436; de Jongh MAC, 2011, J TRAUMA, V71, pE102, DOI 10.1097/TA.0b013e31820e351f; Drake JM, 2012, J NEUROSURG-PEDIATR, V10, P89, DOI 10.3171/2012.3.PEDS11233; Fenlon C, 2018, PREV VET MED, V149, P107, DOI 10.1016/j.prevetmed.2017.11.018; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hemmila MR, 2008, SURGERY, V144, P307, DOI 10.1016/j.surg.2008.05.003; Hemmila MR, 2007, SURGERY, V142, P439, DOI 10.1016/j.surg.2007.07.002; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Huseynova K, 2009, J AM COLL SURGEONS, V208, P547, DOI 10.1016/j.jamcollsurg.2009.01.002; International Society of Surgery and International Association for Trauma Surgery and Intensive Care, 2009, GUID TRAUM QUAL IMPR; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Leeies M, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0593-5; Little RJA., 2002, STAT ANAL MISSING DA, DOI [10.1002/9781119013563, DOI 10.1002/9781119013563]; Malangoni MA, 2007, SURGERY, V142, P448; Miao Y, 2013, P SAS GLOB FORM CAR, P504; Ministere de la Sante et des Services sociaux, CADR NORM SYST INF R; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moore L, 2006, J TRAUMA, V60, P43; Moore L, 2008, ANN EMERG MED, V52, P356, DOI 10.1016/j.annemergmed.2007.09.007; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Moore L, 2017, CAN J SURG, V60, P380, DOI 10.1503/cjs.002817; Moore L, 2016, JAMA SURG, V151, P622, DOI 10.1001/jamasurg.2015.5484; Moore L, 2015, ANN SURG, V262, P1123, DOI 10.1097/SLA.0000000000000963; Moore L, 2015, J TRAUMA ACUTE CARE, V78, P1168, DOI 10.1097/TA.0000000000000663; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; O'Reilly GM, 2010, ACAD EMERG MED, V17, P1122, DOI 10.1111/j.1553-2712.2010.00887.x; Omar M, 2017, J CRIT CARE, V41, P1, DOI 10.1016/j.jcrc.2017.04.031; Osler T, 2012, ARCH SURG-CHICAGO, V147, P152, DOI 10.1001/archsurg.2011.888; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Parachute, 2015, COST INJ CAN REP; Rubin D.B., 2004, MULTIPLE IMPUTATION; Shafi S, 2010, J TRAUMA, V69, P1367, DOI 10.1097/TA.0b013e3181fb785d; Snell KIE, 2018, STAT METHODS MED RES, V27, P3505, DOI 10.1177/0962280217705678; Stelfox HT, 2013, J CLIN EPIDEMIOL, V66, P1320, DOI 10.1016/j.jclinepi.2013.05.018; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2009, CLIN PREDICTION MODE, P497, DOI 10.1007/978-0-387-77244-8; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; TEASDALE G, 1974, LANCET, V2, P81; The American Association for the Surgery of Trauma, 2012, TRAUM FACTS; Turgeon AF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013779; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	52	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01681-5		MAY 2021	11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RY9BW	WOS:000648199400003	33961073				2022-02-07	
J	Lecci, L; Freund, CT; Ayearst, LE; Sitarenios, G; Pickett, B; Crews, FS; Dugan, K; Lange, L; Clark, A; Linz, T; Taravath, S; Williams, M; Keith, J				Lecci, Len; Freund, C. Thomas; Ayearst, Lindsay E.; Sitarenios, Gill; Pickett, Blair; Crews, Faith S.; Dugan, Kelly; Lange, Lori; Clark, Amanda; Linz, Thomas; Taravath, Sasi; Williams, Mark; Keith, Julian			Validating a Short Conners CPT 3 as a Screener: Predicting Self-reported CDC Concussion Symptoms in Children, Adolescents, and Adults	JOURNAL OF PEDIATRIC NEUROPSYCHOLOGY			English	Article						Concussion screening; Neurocognitive assessment; mTBI; Return-to-play decisions; Head injuries	TRAUMATIC BRAIN-INJURY; CONTINUOUS PERFORMANCE-TEST; TEST-RETEST RELIABILITY; HIGH-SCHOOL; SPORT CONCUSSION; RECOVERY; IMPACT; TESTS; EPIDEMIOLOGY; MANAGEMENT	Objective Brevity is critical to the broad adoption of any screening measure. We examine the efficacy of a short Conners Continuous Performance Test (CCPT 3) to screen for concussion symptoms. Method Data were from 20 U.S. sites, including university/schools conducting baseline testing (N = 817) and post-concussion assessments in medical settings (N = 108) from March 2018 to March 2020. Nine hundred twenty-five participants (57.3% female) aged 8-66 (M = 19.4, SD = 6.1) completed the computerized CCPT 3, Balance Error Scoring System, NIH 4-meter gait test, and 31-item Centers for Disease Control and Prevention (CDC) concussion symptom checklist. Results Short CCPT 3 scores correlate highly with full CCPT 3, with coefficients of .70-.96 (M = .88). Short CCPT 3 explains 16.8% variance in CDC concussion symptoms (F-(8,F- 910) = 23.01, p < .001; Cohen's d = .90) and provides incremental validity (15% variance; d = .78) over behavioral measures (F-change (8,F- 842) = 20.11, p < .001). Predictive validity of the short CCPT 3 was greater for those having a recent concussion (22.1% variance, d = 1.07; F-(8,F- 97) = 3.45, p= .002). Scores also predict concussion history. Conclusions The short CCPT 3 yields large effect sizes when predicting CDC concussion symptoms, compares favorably to other concussion measures, and shows no trade-off from the full CCPT, which has previously predicted concussion symptoms and severity. Short CCPT 3 scores can objectively quantify cognitive functioning to serve as a screener and inform return-to-play decisions even for post-acute presentations in children, adolescents, and adults.	[Lecci, Len; Freund, C. Thomas; Crews, Faith S.; Keith, Julian] Univ N Carolina, Dept Psychol, 601 South Coll Rd, Wilmington, NC 28403 USA; [Ayearst, Lindsay E.] Revibe Technol, Wake Forest, NC USA; [Sitarenios, Gill] Atlus Assessments, Toronto, ON, Canada; [Pickett, Blair; Dugan, Kelly] SportGait, Wilmington, NC USA; [Lange, Lori] Univ North Florida, Jacksonville, FL USA; [Clark, Amanda] Univ Tennessee, Chattanooga, TN USA; [Linz, Thomas] Marshall Univ, Huntington, WV USA; [Taravath, Sasi; Williams, Mark] New Hanover Reg Med Ctr, Wilmington, NC USA		Lecci, L (corresponding author), Univ N Carolina, Dept Psychol, 601 South Coll Rd, Wilmington, NC 28403 USA.	leccil@uncw.edu		, Blair/0000-0003-3989-9378			Alsalaheen B, 2017, J ATHL TRAINING, V52, P834, DOI 10.4085/1062-6050-52.7.05; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Centers for Disease Control and Prevention, 2020, HEADS CONC HIGH SCH; Centers for Disease Control and Prevention, 2003, NAT CTR INJ PREV CON; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chen HC, 2009, BRAIN INJURY, V23, P715, DOI 10.1080/02699050903013602; Chen KW, 2020, ARCH CLIN NEUROPSYCH, V35, P545, DOI 10.1093/arclin/acaa004; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Conners C., 2014, CONNERS CONTINUOUS P; Conners C. K., 1995, MULTIHEALTH SYSTEMS; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Defense and Veterans Brain Injury Center, 2019, NAT AC SCI ENG MED E, P137, DOI [10.17226/25317, DOI 10.17226/25317]; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gibson DB, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00126; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Houston MN, 2021, J INT NEUROPSYCH SOC, V27, P23, DOI 10.1017/S1355617720000594; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Keightley Michelle L, 2010, BMJ Case Rep, V2010, DOI 10.1136/bcr.09.2009.2309; Keith J., 2019, J PEDIAT NEUROPSYCHO, V5, P177, DOI [10.1007/s40817-019-00075-1, DOI 10.1007/S40817-019-00075-1]; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kirelik SB, 2016, J EMERG MED, V50, P320, DOI 10.1016/j.jemermed.2015.02.054; Kontos AP, 2019, ARCH CLIN NEUROPSYCH, V34, P762, DOI 10.1093/arclin/acz026.32; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leahy AB, 2018, PATIENT, V11, P147, DOI 10.1007/s40271-017-0279-z; Lecci L, 2020, ARCH CLIN NEUROPSYCH, V35, P265, DOI 10.1093/arclin/acz041; Levan A, 2016, BRAIN IMAGING BEHAV, V10, P1090, DOI 10.1007/s11682-015-9472-7; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Mathiasen R, 2018, J NEUROTRAUM, V35, P691, DOI 10.1089/neu.2017.5072; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKay CD, 2013, BRIT J SPORT MED, V47, pe1, DOI [10.1136/bjsports-2012-092101.17, DOI 10.1136/BJSPORTS-2012-092101.17]; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Meyer GJ, 2001, AM PSYCHOL, V56, P128, DOI 10.1037//0003-066X.56.2.128; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Peters DM, 2013, J GERIATR PHYS THER, V36, P24, DOI 10.1519/JPT.0b013e318248e20d; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Roebuck H, 2016, J SPEECH LANG HEAR R, V59, P501, DOI 10.1044/2015_JSLHR-L-15-0068; Salgado JF, 2018, EUR J PSYCHOL APPL L, V10, P35, DOI 10.5093/ejpalc2018a5; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Sitarenios G., 2019, CONNERS CPT 3 SHORT; Tallberg P, 2019, SCAND J PSYCHOL, V60, P26, DOI 10.1111/sjop.12499; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Yarnold PR, 2017, OPTIMAL DATA ANAL, V6, P26; Zane KL, 2016, ARCH CLIN NEUROPSYCH, V31, P996, DOI 10.1093/arclin/acw078	71	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2199-2681	2199-2673		J PEDIATR NEUROPSYCH	J. Pediatr. Neuropsych.	DEC	2021	7	4					169	181		10.1007/s40817-021-00107-9		MAY 2021	13	Psychology, Clinical; Psychology, Developmental; Clinical Neurology; Psychology	Emerging Sources Citation Index (ESCI)	Psychology; Neurosciences & Neurology	XA1LB	WOS:000649008200001					2022-02-07	
J	Li, C; Yu, TY; Gong, LR; Mu, R; Zhang, Y; Yu, JB				Li, Cui; Yu, Tian-yu; Gong, Li-rong; Mu, Rui; Zhang, Yuan; Yu, Jian-bo			Involvement of Nrf-2/HO-1 pathway in sevoflurane-induced cognitive improvement in rats with traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Nuclear factor erythroid-2-related factor-2; Heme oxygenase-1; Sevoflurane; Cognition; Traumatic brain injury	APOPTOSIS; ISCHEMIA; RESCUES; STRESS; CELLS	Traumatic brain injury (TBI) is an increasingly common emergency disease that usually leads to prolonged physical and cognitive impairments. In this study, we investigated if sevoflurane could induce cognitive improvement in TBI rats. Rats were subjected to head trauma induced by a fluid percussion device. A two-hour exposure to 3% sevoflurane was performed in a chamber immediately after TBI. Sevoflurane inhalation reduced the neurological and cognitive deficits induced by TBI with ameliorated synaptic injuries in the hippocampus. Moreover, after sevoflurane treatment, the expression of nuclear factor erythroid-2-related factor-2 (Nrf-2) and hemeoxygenase-1 (HO-1) in the hippocampus was enhanced 1 d after TBI and maintained at high levels 14 days later, and oxidative stress induced by TBI was inhibited. However, the HO-1 inhibitor, Zinc protoporphyrin (ZnPP), used to demonstrate the involvement of HO-1, suppressed the protective effect of sevoflurane. These results indicate that sevoflurane administered immediately after TBI may protect against TBI-induced synaptic and cognitive impairments by promoting the antioxidant Nrf-2/HO-1 pathway. Sevoflurane may be a promising anesthetic for patients with TBI.	[Li, Cui; Gong, Li-rong; Mu, Rui; Zhang, Yuan; Yu, Jian-bo] Tianjin Med Univ, Tianjin NanKai Hosp, Dept Anesthesiol & Crit Care Med, Tianjin 300100, Peoples R China; [Yu, Tian-yu] Tianjin Med Univ, Tianjin 300070, Peoples R China		Yu, JB (corresponding author), Tianjin NanKai Hosp, Dept Anesthesiol, 6 Changjiang Rd, Tianjin 300100, Peoples R China.	yujianbo11@126.com			Project of Health Committee of Tianjin Province of China [2019044]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772106]	This work was supported by the Project of Health Committee of Tianjin Province of China [grant number 2019044] and the National Natural Science Foundation of China [grant number 81772106].	Afroz S, 2017, NEUROSCIENCE, V347, P22, DOI 10.1016/j.neuroscience.2017.01.051; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Clarkson AN, 2007, LIFE SCI, V80, P1157, DOI 10.1016/j.lfs.2006.12.022; CONZEN PF, 1992, ANESTH ANALG, V74, P79; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Royes LFF, 2019, NEUROSCI BIOBEHAV R, V102, P345, DOI 10.1016/j.neubiorev.2019.05.012; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hertel M, 2002, EUR J NEUROSCI, V15, P1707, DOI 10.1046/j.1460-9568.2002.01992.x; Li FY, 2019, ANN CLIN TRANSL NEUR, V6, P1825, DOI 10.1002/acn3.50878; Li FY, 2019, J CELL BIOCHEM, V120, P14899, DOI 10.1002/jcb.28751; Li R, 2017, BRAIN RES BULL, V130, P236, DOI 10.1016/j.brainresbull.2017.01.016; Liang C, 2013, J NEUROSURG ANESTH, V25, P311, DOI 10.1097/ANA.0b013e31828c6af5; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Richebe P, 2009, CAN J ANAESTH, V56, P126, DOI 10.1007/s12630-008-9023-4; Shin N, 2019, ANTIOXID REDOX SIGN, V30, P1601, DOI 10.1089/ars.2017.7280; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Taille C, 2001, AM J RESP CRIT CARE, V163, P753, DOI 10.1164/ajrccm.163.3.2004202; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang WY, 2016, NEUROSCIENCE, V313, P199, DOI 10.1016/j.neuroscience.2015.11.038; Widman AJ, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00008; Wolahan SM, 2019, J NEUROTRAUM, V36, P212, DOI 10.1089/neu.2018.5674; Yu JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104924; Yu JB, 2016, ANESTHESIOLOGY, V125, P1190, DOI 10.1097/ALN.0000000000001333; Zhang Y, 2015, GENE, V569, P60, DOI 10.1016/j.gene.2015.05.026; Zheng CX, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7893710	35	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 7	2021	405								113200	10.1016/j.bbr.2021.113200			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	TI1TJ	WOS:000672567400003	33636237				2022-02-07	
J	Reed, J; Grillakis, A; Kline, A; Ahmed, AE; Byrnes, KR				Reed, John; Grillakis, Antigone; Kline, Alyssa; Ahmed, Anwar E.; Byrnes, Kimberly R.			Gait analysis in a rat model of traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Controlled cortical impact; DigiGait; Gait; Gliosis; Locomotion; Parietal cortex	CORTICAL IMPACT INJURY; SPINAL-CORD; OVERGROUND LOCOMOTION; ABNORMALITIES; IMPAIRMENT; RECOVERY; MODERATE; LESIONS; INDEX	Gait disruptions following traumatic brain injury (TBI) are noted in the clinical population. To date, thorough analysis of gait changes in animal models of TBI to allow for correlation of pathological alterations and utilization of this as a therapeutic outcome have been limited. We therefore assessed gait using the DigiGait analysis system as well as overall locomotion using the Beam Walk test in adult male Sprague-Dawley rats following a commonly used model of TBI, parietal lobe controlled cortical impact (CCI). Rats underwent DigiGait baseline analysis 24 h prior to injury, followed by a moderate CCI in the left parietal lobe. Performance on the DigiGait was then assessed at 1, 3, 7, and 14 days post-injury, followed by histological analysis of brain tissue. Beam walk analysis showed a transient but significant impairment acutely after injury. Despite observance of gait disturbance in the clinical population, TBI in the parietal lobe of rats resulted in limited alterations in hind or forelimb function. General hindlimb locomotion showed significant but transient impairment. Significant changes in gait were observed to last through the sub-acute period, including right hindpaw angle of rotation and left forelimb and right hindlimb swing phase duration. Slight changes that did not reach statistical significant but may reflect subtle impacts of TBI on gait were reflected in several other measures, such as stride duration, stance duration and stance width. These results demonstrate that moderate-severe injury to the parietal cortex and underlying structures including corpus callosum, hippocampus, thalamus and basal ganglia result in slight changes to gait that can be detected using the Digigait analysis system.	[Reed, John; Grillakis, Antigone; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Neurosci Grad Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Kline, Alyssa; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Ahmed, Anwar E.] Uniformed Serv Univ Hlth Sci, Prevent Med & Biostat, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Room C2099,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	john.r.reed20.mil@mail.mil; Antigone.grillakis.ctr@usuhs.edu; ask97@pitt.edu; kimberly.byrnes@usuhs.edu		Byrnes, Kimberly/0000-0002-7501-7734; Kline, Alyssa/0000-0002-8083-2637	Tri Service Nursing Research Program (TSNRP) [N17P15]	The authors would like to thank Ms. Hannah Byrne, Ms. Allyson Fisher and Mr. Sean Collier for their technical assistance and consultation on this project. This work was supported by the Tri Service Nursing Research Program (TSNRP) grant number N17P15. The content is solely the responsibility of the authors and does not necessarily represent the official vies of the NIH, DoD or Uniformed Services University.	Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Bondi CO, 2018, RESTOR NEUROL NEUROS, V36, P45, DOI 10.3233/RNN-170781; Brabazon F., 2016, J NEUROTRAUM; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Carmel JB, 2010, EUR J NEUROSCI, V32, P1678, DOI 10.1111/j.1460-9568.2010.07440.x; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Frigon A, 2017, J NEUROPHYSIOL, V117, P2224, DOI 10.1152/jn.00978.2016; Geddes RI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169494; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hendriks WTJ, 2006, J NEUROTRAUM, V23, P18, DOI 10.1089/neu.2006.23.18; Henry RJ, 2020, J NEUROTRAUM, V37, P2709, DOI 10.1089/neu.2020.7139; Herman T, 2009, GAIT POSTURE, V29, P237, DOI 10.1016/j.gaitpost.2008.08.013; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Jacobowitz D.M., 2012, BRAIN RES; Jacobs BY, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0456-x; Kawalec JS, 2017, WOODH PUBL SER BIOM, P231, DOI 10.1016/B978-0-08-100286-5.00012-3; Kerrigan DCC, 1999, J HEAD TRAUMA REHAB, V14, P136, DOI 10.1097/00001199-199904000-00004; Lakes EH, 2018, GAIT POSTURE, V63, P73, DOI 10.1016/j.gaitpost.2018.04.023; Lambert CS, 2014, BEHAV BRAIN RES, V274, P334, DOI 10.1016/j.bbr.2014.08.004; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Muir GD, 2000, EUR J NEUROSCI, V12, P1113, DOI 10.1046/j.1460-9568.2000.00987.x; Neckel ND, 2020, J NEUROTRAUM, V37, P517, DOI 10.1089/neu.2018.5959; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Takakusaki K, 2017, J MOV DISORD, V10, P1, DOI 10.14802/jmd.16062; Teutsch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6037015; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Webb NE, 2014, NEUROREHABILITATION, V34, P625, DOI 10.3233/NRE-141074; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wilson J., 2018, NEUROSCI BIOBEHAV R; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052	41	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 7	2021	405								113210	10.1016/j.bbr.2021.113210			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	TI1TG	WOS:000672567100005	33639268				2022-02-07	
J	Behnke, JA; Ye, CT; Setty, A; Moberg, KH; Zheng, JQ				Behnke, Joseph A.; Ye, Changtian; Setty, Aayush; Moberg, Kenneth H.; Zheng, James Q.			Repetitive mild head trauma induces activity mediated lifelong brain deficits in a novel Drosophila model	SCIENTIFIC REPORTS			English	Article							CONTROLLED CORTICAL IMPACT; GLUTAMATE TRANSPORTERS; REACTIVE ASTROCYTES; ALZHEIMERS-DISEASE; NEGATIVE GEOTAXIS; SEX-DIFFERENCES; TAU PATHOLOGY; AXONAL INJURY; EXPRESSION; ENCEPHALOPATHY	Mild head trauma, including concussion, can lead to chronic brain dysfunction and degeneration but the underlying mechanisms remain poorly understood. Here, we developed a novel head impact system to investigate the long-term effects of mild head trauma on brain structure and function, as well as the underlying mechanisms in Drosophila melanogaster. We find that Drosophila subjected to repetitive head impacts develop long-term deficits, including impaired startle-induced climbing, progressive brain degeneration, and shortened lifespan, all of which are substantially exacerbated in female flies. Interestingly, head impacts elicit an elevation in neuronal activity and its acute suppression abrogates the detrimental effects in female flies. Together, our findings validate Drosophila as a suitable model system for investigating the long-term effects of mild head trauma, suggest an increased vulnerability to brain injury in female flies, and indicate that early altered neuronal excitability may be a key mechanism linking mild brain trauma to chronic degeneration.	[Behnke, Joseph A.; Ye, Changtian; Setty, Aayush; Moberg, Kenneth H.; Zheng, James Q.] Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA; [Zheng, James Q.] Emory Univ, Dept Neurol, Sch Med, Atlanta, GA 30322 USA; [Zheng, James Q.] Emory Univ, Ctr Neurodegenerat Dis, Sch Med, Atlanta, GA 30322 USA		Zheng, JQ (corresponding author), Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA.; Zheng, JQ (corresponding author), Emory Univ, Dept Neurol, Sch Med, Atlanta, GA 30322 USA.; Zheng, JQ (corresponding author), Emory Univ, Ctr Neurodegenerat Dis, Sch Med, Atlanta, GA 30322 USA.	james.zheng@emory.edu		Moberg, Kenneth/0000-0002-9820-5543; Ye, Changtian/0000-0002-5381-410X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM083889, R01MH104632, MH107305]; Google Cloud's Academic Research Credits Program	This research project was supported in part by research grants from the National Institutes of Health to JQZ (GM083889, R01MH104632) and to KHM (MH107305). This research was also supported in part by Google Cloud's Academic Research Credits Program to JAB.	Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Beschorner R, 2007, HISTOL HISTOPATHOL, V22, P515, DOI 10.14670/HH-22.515; Bolkan BJ, 2014, DEV NEUROBIOL, V74, P1210, DOI 10.1002/dneu.22199; Brace EJ, 2017, EXP NEUROL, V287, P310, DOI 10.1016/j.expneurol.2016.03.014; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burnouf S, 2015, ACTA NEUROPATHOL, V130, P35, DOI 10.1007/s00401-015-1419-y; Chatterjee S, 2009, HUM MOL GENET, V18, P164, DOI 10.1093/hmg/ddn326; Chiasseu M., 2020, ALZHEIMERS DEMENT, V16; Cho S, 2018, P NATL ACAD SCI USA, V115, P11316, DOI 10.1073/pnas.1800830115; Coelho DS, 2018, CELL REP, V25, P3661, DOI 10.1016/j.celrep.2018.11.098; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Duan SM, 1999, J NEUROSCI, V19, P10193; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Erkkinen MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033118; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; Gao XJJ, 2015, NAT NEUROSCI, V18, P917, DOI 10.1038/nn.4016; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guo F, 2017, P NATL ACAD SCI USA, V114, pE8780, DOI 10.1073/pnas.1706608114; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; He Y, 2014, METHODS, V68, P129, DOI 10.1016/j.ymeth.2014.04.008; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jonson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133272; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kilian JG, 2017, NEUROSCIENCE, V348, P191, DOI 10.1016/j.neuroscience.2017.02.011; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Little DM, 2014, ALZHEIMERS DEMENT, V10, pS188, DOI 10.1016/j.jalz.2014.04.002; Liu HY, 2015, NEUROSCI BULL, V31, P541, DOI 10.1007/s12264-014-1526-0; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neukomm LJ, 2014, P NATL ACAD SCI USA, V111, P9965, DOI 10.1073/pnas.1406230111; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Rauen K, 2021, GEROSCIENCE, V43, P263, DOI 10.1007/s11357-020-00273-2; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Rideout EJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005683; Romero-Ferrero F, 2019, NAT METHODS, V16, P179, DOI 10.1038/s41592-018-0295-5; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Saikumar J, 2021, NAT PROTOC, V16, P263, DOI 10.1038/s41596-020-00415-y; Saikumar J, 2020, P NATL ACAD SCI USA, V117, P17269, DOI 10.1073/pnas.2003909117; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; SCHNEIDER K, 1988, INT J SPORT BIOMECH, V4, P358, DOI 10.1123/ijsb.4.4.358; Shah EJ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00511; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Srivastava AK., 2018, PRE CLIN CLIN METHOD; Sun J, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00006; Sun M., 2017, J VIS EXP, V125, P55602; Takahashi K, 2015, J EXP MED, V212, P319, DOI 10.1084/jem.20140413; Tang SJ, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00976-9; Testa ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058936; Tian RL, 2019, NEURON, V104, P239, DOI 10.1016/j.neuron.2019.07.014; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Wang ZP, 2011, CURR OPIN NEUROBIOL, V21, P189, DOI 10.1016/j.conb.2010.08.010; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zullo JM, 2019, NATURE, V574, P359, DOI 10.1038/s41586-019-1647-8	104	0	0	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 6	2021	11	1							9738	10.1038/s41598-021-89121-7			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL5WX	WOS:000656989400009	33958652	gold, Green Submitted, Green Published			2022-02-07	
J	Cheng, SQ; Mao, X; Lin, XJ; Wehn, A; Hu, SB; Mamrak, U; Khalin, I; Wostrack, M; Ringel, F; Plesnila, N; Terpolilli, NA				Cheng, Shiqi; Mao, Xiang; Lin, Xiangjiang; Wehn, Antonia; Hu, Senbin; Mamrak, Uta; Khalin, Igor; Wostrack, Maria; Ringel, Florian; Plesnila, Nikolaus; Terpolilli, Nicole A.			Acid-Ion Sensing Channel 1a Deletion Reduces Chronic Brain Damage and Neurological Deficits after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; brain edema; cognitive function; controlled cortical impact; traumatic brain injury	CONTROLLED CORTICAL IMPACT; ISCHEMIC CELL-DAMAGE; CEREBRAL-BLOOD-FLOW; LACTIC-ACIDOSIS; SPREADING DEPOLARIZATION; EXTRACELLULAR ACIDOSIS; LONGITUDINAL CHANGES; SYNAPTIC PLASTICITY; DIFFUSION-TENSOR; INTRACELLULAR PH	Traumatic brain injury (TBI) causes long-lasting neurodegeneration and cognitive impairments; however, the underlying mechanisms of these processes are not fully understood. Acid-sensing ion channels 1a (ASIC1a) are voltage-gated Na+- and Ca2+-channels shown to be involved in neuronal cell death; however, their role for chronic post-traumatic brain damage is largely unknown. To address this issue, we used ASIC1a-deficient mice and investigated their outcome up to 6 months after TBI. ASIC1a-deficient mice and their wild-type (WT) littermates were subjected to controlled cortical impact (CCI) or sham surgery. Brain water content was analyzed 24 h and behavioral outcome up to 6 months after CCI. Lesion volume was assessed longitudinally by magnetic resonance imaging and 6 months after injury by histology. Brain water content was significantly reduced in ASIC1a(-/-) animals compared to WT controls. Over time, ASIC1a(-/-) mice showed significantly reduced lesion volume and reduced hippocampal damage. This translated into improved cognitive function and reduced depression-like behavior. Microglial activation was significantly reduced in ASIC1a(-/-) mice. In conclusion, ASIC1a deficiency resulted in reduced edema formation acutely after TBI and less brain damage, functional impairments, and neuroinflammation up to 6 months after injury. Hence, ASIC1a seems to be involved in chronic neurodegeneration after TBI.	[Cheng, Shiqi; Mao, Xiang; Lin, Xiangjiang; Wehn, Antonia; Hu, Senbin; Mamrak, Uta; Khalin, Igor; Plesnila, Nikolaus; Terpolilli, Nicole A.] Munich Univ Hosp, Inst Stroke & Dementia Res, Munich, Germany; [Terpolilli, Nicole A.] Munich Univ Hosp, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany; [Cheng, Shiqi; Mao, Xiang; Lin, Xiangjiang; Wehn, Antonia; Hu, Senbin; Mamrak, Uta; Khalin, Igor; Plesnila, Nikolaus; Terpolilli, Nicole A.] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Wostrack, Maria] Tech Univ Munich, Dept Neurosurg, Munich, Germany; [Ringel, Florian] Univ Med Ctr Mainz, Dept Neurosurg, Mainz, Germany; [Cheng, Shiqi] Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China		Terpolilli, NA (corresponding author), Munich Univ Hosp, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany.	Nicole.Terpolilli@med.uni-muenchen.de		Wostrack, Maria/0000-0001-6439-3665	Munich Cluster of Systems Neurology (SyNergy) [EXC 2145/ID 390857198]; Friedrich-Baur-Foundation [61/18]; China Scholarship CouncilChina Scholarship Council [201706820029]	This project was funded by the Munich Cluster of Systems Neurology (SyNergy; Project ID: EXC 2145/ID 390857198) and the Friedrich-Baur-Foundation (grant no.: 61/18). Shiqi Cheng was supported by the China Scholarship Council (grant no.: 201706820029).	Al-Mufti F, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17431; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Chassagnon IR, 2017, P NATL ACAD SCI USA, V114, P3750, DOI 10.1073/pnas.1614728114; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chu Xiang-Ping, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P288; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Desai M, 2018, NEUROCRIT CARE, V29, P512, DOI 10.1007/s12028-018-0542-8; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Duan B, 2011, J NEUROSCI, V31, P2101, DOI 10.1523/JNEUROSCI.4351-10.2011; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Ghosh M, 2015, ANN NEUROL, V78, P887, DOI 10.1002/ana.24512; Gonzalez-Inchauspe C, 2017, J NEUROSCI, V37, P2589, DOI 10.1523/JNEUROSCI.2566-16.2017; GRAHAM DI, 1971, LANCET, V1, P265; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hanukoglu I, 2017, FEBS J, V284, P525, DOI 10.1111/febs.13840; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HILLERED L, 1985, J CEREBR BLOOD F MET, V5, P259, DOI 10.1038/jcbfm.1985.33; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; KALIMO H, 1981, J CEREBR BLOOD F MET, V1, P313, DOI 10.1038/jcbfm.1981.35; Kassi AAY, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01097; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; KIMELBERG HK, 1990, PROG CLIN BIOL RES, V361, P363; Krieg SM, 2017, J NEUROTRAUM, V34, P1329, DOI 10.1089/neu.2016.4514; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li MH, 2016, J BIOL CHEM, V291, P18370, DOI 10.1074/jbc.M115.713636; Li MH, 2010, J CEREBR BLOOD F MET, V30, P1247, DOI 10.1038/jcbfm.2010.30; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mamet J, 2002, J NEUROSCI, V22, P10662; Mao X, 2020, J NEUROTRAUM, V37, P1331, DOI 10.1089/neu.2019.6510; McLay RN, 1998, PHYSIOL BEHAV, V63, P933, DOI 10.1016/S0031-9384(97)00529-5; Menyhart A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01284-4; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Osmakov DI, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1528, DOI 10.1134/S0006297914130069; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pignataro Giuseppe, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P1; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; Rosenfeld CS, 2014, JOVE-J VIS EXP, DOI 10.3791/51194; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Siesjo B.K., 1996, ADV NEUROL, V71, P234; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Staub F, 1996, ACT NEUR S, V66, P56; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang JJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13873-0; Wang YZ, 2015, ELIFE, V4, DOI 10.7554/eLife.05682; Wang YC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0465-7; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Xiong ZG, 2006, J MEMBRANE BIOL, V209, P59, DOI 10.1007/s00232-005-0840-x; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072379; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	104	0	0	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2021	38	11					1572	1584		10.1089/neu.2020.7568		MAY 2021	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	SL0LA	WOS:000647840800001	33779289				2022-02-07	
J	Huang, YJ; Xu, JZ; Zheng, SQ; Xu, SY; Wang, YJ; Du, J; Xiao, L; Zhang, RK; Wang, H; Tang, YX; Su, T				Huang, Yujia; Xu, Jingzhou; Zheng, Siqi; Xu, Shuyu; Wang, Yajing; Du, Jing; Xiao, Lei; Zhang, Ruike; Wang, Hao; Tang, Yunxiang; Su, Tong			The risk factors for insomnia and sleep-disordered breathing in military communities: A meta-analysis	PLOS ONE			English	Article							EFFECT SIZE; APNEA; PREVALENCE; VETERANS; DISTURBANCES; EPIDEMIOLOGY; PERFORMANCE; SEVERITY; PATTERNS; SOLDIERS	Background Many reviews and meta-analyses had been conducted to investigate risk factors for sleep disorders in the general population. However, no similar research has been performed in the military population though insomnia and sleep-disordered breathing are quite prevalent in that population. Objectives To investigate risk factors for insomnia and sleep-disordered breathing in military personnel. Methods A systematic literature search was performed from inception to March 2021 and 6496 records were produced. Two authors independently screened records for eligibility. Results were presented as odds ratios, and a random-effect model was used to pool results. Data analysis was performed respectively according to military personnel type (i.e., veteran, active-duty personnel). Risk factors were sorted into three categories: sociodemographic, army-specific, and comorbidity. This meta-analysis was registered in PROSPERO before data analysis (registration No: CRD42020221696). Results Twenty-seven articles were finally included in the quantitative analysis. For sleep-disordered breathing in active-duty personnel, four sociodemographic (i.e., overweight/obesity, higher body mass index, male gender, >35 years old) and one comorbidity (i.e., depression) risk factors were identified. For insomnia in active-duty personnel, four sociodemographic (i.e., aging, alcohol dependence, white race, and female gender), two army-specific (i.e., deployment experience, combat experience), and four comorbidity (i.e., depression, post-traumatic stress disorder, traumatic brain injury, and anxiety) risk factors were identified. For insomnia in veterans, one army-specific (i.e., combat experience) and one comorbidity (i.e., post-traumatic stress disorder) risk factor was identified. Conclusions Several risk factors were identified for insomnia and sleep-disordered breathing in the current meta-analysis. Risk factors for veterans and active-duty personnel were partially different. Research on sleep breathing disorders remains limited, and more convincing evidence would be obtained with more relevant studies in the future.	[Huang, Yujia; Xu, Jingzhou; Xu, Shuyu; Wang, Yajing; Du, Jing; Xiao, Lei; Zhang, Ruike; Wang, Hao; Tang, Yunxiang; Su, Tong] Naval Med Univ, Fac Psychol, Dept Med Psychol, Shanghai, Peoples R China; [Zheng, Siqi] Tongji Univ, Dept Psychol, Shanghai, Peoples R China		Tang, YX; Su, T (corresponding author), Naval Med Univ, Fac Psychol, Dept Med Psychol, Shanghai, Peoples R China.	tangyun7633@sina.com; sutong-2006@163.com			Logistics department [CWS20J007, 20BJZ09, 2019QNP014]; Training department [201944816]	1.Yunxiang Tang Grant number CWS20J007 Logistics department, 2.Yunxiang Tang Grant number 20BJZ09) Logistics department, 3.Yunxiang Tang Grant number 201944816) Training department, 4.Tong Su Grant number 2019QNP014) Logistics department. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian AL, 2018, PSYCHIATRY, V81, P391, DOI 10.1080/00332747.2018.1485372; American Academy of Sleep Medicine, 2014, AM ACAD SLEEP MED, V3rd; Baird T, 2018, J CLIN SLEEP MED, V14, P745, DOI 10.5664/jcsm.7096; Ballesio A, 2021, SLEEP MED REV, V55, DOI 10.1016/j.smrv.2020.101378; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blore JD, 2015, PSYCHOL MED, V45, P1565, DOI 10.1017/S0033291714001913; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Cairns A, 2017, SLEEP BREATH, V21, P647, DOI 10.1007/s11325-017-1467-8; Caldwell JA, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz112; Capaldi VF, 2019, CHEST, V155, P215, DOI 10.1016/j.chest.2018.08.1061; Capener DC, 2018, MIL MED, V183, pE266, DOI 10.1093/milmed/usx116; CARSKADON M A, 1990, Pediatrician, V17, P5; Chao LL, 2016, MIL MED, V181, P1127, DOI 10.7205/MILMED-D-15-00474; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; Colvonen PJ, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa119; Cross NE, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz114; Crump C, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12851; de Zambotti M, 2018, SLEEP MED REV, V39, P12, DOI 10.1016/j.smrv.2017.06.009; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Erickson Elizabeth A, 2017, MSMR, V24, P2; Foster SN, 2017, SLEEP HEALTH, V3, P336, DOI 10.1016/j.sleh.2017.07.015; Furukawa TA, 1999, LANCET, V353, P1680, DOI 10.1016/S0140-6736(99)01163-0; Gaffey AE, 2020, J HYPERTENS, V38, P641, DOI 10.1097/HJH.0000000000002311; Gauer R, 2019, AM FAM PHYSICIAN, V99, P482; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Hanske J, 2017, EUR UROL SUPPL, V16; Hermes E, 2014, SLEEP MED, V15, P508, DOI 10.1016/j.sleep.2013.12.010; Iqbal N, 2016, AM J GERIAT PSYCHIAT, V24, P170, DOI 10.1016/j.jagp.2015.08.004; Jacobson MD., 2019, J AM ACAD PHYS ASSIS, V32, P2019; Jan I., 2018, ACCESSION MEDICAL ST; Javaheri S, 2017, J AM COLL CARDIOL, V69, P841, DOI 10.1016/j.jacc.2016.11.069; Jones DM, 2017, AUTON NEUROSCI-BASIC, V208, P36, DOI 10.1016/j.autneu.2017.11.004; Kanefsky R, 2019, PSYCHIAT RES, V279, P34, DOI 10.1016/j.psychres.2019.07.001; Kent BD, 2014, CHEST, V146, P982, DOI 10.1378/chest.13-2403; Kim JW, 2015, CLIN EXP OTORHINOLAR, V8, P376, DOI 10.3342/ceo.2015.8.4.376; King PR, 2017, J PSYCHOSOM RES, V96, P60, DOI 10.1016/j.jpsychores.2017.03.012; Klingaman EA, 2017, J PSYCHIATR PRACT, V23, P270, DOI 10.1097/PRA.0000000000000240; Langton RS, 2016, MIL MED, V181, P913, DOI 10.7205/MILMED-D-15-00295; Lee YC, 2013, J KOREAN MED SCI, V28, P1373, DOI 10.3346/jkms.2013.28.9.1373; Lopez MR, 2013, EPILEPSY BEHAV, V27, P159, DOI 10.1016/j.yebeh.2013.01.008; Martin JL, 2017, WOMEN HEALTH ISS, V27, P366, DOI 10.1016/j.whi.2016.12.003; Martindale SL, 2020, MIL PSYCHOL, V32, P212, DOI 10.1080/08995605.2020.1724595; Miller NL, 2005, SLEEP, V28, P837, DOI 10.1093/sleep/28.7.837; Mosti CB, 2019, REHABIL PSYCHOL, V64, P475, DOI 10.1037/rep0000283; Mysliwiec V, 2015, J CLIN SLEEP MED, V11, P1393, DOI 10.5664/jcsm.5272; Mysliwiec V, 2014, MIL MED, V179, P294, DOI 10.7205/MILMED-D-13-00396; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Pettersson K, 2016, UPSALA J MED SCI, V121, P65, DOI 10.3109/03009734.2016.1144663; Pilakasiri A., 2018, MILITARY MED RES, P5, DOI [10.1186/s40779-018-0153-x, DOI 10.1186/S40779-018-0153-X]; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Sandman N, 2013, SLEEP, V36, P1041, DOI 10.5665/sleep.2806; Scoglio AAJ., 2017, J INTERPERS VIOLENCE, V36; Sharma R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56110-w; Shattuck NL, 2016, ERGONOMICS, V59, P657, DOI 10.1080/00140139.2015.1073794; Somers VK., 2005, DEMENT WCBT P P SM, P1180; Stubbs B., 2017, BMJ, V7, P1, DOI [10.1038/s41467-019-10003-8, 10.1038/s41598-017-07579-w, DOI 10.1136/BMJ.B2535]; Taylor DJ, 2016, SLEEP, V39, P1795, DOI 10.5665/sleep.6156; Troxel WM, 2015, SLEEP MILITARY PROMO; uiHu Y, 2020, NEUROPSYCH DIS TREAT, V16, P43, DOI 10.2147/NDT.S228802; Vozoris NT, 2012, SLEEP MED, V13, P637, DOI 10.1016/j.sleep.2012.01.004; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zhang Y, 2019, SLEEP MED REV, V48, DOI 10.1016/j.smrv.2019.08.004; Zhang Y, 2017, SLEEP MED, V36, P125, DOI 10.1016/j.sleep.2017.04.020	68	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2021	16	5							e0250779	10.1371/journal.pone.0250779			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6GE	WOS:000664611400040	33956821	gold, Green Published			2022-02-07	
J	Archbold, P; Rankin, AT; Webb, M; Davies, R; Nicholas, R; Eames, NWA; Wilson, RK; Vincent, J; McKeever, D; Duddy, K; Matthews, M; Bleakley, C				Archbold, Pooler; Rankin, Alan T.; Webb, Michael; Davies, Richard; Nicholas, Richard; Eames, Niall W. A.; Wilson, Roger K.; Vincent, John; McKeever, Donal; Duddy, Kirsty; Matthews, Mark; Bleakley, Chris			Injury patterns in U15 rugby players in Ulster schools: A Rugby Injury Surveillance (RISUS) Study	TRANSLATIONAL SPORTS MEDICINE			English	Article						adolescents; concussion; injury; rugby	EXTREMITY MUSCULOSKELETAL INJURY; SPORTS-RELATED CONCUSSION; CONSENSUS STATEMENT; MUSCLE INJURIES; CHILDREN; RECOVERY; OUTCOMES; HISTORY; TACKLE; RETURN	Participation in collision sports such as rugby union has inherent risk of injury. The aim of this study was to examine injury patterns and risk factors in adolescent rugby players (U15 years). A prospective injury surveillance study was undertaken involving 26 schools (599 male rugby players, mean age 14.7years). Data were collected over the 2016/17 playing season, with injuries classified by body part and diagnosis. We explored the association between risk factors (demographic/biometric; injury history, protective equipment, training profile, level of play) using cox proportional hazard models with time to injury as the dependent variable. Nearly, 30% of players (178/599) suffered at least one injury. Injury incidence is estimated at 14.7 injuries/1000 match hours. Most injuries occurred in the tackle situation (64.6%, 135/209). Common injury sites were head/face (n = 95, 45.5%), ankle (n = 21, 10.0%), or wrist/hand (n = 15, 7.2%). Concussion (n = 79, 37.8%), wrist/ hand fractures (n = 19, 9.1%), or ankle sprains (n = 16, 7.6%) were the most common diagnoses. Seven concussions (8.9%) resulted in more than 28 days absence from play. A higher risk of injury was associated with: previous concussion (AHR 1.45; 95% CI 1.02 to 2.06), and any previous injury (AHR 1.85; 95% CI 1.23 to 2.78). One in three U15 rugby players sustained an injury over a single playing season. Concussion remains a concern in this age group and should be prioritized in future research.	[Archbold, Pooler; Nicholas, Richard; Eames, Niall W. A.] Royal Victoria Hosp, Belfast, Antrim, North Ireland; [Rankin, Alan T.] Sport Med NI, Belfast, Antrim, North Ireland; [Webb, Michael] Ulster Rugby, Belfast, Antrim, North Ireland; [Davies, Richard; Matthews, Mark; Bleakley, Chris] Ulster Univ, Belfast, Antrim, North Ireland; [Wilson, Roger K.] Musgrave Pk Hosp, Belfast, Antrim, North Ireland; [Vincent, John; McKeever, Donal; Duddy, Kirsty] Queens Univ Belfast, Belfast, Antrim, North Ireland		Bleakley, C (corresponding author), Ulster Univ, Sch Hlth Sci, Belfast BT37 0QB, Antrim, North Ireland.	c.bleakley@ulster.ac.uk			Irish Rugby Football Union; MITRE Trust; Ulster Rugby	Financial support was received by the following institutions: Irish Rugby Football Union, MITRE Trust, and Ulster Rugby.	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; Brown J. C., 2012, South African Journal of Sports Medicine, V24, P49; Brown KA, 2017, TRANSL PEDIATR, V6, P150, DOI 10.21037/tp.2017.04.03; Burman E, 2016, PEDAGOG CULT SOC, V24, P1, DOI 10.1080/14681366.2015.1057215; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; EKSTRAND J, 1983, MED SCI SPORT EXER, V15, P267, DOI 10.1249/00005768-198315030-00014; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Faude O, 2013, SPORTS MED, V43, P819, DOI 10.1007/s40279-013-0061-x; Finch CF, 2014, BRIT J SPORT MED, V48, P1276, DOI 10.1136/bjsports-2012-091729; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Hamilton DF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004975; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kemp S, 2016, BRIT J SPORT MED, V50, P644, DOI 10.1136/bjsports-2015-095780; Kolstrup LA, 2016, EUR J SPORT SCI, V16, P1167, DOI 10.1080/17461391.2016.1205145; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2017, J ATHL TRAINING, V52, P518, DOI 10.4085/1062-6050-52.2.03; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Marshall SW, 2001, J ATHL TRAINING, V36, P334; Mckay D, 2016, PEDIATR EXERC SCI, V28, P488, DOI 10.1123/pes.2016-0021; McLoughlin TF, 2009, J SPORT SCI MED, V8, P148; Nicol A, 2011, J PUBLIC HEALTH-UK, V33, P256, DOI 10.1093/pubmed/fdq047; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pauelsen M, 2017, CLIN J SPORT MED, V27, P283, DOI 10.1097/JSM.0000000000000347; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Pollock AA, 2017, OPEN LETT PREVENTING; Pollock AM, 2017, BRIT J SPORT MED, V51, P1113, DOI 10.1136/bjsports-2016-096996; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Soligard T, 2016, BRIT J SPORT MED, V50, P1030, DOI 10.1136/bjsports-2016-096581; Toohey LA, 2017, BRIT J SPORT MED, V51, P1670, DOI 10.1136/bjsports-2017-097500; Tucker R, 2016, BRIT J SPORT MED, V50, P921, DOI 10.1136/bjsports-2016-096322; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	45	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2573-8488		TRANSL SPORTS MED	Transl. Sports Med.	JUL	2021	4	4					524	533		10.1002/tsm2.248		MAY 2021	10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	TC7OB	WOS:000647773100001		Green Published, hybrid			2022-02-07	
J	Dhillon, NK; Sahi, S; Barmparas, G; Linaval, NT; Lin, TL; Lahiri, S; Brown, CVR; Ley, EJ				Dhillon, Navpreet K.; Sahi, Saad; Barmparas, Galinos; Linaval, Nikhil T.; Lin, Ting Lung; Lahiri, Shouri; Brown, Carlos V. R.; Ley, Eric J.			Cerebrospinal Fluid Cultures in Traumatic Brain Injury: Is It Worth It? A Two-Center Study	SURGICAL INFECTIONS			English	Article						cerebrospinal fluid; infection; sepsis; traumatic brain injury	VENTRICULOSTOMY-RELATED INFECTIONS; COMPLICATIONS	Background: Patients with traumatic brain injury (TBI) frequently develop leukocytosis, fever, and tachycardia that may lead to extensive medical investigations to rule out an infectious process. Cerebrospinal fluid (CSF) is often acquired during this workup, however, the utility of this practice has not been studied previously. We hypothesized that CSF cultures would unlikely yield positive results in patients with TBI. Patients and Methods: A retrospective review was conducted of all patients with TBI admitted to two level 1 trauma centers at urban, academic institutions from January 2009 to December 2016. Data collected included patient demographics, presenting Glasgow Coma Score (GCS), injury profile, injury severity scores (ISS), regional abbreviated injury scale (AIS), hospital and intensive care unit (ICU) length of stay (LOS), ventilator days, and culture results. For purposes of the analysis, CSF cultures with Staphylococcus epidermidis, Staphylococcus aureus, or Candida underwent a chart review and were considered contaminates if indicated. Results: There were 145 patients who had CSF cultures obtained with a median age of 39 years; 77.2% were male. The majority of patients presented after blunt trauma with median GCS of 6, head AIS of 4, and ISS of 25. These patients had prolonged median ICU and hospital stays at 13 and 22 days, respectively. Six (4.1%) CSF cultures demonstrated growth. Four (2.8%) were deemed contaminants, with two growing Staphylococcus epidermidis only, one with both Staphylococcus epidermidis and Staphylococcus aureus, and one with Candida. Two cultures (1.4%) were positive and grew Enterobacter cloacae. Of note, both patients had prior instrumentation with an external ventricular drain. Conclusion: Obtaining CSF cultures in patients with TBI is of low yield, especially in patients without prior external ventricular drain. Other sources of infectious etiologies should be considered in this patient population.	[Dhillon, Navpreet K.; Barmparas, Galinos; Linaval, Nikhil T.; Lin, Ting Lung; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA; [Lahiri, Shouri] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Sahi, Saad; Brown, Carlos V. R.] Univ Texas Austin, Dell Med Sch, Dept Surg, Austin, TX 78712 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03 AG064106] Funding Source: Medline		Agrawal A., 2007, SMJ Singapore Medical Journal, V48, P492; [Anonymous], 2020, NHE FACT SHEET; Arevalo-Rodriguez I, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010807.pub2; Bota DP, 2005, J NEUROSURG, V103, P468, DOI 10.3171/jns.2005.103.3.0468; Chami N, 2017, CLIN BIOCHEM, V50, P822, DOI 10.1016/j.clinbiochem.2017.05.004; CHILDERS MK, 1994, BRAIN INJURY, V8, P335, DOI 10.3109/02699059409150984; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Iorio-Morin C, 2016, CLIN NEUROL NEUROSUR, V142, P48, DOI 10.1016/j.clineuro.2016.01.021; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Levine D, 2015, J HEALTH POLIT POLIC, V40, P421, DOI 10.1215/03616878-2882281; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Merlani P, 2001, BRIT MED J, V323, P620, DOI 10.1136/bmj.323.7313.620; Motti EF, 2008, JAMA-J AM MED ASSOC, V300, P2251, DOI 10.1001/jama.2008.603; Roquilly A, 2017, CLIN IMMUNOL, V177, P87, DOI 10.1016/j.clim.2015.08.006; Segatore M, 1992, J Neurosci Nurs, V24, P104; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Venkatesh B, 2000, Crit Care Resusc, V2, P42	22	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-2964	1557-8674		SURG INFECT	Surg. Infect.	NOV 1	2021	22	9					923	927		10.1089/sur.2020.403		MAY 2021	5	Infectious Diseases; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Surgery	XB7KP	WOS:000647964400001	33956527				2022-02-07	
J	Moschella, EA; Quilter, C; Potter, SJ				Moschella, Elizabeth A.; Quilter, Cheyenne; Potter, Sharyn J.			Comprehensive policies for victims of sexual assault returning to the campus classroom: Lessons from university sports-related concussion policies	JOURNAL OF AMERICAN COLLEGE HEALTH			English	Article; Early Access						Return-to-academics; sexual assault; sports-related concussion; university policy	HIGH-SCHOOL; HEALTH CONSEQUENCES; SOCIAL SUPPORT; MENTAL-HEALTH; VIOLENCE; ABUSE; RAPE; DEPRESSION; INJURIES; OUTCOMES	Objective The current paper presents a comparison of university policies and health and academic accommodations offered to undergraduate students following sexual assault (SA) and sports-related concussions (SRC). Procedures and protocols for universities to consider adapting from their SRC policies to their SA policies are detailed.Participants: The SRC and SA policies at the 50 United States public flagship universities were analyzed.Methods: The research team coded for a number of policy details including health referrals, academic and financial accommodations, and requirements for follow-up with university personnel.Results: Compared to SA polices, SRC policies at the public flagship universities offer more comprehensive academic accommodations and physical and mental health resources. Conclusions: Comprehensive policies for student SA survivors, like those available for students who suffer SRCs, would improve student health and academic outcomes and increase SA survivors' likelihood of graduating college, thereby reducing individual and societal human capital loses.	[Moschella, Elizabeth A.; Potter, Sharyn J.] Univ New Hampshire, Prevent Innovat Res Ctr, 9 Madbury Rd,Suite 405, Durham, NH 03824 USA; [Quilter, Cheyenne] US Mil Acad West Point, West Point, NY USA		Moschella, EA (corresponding author), Univ New Hampshire, Prevent Innovat Res Ctr, 9 Madbury Rd,Suite 405, Durham, NH 03824 USA.	Elizabeth.Moschella@unh.edu		Moschella-Smith, Elizabeth/0000-0001-8874-7691			Ali Russlynn, 2011, DEAR COLLEAGUE LETT; Ameral V, 2020, J INTERPERS VIOLENCE, V35, P5311, DOI 10.1177/0886260517721169; Au TM, 2013, J AFFECT DISORDERS, V149, P209, DOI 10.1016/j.jad.2013.01.026; Banyard V, 2011, PSYCHOL VIOLENCE, V1, P16, DOI 10.1037/a0021691; Banyard VL, 2020, J INTERPERS VIOLENCE, V35, P4375, DOI 10.1177/0886260517715022; Black M C., 2011, NATL INTIMATE PARTNE; Brassil HE, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0200-y; Breck J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17626; Cantor D., 2015, REPORT AAU CAMPUS CL; Carey KB, 2018, J AM COLL HEALTH, V66, P480, DOI 10.1080/07448481.2018.1431915; Centers for Disease Control and Prevention, 2010, HEADS SCH KNOW YOUR; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Clery Center, 2019, SUMM J CLER ACT SUMM J CLER ACT; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Cuevas KM, 2018, J AM OSTEOPATH ASSOC, V118, pE2, DOI 10.7556/jaoa.2018.018; Douglass JA, 2016, NEW FLAGSHIP U SAMPL; Edwards KM, 2019, PSYCHOL VIOLENCE, V9, P431, DOI 10.1037/vio0000203; Eisenberg D., 2016, TOO DISTRESSED TO LE TOO DISTRESSED TO LE; Ferry B., 2021, CONCUSSION; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Hall EE, 2015, CLIN J SPORT MED, V25, P291, DOI 10.1097/JSM.0000000000000133; Haycock K., 2006, ENGINES INEQUALITY D; Holland KJ, 2017, AM J COMMUN PSYCHOL, V59, P50, DOI 10.1002/ajcp.12126; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Jina R, 2013, BEST PRACT RES CL OB, V27, P15, DOI 10.1016/j.bpobgyn.2012.08.012; Knowles SB, 2007, INJURY PREV, V13, P416, DOI 10.1136/ip.2006.014720; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Krippendorff Klaus, 1980, CONTENT ANAL, V3rd; Levesque S, 2016, CAN J HUM SEX, V25, P9, DOI 10.3138/cjhs.251-A5; Lim N., 2014, 2014 TECHNOLOGY SUMM; Luce H, 2010, AM FAM PHYSICIAN, V81, P489; Ma J., 2020, TRENDS COLL PRICING; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martin S.L., 2011, VIOLENCE WOMEN CHILD, P173, DOI [https://doi.org/10.1037/12307-008, DOI 10.1037/12307-008]; Mayers LB, 2013, J NEUROPSYCH CLIN N, V25, P115, DOI 10.1176/appi.neuropsych.11120374; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLaughlin H, 2017, GENDER SOC, V31, P333, DOI 10.1177/0891243217704631; Mengo C, 2016, J COLL STUD RETENT-R, V18, P234, DOI 10.1177/1521025115584750; National Center for Education Statistics, 2010, STAT TRENDS ED RAC E; National Center for Education Statistics, 2019, NUMB DEGR GRANT POST NUMB DEGR GRANT POST; Navalta CP, 2006, J NEUROPSYCH CLIN N, V18, P45, DOI 10.1176/appi.neuropsych.18.1.45; Paterson J., 2019, HIGHER ED DIVE HIGHER ED DIVE; Peterson C, 2017, AM J PREV MED, V52, P691, DOI 10.1016/j.amepre.2016.11.014; Post LA, 2002, J INTERPERS VIOLENCE, V17, P773, DOI 10.1177/0886260502017007005; Potter S, 2018, J AM COLL HEALTH, V66, P496, DOI 10.1080/07448481.2018.1440574; Potter SJ, 2016, AM J PUBLIC HEALTH, V106, P822, DOI 10.2105/AJPH.2016.303082; Potter SJ., 2016, J AM COLL HEALTH, V18, P1; Rothman K, 2021, J INTERPERS VIOLENCE, V36, P9600, DOI 10.1177/0886260519870158; Russell Kelly, 2017, Concussion, V2, pCNC51, DOI 10.2217/cnc-2017-0009; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sabina C, 2014, TRAUMA VIOLENCE ABUS, V15, P201, DOI 10.1177/1524838014521322; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Steine IM, 2012, J INTERPERS VIOLENCE, V27, P1827, DOI 10.1177/0886260511430385; Sugar NF, 2004, AM J OBSTET GYNECOL, V190, P71, DOI 10.1016/S0002-9378(03)00912-8; Ullman SE, 2013, ADDICT BEHAV, V38, P2219, DOI 10.1016/j.addbeh.2013.01.027; Ullman SE, 2009, SUICIDE LIFE-THREAT, V39, P47, DOI 10.1521/suli.2009.39.1.47; United States Department of Education, 2014, VIOL WOM ACT EX SUMM VIOL WOM ACT EX SUMM; United States Department of Education, 2020, SECR DEVOS TAK HIST SECR DEVOS TAK HIST; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Wilson R., 2014, CHRON HIGHER EDUC; Zinzow HM, 2010, J INTERPERS VIOLENCE, V25, P2217, DOI 10.1177/0886260509354887	63	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0744-8481	1940-3208		J AM COLL HEALTH	J. Am. Coll. Health												10.1080/07448481.2021.1926264		MAY 2021	9	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	TG6AP	WOS:000671485700001	34242541				2022-02-07	
J	Vaninetti, M; Lim, M; Khalaf, A; Metzger-Smith, V; Flowers, M; Kunnel, A; Yang, E; Song, D; Lin, LS; Tsai, A; Lee, R; Golshan, S; Leung, A				Vaninetti, Michael; Lim, Mike; Khalaf, Aladdin; Metzger-Smith, Valerie; Flowers, Matthew; Kunnel, Alphonsa; Yang, Eric; Song, David; Lin, Lisa; Tsai, Alice; Lee, Roland; Golshan, Shahrokh; Leung, Albert			fMRI findings in MTBI patients with headaches following rTMS	SCIENTIFIC REPORTS			English	Article							DORSOLATERAL PREFRONTAL CORTEX; MILD TRAUMATIC BRAIN; PAIN; INJURY; THRESHOLDS; PREVALENCE	Mild Traumatic Brain Injury (MTBI) patients with persistent headaches are known to have diminished supraspinal modulatory connectivity from their prefrontal cortices. Repetitive transcranial magnetic stimulation (rTMS) is able to alleviate MTBI-related headache (MTBI-HA). This functional magnetic resonance imaging (fMRI) study assessed supraspinal correlates associated with the headache analgesic effect of rTMS at left prefrontal cortex (LPFC), hypothesizing real rTMS would significantly increase modulatory functions at LPFC in comparison to sham treatment. Subjects with MTBI-HA were randomized to receive either real or sham rTMS treatments and subjected to pre- and post-treatment resting state and evoked heat-pain fMRI as described in a prior study. Real rTMS consisted of 2000 pulses delivered at 10 Hz and 80% of the resting motor threshold at left dorsolateral prefrontal cortex, whereas sham treatment was delivered with same figure-of-eight coil turned 180 degrees. Follow-up fMRI was performed one-week post-treatment. All fMRI data was processed using BrainVoyager QX Software. 14 subjects receiving real and 12 subjects receiving sham treatments completed the study. The REAL group demonstrated significant (P<0.02) decreases in headache frequency and intensity at one week following treatment. fMRI scans in the REAL group showed increased evoked heat pain activity (P<0.002) and resting functional connectivity (P<0.0001) at the LPFC after rTMS. Neither this significant analgesic effect nor these fMRI findings were seen in the sham group. Sham treatment was, however, associated with a decrease in resting state activity at the LPFC (P<0.0001). This study correlates the demonstrated analgesic effect of rTMS in the treatment of MTBI-HA with enhanced supraspinal functional connectivity in the left prefrontal cortex, which is known to be involved in "top-down" pain inhibition along the descending midbrain-thalamic-cingulate pathway. Trial Registration: This study was registered on September 24, 2013, on ClinicalTrials.gov with the identifier: NCT01948947. https://clinicaltrials.gov/ct2/show/NCT01948947.	[Vaninetti, Michael; Leung, Albert] UC San Diego Sch Med, Anesthesiol, La Jolla, CA 92093 USA; [Vaninetti, Michael; Lim, Mike; Khalaf, Aladdin; Metzger-Smith, Valerie; Flowers, Matthew; Kunnel, Alphonsa; Yang, Eric; Leung, Albert] VA San Diego Healthcare Syst, Ctr Pain & Headache Res, San Diego, CA 92161 USA; [Vaninetti, Michael; Leung, Albert] VA San Diego Healthcare Syst, Anesthesia Pain Serv, San Diego, CA 92161 USA; [Song, David; Lee, Roland] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Lin, Lisa; Tsai, Alice] VA San Diego Healthcare Syst, Phys & Rehab Med, San Diego, CA 92161 USA; [Lee, Roland] UC San Diego Sch Med, Radiol, La Jolla, CA 92093 USA; [Golshan, Shahrokh] VA San Diego Healthcare Syst, Biostat Core, San Diego, CA 92161 USA		Vaninetti, M (corresponding author), UC San Diego Sch Med, Anesthesiol, La Jolla, CA 92093 USA.; Vaninetti, M (corresponding author), VA San Diego Healthcare Syst, Ctr Pain & Headache Res, San Diego, CA 92161 USA.; Vaninetti, M (corresponding author), VA San Diego Healthcare Syst, Anesthesia Pain Serv, San Diego, CA 92161 USA.	mvaninetti@health.ucsd.edu			VA Rehabilitation and Research Development SPIRE Awards [21RX001359, 21RX002366]; Department of Defense Congressionally Directed Medical Research Program GrantUnited States Department of Defense [W81XWH-16-1-0754]	The authors thank the funding support from the following agencies: 1) VA Rehabilitation and Research Development SPIRE Awards (21RX001359, 21RX002366) and Department of Defense Congressionally Directed Medical Research Program Grant (W81XWH-16-1-0754).	Caeyenberghs K, 2015, BRAIN CONNECT, V5, P423, DOI 10.1089/brain.2014.0293; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cooper PR, 1993, HEAD INJURY; Defrin R, 2006, CLIN J PAIN, V22, P130, DOI 10.1097/01.ajp.0000154048.68273.d8; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Duecker F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00210; Formisano E., 2005, ADV IMAGE PROCESSING, P479; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Joubert Jacques, 2005, Aust Fam Physician, V34, P621; Kuhn S, 2013, SCHIZOPHRENIA BULL, V39, P358, DOI 10.1093/schbul/sbr151; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leung A, 2014, HEADACHE, V54, P57; Leung A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01133-2; Leung A, 2020, NEUROMODULATION, V23, P267, DOI 10.1111/ner.13094; Leung A, 2018, MOL PAIN, V14, DOI 10.1177/1744806918810297; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Leung AY, 2005, PAIN, V116, P26, DOI 10.1016/j.pain.2005.03.026; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Newsome MR, 2018, BRAIN INJURY, V32, P1236, DOI 10.1080/02699052.2018.1494853; Ong WY, 2019, MOL NEUROBIOL, V56, P1137, DOI 10.1007/s12035-018-1130-9; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Ravn Pernille, 2012, J Pain Res, V5, P313, DOI 10.2147/JPR.S33925; Seminowicz DA, 2017, J PAIN, V18, P1027, DOI 10.1016/j.jpain.2017.03.008; Sevel LS, 2016, BRAIN CONNECT, V6, P357, DOI 10.1089/brain.2015.0405; Shukla S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-45; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27131; Weissman-Fogel I, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000760	41	0	0	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 5	2021	11	1							9573	10.1038/s41598-021-89118-2			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK8GC	WOS:000656453000018	33953315	Green Published, gold			2022-02-07	
J	Wang, Y; Zhou, FQ; Li, Y; Li, J; Kuang, HM; Chen, Q; Hong, T; Gong, HH				Wang, Yao; Zhou, Fuqing; Li, Yan; Li, Jian; Kuang, Hongmei; Chen, Qi; Hong, Tao; Gong, Honghan			Functional plasticity in lateral hypothalamus and its prediction of cognitive impairment in patients with diffuse axonal injury: evidence from a resting-state functional connectivity study	NEUROREPORT			English	Article						cognitive impairment; diffuse axonal injury; lateral hypothalamus; medial hypothalamus; resting-state functional MRI		Objective Diffuse axonal injury (DAI) is a common pathological process after traumatic brain injury, which may cause survivors severe functional disorders, including cognitive impairment and physical disability. Recent literature indicated lateral hypothalamus and medial hypothalamus damage during DAI. Thus, we aim to investigate whether there is imaging evidence of hypothalamic injury in patients with DAI and its clinical association. Methods Twenty-four patients with diagnosed DAI and 26 age and sex-matched healthy controls underwent resting-state functional MRI. We assessed the lateral hypothalamus and medial hypothalamus functional connectivity with seed-based analysis in DAI. Furthermore, a partial correlation was used to measure its clinical association. The prediction of the severity of DAI from the altered lateral hypothalamus and medial hypothalamus connectivity was conducted using a general linear model. Results Compared with healthy control, the DAI group showed significantly decreased lateral hypothalamus functional connectivity with the basal ganglia and cingulate gyrus, which was positively correlated with mini-mental state examination scores (Bonferroni correction at P < 0.0125). Importantly, this disrupted functional connectivity can be used to predict the patients' cognitive state reliably (P = 0.006; P = 0.009, respectively) in DAI. Moreover, we also observed increased connectivity of medial hypothalamus with the superior temporal gyrus and the regions around the operculum. Furthermore, there was a trend of negative correlation between the medial hypothalamus functional connectivity changes to the right superior temporal gyrus and the disability rating scale scores in the DAI group. Conclusion Our results suggest that there are alterations of medial hypothalamus and lateral hypothalamus connectivity in DAI and further understand its clinical symptoms, including related cognitive impairment.	[Wang, Yao; Zhou, Fuqing; Li, Yan; Li, Jian; Kuang, Hongmei; Chen, Qi; Gong, Honghan] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Wang, Yao; Zhou, Fuqing; Li, Yan; Li, Jian; Kuang, Hongmei; Chen, Qi; Gong, Honghan] Nanchang Univ, Neuroimaging Lab, Jiangxi Prov Med Imaging Res Inst, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Hong, Tao] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China		Zhou, FQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Yongwaizheng St 17, Nanchang 330006, Jiangxi, Peoples R China.	fq.chou@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81260217, 81771808]; Jiangxi Provincial Key Research and Development Program [20192BBGL70034]; Distinguished Young Scholars of Jiangxi Province [20171BCB23089]; Science and Technology Plan of Jiangxi Provincial Health Commission [20203130]; Science and Technology Research Project of Education Department of Jiangxi Province [GJJ190134]	This study was funded by the National Natural Science Foundation of China (81260217 and 81771808), Jiangxi Provincial Key Research and Development Program (20192BBGL70034), the Distinguished Young Scholars of Jiangxi Province (20171BCB23089), the Science and Technology Plan of Jiangxi Provincial Health Commission (20203130) and the Science and Technology Research Project of Education Department of Jiangxi Province (GJJ190134). The funders had no role in the study design, data collection and analysis, decision to publish or manuscript preparation.	Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Baroncini M, 2012, NEUROIMAGE, V59, P168, DOI 10.1016/j.neuroimage.2011.07.013; Bhatt S, 2005, NEUROSCIENCE, V133, P17, DOI 10.1016/j.neuroscience.2005.01.065; Bracey EF, 2020, PHYSIOL BEHAV, V222, DOI 10.1016/j.physbeh.2020.112952; Brandt JA, 2004, BRAIN RES, V1004, P91, DOI 10.1016/j.brainres.2003.11.079; Cheu JW, 1998, BRAIN RES, V783, P293, DOI 10.1016/S0006-8993(97)01357-7; DeOliveira L, 1997, PHYSIOL BEHAV, V62, P1171, DOI 10.1016/S0031-9384(97)00351-X; Fjalldal S, 2018, EUR J ENDOCRINOL, V178, P577, DOI 10.1530/EJE-18-0081; Grassi DC, 2018, ARQ NEURO-PSIQUIAT, V76, P189, DOI [10.1590/0004-282X20180007, 10.1590/0004-282x20180007]; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; Lu LY, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01164-9; Maliia MD, 2018, CORTEX, V109, P303, DOI 10.1016/j.cortex.2018.08.024; Marchese SM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01159; Matsuda K, 2019, J NEUROL NEUROSUR PS, V90, P957, DOI 10.1136/jnnp-2018-319174; Matsumoto E, 2004, EXP BRAIN RES, V158, P9, DOI 10.1007/s00221-004-1872-7; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Park KD, 2016, BRAIN INJURY, V30, P407, DOI 10.3109/02699052.2015.1127997; Petrovich GD, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00014; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tinaz S, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00496; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Uruma G, 2015, MAGN RESON MED SCI, V14, P183, DOI 10.2463/mrms.2014-0104; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wu L, 2018, NEUROREPORT, V29, P1282, DOI 10.1097/WNR.0000000000001106; Xiong KL, 2016, NEURORADIOLOGY, V58, P733, DOI 10.1007/s00234-016-1675-0; Zhang S, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00344; Zhou IY, 2014, NEUROIMAGE, V84, P1, DOI 10.1016/j.neuroimage.2013.08.037	28	0	0	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAY 5	2021	32	7					588	595		10.1097/WNR.0000000000001630			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RP2FL	WOS:000641549400008	33850090				2022-02-07	
J	Ezzanad, A; Gomez-Oliva, R; Escobar-Montano, F; Diez-Salguero, M; Geribaldi-Doldan, N; Dominguez-Garcia, S; Botubol-Ares, JM; de los Reyes, C; Duran-Patron, R; Nunez-Abades, P; Macias-Sanchez, AJ; Castro, C; Hernandez-Galan, R				Ezzanad, Abdellah; Gomez-Oliva, Ricardo; Escobar-Montano, Felipe; Diez-Salguero, Monica; Geribaldi-Doldan, Noelia; Dominguez-Garcia, Samuel; Manuel Botubol-Ares, Jose; de los Reyes, Carolina; Duran-Patron, Rosa; Nunez-Abades, Pedro; Macias-Sanchez, Antonio J.; Castro, Carmen; Hernandez-Galan, Rosario			Phorbol Diesters and 12-Deoxy-16-hydroxyphorbol 13,16-Diesters Induce TGF alpha Release and Adult Mouse Neurogenesis	JOURNAL OF MEDICINAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; CRYSTAL-STRUCTURE; DITERPENE ESTERS; LIGAND RELEASE; PROTEIN; BINDING; PROLIFERATION; EUPHORBIACEAE; INHIBITION; IRRITANT	A small library of phorbol 12,13-diesters bearing low lipophilicity ester chains was prepared as potential neurogenic agents in the adult brain. They were also used in a targeted UHPLC-HRMS screening of the latex of Euphorbia resinifera. Two new 12-deoxy-16-hydroxyphorbol 13,16-diesters were isolated, and their structures were deduced using two-dimensional NMR spectroscopy and NOE experiments. The ability of natural and synthetic compounds to stimulate transforming growth factor alpha (TFG alpha) release, to increase neural progenitor cell proliferation, and to stimulate neurogenesis was evaluated. All compounds that facilitated TGF alpha release promoted neural progenitor cell proliferation. The presence of two acyloxy moieties on the tigliane skeleton led to higher levels of activity, which decreased when a free hydroxyl group was at C-12. Remarkably, the compound bearing isobutyryloxy groups was the most potent on the TGF alpha assay and at inducing neural progenitor cell proliferation in vitro, also leading to enhanced neurogenesis in vivo when administered intranasally to mice.	[Ezzanad, Abdellah; Escobar-Montano, Felipe; Manuel Botubol-Ares, Jose; de los Reyes, Carolina; Duran-Patron, Rosa; Macias-Sanchez, Antonio J.; Hernandez-Galan, Rosario] Univ Cadiz, Fac Ciencias, Dept Quim Organ, Cadiz 11510, Spain; [Gomez-Oliva, Ricardo; Diez-Salguero, Monica; Dominguez-Garcia, Samuel; Castro, Carmen] Univ Cadiz, Fac Med, Area Fisiol, Cadiz 11002, Spain; [Gomez-Oliva, Ricardo; Dominguez-Garcia, Samuel; Manuel Botubol-Ares, Jose; Duran-Patron, Rosa; Macias-Sanchez, Antonio J.; Castro, Carmen; Hernandez-Galan, Rosario] Inst Invest & Innovac Biomed Cadiz INIBICA, Cadiz 11009, Spain; [Geribaldi-Doldan, Noelia] Univ Cadiz, Dept Anat & Embriol Humanas, Cadiz 11002, Spain; [Nunez-Abades, Pedro] Univ Seville, Fac Farm, Dept Fisiol, Seville 41012, Spain; [Macias-Sanchez, Antonio J.; Hernandez-Galan, Rosario] Univ Cadiz, Inst Invest Biomol INBIO, Cadiz 11510, Spain		Hernandez-Galan, R (corresponding author), Univ Cadiz, Fac Ciencias, Dept Quim Organ, Cadiz 11510, Spain.; Hernandez-Galan, R (corresponding author), Inst Invest & Innovac Biomed Cadiz INIBICA, Cadiz 11009, Spain.; Hernandez-Galan, R (corresponding author), Univ Cadiz, Inst Invest Biomol INBIO, Cadiz 11510, Spain.	rosario.hernandez@uca.es	Gomez-Oliva, Ricardo/AAS-8875-2020; Carmen, Castro/C-7813-2009; Garcia, Samuel Dominguez/AAS-8879-2020; Montano, Felipe Escobar/AAB-5230-2019	Gomez-Oliva, Ricardo/0000-0003-4093-2550; Carmen, Castro/0000-0002-6802-0572; Garcia, Samuel Dominguez/0000-0003-4319-3466; Montano, Felipe Escobar/0000-0002-9290-9654; Hernandez Galan, Rosario/0000-0003-1887-4796; Macias Sanchez, Antonio Jose/0000-0001-6002-4977; Botubol-Ares, Jose Manuel/0000-0002-2312-612X; Duran Patron, Rosa Maria/0000-0002-5307-4164	Spanish Ministerio de Ciencia, Innovacion y Universidades (MICINN/FEDER) [RTI2018-099908-BC21, RTI2018-099908-B-C22]; Consejeria de Economia, Conocimiento, Empresas y Universidades Junta de Andalucia [FEDER-ANDALUCIA sol2018-00106647-tra]	This work was supported by the Spanish Ministerio de Ciencia, Innovacion y Universidades (grant nos RTI2018-099908-BC21 and RTI2018-099908-B-C22 MICINN/FEDER granted to CC and RHG, respectively) and Consejeria de Economia, Conocimiento, Empresas y Universidades Junta de Andalucia (grant no FEDER-ANDALUCIA sol2018-00106647-tra). We thank the "Servicio de experimentacion y produccion animal (SEPA) de la Universidad de Cadiz" as well as the "Servicios Centrales de apoyo a la investigacion en Ciencias de la Salud (SCICS) de la Universidad de Cadiz" and "Servicios centrales de Ciencia Cadiz".	Appendino G, 2004, EUR J ORG CHEM, V2004, P3413, DOI 10.1002/ejoc.200400122; Appendino G, 1996, J MED CHEM, V39, P3123, DOI 10.1021/jm960063l; Berdugo-Vega G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14935-4; Bertolini TM, 2003, J ORG CHEM, V68, P5028, DOI 10.1021/jo030029w; Carrasco M, 2014, HIPPOCAMPUS, V24, P840, DOI 10.1002/hipo.22274; Dang M, 2013, P NATL ACAD SCI USA, V110, P9776, DOI 10.1073/pnas.1307478110; Dang M, 2011, J BIOL CHEM, V286, P17704, DOI 10.1074/jbc.M110.187823; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dominguez-Garcia S, 2021, NEUROPSYCHOPHARMACOL, V46, P1207, DOI 10.1038/s41386-020-00934-y; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Garcia-Bernal F, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00462; Geribaldi-Doldan N, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00039; Geribaldi-Doldan N, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv085; Gomez-Oliva R, 2020, AGING-US, V12, P13824, DOI 10.18632/aging.103510; GSCHWENDT M, 1973, Z KREBSFORSCH KLIN O, V80, P335, DOI 10.1007/BF00284369; Hecker E, 1974, Fortschr Chem Org Naturst, V31, P377; HERGENHAHN M, 1984, J CANCER RES CLIN, V108, P98, DOI 10.1007/BF00390980; HERGENHAHN M, 1982, J CANCER RES CLIN, V104, P31, DOI 10.1007/BF00402051; Hierro-Bujalance C, 2020, J NEUROCHEM, V154, P673, DOI 10.1111/jnc.14987; JACOBI P, 1970, LIEBIGS ANN CHEM, V741, P13; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; MARSHALL GT, 1984, J AM OIL CHEM SOC, V61, P1220, DOI 10.1007/BF02636256; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Murillo-Carretero M, 2017, BRIT J PHARMACOL, V174, P2373, DOI 10.1111/bph.13846; Newton AC, 2018, CRIT REV BIOCHEM MOL, V53, P208, DOI 10.1080/10409238.2018.1442408; Nothias-Scaglia LF, 2015, J CHROMATOGR A, V1422, P128, DOI 10.1016/j.chroma.2015.09.092; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Rabaneda LG, 2008, FASEB J, V22, P3823, DOI 10.1096/fj.08-109306; Rabaneda LG, 2016, BBA-MOL CELL RES, V1863, P3015, DOI 10.1016/j.bbamcr.2016.09.018; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Shi QW, 2008, CHEM REV, V108, P4295, DOI 10.1021/cr078350s; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; TSENG SS, 1977, J ORG CHEM, V42, P3645, DOI 10.1021/jo00443a002; Vasas A, 2014, CHEM REV, V114, P8579, DOI 10.1021/cr400541j; Vogg G, 1999, J CHROMATOGR A, V855, P563, DOI 10.1016/S0021-9673(99)00728-1; VONSZCZEPANSKI C, 1967, LIEBIGS ANN CHEM, V705, P199; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhang XL, 2013, J NAT PROD, V76, P858, DOI 10.1021/np300832n	45	0	0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-2623	1520-4804		J MED CHEM	J. Med. Chem.	MAY 13	2021	64	9					6070	6084		10.1021/acs.jmedchem.1c00156		MAY 2021	15	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Pharmacology & Pharmacy	SE0SP	WOS:000651785800049	33945688	hybrid			2022-02-07	
J	Tran, DT; Vu, NT; Nguyen, QT; Duong, TD; Hoang, DG; Dinh, SN; Le, SM; Dao, TX; Nguyen, LH				Tran, Dung T.; Vu, Nam T.; Nguyen, Quynh T.; Duong, Toan D.; Hoang, Du G.; Dinh, Son N.; Le, Son M.; Dao, Thanh X.; Nguyen, Long H.			Irreducible Traumatic Radial Head Dislocation Due to Annular Ligament Interposition in a Child with Ulnar Plastic Deformation: A Case Report	ORTHOPAEDIC SURGERY			English	Article						Annular ligament; Dislocation; Elbow; Irreducible radial head dislocation	MONTEGGIA FRACTURE-DISLOCATIONS; OPEN REDUCTION; OSTEOTOMY; RECONSTRUCTION	Background The traumatic dislocation of the radial head in children is commonly treated by closed reduction. Sometimes, however, this strategy of treatment may not be effective due to the location of soft tissues in the radio-shoulder joint. The literature presents a few cases of the irreducible radial head dislocation with ulnar plastic deformation. Because it is a relatively rare condition, such a traumatic dislocation can be easily missed. Neglected injuries can lead to unwanted complications and unpredictable surgical outcomes. Case presentation This study presents a relatively rare case of traumatic radial head dislocation with ulnar plastic deformation in a 3-year-old child, which was successfully treated by open reduction. The examined case did not require osteotomy and ligamentous reconstruction. The initial attempt of closed reduction failed due to annular ligament interposition, which has been detected on MRI. After 3 months of treatment, the range of motion of the operated arm gradually improved. At the 6-month follow-up, the Mayo elbow-performance score indicated an excellent treatment outcome. Conclusions The delayed treatment of radial head dislocation with ulnar plastic deformation can hinder the supination and pronation of the forearm, resulting in elbow/forearm deformity. The earlier this condition is detected, the easier it will be to treat it and the better the treatment outcome will be. The examined case of irreversible traumatic dislocation, successfully treated by open reduction, may help to treat radial head dislocation better.	[Tran, Dung T.; Vu, Nam T.; Duong, Toan D.; Dinh, Son N.; Dao, Thanh X.] Hanoi Med Univ, Ton Tung Str 8, Hanoi 10000, Vietnam; [Nguyen, Quynh T.] St Paul Univ Hosp, Hanoi, Vietnam; [Hoang, Du G.] Bachmai Univ Hosp, Hanoi, Vietnam; [Le, Son M.; Nguyen, Long H.] VietDuc Univ Hosp, Hanoi, Vietnam		Tran, DT (corresponding author), Hanoi Med Univ, Ton Tung Str 8, Hanoi 10000, Vietnam.	dngtrntrung@gmail.com		, Dung/0000-0002-2160-0721; TRAN TRUNG, DUNG/0000-0003-2015-3963			Abdelwahab, 2017, ORTHOP MUSCULAR SYST, V6, P1; Alrashidi Y, 2021, INT J SURG CASE REP, V78, P42, DOI 10.1016/j.ijscr.2020.11.142; Atic R, 2018, J CLIN ANAL MED, V9, P323, DOI 10.4328/JCAM.5754; Aversano F, 2011, J ORTHOP TRAUMA, V25, pE38, DOI 10.1097/BOT.0b013e3181dc245d; Bhaskar A, 2009, INDIAN J ORTHOP, V43, P389, DOI 10.4103/0019-5413.55978; BORDEN S, 1974, J BONE JOINT SURG AM, VA 56, P611, DOI 10.2106/00004623-197456030-00019; Bradley MP, 2007, AM J ORTHOP BELLE ME, V36, P76; El-Sobky TA., 2017, J MUSCULOSKELET SURG, V1, P49; Goyal T, 2015, J PEDIATR ORTHOP B, V24, P191, DOI 10.1097/BPB.0000000000000147; Gupta V, 2013, MALAYS ORTHOP J, V7, P70, DOI 10.5704/MOJ.1303.003; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639, DOI 10.1302/0301-620X.69B4.3611173; Kajiwara R, 2007, J SHOULDER ELB SURG, V16, P1; KAMALI M, 1974, J BONE JOINT SURG AM, VA 56, P841, DOI 10.2106/00004623-197456040-00026; Kelly, 2019, E AFR ORTHOP J, V13, P88; Kemnitz S, 2000, Acta Orthop Belg, V66, P359; Kontakis GM, 2008, ACTA ORTHOP BELG, V74, P546; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; Malik M, 2016, ORTHOPEDICS, V39, pE203, DOI 10.3928/01477447-20151222-01; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; NEVIASER RJ, 1971, CLIN ORTHOP RELAT R, P72; O'Neill BJ, 2009, EUR J TRAUMA EMERG S, V35, P79, DOI 10.1007/s00068-008-8044-6; Peshin C, 2020, J ORTHOP SURG-HONG K, V28, P3; Rajasekaran S, 2014, INT ORTHOP, V38, P2519, DOI 10.1007/s00264-014-2514-8; Rathod N, 2016, INT J ORTHOP SCI, V2, P13; Sai S, 2005, J ORTHOP SCI, V10, P103, DOI 10.1007/s00776-004-0860-x; Sano S, 2008, J SHOULDER ELB SURG, V17, P768, DOI 10.1016/j.jse.2008.03.007; SCHEUER M, 1986, NETH J SURG, V38, P158; Singh A, 2017, INT J ORTHOP, V3, P309; Singh V, 2020, J PEDIATR ORTHOPED, V40, pE293, DOI 10.1097/BPO.0000000000001501; Takase K, 2011, J PEDIATR ORTHOP B, V20, P345, DOI 10.1097/BPB.0b013e32834534cb; Tan JW, 2008, INJURY, V39, P451, DOI 10.1016/j.injury.2007.07.010; TRIANTAFYLLOU SJ, 1992, CLIN ORTHOP RELAT R, P153; Wang MN, 2006, J ORTHOP TRAUMA, V20, P1, DOI 10.1097/01.bot.0000189881.75421.92; Waters PM., 2014, ROCKWOOD WILKINSFRAC; WATSON JAS, 1994, INJURY, V25, P325, DOI 10.1016/0020-1383(94)90246-1; WhanYong Chung, 2016, [Journal of the Korean Orthopaedic Association, 대한정형외과학회지], V51, P443; Yoshihara Y, 2002, J TRAUMA, V53, P984, DOI 10.1097/00005373-200211000-00028; Yuan Z, 2019, J CHILD ORTHOP, V13, P551, DOI 10.1302/1863-2548.13.190115	38	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-7853	1757-7861		ORTHOP SURG	Orthop. Surg.	JUN	2021	13	4					1437	1442		10.1111/os.12981		MAY 2021	6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	TH1XC	WOS:000646612100001	33942980	gold, Green Published			2022-02-07	
J	Vedin, T; Bergenfeldt, H; Holmstrom, E; Lundager-Forberg, J; Edelhamre, M				Vedin, Tomas; Bergenfeldt, Henrik; Holmstrom, Emanuel; Lundager-Forberg, Jakob; Edelhamre, Marcus			Microwave scan and brain biomarkers to rule out intracranial hemorrhage: study protocol of a planned prospective study (MBI01)	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						TBI traumatic brain injury; Biomarkers; Microwaves; CT scan; X-ray; Brain hemorrhage; traumatic		Purpose The aim of this planned study is to evaluate the ability of a cranial microwave scanner in conjunction with nine brain biomarkers (A beta 40, A beta 42, GFAP, H-FABP, S100B, NF-L, NSE, UCH-L1 and IL-10) to detect and rule out traumatic intracranial hemorrhage in an emergency department setting. Traumatic brain injury is a world-wide topic of interest for researchers and clinicians. It affects 2% of the population per annum and presents challenges for physicians as patients' initial signs and symptoms do not always correlate with the extent of brain injury. The gold standard for diagnosis of intracranial hemorrhage is head computerized tomography (CT) with the drawbacks of high cost and radiation exposure. A fast, secure way of diagnosing without these drawbacks has potential to make care more effective and reduce cost. Methods Study will be prospective and enroll adult, consenting patients with head trauma who seek emergency department care. Only patients where the treating physician prescribes a head-CT will be included. The microwave scan and blood sampling will be performed in close temporal proximity to the CT scan. Results will be analyzed with sensitivity, specificity and receiver operator characteristics analysis to provide the best combination of a number of biomarkers and the microwave scan. Conclusion This study will explore the diagnostic accuracy of a head microwave scanner in combination with biomarkers in ruling out intracranial hemorrhage in traumatic brain injury patients presenting to the emergency department. Potentially, this combined diagnostic approach could achieve both high sensitivity and high specificity, thereby reducing the need of CT-head scans when managing these patients. Clinicaltrials.gov identifier: NCT04666766. Registered December 11, 2020.	[Vedin, Tomas; Bergenfeldt, Henrik; Holmstrom, Emanuel; Lundager-Forberg, Jakob; Edelhamre, Marcus] Lund Univ, Clin Sci, Svartbrodragranden 3-5, S-25187 Helsingborg, Sweden		Vedin, T (corresponding author), Lund Univ, Clin Sci, Svartbrodragranden 3-5, S-25187 Helsingborg, Sweden.	tvedin@gmail.com; henrik.bergenfeldt@gmail.com; Emanuel.holmstrom@hotmail.com; jakob.lundager_forberg@med.lu.se; marcus.edelhamre@med.lu.se		Vedin, Tomas/0000-0003-1913-7958	Lund University; Gorthon Foundation, Helsingborg, Sweden	Open access funding provided by Lund University. Study will be partly funded by the Gorthon Foundation, Helsingborg, Sweden.	Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Aygun N, 2002, NEUROSURG CLIN N AM, V13, P313, DOI 10.1016/S1042-3680(02)00009-8; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brenner David J., 2010, Reviews on Environmental Health, V25, P63; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Fhager A, 2018, IEEE MICROW MAG, V19, P78, DOI 10.1109/MMM.2018.2801646; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Fujii Tomoko, 2013, J Emerg Trauma Shock, V6, P252, DOI 10.4103/0974-2700.120365; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Kim B, 2018, AM J EMERG MED, V36, P271, DOI 10.1016/j.ajem.2017.08.009; Kobeissy FH, 2015, BRAIN NEUROTRAUMA, DOI [10.1201/b18126, DOI 10.1201/B18126]; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Ljungqvist J, 2017, J NEUROTRAUM, V34, P2176, DOI 10.1089/neu.2016.4869; Marion DW, 2006, NEUROSURGERY, V58, P655; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Nakahara S, 2010, J TRAUMA, V68, P1044, DOI 10.1097/TA.0b013e3181aca144; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Persson M, 2014, IEEE T BIO-MED ENG, V61, P2806, DOI 10.1109/TBME.2014.2330554; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Svensson S, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0673-8; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vajtr D, 2012, Soud Lek, V57, P7; Vedin T, 2021, EUR J TRAUMA EMERG S, V47, P1451, DOI 10.1007/s00068-019-01145-x; Vedin T, 2019, EUR J TRAUMA EMERG S, V45, P901, DOI 10.1007/s00068-018-0941-8; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	31	0	0	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01671-7		MAY 2021	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RX1BI	WOS:000646956100002	33944977	hybrid			2022-02-07	
J	Zera, SM; Preissner, K; Fischer, H; Stoffel, A				Zera, Sarah M.; Preissner, Kathy; Fischer, Heidi; Stoffel, Ashley			Cognitive orientation to daily occupation group in the adult day rehabilitation setting: A feasibility study	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Metacognitive strategy training; cognitive strategies; stroke; brain injury; group intervention; feasibility	TRAUMATIC BRAIN-INJURY	Introduction The Cognitive Orientation to daily Occupational Performance (CO-OP) Approach(TM) is a leading approach in occupational therapy. Implementing the CO-OP Approach(TM) in a group format in day rehabilitation has not yet been explored. Method In day rehabilitation, a barrier to implementing the CO-OP Approach(TM) is the group model. To address these challenges, this feasibility study involved the development, implementation, and evaluation of a CO-OP group for adults. Four patients participated in six group sessions. Pre- and post-measures included the Canadian Occupational Performance Measure (COPM) and the Assessment of Motor and Process Skills (AMPS). Subjective data were collected to reflect the participant's experiences during the group. Results 80% of participants recruited completed the group. All participants demonstrated improvement in goals addressed within the group and goals not addressed within the group on the COPM. AMPS findings were inconclusive. Subjective findings indicated participants appreciated the group learning environment, valued the CO-OP process, were motivated to participate, and would have liked more groups. Conclusion To our knowledge, this is the first adult CO-OP group in a clinical setting. Results support the feasibility of a CO-OP group in day rehabilitation and the need for further examination of the effectiveness of this intervention.	[Zera, Sarah M.] Midwestern Univ, Occupat Therapy Program, Downers Grove, IL 60515 USA; [Preissner, Kathy; Fischer, Heidi; Stoffel, Ashley] Univ Illinois, Occupat Therapy Program, Chicago, IL USA		Zera, SM (corresponding author), Midwestern Univ, 555 31st St, Downers Grove, IL 60515 USA.	szera@midwestern.edu		Zera, Sarah/0000-0002-2457-6798			Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Bandura A., 2010, CORSINI ENCY PSYCHOL, P1, DOI [DOI 10.1002/9780470479216.CORPSY0836, 10.1002/9780470479216.corpsy0836]; Baranowski T., 2002, HLTH BEHAV HLTH ED T, V3, P165; Chan DYK, 2007, HONG KONG J OCCUP TH, V17, P39, DOI 10.1016/S1569-1861(08)70002-0; Chard, 2006, BRIT J OCCUPATIONAL, V69, P50, DOI [10.1177/030802260606900202, DOI 10.1177/030802260606900202]; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Eriksson Gunilla, 2013, Am J Occup Ther, V67, pe131, DOI 10.5014/ajot.2013.008292; Eyssen ICJM, 2011, J REHABIL RES DEV, V48, P517, DOI 10.1682/JRRD.2010.06.0110; Green D, 2008, HUM MOVEMENT SCI, V27, P363, DOI 10.1016/j.humov.2008.02.009; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Jones K., 2011, ASSESSMENT MOTOR PRO, VI; Kramer P, 2014, EVALUATION OCCUPATIO; Law M., 2014, CANADIAN OCCUPATIONA, V5th; Lee D, 2017, TOP STROKE REHABIL, V24, P601, DOI 10.1080/10749357.2017.1375222; Mandich, 2004, ENABLING OCCUPATION; Martini R, 2014, BRIT J OCCUP THER, V77, P214, DOI 10.4276/030802214X13968769798917; McColl M A, 2000, Can J Occup Ther, V67, P22; McEwen SE, 2010, DISABIL REHABIL, V32, P540, DOI 10.3109/09638280903180189; Nielsen KT, 2015, SCAND J OCCUP THER, V22, P13, DOI 10.3109/11038128.2014.961547; Polatajko, 2013, ENABLING OCCUPATION; Polatajko, 2017, COGNITIVE ORIENTATIO, P11; Polatajko HJ., 2017, COGNITIVE ORIENTATIO; Polatajko HJ., 2017, COGNITIVE ORIENTATIO; Polatajko HJ, 2017, COGNITIVE ORIENTATIO, P135; Polatajko HJ, 2017, COGNITIVE ORIENTATIO; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Tickle-Degnen L, 2013, AM J OCCUP THER, V67, P171, DOI 10.5014/ajot.2013.006270	29	0	0	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	JAN	2022	85	1					14	22	03080226211008713	10.1177/03080226211008713		MAY 2021	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	XZ9RJ	WOS:000660924400001					2022-02-07	
J	Zhou, Y; Lu, WF; Tang, WB				Zhou, Ying; Lu, Weifeng; Tang, Weibing			Gastrointestinal failure score in children with traumatic brain injury	BMC PEDIATRICS			English	Article						Gastrointestinal failure (GIF) score; Traumatic brain injury; Children	CRITICALLY-ILL PATIENTS; DISEASE	Background To review the value of the gastrointestinal failure (GIF) score in children with different degrees of traumatic brain injury (TBI) by analyzing the correlation between outcome and gastrointestinal function. Methods A total of 165 children with TBI who were diagnosed and treated in the surgical intensive care unit (SICU) for longer than 72 h between August 2017 and September 2019 were analyzed. Admission parameters included sex, age, Glasgow Coma Scale (GCS) score, body mass index (BMI), leukocyte count, C-reactive protein (CRP), hemoglobin (Hb), hematocrit (Hct), blood glucose, lactic acid, procalcitonin (PCT), albumin, plasma osmotic pressure, prothrombin time (PT) and activated partial thromboplastin time (APTT). To predict outcomes, the Pediatric Sequential Organ Failure Assessment (SOFA) score, Pediatric Clinical Illness Score (PCIS), and mean GIF score for the first three days were combined. Results The percentage of patients with gastrointestinal dysfunction on the first day was 78.8 %. Food intolerance (FI) and intra-abdominal hypertension (IAH) developed in 36.4 and 21.8 % of the patients, respectively. The GIF score and mean GIF score for the first three days were significantly different between children with different degrees of TBI (P < 0.05); these scores were also significantly different between patients who died and those who survived (P < 0.05). The mean GIF score for the first three days was identified as an independent risk factor for mortality (odds ratio > 1, 95 % confidence interval = 1.457 to 16.016, P < 0.01), as was the PCIS. Receiver operating characteristic (ROC) curve analysis suggested that the mean GIF score for the first three days had the same calibrating power as the PCIS in discriminating the risk of death of children. Conclusions The incidence of gastrointestinal dysfunction in children with TBI is high. The GIF score has the ability to reflect the status of the gastrointestinal system. The mean GIF score for the first three days has high prognostic value for ICU mortality in the SICU.	[Zhou, Ying; Lu, Weifeng; Tang, Weibing] Nanjing Med Univ, Dept Pediat Surg, Childrens Hosp, 72 Guangzhou Rd, Nanjing 210008, Jiangsu, Peoples R China		Tang, WB (corresponding author), Nanjing Med Univ, Dept Pediat Surg, Childrens Hosp, 72 Guangzhou Rd, Nanjing 210008, Jiangsu, Peoples R China.	twbcn@njmu.edu.cn					Agarwala R, 2020, DIGEST DIS SCI, V65, P2419, DOI 10.1007/s10620-019-05952-5; Aperstein Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222599; Blaser AR, 2016, CURR OPIN CRIT CARE, V22, P128, DOI 10.1097/MCC.0000000000000286; Blaser AR, 2012, INTENS CARE MED, V38, P384, DOI 10.1007/s00134-011-2459-y; Cheng MH, 2018, AM J CRIT CARE, V27, P504, DOI 10.4037/ajcc2018255; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Kansu A, 2018, ACTA PAEDIATR, V107, P1036, DOI 10.1111/apa.14240; Kigerl KA, 2018, NEUROTHERAPEUTICS, V15, P60, DOI 10.1007/s13311-017-0583-2; Liu ZQ, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0609-3; Lone NI, 2019, THORAX, V74, P1046, DOI 10.1136/thoraxjnl-2017-210822; Lu Xiu-Lan, 2015, Zhongguo Dang Dai Er Ke Za Zhi, V17, P961; Lu Yanhui, 2019, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V44, P996, DOI 10.11817/j.issn.1672-7347.2019.180372; Bordeje ML, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112616; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mak MHW, 2019, INT J SURG, V72, P71, DOI 10.1016/j.ijsu.2019.10.022; Marker S, 2019, INTENS CARE MED, V45, P609, DOI 10.1007/s00134-019-05589-y; Midenfjord I, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13619; Padar M, 2019, J CRIT CARE, V52, P103, DOI 10.1016/j.jcrc.2019.04.001; Pan PF, 2019, NEUROL SCI, V40, P1105, DOI 10.1007/s10072-019-03739-0; Perceval C, 2019, LANCET CHILD ADOLESC, V3, P655, DOI 10.1016/S2352-4642(19)30182-8; Pereira BM, 2019, ANAESTH INTENSIVE TH, V51, P370, DOI 10.5114/ait.2019.88184; Reintam A, 2008, CRIT CARE, V12, DOI 10.1186/cc6958; Vieira LV, 2018, METAB BRAIN DIS, V33, P1755, DOI 10.1007/s11011-018-0287-2; Vredebregt SJ, 2019, EUR J PEDIATR, V178, P229, DOI 10.1007/s00431-018-3285-9; Wang B, 2015, AMINO ACIDS, V47, P2143, DOI 10.1007/s00726-014-1773-4; Wang DC, 2002, J NEUROTRAUM, V19, P875, DOI 10.1089/08977150260190465; Ware AL, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102106; Wesselink E, 2018, CLIN NUTR ESPEN, V25, P78, DOI 10.1016/j.clnesp.2018.04.001; Zhang D, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012970; Zhang LM, 2019, WORLD NEUROSURG, V132, pE21, DOI 10.1016/j.wneu.2019.09.024	30	0	0	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2431		BMC PEDIATR	BMC Pediatr.	MAY 4	2021	21	1							219	10.1186/s12887-021-02673-5			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	SK3XR	WOS:000656152900002	33947372	Green Submitted, gold, Green Published			2022-02-07	
J	Correia, MA; McLachlin, SD; Cronin, DS				Correia, Matheus A.; McLachlin, Stewart D.; Cronin, Duane S.			Vestibulocollic and Cervicocollic Muscle Reflexes in a Finite Element Neck Model During Multidirectional Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Muscle activation; Vestibulocollic reflex; Cervicocollic reflex; Human body model; Finite element method; Head kinematics; Neck model	HEAD MOVEMENTS; CERVICAL-SPINE; KINEMATICS	Active neck musculature plays an important role in the response of the head and neck during impact and can affect the risk of injury. Finite element Human Body Models (HBM) have been proposed with open and closed-loop controllers for activation of muscle forces; however, controllers are often calibrated to specific experimental loading cases, without considering the intrinsic role of physiologic muscle reflex mechanisms under different loading conditions. This study aimed to develop a single closed-loop controller for neck muscle activation in a contemporary male HBM based on known reflex mechanisms and assess how this approach compared to current open-loop controllers across a range of impact directions and severities. Controller parameters were optimized using volunteer data and independently assessed across twelve impact conditions. The kinematics from the closed-loop controller simulations showed good average CORA rating to the experimental data (0.699) for the impacts following the ISO/TR9790 standard. Compared to previously optimized open-loop activation strategy, the average difference was less than 9%. The incorporation of the reflex mechanisms using a closed-loop controller can provide robust performance for a range of impact directions and severities, which is critical to improving HBM response under a larger spectrum of automotive impact simulations.	[Correia, Matheus A.; McLachlin, Stewart D.; Cronin, Duane S.] Univ Waterloo, Dept Mech Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada		Cronin, DS (corresponding author), Univ Waterloo, Dept Mech Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	dscronin@uwaterloo.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Global Human Body Models Consortium; FCA Canada; GM Canada; Honda RD Americas	Financial support for this research was provided by the Natural Sciences and Engineering Research Council of Canada, Global Human Body Models Consortium, FCA Canada, GM Canada, and Honda R&D Americas; the head-and-neck model provided by the Global Human Body Models Consortium; and computing resources provided by Compute Canada.	Albert DL, 2018, TRAFFIC INJ PREV, V19, pS40, DOI 10.1080/15389588.2018.1524141; Arbogast KB, 2009, STAPP CAR CRASH JO, V53, P329; Barker JB, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4047866; Barker JB, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036464; Blouin JS, 2003, EXP BRAIN RES, V150, P458, DOI 10.1007/s00221-003-1466-9; Brolin Karin, 2005, Traffic Inj Prev, V6, P67, DOI 10.1080/15389580590903203; Correia MA, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109754; Dehner C, 2013, TRAFFIC INJ PREV, V14, P607, DOI 10.1080/15389588.2012.734937; Ejima S., 2005, INT RES COUNC BIOM I, P245; Ewing C. L., 1972, DTIC DOC; Fanta O, 2013, NEUROENDOCRINOL LETT, V34, P708; Gepner B.D., 2018, C P INT RES COUNC BI, P355; Happee R, 2017, J BIOMECH, V58, P203, DOI 10.1016/j.jbiomech.2017.05.005; Hedenstierna S, 2008, COMPUT METHOD BIOMEC, V11, P627, DOI 10.1080/17474230802312516; Iwamoto, 2016, P IRCOBI ASIA C MAY, P33; Iwamoto M, 2017, STUDY MUSCLE CONTROL, P1; Iwamoto Masami, 2012, Stapp Car Crash J, V56, P231; Jakobsson, 2015, ESV THE 24 INT TECHN, P1; Kaneoka K, 2014, DYNAMIC CERVICAL VER; Keshner EA, 2003, J NEUROPHYSIOL, V89, P1891, DOI 10.1152/jn.00836.2001; Kleinbach C, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0399-7; Kumar S, 2005, SPINE, V30, P1742, DOI 10.1097/01.brs.0000172156.84168.ef; Kumar S, 2003, CLIN BIOMECH, V18, P694, DOI 10.1016/S0268-0033(03)00137-2; Le P, 2018, HUM FACTORS, V60, P68, DOI 10.1177/0018720817738598; Meyer GA, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004993; NHTSA, 2012, NATL HIGHWAY TRAFFIC; Olszko AV, 2018, TRAFFIC INJ PREV, V19, pS44, DOI 10.1080/15389588.2017.1390570; Osth J, 2012, COMPUT METHOD BIOMEC, V15, P347, DOI 10.1080/10255842.2010.535523; Panzer MB, 2011, MED ENG PHYS, V33, P1147, DOI 10.1016/j.medengphy.2011.05.004; Peng GCY, 1996, BIOL CYBERN, V75, P309, DOI 10.1007/s004220050297; PETERSON BW, 1985, J NEUROPHYSIOL, V54, P90, DOI 10.1152/jn.1985.54.1.90; Pradhan V., 2017, INFLUENCE ISOMETRICA; Putra IPA, 2021, ANN BIOMED ENG, V49, P115, DOI 10.1007/s10439-020-02512-1; Reynolds JS, 2008, J NEUROPHYSIOL, V99, P2369, DOI 10.1152/jn.00320.2007; Somasundaram K, 2019, J MECH BEHAV BIOMED, V100, DOI 10.1016/j.jmbbm.2019.103398; Stemper BD, 2016, J ORTHOP SPORT PHYS, V46, P834, DOI 10.2519/jospt.2016.6846; Thomas D.J, 1995, HUMAN VOLUNTEER HEAD; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Woltring, 1986, SAE T, V95, P819; Yang K.H., 2017, BASIC FINITE ELEMENT, DOI [10.1016/c2015-0-06702-8, DOI 10.1016/C2015-0-06702-8]	40	0	0	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUL	2021	49	7					1645	1656		10.1007/s10439-021-02783-2		MAY 2021	12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	TS8IK	WOS:000646532600001	33942199				2022-02-07	
J	Fortier-Lebel, O; Jobin, B; Lecuyer-Giguere, F; Gaubert, M; Giguere, JF; Gagnon, JF; Boller, B; Frasnelli, J				Fortier-Lebel, Olivier; Jobin, Benoit; Lecuyer-Giguere, Fanny; Gaubert, Malo; Giguere, Jean-Francois; Gagnon, Jean-Francois; Boller, Benjamin; Frasnelli, Johannes			Verbal Episodic Memory Alterations and Hippocampal Atrophy in Acute Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; Hopkins Verbal Learning Test; memory; mild traumatic brain injury; magnetic resonance imaging; volumetry		Episodic memory deficit is a symptom frequently observed after a mild traumatic brain injury (mTBI). However, few studies have investigated the impact of a single and acute mTBI on episodic memory and structural cerebral changes. To do so, we conducted two experiments. In the first, we evaluated verbal episodic memory by using a word recall test, in 52 patients with mTBI (mean age 33.1 [12.2] years) 2-4 weeks after a first mTBI, compared with 54 healthy controls (31.3 [9.2] years) and followed both groups up for 6 months. In the second, we measured hippocampal volume in a subset of 40 participants (20 patients with mTBI, 20 controls) from Experiment 1 using magnetic resonance imaging (MRI; T1-weighted images) and correlated memory performance scores to hippocampal volume. Experiment 1 showed significantly reduced verbal episodic memory within the first month after an mTBI and a tendency for a reduction 6 months later, more pronounced for men. In Experiment 2, patients with mTBI exhibited a generally reduced hippocampal volume; however, we did not observe any linear correlation between hippocampal volume and memory scores. These results suggest that one single mTBI is associated with both episodic memory alteration and reduced volume of the hippocampus in the acute phase. Future studies are needed to elucidate the link between both measures.	[Fortier-Lebel, Olivier; Boller, Benjamin] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ, Canada; [Frasnelli, Johannes] Univ Quebec Trois Rivieres, Dept Anat, Trois Rivieres, PQ, Canada; [Fortier-Lebel, Olivier; Jobin, Benoit; Lecuyer-Giguere, Fanny; Gaubert, Malo; Giguere, Jean-Francois; Gagnon, Jean-Francois; Frasnelli, Johannes] Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada; [Jobin, Benoit; Gagnon, Jean-Francois; Boller, Benjamin; Frasnelli, Johannes] Inst Univ Geriatr Montreal, Res Ctr, Montreal, PQ, Canada; [Lecuyer-Giguere, Fanny] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Gaubert, Malo] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Gagnon, Jean-Francois] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada		Frasnelli, J (corresponding author), Univ Quebec Trois Rivieres, 3351 Blvd Forges, Trois Rivieres, PQ G8Z 4M3, Canada.	Johannes.A.Frasnelli@uqtr.ca	Jobin, Benoit/AAT-8053-2021; Boller, Benjamin/R-2093-2016	Jobin, Benoit/0000-0002-1357-5116; Boller, Benjamin/0000-0002-6184-1933	Fonds de Recherche du Quebec -SanteFonds de la Recherche en Sante du Quebec; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [PJT 173514]; Research Center at the CIUSS-NI M HSCM	This work was supported by the Fonds de Recherche du Que ' bec -Sante ' (Chercheur Boursier Junior 2#; J.F.), the Canadian Institutes of Health Research (PJT 173514; J.F.), and the Research Center at the CIUSS-NI M HSCM. J.-F.G. holds a Canada Research Chair in Cognitive Decline in Pathological Aging.	Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Bartsch T., 2012, CLIN NEUROBIOLOGY HI; Batista-Nascimento L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/128647; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; Broadway JM, 2019, CORTEX, V120, P240, DOI 10.1016/j.cortex.2019.06.011; BROOKS D N, 1975, Cortex, V11, P329; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chadwick MJ, 2010, CURR BIOL, V20, P544, DOI 10.1016/j.cub.2010.01.053; Daugherty AM, 2016, NEUROIMAGE, V128, P11, DOI 10.1016/j.neuroimage.2015.12.045; Daugherty AM, 2015, J NEUROSCI, V35, P6731, DOI 10.1523/JNEUROSCI.4717-14.2015; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Giguere FL, 2020, CHEM SENSES, V45, P483, DOI 10.1093/chemse/bjaa037; Hudson JA, 2011, ADV CHILD DEV BEHAV, V40, P95; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moodley KK, 2014, FRONT NEUROL NEUROSC, V34, P95, DOI 10.1159/000356430; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stuss DT, 2006, J INT NEUROPSYCH SOC, V12, P261, DOI 10.1017/S1355617706060358; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; Terry DP, 2018, BRAIN IMAGING BEHAV, V12, P631, DOI 10.1007/s11682-017-9719-6; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004; Wilson IA, 2006, TRENDS NEUROSCI, V29, P662, DOI 10.1016/j.tins.2006.10.002; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	49	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2021	38	11					1506	1514		10.1089/neu.2020.7475		MAY 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SL0LA	WOS:000646811500001	33724054				2022-02-07	
J	Stukas, S; Gill, J; Cooper, J; Belanger, L; Ritchie, L; Tsang, A; Dong, K; Streijger, F; Street, J; Paquette, S; Ailon, T; Dea, N; Charest-Morin, R; Fisher, CG; Dhall, S; Mac-Thiong, JM; Wilson, JR; Bailey, C; Christie, S; Dvorak, MF; Wellington, C; Kwon, BK				Stukas, Sophie; Gill, Jasmine; Cooper, Jennifer; Belanger, Lise; Ritchie, Leanna; Tsang, Angela; Dong, Kevin; Streijger, Femke; Street, John; Paquette, Scott; Ailon, Tamir; Dea, Nicolas; Charest-Morin, Raphaele; Fisher, Charles G.; Dhall, Sanjay; Mac-Thiong, Jean-Marc; Wilson, Jefferson R.; Bailey, Christopher; Christie, Sean; Dvorak, Marcel F.; Wellington, Cheryl; Kwon, Brian K.			Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as a Biomarker of Human Acute Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; cerebrospinal fluid; prognosis; spinal cord injury; UCH-L1		A major obstacle for translational research in acute spinal cord injury (SCI) is the lack of biomarkers that can objectively stratify injury severity and predict outcome. Ubiquitin C-terminal hydrolase L1 (UCH-L1) is a neuron-specific enzyme that shows promise as a diagnostic biomarker in traumatic brain injury (TBI), but has not been studied in SCI. In this study, cerebrospinal fluid (CSF) and serum samples were collected over the first 72-96 h post-injury from 32 acute SCI patients who were followed prospectively to determine neurological outcomes at 6 months post-injury. UCH-L1 concentration was measured using the Quanterix Simoa platform (Quanterix, Billerica, MA) and correlated to injury severity, time, and neurological recovery. We found that CSF UCH-L1 was significantly elevated by 10- to 100-fold over laminectomy controls in an injury severity- and time-dependent manner. Twenty-four-hour post-injury CSF UCH-L1 concentrations distinguished between American Spinal Injury Association Impairment Scale (AIS) A and AIS B, and AIS A and AIS C patients in the acute setting, and predicted who would remain "motor complete" (AIS A/B) at 6 months with a sensitivity of 100% and a specificity of 86%. AIS A patients who did not improve their AIS grade at 6 months post-injury were characterized by sustained elevations in CSF UCH-L1 up to 96 h. Similarly, the failure to gain >8 points on the total motor score at 6 months post-injury was associated with higher 24-h CSF UCH-L1. Unfortunately, serum UCH-L1 levels were not informative about injury severity or outcome. In conclusion, CSF UCH-L1 in acute SCI shows promise as a biomarker to reflect injury severity and predict outcome.	[Stukas, Sophie; Gill, Jasmine; Cooper, Jennifer; Wellington, Cheryl] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Stukas, Sophie; Gill, Jasmine; Cooper, Jennifer; Wellington, Cheryl] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Belanger, Lise; Ritchie, Leanna; Tsang, Angela] Univ British Columbia, Vancouver Gen Hosp, Blusson Spinal Cord Ctr, Vancouver Spine Res Program, Vancouver, BC, Canada; [Dong, Kevin; Streijger, Femke; Street, John; Dvorak, Marcel F.; Wellington, Cheryl; Kwon, Brian K.] Univ British Columbia, Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Street, John; Charest-Morin, Raphaele; Fisher, Charles G.; Dvorak, Marcel F.; Kwon, Brian K.] Univ British Columbia, Blusson Spinal Cord Ctr, Vancouver Spine Surg Inst, Dept Orthopaed, Vancouver, BC, Canada; [Paquette, Scott; Ailon, Tamir; Dea, Nicolas] Univ British Columbia, Div Neurosurg, Vancouver, BC, Canada; [Dhall, Sanjay] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Mac-Thiong, Jean-Marc] Hop Sacre Coeur Montreal, Dept Surg, Montreal, PQ, Canada; [Mac-Thiong, Jean-Marc] Univ Montreal, Dept Surg, Chu St Justine, Montreal, PQ, Canada; [Wilson, Jefferson R.] Univ Toronto, Div Neurosurg, St Michaels Hosp, Toronto, ON, Canada; [Bailey, Christopher] Victoria Hosp, Div Orthopaed Surg Schulich Med & Dent, London, ON, Canada; [Christie, Sean] Dalhousie Univ, Halifax Infirm, Div Neurosurg, Halifax, NS, Canada		Kwon, BK (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver Spine Surg Inst, Dept Orthopaed, 6th Floor,Blusson Spinal Cord Ctr,818 West 10th A, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@ubc.ca		Dvorak, Marcel/0000-0002-9404-8448	Paralyzed Veterans of America [3174]; Blusson Integrated Cures Program (BICP)	The authors gratefully acknowledge the grant support from the Paralyzed Veterans of America (Grant #3174) and from the Blusson Integrated Cures Program (BICP) seed grants program. Clinical trial support for subject recruitment and CSF/serum collection was kindly provided by the Praxis Spinal Cord Institute (formerly Rick Hansen Institute).	Badhiwala JH, 2018, J NEUROTRAUM, V35, P1906, DOI 10.1089/neu.2018.5935; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.1984.03340250025015; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Dalkilic T, 2018, J NEUROTRAUM, V35, P435, DOI 10.1089/neu.2017.5357; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Grossman RG, 2014, J NEUROTRAUM, V31, P239, DOI 10.1089/neu.2013.2969; Hulme CH, 2017, SPINAL CORD, V55, P114, DOI 10.1038/sc.2016.174; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lenehan B, 2010, SPINE, V35, pS180, DOI 10.1097/BRS.0b013e3181f32a44; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Shahjouei S, 2018, BRAIN INJURY, V32, P1, DOI 10.1080/02699052.2017.1382717; van Middendorp JJ, 2013, J NEUROTRAUM, V30, P1781, DOI 10.1089/neu.2013.2932; Wang KK, 2017, EXPERT OPIN THER TAR, V21, P627, DOI 10.1080/14728222.2017.1321635; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012	25	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 1	2021	38	15					2055	2064		10.1089/neu.2020.7352		MAY 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TV9JU	WOS:000646809500001	33504255				2022-02-07	
J	Albrecht, JS; Wickwire, EM				Albrecht, Jennifer S.; Wickwire, Emerson M.			Healthcare Utilization Following Traumatic Brain Injury in a Large National Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						administrative claims data; healthcare utilization; traumatic brain injury	LONG-TERM DISABILITY; UNITED-STATES; MEDICAL-CARE; COSTS; DISEASE; HOSPITALIZATION; POPULATION; RISK; DEMENTIA; OUTCOMES	Objective: To evaluate the impact of traumatic brain injury (TBI) on healthcare utilization (HCU) over a 1-year period in a large national sample of individuals diagnosed with TBI across multiple care settings. Setting: Commercial insurance enrollees. Participants: Individuals with and without TBI, 2008-2014. Design: Retrospective cohort. Main Measures: We compared the change in the 12-month sum of inpatient, outpatient, emergency department (ED), and prescription HCU from pre-TBI to post-TBI to the same change among a non-TBI control group. Most rehabilitation visits were not included. We stratified models by age >= 65 and included the month of TBI in subanalysis. Results: There were 207 354 individuals in the TBI cohort and 414 708 individuals in the non-TBI cohort. Excluding the month of TBI diagnosis, TBI resulted in a slight increase in outpatient visits (rate ratio [RtR] = 1.05; 95% confidence interval [CI], 1.04-1.06) but decrease in inpatient HCU (RtR = 0.86; 95% CI, 0.84-0.88). Including the month of TBI in the models resulted in increased inpatient (RtR = 1.55; 95% CI, 1.52-1.58) and ED HCU (RtR = 1.37; 95% CI, 1.34-1.40). Conclusion: In this population of individuals who maintained insurance coverage following TBI, results suggest that TBI may have a limited impact on nonrehabilitation HCU at the population level.	[Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Wickwire, Emerson M.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Wickwire, Emerson M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Albrecht, Jennifer S.] OptumLabs, Cambridge, MA USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu; ewickwire@som.umaryalnd.edu		Albrecht, Jennifer/0000-0003-4838-2274	Agency for Healthcare Quality and ResearchUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560]; American Sleep Medicine Foundation; MerckMerck & Company; ResMed	Dr Albrecht is supported by Agency for Healthcare Quality and Research grant K01HS024560. Dr Wickwire has served as a scientific consultant to Merck, DayZz, and Perdue and is an equity shareholder in WellTap. Their institution has received research funding from the American Sleep Medicine Foundation, Merck, and ResMed.	Albrecht JS, 2020, INT REV PSYCHIATR, V32, P31, DOI 10.1080/09540261.2019.1656176; Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, P178, DOI 10.1097/HTR.0000000000000266; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Deb S, 1999, AM J PSYCHIAT, V156, P374; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Hu JH, 2013, J NEUROTRAUM, V30, P1755, DOI 10.1089/neu.2013.2857; Lechner Michael, 2011, Foundations and Trends in Econometrics, V4, P165, DOI 10.1561/0800000014; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Loan JJM, 2019, INJURY, V50, P82, DOI 10.1016/j.injury.2018.09.029; Marr A., 2004, CENTRAL NERVOUS SYST; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mollayeva T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41916-5; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; OptumLabs, 2020, OPTUMLABS OPTUMLABS; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thurman DJ., 1995, GUIDELINES SURVEILLA; Turner-Stokes L, 2019, J HEAD TRAUMA REHAB, V34, P205, DOI 10.1097/HTR.0000000000000473; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	45	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		E147	E154		10.1097/HTR.0000000000000625			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900004	33201034				2022-02-07	
J	Alomani, H; Fareed, A; Ibrahim, H; Shaltoot, A; Elhalawany, A; Alhajjaj, M; Dakhel, A; Alshammasi, M; Almosallam, O				Alomani, Hakem; Fareed, Abdulbaset; Ibrahim, Hassan; Shaltoot, Ahmed; Elhalawany, Ahmed; Alhajjaj, Mohammad; Dakhel, Abdullah; Alshammasi, Muath; Almosallam, Osamah			Pediatric trauma at a single center in the Qassim region of Saudi Arabia	ANNALS OF SAUDI MEDICINE			English	Article							ROAD TRAFFIC ACCIDENTS; GLOBAL BURDEN; INJURIES; PREVALENCE; DISEASES; CHILDREN; SAFETY; HEAD	BACKGROUND: Trauma is one of the leading causes of pediatric mortality so the prevention of pediatric trauma is an important goal of any healthcare system. There are only a few studies on pediatric trauma in Saudi Arabia. The availability of data is vital for healthcare leaders in planning for healthcare services. OBJECTIVE: Assess the epidemiology, patterns, and outcome of trauma in the pediatric population in the Qassim region in Saudi Arabia. DESIGN: Descriptive medical records review. SETTING: A single-center, academic specialized pediatric referral hospital. PATIENTS AND METHODS: We reviewed all electronic and paper records for children (<14 years of age) admitted with a diagnosis of trauma to Maternity and Childrens Hospital (MCH) in Buraidah city in the two-year period between January 2017 and December 2018. MAIN OUTCOME MEASURES: Type of injury, length of stay, and mortality. SAMPLE SIZE: 133 children. RESULT: In this cohort, 77 cases (58%) were admitted to the pediatric intensive care unit (PICU) and 56 (42%) to the pediatric surgery ward. The median (interquartile range) age was 5 (1.1-8) years, and 92 (69%) were boys. The most frequent trauma was road traffic accidents, accounting for 70 cases (52%), followed by fall from a height for 40 (30%) cases. Traumatic brain injury was the most frequent type of injury, accounting for 56 cases (42%), and blunt abdominal trauma was in 11 cases (8.3%). Neurosurgery was the primary subspecialty actively involved in 62 cases (47%). Of the injured children who were admitted to PICU, 36 (46%) needed mechanical ventilation support, while 7 (9%) of those admitted to PICU required the insertion of intra-costal drainage. The mortality in our study was 3.7% (5 cases); 4 of 5 deaths were secondary to road traffic accidents. CONCLUSION: Pediatric trauma is a serious problem in our region with high mortality compared to international benchmarks. Road traffic accidents are the leading type of pediatric trauma, followed by falls from height. Further studies and perhaps national efforts are needed to identify ways to prevent road traffic accidents, and optimize the data registry and trauma services. LIMITATION: There were many missing data and incomplete files that affect accuracy and preclude generalization.	[Alomani, Hakem; Fareed, Abdulbaset; Ibrahim, Hassan; Shaltoot, Ahmed; Elhalawany, Ahmed; Alhajjaj, Mohammad; Dakhel, Abdullah; Alshammasi, Muath] Matern & Children Hosp, Pediat Intens Care Unit, Buraydah 51451, Qassim, Saudi Arabia; [Almosallam, Osamah] Qassim Univ, Coll Med, Dept Surg, Buraydah, Qassim, Saudi Arabia		Alomani, H (corresponding author), Matern & Children Hosp, Pediat Intens Care Unit, Buraydah 51451, Qassim, Saudi Arabia.	alomany9@hot-mail.com		, Hakem/0000-0002-3807-0595			Al Turki YA, 2014, INT J INJ CONTROL SA, V21, P397, DOI 10.1080/17457300.2013.833943; Alghnam S, 2020, ANN SAUDI MED, V40, P417, DOI 10.5144/0256-4947.2020.417; Alghnam S, 2017, ANN SAUDI MED, V37, P1, DOI 10.5144/0256-4947.2017.1; Alhabdan S, 2013, ANN SAUDI MED, V33, P52, DOI 10.5144/0256-4947.2013.52; Alnasser A, 2018, J NAT SCI BIOL MED, V9, P247; [Anonymous], 2020, SAUD AR POP QASS GEN; [Anonymous], 2012, COOPERATION COUNCIL; Ansari S, 2000, PUBLIC HEALTH, V114, P37, DOI 10.1016/S0033-3506(00)00306-1; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Kassebaum N, 2017, JAMA PEDIATR, V171, P573, DOI 10.1001/jamapediatrics.2017.0250; Khazaee T, 2009, DENA Q J YASUJ FACUL, V4, P59; Mansuri FA, 2015, SAUDI MED J, V36, P418, DOI 10.15537/smj.2015.4.10003; Peden M, 2008, WORLD REPORT CHILD I; Peden MSR, 2004, WORLD REPORT TRAFFIC; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; *WHO, 2002, INJ CHARTB GRAPH OV; WHO, 2009, GLOBAL STATUS REPORT; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925	19	0	0	0	0	K FAISAL SPEC HOSP RES CENTRE	RIYADH	PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA	0256-4947	1319-9226		ANN SAUDI MED	Ann. Saudi Med.	MAY-JUN	2021	41	3					165	170		10.5144/0256-4947.2021.165			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SO7BC	WOS:000659128100006	34085544	gold, Green Published			2022-02-07	
J	Alyousif, H; Aleisawi, H; Alkaff, H; Albusayes, N				Alyousif, Hussain; Aleisawi, Hasan; Alkaff, Hussain; Albusayes, Nora			Terrible triad of the hip: A case report	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Closed reduction; Femoral head fracture-dislocation; Iatrogenic femoral neck fracture; Irreducible hip dislocation; Pipkin type-III	FEMORAL-HEAD; FRACTURES; DISLOCATIONS; OUTCOMES	INTRODUCTION: Pipkin-III femoral head fracture dislocation is a rare injury and its outcome is guarded. Some authors believe femoral neck fracture of Pipkin-III injury is largely iatrogenic. Recent literature showed none of these injuries had excellent outcome, and most patients end up with hip replacement. PRESENTATION OF CASE: A 34-year-old man sustained a traumatic hip injury with fracture-dislocation and an iatrogenic femoral neck fracture during reduction. A modified Gibson approach was performed to reduce and fix the femoral head and neck fractures in a retrograde fashion. Follow-up at 26 months assessment showed viable femoral head, and excellent functional outcome. DISCUSSION: Iatrogenic femoral neck fracture in the setting of femoral head dislocation is not uncommon. Clinical and radiological signs of irreducible dislocation can easily be missed which might lead to devastating complications like iatrogenic femoral neck fracture. Recognition of this unique injury, timely intervention, and meticulous dissection might positively alter the patient's outcome. CONCLUSION: This case serves to enlighten orthopedists about the risk of iatrogenic femoral neck fracture, methods to avoid such complication, and the proper management. (C) 2021 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.	[Alyousif, Hussain; Aleisawi, Hasan; Alkaff, Hussain; Albusayes, Nora] King Saud Med City, Dept Orthoped Surg, Riyadh 12746, Saudi Arabia; [Alyousif, Hussain; Aleisawi, Hasan; Alkaff, Hussain; Albusayes, Nora] King Saud Med City, Riyadh, Saudi Arabia		Aleisawi, H (corresponding author), King Saud Med City, Dept Orthoped Surg, Riyadh 12746, Saudi Arabia.	alanazihasan@gmail.com	Aleisawi, Hasan/AAO-6707-2021	Aleisawi, Hasan/0000-0002-4048-7138; Albusayes, Nora/0000-0003-2178-1961; Alkaff, Hussain/0000-0002-5607-205X			Agha RA, 2020, INT J SURG, V84, P226, DOI 10.1016/j.ijsu.2020.10.034; Dreinhofer KE, 1996, UNFALLCHIRURG, V99, P400; Folwarczna J, 2016, ACTA BIOCHIM POL, V63, P287, DOI 10.18388/abp.2015_1095; Giannoudis PV, 2009, INJURY, V40, P1245, DOI 10.1016/j.injury.2009.10.024; Koerner M, 2020, J ORTHOP TRAUMA, V34, P621, DOI 10.1097/BOT.0000000000001880; Mahomed NN, 2001, J ARTHROPLASTY, V16, P575, DOI 10.1054/arth.2001.23716; Mehta S, 2008, J ORTHOP TRAUMA, V22, P686, DOI 10.1097/BOT.0b013e31818e2a86; Moed BR, 2010, J ORTHOP TRAUMA, V24, P315, DOI 10.1097/BOT.0b013e3181c4aef8; Park KH, 2016, ARCH ORTHOP TRAUM SU, V136, P1107, DOI 10.1007/s00402-016-2481-1; PIPKIN G, 1957, J BONE JOINT SURG AM, V39, P1027, DOI 10.2106/00004623-195739050-00004; Roeder L.F.J.R., 1980, CLIN ORTHOP RELAT RE, V147; Scolaro JA, 2017, J ORTHOP TRAUMATOL, V18, P235, DOI 10.1007/s10195-017-0445-z; Snoap Tyler, 2016, JBJS Case Connect, V6, pe88, DOI 10.2106/JBJS.CC.16.00066; Stannard J.P., 2000, CLIN ORTHOP RELAT RE, V377; Tornetta 3rd, 1997, J Am Acad Orthop Surg, V5, P27; Tosounidis T, 2017, INJURY, V48, P2375, DOI 10.1016/j.injury.2017.10.002; Yu X, 2017, PAK J MED SCI, V33, P650, DOI 10.12669/pjms.333.12633; Yue JJ, 1996, J ORTHOP TRAUMA, V10, P447, DOI 10.1097/00005131-199610000-00001	18	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.	MAY	2021	82								105758	10.1016/j.ijscr.2021.105758			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	TE5BL	WOS:000670025800019	33773958	gold, Green Published			2022-02-07	
J	Becerra, AP; Logsdon, AF; Banks, WA; Ransom, CB				Becerra, Alejandro Parga; Logsdon, Aric F.; Banks, William A.; Ransom, Christopher B.			Traumatic Brain Injury Broadly Affects GABAergic Signaling in Dentate Gyrus Granule Cells	ENEURO			English	Article						epilepsy; GABAA receptor; GABAB receptor; hippocampus; TBI; tonic inhibition	POSTSYNAPTIC GABA(B) RECEPTORS; TONIC INHIBITION; POSTTRAUMATIC EPILEPSY; HIPPOCAMPUS; SUBUNITS; MODULATION; GLUTAMATE; PROTEIN; CURRENTS; NEURONS	Traumatic brain injury (TBI) causes cellular and molecular alterations that contribute to neuropsychiatric disease and epilepsy. GABAergic dysfunction figures prominently in the pathophysiology of TBI, yet the effects of TBI on tonic inhibition in hippocampus remain uncertain. We used a mouse model of severe TBI [controlled cortical impact (CCI)] to investigate GABAergic signaling in dentate gyrus granule cells (DGGCs). Basal tonic GABA currents were not affected by CCI. However, tonic currents induced by the delta subunit-selective GABA(A) receptor agonist 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP; 10 mu M) were reduced by 44% in DGGCs ipsilateral to CCI (CCI-ipsi), but not in contralateral DGGCs. Reduced THIP currents were apparent one week after injury and persisted up to 15 weeks. The frequency of spontaneous IPSCs (sIPSCs) was reduced in CCI-ipsi cells, but the amplitude and kinetics of sIPSCs were unaffected. Immunohistochemical analysis showed reduced expression of GABA(A) receptor delta subunits and GABA(B) receptor B2 subunits after CCI, by 43% and 40%, respectively. Activation of postsynaptic GABA(B) receptors caused a twofold increase in tonic currents, and this effect was markedly attenuated in CCI-ipsi cells (92% reduction). GABA(B) receptor-activated K+ currents in DGGCs were also significantly reduced in CCI-ipsi cells, confirming a functional deficit of GABA(B) receptors after CCI. Results indicate broad disruption of GABAergic signaling in DGGCs after CCI, with deficits in both phasic and tonic inhibition and GABA(B) receptor function. These changes are predicted to disrupt operation of hippocampal networks and contribute to sequelae of severe TBI, including epilepsy.	[Becerra, Alejandro Parga; Ransom, Christopher B.] VA Puget Sound Hlth Care Syst, Epilepsy Ctr Excellence, Seattle, WA 98108 USA; [Becerra, Alejandro Parga; Ransom, Christopher B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Ransom, Christopher B.] Univ Washington, Dept Phys & Biophys, Seattle, WA 98195 USA; [Logsdon, Aric F.; Banks, William A.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Logsdon, Aric F.; Banks, William A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Sch Med, Seattle, WA 98195 USA		Ransom, CB (corresponding author), VA Puget Sound Hlth Care Syst, Epilepsy Ctr Excellence, Seattle, WA 98108 USA.; Ransom, CB (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	cbr5@uw.edu	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	United States Department of Veterans Affairs (Biomedical Laboratory Research and Development)US Department of Veterans Affairs [I01BX002745-0]	This work was supported by Merit Review I01BX002745-0 from the United States Department of Veterans Affairs (Biomedical Laboratory Research and Development) (to C.B.R.).	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Boychuk JA, 2016, EXP NEUROL, V277, P178, DOI 10.1016/j.expneurol.2016.01.005; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cheng VY, 2006, J NEUROSCI, V26, P3713, DOI 10.1523/JNEUROSCI.5024-05.2006; Chuang SH, 2018, J PHARMACOL EXP THER, V364, P180, DOI 10.1124/jpet.117.244673; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Connelly WM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00171; Connelly WM, 2013, J NEUROSCI, V33, P3780, DOI 10.1523/JNEUROSCI.4989-12.2013; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; DURING MJ, 1993, LANCET, V341, P1607; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Gunduz-Bruce H, 2019, NEW ENGL J MED, V381, P903, DOI 10.1056/NEJMoa1815981; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Huang DY, 2015, BIOCHEM BIOPH RES CO, V465, P188, DOI 10.1016/j.bbrc.2015.07.137; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Janssen MJ, 2009, J NEUROSCI, V29, P5116, DOI 10.1523/JNEUROSCI.4737-08.2009; Jin ZB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017084; Kanes S, 2017, LANCET, V390, P480, DOI 10.1016/S0140-6736(17)31264-3; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kobori N, 2014, J NEUROTRAUM, V172, P293; Koepp MJ, 2005, EPILEPSIA, V46, P1625, DOI 10.1111/j.1528-1167.2005.00263.x; Kuczewski N, 2011, J NEUROCHEM, V118, P533, DOI 10.1111/j.1471-4159.2011.07192.x; Kulik A, 2003, J NEUROSCI, V23, P11026; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Markwardt SJ, 2009, J NEUROSCI, V29, P15063, DOI 10.1523/JNEUROSCI.2727-09.2009; McCartney MR, 2007, MOL PHARMACOL, V71, P539, DOI 10.1124/mol.106.028597; Meera P, 2011, J NEUROPHYSIOL, V106, P2057, DOI 10.1152/jn.00450.2011; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Parga A, 2018, SOC NEUROSCIENCE; Patel B, 2016, J NEUROSCI, V36, P607, DOI 10.1523/JNEUROSCI.2047-15.2016; Patenaude C, 2003, J PHYSIOL-LONDON, V553, P155, DOI 10.1113/jphysiol.2003.049015; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; PERREAULT P, 1992, J NEUROSCI, V12, P104; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Ransom CB, 2013, J NEUROPHYSIOL, V109, P803, DOI 10.1152/jn.00460.2012; Ransom CB, 2010, J NEUROSCI, V30, P7672, DOI 10.1523/JNEUROSCI.0290-10.2010; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Santhakumar V, 2006, J NEUROSCI, V26, P3357, DOI 10.1523/JNEUROSCI.4799-05.2006; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Takahashi T, 1998, J NEUROSCI, V18, P3138; Tao WC, 2013, J NEUROSCI, V33, P3738, DOI 10.1523/JNEUROSCI.4829-12.2013; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wlodarczyk AI, 2013, J NEUROSCI, V33, P3905, DOI 10.1523/JNEUROSCI.4193-12.2013; Wu ZQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4998; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Zhan RZ, 2009, J NEUROPHYSIOL, V102, P670, DOI 10.1152/jn.00147.2009	77	0	0	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	MAY-JUN	2021	8	3							0055-20.2021	10.1523/ENEURO.0055-20.2021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RY3DQ	WOS:000647796200001	33514602	gold, Green Published			2022-02-07	
J	Beidler, E; Eagle, S; Wallace, J; Anderson, M; Schmitt, AJ; O'Connor, S; Kontos, AP				Beidler, Erica; Eagle, Shawn; Wallace, Jessica; Anderson, Morgan; Schmitt, Ara J.; O'Connor, Siobhan; Kontos, Anthony P.			Anxiety-related concussion perceptions of collegiate athletes	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain injury; Injury beliefs; Injury psychology; College sports	SPORTS-RELATED CONCUSSION; GENDER-DIFFERENCES; HEAD-INJURY; RISK; NONDISCLOSURE; INTENTIONS; KNOWLEDGE; SYMPTOMS; CARE	Objectives: The purpose of this study was to identify collegiate athletes' anxiety-related concussion perceptions and examine factors that may be related to increased anxiety injury beliefs. Design: Cross-sectional study. Methods: Male and female Division I, II and III NCAA collegiate athletes (n = 482) completed a 10-to 15-minute survey examining their demographics, diagnosed concussion history, concussion knowledge, and public media sources they have previously acquired concussion information from. The survey also included the Perceptions of Concussion Inventory for Athletes (PCI-A) which results in six outcome variables (anxiety, effects, control, clarity, treatment, and symptom variability). Univariable and a backward stepwise multivariable logistic regression model were utilized to identify variables that were associated with greater (above median) negative anxiety related concussion perception scores. Results: Collegiate athletes displayed moderate anxiety-related concussion perceptions (12.8 +/- 3.2; scores ranged from 4 - low anxiety to 20 - high anxiety). The majority of participants reported that concussions are upsetting to them (60.7%), with a sizable proportion being worried (46.7%), fearful (40.7%), or anxious (25.0%) about sustaining a concussion. In the multivariable regression, higher perception that concussions have longterm effects (OR = 2.72; 95% CI: 1.79-4.12), greater beliefs of internal control to influence concussion outcomes (OR = 1.78; 95% CI: 1.15-2.75), and female sex (OR = 1.77; 95% CI: 1.15-2.71) were associated with higher anxiety beliefs. Conclusions: This study for the first time establishes that negative, anxiety-related perceptions about concussions are prevalent in a collegiate athlete population. Addressing these perceptions through evidence-based, educational and management initiatives, such as highlighting that concussions are treatable and most do not result in long-term negative consequences with early diagnosis and proper management, are critical to improve emotions surrounding concussion. This may be particularly important for female athletes in this population. (c) 2021 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [Eagle, Shawn; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Eagle, Shawn; Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Pittsburgh, PA 15260 USA; [Wallace, Jessica] Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL 35487 USA; [Anderson, Morgan] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Schmitt, Ara J.] Duquesne Univ, Dept Counseling Psychol & Special Educ, Pittsburgh, PA 15219 USA; [O'Connor, Siobhan] Dublin City Univ, Sch Hlth & Human Performance, Ctr Injury Prevent & Performance, Dublin, Ireland		Beidler, E (corresponding author), Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA.	johnsone1@duq.edu	O Connor, Siobhan/Q-8568-2018	O Connor, Siobhan/0000-0002-2001-0746			AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anderson M, 2021, J ATHL TRAINING, V56, P157, DOI 10.4085/1062-6050-0102-20; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Baugh CM, 2019, J NEUROTRAUM, V36, P2065, DOI 10.1089/neu.2018.6161; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Brown RB, 2003, J MANAG EDUC, V27, P122, DOI [10.1177/1052562902239251, DOI 10.1177/1052562902239251]; Burghardt GM, 2019, BEHAV PROCESS, V166, DOI 10.1016/j.beproc.2019.06.004; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Fawcett N, 2017, HEALTH CARE MANAG, V36, P210, DOI 10.1097/HCM.0000000000000169; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hovenkamp-Hermelink JHM, 2019, J AFFECT DISORDERS, V253, P26, DOI 10.1016/j.jad.2019.04.005; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Legg AM, 2015, HEALTH EXPECT, V18, P3034, DOI 10.1111/hex.12288; Leventhal H., 1980, CONTRIB MED PSYCHOL, V2, P7; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McAllister-Deitrick J, 2022, CLIN J SPORT MED, V32, P56, DOI 10.1097/JSM.0000000000000833; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice SM, 2019, BRIT J SPORT MED, V53, P722, DOI 10.1136/bjsports-2019-100620; Schmitt AJ, 2021, BRAIN INJURY, V35, P292, DOI 10.1080/02699052.2020.1861655; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	33	0	0	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2021	24	12					1224	1229		10.1016/j.jsams.2021.06.011			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	WQ3FK	WOS:000713704700007	34272167				2022-02-07	
J	Bernier, RA; Venkatesan, UM; Soto, JA; Rabinowitz, AR; Hong, JS; Hillary, FG				Bernier, Rachel A.; Venkatesan, Umesh M.; Soto, Jose A.; Rabinowitz, Amanda R.; Hong, Justin S.; Hillary, Frank G.			Perceived Discrimination and Blood Pressure in Individuals Aging With Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; TBI; cerebrovascular health; discrimination	AFRICAN-AMERICANS; PULSE PRESSURE; MENTAL-HEALTH; RACIAL-DISCRIMINATION; ARTERIAL STIFFNESS; JOHN HENRYISM; ASSOCIATION; STIGMA; EPIDEMIOLOGY; DEPRESSION	Purpose/Objective: Older adults with a history of traumatic brain injury (TBI) remain an understudied population, resulting in a paucity of geriatric-specific guidelines. Given an increased vascular risk among older adults with TBI, we aimed to examine distal predictors of vascular health in this population. Specifically, we sought to compare levels of perceived discrimination in Black and White older adults with a history of complicated mild, moderate, or severe TBI, and to examine the relationship between levels of discrimination and pulse pressure, a measure of vascular health. Research Method/Design: Self-report measures of everyday discrimination (ED) and major experiences of discrimination (MED) were completed by 106 individuals aging with TBI (27 identified as Black, 79 identified as White). Resting blood pressure was collected during the assessment. Results: MED, but not ED, was significantly higher among Black individuals versus White individuals aging with TBI. Greater MED was significantly associated with higher pulse pressure independent of race and antihypertensive medication status. There was a marginally significant race by MED interaction, where the association between MED and pulse pressure was observed in Black individuals but not White individuals. Injury severity was not associated with pulse pressure, nor were there significant severity by discrimination interactions on pulse pressure. Conclusions/Implications: Discrimination, which may arise from multiple sources of bias (e.g., related to race, disability), is associated with vascular burden. These findings suggest that patients' experiences of discrimination should be addressed as a factor that contributes to health and well-being in brain injury rehabilitation.	[Bernier, Rachel A.; Soto, Jose A.; Hillary, Frank G.] Penn State Univ, Dept Psychol, 313 Moore Bldg, University Pk, PA 16802 USA; [Bernier, Rachel A.; Hillary, Frank G.] Penn State Univ, Social & Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA; [Bernier, Rachel A.] Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Venkatesan, Umesh M.; Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Philadelphia, PA USA; [Hong, Justin S.] Hershey Med Ctr, Dept Phys Med & Rehabil, Hershey, PA USA; [Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 313 Moore Bldg, University Pk, PA 16802 USA.; Bernier, RA (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rbernier@health.ucsd.edu; fhillary@psu.edu		Bernier, Rachel/0000-0002-2759-9186; Hong, Justin/0000-0002-1675-6094; Venkatesan, Umesh/0000-0003-1869-8083			Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Blacher J, 2000, ARCH INTERN MED, V160, P1085, DOI 10.1001/archinte.160.8.1085; Burgess DJ, 2008, J HEALTH CARE POOR U, V19, P894, DOI 10.1353/hpu.0.0063; Cadden MH, 2018, SOC SCI MED, V208, P158, DOI 10.1016/j.socscimed.2018.01.015; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Dressler WW, 1998, PSYCHOSOM MED, V60, P620, DOI 10.1097/00006842-199809000-00019; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Forman TA, 1997, PERS SPC PT, V9, P231; Franklin SS, 1997, CIRCULATION, V96, P308; Fredrickson BL, 2013, P NATL ACAD SCI USA, V110, P13684, DOI 10.1073/pnas.1305419110; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Go A., 2013, CIRCULATION, V127, pe62; Greenwald SE, 2002, QJM-INT J MED, V95, P107, DOI 10.1093/qjmed/95.2.107; Harrell JP, 2003, AM J PUBLIC HEALTH, V93, P243, DOI 10.2105/AJPH.93.2.243; JAMES SA, 1994, CULT MED PSYCHIAT, V18, P163, DOI 10.1007/BF01379448; Krieger N, 1996, AM J PUBLIC HEALTH, V86, P1370, DOI 10.2105/AJPH.86.10.1370; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Levine A, 2019, REHABIL PSYCHOL, V64, P146, DOI 10.1037/rep0000266; Lin WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002284; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McMahon Brian T, 2005, Work, V25, P67; Mena JA, 2020, RACE SOC PROBL, V12, P219, DOI 10.1007/s12552-020-09284-2; Mindt MR, 2010, CLIN NEUROPSYCHOL, V24, P429, DOI 10.1080/13854040903058960; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; Nyam TTE, 2019, WORLD NEUROSURG, V122, pE740, DOI 10.1016/j.wneu.2018.10.130; Onete V, 2018, J PSYCHIATR NEUROSCI, V43, P111, DOI 10.1503/jpn.160246; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Poritz JMP, 2019, STIGMA HEALTH, V4, P107, DOI 10.1037/sah0000122; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Pugh M, 2021, J CLIN PSYCHOL MED S, V28, P181, DOI 10.1007/s10880-020-09702-y; Putsch RW, 2004, AM J MANAG CARE, V10, pSP45; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Ryan AM, 2006, J HEALTH CARE POOR U, V17, P116, DOI 10.1353/hpu.2006.0079; SCRAGG R, 1993, NEW ZEAL MED J, V106, P147; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Sims M, 2012, AM J PUBLIC HEALTH, V102, pS258, DOI 10.2105/AJPH.2011.300523; Soto JA, 2011, J ANXIETY DISORD, V25, P258, DOI 10.1016/j.janxdis.2010.09.011; Stergiou-Kita M, 2017, WORK, V57, P245, DOI 10.3233/WOR-172556; Sternthal MJ, 2011, DU BOIS REV, V8, P95, DOI 10.1017/S1742058X11000087; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Thames AD, 2019, PSYCHONEUROENDOCRINO, V106, P277, DOI 10.1016/j.psyneuen.2019.04.016; Thayer ZM, 2017, AM J PHYS ANTHROPOL, V163, P122, DOI 10.1002/ajpa.23190; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Thomson GE, 1997, ANN INTERN MED, V126, P910, DOI 10.7326/0003-4819-126-11-199706010-00011; Van Bortel LMAB, 2001, HYPERTENSION, V38, P914, DOI 10.1161/hy1001.095773; van Leuven SI, 2008, RHEUMATOLOGY, V47, P3, DOI 10.1093/rheumatology/kem202; Villa D, 2021, DISABIL REHABIL, V43, P3298, DOI 10.1080/09638288.2020.1743773; Whelton PK, 2018, CIRCULATION, V138, pE426, DOI 10.1161/CIR.0000000000000597; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200	56	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2021	66	2					148	159		10.1037/rep0000379			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	TF3LK	WOS:000670616800005	34242047				2022-02-07	
J	Betthauser, LM; Albanese, BJ; Cochran, KL; McGarity, S; Schneider, AL; Schmidt, NB; Brenner, LA; Barnes, SM				Betthauser, Lisa M.; Albanese, Brian J.; Cochran, Kathryn L.; McGarity, Suzanne; Schneider, Alexandra L.; Schmidt, Norman B.; Brenner, Lisa A.; Barnes, Sean M.			Acceptability of Cognitive Anxiety Sensitivity Treatment Among Veterans With mTBI	REHABILITATION PSYCHOLOGY			English	Article						anxiety sensitivity; mild traumatic brain injury; OEF/OIF/OND; veterans; computerized program	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC STRESS SYMPTOMS; MENTAL-HEALTH DIAGNOSES; POSTCONCUSSIVE SYMPTOMS; BEHAVIORAL TREATMENT; PANIC DISORDER; RISK-FACTORS; ACTIVE-DUTY; INTERVENTION; REPLICATION	Objective: Anxiety sensitivity (AS) is a transdiagnostic risk factor for persistent physical and psychological symptoms relevant to veterans, such as postconcussive symptoms following mild traumatic brain injury (mTBI). The Cognitive Anxiety Sensitivity Treatment (CAST) computerized intervention has been shown to reduce AS but has not been widely used among veterans. The purpose of this study was to assess the acceptability and feasibility of CAST among veterans with elevated AS and mTBI eligible to receive Veterans Health Administration (VHA) care. Design: Twenty-two veterans with mTBI, elevated cognitive AS, and history of deployment to Iraq and/or Afghanistan completed a single assessment and intervention session. Acceptability was assessed with the Client Satisfaction Quesitonnaire-8 (CSQ-8) and a qualitative interview. Measures of feasibility included study enrollment, ease of participation, and intervention completion. AS was assessed pre- and post-CAST completion. Results: Consistent with interview responses, 77.3% of participants' CSQ-8 scores indicated that veterans found the intervention acceptable. Technological issues, such as internet connectivity, decreased feasibility of consistently delivering the intervention in the research setting readily available to the study team. Decreases on pre-to-post intervention AS outcomes were observed. Conclusions: Acceptability of the CAST intervention in this sample was generally supported. Feasibility of implementing CAST in this study was limited by technological issues. Data did not indicate a critical need to revise content of the CAST intervention. Identified strategies for increasing the feasibility of future research and clinical implementation of CAST are discussed.	[Betthauser, Lisa M.; Cochran, Kathryn L.; McGarity, Suzanne; Schneider, Alexandra L.; Brenner, Lisa A.; Barnes, Sean M.] VA Rocky Mt Mental Illness Res Educ & Clin Ctr MI, Denver, CO USA; [Betthauser, Lisa M.; Cochran, Kathryn L.; McGarity, Suzanne; Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Boulder, CO 80309 USA; [Albanese, Brian J.; Schmidt, Norman B.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Brenner, Lisa A.; Barnes, Sean M.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Boulder, CO 80309 USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Boulder, CO 80309 USA; [Albanese, Brian J.] Auburn Univ, Dept Psychol Sci, Auburn, AL 36849 USA; [Cochran, Kathryn L.] Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA		Betthauser, LM (corresponding author), VA Rocky Mt Mental Illness Res Educ & Clin Ctr MI, Eastern Colorado Healthcare Syst, 1700 North Wheeling St, Aurora, CO 80045 USA.	Lisa.Betthauser@va.gov					Albanese BJ, 2018, COGNITIVE THER RES, V42, P510, DOI 10.1007/s10608-017-9883-4; Albanese BJ, 2017, COGNITIVE THER RES, V41, P902, DOI 10.1007/s10608-017-9863-8; Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Allan NP, 2015, PERS INDIV DIFFER, V74, P78, DOI 10.1016/j.paid.2014.10.003; Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083; Arean P. A., 2013, HIGH QUALITY PSYCHOT, DOI [10.1093/med:psych/9780199782468.001.0001, DOI 10.1093/MED:PSYCH/9780199782468.001.0001]; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Bahraini NH, 2018, PSYCHOL ASSESSMENT, V30, P1013, DOI 10.1037/pas0000555; Boffa JW, 2016, BEHAV THER, V47, P367, DOI 10.1016/j.beth.2016.02.006; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Broman-Fulks JJ, 2008, ANXIETY STRESS COPIN, V21, P117, DOI 10.1080/10615800701762675; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cox BJ, 2001, COGNITIVE THER RES, V25, P525, DOI 10.1023/A:1005580518671; Cox BJ, 2001, BEHAV RES THER, V39, P1349, DOI 10.1016/S0005-7967(00)00106-6; Department of Veteran Affairs and Department of Defense, 2017, VA DOD CLIN PRACT GU; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Feeley N, 2009, CAN J NURS RES, V41, P84; Feldner MT, 2008, J ANXIETY DISORD, V22, P1227, DOI 10.1016/j.janxdis.2008.01.005; First M., 2015, STRUCTURED CLIN INTE; Gardenswartz CA, 2001, BEHAV THER, V32, P725, DOI 10.1016/S0005-7894(01)80017-4; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hasson-Ohayon I., 2006, PSYCHOL SERV, V3, P262, DOI [DOI 10.1037/1541-1559.3.4.262, 10.1037/1541-1559.3.4.262]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Keough ME, 2012, J CONSULT CLIN PSYCH, V80, P766, DOI 10.1037/a0027961; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; Naragon-Gainey K, 2010, PSYCHOL BULL, V136, P128, DOI 10.1037/a0018055; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Norr AM, 2017, J AFFECT DISORDERS, V212, P48, DOI 10.1016/j.jad.2017.01.032; Olatunji BO, 2015, J ANXIETY DISORD, V34, P76, DOI 10.1016/j.janxdis.2015.06.002; Olatunji BO, 2009, PSYCHOL BULL, V135, P974, DOI 10.1037/a0017428; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Raines AM, 2020, ADDICT BEHAV, V104, DOI 10.1016/j.addbeh.2019.106285; Ramsey C, 2017, AM J PUBLIC HEALTH, V107, P329, DOI 10.2105/AJPH.2016.303574; Reiss S., 1985, THEORETICAL ISSUES B, P107; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Schmidt NB, 2000, J CONSULT CLIN PSYCH, V68, P417, DOI 10.1037//0022-006X.68.3.417; Schmidt NB, 2007, J ANXIETY DISORD, V21, P302, DOI 10.1016/j.janxdis.2006.06.002; Schmidt NB, 2017, J CONSULT CLIN PSYCH, V85, P596, DOI 10.1037/ccp0000195; Schmidt NB, 2014, J CONSULT CLIN PSYCH, V82, P1023, DOI 10.1037/a0036651; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Short NA, 2017, BEHAV RES THER, V99, P108, DOI 10.1016/j.brat.2017.09.013; Short NA, 2017, J TRAUMA STRESS, V30, P296, DOI 10.1002/jts.22194; Stewart SH, 2001, PERS INDIV DIFFER, V31, P157, DOI 10.1016/S0191-8869(00)00213-0; TAYLOR S, 1992, J ANXIETY DISORD, V6, P249, DOI 10.1016/0887-6185(92)90037-8; TAYLOR S, 2003, J COGN PSYCHOTHER, V17, P179, DOI DOI 10.1891/088983903780906147; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; TELCH MJ, 1993, BEHAV RES THER, V31, P279, DOI 10.1016/0005-7967(93)90026-Q; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Westling Bengt E., 1999, Scandinavian Journal of Behaviour Therapy, V28, P49; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zvolensky MJ, 2003, CLIN PSYCHOL-SCI PR, V10, P29, DOI 10.1093/clipsy/10.1.29	56	0	0	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2021	66	2					118	127		10.1037/rep0000365			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	TF3LK	WOS:000670616800002	33382335				2022-02-07	
J	Biese, KM; Kliethermes, SA; Watson, AM; McGuine, TA; Lang, PJ; Bell, DR; Brooks, MA				Biese, Kevin M.; Kliethermes, Stephanie A.; Watson, Andrew M.; McGuine, Timothy A.; Lang, Pamela J.; Bell, David R.; Brooks, M. Alison			Musculoskeletal Injuries and Their Association With Previous Concussion History: A Prospective Study of High School Volleyball and Soccer Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head injury; athletic training; pediatrics; females	SPORTS-RELATED CONCUSSION; SUBSEQUENT INJURY; CONTROL DEFICITS; RISK; RECOVERY; RETURN; ADOLESCENTS; STABILITY; INCREASES; CHILDREN	Background: Sports-related concussions may have a neurobiological recovery period that exceeds the period of clinical recovery, and one consequence of an extended neurobiological recovery may be the risk of subsequent musculoskeletal injuries. Most literature citing an increased risk of musculoskeletal injury after a sports-related concussion has been reported in populations other than adolescent athletes. Purpose/Hypothesis: The purpose was to prospectively determine if incidence rates of musculoskeletal injury differ between adolescent athletes with and without a previous sports-related concussion, while controlling for sex, sport, and age. A secondary aim was to determine if this relationship differs between male and female athletes of the same sport. Our hypotheses were that acute-noncontact injury rates would be higher in athletes with a previous sports-related concussion when compared with athletes without a previous sports-related concussion, and that this relationship would exist only in female athletes and not male athletes. Study Design: Cohort study; Level of evidence, 2. Methods: High school soccer and volleyball players were recruited in 2 prospective cohort studies that observed 4837 athletes during their sporting season (females, 80%; soccer, 57%; mean [SD] age, 15.6 [1.1] years). At preseason, all participants self-reported demographics and previous sports-related concussion within the past 12 months. During the sport season, team athletic trainers electronically recorded athlete exposures and injury data, including injury characteristics. Injury rates per 1000 athlete exposures and injury rate ratios (IRRs) with 95% confidence intervals were calculated. All injury rates and IRRs were adjusted for sex, age, and sport. Results: The rate of acute-noncontact lower extremity injury was 87% greater (IRR, 1.87; 95% CI, 1.29-2.74) in participants with a previous sports-related concussion versus those without one. The acute-noncontact lower extremity injury rates (IRRs) for females and males with a previous sports-related concussion were 1.76 (95% CI, 1.19-2.59) and 2.83 (95% CI, 0.85-9.50), respectively. No difference was detected in acute-contact (IRR, 0.98; 95% CI, 0.56-1.73) or overuse (IRR, 1.09; 95% CI, 0.51-2.37) lower extremity injury rates by previous sports-related concussion. Conclusion: Female adolescent athletes who reported a sports-related concussion within the past 12 months were more likely to sustain an acute-noncontact lower extremity injury during their high school sports season when compared with female athletes without a previous sport-related concussion.	[Biese, Kevin M.; Kliethermes, Stephanie A.; Watson, Andrew M.; McGuine, Timothy A.; Lang, Pamela J.; Bell, David R.; Brooks, M. Alison] Univ Wisconsin, Madison, WI 53706 USA; [Biese, Kevin M.; Bell, David R.] Univ Wisconsin, Dept Kinesiol, 1300 Univ Ave, Madison, WI 53706 USA; [Kliethermes, Stephanie A.; Watson, Andrew M.; McGuine, Timothy A.; Lang, Pamela J.; Bell, David R.; Brooks, M. Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI 53706 USA		Biese, KM (corresponding author), Univ Wisconsin, Dept Kinesiol, 1300 Univ Ave, Madison, WI 53706 USA.	kbiese@wisc.edu					Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baker RL, 2016, PHYS MED REH CLIN N, V27, P53, DOI 10.1016/j.pmr.2015.08.001; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Blaiser C, 2019, AM J SPORT MED, V47, P1713, DOI 10.1177/0363546519837724; Eagle SR, 2019, MED SCI SPORT EXER, V51, P1619, DOI 10.1249/MSS.0000000000001974; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Forrest MRL, 2018, SPORTS MED, V48, P2449, DOI 10.1007/s40279-018-0981-6; Gilchrist J, 2008, AM J SPORT MED, V36, P1476, DOI 10.1177/0363546508318188; Harada GK, 2019, AM J SPORT MED, V47, P3256, DOI 10.1177/0363546519872502; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2020, MED SCI SPORT EXER, V52, P1015, DOI 10.1249/MSS.0000000000002225; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Knollman-Porter K, 2019, TOP LANG DISORD, V39, P257, DOI 10.1097/TLD.0000000000000187; Koshida S, 2017, J SPORT SCI, V35, P1059, DOI 10.1080/02640414.2016.1210194; LaBella CR, 2011, ARCH PEDIAT ADOL MED, V165, P1033, DOI 10.1001/archpediatrics.2011.168; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Marion SD, 2003, DEV NEUROPSYCHOL, V23, P399, DOI 10.1207/S15326942DN2303_6; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine T, 2020, BRIT J SPORT MED, V54, P408, DOI 10.1136/bjsports-2018-100238; McGuine Timothy A, 2020, J Athl Train, DOI 10.4085/182-20; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Nyberg G, 2015, CURR RES CONCUSSION, V2, P109; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Williams J, 2016, APPL NEUROPSYCH-CHIL, V5, P35, DOI 10.1080/21622965.2014.939271	41	0	0	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2021	49	6					1634	1641		10.1177/0363546521997116			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	RZ2CK	WOS:000648404300029	33719583				2022-02-07	
J	Bindra, A; Chowdhary, V; Dube, SK; Goyal, K; Mathur, P				Bindra, Ashish; Chowdhary, Vineet; Dube, Surya K.; Goyal, Keshav; Mathur, Purva			The Utility of Serum Procalcitonin in Diagnosing Paroxysmal Sympathetic Hyperactivity in Patients with Traumatic Brain Injury	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Paroxysmal sympathetic hyperactivity; PCT; Sepsis; Traumatic brain injury (TBI)		Background: Paroxysmal sympathetic hyperactivity (PSH) is a grave entity affecting patients following traumatic brain injury (TBI). It presents with cyclic and simultaneous fever, posturing, and other symptoms of sympathetic hyperactivity. Lack of diagnostic tests or biochemical markers and its propensity to mimic other common causes of fever in the neurotrauma intensive care unit (ICU) result in clinical dilemmas and management delay. Case report: We present a case series of four patients (two adults and two pediatrics) with TBI who developed PSH during ICU stay.These patients presented with fever along with variable symptoms of sympathetic hyperactivity. However, the value of serum procalcitonin (PCT) was not elevated, and management of PSH was started. Serial monitoring of PCT helped in differentiating fever due to PSH from sepsis and thus the institution of appropriate and timely treatment of PSH and also helped to use antibiotics rationally. Conclusion: The use of serum PCT in differentiating sepsis from systemic inflammatory reaction and its role in the initiation and titration of antibiotics are well described. PSH is a common entity after TBI, causing episodic fever and sympathetic hyperactivity, often confused with infectious pathology. Our report proposes the role of serum PCT in differentiating PSH from infectious etiology and management of two different clinical entities.	[Bindra, Ashish; Dube, Surya K.; Goyal, Keshav] All India Inst Med Sci, Dept Neuroanesthesiol & Crit Care, Delhi, India; [Chowdhary, Vineet] All India Inst Med Sci, Dept Neurocrit Care, Delhi, India; [Mathur, Purva] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, Delhi, India		Bindra, A (corresponding author), All India Inst Med Sci, Dept Neuroanesthesiol & Crit Care, Delhi, India.	dr_ashi2208@yahoo.com					Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Festic E, 2014, NEUROCRIT CARE, V20, P375, DOI 10.1007/s12028-014-9960-4; Hinson HE, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000271; Hocker SE, 2013, JAMA NEUROL, V70, P1499, DOI 10.1001/jamaneurol.2013.4354; Massaro KSR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-137; Mehta NM, 2008, JPEN-PARENTER ENTER, V32, P281, DOI 10.1177/0148607108316196; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Sager R, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0795-7; Takuya H, 2014, AM J CLIN PATHOL, V141, P43, DOI [10.1309/AJCP4GV7ZFDTANGC, DOI 10.1309/AJCP4GV7ZFDTANGC]	9	0	0	0	0	JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD	NEW DEHLI	4838-24, ANSARI RD, DARYAGANJ, NEW DEHLI, 110 002, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	MAY	2021	25	5					580	583		10.5005/jp-journals-10071-23811			4	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RZ8TT	WOS:000648873200023	34177179	gold, Green Published			2022-02-07	
J	Bliss, RA; Long, A; Anderson, C; Niederee, A; Arellanes, H; Quinlin, K				Bliss, Rebecca A.; Long, Addie; Anderson, Chloe; Niederee, Allison; Arellanes, Hannah; Quinlin, Kelly			Gaze stabilization function does not predict injury incidence among collegiate athletes	TRANSLATIONAL SPORTS MEDICINE			English	Article						concussion; gaze stabilization; injury incidence; vestibular	EXTREMITY MUSCULOSKELETAL INJURY; DYNAMIC VISUAL-ACUITY; HIGH-SCHOOL; CONCUSSION; RELIABILITY; RISK; PERFORMANCE; RECOVERY; VISION; TESTS	Maintenance of visual acuity during head movement is essential for optimal performance in sport. While it seems reasonable to suspect that reduced gaze stabilization might impair physical performance on the playing field and contribute to increased incidence of injury, the relationship between gaze stabilization function and athletic injury has not been examined. The purpose of this study was to examine the influence of gaze stabilization on the incidence of injury in collegiate athletes. A total of 147 collegiate athletes were assessed using the Neurocom Invision gaze stabilization test (GST) prior to season of play in the horizontal plane. Injury reports for each athlete were recorded during the fall season, and then, comparisons between GST performance for those injured versus not were performed. Fifty-eight percent of the athletes were injured during the season. There was no difference in average GST scores or asymmetry between athletes who sustained injury during season and those who did not. Lower horizontal gaze stabilization function does not appear to be associated with an increase in injury incidence in collegiate athletes. Baseline gaze stabilization testing is not recommended for identification of athletes at risk but could be utilized to establish baseline function.	[Bliss, Rebecca A.; Long, Addie; Anderson, Chloe; Niederee, Allison; Arellanes, Hannah] Univ St Mary, Dept Phys Therapy, Leavenworth, KS USA; [Quinlin, Kelly] Northwest Missouri State Univ, Athlet Dept, Maryville, MO 64468 USA		Bliss, RA (corresponding author), Univ Missouri, Dept Phys Therapy, 801 Clark Hall, Columbia, MO 65211 USA.	rebecca.bliss@health.missouri.edu		DHSc, Rebecca Bliss PT/0000-0001-9191-7401			Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Dai BY, 2019, J STRENGTH COND RES, V33, P3015, DOI 10.1519/JSC.0000000000002687; Dunlap Pamela M, 2018, J Am Acad Audiol, DOI 10.3766/jaaa.18015; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Fox Sandra M, 2019, Phys Med Rehabil Clin N Am, V30, P171, DOI 10.1016/j.pmr.2018.09.001; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; Heick JD, 2017, INT J SPORTS PHYS TH, V12, P581; Heinmiller L, 2016, CURR OPIN OPHTHALMOL, V27, P407, DOI 10.1097/ICU.0000000000000296; Honaker JA, 2015, CLIN J SPORT MED, V25, P361, DOI 10.1097/JSM.0000000000000138; Honaker JA, 2010, J VESTIBUL RES-EQUIL, V20, P357, DOI 10.3233/VES-2010-0365; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; NCAA Sport Science Institute, 2020, NCAA INJ SURV PROGR; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Reneker JC, 2019, PHYS THER SPORT, V40, P184, DOI 10.1016/j.ptsp.2019.09.012; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Riska KM, 2016, OTOL NEUROTOL, V37, P545, DOI 10.1097/MAO.0000000000001014; Sinnott AM, 2019, J SCI MED SPORT, V22, P1292, DOI 10.1016/j.jsams.2019.08.004; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Verschueren Jo, 2019, Arch Physiother, V9, P6, DOI 10.1186/s40945-019-0057-4; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	33	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2573-8488		TRANSL SPORTS MED	Transl. Sports Med.	MAY	2021	4	3					356	361		10.1002/tsm2.228			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	SJ0LO	WOS:000655219300006					2022-02-07	
J	Bonney, PA; Gallant, RE; Briggs, RG; Zada, G; Mack, WJ; Giannotta, SL				Bonney, Phillip A.; Gallant, Rachel E.; Briggs, Robert G.; Zada, Gabriel; Mack, William J.; Giannotta, Steven L.			Tracking Scan to Incision Time in Patients with Emergent Operative Traumatic Brain Injuries as a Measure for Systems-Based Practice in Neurosurgical Trainees	WORLD NEUROSURGERY			English	Article						Education; Neurosurgery; Residency; Resident; Surgical training; Traumatic brain injury	SIMULATION TRAINING MODEL; RESIDENT EDUCATION; LEARNING-CURVE; SURGERY; PLACEMENT; SKILLS	BACKGROUND: Evaluation of trainee performance remains a challenge in resident education, particularly for systems-based practice (SysBP) metrics including care coordination and interdisciplinary teamwork. Time to intervention is an important modifiable outcome variable in severe traumatic brain injury (TBI) and may serve as a trackable metric for SysBP evaluation. METHODS: We retrospectively studied time from computed tomography head scan to surgical incision (CTH-INC, minutes) among neurosurgical trainees treating patients with emergently operative TBI as a proxy SysBP measure. Our institutional operative database was utilized to identify all emergent TBI cases between July 2015 and June 2020. Patients evaluated by program year (PGY)-2 residents proceeding directly to the operating room from the emergency department were included. Statistical analysis was performed using linear regression. RESULTS: One hundred sixty-six cases triaged by 14 PGY-2 neurosurgical trainees were analyzed. Median CTH-INC was 104 minutes (interquartile range, 82e136 minutes). CTH-INC improved 20.1% over the academic year (95% confidence interval, 4.3%e33.2%, P = 0.015). Between the first and second 6-month periods, the rate of CTH-INC within 90 minutes (29% vs. 46%, P = 0.04) improved. On a per-individual PGY-2 basis, median CTH-INC ranged from 83-127 minutes, 25th percentile CTH-INC ranged from 62-108 minutes, and fastest CTH-INC ranged from 45-92 minutes. CONCLUSIONS: CTH-INC is an objective and trackable proxy measure for evaluating SysBP during neurosurgical training. Use of CTH-INC or other time metrics in resident evaluations should not supersede the safe and effective delivery of patient care.	[Bonney, Phillip A.; Briggs, Robert G.; Zada, Gabriel; Mack, William J.; Giannotta, Steven L.] Univ Southern Calif, Dept Neurol Surg, Keck Sch Med, Los Angeles, CA 90007 USA; [Gallant, Rachel E.] Childrens Hosp Los Angeles, Dept Pediat Hematol Oncol, Los Angeles, CA 90027 USA		Bonney, PA (corresponding author), Univ Southern Calif, Dept Neurol Surg, Keck Sch Med, Los Angeles, CA 90007 USA.	phil.alan.bonney@gmail.com		Bonney, Phillip/0000-0003-4716-9906; Gallant, Rachel/0000-0003-0860-7184			Ahn J, 2016, SPINE J, V16, P909, DOI 10.1016/j.spinee.2015.07.455; Aldave G, 2017, J NEUROSURG-PEDIATR, V19, P377, DOI 10.3171/2016.10.PEDS16471; Berl Q, 2021, J GYNECOL OBSTET HUM, V50, DOI 10.1016/j.jogoh.2020.101812; Buchanan IA, 2019, OPER NEUROSURG, V17, P616, DOI 10.1093/ons/opz041; Burke JF, 2019, NEUROSURGERY, V85, P199, DOI 10.1093/neuros/nyy537; Camara D, 2019, INT J COMPUT ASS RAD, V14, P139, DOI 10.1007/s11548-018-1885-5; Carlin AM, 2007, AM J SURG, V193, P326, DOI 10.1016/j.amjsurg.2006.09.014; Chan EY, 2015, AM J SURG, V209, P40, DOI 10.1016/j.amjsurg.2014.08.034; Christian EA, 2018, J NEUROSURG, V129, P792, DOI 10.3171/2017.5.JNS162982; Delong WB, 2008, J NEUROSURG-SPINE, V8, P305, DOI 10.3171/SPI/2008/8/4/305; Dyne PL, 2002, ACAD EMERG MED, V9, P1270, DOI 10.1111/j.1553-2712.2002.tb01587.x; Elsmore AJ, 2002, BRIT J NEUROSURG, V16, P448, DOI 10.1080/0268869021000030249; Finn KM, 2018, JAMA INTERN MED, V178, P952, DOI 10.1001/jamainternmed.2018.1244; Gillen JR, 2016, J SURG EDUC, V73, P1052, DOI 10.1016/j.jsurg.2016.05.017; Gonzalvo A, 2009, SPINE, V34, pE761, DOI 10.1097/BRS.0b013e3181b2f928; Jagannathan J, 2009, J NEUROSURG, V110, P820, DOI 10.3171/2009.2.JNS081446; Leach P, 2010, NEUROSURGERY, V67, P1205, DOI 10.1227/NEU.0b013e3181ef25c5; Licci M, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19841; McMahon P, 2012, J NEUROSURG-SPINE, V17, P30, DOI 10.3171/2012.3.SPINE11939; Nousiainen MT, 2016, BONE JOINT J, V98B, P1320, DOI 10.1302/0301-620X.98B10.37031; Oliveira Louise Makarem, 2019, Asian J Neurosurg, V14, P364, DOI 10.4103/ajns.AJNS_269_18; Oyama K, 2015, NEUROSURG REV, V38, P171, DOI 10.1007/s10143-014-0580-4; Parikh K, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/8/E14; Pham MH, 2018, J NEUROSURG-SPINE, V29, P235, DOI 10.3171/2018.1.SPINE17875; Phang SY, 2019, BRIT J NEUROSURG, V33, P486, DOI 10.1080/02688697.2019.1617401; Quraishi NA, 2013, EUR SPINE J, V22, P1383, DOI 10.1007/s00586-012-2635-y; Roberts Susanne M, 2012, J Bone Joint Surg Am, V94, pe1131, DOI 10.2106/JBJS.K.00638; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Selden NR, 2011, NEUROSURGERY, V68, P759, DOI 10.1227/NEU.0b013e3182077969; Shah A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00011; Shen J, 2018, OPER NEUROSURG, V15, P231, DOI 10.1093/ons/opx262; Sultana CJ, 2011, OBSTET GYNECOL, V117, P377, DOI 10.1097/AOG.0b013e318203e582; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Tomatis A, 2019, WORLD NEUROSURG, V130, pE542, DOI 10.1016/j.wneu.2019.06.150; Turkstra TP, 2017, J CLIN ANESTH, V37, P21, DOI 10.1016/j.jclinane.2016.10.034; Varkey P, 2009, ACAD MED, V84, P335, DOI 10.1097/ACM.0b013e31819731fb; Wagner JP, 2018, JAMA SURG, V153, P335, DOI 10.1001/jamasurg.2017.4547; Weiss MY, 2020, OPER NEUROSURG, V18, P202, DOI 10.1093/ons/opz129; Zada G, 2018, OPER NEUROSURG, V14, P72, DOI 10.1093/ons/opx074; Zhu JH, 2020, CHILD NERV SYST, V36, P743, DOI 10.1007/s00381-019-04421-8	42	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E491	E497		10.1016/j.wneu.2021.01.150			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TF2NY	WOS:000670549900016					2022-02-07	
J	Bonney, PA; Gallant, RE; Briggs, RG; Zada, G; Mack, WJ; Giannotta, SL				Bonney, Phillip A.; Gallant, Rachel E.; Briggs, Robert G.; Zada, Gabriel; Mack, William J.; Giannotta, Steven L.			Tracking Scan to Incision Time in Patients with Emergent Operative Traumatic Brain Injuries as a Measure for Systems-Based Practice in Neurosurgical Trainees	WORLD NEUROSURGERY			English	Article						Education; Neurosurgery; Residency; Resident; Surgical training; Traumatic brain injury	SIMULATION TRAINING MODEL; RESIDENT EDUCATION; LEARNING-CURVE; SURGERY; PLACEMENT; SKILLS	-BACKGROUND: Evaluation of trainee performance remains a challenge in resident education, particularly for systems-based practice (SysBP) metrics including care coordination and interdisciplinary teamwork. Time to intervention is an important modifiable outcome variable in severe traumatic brain injury (TBI) and may serve as a trackable metric for SysBP evaluation. -METHODS: We retrospectively studied time from computed tomography head scan to surgical incision (CTHINC, minutes) among neurosurgical trainees treating patients with emergently operative TBI as a proxy SysBP measure. Our institutional operative database was utilized to identify all emergent TBI cases between July 2015 and June 2020. Patients evaluated by program year (PGY)-2 residents proceeding directly to the operating room from the emergency department were included. Statistical analysis was performed using linear regression. -RESULTS: One hundred sixty-six cases triaged by 14 PGY-2 neurosurgical trainees were analyzed. Median CTHINC was 104 minutes (interquartile range, 82-136 minutes). CTH-INC improved 20.1% over the academic year (95% confidence interval, 4.3%-33.2%, P = 0.015). Between the first and second 6-month periods, the rate of CTH-INC within 90 minutes (29% vs. 46%, P = 0.04) improved. On a per-individual PGY-2 basis, median CTH-INC ranged from 83-127 minutes, 25th percentile CTH-INC ranged from 62-108 minutes, and fastest CTH-INC ranged from 45-92 minutes. CONCLUSIONS: CTH-INC is an objective and trackable proxy measure for evaluating SysBP during neurosurgical training. Use of CTH-INC or other time metrics in resident evaluations should not supersede the safe and effective delivery of patient care.	[Bonney, Phillip A.; Briggs, Robert G.; Zada, Gabriel; Mack, William J.; Giannotta, Steven L.] Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA; [Gallant, Rachel E.] Childrens Hosp Angeles, Dept Pediat Hematol Oncol, Los Angeles, CA USA		Bonney, PA (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA.	phil.alan.bonney@gmail.com					Ahn J, 2016, SPINE J, V16, P909, DOI 10.1016/j.spinee.2015.07.455; Aldave G, 2017, J NEUROSURG-PEDIATR, V19, P377, DOI 10.3171/2016.10.PEDS16471; Berl Q, 2021, J GYNECOL OBSTET HUM, V50, DOI 10.1016/j.jogoh.2020.101812; Buchanan IA, 2019, OPER NEUROSURG, V17, P616, DOI 10.1093/ons/opz041; Burke JF, 2019, NEUROSURGERY, V85, P199, DOI 10.1093/neuros/nyy537; Camara D, 2019, INT J COMPUT ASS RAD, V14, P139, DOI 10.1007/s11548-018-1885-5; Carlin AM, 2007, AM J SURG, V193, P326, DOI 10.1016/j.amjsurg.2006.09.014; Chan EY, 2015, AM J SURG, V209, P40, DOI 10.1016/j.amjsurg.2014.08.034; Christian EA, 2018, J NEUROSURG, V129, P792, DOI 10.3171/2017.5.JNS162982; Delong WB, 2008, J NEUROSURG-SPINE, V8, P305, DOI 10.3171/SPI/2008/8/4/305; Dyne PL, 2002, ACAD EMERG MED, V9, P1270, DOI 10.1111/j.1553-2712.2002.tb01587.x; Elsmore AJ, 2002, BRIT J NEUROSURG, V16, P448, DOI 10.1080/0268869021000030249; Finn KM, 2018, JAMA INTERN MED, V178, P952, DOI 10.1001/jamainternmed.2018.1244; Gillen JR, 2016, J SURG EDUC, V73, P1052, DOI 10.1016/j.jsurg.2016.05.017; Gonzalvo A, 2009, SPINE, V34, pE761, DOI 10.1097/BRS.0b013e3181b2f928; Jagannathan J, 2009, J NEUROSURG, V110, P820, DOI 10.3171/2009.2.JNS081446; Leach P, 2010, NEUROSURGERY, V67, P1205, DOI 10.1227/NEU.0b013e3181ef25c5; Licci M, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19841; McMahon P, 2012, J NEUROSURG-SPINE, V17, P30, DOI 10.3171/2012.3.SPINE11939; Nousiainen MT, 2016, BONE JOINT J, V98B, P1320, DOI 10.1302/0301-620X.98B10.37031; Oliveira Louise Makarem, 2019, Asian J Neurosurg, V14, P364, DOI 10.4103/ajns.AJNS_269_18; Oyama K, 2015, NEUROSURG REV, V38, P171, DOI 10.1007/s10143-014-0580-4; Parikh K, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/8/E14; Pham MH, 2018, J NEUROSURG-SPINE, V29, P235, DOI 10.3171/2018.1.SPINE17875; Phang SY, 2019, BRIT J NEUROSURG, V33, P486, DOI 10.1080/02688697.2019.1617401; Quraishi NA, 2013, EUR SPINE J, V22, P1383, DOI 10.1007/s00586-012-2635-y; Roberts Susanne M, 2012, J Bone Joint Surg Am, V94, pe1131, DOI 10.2106/JBJS.K.00638; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Selden NR, 2011, NEUROSURGERY, V68, P759, DOI 10.1227/NEU.0b013e3182077969; Shah A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00011; Shen J, 2018, OPER NEUROSURG, V15, P231, DOI 10.1093/ons/opx262; Sultana CJ, 2011, OBSTET GYNECOL, V117, P377, DOI 10.1097/AOG.0b013e318203e582; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Tomatis A, 2019, WORLD NEUROSURG, V130, pE542, DOI 10.1016/j.wneu.2019.06.150; Turkstra TP, 2017, J CLIN ANESTH, V37, P21, DOI 10.1016/j.jclinane.2016.10.034; Varkey P, 2009, ACAD MED, V84, P335, DOI 10.1097/ACM.0b013e31819731fb; Wagner JP, 2018, JAMA SURG, V153, P335, DOI 10.1001/jamasurg.2017.4547; Weiss MY, 2020, OPER NEUROSURG, V18, P202, DOI 10.1093/ons/opz129; Zada G, 2018, OPER NEUROSURG, V14, P72, DOI 10.1093/ons/opx074; Zhu JH, 2020, CHILD NERV SYST, V36, P743, DOI 10.1007/s00381-019-04421-8	42	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E491	E497		10.1016/j.wneu.2021.01.150			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YJ3CH	WOS:000744410900016					2022-02-07	
J	Bossers, SM; van der Naalt, J; Jacobs, B; Schwarte, LA; Verheul, R; Schober, P				Bossers, Sebastiaan M.; van der Naalt, Joukje; Jacobs, Bram; Schwarte, Lothar A.; Verheul, Robert; Schober, Patrick			Face-to-Face Versus Telephonic Extended Glasgow Outcome Score Testing After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; Extended Glasgow Outcome Scale; traumatic; validation		Objective: The Extended Glasgow Outcome Scale (GOS-E) is used for objective assessment of functional outcome in traumatic brain injury (TBI). In situations where face-to-face contact is not feasible, telephonic assessment of the GOS-E might be desirable. The aim of this study is to assess the level of agreement between face-to-face and telephonic assessment of the GOS-E. Setting: Multicenter study in 2 Dutch University Medical Centers. Inclusion was performed in the outpatient clinic (face-to-face assessment, by experienced neurologist), followed by assessment via telephone of the GOS-E after +/- 2 weeks (by trained researcher). Participants: Patients +/- 6 months after TBI. Design: Prospective validation study. Main Measures: Interrater agreement of the GOS-E was assessed with Cohen's weighted kappa. Results: From May 2014 until March 2018, 50 patients were enrolled; 54% were male (mean age 49.1 years). Median time between trauma and in-person GOS-E examination was 158 days and median time between face-to-face and telephonic GOS-E was 15 days. The quadratic weighted kappa was 0.79. Sensitivity analysis revealed a quadratic weighted kappa of 0.77, 0.78, and 0.70 for moderate-severe, complicated mild, and uncomplicated mild TBI, respectively. Conclusion: No disagreements of more than 1 point on the GOS-E were observed, with the kappa value representing good or substantial agreement. Assessment of the GOS-E via telephone is a valid alternative to the face-to-face interview when in-person contact is not feasible.	[Bossers, Sebastiaan M.; Schwarte, Lothar A.; Verheul, Robert; Schober, Patrick] Amsterdam Univ Med Ctr, Dept Anesthesiol, Locat VUmc, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [van der Naalt, Joukje; Jacobs, Bram] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Bossers, SM (corresponding author), Amsterdam Univ Med Ctr, Dept Anesthesiol, Locat VUmc, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	s.bossers@vumc.nl; j.van.der.naalt@umcg.nl; b.jacobs@umcg.nl; l.schwarte@amsterdamumc.nl; r.verheul@amsterdamumc.nl; p.schober@amsterdamumc.nl		van der Naalt, Joukje/0000-0001-9873-2418			Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Altman D.G., 1990, PRACTICAL STAT MED R; Amoo M, 2018, BRIT J NEUROSURG, V32, P585, DOI 10.1080/02688697.2018.1522416; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bossers SM, 2019, PREHOSP EMERG CARE, V23, P820, DOI 10.1080/10903127.2019.1587126; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Dunn MS, 2019, INJURY, V50, P1534, DOI 10.1016/j.injury.2019.06.012; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Franschman G, 2013, INJURY, V44, P1232, DOI 10.1016/j.injury.2013.06.002; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JENNETT B, 1975, LANCET, V1, P480; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Royal Netherlands Academy of Arts and Sciences, 2018, REPL STUD IMPR REPR; Samanamalee S, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-017-0463-7; Stalnacke BM, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/9216931; Vetter TR, 2018, ANESTH ANALG, V126, P2123, DOI 10.1213/ANE.0000000000002924; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	20	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		E134	E138		10.1097/HTR.0000000000000622			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900001	33201032	Green Published			2022-02-07	
J	Braza, ME; Girotto, JA				Braza, Matthew E.; Girotto, John A.			Persistent Intracranial Hypertension in a Cranial Vault Remodeling Patient With Open Skull Fractures From Horse Kick	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						traumatic brain injury; craniosynostosis; cranial vault remodeling; intracranial hypertension; horse kick		A 4-year-old female with prior cranial vault remodeling for nonsyndromic bilateral coronal craniosynostosis sustained a severe traumatic brain injury with open skull fractures from a horse kick. Her post-traumatic course was complicated by persistently elevated intracranial pressure despite neurosurgical decompressions, maximum medical therapy, and trial of multiple pressure monitoring devices. She eventually had improvement in her intracranial pressures and made a full neurologic recovery. This case highlights the potential severity of horse kick injuries, the possible etiology of persistent intracranial hypertension in cranial vault remodeling patients following traumatic brain injury, the importance of a multi-team approach in the initial evaluation and postoperative follow-up of all craniosynostosis patients, and the necessity of helmet utilization.	[Braza, Matthew E.] Michigan State Univ, Coll Human Med Integrated Plast Surg Residency, Spectrum Hlth, 100 Michigan St NE,Suite 5201, Grand Rapids, MI 49503 USA; [Girotto, John A.] Helen Devos Childrens Hosp, Pediat Plast Surg & Dermatol Ctr, Grand Rapids, MI USA		Braza, ME (corresponding author), Michigan State Univ, Coll Human Med Integrated Plast Surg Residency, Spectrum Hlth, 100 Michigan St NE,Suite 5201, Grand Rapids, MI 49503 USA.	matthew.braza@spectrumhealth.org					Adler CR, 2019, EMERG RADIOL, V26, P639, DOI 10.1007/s10140-019-01718-8; Carmichael SP, 2014, INJURY, V45, P1479, DOI 10.1016/j.injury.2014.03.016; Cemil B, 2009, BRIT J NEUROSURG, V23, P304, DOI 10.1080/02688690802603913; Cherniawsky H, 2014, CLIN PEDIATR, V53, P672, DOI 10.1177/0009922814526977; Ebert LC, 2012, AM J FOREN MED PATH, V33, P167, DOI 10.1097/PAF.0b013e3181efbc24; Eckert V, 2011, CLIN J SPORT MED, V21, P353, DOI 10.1097/JSM.0b013e318221840f; Gilardino MS, 2011, J CRANIOFAC SURG, V22, P1284, DOI 10.1097/SCS.0b013e31821c6b2d; Jagodzinski Tanya, 2005, WMJ, V104, P50; Kiuru Martti J, 2002, Emerg Radiol, V9, P213; Mayberry JC, 2007, J TRAUMA, V62, P735, DOI 10.1097/ta.0b013e318031b5d4; Oode Y, 2016, ACUTE MED SURG, V3, P3, DOI 10.1002/ams2.118; Pollack IF, 1996, PEDIATR NEUROSURG, V24, P202, DOI 10.1159/000121038; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; SIDDIQI SN, 1995, NEUROSURGERY, V36, P703, DOI 10.1227/00006123-199504000-00010; Weber CD, 2017, INT ORTHOP, V41, P2105, DOI 10.1007/s00264-017-3592-1	15	0	0	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1055-6656	1545-1569		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	MAY	2021	58	5					658	661		10.1177/1055665620957537			4	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	RM9CK	WOS:000639952800016	32924544				2022-02-07	
J	Buchanan, DM; Ros, T; Nahas, R				Buchanan, Derrick Matthew; Ros, Tomas; Nahas, Richard			Elevated and Slowed EEG Oscillations in Patients with Post-Concussive Syndrome and Chronic Pain Following a Motor Vehicle Collision	BRAIN SCIENCES			English	Article						chronic pain; diffuse brain injury; electroencephalography; post-concussive syndrome; support vector machine; EEG; concussion; motor vehicle collision; car accident	TRAUMATIC BRAIN-INJURY; SPECTRAL-ANALYSIS; SLEEP; PREVALENCE; SIGNATURES; NETWORK; POWER; DISTURBANCES; CONNECTIVITY; FREQUENCY	(1) Background: Mild traumatic brain injury produces significant changes in neurotransmission including brain oscillations. We investigated potential quantitative electroencephalography biomarkers in 57 patients with post-concussive syndrome and chronic pain following motor vehicle collision, and 54 healthy nearly age- and sex-matched controls. (2) Methods: Electroencephalography processing was completed in MATLAB, statistical modeling in SPSS, and machine learning modeling in Rapid Miner. Group differences were calculated using current-source density estimation, yielding whole-brain topographical distributions of absolute power, relative power and phase-locking functional connectivity. Groups were compared using independent sample Mann-Whitney U tests. Effect sizes and Pearson correlations were also computed. Machine learning analysis leveraged a post hoc supervised learning support vector non-probabilistic binary linear kernel classification to generate predictive models from the derived EEG signatures. (3) Results: Patients displayed significantly elevated and slowed power compared to controls: delta (p = 0.000000, r = 0.6) and theta power (p < 0.0001, r = 0.4), and relative delta power (p < 0.00001) and decreased relative alpha power (p < 0.001). Absolute delta and theta power together yielded the strongest machine learning classification accuracy (87.6%). Changes in absolute power were moderately correlated with duration and persistence of symptoms in the slow wave frequency spectrum (<15 Hz). (4) Conclusions: Distributed increases in slow wave oscillatory power are concurrent with post-concussive syndrome and chronic pain.	[Buchanan, Derrick Matthew] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada; [Buchanan, Derrick Matthew; Nahas, Richard] Seekers Ctr, Ottawa, ON K1Z 5Z9, Canada; [Ros, Tomas] Univ Geneva, Dept Neurosci, Lab Neurol & Imaging Cognit, CH-1202 Geneva, Switzerland; [Nahas, Richard] Univ Ottawa, Dept Family Med, Ottawa, ON K1G 5Z3, Canada		Buchanan, DM (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.; Buchanan, DM (corresponding author), Seekers Ctr, Ottawa, ON K1Z 5Z9, Canada.	matthewbuchanan@cmail.carleton.ca; tomas.ros@unige.ch; richard@seekerscentre.com		Nahas, Richard/0000-0002-9054-4401; Buchanan, Derrick Matthew/0000-0003-4478-2844			[Anonymous], MATLAB STAT TOOLBOX; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bjork MH, 2009, J HEADACHE PAIN, V10, P331, DOI 10.1007/s10194-009-0140-4; Boshra R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53751-9; Boshra R, 2019, IEEE T NEUR SYS REH, V27, P1492, DOI 10.1109/TNSRE.2019.2922553; Calderone DJ, 2014, TRENDS COGN SCI, V18, P300, DOI 10.1016/j.tics.2014.02.005; CHEN ACN, 1983, INT J NEUROSCI, V18, P269, DOI 10.3109/00207458308987371; Choe MK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18999-z; Deiber MP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00059; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Pinheiro ESD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149085; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Dunkley BT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00280; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Gonzalez-Roldan AM, 2016, PAIN MED, V17, P1058, DOI 10.1093/pm/pnw023; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Green AL, 2009, NEUROLOGY, V72, P569, DOI 10.1212/01.wnl.0000342122.25498.8b; Human Brain Institute, HUM BRAIN I DAT; IBM Corp, BM SPSS STAT WIND VE; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Keil J, 2018, NEUROSCIENTIST, V24, P609, DOI 10.1177/1073858418755352; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lewine JD, 2019, J CLIN NEUROPHYSIOL, V36, P298, DOI 10.1097/WNP.0000000000000588; Lim M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00111; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lord LD, 2013, J CEREBR BLOOD F MET, V33, P1347, DOI 10.1038/jcbfm.2013.94; May ES, 2019, HUM BRAIN MAPP, V40, P293, DOI 10.1002/hbm.24373; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meisel C, 2013, J NEUROSCI, V33, P17363, DOI 10.1523/JNEUROSCI.1516-13.2013; Mierswa I, P 12 ACM SIGKDD INT; Misra G, 2017, J NEUROPHYSIOL, V117, P786, DOI 10.1152/jn.00650.2016; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Musall S, 2014, CEREB CORTEX, V24, P1045, DOI 10.1093/cercor/bhs389; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Olsen T, 2019, CURRENT SOURCE DENSI; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Ploner M, 2017, TRENDS COGN SCI, V21, P100, DOI 10.1016/j.tics.2016.12.001; Poil S, NEUROPHYSIOLOGICAL B; Ponomarev V A, 2010, Fiziol Cheloveka, V36, P5; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Ros T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01008; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Sarnthein J, 2006, BRAIN, V129, P55, DOI 10.1093/brain/awh631; Schopflocher D, 2011, PAIN RES MANAG, V16, P445, DOI 10.1155/2011/876306; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Statistics Canada, 2011, ACT LIM BRAIN INJ 20; Stern J, 2006, NEUROIMAGE, V31, P721, DOI 10.1016/j.neuroimage.2005.12.042; Sweeney-Reed CM, 2014, ELIFE, V3, DOI 10.7554/eLife.05352; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; The Centres for Disease Control and Prevention, 2014, TRAUMATIC BRAIN INJU; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; Vuckovic A, 2014, J PAIN, V15, P645, DOI 10.1016/j.jpain.2014.02.005; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	76	0	0	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAY	2021	11	5							537	10.3390/brainsci11050537			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SG6OB	WOS:000653559900001	33923286	Green Published, gold			2022-02-07	
J	Cassimatis, M; Orr, R; Fyffe, A; Browne, G				Cassimatis, Maree; Orr, Rhonda; Fyffe, Andrew; Browne, Gary			Early injury evaluation following concussion is associated with improved recovery time in children and adolescents	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Mild traumatic brain injury; Paediatric; Early treatment; Specialist care	SYMPTOMS	Objectives: Delayed treatment for paediatric concussion may impact recovery trajectory. This study aims to determine the relationship between time to evaluation and concussion recovery in children and adolescents. Design: Retrospective cross-sectional study. Methods: Records from 341 children and adolescents, aged 7-18 years, from a tertiary referral concussion clinic were analysed. All participants were assessed using a standardised concussion test battery by a specialist concussion physician and graded exercise testing. Evaluation time was defined as the number of days from injury occurrence to first presentation at the concussion clinic. Three distinct time to evaluation periods were categorised as: early evaluation ( 14 days), mid evaluation (14-28 days), and late evaluation ( 28 days). The main outcome measure was recovery time (days). Results: A total of 341 participants (mean age 13.0 +/- 2.3, 74% male) were included in the study. Of these, 89 received evaluation during the early phase (mean age 12.2 +/- 2.5, 65% male), 124 during the mid phase (mean age 13.1 +/- 2.2, 81% male) and 128 during the late phase (mean age 13.5 +/- 2.1, 75% male) following injury. Participants receiving late evaluation took three times longer to recover (mean 148.0 days, 95% CI: 121.1-173.9) compared to early (mean 38.7 days, 95% CI: 30.7-46.7) and mid (mean 51.5 days, 95% CI: 39.7-63.4) evaluation. There was a strong positive correlation between recovery time and evaluation time (r = 0.66, p < 0.001). Conclusions: Delaying time to evaluation following a concussion can significantly prolong recovery from injury in children and adolescents. (c) 2021 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Cassimatis, Maree; Orr, Rhonda; Fyffe, Andrew] Univ Sydney, Fac Med & Hlth, Sydney Sch Hlth Sci, Discipline Exercise & Sports Sci, Sydney, NSW, Australia; [Orr, Rhonda; Fyffe, Andrew; Browne, Gary] Childrens Hosp Westmead, Childrens Hosp Inst Sports Med, Sydney Childrens Hosp Network, Westmead, NSW, Australia; [Browne, Gary] Univ Sydney, Discipline Child & Adolescent Hlth, Westmead Clin Sch, Childrens Hosp, Sydney, NSW, Australia		Browne, G (corresponding author), Childrens Hosp Westmead, Childrens Hosp Inst Sports Med, Sydney Childrens Hosp Network, Westmead, NSW, Australia.; Browne, G (corresponding author), Univ Sydney, Discipline Child & Adolescent Hlth, Westmead Clin Sch, Childrens Hosp, Sydney, NSW, Australia.	gary.browne@health.nsw.gov.au					Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Browne GJ, 2016, AUST FAM PHYSICIAN, V45, P470; Choe Meeryo, 2018, Continuum (Minneap Minn), V24, P300, DOI 10.1212/CON.0000000000000569; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Clark R, 2019, J TRAUMA NURS, V26, P297, DOI 10.1097/JTN.0000000000000468; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Hon KL, 2019, SEMIN PEDIATR NEUROL, V30, P117, DOI 10.1016/j.spen.2019.03.017; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2019, JAMA NEUROL, V77, P453; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mastin DF, 2006, J BEHAV MED, V29, P223, DOI 10.1007/s10865-006-9047-6; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mosti C, 2016, NEUROL-CLIN PRACT, V6, P129, DOI 10.1212/CPJ.0000000000000225; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Orr R, 2021, CLIN J SPORT MED, V31, P23, DOI 10.1097/JSM.0000000000000683; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Street TD, 2019, AUST J RURAL HEALTH, V27, P196, DOI 10.1111/ajr.12511; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Yue JK, 2020, J NEUROSCI RURAL PRA, V11, P23, DOI 10.1055/s-0039-3402581	30	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2021	24	12					1235	1239		10.1016/j.jsams.2021.06.012			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WQ3FK	WOS:000713704700009	34244083				2022-02-07	
J	Cinar, E; Grilli, L; Friedman, D; Gagnon, I				Cinar, Eda; Grilli, Lisa; Friedman, Debbie; Gagnon, Isabelle			Tracking postural stability of children and adolescents after a concussion: sport-related versus non-sport-related concussion	TURKISH JOURNAL OF PEDIATRICS			English	Article						mild traumatic brain injury; balance; sport related concussion; non-sport related concussion	TRAUMATIC BRAIN-INJURY; BALANCE CONTROL; UNITED-STATES; GAIT; PERFORMANCE; SYMPTOMS; ISSUES; SYSTEM; SCHOOL	Background. Although postural impairments have long been reported following a concussion in the pediatric population, we still know very little about who is more at risk of presenting those balance problems and how the mechanism of injury (sport vs non-sport) could influence balance problems after concussions. The purpose of this study was to compare balance function in children having sustained a sport-related (SRC) or non-sport-related (NSRC) concussion, to that of children with an orthopedic injury (OI) and to non-injured (NI), over a one-year period. Methods. One-hundred and twelve participants were included in this study. Among them, 38 were concussed, with 27 having sustained a SRC; and 11 an NSRC, as well as 38 NI, and 36 OL Balance function was evaluated at 2 weeks, 3 months, 6 months, and 12 months after a concussion, and at the same time intervals for the control groups. The balance subtest of the Bruininks-Oseretsky Test of Motor Proficiency (BOT2) and Timed Foam Test was used to measure postural instability. Concussion related symptoms were measured by the Post Concussion Symptom Scale (PCSS). Results. There was an improvement in tandem standing on the balance beam (P=.02) and in single-leg standing (SL) on foam surface (P=.02) for all groups over a year. At the 2nd week, NSRC had more postural instability than NI during SL on the balance beam when eyes were closed (P =.01), and performed significantly worse than SRC (P =.01) and NI (P =.01) during SL on the foam surface. NSRC also reported more symptoms than SRC on PCSS (P <0.001). In the 3rd month, NSRC still had lower performance than SRC in SL on foam surface (P =.01). Conclusions. Children sustaining a concussion outside of a sport seem to have higher levels of postural instability up to 3 months post-injury when compared to those injured in sport.	[Cinar, Eda; Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Grilli, Lisa] McGill Univ, Montreal Childrens Hosp, Hlth Ctr, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Dept Pediat & Pediat Surg, Fac Med, Montreal, PQ, Canada		Cinar, E (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada.	eda.cinar@mail.mcgill.ca		Gagnon, Isabelle/0000-0003-2043-1644	SickKids Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This study was funded by the SickKids Foundation and the Canadian Institutes of Health Research.	Adolph KE, 2003, CHILD DEV, V74, P475, DOI 10.1111/1467-8624.7402011; Anderson M, 2011, MEM COGNITION, V39, P1241, DOI 10.3758/s13421-011-0099-7; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dahl E, 2013, J REHABIL MED, V45, P729, DOI 10.2340/16501977-1188; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Deitz Jean C, 2007, Phys Occup Ther Pediatr, V27, P87, DOI 10.1300/J006v27n04_06; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gagnon I, 2001, J HEAD TRAUMA REHAB, V16, P595, DOI 10.1097/00001199-200112000-00007; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Lin Chia-Cheng, 2015, J Nat Sci, V1, pe43; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; SALLIS JF, 1988, AM J EPIDEMIOL, V127, P933, DOI 10.1093/oxfordjournals.aje.a114896; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326	26	0	0	3	3	TURKISH J PEDIATRICS	ANKARA	P K 66 SAMANPAZARI, 06240 ANKARA, TURKEY	0041-4301			TURKISH J PEDIATR	Turk. J. Pediatr.	MAY-JUN	2021	63	3					471	481		10.24953/turkjped.2021.03.014			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	TC0QT	WOS:000668350700014	34254492	gold			2022-02-07	
J	Ciobanu, AM; Popescu, MJ; Manea, MC; Draganescu, D; Lupuliasa, D; Marinescu, D; Sovicek, O				Ciobanu, Adela Magdalena; Popescu, Mara Jidveian; Manea, Mihnea Costin; Draganescu, Doina; Lupuliasa, Dumitru; Marinescu, Dragos; Sovicek, Olivian			THE ROLE OF SERUM IONS DEFICIENCIES IN THE PATHOGENIC MECHANISMS OF ONCOLOGICAL DEPRESSION: PSYCHO-PHARMACOLOGICAL PARTICULARITIES	FARMACIA			English	Article						depression; anxiety; serum ions; cancer	ANTIDIURETIC-HORMONE SECRETION; TRAUMATIC BRAIN-INJURY; ANTIEPILEPTIC DRUGS; CANCER-PATIENTS; NT-PROBNP; HYPONATREMIA; MAGNESIUM; DISORDERS; MYELINOLYSIS; ELECTROLYTE	Cancer patients frequently present symptoms of depression and anxiety that influence the quality of life, compliance and adherence to treatment, disease progression and the overall survival. Psychiatric pathology could be related to the disturbance of serum ion levels, caused by the oncological or psychiatric status and the adverse effects of pharmacological treatment. This article is focused on assessing the relationship between anxiety, depression and stress and serum ion levels. Changes in the homeostasis of serum ions and pH may be factors that favour the risk of oncogenesis in the context of this psychiatric pathology. Knowledge of the involvement of serum ions in specific pathogenic mechanisms suggests the importance of monitoring them in oncological pathology with depression and helps to develop personalized psychopharmacological strategies.	[Ciobanu, Adela Magdalena] Carol Davila Univ Med & Pharm, Fac Med, Neurosci Dept, Discipline Psychiat, 37 Dionisie Lupu St, Bucharest 020021, Romania; [Ciobanu, Adela Magdalena; Manea, Mihnea Costin] Prof Dr Alexandru Obregia Clin Psychiat Hosp, Dept Psychiat, 10th Berceni Rd, Bucharest 041914, Romania; [Popescu, Mara Jidveian] CF2 Clin Hosp, Oncol Dept, 63 Marasti St, Bucharest 012244, Romania; [Manea, Mihnea Costin] Carol Davila Univ Med & Pharm, Fac Dent Med, Discipline Psychiat & Psychol, 37 Dionisie Lupu St, Bucharest 020021, Romania; [Draganescu, Doina] Carol Davila Univ Med & Pharm, Fac Pharm, Dept Pharmaceut Phys & Informat, 6 Traian Vuia St, Bucharest 020956, Romania; [Lupuliasa, Dumitru] Carol Davila Univ Med & Pharm, Fac Pharm, Dept Technol & Biopharmaceut, 6 Traian Vuia St, Bucharest 020956, Romania; [Marinescu, Dragos] Univ Med & Pharm Craiova Brunch, Acad Med Sci Romania, 2 Petru Rares St, Craiova 200349, Romania; [Sovicek, Olivian] Titu Maiorescu Univ Bucharest, Fac Nursing, Dept Pharmacol, 100 Ecaterina Teodoroiu Ave, Targu Jiu 210106, Gorj County, Romania		Popescu, MJ (corresponding author), CF2 Clin Hosp, Oncol Dept, 63 Marasti St, Bucharest 012244, Romania.	marajidveian@gmail.com	Stovicek, Puiu Olivian/AAB-4010-2020; Ciobanu, Adela Magdalena/S-2435-2017; manea, mihnea/AAM-2480-2021	Stovicek, Puiu Olivian/0000-0002-9748-1394; Ciobanu, Adela Magdalena/0000-0003-2520-5486; 			Ahmed F, 2019, MED SCI BASEL, V7, P1; Ahn C, 2017, J VET SCI, V18, P261, DOI 10.4142/jvs.2017.18.3.261; Akechi T, 2003, PSYCHOSOMATICS, V44, P244, DOI 10.1176/appi.psy.44.3.244; Akkuratov EE, 2015, MOL NEUROBIOL, V52, P1726, DOI 10.1007/s12035-014-8975-3; Bassan R, 2005, EUR HEART J, V26, P234, DOI 10.1093/eurheartj/ehi033; Berardi R, 2019, J CANC METASTASIS TR, V5, P1; Bernsen HJJA, 1999, ACTA NEUROL BELG, V99, P189; Berret E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00413; Cannon DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1277, DOI 10.1038/npp.2008.194; Castiglioni S, 2011, MAGNESIUM RES, V24, pS92, DOI 10.1684/mrh.2011.0285; Ciobanu AM, 2014, ROM J MORPHOL EMBRYO, V55, P1203; Dehelean L, 2019, ROM J MORPHOL EMBRYO, V60, P1105; Dekkers OM, 2013, J CLIN ENDOCR METAB, V98, P2277, DOI 10.1210/jc.2012-3582; Efendiev R, 2002, J BIOL CHEM, V277, P11489, DOI 10.1074/jbc.M108182200; Evans CE, 2017, BIOL OPEN, V6, P688, DOI 10.1242/bio.024653; Ferraz Goncalves JA, 2019, PORTO BIOMED J, V4, P1; GUPTA MM, 1977, POSTGRAD MED J, V53, P330, DOI 10.1136/pgmj.53.620.330; Han PC, 2015, ASN NEURO, V7, DOI 10.1177/1759091415578050; Harris G, 2012, CLIN J SPORT MED, V22, P488, DOI 10.1097/JSM.0b013e3182580ce8; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Intravooth T, 2018, EPILEPSY RES, V143, P7, DOI 10.1016/j.eplepsyres.2018.03.023; Jabbar A, 2010, J PAK MED ASSOC, V60, P689; JACKSON C, 1995, AM J PSYCHIAT, V152, P809; Johnstone C, 2018, ANN PALLIAT MED, V7, P265, DOI 10.21037/apm.2017.11.01; KARP BI, 1993, MEDICINE, V72, P359, DOI 10.1097/00005792-199311000-00001; Ke CS, 2002, EXP NEUROL, V178, P194, DOI 10.1006/exnr.2002.8037; Khalaf MAM, 2011, CARDIOVASC TOXICOL, V11, P10, DOI 10.1007/s12012-010-9102-y; Kirpekar Vivek C, 2005, Indian J Psychiatry, V47, P119, DOI 10.4103/0019-5545.55960; Klein RS, 2017, NAT IMMUNOL, V18, P132, DOI 10.1038/ni.3656; Kong H, 2014, CNS NEUROSCI THER, V20, P391, DOI 10.1111/cns.12222; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lee EC, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00067; Li Y, 2020, RENAL FAILURE, V42, P234, DOI 10.1080/0886022X.2020.1735417; Li Zhao, 2020, Journal of Northern Agriculture, V48, P1, DOI 10.12190/j.issn.2096-1197.2020.05.01; Liu M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100907; Lu X, 2017, EXPERT OPIN DRUG SAF, V16, P77, DOI 10.1080/14740338.2017.1248399; Madhusoodanan S, 2015, WORLD J PSYCHIATR, V5, P273, DOI 10.5498/wjp.v5.i3.273; Marinescu I, 2019, REV CHIM-BUCHAREST, V70, P3343; Marinescu I, 2018, ROM J MORPHOL EMBRYO, V59, P955; Marinescu I, 2017, ROM J MORPHOL EMBRYO, V58, P1165; Matos MF, 2011, THROMB RES, V128, P216, DOI 10.1016/j.thromres.2011.04.016; Matsuoka Y, 2003, BIOL PSYCHIAT, V54, P736, DOI 10.1016/S0006-3223(02)01907-8; Moisa C, 2019, FARMACIA, V67, P274, DOI 10.31925/farmacia.2019.2.11; Nakajima H, 2011, CASE REP NEUROL, V3, P263, DOI 10.1159/000334129; Nechifor M, 2009, MAGNESIUM RES, V22, p163S; Niedzwiedz CL, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6181-4; Nielsen FH, 2018, J INFLAMM RES, V11, P25, DOI 10.2147/JIR.S136742; Oronsky B, 2017, CANCER CHEMOTH PHARM, V80, P895, DOI 10.1007/s00280-017-3392-8; Osman A, 2012, J CLIN PSYCHOL, V68, P1322, DOI 10.1002/jclp.21908; Patten SB, 2004, PSYCHOTHER PSYCHOSOM, V73, P207, DOI 10.1159/000077739; Pitman A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1415; Pu SX, 2015, J NEUROL, V262, P101, DOI 10.1007/s00415-014-7537-y; Rabinca AA, 2017, CURR ANAL CHEM, V13, P218, DOI 10.2174/1573411012666160601161703; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Rosa Regis G, 2014, J Med Case Rep, V8, P326, DOI 10.1186/1752-1947-8-326; Schatzberg AF, 2004, TXB PSYCHOPHARMACOLO, V3, P3; Scheau C, 2020, FARMACIA, V68, P984, DOI 10.31925/farmacia.2020.6.4; Serefko A, 2013, PHARMACOL REP, V65, P547, DOI 10.1016/S1734-1140(13)71032-6; Singh G, 2007, J NEUROL NEUROSUR PS, V78, P342, DOI 10.1136/jnnp.2006.106211; Smith HR, 2015, ONCOL LETT, V9, P1509, DOI 10.3892/ol.2015.2944; Sobczuk P, 2020, CANCERS BASEL, V12, P1; Stanculeanu DL, 2017, ROM J MORPHOL EMBRYO, V58, P1091; Tarleton EK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071475; Tobin G, 2018, NEUROL INDIA, V66, P1383, DOI 10.4103/0028-3886.241401; Trementino L, 2010, NEUROENDOCRINOLOGY, V92, P55, DOI 10.1159/000314349; Tsaras Konstantinos, 2018, Asian Pac J Cancer Prev, V19, P1661; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zapata-Urzua C, 2010, TALANTA, V82, P962, DOI 10.1016/j.talanta.2010.05.071; Zhu J, 2017, ANN ONCOL, V28, P1964, DOI 10.1093/annonc/mdx265	69	0	0	1	3	SOC STIINTE FARMACEUTICE ROMANIA	BUCURESTI	BUCURESTI, STR TRAIAN VUIA 6, SECT 1, BUCURESTI, 020956, ROMANIA	0014-8237	2065-0019		FARMACIA	Farmacia	MAY-JUN	2021	69	3					555	565		10.31925/farmacia.2021.3.19			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TA8PT	WOS:000667509000019		gold			2022-02-07	
J	Cools, MJ; Northam, WT; Boyd, M; Alexander, A; Mihalik, JP; Guskiewicz, KM; Carneiro, KA				Cools, Michael J.; Northam, Weston T.; Boyd, Michael; Alexander, Andrew; Mihalik, Jason P.; Guskiewicz, Kevin M.; Carneiro, Kevin A.			Evaluating Primary Care Management of Acute Sport-Related Concussion	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						consensus; documentation; guidelines; physical exam	TRAUMATIC BRAIN-INJURY; VESTIBULAR REHABILITATION; EMERGENCY-DEPARTMENTS; PEDIATRIC CONCUSSION; AGREEMENT STATEMENT; TRENDS; SCHOOL; PHYSICIANS; SYMPTOMS; CHILDREN	Primary care providers (PCPs) are evaluating increasing numbers of concussions, but it is unknown how often they are documenting concussion-specific history and physical examination findings vital for this process. This study reviews clinical documentation to determine how PCPs are evaluating concussed patients. PCPs often did not document important aspects of concussion history, including dizziness (48%), nausea (48%), vision changes (54%), cognitive complaints (54%), emotional changes (83%), sleep difficulties (84%), and neck pain (87%). Additionally, they often did not document important aspects of a concussion physical examination, including detailed neurologic examination (73%), clinical cognitive assessment (87%), balance testing (59%), and neck evaluation (54%). Omitting these parts of the history and physical examination could result in a premature return to play.	[Cools, Michael J.; Northam, Weston T.; Carneiro, Kevin A.] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC 27515 USA; [Boyd, Michael] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC USA; [Alexander, Andrew] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA		Carneiro, KA (corresponding author), Univ N Carolina, Dept Neurosurg, Chapel Hill, NC 27515 USA.	kevin_carneiro@med.unc.edu		Cools, Michael/0000-0001-6891-3744			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bloom O Josh, 2015, N C Med J, V76, P90; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eisenberg M, 2018, CURR OPIN PEDIATR, V30, P344, DOI 10.1097/MOP.0000000000000620; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haider MN, 2020, CLIN J SPORT MED, V30, P513, DOI 10.1097/JSM.0000000000000687; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kajankova M, 2017, J SCHOOL HEALTH, V87, P409, DOI 10.1111/josh.12508; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Leddy J, 2021, CLIN J SPORT MED, V31, P7, DOI 10.1097/JSM.0000000000000686; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nagib S, 2019, J SPORT REHABIL, V28, P764, DOI 10.1123/jsr.2018-0021; Rao DP, 2018, HEALTH PROMOT CHRON, V38, P147, DOI 10.24095/hpcdp.38.3.05; Reisner A, 2017, J PEDIATR-US, V184, P26, DOI 10.1016/j.jpeds.2017.01.045; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Taylor AM, 2018, CLIN PEDIATR, V57, P806, DOI 10.1177/0009922817734363; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Waryasz Gregory R, 2014, R I Med J (2013), V98, P31; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	43	0	0	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	MAY	2021	26	3					148	153		10.1123/ijatt.2019-0131			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	SU0WJ	WOS:000662862100007					2022-02-07	
J	DaCosta, A; Webbe, F; LoGalbo, A				DaCosta, Andrew; Webbe, Frank; LoGalbo, Anthony			The Rey Dot Counting Test as a Tool for Detecting Suboptimal Performance in Athlete Baseline Testing	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Malingering/symptom validity testing; Assessment	IMMEDIATE POST-CONCUSSION; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; HIGH-SCHOOL; IMPACT; SPORTS; SPECIFICITY; SENSITIVITY; PREVALENCE; MOTIVATION; ACADEMY	Objective: The limitations of Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT)'s embedded validity measures (EVMs) are well-documented, as estimates suggest up to 35% of invalid baseline performances go undetected. Few studies have examined standalone performance validity tests (PVT) as a supplement to ImPACT's EVMs. Method: College athletes (n = 1,213) were administered a preseason baseline assessment that included ImPACT and the Rey Dot Counting Test (DCT), a standalone PVT, among other measures. Results: Sixty-nine athletes (5.69%) met criteria for suboptimal effort on either ImPACT or the DCT. The DCT detected more cases of suboptimal effort (n = 50) than ImPACT (n = 21). A chi(2) test of independence detected significant disagreement between the two measures, as only two individuals produced suboptimal effort on both (chi(2)(2) = 1.568, p = .210). Despite this disagreement, there were significant differences between the suboptimal effort DCT group and the adequate effort DCT group across all four ImPACT neurocognitive domains (U = 19,225.000, p < .001; U = 17,859.000, p < .001; U = 13,854.000, p < .001; U = 17,850.500, p < .001). Conclusions: The DCT appears to detect suboptimal effort otherwise undetected by ImPACT's EVMs.	[DaCosta, Andrew; Webbe, Frank; LoGalbo, Anthony] Florida Inst Technol, Sch Psychol, 150 W Univ Blvd, Melbourne, FL 32901 USA		LoGalbo, A (corresponding author), Florida Inst Technol, Sch Psychol, 150 W Univ Blvd, Melbourne, FL 32901 USA.	alogalbo@fit.edu	DaCosta, Andrew/AAF-3065-2021	Webbe, Frank/0000-0002-4370-5698			An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Arrington v. NCAA, 2016, CONSOLIDATED CLASS A; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Binks PG, 1997, ARCH CLIN NEUROPSYCH, V12, P41, DOI 10.1016/S0887-6177(96)00019-4; Boone K., 2002, DOT COUNTING TEST; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Frederick R.I., 2003, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n03_01, DOI 10.1300/J151V02N03_01, https://doi.org/10.1300/J151v02n03_01]; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Law R, 2012, ANXIETY STRESS COPIN, V25, P711, DOI 10.1080/10615806.2011.630070; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V10; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lovell MR., 2007, CLIN INTERPRETIVE MA; Merker B., 2011, ENCY CLIN NEUROPSYCH; Miller JB, 2017, APA HDB FORENSIC NEU, P67, DOI [10.1037/0000032-005, DOI 10.1037/0000032-000]; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Neylan TC, 2010, CHRONOBIOL INT, V27, P1493, DOI 10.3109/07420528.2010.504992; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Salazar CL, 2017, DEV NEUROPSYCHOL, V42, P83, DOI 10.1080/87565641.2017.1303701; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Walton SR, 2018, MED SCI SPORT EXER, V50, P1377, DOI 10.1249/MSS.0000000000001592; Webb JW, 2012, CLIN NEUROPSYCHOL, V26, P1377, DOI 10.1080/13854046.2012.728248; Wojtowicz M., 2015, ARCH CLIN NEUROPSYCH, V30, P505, DOI [10.1093/arclin/acv047.58, DOI 10.1093/ARCLIN/ACV047.58]	38	0	0	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2021	36	3					414	423		10.1093/arclin/acaa052			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TB2DI	WOS:000667754500012	32719864				2022-02-07	
J	Dechambre, X; Carling, C; Mrozek, S; Pillard, F; Decq, P; Piscione, J; Yrondi, A; Brauge, D				Dechambre, Xavier; Carling, Christopher; Mrozek, Segolene; Pillard, Fabien; Decq, Philippe; Piscione, Julien; Yrondi, Antoine; Brauge, David			What Is the Impact of Physical Effort on the Diagnosis of Concussion?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; physical exertion; SCAT; HIA; rugby	EXERCISE; SPORTS; PERFORMANCE; MANAGEMENT; FOOTBALL; SIDELINE; PLAYERS; TEAM; TIME	Objective: Sport-related concussion commonly occurs in contact sports such as rugby. To date, diagnosis is based on the realization of clinical tests conducted pitch-side. Yet, the potential effect of prior physical effort on the results of these tests remains poorly understood. The purpose of this study was to determine whether preceding physical effort can influence the outcome of concussion assessments. Design: Prospective observational study. Setting: University Medicine Center. Patients: A cohort of 40 subjects (20 rugby players and 20 athletes from a range of sports). Intervention: A concussion assessment was performed immediately after physical activity. After a period of 6 months and under the same experimental conditions, the same cohort performed the same tests in resting conditions. Main outcome Measures: Results of concussion tests. Results: In both cohorts, the comparison for postexercise and rest assessments demonstrated a most likely moderate-to-very large increase in the number of symptoms, severity of symptoms, and balance error scoring system score. In the rugby cohort, scores for concentration, delayed memory and standardized assessment of concussion (SAC), likely-to-most likely decreased following completion of physical activity compared with baseline values. The between-cohort comparison reported a most likely greater impact after exercise in the rugby players for delayed recall (0.73 +/- 0.61) and SAC score (0.75 +/- 0.41). Conclusions: Physical activity altered the results of concussion diagnostic tests in athletes from a range of sports and notably in rugby players. Therefore, physical efforts before the concussion incident should be accounted for during pitch-side assessments and particularly during rugby competition and training.	[Dechambre, Xavier] Univ Hosp Toulouse, Dept Gen Med, Toulouse, France; [Carling, Christopher] Univ Cent Lancashire, Inst Coaching & Performance, Preston, Lancs, England; [Mrozek, Segolene] Univ Hosp Toulouse, Dept Anesthesiol & Intens Care, Toulouse, France; [Pillard, Fabien] Univ Hosp Toulouse, Dept Explorat Resp Funct & Sports Med, Toulouse, France; [Decq, Philippe] Univ Hosp Beaujon, AP HP, Dept Neurosurg, Clichy, France; [Piscione, Julien] French Rugby Union Federat, Res Dept, Marcoussis, France; [Yrondi, Antoine] Univ Hosp Toulouse, Dept Psychiat, Toulouse, France; [Brauge, David] Univ Hosp Toulouse, Dept Neurosurg, F-31059 Toulouse, France		Brauge, D (corresponding author), Univ Hosp Toulouse, Dept Neurosurg, F-31059 Toulouse, France.	brauge.d@chu-toulouse.fr		PILLARD, Fabien/0000-0003-3381-9744			Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Batterham AM, 2006, INTJ SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coutts A, 2003, J SPORT SCI, V21, P97, DOI 10.1080/0264041031000070831; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Fuller GW, 2017, J SCI MED SPORT, V21, P47; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Lee JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727261; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	28	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2021	31	3					E144	E149		10.1097/JSM.0000000000000757			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SO2PJ	WOS:000658818900002	31219927	Green Submitted, Green Accepted, Green Published			2022-02-07	
J	Decq, P; Brauge, D; Calmat, A; Cassoudesalle, H; Dehail, P; Deroche, F; Frey, A; Julia, M; Le Van, P; Lecocq, J; Mekies, C; Monroche, A; Pariente, J; Rousseau, R; Vesselle, B; Einsargueix, G				Decq, P.; Brauge, D.; Calmat, A.; Cassoudesalle, H.; Dehail, P.; Deroche, F.; Frey, A.; Julia, M.; Le Van, P.; Lecocq, J.; Mekies, C.; Monroche, A.; Pariente, J.; Rousseau, R.; Vesselle, B.; Einsargueix, G.			Diagnosis clinical criteria of sport related concussion: Toward an operational criteria definition in France	NEUROCHIRURGIE			English	Article						Sport-related concussion; Diagnosis criteria; Concussion syndrome; MTBI	TRAUMATIC BRAIN-INJURY; CT HEAD RULE; EARLY MANAGEMENT; CHILDREN; TRIAGE	Objective. - An expert working group was set up at the initiative of the French Ministry of Sports with the objective of harmonising the management of sport related concussion (SRC) in France, starting with its definition and diagnosis criteria. Results. - Definition: A clinical definition in 4 points have been established as follows: Concussion is a brain injury: 1) caused by a direct or indirect transmission of kinetic energy to the head; 2) resulting in an immediate and transient dysfunction of the brain characterised by at least one of the following disorders: a) Loss of consciousness, b) loss of memory, c) altered mental status, d) neurological signs; 3) possibly followed by one or more functional complaints (concussion syndrome); 4) the signs and symptoms are not explained by another cause. Diagnosis criteria: In the context of the direct or indirect transmission of kinetic energy to the head, the diagnosis of concussion may be asserted if at least one of the following signs or symptoms, observed or reported, is present within the first 24 hours and not explained by another cause: 1) loss of consciousness; 2) convulsions, tonic posturing; 3) ataxia; 4) visual trouble; 5) neurological deficit; 6) confusion; 7) disorientation; 8) unusual behaviour; 9) amnesia; 10) headaches; 11) dizziness; 12) fatigue, low energy; 13) feeling slowed down, drowsiness; 14) nausea; 15) sensitivity to light/noise; 16) not feeling right, in a fog; 17) difficulty concentrating. Conclusion. - Sharing the same definition and the same clinical diagnostic criteria for concussion is the prerequisite for common rules of management for all sports and should allow the pooling of results to improve our knowledge of this pathology. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Decq, P.] Univ Paris, Hop Beaujon, AP HP, Serv Neurochirurg, 100 Ave Gen Leclerc, F-92110 Clichy, France; [Brauge, D.] Univ Paul Sabatier, Hop Toulouse, Hop Pierre Paul Riquet, Serv Neurochirurg, F-31000 Toulouse, France; [Calmat, A.] CNOSF, F-75013 Paris, France; [Cassoudesalle, H.; Dehail, P.] Univ Bordeaux, Serv MPR, CHU Bordeaux, HACS U1219,INSERM, F-33000 Bordeaux, France; [Deroche, F.] Med Sport, Paris, France; [Frey, A.] Ctr Hosp Poissy St Germain, Serv Med Sport, F-78300 Poissy, France; [Julia, M.] Univ Montpellier, CHU Lapeyronie, Serv MPR, F-34000 Montpellier, France; [Le Van, P.] INSEP, Med Sport, F-75012 Paris, France; [Lecocq, J.] Univ Strasbourg, Inst Univ Readaptat Clemenceau Strasbourg, Serv Med & Reeducat Sport, F-67082 Strasbourg, France; [Mekies, C.] Polyclin Parc, Neurol, F-31000 Toulouse, France; [Monroche, A.] Rhumatologie, Angers, France; [Pariente, J.] Univ Paul Sabatier, Hop Toulouse, Hop Pierre Paul Riquet, Serv Neurol,NeuroImaging Ctr,INSERM,UMR1214, F-31000 Toulouse, France; [Rousseau, R.] Clin Nollet, INSEP, Med Sport, F-75012 Paris, France; [Vesselle, B.] Hop Robert Debre, MPR, Med Sport, F-51100 Reims, France; [Einsargueix, G.] Minist Sports, Direct Sports, DSB2, F-75650 Paris, France		Decq, P (corresponding author), Univ Paris, Hop Beaujon, AP HP, Serv Neurochirurg, 100 Ave Gen Leclerc, F-92110 Clichy, France.	philippe.decq@aphp.fr		Cassoudesalle, Helene/0000-0002-9384-5410			[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Rebbeck T, 2019, J ORTHOP SPORT PHYS, V49, P819, DOI 10.2519/jospt.2019.8946; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	22	0	0	1	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	MAY	2021	67	3					222	230		10.1016/j.neuchi.2020.10.010			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RU4GM	WOS:000645106900003	33278426				2022-02-07	
J	Dias, MS; Thamburaj, K				Dias, Mark S.; Thamburaj, Krishnamoorthy			Neuroradiologic timing of intracranial hemorrhage in abusive head trauma	PEDIATRIC RADIOLOGY			English	Article						Abusive head trauma; Children; Computed tomography; Infants; Intracranial hemorrhage; Magnetic resonance imaging; Shaken baby syndrome; Subdural hemorrhage; Timing of injury	I GLUTARIC ACIDURIA; SUBDURAL HEMATOMAS; AGE-DETERMINATION; CHILDREN; INFANTS; COLLECTIONS; INJURIES; CT	Determining the timing of intracranial injuries in general, and abusive head trauma (AHT) in particular, is important to the care of children with traumatic brain injury. Additionally, identifying the time of the injury provides important information as to who might have, and who did not, inflict the trauma. Understanding the appearance and evolution of intracranial findings on neuroimaging has been an important factor in assessing the time of the injury. However, a number of studies in the last two decades have both suggested greater uncertainty about the reliability of this process and advanced our knowledge in this area. In this review, the authors consider the biophysical factors that contribute to the appearance and evolution of intracranial hemorrhage and, in particular, subdural hemorrhage (SDH). The traditional view of SDH is predicated largely on prior studies of intracerebral hemorrhage, although a number of variables make this comparison untenable. Moreover, more recent studies have suggested a number of factors that could alter the density (CT) or signal intensity (MRI) and produce mixed density/intensity SDH. These factors need to be considered in interpreting neuroimaging studies. A number of these recent studies evaluating serial neuroimaging in children with AHT have modified our understanding of intracranial hemorrhage and its evolution in this context. Taken together, the studies to date, having important limitations, provide only broad ranges over which to time injuries. The authors conclude that neuroimaging studies at this time are not likely, in isolation, to be able to accurately pinpoint a specific time of injury; rather, neuroimaging can only provide a range of possible times and should instead be used as a means to supplement or corroborate timing based on clinical presentation and other imaging findings.	[Dias, Mark S.] Penn State Hlth Coll Med, Dept Neurosurg, 30 Hope Dr,Suite 2750, Hershey, PA 17033 USA; [Dias, Mark S.] Penn State Hlth Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Thamburaj, Krishnamoorthy] Penn State Hlth Coll Med, Dept Radiol, Hershey, PA USA		Dias, MS (corresponding author), Penn State Hlth Coll Med, Dept Neurosurg, 30 Hope Dr,Suite 2750, Hershey, PA 17033 USA.; Dias, MS (corresponding author), Penn State Hlth Coll Med, Dept Pediat, Hershey, PA 17033 USA.	mdias@pennstatehealth.psu.edu					Adamsbaum C, 2014, PEDIATR RADIOL, V44, P578, DOI 10.1007/s00247-014-3171-1; Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; Bacopoulou F, 2006, ARCH DIS CHILD, V91, P919, DOI 10.1136/adc.2006.081836; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Droms RJ, 2017, PEDIATR DERMATOL, V34, pE132, DOI 10.1111/pde.13106; FOBBEN ES, 1989, AM J NEURORADIOL, V10, P687; Fox RJ, 1996, NEUROSURGERY, V39, P84, DOI 10.1097/00006123-199607000-00017; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Greiner MV, 2013, AM J NEURORADIOL, V34, P2373, DOI 10.3174/ajnr.A3588; HAYMAN LA, 1989, AM J NEURORADIOL, V10, P681; Hedlund GL, 2012, J AM OSTEOPATH COLL, V1, P23; JANICK PA, 1991, AM J NEURORADIOL, V12, P891; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Krywanczyk A, 2018, J FORENSIC SCI, V63, P902, DOI 10.1111/1556-4029.13634; Lee Kyeong-Seok, 1997, Journal of Korean Medical Science, V12, P353; McKeag H, 2013, J NEUROSURG-PEDIATR, V11, P438, DOI 10.3171/2012.12.PEDS12289; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; Postema FAM, 2014, EMERG RADIOL, V21, P349, DOI 10.1007/s10140-014-1196-2; Sargent S, 1996, J FORENSIC SCI, V41, P314; Sieswerda-Hoogendoorn T, 2014, EUR J RADIOL, V83, P1257, DOI 10.1016/j.ejrad.2014.03.015; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Strauss KA, 2003, AM J MED GENET C, V121C, P53, DOI 10.1002/ajmg.c.20008; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tubbs RS, 2007, J NEUROSURG, V107, P155, DOI 10.3171/JNS-07/07/0155; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Vezina G, 2009, PEDIATR RADIOL, V39, P586, DOI 10.1007/s00247-009-1212-y; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Wittschieber D, 2015, AM J NEURORADIOL, V36, P432, DOI 10.3174/ajnr.A3989; Zouros A, 2004, J NEUROSURG, V100, P512, DOI 10.3171/ped.2004.100.5.0512	34	0	0	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	MAY	2021	51	6			SI		911	917		10.1007/s00247-020-04824-9			7	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	SD6SY	WOS:000651506100010	33999236				2022-02-07	
J	DiRisio, AC; Stopa, BM; Pompeu, YA; Vasudeva, V; Khawaja, AM; Izzy, S; Gormley, WB				DiRisio, Aislyn C.; Stopa, Brittany M.; Pompeu, Yuri A.; Vasudeva, Viren; Khawaja, Ayaz M.; Izzy, Saef; Gormley, William B.			Extra-Axial Fluid Collections After Decompressive Craniectomy: Management, Outcomes, and Treatment Algorithm	WORLD NEUROSURGERY			English	Article; Proceedings Paper	36th Annual Meeting of the American-Association-of-Neurological-Surgeons/Section-on-Disorders-of-the-Spine-and-Peripheral-Nerves of the Congress-of-Neurological-Surgeons (Spine Summit)	MAR 08, 2020	Las Vegas, NV	Amer Assoc Neurol Surg, Congress Neurol Surg, Sect Disorders Spine & Peripheral Nerves		Decompressive craniectomy; Extra-axial collections; Fluid collections; Subarachnoid hemorrhage; Traumatic brain injury	CONTRALATERAL SUBDURAL EFFUSION; TRAUMATIC BRAIN-INJURY; INTRACTABLE INTRACRANIAL HYPERTENSION; RISK-FACTORS; INTERHEMISPHERIC HYGROMA; CLINICAL-FEATURES; HYDROCEPHALUS; COMPLICATIONS; SECONDARY	BACKGROUND: Extra-axial fluid collections (EACs) frequently develop after decompressive craniectomy. Management of EACs remains poorly understood, and information on how to predict their clinical course is inadequate. We aimed to better characterize EACs, understand predictors of their resolution, and delineate the best treatment paradigm for patients. -METHODS: We reviewed patients who developed EACs after undergoing decompressive craniectomy for treatment of refractory intracranial pressure elevations. We excluded patients who had an ischemic stroke, as EACs in these patients have a different clinical course. We performed u nivariate analysis and multiple linear regression to find variables associated with earlier resolution of EACs and stratified our analyses by EAC phenotype (complicated vs. u ncomplicated). We conducted a systematic review to compare our findings with the literature. -RESULTS: Of 96 included patients, 73% were male, and median age was 42.5 years. EACs resolved after a median of 60 days. Complicated EACs were common (62.5%) and required multiple drainage methods before cranioplasty. These were not associated with a protracted course or increased risk of death (P > 0.05). Early bone flap restoration with simultaneous drainage was independently associated with earlier resolution of EACs (b [ 0.56, P < 0.001). Systematic review confirmed lack of standardized direction with respect to EAC management. -CONCLUSIONS: Our analyses reveal 2 clinically relevant phenotypes of EAC: complicated and uncomplicated. Our proposed treatment algorithm involves replacing the bone flap as soon as it is safe to do so and draining refractory EACs aggressively. Further studies to assess longterm clinical outcomes of EACs are warranted.	[DiRisio, Aislyn C.; Stopa, Brittany M.; Pompeu, Yuri A.; Vasudeva, Viren; Khawaja, Ayaz M.; Izzy, Saef; Gormley, William B.] Harvard Med Sch, Brigham & Womens Hosp, Computat Neurosci Outcomes Ctr, Dept Neurosurg, Boston, MA 02115 USA; [Khawaja, Ayaz M.; Izzy, Saef] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [DiRisio, Aislyn C.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Stopa, Brittany M.] Virginia Tech Carillon Sch Med, Roanoke, VA USA; [Pompeu, Yuri A.] Hosp Special Surg, Dept Orthoped, 535 E 70th St, New York, NY 10021 USA		DiRisio, AC (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Computat Neurosci Outcomes Ctr, Dept Neurosurg, Boston, MA 02115 USA.; DiRisio, AC (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	Aislyn.dirisio@icahn.mssm.edu					Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Lin MS, 2015, THESCIENTIFICWORLDJO, V2015; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Ropper AE, 2012, J CLIN NEUROSCI, V19, P231, DOI 10.1016/j.jocn.2011.08.004; Salunke P, 2015, J NEUROSURG, V122, P602, DOI 10.3171/2014.10.JNS14780; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Wan Y, 2016, CLIN NEUROL NEUROSUR, V149, P87, DOI 10.1016/j.clineuro.2016.08.004; Wang HK, 2012, INJURY, V43, P594, DOI 10.1016/j.injury.2010.06.004; Xu GZ, 2014, J CRANIOFAC SURG, V25, P1836, DOI 10.1097/SCS.0b013e3182a21056; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yuan Q, 2015, BRAIN INJURY, V29, P971, DOI 10.3109/02699052.2015.1004760	22	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E188	E196		10.1016/j.wneu.2021.02.052			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	RU9LH	WOS:000645460900023	33639283				2022-02-07	
J	Dube, J; Speelman, A; Daries, V				Dube, Jonathan; Speelman, Aladdin; Daries, Valdiela			Follow-up CT Imaging in Patients With Traumatic Brain Injury in Zimbabwe	RADIOLOGIC TECHNOLOGY			English	Article						traumatic brain injury; follow-up CT brain imaging; neurological complications; atypical radiological findings; intracranial hemorrhage	HEAD COMPUTED-TOMOGRAPHY; MANAGEMENT; SCANS	Purpose To assess the type and degree of neurological complications in patients with traumatic brain injury (TBI) who presented with an initial typical baseline computed tomography (CT) brain scan and to assess the time in which neurological complications developed. Methods A retrospective cross-sectional quantitative research design was conducted in which CT radiology reports of 85 adult patients with TBI and typical baseline CT scans were analyzed during a 2-year period. The evolution of different types of neurological pathology diagnosed on follow-up CT brain imaging in these patients was recorded and analyzed. Results The results showed that 36% of patients (n = 31) presented with atypical neuroradiological findings on follow-up CT imaging. Subdural hematoma was diagnosed in 19% (n = 16), intracerebral hematoma in 8% (n = 7), subarachnoid hematoma in 6% (n = 5), pneumocephalus in 2% (n = 2), and epidural hematoma in 1% (n = 1). The average times elapsed between the traumatic event and acquisition of the baseline CT brain scan and follow-up CT were 8 and 18 hours, respectively. Discussion The most common causal mechanism of trauma in this study was motor vehicle collisions; an increase in motor vehicle collisions might have resulted in many vulnerable road users on poor road infrastructure and communities living in the vicinity of such roads. The severity of neurological status of patients might be associated with a higher likelihood of detecting intracranial pathology on follow-up CT brain imaging. Follow-up CT brain imaging findings have a role in confirming or excluding late neurological complications preceded by a typical baseline CT brain scan. Conclusion Follow-up CT brain imaging performed at 10 hours after the typical baseline CT scan was of value in detecting the evolution of intracranial neurological pathology and resulted in a change in neurological management in one-third of patients.	[Dube, Jonathan] Univ Hosp Kerry Ireland, Tralee, Ireland; [Speelman, Aladdin; Daries, Valdiela] Cape Peninsula Univ Technol, Dept Med Imaging & Therapeut Sci, Cape Town, South Africa; [Speelman, Aladdin; Daries, Valdiela] Cape Peninsula Univ Technol, Hlth & Wellness Sci, Cape Town, South Africa		Dube, J (corresponding author), Univ Hosp Kerry Ireland, Tralee, Ireland.	jdube2648@gmail.com; SpeelmanA@cput.ac.za; DariesV@cput.ac.za					af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Afzal Tayyaba, 2013, J Ayub Med Coll Abbottabad, V25, P187; Anzai Y., 2011, IMAGING MED, V3, P153, DOI [10.2217/iim.11.11, DOI 10.2217/IIM.11.11]; Chi JH, 2003, SEMIN NEUROSURG, V14, P071; Doddamani RS, 2012, INDIAN J NEUROTRAUM, V9, P33, DOI 10.1016/j.ijnt.2012.04.007; Elvik R, 2009, HANDBOOK OF ROAD SAFETY MEASURES, 2ND EDITION, P1; Heidari SF, 2016, J INTENSIVE CRIT CAR, V02, P38, DOI [10.21767/2471-8505.100047, DOI 10.21767/2471-8505.100047]; Joseph B, 2014, AM SURGEON, V80, P43; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Lolli V, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150849; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Makanza I., 2013, THESIS; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Ohaegbulam Samuel C, 2011, Surg Neurol Int, V2, P182, DOI 10.4103/2152-7806.91137; Parma C, 2014, AM SURGEON, V80, P664; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Tenny S, 2021, INTRACRANIAL HEMORRH; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wu C, 2011, JHN J, V6, P3, DOI [10.29046/JHNJ.006.1.002, DOI 10.29046/JHNJ.006.1.002]; Zanamwe N., 2017, GLOBAL FUEL EC INITI	27	0	0	0	0	AMER SOC RADIOLOGIC TECHNOLOGISTS	ALBUQUERQUE	15000 CENTRAL AVE, SE, ALBUQUERQUE, NM 87123 USA	0033-8397	1943-5657		RADIOL TECHNOL	Radiol. Technol.	MAY-JUN	2021	92	5					459	466					8	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	RT8FI	WOS:000644691300004	33903265				2022-02-07	
J	Echemendia, RJ; Thelen, J; Meeuwisse, W; Hutchison, MG; Comper, P; Rizos, J; Bruce, JM				Echemendia, Ruben J.; Thelen, Joanie; Meeuwisse, Willem; Hutchison, Michael G.; Comper, Paul; Rizos, John; Bruce, Jared M.			Use of the Sport Concussion Assessment Tool 5 (SCAT5) in professional hockey, part 1: cross-cultural normative data	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ACCULTURATION; RELIABILITY; PERFORMANCE; SYMPTOMS; SIDELINE; ZURICH; TESTS	Objectives This paper provides comprehensive normative data stratified by language preference and age on the components of the National Hockey League (NHL) Sport Concussion Assessment Tool 5 (SCAT5) in a multilingual sample of professional ice hockey players and compares the findings from a paper form of the NHL SCAT5 with an electronic (App) version of the tool. Methods A total of 1924 male NHL and American Hockey League (AHL) players (ages 17-41) were assessed during preseason medical evaluations (baseline); 1881 were assessed with the NHL SCAT5 App via tablet and 43 received the paper version of the NHL Modified SCAT5. Results No significant differences between the App and paper modes of administration emerged in a subsample of English preference players. Significant SCAT5 differences among language preference groups emerged on measures of cognitive functioning (Immediate Memory,Concentration). No language preference differences emerged on the Delayed Recall component. Using age as a continuous variable, older participants outperformed younger players on Immediate Memory, Delayed Recall and Concentration. Players wearing skates demonstrated significantly more modified Balance Error Scoring System (mBESS) total errors than barefoot players. Normative data tables for language preference groups are presented. Conclusions Significant differences were found between English and non-English language preference groups on the components of SCAT5, which suggest that language-specific normative data, rather than aggregated normative data, are preferable when interpreting test scores. Similarly, age-specific normative data tables may provide greater precision in data interpretation. Due to clear ceiling effects on the mBESS single leg and tandem stances, players should not be tested while wearing skates.	[Echemendia, Ruben J.] Univ Missouri, Psychol, Kansas City, MO 64110 USA; [Echemendia, Ruben J.] Univ Orthoped Ctr, Concuss Care Clin, State Coll, PA 16801 USA; [Thelen, Joanie] Natl Hockey League, New York, NY USA; [Thelen, Joanie] Univ Missouri, Kansas City, MO 64110 USA; [Meeuwisse, Willem] Natl Hockey League, Calgary, AB, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Comper, Paul] Toronto Rehabil Inst, Toronto, ON, Canada; [Rizos, John] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Bruce, Jared M.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA		Echemendia, RJ (corresponding author), Univ Missouri, Psychol, Kansas City, MO 64110 USA.; Echemendia, RJ (corresponding author), Univ Orthoped Ctr, Concuss Care Clin, State Coll, PA 16801 USA.	rechemendia@comcast.net		Thelen, Joan/0000-0003-1802-9111; Echemendia, Ruben/0000-0001-6116-8462	NFL (NFL-Long) through Boston Children's Hospital; GenzymeSanofi-AventisGenzyme Corporation	RJE is a paid consultant for the NHL and co-chair of the NHL/NHLPA Concussion Subcommittee. He is also a paid consultant for Major League Soccer and Princeton University Athletic Medicine. He has a financial interest in EyeGuide and is chair of their Scientific Advisory Board. He is currently a co-PI for a grant funded by the NFL (NFL-Long) through Boston Children's Hospital and occasionally provides expert testimony in matters related to MTBI and sports concussion. JT is a part-time employee of the NHL. WM is Medical Director for the NHL and an employee of the NHL. MGH is a member of the NHL/NHLPA Concussion Subcommittee and a consultant to the NHLPA, for which he receives remuneration. JR is a member of the NHL/NHLPA Concussion Subcommittee and a paid medical/physician consultant to the NHLPA. PC is co-chair of the NHL/NHLPA Concussion Subcommittee and a paid consultant to the NHLPA. JMB is a part-time employee of the NHL. He receives grant funding from Genzyme and is a consultant to Med-IQ and Sporting KC.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Black AM, 2020, J ATHL TRAINING, V55, P116, DOI 10.4085/1062-6050-123-19; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia RJ, 2020, ARCH CLIN NEUROPSYCH, V35, P240, DOI 10.1093/arclin/acz077; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hartshorne JK, 2015, PSYCHOL SCI, V26, P433, DOI 10.1177/0956797614567339; Lenhard A, 2018, CONTINUOUS NORMING C; Lenhard A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222279; Lenhard A, 2018, ASSESSMENT, V25, P112, DOI 10.1177/1073191116656437; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Peviani V, 2016, EPILEPSY BEHAV, V64, P94, DOI 10.1016/j.yebeh.2016.09.011; Razani J, 2007, ARCH CLIN NEUROPSYCH, V22, P333, DOI 10.1016/j.acn.2007.01.008; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Tan Y. W., 2020, CULT BRAIN, V8, P27, DOI [10.1007/s40167-018-0075-1, DOI 10.1007/S40167-018-0075-1]; Touradji P, 2001, J CLIN EXP NEUROPSYC, V23, P643, DOI 10.1076/jcen.23.5.643.1246; Tucker R, 2020, J SCI MED SPORT; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	30	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAY	2021	55	10					550	+		10.1136/bjsports-2020-102071			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SB9TI	WOS:000650327000013	32847811	Bronze			2022-02-07	
J	Eilam-Stock, T; George, A; Charvet, LE				Eilam-Stock, Tehila; George, Allan; Charvet, Leigh E.			Cognitive Telerehabilitation with Transcranial Direct Current Stimulation Improves Cognitive and Emotional Functioning Following a Traumatic Brain Injury: A Case Study	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Rehabilitation	DORSOLATERAL PREFRONTAL CORTEX; WORKING-MEMORY; ANODAL TDCS; NEUROPSYCHIATRIC SEQUELAE; UNITED-STATES; MOTOR; REHABILITATION; ATTENTION; FEASIBILITY; NEUROPLASTICITY	Objective: Cognitive deficits following a traumatic brain injury (TBI) are a leading cause of disability in young adults and there is a critical need for novel approaches to improve cognitive outcomes in TBI survivors. Transcranial direct current stimulation (tDCS) paired with cognitive remediation has emerged as a viable, cost-effective, noninvasive approach for treating cognitive impairments in a wide variety of neurological conditions. Here, we report the first case study utilizing remotely supervised tDCS (RS-tDCS) protocol paired with cognitive remediation in a 29-year-old man with persisting cognitive and emotional sequelae following TBI. Method: Neuropsychological measures were administered before and after the patient completed 20 daily sessions of RS -tDCS (2.0 mA x 20 minutes, left anodal dorsolateral prefrontal cortex montage). During the daily stimulation period, he completed adaptive cognitive training All treatment procedures were delivered at home and monitored in real time via videoconference with a study technician. Results: Following 20 RS-tDCS and cognitive training sessions, he had significant improvements (>1 SD) on tests of attention and working memory, semantic fluency, and information processing speed. Mood was also improved. Conclusions: This is the first demonstration of at-home telerehabilitation with RS-tDCS and cognitive training to improve cognitive outcomes following TBI.	[Eilam-Stock, Tehila; George, Allan; Charvet, Leigh E.] NYU, Dept Neurol, Grossman Sch Med, New York, NY 10017 USA		Charvet, LE (corresponding author), Dept Neurol, 222 East 41st St,10th Floor, New York, NY 10017 USA.	Leigh.charvet@nyulangone.org		Charvet, Leigh/0000-0003-4429-9713	Lourie Foundation, Inc.	This work was supported by the Lourie Foundation, Inc.	Agarwal S, 2018, J CLIN NEUROSCI, V57, P51, DOI 10.1016/j.jocn.2018.08.037; Alonzo A, 2019, J AFFECT DISORDERS, V252, P475, DOI 10.1016/j.jad.2019.04.041; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Bahar-Fuchs A, 2020, J GERONTOL A-BIOL, V75, P747, DOI 10.1093/gerona/glz073; Bahar-Fuchs A, 2017, J ALZHEIMERS DIS, V60, P889, DOI 10.3233/JAD-170404; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bedard ACV, 2014, J AM ACAD CHILD PSY, V53, P1020, DOI 10.1016/j.jaac.2014.05.011; Behe A, 2019, ARCH PHYS MED REHAB, V100, P1381, DOI 10.1016/j.apmr.2019.03.005; Bikson M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00688; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Brasil-Neto Joaquim P, 2012, Front Psychiatry, V3, P80, DOI 10.3389/fpsyt.2012.00080; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Burgess GC, 2010, BIOL PSYCHIAT, V67, P632, DOI 10.1016/j.biopsych.2009.10.036; Bystad M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0180-3; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Charvet L E, 2015, Mult Scler J Exp Transl Clin, V1, p2055217315609629, DOI 10.1177/2055217315609629; Charvet L, 2018, NEUROMODULATION, V21, P383, DOI 10.1111/ner.12583; Charvet LE, 2020, BRAIN STIMUL, V13, P686, DOI 10.1016/j.brs.2020.02.011; Charvet LE, 2018, MULT SCLER J, V24, P1760, DOI 10.1177/1352458517732842; Charvet LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177177; Charvet LE, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00026; Chepenik LG, 2007, EMOTION, V7, P802, DOI 10.1037/1528-3542.7.4.802; Choe J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00034; Clayton AM, 2018, J ECT, V34, pe15, DOI [10.1097/YCT.0000000000000438, 10.1097/YCT.0000000000000474]; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dobbs B, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0457-9; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Donde C, 2017, PROG NEURO-PSYCHOPH, V78, P123, DOI 10.1016/j.pnpbp.2017.05.021; Doruk D, 2014, NEUROSCI LETT, V582, P27, DOI 10.1016/j.neulet.2014.08.043; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Drozdick L. W., 2012, WECHSLER ADULT INTEL, V4th; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Edwards Jerri D, 2017, Alzheimers Dement (N Y), V3, P603, DOI 10.1016/j.trci.2017.09.002; Edwards JD, 2018, NEUROSCI BIOBEHAV R, V84, P72, DOI 10.1016/j.neubiorev.2017.11.004; Elmasry J, 2015, RESTOR NEUROL NEUROS, V33, P263, DOI 10.3233/RNN-140473; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Flak MM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00807; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; Fraser S, 2020, CHILD NEUROPSYCHOL, V26, P612, DOI 10.1080/09297049.2019.1676407; Fuchs TA, 2019, MULT SCLER RELAT DIS, V34, P103, DOI 10.1016/j.msard.2019.06.026; Gaillard WD, 2000, NEUROLOGY, V54, P180, DOI 10.1212/WNL.54.1.180; Ghanavati E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40273-7; Gill J, 2015, BRAIN STIMUL, V8, P253, DOI 10.1016/j.brs.2014.10.018; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Hoofien D, 2001, BRAIN INJURY, V15, P189; Im JJ, 2019, BRAIN STIMUL, V12, P1222, DOI 10.1016/j.brs.2019.06.003; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Kalra ID, 2017, J HEAD TRAUMA REHAB, V32, pE61, DOI 10.1097/HTR.0000000000000359; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Kasschau M, 2016, NEUROMODULATION, V19, P824, DOI 10.1111/ner.12430; Kasschau M, 2015, JOVE-J VIS EXP, DOI 10.3791/53542; Kronberg G, 2017, BRAIN STIMUL, V10, P51, DOI 10.1016/j.brs.2016.10.001; Laakso I, 2015, BRAIN STIMUL, V8, P906, DOI 10.1016/j.brs.2015.05.002; Lampit A, 2019, NEUROREHAB NEURAL RE, V33, P695, DOI 10.1177/1545968319860490; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Lin HL, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P307, DOI 10.1016/B978-0-12-802686-1.00019-5; Lueckel Stephanie N, 2019, R I Med J (2013), V102, P34; Marquez CMS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00333; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McIntire LK, 2014, BRAIN STIMUL, V7, P499, DOI 10.1016/j.brs.2014.04.008; Meesen RLJ, 2014, RESTOR NEUROL NEUROS, V32, P293, DOI 10.3233/RNN-130348; Merzenich MM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00385; Metuki N, 2012, BRAIN STIMUL, V5, P110, DOI 10.1016/j.brs.2012.03.002; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Motter JN, 2016, J AFFECT DISORDERS, V189, P184, DOI 10.1016/j.jad.2015.09.022; Nahum M, 2013, PROG BRAIN RES, V207, P141, DOI 10.1016/B978-0-444-63327-9.00009-6; Nejati V, 2018, NEUROSCIENCE, V369, P109, DOI 10.1016/j.neuroscience.2017.10.042; Nelson JT, 2014, NEUROIMAGE, V85, P909, DOI 10.1016/j.neuroimage.2012.11.061; Nguyen H., 2020, NAT RESOUR RES, P1; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; O'Neil-Pirozzi TM, 2017, INT J NEUROSCI, V127, P592, DOI 10.1080/00207454.2016.1216415; O'Neil-Pirozzi TM, 2016, BRAIN INJURY, V30, P1617, DOI 10.1080/02699052.2016.1199906; de Amorim RLO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00164; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; Parazzini M, 2011, IEEE T BIO-MED ENG, V58, P1773, DOI 10.1109/TBME.2011.2116019; PARTINGTON JE, 1949, PSYCHOL SERVICE CTR, V1, P9; Plewnia C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122578; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Radomski MV, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020776; Ramanathan P, 2019, APHASIOLOGY, V33, P289, DOI 10.1080/02687038.2018.1461801; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Razza LB, 2020, DEPRESS ANXIETY, V37, P594, DOI 10.1002/da.23004; Reis J, 2015, CEREB CORTEX, V25, P109, DOI 10.1093/cercor/bht208; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Richmond LL, 2014, J COGNITIVE NEUROSCI, V26, P2443, DOI 10.1162/jocn_a_00657; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00057; Sarkar A, 2014, J NEUROSCI, V34, P16605, DOI 10.1523/JNEUROSCI.3129-14.2014; Schambra HM, 2011, J NEUROPHYSIOL, V106, P652, DOI 10.1152/jn.00210.2011; Schjetnan AGP, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/170256; Schmidt M., 1996, REY AUDITORY VERBAL; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; Schretlen D., 1997, BRIEF TEST ATTENTION; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segrave RA, 2014, BRAIN STIMUL, V7, P325, DOI 10.1016/j.brs.2013.12.008; Seibt O, 2015, BRAIN STIMUL, V8, P590, DOI 10.1016/j.brs.2015.01.401; Sharma B, 2017, DISABIL REHABIL, V39, P1380, DOI 10.1080/09638288.2016.1195453; Shaw M, 2020, MIL MED, V185, P319, DOI 10.1093/milmed/usz348; Shaw MT, 2021, J TELEMED TELECARE, V27, P39, DOI 10.1177/1357633X19861830; Shaw MT, 2017, JOVE-J VIS EXP, DOI 10.3791/56211; Smith A., 1982, SYMBOL DIGIT MODALIT; Spitz G, 2017, J NEUROTRAUM, V34, P807, DOI 10.1089/neu.2016.4527; Stagg CJ, 2013, J NEUROSCI, V33, P11425, DOI 10.1523/JNEUROSCI.3887-12.2013; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TeamViewer, 2015, TEAMVIEWERTHE ALL IN; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Vinogradov S, 2013, BIOL PSYCHIAT, V73, P935, DOI 10.1016/j.biopsych.2013.03.015; Vinogradov S, 2012, NEUROPSYCHOPHARMACOL, V37, P43, DOI 10.1038/npp.2011.251; Virk S, 2015, NEUROREHABILITATION, V36, P367, DOI 10.3233/NRE-151225; Vsee, 2015, VSEE WORLDS LARGEST; Waters-Metenier S, 2014, J NEUROSCI, V34, P1037, DOI 10.1523/JNEUROSCI.2282-13.2014; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 1945, WECHSLER MEMORY SCAL; White T, 2003, NEUROPSYCHOLOGICAL A; Wilke S, 2017, J NEUROTRAUM, V34, P281, DOI 10.1089/neu.2016.4399; Yoon Kang Sa, 2017, [Journal of the Korean Neurological Association, 대한신경과학회지], V35, P63, DOI 10.17340/jkna.2017.2.1; Zanao TA, 2014, NEUROMODULATION, V17, P737, DOI 10.1111/ner.12167	135	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2021	36	3					442	453		10.1093/arclin/acaa059			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TB2DI	WOS:000667754500016	33885138				2022-02-07	
J	Fann, JR; Hart, T; Ciol, MA; Moore, M; Bogner, J; Corrigan, JD; Dams-O'Connor, K; Driver, S; Dubiel, R; Hammond, FM; Kajankova, M; Watanabe, TK; Hoffman, JM				Fann, Jesse R.; Hart, Tessa; Ciol, Marcia A.; Moore, Megan; Bogner, Jennifer; Corrigan, John D.; Dams-O'Connor, Kristen; Driver, Simon; Dubiel, Rosemary; Hammond, Flora M.; Kajankova, Maria; Watanabe, Thomas K.; Hoffman, Jeanne M.			Improving transition from inpatient rehabilitation following traumatic brain injury: Protocol for the BRITE pragmatic comparative effectiveness trial	CONTEMPORARY CLINICAL TRIALS			English	Article						Traumatic brain injury; Head injury; Transitional care; Community participation; Quality of life; Pragmatic comparative effectiveness study	QUALITY-OF-LIFE; CASE-MANAGEMENT; PARTICIPATION ASSESSMENT; NATIONAL INSTITUTE; OLDER-ADULTS; TELEPHONE; INTERVENTION; DISABILITY; CAREGIVERS; MODEL	Moderate to severe traumatic brain injury (TBI) is a common cause of long-term disability. Due to challenges that include inconsistent access to follow-up care, persons with TBI being discharged from inpatient rehabilitation facilities (IRFs) areat risk for rehospitalization, poor reintegration into the community, family stress, and other unfavorable outcomes resulting from unmet needs. In a six-center randomized pragmatic comparative effectiveness study, the BRITE trial (Brain Injury Rehabilitation: Improving the Transition Experience, ClinicalTrials.gov NCT03422276), we compare the effectiveness of two existing methods for transition from IRF to community living or long-term nursing care. The Rehabilitation Discharge Plan (RDP) includes patient/family educationand referrals for continued care. The Rehabilitation TransitionPlan (RTP) provides RDP plus individualized, manualized care management via phone or videoconference, for 6 months. Nine hundred patients will be randomized (1:1) to RDP or RTP, with caregivers also invited to participate and contribute caregiver-reported outcomes. Extensive stakeholder input, including active participation of persons with TBI and their families, has informed all aspects of trial design and implementation planning. We hypothesize that RTP will result in better patient- and caregiver-reported outcomes (societal participation, quality of life, caregiver well-being) and more efficient use of healthcare resources at 6-months (primary outcome) and 12-months post-discharge, compared to RDP alone. Planned analyses will explore which participants benefit most from each transition model. With few exclusion criteria and other pragmatic features, the findings of this trial are expected to have a broad impact on improving transitions from inpatient TBI rehabilitation.	[Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Sch Med, 1959 NE Pacific St,Box 356560, Seattle, WA 98195 USA; [Hart, Tessa] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Ciol, Marcia A.; Hoffman, Jeanne M.] Univ Washington, Dept Rehabil Med, Sch Med, 1959 NE Pacific St,Box 356490, Seattle, WA 98195 USA; [Moore, Megan] Univ Washington, Sch Social Work, 4101 15th Ave NE, Seattle, WA 98105 USA; [Moore, Megan] Univ Washington, Harborview Injury Prevent & Res Ctr, 4101 15th Ave NE, Seattle, WA 98105 USA; [Bogner, Jennifer; Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, Dept Neurol, One Gustave Levy Pl Box 1163, New York, NY 10029 USA; [Driver, Simon] Baylor Scott & White Res Inst, Dept Sports Therapy & Res, 3434 Live Oak, Dallas, TX 75204 USA; [Dubiel, Rosemary] Baylor Scott & White Inst Rehabil, Dept Phys Med & Rehabil, 909 N Washington Ave, Dallas, TX 75246 USA; [Hammond, Flora M.] Indian Univ, Dept Phys Med & Rehabil, Sch Med, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Kajankova, Maria] Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl Box 1163, New York, NY 10029 USA; [Watanabe, Thomas K.] MossRehab Elkins Pk Einstein Healthcare Network, Dept Phys Med & Rehabil, 60 Township Line Rd, Elkins Pk, PA 19027 USA		Fann, JR (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Sch Med, 1959 NE Pacific St,Box 356560, Seattle, WA 98195 USA.	fann@uw.edu; thart@einstein.edu; marciac@uw.edu; mm99@uw.edu; Jennifer.Bogner@osumc.edu; John.Corrigan@osumc.edu; Kristen.dams-oconnor@mountsinai.org; simon.driver@bswhealth.org; rdubiel@bswrehab.com; Flora.hammond@rhin.com; Maria.kajankova@mountsinai.org; watanabt@einstein.edu; jeanneh@uw.edu		driver, simon/0000-0003-2356-432X	Patient-Centered Outcomes Research Institute(R) (PCORI(R)) AwardPatient-Centered Outcomes Research Institute - PCORI [PCS-1604-35115]	Research reported in this article was funded through a Patient-Centered Outcomes Research Institute (R) (PCORI (R)) Award (PCS-1604-35115). The views presented in this article are solely the responsibility of the authors and do not necessarily represent the views of the PatientCentered Outcomes Research Institute (R) (PCORI (R)), its Board of Governors or Methodology Committee.	Alvarez R, 2016, J GERONTOL SOC WORK, V59, P222, DOI 10.1080/01634372.2016.1195781; [Anonymous], 2015, C TRAUM BRAIN INJ US; Bakas T, 2006, NURS RES, V55, P346, DOI 10.1097/00006199-200609000-00007; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Bedard M, 2000, INT PSYCHOGERIATR, V12, P307, DOI 10.1017/S1041610200006426; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Bell KR, 2015, CONTEMP CLIN TRIALS, V40, P54, DOI 10.1016/j.cct.2014.11.001; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bogner J, 2019, ARCH PHYS MED REHAB, V100, P1801, DOI 10.1016/j.apmr.2019.04.008; Bogner J, 2013, J HEAD TRAUMA REHAB, V28, P337, DOI 10.1097/HTR.0b013e31829af969; Bruce DG, 2005, J GERONTOL A-BIOL, V60, P345, DOI 10.1093/gerona/60.3.345; CARF, INT MED REH PROGR; CMS, 2021, MED BEN POL MAN; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Cross G., 2009, CARE MANAGEMENT OPER; Dams-O'Connor K, 2018, BRAIN INJURY, V32, P431, DOI 10.1080/02699052.2018.1429024; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Dedhia P, 2009, J AM GERIATR SOC, V57, P1540, DOI 10.1111/j.1532-5415.2009.02430.x; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Guevara AB, 2016, J HEAD TRAUMA REHAB, V31, pE48, DOI 10.1097/HTR.0000000000000151; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Gustafsson L, 2013, DISABIL REHABIL, V35, P1380, DOI 10.3109/09638288.2012.740134; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Knier S, 2015, REHABIL NURS, V40, P30, DOI 10.1002/rnj.164; Lannin NA, 2014, NEUROREHABILITATION, V35, P635, DOI 10.3233/NRE-141161; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Markowitz JS, 2003, ALZ DIS ASSOC DIS, V17, P209, DOI 10.1097/00002093-200310000-00003; Masala C, 2008, DISABIL REHABIL, V30, P1233, DOI 10.1080/09638280701602418; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Morimoto T, 2003, AGE AGEING, V32, P218, DOI 10.1093/ageing/32.2.218; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Patterson P K, 1999, Care Manag J, V1, P87; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Perla LY, 2013, REHABIL NURS, V38, P231, DOI 10.1002/rnj.102; Piccenna L, 2017, HEALTH SOC CARE COMM, V25, P458, DOI 10.1111/hsc.12327; Piccenna L, 2016, BRAIN INJURY, V30, P241, DOI 10.3109/02699052.2015.1113569; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; PROMIS, 2020, SAT SOC ROL ACT; Raven MC, 2016, ANN EMERG MED, V68, P467, DOI 10.1016/j.annemergmed.2016.04.015; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sabik LM, 2016, MED CARE, V54, P758, DOI 10.1097/MLR.0000000000000559; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Sirey JA, 2005, PSYCHIAT SERV, V56, P1564, DOI 10.1176/appi.ps.56.12.1564; SOP, 2020, TRAUMATIC BRAIN INJU; Sox HC, 2016, JAMA-J AM MED ASSOC, V316, P1205, DOI 10.1001/jama.2016.11409; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Traumatic Brain Injury Model Systems Program, 2019, TRAUMATIC BRAIN INJU; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	61	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	MAY	2021	104								106332	10.1016/j.cct.2021.106332			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	UP3HB	WOS:000695272900003	33652127				2022-02-07	
J	Fuller, GW; Gardner, A; Tucker, R; Douglas, M; Readhead, C; McDonald, W; Murphy, I; Saco, M; Raftery, M; Falvey, E				Fuller, Gordon Ward; Gardner, Andrew; Tucker, Ross; Douglas, Marc; Readhead, Clint; McDonald, Warren; Murphy, Ian; Saco, Marcelo; Raftery, Martin; Falvey, Eanna			Expansion of cognitive testing for off-field concussion screening in elite rugby players: A cohort study	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; Screening; Sensitivity; Specificity; Agreement; Rugby	COLOR-WORD TEST; TRAUMATIC BRAIN-INJURY; TRAIL; INTERFERENCE; SPORT; DISEASE; TIME	Objectives: Current off-field concussion screening instruments have sub-optimal accuracy and additional testing domains may be necessary to detect the full spectrum of concussion presentations. This study aimed to determine if additional cognitive tests add utility to off-field screening for sport-related concussion. Design: Reproducibility and diagnostic accuracy cohort studies were performed in the 2017 and 2018 seasons of the Super Rugby competition, conducted in Argentina, Australia, Japan, New Zealand, and South Africa. Methods: Abridged versions of Stroop (score, time), Spatial Memory (score, failed trials), and Trail Making Trial-B (time, errors) cognitive tests, modified for off-field use, were examined. Players performed baseline testing prior to each season. Cases undergoing off-field screening as part of the World Rugby Head Injury Assessment Process underwent evaluation with the same cognitive tests during competition matches. Agreement between repeated pre-season baseline measurements, and the diagnostic accuracy of off-field testing against a clinical reference standard of concussion, was evaluated. Results: Data were available for repeated preseason baseline testing in 644 players, and 100 cases undergoing off field concussion screening. There was little individual agreement across pre-season baseline assessments for all tests (Lin's correlation and Gwets AC1 coefficients ranging between 0.2 and 0.3). There was significantly worse performance for the time taken to complete the modified Stroop Test in concussed players undergoing off field screening, compared to non-concussed players (median time 21.1 v 18.4 s, p < 0.01; area under the receiver operating characteristic curve 0.7 (95% CI 0.5-0.8)). Other cognitive measures did not discriminate between injured and un-injured players, with no-statistically significant differences in distribution medians (p = 0.6-0.9) and AUROC values close to 0.5. Conclusions: The time taken to perform a modified Stroop Test may provide additional diagnostic accuracy if added to current off-field concussion screening tools. Abridged Spatial Memory and Trail Making Trial-B tests did not discriminate between concussed and non-concussed players. (c) 2021 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Fuller, Gordon Ward] Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Gardner, Andrew] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Hunter New England Local Hlth Dist Sports Concuss, Newcastle, NSW, Australia; [Tucker, Ross] Univ Cape Town, Sch Management Studies, Cape Town, South Africa; [Douglas, Marc; Raftery, Martin; Falvey, Eanna] World Rugby, Dublin, Ireland; [Readhead, Clint] SARU, Cape Town, South Africa; [McDonald, Warren] Rugby Australia, Moore Park, Australia; [Murphy, Ian] New Zealand Rugby, Auckland, New Zealand; [Saco, Marcelo] Union Argentina Rugby, Buenos Aires, DF, Argentina		Fuller, GW (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England.	g.fuller@sheffield.ac.uk; Andrew.Gardner@newcastle.edu.au; Ross.tucker@mweb.co.za; marcelo.saco@uar.com.ar; ClintR@sarugby.co.za; warren.mcdonald@rugby.com.au; ian.murphy@wdhb.org.nz; marcelo.saco@uar.com.ar; Martin.Raftery@worldrugby.org; Eanna.Falvey@worldrugby.org		Gardner, Andrew/0000-0001-5031-5586; Fuller, Gordon Ward/0000-0001-8532-3500; Falvey, Eanna/0000-0003-3961-1805; McDonald, Warren/0000-0002-3337-2922	World Rugby	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Data collection was supported by World Rugby. World Rugby had no influence in the study design, data collection, analysis, interpretation of data, or in writing the manuscript.	Armengol CG, 2002, CLIN NEUROPSYCHOL, V16, P67, DOI 10.1076/clin.16.1.67.8337; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Bigler ED, 2015, NEUROPATHOLOGY MILD; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; Brooks A, 2014, BR J SPORTS MED, V48, P573, DOI DOI 10.1136/BJSPORTS-2014-093494.38; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Corsi PM., 1973, HUMAN MEMORY MEDIAL THESIS MCGILL U MONT; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; FUKUI T, 1994, EUR NEUROL, V34, P272, DOI 10.1159/000117055; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller GW, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-019-0231-y; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Heaton RK, 1991, COMPREHENSIVE NORMS; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; KOSS E, 1984, INT J NEUROSCI, V24, P53, DOI 10.3109/00207458409079534; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Leiter RG., 1949, PSYCHOL SERVICE CTR, V1, P11; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Sisco SM, 2016, CLIN NEUROPSYCHOL, V30, P1104, DOI 10.1080/13854046.2016.1188989; Soukup V M, 1998, Appl Neuropsychol, V5, P65, DOI 10.1207/s15324826an0502_2; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Woods DL, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00690; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	35	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2021	24	12					1204	1210		10.1016/j.jsams.2021.06.002			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	WQ3FK	WOS:000713704700004	34247976				2022-02-07	
J	Geeraerts, T				Geeraerts, Thomas			Life threatening emergency and non-invasive monitoring: For initial management of the brain injured patient	ANESTHESIE & REANIMATION			French	Article						Brain ultrasound; Intracranial hypertension; Optic nerve sheath; diameter; Transcranial Doppler; Traumatic brain injury	NERVE SHEATH DIAMETER; TRANSCRANIAL DOPPLER; INTRACRANIAL-PRESSURE; ULTRASOUND; SONOGRAPHY	Transcranial Doppler (TCD) allows the non-invasive measurement of red blood cell velocity in the large cerebral arteries. The mean velocity (Vm) measured by Doppler is a surrogate marker of cerebral blood flow. For the middle cerebral artery, measurement of the pulsatility index (PI, normal value for the middle cerebral artery = 1.0 +/- 0.2) and diastolic velocity (Vd, normal value for the middle cerebral artery = 40 +/- 10 cm/s) allows estimation of cerebral distal resistances and perfusion pressure. Patients at risk of intracranial hypertension should undergo TCD in emergency to estimate cerebral blood flow. Ocular ultrasound with measurement of the optic nerve sheath diameter, an indicator of cerebrospinal fluid pressure, can be used to estimate the risk of intracranial hypertension. A normal optic nerve sheath diameter on ocular ultrasound can rule out intracranial hypertension.	[Geeraerts, Thomas] CHU Toulouse, Pole Anesthesie Reanimat, F-31059 Toulouse, France		Geeraerts, T (corresponding author), CHU Toulouse, Pole Anesthesie Reanimat, F-31059 Toulouse, France.	geeraerts.t@chu-toulouse.fr					AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Blehar DJ, 2008, J ULTRAS MED, V27, P407, DOI 10.7863/jum.2008.27.3.407; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Canepa CA, 2019, HIGH ALT MED BIOL, V20, P103, DOI 10.1089/ham.2018.0121; Chan PYN, 2008, HONG KONG J EMERG ME, V15, P197, DOI 10.1177/102490790801500402; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Dentinger A, 2018, ACTA NEUROCHIR SUPPL, V126, P97, DOI 10.1007/978-3-319-65798-1_21; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Gerber S, 2017, LECT NOTES COMPUT SC, V10549, P113, DOI 10.1007/978-3-319-67552-7_14; Hansen HC, 2011, ACTA OPHTHALMOL, V89, pE528, DOI 10.1111/j.1755-3768.2011.02159.x; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Houze-Cerfon CH, 2019, PREHOSP EMERG CARE, V23, P277, DOI 10.1080/10903127.2018.1501444; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Orban JC, 2012, TRANSPLANTATION, V94, P585, DOI 10.1097/TP.0b013e3182612947; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Safety Grp British Med Ultrasound, 2010, ULTRASOUND, V18, P52, DOI 10.1258/ult.2010.100003; Shrestha GS, 2018, INDIAN J CRIT CARE M, V22, P646, DOI 10.4103/ijccm.IJCCM_104_18; Sirek AS, 2014, AVIAT SPACE ENVIR MD, V85, P3, DOI 10.3357/ASEM.3750.2014; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Topcuoglu MA, 2015, J NEUROIMAGING, V25, P906, DOI 10.1111/jon.12233; Verdonck P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111916	24	0	0	1	1	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	2352-5800	2352-5819		ANESTH REANIM	Anesth. Reanim.	MAY	2021	7	3					230	235		10.1016/j.anrea.2021.04.009			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	SF4ON	WOS:000652737300006					2022-02-07	
J	Godoy, DA; Badenes, R; Murillo-Cabezas, F				Godoy, D. A.; Badenes, R.; Murillo-Cabezas, F.			Ten physiological commandments for severe head injury	REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION			Spanish	Article						Severe head trauma; Physiopathology; Intracranial hypertension; Cerebral hypoxia; Physiological neuroprotection	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; MANAGEMENT; METABOLISM; HYPOXIA; LACTATE	Advances in multiparametric brain monitoring have allowed us to deepen our knowledge of the physiopathology of head injury and how it can be treated using the therapies available today. It is essential to understand and interpret a series of basic physiological and physiopathological principles that, on the one hand, provide an adequate metabolic environment to prevent worsening of the primary brain injury and favour its recovery, and on the other hand, allow therapeutic resources to be individually adapted to the specific needs of the patient. Based on these notions, this article presents a decalogue of the physiological objectives to be achieved in brain injury, together with a series of diagnostic and therapeutic recommendations for achieving these goals. We emphasise the importance of considering and analysing the physiological variables involved in the transport of oxygen to the brain, such as cardiac output and arterial oxygen content, together with their conditioning factors and possible alterations. Special attention is paid to the basic elements of physiological neuroprotection, and we describe the multiple causes of cerebral hypoxia, how to approach them, and how to correct them. We also examine the increase in intracranial pressure as a physiopathological element, focussing on the significance of thoracic and abdominal pressure in the interpretation of intracranial pressure. Treatment of intracranial pressure should be based on a step-wise model, the first stage of which should be based on a physiopathological reflection combined with information on the tomographic lesions rather than on rigid numerical values. (C) 2020 Sociedad Espanola de Anestesiologia, Reanimacion y Terapeutica del Dolor. Published by Elsevier Espana, S.L.U. All rights reserved.	[Godoy, D. A.] Sanat Pasteur, Unidad Cuidados Neurointens, Catamarca, Argentina; [Godoy, D. A.] Hosp San Juan Bautista, Unidad Terapia Intens, Catamarca, Argentina; [Badenes, R.] Hosp Clin Univ Valencia, Serv Anestesiol & Reanimac, Valencia, Spain; [Badenes, R.] Univ Valencia, Dept Cirugia, Valencia, Spain; [Badenes, R.] Inst Invest Sanitaria Valencia INCLIVA, Valencia, Spain; [Murillo-Cabezas, F.] Univ Seville, Dept Med, Seville, Spain		Godoy, DA (corresponding author), Sanat Pasteur, Unidad Cuidados Neurointens, Catamarca, Argentina.; Godoy, DA (corresponding author), Hosp San Juan Bautista, Unidad Terapia Intens, Catamarca, Argentina.	dagodoytorres@yahoo.com.ar		Badenes, Rafael/0000-0001-7017-0150			Godoy DA, 2018, NEUROSURG CLIN N AM, V29, P195, DOI 10.1016/j.nec.2017.12.001; Godoy DA, 2017, NEUROL CLIN, V35, P613, DOI 10.1016/j.ncl.2017.06.002; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Dominguez-Roldan JM, INT CONSENSUS MONITO; Dunser MW, 2013, CRIT CARE, V17, DOI 10.1186/cc12727; Garcia-Alvarez M, 2014, LANCET DIABETES ENDO, V2, P339, DOI 10.1016/S2213-8587(13)70154-2; Godoy DA, 2020, GEN CARE MANAGEMENT; Godoy DA, 2020, MED INTENSIVA, DOI [10.1016/j.medin.2020.02.003.S0210-5691(20)30055-3, DOI 10.1016/J.MEDIN.2020.02.003.S0210-5691(20)30055-3]; Godoy DA, 2016, CURR OPIN CRIT CARE, V22, P120, DOI 10.1097/MCC.0000000000000292; Hallisey SD, 2019, EMERG MED CLIN N AM, V37, P395, DOI 10.1016/j.emc.2019.03.005; Hilz MJ, 2019, CLIN AUTON RES, V29, P301, DOI 10.1007/s10286-018-0545-8; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Lazaridis C, 2020, NEUROCRIT CARE, V32, P672, DOI 10.1007/s12028-020-00940-4; Lazaridis C, 2017, J CRIT CARE, V37, P230, DOI 10.1016/j.jcrc.2016.09.027; Magistretti PJ, 2018, NAT REV NEUROSCI, V19, P235, DOI 10.1038/nrn.2018.19; Malbrain ML, ANN INTENSIVE CARE; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Monro A., 1823, OBSERVATIONS STRUCTU, P5; Nourallah B, 2018, ACTA NEUROCHIR, V160, P1315, DOI 10.1007/s00701-018-3555-3; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Pinsky MR, 2007, CHEST, V132, P2020, DOI 10.1378/chest.07-0073; Prabhakar H, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010026.pub2; Revuelto-Rey J, 2012, MED INTENSIVA, V36, P213, DOI 10.1016/j.medin.2011.08.002; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sahuquillo J, J NEUROSURG; Sandfort V, J INTENSIVE CARE MED; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Sav A, 2019, PITUITARY, V22, P201, DOI 10.1007/s11102-019-00958-8; Smith M, 2018, ANESTHESIOLOGY, V128, P401, DOI 10.1097/ALN.0000000000001885; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; The Committee on Trauma, 2018, ATLS R ADV TRAUM LIF; Veenith TV, JAMA NEUROL; Vik A, J NEUROSURG; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	48	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0034-9356	2340-3284		REV ESP ANEST REANIM	Rev. Esp. Anestesiol. Reanim.	MAY	2021	68	5					280	292		10.1016/j.redar.2020.09.005			13	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	RQ2OP	WOS:000642259700004	33487456				2022-02-07	
J	Gopal, S; Rudrappa, S; Sekar, A; Preethish-Kumar, V; Masapu, D				Gopal, Swaroop; Rudrappa, Satish; Sekar, Arunkumar; Preethish-Kumar, Veeramani; Masapu, Dheeraj			Customized and Cost-Effective 3D Printed Mold for Cranioplasty: India's First Single Center Experience	NEUROLOGY INDIA			English	Article						3D cranioplasty; 3D molds; PEEK; PMMA	BONE FLAP; RECONSTRUCTION; IMPLANTS; PRESERVATION; DEFECTS; REPAIR	Context: Autologous bone is the most commonly used flap in cranioplasty to repair the defect; however, synthetic materials are available. Poly methyl methacrylate (PMMA) is an effective polymer owing to its thermoplastic and radiolucent properties comparable to bone strength. Three-dimensional (3D) printing combined with computer-assisted design (CAD) is a simple, low-cost method to print molds that ensure surgical success. Materials and Methods: A total of 114 patients underwent cranioplasty (July 2015-April 2018), and 25 of them using 3D printed template molds due to unavailability of autologous bone. The clinical features, patient demographics, and surgical parameters were analyzed. The visual analog score for cosmesis (VASC) and Odom's score was obtained pre and post-op. Results: The mean age of the patients is 38.4 +/- 14.6 years (Range, 9-66). The primary pathology for undergoing craniectomy is stroke (n = 13; 52%), traumatic brain injury (10; 40%) and tumor (2; 8%). The reason for nonavailability of flap was infection (n = 14;56%), flap resorption (4;16%), and trauma or tumor (7;28%). The mean time for manufacturing the 3D printed template is 13.2 +/- 2.1 h. On follow-up, median Odom's score is excellent in 52% of cases, good in 40%, and fair in 8%. The mean VASC score on follow up is 8.2 +/- 1.3. Three patients developed minor postoperative complications. Conclusion: This is the first study from a single tertiary care center in India to systematically evaluate the outcomes in 3D cranioplasty using CAD and 3D printing technology. This method would be optimal especially in developing countries since PMMA is cost effective and also gives an ideal cosmetic effect.	[Gopal, Swaroop; Rudrappa, Satish; Sekar, Arunkumar] Sakra World Hosp, Inst Neurosci, Dept Neurosurg, Bengaluru 560103, Karnataka, India; [Preethish-Kumar, Veeramani] Sakra World Hosp, Inst Neurosci, Dept Neurol, Bengaluru, Karnataka, India; [Masapu, Dheeraj] Sakra World Hosp, Inst Neurosci, Dept Neuroanasthesia, Bengaluru, Karnataka, India		Gopal, S (corresponding author), Sakra World Hosp, Inst Neurosci, Dept Neurosurg, Bengaluru 560103, Karnataka, India.	swaroopdr@gmail.com		Sekar, Arunkumar/0000-0001-9664-6620			Baldia M, 2017, NEUROL INDIA, V65, P660, DOI 10.4103/neuroindia.NI_210_16; Baldo S, 2010, WORLD NEUROSURG, V73, P552, DOI 10.1016/j.wneu.2010.02.018; Chan DYC, 2017, J CLIN NEUROSCI, V42, P81, DOI 10.1016/j.jocn.2017.04.016; Durand J L, 1997, Ann Chir Plast Esthet, V42, P75; Ernst G, 2018, J NEUROSURG, V129, P1604, DOI 10.3171/2017.6.JNS17943; Goh RCW, 2010, J PLAST RECONSTR AES, V63, P1479, DOI 10.1016/j.bjps.2009.08.010; Goiato MC, 2009, J CRANIOFAC SURG, V20, P1512, DOI 10.1097/SCS.0b013e3181b09b9a; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Honeybul S, 2018, ACTA NEUROCHIR, V160, P885, DOI 10.1007/s00701-018-3514-z; Huang GJ, 2015, J CRANIOFAC SURG, V26, P68, DOI 10.1097/SCS.0000000000001315; Iaccarino C, 2015, J ORAL MAXIL SURG, V73, P2375, DOI 10.1016/j.joms.2015.07.008; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Kim BJ, 2012, J KOREAN NEUROSURG S, V52, P541, DOI 10.3340/jkns.2012.52.6.541; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Luo JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.2.FOCUS129; Malcolm JG, 2018, WORLD NEUROSURG, V116, P60, DOI 10.1016/j.wneu.2018.05.009; MANKOVICH NJ, 1994, OTOLARYNG CLIN N AM, V27, P875; Marbacher S, 2012, NEUROSURG REV, V35, P527, DOI 10.1007/s10143-012-0376-3; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Pandey A, 2018, B WORLD HEALTH ORGAN, V96, P18, DOI 10.2471/BLT.17.191759; Pankratiev BE, 1933, ANN SURG, V97, P321, DOI 10.1097/00000658-193303000-00001; Parthiban JKBC, 2004, NEUROL INDIA, V52, P520; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Rotaru H, 2012, J ORAL MAXIL SURG, V70, pE169, DOI 10.1016/j.joms.2011.09.036; Selvam MM, 2020, NEUROL INDIA, V68, P71, DOI 10.4103/0028-3886.279662; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86; Stieglitz LH, 2014, ACTA NEUROCHIR, V156, P793, DOI 10.1007/s00701-013-1977-5; van de Vijfeijken SECM, 2018, WORLD NEUROSURG, V117, P443, DOI 10.1016/j.wneu.2018.05.193; Vougioukas VI, 2004, NEUROSURGERY, V55, P162, DOI 10.1227/01.NEU.0000126940.20441.E7; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025	34	0	0	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAY-JUN	2021	69	3					611	617		10.4103/0028-3886.319221			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TK1PJ	WOS:000673939000011	34169853				2022-02-07	
J	Hanas, JS; Hocker, JRS; Vannarath, CA; Lerner, MR; Blair, SG; Lightfoot, SA; Hanas, RJ; Couch, JR; Hershey, LA				Hanas, Jay S.; Hocker, James R. S.; Vannarath, Christian A.; Lerner, Megan R.; Blair, Scott G.; Lightfoot, Stan A.; Hanas, Rushie J.; Couch, James R.; Hershey, Linda A.			Distinguishing Alzheimer's Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis	BRAIN SCIENCES			English	Article						Alzheimer's disease (AD); biochemical phenotype analysis; serum profiling; mass spectrometry; VWF; ADAMTS13 axis; traumatic brain injury (TBI); SSPO AD biomarker	MILD COGNITIVE IMPAIRMENT; VON-WILLEBRAND-FACTOR; BRAIN-INJURY; PET; IDENTIFICATION; ASSOCIATION; VALIDATION; DEFICIENCY; PREDICTION; BIOMARKERS	It is important to develop minimally invasive biomarker platforms to help in the identification and monitoring of patients with Alzheimer's disease (AD). Assisting in the understanding of biochemical mechanisms as well as identifying potential novel biomarkers and therapeutic targets would be an added benefit of such platforms. This study utilizes a simplified and novel serum profiling platform, using mass spectrometry (MS), to help distinguish AD patient groups (mild and moderate) and controls, as well as to aid in understanding of biochemical phenotypes and possible disease development. A comparison of discriminating sera mass peaks between AD patients and control individuals was performed using leave one [serum sample] out cross validation (LOOCV) combined with a novel peak classification valuation (PCV) procedure. LOOCV/PCV was able to distinguish significant sera mass peak differences between a group of mild AD patients and control individuals with a p value of 10(-13). This value became non-significant (p = 0.09) when the same sera samples were randomly allocated between the two groups and reanalyzed by LOOCV/PCV. This is indicative of physiological group differences in the original true-pathology binary group comparison. Similarities and differences between AD patients and traumatic brain injury (TBI) patients were also discernable using this novel LOOCV/PCV platform. MS/MS peptide analysis was performed on serum mass peaks comparing mild AD patients with control individuals. Bioinformatics analysis suggested that cell pathways/biochemical phenotypes affected in AD include those involving neuronal cell death, vasculature, neurogenesis, and AD/dementia/amyloidosis. Inflammation, autoimmunity, autophagy, and blood-brain barrier pathways also appear to be relevant to AD. An impaired VWF/ADAMTS13 vasculature axis with connections to F8 (factor VIII) and LRP1 and NOTCH1 was indicated and is proposed to be important in AD development.	[Hanas, Jay S.; Hocker, James R. S.; Vannarath, Christian A.; Hanas, Rushie J.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73104 USA; [Hanas, Jay S.; Lerner, Megan R.; Blair, Scott G.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73104 USA; [Hanas, Jay S.; Lightfoot, Stan A.] Vet Adm Hosp, Oklahoma City, OK 73104 USA; [Couch, James R.; Hershey, Linda A.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK 73104 USA		Hanas, JS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73104 USA.; Hanas, JS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73104 USA.; Hanas, JS (corresponding author), Vet Adm Hosp, Oklahoma City, OK 73104 USA.	Jay-Hanas@ouhsc.edu; James-Hocker@ouhsc.edu; Christian-Vannarath@ouhsc.edu; Megan-Lerner@ouhsc.edu; Scott-Blair@ouhsc.edu; SL20008bl@outlook.com; Rushie99@gmail.com; James-Couch@ouhsc.edu; linda-hershey@ouhsc.edu	Hocker, James R.S./G-7217-2018; Hocker, James Randolph Sanders/AAV-4893-2020	Hocker, James R.S./0000-0002-7111-9119; Hocker, James Randolph Sanders/0000-0002-7111-9119; Couch, James/0000-0003-3033-3482; Hershey, Linda/0000-0001-5090-6634	Oklahoma Center for Neurosciences	This study was funded by a grant from the Oklahoma Center for Neurosciences to J.S.H. and L.A.H.	Alliey-Rodriguez N., 2017, COMMON VARIANTS NRXN, DOI [10.1101/175489, DOI 10.1101/175489]; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Badea A, 2021, MAGN RESON IMAGING, V76, P26, DOI 10.1016/j.mri.2020.09.023; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P4, DOI 10.1186/1471-2288-2-4; Banks WA, 2015, PEPTIDES, V72, P16, DOI 10.1016/j.peptides.2015.03.010; Bastaki F, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0429-0; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Cedazo-Minguez A, 2010, EXP GERONTOL, V45, P5, DOI 10.1016/j.exger.2009.09.008; Chang KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054448; Chen YC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081124; Chew EGY, 2019, NEUROBIOL AGING, V74, DOI 10.1016/j.neurobiolaging.2018.09.013; Cohen J, 1998, STAT POWER ANAL BEHA; Crehan H, 2012, IMMUNOBIOLOGY, V217, P244, DOI 10.1016/j.imbio.2011.07.017; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dobson-Stone C, 2020, BRAIN, V143, P783, DOI 10.1093/brain/awaa039; Ewers M, 2007, NEUROLOGY, V69, P2205, DOI 10.1212/01.wnl.0000286944.22262.ff; Fontana GA, 2018, MICROB CELL, V5, P327, DOI 10.15698/mic2018.07.639; Frentzou GA, 2012, J MOL NEUROSCI, V46, P343, DOI 10.1007/s12031-011-9591-6; Gabin JM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0262-x; Galluzzi S, 2016, J INTERN MED, V279, P576, DOI 10.1111/joim.12482; Gragnano F, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5620314; Guan W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-259; Hampel H, 2018, NAT REV NEUROL, V14, P639, DOI 10.1038/s41582-018-0079-7; Hanas JS, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10080504; Hanas JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215762; Hanas JS, 2018, EXP PARASITOL, V192, P98, DOI 10.1016/j.exppara.2018.07.015; Hocker JR, 2017, CANCER INVEST, V35, P573, DOI 10.1080/07357907.2017.1373120; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Katsel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007642; Koldamova R, 2014, NEUROBIOL DIS, V63, P107, DOI 10.1016/j.nbd.2013.11.005; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Landau SM, 2013, ANN NEUROL, V74, P826, DOI 10.1002/ana.23908; Lin L, 2020, J PROTEOMICS, V215, DOI 10.1016/j.jprot.2020.103671; Linder B, 2015, FEBS LETT, V589, P1598, DOI 10.1016/j.febslet.2015.04.052; Liu YS, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2089-4; Llano DA, 2013, ALZ DIS ASSOC DIS, V27, P233, DOI 10.1097/WAD.0b013e31826d597a; Lunnon K, 2017, NEUROBIOL AGING, V53, P36, DOI 10.1016/j.neurobiolaging.2016.12.029; Manderstedt E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216179; Mazza M, 2011, J ALZHEIMERS DIS, V23, P375, DOI 10.3233/JAD-2010-090700; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miloudi K, 2019, P NATL ACAD SCI USA, V116, P4538, DOI 10.1073/pnas.1814711116; MORRIS JC, 1993, NEUROLOGY, V43, P2457, DOI 10.1212/WNL.43.12.2457; Moscoso A, 2021, JAMA NEUROL, V78, P396, DOI 10.1001/jamaneurol.2020.4986; Nettiksimmons J, 2015, NEUROLOGY, V84, P696, DOI 10.1212/WNL.0000000000001263; Noh Y, 2014, NEUROLOGY, V83, P1936, DOI 10.1212/WNL.0000000000001003; Okamura N, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0500-6; Palmqvist S, 2020, JAMA-J AM MED ASSOC, V324, P772, DOI 10.1001/jama.2020.12134; Palmqvist S, 2015, NEUROLOGY, V85, P1240, DOI 10.1212/WNL.0000000000001991; Paris D, 2010, J NEUROSCI, V30, P11251, DOI 10.1523/JNEUROSCI.2586-10.2010; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Pottier C, 2018, LANCET NEUROL, V17, P548, DOI 10.1016/S1474-4422(18)30126-1; Rabinovici GD, 2011, NEUROLOGY, V77, P2034, DOI 10.1212/WNL.0b013e31823b9c5e; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Randi AM, 2018, BLOOD, V132, P132, DOI 10.1182/blood-2018-01-769018; Ransohoff DF, 2004, GASTROENTEROLOGY, V127, P1028, DOI 10.1053/j.gastro.2004.08.030; Rowe CC, 2013, ANN NEUROL, V74, P905, DOI 10.1002/ana.24040; Sakka L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093179; Schiele F, 2000, ATHEROSCLEROSIS, V152, P475, DOI 10.1016/S0021-9150(99)00501-8; Schindler SE, 2019, NEUROLOGY, V93, pE1647, DOI 10.1212/WNL.0000000000008081; Soper D., 2018, POSTHOC STAT POWER C; Stampfer MJ, 2006, J INTERN MED, V260, P211, DOI 10.1111/j.1365-2796.2006.01687.x; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Vachani A, 2015, J THORAC ONCOL, V10, P629, DOI 10.1097/JTO.0000000000000447; Valenzuela PL, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101108; Wang WZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00376-6; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wolters FJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23865-7; Xin SH, 2018, NEUROTOX RES, V34, P733, DOI 10.1007/s12640-018-9895-1; Xu FL, 2020, ARCH BIOCHEM BIOPHYS, V680, DOI 10.1016/j.abb.2019.108224; Yamazaki Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091965; Ye KQ, 2005, J CELL BIOCHEM, V96, P463, DOI 10.1002/jcb.20549; Yu Q, 2018, EXP NEUROL, V302, P145, DOI 10.1016/j.expneurol.2018.01.009; Zander CB, 2015, CURR OPIN HEMATOL, V22, P452, DOI 10.1097/MOH.0000000000000169; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zhou YT, 2008, NEUROSCI LETT, V444, P109, DOI 10.1016/j.neulet.2008.07.093; Zhu GJ, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009040; Zhu SW, 2020, J ADV RES, V23, P113, DOI 10.1016/j.jare.2020.01.016	80	0	0	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAY	2021	11	5							583	10.3390/brainsci11050583			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SG6TA	WOS:000653573200001	33946285	Green Published			2022-02-07	
J	Hoursan, H; Farahmand, F; Ahmadian, MT; Masjoodi, S				Hoursan, H.; Farahmand, F.; Ahmadian, M. T.; Masjoodi, S.			Anisotropic finite element modelling of traumatic brain injury: A voxel-based approach	SCIENTIA IRANICA			English	Article						3D head model; Traumatic brain injury; Finite element; Anisotropy; Heterogeneity	AXONAL STRAIN; HEAD; PREDICTORS; GENERATION	A computationally efficient 3D human head finite element model was constructed. The model includes the mesoscale geometrical details of the brain including the distinction between white and grey matter, sulci and gyri, the ventricular system, foramen magnum, and cerebrospinal fluid. The heterogeneity and anisotropy from diffusion tensor imaging data were incorporated by applying a one-to-one voxel-based correspondence between diffusion voxels and finite elements. The voxel resolution of the model was optimized to obtain a trade-off between reduced computational cost and higher geometrical details. Three sets of constitutive material properties were extracted from the literature to validate the model against intra-cranial pressure and relative motion test data within the brain. The model exhibited good agreement at pressure tests in frontal and occipital lobes with peak pressure magnitudes of only 8% and 6% higher, which occurred 0.5-3 ms earlier than those of the experimental curves at coup and countercoup sites, respectively. In addition, evaluation of the relative displacement at six locations within the brain indicated acceptable agreement with experimental data. The performance of the authors' model exhibited the highest overall score compared to several previous models, using the correlation and analysis rating method. (C) 2021 Sharif University of Technology. All rights reserved.	[Hoursan, H.; Farahmand, F.; Ahmadian, M. T.] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Farahmand, F.] Univ Tehran Med Sci, RCBTR, Tehran, Iran; [Masjoodi, S.] Univ Tehran Med Sci, Dept Med Phys & Biomed Engn, Sch Med, Tehran, Iran		Ahmadian, MT (corresponding author), Sharif Univ Technol, Dept Mech Engn, Tehran, Iran.	Hesam.hoursan74@student.sharif.edu; Farahmand@sharif.edu; Ahmadian@sharif.edu; Sadeghmasjoodi@gmail.com	Masjoodi, Sadegh/ABD-9783-2021	Masjoodi, Sadegh/0000-0002-5277-9453	INSF (Iran National Science Foundation)Iran National Science Foundation (INSF)	This research has been supported by the INSF (Iran National Science Foundation)	Afshari J., 2019, SCI IRANICA T B, V27, P1867; Bhateja A, 2009, INDIAN J NEUROTRAUM, V6, P115, DOI 10.1016/S0973-0508(09)80004-X; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fung Y.C., 1981, BIOMECHANICS MECH PR; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gehre C., 2009, 21 ESV C JUN 15; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Ho J, 2009, INT J CRASHWORTHINES, V14, P555, DOI 10.1080/13588260902895708; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Hoursan H, 2020, SCI IRAN, V27, P784, DOI 10.24200/sci.2018.50940.1928; Hoursan H., 2015, P ASME 2015 INT DES, DOI [10.1115/DETC2015-46555, DOI 10.1115/DETC2015-46555]; Hoursan H., 2013, ASME 2013 INT MECH E; Hoursan H., 2018, CSME SCGM2018; Hoursan H, 2020, ANN BIOMED ENG, V48, P1337, DOI 10.1007/s10439-020-02458-4; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Karimi A, 2017, COMPUT METHOD BIOMEC, V20, P1350, DOI 10.1080/10255842.2017.1362694; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Leemans A., 2009, 17 ANN M INT SOC MAG, DOI DOI 10.1093/OCCMED/KQR069; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Miller L.E., 2016, ANATOMICALLY ACCURAT; Nahum AM, 1977, SAE TECHNICAL PAPER; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Pearce CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114292; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Razaghi R, 2019, COMPUT METH PROG BIO, V176, P9, DOI 10.1016/j.cmpb.2019.04.015; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Saboori P, 2011, SCI IRAN, V18, P1492, DOI 10.1016/j.scient.2011.11.032; Sepehrband F, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00059; Shafiee A., 2015, MODARES MECH ENG, V15, P248; Takhounts EG, 2008, STAPP CAR C, V52, P1; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou Z, 2019, J NEUROTRAUM, V36, P2099, DOI 10.1089/neu.2018.6143	45	0	0	2	2	SHARIF UNIV TECHNOLOGY	TEHRAN	PO BOX 11155-8639, TEHRAN, 00000, IRAN	1026-3098			SCI IRAN	Sci. Iran.	MAY-JUN	2021	28	3					1271	1283		10.24200/sci.2020.54280.3685			13	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	TP3GE	WOS:000677481100005					2022-02-07	
J	Kanarskii, M; Nekrasova, J; Vitkovskaya, S; Pradhan, P; Peshkov, S; Borisova, E; Borisov, I; Panasenkova, O; Petrova, MV; Pryanikov, I				Kanarskii, Mikhail; Nekrasova, Julia; Vitkovskaya, Svetlana; Pradhan, Pranil; Peshkov, Sergey; Borisova, Elena; Borisov, Ilya; Panasenkova, Olga; Petrova, Marina V.; Pryanikov, Igor			Effect of Retinohypothalamic Tract Dysfunction on Melatonin Level in Patients with Chronic Disorders of Consciousness	BRAIN SCIENCES			English	Article						melatonin; chronic disorder of consciousness; anoxia; traumatic brain injury; ophthalmology; retinohypothalamic tract	VEGETATIVE STATE; SLEEP	Objective: The aim of this study is to compare the secretion level of nocturnal melatonin and the characteristics of the peripheral part of the visual analyzer in patients with chronic disorders of consciousness (DOC). Materials and Methods: We studied the level of melatonin in 22 patients with chronic DOC and in 11 healthy volunteers. The fundus condition was assessed using the ophthalmoscopic method. Results: The average level of nocturnal melatonin in patients with DOC differed by 80% from the level of indole in healthy volunteers. This reveals a direct relationship between etiology, the level of consciousness, gaze fixation, coma recovery scale-revised score and the level of melatonin secretion. Examination by an ophthalmologist revealed a decrease in the macular reflex in a significant number of DOC patients, which in turn correlates negatively with the time from brain injury and positively with low values of nocturnal melatonin.	[Kanarskii, Mikhail; Nekrasova, Julia; Vitkovskaya, Svetlana; Pradhan, Pranil; Peshkov, Sergey; Borisova, Elena; Borisov, Ilya; Panasenkova, Olga; Petrova, Marina V.; Pryanikov, Igor] Fed Res & Clin Ctr Intens Care Med & Rehabilitol, Dept Study Chron Disorder Consciousness, Moscow 117647, Russia; [Petrova, Marina V.] Peoples Friendship Univ Russia, Dept Anestesiol Reanimatol, Moscow 117198, Russia		Pradhan, P (corresponding author), Fed Res & Clin Ctr Intens Care Med & Rehabilitol, Dept Study Chron Disorder Consciousness, Moscow 117647, Russia.	kanarmm@yandex.ru; nekrasova84@yandex.ru; svitkovskaya@fnkcrr.ru; pranilpr@gmail.com; speshkov@fnkcrr.ru; eborisova@fnkcrr.ru; realzel@gmail.com; opanasenkova@fnkcrr.ru; mail@petrovamv.ru; ipryanikov@fnkcrr.ru	Borisov, Ilya/AAB-9734-2022	Borisov, Ilya/0000-0002-5707-118X; Pradhan, Pranil/0000-0002-3505-7504			Bekinschtein TA, 2009, BRAIN INJURY, V23, P915, DOI 10.1080/02699050903283197; Belkin A.A, 2017, CONS MED, V19, P19, DOI [10.26442/2075-1753_19.2.19-23, DOI 10.26442/2075-1753_19.2.19-23]; Blume C, 2019, EUR J NEUROL, V26, P1051, DOI 10.1111/ene.13935; Cipolla-Neto J, 2018, ENDOCR REV, V39, P990, DOI 10.1210/er.2018-00084; do Amaral FG, 2018, ARCH ENDOCRIN METAB, V62, P472, DOI 10.20945/2359-3997000000066; Fukudome Y, 1996, AM J PHYSIOL-REG I, V270, pR1109, DOI 10.1152/ajpregu.1996.270.5.R1109; Giacino J.T., 2004, CRS R COMA RECOVERY; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Guaraldi P, 2014, CHRONOBIOL INT, V31, P741, DOI 10.3109/07420528.2014.901972; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; Krimchansky BZ, 2006, ISR MED ASSOC J, V8, P819; Lech M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00006; Liu JB, 2016, ANNU REV PHARMACOL, V56, P361, DOI 10.1146/annurev-pharmtox-010814-124742; Mattogno PP, 2017, ACTA NEUROCHIR SUPPL, V124, P19, DOI 10.1007/978-3-319-39546-3_4; Oh AJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226197; OKA N, 1982, Neurological Surgery, V10, P157; Pavlov YG, 2017, J SLEEP RES, V26, P629, DOI 10.1111/jsr.12524; Thonnard M, 2014, BRAIN INJURY, V28, P1164, DOI 10.3109/02699052.2014.920521; Trojano L, 2012, J NEUROL, V259, P1888, DOI 10.1007/s00415-012-6435-4; Trojano L, 2018, BRAIN INJURY, V32, P1549, DOI 10.1080/02699052.2018.1504117; Wade DT, 2018, EUR J NEUROL, V25, P619, DOI 10.1111/ene.13572	21	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAY	2021	11	5							559	10.3390/brainsci11050559			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SG7EP	WOS:000653603400001	33925097	gold, Green Published			2022-02-07	
J	Kim, DK; Lee, DH; Lee, BK; Cho, YS; Ryu, SJ; Jung, YH; Lee, JH; Han, JH				Kim, Dong-Ki; Lee, Dong-Hun; Lee, Byung-Kook; Cho, Yong-Soo; Ryu, Seok-Jin; Jung, Yong-Hun; Lee, Ji-Ho; Han, Jun-Ho			Performance of Modified Early Warning Score (MEWS) for Predicting In-Hospital Mortality in Traumatic Brain Injury Patients	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; scoring system; modified early warning score; mortality	BLOOD-PRESSURE; SHOCK INDEX; HYPOTHERMIA; TEMPERATURE; DISCHARGE; SEVERITY; OUTCOMES	The present study aimed to analyze and compare the prognostic performances of the Revised Trauma Score (RTS), Injury Severity Score (ISS), Shock Index (SI), and Modified Early Warning Score (MEWS) for in-hospital mortality in patients with traumatic brain injury (TBI). This retrospective observational study included severe trauma patients with TBI who visited the emergency department between January 2018 and December 2020. TBI was considered when the Abbreviated Injury Scale was 3 or higher. The primary outcome was in-hospital mortality. In total, 1108 patients were included, and the in-hospital mortality was 183 patients (16.3% of the cohort). Receiver operating characteristic curve analyses were performed for the ISS, RTS, SI, and MEWS with respect to the prediction of in-hospital mortality. The area under the curves (AUCs) of the ISS, RTS, SI, and MEWS were 0.638 (95% confidence interval (CI), 0.603-0.672), 0.742 (95% CI, 0.709-0.772), 0.524 (95% CI, 0.489-0.560), and 0.799 (95% CI, 0.769-0.827), respectively. The AUC of MEWS was significantly different from the AUCs of ISS, RTS, and SI. In multivariate analysis, age (odds ratio (OR), 1.012; 95% CI, 1.000-1.023), the ISS (OR, 1.040; 95% CI, 1.013-1.069), the Glasgow Coma Scale (GCS) score (OR, 0.793; 95% CI, 0.761-0.826), and body temperature (BT) (OR, 0.465; 95% CI, 0.329-0.655) were independently associated with in-hospital mortality after adjustment for confounders. In the present study, the MEWS showed fair performance for predicting in-hospital mortality in patients with TBI. The GCS score and BT seemed to have a significant role in the discrimination ability of the MEWS. The MEWS may be a useful tool for predicting in-hospital mortality in patients with TBI.	[Kim, Dong-Ki; Lee, Dong-Hun; Lee, Byung-Kook; Cho, Yong-Soo; Ryu, Seok-Jin; Jung, Yong-Hun; Lee, Ji-Ho; Han, Jun-Ho] Chonnam Natl Univ, Dept Emergency Med, Sch Med, 160 Baekseo Ro, Gwangju 61469, South Korea		Lee, DH (corresponding author), Chonnam Natl Univ, Dept Emergency Med, Sch Med, 160 Baekseo Ro, Gwangju 61469, South Korea.	lifelorddg@naver.com; ggodhkekf@hanmail.com; bbukkuk@hanmail.net; semi-moon@hanmail.net; samahalak@naver.com; xnxn77@hanmail.net; rake21c@naver.com; ckris12345@naver.com		Lee, DongHun/0000-0003-3612-3443; Kim, Dong Ki/0000-0003-4069-1902			Asmar S, 2021, J SURG RES, V257, P493, DOI 10.1016/j.jss.2020.07.062; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Chu WT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59044-w; De Tanti A, 2005, BRAIN INJURY, V19, P1277, DOI 10.1080/02699050500309270; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dubendorfer C, 2013, EUR J TRAUMA EMERG S, V39, P25, DOI 10.1007/s00068-012-0212-z; Frohlich M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0340-2; Gaither JB, 2017, PREHOSP EMERG CARE, V21, P575, DOI 10.1080/10903127.2017.1308609; Guild SJ, 2018, AM J PHYSIOL-REG I, V315, pR1049, DOI 10.1152/ajpregu.00183.2018; Han JLXG, 2017, WORLD NEUROSURG, V108, P885, DOI 10.1016/j.wneu.2017.08.147; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Kelly CA, 2004, ANN EMERG MED, V44, P108, DOI 10.1016/j.annemergmed.2004.03.028; Klauke N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009913; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Kruisselbrink R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151408; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P135, DOI 10.2147/OAEM.S179090; Martin-Rodriguez F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051504; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Najafi Z, 2018, INT EMERG NURS, V36, P27, DOI 10.1016/j.ienj.2017.08.003; Petersen LG, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14039; Powers AY, 2020, J NEUROSURG, V132, P552, DOI 10.3171/2018.11.JNS182199; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rosli D, 2020, WORLD J SURG, V44, P4106, DOI 10.1007/s00268-020-05750-5; Smith CM, 2011, PEDIATR CRIT CARE ME, V12, P449, DOI 10.1097/PCC.0b013e3181f390dd; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; van Breugel JMM, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00330-3; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011; Zhu CS, 2019, J TRAUMA ACUTE CARE, V87, pS159, DOI 10.1097/TA.0000000000002333	35	0	0	1	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAY	2021	10	9							1915	10.3390/jcm10091915			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SC0YM	WOS:000650408200001	33925023	Green Published, gold			2022-02-07	
J	Kim, E; Seo, HG; Lee, HH; Lee, SH; Choi, SH; Yoo, RE; Cho, WS; Yun, SJ; Kang, MG; Oh, BM				Kim, Eunkyung; Seo, Han Gil; Lee, Hyun Haeng; Lee, Seung Hak; Choi, Seung Hong; Yoo, Roh-Eul; Cho, Won-Sang; Yun, Seo Jung; Kang, Min-Gu; Oh, Byung-Mo			Reduced Brainstem Volume After Mild Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Concussion; Traumatic Brain Injury; Magnetic Resonance Imaging; Neuroimaging	GRAY-MATTER VOLUME; AXONAL INJURY; HEAD-INJURY; MRI; CONSCIOUSNESS; REGISTRATION; THALAMUS; MODERATE; TIME	Objective The aims of this study were to investigate changes in regional brain volume after concussion (mild traumatic brain injury) and to examine the relationship between change in brain volume and cognitive deficits. Design Twenty-eight patients with mild traumatic brain injury and 27 age-matched controls were included in this study. Magnetic resonance imaging (3 T) data were obtained from the participants. Structural brain volume changes were examined using tensor-based morphometry, which identifies regional structural differences in the whole brain, including cerebrospinal fluid, gray matter, and white matter. Volume contraction and expansion were compared between groups using a two-sample t test. The association between time post-injury or neurocognitive function and volumetric changes was examined using regression analysis. Results Individuals with mild traumatic brain injury exhibited volume reduction in the brainstem, including the pontine reticular formation. Regional cerebral volume changes were not associated with time post-injury but were significantly associated with neurocognitive function, especially with executive card sorting test, forward digit span test, and performance on verbal learning test. The greater regional cerebral volume was associated with better cognitive performance after mild traumatic brain injury. Conclusion Decreased brainstem volume may indicate its vulnerability to traumatic injury, and cerebral volume in specific regions was positively associated with patients' cognitive function after injury.	[Kim, Eunkyung; Seo, Han Gil; Lee, Hyun Haeng; Lee, Seung Hak; Yun, Seo Jung; Kang, Min-Gu; Oh, Byung-Mo] Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul, South Korea; [Kim, Eunkyung] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Choi, Seung Hong; Yoo, Roh-Eul] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Cho, Won-Sang] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Lee, Hyun Haeng] Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea; [Lee, Hyun Haeng] Konkuk Univ, Med Ctr, Seoul, South Korea; [Lee, Seung Hak] Univ Ulsan, Coll Med, Dept Rehabil Med, Asan Med Ctr, Seoul, South Korea; [Choi, Seung Hong; Yoo, Roh-Eul] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Dept Rehabil Med, Coll Med, Seoul, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Inst Aging, Seoul, South Korea; [Oh, Byung-Mo] Natl Traff Injury Rehabil Hosp, Yangpyeong, South Korea		Oh, BM (corresponding author), Seoul Natl Univ Hosp, Dept Rehabil, 103 Daehak Ro, Seoul 03080, South Korea.	eunkyung@snu.ac.kr; hangilseo@snu.ac.kr; happyhaeng@gmail.com; seunghak@gmail.com; verocay1@snu.ac.kr; jakeunkong@naver.com; nsdrcho@gmail.com; sjselena0611@gmail.com; kangmingu.ryan@gmail.com; keepwiz@gmail.com		Kang, Min-Gu/0000-0002-0680-9607; Kim, Eunkyung/0000-0001-6264-722X			Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bar KJ, 2016, NEUROIMAGE, V134, P53, DOI 10.1016/j.neuroimage.2016.03.071; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Boisgontier MP, 2017, NEUROBIOL AGING, V50, P47, DOI 10.1016/j.neurobiolaging.2016.10.024; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Ha KS, 2002, J KOREAN NEUROPSYCHI, V41, P335; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Khan AR, 2015, NEUROBIOL AGING, V36, pS60, DOI 10.1016/j.neurobiolaging.2014.04.036; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; Kim E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091318; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kwon JS, 2002, J KOREAN NEUROPSYCHI, V41, P347; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Lyoo IK, 2002, J KOREAN NEUROPSYCHI, V41, P538; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Moe HK, 2018, J NEUROTRAUM, V35, P975, DOI 10.1089/neu.2017.5252; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; NESTOR PG, 1993, AM J PSYCHIAT, V150, P1849; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Singh P, 2016, NEURAL REGEN RES, V11, P920, DOI 10.4103/1673-5374.184487; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P315, DOI 10.1007/s002130050351; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	42	0	0	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY	2021	100	5					473	482		10.1097/PHM.0000000000001580			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	RN2KW	WOS:000640181900018	32889861	hybrid, Green Published			2022-02-07	
J	Krasna, D; Montgomery, E; Koffer, J; Segal, M				Krasna, Daniel; Montgomery, Erica; Koffer, Jacob; Segal, Miriam			Bilateral chorea following severe traumatic brain injury treated with risperidone	BMJ CASE REPORTS			English	Article						neurology (drugs and medicines); trauma; movement disorders (other than Parkinsons); trauma CNS; PNS; rehabilitation medicine	MOVEMENT-DISORDERS; HEAD-INJURY	A functionally independent man in his 20s with a history of intellectual disability and epilepsy and family history of Huntington's disease suffered a severe traumatic brain injury. Postinjury, bilateral chorea rendered him dependent for all activities of daily living. Risperidone provided a significant reduction of chorea, decreasing the overall burden of care. Movement disorders are a common sequela of brain injury. Currently, there are no best treatment guidelines for chorea in patients with brain injury. To the authors' knowledge there have been no case reports describing the effects of brain injury on patients with a primary movement disorder. Risperidone was an effective treatment in this case. Further research is needed to establish guidelines for treatment of movement disorders following brain injury and to better understand the effect of brain injuries on primary movement disorders.	[Krasna, Daniel; Montgomery, Erica; Koffer, Jacob; Segal, Miriam] Moss Rehabil Hosp, Phys Med & Rehabil, Elkins Pk, PA 19027 USA		Krasna, D (corresponding author), Moss Rehabil Hosp, Phys Med & Rehabil, Elkins Pk, PA 19027 USA.	krasna.daniel@gmail.com		Krasna, Daniel/0000-0001-8555-8289			Coppen EM, 2017, DRUGS, V77, P29, DOI 10.1007/s40265-016-0670-4; Fhan S., 2011, PRINCIPLES PRACTICE, P335; Krauss JK, 1996, NEUROLOGY, V47, P1488, DOI 10.1212/WNL.47.6.1488; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Krauss JK., 2007, BRAIN INJURY MED PRI; O'Suilleabhain P, 2004, J HEAD TRAUMA REHAB, V19, P305, DOI 10.1097/00001199-200407000-00005	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	MAY	2021	14	5							e241929	10.1136/bcr-2021-241929			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SJ6DA	WOS:000655622200026	34011638				2022-02-07	
J	Kuo, KT; Hunter, BC; Obayashi, M; Lider, J; Teramoto, M; Cortez, M; Hansen, C				Kuo, Keith T.; Hunter, Bradley C.; Obayashi, Mizuho; Lider, Joshua; Teramoto, Masaru; Cortez, Melissa; Hansen, Colby			Novice vs expert inter-rater reliability of the balance error scoring system in children between the ages of 5 and 14	GAIT & POSTURE			English	Article						BESS; Pediatrics; Postural balance; Concussion; Inter-rater reliability	SAMPLE-SIZE REQUIREMENTS; CONCUSSION; TIME	Background: The Balance Error Scoring System (BESS) is a tool to measure balance, however, no studies have shown its reliability between novice and expert raters. Research Question: What is the inter-rater reliability of BESS measurements when performed by novice raters compared to experts, and does completion of a focused, online training module increase the inter-rater reliability among novice raters? Methods: In this reliability study, 5 novice volunteers were asked to independently rate BESS tests from 50 random prerecorded BESS videos of normal healthy subjects aged 5?14. Novice raters regraded the same 50 videos after receiving a formal training. The novices? scores before and after the formal training were compared to one another and then the scores were compared to 4 expert scores. Intraclass correlation (ICC) with 95 % confidence intervals or percent agreements were calculated and compared across groups. Results: For the total BESS score, novice raters showed good reliability (ICC 0.845) which did not change with a formal training (ICC 0.846). Expert raters showed excellent reliability (ICC 0.929). Poor to moderate reliability was noted in the foam stance-single leg in the untrained novice and trained novice group (ICCs 0.452 and 0.64 L respectively). Significance: BESS testing by novice raters with only written instruction and no formal training yields good interrater reliability. In contrast, BESS testing by expert raters yields excellent reliability. A focused training for novice raters conferred a small improvement in the reliability of the scoring of the single leg stance on foam condition but not a significant difference to the overall BESS score. While novices demonstrated promising reliability for overall BESS scores, optimizing clinical research using the BESS with expert raters show the highest reliability.	[Kuo, Keith T.; Lider, Joshua; Teramoto, Masaru; Hansen, Colby] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA; [Hunter, Bradley C.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Obayashi, Mizuho] Johns Hopkins Univ, Krieger Sch Arts & Sci, Baltimore, MD USA; [Cortez, Melissa] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Kuo, Keith T.; Hunter, Bradley C.; Lider, Joshua; Teramoto, Masaru; Cortez, Melissa; Hansen, Colby] 30 North 1900 East, Salt Lake City, UT 84132 USA; [Obayashi, Mizuho] 3400 N Charles St, Baltimore, MD 21218 USA		Kuo, KT (corresponding author), Div Phys Med & Rehabil, 30 North 1900 East, Salt Lake City, UT 84132 USA.	keith.kuo@hsc.utah.edu	Cortez, Melissa/AAC-3475-2021	Cortez, Melissa/0000-0001-5015-441X; Kuo, Keith/0000-0002-3155-1695			Bergene AC, 2016, NORD J WORKING LIFE, V6, P5, DOI 10.19154/njwls.v6i1.4907; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Bruton A., 2000, PHYSIOTHERAPY, V86, P94, DOI [DOI 10.1016/S0031-9406(05)61211-4, 10.1016/S0031-9406(05)61211-4]; Bujang MA, 2017, ARCH OROFAC SCI, V12, P1; Concussion S., 2013, NIH CONSENSUS STATE, P259; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hansen C, 2017, CLIN J SPORT MED, V27, P64, DOI 10.1097/JSM.0000000000000293; Houston MN, 2019, ANN BIOMED ENG, V47, P2128, DOI 10.1007/s10439-019-02274-5; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Shoukri MM, 2004, STAT METHODS MED RES, V13, P251, DOI 10.1191/0962280204sm365ra; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd	23	0	0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	MAY	2021	86						13	16		10.1016/j.gaitpost.2021.02.026			4	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	RT3WY	WOS:000644394000003	33668005				2022-02-07	
J	Kwon, E; Holdsworth, S; Guild, SJ; Scadeng, M; Jayatissa, S; Kollarczik, L; Tayebi, M; Rosset, S; Shim, V				Kwon, Eryn; Holdsworth, Samantha; Guild, Sarah-Jane; Scadeng, Miriam; Jayatissa, Sahan; Kollarczik, Leon; Tayebi, Maryam; Rosset, Samuel; Shim, Vickie			Analyzing the changes in the brain material properties after a mild traumatic brain injury-A pilot study	ENGINEERING REPORTS			English	Article						animal study; brain material properties; traumatic brain injury	MECHANICAL-PROPERTIES; TISSUE; BEHAVIOR	Traumatic brain injury (TBI) is a major health challenge, is very difficult to diagnose, and currently has no accepted treatment options. The difficulty in diagnosis is due to the complex pathophysiology of TBI, where the damage mechanisms span multiple spatial and temporal scales and ultimately manifest as diverse cognitive impairments in brain function. The speed and dynamic nature with which the mechanical insults occur in TBI means that computational models are the best candidate to mimic the in vivo event and to investigate the injury progression in detail. A current weakness in TBI computational models is the poor understanding of how material properties within different regions of the brain change after damage. Here, we developed an animal experiment pipeline where a controlled and reproducible mechanical insult can be applied to a sheep brain in vivo followed by ex vivo compression mechanical testing. For each brain, the compression mechanical testing was conducted across the length of the brain to assess baseline regional variations in material properties and how these properties changed after mechanical impact. Using this pipeline, we have characterized locational variations in the brain material properties both pre and post-TBI. Our preliminary results confirm that there exist locational variations in the brain material properties across all regions of cerebrum. The analysis of post-TBI tissues showed that compressive strength was reduced in the area nearest the direct impact.	[Kwon, Eryn; Guild, Sarah-Jane; Jayatissa, Sahan; Kollarczik, Leon; Tayebi, Maryam; Rosset, Samuel; Shim, Vickie] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand; [Kwon, Eryn; Holdsworth, Samantha; Scadeng, Miriam] Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Med Imaging, Auckland, New Zealand; [Kwon, Eryn; Holdsworth, Samantha; Scadeng, Miriam] Univ Auckland, Fac Med & Hlth Sci, Ctr Brain Res, Auckland, New Zealand; [Guild, Sarah-Jane] Univ Auckland, Dept Physiol, Auckland, New Zealand		Shim, V (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand.	v.shim@auckland.ac.nz		Shim, Vickie Bo Kyung/0000-0002-1680-4287	Ministry of Business, Innovation and EmploymentNew Zealand Ministry of Business, Innovation and Employment (MBIE) [PROP-55749-INTCS-UOA]; University of Auckland Faculty Research Development Fund [3716749]	Ministry of Business, Innovation and Employment, Grant/Award Number: PROP-55749-INTCS-UOA; University of Auckland Faculty Research Development Fund, Grant/Award Number: 3716749	Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Champagne AA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz021; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Estes M., 1970, MECH ENG; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Makdissi M, 2015, AAN ENTERPRISES, V5, P2; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; O'Brien HE, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1567-1; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2013, J BIOMECH, V46, P1276, DOI 10.1016/j.jbiomech.2013.02.014; Shim VB, 2020, IEEE ACCESS, V8, P179457, DOI 10.1109/ACCESS.2020.3026350; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Zillmer EA, 2003, APPL NEUROPSYCHOL, V10, P1, DOI 10.1207/S15324826AN1001_1	35	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2577-8196		ENG REP	Eng. Rep.	MAY	2021	3	5							e12332	10.1002/eng2.12332			15	Computer Science, Interdisciplinary Applications; Engineering, Multidisciplinary; Materials Science, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Computer Science; Engineering; Materials Science	SL0HI	WOS:000656597300003		gold			2022-02-07	
J	Laeke, T; Tirsit, A; Kassahun, A; Sahlu, A; Debebe, T; Yesehak, B; Masresha, S; Deyassa, N; Moen, BE; Lund-Johansen, M; Sundstrom, T				Laeke, Tsegazeab; Tirsit, Abenezer; Kassahun, Azarias; Sahlu, Abat; Debebe, Tequam; Yesehak, Betelehem; Masresha, Samuel; Deyassa, Negussie; Moen, Bente E.; Lund-Johansen, Morten; Sundstrom, Terje			Prospective Study of Surgery for Traumatic Brain Injury in Addis Ababa, Ethiopia: Trauma Causes, Injury Types, and Clinical Presentation	WORLD NEUROSURGERY			English	Article						Head injury; Epidemiology; Low-and middle-income countries; Neurotrauma; Traumatic brain injury	EPIDEMIOLOGY; NEUROTRAUMA; MANAGEMENT; MORTALITY; PATTERNS; SYSTEMS	BACKGROUND: Traumatic brain injury (TBI) is a public health problem in Ethiopia. More knowledge about the epidemiology and neurosurgical management of TBI patients is needed to identify possible focus areas for quality improvement and preventive efforts. METHODS: This prospective cross-sectional study (2012-2016) was performed at the 4 teaching hospitals in Addis Ababa, Ethiopia. All surgically treated TBI patients were included, and data on clinical presentation, injury types, and trauma causes were collected. RESULTS: We included 1087 patients (mean age 29 years; 8.7% females; 17.1% <18 years old). Only 15.5% of TBIs were classified as severe (Glasgow Coma Scale score 3-8). Depressed skull fracture (44.9%) and epidural hematoma (39%) were the most frequent injuries. Very few patients had polytrauma (3.1%). Assault was the most common injury mechanism (69.9%) followed by road traffic accidents (15.8%) and falls (8.1%). More than 80% of patients came from within 200 km of the hospitals, but the median time to admission was 24 hours. Most assault victims (80.4%) were injured >50 km from the hospitals, whereas 46% of road traffic accident victims came from the -rban area. Delayed admission was associated with higher Glasgow Coma Scale scores and nonsevere TBI (P < 0.01). CONCLUSIONS: The injury panorama, delayed admission, and small number of operations performed for severe TBI are linked to a substantial patient selection bias both before and after hospital admission. Our results also suggest that there should be a geographical framework for tailored guidelines, preventive efforts, and development of prehospital and hospital services.	[Laeke, Tsegazeab; Tirsit, Abenezer; Kassahun, Azarias; Sahlu, Abat; Yesehak, Betelehem; Masresha, Samuel] Addis Ababa Univ, Neurosurg Unit, Dept Surg, Addis Ababa, Ethiopia; [Debebe, Tequam] Addis Ababa Univ, Dept Radiol, Addis Ababa, Ethiopia; [Deyassa, Negussie] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Laeke, Tsegazeab; Tirsit, Abenezer; Lund-Johansen, Morten; Sundstrom, Terje] Univ Bergen, Dept Clin Med, Bergen, Norway; [Moen, Bente E.] Univ Bergen, Fac Med, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Lund-Johansen, Morten; Sundstrom, Terje] Haukeland Hosp, Dept Neurosurg, Bergen, Norway		Laeke, T (corresponding author), Addis Ababa Univ, Neurosurg Unit, Dept Surg, Addis Ababa, Ethiopia.; Laeke, T (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	tselaeke@gmail.com					Abebe M, 2011, E CENT AFR J SURG, P16; [Anonymous], 2009, GLOB STAT REP ROAD S; Azaj A., 2013, East and Central African Journal of Surgery, V18, P108; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Central Statistical Agency [Ethiopa], 2014, ETH MIN DEM HLTH SUR; Chattopadhyay Saurabh, 2010, J Inj Violence Res, V2, P99, DOI 10.5249/jivr.v2i2.46; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Elahi C, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.7.FOCUS19316; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Hunchak Cheryl, 2015, BMC Res Notes, V8, P605, DOI 10.1186/s13104-015-1592-z; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jin MC, 2021, J NEUROSURG, V134, P1929, DOI 10.3171/2020.4.JNS193092; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Laeke T, WORLD NEUROSURG; Laeke T, 2019, WORLD NEUROSURG, V127, pE186, DOI 10.1016/j.wneu.2019.03.044; Lalloo R, 2004, SAMJ S AFR MED J, V94, P544; Lund-Johansen M, 2017, WORLD NEUROSURG, V99, P403, DOI 10.1016/j.wneu.2016.12.051; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Malomo TA, 2018, J NEUROSCI RURAL PRA, V9, P545, DOI 10.4103/jnrp.jnrp_502_17; Meskere Yehune, 2015, Ethiop Med J, V53, P141; Nakahara S, 2010, HEALTH POLICY PLANN, V25, P319, DOI 10.1093/heapol/czp063; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Olldashi F, 2019, WORLD NEUROSURG, V128, pE340, DOI 10.1016/j.wneu.2019.04.150; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sagaro GG, 2020, TELEMED REP, V1, P8; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Solano EE, 2017, E CENT AFR J SURG, P22; Tadesse S, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0107-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; United Nations Department of Economic and Social Affairs Population Dynamics, WORLD POP PROSP; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	36	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E460	E468		10.1016/j.wneu.2021.02.003			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YJ3CH	WOS:000744410900013					2022-02-07	
J	Laeke, T; Tirsit, A; Kassahun, A; Sahlu, A; Debebe, T; Yesehak, B; Masresha, S; Deyassa, N; Moen, BE; Lund-Johansen, M; Sundstrom, T				Laeke, Tsegazeab; Tirsit, Abenezer; Kassahun, Azarias; Sahlu, Abat; Debebe, Tequam; Yesehak, Betelehem; Masresha, Samuel; Deyassa, Negussie; Moen, Bente E.; Lund-Johansen, Morten; Sundstrom, Terje			Prospective Study of Surgery for Traumatic Brain Injury in Addis Ababa, Ethiopia: Trauma Causes, Injury Types, and Clinical Presentation	WORLD NEUROSURGERY			English	Article						Epidemiology; Head injury; Low-and middle-income countries; Neurotrauma; Traumatic brain injury	EPIDEMIOLOGY; NEUROTRAUMA; MANAGEMENT; MORTALITY; PATTERNS; SYSTEMS	BACKGROUND: Traumatic brain injury (TBI) is a public health problem in Ethiopia. More knowledge about the epidemiology and neurosurgical management of TBI patients is needed to identify possible focus areas for quality improvement and preventive efforts. METHODS: This prospective cross-sectional study (2012-2016) was performed at the 4 teaching hospitals in Addis Ababa, Ethiopia. All surgically treated TBI patients were included, and data on clinical presentation, injury types, and trauma causes were collected. RESULTS: We included 1087 patients (mean age 29 years; 8.7% females; 17.1% <18 years old). Only 15.5% of TBIs were classified as severe (Glasgow Coma Scale score 3-8). Depressed skull fracture (44.9%) and epidural hematoma (39%) were the most frequent injuries. Very few patients had polytrauma (3.1%). Assault was the most common injury mechanism (69.9%) followed by road traffic accidents (15.8%) and falls (8.1%). More than 80% of patients came from within 200 km of the hospitals, but the median time to admission was 24 hours. Most assault victims (80.4%) were injured >50 km from the hospitals, whereas 46% of road traffic accident victims came from the urban area. Delayed admission was associated with higher Glasgow Coma Scale scores and nonsevere TBI (P < 0.01). CONCLUSIONS: The injury panorama, delayed admission, and small number of operations performed for severe TBI are linked to a substantial patient selection bias both before and after hospital admission. Our results also suggest that there should be a geographical framework for tailored guidelines, preventive efforts, and development of prehospital and hospital services.	[Laeke, Tsegazeab; Tirsit, Abenezer; Kassahun, Azarias; Sahlu, Abat; Yesehak, Betelehem; Masresha, Samuel] Addis Ababa Univ, Coll Hlth Sci, Surg Dept, Neurosurg Unit, Addis Ababa, Ethiopia; [Debebe, Tequam] Addis Ababa Univ, Coll Hlth Sci, Dept Radiol, Addis Ababa, Ethiopia; [Deyassa, Negussie] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Laeke, Tsegazeab; Tirsit, Abenezer; Lund-Johansen, Morten; Sundstrom, Terje] Univ Bergen, Fac Med, Dept Clin Med, Bergen, Norway; [Moen, Bente E.] Univ Bergen, Fac Med, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Lund-Johansen, Morten; Sundstrom, Terje] Haukeland Hosp, Dept Neurosurg, Bergen, Norway		Laeke, T (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Surg Dept, Neurosurg Unit, Addis Ababa, Ethiopia.; Laeke, T (corresponding author), Univ Bergen, Fac Med, Dept Clin Med, Bergen, Norway.	tselaeke@gmail.com	Moen, BE/P-9329-2017	Admasu, Azarias/0000-0001-6404-9135; Laeke, Tsegazeab/0000-0003-4287-1413; Moen, Bente Elisabeth/0000-0002-0435-3124			Abebe M, 2011, E CENT AFR J SURG, V16; [Anonymous], 2009, GLOB STAT REP ROAD S; Azaj A, 2013, E CENT AFR J SURG, P18; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Central Statistical Agency [Ethiopia], 2014, ETH MIN HLTH SURV 20; Chattopadhyay Saurabh, 2010, J Inj Violence Res, V2, P99, DOI 10.5249/jivr.v2i2.46; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Elahi C, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.7.FOCUS19316; Ethiopia, ETHIOPIA RURAL POPUL; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Hunchak Cheryl, 2015, BMC Res Notes, V8, P605, DOI 10.1186/s13104-015-1592-z; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jin MC, 2021, J NEUROSURG, V134, P1929, DOI 10.3171/2020.4.JNS193092; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Laeke T, 2021, WORLD NEUROSURG, DOI [10.1016/j.wneu.2021.02.003, DOI 10.1016/j.wneu.2021.02.003]; Laeke T, 2019, WORLD NEUROSURG, V127, pE186, DOI 10.1016/j.wneu.2019.03.044; Lalloo R, 2004, SAMJ S AFR MED J, V94, P544; Lund-Johansen M, 2017, WORLD NEUROSURG, V99, P403, DOI 10.1016/j.wneu.2016.12.051; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Malomo TA, 2018, J NEUROSCI RURAL PRA, V9, P545, DOI 10.4103/jnrp.jnrp_502_17; Meskere Yehune, 2015, Ethiop Med J, V53, P141; Nakahara S, 2010, HEALTH POLICY PLANN, V25, P319, DOI 10.1093/heapol/czp063; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Olldashi F, 2019, WORLD NEUROSURG, V128, pE340, DOI 10.1016/j.wneu.2019.04.150; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sagaro GG, 2020, TELEMED REP, V1, P8; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Solano EE, 2017, E CENT AFR J SURG, P22; Tadesse S, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0107-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; United Nations Department of Economic and Social Affairs Population Dynamics, WORLD POP PROSP; WorldHealth Organization, GLOB BURD DIS GBD	37	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E460	E468		10.1016/j.wneu.2021.02.003			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TF2NY	WOS:000670549900013					2022-02-07	
J	Lee, S; Wilkins, N; Schmit, BD; Kurpad, SN; Budde, MD				Lee, Seongtaek; Wilkins, Natasha; Schmit, Brian D.; Kurpad, Shekar N.; Budde, Matthew D.			Relationships between spinal cord blood flow measured with flow-sensitive alternating inversion recovery (FAIR) and neurobehavioral outcomes in rat spinal cord injury	MAGNETIC RESONANCE IMAGING			English	Article						Spinal cord injury (SCI); Arterial spin labeling (ASL); Flow-sensitive alternating inversion recovery (FAIR); Spinal cord blood flow (SCBF); And T1-relaxation time		In the traumatically injured spinal cord, decreased perfusion is believed to contribute to secondary tissue damage beyond the primary mechanical impact, and restoration of perfusion is believed to be a promising therapeutic target. However, methods to monitor spinal cord perfusion non-invasively are limited. Perfusion magnetic resonance imaging (MRI) techniques established for the brain have not been routinely adopted to the spinal cord. The purpose of this study was to examine the relationship between spinal cord blood flow (SCBF) and injury severity in a rat thoracic spinal cord contusion injury (SCI) model using flow-sensitive alternating inversion recovery (FAIR) with two variants of the label position. SCBF as a marker of severity was compared to T1 mapping and to spinal cord-optimized diffusion weighted imaging (DWI) with filtered parallel apparent diffusion coefficient. Thirty-eight rats underwent a T10 contusion injury with varying severities (8 sham; 10 mild; 10 moderate; 10 severe) with MRI performed at 1 day post injury at the lesion site and follow-up neurological assessments using the Basso, Beattie, Bresnahan (BBB) locomotor scoring up to 28 days post injury. Using whole cord regions of interest at the lesion epicenter, SCBF was decreased with injury severity and had a significant correlation with BBB scores at 28 days post injury. Importantly, estimates of arterial transit times (ATT) in the injured spinal cord were not altered after injury, which suggests that FAIR protocols optimized to measure SCBF provide more value in the context of acute traumatic injury to the cord. T1 -relaxation time constants were strongly related to injury severity and had a larger extent of changes than either SCBF or DWI measures. These findings suggest that perfusion decreases in the spinal cord can be monitored non-invasively after injury, and multi-parametric MRI assessments of perfusion, diffusion, and relaxation capture unique features of the pathophysiology of preclinical injury.	[Lee, Seongtaek; Schmit, Brian D.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Lee, Seongtaek; Schmit, Brian D.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Lee, Seongtaek; Wilkins, Natasha; Kurpad, Shekar N.; Budde, Matthew D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Kurpad, Shekar N.; Budde, Matthew D.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA		Lee, S (corresponding author), Zablocki VA Med Ctr, Neurosci Res Labs, Res 151,5000 West Natl Ave, Milwaukee, WI 53295 USA.	seolee@mcw.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS109090]	This project was funded by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS109090. We thank Matt Runquist and Qian (Kathleen) Yin for their assistance with MRI.	[Anonymous], 2021, MAGN RESON IMAGING, V78, P42; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Budde MD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00706; Desai RA, 2020, ANN NEUROL, V88, P123, DOI 10.1002/ana.25749; Duhamel G, 2010, P INT SOC MAG RESON, V18, P442; Duhamel G, 2008, MAGN RESON MED, V59, P846, DOI 10.1002/mrm.21567; Duhamel G, 2009, MAGN RESON MED, V62, P430, DOI 10.1002/mrm.22015; Gallagher MJ, 2019, J NEUROTRAUM, V36, P919, DOI 10.1089/neu.2018.5961; GUHA A, 1989, STROKE, V20, P372, DOI 10.1161/01.STR.20.3.372; Harteveld AA, 2020, MAGN RESON MATER PHY, V33, P81, DOI 10.1007/s10334-019-00806-7; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; HICKEY R, 1986, STROKE, V17, P1183, DOI 10.1161/01.STR.17.6.1183; Hirschler L, 2018, MAGN RESON MED, V79, P1314, DOI 10.1002/mrm.26767; HOLTZ A, 1988, ACTA PHYSIOL SCAND, V133, P485, DOI 10.1111/j.1748-1716.1988.tb08432.x; Izumi S, 2010, J THORAC CARDIOV SUR, V139, P1261, DOI 10.1016/j.jtcvs.2009.08.038; Karadimas SK, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6524; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Kise Y, 2015, J THORAC CARDIOV SUR, V149, P360, DOI 10.1016/j.jtcvs.2014.09.121; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; Lynch J, 2017, SPINAL CORD, V55, P964, DOI 10.1038/sc.2017.56; Mazensky D, 2017, ANAT REC, V300, P2091, DOI 10.1002/ar.23694; Muradov JM, 2013, J NEUROTRAUM, V30, P840, DOI 10.1089/neu.2012.2670; Narayana P, 1999, MAGN RESON MED, V41, P315, DOI 10.1002/(SICI)1522-2594(199902)41:2<315::AID-MRM15>3.3.CO;2-2; Pell GS, 1999, MAGN RESON MED, V41, P829; Popa Constantin, 2010, J Med Life, V3, P275; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; RUBINSTEIN A, 1990, NEUROSURGERY, V27, P882, DOI 10.1227/00006123-199012000-00004; SANDLER AN, 1976, J NEUROSURG, V45, P647, DOI 10.3171/jns.1976.45.6.0647; Skinner NP, 2017, MAGN RESON MED, V77, P1639, DOI 10.1002/mrm.26243; Squair JW, 2017, NEUROLOGY, V89, P1660, DOI 10.1212/WNL.0000000000004519; Tachrount M, 2015, P INT SOC MAG RESON, V23, P537; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; WALLACE MC, 1986, CAN J NEUROL SCI, V13, P91, DOI 10.1017/S0317167100035976; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Wilkins N, 2020, J NEUROTRAUM, V37, P889, DOI 10.1089/neu.2019.6731	39	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	MAY	2021	78						42	51		10.1016/j.mri.2021.02.004			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	RB3WZ	WOS:000632046300005	33556483				2022-02-07	
J	Li, LL; Yerra, L; Chang, B; Mathur, V; Nguyen, A; Luo, J				Li, Lulin; Yerra, Lakshmi; Chang, Betty; Mathur, Vidhu; Nguyen, Andy; Luo, Jian			Acute and late administration of colony stimulating factor 1 attenuates chronic cognitive impairment following mild traumatic brain injury in mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Colony stimulating factor 1; Mild traumatic brain injury; Cognitive impairment; Memory	LONG-TERM CONSEQUENCES; POTENTIAL MECHANISMS; CSF-1 RECEPTOR; ACTIVATION; BIOMARKERS; DEFICITS; MEMORY; INFLAMMATION; BIGLYCAN; LIGANDS	Traumatic brain injury (TBI) is a leading cause of long-term neurological disability. Currently there is no effective pharmacological treatment for patients suffering from the long-lasting symptoms of TBI. We recently discovered that colony stimulating factor 1 (CSF1), an essential regulator of macrophage homeostasis, is neuroprotective and reduces neuroinflammation in two models of neurological disease in mice. Here we used a mouse model of repetitive mild TBI (mTBI) to examine whether CSF1 would attenuate cognitive deficits and improve pathological outcomes in two paradigms. In the acute paradigm, a single bolus treatment of CSF1 administered 24 h after injury significantly reduces memory impairment and astrocyte reactivity assessed 3 months later. In the chronic paradigm, the mice were tested 3 months after mTBI when they showed cognitive deficits. The mice were then randomly assigned to receive CSF1 or PBS (as control) treatment. After one month of treatment, the PBStreated mice remained cognitively impaired, but the CSF1-treated showed significant improvements in cognitive function. RNA-seq and Ingenuity Pathway Analysis reveals CSF1 treatment alters cognition- and memoryrelated transcriptomic changes and pathways. The results of this study show that acute as well as delayed CSF1 treatment attenuate chronically impaired cognitive functions and improve pathological outcomes long after mTBI. The wide therapeutic time window of CSF1, together with the fact that CSF1 is approved for human use in clinical trials, strongly supports the potential clinical usefulness of this treatment in patients with mTBI.	[Li, Lulin; Yerra, Lakshmi; Chang, Betty; Mathur, Vidhu; Nguyen, Andy; Luo, Jian] VA Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA		Luo, J (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA.	JLuo@pavir.org	Luo, Jian/B-8449-2014	Luo, Jian/0000-0002-2064-8467; li, lulin/0000-0003-3063-4293	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS092868]	We would like to thank Dr. Tony Wyss-Coray and the Wyss-Coray lab for encouragement and discussions. This work was supported by a grant from the NIH (R01NS092868, J.L).	Alberini CM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021741; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bhat SA, 2021, J NEUROCHEM, V156, P225, DOI 10.1111/jnc.14954; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chitu V, 2016, TRENDS NEUROSCI, V39, P378, DOI 10.1016/j.tins.2016.03.005; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Hu X, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01862-w; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kana V, 2019, J EXP MED, V216, P2265, DOI 10.1084/jem.20182037; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kirby ED, 2015, P NATL ACAD SCI USA, V112, P4128, DOI 10.1073/pnas.1422448112; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Luo J, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Pluvinage JV, 2019, NATURE, V568, P187, DOI 10.1038/s41586-019-1088-4; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rehman SU, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070760; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sahbaie P, 2018, J PAIN; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Sen N, 2019, NEUROSCIENTIST, V25, P420, DOI 10.1177/1073858418816611; Shansky RM, 2019, SCIENCE, V364, P825, DOI 10.1126/science.aaw7570; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tesseur I, 2017, J NEUROSCI, V37, P4584, DOI 10.1523/JNEUROSCI.2952-16.2017; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Wohleb ES, 2018, BIOL PSYCHIAT, V83, P38, DOI 10.1016/j.biopsych.2017.05.026; Wortzel HS, 2012, CURR TREAT OPTION NE, V14, P493, DOI 10.1007/s11940-012-0193-6; Xie YK, 2020, J NEUROCHEM, V152, P368, DOI 10.1111/jnc.14926; Yu XZ, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.09.021; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706	60	0	0	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAY	2021	94						274	288		10.1016/j.bbi.2021.01.022			15	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	RN9VH	WOS:000640700200006	33540074				2022-02-07	
J	Lippa, SM; Gill, J; Brickell, TA; French, LM; Lange, RT				Lippa, Sara M.; Gill, Jessica; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.			Blood Biomarkers Relate to Cognitive Performance Years after Traumatic Brain Injury in Service Members and Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						UCH-L1; GFAP; Tau; NFL; Military; Mild neurocognitive disorder	UCH-L1	Objective: This study examines the relationship of serum total tau, neurofilament light (NFL), ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), and glial fibrillary acidic protein (GFAP) with neurocognitive performance in service members and veterans with a history of traumatic brain injury (TBI). Method: Service members (n = 488) with a history of uncomplicated mild (n = 172), complicated mild, moderate, severe, or penetrating TBI (sTBI; n = 126), injured controls (n = 116), and non-injured controls (n = 74) prospectively enrolled from Military Treatment Facilities. Participants completed a blood draw and neuropsychological assessment a year or more post-injury. Six neuropsychological composite scores and presence/absence of mild neurocognitive disorder (MNCD) were evaluated. Within each group, stepwise hierarchical regression models were conducted. Results: Within the sTBI group, increased serum UCH-L1 was related to worse immediate memory and delayed memory (R (2)Delta = .065-.084, ps < .05) performance, while increased GFAP was related to worse perceptual reasoning (R (2)Delta = .030, p = .036). Unexpectedly, within injured controls, UCH-L1 and GFAP were inversely related to working memory (R (2)Delta = .052-.071, ps < .05), and NFL was related to executive functioning (R (2)Delta = .039, p = .021) and MNCD (Exp(B) = 1.119, p = .029). Conclusions: Results suggest GFAP and UCH-L1 could play a role in predicting poor cognitive outcome following complicated mild and more severe TBI. Further investigation of blood biomarkers and cognition is warranted.	[Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Room 1121,Bldg 51,8901 Wisconsin Ave, Bethesda, MD 20814 USA; [Gill, Jessica] NINR, NIH, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Brickell, Tracey A.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Falls Church, VA USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Room 1121,Bldg 51,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	sara.m.lippa.civ@mail.mil		french, louis/0000-0002-9451-0604			Ben-Porath Y. S., 2011, MMPI 2 RF MINNESOTA; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Green P, 2004, GREENS MED SYMPTOM V; Guglielmotto M, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00320; Heaton R. K., 2004, REVISED COMPREHENSIV; Lippa SM, 2020, J NEUROTRAUM, V37, P608, DOI 10.1089/neu.2019.6696; Lippa SM, 2019, J NEUROTRAUM, V36, P2190, DOI 10.1089/neu.2018.6269; Mora C., 1989, COMBAT EXPOSURE SCAL; Oeckl P, 2019, J ALZHEIMERS DIS, V67, P481, DOI 10.3233/JAD-180325; Pearson, 2009, ADV CLIN SOLUTIONS U; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Verploeg R.D., 2018, TXB CLIN NEUROPSYCHO, V2nd ed., P411; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang KK, 2017, EXPERT OPIN THER TAR, V21, P627, DOI 10.1080/14728222.2017.1321635; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2009, WECHSLER MEMORY SCAL	21	0	0	1	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2021	27	5					508	514	PII S1355617720001071	10.1017/S1355617720001071			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	SD6WJ	WOS:000651515000010	33161932				2022-02-07	
J	Meulenbroek, P; Cherney, LR				Meulenbroek, Peter; Cherney, Leora R.			Computer-based workplace communication training in persons with traumatic brain injury: The work-related communication program	JOURNAL OF COMMUNICATION DISORDERS			English	Article						Job re-entry; Communicative disorders; Speech-language pathology; Traumatic brain injury; Adult; Treatment methods	SOCIAL EFFECTIVENESS; EMOTION RECOGNITION; ABILITY; ADULTS; RETURN; PERCEPTION; OUTCOMES; SKILLS; MODEL; MIND	Objective: This proof-of-concept study presents a computer-based social communication training for spoken workplace interactions called Work-Related Communication (WoRC) training. This program implements didactic training, role-play, and immediate feedback using a simulation approach to improve spoken language performance. The unique target of this training is a category of linguistic markers called politeness markers which are essential for cooperative workplace exchanges. Methods: We recruited eight adults with chronic traumatic brain injury. All participants demonstrated reduced politeness marker use in language sampling before treatment. This study had a quasi-experimental treatment design. We measured the rate of politeness marker use (politeness markers per minute) using the Voicemail Elicitation Task and novel role-play tasks, and the La Trobe Communication Questionnaire as outcome (dependent) variables. Results: After training, participants demonstrated an increase in trained and untrained politeness marker use that was significant for the novel role-play tasks. The La Trobe Communication Questionnaire found that familiar conversation partners reported a significant increase in social communication skills. Conclusion: The WoRC program has implications for introducing a sociolinguistic foundation for social communication training in general and specifically for vocational placement.	[Meulenbroek, Peter] Univ Kentucky, Dept Commun Sci & Disorders, Lexington, KY 40507 USA; [Cherney, Leora R.] Shirley Ryan AbilityLab, Think Speak Lab, 355 East Erie, Chicago, IL 60611 USA; [Cherney, Leora R.] Northwestern Univ, Dept Phys Med & Rehabil, 710N Lake Shore Dr, Chicago, IL 60611 USA		Meulenbroek, P (corresponding author), Univ Kentucky, Coll Hlth Sci, Dept Commun Sci & Disorders, 900 Limestone Ave,Rm 124L, Lexington, KY 40507 USA.	meulenbroek@uky.edu; lcherney@sralab.org		Meulenbroek, Peter/0000-0003-4233-9910	NIDILRRUnited States Department of Health & Human Services [90SF00060100, 90AR5015]	This study was funded in part by two NIDILRR grants (lead author, PM, grant #90SF00060100 and senior author, LRC grant #90AR5015) . The authors have no conflicts of interest to report other than grant funding and the salary they receive from their employers. The authors would like to thank Dr. Leanne Togher for valuable feedback and input on the construction of this manuscript; Dr. Gilson Capilouto for her feedback on wording the general approach used by WoRC training; and Nancy Munro of MobiRole PlayTM for allowance to utilize the software. Also: All research participants for their time and volunteerism, The Center for Aphasia Research and Treatment at the Shirley Ryan AbilityLab, Punam Rahman, Victoria Galarnyk, and Lauren Siragusa.	Benjamin DJ, 2019, AM STAT, V73, P186, DOI 10.1080/00031305.2018.1543135; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bosco FM, 2018, J COMMUN DISORD, V75, P102, DOI 10.1016/j.jcomdis.2018.05.002; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burleson Brant R, 1985, J LANG SOC PSYCHOL, V4, P253, DOI [10.1177/0261927x8543006, DOI 10.1177/0261927X8543006, 10.1177/0261927X8543006]; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Chen XR, 2014, J PRAGMATICS, V71, P117, DOI 10.1016/j.pragma.2014.07.010; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Halliday G. M., 2004, INTRO FUNCTIONAL GRA; Handford Michael., 2010, LANGUAGE BUSINESS M; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Johnson JW, 2001, J APPL PSYCHOL, V86, P984, DOI 10.1037/0021-9010.86.5.984; Jones SM, 2006, HUM COMMUN RES, V32, P217, DOI 10.1111/j.1468-2958.2006.00274.x; Keating E, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00148.x; Koester, 2006, INVESTIGATING WORKPL; KOESTER A, 2010, WORKPLACE DISCOURSE; Levinson, 1987, POLITENESS SOME UNIV; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin J. R., 1992, ENGLISH TEXT SYSTEM; McDonald S, 2017, J NEUROPSYCHOL, V11, P291, DOI 10.1111/jnp.12086; Meulenbroek P, 2019, J SPEECH LANG HEAR R, V62, P3367, DOI 10.1044/2019_JSLHR-L-18-0466; Meulenbroek P, 2019, INT J SPEECH-LANG PA, V21, P128, DOI 10.1080/17549507.2019.1583281; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Munro N., 2017, MOBI ROLEPLAY; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Phillips BN, 2018, REHABIL COUNS BULL, V62, P30, DOI 10.1177/0034355217747690; Phillips BN, 2016, REHABIL COUNS BULL, V60, P16, DOI 10.1177/0034355215601073; Phillips BN, 2014, REHABIL PSYCHOL, V59, P386, DOI 10.1037/rep0000011; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Safont-Jorda Pilar, 2005, RAEL REV ELECT LINGU, V4, P1; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Schnurr S., 2013, EXPLORING PROFESSION; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Sifianou Maria, 1992, POLITENESS PHENOMENA; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Stergiou-Kita M, 2016, BRIT J OCCUP THER, V79, P309, DOI 10.1177/0308022616631759; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Stubbe M., 2003, POWER POLITENESS WOR; Tjulin A, 2010, J OCCUP REHABIL, V20, P311, DOI 10.1007/s10926-009-9209-9; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Trosborg A., 1995, INTERLANGUAGE PRAGMA; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; U.S. Centers for Medicare & Medicaid Services, 2019, MED BEN POL MAN; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Vine Bernadette, 2004, GETTING THINGS DONE; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Willing K., 1992, TALKING IT CLARIFICA; Ybarra O, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00075; Yudofsky S., 2011, TXB TRAUMATIC BRAIN, DOI [10.1176/appi.books.9781585624201.js01, DOI 10.1176/APPI.BOOKS.9781585624201.JS01]; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560	63	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	MAY-JUN	2021	91								106104	10.1016/j.jcomdis.2021.106104			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	SL1GX	WOS:000656667400003	34049089				2022-02-07	
J	Mirabet, V; Garcia, D; Roca, A; Quiroz, AR; Anton, J; Rodriguez-Cadarso, M; Ocete, D; Aranda, L; Melero, A; Guillot, AJ; Yague, N; Guillen, I; Botella, C				Mirabet, Vicente; Garcia, Daniel; Roca, Amparo; Quiroz, Arnold R.; Anton, Joan; Rodriguez-Cadarso, Miguel; Ocete, Dolores; Aranda, Lucas; Melero, Ana; Guillot, Antonio J.; Yague, Nuria; Guillen, Isabel; Botella, Carlos			Cranioplasty with Autologous Bone Flaps Cryopreserved with Dimethylsulphoxide: Does Tissue Processing Matter	WORLD NEUROSURGERY			English	Article						Autologous bone flap; Bone processing; Bone storage; Cranioplasty; Cryopreservation; Decompressive craniectomy	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; MICROBIAL-CONTAMINATION; SKULL BONE; FROZEN; RESORPTION; COMPLICATIONS; INFECTION; STROKE	OBJECTIVE: The aim of this article was to study the outcome of patients who underwent cranioplasty with cryopreserved autologous bone after decompressive craniectomy. METHODS: Data from 74 patients were retrospectively analyzed. They were divided into groups according to the storage time and the age at cranioplasty. To assess the predictive potential for complication, factors were related to successive stages (preoperative, craniectomy, tissue processing, cranioplasty, and postoperative). Cooling and warming rates applied on bone flap were calculated. The ability to inhibit microbial growth was determined exposing bone fragments to a panel of microorganisms. The concentration of antibiotics eluted from the bone was also determined. A bone explant culture method was used to detect living cells in the thawed cranial bone. RESULTS: Hydrocephalus was significantly more frequent in pediatric patients (26.7%) than in adults (5.1%). The overall rate of bone flap resorption was 21.6% (43.7% of which required reoperation). Surgical site infection after cranioplasty was detected in 6.8% of patients. There was no correlation between infection as a postoperative complication and previous microbiological-positive culture during processing. The cause of craniectomy did not influence the risk of bone flap contamination. Vancomycin was the only antibiotic detected in the supernatant where the bone was incubated. Outgrowth from bone explants was observed in 36.8% of thawed skulls. An early start of bone flap processing at the tissue bank had a positive effect on cell viability. CONCLUSIONS: The outcome after autologous cranio-plasty is a multifactorial process, which is modulated by patient-related, surgery-related, and bone-related factors.	[Mirabet, Vicente; Yague, Nuria] Ctr Transfus Comunidad Valenciana, Cell & Tissue Bank, Valencia, Spain; [Garcia, Daniel; Roca, Amparo; Quiroz, Arnold R.; Anton, Joan; Rodriguez-Cadarso, Miguel; Botella, Carlos] Hosp Univ & Politecn La Fe, Serv Microbiol, Valencia, Spain; [Ocete, Dolores; Aranda, Lucas] Consorcio Hosp Gen Univ, Serv Microbiol, Valencia, Spain; [Melero, Ana; Guillot, Antonio J.] Univ Valencia, Dept Pharm Pharmaceut Technol & Parasitol, Valencia, Spain; [Guillen, Isabel] Univ Cardenal Herrera CEU, Fac Hlth Sci, Dept Pharm, Valencia, Spain		Mirabet, V (corresponding author), Ctr Transfus Comunidad Valenciana, Cell & Tissue Bank, Valencia, Spain.	mirabet_vic@gva.es		Guillot Garcia, Antonio Jose/0000-0001-8012-326X			Anto D, 2017, J NEUROSCI RURAL PRA, V8, P595, DOI 10.4103/jnrp.jnrp_270_17; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Bhaskar IP, 2013, ACTA NEUROCHIR, V155, P367, DOI 10.1007/s00701-012-1517-8; Bhaskar IP, 2011, J CLIN NEUROSCI, V18, P1690, DOI 10.1016/j.jocn.2011.02.046; Borger V, 2016, WORLD NEUROSURG, V92, P83, DOI 10.1016/j.wneu.2016.04.113; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Calori GM, 2017, CLIN CASES MINER BON, V14, P186, DOI 10.11138/ccmbm/2017.14.1.186; Caselli-Fernandez LM, 2006, EJHP PRACT, V12, P29; Chan DYC, 2017, J CLIN NEUROSCI, V42, P81, DOI 10.1016/j.jocn.2017.04.016; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Chiang HY, 2011, J NEUROSURG, V114, P1746, DOI 10.3171/2011.1.JNS10782; Corliss B, 2016, WORLD NEUROSURG, V96, P510, DOI 10.1016/j.wneu.2016.09.025; Crotti F M, 1979, J Neurosurg Sci, V23, P289; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Fan MC, 2018, WORLD NEUROSURG, V109, pE853, DOI 10.1016/j.wneu.2017.10.112; Georgiou K, 2010, BONE, V47, pS387, DOI 10.1016/j.bone.2010.09.149; Gottsche J, 2020, J NEUROL SURG PART A, V81, P227, DOI 10.1055/s-0039-1698391; Honeybul S, 2016, BRIT J NEUROSURG, V30, P523, DOI 10.1080/02688697.2016.1187259; Iaccarino C, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01357; Im SH, 2012, J KOREAN NEUROSURG S, V52, P396, DOI 10.3340/jkns.2012.52.4.396; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Kim JH, 2019, ACTA NEUROCHIR, V161, P25, DOI 10.1007/s00701-018-3749-8; Kim JH, 2018, WORLD NEUROSURG, V115, pE111, DOI 10.1016/j.wneu.2018.03.197; Klinger DR, 2014, WORLD NEUROSURG, V82, pE525, DOI 10.1016/j.wneu.2013.08.005; Korhonen TK, 2019, ACTA NEUROCHIR, V161, P473, DOI 10.1007/s00701-018-03791-3; Korhonen TK, 2019, J NEUROSURG, V130, P1672, DOI 10.3171/2017.12.JNS172013; Lee JH, 2019, YONSEI MED J, V60, P1067, DOI 10.3349/ymj.2019.60.11.1067; Lee Si Hoon, 2014, Korean J Neurotrauma, V10, P10, DOI 10.13004/kjnt.2014.10.1.10; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x; Mirabet V, 2018, CELL TISSUE BANK, V19, P489, DOI 10.1007/s10561-018-9693-2; Mirabet V, 2011, TRANSFUSION, V51, P443, DOI 10.1111/j.1537-2995.2010.02936.x; Morton RP, 2016, J NEUROSURG, V125, P766, DOI 10.3171/2015.8.JNS151390; Park SP, 2017, J KOREAN NEUROSURG S, V60, P749, DOI 10.3340/jkns.2017.0203.002; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schutz A, 2019, J NEUROSURG, V131, P1607, DOI 10.3171/2018.6.JNS172605; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; von der Brelie C, 2016, J NEUROL SURG PART A, V77, P19, DOI 10.1055/s-0035-1558410; Walcott BP, 2013, J NEUROSURG, V118, P757, DOI 10.3171/2013.1.JNS121626; Winkler H, 2000, J ANTIMICROB CHEMOTH, V46, P423, DOI 10.1093/jac/46.3.423; Zhang J, 2017, J NEUROSURG, V127, P1449, DOI 10.3171/2016.8.JNS16204; Zheng F, 2018, J INT MED RES, V46, P2503, DOI 10.1177/0300060518755148	48	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E582	E591		10.1016/j.wneu.2021.01.131			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TF2NY	WOS:000670549900027					2022-02-07	
J	Mirabet, V; Garcia, D; Roca, A; Quiroz, AR; Anton, J; Rodriguez-Cadarso, M; Ocete, D; Aranda, L; Melero, A; Guillot, AJ; Yague, N; Guillen, I; Botella, C				Mirabet, Vicente; Garcia, Daniel; Roca, Amparo; Quiroz, Arnold R.; Anton, Joan; Rodriguez-Cadarso, Miguel; Ocete, Dolores; Aranda, Lucas; Melero, Ana; Guillot, Antonio J.; Yague, Nuria; Guillen, Isabel; Botella, Carlos			Cranioplasty with Autologous Bone Flaps Cryopreserved with Dimethylsulphoxide: Does Tissue Processing Matter	WORLD NEUROSURGERY			English	Article						Autologous bone flap; Bone processing; Bone storage; Cranioplasty; Cryopreservation; Decompressive craniectomy	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; MICROBIAL-CONTAMINATION; SKULL BONE; FROZEN; RESORPTION; COMPLICATIONS; INFECTION; STROKE	-OBJECTIVE: The aim of this article was to study the outcome of patients who underwent cranioplasty with cryopreserved autologous bone after decompressive craniectomy. -METHODS: Data from 74 patients were retrospectively analyzed. They were divided into groups according to the storage time and the age at cranioplasty. To assess the predictive potential for complication, factors were related to successive stages (preoperative, craniectomy, tissue processing, cranioplasty, and postoperative). Cooling and warming rates applied on bone flap were calculated. The ability to inhibit microbial growth was determined exposing bone fragments to a panel of microorganisms. The concentration of antibiotics eluted from the bone was also determined. A bone explant culture method was used to detect living cells in the thawed cranial bone. -RESULTS: Hydrocephalus was significantly more frequent in pediatric patients (26.7%) than in adults (5.1%). The overall rate of bone flap resorption was 21.6% (43.7% of which required reoperation). Surgical site infection after cranioplasty was detected in 6.8% of patients. There was no correlation between infection as a postoperative complication and previous microbiological-positive culture during processing. The cause of craniectomy did not influence the risk of bone flap contamination. Vancomycin was the only antibiotic detected in the supernatant where the bone was incubated. Outgrowth from bone explants was observed in 36.8% of thawed skulls. An early start of bone flap processing at the tissue bank had a positive effect on cell viability. -CONCLUSIONS: The outcome after autologous cranioplasty is a multifactorial process, which is modulated by patient-related, surgery-related, and bone-related factors.	[Mirabet, Vicente; Yague, Nuria] Ctr Transfus Comunidad Valenciana, Cell & Tissue Bank, Valencia, Spain; [Garcia, Daniel; Roca, Amparo; Quiroz, Arnold R.; Anton, Joan; Rodriguez-Cadarso, Miguel; Botella, Carlos] Hosp Univ & Politecn La Fe, Serv Neurosurg, Valencia, Spain; [Ocete, Dolores; Aranda, Lucas] Consorcio Hosp Gen Univ, Microbiol Serv, Valencia, Spain; [Melero, Ana; Guillot, Antonio J.] Univ Valencia, Dept Pharm Pharmaceut Technol & Parasitol, Valencia, Spain; [Guillen, Isabel] Univ Cardenal Herrera CEU, Dept Pharm, Fac Hlth Sci, Valencia, Spain		Mirabet, V (corresponding author), Ctr Transfus Comunidad Valenciana, Cell & Tissue Bank, Valencia, Spain.	mirabet_vic@gva.es					Anto D, 2017, J NEUROSCI RURAL PRA, V8, P595, DOI 10.4103/jnrp.jnrp_270_17; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Bhaskar IP, 2013, ACTA NEUROCHIR, V155, P367, DOI 10.1007/s00701-012-1517-8; Bhaskar IP, 2011, J CLIN NEUROSCI, V18, P1690, DOI 10.1016/j.jocn.2011.02.046; Borger V, 2016, WORLD NEUROSURG, V92, P83, DOI 10.1016/j.wneu.2016.04.113; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Calori GM, 2017, CLIN CASES MINER BON, V14, P186, DOI 10.11138/ccmbm/2017.14.1.186; Caselli-Fernandez LM, 2006, EJHP PRACT, V12, P29; Chan DYC, 2017, J CLIN NEUROSCI, V42, P81, DOI 10.1016/j.jocn.2017.04.016; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Chiang HY, 2011, J NEUROSURG, V114, P1746, DOI 10.3171/2011.1.JNS10782; Corliss B, 2016, WORLD NEUROSURG, V96, P510, DOI 10.1016/j.wneu.2016.09.025; Crotti F M, 1979, J Neurosurg Sci, V23, P289; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Fan MC, 2018, WORLD NEUROSURG, V109, pE853, DOI 10.1016/j.wneu.2017.10.112; Georgiou K, 2010, BONE, V47, pS387, DOI 10.1016/j.bone.2010.09.149; Gottsche J, 2020, J NEUROL SURG PART A, V81, P227, DOI 10.1055/s-0039-1698391; Honeybul S, 2016, BRIT J NEUROSURG, V30, P523, DOI 10.1080/02688697.2016.1187259; Iaccarino C, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01357; Im SH, 2012, J KOREAN NEUROSURG S, V52, P396, DOI 10.3340/jkns.2012.52.4.396; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Kim JH, 2019, ACTA NEUROCHIR, V161, P25, DOI 10.1007/s00701-018-3749-8; Kim JH, 2018, WORLD NEUROSURG, V115, pE111, DOI 10.1016/j.wneu.2018.03.197; Klinger DR, 2014, WORLD NEUROSURG, V82, pE525, DOI 10.1016/j.wneu.2013.08.005; Korhonen TK, 2019, ACTA NEUROCHIR, V161, P473, DOI 10.1007/s00701-018-03791-3; Korhonen TK, 2019, J NEUROSURG, V130, P1672, DOI 10.3171/2017.12.JNS172013; Lee JH, 2019, YONSEI MED J, V60, P1067, DOI 10.3349/ymj.2019.60.11.1067; Lee Si Hoon, 2014, Korean J Neurotrauma, V10, P10, DOI 10.13004/kjnt.2014.10.1.10; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x; Mirabet V, 2018, CELL TISSUE BANK, V19, P489, DOI 10.1007/s10561-018-9693-2; Mirabet V, 2011, TRANSFUSION, V51, P443, DOI 10.1111/j.1537-2995.2010.02936.x; Morton RP, 2016, J NEUROSURG, V125, P766, DOI 10.3171/2015.8.JNS151390; Park SP, 2017, J KOREAN NEUROSURG S, V60, P749, DOI 10.3340/jkns.2017.0203.002; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schutz A, 2019, J NEUROSURG, V131, P1607, DOI 10.3171/2018.6.JNS172605; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; von der Brelie C, 2016, J NEUROL SURG PART A, V77, P19, DOI 10.1055/s-0035-1558410; Walcott BP, 2013, J NEUROSURG, V118, P757, DOI 10.3171/2013.1.JNS121626; Winkler H, 2000, J ANTIMICROB CHEMOTH, V46, P423, DOI 10.1093/jac/46.3.423; Zhang J, 2017, J NEUROSURG, V127, P1449, DOI 10.3171/2016.8.JNS16204; Zheng F, 2018, J INT MED RES, V46, P2503, DOI 10.1177/0300060518755148	48	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E582	E591		10.1016/J.WNEu.2021.01.131			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YJ3CH	WOS:000744410900027					2022-02-07	
J	Moffitt, JK; Cepeda, A; Wainwright, DJ; Demian, N; Wainwright, DJ; Nguyen, PD; Teichgraeber, JF; Greives, MR				Moffitt, Joseph Kevin; Cepeda, Alfredo, Jr.; Wainwright, D'Arcy J.; Demian, Nagi; Wainwright, David J.; Nguyen, Phuong D.; Teichgraeber, John F.; Greives, Matthew R.			The Epidemiology and Management of Pediatric Maxillary Fractures	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial trauma; facial fractures; Le Fort fractures; pediatric maxillofacial trauma	FACIAL FRACTURES; MAXILLOFACIAL FRACTURES; MIDFACIAL FRACTURES; INJURIES; CHILDREN; TRAUMA; ADOLESCENTS; PATTERNS	Background: Most literature regarding traumatic Le Fort or maxillary fractures exists in the adult population, with limited information regarding the epidemiology and management of pediatric fractures. The purpose of this study was to evaluate fracture mechanism, surgical management, and associated injuries in pediatric patients with Le Fort fractures. Methods: A retrospective chart analysis of all pediatric patients age <= 18 years diagnosed with facial fractures at a single level 1 trauma center over a 10-year period (January 2006-December 2015) was performed. Demographics, fracture location, mechanism of injury, and hospital course were abstracted as well as associated injuries and need for operative management. Results: A total of 1274 patients met inclusion criteria. Sixty-nine (5.4%) presented with Le Fort fractures. Factors associated with Le Fort fractures included motor vehicle collisions (P < 0.001), increased age (P < 0.001), and traumatic brain injury (P < 0.04). Patients with Le Fort fractures were more likely to need intensive care unit admission (P < 0.001), surgical management (P < 0.001), transfusions (P < 0.001), secondary fixation surgery (P < 0.001), and have a longer length of stay (P < 0.001). Multivariate showed increased odds for increased age (OR 1.1; 95%CI 1.04-1.17) and concomitant orbit fractures (OR 8.33; 95%CI 4.08-19.34). Decreased odds were associated for all mechanisms of injury other than motor vehicle collisions (Other blunt trauma: OR 0.36; 95%CI 0.2-0.6. Penetrating trauma: OR 0.13; 95%CI 0.01-0.6). Conclusion: Maxillary or Le Fort fractures represent a small portion of pediatric facial fractures but require high rates of operative management. The high velocity required to create this fracture type is associated with significant traumatic comorbidities, which can complicate the hospital course.	[Moffitt, Joseph Kevin; Cepeda, Alfredo, Jr.; Wainwright, D'Arcy J.; Nguyen, Phuong D.; Teichgraeber, John F.; Greives, Matthew R.] Univ Texas Hlth Sci Ctr Houston, Div Pediat Plast Surg, Dept Pediat Surg, McGovern Sch Med, 6431 Fannin St, Houston, TX 77030 USA; [Moffitt, Joseph Kevin; Cepeda, Alfredo, Jr.; Wainwright, D'Arcy J.; Nguyen, Phuong D.; Teichgraeber, John F.; Greives, Matthew R.] Childrens Mem Hermann Hosp, Houston, TX USA; [Demian, Nagi] Univ Texas Hlth Sci Ctr Houston, Div Oral Maxillofacial Surg, Dept Surg, McGovern Sch Med, Houston, TX 77030 USA; [Wainwright, David J.] Univ Texas Hlth Sci Ctr Houston, Div Plast Surg, Dept Surg, McGovern Sch Med, Houston, TX 77030 USA		Greives, MR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Pediat Plast Surg, Dept Pediat Surg, McGovern Sch Med, 6431 Fannin St, Houston, TX 77030 USA.	Matthew.R.Greives@uth.tmc.edu					Bagheri SC, 2005, J ORAL MAXIL SURG, V63, P1123, DOI 10.1016/j.joms.2005.04.003; Boyette JR, 2014, OTOLARYNG CLIN N AM, V47, P747, DOI 10.1016/j.otc.2014.06.008; CURREY JD, 1975, J BONE JOINT SURG AM, V57, P810; Davidson EH, 2015, J CRANIOFAC SURG, V26, P1523, DOI 10.1097/SCS.0000000000001818; Ferreira P, 2004, BRIT J ORAL MAX SURG, V42, P501, DOI 10.1016/j.bjoms.2004.06.006; Ferreira PC, 2005, PLAST RECONSTR SURG, V115, P1500, DOI 10.1097/01.PRS.0000160268.20294.FD; Ferreira PC, 2015, J CRANIO MAXILL SURG, V43, P437, DOI 10.1016/j.jcms.2015.01.008; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Grunwaldt L, 2011, PLAST RECONSTR SURG, V128, P1263, DOI 10.1097/PRS.0b013e318230c8cf; IIZUKA T, 1995, ARCH OTOLARYNGOL, V121, P1366; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Kim DB, 1997, WESTERN J MED, V167, P100; Macmillan A, 2018, J ORAL MAXIL SURG, V76, P1044, DOI 10.1016/j.joms.2017.11.039; MCGRAW BL, 1990, ARCH OTOLARYNGOL, V116, P41; Moffitt JK, 2019, J CRANIOFAC SURG, V30, P854, DOI 10.1097/SCS.0000000000005245; Naran S, 2014, PLAST RECONSTR SURG, V133, P364, DOI 10.1097/01.prs.0000436842.07871.b6; Phillips Bradley J, 2017, Bull Emerg Trauma, V5, P221, DOI 10.18869/acadpub.beat.5.4.499.; Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P8, DOI 10.1097/01.blo.0000155377.95940.81; Siy RW, 2011, J CRANIOFAC SURG, V22, P1190, DOI [10.1097/SCS.0b013e31821c0cf9, 10.1097/SCS.0b013e31822eaabc]; Tessier P, 1972, Plast Reconstr Surg, V50, P600; Tessier P., 1972, MULIPTLE REF, V50, P497; Viviano SL, 2017, J CRANIOFAC SURG, V28, P2004, DOI 10.1097/SCS.0000000000004036; Vyas RM, 2008, J CRANIOFAC SURG, V19, P339, DOI 10.1097/SCS.0b013e31814fb5e3; Zhou HH, 2013, INT J PEDIATR OTORHI, V77, P494, DOI 10.1016/j.ijporl.2012.12.017; Zimmermann C E, 2006, Int J Oral Maxillofac Surg, V35, P2, DOI 10.1016/j.ijom.2005.09.014	25	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2021	32	3					859	862		10.1097/SCS.0000000000007050			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	ST2LZ	WOS:000662282900055	32941219				2022-02-07	
J	Mohapatra, B; Laures-Gore, J				Mohapatra, Bijoyaa; Laures-Gore, Jacqueline			Moving Toward Accurate Assessment of Working Memory in Adults With Neurogenically Based Communication Disorders	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; WAIS-IV; INDIVIDUAL-DIFFERENCES; SHORT-TERM; DIGIT SPAN; EPISODIC BUFFER; OLDER-ADULTS; WMS-IV; LANGUAGE; VALIDITY	Purpose: This article presents a viewpoint highlighting concerns regarding currently available assessments of working memory in adults with neurogenic communication disorders. Additionally, we provide recommendations for improving working memory assessment in this population. Method: This viewpoint includes a critique of clinical and experimental working memory tests relevant to speech-language pathologists. We consider the terminology used to describe memory, as well as discuss language demands and test construction. Results: Clinical and experimental testing of working memory in adults with neurogenic communication disorders is challenged due to theoretical, methodological, and practical limitations. The major limitations are characterized as linguistic and task demands, presentation and response modality effects, test administration, and scoring parameters. Taking these limitations into consideration, several modifications to working memory testing and their relevance to neurogenic populations are discussed. Conclusions: The recommendations provided in this article can better guide clinicians and researchers to advocate for improved tests of working memory in adults with neurogenic communication disorders. Future research should continue to address these concerns and consider our recommendations.	[Mohapatra, Bijoyaa] New Mexico State Univ, Dept Commun Disorders, Las Cruces, NM 88003 USA; [Laures-Gore, Jacqueline] Georgia State Univ, Dept Commun Sci & Disorders, Atlanta, GA 30303 USA		Mohapatra, B (corresponding author), New Mexico State Univ, Dept Commun Disorders, Las Cruces, NM 88003 USA.	bmohap@nmsu.edu					Aben B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00301; Acheson DJ, 2009, PSYCHOL BULL, V135, P50, DOI 10.1037/a0014411; Adamovich B. B., 1992, SCALES COGNITIVE ABI; Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; BADDELEY A, 1992, SCIENCE, V255, P556, DOI 10.1126/science.1736359; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baines KA., 1999, ASSESSMENT LANGUAGE; Barrouillet P, 2009, DEV PSYCHOL, V45, P477, DOI 10.1037/a0014615; Bayles KA, 2003, J COMMUN DISORD, V36, P209, DOI 10.1016/S0021-9924(03)00020-0; Belleville S, 2003, NEUROPSYCHOLOGY, V17, P69, DOI 10.1037//0894-4105.17.1.69; Borella E, 2020, PSYCHOL RES-PSYCH FO, V84, P1622, DOI 10.1007/s00426-019-01173-7; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Buelow MT, 2013, ARCH CLIN NEUROPSYCH, V28, P356, DOI 10.1093/arclin/act006; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Bulzacka E, 2016, ARCH CLIN NEUROPSYCH, V31, P915, DOI 10.1093/arclin/acw063; Cahana-Amitay D, 2018, J NEUROLINGUIST, V48, P90, DOI 10.1016/j.jneuroling.2018.04.007; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Caspari I, 1998, BRAIN COGNITION, V37, P205, DOI 10.1006/brcg.1997.0970; Cherney L. R., 2009, STROKE RECOVERY REHA, P155; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cowan N., 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Cowan N, 2017, PSYCHON B REV, V24, P1158, DOI 10.3758/s13423-016-1191-6; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Cullum CM, 2010, PRACT RESOUR MENT, P167, DOI 10.1016/B978-0-12-375035-8.10006-0; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DeDe G, 2014, APHASIOLOGY, V28, P692, DOI 10.1080/02687038.2014.895973; DOBBS AR, 1989, PSYCHOL AGING, V4, P500, DOI 10.1037/0882-7974.4.4.500; Downey R. A, 2004, CLIN APH C; Drozdick L. W., 2012, CONT INTELLECTUAL AS, P197; Drozdick LW, 2013, PRACT RESOUR MENT, P407, DOI 10.1016/B978-0-12-386934-0.00009-2; Egeland J, 2015, APPL NEUROPSYCH-ADUL, V22, P445, DOI 10.1080/23279095.2014.992069; Ellmo W., 1995, SPEECH BIN; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Estabrooks N., 1991, BRIEF TEST HEAD INJU; Ettenhofer ML, 2020, ANN CLIN TRANSL NEUR, V7, P507, DOI 10.1002/acn3.51020; Fan HZ, 2019, ARCH CLIN NEUROPSYCH, V34, P81, DOI 10.1093/arclin/acy016; Fischer-Baum S, 2016, NEUROPSYCHOLOGY, V30, P791, DOI 10.1037/neu0000286; Fougnie D, 2008, NEW RES SHORT TERM M, V1, P45; Golden C. J., 1990, CLIN INTERPRETATION; Groth-Marnat G., 2016, HDB PSYCHOL ASSESSME, V6th ed.; Haatveit BC, 2010, J CLIN EXP NEUROPSYC, V32, P871, DOI 10.1080/13803391003596421; Wright HH, 2007, APHASIOLOGY, V21, P802, DOI 10.1080/02687030701192414; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hill BD, 2010, J CLIN EXP NEUROPSYC, V32, P315, DOI 10.1080/13803390903032529; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Ivanova MV, 2018, NEUROPSYCHOLOGIA, V115, P25, DOI 10.1016/j.neuropsychologia.2018.03.003; Ivanova MV, 2017, APHASIOLOGY, V31, P265, DOI 10.1080/02687038.2016.1172699; Ivanova MV, 2014, J COMMUN DISORD, V52, P78, DOI 10.1016/j.jcomdis.2014.06.001; Ivanova MV, 2012, APHASIOLOGY, V26, P556, DOI 10.1080/02687038.2011.618219; Iverson GL, 2013, PRACT RESOUR MENT, P485, DOI 10.1016/B978-0-12-386934-0.00010-9; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Laures-Gore J, 2011, APHASIOLOGY, V25, P43, DOI 10.1080/02687031003714426; Lehnert G, 2008, COGN PROCESS, V9, P53, DOI 10.1007/s10339-007-0187-6; Levinoff Elise J, 2005, Brain Cogn, V57, P127, DOI 10.1016/j.bandc.2004.08.058; LI SC, 1995, J EXP PSYCHOL LEARN, V21, P837, DOI 10.1037/0278-7393.21.4.837; Martin N, 2018, J NEUROLINGUIST, V48, P199, DOI 10.1016/j.jneuroling.2018.02.006; Mayer JF, 2012, J COMMUN DISORD, V45, P325, DOI 10.1016/j.jcomdis.2012.06.002; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Mohapatra B., 2019, CLIN ARCH COMMUNICAT, V4, P137, DOI [10.21849/cacd.2019.00129, DOI 10.21849/CACD.2019.00129]; Mohapatra B, 2020, INT J THER REHABIL, V27, DOI 10.12968/ijtr.2019.0098; Mohapatra B, 2020, INT J SPEECH-LANG PA, V22, P487, DOI 10.1080/17549507.2019.1691262; Morrow EL, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00270; Murray L, 2018, NEUROPSYCHOL REHABIL, V28, P309, DOI 10.1080/09602011.2016.1174718; Murray LL, 2000, BRAIN LANG, V72, P40, DOI 10.1006/brln.1999.2281; Nittrouer S, 2016, J SPEECH LANG HEAR R, V59, P1520, DOI 10.1044/2016_JSLHR-H-15-0404; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Oswald FL, 2015, BEHAV RES METHODS, V47, P1343, DOI 10.3758/s13428-014-0543-2; Ovsiew GP, 2020, J CLIN EXP NEUROPSYC, V42, P473, DOI 10.1080/13803395.2020.1758635; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Raiford SE, 2010, PRACT RESOUR MENT, P25, DOI 10.1016/B978-0-12-375035-8.10002-3; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P29, DOI 10.1016/S0887-6177(96)00015-7; Rigon A, 2020, J CLIN EXP NEUROPSYC, V42, P14, DOI 10.1080/13803395.2019.1659755; Ross-Swain DG., 1996, ROSS INFORM PROCESSI; Rudner M, 2008, COGN PROCESS, V9, P19, DOI 10.1007/s10339-007-0183-x; Shaughnessy M. F, 2019, EC NEUROLOGY, V11, P156; Shelton JT, 2009, INTELLIGENCE, V37, P283, DOI 10.1016/j.intell.2008.11.005; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Silkes JP, 2021, AM J SPEECH-LANG PAT, V30, P391, DOI 10.1044/2020_AJSLP-19-00105; Skagerlund K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211283; Soble JR, 2019, APPL NEUROPSYCH-ADUL, V26, P311, DOI 10.1080/23279095.2017.1418744; Stopford CL, 2012, CORTEX, V48, P429, DOI 10.1016/j.cortex.2010.12.002; Theiling J, 2013, Z NEUROPSYCHOL, V24, P239, DOI 10.1024/1016-264X/a000104; Tomoeda C., 1993, ARIZONA BATTERY COMM; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Unsworth N, 2006, J MEM LANG, V54, P68, DOI 10.1016/j.jml.2005.06.003; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Unsworth N, 2009, MEMORY, V17, P635, DOI 10.1080/09658210902998047; van Ool JS, 2018, DEV NEUROREHABIL, V21, P101, DOI 10.1080/17518423.2016.1277799; Varkanitsa M, 2018, J NEUROLINGUIST, V48, P4, DOI 10.1016/j.jneuroling.2018.03.003; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2009, WECHSLER MEMORY SCAL; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wells EL, 2018, RES DEV DISABIL, V72, P166, DOI 10.1016/j.ridd.2017.10.024; Wilson B, 2008, RIVERMEAD BEHAVIOURA; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Wright H., 2003, J INT NEUROPSYCHOLOG, V9, P302; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	110	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2021	30	3					1292	1300		10.1044/2021_AJSLP-20-00305			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	SH5UD	WOS:000654200300021	33970679				2022-02-07	
J	Nagumo, MM; Ferretti-Rebustini, RED; Balbinotti, MAA; da Silva, DV; Hayashi, CY; Paiva, WS; Teixeira, MJ; de Amorim, RLO				Nagumo, Marcia Mitie; de Lucena Ferretti-Rebustini, Renata Eloah; Abaide Balbinotti, Marcos Alencar; da Silva, Daniele Vieira; Hayashi, Cintya Yukie; Paiva, Wellingson Silva; Teixeira, Manoel Jacobsen; Oliveira de Amorim, Robson Luis			Brazilian version of the Rivermead Post-Concussion Symptoms Questionnaire	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						Brain Injuries; Traumatic; Post-Concussion Syndrome; Translating; Psychometrics	HEAD-INJURY; ADAPTATION	Background: After a traumatic brain injury, post-concussion symptoms are commonly reported by patients. Although common, these symptoms are difficult to diagnose and recognize. To date, no instruments evaluating post-concussion symptoms have been culturally translated or adapted to the Brazilian context. Objective: To culturally adapt the Rivermead Post-Concussion Symptoms Questionnaire for use in Brazilian Portuguese. Methods: Cross-cultural adaptation was done in five steps: translation, synthesis of translations, back-translation, evaluation by two expert committees and two pretests among adults in a target population. Results: The semantic, idiomatic, cultural and experimental aspects of the adaptation were considered adequate. The content validity coefficient of the items regarding language clarity, pratical pertinence, relevance and dimensionality were considered adequate for evaluating the desired latent variable. Both pretests demonstrated that the instrument had satisfactory acceptability. Conclusion: The Brazilian version, named Questionario Rivermead de Sintomas pos Concussionais (RPQ-Br), has been adapted, and is ready for use in the Brazilian context.	[Nagumo, Marcia Mitie; Hayashi, Cintya Yukie; Paiva, Wellingson Silva; Teixeira, Manoel Jacobsen; Oliveira de Amorim, Robson Luis] Univ Sao Paulo, Fac Med, Dept Neurol, Sao Paulo, SP, Brazil; [de Lucena Ferretti-Rebustini, Renata Eloah; da Silva, Daniele Vieira] Univ Sao Paulo, Programa Posgrad Enfermagem Saude Adulto, Escola Enfermagem, Sao Paulo, SP, Brazil; [Abaide Balbinotti, Marcos Alencar] Univ Quebec Trois Rivieres, Dept Psychol, Quebec City, PQ, Canada; [Oliveira de Amorim, Robson Luis] Univ Fed Amazonas, Manaus, Amazonas, Brazil		Nagumo, MM (corresponding author), Univ Sao Paulo, Fac Med, Dept Neurol, Sao Paulo, SP, Brazil.	marcianagumo@gmail.com	Paiva, Wellingson S/G-5517-2013; Amorim, Robson/A-6392-2014; Ferretti-Rebustini, Renata Eloah de Lucena/C-8126-2012; nagumo, marcia/O-7515-2014	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519; Ferretti-Rebustini, Renata Eloah de Lucena/0000-0002-6159-5787; teixeira, manoel jacobsen/0000-0002-7974-6045; nagumo, marcia/0000-0002-0181-8651			Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Alexandre NMC, 2011, CIENC SAUDE COLETIVA, V16, P3061, DOI 10.1590/S1413-81232011000800006; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hernandez-Nieto RA, 2002, CONTRIBUTIONS STAT A; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Likert R, 1932, ARCH PSYCHOL, V22, P55; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; WALTZ CF, 1991, MEASUREMENT NURSING	16	0	0	0	0	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAY	2021	79	5					390	398		10.1590/0004-282X-ANP-2020-0273			9	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	TB1EN	WOS:000667685500004	34161527	gold			2022-02-07	
J	Nekrasova, J; Kanarskii, M; Borisov, I; Pradhan, P; Shunenkov, D; Vorobiev, A; Smirnova, M; Pasko, V; Petrova, MV; Luginina, E; Pryanikov, I				Nekrasova, Julia; Kanarskii, Mikhail; Borisov, Ilya; Pradhan, Pranil; Shunenkov, Denis; Vorobiev, Alexey; Smirnova, Maria; Pasko, Vera; Petrova, Marina V.; Luginina, Elena; Pryanikov, Igor			One-Year Demographical and Clinical Indices of Patients with Chronic Disorders of Consciousness	BRAIN SCIENCES			English	Article						chronic disorder of consciousness; vegetative state; survival rate; recovery of consciousness; prognosis	BRAIN-INJURY; RECOVERY; STATE	This work aims to evaluate the prognostic value of the demographical and clinical data on long-term outcomes (up to 12 months) in patients with severe acquired brain injury with vegetative state/unresponsive wakefulness syndrome (VS/UWS/UWS) or a minimally conscious state (MCS). Patients (n = 211) with VS/UWS/UWS (n = 123) and MCS (n = 88) were admitted to the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology after anoxic brain injury (n = 53), vascular lesions (n = 59), traumatic brain injury (n = 93), and other causes (n = 6). At the beginning of the 12-month study, younger age and a higher score by the Coma Recovery Scale-Revised (CRS-R) predicted a survival. However, no reliable markers of significant positive dynamics of consciousness were found. Based on the etiology, anoxic brain injury has the most unfavorable prognosis. For patients with vascular lesions, the first three months after injury have the most important prognostic value. No correlations were found between survival, increased consciousness, and gender. The demographic and clinical characteristics of patients with chronic DOC can be used to predict long-term mortality in patients with chronic disorders of consciousness. Further research should be devoted to finding reliable predictors of recovery of consciousness.	[Nekrasova, Julia; Kanarskii, Mikhail; Borisov, Ilya; Pradhan, Pranil; Shunenkov, Denis; Vorobiev, Alexey; Smirnova, Maria; Pasko, Vera; Petrova, Marina V.; Luginina, Elena; Pryanikov, Igor] Fed Res & Clin Ctr Intens Care Med & Rehabilitol, Dept Study Chron Disorder Consciousness, Moscow 107031, Russia; [Petrova, Marina V.] Peoples Friendship Univ Russia, Dept Anestesiol Reanimatol, Moscow 117198, Russia		Pradhan, P (corresponding author), Fed Res & Clin Ctr Intens Care Med & Rehabilitol, Dept Study Chron Disorder Consciousness, Moscow 107031, Russia.	ynekrasova@fnkcrr.ru; kanarmm@yandex.ru; realzel@gmail.com; pranilpr@gmail.com; dshunenkov@fnkcrr.ru; avorobiev@fnkcrr.ru; msmirnova@fnkcrr.ru; vpasko@fnkcrr.ru; mail@petrovamv.ru; eluginina@fnkcrr.ru; ipryanikov@fnkcrr.ru	Borisov, Ilya/AAB-9734-2022	Borisov, Ilya/0000-0002-5707-118X; Pradhan, Pranil/0000-0002-3505-7504			Aidinoff E, 2018, BRAIN INJURY, V32, P297, DOI 10.1080/02699052.2017.1418535; Bagnato Sergio, 2017, J Neurotrauma, V34, P535, DOI 10.1089/neu.2016.4418; Baricich A, 2017, FUNCT NEUROL, V32, P131; Bruno M-A., 2012, COMA DISORDERS CONSC, P11, DOI [DOI 10.1007/978-1-4471-2440-5_2, 10.1007/978-1-4471-2440-5_2]; Bruno MA, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-35; Chen WG, 2020, WORLD J CLIN CASES, V8, P2520, DOI 10.12998/wjcc.v8.i12.2520; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Estraneo A, 2019, BRAIN INJURY, V33, P1633, DOI 10.1080/02699052.2019.1658220; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2020, NEUROLOGY, V95, pE1488, DOI 10.1212/WNL.0000000000010254; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 1997, SEMIN NEUROL, V17, P105, DOI 10.1055/s-2008-1040919; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee HY, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01758-5; Li YB, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012321; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Owen AM, 2013, ANNU REV PSYCHOL, V64, P109, DOI 10.1146/annurev-psych-113011-143729; Pascarella A, 2018, FUNCT NEUROL, V33, P19, DOI 10.11138/FNeur/2018.33.1.019; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; van Erp WS, 2019, J NEUROL, V266, P3144, DOI 10.1007/s00415-019-09542-3; Yelden K, 2018, DISABIL REHABIL, V40, P2433, DOI 10.1080/09638288.2017.1339209	28	0	0	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAY	2021	11	5							651	10.3390/brainsci11050651			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SG7XS	WOS:000653653700001	34065687	gold, Green Published			2022-02-07	
J	Neumann, D; Sander, AM; Witwer, N; Jang, JH; Bhamidipalli, SS; Hammond, FM				Neumann, Dawn; Sander, Angelle M.; Witwer, Noelle; Jang, Jeong Hoon; Bhamidipalli, Surya Sruthi; Hammond, Flora M.			Evaluating Negative Attributions in Persons With Brain Injury: A Comparison of 2 Measures	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anger; attributions; blame; brain injury; hostility; intent	AGGRESSION; BIAS; QUESTIONNAIRE; ANGER	Objectives: To compare construct and predictive validity, readability, and time-to-administer of 2 negative attribution measures in participants with traumatic brain injury (TBI). Setting: Two TBI rehabilitation hospitals. Participants: Eighty-five adults with complicated mild to severe TBI. Main Measures: Negative attributions (intent, hostility, and blame) and anger responses to hypothetical scenarios were measured with the Epps scenarios and the Ambiguous Intention Hostility Questionnaire (AIHQ). Trait aggression was measured with the Buss-Perry Aggression Questionnaire (BPAQ). Results: Associations between attributions and anger responses (ie, construct validity) within each measure were significant (Epps: r = 0.61-0.74; AIHQ: r = 0.39-0.71); however, associations were stronger for Epps (Ps < .001). Receiver operating characteristics (ROC) revealed attributions from both measures predicted BPAQ scores (area under the ROC curves = 0.6-0.8); predictive validity did not statistically differ between the 2 measures. Both had comparable readability (fifth- to sixth-grade levels), but Epps required longer administration times. Conclusion: Negative attributions affect anger and aggression after TBI, making it important to identify suitable assessments for the TBI population. While psychometric properties of the AIHQ and Epps scenarios should be further explored, this study offers early support for the use of either instrument in persons with TBI. Advantages and disadvantages of the AIHQ and Epps scenarios are highlighted.	[Neumann, Dawn; Hammond, Flora M.] Dept Phys Med & Rehabil, Indianapolis, IN USA; [Jang, Jeong Hoon; Bhamidipalli, Surya Sruthi] Dept Biostat, Indianapolis, IN USA; [Witwer, Noelle] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Neumann, Dawn; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Sander, Angelle M.] Baylor Coll Med, Div Clin Neuropsychol & Rehabil Psychol, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Memorial Hermann, Brain Injury Res Ctr, Houston, TX USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dneumann73@gmail.com; Angelle.Sander@memorialhermann.org; noellewitwer@gmail.com; jeojang@iu.ed; sbhamid@iu.edu; flora.hammond@rhin.com			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90IF00-9501-00]	This study was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), award #90IF00-9501-00.	An SK, 2010, SCHIZOPHR RES, V118, P54, DOI 10.1016/j.schres.2010.01.025; Bailey CA, 2008, J YOUTH ADOLESCENCE, V37, P713, DOI 10.1007/s10964-007-9211-5; Buck B, 2017, J PSYCHIATR RES, V89, P48, DOI 10.1016/j.jpsychires.2017.01.004; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Combs Dennis R, 2007, Cogn Neuropsychiatry, V12, P128, DOI 10.1080/13546800600787854; Combs Dennis R, 2009, Cogn Neuropsychiatry, V14, P30, DOI 10.1080/13546800902732970; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; EPPS J, 1995, COGNITIVE THER RES, V19, P159, DOI 10.1007/BF02229692; Evans JD, 1996, STRAIGHTFORWARD STAT; Greve KW, 2001, BRAIN INJURY, V15, P255; Gross J., 2007, HDB EMOTION REGULATI, V2nd, P1; Holtzworth-Munroe Amy, 2000, Behavior Therapy, V31, P603, DOI 10.1016/S0005-7894(00)80034-9; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Neumann D, 2021, J HEAD TRAUMA REHAB, V36, pE61, DOI 10.1097/HTR.0000000000000600; Neumann D, 2020, J HEAD TRAUMA REHAB, V35, pE450, DOI 10.1097/HTR.0000000000000581; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P197, DOI 10.1097/HTR.0000000000000259; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Palmer EJ, 2005, AGGRESSIVE BEHAV, V31, P56, DOI 10.1002/ab.20072; Pepe M S, 2003, STAT EVALUATION MED; Pinkham AE, 2014, SCHIZOPHRENIA BULL, V40, P813, DOI 10.1093/schbul/sbt081; Simundic Ana-Maria, 2009, EJIFCC, V19, P203; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Steinberg M. S., 1983, J SOC CLIN PSYCHOL, V1, P312, DOI [10.1521/jscp.1983.1.4.312, DOI 10.1521/JSCP.1983.1.4.312]; Witwer N., 2019, ARCH PHYS MED REHAB, V100, pE44; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	28	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		E170	E177		10.1097/HTR.0000000000000635			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900009	33201039	Green Submitted			2022-02-07	
J	Nishijima, DK; Gosdin, M; Naz, H; Tancredi, DJ; Hewes, HA; Myers, SR; Stanley, RM; Adelson, PD; Burd, RS; Finkelstein, Y; VanBuren, J; Casper, TC; Kuppermann, N				Nishijima, Daniel K.; Gosdin, Melissa; Naz, Hiba; Tancredi, Daniel J.; Hewes, Hilary A.; Myers, Sage R.; Stanley, Rachel M.; Adelson, P. David; Burd, Randall S.; Finkelstein, Yaron; VanBuren, John; Casper, T. Charles; Kuppermann, Nathan		TIC-TOC Collaborators Pediat Emer	Assessment of primary outcome measures for a clinical trial of pediatric hemorrhagic injuries	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Children; Trauma; Tranexamic acid; Outcome measure; Consensus; Pediatric Quality of Life	TRAUMATIC BRAIN-INJURY; TRANEXAMIC ACID; CHILDREN; HYPOTHERMIA	Objective: We evaluated the acceptability of the Pediatric Quality of Life Inventory (PedsQL) and other outcomes as the primary outcomes for a pediatric hemorrhagic trauma trial (TIC-TOC) among clinicians. Methods: We conducted a mixed-methods study that included an electronic questionnaire followed by teleconference discussions. Participants confirmed or rejected the PedsQL as the primary outcome for the TIC-TOC trial and evaluated and proposed alternative primary outcomes. Responses were compiled and a list of themes and representative quotes was generated. Results: 73 of 91 (80%) participants completed the questionnaire. 61 (84%) participants agreed that the PedsQL is an appropriate primary outcome for children with hemorrhagic brain injuries. 32 (44%) participants agreed that the PedsQL is an acceptable primary outcome for children with hemorrhagic torso injuries, 27 (38%) participants were neutral, and 13 (18%) participants disagreed. Several themes were identified from responses, including that the PedsQL is an important and patient-centered outcome but may be affected by other factors, and that intracranial hemorrhage progression assessed by brain imaging (among patients with brain injuries) or blood product transfusion requirements (among patients with torso injuries) may be more objective outcomes than the PedsQL. Conclusions: The PedsQL was a well-accepted proposed primary outcome for children with hemorrhagic brain injuries. Traumatic intracranial hemorrhage progression was favored by a subset of clinicians. A plurality of participants also considered the PedsQL an acceptable outcome for children with hemorrhagic torso injuries. Blood product transfusion requirement was favored by fewer participants. (c) 2020 Elsevier Inc. All rights reserved.	[Nishijima, Daniel K.] Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 V St,PSSB 2100, Sacramento, CA 95817 USA; [Gosdin, Melissa; Naz, Hiba] Univ Calif Davis, Sch Med, Ctr Healthcare Policy & Res, 2103 Stockton Blvd, Sacramento, CA 95817 USA; [Tancredi, Daniel J.] Univ Calif Davis, Sch Med, Dept Pediat, 2516 Stockton Blvd,Room 379, Sacramento, CA 95817 USA; [Hewes, Hilary A.] Univ Utah, Sch Med, Div Pediat Emergency Med, Dept Pediat, 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 USA; [Myers, Sage R.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat,Div Pediat Emergency Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Stanley, Rachel M.] Ohio State Univ, Nationwide Childrens Hosp, Sch Med, Dept Pediat,Div Pediat Emergency Med, 700 Childrens Dr, Columbus, OH 43205 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurol Surg, 1919 E Thomas Rd, Phoenix, AZ 85016 USA; [Burd, Randall S.] Childrens Natl Med Ctr, Div Trauma & Burn Surg, 111 Michigan Ave NW, Washington, DC 20010 USA; [Finkelstein, Yaron] Univ Toronto, Hosp Sick Children, Sch Med, Dept Pediat,Div Pediat Emergency Med, Toronto, ON M5G1X8, Canada; [Finkelstein, Yaron] Univ Toronto, Hosp Sick Children, Sch Med, Dept Pediat,Div Clin Pharmacol & Toxicol, Toronto, ON M5G1X8, Canada; [VanBuren, John; Casper, T. Charles] Univ Utah, Sch Med, Dept Pediat, 295 Chipeta Way, Salt Lake City, UT 84108 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 V St, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, 4150 V St, Sacramento, CA 95817 USA		Nishijima, DK (corresponding author), Univ Calif Davis, Med Ctr, 4150 V St PSSB,2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu; mmgosdin@ucdavis.edu; knaz@ucdavis.edu; djtancredi@ucdavis.edu; hilary.hewes@hsc.utah.edu; myerss@email.chop.edu; rachel.stanley@nationwidechildrens.org; dadelson@phoenixchildrens.com; rburd@childrensnational.org; yaron.finkelstein@sickkids.ca; John.vanburen@hsc.utah.edu; Charlie.Casper@hsc.utah.edu; nkuppermann@ucdavis.edu			National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R34HL135214]; Utah Trial Innovation Center - National Center for Advancing Translational Sciences (NCATS) [U24TR001597]; Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]	Research reported in this publicationwas supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health under Award Number R34HL135214. Additional support has been provided by the Utah Trial Innovation Center funded by the National Center for Advancing Translational Sciences (NCATS) under cooperative agreement U24TR001597. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This project is also supported in part by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Andrade C, 2015, J CLIN PSYCHIAT, V76, pE1320, DOI 10.4088/JCP.15f10377; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Boynton PM, 2004, BRIT MED J, V328, P1312, DOI 10.1136/bmj.328.7451.1312; Brenner A, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2900-4; Creswell J.W., 2003, HDB MIXED METHODS SO, P209; Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002; Eckert MJ, 2014, J TRAUMA ACUTE CARE, V77, P852, DOI 10.1097/TA.0000000000000443; Faraoni D, 2014, ANESTH ANALG, V118, P628, DOI 10.1213/ANE.0000000000000080; Hanson B, 2008, INJURY, V39, P656, DOI 10.1016/j.injury.2008.02.014; Hasegawa Tomomi, 2014, Asian Cardiovasc Thorac Ann, V22, P1039, DOI 10.1177/0218492314527991; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Kruse S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0168-2; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Nishijima DK, 2019, ANN EMERG MED, V74, P79, DOI 10.1016/j.annemergmed.2018.11.018; Pasquali SK, 2012, J THORAC CARDIOV SUR, V143, P550, DOI 10.1016/j.jtcvs.2011.06.048; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h121; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; STEIN REK, 1990, MED CARE, V28, P1041, DOI 10.1097/00005650-199011000-00006; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Tzimenatos L, 2015, PEDIATR EMERG CARE, V31, P70, DOI 10.1097/PEC.0000000000000303; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016	29	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2021	43						210	216		10.1016/j.ajem.2020.03.001			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	YJ2OI	WOS:000744374600038					2022-02-07	
J	Nishijima, DK; Gosdin, M; Naz, H; Tancredi, DJ; Hewes, HA; Myers, SR; Stanley, RM; Adelson, PD; Burd, RS; Finkelstein, Y; VanBuren, J; Casper, TC; Kuppermann, N				Nishijima, Daniel K.; Gosdin, Melissa; Naz, Hiba; Tancredi, Daniel J.; Hewes, Hilary A.; Myers, Sage R.; Stanley, Rachel M.; Adelson, P. David; Burd, Randall S.; Finkelstein, Yaron; VanBuren, John; Casper, T. Charles; Kuppermann, Nathan			Assessment of primary outcome measures for a clinical trial of pediatric hemorrhagic injuries	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Children; Trauma; Tranexamic acid; Outcome measure; Consensus; Pediatric Quality of Life	TRAUMATIC BRAIN-INJURY; TRANEXAMIC ACID; CHILDREN; HYPOTHERMIA	Objective: We evaluated the acceptability of the Pediatric Quality of Life Inventory (PedsQL) and other outcomes as the primary outcomes for a pediatric hemorrhagic trauma trial (TIC-TOC) among clinicians. Methods: We conducted a mixed-methods study that included an electronic questionnaire followed by teleconference discussions. Participants confirmed or rejected the PedsQL as the primary outcome for the TIC-TOC trial and evaluated and proposed alternative primary outcomes. Responses were compiled and a list of themes and representative quotes was generated. Results: 73 of 91 (80%) participants completed the questionnaire. 61 (84%) participants agreed that the PedsQL is an appropriate primary outcome for children with hemorrhagic brain injuries. 32 (44%) participants agreed that the PedsQL is an acceptable primary outcome for children with hemorrhagic torso injuries, 27 (38%) participants were neutral, and 13 (18%) participants disagreed. Several themes were identified from responses, including that the PedsQL is an important and patient-centered outcome but may be affected by other factors, and that intracranial hemorrhage progression assessed by brain imaging (among patients with brain injuries) or blood product transfusion requirements (among patients with torso injuries) may be more objective outcomes than the PedsQL. Conclusions: The PedsQL was a well-accepted proposed primary outcome for children with hemorrhagic brain injuries. Traumatic intracranial hemorrhage progression was favored by a subset of clinicians. A plurality of participants also considered the PedsQL an acceptable outcome for children with hemorrhagic torso injuries. Blood product transfusion requirement was favored by fewer participants. (C) 2020 Elsevier Inc. All rights reserved.	[Nishijima, Daniel K.; Kuppermann, Nathan] UC Davis Sch Med, Dept Emergency Med, 4150 V St,PSSB 2100, Sacramento, CA 95817 USA; [Gosdin, Melissa; Naz, Hiba] UC Davis Sch Med, Ctr Healthcare Policy & Res, 2103 Stockton Blvd, Sacramento, CA 95817 USA; [Tancredi, Daniel J.] UC Davis Sch Med, Dept Pediat, 2516 Stockton Blvd,Room 379, Sacramento, CA 95817 USA; [Hewes, Hilary A.] Univ Utah, Primary Childrens Hosp, Dept Pediat, Div Pediat Emergency Med,Sch Med, 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 USA; [Myers, Sage R.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Emergency Med,Perelman Sch Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Stanley, Rachel M.] Ohio State Univ, Nationwide Childrens Hosp, Dept Pediat, Div Pediat Emergency Med,Sch Med, 700 Childrens Dr, Columbus, OH 43205 USA; [Adelson, P. David] Phoenix Childrens Hosp, Dept Neurol Surg, Barrow Neurol Inst, 1919 E Thomas Rd, Phoenix, AZ 85016 USA; [Burd, Randall S.] Childrens Natl Med Ctr, Div Trauma & Burn Surg, 111 Michigan Ave NW, Washington, DC 20010 USA; [Finkelstein, Yaron] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med,Sch Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Finkelstein, Yaron] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin Pharmacol & Toxicol,Sch Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [VanBuren, John; Casper, T. Charles] Univ Utah, Sch Med, Dept Pediat, 295 Chipeta Way, Salt Lake City, UT 84108 USA; [Kuppermann, Nathan] UC Davis Sch Med, Dept Pediat, 4150 V St,PSSB 2100, Sacramento, CA 95817 USA		Nishijima, DK (corresponding author), Univ Calif Davis, Med Ctr, 4150 V St PSSB 2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu; mmgosdin@ucdavis.edu; knaz@ucdavis.edu; djtancredi@ucdavis.edu; hilary.hewes@hsc.utah.edu; myerss@email.chop.edu; rachel.stanley@nationwidechildrens.org; dadelson@phoenixchildrens.com; rburd@childrensnational.org; yaron.finkelstein@sickkids.ca; John.vanburen@hsc.utah.edu; Charlie.Casper@hsc.utah.edu; nkuppermann@ucdavis.edu			National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R34HL135214]; Utah Trial Innovation Center - National Center for Advancing Translational Sciences (NCATS) [U24TR001597]; Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health under Award Number R34HL135214. Additional support has been provided by the Utah Trial Innovation Center funded by the National Center for Advancing Translational Sciences (NCATS) under cooperative agreement U24TR001597. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This project is also supported in part by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Andrade C, 2015, J CLIN PSYCHIAT, V76, pE1320, DOI 10.4088/JCP.15f10377; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Boynton PM, 2004, BRIT MED J, V328, P1312, DOI 10.1136/bmj.328.7451.1312; Brenner A, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2900-4; Creswell J.W., 2003, HDB MIXED METHODS SO, P209; Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002; Eckert MJ, 2014, J TRAUMA ACUTE CARE, V77, P852, DOI 10.1097/TA.0000000000000443; Faraoni D, 2014, ANESTH ANALG, V118, P628, DOI 10.1213/ANE.0000000000000080; Hanson B, 2008, INJURY, V39, P656, DOI 10.1016/j.injury.2008.02.014; Hasegawa Tomomi, 2014, Asian Cardiovasc Thorac Ann, V22, P1039, DOI 10.1177/0218492314527991; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Kruse S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0168-2; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Nishijima DK, 2019, ANN EMERG MED, V74, P79, DOI 10.1016/j.annemergmed.2018.11.018; Pasquali SK, 2012, J THORAC CARDIOV SUR, V143, P550, DOI 10.1016/j.jtcvs.2011.06.048; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h121; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; STEIN REK, 1990, MED CARE, V28, P1041, DOI 10.1097/00005650-199011000-00006; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Tzimenatos L, 2015, PEDIATR EMERG CARE, V31, P70, DOI 10.1097/PEC.0000000000000303; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016	29	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2021	43						210	216		10.1016/j.ajem.2020.03.001			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TK5SX	WOS:000674219200038					2022-02-07	
J	O'Connor, S; Leahy, R; Whyte, E; Farrington, S				O'Connor, Siobhan; Leahy, Roisin; Whyte, Enda; Farrington, Shane			Male and female Gaelic games coaches' and referees' experiences, knowledge and views on sports-related concussion	PHYSICAL THERAPY IN SPORT			English	Article						Traumatic brain injury; Concussion management; GAA	COMMUNICATION; STRATEGIES; BEHAVIORS; RISK	Objectives: Concern regarding identification and management of sports-related concussion (SRC) in the community sports of Gaelic games exists. This study aimed to examine Gaelic games coaches' and referees' previous SRC experiences, knowledge of and attitudes on SRC and views on SRC education. Design: Cross-sectional study; Setting: Online survey instrument. Participants: Irish male and female Gaelic games coaches (n = 144) and referees (n = 110). Main outcome measures: Demographics, SRC previous experience, SRC knowledge, attitudes towards SRC reporting and previous and future interest in SRC education. Results: Most coaches (70.1%) and referees (74.5%) previously dealt with a suspected SRC event. In the most recent SRC event, coaches predominantly removed the player from play (97.0%) and referees frequently informed medical staff (97.1%) or coaches present (96.3%). Coaches and referees were predominantly (>90%) able to identify common SRC signs and symptoms such as dizziness, nausea, confusion, poor balance and headache. Coaches and referees displayed positive attitudes towards removing players from play regardless of game importance. Conclusions: Good knowledge of common SRC symptoms were displayed, however their ability to recognise false signs and symptoms was limited. Widespread promotion of Gaelic games SRC education across all stakeholders is warranted and should target the misconceptions highlighted in this study. (c) 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[O'Connor, Siobhan; Leahy, Roisin; Whyte, Enda; Farrington, Shane] Dublin City Univ, Sch Hlth & Human Performance, Ctr Injury Prevent & Performance, Athlet Therapy & Training, Dublin, Ireland		O'Connor, S (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, A144B, Dublin 9, Ireland.	siobhan.oconnor@dcu.ie	O Connor, Siobhan/Q-8568-2018	O Connor, Siobhan/0000-0002-2001-0746; Leahy, Roisin/0000-0002-9902-5683	Health Research Board Summer Student Scholarship [ss2017113]	This work was funded by the Health Research Board Summer Student Scholarship (Grant ID: ss2017113) .	Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Beidler E, 2021, J ATHL TRAINING, V56, P77, DOI 10.4085/1062-6050-0575.19; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Blake C., 2014, BRIT J SPORT MED, V48, P569, DOI 10.1136/bjsports-2014-093494.25; Cohen J., 2013, STAT POWER ANAL BEHA; CONNOR S, 2019, SPORTS HEALTH, V11, P498, DOI DOI 10.1177/1941738119875978; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Gaelic Athletic Association Ladies Gaelic Athletic Association & Camogie Association, 2018, CONC MAN GUID GAEL G, P1; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Leahy R, 2020, PHYS THER SPORT, V43, P236, DOI 10.1016/j.ptsp.2019.06.004; Mooney James, 2020, Concussion, V5, pCNC76, DOI 10.2217/cnc-2020-0004; OConnor S., 2019, CLIN J SPORT MED, DOI [10.1097/JSM.00000000, DOI 10.1097/JSM.00000000]; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Reid D., 2019, KNOWLEDGE ATTITUDE B; Roe M, 2016, J ATHL TRAINING, V51, P303, DOI 10.4085/1062-6050-51.4.07; Sullivan L, 2018, J SPORT HEALTH SCI, V7, P102, DOI 10.1016/j.jshs.2017.05.003	25	0	0	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAY	2021	49						1	7		10.1016/j.ptsp.2021.01.011			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	RO1GA	WOS:000640795700001	33548730	hybrid			2022-02-07	
J	Ogolo, DE; Ibe, MO				Ogolo, Donald Ekomobong; Ibe, Michael O.			Determinants of Outcome in Traumatic Head Injuries: A South East Nigeria Experience	WORLD NEUROSURGERY			English	Article						Age; Head; Injuries; Mortality; Severity; Traumatic	BRAIN-INJURY; EPIDEMIOLOGIC ASPECTS	OBJECTIVES: The objectives of this study were to ascertain factors significantly responsible for mortality from traumatic head injuries and prescribe measures necessary to circumvent such outcome. METHODS: A retrospective cohort study of all traumatic head injuries seen at our facility from October 2013 to September 2015 was done utilizing data from patient's case notes, ward registers, and casualty department. Extracted data were analyzed using descriptive statistics. RESULTS: A total of 221 patient records were analyzed with 161 men and 60 women. It was observed that although the younger age group (19-30 years) was the most frequently affected by traumatic head injuries (36.2%), the elderly (>60 years) were 4.6 times more likely to die from traumatic head injuries than any other age group. Also, those with severe head injuries were 58 times more likely to die than any other category of head injury, even though the commonest category of head injuries seen were mild head injuries (68.7%). Patients with traumatic head injury from road traffic accidents were 5.8 times more likely to die than any other cause. The sex of the patient and the length of hospital stay had no significant influence on mortality from traumatic head injuries. CONCLUSIONS: The postresuscitation Glasgow Coma Scale score, age of the patient, and mechanism of head injuries are important determining factors of outcome in traumatic head injuries, with the Glasgow Coma Scale score being the single most important determining factor. Efforts should be made at preventing such causes, with prompt and aggressive care instituted for cases at risk of unfavorable outcome.	[Ogolo, Donald Ekomobong; Ibe, Michael O.] Alex Ekweme Fed Univ, Dept Surg, Div Neurosurg, Teaching Hosp, Abakaliki, Nigeria		Ogolo, DE (corresponding author), Alex Ekweme Fed Univ, Dept Surg, Div Neurosurg, Teaching Hosp, Abakaliki, Nigeria.	donekom@yahoo.com					Adegbehingbe BO, 2004, AFR J TRAUMA, V2, P35; Adeloye A, 1997, E AFR MED J, V74, P822; Adeolu A, 2004, INTERNET J EPIDEMIOL, V2, P2; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chalya Phillipo L, 2010, Tanzan J Health Res, V12, P214; Emejulu JKC, 2010, E CENT AFR J SURG, V15, P28; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Langlios JA, 2004, TRAUMATIC BRAIN INJU; Langlois JA, 1997, AM J PUBLIC HEALTH, V87, P393, DOI 10.2105/AJPH.87.3.393; Muyembe VM, 1998, E AFR MED J, V75, P364; OHAEGBULAM SC, 1978, AFR J MED MED SCI, V7, P23; Peden M., 2004, WORLD REPORT ROAD TR; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; SOSIN DM, 1992, JAMA-J AM MED ASSOC, V267, P1649, DOI 10.1001/jama.267.12.1649; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yusuf AS, 2014, NIGER J BASIC CLIN S, V11, P80	20	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E386	E391		10.1016/j.wneu.2021.02.012			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	TF2NY	WOS:000670549900005					2022-02-07	
J	Ogolo, DE; Tbe, MO				Ogolo, Donald Ekomobong; Tbe, Michael O.			Determinants of Outcome in Traumatic Head Injuries: A South East Nigeria Experience	WORLD NEUROSURGERY			English	Article						Age; Head; Injuries; Mortality; Severity; Traumatic	BRAIN-INJURY; EPIDEMIOLOGIC ASPECTS	-OBJECTIVES: The objectives of this study were to ascertain factors significantly responsible for mortality from traumatic head injuries and prescribe measures necessary to circumvent such outcome. -METHODS: A retrospective cohort study of all traumatic head injuries seen at our facility from October 2013 to September 2015 was done utilizing data from patient's case notes, ward registers, and casualty department. Extracted data were analyzed using descriptive statistics. -RESULTS: A total of 221 patient records were analyzed with 161 men and 60 women. It was observed that although the younger age group (19e30 years) was the most frequently affected by traumatic head injuries (36.2%), the elderly (>60 years) were 4.6 times more likely to die from traumatic head injuries than any other age group. Also, those with severe head injuries were 58 times more likely to die than any other category of head injury, even though the commonest category of head injuries seen were mild head injuries (68.7%). Patients with traumatic head injury from road traffic accidents were 5.8 times more likely to die than any other cause. The sex of the patient and the length of hospital stay had no significant influence on mortality from traumatic head injuries. -CONCLUSIONS: The postresuscitation Glasgow Coma Scale score, age of the patient, and mechanism of head injuries are important determining factors of outcome in traumatic head injuries, with the Glasgow Coma Scale score being the single most important determining factor. Efforts should be made at preventing such causes, with prompt and aggressive care instituted for cases at risk of unfavorable outcome.	[Ogolo, Donald Ekomobong; Tbe, Michael O.] Alex Ekweme Fed Univ Teaching Hosp, Div Neurosurg, Dept Surg, Abakaliki, Nigeria		Ogolo, DE (corresponding author), Alex Ekweme Fed Univ Teaching Hosp, Div Neurosurg, Dept Surg, Abakaliki, Nigeria.	donekom@yahoo.com					Adegbehingbe BO, 2004, AFR J TRAUMA, V2, P35; Adeloye A, 1997, E AFR MED J, V74, P822; Adeolu A, 2004, INTERNET J EPIDEMIOL, V2, P2; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chalya Phillipo L, 2010, Tanzan J Health Res, V12, P214; Emejulu JKC, 2010, E CENT AFR J SURG, V15, P28; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Langlios JA, 2004, TRAUMATIC BRAIN INJU; Langlois JA, 1997, AM J PUBLIC HEALTH, V87, P393, DOI 10.2105/AJPH.87.3.393; Muyembe VM, 1998, E AFR MED J, V75, P364; OHAEGBULAM SC, 1978, AFR J MED MED SCI, V7, P23; Peden M., 2004, WORLD REPORT ROAD TR; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; SOSIN DM, 1992, JAMA-J AM MED ASSOC, V267, P1649, DOI 10.1001/jama.267.12.1649; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yusuf AS, 2014, NIGER J BASIC CLIN S, V11, P80	20	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E386	E391		10.1016/j.wneu.2021.02.012			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	YJ3CH	WOS:000744410900005					2022-02-07	
J	Otto, JL; Smolenski, DJ; Stewart, L; Workman, DE; Kincaid, M; Belsher, BE; Bush, N; Evatt, DP				Otto, Jean Lin; Smolenski, Derek J.; Stewart, Lindsay; Workman, Don E.; Kincaid, Melissa; Belsher, Brad E.; Bush, Nigel; Evatt, Daniel P.			Explosive ordnance disposal personnel in the US military have higher risk of insomnia and post-traumatic stress disorder: a large retrospective cohort study	ANNALS OF EPIDEMIOLOGY			English	Article						Explosive ordnance disposal; Posttraumatic stress disorder; Insomnia; Traumatic brain injury; Military	MENTAL-HEALTH PROBLEMS; IRAQ	Purpose: We examined the risk of post-traumatic stress disorder (PTSD), affective disorders, alcohol/substance-related disorders, traumatic brain injury (TBI) and insomnia, among explosive ordnance disposal (EOD) technicians compared to the general population of active-duty non-EOD personnel in the U.S. military. Methods : We conducted a retrospective cohort study using administrative and healthcare utilization data from fiscal year 2004 (FY2004) to FY2015 for this comparison. We used propensity score matching to balance baseline covariates, and discrete-time hazard models to compare the odds of occurrence of the outcomes. Results: EOD personnel had higher odds of having a new diagnosis of insomnia (odds ratio [OR] = 1.33; 95% confidence interval [CI]:1.22-1.45) and PTSD (OR = 1.23; 95% CI:1.08-1.41) than did non-EOD personnel. EOD technicians had lower odds of having a new diagnosis of affective disorders (OR = 0.83; 95% CI:0.79-0.87) and alcohol/substance-related disorders (OR = 0.59; 95% CI:0.54-0.64) than did nonEOD personnel. There was little evidence of a difference in the odds of a TBI diagnosis (OR = 1.07; 95% CI:0.99-1.16). Conclusions: As reliance on EOD forces continues, ongoing vigilance of the stressors, health sequelae and disincentives to access mental health care among this military occupation should be monitored and mitigated wherever possible. (c) 2021 Elsevier Inc. All rights reserved.	[Otto, Jean Lin; Smolenski, Derek J.; Stewart, Lindsay; Workman, Don E.; Kincaid, Melissa; Belsher, Brad E.; Bush, Nigel; Evatt, Daniel P.] Dept Def, Psychol Hlth Ctr Excellence, Silver Spring, MD 20910 USA		Evatt, DP (corresponding author), Dept Def Silver Spring, Psychol Hlth Ctr Excellence, 1335 East West Highway, Silver Spring, MD 20910 USA.	Daniel.P.Evatt.civ@mail.mil		Smolenski, Derek/0000-0003-4767-075X; Kincaid, Melissa/0000-0003-2417-3312			[Anonymous], ARMED FORCES HLTH SU; [Anonymous], 2011, 649008 DEP DEF INSTR; Brundage John F, 2015, MSMR, V22, P2; Department of Defense Instructions 1010.04, 2014, PROBL SUBST US DOD P; Government accounting office, 2013, GAO13385; Guo S., 2014, PROPENSITY SCORE ANA; Hardison, 2012, REDUCING ATTRITION S; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Internal Revenue Service, 2014, ARM FORC TAX GUID US; Joint Chiefs of Staff, 2016, JOINT JOINT EXPL ORD, V3-42; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Memorandum, 2013, CLIN PRACT GUID DEPL; Mendenhall R., 2014, 1435 EOD NAV HLTH RE; Otto JL, 2019, ANN EPIDEMIOL, V35, P66, DOI 10.1016/j.annepidem.2019.04.001; StataCorp, 2017, STATA STAT SOFTWARE; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor Marcus K, 2019, J Spec Oper Med, V19, P61; U.S. Air Force, EXPL ORD DISP EOD; U.S. Navy, NAV WARR CHALL; United States Department of Defense, CAS STAT; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845	22	0	0	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1047-2797	1873-2585		ANN EPIDEMIOL	Ann. Epidemiol.	MAY	2021	57						40	45		10.1016/j.annepidem.2021.02.001			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	RK3JO	WOS:000638196100006	33581242				2022-02-07	
J	Pan, CS; Wimer, BM; Welcome, DE; Wu, JZ				Pan, Christopher S.; Wimer, Bryan M.; Welcome, Daniel E.; Wu, John Z.			An Approach to Characterize the Impact Absorption Performance of Construction Helmets in Top Impact	JOURNAL OF TESTING AND EVALUATION			English	Article						construction helmet; experiment; impact test; top strike; safety margin	TRAUMATIC BRAIN-INJURIES; HEAD KINEMATICS; PROBABILITY	The helmets used by construction site workers are mainly designed for head protection when objects are dropped from heights. Construction helmets are also casually called "hard hats" in industries. Common construction helmets are mostly categorized as type 1 according to different standards. All type 1 helmets have to pass type 1 standard impact tests, which are top impact tests-the helmet is fixed and is impacted by a free falling impactor on the top crown of the helmet shell. The purpose of this study was to develop an approach that can determine the performance characterization of a helmet. A total of 31 drop impact tests using a representative type 1 helmet model were performed at drop heights from 0.30 to 2.23 m, which were estimated to result in impact speeds from 2.4 to 6.6 m/s. Based on our results, we identified a critical drop height that was used to evaluate the performance of helmets. The peak impact forces and peak accelerations varied nonproportionally with the drop height. When the drop height is less than the critical height, the peak force and peak acceleration increase gradually and slowly with increasing drop height. When the drop height is greater than the critical height, the peak force and peak acceleration increase steeply with even a slight increase in drop height. Based on the critical drop height, we proposed an approach to determine the safety margin of a helmet. The proposed approach would make it possible to determine the performance characteristics of a helmet and to estimate the safety margin afforded by the helmet, if the helmet first passes the existing standardized tests. The proposed test approach would provide supplementary information for consumers to make knowledgeable decisions when selecting construction helmets.	[Pan, Christopher S.; Wimer, Bryan M.] Natl Inst Occupat Safety & Hlth, Div Safety Res, 1095 Willowdale Rd, Morgantown, WV 26505 USA; [Welcome, Daniel E.; Wu, John Z.] Natl Inst Occupat Safety & Hlth, Hlth Effects Lab, 1095 Willowdale Rd, Morgantown, WV 26505 USA		Wu, JZ (corresponding author), Natl Inst Occupat Safety & Hlth, Hlth Effects Lab, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	jwu@cdc.gov					American National Standard for Industrial Head Protection, 2014, Z8912014 ANSIISEA; [Anonymous], 2012, 140522012A12012 BS E; EN, 2012, 3972012A12012 BS EN; Eppinger R. H., 1996, TRAUMATIC BRAIN INJU, P39; GILCHRIST A, 1987, J OCCUP ACCID, V9, P199, DOI 10.1016/0376-6349(87)90012-5; Hibbeler RC, 2011, MECH MATER, V8th; Hino Y, 2012, WORK, V41, P3339, DOI 10.3233/WOR-2012-0602-3339; Ivarsson J, 2003, J BIOMECH ENG-T ASME, V125, P523, DOI 10.1115/1.1590360; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kica J, 2014, J SAFETY RES, V51, P49, DOI 10.1016/j.jsr.2014.09.003; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; Konda S, 2015, INJURY PREV, V21, P115, DOI 10.1136/injuryprev-2014-041323; Liu M, 2011, WORK, V39, P283, DOI 10.3233/WOR-2011-1176; Lombardi DA, 2011, SCAND J WORK ENV HEA, V37, P525, DOI 10.5271/sjweh.3174; MILLS NJ, 1993, SAFETY SCI, V16, P221, DOI 10.1016/0925-7535(93)90045-F; Prasad P., 1985, SAE TRANSACTIONS, V94, P106; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Safety and Health Regulations for Construction, 2012, OSHA1926100; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008; Wu J. Z., 2019, 31 ANN INT OCC ERG S	22	0	0	1	4	AMER SOC TESTING MATERIALS	W CONSHOHOCKEN	100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959 USA	0090-3973	1945-7553		J TEST EVAL	J. Test. Eval.	MAY	2021	49	3					2162	2174		10.1520/JTE20180604			13	Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	RO3UK	WOS:000640970800051					2022-02-07	
J	Pickett, B; Bytomski, JR; Zafonte, RD				Pickett, Brent; Bytomski, Jeffrey R.; Zafonte, Ross D.			Evidence based management of sports related concussion	JOURNAL OF OSTEOPATHIC MEDICINE			English	Article						clinical guidelines; concussion; return to play; sports	HIGH-SCHOOL; RECOVERY; EXERCISE; FOOTBALL; STATEMENT; MEDICINE; RISK	Sports related concussion (SRC) is a common condition evaluated by healthcare professionals. In an article entitled "Return to Play After Concussion: Clinical Guidelines for Young Athletes" published in the December 2019 issue of the Journal of the American Osteopathic Association, guidelines for the management of SRC were presented to assist healthcare professionals in the management of patients with SRC. However, much of the information presented in that article is contradicted by current expert recommendations and evidence based practice guidelines. The management of SRC has evolved to a nuanced, domain driven diagnosis requiring a multidisciplinary treatment team and a customized management plan for each patient to ensure competent treatment of patients with SRC. As such, this Commentary summarizes current recommendations for diagnosis and management of SRC.	[Pickett, Brent] Duke Hlth, Off James R Urbaniak, 3475 Erwin Rd, Durham, NC 27705 USA; [Pickett, Brent; Bytomski, Jeffrey R.] Duke Hlth, Sports Sci Inst, 3475 Erwin Rd, Durham, NC 27705 USA; [Zafonte, Ross D.] Harvard Med Sch, Spaulding Rehabil Hosp, Boston, MA 02115 USA		Pickett, B (corresponding author), Duke Hlth, Off James R Urbaniak, 3475 Erwin Rd, Durham, NC 27705 USA.; Pickett, B (corresponding author), Duke Hlth, Sports Sci Inst, 3475 Erwin Rd, Durham, NC 27705 USA.	brent.pickett@duke.edu					[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Berry JAD, 2019, J AM OSTEOPATH ASSOC, V119, P833, DOI 10.7556/jaoa.2019.135; Collins MW, 2015, STAT AGR TARG EV ACT; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Echemendia R, 2017, Br J Sports Med, V51, P862; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Grashow R, 2020, ANN NEUROL, V88, P106, DOI 10.1002/ana.25747; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2020, FRONT NEUROL, V11; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kmush BL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4442; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; NCAA Sport Science Institute, 2016, INT CONS DIAGN MAN S, P1; Schilling S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010351; Silverberg ND, 2021, ARCH PHYS MED REHAB, V102, P76, DOI 10.1016/j.apmr.2020.08.022; Terry DP, 2021, CLIN J SPORT MED, V31, P430, DOI 10.1097/JSM.0000000000000791; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Williams VB, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0569-5; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	33	0	0	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY		2702-3648		J OSTEOPATH MED	J. Osteopath. Med.	MAY	2021	121	5					499	502		10.1515/jom-2021-0058			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TZ3KE	WOS:000684373000008	33831982				2022-02-07	
J	Pollifrone, M; Callender, L; Bennett, M; Driver, S; Petrey, L; Hamilton, R; Dubiel, R				Pollifrone, Maria; Callender, Librada; Bennett, Monica; Driver, Simon; Petrey, Laura; Hamilton, Rita; Dubiel, Rosemary			Predictors for 30-Day Readmissions After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						30-day readmissions; healthcare utilization; traumatic brain injury	HOSPITAL READMISSIONS; CONTINUOUS CHAIN; REHABILITATION; CARE; REHOSPITALIZATIONS; COST	Objective: To examine predictors for 30-day readmission post-onset of traumatic brain injury (TBI) after initial trauma hospitalization. Design: Retrospective cohort. Participants: In total, 5284 patients with an acute TBI admitted from January 1, 2006, through December 31, 2015. Methods: Demographic and clinical data after initial TBI onset were extracted from the local trauma registry and matched with the Dallas-Fort Worth Hospital Council registry. Multiple logistic regression analysis was used to determine factors significantly associated with 30-day readmission. Top diagnosis codes for 30-day readmission were also described. Results: Patients were primarily male (64.6%), non-Hispanic White (47.6%), uninsured (35.4%), and aged 46.1 +/- 23.3 years. In total, 448 patients (8.5%) had a 30-day readmission. Median cumulative charges for each readmitted subject was $34 313. Factors significantly associated with 30-day readmission were falling as the cause of injury, having increased Charlson Comorbidity Index and Injury Severity Score, and discharging to a skilled nursing facility or long-term acute care. Being uninsured was associated with decreased odds of a 30-day readmission. Top diagnosis codes among the readmission visits included cardiac codes (57.7%), fluid and acid-base disorders (54.8%), and hypertension (50.1%). Conclusion: These data highlight those at risk for 30-day readmission across a diverse population of TBI at a large medical center. Interventions such as health literacy education or patient navigation may help mitigate 30-day readmission for at-risk patients.	[Pollifrone, Maria; Hamilton, Rita; Dubiel, Rosemary] Baylor Scott & White Inst Rehabil, Dallas, TX USA; [Callender, Librada; Bennett, Monica] Baylor Scott & White Res Inst, Dallas, TX USA; [Driver, Simon] Baylor Scott & White Res, Sports Therapy & Res, Frisco, TX USA; [Petrey, Laura] Baylor Scott & White Univ Ctr, Dept Gen Surg, Dallas, TX USA		Dubiel, R (corresponding author), Baylor Scott & White Inst Rehabil, Phys Med & Rehabil, 909 N Washington Ave, Dallas, TX 75246 USA.	maria.pollifrone@bswhealth.org; librada.callender@bswhealth.org; monica.bennett@bshwealth.org; sjdriver@bswrehab.com; laura.petrey@bswhealth.org; rita.hamilton@BSWHealth.org; RDubiel@BSWrehab.com		driver, simon/0000-0003-2356-432X			Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Boutin A., 2013, CRIT CARE, V17, pP331; Canner JK, 2016, BRAIN INJURY, V30, P1570, DOI 10.1080/02699052.2016.1199898; Centers for Medicare & Medicaid Services, 2019, AC CAR HOSP INP PROS; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Cui XN, 2019, RURAL REMOTE HEALTH, V19, DOI [10.22605/RRH5270, 10.22605/rrh5270]; Dallas Fort Worth Hospital Council, 2019, HOM PAG; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS293, DOI 10.1016/j.apmr.2014.08.026; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Medicode, 2001, ICD 9 CM INT CLASS D; Mull HJ, 2013, MED CARE, V51, P589, DOI 10.1097/MLR.0b013e31829019a4; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Oh EG, 2021, J PATIENT SAF, V17, P305, DOI 10.1097/PTS.0000000000000596; Rottman-Sagebiel Rebecca, 2018, Fed Pract, V35, P42; Salisbury DB, 2017, ARCH PHYS MED REHAB, V98, P425, DOI 10.1016/j.apmr.2016.09.117; Sanclemente-Boli T, 2019, MED CLIN-BARCELONA, V153, P446, DOI 10.1016/j.medcli.2019.02.026; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265	23	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		E178	E185		10.1097/HTR.0000000000000630			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900011	33201037				2022-02-07	
J	Prus, R; Appelhans, O; Logash, M; Pokotylo, P; Nowicki, GJ; Slusarska, B				Prus, Ruslan; Appelhans, Olena; Logash, Maksim; Pokotylo, Petro; Nowicki, Grzegorz Jozef; Slusarska, Barbara			A Histological and Morphometric Assessment of the Adult and Juvenile Rat Livers after Mild Traumatic Brain Injury	CELLS			English	Article						traumatic brain injury; mild traumatic brain injury; liver; juvenile rats; extracranial complication	ORGAN DYSFUNCTION; STRESS; IMPACT; CYTOKINES	Traumatic brain injury (TBI) is one of the most severe problems of modern medicine that plays a dominant role in morbidity and mortality in economically developed countries. Our experimental study aimed to evaluate the histological and morphological changes occurring in the liver of adult and juvenile mildly traumatized rats (mTBI) in a time-dependent model. The experiment was performed on 70 adult white rats at three months of age and 70 juvenile rats aged 20 days. The mTBI was modelled by the Impact-Acceleration Model-free fall of weight in the parieto-occipital area. For histopathological comparison, the samples were taken on the 1st, 3rd, 5th, 7th, 14th, and 21st days after TBI. In adult rats, dominated changes in the microcirculatory bed in the form of blood stasis in sinusoidal capillaries and veins, RBC sludge, and adherence to the vessel wall with the subsequent appearance of perivascular and focal leukocytic infiltrates. In juvenile rats, changes in the parenchyma in the form of hepatocyte dystrophy prevailed. In both groups, the highest manifestation of the changes was observed on 5-7 days of the study. On 14-21 days, compensatory phenomena prevailed in both groups. Mild TBI causes changes in the liver of both adult and juvenile rats. The morphological pattern and dynamics of liver changes, due to mild TBI, are different in adult and juvenile rats.	[Prus, Ruslan; Appelhans, Olena] Odessa Natl Med Univ, Dept Normal & Pathol Clin Anat, UA-65000 Odessa, Ukraine; [Logash, Maksim; Pokotylo, Petro] Lviv Natl Med Univ, Dept Normal Anat, UA-79010 Lvov, Ukraine; [Nowicki, Grzegorz Jozef; Slusarska, Barbara] Med Univ Lublin, Dept Family Med & Community Nursing, PL-20081 Lublin, Poland		Logash, M (corresponding author), Lviv Natl Med Univ, Dept Normal Anat, UA-79010 Lvov, Ukraine.	ruslan.prus@onmedu.edu.ua; olena.appelhans@onmedu.edu.ua; kaf_normanatomy@meduniv.lviv.ua; anatompetro@meduniv.lviv.ua; gnowicki84@gmail.com; barbara.slusarska@umlub.pl	Slusarska, Barbara/AAO-6903-2021; Petro, Pokotylo/W-4836-2018; Logash, Maksim/P-8237-2016	Slusarska, Barbara/0000-0003-0101-9216; Petro, Pokotylo/0000-0003-2104-0100; Logash, Maksim/0000-0003-3978-7616; Appel'hans, Olena/0000-0002-2344-6502; Nowicki, Grzegorz/0000-0002-0503-8847; Prus, Ruslan/0000-0002-8548-6892			Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Brienza N, 2006, INTENS CARE MED, V32, P267, DOI 10.1007/s00134-005-0023-3; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Carroll EL, 2020, J HEAD TRAUMA REHAB, V35, pE513, DOI 10.1097/HTR.0000000000000575; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030390; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; DEKLOET ER, 1988, PROG BRAIN RES, V73, P101; DeLegge MH, 2008, NUTR CLIN PRACT, V23, P35, DOI 10.1177/011542650802300135; Espelid S, 1996, FISH SHELLFISH IMMUN, V6, P95, DOI 10.1006/fsim.1996.0011; Greenstein A, 2020, J CLIN ONCOL, V38; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Gundappa P., 2019, J NEUROANAESTHESIOL, V6, P200, DOI [10.1055/s-0039-1692883, DOI 10.1055/S-0039-1692883]; Harbrecht BG, 2002, J TRAUMA, V53, P517, DOI 10.1097/00005373-200209000-00020; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Howard V, 2004, UNBIASED STEREOLOGY, P296; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENSEN EB, 1979, J MICROSC-OXFORD, V115, P19, DOI 10.1111/j.1365-2818.1979.tb00149.x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kemp CD, 2008, AM SURGEON, V74, P866; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meretskyi V, 2012, HOSP SURG, P56; Meretskyi V.M., 2012, Ukrainian Patent, Patent No. 74935; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Narad ME, 2020, J HEAD TRAUMA REHAB, V35, pE271, DOI 10.1097/HTR.0000000000000550; Olsen M, 2019, EUR J PAEDIATR NEURO, V23, P500, DOI 10.1016/j.ejpn.2019.01.009; Ortega E, 2003, EXERC IMMUNOL REV, V9, P70; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Robba C, 2020, CURR OPIN CRIT CARE, V26, P137, DOI 10.1097/MCC.0000000000000707; Romeo RD, 2018, FRONT NEUROENDOCRIN, V49, P43, DOI 10.1016/j.yfrne.2017.12.003; Roth J. A., 1985, Animal stress, P225; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; [Семенова Жанна Борисовна Semenova Zh.B.], 2016, [Российский вестник детской хирургии, анестезиологии и реаниматологии, The Russian bulletin of childrens surgery, anesthesiology and resuscitation, Rossiiskii vestnik detskoi khirurgii, anesteziologii i reanimatologii], V6, P112; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Tsoory M, 2006, INT J NEUROPSYCHOPH, V9, P713, DOI 10.1017/S1461145705006255; Vazquez DM, 1998, PSYCHONEUROENDOCRINO, V23, P663; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yelsky V.N., 2008, SIMULATION TRAUMATIC, P139	59	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	MAY	2021	10	5							1121	10.3390/cells10051121			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	SI2UM	WOS:000654681700001	34066539	gold, Green Published			2022-02-07	
J	Riemann, L; Voormolen, DC; Rauen, K; Zweckberger, K; Unterberg, A; Younsi, A				Riemann, Lennart; Voormolen, Daphne C.; Rauen, Katrin; Zweckberger, Klaus; Unterberg, Andreas; Younsi, Alexander		Collaborative European NeuroTrauma	Persistent postconcussive symptoms in children and adolescents with mild traumatic brain injury receiving initial head computed tomography	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						mild traumatic brain injury; pediatric; postconcussive symptoms; CT imaging; Rivermead Post Concussion Symptoms Questionnaire; RPQ; health-related quality of life; HRQOL; trauma	QUALITY-OF-LIFE; CONCUSSION; PREVALENCE; QOLIBRI	OBJECTIVE The aim of this paper was to evaluate the prevalence of postconcussive symptoms and their relation to health-related quality of life (HRQOL) in pediatric and adolescent patients with mild traumatic brain injury (mTBI) who received head CT imaging during initial assessment. METHODS Patients aged between 5 and 21 years with mTBI (Glasgow Coma Scale scores 13-15) and available Rivermead Post Concussion Questionnaire (RPQ) at 6 months of follow-up in the multicenter, prospectively collected CENTER-TBI (Collaborative European NeuroTrauma Effectiveness Research in TBI) study were included. The prevalence of postconcussive symptoms was assessed, and the occurrence of postconcussive syndrome (PSC) based on the ICD-10 criteria, was analyzed. HRQOL was compared in patients with and without PCS using the Quality of Life after Brain Injury (QOLIBRI) questionnaire. RESULTS A total of 196 adolescent or pediatric mTBI patients requiring head CT imaging were included. High-energy trauma was prevalent in more than half of cases (54%), abnormalities on head CT scans were detected in 41%, and admission to the regular ward or intensive care unit was necessary in 78%. Six months postinjury, 36% of included patients had experienced at least one moderate or severe symptom on the RPQ. PCS was present in 13% of adolescents and children when considering symptoms of at least moderate severity, and those patients had significantly lower QOLIBRI total scores, indicating lower HRQOL, compared with young patients without PCS (57 vs 83 points, p < 0.001). CONCLUSIONS Adolescent and pediatric mTBI patients requiring head CT imaging show signs of increased trauma severity. Postconcussive symptoms are present in up to one-third of those patients, and PCS can be diagnosed in 13% 6 months after injury. Moreover, PCS is significantly associated with decreased HRQOL.	[Riemann, Lennart; Zweckberger, Klaus; Unterberg, Andreas; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Voormolen, Daphne C.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Rauen, Katrin] Univ Zurich, Univ Hosp Psychiat Zurich, Dept Geriatr Psychiat, Zurich, Switzerland; [Rauen, Katrin] Univ Zurich, Inst Regenerat Med, Zurich, Switzerland		Younsi, A (corresponding author), Heidelberg Univ Hosp, Heidelberg, Germany.	alexander.younsi@med.uni-heidelberg.de	Vande Vyvere, Thijs/AAB-5180-2022; Posti, Jussi P./Y-2908-2019; Belli, Antonio/I-3799-2015; Gomez, Pedro/E-2411-2014	Vande Vyvere, Thijs/0000-0003-4032-5443; Posti, Jussi P./0000-0002-5925-5193; Stewart, William/0000-0003-2199-2582; Dark, Paul/0000-0003-3309-0164; Radoi, Andreea/0000-0002-0677-3544; Takala, Riikka/0000-0001-6342-0043; Belli, Antonio/0000-0002-3211-9933; Zeiler, Frederick/0000-0003-1737-0510; Sakowitz, Oliver/0000-0003-3248-6335; Newcombe, Virginia/0000-0001-6044-9035; van der Naalt, Joukje/0000-0001-9873-2418; Gomez, Pedro/0000-0002-4185-5238; Van Essen, Thomas/0000-0003-4657-5283	European Union 7th Framework program (EC) [602150]; OneMind (USA); Hannelore Kohl Stiftung (Germany)	CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany) and OneMind (USA).	Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; [Anonymous], 1992, ICD 10 CLASS MENT BE; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Filbay S, 2019, SPORTS MED, V49, P1723, DOI 10.1007/s40279-019-01163-0; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Howell DR, 2019, CLIN PEDIATR, V58, P42, DOI 10.1177/0009922818806308; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mayer AR, 2020, J NEUROTRAUM, V37, P1504, DOI 10.1089/neu.2019.6805; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Orbach Y, 2007, CHILD DEV, V78, P1100, DOI 10.1111/j.1467-8624.2007.01055.x; Paniccia M, 2020, DEV NEUROREHABIL, V23, P534, DOI 10.1080/17518423.2020.1736683; Petersen S, 2003, SCAND J PUBLIC HEALT, V31, P367, DOI 10.1080/14034940210165064; Philipp J, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1050-8; Plourde V, 2018, J INT NEUROPSYCH SOC, V24, P540, DOI 10.1017/S1355617718000061; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Winkler R, 2015, J HEAD TRAUMA REHAB, V30, P324, DOI 10.1097/HTR.0000000000000114; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	33	0	0	1	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2021	27	5					538	547		10.3171/2020.9.PEDS20421			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	RW7YX	WOS:000646737900006	33636701				2022-02-07	
J	Roby, PR; Lynall, RC; Cools, MJ; Marshall, SW; Fonseca, JC; Stevens, JR; Mihalik, JP				Roby, Patricia R.; Lynall, Robert C.; Cools, Michael J.; Marshall, Stephen W.; Fonseca, Janna C.; Stevens, James R.; Mihalik, Jason P.			Hyperbaric Oxygen Therapy to Treat Acute Sport-Related Traumatic Brain Injuries: A Case Series	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						adolescent; concussion; symptoms	CEREBRAL-BLOOD-FLOW; STANDARDIZED ASSESSMENT; PROLONGED RECOVERY; HIGH-SCHOOL; CONCUSSION; SENSITIVITY; PREDICTORS; MODEL	We report on hyperbaric oxygen (HBO2) therapy used to improve postinjury outcomes in eight acutely concussed high school student-athletes (5 males, 3 females, mean age = 16.0 +/- 1.2 years). Patients were randomly assigned into one of three intervention groups: (a) HBO2 therapy; (b) hyperbaric therapy with compressed medical-grade air (HBA); or (c) normobaric 100% O-2 therapy. All patients completed five 1-hr treatments within the first 10 days following his or her concussion. Main outcome measures included mental status examination, symptom burden, and the number of days from injury until the physician permitted the student-athlete to return to activity. Patients receiving HBO2 treatment experienced the greatest absolute symptom reduction over the five treatment sessions. No meaningful differences were found in mental status examination. All participants returned to activity in a similar timeframe. HBO2 therapy may be an effective option for the acute treatment of postconcussion symptoms, particularly in young athletes presenting with a high symptom burden.	[Roby, Patricia R.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Lynall, Robert C.] Univ Georgia, UGA Concuss Res Lab, Dept Kinesiol, Athens, GA USA; [Cools, Michael J.; Marshall, Stephen W.] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Fonseca, Janna C.; Stevens, James R.] Carolina Family Practice & Sports Med, Raleigh, NC USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA.	jmihalik@email.unc.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Cools, Michael/0000-0001-6891-3744	National Operating Committee on Standards for Athletic Equipment (NOCSAE)	This case series was funded by the National Operating Committee on Standards for Athletic Equipment (NOCSAE). The results of this case series do not constitute endorsement by the NOCSAE. The results of the case series are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The authors have no conflicts of interests to disclose related to this case series.	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; BIRD AD, 1965, LANCET, V1, P355; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; HARGENS AR, 1981, J BONE JOINT SURG AM, V63, P631, DOI 10.2106/00004623-198163040-00014; Huang L, 2016, MED GAS RES, V6, P187, DOI 10.4103/2045-9912.196900; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; NYLANDER G, 1984, BURNS, V10, P193, DOI 10.1016/0305-4179(84)90026-3; Patel AV, 2007, J ATHL TRAINING, V42, P66; PIERCE AK, 1969, ANNU REV MED, V20, P431, DOI 10.1146/annurev.me.20.020169.002243; SUKOFF MH, 1982, NEUROSURGERY, V10, P29, DOI 10.1227/00006123-198201000-00006; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Wang F, 2016, NEUROL SCI, V37, P693, DOI 10.1007/s10072-015-2460-2; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	25	0	0	1	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	MAY	2021	26	3					140	144		10.1123/ijatt.2019-0135			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	SU0WJ	WOS:000662862100005		Bronze			2022-02-07	
J	Ryan, NP; Greenhom, M; Gordon, AL; Ditchfield, M; Coleman, L; Cooper, A; Crowe, L; Hunt, R; Monagle, P; Mackay, MT; Anderson, V				Ryan, Nicholas P.; Greenhom, Mardee; Gordon, Anne L.; Ditchfield, Michael; Coleman, Lee; Cooper, Anna; Crowe, Louise; Hunt, Rod W.; Monagle, Paul; Mackay, Mark T.; Anderson, Vicki			Social Cognitive Dysfunction Following Pediatric Arterial Ischemic Stroke Evidence From a Prospective Cohort Study	STROKE			English	Article						adolescent; child; emotion; social cognition; theory of mind	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CONATIVE THEORY; CHILDHOOD; CHILDREN; MIND; ADOLESCENTS; EMERGENCE; DEFICITS; OUTCOMES	Background and Purpose: Childhood and adolescence coincide with rapid maturation of distributed brain networks supporting social cognition; however, little is known about the impact of early ischemic brain insult on the acquisition of these skills. This study aimed to examine the influence of arterial ischemic stroke (AIS) on facial emotion recognition and theory of mind (ToM) abilities of children and adolescents initially recruited to a single-center, prospective longitudinal study of recovery following AIS. Methods: The study involved 67 participants, including 30 children with AIS (mean time since stroke=5 years) and 37 age-matched typically developing controls who were assessed on measures of cognitive ToM, facial emotion recognition, and affective ToM. Acute clinical magnetic resonance imaging, including diffusion-weighted imaging sequences, were used to evaluate prospective structure-function relationships between acute lesion characteristics (size, location, and arterial territories affected) and long-term social cognitive abilities. Results: Relative to age-matched typically developing controls, children with AIS showed significantly worse performance on measures of basic facial emotion processing, cognitive ToM, and affective ToM. In univariate models, poorer ToM was associated with larger infarcts, combined cortical-subcortical pathology, and involvement of multiple arterial territories. In multivariate analyses, larger lesions and multiterritory infants were predictive of ToM processing but not facial emotion recognition. Poorer cognitive ToM predicted less frequent prosocial behavior and increased peer problems. Conclusions: Social cognitive skills appear vulnerable to disruption from early ischemic brain insult. In the first study to examine social cognition in a prospective cohort of children with AIS, our findings suggest that acute magnetic resonance imaging-based lesion characteristics may have predictive value for long-term social cognitive outcomes and may assist to identify children at elevated risk for social cognitive dysfunction.	[Ryan, Nicholas P.; Greenhom, Mardee; Coleman, Lee; Cooper, Anna; Crowe, Louise; Hunt, Rod W.; Monagle, Paul; Mackay, Mark T.; Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Ryan, Nicholas P.] Deakin Univ, Sch Psychol, Geelong, Vic, Australia; [Ryan, Nicholas P.; Cooper, Anna; Hunt, Rod W.; Monagle, Paul; Mackay, Mark T.; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Gordon, Anne L.] Guys & St Thomas NHS Fdn Trust, Paediat Neurosci Dept, Evelina London Childrens Hosp, London, England; [Gordon, Anne L.] Kings Coll London, Dept Populat Hlth Sci, London, England; [Ditchfield, Michael] Monash Childrens Hosp, Paediat Imaging, Melbourne, Vic, Australia; [Ditchfield, Michael] Monash Univ, Dept Radiol & Paediat, Melbourne, Vic, Australia; [Coleman, Lee] Royal Childrens Hosp, Dept Med Imaging, Melbourne, Vic, Australia; [Hunt, Rod W.] Royal Childrens Hosp, Dept Neonatal Med, Melbourne, Vic, Australia; [Monagle, Paul] Royal Childrens Hosp, Dept Haematol, Melbourne, Vic, Australia; [Mackay, Mark T.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia		Ryan, NP (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au		Ryan, Nicholas/0000-0002-0878-8889; Ditchfield, Michael/0000-0003-1707-3671; Hunt, Rodney/0000-0002-2446-1739	Murdoch Children's Research Institute; Royal Children's Hospital, Melbourne	This research received funding and infrastructure support from the Murdoch Children's Research Institute and Royal Children's Hospital, Melbourne.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson V, 2014, SOC NEUROSCI-UK, V9, P471, DOI 10.1080/17470919.2014.932308; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Cooper AN, 2018, NEUROLOGY, V90, pE365, DOI 10.1212/WNL.0000000000004906; Cooper AN, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3870; Craney T. A., 2002, Quality Engineering, V14, P391, DOI 10.1081/QEN-120001878; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Dunbar M. J., 2020, STROKE S1, V51; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gordon AL, 2015, INT J STROKE, V10, P1068, DOI 10.1111/ijs.12489; Greenham M, 2016, STROKE, V47, P1159, DOI 10.1161/STROKEAHA.115.011622; Grossmann T, 2007, EUR J NEUROSCI, V25, P909, DOI 10.1111/j.1460-9568.2007.05379.x; Hajek CA, 2014, J CHILD NEUROL, V29, P887, DOI 10.1177/0883073813491828; Hetherington R, 2005, J CHILD NEUROL, V20, P553, DOI 10.1177/08830738050200070201; Husson B, 2010, PEDIATRICS, V126, pE912, DOI 10.1542/peds.2009-3611; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Johnson MH, 2000, CHILD DEV, V71, P75, DOI 10.1111/1467-8624.00120; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Korkman M., 2007, NEPSY, V2nd; Leppanen JM, 2006, ADV CHILD DEV BEHAV, V34, P207, DOI 10.1016/S0065-2407(06)80008-X; Leventer RJ, 1999, NEUROLOGY, V53, P715, DOI 10.1212/WNL.53.4.715; Lo W, 2020, J CHILD NEUROL, V35, P228, DOI 10.1177/0883073819887590; Lo W, 2014, INT J STROKE, V9, P1037, DOI 10.1111/ijs.12222; Long B, 2011, DEV NEUROPSYCHOL, V36, P971, DOI 10.1080/87565641.2011.581537; Mallick AA, 2010, EUR J PAEDIATR NEURO, V14, P197, DOI 10.1016/j.ejpn.2009.09.006; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Nijsse B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213725; O'Keeffe F, 2017, DEV NEUROREHABIL, V20, P428, DOI 10.1080/17518423.2017.1282052; Perner Josef, 1991, UNDERSTANDING REPRES; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Rajhans P, 2016, DEV COGN NEUROS-NETH, V19, P115, DOI 10.1016/j.dcn.2016.01.004; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2017, SOC COGN AFFECT NEUR, V12, P1414, DOI 10.1093/scan/nsx066; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Stiekema APM, 2021, NEUROPSYCHOL REHABIL, V31, P278, DOI 10.1080/09602011.2019.1692670; Tatu L, 2012, FRONT NEUROL NEUROSC, V30, P99, DOI 10.1159/000333602; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Wellman, 1992, CHILDS THEORY MIND; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009	55	0	0	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	MAY	2021	52	5					1609	1617		10.1161/STROKEAHA.120.032955			9	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Cardiovascular System & Cardiology	RT7SE	WOS:000644656300020	33827249	Bronze, Green Submitted			2022-02-07	
J	Sadler, K; Turcotte, K; Babul, S				Sadler, Karen; Turcotte, Kate; Babul, Shelina			Collaboration, Training and Resources to Support School Policy Development and Recovery from Concussion	HEALTH BEHAVIOR AND POLICY REVIEW			English	Article						concussion management; concussion policy; school health; adolescent health; child health; mild traumatic brain injury	SPORT-RELATED CONCUSSION; MANAGEMENT; OUTCOMES; LESSONS; HEALTH; TERM	Objective: Concussion is a public health concern across all ages, yet there is little research on providing concussion education and training within the educational context. The Concussion Awareness Training Tool for School Professionals (CATT SP) was developed to provide the necessary concussion education and resources for school professionals to support a student with concussion while integrating back to school. Methods: The CATT SP module underwent a 2016 pre/post-intervention evaluation to determine if knowledge and attitudes significantly improved among educators and administrators following completion of the CATT SP, as well as a 2018-19 pilot study within a school district in British Columbia with an accompanying Quality Assurance/Quality Improvement assessment. Results: A statistically significant positive change in knowledge (p = .027) was found among those who indicated that they had accessed CATT SP. Results of the pilot study and QA/QI assessment found support of the use of CATT within the school district. Conclusions: Evidence-based concussion training and resources are key components for school professionals who are collaboratively supporting a student's individualized return to school and learning following a concussion, and when developing and implementing a concussion policy within districts and school.	[Sadler, Karen; Turcotte, Kate] BC Injury Res & Prevent Unit, Vancouver, BC, Canada; [Babul, Shelina] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada		Sadler, K (corresponding author), BC Injury Res & Prevent Unit, Vancouver, BC, Canada.	karen.sadler@bcchr.ca		Turcotte, Kate/0000-0001-9905-1147			Bach S, THESIS U TORONTO; Baran ML, 2020, APPL SOCIAL SCI APPR; Case RJL, 2017, NEW ZEAL J EDUC STUD, V52, P159, DOI 10.1007/s40841-017-0080-5; Cohen R, 2006, PSYCHOL SCHOOLS, V43, P419, DOI 10.1002/pits.20156; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Government of Canada, GOV CAN INV NEW PROJ; Government of Canada, CONC SYMPT TREATM; Government of Ontario Ministry of Education, SCH BOARD POL CONC; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Hachem LD, 2016, CAN J NEUROL SCI, V43, P554, DOI 10.1017/cjn.2016.41; Healthy Schools BC, COMPR SCH HLTH; Hon KL, 2019, SEMIN PEDIATR NEUROL, V30, P117, DOI 10.1016/j.spen.2019.03.017; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; LaRocca R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-751; Lowry R, 2019, AM J PREV MED, V57, P733, DOI 10.1016/j.amepre.2019.08.016; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Matveev R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6232-9; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckinlay A, 2019, DISABIL REHABIL, V41, P1419, DOI 10.1080/09638288.2018.1429500; Michael SL, 2015, J SCHOOL HEALTH, V85, P740, DOI 10.1111/josh.12309; Organization WH, GLOB SCH HLTH IN; Pan-Canadian Joint Consortium for School Health, GOV WORK HLTH ED SEC; Potteiger AJ, 2016, STRATEGIES, V29, P48; Purcell LK, 2019, BRIT J SPORT MED, V53, P250, DOI 10.1136/bjsports-2017-097853; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Scratch SE, 2019, J HEAD TRAUMA REHAB, V34, P385, DOI 10.1097/HTR.0000000000000542; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Thielking M, 2018, EDUC DEV PSYCHOL, V35, P18, DOI 10.1017/edp.2018.4; US Centers for Disease Control and Prevention, HLTH AC HLTH SCH; US Centers for Disease Control and Prevention, BAS INF TRAUM BRAIN; US Department of Health and Human Services, HLTH PEOPL 2030; US Department of Health and Human Services Of- fice of Disease Prevention and Health Promotion, IVP05 US DEP HLTH HU; US Department of Health and Human services Office of Disease Prevention and Health Promotion, EHD01 US DEP HLTH HU; US Department of Health and Human Services Office of Disease Prevention and Health Promotion, AH07 US DEP HLTH HUM; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Weber ML, 2019, J SCH NURS, V35, P378, DOI 10.1177/1059840518774391; WHO UNESCO, GLOB STAND HLTH PROM	41	0	0	0	0	PARIS SCHOLAR PUBLISHING LTD	ALHAMBRA	1508 S GARFIELD AVE, ALHAMBRA, CA, UNITED STATES	2326-4403			HEALTH BEHAV POLICY	Health Behav. Policy Rev.	MAY	2021	8	3					257	268		10.14485/HBPR.8.3.7			12	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	TD9OX	WOS:000669648600007		hybrid			2022-02-07	
J	Sander, C; Oppermann, H; Nestler, U; Sander, K; von Dercks, N; Meixensberger, J				Sander, Caroline; Oppermann, Henry; Nestler, Ulf; Sander, Katharina; von Dercks, Nikolaus; Meixensberger, Juergen			Causes and Predictors of Unplanned Readmission in Cranial Neurosurgery	WORLD NEUROSURGERY			English	Article						Diagnosis groups; Functional neurosurgery; Hydrocephalus; Neoplasm; Traumatic head injury; Unplanned readmission	DEEP BRAIN-STIMULATION; 30-DAY READMISSION; RATES; CRANIOTOMY; SURGERY; SYSTEM; RETURN; TUMOR	-OBJECTIVE: A better understanding of the risks and reasons for unplanned readmission is an essential component in reducing costs in the health care system and in optimizing patient safety and satisfaction. The reasons for unplanned readmission vary between different disciplines and procedures. The aim of this study was to identify reasons for readmission in view of different diagnoses in cranial neurosurgery. -METHODS: In this single-center retrospective study, adult patients after neurosurgical treatment were analyzed and grouped according to the indication based on International Classification of Diseases and Related Health Problems, Tenth Revision, German Modification diagnosis codes. The main outcome measure was unplanned readmission within 30 days of discharge. Further logistic regression models were performed to identify factors associated with unplanned rehospitalization. -RESULTS: Of the 2474 patients analyzed, 183 underwent -nplanned rehospitalization. Readmission rates differed between the diagnosis groups, with 9.19% in neoplasm, 8.26% in hydrocephalus, 5.76% in vascular, 6.13% after trauma, and 8.05% in the functional group. Several causes were considered to be preventable, such as wound healing disorders, seizures, or social reasons. Younger age, length of first stay, surgical treatment, and side diagnoses were predictors for unplanned readmission. Diagnoses with an increased risk of readmission were glioblastoma, traumatic subdural hematoma, or chronic subdural hematoma. -CONCLUSIONS: Reasons and predictors for an unplanned readmission differ considerably among the index diagnosis groups. In addition to well-known reasons for readmission, we identified social indication, meaning a lack of home care, which is particularly prevalent in oncologic and elderly patients. A transitional care program could benefit these vulnerable patients.	[Sander, Caroline; Oppermann, Henry; Nestler, Ulf; Meixensberger, Juergen] Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany; [von Dercks, Nikolaus] Univ Hosp Leipzig, Dept Med Controlling, Leipzig, Germany		Sander, C (corresponding author), Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany.	caroline.sander@medizin.uni-leipzig.de					Buchanan CC, 2014, J NEUROSURG, V121, P170, DOI 10.3171/2014.4.JNS13944; Chern JJ, 2014, J NEUROSURG-PEDIATR, V13, P525, DOI 10.3171/2014.2.PEDS13493; Cusimano MD, 2017, J NEUROSURG, V127, P342, DOI 10.3171/2016.7.JNS152226; Dasenbrock HH, 2016, CANCER-AM CANCER SOC, V122, P1708, DOI 10.1002/cncr.29984; Dickinson H, 2015, J NEUROSURG, V122, P61, DOI 10.3171/2014.8.JNS1498; Dignan FL, 2013, CLIN TRANSPLANT, V27, pE56, DOI 10.1111/ctr.12065; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Donoho DA, 2019, WORLD NEUROSURG, V128, pE38, DOI 10.1016/j.wneu.2019.03.217; Farahmand D, 2009, J NEUROL NEUROSUR PS, V80, P1248, DOI 10.1136/jnnp.2007.141416; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Glebova NO, 2016, J VASC SURG, V63, P746, DOI 10.1016/j.jvs.2015.09.032; Ivanovic J, 2014, J AM COLL SURGEONS, V218, P1024, DOI 10.1016/j.jamcollsurg.2013.12.043; James Z, 2019, BRIT J NEUROSURG, DOI 10.1080/02688697.2019.1600658; Koo AB, 2020, WORLD NEUROSURG, V139, pE212, DOI 10.1016/j.wneu.2020.03.168; Liu JY, 2019, NEUROSURGERY, V85, P672, DOI 10.1093/neuros/nyy424; Marcus LP, 2014, J NEUROSURG, V120, P1201, DOI 10.3171/2014.1.JNS131264; Moghavem N, 2015, J NEUROSURG, V123, P189, DOI 10.3171/2014.12.JNS14447; Nadel JL, 2020, NEUROSURGERY, V86, P843, DOI 10.1093/neuros/nyz299; Nuno M, 2014, NEUROSURGERY, V74, P196, DOI 10.1227/NEU.0000000000000243; Owler B, 2009, J NEUROL NEUROSUR PS, V80, P1185, DOI 10.1136/jnnp.2009.174524; Rambachan A, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.08.020; Robertson FC, 2018, J NEUROSURG, V128, P1570, DOI 10.3171/2017.2.JNS161770; Rumalla K, 2018, CLIN NEUROL NEUROSUR, V171, P129, DOI 10.1016/j.clineuro.2018.06.013; Sander C, 2020, ACTA NEUROCHIR, V162, P2647, DOI 10.1007/s00701-020-04521-4; Schipmann S, 2019, ACTA NEUROCHIR, V161, P1057, DOI 10.1007/s00701-018-03792-2; Schipmann S, 2019, ACTA NEUROCHIR, V161, P287, DOI 10.1007/s00701-018-03790-4; Schmidt HM, 2017, ANN SURG, V266, P814, DOI 10.1097/SLA.0000000000002445; Schneider RB, 2020, PARKINSONISM RELAT D, V70, P96, DOI 10.1016/j.parkreldis.2019.11.023; Shah MN, 2013, J NEUROSURG, V119, P1043, DOI 10.3171/2013.3.JNS121769; Wrubel DM, 2014, J NEUROSURG-PEDIATR, V13, P216, DOI 10.3171/2013.10.PEDS13248; Zegers M, 2011, PATIENT SAF SURG, V5, DOI 10.1186/1754-9493-5-13	31	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E622	E635		10.1016/j.wneu.2021.01.123			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YJ3CH	WOS:000744410900031					2022-02-07	
J	Sander, C; Oppermann, H; Nestler, U; Sander, K; Von Dercks, N; Meixensberger, J				Sander, Caroline; Oppermann, Henry; Nestler, Ulf; Sander, Katharina; von Dercks, Nikolaus; Meixensberger, Juergen			Causes and Predictors of Unplanned Readmission in Cranial Neurosurgery	WORLD NEUROSURGERY			English	Article						Diagnosis groups; Functional neurosurgery; Hydrocephalus; Neoplasm; Traumatic head injury; Unplanned readmission	DEEP BRAIN-STIMULATION; 30-DAY READMISSION; RATES; CRANIOTOMY; SURGERY; SYSTEM; RETURN; TUMOR	OBJECTIVE: A better understanding of the risks and reasons for unplanned readmission is an essential component in reducing costs in the health care system and in optimizing patient safety and satisfaction. The reasons for unplanned readmission vary between different disciplines and procedures. The aim of this study was to identify reasons for readmission in view of different diagnoses in cranial neurosurgery. METHODS: In this single-center retrospective study, adult patients after neurosurgical treatment were analyzed and grouped according to the indication based on International Classification of Diseases and Related Health Problems, Tenth Revision, German Modification diagnosis codes. The main outcome measure was unplanned readmission within 30 days of discharge. Further logistic regression models were performed to identify factors associated with unplanned rehospitalization. RESULTS: Of the 2474 patients analyzed, 183 underwent unplanned rehospitalization. Readmission rates differed between the diagnosis groups, with 9.19% in neoplasm, 8.26% in hydrocephalus, 5.76% in vascular, 6.13% after trauma, and 8.05% in the functional group. Several causes were considered to be preventable, such as wound healing disorders, seizures, or social reasons. Younger age, length of first stay, surgical treatment, and side diagnoses were predictors for unplanned readmission. Diagnoses with an increased risk of readmission were glioblastoma, traumatic subdural hematoma, or chronic subdural hematoma. CONCLUSIONS: Reasons and predictors for an unplanned readmission differ considerably among the index diagnosis groups. In addition to well-known reasons for readmission, we identified social indication, meaning a lack of home care, which is particularly prevalent in oncologic and elderly patients. A transitional care program could benefit these vulnerable patients.	[Sander, Caroline; Oppermann, Henry; Nestler, Ulf; Meixensberger, Juergen] Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany; [von Dercks, Nikolaus] Univ Hosp Leipzig, Dept Med Controlling, Leipzig, Germany		Sander, C (corresponding author), Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany.	caroline.sander@medizin.uni-leipzig.de	Nestler, Ulf/D-6503-2014	Nestler, Ulf/0000-0002-2963-4344			Buchanan CC, 2014, J NEUROSURG, V121, P170, DOI 10.3171/2014.4.JNS13944; Chern JJ, 2014, J NEUROSURG-PEDIATR, V13, P525, DOI 10.3171/2014.2.PEDS13493; Cusimano MD, 2017, J NEUROSURG, V127, P342, DOI 10.3171/2016.7.JNS152226; Dasenbrock HH, 2016, CANCER-AM CANCER SOC, V122, P1708, DOI 10.1002/cncr.29984; Dickinson H, 2015, J NEUROSURG, V122, P61, DOI 10.3171/2014.8.JNS1498; Dignan FL, 2013, CLIN TRANSPLANT, V27, pE56, DOI 10.1111/ctr.12065; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Donoho DA, 2019, WORLD NEUROSURG, V128, pE38, DOI 10.1016/j.wneu.2019.03.217; Farahmand D, 2009, J NEUROL NEUROSUR PS, V80, P1248, DOI 10.1136/jnnp.2007.141416; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Glebova NO, 2016, J VASC SURG, V63, P746, DOI 10.1016/j.jvs.2015.09.032; Ivanovic J, 2014, J AM COLL SURGEONS, V218, P1024, DOI 10.1016/j.jamcollsurg.2013.12.043; James Z, 2019, BRIT J NEUROSURG, DOI 10.1080/02688697.2019.1600658; Koo AB, 2020, WORLD NEUROSURG, V139, pE212, DOI 10.1016/j.wneu.2020.03.168; Liu JY, 2019, NEUROSURGERY, V85, P672, DOI 10.1093/neuros/nyy424; Marcus LP, 2014, J NEUROSURG, V120, P1201, DOI 10.3171/2014.1.JNS131264; Moghavem N, 2015, J NEUROSURG, V123, P189, DOI 10.3171/2014.12.JNS14447; Nadel JL, 2020, NEUROSURGERY, V86, P843, DOI 10.1093/neuros/nyz299; Nuno M, 2014, NEUROSURGERY, V74, P196, DOI 10.1227/NEU.0000000000000243; Owler B, 2009, J NEUROL NEUROSUR PS, V80, P1185, DOI 10.1136/jnnp.2009.174524; Rambachan A, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.08.020; Robertson FC, 2018, J NEUROSURG, V128, P1570, DOI 10.3171/2017.2.JNS161770; Rumalla K, 2018, CLIN NEUROL NEUROSUR, V171, P129, DOI 10.1016/j.clineuro.2018.06.013; Sander C, 2020, ACTA NEUROCHIR, V162, P2647, DOI 10.1007/s00701-020-04521-4; Schipmann S, 2019, ACTA NEUROCHIR, V161, P1057, DOI 10.1007/s00701-018-03792-2; Schipmann S, 2019, ACTA NEUROCHIR, V161, P287, DOI 10.1007/s00701-018-03790-4; Schmidt HM, 2017, ANN SURG, V266, P814, DOI 10.1097/SLA.0000000000002445; Schneider RB, 2020, PARKINSONISM RELAT D, V70, P96, DOI 10.1016/j.parkreldis.2019.11.023; Shah MN, 2013, J NEUROSURG, V119, P1043, DOI 10.3171/2013.3.JNS121769; Wrubel DM, 2014, J NEUROSURG-PEDIATR, V13, P216, DOI 10.3171/2013.10.PEDS13248; Zegers M, 2011, PATIENT SAF SURG, V5, DOI 10.1186/1754-9493-5-13	31	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E622	E635		10.1016/j.wneu.2021.01.123			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TF2NY	WOS:000670549900031					2022-02-07	
J	Sarmiento, K; Waltzman, D; Borradaile, K; Hurwitz, A; Conroy, K; Grazi, J				Sarmiento, Kelly; Waltzman, Dana; Borradaile, Kelley; Hurwitz, Andrew; Conroy, Kara; Grazi, Jaimie			A Qualitative Study of Youth Football Coaches' Perception of Concussion Safety in American Youth Football and Their Experiences With Implementing Tackling Interventions	INTERNATIONAL SPORT COACHING JOURNAL			English	Article						athletics; injury; player; sporting; tackle	TRAUMATIC BRAIN-INJURIES; UNITED-STATES; SPORTS; CHILDREN; RISK	Due in part to concern about the potential long-term effects of concussion and repetitive head injuries in football, some programs have implemented tackling interventions. This paper explores youth football coaches' perception of football safety and their experiences implementing these interventions aimed at athlete safety. Using a qualitative approach, coaches were interviewed by means of a semi-structured protocol that covered: (a) demographics; (b) background and experiences with contact sports; (c) perceived concussion risks and benefits of youth football; (d) experiences with tackling technique; (e) experiences with mouth guard sensors; and (f) personal sources of training related to football safety. Most coaches felt that learning tackling at a young age helped prepare them for their playing later in life and believed that youth should begin playing tackle football at a young age. Coaches were mixed regarding their concerns about the risk for concussion and subconcussive head impacts. Still, most were receptive to changes in rules and policies aimed at making football safer. Findings from this study demonstrate that youth football coaches are important stakeholders to consider when implementing changes to youth football. Understanding coach perceptions and experiences may inform future efforts aimed to educate coaches on rules and policies to make the game safer for youth athletes.	[Sarmiento, Kelly; Waltzman, Dana] Ctr Dis Control & Prevent CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Borradaile, Kelley; Hurwitz, Andrew; Conroy, Kara; Grazi, Jaimie] Math Policy Inc, Princeton, NJ USA		Sarmiento, K (corresponding author), Ctr Dis Control & Prevent CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	KSarmiento@cdc.gov			U.S. Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [200-2016-92131 (2016)]	This study was funded through contract 200-2016-92131 (2016) from the U.S. Centers for Disease Control and Prevention. The authors declare that they have no conflicts of interest. The findings and conclusions in this manuscript are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bachynski KE, 2021, LANCET NEUROL, V20, P791, DOI 10.1016/S1474-4422(19)30250-9; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Braun V., 2012, ENCY CRITICAL PSYCHO, DOI [10.1037/13620-000, DOI 10.1037/13620-004]; Caron JG, 2015, INT SPORT COACH J, V2, P285, DOI 10.1123/iscj.2015-0022; CDC (U.S. Department of Health and Human Services Centers for Disease Control and Prevention), 2013, RES SCH HLTH POL PRA; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Chrisman SPD, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2402; Conner M, 2017, PSYCHOL HEALTH, V32, P895, DOI 10.1080/08870446.2017.1336240; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dyck J.J., 2016, UMASS LOWELL CTR PUB; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2019, JAMA PEDIATR, V173, P309, DOI 10.1001/jamapediatrics.2018.5498; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glanz K., 2002, HLTH BEHAV HLTH ED T, V3rd ed; Gould D, 2007, J APPL SPORT PSYCHOL, V19, P16, DOI 10.1080/10413200601113786; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hurwitz A., 2018, INT NEUR SOC 46 ANN; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Poucher ZA, 2020, INT REV SPORT EXER P, V13, P163, DOI 10.1080/1750984X.2019.1656276; Prevention C. F. D. C. a., 2019, TRAUM BRAIN INJ CONC; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Rupert DJ, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6980; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Shanley E, 2021, CLIN J SPORT MED, V31, P120, DOI 10.1097/JSM.0000000000000711; Smith B, 2018, INT REV SPORT EXER P, V11, P101, DOI [10.1080/1750984X.2017.1317357, 10.1080/1750984x.2017.1317357, 10.1109/ACSD.2018.000-4]; So JY, 2013, HEALTH COMMUN, V28, P72, DOI 10.1080/10410236.2012.708633; Waltzman D, 2019, J SAFETY RES, V68, P157, DOI 10.1016/j.jsr.2018.11.005; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	38	0	0	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2328-918X	2328-9198		INT SPORT COACH J	Int. Sport Coach J.	MAY	2021	8	2					244	252		10.1123/iscj.2020-0004			9	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	RR0PS	WOS:000642811700011	33598504	Green Accepted			2022-02-07	
J	Sedden, M; Fisher, R; Onstott, K				Sedden, Mandy; Fisher, Rodney; Onstott, Kimberly			Computed Tomography for Emergent Brain Injuries	RADIOLOGIC TECHNOLOGY			English	Article							PROJECTION RECONSTRUCTION TECHNIQUES; TUBE CURRENT MODULATION; NERVE SHEATH DIAMETER; DUAL-ENERGY CT; IMAGE QUALITY; ITERATIVE RECONSTRUCTION; INTRACRANIAL-PRESSURE; IODINATED CONTRAST; CONCUSSION; HEMORRHAGE	Cerebral injuries account for many hospital emergency department admissions following trauma and can lead to short-term and long-term adverse effects, including increased mortality rates. Traumatic brain injuries encompass several neurological issues, such as hemorrhages, hematomas, concussions, and edema. Neurological assessment using the Glasgow Coma Scale and computed tomography (CT) are essential in finding cerebral lesions and initiating immediate neurosurgical or medical interventions. Head CT scans, including dual-energy, sequential, and helical, provide physicians a deeper understanding of the level of trauma. With fast scan times and reconstructive algorithms, CT is the modality of choice in trauma cases.	[Sedden, Mandy; Fisher, Rodney; Onstott, Kimberly] Midwestern State Univ, Robert D & Carol Gunn Coll Hlth Sci & Human Serv, Shimadzu Sch Radiol Sci, Wichita Falls, TX 76308 USA; [Sedden, Mandy] Radiol Technol, Royal Domingo Student Essay Comm, Assoc Collegiate Educators, Milwaukee, WI 53210 USA; [Fisher, Rodney] Texas Soc Radiol Technologists, Plano, TX USA; [Fisher, Rodney] Joint Review Comm Educ Programs Nucl Med Technol, Palo Alto, CA USA		Sedden, M (corresponding author), Midwestern State Univ, Robert D & Carol Gunn Coll Hlth Sci & Human Serv, Shimadzu Sch Radiol Sci, Wichita Falls, TX 76308 USA.; Sedden, M (corresponding author), Radiol Technol, Royal Domingo Student Essay Comm, Assoc Collegiate Educators, Milwaukee, WI 53210 USA.						Albrecht MH, 2019, RADIOLOGY, V293, P260, DOI 10.1148/radiol.2019182297; Ayaz H, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.5.051411; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; Bekerman I, 2016, AM J EMERG MED, V34, P2336, DOI 10.1016/j.ajem.2016.08.045; Bekerman I, 2016, J NEUROL SCI, V368, P285, DOI 10.1016/j.jns.2016.07.023; Birenbaum D, 2011, WEST J EMERG MED, V12, P67; Bodanapally UK, 2019, RADIOLOGY, V292, P730, DOI 10.1148/radiol.2019190078; Bushong SC., 2017, RADIOLOGIC SCI TECHN, V11th; Byyny RL, 2008, ANN EMERG MED, V51, P697, DOI 10.1016/j.annemergmed.2007.10.007; Caputo LM, 2017, NEUROHOSPITALIST, V7, P70, DOI 10.1177/1941874416672783; Chatfield MB., 2019, 184 NAT COUNC RAD PR; Das SK, 2017, POL J RADIOL, V82, P240, DOI 10.12659/PJR.900196; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Ehman EC, 2014, RADIOGRAPHICS, V34, P849, DOI 10.1148/rg.344135128; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gatewood MO, 2015, AM J EMERG MED, V33, P559, DOI 10.1016/j.ajem.2015.01.010; Gently I., 2020, IMAGE GENTLY CT SCAN; Grajo JR, 2016, APPL RADIOL, V45, P6; Guenette JP, 2018, NEUROIMAG CLIN N AM, V28, P43, DOI 10.1016/j.nic.2017.09.004; Gupta R, 2010, RADIOLOGY, V257, P205, DOI 10.1148/radiol.10091806; Hagen CK, 2020, PHYS REV APPL, V14, DOI 10.1103/PhysRevApplied.14.014069; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; HOUNSFIELD GN, 1976, AM J ROENTGENOL, V127, P3, DOI 10.2214/ajr.127.1.3; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Ker J, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19092167; Kim M, 2019, NEUROSPINE, V16, P657, DOI 10.14245/ns.1938396.198; Kuntz R, 1998, EUR J RADIOL, V26, P235, DOI 10.1016/S0720-048X(97)01179-0; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lee JG, 2017, KOREAN J RADIOL, V18, P570, DOI 10.3348/kjr.2017.18.4.570; Li HO, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150005; Malatt C, 2014, J EMERG MED, V47, P646, DOI 10.1016/j.jemermed.2014.06.042; McKetty MH, 1998, RADIOGRAPHICS, V18, P151, DOI 10.1148/radiographics.18.1.9460114; McKnight CD, 2014, PEDIATR RADIOL, V44, P997, DOI 10.1007/s00247-014-2943-y; Morgan J. E., 2008, TXB CLIN NEUROPSYCHO; Murray NM, 2020, J NEUROINTERV SURG, V12, P156, DOI 10.1136/neurintsurg-2019-015135; Nakaura T, 2016, NEURORADIOLOGY, V58, P245, DOI 10.1007/s00234-015-1631-4; Naruto N, 2018, JPN J RADIOL, V36, P69, DOI 10.1007/s11604-017-0701-4; Nayebaghayee Hossein, 2016, Asian J Neurosurg, V11, P46, DOI 10.4103/1793-5482.165780; Notohamiprodjo S, 2015, EUR RADIOL, V25, P140, DOI 10.1007/s00330-014-3374-8; Odle TG, 2017, RADIOL TECHNOL, V88, p621CT; Orenstein B., 2013, RADIOL TODAY, V14, P12; Pace Ivana, 2015, Radiol Technol, V86, P373; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Pesapane Filippo, 2018, Eur Radiol Exp, V2, P35, DOI 10.1186/s41747-018-0061-6; Phan CM, 2012, AM J NEURORADIOL, V33, P1088, DOI 10.3174/ajnr.A2909; Podgorsak AR, 2018, P SPIE INT SOC OPT E, V10578, P1; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Postma Alida A, 2015, Curr Radiol Rep, V3, P16; Prevedello LM, 2017, RADIOLOGY, V285, P923, DOI 10.1148/radiol.2017162664; Raja AS, 2017, WEST J EMERG MED, V18, P454, DOI 10.5811/westjem.2017.1.32677; Ren LH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072392; Ren QG, 2012, EUR J RADIOL, V81, P2597, DOI 10.1016/j.ejrad.2011.12.041; Romans LE, 2019, COMPUTED TOMOGRAPHY; Schauer DA, 2009, HEALTH PHYS, V97, P1, DOI 10.1097/01.HP.0000356672.44380.b7; Seeram E, 2016, COMPUTED TOMOGRAPHY, VFourth; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sherer MAS, 2018, RAD PROTECTION MED R; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Siegel JA, 2016, TECHNOL CANCER RES T, V15, P249, DOI 10.1177/1533034615578011; Sonmez BM, 2019, J NATL MED ASSOC, V111, P210, DOI 10.1016/j.jnma.2018.10.009; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Vaiman M, 2016, J NEUROTRAUM, V33, P2147, DOI 10.1089/neu.2015.4293; van den Hout WJ, 2018, EUR J TRAUMA EMERG S, V44, P607, DOI 10.1007/s00068-017-0831-5; van Straten M, 2007, AM J NEURORADIOL, V28, P421; Vasconcelos FFX, 2020, ENG APPL ARTIF INTEL, V91, DOI 10.1016/j.engappai.2020.103585; Vela JH, 2017, RADIOL TECHNOL, V88, P263; Wang J, 2012, RADIOLOGY, V262, P191, DOI 10.1148/radiol.11110470; Watanabe Y, 2009, EUR RADIOL, V19, P1019, DOI 10.1007/s00330-008-1213-5; Wei SC, 2010, AM J NEURORADIOL, V31, P334, DOI 10.3174/ajnr.A1824; Wenz H, 2016, EUR J RADIOL OPEN, V3, P182, DOI 10.1016/j.ejro.2016.05.006; Wesolowski JR, 2005, SEMIN ULTRASOUND CT, V26, P376, DOI 10.1053/j.sult.2005.07.007; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wisely I., 2020, IMAGE WISELY COMPUTE; Wu R, 2015, DEEP IMAGE SCALING I, V7; Zacharia TT, 2011, EMERG RADIOL, V18, P103, DOI 10.1007/s10140-010-0908-5; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	78	0	0	0	0	AMER SOC RADIOLOGIC TECHNOLOGISTS	ALBUQUERQUE	15000 CENTRAL AVE, SE, ALBUQUERQUE, NM 87123 USA	0033-8397	1943-5657		RADIOL TECHNOL	Radiol. Technol.	MAY-JUN	2021	92	5					487CT	504CT					18	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	RT8FI	WOS:000644691300007	33903268				2022-02-07	
J	Seto, K; Lloyd, M; Chan, V; Chung, HN; Balogh, R				Seto, Katherine; Lloyd, Meghann; Chan, Vincy; Chung, Hannah; Balogh, Robert			Traumatic Brain Injury Incidence in Adults with Intellectual and Developmental Disabilities	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Intellectual disabilities; Developmental disabilities; Incidence; Epidemiology	NEW-ZEALAND; BURDEN; POPULATION; PREVALENCE; CHILDREN; HEALTH	Background: In Ontario, there are approximately 66,000 adults living with a diagnosis of intellectual and developmental disabilities (IDD). These individuals are nearly twice as likely to experience an injury compared to the general population. Falls are an important contributor to injuries in persons with IDD and in the general population, and are consistently found to be the leading cause of traumatic brain injury (TBI). There is currently no literature that quantitatively examines TBI among persons with IDD. The purpose of this study was to compare the risk of TBI for adults with and without IDD in Ontario over time and by demographic information. Methods: Using administrative health databases, two main cohorts were identified: (1) adults with IDD, and (2) a random 10% sample of adults without IDD. Within each cohort, annual crude and adjusted incidence of TBI were calculated among unique individuals for each fiscal year from April 1, 2002 to March 31, 2017. Results: Over the 15-year study period, the average annual adjusted incidence of TBI was approximately 2.8 new cases per 1000 among Ontario adults with IDD, compared to approximately 1.53 per 1000 among those without IDD. In both cohorts, a higher proportion of TBI cases were younger (19-29 years) and male. Conclusions: During the study period, persons with IDD experienced a significantly higher risk of TBI compared to the general population indicating the possibility, and need, for targeted TBI prevention.	[Seto, Katherine; Lloyd, Meghann; Balogh, Robert] Univ Ontario Inst Technol, Fac Hlth Sci, 2000 Simcoe St N, Oshawa, ON L1G 0C5, Canada; [Chan, Vincy] Univ Hlth Network, KITE Toronto Rehab, Toronto, ON, Canada; [Chung, Hannah; Balogh, Robert] ICES, Toronto, ON, Canada		Seto, K (corresponding author), Univ Ontario Inst Technol, Fac Hlth Sci, 2000 Simcoe St N, Oshawa, ON L1G 0C5, Canada.	katherine.seto@ontariotechu.net		Seto, Katherine/0000-0003-0031-7908	ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario; University of Ontario Institute of Technology; Ontario Graduate ScholarshipOntario Graduate Scholarship	This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). This study also received internal funding from the University of Ontario Institute of Technology, as well as funding from the Ontario Graduate Scholarship. Parts of this material are based on data and information compiled and provided by MOHLTC, CIHI. The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred.	[Anonymous], 2015, C TRAUM BRAIN INJ US; Ao BT, 2015, NEUROEPIDEMIOLOGY, V44, P255, DOI 10.1159/000431043; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Clark M., 2016, TRANSLATIONAL RES TR; Commission on Accreditation of Rehabilitation Facilities, 2015, STAND MAN; Cox CR, 2010, J INTELL DISABIL RES, V54, P1045, DOI 10.1111/j.1365-2788.2010.01333.x; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finlayson J, 2010, J INTELL DISABIL RES, V54, P966, DOI 10.1111/j.1365-2788.2010.01319.x; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Government of Ontario, 2019, EX FALLS PREV PROGR; Hsieh K, 2012, AJIDD-AM J INTELLECT, V117, P442, DOI 10.1352/1944-7558-117.6.442; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lin E, 2013, J INTELL DISABIL RES, V57, P462, DOI 10.1111/jir.12002; Lin E., 2019, ADDRESSING GAPS HLTH; Lunsky Y, 2013, ATLAS PRIMARY CARE A; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; McKinlay A, 2012, NEUROREHABILITATION, V30, P183, DOI 10.3233/NRE-2012-0743; Ng R., 2015, BRAIN DISORDERS ONTA, P146; Ontario Neurotrauma Foundation, 2019, ACQ BRAIN INJ; Public Health Agency of Canada & Neurological Health Charities Canada, 2014, 140100 PUBL HLTH AG; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Samulowitz A, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/6358624; SAS Institute Inc, 2020, RANUNI FUNCTION; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Slayter EM, 2006, MENT RETARD, V44, P212, DOI 10.1352/0047-6765(2006)44[212:IPACAA]2.0.CO;2; Statistics Canada, 2015, POST COD CONV FIL PL; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001	27	0	0	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2021	48	3					392	399	PII S031716712000181X	10.1017/cjn.2020.181			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RT4KO	WOS:000644429600013	32814611				2022-02-07	
J	Shibahashi, K; Hoda, H; Okura, Y; Hamabe, Y				Shibahashi, Keita; Hoda, Hidenori; Okura, Yoshihiro; Hamabe, Yuichi			Acceptable Blood Pressure Levels in the Prehospital Setting for Patients with Traumatic Brain Injury: A Multicenter Observational Study	WORLD NEUROSURGERY			English	Article						Blood pressure; Hypotension; Mortality; Prehospital; Risk factor; Traumatic brain injury	PROGNOSTIC VALUE; HYPOTENSION; GUIDELINES; MANAGEMENT; TARGETS	- BACKGROUND: Safe blood pressure levels in the prehospital setting for patients with traumatic brain injury (TBI) remain unclear. We aimed to investigate the association between prehospital blood pressure and the outcomes of patients with TBI to determine optimal threshold for hypotension that could be considered in the prehospital setting. - METHODS: Using data from the Japan Trauma Data Bank, we identified adult patients (aged >= 18 years) who experienced severe TBI (maximum head Abbreviated Injury Severity score >= 3) and were transported directly from the scene of the blunt trauma occurrence to the hospital, between 2004 and 2019. We excluded patients with prehospital systolic blood pressure (SBP) levels of <60 and >= 160 mm Hg. Using mixed effects logistic regression models, we investigated the association between prehospital SBP and in-hospital mortality, considering the hospital ID as a random effect variable. In addition, we also conducted a stratified analysis based on age (<60 vs. >= 60 years). RESULTS: A total of 34,175 patients (16,114 aged <60 years and 18,061 aged >= 60 years) were eligible for the analyses. Plotting the adjusted odds ratios for in-hospital mortality as a function of SBP produced J-shaped curves. An SBP <110 mm Hg was significantly associated with inhospital mortality, with an adjusted odds ratio of 1.52 (95% confidence interval: 1.39-1.65). Stratified analyses revealed that the threshold did not differ between the age groups. CONCLUSIONS: An SBP <110 mm Hg in the prehospital setting is significantly associated with higher in-hospital mortality.	[Shibahashi, Keita; Hoda, Hidenori; Okura, Yoshihiro; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Hoda, Hidenori/0000-0002-4283-4412			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Hasler RM, 2011, EUR SPINE J, V20, P2174, DOI 10.1007/s00586-011-1866-7; Hirose T, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018687; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Marion DW, 2006, NEUROSURGERY, V58, P655; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Okada Y, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029706; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; Shibahashi K, 2018, WORLD NEUROSURG, V120, pE667, DOI 10.1016/j.wneu.2018.08.142; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016	22	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E504	E511		10.1016/j.wneu.2021.01.145			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TF2NY	WOS:000670549900018					2022-02-07	
J	Shibahashi, K; Hoda, H; Okura, Y; Hamabe, Y				Shibahashi, Keita; Hoda, Hidenori; Okura, Yoshihiro; Hamabe, Yuichi			Acceptable Blood Pressure Levels in the Prehospital Setting for Patients with Traumatic Brain Injury: A Multicenter Observational Study	WORLD NEUROSURGERY			English	Article						Blood pressure; Hypotension; Mortality; Prehospital; Risk factor; Traumatic brain injury	AMERICAN-COLLEGE; PROGNOSTIC VALUE; MANAGEMENT; HYPOTENSION; GUIDELINES; TARGETS	BACKGROUND: Safe blood pressure levels in the pre hospital setting for patients with traumatic brain injury (TBI) remain unclear. We aimed to investigate the association between prehospital blood pressure and the outcomes of patients with TBI to determine optimal threshold for hypotension that could be considered in the prehospital setting. METHODS: Using data from the Japan Trauma Data Bank, we identified adult patients (aged double dagger 18 years) who experienced severe TBI (maximum head Abbreviated Injury Severity score double dagger 3) and were transported directly from the scene of the blunt trauma occurrence to the hospital, between 2004 and 2019. We excluded patients with pre hospital systolic blood pressure (SBP) levels of <60 and double dagger 160 mm Hg. Using mixed effects logistic regression models, we investigated the association between pre hospital SBP and in-hospital mortality, considering the hospital ID as a random effect variable. In addition, we also conducted a stratified analysis based on age (<60 vs. double dagger 60 years). RESULTS: A total of 34,175 patients (16,114 aged <60 years and 18,061 aged double dagger 60 years) were eligible for the analyses. Plotting the adjusted odds ratios for in-hospital mortality as a function of SBP produced J-shaped curves. An SBP <110 mm Hg was significantly associated with in hospital mortality, with an adjusted odds ratio of 1.52 (95% confidence interval: 1.39e1.65). Stratified analyses revealed that the threshold did not differ between the age groups. CONCLUSIONS: An SBP <110 mm Hg in the prehospital setting is significantly associated with higher in-hospital mortality.	[Shibahashi, Keita; Hoda, Hidenori; Okura, Yoshihiro; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan.	kshibahashi@yahoo.co.jp					Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Hasler RM, 2011, EUR SPINE J, V20, P2174, DOI 10.1007/s00586-011-1866-7; Hirose T, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018687; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Marion DW, 2006, NEUROSURGERY, V58, P655; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Okada Y, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029706; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; Shibahashi K, 2018, WORLD NEUROSURG, V120, pE667, DOI 10.1016/j.wneu.2018.08.142; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]	22	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E504	E511		10.1016/j.wneu.2021.01.145			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YJ3CH	WOS:000744410900018					2022-02-07	
J	Shih, RY; Burns, J; Ajam, AA; Broder, JS; Chakraborty, S; Kendi, AT; Lacy, ME; Ledbetter, LN; Lee, RK; Liebeskind, DS; Pollock, JM; Prall, JA; Ptak, T; Raksin, PB; Shaines, MD; Tsiouris, AJ; Utukuri, PS; Wang, LLL; Corey, AS				Shih, Robert Y.; Burns, Judah; Ajam, Amna A.; Broder, Joshua S.; Chakraborty, Santanu; Kendi, A. Tuba; Lacy, Mary E.; Ledbetter, Luke N.; Lee, Ryan K.; Liebeskind, David S.; Pollock, Jeffrey M.; Prall, J. Adair; Ptak, Thomas; Raksin, P. B.; Shaines, Matthew D.; Tsiouris, A. John; Utukuri, Pallavi S.; Wang, Lily L.; Corey, Amanda S.		Expert Panel Neurological Imaging	ACR Appropriateness Criteria (R) Head Trauma: 2021 Update	JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY			English	Article						Appropriateness Criteria; Appropriate Use Criteria; AUC; CT; Head trauma; MRI; Traumatic brain injury	VENOUS SINUS THROMBOSIS; NEW-ORLEANS CRITERIA; BRAIN-INJURY; COMPUTED-TOMOGRAPHY; COST-EFFECTIVENESS; CT; MANAGEMENT; RULE; STRATEGIES; PREDICTION	Head trauma (ie, head injury) is a significant public health concern and is a leading cause of morbidity and mortality in children and young adults. Neuroimaging plays an important role in the management of head and brain injury, which can be separated into acute (0-7 days), subacute (<3 months), then chronic (>3 months) phases. Over 75% of acute head trauma is classified as mild, of which over 75% have a normal Glasgow Coma Scale score of 15, therefore clinical practice guidelines universally recommend selective CT scanning in this patient population, which is often based on clinical decision rules. While CT is considered the first-line imaging modality for suspected intracranial injury, MRI is useful when there are persistent neurologic deficits that remain unexplained after CT, especially in the subacute or chronic phase. Regardless of time frame, head trauma with suspected vascular injury or suspected cerebrospinal fluid leak should also be evaluated with CT angiography or thin-section CT imaging of the skull base, respectively. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.	[Shih, Robert Y.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Burns, Judah] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Ajam, Amna A.] Ohio State Univ, Columbus, OH 43210 USA; [Broder, Joshua S.] Duke Univ, Sch Med, Durham, NC USA; [Broder, Joshua S.] Duke Univ, Sch Med, Div Emergency Med, Dept Surg, Durham, NC USA; [Chakraborty, Santanu] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Chakraborty, Santanu] Univ Ottawa, Dept Radiol, Ottawa, ON, Canada; [Kendi, A. Tuba] Canadian Assoc Radiologists, CAR Representat ACR Qual Commiss, Ottawa, ON, Canada; [Kendi, A. Tuba] Mayo Clin, Rochester, MN USA; [Kendi, A. Tuba] Mayo Clin, Nucl Med Therapies, Rochester, MN USA; [Lacy, Mary E.] Univ New Mexico, Albuquerque, NM 87131 USA; [Ledbetter, Luke N.] Amer Coll Physicians, Albuquerque, NM USA; [Ledbetter, Luke N.] Univ Calif Los Angeles, Los Angeles, CA USA; [Lee, Ryan K.] Einstein Healthcare Network, Philadelphia, PA USA; [Liebeskind, David S.] Univ Calif Los Angeles, Los Angeles, CA USA; [Liebeskind, David S.] Amer Acad Neurol, Los Angeles, CA USA; [Pollock, Jeffrey M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Pollock, Jeffrey M.] Oregon Hlth & Sci Univ, Case Point, Portland, OR 97201 USA; [Prall, J. Adair] Littleton Adventist Hosp, Littleton, CO USA; [Prall, J. Adair] Guidelines Comm Joint Sect Trauma & Crit Care, Littleton, CO USA; [Ptak, Thomas] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Med Ctr, Baltimore, MD 21201 USA; [Ptak, Thomas] Univ Maryland, Med Ctr, Community Radiol, Chicago, IL USA; [Ptak, Thomas] R Adams Cowley Shock Trauma Center, Emergency & Trauma Imaging, Chicago, IL USA; [Raksin, P. B.] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; [Raksin, P. B.] Amer Assoc Neurol Surg, Congress Neurol Surg Sect Neurotrauma & Neurocrit, Chicago, IL USA; [Raksin, P. B.] Amer Assoc Neurol Surg, Congress Neurol Surg Sect Neurotrauma & Neurocrit, Chicago, IL USA; [Raksin, P. B.] Neurosurg ICU, Congress Neurol Surg Sect Neurotrauma & Neurocrit, Chicago, IL USA; [Shaines, Matthew D.] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY USA; [Tsiouris, A. John] Albert Einstein Coll Med, Residency Program, Moses Weiler Internal Med, New York, NY USA; [Shaines, Matthew D.] Div Hosp Med, New York, NY USA; [Tsiouris, A. John] Weill Cornell Med, New York, NY USA; [Utukuri, Pallavi S.] Columbia Univ, Med Ctr, New York, NY USA; [Wang, Lily L.; Corey, Amanda S.] Univ Cincinnati, Med Ctr, Cincinnati, OH USA; [Corey, Amanda S.] Emory Univ, Atlanta, GA 30322 USA		Shih, RY (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.			Shih, Robert/0000-0001-8316-2061			Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; American College of Radiology, ACR APPR CRIT RAD DO; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; [Anonymous], 2007, HEAD INJ TRIAG ASS I; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Baugnon KL, 2014, NEUROIMAG CLIN N AM, V24, P439, DOI 10.1016/j.nic.2014.03.001; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bertsimas D, 2019, JAMA PEDIATR, V173, P648, DOI 10.1001/jamapediatrics.2019.1068; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, TBI REL EM DEP ED VI; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Dalziel K, 2019, ANN EMERG MED, V73, P429, DOI 10.1016/j.annemergmed.2018.09.030; Davey K, 2018, ANN EMERG MED, V72, P342, DOI 10.1016/j.annemergmed.2018.03.034; Dhandapani S, 2014, J CLIN NEUROSCI, V21, P745, DOI 10.1016/j.jocn.2013.07.038; Douglas DB, 2018, CURR OPIN NEUROL, V31, P362, DOI 10.1097/WCO.0000000000000567; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Fiser SM, 1998, AM SURGEON, V64, P1088; George E, 2019, EMERG RADIOL, V26, P75, DOI 10.1007/s10140-018-1630-y; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hale AT, 2019, J NEUROSURG-PEDIATR, V23, P219, DOI 10.3171/2018.8.PEDS18370; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hiremath SB, 2019, DIAGN INTERV IMAG, V100, P3, DOI 10.1016/j.diii.2018.05.003; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Isokuortti H, 2014, INJURY, V45, P1340, DOI 10.1016/j.injury.2014.04.012; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Joseph B, 2014, AM SURGEON, V80, P43; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; Korley FK, 2018, J NEUROTRAUM, V36, P182, DOI DOI 10.1089/NEU.2017; Linsenmaier U, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150827; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; Mason SM, 2019, EMERG MED J, V36, P47, DOI 10.1136/emermed-2018-207621; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Oh Ji-Woong, 2017, Korean J Neurotrauma, V13, P63, DOI 10.13004/kjnt.2017.13.2.63; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pons E, 2019, EUR RADIOL, V29, P2632, DOI 10.1007/s00330-018-5954-5; Reljic T, 2014, J NEUROTRAUM, V31, P78, DOI 10.1089/neu.2013.2873; Ryan ME, 2020, J AM COLL RADIOL, V17, pS125, DOI 10.1016/j.jacr.2020.01.026; Salmela MB, 2017, J AM COLL RADIOL, V14, pS34, DOI 10.1016/j.jacr.2017.01.051; Schroeder JW, 2017, J AM COLL RADIOL, V14, pS500; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Slasky SE, 2017, J COMPUT ASSIST TOMO, V41, P891, DOI 10.1097/RCT.0000000000000620; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stone JA, 1999, AM J NEURORADIOL, V20, P706; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Su YS, 2019, J NEUROTRAUM, V36, P2083, DOI 10.1089/neu.2018.6020; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wei SC, 2010, AM J NEURORADIOL, V31, P334, DOI 10.3174/ajnr.A1824; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wooten DW, 2019, J NEUROTRAUM, V36, P3233, DOI 10.1089/neu.2018.6178; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6; Zapalac JS, 2002, OTOLARYNG HEAD NECK, V126, P669, DOI 10.1067/mhn.2002.125755; Zhou B, 2019, J COMPUT ASSIST TOMO, V43, P690, DOI 10.1097/RCT.0000000000000913	67	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1546-1440	1558-349X		J AM COLL RADIOL	J. Am. Coll. Radiol.	MAY	2021	18	5		S			S13	S36		10.1016/j.jacr.2021.01.006			24	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	RZ5ZI	WOS:000648675100003	33958108	Bronze			2022-02-07	
J	Sidpra, J; Chhabda, S; Oates, AJ; Bhatia, A; Blaser, SI; Mankad, K				Sidpra, Jai; Chhabda, Sahil; Oates, Adam J.; Bhatia, Aashim; Blaser, Susan, I; Mankad, Kshitij			Abusive head trauma: neuroimaging mimics and diagnostic complexities	PEDIATRIC RADIOLOGY			English	Article						Abusive head trauma; Brain; Child abuse; Children; Computed tomography; Infants; Magnetic resonance imaging; Mimics; Non-accidental injury; Shaken baby syndrome; Traumatic brain injury	GLUTARIC ACIDURIA TYPE-1; STURGE-WEBER-SYNDROME; VITAMIN-D STATUS; BENIGN EXTERNAL HYDROCEPHALUS; EHLERS-DANLOS-SYNDROME; SHAKEN BABY SYNDROME; SUBDURAL-HEMATOMA; RETINAL HEMORRHAGES; OSTEOGENESIS IMPERFECTA; INTRACRANIAL HEMORRHAGE	Traumatic brain injury is responsible for approximately half of all childhood deaths from infancy to puberty, the majority of which are attributable to abusive head trauma (AHT). Due to the broad way patients present and the lack of a clear mechanism of injury in some cases, neuroimaging plays an integral role in the diagnostic pathway of these children. However, this nonspecific nature also presages the existence of numerous conditions that mimic both the clinical and neuroimaging findings seen in AHT. This propensity for misdiagnosis is compounded by the lack of pathognomonic patterns and clear diagnostic criteria. The repercussions of this are severe and have a profound stigmatic effect. The authors present an exhaustive review of the literature complemented by illustrative cases from their institutions with the aim of providing a framework with which to approach the neuroimaging and diagnosis of AHT.	[Sidpra, Jai] UCL, Med Sch, London, England; [Chhabda, Sahil; Mankad, Kshitij] Great Ormond St Hosp Sick Children, Dept Radiol, Great Ormond St, London WC1N 3JH, England; [Oates, Adam J.] Birmingham Childrens Hosp, Dept Radiol, Birmingham, W Midlands, England; [Bhatia, Aashim] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA USA; [Blaser, Susan, I] Hosp Sick Children, Dept Radiol, Toronto, ON, Canada		Mankad, K (corresponding author), Great Ormond St Hosp Sick Children, Dept Radiol, Great Ormond St, London WC1N 3JH, England.	kshitij.mankad@gosh.nhs.uk		Sidpra, Jai/0000-0003-1985-5503			Abulebda K, 2017, CLIN CASE REP, V5, P1348, DOI 10.1002/ccr3.1052; Adams GGW, 2013, BRIT J OPHTHALMOL, V97, P1138, DOI 10.1136/bjophthalmol-2012-302429; Agrawal S, 2012, PEDIATRICS, V129, pE1388, DOI 10.1542/peds.2011-2772; Ambade Vipul Namdeorao, 2007, J Forensic Leg Med, V14, P92, DOI 10.1016/j.jcfm.2006.02.020; American Society of Pediatric Neuroradiology, 2020, ASPNR CASE WEEK; Anderst JD, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3485; Armstrong-Wells J, 2009, PEDIATRICS, V123, P823, DOI 10.1542/peds.2008-0874; Au-Yong ITH, 2009, BRIT J RADIOL, V82, P735, DOI 10.1259/bjr/81603888; Barber I, 2014, PEDIATR RADIOL, V44, P613, DOI 10.1007/s00247-014-3099-5; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bellary SS, 2013, CLIN ANAT, V26, P922, DOI 10.1002/ca.22262; BENARI Y, 1986, EUR J OBSTET GYN R B, V22, P249, DOI 10.1016/0028-2243(86)90073-0; Benoit R, 2000, J TRAUMA, V49, P477, DOI 10.1097/00005373-200009000-00015; Bertini I, 2008, CELL MOL LIFE SCI, V65, P89, DOI 10.1007/s00018-007-7439-6; Binenbaum G, 2015, JAMA OPHTHALMOL, V133, P1261, DOI 10.1001/jamaophthalmol.2015.2868; Bishop FS, 2007, J NEUROSURG, V106, P222, DOI 10.3171/ped.2007.106.3.222; Biswas A, 2016, BMJ CASE REP, V2016; Bode-Janisch S, 2012, FORENSIC SCI INT, V214, pE34, DOI 10.1016/j.forsciint.2011.07.044; Boy N, 2017, J INHERIT METAB DIS, V40, P75, DOI 10.1007/s10545-016-9999-9; Brousseau TJ, 2005, J EMERG MED, V29, P283, DOI 10.1016/j.jemermed.2005.02.009; Caccamo D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030892; Cain DW, 2020, STROKE, V51, P315, DOI 10.1161/STROKEAHA.119.025987; Calame D, 2019, NEUROLOGY, V92; Carpenter SL, 2013, PEDIATRICS, V131, pE1357, DOI 10.1542/peds.2013-0196; CASSELSBROWN A, 1994, BRIT J OPHTHALMOL, V78, P486, DOI 10.1136/bjo.78.6.486; Castori M, 2015, AM J MED GENET C, V169, P289, DOI 10.1002/ajmg.c.31460; Chapman T, 2010, PEDIATR RADIOL, V40, P1184, DOI 10.1007/s00247-009-1470-8; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Choudhary AK, 2020, PEDIATR RADIOL, V50, P15, DOI 10.1007/s00247-019-04539-6; Choudhary AK, 2015, PEDIATR RADIOL, V45, P1803, DOI 10.1007/s00247-015-3399-4; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Choudhary AK, 2010, SURG RADIOL ANAT, V32, P807, DOI 10.1007/s00276-010-0633-5; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; CHUGANI HT, 1989, J PEDIATR-US, V114, P244, DOI 10.1016/S0022-3476(89)80790-5; CLARK RSB, 1995, CLIN PEDIATR, V34, P281, DOI 10.1177/000992289503400512; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Comi Anne M., 2007, Lymphatic Research and Biology, V5, P257, DOI 10.1089/lrb.2007.1016; Coote JM, 2000, CLIN RADIOL, V55, P70, DOI 10.1053/crad.1999.0065; CREMIN B, 1982, SKELETAL RADIOL, V8, P35, DOI 10.1007/BF00361366; Currarino G, 2000, PEDIATR RADIOL, V30, P823, DOI 10.1007/s002470000337; D'hondt S, 2018, GENET MED, V20, P562, DOI 10.1038/gim.2017.138; De Vito A, 2020, ACTA PAEDIATR, V109, P426, DOI 10.1111/apa.15033; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; Dias MS, 2002, NEUROSURG CLIN N AM, V13, P247, DOI 10.1016/S1042-3680(01)00009-2; Doberentz E, 2014, LEGAL MED-TOKYO, V16, P333, DOI 10.1016/j.legalmed.2014.06.011; Doward W, 2001, PEDIATR NEUROSURG, V35, P335, DOI 10.1159/000050448; Droms RJ, 2017, PEDIATR DERMATOL, V34, pE132, DOI 10.1111/pde.13106; Duhaime AC, 2019, J NEUROSURG-PEDIATR, V24, P481, DOI 10.3171/2019.7.PEDS18394; Dyer C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2932; Eklund MJ, 2016, CLIN IMAG, V40, P806, DOI 10.1016/j.clinimag.2016.03.010; Elinder G, 2018, ACTA PAEDIATR, V107, P3, DOI 10.1111/apa.14473; Erdem G, 2002, PEDIATR NEUROL, V27, P221, DOI 10.1016/S0887-8994(02)00428-9; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Faqeih E, 2009, AM J MED GENET A, V149A, P461, DOI 10.1002/ajmg.a.32653; Feldman K, 2009, PEDIATR RADIOL, V39, P1127, DOI 10.1007/s00247-009-1285-7; FERRONE PJ, 1994, ARCH OPHTHALMOL-CHIC, V112, P1185, DOI 10.1001/archopht.1994.01090210069018; Flaherty EG, 2014, PEDIATRICS, V133, pE477, DOI 10.1542/peds.2013-3793; Francis PJ, 2004, EUR J PEDIATR, V163, P420, DOI 10.1007/s00431-004-1440-y; Gago LC, 2003, RETINA-J RET VIT DIS, V23, P724, DOI 10.1097/00006982-200310000-00027; Ganesh A, 2004, OPHTHALMOLOGY, V111, P1428, DOI 10.1016/j.ophtha.2003.10.028; George CLS, 2017, J PEDIATR-US, V181, P326, DOI 10.1016/j.jpeds.2016.10.070; Ghosh PS, 2013, J CHILD NEUROL, V28, P95, DOI 10.1177/0883073812441059; Girard N, 2016, PEDIATR RADIOL, V46, P603, DOI 10.1007/s00247-015-3509-3; GRESHAM EL, 1975, PEDIATR CLIN N AM, V22, P317; HAMZA M, 1987, PEDIATR NEUROL, V3, P218, DOI 10.1016/0887-8994(87)90021-X; Handy TC, 1999, J FORENSIC SCI, V44, P1114; Hanlon L, 2006, ARCH DIS CHILD-FETAL, V91, pF272, DOI 10.1136/adc.2005.082347; Hansen JB, 2018, J NEUROSURG-PEDIATR, V21, P31, DOI 10.3171/2017.7.PEDS17317; Hattenbach LO, 1999, J AAPOS, V3, P188, DOI 10.1016/S1091-8531(99)70066-2; Higueros E, 2017, ACTAS DERMO-SIFILOGR, V108, P407, DOI 10.1016/j.ad.2016.09.022; Holden KR, 1999, J CHILD NEUROL, V14, P708, DOI 10.1177/088307389901401104; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Hughes J, 2016, ARCH DIS CHILD, V101, P310, DOI 10.1136/archdischild-2014-306803; Hui KTP, 2011, HONG KONG J PAEDIATR, V16, P184; Hurley M, 2010, BRIT J RADIOL, V83, P736, DOI 10.1259/bjr/36871113; Iaconetta G, 2006, NEUROL SCI, V26, P451, DOI 10.1007/s10072-006-0532-z; Idriz S, 2015, RADIOGRAPHICS, V35, P1585, DOI 10.1148/rg.2015140177; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kafil-Hussain NA, 2000, J PEDIAT OPHTH STRAB, V37, P289; Kaushal S, 2017, CASE REP PEDIAT, V2017, DOI 10.1155/2017/7213629; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Kelly P, 2015, ARCH DIS CHILD, V100, P1123, DOI 10.1136/archdischild-2014-306960; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Khandanpour N, 2012, RADIOGRAPHICS, V32, P2101, DOI 10.1148/rg.327125716; Kim D, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0147-5; Kleinman PK, 2015, DIAGNOSTIC IMAGING C, DOI [10.1017/CBO9780511862366, DOI 10.1017/CBO9780511862366]; Larsen KB, 2019, FORENSIC SCI INT, V296, P115, DOI 10.1016/j.forsciint.2019.01.011; Lawlor DA, 2013, LANCET, V381, P2176, DOI 10.1016/S0140-6736(12)62203-X; Lee YJ, 2016, QUANT IMAGING MED SU, V6, P478, DOI 10.21037/qims.2016.08.02; Leventhal JM, 2017, JAMA-J AM MED ASSOC, V318, P1317, DOI 10.1001/jama.2017.11703; Levin AV, 2016, J FAM VIOLENCE, V31, P797, DOI 10.1007/s10896-016-9840-0; Lindberg Daniel M, 2019, Int J Child Maltreat, V2, P1, DOI 10.1007/s42448-019-00021-w; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lopez J, 2013, J CHILD NEUROL, V28, P672, DOI 10.1177/0883073812449514; Lucas S, 2017, ACTA PAEDIATR, V106, P1033, DOI 10.1111/apa.13840; Madon N., 2018, J FORENSIC SCI MED, V4, P174, DOI [10.4103/jfsm.jfsm_93_17.50, DOI 10.4103/JFSM.JFSM_93_17.50, 10.4103/jfsm.jfsm_93_17]; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire SA, 2013, EYE, V27, P28, DOI 10.1038/eye.2012.213; MAKIN GJV, 1986, STROKE, V17, P106, DOI 10.1161/01.STR.17.1.106; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Manara R, 2017, AM J NEURORADIOL, V38, P1858, DOI 10.3174/ajnr.A5192; Manara R, 2017, AM J NEURORADIOL, V38, P1850, DOI 10.3174/ajnr.A5186; Mankad K, 2019, EUR J PAEDIATR NEURO, V23, P19, DOI 10.1016/j.ejpn.2018.11.006; Marini JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.52; Marino MA, 2014, NEURORADIOL J, V27, P245, DOI 10.15274/NRJ-2014-10020; Marshman WE, 1999, J AAPOS, V3, P255, DOI 10.1016/S1091-8531(99)70013-3; Martin-Millan M, 2005, EUR NEUROL, V53, P159, DOI 10.1159/000086126; Matthews GP, 1996, J PEDIATR OPHTHALMOL, V33, P260, DOI 10.3928/0191-3913-19960701-13; McDougall RJ, 2016, CHILD NERV SYST, V32, P579, DOI 10.1007/s00381-015-2862-8; McKeag H, 2013, J NEUROSURG-PEDIATR, V11, P438, DOI 10.3171/2012.12.PEDS12289; McLean LA, 2012, AM J NEURORADIOL, V33, P1281, DOI 10.3174/ajnr.A2967; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; MENEZES AH, 1983, NEUROSURGERY, V13, P452, DOI 10.1227/00006123-198310000-00021; MENTICOGLOU SM, 1995, OBSTET GYNECOL, V86, P589, DOI 10.1016/S0029-7844(95)80022-0; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; Nassogne MC, 2002, CHILD NERV SYST, V18, P729, DOI 10.1007/s00381-002-0630-z; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Paddock M, 2017, CLIN RADIOL, V72, P179, DOI 10.1016/j.crad.2016.11.016; Paddock M, 2017, CLIN RADIOL, V72, P189, DOI 10.1016/j.crad.2016.11.015; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pepe G, 2016, APPL CLIN GENET, V9, P55, DOI 10.2147/TACG.S96233; Per H, 2013, NEUROL SCI, V34, P51, DOI 10.1007/s10072-012-0965-5; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Pollina J, 2001, PEDIATR NEUROSURG, V35, P113, DOI 10.1159/000050403; Pontarelli EM, 2014, PEDIATR EMERG CARE, V30, P677, DOI 10.1097/PEC.0000000000000226; Rabbitt AL, 2020, PEDIATR RADIOL, V50, P83, DOI 10.1007/s00247-019-04517-y; Reddy AR, 2010, EUR J OPHTHALMOL, V20, P799, DOI 10.1177/112067211002000427; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Renaud A, 2013, INSIGHTS IMAGING, V4, P417, DOI 10.1007/s13244-013-0258-4; Rolfes MC, 2019, CHILD ABUSE NEGLECT, V91, P95, DOI 10.1016/j.chiabu.2019.03.008; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Rooms L, 2003, PEDIATRICS, V111, pE636, DOI 10.1542/peds.111.5.e636; Royal College of Paediatrics and Child Health, 2018, CHILD PROT EV SYST R; Royal College of Paediatrics and Child Health, 2015, CHILD PROT EV SYST R; Royal College of Paediatrics and Child Health, 2019, CHILD PROT EV SYST R; Russell-Eggitt IM, 2000, J ROY SOC MED, V93, P591, DOI 10.1177/014107680009301110; Sanchez T, 2010, EMERG RADIOL, V17, P413, DOI 10.1007/s10140-010-0877-8; Sasaki-Adams D, 2008, J NEUROSURG-PEDIATR, V1, P229, DOI 10.3171/PED/2008/1/3/229; Scheier E, 2019, ACTA PAEDIATR, V108, P2170, DOI 10.1111/apa.14971; Schilling S, 2011, PEDIATRICS, V127, P835, DOI 10.1542/peds.2010-0533; Sidpra J, 2021, CHILD NERV SYST, V37, P919, DOI 10.1007/s00381-020-04870-6; SIEGEL BM, 1957, AM J MED, V22, P315, DOI 10.1016/0002-9343(57)90016-5; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Steiner RD, 1993, GENEREVIEWS; Tan WH, 2005, PEDIATRICS, V116, P757, DOI 10.1542/peds.2004-1897; The Royal College of Paediatrics and Child Health The Royal College of Ophthalmologists, 2013, ABUSIVE HEAD TRAUMA; TOKORO K, 1988, NEUROSURGERY, V22, P595, DOI 10.1227/00006123-198803000-00029; Treister Daniel S, 2014, Case Rep Radiol, V2014, P143408, DOI 10.1155/2014/143408; Tsui H, 2006, EUR J NEUROL, V13, P780, DOI 10.1111/j.1468-1331.2006.01369.x; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Twomey EL, 2003, PEDIATR RADIOL, V33, P823, DOI 10.1007/s00247-003-0956-z; van Dijk FS, 2011, MOL SYNDROMOL, V2, P1, DOI 10.1159/000332228; Vanakker OM, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/712903; Vester MEM, 2016, EUR J PEDIATR, V175, P1001, DOI 10.1007/s00431-016-2734-6; Vester MEM, 2015, FORENSIC SCI MED PAT, V11, P405, DOI 10.1007/s12024-015-9698-0; Vinchon M, 2010, CHILD NERV SYST, V26, P1195, DOI 10.1007/s00381-010-1105-2; WETZEL RC, 1995, PEDIATRICS, V95, P771; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; Wiedijk JEF, 2016, FORENSIC SCI INT, V260, pE11, DOI 10.1016/j.forsciint.2016.01.025; Wityk RJ, 2002, STROKE, V33, P680, DOI 10.1161/hs0302.103816; Wright JN, 2017, AM J ROENTGENOL, V208, P991, DOI 10.2214/AJR.16.17602; Wu CC, 2017, J CLIN ENDOCR METAB, V102, P3111, DOI 10.1210/jc.2017-01127; Yew AY, 2011, PEDIATR NEUROSURG, V47, P1, DOI 10.1159/000322357; Zahl SM, 2011, NEUROSURG REV, V34, P417, DOI 10.1007/s10143-011-0327-4	168	0	0	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	MAY	2021	51	6			SI		947	965		10.1007/s00247-020-04940-6			19	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	SD6SY	WOS:000651506100014	33999237				2022-02-07	
J	Stetter, C; Lopez-Caperuchipi, S; Hopp-Kramer, S; Bieber, M; Kleinschnitz, C; Siren, AL; Albert-Weissenberger, C				Stetter, Christian; Lopez-Caperuchipi, Simon; Hopp-Kraemer, Sarah; Bieber, Michael; Kleinschnitz, Christoph; Siren, Anna-Leena; Albert-Weissenberger, Christiane			Amelioration of Cognitive and Behavioral Deficits after Traumatic Brain Injury in Coagulation Factor XII Deficient Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						closed head injury; contact-kinin system; object recognition memory; IntelliCage; Crespi effect; stress	CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; THROMBUS FORMATION; DYSFUNCTION; LESIONS; EDEMA; MODEL; CARDIOMYOPATHY; INFLAMMATION; ACTIVATION	Based on recent findings that show that depletion of factor XII (FXII) leads to better posttraumatic neurological recovery, we studied the effect of FXII-deficiency on post-traumatic cognitive and behavioral outcomes in female and male mice. In agreement with our previous findings, neurological deficits on day 7 after weight-drop traumatic brain injury (TBI) were significantly reduced in FXII-/- mice compared to wild type (WT) mice. Also, glycoprotein Ib (GPIb)-positive platelet aggregates were more frequent in brain microvasculature of WT than FXII-/- mice 3 months after TBI. Six weeks after TBI, memory for novel object was significantly reduced in both female and male WT but not in FXII-/- mice compared to sham-operated mice. In the setting of automated home-cage monitoring of socially housed mice in IntelliCages, female WT mice but not FXII-/- mice showed decreased exploration and reacted negatively to reward extinction one month after TBI. Since neuroendocrine stress after TBI might contribute to trauma-induced cognitive dysfunction and negative emotional contrast reactions, we measured peripheral corticosterone levels and the ration of heart, lung, and spleen weight to bodyweight. Three months after TBI, plasma corticosterone levels were significantly suppressed in both female and male WT but not in FXII-/- mice, while the relative heart weight increased in males but not in females of both phenotypes when compared to sham-operated mice. Our results indicate that FXII deficiency is associated with efficient post-traumatic behavioral and neuroendocrine recovery.	[Stetter, Christian; Lopez-Caperuchipi, Simon; Hopp-Kraemer, Sarah; Siren, Anna-Leena; Albert-Weissenberger, Christiane] Univ Hosp Wurzburg, Dept Neurosurg, Josef Schneider Str 11, D-97080 Wurzburg, Germany; [Hopp-Kraemer, Sarah; Bieber, Michael; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany; [Kleinschnitz, Christoph] Univ Hosp Essen, Dept Neurol, Hufelandstr 55, D-45147 Essen, Germany; [Kleinschnitz, Christoph] Univ Hosp Essen, Ctr Translat & Behav Neurosci C TNBS, Hufelandstr 55, D-45147 Essen, Germany; [Albert-Weissenberger, Christiane] Julius Maximilians Univ Wurzburg, Dept Neurophysiol, Inst Physiol, Rontgenring 9, D-97070 Wurzburg, Germany		Siren, AL (corresponding author), Univ Hosp Wurzburg, Dept Neurosurg, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	stetter_c@ukw.de; simonlopez@gmx.de; hopp_s@ukw.de; bieber_m@ukw.de; christoph.kleinschnitz@uk-essen.de; siren_a@ukw.de; christiane.albert-weissenberger@uni-wuerzburg.de		Siren, Anna-Leena/0000-0002-2217-0081; LOPEZ CAPERUCHIPI, SIMON/0000-0002-1057-3086; Bieber, Michael/0000-0002-5535-6480	German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EW1502B]; Interdisciplinary Clinical Research Center (IZKF) Wurzburg [E-313]; Deutsche Forschungsgemeinschaft (DFG), Research Unit FOR2879German Research Foundation (DFG) [428778684]; Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Center TR240German Research Foundation (DFG)	This work was supported by the German Federal Ministry of Education and Research under the framework of EU-ERA-NET NEURON CnsAFlame (BMBF 01EW1502B), the Interdisciplinary Clinical Research Center (IZKF) Wurzburg (E-313) and the Deutsche Forschungsgemeinschaft (DFG), Research Unit FOR2879 (project number: 428778684) and Collaborative Research Center TR240 (project B04).	Ahn HJ, 2017, CURR OPIN HEMATOL, V24, P427, DOI 10.1097/MOH.0000000000000368; Albert-Weissenberger C, 2019, J NEUROIMMUNOL, V326, P9, DOI 10.1016/j.jneuroim.2018.10.011; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bieber M, 2017, ANN NEUROL, V82, P729, DOI 10.1002/ana.25073; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Cheah CF, 2017, NEUROCRIT CARE, V26, P284, DOI 10.1007/s12028-016-0334-y; Chen ZL, 2017, BLOOD, V129, P2547, DOI 10.1182/blood-2016-11-753202; Clarkson JM, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.1636; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; De Meyer SF, 2016, STROKE, V47, P1165, DOI 10.1161/STROKEAHA.115.011238; Dere E, 2018, NEUROBIOL LEARN MEM, V150, P136, DOI 10.1016/j.nlm.2018.02.023; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Flaherty C.F., 1991, PSYCHOPHARMACOL ANXI, V46, P213, DOI [10.1016/b978-0-08-040698-5.50014-4, DOI 10.1016/B978-0-08-040698-5.50014-4]; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gobel K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11626; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; HENKE PG, 1979, CAN J PSYCHOL, V33, P133, DOI 10.1037/h0081711; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Hopp S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0815-8; Hopp S, 2016, ANN NEUROL, V79, P970, DOI 10.1002/ana.24655; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Kiryk A, 2020, BEHAV BRAIN RES, V388, DOI 10.1016/j.bbr.2020.112620; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kunz M, 2013, J NEUROTRAUM, V30, P1638, DOI 10.1089/neu.2012.2774; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas C, 2018, BLOOD, V131, P1903, DOI 10.1182/blood-2017-04-569111; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; RAJS J, 1976, BRIT HEART J, V38, P396; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Simao F, 2017, BLOOD, V129, P2280, DOI 10.1182/blood-2016-09-740670; SWANSON AM, 1969, J COMP PHYSIOL PSYCH, V68, P562, DOI 10.1037/h0027646; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Tucker LB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00509; Vogel A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71879-x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zamolodchikov D, 2015, P NATL ACAD SCI USA, V112, P4068, DOI 10.1073/pnas.1423764112; Zhao Q, 2019, J NEUROTRAUM, V36, P619, DOI 10.1089/neu.2018.5766; Zihl J, 2015, J CLIN MED, V4, P1051, DOI 10.3390/jcm4051051	52	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	MAY	2021	22	9							4855	10.3390/ijms22094855			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	SC0JN	WOS:000650369300001	34063730	Green Published			2022-02-07	
J	Sushkova, OS; Gabova, AV; Zhavoronkova, LA; Karabanov, AV; Kershner, IA; Morozov, AA; Sinkin, MV; Tolmacheva, RA; Chigaleychik, LA; Obukhov, YV				Sushkova, O. S.; Gabova, A., V; Zhavoronkova, L. A.; Karabanov, A., V; Kershner, I. A.; Morozov, A. A.; Sinkin, M., V; Tolmacheva, R. A.; Chigaleychik, L. A.; Obukhov, Yu, V			Extraction of Diagnostic Information on Brain Diseases by Analyzing Wavelet Spectra of Biomedical Signals	BIOMEDICAL ENGINEERING-MEDITSINSKAYA TEKNIKA			English	Article								New approaches to the analysis of Morlet wavelet spectra of electroencephalograms, electromyograms, and accelerometer signals are proposed. The proposed approaches are based on the analysis of time-frequency distributions of local extrema and ridges of wavelet spectrograms. The paper describes the results of application of the proposed techniques for the diagnosis of the early stage of Parkinson's disease and essential tremor, monitoring of postoperative patients with epilepsy, and assessment of inter-channel phase coupling of EEG during cognitive tests of patients after traumatic brain injury.	[Sushkova, O. S.; Kershner, I. A.; Morozov, A. A.; Tolmacheva, R. A.; Obukhov, Yu, V] Russian Acad Sci, Kotelnikov Inst Radioengn & Elect, Moscow, Russia; [Gabova, A., V; Zhavoronkova, L. A.] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Karabanov, A., V; Chigaleychik, L. A.] Res Ctr Neurol, Moscow, Russia; [Sinkin, M., V] Sklifosovsky Res Inst Emergency Med, Moscow Healthcare Dept, Moscow, Russia		Sushkova, OS (corresponding author), Russian Acad Sci, Kotelnikov Inst Radioengn & Elect, Moscow, Russia.	o.sushkova@mail.ru			Russian Foundation for Basic Research (RFBR)Russian Foundation for Basic Research (RFBR) [1837-20021, 18-29-02035, 18-07-00609]	This work was carried out within the framework of a state assignment and partially supported by the Russian Foundation for Basic Research (RFBR projects Nos. 1837-20021, 18-29-02035, and 18-07-00609).	Guillemain P, 1996, P IEEE, V84, P561, DOI 10.1109/5.488700; Kershner I. A., 2020, P 14 INT SCI C PHYS, V1, P253; Kershner IA., 2019, RADIOELEKTRON NANOSI, V11, P237, DOI 10.17725/rensit.2019.11.237; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Obukhov K., 2019, J PHYS C SER, V1096, P1; Sushkova O. S., 2020, VLADIMIR SUZDAL, V1, P267; Sushkova OS, 2018, LECT NOTES ARTIF INT, V11238, P253, DOI 10.1007/978-3-030-03928-8_21; Sushkova OS., 2015, RADIOTEKH ELEKTRON+, V60, P1064; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tolmacheva R. A., 2020, P 14 INT SCI C PHYS, V1, P130; Tolmacheva RA., 2018, RADIOTEKH ELEKTRON+, V63, P1009; Zhavoronkova LA., 2017, DOES HUMAN BRAIN SIM, P68	12	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0006-3398	1573-8256		BIOMED ENG-MEDIT TEK	Biomed. Eng. Meditsinskaya Teknika	MAY	2021	55	1					21	25		10.1007/s10527-021-10063-5			5		Emerging Sources Citation Index (ESCI)		YO9QA	WOS:000748266300006					2022-02-07	
J	Teichmann, D; Lynch, JC; Heldt, T				Teichmann, Daniel; Lynch, James C.; Heldt, Thomas			Distortion of the Intracranial Pressure Waveform by Extraventricular Drainage System	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Catheters; Pressure measurement; Ice; Monitoring; Distortion; Biomedical measurement; Resonant frequency; Extraventricular drainage; frequency response; intracranial pressure; pressure measurement; step response	TRAUMATIC BRAIN-INJURY; FLUID PULSE-WAVE; VENTRICULAR DRAINAGE; DYNAMIC-RESPONSE; FREQUENCY; REACTIVITY; GUIDELINES; MANAGEMENT; ELASTANCE	Objective: To investigate whether intracranial pressure (ICP) waveform measurements obtained from extraventricular drainage (EVD) systems are suitable for the calculation of intracranial elastance (ICE) or cerebrovascular pressure autoregulation (PAR) indices. Methods: The transfer characteristic of an EVD system is investigated by its step and frequency responses with focus on the low frequency (LF) range from 0.02 to 0.065 Hz (important in PAR) and the location of the system's first resonance frequency (important for ICE). The effects of opening the distal end of the EVD for drainage of cerebrospinal fluid and the presence of trapped air bubbles are also investigated. Results: The EVD system exhibits a first resonant frequency below 4 Hz, resulting in significant distortion of the measured ICP waveform. The frequency response in the LF range only remains flat when the EVD is closed. Opening the drain results in drops in magnitude and phase along the entire frequency range above DC. Air bubbles close to the EVD catheter tip affect the LF range while an air bubble close to the pressure transducer further decreases the first resonant frequency. Tests with actual ICP waveforms confirmed EVD-induced waveform distortions that can lead to erroneous ICE estimation. Conclusion: EVD-based ICP measurements distort the waveform morphology. PAR indices based on LF information are only valid if the EVD is closed. EVD-based ICE estimation is to be avoided. Significance: ICP waveform analyses to derive information about ICE and PAR should be critically questioned if only EVD derived ICP signals are at hand.	[Teichmann, Daniel; Lynch, James C.; Heldt, Thomas] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Teichmann, Daniel] Univ Southern Denmark, Maersk McKinney Moller Inst, SDU Hlth Informat & Technol, Odense, Denmark; [Lynch, James C.; Heldt, Thomas] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Lynch, James C.; Heldt, Thomas] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA		Heldt, T (corresponding author), MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.; Heldt, T (corresponding author), MIT, Res Lab Elect, Cambridge, MA 02139 USA.; Heldt, T (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	thomas@mit.edu		Teichmann, Daniel/0000-0003-3716-3201	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [TE 1174/2-1]; Philips Healthcare; Cronin Graduate Fellowship in the Department of Electrical Engineering, and Computer Science, Massachusetts Institute of Technology	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Grant TE 1174/2-1, a grant from Philips Healthcare, and by a Cronin Graduate Fellowship in the Department of Electrical Engineering, and Computer Science, Massachusetts Institute of Technology.	Anile C, 2014, INTERDISCIP NEUROSUR, V1, P26, DOI 10.1016/j.inat.2014.03.002; Aries MJH, 2015, NEUROCRIT CARE, V23, P347, DOI 10.1007/s12028-015-0107-z; Birch AA, 2006, NEUROCRIT CARE, V5, P51, DOI 10.1385/NCC:5:1:51; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chernoff D. M., 1982, THESIS; CHOPP M, 1980, J NEUROSURG, V53, P516, DOI 10.3171/jns.1980.53.4.0516; Cross TJ, 2016, J APPL PHYSIOL, V121, P503, DOI 10.1152/japplphysiol.00155.2016; CZOSNYKA M, 1988, ACTA NEUROCHIR, V93, P140, DOI 10.1007/BF01402897; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2017, ACTA NEUROCHIR, V159, P2063, DOI 10.1007/s00701-017-3310-1; Czosnyka Z, 2005, J NEUROSURG, V103, P767, DOI 10.3171/jns.2005.103.4.0767; FOLTZ EL, 1981, SURG NEUROL, V15, P283, DOI 10.1016/S0090-3019(81)80009-2; FRY DL, 1957, CIRC RES, V5, P40, DOI 10.1161/01.RES.5.1.40; Gabe I. T., 1972, CARDIOVASCULAR FLUID, P11; GARDNER RM, 1981, ANESTHESIOLOGY, V54, P227, DOI 10.1097/00000542-198103000-00010; GEDDES L A, 1988, Journal of Clinical Engineering, V13, P59; Heldt T, 2019, ANNU REV BIOMED ENG, V21, P523, DOI 10.1146/annurev-bioeng-060418-052257; HENRY WL, 1967, J APPL PHYSIOL, V23, P1007, DOI 10.1152/jappl.1967.23.6.1007; Hersh LT, 2015, J CLIN MONIT COMPUT, V29, P659, DOI 10.1007/s10877-014-9649-4; Hickey JV, 2009, BIOL RES NURS, V11, P174, DOI 10.1177/1099800409332902; Hockel K, 2018, ACTA NEUROCHIR SUPPL, V126, P281, DOI 10.1007/978-3-319-65798-1_55; Howells T, 2017, J CLIN MONIT COMPUT, V31, P469, DOI 10.1007/s10877-016-9863-3; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; KLEINMAN B, 1989, J CLIN MONITOR, V5, P137, DOI 10.1007/BF01617889; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; KROVETZ LJ, 1974, CIRCULATION, V50, P992, DOI 10.1161/01.CIR.50.5.992; LAPOINTE AC, 1974, IEEE T BIO-MED ENG, VBM21, P76, DOI 10.1109/TBME.1974.324373; LATIMER KE, 1969, MED BIOL ENG, V7, P143, DOI 10.1007/BF02474172; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Lee S, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2019.0884; LI JKJ, 1976, J APPL PHYSIOL, V40, P839, DOI 10.1152/jappl.1976.40.5.839; LIN ES, 1991, BRIT J ANAESTH, V66, P476, DOI 10.1093/bja/66.4.476; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; PIPER IR, 1990, ACT NEUR S, V51, P387; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; SCHWID HA, 1988, J CLIN MONITOR, V4, P181, DOI 10.1007/BF01621814; SZEWCZYKOWSKI J, 1977, J NEUROSURG, V47, P19, DOI 10.3171/jns.1977.47.1.0019; TAKIZAWA H, 1986, J NEUROL NEUROSUR PS, V49, P1135, DOI 10.1136/jnnp.49.10.1135; Tsuncda S, 1980, INTRACRANIAL PRESSUR, P188; VANLANGEN H, 1993, J CLIN MONITOR, V9, P335; WILKINSON HA, 1989, NEUROSURGERY, V24, P348, DOI 10.1227/00006123-198903000-00007	44	0	0	1	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	MAY	2021	68	5					1646	1657		10.1109/TBME.2020.3036283			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	RP8IR	WOS:000641967300020	33156777	Bronze, Green Published			2022-02-07	
J	Trotta, JK; Ekanayake, V; Ettenhofer, ML; Hungerford, LD; Lange, RT; Bailie, JM; Brickell, TA; Kennedy, JE; French, LM				Trotta, Jenna K.; Ekanayake, Vindhya; Ettenhofer, Mark L.; Hungerford, Lars D.; Lange, Rael T.; Bailie, Jason M.; Brickell, Tracey A.; Kennedy, Jan E.; French, Louis M.			Intracranial Abnormalities Are Associated With Fewer Self-Reported Symptoms in Military Service Members Following Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						intracranial abnormalities; moderate-to-severe TBI; self-awareness; TBI; traumatic brain injury	BEHAVIORAL LIMITATIONS; IMPAIRED AWARENESS; BODILY INJURIES; PTSD; COMPLAINTS; DEFICITS; IMPACT; TBI; CHECKLIST; VETERANS	Objective: This study examined the relationship between intracranial abnormalities (ICAs) and self-reported neurobehavioral and posttraumatic stress (PTS) symptoms in members of the military with moderate-to-severe traumatic brain injury (msTBI). Method: Participants included 539 members of the US military with nonpenetrating msTBI. Self-reported neurobehavioral and PTS symptoms were assessed using the Neurobehavioral Symptom Inventory and the PTSD Checklist-Civilian Version. ICAs were categorized as present/absent (by subtype) based upon medical record review. Spearman rank-order correlations and stepwise multiple regression analyses examined univariate and combined predictive relationships between ICAs and self-reported symptoms. Results: The presence of any ICA was associated with reduced self-reported neurobehavioral and PTS symptoms. ICA-associated reductions were largest for PTS, followed by affective and cognitive neurobehavioral symptoms, and relatively weak for somatic/sensory and vestibular symptoms. Effects of different types of ICAs were comparable. Greater time since injury was related to greater symptom report, whereas duration of loss of consciousness and posttraumatic amnesia were not consistently related to self-reported symptoms. Conclusions: Results suggest that ICAs are associated with suppression of reported PTS and neurobehavioral symptoms-potentially via reduction in self-awareness. These findings support comprehensive, objective evaluation to identify impairments in self-awareness and functioning in msTBI patients.	[Trotta, Jenna K.; Ekanayake, Vindhya; Ettenhofer, Mark L.; Hungerford, Lars D.; Lange, Rael T.; Bailie, Jason M.; Brickell, Tracey A.; Kennedy, Jan E.; French, Louis M.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Trotta, Jenna K.; Ekanayake, Vindhya; Ettenhofer, Mark L.; Hungerford, Lars D.] Naval Med Ctr San Diego, San Diego, CA USA; [Trotta, Jenna K.; Ettenhofer, Mark L.; Hungerford, Lars D.; Lange, Rael T.; Bailie, Jason M.; Brickell, Tracey A.; Kennedy, Jan E.] Gen Dynam Hlth Solut, Falls Church, VA USA; [Ekanayake, Vindhya] Amer Hosp Serv Grp, Exton, PA USA; [Ettenhofer, Mark L.; Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Ettenhofer, Mark L.] Univ Calif San Diego, San Diego, CA 92103 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, Camp Pendleton, CA USA; [Kennedy, Jan E.] Brooke Army Med Ctr, Ft Sam Houston, TX USA		Trotta, JK (corresponding author), Naval Med Ctr San Diego, Def & Vet Brain Injury Ctr, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.	jennaktrotta@gmail.com; vinkumari16@gmail.com; mark.ettenhofer@usuhs.edu; lars.d.hungerford.ctr@mail.mil; rlange@dvbic.org; jason.m.bailie.ctr@mail.mil; tbrickell@dvbic.org; jan.e.kennedy2.ctr@mail.mil; louis.m.french.civ@mail.mil			Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	Institutional support for this work was provided by the Defense and Veterans Brain Injury Center. The views and opinions presented in this article are those of the authors and do not necessarily represent the positions of the Department of Defense, the Department of the Navy, or the US government.	Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DeBruyne NF., 2018, AM WAR MILITARY OPER; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TRAU; Defense and Veterans Brain Injury Center, 2019, TBI BAS; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; French LM, 2014, J NEUROTRAUM, V31, P1607, DOI 10.1089/neu.2014.3401; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Karney B. R., 2008, INVISIBLE WOUNDS WAR, P119; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lamberts KF, 2017, BRAIN IMPAIR, V18, P130, DOI 10.1017/BrImp.2016.28; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Leung DPK, 2011, INT J REHABIL RES, V34, P187, DOI 10.1097/MRR.0b013e3283487f31; Licona NE, 2017, ARCH PHYS MED REHAB, V98, P391, DOI 10.1016/j.apmr.2016.09.131; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smeets SMJ, 2017, NEUROPSYCHOL REHABIL, V27, P116, DOI 10.1080/09602011.2015.1077144; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	49	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		164	174		10.1097/HTR.0000000000000637			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900008	33201040				2022-02-07	
J	Turcato, G; Zaboli, A; Zannoni, M; Ricci, G; Zorzi, E; Ciccariello, L; Tenci, A; Pfeifer, N; Maccagnani, A; Bonora, A				Turcato, Gianni; Zaboli, Arian; Zannoni, Massimo; Ricci, Giorgio; Zorzi, Elisabetta; Ciccariello, Laura; Tenci, Andrea; Pfeifer, Norbert; Maccagnani, Antonio; Bonora, Antonio			Risk factors associated with intracranial bleeding and neurosurgery in patients with mild traumatic brain injury who are receiving direct oral anticoagulants	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Mild traumatic brain injury; Direct oral anticoagulants; Decision curve analysis; Nomogram; Risk factors; Post-traumatic intracranial haemorrhage	HEAD-INJURY; ATRIAL-FIBRILLATION; GUIDELINE; THERAPY; ADULTS	Background: The established clinical risk factors for post-traumatic intracranial bleeding have not been evaluated in patients receiving DOACs yet. Aim: Evaluating the association between clinic and patient characteristics and post-traumatic intracranial bleeding (ICH) in patients with mild traumatic brain injury (MTBI) and DOACs. Methods: This is a retrospective observational study conducted on three Emergency Departments. Multivariate analysis provided association in terms of OR with the risk of ICH. The performance of the multivariate model, described in a nomogram, has been tested with discrimination and decision curve analysis. Results: Of 473 DOACs patients with MTBI, 8.5% had post-traumatic ICH. On multivariable analysis, major dynamics (odds ratio [OR] 6.255), post-traumatic amnesia (OR 3.961), post-traumatic loss of consciousness (LOC, OR 7.353), Glasgow Coma Scale (GCS) score b 15 (OR 3.315), post-traumatic headache (OR 4.168) and visible trauma above the clavicles (OR 3.378) were associated with a higher likelihood of ICH. The multivariate model, used for the nomogram construction, showed a good performance (AUC bias corrected with 5000 bootstraps resample 0.78). The DCAs showed a net clinical benefit of the prognostic model. Conclusions: Clinical risk factors can be used in DOACs patients to better define the risk of post-traumatic ICH. ? 2020 Elsevier Inc. All rights reserved.	[Turcato, Gianni; Zaboli, Arian; Ciccariello, Laura; Pfeifer, Norbert] Azienda Sanit Alto Adige, Franz Tappeiner Hosp Merano, Dept Emergency Med, Merano, Bolzano, Italy; [Zannoni, Massimo; Ricci, Giorgio; Maccagnani, Antonio; Bonora, Antonio] Univ Verona, Dept Emergency Med, Verona, Italy; [Zorzi, Elisabetta] Azienda Osped Scaligera, Girolamo Fracastoro Hosp San Bonifacio, Dept Cardiol & Intens Care Cardiol, Verona, Italy; [Tenci, Andrea] Azienda Osped Scaligera, Girolamo Fracastoro Hosp San Bonifacio, Dept Emergency Med, Verona, Italy		Turcato, G (corresponding author), Azienda Sanit Alto Adige, Franz Tappeiner Hosp Merano, Dept Emergency Med, Merano, Bolzano, Italy.	gianni.turcato@yahoo.it					Atzema C, 2004, ANN EMERG MED, V44, P47, DOI 10.1016/j.annemergmed.2004.02.032; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Campiglio L, 2017, NEUROL-CLIN PRACT, V7, P296, DOI 10.1212/CPJ.0000000000000375; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Foks KA, 2019, J NEUROTRAUM, V36, P2377, DOI 10.1089/neu.2018.6354; Fuller GW, 2019, ANN EMERG MED, V73, P66, DOI 10.1016/j.annemergmed.2018.07.020; Hoffman M, 2017, ARTERIOSCL THROM VAS, V37, P1812, DOI 10.1161/ATVBAHA.117.306995; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Kalabalik J, 2015, DRUGS, V75, P979, DOI 10.1007/s40265-015-0405-y; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Steinberg BA, 2017, AM HEART J, V194, P132, DOI 10.1016/j.ahj.2017.08.011; Steiner T, 2018, J STROKE, V20, P292, DOI 10.5853/jos.2018.02250; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Uccella L, 2018, WORLD NEUROSURG, V110, pE339, DOI 10.1016/j.wneu.2017.10.173; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; Van Calster B, 2018, EUR UROL, V74, P796, DOI 10.1016/j.eururo.2018.08.038; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	26	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2021	43						180	185		10.1016/j.ajem.2020.02.046			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	YJ2OI	WOS:000744374600033					2022-02-07	
J	Turcato, G; Zaboli, A; Zannoni, M; Ricci, G; Zorzi, E; Ciccariello, L; Tenci, A; Pfeifer, N; Maccagnani, A; Bonora, A				Turcato, Gianni; Zaboli, Arian; Zannoni, Massimo; Ricci, Giorgio; Zorzi, Elisabetta; Ciccariello, Laura; Tenci, Andrea; Pfeifer, Norbert; Maccagnani, Antonio; Bonora, Antonio			Risk factors associated with intracranial bleeding and neurosurgery in patients with mild traumatic brain injury who are receiving direct oral anticoagulants	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Mild traumatic brain injury; Direct oral anticoagulants; Decision curve analysis; Nomogram; Risk factors; Post-traumatic intracranial haemorrhage	HEAD-INJURY; ATRIAL-FIBRILLATION; GUIDELINE; THERAPY; ADULTS	Background: The established clinical risk factors for post-traumatic intracranial bleeding have not been evaluated in patients receiving DOACs yet. Aim: Evaluating the association between clinic and patient characteristics and post-traumatic intracranial bleeding (ICH) in patients with mild traumatic brain injury (MTBI) and DOACs. Methods: This is a retrospective observational study conducted on three Emergency Departments. Multivariate analysis provided association in terms of OR with the risk of ICH. The performance of the multivariate model, described in a nomogram, has been tested with discrimination and decision curve analysis. Results: Of 473 DOACs patients with MTBI, 8.5% had post-traumatic ICH. On multivariable analysis, major dynamics (odds ratio [OR] 6.255), post-traumatic amnesia (OR 3.961), post-traumatic loss of consciousness (LOC, OR 7.353), Glasgow Coma Scale (GCS) score < 15 (OR 3.315), post-traumatic headache (OR 4.168) and visible trauma above the clavicles (OR 3.378) were associated with a higher likelihood of ICH. The multivariate model, used for the nomogram construction, showed a good performance (AUC bias corrected with 5000 bootstraps resample 0.78). The DCAs showed a net clinical benefit of the prognostic model. Conclusions: Clinical risk factors can be used in DOACs patients to better define the risk of post-traumatic ICH. (C) 2020 Elsevier Inc. All rights reserved.	[Turcato, Gianni; Zaboli, Arian; Ciccariello, Laura; Pfeifer, Norbert] Azienda Sanitaria Alto Adige, Dept Emergency Med, Franz Tappeiner Hosp Merano, Bolzano, Italy; [Zannoni, Massimo; Ricci, Giorgio; Maccagnani, Antonio; Bonora, Antonio] Univ Verona, Dept Emergency Med, Verona, Italy; [Zorzi, Elisabetta] Azienda Osped Scaligera, Dept Cardiol & Intens Care Cardiol, Girolamo Fracastoro Hosp San Bonifacio, Verona, Italy; [Tenci, Andrea] Azienda Osped Scaligera, Dept Emergency Med, Girolamo Fracastoro Hosp San Bonifacio, Verona, Italy		Turcato, G (corresponding author), Azienda Sanitaria Alto Adige, Dept Emergency Med, Franz Tappeiner Hosp Merano, Bolzano, Italy.	gianni.turcato@yahoo.it					Atzema C, 2004, ANN EMERG MED, V44, P47, DOI 10.1016/j.annemergmed.2004.02.032; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Campiglio L, 2017, NEUROL-CLIN PRACT, V7, P296, DOI 10.1212/CPJ.0000000000000375; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Foks KA, 2019, J NEUROTRAUM, V36, P2377, DOI 10.1089/neu.2018.6354; Fuller GW, 2019, ANN EMERG MED, V73, P66, DOI 10.1016/j.annemergmed.2018.07.020; Hoffman M, 2017, ARTERIOSCL THROM VAS, V37, P1812, DOI 10.1161/ATVBAHA.117.306995; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Kalabalik J, 2015, DRUGS, V75, P979, DOI 10.1007/s40265-015-0405-y; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Steinberg BA, 2017, AM HEART J, V194, P132, DOI 10.1016/j.ahj.2017.08.011; Steiner T, 2018, J STROKE, V20, P292, DOI 10.5853/jos.2018.02250; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Uccella L, 2018, WORLD NEUROSURG, V110, pE339, DOI 10.1016/j.wneu.2017.10.173; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; Van Calster B, 2018, EUR UROL, V74, P796, DOI 10.1016/j.eururo.2018.08.038; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	26	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2021	43						180	185		10.1016/j.ajem.2020.02.046			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TK5SX	WOS:000674219200033					2022-02-07	
J	Uryga, A; Czyz, M; Adamik, B; Tabakow, P; Kasprowicz, M; Burzynska, M				Uryga, Agnieszka; Czyz, Marcin; Adamik, Barbara; Tabakow, Pawel; Kasprowicz, Magdalena; Burzynska, Malgorzata			Serum biomarkers and cerebral autoregulation as early warnings of delayed cerebral ischemia risk in patients after aneurysmal subarachnoid haemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						S100B protein; Cerebral autoregulation; Biomarkers; Delayed cerebral ischemia; Subarachnoid haemorrhage	REACTIVE PROTEIN/ALBUMIN RATIO; TRAUMATIC BRAIN-INJURY; OUTCOME PREDICTION; S100B; MANAGEMENT; MORTALITY; SEVERITY	Background: Identifying patients at risk of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (aSAH) remains challenging. This study aimed to evaluate the concentration of serum biomarkers along with cerebral autoregulation impairment on DCI. Methods: 55 patients suffering from aSAH were enrolled in the study. Serum S100 protein B (S100B) was tested both on the day of admission and over three consecutive days following the occurrence of aSAH. Cerebral autoregulation was assessed using a tissue oxygenation index (TOxa) based on near-infrared spectroscopy. Results: Changes in serum S100B levels interacted with DCI status (presence vs. absence): F = 3.84, p = 0.016. Patients with DCI had higher S100B concentration level on day 3 than those without DCI (3. 54 +/- 0.50 ng/ml vs. 0.58 +/- 0.43 ng/ml, p = 0.001). S100B concentration on day 3 following aSAH predicted DCI (AUC = 0.77, p = 0.006). Raised level of serum S100B on day 3 was related with higher TOxa, thus with impaired cerebral autoregulation (r(S) = 0.52, p = 0.031). Multivariate logistic regression analysis showed that impaired cerebral autoregulation and elevated S100B concentration on day 3 increase the likelihood of DCI. Conclusions: Tracking changes in the serum biomarkers concentration along with monitoring of cerebral autoregulation, may play a role in early detection of patients at risk of DCI after aSAH. These results need to be validated in larger prospective cohorts. (C) 2021 Elsevier Ltd. All rights reserved.	[Uryga, Agnieszka; Kasprowicz, Magdalena] Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland; [Czyz, Marcin] Univ Hosp Birmingham NHS FT, Queen Elizabeth Hosp Birmingham, Dept Neurosurg, Birmingham, W Midlands, England; [Adamik, Barbara; Burzynska, Malgorzata] Wroclaw Med Univ, Dept Anaesthesiol & Intens Care, Wroclaw, Poland; [Tabakow, Pawel] Wroclaw Med Univ, Dept Neurosurg, Wroclaw, Poland		Uryga, A (corresponding author), Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	agnieszka.uryga@pwr.edu.pl	Adamik, Barbara/H-8696-2016	Adamik, Barbara/0000-0002-0541-841X; Czyz, Marcin/0000-0001-7224-4272; Kasprowicz, Magdalena/0000-0002-2271-7737; Uryga, Agnieszka/0000-0001-8183-7643; Tabakow, Pawel/0000-0001-8638-3871; Burzynska, Malgorzata/0000-0003-2318-7130	National Science Center (Poland)National Science Centre, Poland [2013/09/B/NZ4/01343]; Wroclaw Medical University (Poland) [ST. A170.18.024]; Polish National Agency for Academic Exchange under the International Academic Partnerships programmePolish National Agency for Academic Exchange (NAWA); Foundation for Polish Science (FNP)Foundation for Polish Science	This research was supported by the National Science Center (Poland) under grant No. 2013/09/B/NZ4/01343 and by the Wroclaw Medical University (Poland) under grant No. ST. A170.18.024. A. Uryga and M. Kasprowicz acknowledge the support of the Polish National Agency for Academic Exchange under the International Academic Partnerships programme. A. Uryga is supported by the Foundation for Polish Science (FNP). The sponsor had no role in the design or conduct of this research.	Carandang RA, 2015, CURR TRAUMA REP, V1, P125, DOI 10.1007/s40719-015-0022-y; Balanca B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061746; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Budohoski KP, 2016, ACTA NEUROCHIR SUPPL, V122, P199, DOI 10.1007/978-3-319-22533-3_40; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000277.pub3; Etminan N, 2016, NAT REV NEUROL, V12, P699, DOI 10.1038/nrneurol.2016.150; Evensen KB, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00195-3; Francoeur CL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1447-6; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hong CM, 2014, BIOMARKERS, V19, P95, DOI 10.3109/1354750X.2014.881418; Jabbarli R, 2020, NEUROSURG REV, V43, P825, DOI 10.1007/s10143-018-1037-y; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Jung CS, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/560305; Kaplan M, 2017, HEPATOB PANCREAT DIS, V16, P424, DOI 10.1016/S1499-3872(17)60007-9; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Kiiski H, 2018, J NEUROL SCI, V390, P129, DOI 10.1016/j.jns.2018.04.030; Lai PMR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151853; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; Li R, 2017, CHINESE NEUROSURGICA, V3, P24, DOI [10.1186/s41016-017-0089-0, DOI 10.1186/S41016-017-0089-0, DOI 10.1186/s41016-017-0089-0]; Nishikawa H, 2017, NEURAL REGEN RES, V12, P1982, DOI 10.4103/1673-5374.221150; Oh TK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33361-7; Park JJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051595; Park JE, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100333; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Rivera-Lara L, 2017, NEUROCRIT CARE, V27, P362, DOI 10.1007/s12028-017-0421-8; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Suzuki H, 2018, NEURAL REGEN RES, V13, P1175, DOI 10.4103/1673-5374.235022; Zhang DD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01186; Zhang WS, 2018, EXP THER MED, V16, P816, DOI 10.3892/etm.2018.6231; Zheng K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00123; Zheng YK, 2017, CLIN CHIM ACTA, V475, P64, DOI 10.1016/j.cca.2017.10.009	40	0	0	3	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2021	87						35	43		10.1016/j.jocn.2021.02.009			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RN8BZ	WOS:000640577800008	33863531				2022-02-07	
J	Wang, D; Fang, B; Wang, ZL; Li, XQ; Chen, FS				Wang, Dan; Fang, Bo; Wang, Zhilin; Li, Xiaoqian; Chen, Fengshou			Sevoflurane pretreatment regulates abnormal expression of MicroRNAs associated with spinal cord ischemia/reperfusion injury in rats	ANNALS OF TRANSLATIONAL MEDICINE			English	Article						Spinal cord ischemia/reperfusion injury (SCII); microRNA; bioinformatics analysis; miR-21-5p; MAP2K3; PPP1R3B	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; BARRIER DISRUPTION; CEREBRAL-ISCHEMIA; APOPTOSIS; PROFILES; NEUROPROTECTION; SUPPRESSION; ACTIVATION; INHIBITOR	Background: Spinal cord ischemia/reperfusion injury (SCII) is one of the most serious spinal cord complications that stem from varied spine injuries or thoracoabdominal aortic surgery. Nevertheless, the molecular mechanisms underlying the SCII remain unclear. Methods: Male Sprague-Dawley (SD) rats were randomly divided into 5 groups of sham, SCII 24 h, SCII 72 h, sevoflurane preconditioning SCII 24 h (SCII 24 h+sevo), and sevoflurane preconditioning SCII 72 h (SCII 72 h+sevo) group. We then analyzed the expression of differentially expressed micro RNAs (DEmiRNAs) in these groups and their target genes. Functional enrichment analysis of their target genes was further performed using Metascape software. The microRNA-messenger RNA-pathway (miRNA-mRNA-pathway) network and the sevoflurane-miRNA-mRNA-pathway integrative network were further constructed to explore the molecular mechanisms underlying SCII and neuroprotective effects of sevoflurane against SCII. Molecular docking was also performed to evaluate the interactions between hub targets and sevoflurane. Finally, the expression levels of miR-21-5p and its target genes [mitogen-activated protein kinase kinase 3 and protein phosphatase 1 regulatory subunit 3B (MAP2K3 and PPP1R3B)] were measured using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blot analyses. Results: We found that sevoflurane alters several miRNA expression following SCII at 24 and 72 h after reperfusion. It was shown that miR-221-3p, miR-181a-1-3p, and miR-21-5p were upregulated both at 24 and 72 h in the sevoflurane pre-treatment reperfusion groups. Functional enrichment analysis revealed that target genes for the above co-DEmiRNAs at 24 and 72 h in the SCII group with sevoflurane pretreatment participated in the mitogen-activated protein kinase (MAPK), ErbB, apoptosis, and transforming growth factor-beta (TGF-beta) signaling pathways. Both MAP2K3 and PPP1R3B were found to be common targets for sevoflurane and miRNA-mRNA-pathway (rno-miR-21-5p). It was shown that MAP2K3 regulates the MAPK signaling and the T cell receptor signaling pathways, whereas PPP1R3B regulates the ErbB signaling pathway. Molecular docking further revealed that sevoflurane strongly binds the MAP2K3 and PPP1R3B proteins. Compared to the sham group, SCII induced significant under-expression of miR-21-5p but upregulated PPP1R3B and MAP2K3 proteins; sevoflurane pretreatment increased the expression of miR-215p but decreased those of PPP1R3B and MAP2K3 proteins. Conclusions: In general, sevoflurane regulates the expression of several miRNAs following SCII. In particular, sevoflurane might protect against SCII via regulating the expression of miR-21-5p, its target genes (MAP2K3 and PPP1R3B), and related signaling pathways.	[Wang, Dan; Fang, Bo; Wang, Zhilin; Li, Xiaoqian; Chen, Fengshou] China Med Univ, Dept Anesthesiol, Hosp 1, 155 Nangjing North St, Shenyang 110001, Peoples R China		Chen, FS (corresponding author), China Med Univ, Dept Anesthesiol, Hosp 1, 155 Nangjing North St, Shenyang 110001, Peoples R China.	haoxiu19881988@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971152]	This study was supported financially by the National Natural Science Foundation of China (81971152).	Aslan A, 2009, EUR SPINE J, V18, P336, DOI 10.1007/s00586-008-0872-x; Balsam LB, 2017, J THORAC CARDIOV SUR, V154, P1509, DOI 10.1016/j.jtcvs.2017.06.010; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Chandran R, 2017, NEUROCHEM INT, V111, P12, DOI 10.1016/j.neuint.2017.01.015; Chandrasekar A, 2018, J NEUROTRAUM, V35, P2718, DOI 10.1089/neu.2017.5270; Chen FS, 2020, BRAIN RES, V1727, DOI 10.1016/j.brainres.2019.146489; Chen R, 2019, NEUROSCI LETT, V690, P11, DOI 10.1016/j.neulet.2018.09.060; Davis AP, 2019, NUCLEIC ACIDS RES, V47, pD948, DOI 10.1093/nar/gky868; Ding Q, 2009, ANESTH ANALG, V109, P1263, DOI 10.1213/ane.0b013e3181b2214c; Fang B, 2015, CELL PHYSIOL BIOCHEM, V36, P373, DOI 10.1159/000430107; Fu J, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01790-8; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Guo WJ, 2020, J ETHNOPHARMACOL, V263, DOI 10.1016/j.jep.2020.113202; He XJ, 2017, MOL MED REP, V15, P2120, DOI 10.3892/mmr.2017.6231; Hu JR, 2013, J PHARMACOL SCI, V121, P343, DOI 10.1254/jphs.12235SC; Jin RL, 2017, BIOMED PHARMACOTHER, V94, P47, DOI 10.1016/j.biopha.2017.07.053; Li JA, 2016, NEURAL REGEN RES, V11, P1824, DOI 10.4103/1673-5374.194754; Li WJ, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0266-y; Li XQ, 2018, BRAIN BEHAV IMMUN, V74, P154, DOI 10.1016/j.bbi.2018.09.002; Li XQ, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0243-1; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0069-7; Li XQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-62; Li XG, 2018, J MOL NEUROSCI, V66, P437, DOI 10.1007/s12031-018-1179-y; Liu YQ, 2015, INT J CLIN EXP MED, V8, P6427; Liu ZG, 2020, NEURAL REGEN RES, V15, P2123, DOI 10.4103/1673-5374.280323; Shi CX, 2020, MOL MED REP, V21, P123, DOI 10.3892/mmr.2019.10832; Shi H, 2013, CNS NEUROL DISORD-DR, V12, P381, DOI 10.2174/1871527311312030011; Su YL, 2019, FASEB J, V33, P10859, DOI 10.1096/fj.201900743R; Na HT, 2021, INT J NEUROSCI, V132, P77, DOI 10.1080/00207454.2020.1835901; Tang MX, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190597; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang Q, 2011, J SURG RES, V169, P292, DOI 10.1016/j.jss.2009.11.707; Wang RL, 2020, CLIN EXP PHARMACOL P, V47, P372, DOI 10.1111/1440-1681.13212; Wang XY, 2019, EUR J PHARMACOL, V851, P80, DOI 10.1016/j.ejphar.2019.02.027; Wu Y, 2019, AM J TRANSL RES, V11, P2570; Xiang Y, 2015, EUR J PAIN, V19, P686, DOI 10.1002/ejp.590; Yamamoto M, 2020, INT J MOL MED, V45, P1141, DOI 10.3892/ijmm.2020.4477; Yao XF, 2018, J MOL NEUROSCI, V65, P43, DOI 10.1007/s12031-018-1067-5; Ye J, 2020, EUR REV MED PHARMACO, V24, P2165, DOI 10.26355/eurrev_202003_20481; Yu F, 2020, EUR REV MED PHARMACO, V24, P5082, DOI 10.26355/eurrev_202005_21201; Yu Q, 2019, NEURAL REGEN RES, V14, P265, DOI 10.4103/1673-5374.244790; Yu XD, 2019, IMMUNOBIOLOGY, V224, P638, DOI 10.1016/j.imbio.2019.07.004; Zhai FG, 2012, NEURAL REGEN RES, V7, P917, DOI 10.3969/j.issn.1673-5374.2012.12.007; Zhang HS, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.116935; Zhang SB, 2018, CELL PHYSIOL BIOCHEM, V46, P1455, DOI 10.1159/000489186; Zhang T, 2019, SPINAL CORD, V57, P141, DOI 10.1038/s41393-018-0180-1; Zhang YN, 2019, CHEM-BIOL INTERACT, V308, P332, DOI 10.1016/j.cbi.2019.06.008; Zhou J, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190625; Zhou M, 2019, MOL MED REP, V20, P1797, DOI 10.3892/mmr.2019.10408; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zhou ZB, 2020, PEERJ, V8, DOI 10.7717/peerj.8293	52	0	0	1	1	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2305-5839	2305-5847		ANN TRANSL MED	ANN. TRANSL. MED.	MAY	2021	9	9							752	10.21037/atm-20-7864			22	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	UN4XD	WOS:000694019000014	34268365	gold, Green Published			2022-02-07	
J	Wang, ZL; Zhang, JW; Sun, XF; Wang, PB; Xiao, HX; Ding, TH; Xie, JF; Han, XT				Wang, Zhenglei; Zhang, Jingwen; Sun, Xianfeng; Wang, Pengbo; Xiao, Houxiu; Ding, Tonghai; Xie, Jianfeng; Han, Xiaotao			Fully redundant auxiliary system for gyrotron-based terahertz sources in long-term operation	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								The Wuhan National High Magnetic Field Center is incorporating the flat-top pulsed magnetic field (FTPMF) into pulse gyrotrons. It will be the first chance to make a pulse-magnet gyrotron available for generating a long-pulse radiation of 100 ms or above without affecting its high operating frequency and high radiation power. However, unlike continuous wave gyrotrons, pulse gyrotrons in long-term operation have their own challenges, namely, misalignment caused by concussions, much stronger low-frequency electromagnetic interference from the pulse magnet, and inevitable explosion. This article will focus on the difficulties faced by pulse gyrotrons in years of operation, discuss the protection and restoration from failures, and, consequently, propose a fully redundant, explosion-proof, and quickly recoverable auxiliary system for long-term operation of pulse gyrotrons. This system integrates the control unit of traditional pulsed magnets and superconducting magnets so that it can be compatible with any form of gyrotron facilities. Therefore, once the FTPMF or the superconducting magnet is available, the long-pulse radiation will be obtained. Several experimental results, including the most recent explosion, show the reliability of the proposed system.	[Wang, Zhenglei; Zhang, Jingwen; Sun, Xianfeng; Wang, Pengbo; Xiao, Houxiu; Ding, Tonghai; Xie, Jianfeng; Han, Xiaotao] Huazhong Univ Sci & Technol, Wuhan 430074, Hubei, Peoples R China		Han, XT (corresponding author), Huazhong Univ Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	wangzhenglei@hust.edu.cn; jw_zh@hust.edu.cn; sunxiangfeng@hust.edu.cn; wangpengbo@hust.edu.cn; xiaohouxiu@hust.edu.cn; thding@hust.edu.cn; xiejianfeng@hust.edu.cn; xthan@hust.edu.cn	; Han, Xiaotao/K-4648-2012	Zhang, Jingwen/0000-0003-3486-3392; Han, Xiaotao/0000-0002-7089-9598	National Key Research and Development Plan Project of China [2016YFA0401703]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51821005]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2019kfyXKJC017]	This work was supported, in part, by the National Key Research and Development Plan Project of China (Grant No. 2016YFA0401703), the National Natural Science Foundation of China (Grant No. 51821005), and the Fundamental Research Funds for the Central Universities (Grant No. 2019kfyXKJC017).	Cavalcante FD, 2003, IEEE POWER ELECTRON, P1807; Chen X, 2019, 2019 44 INT C INFR M, P1; Dumbrajs O, 2003, PHYS PLASMAS, V10, P1183, DOI 10.1063/1.1561277; Garola AR, 2021, IEEE T NUCL SCI, V68, P245, DOI 10.1109/TNS.2020.3035146; Glyavin M.Y., 2009, TERAHERTZ SCI TECHNO, V2, P150, DOI 10.11906/TST.150-155.2009.12.16; Glyavin MY, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.015101; Glyavin MY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4757290; Glyavin MY, 2011, INSTRUM EXP TECH+, V54, P77, DOI 10.1134/S0020441211010064; Li L, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2182629; Liu QY, 2021, MATTER RADIAT EXTREM, V6, DOI 10.1063/5.0040208; Ma SX, 2014, IEEE T PLASMA SCI, V42, P1709, DOI 10.1109/TPS.2014.2320288; Nguyen DN, 2016, IEEE T APPL SUPERCON, V26, DOI 10.1109/TASC.2016.2515982; Saito T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.155001; Sakamoto K, 2007, NAT PHYS, V3, P411, DOI 10.1038/nphys599; Uchiyama A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4825383; Wang PB, 2020, IEEE T THZ SCI TECHN, V10, P460, DOI 10.1109/TTHZ.2020.2979116; Wang S, 2020, IEEE T APPL SUPERCON, V30, DOI 10.1109/TASC.2020.2969108; Xiao HX, 2014, IEEE T POWER ELECTR, V29, P4532, DOI 10.1109/TPEL.2013.2285125; Xu WY, 2016, FUSION ENG DES, V113, P119, DOI 10.1016/j.fusengdes.2016.11.002; Zhang SZ, 2020, IEEE T POWER ELECTR, V35, P2436, DOI 10.1109/TPEL.2019.2931488; Zhang ZC, 2014, FUSION ENG DES, V89, P582, DOI 10.1016/j.fusengdes.2014.03.030	21	0	0	2	6	AIP Publishing	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	MAY 1	2021	92	5							054711	10.1063/5.0050044			8	Instruments & Instrumentation; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Instruments & Instrumentation; Physics	UK7DR	WOS:000692127100003	34243330				2022-02-07	
J	Williams, RM; Johnson, RS; Valier, ARS; Bay, RC; McLeod, TCV				Williams, Richelle M.; Johnson, Rachel S.; Valier, Alison R. Snyder; Bay, R. Curtis; McLeod, Tamara C. Valovich			Evaluating Multiple Domains of Health in High School Athletes With Sport-Related Concussion	JOURNAL OF SPORT REHABILITATION			English	Article						brain injury; adolescence; depression; anxiety; PROMIS	QUALITY-OF-LIFE; NEUROCOGNITIVE PERFORMANCE; PSYCHOMETRIC PROPERTIES; RECURRENT CONCUSSION; CONSENSUS STATEMENT; DEPRESSION; PATIENT; SYMPTOMS; OUTCOMES; ANXIETY	Context: Concussions are shown to hinder multiple health dimensions, including health-related quality of life (HRQOL), suggesting a need for a whole-person approach to assessment and treatment. Patient-reported outcome measures are one method to gather the patient's perspective regarding their HRQOL. Objective: To evaluate perceived HRQOL using the Patient-Reported Outcomes Measurement Information System Pediatric-25 subscale in patients throughout concussion recovery. Design: Prospective cohort, descriptive survey. Setting: There were 9 high school athletic training facilities. Participants: A total of 70 patients with diagnosed concussions (51 males, 7 females, 12 unreported; age = 15.7 [0.9] y, height = 174.6 [8.4] cm, mass = 72.8 [14.8] kg, grade = 10.0 [0.9] level). Interventions: Patient-Reported Outcomes Measurement Information System Pediatric-25 was administered at 3 days, 10 days postconcussion, and return to play (RTP). Main Outcome Measures: Patient-Reported Outcomes Measurement Information System Pediatric-25 subscale T scores and self-reported concussion history (yes/no). Results: A total of 70 patients completed the study. For the Pediatric-25 subscales, the severity of problems associated with Physical Function Mobility, Anxiety, Depression, Fatigue, and Pain Interference were highest 3 days postconcussion, decreasing at 10 days and RTP (all p < .05). No differences were found between days 3 and 10 for Peer Relationship scores, but improvements were identified at RTP (p < .05). Pediatric-25 subscale scores at the 3 measurements were not statistically associated with concussion history (all p > .05). Ceiling and floor effects were present in all subscales throughout each timepoint, except for Physical Function Mobility (14.7%), and pain interference (11.8%) at day 3 postinjury. Conclusions: Patients who had suffered a concussion improved from day 3 through RTP on multiple health domains as demonstrated through the Pediatric-25 subscales. These findings highlight the need for health care professionals to serially monitor HRQOL and social factors that may affect the patient postconcussion as part of a multifactorial assessment. Ceiling effects in high functioning adolescent athletes were present; thus, efforts should be made to identify appropriate scales for use in managing recovery in athletic populations.	[Williams, Richelle M.] Drake Univ, Dept Athlet Training, Des Moines, IA 50311 USA; [Johnson, Rachel S.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Valier, Alison R. Snyder; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA; [Valier, Alison R. Snyder; McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med, Mesa, AZ 85206 USA; [Valier, Alison R. Snyder] AT Still Univ, Dept Res Support, Mesa, AZ 85206 USA; [Bay, R. Curtis] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ 85206 USA		Williams, RM (corresponding author), Drake Univ, Dept Athlet Training, Des Moines, IA 50311 USA.	Richelle.williams@drake.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; DeWalt DA, 2013, HEALTH PSYCHOL, V32, P1093, DOI 10.1037/a0032670; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Gu H, 2019, MIXED MODEL APPROACH, DOI DOI 10.3768/RTIPRESS.2009.MR.0009.0903; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Houston MN, 2016, J ATHL TRAINING, V51, P442, DOI 10.4085/1062-6050-51.7.03; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Irwin DE, 2010, QUAL LIFE RES, V19, P2417; Kirkley A, 2003, ARTHROSCOPY, V19, P1121, DOI 10.1016/j.arthro.2003.10.028; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lai JS, 2013, QUAL LIFE RES, V22, P2417, DOI 10.1007/s11136-013-0357-1; Lam KC, 2013, J ATHL TRAINING, V48, P233, DOI 10.4085/1062-6050-48.2.12; Ljungqvist A, 2009, BRIT J SPORT MED, V43, P631, DOI 10.1136/bjsm.2009.064394; Mayfield R, 2013, ATHLETIC TRAINING SP, V5, P265, DOI DOI 10.3928/19425864-20131017-01; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGuine TA, 2012, CLIN J SPORT MED, V22, P334, DOI 10.1097/JSM.0b013e318257a40b; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2009, J ATHL TRAINING, V44, P603, DOI 10.4085/1062-6050-44.6.603; McLeod TV, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000394; Michener LA, 2011, J SPORT REHABIL, V20, P37, DOI 10.1123/jsr.20.1.37; National Institute of Neurological Disorders, SPORTS RELATED CONCU; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; OSOBA D, 1994, J CLIN ONCOL, V12, P608, DOI 10.1200/JCO.1994.12.3.608; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Schunemann HJ, 2005, HEALTH SERV RES, V40, P593, DOI 10.1111/j.1475-6773.2005.0k375.x; Snyder AR, 2010, J SPORT REHABIL, V19, P237, DOI 10.1123/jsr.19.3.237; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; System patient-reported outcomes measurement information, 2015, PROMIS PEDIAT PROFIL; Thissen D, 2016, QUAL LIFE RES, V25, P13, DOI 10.1007/s11136-015-1058-8; Valier AR, 2016, ARCH PHYS MED REHAB, V97, P1202, DOI 10.1016/j.apmr.2015.11.015; Valier AR, 2015, ATHL TRAIN ED J, V10, P91, DOI [DOI 10.4085/100191, 10.4085/100191]; Valovich McLeod T, 2013, 4 INT C CONC SPORT, V47; Varni JW, 2014, QUAL LIFE RES, V23, P1233, DOI 10.1007/s11136-013-0544-0; Varni JW, 2014, QUAL LIFE RES, V23, P349, DOI 10.1007/s11136-013-0439-0; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	48	0	0	1	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAY	2021	30	4					545	551		10.1123/jsr.2019-0517			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	RQ5YK	WOS:000642494100003	33038870				2022-02-07	
J	Wu, H; Gong, L; Qian, ZX; Mao, Q				Wu, Hong; Gong, Liang; Qian, Zhongxin; Mao, Qing			Analysis of the influencing factors and nursing strategy for acute atelectasis after traumatic brain injury surgery	ANNALS OF PALLIATIVE MEDICINE			English	Article						Traumatic brain injury (TBI); acute atelectasis; influence factor; nursing	CELL LUNG-CANCER; VENTILATION	Background: Acute atelectasis is common after traumatic brain injury (TBI), but the related factors and treatment are still unclear. This study is to analyze the independent risk factors for acute atelectasis after TBI and propose an interventional nursing strategy, in order to correct respiratory function and improve the prognosis of patients. Methods: The clinical data of 93 patients with TBI admitted to our hospital from April 2015 to October 2019 were retrospectively analyzed. Clinical data were analyzed by single factor analysis, the cutoff value of influencing factors was obtained by receiver operating characteristic (ROC) curve analysis, and the influencing factors for acute atelectasis after TBI were examined by multi-factor logistic regression. Results: Twenty- two patients (23.66%) were complicated with acute atelectasis during the observation period, while the remaining 71 patients (76.34%) did not have acute atelectasis. Univariate analysis showed that there were significant differences in the Glasgow Coma Scale (GCS), history of vomiting and aspiration, mannitol use, mechanical ventilation, hypoalbuminemia, and serum hypoxia-inducible factor-1 alpha (HIF-1 alpha) between the acute atelectasis group and the non-acute atelectasis group (P<0.05). The AUC area of HIF1 alpha level predicting acute atelectasis was 0.896 [95% confidence interval (CI): 0.814-0.978, P=0.042], and the cut-off value was 2.12 mmol/L, with a sensitivity of 76.9% and a specificity of 93.3%. Logistic regression analysis showed that a history of vomiting and aspiration [odds ratio (OR) 3.908, 95% confidence interval (CI): 1.201-12.712], mechanical ventilation (OR 3.250, 95% CI: 1.139-9.271), hypoalbuminemia (OR 5.741, 95% Cl: 1.926-17.113), and HIF-1 alpha >= 2.12 mmol/L (OR 6.623, 95% CI: 2.364-16.346) were independent risk factors for acute atelectasis after TBI. Conclusions: A history of vomiting and aspiration, mechanical ventilation, hypoalbuminemia, and high expression of HIF-1 alpha are all independent risk factors for postoperative acute atelectasis in patients with TBI. In clinical practice, patients should be guided to swallow properly, breathe smoothly, eat well, and regularly check the relevant indexes.	[Wu, Hong; Mao, Qing] Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, Shanghai 200125, Peoples R China; [Gong, Liang; Qian, Zhongxin] Punan Hosp, Dept Neurosurg, Shanghai, Peoples R China		Mao, Q (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, Shanghai 200125, Peoples R China.	neurojack@163.com			Outstanding Clinical Discipline Project of Shanghai Pudong [PWYgy2018-04]; National Natural Science FundNational Natural Science Foundation of China (NSFC) [81571883]	This study was funded by the Outstanding Clinical Discipline Project of Shanghai Pudong (PWYgy2018-04) and the National Natural Science Fund (No. 81571883).	Alali AS, 2020, J NEUROSURG, V132, P537, DOI 10.3171/2018.10.JNS18964; Betensley A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6010002; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093167; Chen WG, 2019, CLIN EXP METASTAS, V36, P39, DOI 10.1007/s10585-018-9951-5; De la Garza Maria Miguelina, 2018, Oncotarget, V9, P32972, DOI 10.18632/oncotarget.26030; Dellazizzo L, 2019, J NEUROSURG, V131, P1639, DOI 10.3171/2018.5.JNS18651; ENJETI S, 1982, J APPL PHYSIOL, V52, P647, DOI 10.1152/jappl.1982.52.3.647; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Guo L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/232791; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Hua Q, 2020, THERANOSTICS, V10, P4762, DOI 10.7150/thno.43839; Ladha K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3646; Marini JJ, 2019, CHEST, V155, P1049, DOI 10.1016/j.chest.2018.11.014; Messing BP, 2017, DYSPHAGIA, V32, P487, DOI 10.1007/s00455-017-9790-6; Pandian V, 2019, AM J CRIT CARE, V28, P56, DOI 10.4037/ajcc2019883; Peroni D G, 2000, Paediatr Respir Rev, V1, P274, DOI 10.1053/prrv.2000.0059; Qin JQ, 2018, J THORAC DIS, V10, DOI 10.21037/jtd.2018.07.47; Schindler MB, 2005, CRIT CARE, V9, P341, DOI 10.1186/cc3766; Steele CM, 2015, DYSPHAGIA, V30, P2, DOI 10.1007/s00455-014-9578-x; Umemoto G, 2020, INTERNAL MED, V59, P7, DOI 10.2169/internalmedicine.2373-18; Wettervik TS, 2020, WORLD NEUROSURG, V133, pE567, DOI 10.1016/j.wneu.2019.09.099; Wohlkoenig C, 2017, LUNG CANCER, V111, P15, DOI 10.1016/j.lungcan.2017.06.013; Zhang XL, 2017, ONCOL LETT, V14, P2677, DOI 10.3892/ol.2017.6479; Zhou F, 2017, MOL CELL BIOCHEM, V428, P171, DOI 10.1007/s11010-016-2927-3	26	0	0	2	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	MAY	2021	10	5					5425	5432		10.21037/apm-21-790			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	SL9PG	WOS:000657245600043	33977755	gold			2022-02-07	
J	Xue, K; Jin, Z; Zhang, BB; Han, GQ; Zhang, C				Xue, Kai; Jin, Zheng; Zhang, Binbin; Han, Guoqing; Zhang, Chen			Effects of Recombinant Human Erythropoietin on Inflammatory Factors in Rats with Traumatic Brain Injury	INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						Recombinant human erythropoietin; traumatic brain injury; inflammatory response; mitochondrial injury	MITOCHONDRIAL DYNAMICS	To study the effects of recombinant human erythropoietin on inflammatory factors in rats with traumatic brain injury is the main objective. A total of 45 specific-pathogen-free grade male Sprague-Dawley rats were randomly assigned into sham operation group (sham group), model group and recombinant human erythropoietin intervention group (treatment group) (n=15). Model and treatment groups were prepared into traumatic brain injury model by hitting the head through the modified Feeney's free-fall impact method, while the head of sham group was not hit. After modeling, treatment group was intraperitoneally injected with recombinant human erythropoietin at 5000 IU/kg daily and sham and model groups were intraperitoneally injected with the same dose of normal saline. The rats were killed after 7 d of continuous administration. The changes of brain mitochondrial membrane potential were detected through rhodamine 123 staining and immunocytochemistry and Western blotting were separately employed to measure the expressions of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in brain tissues and the expression levels of dynamin-related protein 1, fission 1, mitofusin 2 and optic atrophy 1, mitochondrial dynamics related proteins in brain tissues. Compared with sham group, model group exhibited significantly weakened rhodamine 123 fluorescence intensity, increased expressions of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha, dynamin-related protein 1 and fission 1 and reduced expressions of mitofusin 2 and optic atrophy 1 in brain tissues (p<0.05). In comparison with model group, treatment group had significantly enhanced rhodamine 123 fluorescence intensity, reduced expressions of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha, dynamin-related protein 1 and fission 1 and elevated expressions of mitofusin 2 and optic atrophy 1 in brain tissues (p<0.05). Recombinant human erythropoietin can protect the brain after traumatic brain injury by relieving the inflammatory response and mitochondrial injury after traumatic brain injury.	[Xue, Kai; Jin, Zheng; Zhang, Binbin; Han, Guoqing; Zhang, Chen] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300350, Peoples R China		Xue, K (corresponding author), Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300350, Peoples R China.	766364170@qq.com			Tianjin health and Health Committee Science and Technology Project [QN20009]	This study was financially supported by Tianjin health and Health Committee Science and Technology Project (No. QN20009).	Bai XF, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009532; Blixt J, 2018, J NEUROTRAUM, V35, P671, DOI 10.1089/neu.2017.5015; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Evans LP, 2018, ANN CLIN TRANSL NEUR, V5, P240, DOI 10.1002/acn3.523; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Metcalf K, 2020, APPL NEUROPSYCH-ADUL, V27, P421, DOI 10.1080/23279095.2018.1559166; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087; Vestergaard MB, 2018, J APPL PHYSIOL, V124, P1107, DOI 10.1152/japplphysiol.00869.2017; Wang H, 2018, BONE, V106, P126, DOI 10.1016/j.bone.2017.10.010; Yang YK, 2017, NEUROREPORT, V28, P1232, DOI 10.1097/WNR.0000000000000901	16	0	0	1	1	INDIAN PHARMACEUTICAL ASSOC	MUMBAI	KALINA, SANTA CRUZ EAST, MUMBAI, 00000, INDIA	0250-474X	1998-3743		INDIAN J PHARM SCI	Indian J. Pharm. Sci.	MAY-JUN	2021	83	3					541	546		10.36468/pharmaceutical-sciences.803			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TM0AB	WOS:000675215900015		Bronze			2022-02-07	
J	Yang, T; Mudabbar, MS; Fu, Q; Liu, B				Yang, Ting; Mudabbar, Muhammad Saqib; Fu, Qiang; Liu, Bin			Anesthetic management for tracheal stent removal with severe scar stenosis	ANAESTHESIA PAIN & INTENSIVE CARE			English	Article						Dyspnea; Bronchoscopy; Tracheal intubation; Mechanical ventilation		A 28-year-old patient, ASA Grade II, was admitted to the hospital with dyspnea for the last few months. Upon bro choscopy, tracheal stenosis was observed and the symptoms were temporarily relieved by balloon dilation. The patient was then given argon knife treatment and the bronchial lesions were resected through a bronchoscope. Then two tracheal stents were placed to relieve the symptoms of dyspnea which too failed and had to be removed. Since the patient had a history of traumatic brain injury more than a year ago and underwent tracheal intubation, tracheostomy, invasive ventilator ventilation, and extubation after the condition improved. Stent removal had significant anesthetic challenges due to the small size of the lumen. After going through a few anesthesia plans, a high-frequency jet ventilator was used to maintain oxygen saturation. The procedure was successful and the patient showed a good prognosis.	[Yang, Ting; Fu, Qiang] Southwest JiaoTong Univ, Peoples Hosp Chengdu 3, Dept Anesthesiol, 82 Qinglong St, Chengdu 610031, Sichuan, Peoples R China; [Mudabbar, Muhammad Saqib] Southwest Med Univ, Dept Cardiovasc Med, Luzhou City, Sichuan, Peoples R China; [Liu, Bin] Sichuan Univ, West China Hosp, Dept Anesthesiol, 37 Guoxue Alley, Chengdu, Sichuan, Peoples R China		Yang, T (corresponding author), Southwest JiaoTong Univ, Peoples Hosp Chengdu 3, Dept Anesthesiol, 82 Qinglong St, Chengdu 610031, Sichuan, Peoples R China.	365417706@qq.com					Berard D, 2021, J MECH BEHAV BIOMED, V114, DOI 10.1016/j.jmbbm.2020.104211; [苌恩强 Chang Enqiang], 2019, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V39, P1311; Chen Ning, 2005, STANFORD CLIN ANESTH, P215; COTTON RT, 1984, J PEDIATR SURG, V19, P699, DOI 10.1016/S0022-3468(84)80355-3; Gottlieb J, 2009, EUR RESPIR J, V34, P1417, DOI 10.1183/09031936.00041909; Hirshoren N, 2009, HEAD NECK-J SCI SPEC, V31, P111, DOI 10.1002/hed.20925; Li Yi, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P454; Lorenz Robert R, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P467, DOI 10.1097/00020840-200312000-00011; Lunn W, 2005, CHEST, V127, P2106, DOI 10.1378/chest.127.6.2106; Noppen M, 2005, CHEST, V127, P482, DOI 10.1378/chest.127.2.482; ONEILL JA, 1984, J PEDIATR SURG, V19, P235, DOI 10.1016/S0022-3468(84)80176-1; Potter J, 2021, BRIT J ORAL MAX SURG, V59, P82, DOI 10.1016/j.bjoms.2020.08.036; Sanivarapu RR, 2021, STATPEARLS	13	0	0	0	0	ANAESTHESIA PAIN & INTENSIVE CARE	ISLAMABAD	C/O TARIQ HAYAT KHAN, ED, 60-A, NAZIM-UD-DIN RD, ISLAMABAD, 00000, PAKISTAN	1607-8322	2220-5799		ANAESTH PAIN INTENSI	Anaesth. Pain Intensive Care	MAY-JUN	2021	25	3					391	+		10.35975/apic.v25i3.1521			5	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	SP8VU	WOS:000659942300021					2022-02-07	
J	Zhang, DF; Tarabochia, M; von Keudell, A				Zhang, Dafang; Tarabochia, Matthew; von Keudell, Arvind			Association of trauma severity scores with limb amputation and death in acute leg compartment syndrome	EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY			English	Article						Cute compartment syndrome; Injury severity score; Revised trauma score; Glasgow coma scale; Fasciotomy; Leg		Purpose Limb amputation and death are devastating sequelae of acute compartment syndrome (ACS), and have been posited to result either from the initial injury burden or from pathophysiologic sequelae, such as rhabdomyolysis leading to acute renal failure. We aimed to test the hypothesis that severity of trauma is associated with limb amputation and death in patients with traumatic leg ACS. Methods We retrospectively reviewed 302 patients with ACS of 302 legs treated with fasciotomies from 2000 to 2015 at two tertiary trauma centers. Our response variables were death and limb amputation during inpatient hospital admission. Three common trauma severity scores, injury severity score (ISS), revised trauma score (RTS), and Glasgow coma scale (GCS), were studied. Patient- and injury-related explanatory variables were studied. Bivariate analyses were used to identify factors associated with limb amputation and death. Results Of 302 patients, 13 (4%) underwent limb amputation and 10 (3%) died during the inpatient admission. Only one of 10 patients who expired died secondary to acute renal failure. ISS and GCS were significantly associated with limb amputation, and RTS was marginally associated. ISS, RTS, and GCS were significantly associated with death. Moreover, smoking and open fracture were significantly associated with limb amputation, and diabetes mellitus, presence of fracture, closed head injury, and chest or abdominal injury were associated with death. Conclusion Trauma severity scores are associated with both limb amputation and death during inpatient admission for traumatic leg ACS. These adverse sequelae of leg ACS are likely driven by the initial injury burden.	[Zhang, Dafang; von Keudell, Arvind] Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA; [Zhang, Dafang; Tarabochia, Matthew; von Keudell, Arvind] Harvard Med Sch, Boston, MA 02115 USA; [Tarabochia, Matthew] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA		Zhang, DF (corresponding author), Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA.; Zhang, DF (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	dzhang9@partners.org		Zhang, Dafang/0000-0003-0155-8244			Anderson JJ, 2012, DIABET FOOT ANKLE, V3, DOI 10.3402/dfa.v3i0.19178; Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Better OS, 1997, RENAL FAILURE, V19, P647, DOI 10.3109/08860229709109030; Bodansky D, 2018, INJURY, V49, P1699, DOI 10.1016/j.injury.2018.04.020; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chatzizisis YS, 2008, EUR J INTERN MED, V19, P568, DOI 10.1016/j.ejim.2007.06.037; Jensen SL, 1997, EUR J VASC ENDOVASC, V13, P48, DOI 10.1016/S1078-5884(97)80050-0; McQueen MM, 2000, J BONE JOINT SURG BR, V82B, P200, DOI 10.1302/0301-620X.82B2.9799; Mortensen SJ, 2020, INJURY, V51, P522, DOI 10.1016/j.injury.2019.11.022; RORABECK CH, 1984, J BONE JOINT SURG BR, V66, P93, DOI 10.1302/0301-620X.66B1.6693486; RUSH DS, 1989, J VASC SURG, V10, P343, DOI 10.1067/mva.1989.14338; TEASDALE G, 1974, LANCET, V2, P81; Turel M, 2008, NATL MED J INDIA, V21, P284; von Keudell AG, 2015, LANCET, V386, P1299, DOI 10.1016/S0140-6736(15)00277-9; Zhang D., 2019, HAND N Y, DOI [10.1177/1558944719884662, DOI 10.1177/1558944719884662]; Zhang DF, 2020, EUR J ORTHOP SURG TR, V30, P1089, DOI 10.1007/s00590-020-02662-x; Zhang DF, 2020, EUR J ORTHOP SURG TR, V30, P359, DOI 10.1007/s00590-019-02563-8; Zimmerman JL, 2013, CHEST, V144, P1058, DOI 10.1378/chest.12-2016	19	0	0	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1633-8065	1432-1068		EUR J ORTHOP SURG TR	Eur. J. Orthop. Surg. Traumatol.	MAY	2021	31	4					621	625		10.1007/s00590-020-02818-9			5	Orthopedics; Surgery	Emerging Sources Citation Index (ESCI)	Orthopedics; Surgery	SK8CN	WOS:000656443100003	33098005				2022-02-07	
J	Zhang, WH; Wu, HH; Zhang, SX; Zhang, HJ; Xue, CL; Li, GJ; Liu, JC; Liu, GZ				Zhang, Wanhong; Wu, Henghao; Zhang, Shengxu; Zhang, Haijun; Xue, Changli; Li, Gejun; Liu, Junchao; Liu, Guanzheng			Can S100B Predict and Evaluate Post-Traumatic Hydrocephalus	WORLD NEUROSURGERY			English	Article						Intracranial pressure; Post-traumatic hydrocephalus; S100B protein; Severity of hydrocephalus	NORMAL-PRESSURE HYDROCEPHALUS; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; PROGNOSTIC VALUE; SERUM MARKER; PROTEIN; RELIABILITY; BIOMARKERS; S-100B; DAMAGE	OBJECTIVE: Post-traumatic hydrocephalus (PTH) is a common complication of craniocerebral injury. If not diagnosed in time, PTH can lead to clinical deterioration and a poor prognosis. The early diagnosis of PTH can lead to success with early treatment. However, PTH can be easily ignored during rehabilitation. The main purpose of the present study was to investigate whether plasma S100B protein levels can be used as a biochemical predictive index of PTH. We also explored the correlation among S100B protein levels, intracranial pressure, and PTH severity. -METHODS: The data from 235 patients with traumatic brain injury treated from June 2014 to June 2019 in our hospital were retrospectively analyzed. Statistical analysis was performed on 3 serum S100B samples from each patient. The first sample was taken 1-3 days after the injury and surgery. The second sample was harvested during the stable period after treatment, and the third sample was taken when PTH had been confirmed by computed tomography. We analyzed the change in S100B protein levels, and intracranial pressure was measured by lumbar puncture. -RESULTS: A total of 235 patients (Glasgow coma scale score <12) with traumatic brain injury were investigated. Of these 235 patients, 46 (19%) had developed PTH. The first and second S100B samples showed no significant differences between the patients with and without PTH. In the third sample, the S100B level of the patients with PTH was significantly greater than that of the patients without PTH, with a statistically significant difference. Statistical analysis found no correlation between the S100B level and the severity of PTH. -CONCLUSIONS: Measurements of serum S100B can be used to predict for PTH. We found a positive correlation between S100B levels and intracranial pressure but no correlation with the severity of PTH. Thus, serum S100B could have important clinical significance for the early detection and evaluation of PTH.	[Zhang, Wanhong; Wu, Henghao; Zhang, Shengxu; Zhang, Haijun; Xue, Changli; Li, Gejun; Liu, Junchao; Liu, Guanzheng] Kaifeng Cent Hosp, Dept Neurosurg, Kaifeng, Peoples R China		Liu, GZ (corresponding author), Kaifeng Cent Hosp, Dept Neurosurg, Kaifeng, Peoples R China.	564681993@qq.com			Science Development Project Foundation of Kaifeng,Henan, China [1503020]	The research was supported by Science Development Project Foundation of Kaifeng,Henan, China (No. 1503020).	Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Hendoui N, 2013, EUR REV MED PHARMACO, V17, P477; Ishikawa M, 2008, NEUROL MED-CHIR, V48, pS1, DOI 10.2176/nmc.48.S1; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Low CYD, 2013, J CLIN NEUROSCI, V20, P867, DOI 10.1016/j.jocn.2012.06.007; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Park SH, 2018, WORLD NEUROSURG, V118, pE534, DOI 10.1016/j.wneu.2018.06.234; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Rezaii PG, 2019, J NEUROTRAUM, V36, P2407, DOI 10.1089/neu.2018.6053; Rohlwink UK, 2014, CLIN CHEM, V60, P823, DOI 10.1373/clinchem.2013.212472; Tarnaris A, 2009, J NEUROSURG, V110, P837, DOI 10.3171/2007.9.17572; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Tribl G, 2000, BRAIN INJURY, V14, P345; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026	19	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E931	E934		10.1016/j.wneu.2021.01.075			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RV1RZ	WOS:000645619300026	33508492				2022-02-07	
J	Zhuang, YK; Wang, WH; Chen, L; Lu, W; Xu, M				Zhuang, Yaokun; Wang, Wenhua; Chen, Long; Lu, Wei; Xu, Min			Serum apelin-13 and risk of death following severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Apelin-13; Severity; Mortality		Background: Apelin-13 can be expressed in brain tissue and exert neuroprotective effects. We attempted to determine whether serum apelin-13 is a prognostic biomarker for severe traumatic brain injury (sTBI). Methods: Of 126 sTBI patients and 126 healthy controls, serum apelin-13 concentrations were quantified using ELISA. The trauma severity was assessed by Glasgow coma scale scores and Rotterdam computerized tomography scores. The relationship between serum apelin-13 concentrations and posttraumatic 30-day mortality was assessed using multivariate analysis. Results: Serum apelin-13 concentrations were significantly lower in patients than in controls. Serum apelin-13 concentrations of non-surviving and surviving patients within posttraumatic 30 days were strongly correlated with Glasgow coma scale scores and Rotterdam computerized tomography scores. Serum apelin-13 emerged as an independent predictor for 30-day mortality and overall survival. There was a significant discriminatory capability with respect to serum apelin-13 concentrations for the risk of 30-day death. Moreover, its prognostic predictive ability was similar to those of Glasgow coma scale scores and Rotterdam computerized tomography scores. Conclusions: Declined serum apelin-13 concentrations, in substantial correlation with increasing severity, are independently associated with short-term mortality, hinting than serum apelin-13 might represent a useful prognostic biomarker for sTBI.	[Zhuang, Yaokun] Zhejiang Chinese Med Univ, Clin Med Coll 4, Hangzhou 310053, Zhejiang, Peoples R China; [Wang, Wenhua; Chen, Long; Lu, Wei; Xu, Min] Nanjing Univ Chinese Med, Kunshan Affiliated Hosp, Kunshan Hosp Tradit Chinese Med, Dept Neurosurg, Kunshan 215300, Jiangsu, Peoples R China		Xu, M (corresponding author), Nanjing Univ Chinese Med, Kunshan Affiliated Hosp, Kunshan Hosp Tradit Chinese Med, Dept Neurosurg, Kunshan 215300, Jiangsu, Peoples R China.	xumin7788@126.com					Bao HJ, 2015, NEUROCHEM RES, V40, P89, DOI 10.1007/s11064-014-1469-x; Bao HJ, 2016, NEUROSCI LETT, V628, P219, DOI 10.1016/j.neulet.2016.06.046; Chu HL, 2017, CEREBROVASC DIS, V44, P10, DOI 10.1159/000460261; Duan JL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1406-7; Kalantaripour TP, 2016, BIOMED PHARMACOTHER, V84, P258, DOI 10.1016/j.biopha.2016.09.048; Khaksari M, 2012, J MOL NEUROSCI, V48, P201, DOI 10.1007/s12031-012-9808-3; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Liu Y, 2019, BIOCHEM BIOPH RES CO, V513, P105, DOI 10.1016/j.bbrc.2019.03.151; Masoumi J, 2018, NEUROPEPTIDES, V70, P76, DOI 10.1016/j.npep.2018.05.008; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Saint-Geniez M, 2002, MECH DEVELOP, V110, P183, DOI 10.1016/S0925-4773(01)00558-5; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang X, 2020, TRANSL STROKE RES, V11, P700, DOI 10.1007/s12975-019-00769-w; Waqas M, 2016, BRIT J NEUROSURG, V30, P258, DOI 10.3109/02688697.2016.1139047; Williams OH, 2015, J NEUROL, V262, P1394, DOI 10.1007/s00415-015-7741-4; Xu WL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1620-3; Xu WL, 2018, NEUROSCIENCE, V388, P284, DOI 10.1016/j.neuroscience.2018.07.023	19	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	MAY	2021	516						64	68		10.1016/j.cca.2021.01.014			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	RA2OO	WOS:000631257500008	33508251				2022-02-07	
J	de la Cruz, SH; Rocha, L; Santiago-Castaneda, C; Sanchez-Lopez, A; Pinedo-Rodriguez, AD; Medina-Terol, GJ; Centurion, D				Huerta de la Cruz, Saul; Rocha, Luisa; Santiago-Castaneda, Cindy; Sanchez-Lopez, Araceli; Pinedo-Rodriguez, Alma D.; Medina-Terol, Grecia J.; Centurion, David			Hydrogen Sulfide Subchronic Treatment Improves Hypertension Induced by Traumatic Brain Injury in Rats through Vasopressor Sympathetic Outflow Inhibition	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						cardiovascular; hydrogen sulfide; sensorimotor function; sympathetic system; traumatic brain injury	HEART-RATE-VARIABILITY; NITRIC-OXIDE; OXIDATIVE STRESS; MODEL; H2S; DEXMEDETOMIDINE; HYPERACTIVITY; AUTOPHAGY; RESPONSES; SEVERITY	Traumatic brain injury (TBI) represents a critical public health problem around the world. To date, there are no accurate therapeutic approaches for the management of cardiovascular impairments induce by TBI. In this regard, hydrogen sulfide (H2S), a novel gasotransmitter, has been proposed as a neuro- and cardioprotective molecule. This study was designed to determine the effect of subchronic management with sodium hydrosulfide (NaHS) on hemodynamic, vasopressor sympathetic outflow and sensorimotor alterations produced by TBI. Animals underwent a lateral fluid percussion injury, and changes in hemodynamic variables were measured by pletismographic methods. In addition, vasopressor sympathetic outflow was assessed by a pithed rat model. Last, sensorimotor impairments were evaluated by neuroscore test and beam-walking test. At seven, 14, 21, and 28 days after moderate-severe TBI, the animals showed: (1) a decrease on sensorimotor function in the neuroscore test and beam-walking test; (2) an increase in heart rate, systolic, diastolic, and mean blood pressure; (3) progressive sympathetic hyperactivity; and (4) a decrease in vasopressor responses induced by noradrenaline (alpha(1/2)-adrenoceptors agonist) and UK 14,304 (selective alpha(2)-adrenoceptor agonist). Interestingly, intraperitoneal daily injections of NaHS, an H2S donor (3.1 and 5.6 mg/kg), during seven days after TBI prevented the development of the impairments in hemodynamic variables, which were similar to those obtained in sham animals. Moreover, NaHS treatment prevented the sympathetic hyperactivity and decreased noradrenaline-induced vasopressor responses. No effects on sensorimotor dysfunction were observed, however. Taken together, our results suggest that H2S ameliorates the hemodynamic and sympathetic system impairments observed after TBI.	[Huerta de la Cruz, Saul; Rocha, Luisa; Santiago-Castaneda, Cindy; Sanchez-Lopez, Araceli; Pinedo-Rodriguez, Alma D.; Medina-Terol, Grecia J.; Centurion, David] Cinvestav Coapa, Dept Farmacobiol, Czda Tenorios 235, Mexico City 14330, DF, Mexico		Centurion, D (corresponding author), Cinvestav Coapa, Dept Farmacobiol, Czda Tenorios 235, Mexico City 14330, DF, Mexico.	dcenturi@cinvestav.mx	Centurion, David/A-4507-2008	Centurion, David/0000-0003-4030-8491; Huerta de la Cruz, Saul/0000-0002-5968-9506	National Council for Science and Technology (CONACyT)Consejo Nacional de Ciencia y Tecnologia (CONACyT) [252702]	The National Council for Science and Technology (CONACyT) supported this study (Grant No. 252702).	An CR, 2016, TRANSL STROKE RES, V7, P512, DOI 10.1007/s12975-016-0483-5; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Borroto-Escuela DO, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00037; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Centurion D., 2009, MODELS NEUROPHARMACO, P91; Centurion D, 2018, EUR J PHARMACOL, V823, P35, DOI 10.1016/j.ejphar.2018.01.030; Centurion D, 2016, EUR J PHARMACOL, V770, P40, DOI 10.1016/j.ejphar.2015.11.057; Che XR, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00392; Chen JG, 2019, EUR J NEUROSCI, V50, P1972, DOI 10.1111/ejn.14374; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dominguez-Rodriguez M, 2017, FRONT PHARMACOL, V8, P1, DOI 10.3389/fphar.2017.00522; Duan XC, 2015, AM J HYPERTENS, V28, P1106, DOI 10.1093/ajh/hpu299; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Frieden T.R., 2015, CDC NIH REP C, P1, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; GILLESPIE JS, 1967, BRIT J PHARM CHEMOTH, V30, P78, DOI 10.1111/j.1476-5381.1967.tb02114.x; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gomez CB, 2019, EUR J PHARMACOL, V863, DOI 10.1016/j.ejphar.2019.172707; GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105; Guo Q, 2016, PHYSIOL RES, V65, P413, DOI 10.33549/physiolres.933050; Guo Q, 2011, J PHARMACOL EXP THER, V338, P458, DOI 10.1124/jpet.111.180711; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hilz MJ, 2017, J NEUROL, V264, P1956, DOI 10.1007/s00415-017-8581-1; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Huang P, 2015, NITRIC OXIDE-BIOL CH, V46, P192, DOI 10.1016/j.niox.2015.01.004; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Karimi SA, 2017, BRAIN RES BULL, V134, P177, DOI 10.1016/j.brainresbull.2017.07.014; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khademullah CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064495; Kimura H., 2012, GASOTRANSMITTERS PHY, P71, DOI [10.1007/978-3-642-30338-8_3., DOI 10.1007/978-3-642-30338-8_3]; KLEINMAN LI, 1964, J APPL PHYSIOL, V19, P360, DOI 10.1152/jappl.1964.19.2.360; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; LEVIN BE, 1994, RESTOR NEUROL NEUROS, V7, P5, DOI 10.3233/RNN-1994-7102; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Malik R, 2016, BRAIN RES, V1633, P1, DOI 10.1016/j.brainres.2015.12.029; McCorry LK, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710478; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Meng GL, 2018, BRIT J PHARMACOL, V175, P1146, DOI 10.1111/bph.13825; National Research Council of the National Academies, 2011, GUIDE CARE USE LAB A, V8th; Ndode-Ekane XE, 2019, EPILEPSY RES, V151, P7, DOI 10.1016/j.eplepsyres.2019.01.006; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Nyam TTE, 2019, WORLD NEUROSURG, V122, pE740, DOI 10.1016/j.wneu.2018.10.130; O'Bryant AJ, 2011, BEHAV BRAIN RES, V224, P112, DOI 10.1016/j.bbr.2011.05.028; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Panthi S, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0108-x; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Ruiz-Salinas I, 2016, BASIC CLIN PHARMACOL, V119, P165, DOI 10.1111/bcpt.12556; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Sun GC, 2015, BRIT J PHARMACOL, V172, P2507, DOI 10.1111/bph.13074; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Umemoto Y, 2019, EUR J PHARMACOL, V848, P121, DOI 10.1016/j.ejphar.2019.01.035; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23003-3; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang JY, 2017, MED GAS RES, V7, P113, DOI 10.4103/2045-9912.208517; Zhang MY, 2017, CELL MOL NEUROBIOL, V37, P291, DOI 10.1007/s10571-016-0369-9; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhong GZ, 2003, J HYPERTENS, V21, P1879, DOI 10.1097/00004872-200310000-00015; Ziolkowski N, 2010, CAN J PHYSIOL PHARM, V88, P220, DOI 10.1139/Y10-013	73	0	0	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7552		APR 2021	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RW8TW	WOS:000646793300001	33626966				2022-02-07	
J	Rauch, S; Marzolo, M; Cappello, TD; Strohle, M; Mair, P; Pietsch, U; Brugger, H; Strapazzon, G				Rauch, Simon; Marzolo, Matilde; Cappello, Tomas Dal; Strohle, Mathias; Mair, Peter; Pietsch, Urs; Brugger, Hermann; Strapazzon, Giacomo		IATR Study grp	Severe traumatic brain injury and hypotension is a frequent and lethal combination in multiple trauma patients in mountain areas - an analysis of the prospective international Alpine Trauma Registry	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; Traumatic brain injury; Hypotension; Shock; Mountain rescue	LIFE-SUPPORT; HEAD-INJURY; RESCUE; RESUSCITATION; MANAGEMENT; GUIDELINES; PHYSICIANS; MORTALITY; INSULTS; SYSTEMS	Background Hypotension is associated with worse outcome in patients with traumatic brain injury (TBI) and maintaining a systolic blood pressure (SBP) >= 110 mmHg is recommended. The aim of this study was to assess the incidence of TBI in patients suffering multiple trauma in mountain areas; to describe associated factors, treatment and outcome compared to non-hypotensive patients with TBI and patients without TBI; and to evaluate pre-hospital variables to predict admission hypotension. Methods Data from the prospective International Alpine Trauma Registry including mountain multiple trauma patients (ISS >= 16) collected between 2010 and 2019 were analysed. Patients were divided into three groups: 1) TBI with hypotension, 2) TBI without hypotension and 3) no TBI. TBI was defined as Abbreviated Injury Scale (AIS) of the head/neck >= 3 and hypotension as SBP < 110 mmHg on hospital arrival. Results A total of 287 patients were included. Fifty (17%) had TBI and hypotension, 92 (32%) suffered TBI without hypotension and 145 (51%) patients did not have TBI. Patients in group 1 were more severely injured (mean ISS 43.1 +/- 17.4 vs 33.3 +/- 15.3 vs 26.2 +/- 18.1 for group 1 vs 2 vs 3, respectively, p < 0.001). Mean SBP on hospital arrival was 83.1 +/- 12.9 vs 132.5 +/- 19.4 vs 119.4 +/- 25.8 mmHg (p < 0.001) despite patients in group 1 received more fluids. Patients in group 1 had higher INR, lower haemoglobin and lower base excess (p < 0.001). More than one third of patients in group 1 and 2 were hypothermic (body temperature < 35 degrees C) on hospital arrival while the rate of admission hypothermia was low in patients without TBI (41% vs 35% vs 21%, for group 1 vs 2 vs 3, p = 0.029). The rate of hypothermia on hospital arrival was different between the groups (p = 0.029). Patients in group 1 had the highest mortality (24% vs 10% vs 1%, p < 0.001). Conclusion Multiple trauma in the mountains goes along with severe TBI in almost 50%. One third of patients with TBI is hypotensive on hospital arrival and this is associated with a worse outcome. No single variable or set of variables easily obtainable at scene was able to predict admission hypotension in TBI patients.	[Rauch, Simon; Marzolo, Matilde; Cappello, Tomas Dal; Brugger, Hermann; Strapazzon, Giacomo] Eurac Res, Inst Mt Emergency Med, Bolzano, Italy; [Rauch, Simon] Hosp Merano, Dept Anaesthesiol & Intens Care, Merano, Italy; [Strohle, Mathias; Mair, Peter] Univ Hosp Innsbruck, Dept Anaesthesiol & Intens Care, Innsbruck, Austria; [Pietsch, Urs] St Gallen Hosp, Dept Anaesthesiol & Intens Care, St Gallen, Switzerland; [Pietsch, Urs] Swiss Air Rescue Rega, Zurich, Switzerland		Rauch, S (corresponding author), Eurac Res, Inst Mt Emergency Med, Bolzano, Italy.; Rauch, S (corresponding author), Hosp Merano, Dept Anaesthesiol & Intens Care, Merano, Italy.	simon.rauch@eurac.edu		Strohle, Mathias/0000-0002-6623-7823; Gasteiger, Lukas/0000-0002-4659-9114; Rauch, Simon/0000-0002-3264-6303			Atkinson Beth, 2019, CRAN; Ausserer J, 2017, INJURY, V48, P20, DOI 10.1016/j.injury.2016.09.005; Balvers Kirsten, 2016, J Emerg Trauma Shock, V9, P97, DOI 10.4103/0974-2700.185276; Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Dick WF, 1999, RESUSCITATION, V42, P81, DOI 10.1016/S0300-9572(99)00102-1; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Glen J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3051; Gosteli G, 2016, INJURY, V47, P1414, DOI 10.1016/j.injury.2016.03.025; Gupta Babita, 2017, J Anaesthesiol Clin Pharmacol, V33, P3, DOI 10.4103/0970-9185.202185; Hamada SR, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2026-9; Hylands M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017559; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Krzywinksi M, 2017, NAT METHODS, V14, P757, DOI 10.1038/nmeth.4370; Kudo D, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0202-z; Lou XY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009966; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marsigny B, 1999, WILD ENVIRON MED, V10, P152, DOI 10.1580/1080-6032(1999)010[0152:MMRITM]2.3.CO;2; Pietsch U, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0598-2; R Core Team, 2021, R LANG ENV STAT COMP; Sessler DI, 2016, LANCET, V387, P2655, DOI 10.1016/S0140-6736(15)00981-2; Shackford SR, 2011, J TRAUMA, V70, pS32, DOI 10.1097/TA.0b013e31821a5858; Simon R, 2018, AM J EMERG MED, V36, P1749, DOI 10.1016/j.ajem.2018.01.068; Sims CA, 2019, JAMA SURG, V154, P994, DOI 10.1001/jamasurg.2019.2884; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Strapazzon G., 2013, RESUSCITATION, V84, pS96, DOI [10.1016/j.resuscitation.2013.08.245, DOI 10.1016/J.RESUSCITATION.2013.08.245]; Sumann G, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00790-1; Thole R Tucker, 2004, Curr Sports Med Rep, V3, P128; Timm A, 2014, INJURY, V45, pS43, DOI 10.1016/j.injury.2014.08.017; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Tran A, 2018, J TRAUMA ACUTE CARE, V84, P802, DOI 10.1097/TA.0000000000001816; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80	38	0	0	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 30	2021	29	1							61	10.1186/s13049-021-00879-1			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RV5XX	WOS:000645906500001	33931076	Green Published, gold			2022-02-07	
J	Shi, Y; Zhou, XQ; Yang, RH; Ying, SM; Wang, LC				Shi, Ying; Zhou, Xiaqing; Yang, Ruhui; Ying, Songmin; Wang, Lingcong			Panax notoginseng protects the rat brain function from traumatic brain injury by inhibiting autophagy via mammalian targeting of rapamycin	AGING-US			English	Article						traumatic brain injury; autophagy; mTOR signaling pathway; P. notoginseng		Traumatic brain injury (TBI) remains one of the leading causes of death and disability worldwide. Our previous studies have found that traditional Chinese medicine, Panax notoginseng (P. notoginseng) can reduce cerebral hemorrhage in rats with TBI. Yet, the exact mechanism still remains unclear. According to the random number table, 36 SD rats were randomly divided into six groups: Sham group (negative control group), Model group, PIK inhibitor group (positive group), P. notoginseng group (experimental group), Rapamycin group, and Panax notoginseng+Rapamycin group (experimental group). In the Model group (M group, the group showing signs of TBI without any treatment), the neural function defect score was significantly decreased, while sequestosome 1 (P62), Beclin 1, and microtubule-associated protein 1 light chain 3 (LC3-II) were significantly increased. The brain tissue was significantly damaged, and many autophagosomes were observed in the cytoplasm. Compared with the Model group and the Rapamycin group (M+Rapa group, the group showing signs of TBI with Rapamycin treatment), P62, Beclin 1, and LC3-II were significantly decreased, the score of neural function defect was significantly improved, and the brain tissue damage was significantly reduced in the PIK (phosphatidylinositol 3-kinase) inhibitor group (M+LY group, the group showing signs of TBI with PIK inhibitor treatment). Compared with the Model group, mTOR was decreased and LC3-II was increased; however, there were no significant changes in neural function defect score, HE staining, Nissl staining, and transmission electron microscopy in the Rapamycin group. Compared with the Model group, the neural function defect score at 72h was significantly improved, mTOR was significantly increased, P62, Beclin 1, and LC3-II significantly decreased, brain tissue damage was reduced in HE staining and Nissl staining, autophagosomes were reduced in cytoplasm by transmission electron microscopy in the P. notoginseng group (M+PN group, the group showing signs of TBI with P. notoginseng treatment). Also, there was no significant difference between P. notoginseng group and P. notoginseng+Rapamycin group (M+PN+Rapa group, the group showing signs of TBI with P. notoginseng+Rapamycin treatment). P. notoginseng protects the rat brain function from TBI by inhibiting autophagy through the mTOR signaling pathway and other autophagy pathways.	[Shi, Ying] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Intens Care Unit, Hangzhou, Peoples R China; [Zhou, Xiaqing] Zhejiang Chinese Med Univ, Hangzhou, Peoples R China; [Yang, Ruhui] Lishui Univ, Dept Pharmacol, Coll Med & Hlth, Lishui, Peoples R China; [Ying, Songmin] Zhejiang Univ, Dept Pharmacol, Sch Med, Hangzhou, Peoples R China; [Wang, Lingcong] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Intens Care Unit, Affiliated Rehabil Hosp 1, Hangzhou, Peoples R China		Wang, LC (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Intens Care Unit, Affiliated Rehabil Hosp 1, Hangzhou, Peoples R China.	wlc501@139.com			Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY17H290006]; Scientific research projects of Zhejiang Provincial Department of Education [Y202045214]; Zhejiang Provincial Program for the Cultivation of High Level Innovative Health Talents [2014-108]	This study was supported by grants from the Natural Science Foundation of Zhejiang Province (Grant no. LY17H290006) , the Scientific research projects of Zhejiang Provincial Department of Education (no. Y202045214) , Zhejiang Provincial Program for the Cultivation of High Level Innovative Health Talents (2014-108) .	[Anonymous], 2013, MMWR SURVEILL SUMM, V66, P1, DOI [10.15585/mmwr.ss6609a1, DOI 10.15585/MMWR.SS6609A1]; Galluzzi L, 2016, NAT REV NEUROSCI, V17, P467, DOI 10.1038/nrn.2016.51; Huang LQ, 2019, OPEN LIFE SCI, V14, P179, DOI 10.1515/biol-2019-0020; Jang T, 2021, J TRADIT CHIN MED, V41, P1; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wolf MS, 2019, NEUROBIOL DIS, V122, P9, DOI 10.1016/j.nbd.2018.04.018; Wu JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070693; Xu DY, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00274; Yrjanheikki J, 2005, BRAIN RES, V1052, P174, DOI 10.1016/j.brainres.2005.06.004; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zheng QW, 2011, CIRC RES, V109, P296, DOI 10.1161/CIRCRESAHA.111.244707; Zhu C, 2021, J TRADIT CHIN MED, V41, P1	16	0	0	1	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	APR 30	2021	13	8					11207	11217					11	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	RW1CE	WOS:000646260200002	33819197	gold, Green Published			2022-02-07	
J	Wang, R; Chu, CY; Wei, ZL; Chen, L; Xu, JD; Liang, YJ; Janowski, M; Stevens, RD; Walczak, P				Wang, Rui; Chu, Chengyan; Wei, Zhiliang; Chen, Lin; Xu, Jiadi; Liang, Yajie; Janowski, Miroslaw; Stevens, Robert D.; Walczak, Piotr			Traumatic brain injury does not disrupt costimulatory blockade-induced immunological tolerance to glial-restricted progenitor allografts	JOURNAL OF NEUROINFLAMMATION			English	Article						Glial-restricted progenitors; Co-stimulation blockade; Immunological tolerance; Traumatic brain injury; Neuroinflammation	IMMUNE-RESPONSE; MOUSE; MODEL; IMMUNOSUPPRESSION; NEUROINFLAMMATION; TRANSPLANTATION; NEUROGENESIS; RESCUE; TISSUE; CELLS	Background Cell transplantation-based treatments for neurological disease are promising, yet graft rejection remains a major barrier to successful regenerative therapies. Our group and others have shown that long-lasting tolerance of transplanted stem cells can be achieved in the brain with systemic application of monoclonal antibodies blocking co-stimulation signaling. However, it is unknown if subsequent injury and the blood-brain barrier breach could expose the transplanted cells to systemic immune system spurring fulminant rejection and fatal encephalitis. Therefore, we investigated whether delayed traumatic brain injury (TBI) could trigger graft rejection. Methods Glial-restricted precursor cells (GRPs) were intracerebroventricularly transplanted in immunocompetent neonatal mice and co-stimulation blockade (CoB) was applied 0, 2, 4, and 6 days post-grafting. Bioluminescence imaging (BLI) was performed to monitor the grafted cell survival. Mice were subjected to TBI 12 weeks post-transplantation. MRI and open-field test were performed to assess the brain damage and behavioral change, respectively. The animals were decapitated at week 16 post-transplantation, and the brains were harvested. The survival and distribution of grafted cells were verified from brain sections. Hematoxylin and eosin staining (HE) was performed to observe TBI-induced brain legion, and neuroinflammation was evaluated immunohistochemically. Results BLI showed that grafted GRPs were rejected within 4 weeks after transplantation without CoB, while CoB administration resulted in long-term survival of allografts. BLI signal had a steep rise following TBI and subsequently declined but remained higher than the preinjury level. Open-field test showed TBI-induced anxiety for all animals but neither CoB nor GRP transplantation intensified the symptom. HE and MRI demonstrated a reduction in TBI-induced lesion volume in GRP-transplanted mice compared with non-transplanted mice. Brain sections further validated the survival of grafted GRPs and showed more GRPs surrounding the injured tissue. Furthermore, the brains of post-TBI shiverer mice had increased activation of microglia and astrocytes compared to post-TBI wildtype mice, but infiltration of CD45+ leukocytes remained low. Conclusions CoB induces sustained immunological tolerance towards allografted cerebral GRPs which is not disrupted following TBI, and unexpectedly TBI may enhance GRPs engraftment and contribute to post-injury brain tissue repair.	[Wang, Rui; Chu, Chengyan; Wei, Zhiliang; Chen, Lin; Xu, Jiadi] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA; [Wang, Rui; Stevens, Robert D.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Wang, Rui; Stevens, Robert D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; [Wang, Rui; Stevens, Robert D.] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21287 USA; [Wang, Rui] China Med Univ, Dept Crit Care Med, Shengjing Hosp, Shenyang 110006, Peoples R China; [Chu, Chengyan; Liang, Yajie; Janowski, Miroslaw; Walczak, Piotr] Univ Maryland Baltimore, Diagnost Radiol & Nucl Med, 670 W Baltimore St,HSF III Rm 1176, Baltimore, MD 21201 USA; [Wei, Zhiliang; Chen, Lin; Xu, Jiadi] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA		Walczak, P (corresponding author), Univ Maryland Baltimore, Diagnost Radiol & Nucl Med, 670 W Baltimore St,HSF III Rm 1176, Baltimore, MD 21201 USA.	pwalczak@som.umaryland.edu	Chen, Lin/X-7492-2019	Chen, Lin/0000-0003-0108-4309; Janowski, Miroslaw/0000-0001-5261-7975; Walczak, Piotr/0000-0002-3733-3322	 [2017-MSCRFF-3942];  [2019-MSCRFF-5031]	This work was supported by 2017-MSCRFF-3942 and 2019-MSCRFF-5031.	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Chu CY, 2020, INT J RADIAT ONCOL, V108, P745, DOI 10.1016/j.ijrobp.2020.05.027; Chu CY, 2020, J CONTROL RELEASE, V317, P312, DOI 10.1016/j.jconrel.2019.11.019; Chu CY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00921; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; Gorelik M, 2012, CELL TRANSPLANT, V21, P2149, DOI 10.3727/096368912X636911; Gorelik M, 2012, RADIOLOGY, V265, P175, DOI 10.1148/radiol.12112212; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; ILDSTAD ST, 1992, TRANSPLANTATION, V53, P815, DOI 10.1097/00007890-199204000-00022; Janowski M, 2012, NAT METHODS, V9, P856, DOI 10.1038/nmeth.2146; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Li S, 2019, BRAIN, V142, P3456, DOI 10.1093/brain/awz275; Lyczek A, 2017, EXP NEUROL, V291, P74, DOI 10.1016/j.expneurol.2017.02.005; Malysz-Cymborska I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34723-x; Marteyn A, 2016, STEM CELLS, V34, P984, DOI 10.1002/stem.2263; Phillips Andre W, 2012, J Vis Exp, DOI 10.3791/3462; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; SAYEGH MH, 1995, J AM SOC NEPHROL, V6, P1143; Schwarz SC, 1997, EXP BRAIN RES, V115, P71, DOI 10.1007/PL00005687; SRINIVAS NR, 1995, J PHARM SCI, V84, P1488, DOI 10.1002/jps.2600841217; Steinbeck JA, 2015, NEURON, V86, P187, DOI 10.1016/j.neuron.2015.03.002; Sypecka J, 2014, MOL NEUROBIOL, V49, P685, DOI 10.1007/s12035-013-8549-9; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	28	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	APR 30	2021	18	1							104	10.1186/s12974-021-02152-9			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	SK6HK	WOS:000656316600002	33931070	Green Published, gold			2022-02-07	
J	Yehene, E; Manevich, A; Rubin, SS				Yehene, Einat; Manevich, Alexander; Rubin, Simon Shimshon			Caregivers' Grief in Acquired Non-death Interpersonal Loss (NoDIL): A Process Based Model With Implications for Theory, Research, and Intervention	FRONTIERS IN PSYCHOLOGY			English	Article						caregiving; grief; attachment; continuing bonds matrix; interpersonal loss; ambiguous loss; bereavement	TRAUMATIC BRAIN-INJURY; DUAL PROCESS MODEL; CHRONIC SORROW; AMBIGUOUS LOSS; 2-TRACK MODEL; BEREAVEMENT; BURDEN; CHILD; CONSCIOUSNESS; CHALLENGES	The number of family members caring and caregiving for a loved one undergoing physical and mental changes continues to increase dramatically. For many, this ongoing experience not only involves the "burden of caregiving" but also the "burden of grief" as their loved-one's newfound medical condition can result in the loss of the person they previously knew. Dramatic cognitive, behavioral, and personality changes, often leave caregivers bereft of the significant relationship they shared with the affected person prior to the illness or injury. This results in what we term conditions of acquired "non-death interpersonal loss" (NoDIL). Current approaches to these losses use an amalgam of models drawn from both death and non-death loss. Despite their utility, these frameworks have not adequately addressed the unique processes occurring in the interpersonal sphere where the grieving caregiver needs to reach some modus vivendi regarding the triad of "who the person was," "who they are now," and "who they will yet become." In this paper we propose a process-based model which addresses cognitive-emotional-behavioral challenges caregivers meet in the face of their new reality. These require a revision of the interpersonal schemas and the relationships that takes into account the ongoing interactions with the affected family member. The model and its utility to identify adaptive and maladaptive responses to NoDIL is elaborated upon with clinical material obtained from caregivers of people diagnosed with major neuro-cognitive disorder and pediatric traumatic brain injury. The article concludes with implications for theory, research and clinical intervention.	[Yehene, Einat] Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel; [Manevich, Alexander; Rubin, Simon Shimshon] Univ Haifa, Sch Psychol Sci, Haifa, Israel; [Manevich, Alexander; Rubin, Simon Shimshon] Univ Haifa, Int Lab Study Loss Bereavement & Human Resilience, Haifa, Israel; [Rubin, Simon Shimshon] Max Stern Acad Coll Emek Yezreel, Dept Psychol, Jezreel Valley, Israel		Yehene, E (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel.	einat.yehene@gmail.com					Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Bleijlevens MHC, 2015, J ADV NURS, V71, P1378, DOI 10.1111/jan.12561; Bodley-Scott SEM, 2015, BRAIN IMPAIR, V16, P205, DOI 10.1017/BrImp.2015.22; Boelen PA, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1771008; Boerner K, 2009, BEREAVE CARE, V28, P10, DOI 10.1080/02682620903355382; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Boss P, 1999, Harv Ment Health Lett, V16, P4; Boss P, 2007, FAM RELAT, V56, P105, DOI 10.1111/j.1741-3729.2007.00444.x; Boss P, 2014, BEREAVE CARE, V33, P63, DOI 10.1080/02682621.2014.933573; Boss P, 2012, FAM PROCESS, V51, P456, DOI 10.1111/famp.12005; Boss P, 2010, PASTOR PSYCHOL, V59, P137, DOI 10.1007/s11089-009-0264-0; Bowlby J., 1973, ATTACHMENT LOSS; Bowlby J, 1980, ATTACHMENT LOSS VOLU; Bowlby J., 1982, ATTACHMENT, V1; Bravo-Benitez J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234821; Bruce E.J., 2001, NONFINITE LOSS GRIEF; CASSIDY J, 2016, HDB ATTACHMENT; Chan D, 2013, INT J GERIATR PSYCH, V28, P1, DOI 10.1002/gps.3795; Chou K R, 2000, J Pediatr Nurs, V15, P398, DOI 10.1053/jpdn.2000.16709; Collings C, 2008, BRIT J SOC WORK, V38, P1499, DOI 10.1093/bjsw/bcm055; Coughlin MB, 2017, J PEDIATR NURS, V37, P108, DOI 10.1016/j.pedn.2017.06.011; Covelli V, 2016, ACTA NEUROL SCAND, V134, P352, DOI 10.1111/ane.12550; Doka K, 2008, HDB BEREAVEMENT RES; Doka KJ, 2010, SER DEATH DYING, P1; Doka KJ., 2002, DISENFRANCHISED GRIE; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; de la Morena MJE, 2013, ACTA NEUROL SCAND, V127, P413, DOI 10.1111/ane.12061; Folkman S., 1984, STRESS; Freud S, 1918, INT Z ARZTL PSYCHOAN, V4, P288; GaIatzer-Levy IR, 2018, CLIN PSYCHOL REV, V63, P41, DOI 10.1016/j.cpr.2018.05.008; Galimberti D, 2018, NEURODEGENER DIS; Gerain P, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01748; Giovannetti AM, 2013, ACTA NEUROL SCAND, V127, P10, DOI 10.1111/j.1600-0404.2012.01666.x; Harris D.L., 2019, NONDEATH LOSS GRIEF; Harris DL, 2011, SER DEATH DYING, P1; Hobdell Elizabeth, 2004, J Neurosci Nurs, V36, P82; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; Jordan JR, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00766; Kbler-Ross E., 1969, DEATH DYING; Killikelly C, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2018.1476441; Klass D., 1996, CONTINUING BONDS NEW; Klass Dennis, 2018, CONTINUING BONDS BER; Lahousen T, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00914; Li Q., 2020, FRONT PSYCHIATRY, V11, P1516; Liew TM, 2020, J AM GERIATR SOC, V68, P2348, DOI 10.1111/jgs.16717; Lim Jung-won, 2004, Health Qual Life Outcomes, V2, P50; Lindauer A, 2014, J ADV NURS, V70, P2196, DOI 10.1111/jan.12411; Lond BJ, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1829104; Magnani FG, 2020, NEUROL SCI, V41, P2773, DOI 10.1007/s10072-020-04394-6; Malkinson R., 2000, TRAUMATIC NONTRAUMAT; Malkinson R., 2007, COGNITIVE GRIEF THER; Manevich A., 2021, OBM GERIAT, V5, P1; Marwit SJ, 2006, BRAIN INJURY, V20, P1419, DOI 10.1080/02699050601082214; Meichsner F, 2020, AM J GERIAT PSYCHIAT, V28, P560, DOI 10.1016/j.jagp.2019.12.010; Merriam-Webster, 2020, BEREAVE AVAILABLE; Neimeyer RA, 2006, DEATH STUD, V30, P715, DOI 10.1080/07481180600848322; Neimeyer RA, 2016, BEHAV CHANGE, V33, P65, DOI 10.1017/bec.2016.4; O'Brien M, 2007, FAM RELAT, V56, P135, DOI 10.1111/j.1741-3729.2007.00447.x; OLSHANSKY S, 1962, SOC CASEWORK-JCSW, V43, P190, DOI 10.1177/104438946204300404; Olshansky SJ, 2018, JAMA-J AM MED ASSOC, V320, P1323, DOI 10.1001/jama.2018.12621; Pagani M, 2014, CLIN PSYCHOL PSYCHOT, V21, P420, DOI 10.1002/cpp.1848; Parkes C.M., 2001, HDB BEREAVEMENT RES; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pertl MM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01801; Petersen H, 2015, HEALTH SOC WORK, V40, P325, DOI 10.1093/hsw/hlv063; Rando T. A., 1984, GRIEF DYING DEATH CL; Riley Gerard A, 2016, Concussion, V1, pCNC18, DOI 10.2217/cnc-2016-0012; Roos Susan., 2002, CHRONIC SORROW LIVIN; RUBIN S, 1981, AM J ORTHOPSYCHIAT, V51, P101, DOI 10.1111/j.1939-0025.1981.tb01352.x; Rubin S.S., 2012, WORKING BEREAVED MUL; Rubin SS, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.537596; Rubin SS, 2021, DEATH STUD, V45, P755, DOI 10.1080/07481187.2019.1688014; RUBIN SS, 1992, OMEGA-J DEATH DYING, V24, P183, DOI 10.2190/2V09-H301-YMGG-M065; Rubin SS, 1999, DEATH STUD, V23, P681, DOI 10.1080/074811899200731; Saban KL, 2016, BIOL RES NURS, V18, P50, DOI 10.1177/1099800414568661; Smid GE, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1776563; Soeterik SM, 2018, NEUROPSYCHOL REHABIL, V28, P1392, DOI 10.1080/09602011.2018.1529603; Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046; Stroebe M.S., 2008, HDB BEREAVEMENT RES; Stroebe M, 2016, OMEGA-J DEATH DYING, V74, P96, DOI 10.1177/0030222816666540; Stroebe M, 2010, OMEGA-J DEATH DYING, V61, P273, DOI 10.2190/OM.61.4.b; Tan MMJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00561; Tzuang M., 2014, OXFORD HDB CLIN GERO, P797; Volicer L, 2005, CURR PSYCHOS THER RE, V3, P20; Watson B, 2019, GERONTOLOGIST, V59, pE597, DOI 10.1093/geront/gny049; Whittingham K, 2013, CHILD CARE HLTH DEV, V39, P366, DOI 10.1111/j.1365-2214.2012.01396.x; Worden J.W., 2018, GRIEF COUNSELING GRI, V5; World Health Organization W, 2018, INT CLASSIFICATION D; Yehene E., 2019, BE REALISTIC HOPE MI; Yehene E, 2021, NEUROPSYCHOL REHABIL, V31, P105, DOI 10.1080/09602011.2019.1668280; Yehene E, 2019, NEUROREHABILITATION, V45, P11, DOI 10.3233/NRE-192751; Yehene E, 2020, DEATH STUD, V44, P510, DOI 10.1080/07481187.2019.1586795; Zaksh Y, 2019, CLIN REHABIL, V33, P345, DOI 10.1177/0269215518802339; Zarit SH, 2008, AGING MENT HEALTH, V12, P5, DOI 10.1080/13607860701616317	95	0	0	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	APR 30	2021	12								676536	10.3389/fpsyg.2021.676536			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	SB3XW	WOS:000649932500001	33995234	gold, Green Published			2022-02-07	
J	Gorgens, KA; Meyer, L; Dettmer, J; Standeven, M; Goodwin, E; Marchi, C; Lyman, H				Gorgens, Kim A.; Meyer, Laura; Dettmer, Judy; Standeven, Molly; Goodwin, Emily; Marchi, Cory; Lyman, Hollis			Traumatic Brain Injury in Community Corrections: Prevalence and Differences in Compliance and Long-Term Outcomes Among Men and Women on Probation	CRIMINAL JUSTICE AND BEHAVIOR			English	Article						probation; recidivism; community corrections; community supervision; risk-need-responsivity	BATTERY-SCREENING MODULE; VALIDITY; RELIABILITY; RISK; POPULATION; BEHAVIOR; HISTORY; SAMPLE; TESTS	There are 4.5 million adults in community corrections (e.g., probation and parole), nearly twice the number of people incarcerated in jails and prisons combined. Research suggests that more than half of men in jail have experienced at least one traumatic brain injury (TBI). Very little is known about TBI history in probation. This study reviewed TBI history, cognitive and psychosocial data, and judicial records. Results showed that 47% of persons on probation report TBI. People on probation with TBI also had comorbid behavioral health conditions like mental illness, substance abuse, trauma history, and attempted suicide. They were more likely to be determined to be high risk by probation officers, had a higher rate of felony convictions, had lower rates of successful probation completion, and were significantly more likely to re-offend. Attention to responsivity factors like TBI may help probation provide accommodations that support successful engagement in probation and treatment.	[Gorgens, Kim A.] Univ Denver, Grad Sch Profess Psychol, 2450 South Vine St,MSC 4101, Denver, CO 80208 USA; [Meyer, Laura] Univ Denver, Grad Sch Profess Psychol, Courses Stat & Res, Denver, CO 80208 USA; [Standeven, Molly; Marchi, Cory] Univ Denver, Grad Sch Profess Psychol, Clin Psychol, Denver, CO 80208 USA; [Goodwin, Emily; Lyman, Hollis] Univ Denver, Denver, CO 80208 USA; [Dettmer, Judy] Natl Assoc State Head Injury Adm, Alabaster, AL USA		Gorgens, KA (corresponding author), Univ Denver, Grad Sch Profess Psychol, 2450 South Vine St,MSC 4101, Denver, CO 80208 USA.	Kimberly.Gorgens@du.edu		Gorgens, Kim/0000-0003-4413-0600	Colorado Evaluation and Action Lab of the University of Denver; U.S. Administration for Community Living, Department of Health and Human Services, Washington, DC [H21MC17232]	This research was supported in part by the Colorado Evaluation and Action Lab of the University of Denver. The opinions expressed are those of the authors and do not represent the views of the Colorado Lab or the University of Denver. This project was also supported in part by Grant H21MC17232 from the U.S. Administration for Community Living, Department of Health and Human Services, Washington, DC 20201. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not, therefore, necessarily represent official Administration for Community Living policy.	Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Blonigen Daniel M, 2017, Crim Justice Policy Rev, V28, P790, DOI 10.1177/0887403416628601; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Clasby B, 2020, DISABIL REHABIL, V42, P2412, DOI 10.1080/09638288.2019.1635214; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Eghwrudjakpor PO, 2008, LIBYAN J MED, V3, P192, DOI 10.4176/080908; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Gorgens K, 2018, ENCY CLIN NEUROPSYCH, P590; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hong JS, 2013, RESID TREAT CHILD YO, V30, P131, DOI 10.1080/0886571X.2013.785230; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kajstura A., 2019, WOMENS MASS INCARCER; Kopak AM, 2016, AM J CRIM JUSTICE, V41, P14, DOI 10.1007/s12103-015-9330-6; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; McKinlay Audrey, 2016, Concussion, V1, pCNC25, DOI 10.2217/cnc-2016-0011; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nagele D, 2018, J OFFENDER REHABIL, V57, P562, DOI 10.1080/10509674.2018.1549178; O'Rourke C, 2018, BRAIN INJURY, V32, P1787, DOI 10.1080/02699052.2018.1539872; O'Sullivan M, 2019, J CORRECT HEALTH CAR, V25, P313, DOI 10.1177/1078345819879898; Palijan TZ, 2010, PSYCHIAT DANUB, V22, P253; Petruccelli K, 2019, CHILD ABUSE NEGLECT, V97, DOI 10.1016/j.chiabu.2019.104127; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Porter N.D, 2016, STATE SENTENCING 201; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Reeves D., 1995, NCRF9501; Schofield PW, 2019, BRAIN INJURY, V33, P412, DOI 10.1080/02699052.2018.1552020; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Strauss D, 2004, NEUROREHABILITATION, V19, P257; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Vadini F, 2018, J AFFECT DISORDERS, V225, P273, DOI 10.1016/j.jad.2017.08.030; Wagner P., 2020, MASS INCARCERATION W; Wall K, 2018, CRIM JUSTICE BEHAV, V45, P1588, DOI 10.1177/0093854818778082; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579; Zollman, 2016, MANUAL TRAUMATIC BRA	48	0	0	5	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0093-8548	1552-3594		CRIM JUSTICE BEHAV	Crim. Justice Behav.	DEC	2021	48	12					1679	1693	00938548211010316	10.1177/00938548211010316		APR 2021	15	Psychology, Clinical; Criminology & Penology	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology	WJ3VU	WOS:000649138300001					2022-02-07	
J	Koul, A; Sheikh, A; Bhat, S; Ahad, A; Qadir, R; Khurseed, N; Kamil, R				Koul, Ajaz; Sheikh, Arif; Bhat, Sajad; Ahad, Abrar; Qadir, Ruhail; Khurseed, Nayl; Kamil, Raja			Nosocomial Infections in Patients with Traumatic Brain Injury: A Hospital-Based Study from North India	INDIAN JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; nosocomial infections		Background Traumatic brain injury (TBI) is a major global health concern, it being a leading cause of morbidity and mortality in young adults. Infections acquired in the hospital setting are one of many risk factors that are associated with higher mortality in this population. Despite significant impact on the overall outcome, infections in TBI patients are largely understudied and underreported. The purpose of this study was to study the profile of infectious complications in patients with TBI and impact of these infections on the hospital outcome of these patients. Materials and Methods The medical records of all the patients with a diagnosis of TBI admitted in our hospital from January 2017 to January 2020 were reviewed. They were screened for presence of any predefined infection acquired at any time during their hospital stay. Data regarding demographics, focus of infection, results of various cultures, and hospital outcome was recorded. Results A total of 60 patients with TBI who had developed nosocomial infections were included in this observational study. Patients were mostly young, with a mean age of 36.6 years. Majority (66.6%) of patients who developed infectious complications had Glasgow coma scale (GCS) score of less than 10. Respiratory tract and urinary tract were the most common sites of infections in these patients. Burkholderia cepecia and Acinetobacter baumannii were the two most common isolated organisms. All-cause mortality in this population was 23.3%. Conclusions Most TBI patients are young, in their productive period of lives, and do not have major comorbidities. Invariably, they have low GCS scores and encounter a breach of their surface immunity due to catheters, procedures, and intubation. Such patients make an extremely significant impact on hospital resources as well as poor economic outcomes.	[Koul, Ajaz; Sheikh, Arif; Bhat, Sajad; Qadir, Ruhail; Kamil, Raja] Sherikashmir Inst Med Sci, Dept Med & Infect Dis, SKIMS, Srinagar 190011, Kashmir, India; [Ahad, Abrar; Khurseed, Nayl] Sherikashmir Inst Med Sci, Dept Neurosurg, SKIMS, Srinagar, Kashmir, India		Koul, A (corresponding author), Sherikashmir Inst Med Sci, Dept Med & Infect Dis, SKIMS, Srinagar 190011, Kashmir, India.	ajazkoul@yahoo.com					Amoo M, 2018, BRIT J NEUROSURG, V32, P585, DOI 10.1080/02688697.2018.1522416; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; Dhillon NK, 2018, J SURG RES, V224, P140, DOI 10.1016/j.jss.2017.11.031; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Hazeldine J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002338; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kourbeti IS, 2011, BRIT J NEUROSURG, V25, P9, DOI 10.3109/02688697.2010.500411; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; RELLO J, 1992, CHEST, V102, P525, DOI 10.1378/chest.102.2.525; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Yadollahi M, 2018, CHIN J TRAUMATOL, V21, P267, DOI 10.1016/j.cjtee.2018.03.002	17	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.	DEC	2021	10	03					216	219		10.1055/s-0041-1722829		APR 2021	4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	XV0EH	WOS:000645377600002		gold			2022-02-07	
J	Krishna, G; Aggarwal, V; Singh, I				Krishna, Gopal; Aggarwal, Varun; Singh, Ishwar			Prospective Analysis of Coagulopathy Associated with Isolated Traumatic Brain Injury and Clinical Outcome	INDIAN JOURNAL OF NEUROSURGERY			English	Article; Early Access						coagulopathy; TBI; DIC score; head injury		Introduction Traumatic brain injury (TBI) affects the coagulation pathway in a distinct way than does extracranial trauma. The extent of coagulation abnormalities varies from bleeding diathesis to disseminated thrombosis. Design Prospective study. Methods The study included 50 patients of isolated TBI with cohorts of moderate (MHI) and severe head injury (SHI). Coagulopathy was graded according to the values of parameters in single laboratory. The incidence of coagulopathy according to the severity of TBI and correlation with disseminated intravascular coagulation (DIC) score, platelets, prothrombin time (PT), activated partial thromboplastin time (APTT), D-dimer, and fibrinogen was observed. The comparison was also made between expired and discharged patients within each group. It also compared coagulation derailments with clinical presentation (Glasgow Coma Scale [GCS]) and outcome (Glasgow Outcome Scale [GOS]). Results Road traffic accident was the primary (72%) mode of injury. Fifty-two percent had MHI and rest had SHI. Eighty-four percent of cases were managed conservatively. The mean GCS was 12.23 and 5.75 in MHI and SHI, respectively. Sixty-two percent of MHI and 96% of the patients with SHI had coagulation abnormalities. On statistical analysis, DIC score (p < 0.001) strongly correlated with the severity of head injury and GOS. PT and APTT were also significantly associated with the severity of TBI. In patients with moderate TBI, D-dimer and platelet counts showed association with clinical outcome. Fibrinogen levels did not show any statistical significance. The mean platelet counts remained normal in both the groups of TBI. The mean GOS was 1.54 and 4.62 in SHI and MHI, respectively. Conclusion Coagulopathy is common in isolated TBI. The basic laboratory parameters are reliable predictors of coagulation abnormalities in TBI. Coagulopathy is directly associated with the severity of TBI, GCS, and poor outcome.	[Krishna, Gopal; Aggarwal, Varun; Singh, Ishwar] Pt BD Sharma Postgrad Inst Med Sci, Dept Neurosurg, Rohtak 124001, Haryana, India		Krishna, G (corresponding author), Pt BD Sharma Postgrad Inst Med Sci, Dept Neurosurg, Rohtak 124001, Haryana, India.	gopalblue222@gmail.com					Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Alexiou GA, 2011, INJURY, V42, P113, DOI 10.1016/j.injury.2010.06.019; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chabok SY, 2010, NEUROSURG QUART, V20, P65, DOI 10.1097/WNQ.0b013e3181d2746d; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Dharap SB, 2017, J POSTGRAD MED, V63, P169, DOI 10.4103/0022-3859.201417; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Eshete A, 2018, ETHIOP J HEALTH SCI, V28, P323, DOI 10.4314/ejhs.v28i3.10; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fuller G., 2008, CRIT CARE, V12, P126; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Gutman SA., 2001, OCCUPATIONAL THERAPY, V5th, P671; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Khan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132229; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Kweon JG., 1991, J KOREAN NEUROSURG S, V20, P406; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; May AK, 1997, AM SURGEON, V63, P233; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Pereira EAC, 2009, ACTA NEUROCHIR, V151, P1521, DOI 10.1007/s00701-009-0258-9; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van Gent JAN, 2020, ACTA NEUROCHIR, V162, P329, DOI 10.1007/s00701-019-04111-z; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108	47	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.												10.1055/s-0041-1728989		APR 2021	7	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	RU8FQ	WOS:000645377600001		gold			2022-02-07	
J	Eyolfson, E; Bhatt, D; Wang, MLD; Lohman, AW; Mychasiuk, R				Eyolfson, Eric; Bhatt, Dhyey; Wang, Melinda; Lohman, Alexander W.; Mychasiuk, Richelle			Paternal exposure to exercise and/or caffeine and alcohol modify offspring behavioral and pathophysiological recovery from repetitive mild traumatic brain injury in adolescence	GENES BRAIN AND BEHAVIOR			English	Article; Early Access						concussion; cytokines; fathers; mRNA; nucleus accumbens; prefrontal cortex; telomere length	MEDIAL PREFRONTAL CORTEX; ANXIETY-LIKE BEHAVIOR; DNA METHYLATION; NUCLEUS-ACCUMBENS; TELOMERE LENGTH; LOCOMOTOR-ACTIVITY; PRENATAL EXPOSURE; RODENT MODEL; MOUSE MODEL; DOPAMINE	Only recently has the scope of parental research expanded to include the paternal sphere with epidemiological studies implicating stress, nutrition and alcohol consumption in the neurobiological and behavioral characteristics of offspring. This study was designed to determine if paternal exposure to caffeine, alcohol and exercise prior to conception would improve or exacerbate offspring recovery from adolescent repetitive mild traumatic brain injury (RmTBI). Sires received 7 weeks of standard drinking water, or caffeine and ethanol and were housed in regular cages or cages with running wheels, prior to being mated to control females. At postnatal day 40, offspring were administered RmTBI or sham injuries and were assessed for post concussive symptomology. Post-mortem quantitative real-time polymerase chain reaction (qRT-PCR) was used to assess gene expression in the prefrontal cortex (PFC), nucleus accumbens (NAc) and changes in telomere length. Additionally, enzyme-linked immunosorbent assay (ELISA's) were run on serum to detect levels of cytokines, chemokines and sex hormones. Paternal experience did not improve or exacerbate RmTBI behavioral outcomes. However, female and male offspring displayed unique responses to RmTBI and paternal experience, resulting in changes in physical, behavioral and molecular outcomes. Injury and paternal exercise modified changes in female offspring, whereas male offspring were affected by paternal exercise, caffeine and alcohol treatment. Additionally, paternal experience and RmTBI modified expression of many genes in the PFC, NAc, telomere length and levels of sex hormones. Although further exploration is required to understand the heterogeneity that exists in disease risk and resiliency, this study provides corroborating evidence that paternal experiences prior to conception influences offspring development.	[Eyolfson, Eric; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Eyolfson, Eric; Bhatt, Dhyey; Wang, Melinda; Lohman, Alexander W.; Mychasiuk, Richelle] Hotchkiss Brain Inst, Calgary, AB, Canada; [Eyolfson, Eric; Bhatt, Dhyey; Wang, Melinda; Lohman, Alexander W.; Mychasiuk, Richelle] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Bhatt, Dhyey; Lohman, Alexander W.] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Mychasiuk, Richelle] Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia		Mychasiuk, R (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	richelle.mychasiuk@monash.edu		Eyolfson, Eric/0000-0002-2201-5444; Mychasiuk, Richelle/0000-0001-5291-5083	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [PJT -153051]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [1304881]	Canadian Institutes of Health Research, Grant/Award Number: PJT -153051; Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: 1304881	Acquas E, 2002, NEUROPSYCHOPHARMACOL, V27, P182, DOI 10.1016/S0893-133X(02)00290-7; Ahmadi H, 2013, NEUROPHARMACOLOGY, V71, P112, DOI 10.1016/j.neuropharm.2013.03.017; Almeida C, 2015, PAIN, V156, P504, DOI 10.1097/01.j.pain.0000460339.23976.12; Autry Anita E, 2015, [Frontiers in Biology, 生物学前沿], V10, P439; Avale ME, 2004, MOL PSYCHIATR, V9, P718, DOI 10.1038/sj.mp.4001474; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bayraktar G, 2018, NEUROSCIENTIST, V24, P171, DOI 10.1177/1073858417707457; de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x; Binder NK, 2015, REPRODUCTION, V149, P435, DOI 10.1530/REP-14-0676; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Braun K, 2014, J NEUROENDOCRINOL, V26, P697, DOI 10.1111/jne.12174; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Conner KE, 2020, ALCOHOL CLIN EXP RES, V44, P125, DOI 10.1111/acer.14245; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Del Arco A, 2008, PHARMACOL BIOCHEM BE, V90, P226, DOI 10.1016/j.pbb.2008.04.011; Delker E, 2016, ALCOHOL RES-CURR REV, V38, P7; Denham J, 2015, EPIGENOMICS-UK, V7, P717, DOI 10.2217/epi.15.29; Dias TR, 2015, TOXICOLOGY, V328, P12, DOI 10.1016/j.tox.2014.12.003; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Elliott E, 2016, J NEUROSCI, V36, P730, DOI 10.1523/JNEUROSCI.0971-15.2016; Emanuele MA, 2001, ALCOHOL RES HEALTH, V25, P282; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Finegersh A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099078; Foley TE, 2008, NEUROMOL MED, V10, P67, DOI 10.1007/s12017-008-8032-3; Fraunberger EA, 2020, J NEUROTRAUM, V37, P1315, DOI 10.1089/neu.2019.6714; Frick KM, 2018, CURR OPIN BEHAV SCI, V23, P65, DOI 10.1016/j.cobeha.2018.03.011; Garrett BE, 1997, PHARMACOL BIOCHEM BE, V57, P533, DOI 10.1016/S0091-3057(96)00435-2; Haaland TR, 2017, AM NAT, V190, P534, DOI 10.1086/693484; HANNIGAN JH, 1995, ALCOHOL CLIN EXP RES, V19, P238, DOI 10.1111/j.1530-0277.1995.tb01498.x; Harvey BH, 2004, PSYCHOPHARMACOLOGY, V175, P494, DOI 10.1007/s00213-004-1836-4; Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x; Hehar H., 2015, NONGENET INHERITANCE, V2, P23; Hehar H., 2017, SCI REP-UK, V7, P1; Hehar H, 2016, NEUROSCIENCE, V332, P61, DOI 10.1016/j.neuroscience.2016.06.039; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; HUGHES RN, 1986, LIFE SCI, V38, P861, DOI 10.1016/0024-3205(86)90253-5; HUGHES RN, 1991, NEUROTOXICOL TERATOL, V13, P641, DOI 10.1016/0892-0362(91)90048-2; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Jacome LF, 2010, NEUROBIOL LEARN MEM, V94, P488, DOI 10.1016/j.nlm.2010.08.016; Jamerson PA, 2004, DEV BRAIN RES, V149, P103, DOI 10.1016/j.devbrainres.2003.12.010; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Kim P, 2014, J NEUROSCI RES, V92, P658, DOI 10.1002/jnr.23275; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Kopec AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06118-z; Kopp BL, 2013, PHYSIOL BEHAV, V122, P246, DOI 10.1016/j.physbeh.2013.05.030; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009; Lau-Barraco C, 2014, SUBST USE MISUSE, V49, P1241, DOI 10.3109/10826084.2014.891619; Liang F, 2014, NEUROPHARMACOLOGY, V81, P126, DOI 10.1016/j.neuropharm.2014.01.025; Luukkaa V, 1998, J CLIN ENDOCR METAB, V83, P3243, DOI 10.1210/jc.83.9.3243; Ma Hui, 2014, Shanghai Arch Psychiatry, V26, P61, DOI 10.3969/j.issn.1002-0829.2014.02.002; Mabandla MV, 2009, METAB BRAIN DIS, V24, P525, DOI 10.1007/s11011-009-9161-6; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mateen BA, 2017, J NEUROTRAUM, V34, P2379, DOI 10.1089/neu.2017.5007; McPherson NO, 2015, AM J PHYSIOL-ENDOC M, V308, pE805, DOI 10.1152/ajpendo.00013.2015; Mee-inta O, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070691; Metz GA., 2005, BEHAV LAB RAT HDB TE; Morris MJ, 2016, NEUROBIOL LEARN MEM, V135, P139, DOI 10.1016/j.nlm.2016.08.012; Munoz-Villegas P, 2017, PHARMACOL BIOCHEM BE, V153, P88, DOI 10.1016/j.pbb.2016.12.011; Murashov AK, 2016, FASEB J, V30, P775, DOI 10.1096/fj.15-274274; Mychasiuk R, 2013, NEUROSCIENCE, V241, P100, DOI 10.1016/j.neuroscience.2013.03.025; Mychasiuk R, 2011, NEUROSCIENCE, V180, P105, DOI 10.1016/j.neuroscience.2011.02.026; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Mychasiuk R, 2012, BEHAV BRAIN RES, V228, P294, DOI 10.1016/j.bbr.2011.11.036; Nelson CA, 2020, TRENDS NEUROSCI, V43, P133, DOI 10.1016/j.tins.2020.01.002; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Olopade Funmilayo Eniola, 2018, Journal of Caffeine and Adenosine Research, V8, P27, DOI 10.1089/caff.2017.0010; OUELLETTE EM, 1977, NEW ENGL J MED, V297, P528, DOI 10.1056/NEJM197709082971003; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Qian JJ, 2020, TRENDS ENDOCRIN MET, V31, P218, DOI 10.1016/j.tem.2019.11.004; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Short AK, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.82; Simon DW., 2017, NAT REV NEUROL, V13, P171; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Souza AC, 2015, BRAIN RES, V1595, P10, DOI 10.1016/j.brainres.2014.10.039; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; Symons GF, 2020, J CONCUSSION, V4, DOI 10.1177/2059700220975609; Talebi AR, 2011, ALCOHOL, V45, P403, DOI 10.1016/j.alcohol.2010.10.005; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Tchekalarova J, 2005, BEHAV BRAIN RES, V160, P99, DOI 10.1016/j.bbr.2004.11.018; Tena-Sempere M., 1999, J ENDOCRINOL, V161, P211, DOI DOI 10.1677/J0E.0.1610211; Testen A, 2019, NEUROSCIENCE, V400, P98, DOI 10.1016/j.neuroscience.2018.12.044; Thanos PK, 2004, ALCOHOL CLIN EXP RES, V28, P720, DOI 10.1097/01.ALC.0000125270.30501.08; Torabi M, 2017, NEUROSCI LETT, V659, P110, DOI 10.1016/j.neulet.2017.08.074; Tran NL, 2016, FOOD CHEM TOXICOL, V94, P227, DOI 10.1016/j.fct.2016.06.007; Unal M., 2005, Acta Physiologica Hungarica, V92, P173, DOI 10.1556/APhysiol.92.2005.2.8; van Steenwyk G, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy023; Vendruscolo LF, 2015, J CLIN INVEST, V125, P3193, DOI 10.1172/JCI79828; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vida Katalin, 2015, Journal of Caffeine Research, V5, P11, DOI 10.1089/jcr.2014.0022; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wedick NM, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-86; Wells BE, 2013, AM J DRUG ALCOHOL AB, V39, P8, DOI 10.3109/00952990.2012.720320; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; WOZNIAK DF, 1991, PSYCHOPHARMACOLOGY, V105, P289, DOI 10.1007/BF02244324; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yamakawa GR, 2019, NEUROSCIENCE, V413, P264, DOI 10.1016/j.neuroscience.2019.06.022; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yeshurun S, 2019, MOL PSYCHIATR, V24, P536, DOI 10.1038/s41380-018-0039-z; Zarrindast MR, 2015, ARCH IRAN MED, V18, P591, DOI 0151809/AIM.009; Zilles K., 1985, CORTEX RAT STEREOTAX; Zimmerman L., 2016, ROLE LEADERSHIP OCCU, V14, P1, DOI [https://doi.org/10.1108/S1479-355520160000014001, DOI 10.1108/S1479-355520160000014001]	119	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1601-1848	1601-183X		GENES BRAIN BEHAV	Genes Brain Behav.											gbb12736	10.1111/gbb.12736		APR 2021	20	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	RU3MV	WOS:000645054300001	33876557				2022-02-07	
J	Labiste, CC; McElroy, E; Chaniotakis, S; Duong, N; Haffizulla, F				Labiste, Chase C.; McElroy, Evan; Chaniotakis, Sotiris; Duong, Nicolette; Haffizulla, Farzanna			Effectiveness of PitchSafe on Knowledge and Attitude of Baseball-Related Concussion	CUREUS			English	Article						youth sports; brain concussion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; SPORTS; SYMPTOMS; FOOTBALL	Background Traumatic brain injuries (TBIs), specifically concussions, affect many athletes and have dangerous immediate and long-term sequelae. Lack of awareness surrounding concussion impedes prevention, identification, and treatment. This study aims to assess parental knowledge and attitudes regarding concussions in youth baseball before and after administering an educational intervention called PitchSafe. PitchSafe is a short video that contains examples of baseball-related head injuries such as collisions, falls, and direct hits by baseballs; the signs and symptoms of a concussion; testimony from a former baseball player who sustained a TBI playing baseball; and a brochure detailing the potential signs, symptoms, and treatment plans associated with concussions. Methodology The Rosenbaum Concussion Knowledge and Attitudes Survey (RoCKAS) was used to assess three indices of parental understanding of concussion: Concussion Knowledge Index (CKI), Concussion Attitudes Index (CAI), and signs and symptoms of concussions (SS). The RoCKAS was administered at baseline and after the PitchSafe tool was administered. Parents were re-assessed one year following the initial distribution of survey materials utilizing the long-term follow-up (LTFU) RoCKAS. A paired sample t-test was conducted to compare the baseline, post-intervention (PI), and LTFU CKI, CAI, and SS among participants. Results The mean scores for CKI were 68% +/- 12%, 76% +/- 4%, and 76% +/- 5% for baseline, PI, and LTFU, respectively. The mean scores for SS were 46% +/- 20%, 62% +/- 14%, and 64% +/- 16% for baseline, PI, and LTFU, respectively. The mean scores for CAI were 87% +/- 6%, 91% +/- 5%, and 92% +/- 4% for baseline, PI, and LTFU, respectively. Conclusions PitchSafe increased youth baseball parents' long-term knowledge of concussions, ability to identify signs and symptoms of concussions, and may promote safer attitudes toward concussions. These findings support more widespread use of educational tools through social media and in clinical settings.	[Labiste, Chase C.; McElroy, Evan; Chaniotakis, Sotiris; Duong, Nicolette] Nova Southeastern Univ, Dr Kiran C Patel Coll Allopath Med, Internal Med, Ft Lauderdale, FL 33314 USA; [Haffizulla, Farzanna] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Internal Med, Ft Lauderdale, FL 33314 USA		Labiste, CC (corresponding author), Nova Southeastern Univ, Dr Kiran C Patel Coll Allopath Med, Internal Med, Ft Lauderdale, FL 33314 USA.	cl1691@mynsu.nova.edu					Axe MJ, 2014, INT J SPORTS PHYS TH, V9, P346; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Centers for Disease Control and Prevention, 2020, HEADS; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dolick L, 2019, J SPORT MED ALLIED H, V5, P6, DOI [10.25035/jsmahs.05.01.06, DOI 10.25035/JSMAHS.05.01.06]; Gallagher C, 2017, BR J SPORTS MED, V51, P60, DOI [10.1136/bjsports-2016-097270.158, DOI 10.1136/BJSPORTS-2016-097270.158]; Gottlieb S, 2000, BRIT MED J, V321, P1100; Hardre PL, 2012, EDUC PSYCHOL MEAS, V72, P1015, DOI 10.1177/0013164412451977; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lystad Reidar P, 2018, Inj Epidemiol, V5, P25, DOI 10.1186/s40621-018-0155-x; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; Marshall Cameron M, 2012, J Can Chiropr Assoc, V56, P299; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; TBI, 2020, GET FACTS CONC TRAUM; Weerdenburg K, 2016, PAED CHILD HEALT-CAN, V21, pE22, DOI 10.1093/pch/21.3.e22; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013	29	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	APR 28	2021	13	4							e14732	10.7759/cureus.14732			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RU7EX	WOS:000645308100006	34084667	gold, Green Published			2022-02-07	
J	Peek-Asa, C; Coman, MA; Zorn, A; Chikhladze, N; Cebanu, S; Tadevosyan, A; Hamann, CJ				Peek-Asa, Corinne; Coman, Madalina Adina; Zorn, Alison; Chikhladze, Nino; Cebanu, Serghei; Tadevosyan, Artashes; Hamann, Cara J.			Association of traumatic brain injury severity and time to definitive care in three low-middle-income European countries	INJURY PREVENTION			English	Article						traumatic brain injury; registry; global	PREHOSPITAL TIME; GOLDEN HOUR; MORTALITY; EPIDEMIOLOGY	Background Low-middle-income countries experience among the highest rates of traumatic brain injury in the world. Much of this burden may be preventable with faster intervention, including reducing the time to definitive care. This study examines the relationship between traumatic brain injury severity and time to definitive care in major trauma hospitals in three low-middle-income countries. Methods A prospective traumatic brain injury registry was implemented in six trauma hospitals in Armenia, Georgia and the Republic of Moldova for 6 months in 2019. Brain injury severity was measured using the Glasgow Coma Scale (GCS) at admission. Time to definitive care was the time from injury until arrival at the hospital. Cox proportionate hazards models predicted time to care by severity, controlling for age, sex, mechanism, mode of transportation, location of injury and country. Results Among 1135 patients, 749 (66.0%) were paediatric and 386 (34.0%) were adults. Falls and road traffic were the most common mechanisms. A higher proportion of adult (23.6%) than paediatric (5.4%) patients had GCS scores indicating moderate (GCS 9-11) or severe injury (GCS 0-8) (p<0.001). Less severe injury was associated with shorter times to care, while more severe injury was associated with longer times to care (HR=1.05, 95% CI 1.01 to 1.09). Age interacted with time to care, with paediatric cases receiving faster care. Conclusions Implementation of standard triage and transport protocols may reduce mortality and improve outcomes from traumatic brain injury, and trauma systems should focus on the most severe injuries.	[Peek-Asa, Corinne; Hamann, Cara J.] Univ Iowa, Occupat & Environm Hlth, Iowa City, IA USA; [Coman, Madalina Adina] Babes Bolyai Univ, Fac Polit Adm & Commun Sci, Publ Hlth, Cluj Napoca, Cluj, Romania; [Zorn, Alison] Univ Iowa, Biostat, Iowa City, IA USA; [Chikhladze, Nino] Ivane Javakhishvili Tbilisi State Univ, Publ Hlth, Tbilisi, Georgia; [Cebanu, Serghei] Moldova State Univ, Dept Hyg, Kishinev, Moldova; [Tadevosyan, Artashes] Yerevan State Med Univ, Dept Publ Hlth & Healthcare Org, Yerevan, Armenia		Peek-Asa, C (corresponding author), Iowa Board Regents, Occupat & Environm Hlth, Urbandale, IA 52242 USA.	corinne-peek-asa@uiowa.edu	Cebanu, Serghei/AAD-2079-2022; Coman, Madalina/AAS-9973-2021	Cebanu, Serghei/0000-0002-2493-4882; Hamann, Cara/0000-0001-8916-7285	NIH--Fogarty International Center project iCREATE: Increasing Capacity for Research in Eastern Europe (National Institutes of Health, Fogarty International Center) [2D43TW007261]; NIH--National Institute for Neurological Disease and Stroke project INITIATE: International Collaboration to Increase Traumatic Brain Injury in Europe [5R21NS098850]	This work was funded by the NIH--Fogarty International Center project iCREATE: Increasing Capacity for Research in Eastern Europe (National Institutes of Health, Fogarty International Center 2D43TW007261, Peek--Asa and Dulf, Co--PIs) and NIH--National Institute for Neurological Disease and Stroke project INITIATE: International Collaboration to Increase Traumatic Brain Injury in Europe (5R21NS098850, Peek--Asa and Dulf, Co--PIs).	Bedard AF, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00324-7; Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Boschini LP, 2016, INJURY, V47, P1118, DOI 10.1016/j.injury.2016.01.015; Botchey IM, 2017, SURGERY, V162, pS45, DOI 10.1016/j.surg.2017.01.030; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Dulf D, 2021, WORLD NEUROSURG, V146, pE517, DOI 10.1016/j.wneu.2020.10.115; Evaniew N, 2014, J ORTHOP TRAUMA, V28, pS15, DOI 10.1097/BOT.0000000000000103; FEERO S, 1995, AM J EMERG MED, V13, P133, DOI 10.1016/0735-6757(95)90078-0; GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators, LANCET NEUROL, V2019, P56; Kidher E, 2012, INJURY, V43, P1386, DOI 10.1016/j.injury.2011.04.014; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mahran A, 2020, J PEDIATR UROL, V16, DOI 10.1016/j.jpurol.2020.07.019; Murad MK, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-13; Murad MK, 2012, PREHOSP DISASTER MED, V27, P36, DOI 10.1017/S1049023X11006819; Newberry JA, 2019, EMERG MED J, V36, P176, DOI 10.1136/emermed-2018-207900; Newgard CD, 2016, J AM COLL SURGEONS, V222, P146, DOI 10.1016/j.jamcollsurg.2015.10.016; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Rehn Marius, 2011, Scand J Trauma Resusc Emerg Med, V19, P17, DOI 10.1186/1757-7241-19-17; Riemann L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00345; Settervall Cristina Helena Costanti, 2011, Rev. Latino-Am. Enfermagem, V19, P1337; Staudenmayer K, 2016, J TRAUMA ACUTE CARE, V80, P412, DOI 10.1097/TA.0000000000000956; Suryanto MN, 2017, PREHOSP DISASTER MED, V32, P64, DOI 10.1017/S1049023X1600114X; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Van Ditshuizen JC, 2020, J TRAUMA ACUTE CARE, V89, P801, DOI 10.1097/TA.0000000000002850; van Rein EAJ, 2017, J TRAUMA ACUTE CARE, V83, P328, DOI 10.1097/TA.0000000000001516; Wyen H, 2013, EMERG MED J, V30, P1048, DOI 10.1136/emermed-2012-201962; Zabek M, 2007, NEUROL NEUROCHIR POL, V41, P22	29	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	FEB	2022	28	1					54	60		10.1136/injuryprev-2020-044049		APR 2021	7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	YN6CY	WOS:000727513500001	33910969				2022-02-07	
J	[Anonymous]				[Anonymous]			Abstracts from the 2020 Research and Thesis Poster Session of the 55th Annual American Dance Therapy Association Conference, Online	AMERICAN JOURNAL OF DANCE THERAPY			English	Article						Dance; movement therapy research; Research posters; Abstracts; Conference proceedings		The Research and Practice Committee of the American Dance Therapy Association (ADTA) presents the research poster session at each annual conference. The abstracts reported in this paper were selected by the authors for the 2020 Virtual Research and Thesis Poster Session at the 55(th) Annual ADTA Conference. This year, the 55th Annual ADTA conference took place online, on a virtual platform, featuring three major themes: 1) Emotional regulation and narrative therapy; 2) Dementia, Parkinson's disease, traumatic brain injury, and use of props across all ages; 3) Identity, inclusion and diversity issues within dance/movement therapy. The following ten poster abstracts have been selected for their quality and contributions to dance/movement therapy literature and feature a wide range of scholarly works in current research.										0	0	0	0	0	KLUWER ACADEMIC-HUMAN SCIENCES PRESS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0146-3721	1573-3262		AM J DANCE THER	Am. J. Dance Ther.	JUN	2021	43	1					92	102		10.1007/s10465-021-09344-z		APR 2021	11	Psychology, Multidisciplinary; Rehabilitation	Emerging Sources Citation Index (ESCI)	Psychology; Rehabilitation	TA7LY	WOS:000645218500002					2022-02-07	
J	Andreassen, M; Danielsson, H; Hemmingsson, H; Jaarsma, T				Andreassen, Maria; Danielsson, Henrik; Hemmingsson, Helena; Jaarsma, Tiny			An interactive digital calendar with mobile phone reminders (RemindMe) for people with cognitive impairment: a pilot randomized controlled trial	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article; Early Access						Brain injuries; occupational therapy; prospective memory; rehabilitation; self-help devices; smartphone; stroke; time management	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; REHABILITATION; TECHNOLOGY; STROKE; TASKS	Background People with cognitive impairment often need support to perform everyday-life activities. Interventions are available, but evidence-based interventions are lacking. Aim This pilot RCT aimed to investigate use of an intervention with an interactive digital calendar with mobile phone reminders (RemindMe) in relation to change in outcomes and impact on occupational performance, independence, health-related quality of life, and psychosocial impact of the support for people with cognitive impairment. Method The study design was a multi-centre parallel-group pilot RCT [ClinicalTrails.gov, identifier: NCT04470219]. Fifteen participants from primary rehabilitation centres in Sweden were recruited and randomly assigned to intervention group (n = 8) receiving the intervention with RemindMe, or control group (n = 7) receiving usual treatment by an occupational therapist. Data were collected at baseline, after two- and four months, and analysed using descriptive and non-parametric statistics. Result The Canadian Occupational Performance Measure (COPM), and the Functional Independence Measure (FIM item n-r) showed significant differences. There were no significant differences in health-related quality of life nor in the psychosocial impact of the used support. Conclusion Plausible changes in outcome measures were found in COPM and FIM (items n-r). These instruments indicate change in outcome measures and impact on occupational performance and independence.	[Andreassen, Maria; Hemmingsson, Helena; Jaarsma, Tiny] Linkoping Univ, Dept Hlth Med & Caring Sci, S-60174 Norrkoping, Sweden; [Danielsson, Henrik] Linkoping Univ, Swedish Inst Disabil Res, Linkoping, Sweden; [Danielsson, Henrik] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Hemmingsson, Helena] Stockholm Univ, Dept Special Educ, Stockholm, Sweden		Andreassen, M (corresponding author), Linkoping Univ, Dept Hlth Med & Caring Sci, S-60174 Norrkoping, Sweden.	maria.andreassen@liu.se	; Danielsson, Henrik/F-5986-2010	Hemmingsson, Helena/0000-0003-1281-6392; Danielsson, Henrik/0000-0002-0446-0827; Andreassen, Maria/0000-0001-8962-196X	VR FORTE [2014-4100]; Region Ostergotland [LIO-815111]; Swedish Stroke Association (STROKE-Riksforbundet)	This work was part of the research programme, ICT4Self-Care, supported by [VR FORTE] under Grant [2014-4100]; [the Research and scholarship management in Region _Osterg_otland] under Grant [LIO-815111]; and [The Swedish Stroke Association (STROKE-Riksforbundet)].	Andreassen M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072222; Axelsson SW, 2016, TECHNOLOGIES, V4, DOI 10.3390/technologies4030029; Baric V, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1128-9; Bateman DR, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7814; Beck CT., 2017, NURSING RES PRINCIPL; Boman IL, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0238-x; Bradbury K., 2014, EVID BASE COMPL ALTE, V2014, P1; Branco JP, 2019, EUR J PHYS REHAB MED, V55, P1, DOI 10.23736/S1973-9087.18.05161-4; Brandt A, 2020, DISABIL REHABIL-ASSI, V15, P810, DOI 10.1080/17483107.2020.1765032; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cohen J., 2013, STAT POWER ANAL BEHA; Day H, 2002, DISABIL REHABIL, V24, P31, DOI 10.1080/09638280110066343; Devitt Rachel, 2004, Occup Ther Health Care, V17, P63, DOI 10.1080/J003v17n03_05; Eldridge SM, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5239; Ferguson S, 2015, BRAIN INJURY, V29, P583, DOI 10.3109/02699052.2014.1002109; Fritz H, 2017, J OCCUP SCI, V24, P446, DOI 10.1080/14427591.2017.1366354; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillen G., 2015, STROKE REHABILITATIO; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Grimby G, 1996, SCAND J REHABIL MED, V28, P51; Hunger M, 2012, QUAL LIFE RES, V21, P1205, DOI 10.1007/s11136-011-0024-3; Kettlewell J, 2019, CLIN REHABIL, V33, P1705, DOI 10.1177/0269215519865774; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lannin N, 2014, CLIN REHABIL, V28, P470, DOI 10.1177/0269215513512216; Lo Buono V, 2017, J HEALTH PSYCHOL, V22, P16, DOI 10.1177/1359105315595117; Medical Research Council (MRC), 2019, DEV EV COMPL INT; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Organisation mondiale de la sante World Health Organization & World Health Organization Staff, 2001, INT CLASS FUNCT DIS; Pretz CR, 2016, J NEUROTRAUM, V33, P1358, DOI 10.1089/neu.2015.4138; Ronnlund M, 2003, AGING NEUROPSYCHOL C, V10, P182, DOI 10.1076/anec.10.3.182.16449; Stephens JA, 2015, OTJR-OCCUP PART HEAL, V35, P5, DOI 10.1177/1539449214561765; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; Tamez E, 2011, BEHAV NEUROL, V24, P177, DOI [10.1155/2011/139703, 10.3233/BEN-2011-0328]; Taylor R. R., 2017, KIELHOFNERS MODEL HU; The National Board of Health and Welfare, 2018, NAT GUID STROK CAR S; Viscogliosi C, 2019, CAN J AGING, V38, P222, DOI 10.1017/S0714980818000521; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	38	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.												10.1080/11038128.2021.1917654		APR 2021	12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	SI2VB	WOS:000654683200001	33909985	Green Published, hybrid			2022-02-07	
J	Benassi, M; Frattini, D; Garofalo, S; Bolzani, R; Pansell, T				Benassi, Mariagrazia; Frattini, Davide; Garofalo, Sara; Bolzani, Roberto; Pansell, Tony			Visuo-motor integration, vision perception and attention in mTBI patients. Preliminary findings	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; TRAUMATIC BRAIN-INJURY; COORDINATION; ADJUSTMENTS; PERFORMANCE; CHILDREN; DEFICITS; HAND; 1ST	Patients with mild traumatic brain injuries (mTBI) often report difficulties in motor coordination and visuo-spatial attention. However, the consequences of mTBI on fine motor and visuo-motor coordination are still not well understood. We aimed to evaluate whether mTBI had a concomitant effect on fine motor ability and visuo-motor integration and whether this is related to visual perception and visuo-spatial attention impairments, including patients at different symptoms stage. Eleven mTBI patients (mean age 22.8 years) and ten healthy controls participated in the study. Visuo-motor integration of fine motor abilities and form recognition were measured with the Beery-Buktenica Developmental Test of Visual-Motor Integration test, motion perception was evaluated with motion coherence test, critical flicker fusion was measured with Pocket CFF tester. Visuo-spatial was assessed with the Ruff 2 & 7 Selection Attention Test. mTBI patients showed reduced visuo-motor integration, form recognition, and motor deficits as well as visuo-spatial attention impairment, while motion perception and critical flicker fusion were not impaired. These preliminary findings suggest that the temporary brain insults deriving from mTBI compromise fine motor skills, visuomotor integration, form recognition, and visuo-spatial attention. The impairment in visuo-motor coordination was associated with speed in visuo-attention and correlated with symptoms severity while motor ability was correlated with time since concussion. Given the strong correlation between visuomotor coordination and symptom severity, further investigation with a larger sample seems warranted. Since there appeared to be differences in motor skills with respect to symptom stage, further research is needed to investigate symptom profiles associated with visuomotor coordination and fine motor deficits in mTBI patients.	[Benassi, Mariagrazia; Frattini, Davide; Garofalo, Sara; Bolzani, Roberto] Univ Bologna, Dept Psychol, Bologna, Italy; [Pansell, Tony] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden		Benassi, M (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	mariagrazia.benassi@unibo.it		Frattini, Davide/0000-0002-8055-987X; Pansell, Tony/0000-0001-7642-8263			Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Beery KA., 2010, ENCY CHILD BEHAV DEV; Benassi M, 2018, CHILD DEV, V89, pE494, DOI 10.1111/cdev.12945; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Cacola P, 2018, INT J DEV NEUROSCI, V65, P83, DOI 10.1016/j.ijdevneu.2017.11.001; Cantarero G, 2020, NEUROREHAB NEURAL RE, V34, P804, DOI 10.1177/1545968320943578; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Eisen-Enosh A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15034-z; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Kaiser ML, 2009, J OCC THER SCH EARLY, V2, P87, DOI 10.1080/19411240903146228; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Messinis L, 2007, ARCH CLIN NEUROPSYCH, V22, P773, DOI 10.1016/j.acn.2007.06.005; Nardella A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098948; Passarelli L, 2011, J NEUROSCI, V31, P1790, DOI 10.1523/JNEUROSCI.4784-10.2011; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Piponnier JC, 2016, J NEUROTRAUM, V33, P242, DOI 10.1089/neu.2014.3832; Schrupp LE, 2009, OPTOMETRY, V80, P642, DOI 10.1016/j.optm.2009.04.097; Seitz AR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000028; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Spiegel DP, 2016, VISION RES, V122, P43, DOI 10.1016/j.visres.2016.03.004; Staugaard CF, 2016, NEUROPSYCHOLOGIA, V92, P69, DOI 10.1016/j.neuropsychologia.2016.06.020; Studenka BE, 2019, J SPORT HEALTH SCI, V8, P540, DOI 10.1016/j.jshs.2017.03.006; Sutton GP, 2011, PSYCHOL ASSESSMENT, V23, P805, DOI 10.1037/a0023370; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yu HH, 2015, NEUROSCI RES, V93, P47, DOI 10.1016/j.neures.2014.09.004	40	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2021	16	4							e0250598	10.1371/journal.pone.0250598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8OK	WOS:000665456800026	33905440	Green Published, gold			2022-02-07	
J	Gupta, M; Yekula, A; Barba, D; Pannell, JS; Tomlin, J				Gupta, Mihir; Yekula, Anudeep; Barba, David; Pannell, J. Scott; Tomlin, Jeffrey			Traumatic ischemic injury in a top of the basilar distribution: a case report	BMC NEUROLOGY			English	Article						Top of the basilar; Traumatic brain injury; Case report		Background Top of the basilar syndrome is a rare, heterogeneous disorder that has previously only been described in the setting of acute ischemic stroke in predominantly elderly patients. We present the first reported case of traumatic brain injury (TBI) causing ischemia in a top of the basilar distribution. Case presentation A 19-year-old woman suffered an acute subdural hematoma and sustained hypoxemia after being struck by a motor vehicle. Neurosurgical evacuation of the hematoma was undertaken. Magnetic resonance imaging revealed ischemic injury in the midbrain and diencephalic structures fitting a top of the basilar distribution. No associated vascular injury was identified. The patient was eventually discharged in a state of persistent unresponsive wakefulness. Conclusions Ischemia in a top of the basilar distribution may occur in the setting of TBI. A high degree of clinical suspicion is required to identify this disorder. Further study of the complex inflammatory microenvironment and associated tissue perfusion dynamics in TBI are needed in order to elucidate the mechanisms underlying ischemic injury patterns, develop management paradigms and predict prognosis.	[Gupta, Mihir; Barba, David; Pannell, J. Scott; Tomlin, Jeffrey] Univ Calif San Diego, Dept Neurosurg, 1335 Sunset Cliffs Blvd, San Diego, CA 92107 USA; [Yekula, Anudeep] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Tomlin, Jeffrey] Naval Med Ctr Portsmouth, Dept Neurosurg, Portsmouth, VA USA		Gupta, M (corresponding author), Univ Calif San Diego, Dept Neurosurg, 1335 Sunset Cliffs Blvd, San Diego, CA 92107 USA.	mig044@health.ucsd.edu		Gupta, Mihir/0000-0003-1329-2906; Yekula, Anudeep/0000-0002-0713-0292			CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kumral E, 2002, STROKE, V33, P2224, DOI 10.1161/01.STR.0000027438.93029.87; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091	5	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	APR 27	2021	21	1							178	10.1186/s12883-021-02207-7			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RT7PC	WOS:000644648300001	33902491	gold, Green Published			2022-02-07	
J	Huang, CM; Huang, RH; Majid, BY				Huang, Chiming; Huang, Rosa H.; Majid, Bani Yaghoub			Traumatic brain injury risk assessment with smart technology	JOURNAL OF DEFENSE MODELING AND SIMULATION-APPLICATIONS METHODOLOGY TECHNOLOGY-JDMS			English	Article; Early Access						Concussion; traumatic brain injury; kinematics; pitch; roll; yaw	HEAD IMPACTS; CONCUSSION	Mild traumatic brain injuries (mTBIs) continue to burden our warfighters. The high-tech industry has delivered wearable Micro-Electro-Mechanical System (MEMS) head-impact sensors to monitor impact forces. So far, these MEMS sensors have categorically failed to detect mTBIs and are therefore of no clinical utility for diagnosis. Our recent studies have shown that human head kinematics is anisotropic with respect to pitch-roll-yaw degrees of freedom of the head and neck. In the present project, we generated head acceleration datasets on non-injurious impacts and mTBI events based on mean values from the literature. We then augmented the simulated data with pitch-roll-yaw information followed by machine learning with a Classification and Regression Tree analysis. Our results revealed that head angular acceleration in pitch is the best predictor. More than 81.3 % of concussive injuries had head angular accelerations in pitch exceeding 3527 rad/s(2). Out of 18.6% of concussive injuries with head angular accelerations in pitch under 3527 rad/s(2), 75% of these cases had head angular accelerations in roll exceeding 1679 rad/s(2). This study shows that artificial intelligence and machine learning should be able to provide accurate identification of subject-specific concussive thresholds in real time and in the field, thereby moving concussion diagnosis toward precision medicine.	[Huang, Chiming] Univ Missouri, Sch Biol & Chem Sci, 5100 Rockhill Rd, Kansas City, MO 64110 USA; [Huang, Rosa H.] Univ Missouri, Sch Med, Kansas City, MO USA; [Majid, Bani Yaghoub] Univ Missouri, Dept Math & Stat, Kansas City, MO USA		Huang, CM (corresponding author), Univ Missouri, Sch Biol & Chem Sci, 5100 Rockhill Rd, Kansas City, MO 64110 USA.; Huang, CM (corresponding author), Univ Missouri, Sch Biol & Chem Sci, Kansas City, MO USA.	huangc@umkc.edu			Leonard Wood Institute; US Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]; Helen S. Boylan Foundation; UMKC Institute for Data Education, Analytics and Science	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Leonard Wood Institute in cooperation with the US Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-14-2-0034. This study was also supported by the Helen S. Boylan Foundation and a grant from the UMKC Institute for Data Education, Analytics and Science.	Army Technology, BAE SUPPLY ADDITIONA; Boothe DL, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00236; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Fitzpatrick RC, 2006, CURR BIOL, V16, P1509, DOI 10.1016/j.cub.2006.05.063; Good TJ., 2015, THESIS U TORONTO CAN; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hernandez F, 2019, J NEUROTRAUM, V36, P1125, DOI 10.1089/neu.2016.4758; Huang C., CONCUSSIVE THRESHOLD; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Purves D., 2017, NEUROSCIENCE; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Somvanshi M., 2016, P INT C COMP COMM CO, P1, DOI 10.1109/ICCUBEA.2016.7860040; The National Institute of Health Pediatric Concussion Workshop, 2016, NIH PEDIAT CONCUSSIO; The United States Army Acquisition Support Center, MED COMMUNICATIONS C; Traumatic Brain Injury Center of Excellence, DOD TBI NUMBERS; Turgoose D, 2018, Open Acc J Neurol Neurosurg, V7; Wei Li, 2011, Proceedings of the 2011 Seventh International Conference on Computational Intelligence and Security (CIS 2011), P1279, DOI 10.1109/CIS.2011.283; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	22	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1548-5129	1557-380X		J DEF MODEL SIMUL-AP	J. Def. Model. Simul.-Appl. Methodol. Technol.-JDMS											15485129211008529	10.1177/15485129211008529		APR 2021	9	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	RY5BX	WOS:000647927900001					2022-02-07	
J	Wada, D; Hayakawa, K; Saito, F; Yoshiya, K; Nakamori, Y; Kuwagata, Y				Wada, Daiki; Hayakawa, Koichi; Saito, Fukuki; Yoshiya, Kazuhisa; Nakamori, Yasushi; Kuwagata, Yasuyuki			Combined brain and thoracic trauma surgery in a hybrid emergency room system: a case report	BMC SURGERY			English	Article						Hybrid emergency room (Hybrid ER); Thoracic endovascular aneurysm repair (TEVAR); Intracranial pressure (ICP); Cerebral perfusion pressure; Traumatic brain injury	BODY COMPUTED-TOMOGRAPHY; BLEEDING CONTROL; MANAGEMENT; IMPACT; MORTALITY; INJURIES	Background A novel trauma workflow system called the hybrid emergency room (Hybrid ER), which combines a sliding CT scanner system with interventional radiology features (IVR-CT), was initially instituted in our emergency department in 2011. Use of the Hybrid ER enables CT diagnosis and emergency therapeutic interventions without transferring the patient to another room. We describe an illustrative case of severe multiple blunt trauma that included injuries to the brain and torso to highlight the ability to perform multiple procedures in the Hybrid ER. Case presentation A 46-year-old man sustained multiple injuries after falling from height. An early CT scan performed in the Hybrid ER revealed grade IIIa thoracic aortic injury, left lung contusion, and right subdural haematoma and subarachnoid haemorrhage. Without relocating the patient, all definitive procedures, including trepanation, total pneumonectomy, and thoracic endovascular aneurysm repair were performed in the Hybrid ER. At 5.72 h after definitive surgery was begun, the patient was transferred to the intensive care unit. Conclusions The Hybrid ER has the potential to facilitate the performance of multiple definitive procedures in combination to treat severe multiple blunt trauma including injuries to the brain and torso. Emergency departments with more than one resuscitation room would benefit from a Hybrid ER to treat complex emergency cases.	[Wada, Daiki; Saito, Fukuki; Yoshiya, Kazuhisa; Nakamori, Yasushi] Kansai Med Univ, Gen Med Ctr, Dept Emergency & Crit Care Med, 10-15 Fumizono Cho, Moriguchi, Osaka 5708507, Japan; [Hayakawa, Koichi] Nagasaki Univ, Coordinat Off Emergency Med & Int Response, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan; [Kuwagata, Yasuyuki] Kansai Med Univ Hosp, Dept Emergency & Crit Care Med, 2-3-1 Shinmachi, Hirakata, Osaka 5731191, Japan		Wada, D (corresponding author), Kansai Med Univ, Gen Med Ctr, Dept Emergency & Crit Care Med, 10-15 Fumizono Cho, Moriguchi, Osaka 5708507, Japan.	dk0116-w@live.jp					Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Bunya N, 2017, INT J EMERG MED, V10, DOI 10.1186/s12245-017-0145-8; Committee on Trauma, 2009, AM COLL SURGEONS ADV, V8; Dai DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074204; GAILLARD M, 1990, J TRAUMA, V30, P93, DOI 10.1097/00005373-199001000-00015; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Huber S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0052-4; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inthorn D, 1992, Anasthesiol Intensivmed Notfallmed Schmerzther, V27, P498, DOI 10.1055/s-2007-1000347; Jin PHPFK, 2008, J TRAUMA, V64, P1320, DOI 10.1097/TA.0b013e318059b9ae; Kinoshita T, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0218-x; Kinoshita T, 2019, ANN SURG, V269, P370, DOI 10.1097/SLA.0000000000002527; Miyazaki K, 2019, AM J EMERG MED, V37, P2132, DOI 10.1016/j.ajem.2019.01.039; Philipp MO, 2003, EUR J RADIOL, V48, P2, DOI 10.1016/S0720-048X(03)00206-7; Ried M, 2013, CRIT CARE, V17, DOI 10.1186/cc12782; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Wada D, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0484-3; Wada D, 2013, CRIT CARE, V17, DOI 10.1186/cc12861; Wada D, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-52; Watanabe H, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0532-z; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4; Yeguiayan JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11375	24	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2482		BMC SURG	BMC Surg.	APR 27	2021	21	1							219	10.1186/s12893-021-01218-y			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RW8NO	WOS:000646776700001	33906660	Green Published, gold			2022-02-07	
J	Rostowsky, KA; Irimia, A				Rostowsky, Kenneth A.; Irimia, Andrei		Alzheimers Dis Neuroimaging Initia	Acute cognitive impairment after traumatic brain injury predicts the occurrence of brain atrophy patterns similar to those observed in Alzheimer's disease	GEROSCIENCE			English	Article						Traumatic brain injury; Alzheimer&#8217; s disease; Mild cognitive impairment; Neuroimaging		Traumatic brain injuries (TBIs) are often followed by persistent structural brain alterations and by cognitive sequalae, including memory deficits, reduced neural processing speed, impaired social function, and decision-making difficulties. Although mild TBI (mTBI) is a risk factor for Alzheimer's disease (AD), the extent to which these conditions share patterns of macroscale neurodegeneration has not been quantified. Comparing such patterns can not only reveal how the neurodegenerative trajectories of TBI and AD are similar, but may also identify brain atrophy features which can be leveraged to prognosticate AD risk after TBI. The primary aim of this study is to systematically map how TBI affects white matter (WM) and gray matter (GM) properties in AD-analogous patterns. Our findings identify substantial similarities in the regional macroscale neurodegeneration patterns associated with mTBI and AD. In cerebral GM, such similarities are most extensive in brain areas involved in memory and executive function, such as the temporal poles and orbitofrontal cortices, respectively. Our results indicate that the spatial pattern of cerebral WM degradation observed in AD is broadly similar to the pattern of diffuse axonal injury observed in TBI, which frequently affects WM structures like the fornix, corpus callosum, and corona radiata. Using machine learning, we find that the severity of AD-like brain changes observed during the chronic stage of mTBI can be accurately prognosticated based on acute assessments of post-traumatic mild cognitive impairment. These findings suggest that acute post-traumatic cognitive impairment predicts the magnitude of AD-like brain atrophy, which is itself associated with AD risk.	[Rostowsky, Kenneth A.; Irimia, Andrei] Univ Southern Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Irimia, Andrei] Univ Southern Calif, Corwin D Denney Res Ctr, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90007 USA		Irimia, A (corresponding author), Univ Southern Calif, Corwin D Denney Res Ctr, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90007 USA.	irimia@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 100973]; DoDUnited States Department of Defense [W81-XWH-1810413]; Hanson-Thorell Research Scholarship; Undergraduate Research Associate Program (URAP) at the University of Southern California; Alzheimer's Disease Neuroimaging Initiative (ADNI, NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 AG024904]; DoD ADNIUnited States Department of Defense [W81XWH-12-2-0012]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); AbbVieAbbVie; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; BiogenBiogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; CereSpir, Inc.; CogstateCogState Limited; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; EuroImmun; F. Hoffmann-La Roche LtdHoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech; Fujirebio; GE HealthcareGeneral ElectricGE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.Johnson & JohnsonJohnson & Johnson USA; LundbeckLundbeck Corporation; Merck Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Transition Therapeutics; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Lumosity; Neurotrack Technologies	This work was supported by NIH grant R01 NS 100973 to A.I., by DoD award W81-XWH-1810413 to A.I., by a Hanson-Thorell Research Scholarship to A.I., and by a grant from the Undergraduate Research Associate Program (URAP) at the University of Southern California toA.I. Data collection and sharing for this project were funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI, NIH Grant U01 AG024904) and DoD ADNI (DoD award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd, and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Alves GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052859; Amlien IK, 2014, NEUROSCIENCE, V276, P206, DOI 10.1016/j.neuroscience.2014.02.017; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; BRUN A, 1981, HISTOPATHOLOGY, V5, P549, DOI 10.1111/j.1365-2559.1981.tb01818.x; Burgmans S, 2010, NEUROIMAGE, V49, P2083, DOI 10.1016/j.neuroimage.2009.10.035; Calvillo M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01423; Cazalis Fabienne, 2011, Front Neurol, V1, P158, DOI 10.3389/fneur.2010.00158; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101; Chen Shao-qiong, 2007, Journal of Zhejiang University-Science B, V8, P242, DOI 10.1631/jzus.2007.B0242; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Collette F, 1999, CORTEX, V35, P57, DOI 10.1016/S0010-9452(08)70785-8; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Duering M, 2014, NEUROLOGY, V82, P1946, DOI 10.1212/WNL.0000000000000475; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Eshkoor SA, 2015, CLIN INTERV AGING, V10, P687, DOI 10.2147/CIA.S73922; Fortin JP, 2018, NEUROIMAGE, V167, P104, DOI 10.1016/j.neuroimage.2017.11.024; Fortin JP, 2017, NEUROIMAGE, V161, P149, DOI 10.1016/j.neuroimage.2017.08.047; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Georges A, 2020, TRAUMATIC BRAIN INJU; Gilmore JH, 2007, AM J NEURORADIOL, V28, P1789, DOI 10.3174/ajnr.A0751; Gilmour G, 2019, NEUROSCI BIOBEHAV R, V97, P47, DOI 10.1016/j.neubiorev.2018.09.025; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Guarino A, 2019, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00437; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Halgren E, 2011, HUM BRAIN MAPP, V32, P1260, DOI 10.1002/hbm.21106; Han H, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080198; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hinkebein JH, 2003, BRAIN INJURY, V17, P1035, DOI 10.1080/0269905031000110490; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Hoffelder T, 2015, J BIOPHARM STAT, V25, P417, DOI 10.1080/10543406.2014.920344; Hsu JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137121; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irimia A, 2006, PHYS MED BIOL, V51, P1347, DOI 10.1088/0031-9155/51/5/022; Irimia A, 2005, J PHYS A-MATH GEN, V38, P8123, DOI 10.1088/0305-4470/38/37/012; Irimia A, 2005, PHYS MED BIOL, V50, P4429, DOI 10.1088/0031-9155/50/18/012; Irimia A, 2020, GEROSCIENCE, V42, P1411, DOI 10.1007/s11357-020-00245-6; Irimia A, 2020, I S BIOMED IMAGING, P1690, DOI 10.1109/ISBI45749.2020.9098476; Irimia A, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00009; Irimia A, 2018, NEUROBIOL AGING, V66, P158, DOI 10.1016/j.neurobiolaging.2018.02.026; Irimia A, 2015, BRAIN IMAGING BEHAV, V9, P678, DOI 10.1007/s11682-014-9321-0; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Irimia A, 2015, J CLIN NEUROSCI, V22, P627, DOI 10.1016/j.jocn.2014.09.019; Irimia A, 2013, CLIN NEUROPHYSIOL, V124, P2129, DOI 10.1016/j.clinph.2013.04.336; Iscan Z, 2015, HUM BRAIN MAPP, V36, P3472, DOI 10.1002/hbm.22856; Iverson, 2020, GLASGOW COMA SCALE; Ji F, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0292-4; Johansson B, 2020, BRAIN INJURY, V34, P229, DOI 10.1080/02699052.2019.1683898; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jonasson A, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1056; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kim YJ, 2015, EUR J NEUROL, V22, P709, DOI 10.1111/ene.12645; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kircher T, 2011, BRAIN RES, V1391, P71, DOI 10.1016/j.brainres.2011.03.054; Kljajevic V, 2015, CROAT MED J, V56, P573, DOI 10.3325/cmj.2015.56.573; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; LANGE KW, 1995, J NEUROL NEUROSUR PS, V58, P598, DOI 10.1136/jnnp.58.5.598; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lee SH, 2015, NEUROSCIENCE, V301, P79, DOI 10.1016/j.neuroscience.2015.05.049; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lima E. A., 2006, SQUID HDB, V2, P139, DOI [10.1002/9783527609956.ch10, DOI 10.1002/9783527609956.CH10]; Liu JY, 2020, AM J NEURORADIOL, V41, P1397, DOI 10.3174/ajnr.A6622; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MACK JL, 1995, NEUROPSYCHOLOGY, V9, P556, DOI 10.1037/0894-4105.9.4.556; Marco EJ, 2012, J INT NEUROPSYCH SOC, V18, P521, DOI 10.1017/S1355617712000045; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Melrose RJ, 2009, INT J GERIATR PSYCH, V24, P885, DOI 10.1002/gps.2229; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; NESTOR PG, 1991, DEV NEUROPSYCHOL, V7, P243, DOI 10.1080/87565649109540491; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Ozga-Hess JE, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113217; Paek EJ, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00073; Parente DB, 2008, AM J ROENTGENOL, V190, P1369, DOI 10.2214/AJR.07.2617; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Porcelli S, 2019, NEUROSCI BIOBEHAV R, V97, P10, DOI 10.1016/j.neubiorev.2018.09.012; Rostowsky KA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00948; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sachdev PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142388; Santhanam P, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1161; Satler Corina, 2017, Dement. neuropsychol., V11, P137, DOI 10.1590/1980-57642016dn11-020006; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Shah S., 2016, NEURAL BASES IMPAIRE; Shao MH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00878; Shaver TK, 2019, BRAIN RES, V1704, P103, DOI 10.1016/j.brainres.2018.10.004; Shin G, 2015, NEUROIMAGE, V113, P78, DOI 10.1016/j.neuroimage.2015.03.046; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Su E, 2015, FRONT NEUROSCI, V57, P41; Taylor, 2020, DIFFUSE AXONAL INJUR; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Vik Anne, 2006, Tidsskr Nor Laegeforen, V126, P2940; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Wang B, 2014, I S BIOMED IMAGING, P529, DOI 10.1109/ISBI.2014.6867925; Wang B, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1152, DOI 10.1109/ISBI.2012.6235764; Wang SY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49350-3; Warkentin S, 2008, NEUROPSYCHOLOGIA, V46, P1193, DOI 10.1016/j.neuropsychologia.2007.08.029; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Wellek S, 1996, BIOMETRICAL J, V38, P695, DOI 10.1002/bimj.4710380608; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	145	0	0	0	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	2509-2715	2509-2723		GEROSCIENCE	GeroScience	AUG	2021	43	4			SI		2015	2039		10.1007/s11357-021-00355-9		APR 2021	25	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	WU2HV	WOS:000644302800001	33900530	Green Published			2022-02-07	
J	Shahrestani, S; Ballatori, AM; Ton, A; Chen, XT; Zargarian, A; Chan, AK; Strickland, BA; Brunswick, A; Micko, A; Zada, G				Shahrestani, Shane; Ballatori, Alexander M.; Ton, Andy; Chen, Xiao T.; Zargarian, Ariana; Chan, Andrew K.; Strickland, Ben A.; Brunswick, Andrew; Micko, Alexander; Zada, Gabriel			Demographic-Dependent Risk of Developing Severe Novel Psychiatric Disorders after Concussion	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						anxiety; concussion; depression; homicidal ideation; suicidal ideation; traumatic brain injury		Current guidelines for patients experiencing a concussion or mild traumatic brain injury (mTBI) often focus on conservative care and observation. However, mTBI may increase the risk of severe novel psychiatric disorders (NPDs) within 180 days, and long-term management of mTBI should include psychiatric evaluation in patient populations. Retrospective cohort analysis was conducted using 8 years of the Nationwide Readmission Database. All individuals who were admitted for concussion and were readmitted within 180 days were queried. This cohort was then subdivided based on age, sex, and whether they experienced loss of consciousness (LOC) to control for demographic-dependent confounding. A binary decision tree provided recommendations for patients who may be at risk of developing severe NPDs. Analysis included 12,080 patients who experienced concussion. Males and females with LOC had higher rates of depression in all age quartiles within 180 days (p < 0.05). Young females with LOC had increased rates of suicidal ideation (p < 0.01), and those >25 years of age had increased rates of anxiety (p < 0.005). Adult males with LOC had increased rates of suicidal ideation (p < 0.002) and males >75 years of age had increased rates of anxiety at readmission (p < 0.05). Males without LOC had increased rates of depression (p < 0.005), with men in the second quartile also at higher risk of developing anxiety (p < 0.05). Females without LOC showed the fewest number of NPDs at readmission. Concussion may be associated with increased rates of NPDs in the first 6 months following discharge. We use these data to develop recommendations for psychiatric screening of patients with mTBI.	[Shahrestani, Shane; Ballatori, Alexander M.; Ton, Andy; Chen, Xiao T.; Strickland, Ben A.; Brunswick, Andrew; Micko, Alexander; Zada, Gabriel] Univ Southern Calif, Keck Sch Med, Dept Neurosurg, 1200 State St, Los Angeles, CA 90033 USA; [Zargarian, Ariana] Univ Southern Calif, Dept Psychiat, Keck Sch Med, Los Angeles, CA 90007 USA; [Chan, Andrew K.] UCSF Sch Med, Dept Neurosurg, San Francisco, CA USA; [Micko, Alexander] Med Univ Vienna, Dept Neurosurg, Vienna, Austria		Shahrestani, S (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Neurosurg, 1200 State St, Los Angeles, CA 90033 USA.	shanesha@usc.edu					Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Powell JW, 2001, J ATHL TRAINING, V36, P307; Rose C, 2003, AM J NURS, V103, P101, DOI 10.1097/00000446-200309000-00028; Rosenzweig L, 1992, J Psychosoc Nurs Ment Health Serv, V30, P5; Rundell JR, 2000, PSYCHIAT QUART, V71, P245, DOI 10.1023/A:1004682111070	22	0	0	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7467		APR 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RT1AF	WOS:000644198400001	33678007				2022-02-07	
J	Sy, ECN; Cisse, Y; Thiam, AB; Barry, LF; Mbaye, M; Diop, A; Thioub, M; Faye, M; Fahad, A; Ndongo, MM; Soilihi, AA; Doumbia, N; Ba, MC; Badiane, SB				Sy, El Hadji Cheikh Ndiaye; Cisse, Yakhya; Thiam, Alioune Badara; Barry, Lounceny Fatoumata; Mbaye, Maguette; Diop, Abdoulaye; Thioub, Mbaye; Faye, Mohameth; Fahad, Attoumane; Ndongo, Mouhamadou Moustapha; Soilihi, Ansaou Aboudou; Doumbia, Nantenin; Ba, Momar Code; Badiane, Seydou Boubacar			Decompressive craniectomy: indications and results of 24 cases at the neurosurgery clinic of Fann university hospital of Dakar	PAN AFRICAN MEDICAL JOURNAL			English	Article						Craniectomy; decompression; infarction; trauma	TRAUMATIC BRAIN-INJURY; MALIGNANT INFARCTION; PROGNOSTIC-FACTORS; CRANIOTOMY; SURGERY; HEMICRANIECTOMY; MANAGEMENT; PRESSURE	Decompressive craniectomy is a surgical technique considered to be the last step in the management of intracranial hypertension. The objective of our study was to evaluate our results in the management of intracranial hypertension by decompressive craniectomy. This was a retrospective study of 24 cases of decompressive craniectomy performed over a 9-year period (from January 2010 to December 2019) at the Fann Neurosurgery Clinic. The mean age of the patients was 33.82 years, there was a male predominance with a sex ratio of 2.42. The most frequent indication was severe cranioencephalic trauma with 50%. The cerebral computed tomography (CT) scan was the key examination and was performed in all our patients. Complications were entirely infectious and were the cause of 73.33% of deaths. Thirty-five percent of the patients had received prior treatment before the decompressive craniectomy. The functional prognosis was good in 44.44% of cases, moderate in 33.33% of cases, 1 (11.11%) patient had a severe disability and 1 (11.11%) patient was in a vegetative state. Mortality rate was 62.5% of patients in our study series. Despite the lack of sophisticated techniques for diagnosis and monitoring of intracranial hypertension, our results remain acceptable with 37.5% survival. The early completion of this surgery allows us to be more efficient with a significant reduction in morbidity and mortality.	[Sy, El Hadji Cheikh Ndiaye; Cisse, Yakhya; Thiam, Alioune Badara; Barry, Lounceny Fatoumata; Mbaye, Maguette; Thioub, Mbaye; Fahad, Attoumane; Ndongo, Mouhamadou Moustapha; Soilihi, Ansaou Aboudou; Doumbia, Nantenin; Ba, Momar Code; Badiane, Seydou Boubacar] Fann Univ Hosp Ctr, Neurosurg Dept, Dakar, Senegal; [Diop, Abdoulaye] Ziguinchor Reg Hosp, Neurosurg Unit, Ziguinchor, Senegal; [Faye, Mohameth] Idrissa Pouye Gen Hosp, Neurosurg Dept, Dakar, Senegal		Cisse, Y (corresponding author), Fann Univ Hosp Ctr, Neurosurg Dept, Dakar, Senegal.	yakhyacisse@hotmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agrawal D, 2005, EUR J CLIN MICROBIOL, V24, P772, DOI 10.1007/s10096-005-0017-7; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Debiais S, 2015, UNDER USE DECOMPRESS; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Faleiro RM, 2008, ARQ NEURO-PSIQUIAT, V66, P369, DOI 10.1590/S0004-282X2008000300017; Fourcade O, 2006, ANN FR ANESTH, V25, P858, DOI 10.1016/j.annfar.2006.03.015; Gupta R, 2004, STROKE, V35, P539, DOI 10.1161/01.STR.0000109772.64650.18; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Idali B, 2004, MED MALADIES INFECT, V34, P221, DOI 10.1016/j.medmal.2003.12.011; JENNETT B, 1975, LANCET, V1, P480; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kocher T., 1901, HIRNERSCHUTTERUNG HI, V3, P262; Kumar GSS, 2004, NEUROL INDIA, V52, P504; Mori K, 2004, SURG NEUROL, V62, P420, DOI 10.1016/j.surneu.2003.12.017; Motah M, 2010, AFR J NEUROL SCI, V29, P51; NORRIS JS, 1993, BRIT J HOSP MED, V49, P213; Ong YK, 2002, CHILD NERV SYST, V18, P340, DOI 10.1007/s00381-002-0597-9; Oyelese AA, 2005, NEUROSURGERY, V57, P594, DOI 10.1227/01.NEU.0000170437.79760DF; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Wada Y, 2002, NEUROL MED-CHIR, V42, P414, DOI 10.2176/nmc.42.414; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	35	0	0	0	0	AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET	KAMPALA	PO BOX 12874, KAMPALA, 00000, UGANDA		1937-8688		PAN AFR MED J	Pan Afr. Med. J.	APR 26	2021	38								399	10.11604/pamj.2021.38.399.27571			12	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	UR2LE	WOS:000696584800001	34381543				2022-02-07	
J	Glendon, K; Pain, M; Blenkinsop, G; Belli, A				Glendon, K.; Pain, M.; Blenkinsop, G.; Belli, A.			Does Vestibular-Ocular-Motor (VOM) Impairment Affect Time to Return to Play, Symptom Severity, Neurocognition and Academic Ability in Student-Athletes following acute Concussion?	BRAIN INJURY			English	Article						Sports-Related Concussion; Vestibular-Ocular-Motor Screening; neurocognition; academic capability		Introduction: Research indicates Sports-Related Concussion (SRC) impairs Vestibular-Ocular-Motor (VOM) function. The aim was to explore if VOM impairment correlates with longer Return To Play (RTP), symptom burden, neurocognitive performance and academic capability. Participants: 40 (61.4% male) Loughborough University, UK, rugby union student-athletes who sustained 42 SRCs. Methods: Student-athletes completed an assessment battery during pre-season (baseline), 2, 4, 8 and 14 days post-SRC and prior to RTP and were managed according to the rugby Football Union' community pathway. Outcome measures: Vestibular Ocular-Motor Screening (VOMS), Immediate Post-Concussion Assessment and Cognitive Test, Post-Concussion Symptom Scale, Perceived Academic Impairment Tool questionnaire and percentage of academic activities specifically missed due to SRC. Results: VOMS scores were significantly (p < 0.005) greater than baseline at all time points except RTP. Presence of VOM dysfunction at 14 days post-SRC significantly correlated with a longer RTP, greater symptom burden and increased odds ratio at 2, 4 and 8 days and academic time loss at 2, 4 and 8 days post-SRC. Conclusion: VOM impairment is associated with an increased symptom burden and impaired academic capability, and a longer time to RTP when present at 14 days post-SRC.	[Glendon, K.; Pain, M.; Blenkinsop, G.] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Belli, A.] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England		Glendon, K (corresponding author), Loughborough Univ, Performance Ctr, Sch Sport Exercise & Hlth Sci, Epinal Way, Loughborough LE11 3TU, Leics, England.	k.glendon@lboro.ac.uk	; Belli, Antonio/I-3799-2015	Glendon, Kerry/0000-0003-4261-6420; Belli, Antonio/0000-0002-3211-9933	Musculoskeletal Association of Chartered Physiotherapists; Association of chartered physiotherapists in sports and exercise medicine [ACPSEM Research Grant]	This work was supported by the Musculoskeletal Association of Chartered Physiotherapists [Level 3 Award]; Association of chartered physiotherapists in sports and exercise medicine [ACPSEM Research Grant].	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Brown R., 2018, BUCS SUPER RUGBY INJ; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Ciuffreda, 2002, CURR TREAT OPTION NE, V4, DOI 10.1007/s11940-002-0027-z; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Concussion Safety Protocol Management | NCAA.org, 2020, CONC SAF PROT MAN; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Dessy AM., 2017, CUREUS, V9; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Eddy R, 2020, CLIN J SPORT MED, V30, P239, DOI 10.1097/JSM.0000000000000586; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; England Rugby, 2019, AD CONC MAN GUID; Fuller GW., 2018, BR J SPORTS MED; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grossberg S, 2015, BRAIN RES, V1621, P270, DOI 10.1016/j.brainres.2014.11.018; Hair JF., 2006, MULTIVARIATE DATA AN, V6; Hall EE, 2015, CLIN J SPORT MED, V25, P291, DOI 10.1097/JSM.0000000000000133; Howell DR, 2020, J SCI MED SPORT, V23, P112, DOI 10.1016/j.jsams.2019.08.294; Howell DR, 2018, J CHILD NEUROL, V33, P794, DOI 10.1177/0883073818789320; IVERSON G, 2003, CLIN NEUROPSYCHOL, V17; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP., 2011, HDB SPORT NEUROPSYCH; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGinnis I, 2019, INT J ATHL THER TRAI, V24, P95, DOI 10.1123/ijatt.2018-0007; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Merritt VC, 2015, DEV NEUROPSYCHOL, V40, P45, DOI 10.1080/87565641.2014.979928; Molloy JH, 2017, J SCI MED SPORT, V20, P708, DOI 10.1016/j.jsams.2017.02.002; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Moran RN, 2018, SCAND J MED SCI SPOR, V28, P2686, DOI 10.1111/sms.13286; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2019, J ORTHOP SPORT PHYS, V49, P787, DOI 10.2519/jospt.2019.8855; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; SCHATZ P, 2006, ARCH CLIN NEUROPSYCH, V21, DOI DOI 10.1002/CENTRAL/CN-00552120/FULL; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P140, DOI 10.1016/j.msksp.2019.05.007; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P151, DOI 10.1016/j.msksp.2019.01.006; Schweizer TA., 2017, NEUROIMAGE CLIN, DOI 10.1016/j.nicl.2017.07.019; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Wallace J., 2018, ATHL TRAIN ED J ALLE, V13; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055; Willer BS., 2019, ARCH PHYS MED REHABI; Worts PR, 2019, AM J SPORT MED, V47, pNP13, DOI 10.1177/0363546518817763; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	66	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					788	797		10.1080/02699052.2021.1911001		APR 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000643849300001	33896286				2022-02-07	
J	Kent, JB; Sasser, P; Austin, AV; MacKnight, JM				Kent, Jeremy B.; Sasser, Phillip; Austin, Ashley V.; MacKnight, John M.			Are you missing a concussion by watching American football? Video analysis of ball location in a Division 1 football program	BRAIN INJURY			English	Article						Sport-related concussion; football position; collision partner; medical observer; ATC spotter		Objective Action in a football game occurs quickly. Medical staff can miss a sport-related concussion (SRC) if they do not observe it directly. The objective of this study is to determine if SRCs occur more frequently at ball than away from ball during gameplay. Game-specific concussion statistics can enhance medical provider care of athletes. Methods We used gameplay videos of an NCAA Division I football program to analyze SRCs and determine the primary tackler or ball handler during each concussion play. We compared the relative risk of SRCs for the primary ball handlers/tacklers to that of the other 10 players on the same team during that play. Results Over 10 seasons, 26 SRCs occurred at ball for the primary ball handler/tackler position (0.22 SRCs/game) versus 16 away from ball (0.13 SRCs/game). The relative risk of an SRC according to exposure (at ball) vs. no exposure (away from ball) was 16.2 (CI 8.7-30.2, P < .05). Special teams had more SRCs away from ball than at ball, but this was not significant (relative risk 3.32, CI 0.90-12.3, P > .05). Conclusions The study provides medical staff guidance to more efficiently identify in-game SRCs and supports evidence for rules changes.	[Kent, Jeremy B.] Univ Virginia Hlth Syst, Dept Family Med, UVa Sports Med, Charlottesville, VA 22903 USA; [Sasser, Phillip] Univ Wisconsin Hlth, Dept Pediat, Madison, WI USA; [Austin, Ashley V.] Univ Washington, Sch Med, Dept Family Med, Seattle, WA 98195 USA; [MacKnight, John M.] Univ Virginia Hlth Syst, UVA Sports Med, Charlottesville, VA USA		Kent, JB (corresponding author), Univ Virginia Hlth Syst, Dept Family Med, UVa Sports Med, Charlottesville, VA 22903 USA.	Jbk7y@virginia.edu		Kent, Jeremy/0000-0002-5348-1018			Austin AV, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120903294; Baugh C.M., 2016, CONCUSSION, V1, P1, DOI [DOI 10.2217/CNC.15.6, 10.2217/cnc.15.6]; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Frey A, 2018, VIS COGN, V26, P412, DOI 10.1080/13506285.2018.1472163; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hebert O, 2016, J SCI MED SPORT SPOR, V19; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson G., 2015, NCAA APPROVES EXPT R; Kent JB, 2020, BRAIN INJURY, V34, P1100, DOI 10.1080/02699052.2020.1782473; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Sheth SB, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000684; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Tjong VK, 2017, JAAOS GLOB RES REV, V1, DOI 10.5435/JAAOSGlobal-D-17-00070; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Zuckerman SL, 2020, PHYSICIAN SPORTSMED, V48, P1	39	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					880	885		10.1080/02699052.2021.1917658		APR 2021	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000643837300001	33896298				2022-02-07	
J	Rodriguez, KE; Anderson, LM; Ott, CA; O'Haire, ME				Rodriguez, Kerri E.; Anderson, Lindsey M.; Ott, Carol A.; O'Haire, Marguerite E.			The Effect of a PTSD Service Dog on Military Veterans' Medication Regimens: A Cross-Sectional Pilot Study	ANTHROZOOS			English	Article						Human&#8211; animal interaction; pharmacotherapy; posttraumatic stress disorder; PTSD; service dogs; veterans		Recent research suggests that service dogs may have clinically relevant benefits for military veterans with posttraumatic stress disorder (PTSD). However, the effects of PTSD service dogs on veterans' medication use have been largely unexplored. The objective of this study was to quantify the effect of PTSD service dogs on medication use among a population of military veterans with PTSD. In a cross-sectional design (n = 96), United States post-9/11 military veterans with PTSD were recruited from a single service dog provider including veterans living with a PTSD service dog (n = 52) and veterans on the waitlist (n = 44). Both populations of veterans received treatment as usual. Participants completed an online survey of self-reported medication regimens and medication changes. Regression models quantified the effect of having a service dog on physical health, mental health, pain, and sleep medications while controlling for confounding variables (age, gender identity, relationship status, traumatic brain injuries, and physical health). Results indicated that there were no significant effects of having a service dog on overall self-reported medication use nor any specific medication category (p's > 0.06). However, veterans with a service dog were more likely than those on the waitlist to report that their doctor had decreased dosage or removed medications since getting their service dog. The results of this preliminary cross-sectional research should be interpreted with caution, as future within-subject and pharmacy-verified research is necessary to understand the causality of these findings.	[Rodriguez, Kerri E.; O'Haire, Marguerite E.] Purdue Univ, Coll Vet Med, Ctr Human Anim Bond, Dept Comparat Pathobiol, 725 Harrison St, W Lafayette, IN 47907 USA; [Rodriguez, Kerri E.] Colorado State Univ, Human Anim Bond Colorado, Sch Social Work, Ft Collins, CO 80523 USA; [Anderson, Lindsey M.; Ott, Carol A.] Purdue Univ, Coll Pharm, W Lafayette, IN 47907 USA; [Anderson, Lindsey M.] Eskenazi Hlth, Indianapolis, IN USA		O'Haire, ME (corresponding author), Purdue Univ, Coll Vet Med, Ctr Human Anim Bond, Dept Comparat Pathobiol, 725 Harrison St, W Lafayette, IN 47907 USA.	mohaire@purdue.edu			Human-Animal Bond Research Initiative (HABRI) [D15HA-031]; Bayer Animal HealthBayer AG; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [KL2TR001106, UL1TR001108]	This study was funded by the Human-Animal Bond Research Initiative (HABRI; Grant number D15HA-031) and Bayer Animal Health. Its publication was made possible with support from Grant numbers KL2TR001106 and UL1TR001108 (A. Shekhar, PI) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award.	ANDERSON WP, 1992, MED J AUSTRALIA, V157, P298, DOI 10.5694/j.1326-5377.1992.tb137178.x; BATELAAN NM, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3927; Bergen-Cico D, 2018, J ALTERN COMPLEM MED, V24, P1166, DOI 10.1089/acm.2018.0179; Berger W, 2009, PROG NEURO-PSYCHOPH, V33, P169, DOI 10.1016/j.pnpbp.2008.12.004; Bradley L, 2015, ANTHROZOOS, V28, P635, DOI 10.1080/08927936.2015.1070006; BUland E., 2018, MENT HLTH PREV, V10, P42, DOI [10.1016/j.mhp.2018.01.002, DOI 10.1016/J.MHP.2018.01.002]; ClinicalTrials.gov, 2019, IDENTIFIER NCT020398; ClinicalTrials.gov, 2019, IDENTIFIER NCT032458; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Husband A, 2020, J SUBST USE, V25, P113, DOI 10.1080/14659891.2019.1664663; Iqbal SU, 2007, VETERANS RAND 12 ITE, P1; Katz C., 2011, DIFFERENT VIEWS ANXI; Krause-Parello CA, 2018, ANTHROZOOS, V31, P61, DOI 10.1080/08927936.2018.1406201; Krause-Parello CA, 2016, NURS EDUC TODAY, V47, P43, DOI 10.1016/j.nedt.2016.04.020; Krystal AD, 2007, BIOL PSYCHIAT, V61, P925, DOI 10.1016/j.biopsych.2007.02.020; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Libby DJ, 2013, PSYCHOL TRAUMA-US, V5, P277, DOI 10.1037/a0027082; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Marcus DA, 2013, PAIN MED, V14, P43, DOI 10.1111/j.1526-4637.2012.01522.x; McCauley JL, 2012, CLIN PSYCHOL-SCI PR, V19, P283, DOI 10.1111/cpsp.12006; Mohamed S, 2008, J CLIN PSYCHIAT, V69, P959, DOI 10.4088/JCP.v69n0611; Najavits Lisa M, 2015, F1000Prime Rep, V7, P43, DOI 10.12703/P7-43; O'Haire ME, 2018, J CONSULT CLIN PSYCH, V86, P179, DOI 10.1037/ccp0000267; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Parslow RA, 2003, MED J AUSTRALIA, V179, P466, DOI 10.5694/j.1326-5377.2003.tb05649.x; Patel SI, 2017, MAYO CLIN PROC, V92, P1368, DOI 10.1016/j.mayocp.2017.06.014; Raskind M.A., 2009, POSTTRAUMATIC STRESS, DOI [https://doi.org/10.1007/978-1-60327-329-9_16, DOI 10.1007/978-1-60327-329-9_16]; Richardson JD, 2017, PSYCHIAT RES, V258, P488, DOI 10.1016/j.psychres.2017.08.091; Rodriguez KE, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01638; Rodriguez KE, 2018, PSYCHONEUROENDOCRINO, V98, P202, DOI 10.1016/j.psyneuen.2018.04.026; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; US Department of Veterans Affairs/US Departent of Defense Management of Post-Traumatic Stress Disorders Working Group, 2017, VADOD CLIN PRACTICE; Walther S, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00001; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Whitworth JD, 2019, SOC WORK HEALTH CARE, V58, P412, DOI 10.1080/00981389.2019.1580238; Woodward SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179912; Yarborough BJH, 2018, PSYCHIATR REHABIL J, V41, P118, DOI 10.1037/prj0000294; Yarborough BJH, 2017, PSYCHIAT SERV, V68, P730, DOI 10.1176/appi.ps.201500383; Zohar J, 2002, J CLIN PSYCHOPHARM, V22, P190, DOI 10.1097/00004714-200204000-00013	43	0	0	3	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0892-7936	1753-0377		ANTHROZOOS	Anthrozoos	MAY 4	2021	34	3					393	406		10.1080/08927936.2021.1898219		APR 2021	14	Anthropology; Environmental Studies; Sociology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anthropology; Environmental Sciences & Ecology; Sociology; Veterinary Sciences	SA2CL	WOS:000642548500001	34140755	Green Accepted			2022-02-07	
J	Brooks, JS; Redgrift, A; Champagne, AA; Dickey, JP				Brooks, Jeffrey S.; Redgrift, Adam; Champagne, Allen A.; Dickey, James P.			The Hammer and the Nail: Biomechanics of Striking and Struck Canadian University Football Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Linear; Rotational; Acceleration; Head impacts; Impact biomechanics; Injury prevention; Football; Sub-concussive impacts		This study sought to evaluate head accelerations in both players involved in a football collision. Players on two opposing Canadian university teams were equipped with helmet mounted sensors during one game per season, for two consecutive seasons. A total of 276 collisions between 58 instrumented players were identified via video and cross-referenced with sensor timestamps. Player involvement (striking and struck), impact type (block or tackle), head impact location (front, back, left and right), and play type were recorded from video footage. While struck players did not experience significantly different linear or rotational accelerations between any play types, striking players had the highest linear and rotational head accelerations during kickoff plays (p <= .03). Striking players also experienced greater linear and rotational head accelerations than struck players during kickoff plays (p = .001). However, struck players experienced greater linear and rotational accelerations than striking players during kick return plays (p <= .008). Other studies have established that the more severe the head impact, the greater risk for injury to the brain. This paper's results highlight that kickoff play rule changes, as implemented in American college football, would decrease head impact exposure of Canadian university football athletes and make the game safer.	[Brooks, Jeffrey S.; Redgrift, Adam; Dickey, James P.] Western Univ, Fac Hlth Sci, Sch Kinesiol, 1151 Richmond St, London, ON, Canada; [Champagne, Allen A.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Champagne, Allen A.] Queens Univ, Sch Med, Kingston, ON, Canada		Dickey, JP (corresponding author), Western Univ, Fac Hlth Sci, Sch Kinesiol, 1151 Richmond St, London, ON, Canada.	jdickey@uwo.ca	Dickey, James P/K-6776-2013; Brooks, Jeffrey/ABA-4226-2021	Dickey, James P/0000-0002-4101-835X; Brooks, Jeffrey/0000-0002-1842-4763			Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Asken BM, 2019, ANN BIOMED ENG, V47, P2094, DOI 10.1007/s10439-018-2088-5; Bailey AM, 2020, ANN BIOMED ENG, V48, P2678, DOI 10.1007/s10439-020-02637-3; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brooks, 2016, THESIS U W ONTARIO L; Brooks J.S., J APPL BIOMECH; Campbell k, 2014, THESISI U W ONTARIO; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Campolettano ET, 2019, ANN BIOMED ENG, V47, P2086, DOI 10.1007/s10439-019-02309-x; Champagne AA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz021; Champagne AA, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101753; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Diakogeorgiou E, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118761031; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Giza C.C., 2020, MED SCI SPORT EXER E; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenth R., 2021, EMMEANS ESTIMATED MA; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Mihalik JP, 2014, AM SOC TEST MATER, V1552, P41, DOI 10.1520/STP155220120108; Muise DP, 2016, INT J ATHL THER TRAI, V21, P36, DOI 10.1123/ijatt.2016-0005; Nevins D, 2016, PROCEDIA ENGINEER, V147, P186, DOI 10.1016/j.proeng.2016.06.211; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Phillips N, 2020, ANN BIOMED ENG, V48, P2508, DOI 10.1007/s10439-020-02624-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Rowson B, 2020, ANN BIOMED ENG, V48, P2734, DOI 10.1007/s10439-020-02684-w; Ruestow PS, 2015, J OCCUP ENVIRON HYG, V12, P875, DOI 10.1080/15459624.2015.1072632; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stitzel J.D., 2013, 2013 OH STAT U BIOM; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Wasserman EB, 2020, CLIN J SPORT MED, V30, P366, DOI 10.1097/JSM.0000000000000615; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5	51	0	0	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2875	2885		10.1007/s10439-021-02773-4		APR 2021	11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000642840200001	33893576	hybrid, Green Published			2022-02-07	
J	Corrigan, F; Cernak, I; McAteer, K; Hellewell, SC; Rosenfeld, JV; Turner, RJ; Vink, R				Corrigan, Frances; Cernak, Ibolja; McAteer, Kelly; Hellewell, Sarah C.; Rosenfeld, Jeffrey, V; Turner, Renee J.; Vink, Robert			NK1 antagonists attenuate tau phosphorylation after blast and repeated concussive injury	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SUBSTANCE-P; EXPRESSION; PATHOLOGY; ACTIVATION; OLIGOMERS; CHANNELS	Exposure to repeated concussive traumatic brain injury (TBI) and to blast-induced TBI has been associated with the potential development of the neurodegenerative condition known as chronic traumatic encephalopathy (CTE). CTE is characterized by the accumulation of hyperphosphorylated tau protein, with the resultant tau tangles thought to initiate the cognitive and behavioral manifestations that appear as the condition progresses. However, the mechanisms linking concussive and blast TBI with tau hyperphosphorylation are unknown. Here we show that single moderate TBI, repeated concussive TBI and blast-induced mild TBI all result in hyperphosphorylation of tau via a substance P mediated mechanism. Post-injury administration of a substance P, NK1 receptor antagonist attenuated the injury-induced phosphorylation of tau by modulating the activity of several key kinases including Akt, ERK1/2 and JNK, and was associated with improvement in neurological outcome. We also demonstrate that inhibition of the TRPV1 mechanoreceptor, which is linked to substance P release, attenuated injury-associated tau hyperphosphorylation, but only when it was administered prior to injury. Our results demonstrate that TBI-mediated stimulation of brain mechanoreceptors is associated with substance P release and consequent tau hyperphosphorylation, with administration of an NK1 receptor antagonist attenuating tau phosphorylation and associated neurological deficits. NK1 antagonists may thus represent a pharmacological approach to attenuate the potential development of CTE following concussive and blast TBI.	[Corrigan, Frances; Vink, Robert] Univ South Australia, Clin & Hlth Sci, GPO Box 2471, Adelaide, SA 5001, Australia; [Corrigan, Frances; McAteer, Kelly; Turner, Renee J.] Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA, Australia; [Cernak, Ibolja; Hellewell, Sarah C.] Mercer Univ, Sch Med, Dept Biomed Sci, Macon, GA 31207 USA; [Rosenfeld, Jeffrey, V] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey, V] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia		Vink, R (corresponding author), Univ South Australia, Clin & Hlth Sci, GPO Box 2471, Adelaide, SA 5001, Australia.	Robert.Vink@unisa.edu.au		Corrigan, Frances/0000-0001-6150-8893; Hellewell, Sarah/0000-0002-2179-2209	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1068712]	We sincerely thank Drs David Cook and James Meabon from the University of Washington for their expert assistance with the tau immunohistochemistry in the blast studies. This study was funded by the Australian National Health and Medical Research Council, project grant number 1068712.	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Ang SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024535; Blackshaw LA, 2014, BRIT J PHARMACOL, V171, P2528, DOI 10.1111/bph.12641; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Collins-Praino L., 2018, J NEUROINFLAMM NEURO, V2; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Feng NH, 2008, AM J PHYSIOL-RENAL, V294, pF316, DOI 10.1152/ajprenal.00308.2007; Fiebich BL, 2000, J IMMUNOL, V165, P5606, DOI 10.4049/jimmunol.165.10.5606; Fontaine SN, 2015, CELL MOL LIFE SCI, V72, P1863, DOI 10.1007/s00018-015-1839-9; Guerrero-Munoz MJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00464; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hoffmann T., 2005, Australian Patent, Patent No. [WO2003/006016, 2003006016]; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Klomp JE, 2016, P NATL ACAD SCI USA, V113, P14976, DOI 10.1073/pnas.1609675114; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Mantyh PW, 2002, J CLIN PSYCHIAT, V63, P6; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Sun H, 2009, J PHARMACOL EXP THER, V331, P851, DOI 10.1124/jpet.109.160473; Sun J, 2009, FASEB J, V23, P997, DOI 10.1096/fj.08-121756; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Yelverton JT, 1996, J TRAUMA, V40, pS111, DOI 10.1097/00005373-199603001-00025	32	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 23	2021	11	1							8861	10.1038/s41598-021-88237-0			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU1ZG	WOS:000644948300008	33893374	Green Accepted, gold, Green Published			2022-02-07	
J	O'Neill, JA; Rose, SC; Davidson, AM; Shiplett, KM; Castillo, A; McNally, KA				O'Neill, Jilian A.; Rose, Sean C.; Davidson, Ashley M.; Shiplett, Kathleen M.; Castillo, Anthony; McNally, Kelly A.			Predictors of Treatment Response to Multidisciplinary Care for Persistent Symptoms after Pediatric Concussion	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Concussion; multidisciplinary treatment; pediatrics; mild tbi; post-concussive symptoms		Purpose: To assess which pediatric patients experiencing persistent post-concussive symptoms (PCS) benefit most from multidisciplinary treatment including specialists in Neurology, Neuropsychology, Physical Therapy, and Athletic Training, and to explore the effectiveness of this approach. Methods: A retrospective chart review of 56 adolescents 10-20 years old (M = 15.0 +/- 2.1) receiving multidisciplinary care for PCS (>30 days) was conducted. Results: Systolic blood pressure and Body Mass Index predicted time to concussion resolution (p < .05), such that higher values were associated with slower resolution. PCS scores significantly decreased between participants' initial and final clinic visits, p < .01, and among the 25 participants for whom pre-intervention PCS scores were available, symptom severity scores significantly declined following multidisciplinary intervention compared to pre-referral values (p < .01). Conclusions: Exploratory analyses reveal that multidisciplinary treatment is a promising approach for reducing symptoms among adolescents with PCS, and that those with greater levels of physical fitness may benefit most.	[O'Neill, Jilian A.] Oakland Neuropsychol Ctr, Bloomfield Hills, MI USA; [O'Neill, Jilian A.; Castillo, Anthony; McNally, Kelly A.] Nationwide Childrens Hosp, Dept Pediat Psychol & Neuropsychol, Columbus, OH USA; [O'Neill, Jilian A.; Rose, Sean C.; McNally, Kelly A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Rose, Sean C.] Nationwide Childrens Hosp, Dept Neurol, Columbus, OH USA; [Davidson, Ashley M.] Nationwide Childrens Hosp, Dept Sports Med, Columbus, OH USA; [Shiplett, Kathleen M.] Nationwide Childrens Hosp, Dept Clin Therapies, Columbus, OH USA		O'Neill, JA (corresponding author), 4190 Telegraph Rd,Suite 2700, Bloomfield Hills, MI 48302 USA.	jilianoneillphd@gmail.com					Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; CONCATO J, 1995, J CLIN EPIDEMIOL, V48; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P132; Delis DC., D KEFS DELIS KAPLAN; DEMER JL, 1994, AM J OTOL, V15, P340; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gauvin-Lepage J, 2020, CLIN J SPORT MED, V30, P423, DOI 10.1097/JSM.0000000000000634; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; IBM Corp, 2019, IBM SPSS STAT WINDOW; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Moore Brian M, 2016, J Allied Health, V45, pe59; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Partington J., 1949, HALSTEAD REITAN TRAI; PEDUZZI P, 1995, J CLIN EPIDEMIOL, V48; REITAN R, 1971, PERCEPT MOTOR SKILL, V33; RIEMANN B, 1999, J SPORT REHABIL, V8; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Torrance B, 2007, VASC HEALTH RISK MAN, V3, P139; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	37	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	JAN 2	2022	25	1					38	44		10.1080/17518423.2021.1917719		APR 2021	7	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	YH7AW	WOS:000642173400001	33881383				2022-02-07	
J	Uberti, M; Hasan, S; Holmes, D; Ganau, M; Uff, C				Uberti, Micaela; Hasan, Shumaila; Holmes, David; Ganau, Mario; Uff, Chris			Clinical Significance of Isolated Third Cranial Nerve Palsy in Traumatic Brain Injury: A Detailed Description of Four Different Mechanisms of Injury through the Analysis of Our Case Series and Review of the Literature	EMERGENCY MEDICINE INTERNATIONAL			English	Article							OCULOMOTOR NERVE; MORTALITY	Third cranial nerve palsy (3cnP) following traumatic brain injury (TBI) is a worrying neurological sign and is often associated with an expanding mass lesion, such as extradural or acute subdural haematomas. Isolated 3cnP can be found in the absence of posttraumatic space-occupying mass lesion, yet it is often considered as a devastating prognostic factor in the context of diffuse axonal injury (DAI). Through the analysis of five exemplificative cases and a thorough review of the literature, we identified four possible mechanisms leading to 3cnP: (1) a partial rootlet avulsion at the site of exit from the midbrain, representing a direct shearing injury to the nerve; (2) a direct traction injury due to the nerve stretching against the posterior petroclinoid ligament at the base of the oculomotor triangle secondary to the downward displacement of the brainstem at the time of impact; (3) a direct vascular compression as a result of internal carotid artery (ICA) dissection or pseudoaneurysm; (4) an indirect injury caused by impaired blood supply to the third nerve in addition to the detrimental biochemical effects of the underlying brain injury itself. Understanding the exact mechanism underlying the onset of 3cnP is key to provide an informed clinical decision-making to the patients and ensure their best chances of recovery. Our experience corroborates data from the literature showing that, even in Grade III DAI, prompt recognition of isolated 3cnP can guide adequate treatment. Nonetheless, even when an overall good neurological outcome is achieved, recovery of isolated 3cnP is dismal, and only rarely the visual deficit completely resolves.	[Uberti, Micaela; Hasan, Shumaila; Holmes, David; Uff, Chris] Royal London Hosp, Dept Neurosurg, London E1 1FR, England; [Ganau, Mario] Oxford Univ Hosp, Dept Neurosurg, Oxford OX3 9DU, England; [Uff, Chris] Queen Mary Univ London, Ctr Trauma Sci, London E1 4NS, England		Hasan, S (corresponding author), Royal London Hosp, Dept Neurosurg, London E1 1FR, England.	micaela.uberti@nhs.net; shumailahasan@hotmail.com; david.holmes9@nhs.net; mario.ganau@alumni.harvard.edu; cuff@nhs.net	Ganau, Mario/AAY-7233-2020	Ganau, Mario/0000-0002-8676-1147; Hasan, Shumaila/0000-0002-0158-703X			Balcer LJ, 1996, AM J OPHTHALMOL, V122, P437, DOI 10.1016/S0002-9394(14)72078-1; Bruce BB, 2007, SEMIN NEUROL, V27, P257, DOI 10.1055/s-2007-979681; Chen CC, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.016311; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; ELSTON JS, 1984, BRIT J OPHTHALMOL, V68, P538, DOI 10.1136/bjo.68.8.538; Erenler Ali Kemal, 2015, Asian J Neurosurg, V10, P265, DOI 10.4103/1793-5482.161169; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Ganau L, 2012, AVIAT SPACE ENVIR MD, V83, P899, DOI 10.3357/ASEM.3331.2012; Ganau M, 2013, MINERVA ANESTESIOL, V79, P310; Ganau M, 2021, NEUROSURG REV, V44, P2959, DOI 10.1007/s10143-020-01467-0; Kaido T, 2006, J CLIN NEUROSCI, V13, P852, DOI 10.1016/j.jocn.2005.08.020; Kim E, 2013, J KOREAN NEUROSURG S, V54, P434, DOI 10.3340/jkns.2013.54.5.434; Kogan Michael, 2014, Surg Neurol Int, V5, pS497, DOI 10.4103/2152-7806.145653; Lang J, 2016, IDEGGYOGY SZEMLE, V69, P227, DOI 10.18071/isz.69.0227; Lohani S, 2020, WORLD NEUROSURG, V135, DOI 10.1016/j.wneu.2019.12.017; Maragkos GA, 2018, J NEUROTRAUM, V35, P2605, DOI 10.1089/neu.2018.5682; MEMON MY, 1971, J NEUROSURG, V35, P461, DOI 10.3171/jns.1971.35.4.0461; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; NAGASEKI Y, 1989, ACTA NEUROCHIR, V97, P117, DOI 10.1007/BF01772821; Nakagawa Yu, 2017, Surg Neurol Int, V8, P20, DOI 10.4103/2152-7806.199556; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Signorelli F, 2020, J NEUROINTERV SURG, V12, P964, DOI 10.1136/neurintsurg-2020-015802; Syrmos N, 2013, CASE REP SURG, V2013, DOI 10.1155/2013/209750; Wan YZ, 2019, EMERG MED INT, V2019, DOI 10.1155/2019/4680184	24	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.	APR 23	2021	2021								5550371	10.1155/2021/5550371			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SD5UH	WOS:000651441200002	33976940	Green Published, gold			2022-02-07	
J	Cho, H; Heijnen, MJH; Craig, BA; Rietdyk, S				Cho, HyeYoung; Heijnen, Michel J. H.; Craig, Bruce A.; Rietdyk, Shirley			Falls in young adults: The effect of sex, physical activity, and prescription medications	PLOS ONE			English	Article							COMMUNITY-DWELLING ADULTS; GENDER-DIFFERENCES; COLLEGE-STUDENTS; OLDER-ADULTS; ENVIRONMENTAL-FACTORS; ALCOHOL; INJURIES; HEALTHY; RECALL; CIRCUMSTANCES	Falls are a major public health issue not only for older adults but also young adults, with fall-related injuries occurring more frequently in adult females than males. However, the sex differences in the frequency and circumstances of falls in young adults are understudied. This research quantified the frequency and circumstances of falls as a function of sex, physical activity, and prescription medications in young adults. For 16 weeks, young adult participants (N = 325; 89 males; 19.9 +/- 1.1 years) responded to a daily email asking if they had slipped, tripped, or fallen in the past 24 hours. Falls and fall-related injuries were not uncommon in young adults: 48% fell at least once, 25% fell more than once, and 10% reported an injury. The most common activities at the time of the fall for females were walking (44%) and sports (33%), and for males, sports (49%) and walking (37%). A zero-inflated Poisson model revealed that higher number of falls were associated with the following: higher levels of physical activity (p = 0.025), higher numbers of medications (p<0.0001), and being male (p = 0.008). Regarding circumstances of falling, females were more likely to be talking to a friend at the time of the fall (OR (95% CI): 0.35 (0.14-0.73); p = 0.01). For slips and trips without a fall, males and females reported the same number of slips (OR (95% CI): 0.885 (0.638-1.227) p = 0.46), but females reported more trips (OR (95% CI): 0.45 (0.30-0.67); p<0.01). Only females reported serious injuries such as concussion and fracture. In conclusion, the rate of falls in young adults was affected by physical activity levels, number of medications, and sex. Quantifying and understanding these differences leads to increased knowledge of falls across the lifespan and is instrumental in developing interventions to prevent falls.	[Cho, HyeYoung; Rietdyk, Shirley] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Cho, HyeYoung; Rietdyk, Shirley] Purdue Univ, Ctr Aging & Life Course, W Lafayette, IN 47907 USA; [Heijnen, Michel J. H.] Univ N Carolina, Sch Hlth & Appl Human Sci, Wilmington, NC USA; [Craig, Bruce A.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA		Rietdyk, S (corresponding author), Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA.; Rietdyk, S (corresponding author), Purdue Univ, Ctr Aging & Life Course, W Lafayette, IN 47907 USA.	srietdyk@purdue.edu		Cho, HyeYoung/0000-0002-0722-8206	Purdue University Libraries Open Access Publishing Fund	Publication of this article was funded in part by Purdue University Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Allin LJ, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01605-9; Beliefs YagilD., 2000, TRANSP RES F, V3, P1, DOI [10.1016/S1369-8478%2800%2900004-8, DOI 10.1016/S1369-8478%2800%2900004-8]; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Blazewick DH, 2018, AM J EMERG MED, V36, P608, DOI 10.1016/j.ajem.2017.09.034; CDC. Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Chen CM, 2017, SUBST USE MISUSE, V52, P1120, DOI 10.1080/10826084.2017.1293101; Cho H, 2019, GAIT POSTURE, V73, P273, DOI 10.1016/j.gaitpost.2019.07.380; Cho SH, 2004, CLIN BIOMECH, V19, P145, DOI 10.1016/j.clinbiomech.2003.10.003; Chou LS, 1998, J BIOMECH, V31, P685, DOI 10.1016/S0021-9290(98)00081-5; Compo NS, 2017, LAW HUMAN BEHAV, V41, P202, DOI 10.1037/lhb0000224; Court-Brown CM, 2017, INJURY, V48, P819, DOI 10.1016/j.injury.2017.02.021; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; de Jong MR, 2013, THER ADV DRUG SAF, V4, P147, DOI 10.1177/2042098613486829; Den Otter AR, 2011, GAIT POSTURE, V34, P169, DOI 10.1016/j.gaitpost.2011.04.004; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Duckham RL, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-133; Dufour AB, 2009, ARTHRIT CARE RES, V61, P1352, DOI 10.1002/art.24733; Foster RJ, 2014, EXP GERONTOL, V55, P152, DOI 10.1016/j.exger.2014.04.009; Freedman VA, 2006, MILBANK Q, V84, P493, DOI 10.1111/j.1468-0009.2006.00456.x; Ganz DA, 2005, J AM GERIATR SOC, V53, P2190, DOI 10.1111/j.1532-5415.2005.00509.x; Gebel K, 2015, JAMA INTERN MED, V175, P970, DOI 10.1001/jamainternmed.2015.0541; Gjoreski M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060800; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Hannan MT, 2010, AM J EPIDEMIOL, V171, P1031, DOI 10.1093/aje/kwq024; Heijnen MJH, 2012, EXP BRAIN RES, V223, P219, DOI 10.1007/s00221-012-3253-y; Heijnen MJH, 2016, HUM MOVEMENT SCI, V46, P86, DOI 10.1016/j.humov.2015.12.007; Hill K, 1999, AUST NZ J PUBL HEAL, V23, P41, DOI 10.1111/j.1467-842X.1999.tb01203.x; HINGSON R, 1987, J STUD ALCOHOL, V48, P212, DOI 10.15288/jsa.1987.48.212; Hingson RW, 2002, J STUD ALCOHOL, V63, P136, DOI 10.15288/jsa.2002.63.136; Jacobs JV, 2016, GAIT POSTURE, V49, P159, DOI 10.1016/j.gaitpost.2016.06.030; James MK, 2018, J SAFETY RES, V64, P83, DOI 10.1016/j.jsr.2017.12.010; Johnston LD, 2003, MONITORING FUTURE NA, VII; Kerrigan DC, 1998, AM J PHYS MED REHAB, V77, P2, DOI 10.1097/00002060-199801000-00002; Ko SU, 2011, J BIOMECH, V44, P1974, DOI 10.1016/j.jbiomech.2011.05.005; Kool B, 2009, INJURY PREV, V15, P341, DOI 10.1136/ip.2008.021303; Kool B, 2012, INJURY PREV, V18, P200, DOI 10.1136/injuryprev-2011-040202; Krems C, 2004, J SPORT MED PHYS FIT, V44, P71; Laflamme L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123390; Lee J, 2020, GERIATR NURS, V41, P747, DOI 10.1016/j.gerinurse.2020.05.005; LUNDEBERG MA, 1994, J EDUC PSYCHOL, V86, P114, DOI 10.1037/0022-0663.86.1.114; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Masse LC, 2012, J PHYS ACT HEALTH, V9, pS44, DOI 10.1123/jpah.9.s1.s44; McErlean DR, 2017, AUSTRALAS EMERG NURS, V20, P12, DOI 10.1016/j.aenj.2016.11.001; Miyasike-daSilva V, 2016, EXP BRAIN RES, V234, P3233, DOI 10.1007/s00221-016-4721-6; Morin L, 2019, CLIN EPIDEMIOL, V11, P483, DOI 10.2147/CLEP.S201614; Muir BC, 2020, GAIT POSTURE, V77, P100, DOI 10.1016/j.gaitpost.2020.01.020; Neder JA, 1999, EUR J APPL PHYSIOL O, V79, P522, DOI 10.1007/s004210050547; Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005; NISSAN M, 1990, J BIOMED ENG, V12, P165, DOI 10.1016/0141-5425(90)90139-E; Peel N, 2000, ACCIDENT ANAL PREV, V32, P371, DOI 10.1016/S0001-4575(99)00066-4; Peeters GMEE, 2010, J GERONTOL A-BIOL, V65, P743, DOI 10.1093/gerona/glq013; Pereira CLN, 2014, DISABIL REHABIL, V36, P117, DOI 10.3109/09638288.2013.782355; Persell SD, 2007, J GEN INTERN MED, V22, P1523, DOI 10.1007/s11606-007-0334-x; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Raffegeau TE, 2018, GAIT POSTURE, V64, P59, DOI 10.1016/j.gaitpost.2018.05.029; Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Telonio A, 2014, EXP GERONTOL, V50, P26, DOI 10.1016/j.exger.2013.11.007; Thomas NM, 2020, EXP GERONTOL, V132, DOI 10.1016/j.exger.2020.110839; Timsina LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176561; Tom A, 2011, ACCIDENT ANAL PREV, V43, P1794, DOI 10.1016/j.aap.2011.04.012; Verma SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150939; Verma SK, 2010, J OCCUP ENVIRON HYG, V7, P491, DOI 10.1080/15459624.2010.486693; Weerdesteyn V, 2006, GERONTOLOGY, V52, P131, DOI 10.1159/000091822; Westerterp KR, 2020, EUR J CLIN NUTR, V74, P135, DOI 10.1038/s41430-019-0408-y; Westerterp KR, 2001, J GERONTOL A-BIOL, V56, P7, DOI 10.1093/gerona/56.suppl_2.7; Winter D.A., 1991, BIOMECHANICS MOTOR C; Yang YJ, 2015, J AM MED DIR ASSOC, V16, P388, DOI 10.1016/j.jamda.2014.12.003; Yoshimura E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238713; Zietz D, 2009, J MOTOR BEHAV, V41, P357, DOI 10.3200/JMBR.41.4.357-366	72	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2021	16	4							e0250360	10.1371/journal.pone.0250360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RT0DC	WOS:000644138300011	33886646	Green Published, gold			2022-02-07	
J	Hecht, S; Anderson, KM; Castel, A; Griffin, JF; Hespel, AM; Nelson, N; Sun, XC				Hecht, Silke; Anderson, Kimberly M.; Castel, Aude; Griffin, John F.; Hespel, Adrien-Maxence; Nelson, Nathan; Sun, Xiaocun			Agreement of Magnetic Resonance Imaging With Computed Tomography in the Assessment for Acute Skull Fractures in a Canine and Feline Cadaver Model	FRONTIERS IN VETERINARY SCIENCE			English	Article						MRI; CT; trauma; head; CNS; dog; cat	TRAUMATIC BRAIN-INJURY; HEAD TRAUMA; SUBARACHNOID HEMORRHAGE; MR; DOGS; CT; MANAGEMENT; DIAGNOSIS; SEQUENCE	Computed tomography (CT) is the imaging modality of choice to evaluate patients with acute head trauma. However, magnetic resonance imaging (MRI) may be chosen in select cases. The objectives of this study were to evaluate the agreement of MRI with CT in the assessment for presence or absence of acute skull fractures in a canine and feline cadaver model, compare seven different MRI sequences (T1-W, T2-W, T2-FLAIR, PD-W, T2*-W, "SPACE" and "VIBE"), and determine agreement of four different MRI readers with CT data. Pre- and post-trauma CT and MRI studies were performed on 10 canine and 10 feline cadaver heads. Agreement of MRI with CT as to presence or absence of a fracture was determined for 26 individual osseous structures and four anatomic regions (cranium, face, skull base, temporomandibular joint). Overall, there was 93.5% agreement in assessing a fracture as present or absent between MRI and CT, with a significant difference between the pre and post trauma studies (99.4 vs. 87.6%; p < 0.0001; OR 0.042; 95% CI 0.034-0.052). There was no significant difference between dogs and cats. The agreement for the different MRI sequences with CT ranged from 92.6% (T2*-W) to 94.4% (PD-W). There was higher agreement of MRI with CT in the evaluation for fractures of the face than other anatomic regions. Agreement with CT for individual MRI readers ranged from 92.6 to 94.7%. A PD-W sequence should be added to the MR protocol when evaluating the small animal head trauma patient.	[Hecht, Silke; Anderson, Kimberly M.; Castel, Aude; Hespel, Adrien-Maxence] Univ Tennessee, Dept Small Anim Clin Sci, Knoxville, TN 37996 USA; [Griffin, John F.] Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Nelson, Nathan] North Carolina State Univ, Dept Mol & Biomed Sci, Raleigh, NC USA; [Sun, Xiaocun] Univ Tennessee, Off Informat Technol, Knoxville, TN USA; [Castel, Aude] Univ Montreal, Fac Vet Med, Dept Clin Sci, Montreal, PQ, Canada		Hecht, S (corresponding author), Univ Tennessee, Dept Small Anim Clin Sci, Knoxville, TN 37996 USA.	shecht@utk.edu	Hespel, Adrien-Maxence/I-6239-2019	Hespel, Adrien-Maxence/0000-0002-9060-2309	Department of Small Animal Clinical Services, College of Veterinary Medicine, University of Tennessee	Publication fee provided by the Department of Small Animal Clinical Services, College of Veterinary Medicine, University of Tennessee.	Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Caine A, 2019, J FELINE MED SURG, V21, P1111, DOI 10.1177/1098612X18819162; Chai O, 2017, AM J VET RES, V78, P1085, DOI 10.2460/ajvr.78.9.1085; Cho SB, 2019, AM J NEURORADIOL, V40, P109, DOI 10.3174/ajnr.A5916; De Paolo MH, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00242; De Paolo MH, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00241; DEWEY CW, 2003, PRACTICAL GUIDE CANI, P99; DiFazio J, 2013, VET CLIN N AM-SMALL, V43, P915, DOI 10.1016/j.cvsm.2013.03.002; Du J, 2013, NMR BIOMED, V26, P489, DOI 10.1002/nbm.2906; Duckworth JL, 2010, CURR OPIN CRIT CARE, V16, P92, DOI 10.1097/MCC.0b013e3283374900; Eubanks DL, 2013, J VET DENT, V30, P180, DOI 10.1177/089875641303000313; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hecht S., 2011, Veterinary computed tomography, P185; Hecht S, 2010, VET CLIN N AM-SMALL, V40, P39, DOI 10.1016/j.cvsm.2009.09.006; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Knight R, 2019, J FELINE MED SURG, V21, P1120, DOI 10.1177/1098612X18819183; Kralik SF, 2019, NEURORADIOLOGY, V61, P81, DOI 10.1007/s00234-018-2127-9; Kuo KW, 2018, VET CLIN N AM-SMALL, V48, P111, DOI 10.1016/j.cvsm.2017.08.005; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lee Bruce, 2005, NeuroRx, V2, P372; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Mirvis S E, 1994, J Intensive Care Med, V9, P305; Noguchi K, 1997, RADIOLOGY, V203, P257, DOI 10.1148/radiology.203.1.9122404; NolteErnsting CCA, 1996, SKELETAL RADIOL, V25, P413, DOI 10.1007/s002560050108; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Park JE, 2018, AM J ROENTGENOL, V210, P876, DOI 10.2214/AJR.17.18490; PHILLIPS IR, 1979, J SMALL ANIM PRACT, V20, P661, DOI 10.1111/j.1748-5827.1979.tb06679.x; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; Smith LGF, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.9.FOCUS19652; Tang MY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/312142; Thomas WB, 1999, CLIN TECH SMALL AN P, V14, P125, DOI 10.1016/S1096-2867(99)80030-9; Wetzel SG, 2002, AM J NEURORADIOL, V23, P995; Wisner ER., 2015, ATLAS SMALL ANIMAL C, P153; Woodcock RJ, 2001, AM J NEURORADIOL, V22, P1698; Yanai H, 2015, JAVMA-J AM VET MED A, V246, P1222, DOI 10.2460/javma.246.11.1222; Zalcman AR., 2018, DIAGNOSTIC MRI DOGS, P130; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	40	0	0	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2297-1769		FRONT VET SCI	Front. Vet. Sci.	APR 22	2021	8								603775	10.3389/fvets.2021.603775			9	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	RX5VR	WOS:000647291800001	33969028	Green Published, gold			2022-02-07	
J	Lindau, M; Lundberg, M; Najstrom, M				Lindau, Maria; Lundberg, Milena; Najstrom, Mats			WAIS-IV short form applied to a mixed neurological Swedish clinical sample	NORDIC PSYCHOLOGY			English	Article; Early Access						short form; WAIS-IV; cultural adaptation; clinical applicability	PERFORMANCE; UTILITY	The Wechsler Adult Intelligence Scale, fourth version (WAIS-IV), is a frequently used instrument for neuropsychological assessment. The aim was to assess the degree of conformity between the Scandinavian adaptation of the WAIS-IV and a short form of this scale (SF) in a mixed sample of neurological diagnoses. The SF comprised Block Design, Similarities, Digit Span, Arithmetic, Information, Digit Symbol (in the WAIS-IV named Coding), and Picture Completion, the latter here replaced by Matrix Reasoning. The sample consisted of 150 patients and included multiple sclerosis (n = 27), brain tumor (n = 15), traumatic brain injury (n = 60) and vascular brain damage (n = 48). There was a lack of congruence between the WAIS-IV and the SF in the entire sample, revealing selectively significantly higher scores for the SF on Full Scale IQ (FSIQ) and Processing Speed Index (PSI). On a diagnostic group level, the discrepancies were as follows: in the traumatic brain injury group on FSIQ, Verbal Comprehension Index (VCI) and PSI, in the vascular damage group the FSIQ was significantly higher on SF compared to the WAIS-IV. Since the results revealed several mismatches between the SF and the WAIS-IV, except for the MS and traumatic brain tumor group, there is a lack of interchangeability between these two sets of tests. Thus, generally the SF cannot be recommended as a substitute for the WAIS-IV in this type of mixed Swedish neurological sample. The small sample sizes make the generalizability of this study limited.	[Lindau, Maria; Najstrom, Mats] Stockholm Univ, Dept Psychol, Stockholm, Sweden; [Lundberg, Milena] Neurologmottagningen Gavle, Gavle, Region Gavlebor, Sweden		Lindau, M (corresponding author), Stockholm Univ, Dept Psychol, Stockholm, Sweden.	maria.lindau@psychology.su.se			Centrum for Kompetensutveckling inom Vard och Omsorg (CKVO) at Stockholm University, Sweden	The financial support provided by Centrum for Kompetensutveckling inom Vard och Omsorg (CKVO) at Stockholm University, Sweden, has been of great help in the carrying through of the research.	Brace N., 2012, SPSS PSYCHOL, V5; Bulzacka E, 2016, ARCH CLIN NEUROPSYCH, V31, P915, DOI 10.1093/arclin/acw063; Callahan CD, 1997, ARCH CLIN NEUROPSYCH, V12, P133, DOI 10.1016/S0887-6177(96)00029-7; Daugherty JC, 2017, APPL NEUROPSYCH-ADUL, V24, P16, DOI 10.1080/23279095.2015.1036992; Denney DA, 2015, ARCH CLIN NEUROPSYCH, V30, P404, DOI 10.1093/arclin/acv035; Doll Edgar A, 1917, Psychol Clin, V11, P197; Girard TA, 2010, ASSESSMENT, V17, P400, DOI 10.1177/1073191110369763; Maria L, 2019, NORD PSYCHOL, V71, P148, DOI 10.1080/19012276.2018.1520643; Meyers JE, 2013, APPL NEUROPSYCH-ADUL, V20, P249, DOI 10.1080/09084282.2012.710180; Pilgrim B M, 1999, Appl Neuropsychol, V6, P243, DOI 10.1207/s15324826an0604_7; Rabin AI, 1943, J APPL PSYCHOL, V27, P320, DOI 10.1037/h0060227; Ramirez-Aubone C., 2019, EPILEPSY SURG INTRIN, P75; Ryan JJ, 1996, ARCH CLIN NEUROPSYCH, V11, P207, DOI 10.1016/0887-6177(95)00054-2; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Strauss E., 1996, COMPENDIUM NEUROPSYC, V2nd ed.; Ubeda R, 2016, PSYCHOL SOC EDUC, V8, P81, DOI 10.25115/psye.v8i1.549; van Ool JS, 2018, DEV NEUROREHABIL, V21, P101, DOI 10.1080/17518423.2016.1277799; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 2010, WAIS 4 WECHSLER ADUL, Vfourth; Zucchella Chiara, 2018, Pract Neurol, V18, P227, DOI 10.1136/practneurol-2017-001743	21	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1901-2276	1904-0016		NORD PSYCHOL	Nord. Psychol.												10.1080/19012276.2021.1918225		APR 2021	11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	TD5EY	WOS:000669351300001		hybrid			2022-02-07	
J	Zhong, SL; Liang, XX; Wang, J; Mellsop, G; Zhou, JS; Wang, XP				Zhong, Shaoling; Liang, Xiaoxi; Wang, Jun; Mellsop, Graham; Zhou, Jiansong; Wang, Xiaoping			Simulated malingering on binomial forced-choice digit memory test - using eye movements to understand faking cognition impairment process	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						Eye-tracking; forensic neuropsychology; feigned cognitive impairment; poor effort		Intentional faking and/or exaggeration of disability increase unnecessary burden and costs for society, and they could be difficult to detect. This study aimed to explore which and how eye-based measures could be applied in detecting malingering of traumatic brain injury in a laboratory setting. Undergraduates were randomly grouped into two conditions in a mixed study-design experiment: malingering (n = 25) and honest (n = 24). Binomial forced-choice digit memory test (BFDMT) was used to test performance validity. Behavioral and eye-based measures were collected. Compared to the honest individuals, the malingering participants exhibited longer dwell time, glance duration, and fixation time and more glance count and fixation count in false response while less dwell, glance, and fixations in true response. Individuals coached to malinger had more dwell, glance, and fixations in false than in true response. Findings suggested that gaze pattern may have a potential application in understanding the faking process and detecting malingering. In addition, individuals that were incentivized to malinger allocated intensive attention to desirable information as a strategy to avoid detection and maximize gains in this simulated setting.	[Zhong, Shaoling; Liang, Xiaoxi; Wang, Jun; Zhou, Jiansong; Wang, Xiaoping] Cent South Univ, Xiangya Hosp 2, China Natl Technol Inst Mental Disorders, Natl Clin Res Ctr Mental Disorders,Dept Psychiat, Changsha, Hunan, Peoples R China; [Mellsop, Graham] Univ Auckland, Dept Psychol Med, Auckland, New Zealand		Wang, XP (corresponding author), Cent South Univ, Xiangya Hosp 2, China Natl Technol Inst Mental Disorders, Natl Clin Res Ctr Mental Disorders,Dept Psychiat, Changsha, Hunan, Peoples R China.	503045@csu.edu.cn			National Key Research and Development Program of China [2016YFC0800701]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371500, 81501637]	This work was supported by the National Key Research and Development Program of China [grant number 2016YFC0800701] and the National Natural Science Foundation of China [grant number 81371500, 81501637].	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Balcetis E, 2006, J PERS SOC PSYCHOL, V91, P612, DOI 10.1037/0022-3514.91.4.612; Barry DM, 2016, ARCH CLIN NEUROPSYCH, V31, P963, DOI 10.1093/arclin/acw070; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Cook AE, 2012, J EXP PSYCHOL-APPL, V18, P301, DOI 10.1037/a0028307; Crighton AH, 2015, ARCH CLIN NEUROPSYCH, V30, P181, DOI 10.1093/arclin/acv002; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gao XA, 2011, BEHAV RES THER, V49, P252, DOI 10.1016/j.brat.2011.01.009; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Gutierrez JM, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P151, DOI 10.1007/978-1-4614-0442-2_4; Halevy N, 2014, J PERS SOC PSYCHOL, V106, P398, DOI 10.1037/a0035351; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Heaver B, 2011, MEMORY, V19, P398, DOI 10.1080/09658211.2011.575788; Heyanka DJ, 2015, ARCH CLIN NEUROPSYCH, V30, P369, DOI 10.1093/arclin/acv025; Holmqvist K., 2011, EYE TRACKING COMPREH; Hyona J, 2006, BRIT J PSYCHOL, V97, P31, DOI 10.1348/000712605X53678; Jacob RJK, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P573, DOI 10.1016/B978-044451020-4/50031-1; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Knoll J, 2006, PSYCHIAT CLIN N AM, V29, P629, DOI 10.1016/j.psc.2006.04.001; LARRABEE GJ, 2003, CLIN NEUROPSYCHOL, V17; Liu R., 2001, CHINESE J CLIN PSYCH, V9, P173; Marchak FM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00736; Mazza C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227113; McCullumsmith CB, 2011, PSYCHIAT CLIN N AM, V34, P621, DOI 10.1016/j.psc.2011.05.013; Millen AE, 2017, Q J EXP PSYCHOL, V70, P930, DOI 10.1080/17470218.2016.1172093; MITTENBERG W, 2002, J CLIN EXP NEUROPSYC, V24; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Perelman BS, 2014, PEERJ, V2, DOI 10.7717/peerj.260; Pittarello A, 2016, PSYCHON B REV, V23, P609, DOI 10.3758/s13423-015-0935-z; Proudfoot JG, 2016, J MANAGE INFORM SYST, V33, P332, DOI 10.1080/07421222.2016.1205929; Roma P, 2020, PSYCHOL INJ LAW, V13, P57, DOI 10.1007/s12207-019-09368-4; Ryan JD, 2007, MEMORY, V15, P508, DOI 10.1080/09658210701391022; Schindler Sebastian, 2013, BMC Psychol, V1, P12, DOI 10.1186/2050-7283-1-12; Schwedes C, 2016, MEM COGNITION, V44, P1244, DOI 10.3758/s13421-016-0630-y; Schwedes C, 2012, MEM COGNITION, V40, P642, DOI 10.3758/s13421-011-0173-1; Snyder KA, 2008, PSYCHON B REV, V15, P315, DOI 10.3758/PBR.15.2.315; Tomer E, 2020, APPL NEUROPSYCH-ADUL, V27, P49, DOI 10.1080/23279095.2018.1480483; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168	44	0	0	3	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.	NOV 2	2021	32	6					808	824		10.1080/14789949.2021.1918211		APR 2021	17	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	XJ5ZV	WOS:000641805600001					2022-02-07	
J	Harmon, KG; Whelan, BM; Aukerman, DF; Bohr, AD; Nerrie, JM; Elkinton, HA; Holliday, M; Poddar, SK; Chrisman, SPD; McQueen, MB				Harmon, Kimberly G.; Whelan, Bridget M.; Aukerman, Douglas F.; Bohr, Adam D.; Nerrie, J. Matthew; Elkinton, Heather A.; Holliday, Marissa; Poddar, Sourav K.; Chrisman, Sara P. D.; McQueen, Matthew B.			Diagnostic accuracy and reliability of sideline concussion evaluation: a prospective, case-controlled study in college athletes comparing newer tools and established tests	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Adolescent; Injury; Diagnosis	SPORT-RELATED CONCUSSION; KING-DEVICK TEST; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPECIFICITY; SENSITIVITY; AGREEMENT; ZURICH; SCAT3	Objective To assess diagnostic accuracy and reliability of sideline concussion tests in college athletes. Methods Athletes completed baseline concussion tests including Post-Concussion Symptom Scale, Standardised Assessment of Concussion (SAC), modified Balance Error Scoring System (m-BESS), King-Devick test and EYE-SYNC Smooth Pursuits. Testing was repeated in athletes diagnosed acutely with concussion and compared to a matched teammate without concussion. Results Data were collected on 41 concussed athletes and 41 matched controls. Test-retest reliability for symptom score and symptom severity assessed using control athletes was 0.09 (-0.70 to 0.88) and 0.08 (-1.00 to 1.00) (unweighted kappa). Intraclass correlations were SAC 0.33 (-0.02 to 0.61), m-BESS 0.33 (-0.2 to 0.60), EYE-SYNC Smooth Pursuit tangential variability 0.70 (0.50 to 0.83), radial variability 0.47 (0.19 to 0.69) and King-Devick test 0.71 (0.49 to 0.84). The maximum identified sensitivity/specificity of each test for predicting clinical concussion diagnosis was: symptom score 81%/94% (3-point increase), symptom severity score 91%/81% (3-point increase), SAC 44%/72% (2-point decline), m-BESS 40%/92% (5-point increase), King-Devick 85%/76% (any increase in time) and EYE-SYNC Smooth Pursuit tangential variability 48%/58% and radial variability 52%/61% (any increase). Adjusted area under the curve was: symptom score 0.95 (0.89, 0.99), symptom severity 0.95 (95% CI 0.88 to 0.99), SAC 0.66 (95% CI 0.54 to 0.79), m-BESS 0.71 (0.60, 0.83), King-Devick 0.78 (0.69, 0.87), radial variability 0.47 (0.34, 0.59), tangential variability 0.41 (0.30, 0.54) Conclusion Test-retest reliability of most sideline concussion tests was poor in uninjured athletes, raising concern about the accuracy of these tests to detect new concussion. Symptom score/severity had the greatest sensitivity and specificity, and of the objective tests, the King-Devick test performed best.	[Harmon, Kimberly G.; Whelan, Bridget M.] Univ Washington, Family Med, Seattle, WA 98195 USA; [Aukerman, Douglas F.] Oregon State Univ, Dept Family Med, Corvallis, OR USA; [Bohr, Adam D.; McQueen, Matthew B.] Univ Colorado, Dept Integrat Physiol, Boulder, CO USA; [Nerrie, J. Matthew] Univ Washington, Intercollegiate Athlet, Seattle, WA USA; [Elkinton, Heather A.] Oregon State Univ, Intercollegiate Athlet, Corvallis, OR USA; [Holliday, Marissa] Univ Colorado, Intercollegiate Athlet, Boulder, CO USA; [Poddar, Sourav K.] Univ Colorado, Dept Family Med, Anschutz Med Campus, Aurora, CO USA; [Chrisman, Sara P. D.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Chrisman, Sara P. D.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Harmon, KG (corresponding author), Univ Washington, Family Med, Seattle, WA 98195 USA.	kharmon@uw.edu		Harmon, Kimberly/0000-0002-3670-6609; Chrisman, Sara/0000-0001-5373-7223	University of WashingtonUniversity of Washington	Funding for this study was provided by a generous donation from University of Washington alumni Jack and Luellen Charneski.	Anderson Morgan, 1800, J Athl Train, DOI 10.4085/1062-6050-0102.20; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Azad AM., 2016, BMJ OPEN SPORT EXERC, V2, pe000117, DOI [10.1136/bmjsem-2016-000117, DOI 10.1136/BMJSEM-2016-000117]; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Breedlove KM, 2019, J ATHL TRAINING, V54, P1241, DOI 10.4085/1062-6050-219-18; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chrisman SPD, 2019, ANN BIOMED ENG, V47, P2122, DOI 10.1007/s10439-018-02150-8; Clugston JR, 2019, J ATHL TRAINING, V54, P1247, DOI 10.4085/1062-6050-455-18; Clugston JR, 2020, CLIN J SPORT MED, V30, pE139, DOI 10.1097/JSM.0000000000000691; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Garcia GGP, 2020, NEUROSURGERY, V87, P971, DOI 10.1093/neuros/nyaa150; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hecimoyich M, 2018, J SCI MED SPORT, V21, P1004, DOI 10.1016/j.jsams.2018.03.011; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Li Fangyu, 2018, Shanghai Arch Psychiatry, V30, P207, DOI 10.11919/j.issn.1002-0829.218052; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Naidu D, 2018, J NEUROTRAUM, V35, P2283, DOI 10.1089/neu.2017.5490; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Sundaram V, 2019, J SCI MED SPORT, V22, P1287, DOI 10.1016/j.jsams.2019.07.015; SYNCTHINK I., 2020, ASS BATT OV; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	42	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2022	56	3					144	+		10.1136/bjsports-2020-103840		APR 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	YM5TI	WOS:000726963300001	33883170				2022-02-07	
J	Huang, H; Xia, AQ; Sun, L; Lu, C; Liu, Y; Zhu, ZJ; Wang, SY; Cai, JY; Zhou, XY; Liu, S				Huang, Huan; Xia, Anqi; Sun, Li; Lu, Chun; Liu, Ying; Zhu, Zhenjie; Wang, Siye; Cai, Junyan; Zhou, Xiaoyun; Liu, Su			Pathogenic Functions of Tumor Necrosis Factor Receptor-Associated Factor 6 Signaling Following Traumatic Brain Injury	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						neuroinflammation; traumatic brain injury; rat model; lipopolysaccharide; TRAF6		Neuroinflammation contributes to delayed (secondary) neurodegeneration following traumatic brain injury (TBI). Tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling may promote post-TBI neuroinflammation, thereby exacerbating secondary injury. This study investigated the pathogenic functions of TRAF6 signaling following TBI in vivo and in vitro. A rat TBI model was established by air pressure contusion while lipopolysaccharide (LPS) exposure was used to induce inflammatory-like responses in cultured astrocytes. Model rats were examined for cell-specific expression of TRAF6, NF-kappa B, phosphorylated (p)-NF-kappa B, MAPKs (ERK, JNK, and p38), p-MAPKs, chemokines (CCL2 and CXCL1), and chemokine receptors (CCR2 and CXCR2) by immunofluorescence, RT-qPCR, western blotting, and ELISA, for apoptosis by TUNEL staining, and spatial cognition by Morris water maze testing. These measurements were compared between TBI model rats receiving intracerebral injections of TRAF6-targeted RNAi vector (AAV9-TRAF6-RNAi), empty vector, MAPK/NF-kappa B inhibitors, or vehicle. Primary astrocytes were stimulated with LPS following TRAF6 siRNA or control transfection, and NF-kappa B, MAPKs, chemokine, and chemokine receptor expression levels evaluated by western blotting and ELISA. TRAF6 was expressed mainly in astrocytes and neurons of injured cortex, peaking 3 days post-TBI. Knockdown by AAV9-TRAF6-RNAi improved spatial learning and memory, decreased TUNEL-positive cell number in injured cortex, and downregulated expression levels of p-NF-kappa B, p-ERK, p-JNK, p-p38, CCL2, CCR2, CXCL1, and CXCR2 post-TBI. Inhibitors of NF-kappa B, ERK, JNK, and p38 significantly suppressed CCL2, CCR2, CXCL1, and CXCR2 expression following TBI. Furthermore, TRAF6-siRNA inhibited LPS-induced NF-kappa B, ERK, JNK, p38, CCL2, and CXCL1 upregulation in cultured astrocytes. Targeting TRAF6-MAPKs/NF-kappa B-chemokine signaling pathways may provide a novel therapeutic approach for reducing post-TBI neuroinflammation and concomitant secondary injury.	[Huang, Huan; Xia, Anqi; Sun, Li; Zhu, Zhenjie; Wang, Siye; Cai, Junyan; Zhou, Xiaoyun; Liu, Su] Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong, Peoples R China; [Huang, Huan; Xia, Anqi] Nantong Univ, Sch Med, Nantong, Peoples R China; [Lu, Chun] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Rehabil Med, Shanghai, Peoples R China; [Liu, Ying] Nantong Univ, Affiliated Hosp, Dept Pathol, Nantong, Peoples R China		Liu, S (corresponding author), Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong, Peoples R China.	327202278@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81702223]; Science and Technology Planning Project of Nantong [MS22019006]	This project was funded by the National Natural Science Foundation of China (No. 81702223) and Science and Technology Planning Project of Nantong (MS22019006).	Aarts SABM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0875-9; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Chen L, 2019, J CELL MOL MED, V23, P3325, DOI 10.1111/jcmm.14223; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dou Y, 2018, CURR NEUROPHARMACOL, V16, P1306, DOI 10.2174/1570159X16666180412094655; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Geng FY, 2016, NEUROIMMUNOMODULAT, V23, P122, DOI 10.1159/000445689; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim JY, 2015, J KOREAN MED SCI, V30, P943, DOI 10.3346/jkms.2015.30.7.943; Kong L, 2019, IMMUNOPHARM IMMUNOT, V41, P349, DOI 10.1080/08923973.2019.1608560; Li MM, 2019, EXP CELL RES, V376, P133, DOI 10.1016/j.yexcr.2019.02.005; Li T, 2017, J NEUROSCI, V37, P12123, DOI 10.1523/JNEUROSCI.1751-17.2017; Liu GJ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00311; Liu JJ, 2019, NEUROIMMUNOMODULAT, V26, P102, DOI 10.1159/000495467; Liu S, 2018, INFLAMMATION, V41, P2003, DOI 10.1007/s10753-018-0843-2; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Lu Y, 2014, PAIN, V155, P2618, DOI 10.1016/j.pain.2014.09.027; Marshall J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11316-8; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Meng ZY, 2017, J IMMUNOL, V198, P820, DOI 10.4049/jimmunol.1600334; Qian HH, 2017, MOL MED REP, V16, P3922, DOI 10.3892/mmr.2017.7079; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Song FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149991; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Wan SY, 2021, BRAIN RES, V1752, DOI 10.1016/j.brainres.2020.147228; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Wu GY, 2018, NEUROBIOL DIS, V110, P59, DOI 10.1016/j.nbd.2017.11.009; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zeng KW, 2015, J CELL BIOCHEM, V116, P1286, DOI 10.1002/jcb.25084	35	0	0	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	APR 21	2021	14								629910	10.3389/fnmol.2021.629910			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RX2WY	WOS:000647087700001	33967693	Green Submitted, gold, Green Published			2022-02-07	
J	Lester, EG; Mace, RA; Bannon, SM; Popok, PJ; Gates, MV; Meyers, E; Tehan, T; Sagueiro, D; Rosand, J; Macklin, EA; Vranceanu, AM				Lester, Ethan G.; Mace, Ryan A.; Bannon, Sarah M.; Popok, Paula J.; Gates, Melissa V.; Meyers, Emma; Tehan, Tara; Sagueiro, Danielle; Rosand, Jonathan; Macklin, Eric A.; Vranceanu, Ana-Maria			Can a Dyadic Resiliency Program Improve Quality of Life in Cognitively Intact Dyads of Neuro-ICU Survivors and Informal Caregivers? Results from a Pilot RCT	NEUROCRITICAL CARE			English	Article						Dyads; Caregivers; Quality of life; Neurological illness; Neuro-ICU		Background Neuro-ICU hospitalization for an acute neurological illness is often traumatic and associated with heightened emotional distress and reduced quality of life (QoL) for both survivors and their informal caregivers (i.e., family and friends providing unpaid care). In a pilot study, we previously showed that a dyadic (survivor and caregiver together) resiliency intervention (Recovering Together [RT]) was feasible and associated with sustained improvement in emotional distress when compared with an attention placebo educational control. Here we report on changes in secondary outcomes assessing QoL. Methods Survivors (n = 58) and informal caregivers (n = 58) completed assessments at bedside and were randomly assigned to participate together as a dyad in the RT or control intervention (both 6 weeks, two in-person sessions at bedside and four sessions via live video post discharge). We measured QoL domain scores (physical health, psychological, social relations, and environmental), general QoL, and QoL satisfaction using the World Health Organization Quality of Life Abbreviated Instrument at baseline, post treatment, and 3 months' follow-up. We conducted mixed model analyses of variance with linear contrasts to estimate (1) within-group changes in QoL from baseline to post treatment and from post treatment to 3 months' follow-up and (2) between-group differences in changes in QoL from baseline to post treatment and from post treatment to 3 months' follow-up. Results We found significant within-group improvements from baseline to post treatment among RT survivors for physical health QoL (mean difference 1.73; 95% confidence interval [CI] 0.39-3.06; p = 0.012), environmental QoL (mean difference 1.29; 95% CI 0.21-2.36; p = 0.020), general QoL (mean difference 0.55; 95% CI 0.13-0.973; p = 0.011), and QoL satisfaction (mean difference 0.87; 95% CI 0.36-1.37; p = 0.001), and those improvements sustained through the 3-month follow-up. We found no significant between-group improvements for survivors or caregivers from baseline to post treatment or from post treatment to 3 months' follow-up for any QoL variables (i.e., domains, general QoL, and QoL satisfaction together). Conclusions In this pilot study, we found improved QoL among survivors, but not in caregivers, who received RT and improvements sustained over time. These RT-related improvements were not significantly greater than those observed in the control. Results support a fully powered randomized controlled trial to allow for a definitive evaluation of RT-related effects among dyads of survivors of acute brain injury and their caregivers.	[Lester, Ethan G.; Mace, Ryan A.; Bannon, Sarah M.; Popok, Paula J.; Gates, Melissa V.; Meyers, Emma; Vranceanu, Ana-Maria] Harvard Med Sch, Massachusetts Gen Hospital, Dept Psychiat, Integrated Brain Hlth Clin & Res Program, One Bowdoin Sq,1st Floor,Suite 100, Boston, MA 02115 USA; [Lester, Ethan G.; Mace, Ryan A.; Bannon, Sarah M.; Meyers, Emma; Rosand, Jonathan; Macklin, Eric A.; Vranceanu, Ana-Maria] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Tehan, Tara; Sagueiro, Danielle; Rosand, Jonathan] Massachusetts Gen Hosp, Neurosci Intens Care Unit, Boston, MA 02114 USA; [Rosand, Jonathan; Vranceanu, Ana-Maria] Massachusetts Gen Hosp, Henry & Allison McCance Ctr Brain Hlth, Boston, MA 02114 USA; [Macklin, Eric A.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA		Vranceanu, AM (corresponding author), Harvard Med Sch, Massachusetts Gen Hospital, Dept Psychiat, Integrated Brain Hlth Clin & Res Program, One Bowdoin Sq,1st Floor,Suite 100, Boston, MA 02115 USA.	avranceanu@mgh.harvard.edu	Janson, Patrick/AAC-7581-2022		American Heart AssociationAmerican Heart Association [5R21 NR017979]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital	This study was funded by a grant-in-aid from the American Heart Association, Grant 5R21 NR017979 from the National Institute of Nursing Research to Dr. Vranceanu, and the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital.	Alfheim HB, 2019, AUST CRIT CARE, V32, P479, DOI 10.1016/j.aucc.2018.09.005; Bannon, 2021, EMOTIONAL DISTRESS N; Bannon S, 2020, PILOT FEASIBILITY ST, V6, DOI 10.1186/s40814-020-00615-z; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bohart S, 2018, INTENS CRIT CARE NUR, V47, P39, DOI 10.1016/j.iccn.2018.03.002; Broglio K, 2018, JAMA-J AM MED ASSOC, V319, P2223, DOI 10.1001/jama.2018.6360; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Choi KW, 2018, CRIT CARE MED, V46, P713, DOI 10.1097/CCM.0000000000002988; Comini L, 2016, RESP CARE, V61, P405, DOI 10.4187/respcare.04079; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Daniels Lisa M, 2018, Mayo Clin Proc Innov Qual Outcomes, V2, P359, DOI 10.1016/j.mayocpiqo.2018.10.001; de Mol M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4793-8; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Evans C. H., 2001, SMALL CLIN TRIALS IS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frick S, 2002, INTENS CARE MED, V28, P1405, DOI 10.1007/s00134-002-1434-z; Funes CJ, 2019, J NEURO-ONCOL, V143, P505, DOI 10.1007/s11060-019-03182-3; Garton ALA, 2017, STROKE, V48, P507, DOI 10.1161/STROKEAHA.116.015234; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hawthorne G, 2006, SOC INDIC RES, V77, P37, DOI 10.1007/s11205-005-5552-1; Iribarren-Diarasarri S, 2009, INTENS CARE MED, V35, P833, DOI 10.1007/s00134-009-1418-3; Jackson JC, 2015, PSYCHIAT CLIN N AM, V38, P91, DOI 10.1016/j.psc.2014.11.002; Jang Y, 2004, ARCH PHYS MED REHAB, V85, P1890, DOI 10.1016/j.apmr.2004.02.032; Jensen JF, 2016, INTENS CARE MED, V42, P1733, DOI 10.1007/s00134-016-4522-1; Fumis RRL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221218; McCurley JL, 2019, NEUROCRIT CARE, V30, P581, DOI 10.1007/s12028-018-0641-6; Meyers E, 2020, GEN HOSP PSYCHIAT, V62, P87, DOI 10.1016/j.genhosppsych.2019.12.003; Meyers EE, 2020, COGN BEHAV PRACT, V27, P321, DOI 10.1016/j.cbpra.2020.02.001; Meyers EE, 2020, PSYCHOSOMATICS, V61, P135, DOI 10.1016/j.psym.2019.11.007; National Alliance for Caregiving, 2015, CAR US; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Presciutti A, 2021, NEUROCRIT CARE, V34, P54, DOI 10.1007/s12028-020-00980-w; Pucciarelli G, 2021, EUR J CARDIOVASC NUR, V20, P14, DOI 10.1177/1474515120926069; Rosen H, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01345-9; Shaffer KM, 2017, NEUROCRIT CARE, V27, P180, DOI 10.1007/s12028-016-0358-3; Soliman IW, 2015, J CRIT CARE, V30, P181, DOI 10.1016/j.jcrc.2014.09.009; Stricker KH, 2005, ACTA ANAESTH SCAND, V49, P975, DOI 10.1111/j.1399-6576.2005.00702.x; TEASDALE G, 1974, LANCET, V2, P81; Trevick SA, 2017, NEUROCRIT CARE, V26, P436, DOI 10.1007/s12028-016-0372-5; van Beusekom I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217225; van Beusekom I, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1185-9; Vranceanu AM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20807; Vranceanu AM, 2016, NEUROLOGY, V87, P806, DOI 10.1212/WNL.0000000000003005; Wilz G, 2007, BEHAV RES THER, V45, P2508, DOI 10.1016/j.brat.2007.04.010; Zale EL, 2018, GEN HOSP PSYCHIAT, V52, P27, DOI 10.1016/j.genhosppsych.2018.02.012	47	0	0	1	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2021	35	3					756	766		10.1007/s12028-021-01222-3		APR 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	XS0FS	WOS:000641663700001	33880701				2022-02-07	
J	Ordookhanian, C; Amidon, RF; Kaloostian, SW; Vartanian, T; Kaloostian, P				Ordookhanian, Christ; Amidon, Ryan F.; Kaloostian, Sean W.; Vartanian, Talia; Kaloostian, Paul			COVID-19-Induced Hypoxia With Accompanying Syncope Event and Traumatic Injury	CUREUS			English	Article						syncope; covid-19; coronavirus disease; brain hypoxia; acute trauma care; anti-coagulation; coronavirus pandemic; d-dimer; acute respiratory distress syndrome (ards)		The Centers for Disease Control and Prevention identified the first case of the novel coronavirus disease 2019 (COVID-19) on January 21, 2020 in the United States. Since its arrival, the virus has caused widespread havoc on the nation as a whole as well as on all individuals. The coronavirus family is not new to the field of medicine. In fact, the viral pathogenicity dates back to the early 1960s, with more information on the respiratory preference and the ability to cause acute respiratory pathology coming later in 2002. The novel coronavirus, severe acute respiratory syndrome coronavirus 2, causes a disease commonly referred to as COVID-19, which has a well documented course of severe respiratory pathology along with interesting systemic consequences that often complicate the clinical picture. This case presents an otherwise healthy young 35-year-old male who contracted the novel coronavirus, leading to multi-organ hypoxia and triggering a syncopal episode which resulted in physical trauma to the head leading to a minor subarachnoid hemorrhage.	[Ordookhanian, Christ] Univ Calif Riverside, Sch Med, Med, Riverside, CA 92521 USA; [Amidon, Ryan F.] Med Coll Wisconsin, Med, Milwaukee, WI 53226 USA; [Kaloostian, Sean W.] Haider Spine Ctr, Neurol Surg, Riverside, CA USA; [Vartanian, Talia] Univ Southern Calif, Phys Med & Rehabil, Los Angeles, CA 90007 USA; [Kaloostian, Paul] Riverside Community Hosp, Med, Riverside, CA 92501 USA		Kaloostian, P (corresponding author), Riverside Community Hosp, Med, Riverside, CA 92501 USA.	pkaloostian@gmail.com		Amidon, Ryan/0000-0002-3857-2667			Centers for Disease Control and Prevention, 2019, KEY FACTS INFL FLU; Centers for Disease Control and Prevention, 2021, SYMPT COR; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Guan WJ, 2020, NEW ENGL J MED, DOI [10.1056/NEJMoa2002032, DOI 10.1056/NEJMOA2002032]; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Huang W, 2020, CYTOM PART A, V97, P772, DOI 10.1002/cyto.a.24172; Iadecola C, 2020, CELL, V183, P16, DOI 10.1016/j.cell.2020.08.028; Li JW, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03033-y; Meythaler JM, 1998, ARCH PHYS MED REHAB, V79, P766, DOI 10.1016/S0003-9993(98)90354-9; Navas-Blanco JR, 2020, BMC ANESTHESIOL, V20, DOI 10.1186/s12871-020-01095-7; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Schutgens RE, 2020, HEMASPHERE, V4, DOI 10.1097/HS9.0000000000000422; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Taylor, 2020, DIFFUSE AXONAL INJUR; Temgoua Mazou Ngou, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00417-7; Wang CZ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-6090	17	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	APR 21	2021	13	4							e14602	10.7759/cureus.14602			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RQ7OY	WOS:000642605500003	34040903	gold, Green Published			2022-02-07	
J	Reyes, J; Mitra, B; Makdissi, M; Clifton, P; Nguyen, JVK; Harcourt, P; Howard, TS; Cameron, PA; Rosenfeld, JV; Major, BP; Willmott, C				Reyes, Jonathan; Mitra, Biswadev; Makdissi, Michael; Clifton, Patrick; Nguyen, Jack V. K.; Harcourt, Peter; Howard, Teresa S.; Cameron, Peter A.; Rosenfeld, Jeffrey, V; Major, Brendan P.; Willmott, Catherine			Visible Signs of Concussion and Cognitive Screening in Community Sports	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						athletic injuries; Australian football; brain concussion; head; visible signs; sport concussion assessment tool; sports-related concussion	VIDEO ANALYSIS; NORMATIVE DATA; HIGH-SCHOOL; VALIDITY; RELIABILITY; SENSITIVITY; DEPRESSION; PLAYERS; PAIN	Video surveillance and detection of players with visible signs of concussion by experienced medical staff facilitates rapid on-field screening of suspected concussion in professional sports. This method, however has not been validated in community sports where video footage is unavailable. This study aimed to explore the utility of visible signs of concussion to identify players with decrements in performance on concussion screening measures. In this observational prospective cohort study, personnel with basic training observed live matches across a season (60 matches) of community male and female Australian football for signs of concussion outlined in the community-based Head Injury Assessment form (HIAf). Players identified to have positive signs of concussion (CoSign+) following an impact were compared with players without signs (CoSign-). Outcome measures, the Sport Concussion Assessment Tool (SCAT3) and Cogstate, were administered at baseline and post-match. CoSign+ (n = 22) and CoSign- (n = 61) groups were similar with respect to age, sex, education, baseline mood, and medical history. CoSign+ players exhibited worse orientation, concentration, and recall, and slower reaction time in attention and working memory tasks. Comparing individual change from baseline to post-match assessment revealed 100% (95% confidence interval [CI]: 84-100%) of CoSign+ players demonstrated clinically significant deficits on SCAT3 or Cogstate tasks, compared with 59% (95% CI: 46-71%) of CoSign- players. All CoSign+ players observed to have a blank/vacant look demonstrated clinically significant decline on the Standardized Assessment of Concussion (SAC). Detection of visible signs of concussion represents a rapid, real-time method for screening players suspected of concussion in community sports where video technology and medical personnel are rarely present. Consistent with community guidelines, it is recommended that all CoSign+ players be immediately removed from play for further concussion screening.	[Reyes, Jonathan; Nguyen, Jack V. K.; Willmott, Catherine] Monash Univ, Turner Inst Brain & Mental Hlth, Clayton Campus, Melbourne, Vic, Australia; [Mitra, Biswadev; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton Campus, Melbourne, Vic, Australia; [Howard, Teresa S.; Rosenfeld, Jeffrey, V] Monash Univ, Dept Surg, Clayton Campus, Melbourne, Vic, Australia; [Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey, V] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Makdissi, Michael] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia; [Makdissi, Michael] Olymp Pk Sports Med Ctr, Melbourne, Vic, Australia; [Clifton, Patrick; Harcourt, Peter] Australian Football League, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey, V] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA; [Major, Brendan P.] Monash Univ, Melbourne, Vic, Australia; [Willmott, Catherine] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Willmott, C (corresponding author), Monash Univ, Turner Clin, Ground Floor,Bldg 1,270 Ferntree Gully Rd, Notting Hill, Vic 3168, Australia.	catherine.willmott@monash.edu		Nguyen, Jack/0000-0002-6698-1935; makdissi, michael/0000-0003-0334-7133	National Health & Medical Research Council (NH & MRC) Canberra, Australia [APP1133923]; Alfred Trauma Service (ATS); AFL	This study was supported by a National Health & Medical Research Council (NH & MRC) Canberra, Australia grant (APP1133923, 2016), the Alfred Trauma Service (ATS), and the AFL. The ATS and the Turner Institute for Brain and Mental Health provided in-kind support across the course of this study including: research accounting support, high-level stakeholder engagement, attending investigator meetings as required, and a research assistant. The AFL provided direct funding to cover the costs of research assistant salaries, as well as in-kind support in the form of AFL staff time to: educate investigators in relation to current AFL concussion management processes, attend investigator meetings, assist with access to participating clubs, and assist in manuscript preparation. The X2 Interactive Concussion Examination was purchased on a commercial basis, and no author has any financial interest in the product or distributor of the product.	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Aughey RJ, 2010, INT J SPORT PHYSIOL, V5, P394, DOI 10.1123/ijspp.5.3.394; Bekker S, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0189-5; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Davis G.A., 2017, MANAGEMENT CONCUSSIO; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Donaldson A, 2017, INJURY PREV, V23, P273, DOI 10.1136/injuryprev-2015-041737; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elbin RJ, 2020, NEUROSURGERY, V87, P530, DOI 10.1093/neuros/nyaa072; Finch CF, 2017, BRIT J SPORT MED, V51, P1734, DOI 10.1136/bjsports-2017-098212; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Garrett J, 2019, INT J SPORT PHYSIOL, V14, P598, DOI 10.1123/ijspp.2018-0253; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Houck Z, 2019, BRAIN INJURY, V33, P480, DOI 10.1080/02699052.2019.1565897; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Lee JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727261; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Makdissi M., 2016, BRIT J SPORT MED, V51, pA79, DOI DOI 10.1136/BJSPORTS-2016-097270.205; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McAllister TW, 2018, HAND CLINIC, V158, P153, DOI 10.1016/B978-0-444-63954-7.00016-1; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moore DJ, 2013, PAIN, V154, P1840, DOI 10.1016/j.pain.2013.06.006; Peltonen K, 2020, TRANSL SPORTS MED, V3, P565, DOI 10.1002/tsm2.179; Reyes J, 2020, AM J SPORT MED, V48, P1485, DOI 10.1177/0363546520912416; Sanchez CA, 2011, MEMORY, V19, P226, DOI 10.1080/09658211.2010.547861; Sullivan L, 2018, J SPORT HEALTH SCI, V7, P102, DOI 10.1016/j.jshs.2017.05.003; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785	36	0	0	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7425		APR 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RQ5RS	WOS:000642476600001	33678008				2022-02-07	
J	Gao, SY; Fabio, A; Rosario, BL; Kelly, MK; Beers, SR; Bell, MJ; Wisniewski, SR				Gao, Shiyao; Fabio, Anthony; Rosario, Bedda L.; Kelly, M. Kathleen; Beers, Sue R.; Bell, Michael J.; Wisniewski, Stephen R.			Characteristics Associated with the Use of an Inpatient Rehabilitation or Skilled Nursing Facility after Acute Care in Children with Severe Traumatic Brain Injury	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Child; severe traumatic brain injury; inpatient rehabilitation; non-inpatient rehabilitation		To characterize inpatient rehabilitation services for children with severe traumatic brain injury (TBI), we included 254 children, whose parents/guardians reported receipt of rehabilitation within a 12-month follow-up period, from a multinational observational study. Children discharged to an inpatient rehabilitation or skilled nursing facility after acute care were classified into the "inpatient rehabilitation" group, and children discharged home after acute care were classified into the "non-inpatient rehabilitation" group. Multivariable regression analyses determined the associations of sociodemographic and clinical characteristics with rehabilitation groups. Children receiving inpatient rehabilitation had a shorter length of acute hospitalization. Children from the UK were less likely to receive inpatient rehabilitation compared to children from the US. Future studies are warranted to extend current findings by identifying the reasons behind differential access to inpatient rehabilitation among children with severe TBI.	[Gao, Shiyao; Fabio, Anthony; Rosario, Bedda L.; Wisniewski, Stephen R.] Univ Pittsburgh, Epidemiol Data Ctr, 4420 Bayard St,Suite 600, Pittsburgh, PA 15260 USA; [Kelly, M. Kathleen] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15260 USA; [Beers, Sue R.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Childrens Natl Hosp, Dept Pediat, Div Crit Care Med, Washington, DC USA		Wisniewski, SR (corresponding author), Univ Pittsburgh, Epidemiol Data Ctr, 4420 Bayard St,Suite 600, Pittsburgh, PA 15260 USA.	wisniew@edc.pitt.edu			National Institute of Neurological Disorders and Stroke of the US National Institute of Health [U01 NS081041]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the US National Institute of Health under Award Number U01 NS081041. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke, the National Institute of Health or the US Department of Health and Human Services.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Berry JG, 2016, JAMA PEDIATR, V170, P326, DOI 10.1001/jamapediatrics.2015.4836; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Commission on Accreditation of Rehabilitation Facilities, 2019, 2019 MED REH PROGR D; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Forrest G, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017096; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Friedman SL, 2014, PEDIATRICS, V134, P836, DOI 10.1542/peds.2014-2279; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gao SY, 2018, J HEAD TRAUMA REHAB, V33, pE40, DOI 10.1097/HTR.0000000000000338; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Hayes L, 2017, ARCH DIS CHILD, V102, P813, DOI 10.1136/archdischild-2016-312166; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Joyce T, 2019, STATPEARLS; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Larson EL, 2014, CLIN PEDIATR, V53, P1041, DOI 10.1177/0009922814540986; Lefebvre H, 2012, BRAIN INJURY, V26, P1084, DOI 10.3109/02699052.2012.666364; Mansfield AK, 2015, FAM PROCESS, V54, P82, DOI 10.1111/famp.12080; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Menon DK, 2019, LANCET NEUROL, V18, P28, DOI 10.1016/S1474-4422(18)30463-0; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Nguyen HT, 2017, J PEDIATR-US, V182, P342, DOI 10.1016/j.jpeds.2016.11.039; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Prevention, 2015, C TRAYM BRAIN INJ US; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Smedley BD, 2003, UNEQUAL TREATMENT CO; Tasker RC, 2017, J NEUROTRAUM, V27; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; TESTA J, 2006, J HEAD TRAUMA REHAB, V21; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Yang Y., 2020, GGLASSO GROUP LASSO; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	49	0	0	3	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	OCT 3	2021	24	7					466	477		10.1080/17518423.2021.1908441		APR 2021	12	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	UP5VS	WOS:000641504200001	33872126				2022-02-07	
J	Mercier, LJ; Kruger, N; Le, QB; Fung, TS; Kline, GA; Debert, CT				Mercier, Leah J.; Kruger, Natalia; Le, Quynk B.; Fung, Tak S.; Kline, Gregory A.; Debert, Chantel T.			Growth hormone deficiency testing and treatment following mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							ANTERIOR-PITUITARY FUNCTION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GH REPLACEMENT; HYPOPITUITARISM; ADULTS; INSUFFICIENCY; PREVALENCE; GUIDELINES; VALIDITY; PATIENT	Pituitary dysfunction, specifically growth hormone (GH) deficiency, can occur following traumatic brain injury. Our objective was to characterize the prevalence of GH deficiency (GHD) testing and response to recombinant human GH (rhGH) treatment in adults with persistent symptoms following mild traumatic brain injury (mTBI) referred for assessment of pituitary dysfunction. A retrospective chart review was conducted of patients seen at an outpatient brain injury clinic with a diagnosis of mTBI and persistent post-concussive symptoms who were referred to endocrinology. Clinical assessments of symptoms were collected. Investigations and results of GHD were collected, including initiation of rhGH treatment and treatment response. Of the 253 patients seen in both brain injury and endocrinology clinics, 97 with mTBI were referred for investigation of pituitary dysfunction and 73 (75%) had dynamic testing for assessment of GHD. Of the 26 individuals diagnosed with GHD, 23 (88%) started rhGH. GH therapy was inconsistently offered based on interpretation of GH dynamic testing results. Of those who started rhGH, 18 (78%) had a useful treatment response. This study suggests that clinical management of these patients is varied, highlighting a need for clear guidelines for the diagnosis and management of GHD following mTBI.	[Mercier, Leah J.; Kruger, Natalia; Debert, Chantel T.] Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, Calgary, AB, Canada; [Le, Quynk B.] Alberta Hlth Serv, Endocrinol & Metab Program, Calgary, AB, Canada; [Fung, Tak S.] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Kline, Gregory A.] Univ Calgary, Div Endocrinol, Dept Med, Calgary, AB, Canada		Mercier, LJ (corresponding author), Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, Calgary, AB, Canada.	leah.mercier@ucalgary.ca					Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2007, NAT CLIN PRACT ENDOC, V3, P318, DOI 10.1038/ncpendmet0460; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Emelifeonwu JA, 2020, J NEUROTRAUM, V37, P217, DOI 10.1089/neu.2018.6349; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fleseriu M, 2016, J CLIN ENDOCR METAB, V101, P3888, DOI 10.1210/jc.2016-2118; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; Hacioglu A, 2019, PITUITARY, V22, P322, DOI 10.1007/s11102-019-00937-z; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Ioachimescu AG, 2015, PITUITARY, V18, P535, DOI 10.1007/s11102-014-0606-5; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Koltowska-Haggstrom M, 2005, HORM RES, V64, P46, DOI 10.1159/000087444; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lithgow K, 2018, JRM CC, V1; Lithgow K, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0247-1; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Undurti A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00072; Wright T, 2020, J NEUROTRAUM, V37, P1052, DOI 10.1089/neu.2019.6690; Yuen KCJ, 2019, ENDOCR PRACT, V25, P1191, DOI 10.4158/GL-2019-0405	39	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 20	2021	11	1							8534	10.1038/s41598-021-87385-7			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RQ6GW	WOS:000642516200007	33879807	gold, Green Published			2022-02-07	
J	Wellard, J; Kuwabara, M; Adelson, PD; Appavu, B				Wellard, Jeffrey; Kuwabara, Michael; Adelson, P. David; Appavu, Brian			Physiologic Characteristics of Hyperosmolar Therapy After Pediatric Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						hyperosmolar therapy; hypertonic saline; mannitol; traumatic brain injury; pediatrics; cerebrovascular pressure reactivity; multimodality monitoring	CEREBROVASCULAR PRESSURE REACTIVITY; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; CHILDREN; HYPERTENSION; MANAGEMENT; GUIDELINES; MANNITOL	All work was performed at the Barrow Neurological Institute at Phoenix Children's Hospital. Objective: Investigate injury severity, neuroimaging, physiology, and outcomes with bolus hyperosmolar therapy (HT) of 3% hypertonic saline or mannitol. Methods: Retrospective cohort analysis was performed. Physiologic variables included intracranial pressure (ICP), arterial blood pressure (ABP), and heart rate (HR). Volume-pressure compensation (PVC) indices included ICP pulse amplitude (AMP) and correlation of AMP and ICP (RAP). Cerebrovascular pressure reactivity (CVPR) indices included pressure reactivity index (PRx), pulse amplitude index (PAx), wavelet PRx (wPRx), and correlation of AMP and cerebral perfusion pressure (RAC). Heart rate variability (HRV) indices included heart rate standard deviation (HRsd), heart rate root mean square of successive differences (HRrmssd) and low-high frequency ratio (LHF). Outcome was assessed using Glasgow Outcomes Scale Extended Pediatrics, 12-months post-injury. Generalized estimating equations was applied to investigate associations of physiologic changes and pre-treatment indices with HT efficacy. Repeated measures analysis of variance was applied to investigate changes after HT without intracranial hypertension (ICH). Wilcoxon rank-sum was applied to investigate HT responsiveness with age, injury severity, neuroimaging, and outcomes. Results: Thirty children received bolus HT. ICH reduction after HT was associated with reduced ICP (p = 0.0064), ABP (p = 0.0126), PRx (p = 0.0063), increased HRsd (p = 0.0408), and decreased pretreatment RAC (p = 0.0115) and wPRx (p = 0.0072). HT-responsive patients were older and had improved outcomes (p = 0.0394). HT without ICH was associated with increased ICP (P < 0.0001) and ABP (P < 0.0001), increases in all HRV indices and decreases in all PVC indices. Conclusion: After pediatric TBI, efficacious HT is associated with decreased ICP and ABP, pre-treatment indices suggesting efficient CVPR, and potentially improved outcomes.	[Wellard, Jeffrey; Kuwabara, Michael; Adelson, P. David; Appavu, Brian] Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Kuwabara, Michael] Phoenix Childrens Hosp, Dept Radiol, Phoenix, AZ USA; [Adelson, P. David; Appavu, Brian] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurosci, Phoenix, AZ 85016 USA		Appavu, B (corresponding author), Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA.; Appavu, B (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurosci, Phoenix, AZ 85016 USA.	bappavu@phoenixchildrens.com			United States Department of Defense Congressionally Directed Medical Research ProgramsUnited States Department of DefenseDefense Threat Reduction Agency [W81XWH-19-1-0514]	This study was funded in part by the United States Department of Defense Congressionally Directed Medical Research Programs (W81XWH-19-1-0514).	Appavu B, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01261; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Camm AJ, 1996, CIRCULATION, V93, P1043; CARR GJ, 1992, STAT MED, V11, P1033, DOI 10.1002/sim.4780110805; Diringer MN, 2012, NEUROSURGERY, V70, P1215, DOI 10.1227/NEU.0b013e3182417bc2; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Froese L, 2020, ACTA NEUROCHIR, V162, P2683, DOI 10.1007/s00701-020-04579-0; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kim Hae-Young, 2015, Restor Dent Endod, V40, P91, DOI 10.5395/rde.2015.40.1.91; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Liu XY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002348; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; SYKORA E, 2012, NEUROCRIT CARE, V16, P258, DOI DOI 10.1007/S12028-011-9630-8; TEASDALE G, 1974, LANCET, V2, P81; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086	29	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 20	2021	12								662089	10.3389/fneur.2021.662089			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RW6AF	WOS:000646603700001	33959090	gold, Green Published			2022-02-07	
J	De Crescenzo, LA; Gabella, BA; Johnson, J				De Crescenzo, Lauren Alexis; Gabella, Barbara Alison; Johnson, Jewell			Interrupted time series design to evaluate ICD-9-CM to ICD-10-CM coding changes on trends in Colorado emergency department visits related to traumatic brain injury	INJURY EPIDEMIOLOGY			English	Article						Traumatic brain injury; Hospital emergency department; Regression analysis; International classification of disease codes		BackgroundThe transition in 2015 to the Tenth Revision of the International Classification of Disease, Clinical Modification (ICD-10-CM) in the US led the Centers for Disease Control and Prevention (CDC) to propose a surveillance definition of traumatic brain injury (TBI) utilizing ICD-10-CM codes. The CDC's proposed surveillance definition excludes "unspecified injury of the head," previously included in the ICD-9-CM TBI surveillance definition. The study purpose was to evaluate the impact of the TBI surveillance definition change on monthly rates of TBI-related emergency department (ED) visits in Colorado from 2012 to 2017.ResultsThe monthly rate of TBI-related ED visits was 55.6 visits per 100,000 persons in January 2012. This rate in the transition month to ICD-10-CM (October 2015) decreased by 41 visits per 100,000 persons (p-value <0.0001), compared to September 2015, and remained low through December 2017, due to the exclusion of "unspecified injury of head" (ICD-10-CM code S09.90) in the proposed TBI definition. The average increase in the rate was 0.33 visits per month (p<0.01) prior to October 2015, and 0.04 visits after. When S09.90 was included in the model, the monthly TBI rate in Colorado remained smooth from ICD-9-CM to ICD-10-CM and the transition was no longer significant (p=0.97).ConclusionThe reduction in the monthly TBI-related ED visit rate resulted from the CDC TBI surveillance definition excluding unspecified head injury, not necessarily the coding transition itself. Public health practitioners should be aware that the definition change could lead to a drastic reduction in the magnitude and trend of TBI-related ED visits, which could affect decisions regarding the allocation of TBI resources. This study highlights a challenge in creating a standardized set of TBI ICD-10-CM codes for public health surveillance that provides comparable yet clinically relevant estimates that span the ICD transition.	[De Crescenzo, Lauren Alexis] Colorado Sch Publ Hlth, Denver, CO USA; [Gabella, Barbara Alison; Johnson, Jewell] Colorado Dept Publ Hlth & Environm, 4300 Cherry Creek Dr South,A4, Denver, CO 80246 USA		Gabella, BA (corresponding author), Colorado Dept Publ Hlth & Environm, 4300 Cherry Creek Dr South,A4, Denver, CO 80246 USA.	barbara.gabella@state.co.us			Centers for Disease Control and Prevention in the United States Health and Human Services Department (HHS) [6NU17CE92484103]	This publication was supported in part by Grant Number 6NU17CE92484103 from the Centers for Disease Control and Prevention in the United States Health and Human Services Department (HHS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the HHS or the Colorado Department of Public Health and Environment or the Colorado Hospital Association.	Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Colorado Department of Local Affairs, 2018, POP DAT POP DAT; Colorado Department of Public Health and Environment, 2015, INJ COL 2012 2014 INJ COL 2012 2014; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Gabella BA, 2021, INJURY PREV, V27, pi42, DOI 10.1136/injuryprev-2019-043510; Hedegaard H., 2020, NATL HLTH STAT REPOR; Hedegaard H., 2016, NATL HLTH STAT REPOR, V89; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Israeli Center for Trauma and Emergency Medicine Research Gertner Institute Sheba Medical Center, BAR INJ DIAGN MATR C BAR INJ DIAGN MATR C; Marr A., 2004, CENTRAL NERVOUS SYST; National Center for Health Statistics, 2015, INT CLASSIFICATION D; National Conference of State Legislators, 2018, TRAUMATIC BRAIN INJU; Nikpay S, 2017, ANN EMERG MED, V70, P215, DOI 10.1016/j.annemergmed.2017.03.023; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Peterson A, 2021, INJURY PREV, V27, pi13, DOI 10.1136/injuryprev-2019-043517; Sebastiao YV, 2021, INJURY EPIDEMIOL, V8, DOI 10.1186/s40621-021-00298-x; Slavova Svetla, 2018, Inj Epidemiol, V5, P36, DOI 10.1186/s40621-018-0165-8; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Warwick J, 2020, BRAIN INJURY, V34, P1763, DOI 10.1080/02699052.2020.1849801	22	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	APR 19	2021	8	1							15	10.1186/s40621-021-00308-y			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TP5MJ	WOS:000677643200001	33866966	Green Published, gold			2022-02-07	
J	De Vito, A; Maino, C; Lombardi, S; Ragusi, M; Franzesi, CT; Ippolito, D; Sironi, S				De Vito, Andrea; Maino, Cesare; Lombardi, Sophie; Ragusi, Maria; Franzesi, Cammillo Talei; Ippolito, Davide; Sironi, Sandro			Model-based reconstruction algorithm in the detection of acute trauma-related lesions in brain CT examinations	NEURORADIOLOGY JOURNAL			English	Article						Multidetector computed tomography; knowledge bases; traumatic brain injuries		Background and purpose: To evaluate the added value of a model-based reconstruction algorithm in the assessment of acute traumatic brain lesions in emergency non-enhanced computed tomography, in comparison with a standard hybrid iterative reconstruction approach. Materials and methods: We retrospectively evaluated a total of 350 patients who underwent a 256-row non-enhanced computed tomography scan at the emergency department for brain trauma. Images were reconstructed both with hybrid and model-based iterative algorithm. Two radiologists, blinded to clinical data, recorded the presence, nature, number, and location of acute findings. Subjective image quality was performed using a 4-point scale. Objective image quality was determined by computing the signal-to-noise ratio and contrast-to-noise ratio. The agreement between the two readers was evaluated using k-statistics. Results: A subjective image quality analysis using model-based iterative reconstruction gave a higher detection rate of acute trauma-related lesions in comparison to hybrid iterative reconstruction (extradural haematomas 116 vs. 68, subdural haemorrhages 162 vs. 98, subarachnoid haemorrhages 118 vs. 78, parenchymal haemorrhages 94 vs. 64, contusive lesions 36 vs. 28, diffuse axonal injuries 75 vs. 31; all P<0.001). Inter-observer agreement was moderate to excellent in evaluating all injuries (extradural haematomas k=0.79, subdural haemorrhages k=0.82, subarachnoid haemorrhages k=0.91, parenchymal haemorrhages k=0.98, contusive lesions k=0.88, diffuse axonal injuries k=0.70). Quantitatively, the mean standard deviation of the thalamus on model-based iterative reconstruction images was lower in comparison to hybrid iterative one (2.12 +/- 0.92 vsa 3.52 +/- 1.10; P=0.030) while the contrast-to-noise ratio and signal-to-noise ratio were significantly higher (contrast-to-noise ratio 3.06 +/- 0.55 vs. 1.55 +/- 0.68, signal-to-noise ratio 14.51 +/- 1.78 vs. 8.62 +/- 1.88; P<0.0001). Median subjective image quality values for model-based iterative reconstruction were significantly higher (P=0.003). Conclusion: Model-based iterative reconstruction, offering a higher image quality at a thinner slice, allowed the identification of a higher number of acute traumatic lesions than hybrid iterative reconstruction, with a significant reduction of noise.	[De Vito, Andrea; Maino, Cesare; Lombardi, Sophie; Ragusi, Maria; Franzesi, Cammillo Talei; Ippolito, Davide] San Gerardo Hosp, Dept Diagnost Radiol, Monza, Italy; [De Vito, Andrea; Maino, Cesare; Lombardi, Sophie; Ragusi, Maria; Franzesi, Cammillo Talei; Ippolito, Davide; Sironi, Sandro] Univ Milano Bicocca, Sch Med, Milan, Italy; [Sironi, Sandro] Papa Giovanni XXIII Hosp, Dept Diagnost Radiol, Bergamo, BG, Italy		Ippolito, D (corresponding author), Univ Milano Bicocca, Dept Diagnost Radiol, San Gerardo Hosp, Via Pergolesi 33 2, I-20900 Monza, MB, Italy.	davide.atena@tiscali.it	Ippolito, Davide/AAL-3815-2020	Ippolito, Davide/0000-0002-2696-7047			Chang W, 2013, INVEST RADIOL, V48, P598, DOI 10.1097/RLI.0b013e3182899104; Chen BY, 2013, MED PHYS, V40, DOI 10.1118/1.4823463; DIACONIS JN, 1980, CT-J COMPUT TOMOGR, V4, P261, DOI 10.1016/0149-936X(80)90018-1; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; Gunn MLD, 2010, EMERG RADIOL, V17, P209, DOI 10.1007/s10140-009-0850-6; Herin E, 2015, EUR RADIOL, V25, P2362, DOI 10.1007/s00330-015-3656-9; Hidajat N, 1999, INVEST RADIOL, V34, P51, DOI 10.1097/00004424-199901000-00008; Iyama Y, 2017, J COMPUT ASSIST TOMO, V41, P884, DOI 10.1097/RCT.0000000000000626; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lombardi S, 2018, NEURORADIOLOGY, V60, P1273, DOI 10.1007/s00234-018-2092-3; Love A, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130388; Machida H, 2013, AM J NEURORADIOL, V34, P971, DOI 10.3174/ajnr.A3320; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Nakaura T, 2016, NEURORADIOLOGY, V58, P245, DOI 10.1007/s00234-015-1631-4; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nishizawa M, 2015, JPN J RADIOL, V33, P26, DOI 10.1007/s11604-014-0376-z; Notohamiprodjo S, 2015, EUR RADIOL, V25, P140, DOI 10.1007/s00330-014-3374-8; Pickhardt PJ, 2012, AM J ROENTGENOL, V199, P1266, DOI 10.2214/AJR.12.9382; Ren QG, 2012, EUR J RADIOL, V81, P2597, DOI 10.1016/j.ejrad.2011.12.041; Schlattl H, 2010, PHYS MED BIOL, V55, P6243, DOI 10.1088/0031-9155/55/20/013; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5	22	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1971-4009	2385-1996		NEURORADIOL J	Neuradiology J.	OCT	2021	34	5					462	469	19714009211008751	10.1177/19714009211008751		APR 2021	8	Neuroimaging	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WN1CA	WOS:000644982500001	33872086				2022-02-07	
J	Dympep, B; Balakrishnan, TM; Raj, ADN; Jaganmohan, J				Dympep, Badamutlang; Balakrishnan, Thalaivirithan Margabandu; Raj, A. Diana Niranjani; Jaganmohan, Janardhanam			Long head function preserving modification of Somsak's nerve transfer for the reanimation of shoulder abduction in the adult upper partial brachial plexus injuries: a cadaver and clinical study	EUROPEAN JOURNAL OF PLASTIC SURGERY			English	Article						Nerve to the long head of triceps; Adult upper partial brachial plexus injury; Modified Somsak&#8217; s procedure; Function preserving nerve transfers; Target neurotization; Distal nerve transfers		Background We modified the conventional Somsak procedure to preserve the innervation to the long head of triceps, which is an indispensable component of inferior and posterior shoulder stability. The latter is also an extensor and external rotator of the shoulder. Our modification is also based on the finding that normal force of the reinnervated muscle could be achieved with just one-third of the axonal population. Shoulder abduction and external rotation are second priority in adult brachial plexus injury (ABPI) treatment. The aim of this study is to evaluate the functional outcomes of our modification of Somsak's procedure Methods A preliminary cadaver study was conducted by us to study the anatomy of the donor nerve (the nerve to the long head of triceps-NLHOT) and feasibility for function preserving nerve transfer to the anterior branch of the axillary nerve. We followed this with a retrospective study (2007 to 2017) in which the documents of 46 closed adult upper partial brachial plexus injuries (AUPBPI) patients who had undergone only the modified Somsak's procedure for the shoulder animation were assessed. All patients had levels 1, 2, and 3 preganglionic or wide gap postganglionic injuries involving the C5 and C6 spinal nerves. The patients also had a simultaneous target neurotization procedure for elbow flexion. Results The cadaver study highlighted the vasa nervorum and branching patterns of the axillary nerve and NLHOT. The cadaver study also established the ways and means of harvesting the vascularized size-matched branch of NLHOT facilitating target neurotization to the anterior branch of the axillary nerve. On evaluation with the institution objective assessment score, 42 patients (91.3%) had grade 4 scores and four patients (8.7%) had grade 3 scores (p < 0.05). At the end of the follow-up period, patients were assessed with the institutional subjective assessment score, which showed that 43 patients (93.5%) had grade "A" and three patients (6.5%) had grade "B" scores (p < 0.05). Conclusions Preserving the innervation of the long head of triceps bestows good shoulder stability. A diligent intraneural dissection along the nerve to the long head of triceps fetches a branch of adequate size and length and possibly with a sufficient number of regenerating axons, facilitating a tensionless coaptation of vascularized nerve ends and resulting in useful functional outcomes. Thus the modified Somsak's procedure can be a useful addendum in the shoulder animation of AUPBPI patients. Level of evidence: Level III, therapeutic study	[Dympep, Badamutlang; Balakrishnan, Thalaivirithan Margabandu; Raj, A. Diana Niranjani; Jaganmohan, Janardhanam] Madras Med Coll & Govt Gen Hosp, Dept Plast & Faciomaxillary Surg, Chennai 600003, Tamil Nadu, India		Balakrishnan, TM (corresponding author), Madras Med Coll & Govt Gen Hosp, Dept Plast & Faciomaxillary Surg, Chennai 600003, Tamil Nadu, India.	thalaiviri.b@gmail.com					AZIZ W, 1990, J BONE JOINT SURG BR, V72, P701, DOI 10.1302/0301-620X.72B4.2380231; Cardenas-Mejia A, 2008, PLAST RECONSTR SURG, V122, P1470, DOI 10.1097/PRS.0b013e3181881fc5; Chwei Chen-Chuang D., 2018, PLAST SURG-CHIR PLAS, P813; DEZEPETNEK JET, 1992, J NEUROPHYSIOL, V67, P1385, DOI 10.1152/jn.1992.67.5.1385; Gu YD, 1996, CLIN ORTHOP RELAT R, P119; Hentz, 2006, PLASTIC SURG, P515; Leechavengvongs S, 2003, J HAND SURG-AM, V28A, P633, DOI 10.1016/S0363-5023(03)00199-0; Leechavengvongs S, 1998, J HAND SURG-AM, V23A, P711, DOI 10.1016/S0363-5023(98)80059-2; Leffert RD., 1985, BRACHIAL PLEXUS INJU, P189; LURJE A, 1948, ANN SURG, V127, P317, DOI 10.1097/00000658-194802000-00009; MacKinnon SE, 1999, HAND CLIN, V15, P643; McMinn RMH., 1998, LASTS ANATOMY REGION, P76; Merrell GA, 2001, J HAND SURG-AM, V26A, P303, DOI 10.1053/jhsu.2001.21518; Millesi H., 1988, HAND, P645; Narakas AO., 1991, OPERATIVE NERVE REPA, P1329; Nasu Hisayo, 2019, JSES Open Access, V3, P5, DOI 10.1016/j.jses.2019.01.001; Nath RK, 2000, HAND CLIN, V16, P131; OBERLIN C, 1994, J HAND SURG-AM, V19A, P232, DOI 10.1016/0363-5023(94)90011-6; Saha AK., 1967, ACTA ORTHOP SCAND, VSuppl 97, P5; Samardzic M, 2002, NEUROSURGERY, V50, P1277, DOI 10.1097/00006123-200206000-00019; SAMARDZIC M, 1992, J NEUROSURG, V76, P191, DOI 10.3171/jns.1992.76.2.0191; Samardzic M, 2000, NEUROSURGERY, V46, P93, DOI 10.1093/neurosurgery/46.1.93; Standring S, 2005, GRAYS ANATOMY ANATOM, P832; TAYLOR GI, 1994, PLAST RECONSTR SURG, V94, P1, DOI 10.1097/00006534-199407000-00001; TRAVILL AA, 1962, ANAT REC, V144, P373, DOI 10.1002/ar.1091440408; Witoonchart K, 2003, J HAND SURG-AM, V28A, P628, DOI 10.1016/S0363-5023(03)00200-4	26	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0930-343X	1435-0130		EUR J PLAST SURG	Eur. J. Plast. Surg.	OCT	2021	44	5					641	652		10.1007/s00238-021-01804-6		APR 2021	12	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	UQ2SA	WOS:000641199500003					2022-02-07	
J	Keidan, L; Barash, A; Lenzner, Z; Pick, CG; Been, E				Keidan, Lee; Barash, Alon; Lenzner, Ziv; Pick, Chaim G.; Been, Ella			Sexual dimorphism of the posterior cervical spine muscle attachments	JOURNAL OF ANATOMY			English	Article						gender; multifidus; neck muscles; neck pain; sex; splenius; whiplash		Cervical spinal injury and neck pain are common disorders with wide physical implications. Neck pain and disability are reported to occur in females more often than in males, and chronic or persistent neck pain after whiplash is twice as common in females. Female athletes also sustain a higher percentage of concussions compared to male athletes. Still, while sexual differences in clinical presentation and outcome are well-established, the underlying etiology for the disparity remains less clear. It is well-established that the origin and insertion landmarks of posterior neck muscles are highly variable, but we do not know if these interindividual differences are associated with sex. Expanding our knowledge on sexual dimorphism in the anatomy of the cervical muscles is essential to our understanding of the possible biomechanical differences between the sexes and hence improves our understanding as to why females suffer from cervical pain more than males. It is also of paramount importance for accurate planning of posterior cervical spine surgery, which cuts through the posterior cervical musculature. Therefore, our main objective is to characterize the anatomy of posterior neck musculature and to explore possible sexual differences in the location of their attachment points. Meticulous posterior neck dissection was performed on 35 cadavers, 19 females, and 16 males. In each specimen, 8 muscle groups were examined bilaterally at 45 osseous anatomical landmarks. Muscles and their attachment sites were evaluated manually then photographed and recorded using Microscribe Digitizer technology built into 3D models. A comparison of attachment landmarks between males and females for each muscle was conducted. Out of the eight muscles that were measured, only two muscles demonstrated significant sex-related anatomical differences-Spinotranversales (splenius capitis and cervicis) and Multifidus. Male Spinotransversales muscle has more attachment points than female. It showed more cranial insertion points in the upper cervical attachments (superior nuchal line, C-1 posterior tubercle, and mastoid process) and more caudal insertion points in the spinous processes and transverse processes of the lower cervical and upper thoracic vertebrae. Thus, the male subjects in this study exhibited a greater coverage of the posterior neck both cranially and caudally. Female Multifidus has more attachment points on the spinous processes and articular processes at middle and lower cervical vertebrae and at the transverse processes of the upper thoracic vertebrae. All remaining muscles exhibited no sexual differences. Our findings highlight, for the first time, a sexual dimorphism in attachment points of posterior cervical musculature. It reinforces the notion that the female neck is not a scaled version of the male neck. These differences in muscle attachment could partially explain differences in muscle torque production and range of motion and thus biomechanical differences in cervical spine stabilization between sexes. It sheds a much-needed light on the reason for higher whiplash rates, concussion, and chronic cervical pain among females. Surgeons should take these sexual morphological differences into consideration when deliberating the best surgical approach for posterior cervical surgery.	[Keidan, Lee; Pick, Chaim G.; Been, Ella] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Barash, Alon] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel; [Lenzner, Ziv] Bezalel Acad Arts & Design, Screen Based Art Dept, Jerusalem, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sylvan Adams Sports Inst, Tel Aviv, Israel; [Been, Ella] Ono Acad Coll, Fac Hlth Profess, Dept Sports Therapy, Kiryat Ono, Israel		Been, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel.	beenella1@gmail.com		Barash, Alon/0000-0001-9682-6875	Ari and Regine Aprijaskis Fund; Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases	This research was supported in part by the Ari and Regine Aprijaskis Fund, and in part by the Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases.	Alexander S, 2019, J CLIN NEUROSCI, V62, P260, DOI 10.1016/j.jocn.2018.11.044; Alobaidy MA, 2016, J SHOULDER ELB SURG, V25, P136, DOI 10.1016/j.jse.2015.08.036; Anderson JS, 2005, SPINE, V30, pE86, DOI 10.1097/01.brs.0000153700.97830.02; Banu M.A., 2014, BANGLADESH J ANATOMY, V12, P7; Barmou MM, 2018, INT ORTHOD, V16, P314, DOI [10.1016/j.ortho.2018.03.006, 10.1016/j.ortho.2018.03.005]; BARNSLEY L, 1994, PAIN, V58, P283, DOI 10.1016/0304-3959(94)90123-6; Beaton LE, 1942, ANAT REC, V83, P41, DOI 10.1002/ar.1090830105; Been E, 2017, SPINE J, V17, P880, DOI 10.1016/j.spinee.2017.02.007; Blouin JS, 2007, J NEUROPHYSIOL, V98, P920, DOI 10.1152/jn.00183.2007; Borst J, 2011, CLIN BIOMECH, V26, P343, DOI 10.1016/j.clinbiomech.2010.11.019; Boyd-Clark LC, 2001, J ANAT, V199, P709, DOI 10.1046/j.1469-7580.2001.19960709.x; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Covassin T, 2003, J ATHL TRAINING, V38, P238; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Enciso R, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1119; Ezra D, 2017, SPINE J, V17, P135, DOI 10.1016/j.spinee.2016.08.022; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fernandez-De-Las-Penas C, 2008, J ORTHOP SPORT PHYS, V38, P175, DOI 10.2519/jospt.2008.2598; Harder S, 1998, J CLIN EPIDEMIOL, V51, P377, DOI 10.1016/S0895-4356(98)00011-0; Kamibayashi LK, 1998, SPINE, V23, P1314, DOI 10.1097/00007632-199806150-00005; Keshner EA, 2003, J NEUROPHYSIOL, V89, P1891, DOI 10.1152/jn.00836.2001; Koren L, 2015, EUR J TRAUMA EMERG S, V41, P287, DOI 10.1007/s00068-014-0419-2; Kristjansson E, 2004, MANUAL THER, V9, P83, DOI 10.1016/S1356-689X(03)00059-6; Lieber RL, 2011, PHILOS T R SOC B, V366, P1466, DOI 10.1098/rstb.2010.0316; LIND B, 1989, ARCH PHYS MED REHAB, V70, P692; Linder A, 2008, TRAFFIC INJ PREV, V9, P592, DOI 10.1080/15389580802384669; M?ller K., 2002, MANUELLE THERAPIE, V6, P21; MAKELA M, 1991, AM J EPIDEMIOL, V134, P1356; Nasiri E, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.22465; Noussios G., 2014, INTERNET J HUMAN ANA, V3, P1; Nyemb P.M.M.N., 2017, MOJ ANATOMY PHYSL, V4, P385; Owaydhah WH, 2017, SURG RADIOL ANAT, V39, P767, DOI 10.1007/s00276-016-1782-y; Pan FM, 2018, J BIOMECH, V75, P13, DOI 10.1016/j.jbiomech.2018.04.047; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Peolsson A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30415; Phillips J.H., 2018, MANAGEMENT DISORDERS, P3; Rankin G, 2005, MANUAL THER, V10, P108, DOI 10.1016/j.math.2004.08.004; Rivard J, 2017, MUSCULOSKEL SCI PRAC, V30, P56, DOI 10.1016/j.msksp.2017.05.007; Russ DW, 2012, J CACHEXIA SARCOPENI, V3, P95, DOI 10.1007/s13539-011-0054-2; Schomacher J, 2013, CLIN J PAIN, V29, P898, DOI 10.1097/AJP.0b013e318278d4c4; Schomacher J, 2013, MANUAL THER, V18, P360, DOI 10.1016/j.math.2013.05.009; Schomacher J, 2012, MANUAL THER, V17, P544, DOI 10.1016/j.math.2012.05.012; Schomacher J, 2012, CLIN NEUROPHYSIOL, V123, P1403, DOI 10.1016/j.clinph.2011.11.033; Sebastian A, 2016, SPINE J, V16, P504, DOI 10.1016/j.spinee.2015.12.009; Sidon E, 2018, J WOMENS HEALTH, V27, P946, DOI 10.1089/jwh.2017.6687; Stemper BD, 2003, J BIOMECH, V36, P1281, DOI 10.1016/S0021-9290(03)00159-3; Stemper BD, 2016, J ORTHOP SPORT PHYS, V46, P834, DOI 10.2519/jospt.2016.6846; Stephen A.J., 2015, DIGITAL APPL ARCHAEO, V2, P28, DOI [10.1016/j.daach.2015.03.002, DOI 10.1016/J.DAACH.2015.03.002]; Suderman BL, 2017, ANN BIOMED ENG, V45, P2009, DOI 10.1007/s10439-017-1830-8; TAKEBE K, 1974, ANAT RECORD, V179, P477, DOI 10.1002/ar.1091790407; Tatarek Nancy E, 2005, Spine J, V5, P623, DOI 10.1016/j.spinee.2005.07.009; Thompson NW, 2001, ULSTER MED J, V70, P22; Ulbrich EJ, 2014, RADIOLOGY, V271, P172, DOI 10.1148/radiol.13120370; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Versteegen GJ, 2000, EUR SPINE J, V9, P547, DOI 10.1007/s005860000150; Wegley R S, 1986, J Orthop Sports Phys Ther, V8, P15; Yan Y., 2018, AS C MACH LEARN, P662; Yun Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016041; Zdilla MJ, 2015, J KOR ASSOC ORAL MAX, V41, P165, DOI 10.5125/jkaoms.2015.41.3.165; Zheng, 2011, SEX DIFFERENCES HUMA	60	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	SEP	2021	239	3					589	601		10.1111/joa.13448		APR 2021	13	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	TW7SV	WOS:000641175100001	33876427				2022-02-07	
J	Tan, L; Wang, N; Gu, ZL; Zhu, JB; Liu, CY; Xu, ZH				Tan, Li; Wang, Ning; Gu, Zhilin; Zhu, Jiebin; Liu, Chunyan; Xu, Zhenhua			Arousing Effects of Electroacupuncture on the "Shuigou Point" in Rats with Disorder of Consciousness after Traumatic Brain Injury	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							HYPOCRETIN-1 OREXIN-A; HYPOTHALAMIC REGULATION; INDUCED COMA; SLEEP; STIMULATION; STATE; CONNECTIVITY; MODERATE; PROFILE; MODEL	Orexin is an important neuropeptide that stimulates cortical activation and arousal and is involved in the regulation of wakefulness and arousal. Our previous meta-analysis showed that acupuncture fared well in the treatment of TBI-induced DOC in which "shuigou (DU 26)" was the most important and frequent point targeted. In the present study, we investigated whether electroacupuncture (EA) promotes TBI-induced unconsciousness wakefulness via orexin pathway. A TBI rat model was established using a control cortical impact (CCI) model. In the stimulated group, TBI rats received EA (15 Hz, 1.0 mA, 15 min). In the antagonist group, TBI rats were intraperitoneally injected with the orexin receptor 1 (OX1R) antagonist SB334867 and received EA. Unconsciousness time was observed in each group after TBI, and electrocorticography (ECoG) was applied to detect rats' EEG activity. Immunohistochemistry, enzyme-linked immunosorbent assay, and western blot were used to assess the levels of orexin-1(OX1) and OX1R expression in the mPFC. We show that duration of unconsciousness and the ratio of delta power in ECoG in the EA group were significantly reduced compared with those in the TBI group. EA could increase OX1 and OX1R expression in the mPFC and reduced the loss of orexin-producing neurons in LHA. However, all the efficacy of EA was blocked by the OX1R antagonist SB334867. Our findings suggest that EA promotes the recovery of consciousness of TBI-induced unconscious rats via upregulation of OX1and OX1R expression in mPFC.	[Tan, Li; Gu, Zhilin; Zhu, Jiebin; Liu, Chunyan; Xu, Zhenhua] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou 510006, Peoples R China; [Tan, Li] Shenzhen Longhua Dist Cent Hosp, Shenzhen 518110, Peoples R China; [Wang, Ning] Sun Yat Sen Univ, Affiliated Hosp 7, Shenzhen 518107, Peoples R China		Xu, ZH (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou 510006, Peoples R China.	nitatanli@icloud.com; wangn79@mail.sysu.edu.cn; zhilingu@gzucm.edu.cn; jiebin002@gzucm.edu.cn; chunyanl28@gzucm.edu.cn; xzh197011@163.com		Tan, Li/0000-0002-3068-9078	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81974582]	The authors acknowledge the support of the National Natural Science Foundation of China (No. 81974582).	Alster Jason, 1993, Brain Injury, V7, P191, DOI 10.3109/02699059309029672; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Ardeshna Nikesh I, 2016, Neurodiagn J, V56, P1; Barker-Collo S, 2019, NEW ZEAL MED J, V132, P40; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Bayer L, 2004, J NEUROSCI, V24, P6760, DOI 10.1523/JNEUROSCI.1783-04.2004; Boly M, 2012, BRAIN CONNECT, V2, P1, DOI 10.1089/brain.2011.0049; Bourdillon P, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00223; Cerri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112849; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; Deboer T, 2003, SLEEP, V26, P567, DOI 10.1093/sleep/26.5.567; Feng Z, 2015, NEURAL REGEN RES, V10, P594, DOI 10.4103/1673-5374.155433; Fu Ying-ying, 2009, Zhongguo Zhen Jiu, V29, P107; Gabelle A, 2017, NEUROBIOL AGING, V53, P59, DOI 10.1016/j.neurobiolaging.2017.01.011; Gao GY, 2020, LANCET NEUROL, V19, P670, DOI 10.1016/S1474-4422(20)30182-4; George P., 2007, RAT BRAIN STEREOTAXI, V6th; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gravett N, 2011, J CHEM NEUROANAT, V41, P86, DOI 10.1016/j.jchemneu.2010.11.005; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; Haveman ME, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2656-6; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Jaehne EJ, 2011, ADDICT BIOL, V16, P7, DOI 10.1111/j.1369-1600.2009.00196.x; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Jia XJ, 2012, NEUROPHARMACOLOGY, V62, P775, DOI 10.1016/j.neuropharm.2011.08.047; Jones S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010043; Kundu B, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.5.FOCUS18168; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Liu Jian-ping, 2010, Zhongguo Zhen Jiu, V30, P206; Luppi AI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12658-9; Ma JS, 2014, SLEEP, V37, P1609, DOI 10.5665/sleep.4068; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modi HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182707; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Portnova GV, 2019, BRAIN INJURY, V33, P370, DOI 10.1080/02699052.2018.1553310; Rejdak K, 2005, J NEUROL NEUROSUR PS, V76, P597, DOI 10.1136/jnnp.2004.049247; Ren SC, 2018, SCIENCE, V362, P429, DOI 10.1126/science.aat2512; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Smart D, 2001, BRIT J PHARMACOL, V132, P1179, DOI 10.1038/sj.bjp.0703953; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Tan L., 2019, GUIDING J TRADITIONA, V25, P70; Tan L, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/5190515; Van Deynse H, 2019, BRAIN INJURY, V33, P1234, DOI 10.1080/02699052.2019.1641224; Vassalli A, 2017, P NATL ACAD SCI USA, V114, pE5464, DOI 10.1073/pnas.1700983114; Zhang Yi-Min, 2013, Zhen Ci Yan Jiu, V38, P158; Zobeiri M, 2018, BRAIN STRUCT FUNCT, V223, P1537, DOI 10.1007/s00429-017-1559-z	58	0	0	4	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.	APR 19	2021	2021								6611461	10.1155/2021/6611461			10	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	SX0EE	WOS:000664884500003	33959185	Green Published, gold			2022-02-07	
J	Cairncross, M; Brooks, BL; Virani, S; Silverberg, ND				Cairncross, Molly; Brooks, Brian L.; Virani, Shane; Silverberg, Noah D.			Fear avoidance behavior in youth with poor recovery from concussion: measurement properties and correlates of a new scale	CHILD NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; concussion; post-concussion symptoms; avoidance behavior; psychometrics		The objective of the current study was to develop a measure of fear avoidance behavior after concussion for youth and parent respondents and examine its basic psychometric properties and correlates. Children (N = 51) who were seen in a hospital concussion clinic after sustaining a concussion (M = 7.6 months, SD = 7.01) and their primary caregiver (N = 51)completed self- and informant-report measures of fear avoidance (Pediatric Fear Avoidance Behavior after Traumatic Brain Injury Questionnaire; PFAB-TBI), post-concussion symptoms (Health Behavior Inventory), emotional distress (Strengths and Difficulties Questionnaire), and quality of life (Pediatric Quality of Life Inventory Version 4.0). The self- and informant-report PFAB-TBI scores were moderately correlated (r = 0.51, p < 0.001). Neither measure demonstrated floor or ceiling effects. Both had strong internal consistency (Cronbach's alpha = 0.87 and 0.89, respectively). The PFAB-TBI self-report was positively correlated with somatic symptoms (r = 0.37), emotional distress (r = 0.39), and negatively associated with quality of life (r = -0.57). The PFAB-TBI informant-report was positively associated with informant reported somatic symptoms (r = 0.52) and emotional distress (r = .50) Overall, the PFAB-TBI has desirable basic measurement properties and expected correlations with clinical outcomes. This measure can potentially help clinicians and researchers better understand the impacts of fear avoidance behavior after pediatric concussion.	[Cairncross, Molly; Silverberg, Noah D.] Univ British Columbia, Dept Psychol, 4225 Laurel St, Vancouver, BC V5Z 2G9, Canada; [Cairncross, Molly; Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Res Program, Rehabil, Vancouver, BC, Canada; [Brooks, Brian L.; Virani, Shane] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat Clin Neurosci & Psychol, Calgary, AB, Canada; [Virani, Shane] Univ Calgary, Dept Pediat, Calgary, AB, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Dept Psychol, 4225 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@ubc.ca			Kinsmen Chair of Pediatric Neurosciences; ACHRI Neurotrauma Fund; ACH Neurosciences Program; Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	The BrainChild database, which is the centralized REDCap digital storage system for all data collected in neuropsychological assessments at Alberta Children's Hospital, has received past funding support from the Kinsmen Chair of Pediatric Neurosciences, the ACHRI Neurotrauma Fund, and the ACH Neurosciences Program (Conny Betuzzi, manager). Brian Brooks acknowledges salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award. Noah Silverberg acknowledges salary funding from the Michael Smith Foundation for Health Research.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Centers for Disease Control and Prevention (CDC), 2003, C MILD TRAUM BRAIN I; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Durish CL, 2019, J INT NEUROPSYCH SOC, V25, P346, DOI 10.1017/S1355617718001169; GOODMAN R, 2001, J AM ACAD CHILD ADOL, V40; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Salbach-Andrae H, 2009, EUR CHILD ADOLES PSY, V18, P136, DOI 10.1007/s00787-008-0710-z; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Simons LE, 2015, CEPHALALGIA, V35, P36, DOI 10.1177/0333102414534084; Simons LE, 2012, J PAIN, V13, P827, DOI 10.1016/j.jpain.2012.05.002; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates K.O., 2014, CONCUSSIONS ATHLETIC, P167, DOI [10.1007/978-1-4939-0295-8, DOI 10.1007/978-1-4939-0295-8]; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	27	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	OCT 3	2021	27	7					911	921		10.1080/09297049.2021.1908533		APR 2021	11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UM6OA	WOS:000641790700001	33876703				2022-02-07	
J	Hicks, AJ; Spitz, G; Rowe, CC; Roberts, CM; McKenzie, DP; Ponsford, JL				Hicks, Amelia J.; Spitz, Gershon; Rowe, Christopher C.; Roberts, Caroline M.; McKenzie, Dean P.; Ponsford, Jennie L.			Does cognitive decline occur decades after moderate to severe traumatic brain injury? A prospective controlled study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Traumatic brain injury; TBI; cognition; cognitive decline; aging		This prospective controlled study examined long-term trajectories of neuropsychological performance in individuals with traumatic brain injury (TBI) compared to healthy controls, and the impact of IQ, age at injury, time since injury, and injury severity on change over time. Fifty-three individuals with moderate to severe TBI (60.37% male; M = 59.77 yrs, SD = 14.03), and 26 controls (46.15% male; M = 63.96 yrs, SD = 14.42) were studied prospectively (M = 12.72 yrs between assessments). Participants completed measures of premorbid IQ (Weschler Test of Adult Reading), processing speed (Digit Symbol Coding Test), working memory (Digit Span Backwards), memory (Rey Auditory Verbal Learning Test) and executive function (Trail Making Test Part B; Hayling Errors), at a mean of 10.62 yrs (Initial) and 23.91 yrs (Follow-Up) post injury. Individuals with TBI did not show a significantly greater decline in neuropsychological performance over time compared with demographically similar controls. There was no association between change over time with IQ, time since injury or injury severity. Being older at injury had a greater adverse impact on executive function at follow-up. In this small sample, a single moderate to severe TBI was not associated with ongoing cognitive decline up to three decades post injury. Changes in cognitive function were similar between the groups and likely reflect healthy aging.	[Hicks, Amelia J.; Spitz, Gershon; Roberts, Caroline M.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Rowe, Christopher C.] Austin Hlth, Dept Mol Imaging & Therapy, Heidelberg, Vic, Australia; [Rowe, Christopher C.] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Parkville, Vic, Australia; [McKenzie, Dean P.] Epworth HealthCare Melbourne, Res Dev & Governance Unit, Melbourne, Vic, Australia; [McKenzie, Dean P.] Monash Univ Melbourne, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia		Hicks, AJ (corresponding author), Monash Epworth Rehabil Res Ctr, Ground Floor,185-187 Hoddle St, Richmond, Vic 3121, Australia.	amelia.hicks@monash.edu	Rowe, Christopher/AAX-8748-2021; Ponsford, Jennie/H-8341-2014; Spitz, Gershon/H-7755-2014	Ponsford, Jennie/0000-0003-0430-125X; Spitz, Gershon/0000-0002-7810-1480; McKenzie, Dean/0000-0002-0006-9062; Hicks, Amelia/0000-0002-1152-0576; Roberts, Caroline/0000-0003-1200-4415; Rowe, Christopher/0000-0003-3910-2453	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP 1127007]	This work was supported by the National Health and Medical Research Council (NHMRC) under Grant APP 1127007.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; CORKIN S, 1989, J NEUROSCI, V9, P3876; Crownover J, 2012, CURR GERIATR REP, V1, P149, DOI 10.1007/s13670-012-0021-6; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hicks AJ, 2019, J NEUROTRAUM, V36, P3191, DOI 10.1089/neu.2018.6346; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ibm C., 2017, IBM SPSS STAT WINDOW; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Li Wei, 2017, Alzheimers Dement (Amst), V6, P196, DOI 10.1016/j.dadm.2017.01.008; Manoli R, 2021, DISABIL REHABIL, V43, P2531, DOI 10.1080/09638288.2019.1706105; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mollayeva T, 2019, NEUROSCI BIOBEHAV R, V99, P198, DOI 10.1016/j.neubiorev.2019.01.011; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Reitan RM, 1992, TRAIL MAKING TEST MA; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schmidt M., 1996, REY AUDITORY VERBAL; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Seltman H.J., 2012, EXPT DESIGN ANAL; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; StataCorp, 2019, STATA STAT SOFTWARE; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tolli A, 2018, BRAIN INJURY, V32, P1465, DOI 10.1080/02699052.2018.1497203; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	58	0	0	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1914674		APR 2021	20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	RO8WC	WOS:000641320400001	33858304				2022-02-07	
J	Kim, S; Connaughton, DP; Sagas, M				Kim, Sungwon; Connaughton, Daniel P.; Sagas, Michael			An examination of concussion education, management, and safety practices of girls' high school soccer coaches	JOURNAL FOR THE STUDY OF SPORTS AND ATHLETES IN EDUCATION			English	Article; Early Access						risk; youth sport; head injury; interscholastic; education; policy; athletic trainer; traumatic brain injury		The concussion rate in girls' soccer is among the highest in high school athletics. As such, coaches have a professional and ethical responsibility to reduce and properly manage concussions. The primary purpose of this study was to examine concussion education received, presence of athletic trainers, awareness of organizational concussion policy, concussion safety practices based on the presence of athletic trainers and coaches' demographic/professional background. Participants included 140 head coaches who voluntarily completed a survey. Results revealed the NFHS's Concussion in Sport (93.6%) was the most popular educational training received. Approximately 63% of coaches responded from schools where athletic trainers were present during all soccer games. A notable percentage of respondents did not know their high schools' concussion policy such as concussion education requirements (27.1%) and penalty from non-compliance (23.6%). This exploratory study informs stakeholders on the current status of concussion management policies and practices in high school girls' soccer.	[Kim, Sungwon] St Johns Univ, Div Sport Management, Queens, NY USA; [Connaughton, Daniel P.] Univ Florida, Dept Sport Management, Gainesville, FL USA; [Sagas, Michael] Univ Florida, Lab Athlete Dev Res LADR, Gainesville, FL USA		Kim, S (corresponding author), St Johns Univ, 8000 Utopia Pkwy, Queens, NY 11439 USA.	kims1@stjohns.edu					Agel J, 2007, J ATHL TRAINING, V42, P249; American Academy of Neurology, 2010, POSITION STATEMENT S; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Bloom G.A., 2014, POSITIVE HUMAN FUNCT, V3; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Caron JG, 2015, INT SPORT COACH J, V2, P285, DOI 10.1123/iscj.2015-0022; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; DiStefano LJ, 2018, J ATHL TRAINING, V53, P880, DOI 10.4085/1062-6050-156-17; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; Falavigna A, 2012, J NEUROSURG-PEDIATR, V9, P562, DOI 10.3171/2011.12.PEDS11169; Florida High School Athletic Association, 2017, BYLAWS FLORIDA HIGH; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Johnson A, 2015, NBC NEWS; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kim S, 2017, J LEG ASP SPORT, V27, P162, DOI [10.1123/jlas. 2016-0007, DOI 10.1123/JLAS.2016-0007]; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; National Federation of High School Athletic Associations, 2018, SUGGESTED GUIDELINES, DOI [1018446/suggested_guidelines__management_concussion_april_2017.pdf., DOI 1018446/SUGGESTED_GUIDELINES__MANAGEMENT_CONCUSSION_APRIL_2017.PDF]; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Participation Statistics, 2019, NATL FEDERATION STAT; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Robbins J, 2001, J SPORT BEHAV, V24, P277; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Valovich McLeod TC, 2015, KINESIOL REV, V4, P131, DOI DOI 10.1123/KR.2015-0007; Williams Nolan, 2012, Front Neurol, V3, P130, DOI 10.3389/fneur.2012.00130; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	57	0	0	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1935-7397	1935-7400		J STUDY SPORTS ATHL	J. Study Sports Athl. Educ.												10.1080/19357397.2021.1915692		APR 2021	18	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	RO9RL	WOS:000641376200001					2022-02-07	
J	Yanagawa, Y; Murai, Y; Kushida, Y; Sakurada, M				Yanagawa, Youichi; Murai, Yuta; Kushida, Yoshihiro; Sakurada, Mutsumi			Transient Trabecular Formation in the Bladder and Delayed Free Air due to Traumatic Intraperitoneal Bladder Rupture	CUREUS			English	Article						bladder perforation; free air; trabecular formation; image; bladder		An H-section steel bar that had been set against the wall fell and hit the abdomen and then both legs of a 33-year-old Chinese man. As his vital signs were stable and his chief complaint was leg pain, he was transferred to a local medical facility. After the confirmation of gross hematuria by an indwelling a bladder catheter there, he was transported to our hospital. On arrival, his vital signs were stable. His main complaint was foot pain. He had a scabbing injury at the scrotum and bilateral foot joint deformity. Whole-body computed tomography (CT) from head to toe revealed trabecular formation in the bladder and slight fluid collection in the rectovesical pouch, as well as bilateral fracture-dislocations at the ankles. The urinary tract injury and the fluid collection in the rectovesical pouch were managed conservatively, and the lower limbs were treated tentatively. Follow-up CT on day 3 revealed multiple free air pockets in the intra-abdominal cavity, which was considered to indicate perforation of the duodenal ulcer and treated conservatively. However, he showed abdominal pain on day 7, and repeated CT revealed increased fluid in the intraabdominal cavity. Urgent laparoscopy showed intact bowels and perforation of the bladder that was closed by suturing. He ultimately obtained a survival outcome. This is the first case of transient trabecular formation in the bladder and delayed free air due to traumatic intraperitoneal bladder rupture. This unique case adds another radiological finding to the list of documented etiologies of traumatic bladder perforation.	[Yanagawa, Youichi; Kushida, Yoshihiro] Juntendo Univ, Shizuoka Hosp, Acute Crit Care Med, Izunokuni, Japan; [Murai, Yuta; Sakurada, Mutsumi] Juntendo Univ, Shizuoka Hosp, Surg, Izunokuni, Japan		Yanagawa, Y (corresponding author), Juntendo Univ, Shizuoka Hosp, Acute Crit Care Med, Izunokuni, Japan.	yyanaga@juntendo.ac.jp					EGGHART G, 1984, UROLOGE A, V23, P348; Felix M, 1997, Acta Med Port, V10, P217; Goto S, 2010, CLIN KIDNEY J, V3, P474, DOI 10.1093/ndtplus/sfq107; Guttmann I, 2013, CLIN SPORT MED, V32, P239, DOI 10.1016/j.csm.2012.12.006; Jain A, 2018, INDIAN J NUCL MED, V33, P253, DOI 10.4103/ijnm.IJNM_27_18; MERGUERIAN PA, 1985, J UROLOGY, V134, P747, DOI 10.1016/S0022-5347(17)47422-2; Sajjad H, 2021, BLADDER RUPTURE; Smereczynski A, 2014, J ULTRASON, V14, P339, DOI 10.15557/JoU.2014.0034; Trinci M, 2020, RADIOL MED, V125, P907, DOI 10.1007/s11547-020-01190-2	9	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	APR 16	2021	13	4							e14520	10.7759/cureus.14520			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RO3TX	WOS:000640969500009	34012733	gold, Green Published			2022-02-07	
J	Abouhashem, S; Albakry, A; El-Atawy, S; Fawzy, F; Elgammal, S; Khattab, O				Abouhashem, Safwat; Albakry, Amr; El-Atawy, Shawkat; Fawzy, Faten; Elgammal, Sahar; Khattab, Omar			Prediction of early mortality after primary decompressive craniectomy in patients with severe traumatic brain injury	EGYPTIAN JOURNAL OF NEUROSURGERY			English	Article						Traumatic brain injury; Decompressive craniectomy; Mortality; Outcome	HEAD-INJURY; PROGNOSTIC-FACTORS; COMA; METAANALYSIS; PRESSURE; GENDER	Objectives Traumatic brain injury (TBI) is a worldwide major health problem associated with a high rate of morbidity and mortality. Intracranial hypertension following TBI is the main but not the only cause of early mortality. Decompressive craniectomy (DC) is used to decrease the intracranial pressure (ICP) and prevent brain herniation following TBI; however, the clinical outcome after DC for patients with TBI generates continuous debate. Prediction of early mortality after DC will help in making the surgery decision. The aim of this study is to predict early mortality after DC based on the initial clinical and radiological findings. Methods In this study, 104 patients with severe traumatic brain injury have been treated by decompressive craniectomy and were retrospectively analyzed. Patients were divided into two groups; group I involved 32 patients who died within 28 days while group II involved 72 patients who survived after 28 days. The relationship between initial Glasgow Coma Scale score (GCS), pupil size and reactivity, associated injuries, and radiological findings were analyzed as predictor factors for early mortality. Results A total of 104 patients with severe TBI have been treated by DC and were analyzed; the early mortality occurred in 32 patients, 30.77%. There is a significant difference between groups in gender, mean GCS, Marshall scale, presence of isochoric pupils, and lung injury. After stratification, odds of early mortality increases with the lower GCS, higher Marshall scale, lung injury, and abdominal injury while male gender and the presence of isochoric pupils decrease the odds of mortality. After univariate regression, the significant impact of GCS disappears except for GCS-8 which decreases the odds of mortality in comparison to other GCS scores while higher Marshall scale, presence of isochoric pupils, and lung injury increase the odds of mortality, but most of these effects disappear after multiple regressions except for lung injury and isochoric pupils. Conclusion Prediction of early mortality after DC is multifactorial, but the odds of early mortality after decompressive craniectomy in severe traumatic brain injury are progressively increased with the lower GCS, higher Marshall scale, and the presence of lung or abdominal injury.	[Abouhashem, Safwat; Albakry, Amr] Zagazig Univ, Fac Med, Dept Neurosurg, Zagazig, Egypt; [Abouhashem, Safwat] Saudi German Hosp, Riyadh, Saudi Arabia; [Abouhashem, Safwat] Kingdome Hosp, Surg Dept, Riyadh, Saudi Arabia; [El-Atawy, Shawkat; Fawzy, Faten; Elgammal, Sahar] Zagazig Univ, Fac Med, Zagazig, Egypt; [Khattab, Omar] Kingdom Hosp, Intens Care Unit, Riyadh, Saudi Arabia		Abouhashem, S (corresponding author), Zagazig Univ, Fac Med, Dept Neurosurg, Zagazig, Egypt.; Abouhashem, S (corresponding author), Saudi German Hosp, Riyadh, Saudi Arabia.; Abouhashem, S (corresponding author), Kingdome Hosp, Surg Dept, Riyadh, Saudi Arabia.	sabohashem@gmail.com	; AlBakry, Amr/V-2101-2017	Abouhashem, Safwat/0000-0002-4328-1995; AlBakry, Amr/0000-0003-0908-8443			Badiger SP., 2016, INT SURG J, V3, P1959, DOI DOI 10.18203/2349-2902.ISJ20163172; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Baltas I, 1998, J Neurosurg Sci, V42, P85; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; DAVIS RA, 1984, SURG GYNECOL OBSTET, V159, P597; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Grille Pedro, 2015, Rev. bras. ter. intensiva, V27, P113, DOI 10.5935/0103-507X.20150021; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kraus J. F., 2000, NEUROSURG FOCUS, V8, P1, DOI [10.3171/foc.2000.8.1.156, DOI 10.3171/foc.2000.8.1.156]; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Lilja-Cyron A, 2020, NEUROSURGERY, V86, P231, DOI 10.1093/neuros/nyz049; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Mezue WC, 2015, OPEN ACCESS SURG, V8, P73, DOI 10.2147/OAS.S52742; Mohammadifard M, 2018, EUR J TRANSL MYOL, V28, P265, DOI 10.4081/ejtm.2018.7542; Moon Ji Won, 2017, Korean J Neurotrauma, V13, P1, DOI 10.13004/kjnt.2017.13.1.1; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Rossini Z, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00458; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Wagner CK, 2001, J NEUROBIOL, V47, P176, DOI 10.1002/neu.1025; Wilson MH, 2014, INT J CLIN PRACT, V68, P5, DOI 10.1111/ijcp.12246	37	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2520-8225		EGYPT J NEUROSURG	Egypt. J. Neurosurg.	APR 15	2021	36	1							1	10.1186/s41984-020-00096-5			8	Clinical Neurology; Surgery	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Surgery	WC9WW	WOS:000704601400001		gold			2022-02-07	
J	Afsar, M; Darshini, KJ; Shukla, D; Vandana, V; Rajeswaran, J				Afsar, Mohammed; Darshini, Kamasetru Jeevendrakumar; Shukla, Dhaval; Vandana, Valiyaparambath; Rajeswaran, Jamuna			Neuropsychological and Linguistic Outcomes after Gunshot Injury to Cerebellum: A Case Report	INDIAN JOURNAL OF NEUROTRAUMA			English	Article; Early Access						gunshot injury; brain injury; cerebellar cognitive affective syndrome; cerebellum; neuropsychological impairments		Craniocerebral gunshot injuries (CGIs) are highly fatal and mostly seen in the military settings. CGIs to the posterior cortical regions and cerebellum in civilian population are uncommon. Cerebellum once thought to be mediating the motor and vestibular functions is increasingly seen as an important structure for human cognition and affect. We present a case of a 53-year-old police inspector who sustained a gunshot injury in the suboccipital region with resulting damage to predominantly left cerebellum and right occipital lobe. Patient presented with complaints of neck pain, reduced clarity of speech, and mild forgetfulness for day-to-day affairs after 7 months of injury. A comprehensive neuropsychological assessment revealed impairments in motor speed, processing speed, sustained attention, executive functions (verbal fluency, working memory), and encoding component of memory functions. The speech-language assessment revealed mild dysarthria and mild word finding difficulties. His profile with mild to moderate deficits in neuropsychological and speech language functioning was partly congruent with the cerebellar cognitive affective syndrome or Schmahmann's syndrome. The spontaneous recovery and extent of damage to cerebellum may explain the milder form of the syndrome. The case highlights the need to routinely screen for cognitive-affective disturbances in patients with traumatic lesions to cerebellum.	[Afsar, Mohammed; Rajeswaran, Jamuna] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore, Karnataka, India; [Darshini, Kamasetru Jeevendrakumar; Vandana, Valiyaparambath] Natl Inst Mental Hlth & Neurosci, Dept Speech Pathol & Audiol, Bangalore, Karnataka, India; [Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India		Rajeswaran, J (corresponding author), Natl Inst Mental Hlth Neurosci NIMHANS, Dept Clin Psychol, 3rd Floor,MV Govindaswamy Ctr, Bangalore 560029, Karnataka, India.	drjamunarajan@gmail.com					APPOLLONIO IM, 1993, NEUROLOGY, V43, P1536, DOI 10.1212/WNL.43.8.1536; Arasanz CP, 2012, CORTEX, V48, P718, DOI 10.1016/j.cortex.2011.02.021; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; de Oliveira-Souza R, 2001, NEUROCASE, V7, P383, DOI 10.1076/neur.7.5.383.16244; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Enderby P, 1983, FRENCHAY DYSARTHRIA; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Kapur N, 2009, BRAIN INJURY, V23, P985, DOI 10.3109/02699050903373469; Karanth, 1980, W APHASIA BATTERY HI; Manto Mario, 2015, Cerebellum Ataxias, V2, P2, DOI 10.1186/s40673-015-0023-1; Rao S. L., 2004, NIMHANS NEUROPSYCHOL; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2019, NEUROSCI LETT, V688, P62, DOI 10.1016/j.neulet.2018.07.005; Seniow J, 2003, BRAIN INJURY, V17, P701, DOI 10.1080/0269905031000088621; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279	15	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma												10.1055/s-0041-1727294		APR 2021	4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RN5WH	WOS:000640423100005		hybrid			2022-02-07	
J	Camara-Costa, H; Viot, S; Francillette, L; Opatowski, M; Toure, H; Brugel, D; Laurent-Vannier, A; Meyer, P; Watier, L; Dellatolas, G; Chevignard, M				Camara-Costa, Hugo; Viot, Solene; Francillette, Leila; Opatowski, Marion; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Meyer, Philippe; Watier, Laurence; Dellatolas, Georges; Chevignard, Mathilde			Memory functioning 7 years after severe childhood traumatic brain injury: Results of the Traumatisme Grave de l'Enfant study	JOURNAL OF NEUROPSYCHOLOGY			English	Article; Early Access						adolescent; child; long term follow&#8208; up; longitudinal cohort study; memory; severe traumatic brain injury		Objective To explore memory functioning 7 years after severe paediatric traumatic brain injury (TBI), associated factors, and relationships with other outcomes. Method Children aged 0-15 years (n = 65), consecutively admitted over a 3-year period in a single trauma centre, who survived after severe non-inflicted TBI, were included in a prospective longitudinal study. Memory assessments were performed 7 years post-injury using the Children's Memory Scale or the Wechsler Memory Scale (WMS IV), according to age. The General Memory Score (GMS-7) was the primary outcome. Results Thirty-seven patients were available for assessment at 7 years post-injury. Mean GMS-7 was in the low average range (M = 84.9, SD = 12.1). Lower GMS-7 was significantly associated with markers of higher injury severity, such as length of coma. One year post-injury functional and disability outcomes explained 74% of the variance of GMS-7. Concurrent intellectual ability and type of ongoing education correlated strongly with GMS-7. Age at injury and parental education were not associated with memory outcome. Conclusions Memory functioning is variable but often strongly impaired several years after severe paediatric TBI, and is mostly related to injury severity, functional outcomes measured 1 year post-injury, and concomitant cognitive and educational outcomes. GMS-7 was lower at 7 years than one year post-injury, supporting the importance of long term follow-up.	[Camara-Costa, Hugo; Francillette, Leila; Chevignard, Mathilde] Sorbonne Univ, CNRS, INSERM, Lab Imagerie Biomed, Paris, France; [Camara-Costa, Hugo; Dellatolas, Georges; Chevignard, Mathilde] Sorbonne Univ, GRC 24 Handicap Moteur & Cognitif & Readaptat HaM, Paris, France; [Viot, Solene; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury, St Maurice, France; [Viot, Solene; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Viot, Solene] Bordeaux Univ Hosp, Phys & Rehabil Med Unit, Bordeaux, France; [Opatowski, Marion; Watier, Laurence] Univ Paris Saclay, Inst Pasteur, INSERM, UVSQ,Biostat Biomat Pharmacoepidemiol & Infect Di, Paris, France; [Meyer, Philippe] Hop Necker Enfants Malad, Pediat Anesthesiol Dept, Paris, France; [Meyer, Philippe] Univ Paris 05, Fac Med Rene Descartes, Paris, France		Camara-Costa, H (corresponding author), Sorbonne Univ, Hop Pitie Salpetriere, Lab Imagerie Biomed LIB, Serv Med Phys & Readaptat, 47 Blvd Hop, F-75013 Paris, France.	hugocamaracosta@gmail.com	Dellatolas, Georges/AAW-1377-2021	Meyer, Philippe G/0000-0002-3829-6631	Departement de la Recherche Clinique et du Developpement, AP-HP (Paris) [AOM 03018, PHRC 2003]; French Ministry of Health's general direction of health and direction of research, studies, assessment and statistics; national fund for health insurance of salaried workers; national fund for solidarity and autonomy; national institute for prevention and education for health; French Speaking Society of Research in Children with Disabilities (SFERHE); French Traumatic Brain Injury Society (France Traumatisme Cranien - FTC); French Speaking Society of Physical Medicine and Rehabilitation (SOFMER); national fund for health insurance of independent workers	The initial data collection for the initiation of the cohort study was funded by the Departement de la Recherche Clinique et du Developpement, AP-HP (Paris, No. PHRC 2003; AOM 03018). The 7-year follow-up study was funded by a co-funding by the French Ministry of Health's general direction of health and direction of research, studies, assessment and statistics, by the national fund for health insurance of salaried workers, the national fund for health insurance of independent workers, by the national fund for solidarity and autonomy and by the national institute for prevention and education for health, in the call for research projects launched by the IReSP in 2011. In depth analyses and manuscript preparation were also funded by two grant(s) awarded to Hugo Camara-Costa: one grant from the French Speaking Society of Research in Children with Disabilities (SFERHE, ) and one joint grant from the French Traumatic Brain Injury Society (France Traumatisme Cranien - FTC) and the French Speaking Society of Physical Medicine and Rehabilitation (SOFMER, www.sofmer.com).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM., 2003, MANUAL ASEBA ADULT F; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bernier RA, 2019, HAND CLINIC, V163, P411, DOI 10.1016/B978-0-12-804281-6.00022-7; de Haan KLB, 2015, FAM PROCESS, V54, P116, DOI 10.1111/famp.12113; Camara-Costa H, 2020, QUAL LIFE RES, V29, P515, DOI 10.1007/s11136-019-02305-7; Camara-Costa H, 2020, J HEAD TRAUMA REHAB, V35, P104, DOI 10.1097/HTR.0000000000000502; Camara-Costa H, 2020, DISABIL REHABIL, V42, P2402, DOI 10.1080/09638288.2019.1594398; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chevignard M, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000295; Cohen M. J., 2001, CMS ECHELLE MEMOIRE; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; DeMaster D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.832; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dollman AK, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00121; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Gioia G.A., 2014, BRIEF INVENTAIRE D V; Gorman S, 2017, DEV NEUROPSYCHOL, V42, P127, DOI 10.1080/87565641.2017.1315581; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Johnson VM, 2018, APPL NEUROPSYCH-CHIL, V7, P298, DOI 10.1080/21622965.2017.1330688; King DJ, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101844; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Krasny-Pacini A, 2017, DEV NEUROREHABIL, V20, P456, DOI 10.1080/17518423.2016.1265605; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Lah S, 2018, J NEUROTRAUM, V35, P2036, DOI 10.1089/neu.2017.5250; Lah S, 2019, J NEUROPSYCHOL, V13, P253, DOI 10.1111/jnp.12141; Lah S, 2017, J NEUROTRAUM, V34, P2536, DOI 10.1089/neu.2016.4872; Lah S, 2011, BRAIN INJURY, V25, P44, DOI 10.3109/02699052.2010.531693; Le Fur C, 2020, ANN PHYS REHABIL MED, V63, P270, DOI 10.1016/j.rehab.2019.09.003; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Mayes AR, 2003, CORTEX, V39, P567, DOI 10.1016/S0010-9452(08)70855-4; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; McCauley SR, 2011, J CLIN EXP NEUROPSYC, V33, P639, DOI 10.1080/13803395.2010.547844; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCauley SR, 2010, J INT NEUROPSYCH SOC, V16, P335, DOI 10.1017/S135561770999138X; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; Monahan MC, 2001, ARCH CLIN NEUROPSYCH, V16, P193, DOI 10.1016/S0887-6177(99)00064-5; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Neumane S, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2020.01.008; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Roth R.M., 2015, BRIEF A INVENTAIRE D; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Silberg T, 2016, CHILD NEUROPSYCHOL, V22, P600, DOI 10.1080/09297049.2015.1028348; Speranza M, 2012, CAN J PSYCHIAT, V57, P570, DOI 10.1177/070674371205700908; Tavano A, 2014, BRAIN INJURY, V28, P900, DOI 10.3109/02699052.2014.890742; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2009, J HEALTH PSYCHOL, V14, P611, DOI 10.1177/1359105309103580; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Verger K, 2001, REV NEUROLOGIA, V33, P30, DOI 10.33588/rn.3301.2001103; Viot S, 2019, BRAIN INJURY, V33, P1208, DOI 10.1080/02699052.2019.1631485; Volpe DSJ, 2017, BRAIN INJURY, V31, P1689, DOI 10.1080/02699052.2017.1358398; Wechsler D., 2005, ECHELLE INTELLIGENCE; Wechsler D., 1996, ECHELLE INTELLIGENCE; Wechsler D, 2002, EDITIONS CTR PSYCHOL; Wechsler D, 2012, MEM 4 ECHELLE CLIN M; Wechsler D, 2008, ECHELLE INTELLIGENCE; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	82	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.												10.1111/jnp.12247		APR 2021	28	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	RN2PV	WOS:000640194800001	33856121	Green Submitted			2022-02-07	
J	DiPasquale, J; Trammell, M; Clark, K; Fowler, H; Callender, L; Bennett, M; Swank, C				DiPasquale, Jake; Trammell, Molly; Clark, Kelly; Fowler, Hayden; Callender, Librada; Bennett, Monica; Swank, Chad			Intensity of usual care physical therapy during inpatient rehabilitation for people with neurologic diagnoses	PM&R			English	Article								Background Early, intense rehabilitation is essential to promote recovery after stroke, spinal cord injury (SCI), and traumatic brain injury (TBI). However, intensity of usual care rehabilitation interventions during inpatient rehabilitation are poorly characterized. Objective To describe the intensity of usual care rehabilitation interventions completed during the subacute phase of recovery from neurologic injury. Design Observational. Setting Inpatient rehabilitation facility. Interventions Twenty-two usual care physical therapy interventions were grouped into six categories: gait (four activities), functional (two), strengthening (four), aerobic (six), balance (four), and wheelchair (two). Patients Patients admitted to inpatient rehabilitation with a primary diagnosis of stroke, SCI or TBI within 6 months of injury. Main Outcome Measure(s) Cardiovascular intensity (physiological and perceived) was recorded during rehabilitation activity sessions. Physiological intensity was assessed by heart rate reserve (HRR) via a Polar A370 Fitness Watch and characterized as very light (<30%), light (30-39%), moderate (40-59%), vigorous (60-89%), and near maximal (>= 90%). Perceived intensity was assessed using the Rating of Perceived Exertion scale. Results Patients (stroke n = 16 [number of activity sessions = 388/average session duration = 15.1 min]; SCI n = 15 [299/27.3 min]; TBI n = 15 [340/13.4 min]) participated. For patients with stroke, moderate-to-vigorous HRR was attained between 42% (aerobic exercise) to 55% (wheelchair propulsion) of activity sessions. For patients with SCI, moderate-to-vigorous HRR was attained between 29% (strength training) to 46% (gait training) of activity sessions. For patients with TBI, moderate-to-vigorous HRR was attained between 29% (balance activities) to 47% (gait training) of activity sessions. Associations between HRR and rate of perceived exertion were very weak across stroke (r = 0.12), SCI (r = 0.18), and TBI (r = 0.27). Conclusions Patients with stroke, SCI, and TBI undergoing inpatient rehabilitation achieve moderate-to-vigorous intensity during some usual care activities such as gait training. Patient perception of intensity was dissimilar to physiological response.	[DiPasquale, Jake; Trammell, Molly; Clark, Kelly; Fowler, Hayden; Callender, Librada; Swank, Chad] Baylor Scott & White Inst Rehabil, 909 N Washington Ave, Dallas, TX 75246 USA; [Bennett, Monica] Baylor Scott & White Res Inst, Dallas, TX USA		Swank, C (corresponding author), Baylor Scott & White Inst Rehabil, 909 N Washington Ave, Dallas, TX 75246 USA.	cswank@bswrehab.com		DiPasquale, Jake/0000-0003-3756-5227			AAPM&R, INP REH POS STAT 202; Alamro RA, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0453-0; Arney BE, 2019, INT J SPORT PHYSIOL, V14, P994, DOI 10.1123/ijspp.2018-0637; Au JS, 2017, MED SCI SPORT EXER, V49, P1190, DOI 10.1249/MSS.0000000000001203; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Borg G., 1998, BORGS PERCEIVED EXER; Bowden MG., 2020, ARCH REHABIL RES CLI, V2; Chin LMK, 2015, J HEAD TRAUMA REHAB, V30, P382, DOI 10.1097/HTR.0000000000000062; Chiou KS, 2016, J HEAD TRAUMA REHAB, V31, pE60, DOI 10.1097/HTR.0000000000000161; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Compagnat M, 2018, TOP STROKE REHABIL, V25, P145, DOI 10.1080/10749357.2017.1399229; Cragg Jacquelyn J, 2013, Neurology, V81, P723, DOI 10.1212/WNL.0b013e3182a1aa68; Davis SE., 2008, ACSMS HLTH RELATED P; Dobkin BH, 2009, CURR OPIN NEUROL, V22, P563, DOI 10.1097/WCO.0b013e3283314b11; Driver S, 2016, BRAIN IMPAIR, V17, P55, DOI 10.1017/BrImp.2015.20; Dutsch M, 2007, NEUROLOGY, V69, P2249, DOI 10.1212/01.wnl.0000286946.06639.a7; Evans Nicholas, 2015, Top Spinal Cord Inj Rehabil, V21, P122, DOI 10.1310/sci2102-122; Faust L, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0250-6; Fehlings MG, 2017, GLOB SPINE J, V7, p84S, DOI 10.1177/2192568217703387; Galloway M, 2019, PHYS THER REHABIL J, V99, P821, DOI 10.1093/ptj/pzz038; Ginis KAM, 2018, SPINAL CORD, V56, P308, DOI 10.1038/s41393-017-0017-3; Herter KR, 2016, ARCH PHYS MED REHAB, V97, P1620, DOI 10.1016/j.apmr.2016.05.009; Hicks AL, 2011, SPINAL CORD, V49, P1103, DOI 10.1038/sc.2011.62; Hornby TG, 2020, J NEUROL PHYS THER, V44, P49, DOI 10.1097/NPT.0000000000000303; Ivey FM, 2008, J CARDIOPULM REHABIL, V28, P2, DOI 10.1097/01.HCR.0000311501.57022.a8; Jakicic JM, 2019, MED SCI SPORT EXER, V51, P1213, DOI 10.1249/MSS.0000000000001933; Kilpatrick MW, 2009, MED SCI SPORT EXER, V41, P681, DOI 10.1249/MSS.0b013e31818a0f09; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Koopman ADM, 2013, J REHABIL MED, V45, P92, DOI 10.2340/16501977-1072; Kuys S, 2006, PHYSIOTHER RES INT, V11, P219, DOI 10.1002/pri.344; MacKay-Lyons M, 2020, PHYS THER, V100, P149, DOI 10.1093/ptj/pzz153; MacKay-Lyons MJ, 2002, ARCH PHYS MED REHAB, V83, P1378, DOI 10.1053/apmr.2002.35089; MATHIOWETZ V, 1994, AM J OCCUP THER, V48, P733, DOI 10.5014/ajot.48.8.733; Meir G, 2015, MEAS PHYS EDUC EXERC, V19, P167, DOI 10.1080/1091367X.2015.1061531; Molteni F, 2017, EUR J PHYS REHAB MED, V53, P676, DOI 10.23736/S1973-9087.17.04591-9; Moncion K, 2020, J NEUROL PHYS THER, V44, P179, DOI 10.1097/NPT.0000000000000318; Moore, 2009, ACSMS EXERCISE MANAG, P287; Moore CG, 2011, CTS-CLIN TRANSL SCI, V4, P332, DOI 10.1111/j.1752-8062.2011.00347.x; Morris TP, 2018, J NEUROL PHYS THER, V42, P268, DOI 10.1097/NPT.0000000000000239; Nightingale TE, 2017, ARCH PHYS MED REHAB, V98, P1693, DOI 10.1016/j.apmr.2016.12.008; Nyam TTE, 2019, WORLD NEUROSURG, V122, pE740, DOI 10.1016/j.wneu.2018.10.130; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub3; Ramsey J, 2018, BRAIN INJURY, V32, P1518, DOI 10.1080/02699052.2018.1500715; Raphaely-Beer N, 2020, BRAIN RES, V1733, DOI 10.1016/j.brainres.2020.146711; Riebe D., 2018, ACSMS GUIDELINES EXE; Roy Stephen, 2015, Int J Exerc Sci, V8, P318; Sage M, 2013, TOP STROKE REHABIL, V20, P519, DOI 10.1310/tsr2006-519; Sandberg K, 2016, ARCH PHYS MED REHAB, V97, P1244, DOI 10.1016/j.apmr.2016.01.030; Sartor F, 2018, BMC SPORTS SCI MED R, V10, DOI 10.1186/s13102-018-0098-0; SMUTOK MA, 1980, ARCH PHYS MED REHAB, V61, P569; Stahl Sarah E, 2016, BMJ Open Sport Exerc Med, V2, pe000106; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Teeter L, 2012, J SPINAL CORD MED, V35, P503, DOI 10.1179/2045772312Y.0000000058; van der Scheer JW, 2017, NEUROLOGY, V89, P736, DOI 10.1212/WNL.0000000000004224; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Zbogar D, 2017, ARCH PHYS MED REHAB, V98, P2449, DOI 10.1016/j.apmr.2017.05.009	57	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JAN	2022	14	1					46	57		10.1002/pmrj.12577		APR 2021	12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	YK9AB	WOS:000640250500001	33599119				2022-02-07	
J	Gao, GY; Liang, YM; Jiang, JY; Yang, YL; Qing, HP; Qian, SK; Yang, XF; Feng, H; Yu, RT; Liu, ZX; Liu, JM; Yang, HT; Yang, CH; Long, LS; Zhang, J; Zhu, XJ; Huang, Q; Liu, BY; Tong, WS; Sun, XC; Yang, ML; Zhang, N; Fang, NC; Qi, ST; Song, XW; Tu, CJ; Wang, N; Wu, TS; Song, GL; Tong, ZZ; Fu, XA; Fan, YJ; Ni, XY; Cui, JZ; Liang, EH; Bao, N; Feng, DF; Xu, W; Li, WP; Fu, Z; Wang, Z; Wang, YH; Yuan, JL; Jin, GL; Chen, LB; Li, ST; Sun, YH; Zhang, JL; Lei, T; Du, HG				Gao, G. Y.; Liang, Y. M.; Jiang Ji-yao; Yang Yi-lin; Qing Huaping; Qian Suo-kai; Yang Xiao-feng; Feng Hua; Yu Ru-tong; Liu Zhi-xiong; Liu Jian-ming; Yang Hua-tang; Yang Chao-hua; Long Lian-shen; Zhang Jun; Zhu Xiao-jiang; Huang Qiang; Liu Bai-yun; Tong Wu-song; Sun Xiao-chun; Yang Mulin; Zhang Nu; Fang Nai-cheng; Qi Song-tao; Song Xi-wen; Tu Chuan-jian; Wang Ning; Wu Tian-shun; Song Guang-lin; Tong Zheng-zhong; Fu Xian-an; Fan Yong-jun; Ni Xiang-yang; Cui Jianzhong; Liang En-he; Bao Nan; Feng Dong-fu; Xu Wei; Li Wei-ping; Fu Zheng; Wang Zhong; Wang Yu-hai; Yuan Jian-lie; Jin Guo-liang; Chen Lin-bao; Li Shiting; Sun Yu-hai; Zhang Jian-lin; Lei Ting; Du Hang-geng		Chinese Head Trauma Study Collabor	Chinese Head Trauma Data Bank: Effect of Gender on the Outcome of Patients With Acute Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						acute traumatic brain injury; gender; outcome		Gender may be related with the outcome of patients with acute traumatic brain injury (TBI). We explored the effect of gender on the outcome of 7145 patients with acute TBI. There was no statistical difference between male and female sex in the causes of trauma, age, Glasgow Coma Scale score, computed tomgraphy findings, and surgical management. The mortality of 7145 patients with acute TBI in males and females was 7.48% and 7.22%, respectively, with the corresponding unfavorable outcomes of 16.05% and 17.23%, respectively (p > 0.05 in both cases). The mortality of 1626 patients with severe TBI in males and females was 19.68% and 20.72%, respectively, with the corresponding unfavorable outcomes of 46.96% and 48.85%, respectively (p > 0.05 in both cases). Our data suggest that sex does not play a role in the outcome of patients with acute TBI.	[Gao, G. Y.; Liang, Y. M.; Jiang Ji-yao] Shanghai Renji Hosp, Shanghai, Peoples R China; [Yang Yi-lin; Qing Huaping] Jiangsu Changzhou First Peoples Hosp, Changzhou, Jiangsu, Peoples R China; [Qian Suo-kai] Nanchang 94 Hosp, Nanchang, Jiangxi, Peoples R China; [Yang Xiao-feng] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Feng Hua] Chongqing Xinan Hosp, Chongqing, Peoples R China; [Yu Ru-tong] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China; [Liu Zhi-xiong] Changsha Xiangya Hosp, Changsha, Hunan, Peoples R China; [Liu Jian-ming] Shanghai Changhai Hosp, Shanghai, Peoples R China; [Yang Hua-tang] Hebei Hangdan Hosp, Hangdan, Hebei, Peoples R China; [Yang Chao-hua] Sichuan Huaxi Hosp, Chengdu, Sichuan, Peoples R China; [Long Lian-shen] Zhejiang Huzhou 98 Hosp, Huzhou, Zhejiang, Peoples R China; [Zhang Jun] Shenzhen Longgang Hosp, Shenzhen, Peoples R China; [Zhu Xiao-jiang] Shanghai First Peoples Hosp, Shanghai, Peoples R China; [Huang Qiang] Zhejiang Qiuzhou Hosp, Qiuzhou, Zhejiang, Peoples R China; [Liu Bai-yun] Beijing Tiantan Hosp, Beijing, Peoples R China; [Tong Wu-song] Shanghai Pudong Hosp, Shanghai, Peoples R China; [Sun Xiao-chun] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Yang Mulin] Nanchang Wujing Hosp, Nanchang, Jiangxi, Peoples R China; [Zhang Nu] Wenzhou Med Coll, Wenzhou, Peoples R China; [Fang Nai-cheng] Zhejiang Zhuji Hosp, Zhuji, Zhejiang, Peoples R China; [Qi Song-tao] Guangzhou Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Song Xi-wen] Shanghai Fengcheng Hosp, Shanghai, Peoples R China; [Tu Chuan-jian] Zhejiang Shaoxin Cty Hosp, Shaoxin, Zhejiang, Peoples R China; [Wang Ning] Harbin Med Univ, Harbin, Heilongjiang, Peoples R China; [Wu Tian-shun] Jiangxi Qianshan Hosp, Qianshan, Jiangxi, Peoples R China; [Song Guang-lin] Shandong Jiaozhou Hosp, Jiaozhou, Shandong, Peoples R China; [Tong Zheng-zhong] Jilin Tonghua Hosp, Jilin, Jilin, Peoples R China; [Fu Xian-an] Suzhou North Hosp, Suzhou, Peoples R China; [Fan Yong-jun] Jiangsu Lianyungang Second Hosp, Lianyungang, Jiangsu, Peoples R China; [Ni Xiang-yang] Jiangsu Yancheng Chinese Hosp, Yancheng, Jiangsu, Peoples R China; [Cui Jianzhong] Hebei Tangshan Workers Hosp, Tangshan, Hebei, Peoples R China; [Liang En-he] Tianjin Huanhu Hosp, Tianjin, Peoples R China; [Bao Nan] Shanghai Childrens Hosp, Shanghai, Peoples R China; [Feng Dong-fu] Shanghai 3 Hosp, Shanghai, Peoples R China; [Xu Wei] Kunming Med Coll, Kunming, Yunnan, Peoples R China; [Li Wei-ping] Shenzhen Second Peoples Hosp, Shenzhen, Peoples R China; [Fu Zheng] Jiangsu Peoples Hosp, Nanjing, Jiangsu, Peoples R China; [Wang Zhong] Suzhou Univ, Affiliated Hosp, Suzhou, Peoples R China; [Wang Yu-hai] Jiangsu Wuxie 101 Hosp, Wuxie, Jiangsu, Peoples R China; [Yuan Jian-lie] Zhejiang Jinhua Hosp, Jinhua, Zhejiang, Peoples R China; [Jin Guo-liang] Zhejiang Shaoxin Hosp, Shaoxin, Zhejiang, Peoples R China; [Chen Lin-bao] Shanghai 7 Hosp, Shanghai, Peoples R China; [Li Shiting] Shanghai Xinhua Hosp, Shanghai, Peoples R China; [Sun Yu-hai] Shanghai Zhoupu Hosp, Shanghai, Peoples R China; [Zhang Jian-lin] Tianjin Gen Hosp, Tianjin, Peoples R China; [Lei Ting] Wuhan Tongji Hosp, Wuhan, Hubei, Peoples R China; [Du Hang-geng] Hangzhou Xinhua Hosp, Hangzhou, Zhejiang, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, 1630 Dongfang Rd, Shanghai 200127, Peoples R China.	Jiangjyb@online.sh.cn					Arellano-Orden V, 2011, NEUROCRIT CARE, V14, P18, DOI 10.1007/s12028-010-9441-3; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bullock R., 2000, BRAIN TRAUMA FDN J N, V17, P449; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fearnside M.R., 1993, BRIT J NEUROSURG, Vpre-hosptial, P267; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; TEASDALE G, 1974, LANCET, V2, P81; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596	24	0	0	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1164	1167		10.1089/neu.2011.2134			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000637508500021	23039042				2022-02-07	
J	Gomez-Rhenals, E; Rahman, MM; Moscote-Salazar, LR; Garcia-Ballestas, E; Florez, W; Agrawal, A				Gomez-Rhenals, Edgar; Rahman, Md Moshiur; Moscote-Salazar, Luis Rafael; Garcia-Ballestas, Ezequiel; Florez, William; Agrawal, Amit			Management of Traumatic Brain Injury in Pregnancy: Simultaneous Craniectomy and Cesarean Section Surgeries	INDIAN JOURNAL OF NEUROTRAUMA			English	Article									[Gomez-Rhenals, Edgar] Univ Sinu Cartagena Indias, Dept Gynecol & Obstet, Bolivar, Colombia; [Rahman, Md Moshiur] Holy Family Red Crescent Med Coll, Dept Neurosurg, Dhaka 1000, Bangladesh; [Moscote-Salazar, Luis Rafael; Garcia-Ballestas, Ezequiel] Univ Cartagena, Fac Med, Ctr Biomed Res, Cartagena, Colombia; [Florez, William] Latin Amer Council Neurocrit Care, Cartagena, Colombia; [Agrawal, Amit] All India Inst Med Sci Bhopal, Dept Neurosurg, Bhopal, Madhya Pradesh, India		Rahman, MM (corresponding author), Holy Family Red Crescent Med Coll, Dept Neurosurg, Dhaka 1000, Bangladesh.	dr.tutul@yahoo.com	Moscote-Salazar, Luis Rafael/K-6307-2012; Agrawal, Amit/C-1511-2011	Moscote-Salazar, Luis Rafael/0000-0002-4180-6962; Agrawal, Amit/0000-0002-3287-5448; Rahman, Md Moshiur/0000-0002-1183-6829; Florez Perdomo, William Andres/0000-0002-6951-1277			Barraco RD, 2010, J TRAUMA, V69, P211, DOI 10.1097/TA.0b013e3181dbe1ea; Chang LL, 1999, CAN J ANAESTH, V46, P61, DOI 10.1007/BF03012517; Choy B, 2020, BRIT J NEUROSURG, DOI 10.1080/02688697.2020.1817320; Gioti I, 2019, ACTA NEUROCHIR, V161, P1349, DOI 10.1007/s00701-019-03921-5; Han Kun Hee, 2018, Korean J Neurotrauma, V14, P146, DOI 10.13004/kjnt.2018.14.2.146; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Kashkoush AI, 2017, J CLIN NEUROSCI, V39, P9, DOI 10.1016/j.jocn.2017.02.046; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Mendez-Figueroa H, 2013, AM J OBSTET GYNECOL, V209, P1, DOI 10.1016/j.ajog.2013.01.021; Mongraw-Chaffin ML, 2010, HYPERTENSION, V56, P166, DOI 10.1161/HYPERTENSIONAHA.110.150078; Tawfik MM, 2015, SAUDI J ANAESTH, V9, P207, DOI 10.4103/1658-354X.152890	11	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2021	18	02					146	147		10.1055/s-0041-1727405		APR 2021	2	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XU0LH	WOS:000640423100002		hybrid			2022-02-07	
J	Hibshman, N; Yengo-Kahn, A; Wiseman, A; Kelly, PD; Wu, J; Monk, S; Harris, G; Gannon, S; Shannon, C; Bonfield, CM				Hibshman, Natalie; Yengo-Kahn, Aaron; Wiseman, Alyssa; Kelly, Patrick D.; Wu, Jeffanie; Monk, Steve; Harris, Glenn; Gannon, Stephen; Shannon, Chevis; Bonfield, Christopher M.			Child participation in collision sports and football: what influences parental decisions?	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Collision sports; concussion; contact sports; parenting; sport-related concussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; PHYSICAL-ACTIVITY; CONCUSSIONS	Objective: Sport participation promotes health benefits for children. Current media and scientific coverage of sport-related head injury may influence a parent's decision on sports participation. Physicians must understand what influences these decisions to effectively counsel patients and families. This study sought to better understand and quantify the parental decisions to allow/disallow collision sports, including football participation. Methods: A 31-question survey related to child/parent demographics, sports history, and influences to allow/disallow sport participation was available to parents in the United States through a national volunteer registry, between November 2016 and September 2019. Pearson's chi-squared and Wilcoxon's signed-rank test were used to analyze categorical and continuous variables, respectively. Multivariate logistic regression was performed to identify the most powerful factors associated with the decision. Results: Of the 884 responses, 430 (49%) parents would disallow collision sport participation and 334 (38%) would disallow football. Parents who would allow collision sports more commonly cited child desire, while those parents who would disallow cited safety concern as the greatest influence to generally disallow a sport. Those who would disallow reported doctors (35.1% vs 25.3%; P = 0.002), media (12.8% vs 7.3%; P = 0.006) and other parents (11.2% vs 7.3%; P = 0.045) as influences. A child's age (OR 1.039, 95%CI 1.007-1.073; P = 0.018) was independently associated with their parent responding that they would allow collision sports. Parent educational status showed that those with higher than a bachelor's degree would be less likely to allow football participation (OR 0.635, 95%CI 0.443-0.910; P = 0.013). Conclusions: Parents incorporate many sources of information into the decision to allow or disallow their child to participate in collision sports. A child's desire to play a sport and child safety are driving factors for parents faced with the decision of whether to allow participation in collision sports. Physician input is more frequently influential to parents than the media, underscoring the responsibility of physicians to engage families on the risks, benefits, and resources available for sport participation.	[Hibshman, Natalie; Wu, Jeffanie] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Hibshman, Natalie; Yengo-Kahn, Aaron; Bonfield, Christopher M.] Vanderbilt Univ Sch Med, Vanderbilt Sport Concuss Ctr, Nashville, TN USA; [Hibshman, Natalie; Yengo-Kahn, Aaron; Wiseman, Alyssa; Wu, Jeffanie; Gannon, Stephen; Shannon, Chevis; Bonfield, Christopher M.] Vanderbilt Univ, Surg Outcomes Ctr Kids, Monroe Carrell Jr Hosp, 221 Kirkland Hall, Nashville, TN 37235 USA; [Yengo-Kahn, Aaron; Kelly, Patrick D.; Shannon, Chevis; Bonfield, Christopher M.] Vanderbilt Univ Sch Med, Dept Neurol Surg, Nashville, TN USA; [Monk, Steve] Carolinas Med Ctr, Dept Neurol Surg, Charlotte, NC 28203 USA; [Harris, Glenn] Northwestern Univ, McGaw Hosp, Dept Neurol, Chicago, IL USA		Hibshman, N (corresponding author), Vanderbilt Univ, Med Ctr North T 4224, Sch Med, 1161 21st Ave S, Nashville, TN 37212 USA.	natalie.hibshman@vanderbilt.edu		Kelly, Patrick/0000-0003-4911-4239			Adelson E., FOOTBALL CTE FEAR OV; Agata K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122793; Alderman BL, 2010, J PHYS ACT HEALTH, V7, P60, DOI 10.1123/jpah.7.1.60; Andersen MH, 2019, SCAND J PUBLIC HEALT, V47, P832, DOI 10.1177/1403494818791405; Arnold C., NEW YORK LAWMAKERS A; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bedard C, 2020, J ADOLESCENT HEALTH, V66, P352, DOI 10.1016/j.jadohealth.2019.09.017; Boneau RD, 2020, COMMUN SPORT, V8, P26, DOI 10.1177/2167479518816104; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Chase MA, 2001, RES Q EXERCISE SPORT, V72, P47, DOI 10.1080/02701367.2001.10608931; Cheung PYP, 2010, HEALTH EDUC, V110, P351, DOI 10.1108/09654281011068513; Chuck E., DESPITE EVIDENCE SKE; Cohen R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01974; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Daugherty J, 2018, BRAIN INJURY, V32, P1773, DOI 10.1080/02699052.2018.1530801; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dobosz RP, 1999, ADOLESCENCE, V34, P215; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Fontana J, 2021, HEALTH COMMUN, DOI 10.1080/10410236.2021.1876326; Fransen K, 2017, J SCI MED SPORT, V20, P800, DOI 10.1016/j.jsams.2016.11.024; Fransen K, 2014, J SPORT SCI, V32, P1389, DOI 10.1080/02640414.2014.891291; Fuller CW, 2008, INJURY PREV, V14, P256, DOI 10.1136/ip.2008.018739; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gregory S., IS IT UNETHICAL WATC; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Kroshus E, 2019, INJURY PREV, V25, P278, DOI 10.1136/injuryprev-2017-042677; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Landesman P., 2015, CONCUSSION; Lannan K., CONCUSSION THREAT YO; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Leo FM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218167; Logan K, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2019-0997; Love S, 2015, AM J SPORT MED, V43, P1260, DOI 10.1177/0363546514535187; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGlynn J, 2020, J SPORT SOC ISSUES, V44, P261, DOI 10.1177/0193723520903226; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nowinski C., YOUTH TACKLE FOOTBAL; Omalu B., DONT LET KIDS PLAY F; Ornelas IJ, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-3; Quaye AA, 2019, J CLIN NURS, V28, P4525, DOI 10.1111/jocn.15042; Schaller VE., OPINION STOP BLAMING; Snedden TR, 2019, AM J HEALTH PROMOT, V33, P675, DOI 10.1177/0890117118817715; Staropoli N., CONCUSSION DOC CALLS; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Vella SA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-113; Welk GJ, 2003, PEDIATR EXERC SCI, V15, P19, DOI 10.1123/pes.15.1.19; Wolfson DI, 2020, BRAIN INJURY, V34, P528, DOI 10.1080/02699052.2020.1725843; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	51	0	0	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1908867		APR 2021	10	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	RN8IQ	WOS:000640595100001	33764271				2022-02-07	
J	Johnson, RA; Albright, DL; Marzolf, JR; Bibbo, JL; Yaglom, HD; Crowder, SM; Carlisle, GM; Grindler, K; Harms, N; Willard, A; Wassman, M; Russell, CL				Johnson, Rebecca A.; Albright, David L.; Marzolf, James R.; Bibbo, Jessica L.; Yaglom, Hayley D.; Crowder, Sandra M.; Carlisle, Gretchen M.; Grindler, Karen; Harms, Nathan; Willard, Amy; Wassman, Marita; Russell, Cynthia L.			Experiences of Military Veterans in a Therapeutic Horseback Riding Program	CLINICAL NURSING RESEARCH			English	Article						animal-assisted intervention; equine assisted therapy; military veterans; posttraumatic stress disorder; therapeutic horseback riding	POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; DOGS; PAIN	Posttraumatic stress disorder commonly occurs among U.S. military veterans. Therapeutic horseback riding (THR) has emerged as an adjunct therapy. We explored 20 veterans' perceived benefits, drawbacks and views of a 6-week THR program. Participants had confirmed diagnoses of posttraumatic stress disorder, traumatic brain injury, or both. Veterans rode the same horse weekly, the same day, at the same time. Data were collected as part of a randomized clinical trial testing the effects of THR on Post-Traumatic Stress Disorder. Veterans responded to an open-ended questionnaire. Content analysis was used for data analysis. Benefits were "Connection to the Horse," "Relaxing," "180 Degree Change," and "Meeting New People." Drawbacks were "None," "Struggle to Get There," "Pain," "Too Short," and "It is Structured." Overall perceptions were "I Absolutely Loved It," "Feel Again," "The Horse," "The People," and "No Worries." Participants viewed THR as positive. Findings may elucidate why THR may be clinically beneficial.	[Johnson, Rebecca A.] Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65211 USA; [Yaglom, Hayley D.] Univ Missouri, Sch Hlth Profess, Columbia, MO USA; [Carlisle, Gretchen M.] Univ Missouri, Coll Vet Med, Res Ctr Human Anim Interact, Columbia, MO USA; [Albright, David L.] Univ Alabama, Social Work, Tuscaloosa, AL USA; [Albright, David L.] Univ Alabama, Mental Hlth Res, Tuscaloosa, AL USA; [Marzolf, James R.] Whole Hlth Inst, Hlth Sect Finance & Policy, Bentonville, AR USA; [Bibbo, Jessica L.] Benjamin Rose Inst Aging, Ctr Res & Educ, Cleveland, OH USA; [Yaglom, Hayley D.] Translat Genom Res Inst North, Flagstaff, AZ USA; [Crowder, Sandra M.] Missouri Dept Vocat Rehabil, Jefferson City, MO USA; [Grindler, Karen] Cedar Creek Therapeut Riding Ctr, Columbia, MO USA; [Harms, Nathan; Willard, Amy] TREE House Greater St Louis, Wentzville, MO USA; [Wassman, Marita] Ride St Louis, Kimmswick, MO USA; [Russell, Cynthia L.] Univ Missouri Kansas City, Sch Nursing & Hlth Studies, Kansas City, MO USA		Johnson, RA (corresponding author), Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65211 USA.	rajohnson@missouri.edu	Marzolf, James R./AAV-8192-2021		Horses and Humans Research Foundation [00040568]; University of Missouri Interdisciplinary Center on Aging Research Enrichment and Dissemination (READ) grant (Albright)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by a grant from the Horses and Humans Research Foundation (#00040568) and the University of Missouri Interdisciplinary Center on Aging Research Enrichment and Dissemination (READ) grant (Albright no grant numbers are used in this mechanism). Neither funder played a role in the development, conduct of the study, analyses or interpretation of the data, nor were they involved in writing this manuscript.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arnon S, 2020, MIL MED, V185, pE557, DOI 10.1093/milmed/usz444; Bryant RA, 2008, J CONSULT CLIN PSYCH, V76, P695, DOI 10.1037/a0012616; Chesney MA, 2006, BRIT J HEALTH PSYCH, V11, P421, DOI 10.1348/135910705X53155; Cohen J, 1998, STAT POWER ANAL BEHA; Currier JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101741; Daskalakis NP, 2013, ENDOCRIN METAB CLIN, V42, P503, DOI 10.1016/j.ecl.2013.05.004; de Assis MA, 2008, CLINICS, V63, P473, DOI 10.1590/S1807-59322008000400010; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; EDDY J, 1988, J PSYCHOL, V122, P39, DOI 10.1080/00223980.1988.10542941; Farias-Tomaszewski S., 2001, Therapeutic Recreation Journal, V35, P250; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; Fox VM, 1984, ADAPT PHYS ACT Q, V1, P30; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hammer Ann, 2005, Physiotherapy Theory and Practice, V21, P51, DOI 10.1080/09593980590911525; Henriksen J D, 1971, Arch Phys Med Rehabil, V52, P282; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2011, JAMA-J AM MED ASSOC, V306, P549, DOI 10.1001/jama.2011.1096; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Johnson RA, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0149-6; Johnson RA, 2010, CLIN NURS RES, V19, P387, DOI 10.1177/1054773810373122; Kawamura N, 2009, J PSYCHOSOC NURS MEN, V47, P41, DOI 10.3928/02793695-20090101-08; Klontz BT, 2007, SOC ANIM, V15, P257, DOI 10.1163/156853007X217195; LaFleur L., 2015, THESIS ANTIOCH U SEA; Lanning Beth A, 2013, J Rehabil Res Dev, V50, pvii, DOI 10.1682/JRRD.2013.07.0159; Lechner HE, 2003, SPINAL CORD, V41, P502, DOI 10.1038/sj.sc.3101492; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; Mowatt RA, 2011, THER RECREAT J, V45, P286; Newman Caren L, 2007, Int J Emerg Ment Health, V9, P133; Norbeck E.H, 2009, EFFECTS THERAPEUTIC; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Palmer E., 2017, INT J ART THER INSCA, V22, P132, DOI [10.1080/17454832.2016.1277250, DOI 10.1080/17454832.2016.1277250]; Pet Partners Terminology, 2021, IND TERMS; Rosenthal S R, 1975, Rehabil Lit, V36, P144; Schoenfeld BJ, 2013, STRENGTH COND J, V35, P16; Shelef A, 2019, MIL MED, V184, P394, DOI 10.1093/milmed/usz036; Silkwood-Sherer D., 2003, PATH INT STRIDES, V9, P14; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tsai J, 2015, EPIDEMIOL REV, V37, P177, DOI 10.1093/epirev/mxu004; U.S. Department of Veterans Affairs, 2017, TRAUMATIC BRAIN INJU; U.S. Department of Veterans Affairs, 2017, UNDERSTANDING TRAUMA; U. S. Department of Veterans Affairs and Department of Defense, 2017, VADOD CLIN PRACTICE; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vespa J. E., 2020, AM COMMUNITY SURVEY; White-Lewis S, 2019, APPL NURS RES, V49, P5, DOI 10.1016/j.apnr.2019.07.002; Yorke J, 2003, THERAPEUTIC VALUE EQ; Young RL, 2005, INT J THER REHABIL, V12, P120, DOI 10.12968/ijtr.2005.12.3.19556	51	0	0	4	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1054-7738	1552-3799		CLIN NURS RES	Clin. Nurs. Res.	SEP	2021	30	7					923	933	10547738211003580	10.1177/10547738211003580		APR 2021	11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	TZ6RR	WOS:000643462400001	33855883				2022-02-07	
J	Nayak, N; Singh, PR; Sharma, RK; Gupta, SK; Gandhoke, CS; Sharma, AK				Nayak, Nitish; Singh, Prashant Raj; Sharma, Raghvendra Kumar; Gupta, Surendra Kumar; Gandhoke, Charandeep Singh; Sharma, Anil Kumar			Impact of COVID-19 Pandemic during the Lockdown on the Traumatic Brain Injury-An Institutional Experience	INDIAN JOURNAL OF NEUROTRAUMA			English	Article; Early Access						traumatic brain injury; COVID; pandemic; lockdown; road traffic accident		Background Traumatic brain injuries (TBIs) contribute to a significant socioeconomic impact, primarily affecting the lower-income sections of the society. The COVID-19 pandemic has resulted in a marked reduction in in-patient attendance. We are highlighting the impact of lockdown in neurotrauma cases in our institution compared to the prelockdown period. Methods We have done the retrospective review of the patients admitted due to TBI in prelockdown (January 14-March 21, 2020) and lockdown period (March 25-May 31, 2020) for the same duration of the 68 days at our tertiary institution. We have included demographic characteristics (age, sex), mode of injury, the severity of TBI, radiological diagnosis (computed tomography scan), and treatment obtained in our study. We compared the data for percentage (%) reduction of TBI cases and factors responsible for it during the lockdown period. Result A total of 166 patients were included in both groups. TBI's most common mechanism was road traffic accident, but we observed an increase in self-fall (16.9% vs. 38.1%) and assault (11.2% vs. 19%) during the lockdown period. We have noted that moderate TBI increased during the lockdown period by 17%. Overall, there is a reduction of 67% in TBI cases during the lockdown period. Conclusion The COVID pandemic has limited road traffic activity, and strict implementation of lockdown has restricted the infection and has reduced the neurotrauma emergencies. Simultaneously, moderate TBI cases have increased because of the lack of transportation facility and delay in the management of mild TBI cases.	[Nayak, Nitish; Singh, Prashant Raj; Sharma, Raghvendra Kumar; Gupta, Surendra Kumar; Gandhoke, Charandeep Singh; Sharma, Anil Kumar] All India Inst Med Sci Raipur, Dept Neurosurg, Raipur 492099, Madhya Pradesh, India		Sharma, AK (corresponding author), All India Inst Med Sci Raipur, Dept Neurosurg, Raipur 492099, Madhya Pradesh, India.	dr.anilsharma02@gmail.com	; KUMAR, ANIL/O-8413-2018	singh, prashant/0000-0003-0092-4943; KUMAR, ANIL/0000-0003-2974-9720			[Anonymous], 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3422; Christey G, 2020, NEW ZEAL MED J, V133, P81; Dandona R, 2020, LANCET PUBLIC HEALTH, V5, pE86, DOI 10.1016/S2468-2667(19)30246-4; Figueroa JM, 2021, WORLD NEUROSURG, V146, pe1, DOI 10.1016/j.wneu.2020.08.083; Fontanella MM, 2020, WORLD NEUROSURG, V139, pE818, DOI 10.1016/j.wneu.2020.04.204; Ghosh P, 2020, JMIR PUBLIC HLTH SUR, V6, P307, DOI 10.2196/20341; Gururaj G, 2005, NATL I MENTAL HLTH N, P61; Hsiao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002621; Lara-Reyna J, 2020, WORLD NEUROSURG, V143, pE344, DOI 10.1016/j.wneu.2020.07.155; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Ministry of Road Transport and Highways Transport Research Wing, 2018, ROAD ACCIDENTS INDIA; Pinggera D, 2021, EUR J TRAUMA EMERG S, V47, P653, DOI 10.1007/s00068-020-01445-7; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Venkataram T, 2020, NEUROL INDIA, V68, P595, DOI 10.4103/0028-3886.289004; World Health Organization, 2018, Global status report on alcohol and health 2018	15	0	0	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma												10.1055/s-0041-1725569		APR 2021	5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RN5WH	WOS:000640423100003		hybrid			2022-02-07	
J	Quan, XY; Song, L; Zheng, XM; Liu, SJ; Ding, HQ; Li, SJ; Xu, GH; Li, X; Liu, L				Quan, Xingyun; Song, Li; Zheng, Xiaomei; Liu, Shenjie; Ding, Huaqiang; Li, Sijing; Xu, Guanghui; Li, Xin; Liu, Liang			Reduction of Autophagosome Overload Attenuates Neuronal Cell Death After Traumatic Brain Injury	NEUROSCIENCE			English	Article						autophagy; autophagosome; VPS34; SAR405; neuronal cell death; traumatic brain injury		studies have shown that alterations in autophagy-related proteins exist extensively after traumatic brain injury (TBI). However, whether autophagy is enhanced or suppressed by TBI remains controversial. In our study, a controlled cortical impact was used to establish a model of moderate TBI in rats. We found that a significant increase in protein levels of LC3-II and SQSTM1 in the injured cortex group. However, there were no significant differences in protein levels of VPS34, Beclin-1, and phosphor-ULK1, which are the promoters of autophagy. Lysosome dysfunction after TBI might lead to autophagosome accumulation. In addition, the highly specific autophagy inhibitor SAR405 administration reduced TBI-induced apoptosis-related protein cleaved caspase-3 and cleaved caspase-9 levels in the ipsilateral cortex, as well as brain edema and neurological defects accessed by mNSS. Furthermore, chloroquine treatment reversed the beneficial effects of SAR405 by increasing the accumulation of autophagosomes. Finally, our data showed that autophagy inhibition by VPS34 gene knockout method attenuated cell death after TBI. Our findings indicate that impaired autophagosome degradation is involved in the pathological reaction after TBI, and the inhibition of autophagy contributes to attenuate neuronal cell death and functional defects. ? 2021 IBRO. Published by Elsevier Ltd. All rights reserved.	[Quan, Xingyun; Song, Li; Liu, Shenjie; Li, Sijing; Xu, Guanghui; Li, Xin; Liu, Liang] Southwest Med Univ, Dept Neurosurg, Affiliated Hosp, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China; [Zheng, Xiaomei] Southwest Med Univ, Dept Neurol, Affiliated Hosp, Luzhou, Sichuan, Peoples R China; [Ding, Huaqiang] Peoples Hosp Chongqing Yubei, Dept Neurosurg, Chongqing, Peoples R China; [Liu, Liang] Sichuan Clin Res Ctr Neurosurg, Shenyang, Peoples R China; [Liu, Liang] Southwest Med Univ, Neurol Dis & Brain Funct Lab, Clin Med Res Ctr, Luzhou, Sichuan, Peoples R China; [Liu, Liang] Academician Expert Workstn Sichuan Prov, Luzhou, Sichuan, Peoples R China		Liu, L (corresponding author), Southwest Med Univ, Dept Neurosurg, Affiliated Hosp, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China.	liulst@163.com			Project of Sichuan Provincial Health Department [110371]; Project of Sichuan Medical Association [S17074]; Key projects of Education Department of Sichuan [12ZA075]; Luzhou Science and Technology Bureau Project [2017-S-40]	This work was supported by grants from the Project of Sichuan Provincial Health Department (110371); the Project of Sichuan Medical Association (S17074); the Key projects of Education Department of Sichuan (12ZA075); the Luzhou Science and Technology Bureau Project (2017-S-40).	Au AK, 2017, NEUROCRIT CARE, V26, P348, DOI 10.1007/s12028-016-0351-x; Chen CW, 2012, AUTOPHAGY, V8, P1510, DOI 10.4161/auto.21289; Cui CM, 2015, MOL MED REP, V12, P2323, DOI 10.3892/mmr.2015.3611; Cui CM, 2017, CELL PHYSIOL BIOCHEM, V42, P1888, DOI 10.1159/000479571; Cui DR, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.318; Gao YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0939-5; Geronimo-Olvera C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.299; Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608; Hui KK, 2019, AUTOPHAGY, V15, P1848, DOI 10.1080/15548627.2019.1637643; Jalin AMAA, 2019, EXP NEUROL, V314, P20, DOI 10.1016/j.expneurol.2019.01.002; Jin YC, 2016, WORLD NEUROSURG, V88, P433, DOI 10.1016/j.wneu.2015.10.055; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Li K, 2019, BIOL PSYCHIAT, V85, P214, DOI 10.1016/j.biopsych.2018.07.026; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Pasquier B, 2015, AUTOPHAGY, V11, P725, DOI 10.1080/15548627.2015.1033601; Peng JH, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2019.101121; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Wang C, 2015, NEUROCHEM RES, V40, P1739, DOI 10.1007/s11064-015-1657-3; Wang JW, 2018, AUTOPHAGY, V14, P2007, DOI 10.1080/15548627.2018.1501133; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xing SH, 2012, AUTOPHAGY, V8, P63, DOI 10.4161/auto.8.1.18217; Xu Y, 2016, J NEUROCHEM, V139, P795, DOI 10.1111/jnc.13851; Zeng XJ, 2020, J CELL MOL MED, V24, P7000, DOI 10.1111/jcmm.15361; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang PJ, 2017, CNS NEUROL DISORD-DR, V16, P724, DOI 10.2174/1871527316666170124164306; Zhao WY, 2017, BRAIN RES, V1669, P141, DOI 10.1016/j.brainres.2017.06.006	40	0	0	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 15	2021	460						107	119		10.1016/j.neuroscience.2021.02.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RE4EL	WOS:000634109400008	33600885				2022-02-07	
J	Deuschle, C; Keith, J; Dugan, K; Williams, M; Taravath, S; Lecci, L				Deuschle, Christina; Keith, Julian; Dugan, Kelly; Williams, Mark; Taravath, Sasi; Lecci, Len			Baseline Concussion Testing Increases Agreement With Favorable Concussion Safety Decisions in Hypothetical Scenarios	HEALTH EDUCATION & BEHAVIOR			English	Article; Early Access						baseline testing; concussion; decision making; improving safety; RoCKAS-ST	TRAUMATIC BRAIN-INJURY; KNOWLEDGE; BEHAVIOR; ATTITUDES; EPIDEMIOLOGY; METAANALYSIS; IMPACT	Background Dangers of sports-related concussion are well documented, and those participating in sports involving significant contact are at an even higher risk relative to the general population. Despite extensive concussion education, athletes still make decisions that would be considered unsafe, such as underreporting and continuing to play despite experiencing symptoms. Although baseline testing is an increasingly common practice at all levels of sport, little is known about its ability to improve player safety perceptions. Aims The current study examines whether taking part in a standardized baseline concussion assessment changes athletes' knowledge, attitudes, or perceptions of concussion safety decisions. Method A total of 229 club and National Collegiate Athletic Association athletes completed a modified Rosenbaum Concussion Knowledge and Attitudes Survey-Student Version (RoCKAS-ST), which was used to evaluate knowledge, attitudes, and perceptions of concussion safety decisions in hypothetical scenarios. Athletes were randomly assigned to either complete baseline concussion testing prior to the RoCKAS-ST or complete baseline testing after the RoCKAS-ST. Results Athletes randomly assigned to complete baseline testing before the RoCKAS-ST demonstrated greater agreement with favorable concussion safety decisions in hypothetical scenarios relative to athletes completing baseline testing after the RoCKAS-ST. The two conditions did not differ with respect to concussion knowledge or attitudes. Discussion Baseline testing appears to have an added benefit of resulting in more favorable perceptions toward making safe decisions following suspected concussions. Conclusion Baseline testing may provide an effective means of improving a broader constellation of concussion safety behavior, particularly in club athletes, who are typically underserved in terms of concussion-related resources and care.	[Deuschle, Christina; Keith, Julian; Dugan, Kelly; Lecci, Len] Univ North Carolina Wilmington, Wilmington, NC USA; [Williams, Mark; Taravath, Sasi] New Hanover Reg Med Ctr, Wilmington, NC USA		Lecci, L (corresponding author), Univ North Carolina Wilmington, Dept Psychol, 601 South Coll Rd,Box 5612, Wilmington, NC 28403 USA.	leccil@uncw.edu					[Anonymous], 2015, C TRAUM BRAIN INJ US; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Brain Injury Association of America , BRAIN INJ BAS; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Glasman LR, 2006, PSYCHOL BULL, V132, P778, DOI 10.1037/0033-2909.132.5.778; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lecci L, 2020, ARCH CLIN NEUROPSYCH, V35, P265, DOI 10.1093/arclin/acz041; MANFREDO MJ, 1988, J SOC PSYCHOL, V128, P731, DOI 10.1080/00224545.1988.9924553; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Michigan State University , CONC MAN PLAN; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; National Collegiate Athletic Association, 2017, CONC DIAGN MAN BEST; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schneider RC, 2008, RECREAT SPORTS J, V32, P62, DOI 10.1123/rsj.32.1.62; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; University of Cincinnati, U CINC CLUB SPORT ST; University of Colorado Colorado Springs, 2019, CLUB SPORTS OFF HDB; University of Wyoming , 2019, CLUB SPORTS MAN U WY; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482	33	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.											10901981211003509	10.1177/10901981211003509		APR 2021	8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	RT7HB	WOS:000644627000001	33853415				2022-02-07	
J	Posti, JP; Kyto, V; Sipila, JOT; Rautava, P; Luoto, TM				Posti, Jussi P.; Kyto, Ville; Sipila, Jussi O. T.; Rautava, Paivi; Luoto, Teemu M.			High-Risk Periods for Adult Traumatic Brain Injuries: A Nationwide Population-Based Study	NEUROEPIDEMIOLOGY			English	Article						Traumatic brain injury; Mortality; Seasonality; High-risk time; Epidemiology		Introduction: There is minimal existing available information on nationwide seasonal peaks in traumatic brain injuries (TBIs). This lack of information is an impediment to the effective development of prevention programs, societal policies, and hinders the resourcing of medical emergency services. Our current aim is to study nationwide population-based high-risk periods TBI over a 15-year study period in Finland. Methods: Nationwide databases were searched for all admissions with a TBI diagnosis and later for deaths of persons >= 16 years of age during 2004-2018. The search included all hospitals that provide acute TBI care in Finland. Results: The study period included 69,231 TBI-related hospital admissions (men = 62%). We found that for men, the highest rate of TBIs occurred on Saturdays, whereas women experience the highest rate of TBIs on Mondays. The highest rate of TBIs in men occurred in July, while women experienced the highest rate of TBIs in January. TBI-related hospital admissions (incidence risk ratio [IRR] 1.090, 95% CI 1.07-1.11, p < 0.0001) and mortality within 30 days after TBI (hazard ratio [HR] 1.057, 95% CI 1.001-1.116, p = 0.0455) were more common on public holidays and weekends than on weekdays. There was an increasing trend in the proportion of TBI-related hospital admissions occurring on public holidays and weekends from 2004 (31.5%) to 2018 (33.4%) (p = 0.0007). In summer months, TBI-related hospital admissions (IRR 1.10, 95% CI 1.08-1.12, p < 0.0001) and 30-day mortality (HR 1.069, 95% CI 1.010-1.131, p = 0.0211) were more common than in other months. TBIs occurred more often in younger and healthier individuals on these index days and times. In terms of specific public holidays, the TBI risk was overall higher on New Year's Eves and Days (IRR 1.40, 95% CI 1.25-1.58, p < 0.0001) and Midsummer's Eves and Days (IRR 1.36, 95% CI 1.20-1.54, p < 0.0001), compared to nonworking days. This finding was significant in both genders. Conclusions: TBI-related hospital admissions and mortality were more common on public holidays, weekends, and in summer months in Finland. People who sustained TBIs on these days were on average younger and healthier. The occurrence of TBIs on public holidays and weekends is increasing at an alarming rate.	[Posti, Jussi P.; Sipila, Jussi O. T.] Turku Univ Hosp, Dept Neurosurg, Neuroctr, Turku, Finland; [Posti, Jussi P.; Sipila, Jussi O. T.] Turku Univ Hosp, Turku Brain Injury Ctr, Neuroctr, Turku, Finland; [Posti, Jussi P.; Kyto, Ville; Sipila, Jussi O. T.; Rautava, Paivi] Univ Turku, Turku, Finland; [Kyto, Ville] Turku Univ Hosp, Heart Ctr, Turku, Finland; [Kyto, Ville] Turku Univ Hosp, Ctr Populat Hlth Res, Turku, Finland; [Kyto, Ville] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Kyto, Ville] Hosp Dist Southwest Finland, Adm Ctr, Turku, Finland; [Sipila, Jussi O. T.] North Karelia Cent Hosp, Dept Neurol, Siun Sote, Joensuu, Finland; [Rautava, Paivi] Turku Univ Hosp, Clin Res Ctr, Turku, Finland; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere, Finland		Posti, JP (corresponding author), Turku Univ Hosp, Dept Neurosurg, Neuroctr, Turku, Finland.; Posti, JP (corresponding author), Turku Univ Hosp, Turku Brain Injury Ctr, Neuroctr, Turku, Finland.; Posti, JP (corresponding author), Univ Turku, Turku, Finland.	jussi.posti@utu.fi	Kyto, Ville/D-7971-2014; Posti, Jussi P./Y-2908-2019; Sipila, Jussi/C-8585-2015	Kyto, Ville/0000-0002-4521-1093; Posti, Jussi P./0000-0002-5925-5193; Luoto, Teemu/0000-0002-7329-3284; Sipila, Jussi/0000-0003-0183-9054	Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in Health Sciences, Finland [11129]; Maire Taponen Foundation; Finnish Government's Special Financial Transfer tied to academic research in Health Sciences, Finland; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Paulo Foundation; Finnish Brain Foundation sr; Emil Aaltonen Foundation sr; Science Fund of the City of Tampere; Finnish Medical Society Duodecim	Dr. Posti has received funding from the Academy of Finland (#17379) and the Government's Special Financial Transfer tied to academic research in Health Sciences, Finland (#11129) and the Maire Taponen Foundation. Professor Rautava and Dr. Kyto received funding from the Finnish Government's Special Financial Transfer tied to academic research in Health Sciences, Finland. Dr. Kyto has also received a grant from the Finnish Cultural Foundation and the Paulo Foundation. Dr. Luoto has received funding from the Government's Special Financial Transfer tied to academic research in Health Sciences, Finland. Additionally, Dr. Luoto has received research grants from the Finnish Brain Foundation sr, the Emil Aaltonen Foundation sr, the Maire Taponen Foundation, the Science Fund of the City of Tampere, and the Finnish Medical Society Duodecim.	Becker David J, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P23, DOI 10.1586/14737167.8.1.23; Bjarko VV, 2019, WORLD NEUROSURG, V122, pE684, DOI 10.1016/j.wneu.2018.10.122; Borodulin K, 2008, J PHYS ACT HEALTH, V5, P242, DOI 10.1123/jpah.5.2.242; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cantwell K, 2015, PREHOSP EMERG CARE, V19, P425, DOI 10.3109/10903127.2014.995843; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Eom Ki Seong, 2020, Korean J Neurotrauma, V16, P28, DOI 10.13004/kjnt.2020.16.e2; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makela P, 2005, INT J EPIDEMIOL, V34, P765, DOI 10.1093/ije/dyi025; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Posti JP, 2020, AGE AGEING, V49, P779, DOI 10.1093/ageing/afaa037; Posti JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41913-8; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Shakya I, 2020, J SAFETY RES, V74, P125, DOI 10.1016/j.jsr.2020.06.001; Shi L, 2016, CIRCULATION, V134, P1510, DOI 10.1161/CIRCULATIONAHA.116.024535; Shinsugi C, 2015, ENVIRON HEALTH PREV, V20, P36, DOI 10.1007/s12199-014-0421-7; Sierosawski J., 2017, SYNTHESIS REPORT, P73; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Taylor MS, 2020, TRAFFIC INJ PREV, V21, P55, DOI 10.1080/15389588.2019.1666981; Tigerstedt C, 2020, NORD STUD ALCOHOL DR, V37, P609, DOI 10.1177/1455072520954324; Yla-Anttila, 2005, FINLAND KNOWLEDGE EC	28	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology	JUN	2021	55	3					216	223		10.1159/000515395		APR 2021	8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	SU2OD	WOS:000640289200001	33853074				2022-02-07	
J	Afsar, M; Shukla, D; Bhaskarapillai, B; Rajeswaran, J				Afsar, Mohammed; Shukla, Dhaval; Bhaskarapillai, Binukumar; Rajeswaran, Jamuna			Cognitive Retraining in Traumatic Brain Injury: Experience from Tertiary Care Center in Southern India	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						cognitive impairment; cognitive rehabilitation; cognitive retraining; neuropsychological rehabilitation; post-concussive symptoms; traumatic brain injury		Objective Traumatic brain injury (TBI) is a leading cause of mortality and chronic disability across the globe. This study aimed to understand the effects of cognitive retraining (CR) intervention on neuropsychological functions, symptom reporting, and quality of life in patients with moderate to severe TBI. Materials and Methods The present single-group intervention study with a pre-post design included 12 patients diagnosed with moderate to severe TBI within 3-24 months post injury. Outcome measures included National Institute of Mental Health and Neuro Sciences (NIMHANS) Neuropsychology Battery, Perceived Stress Scale, Rivermead Post-Concussion Symptom Questionnaire, World Health Organization Quality of Life Scale-Brief, and Visual Analogue Scale. All patients underwent a total of 20 sessions of hospital-based CR, spanning over a period of 2 months. The CR included tasks targeting to enhance processing speed, attention, executive function, learning, and memory. Outcome assessments were conducted at baseline and immediately at post intervention. Statistical Analysis Mean, standard deviation, frequency, and percentage were used as measures of descriptive statistics. Pre- and postintervention scores were compared using Wilcoxon signed-rank test. Results The results showed that at post intervention, significant improvements were found in processing speed, working memory, planning, visuo-spatial construction, visual memory, and verbal encoding. Subjective symptom reporting, perceived stress, and quality of life in psychological domain also improved. Conclusion CR can be helpful in improving not only cognition but also symptom reporting and quality of life in moderate to severe TBI.	[Afsar, Mohammed; Rajeswaran, Jamuna] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore, Karnataka, India; [Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Bhaskarapillai, Binukumar] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore, Karnataka, India		Rajeswaran, J (corresponding author), Natl Inst Mental Hlth & Neuro Sci NIMHANS, MV Govindaswamy Ctr, Dept Clin Psychol, 3rd Floor, Bangalore 560029, Karnataka, India.	drjamunarajan@gmail.com		Afsar, Mohammed/0000-0002-4429-8318; Bhaskarapillai, Binukumar/0000-0003-3056-941X	Cognitive Science Research Initiative (CSRI) of Department of Science and Technology, Government of India [SR/CSRI/150/2014]	This work was supported by the Cognitive Science Research Initiative (CSRI) of Department of Science and Technology, Government of India (Grant reference: SR/CSRI/150/2014, dated 03.03.2016).	Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Ardilla A, 2007, INT HDB CROSS CULTUR, P1; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Burton Adrian, 2016, Lancet Neurol, V15, P1011, DOI 10.1016/S1474-4422(16)30131-4; Chopra S, 2017, INDIAN J NEUROTRAUM, V14, P6, DOI 10.1055/s-0037-1602722; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; COHEN S, 1988, CLAR SYMP, P31; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fernandez E, 2012, MEDICC REV, V14, P32, DOI 10.37757/MR2012V14.N4.8; Gururaj G., 2005, TRAUMATIC BRAIN INJU; Gurusamy J, 2019, BMC NURS, V18, DOI 10.1186/s12912-019-0388-1; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Jamuna N, 2010, INDIAN J NEUROTRAUM, V7, P93; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kanchan A, 2018, INDIAN J PSYCHIAT, V60, P38, DOI 10.4103/psychiatry.IndianJPsychiatry_118_17; Kannan S., 2019, IP INDIAN J NEUROSCI, V5, P160; Kannan S., 2017, INDIAN J HLTH WELLBE, V8, P1008; Kashyap H, 2010, INDIAN J NEUROTRAUM, V7, P89, DOI 10.1016/S0973-0508(10)80020-6; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Mehrotra K, 2018, ASIAN J PSYCHIATR, V31, P58, DOI 10.1016/j.ajp.2018.01.021; Mohanty M, 2013, ANN NEUROSCI, V20, P31, DOI 10.5214/ans.0972.7531.200111; Patil M, 2017, J NEUROSCI RURAL PRA, V8, P357, DOI 10.4103/jnrp.jnrp_53_17; Rao, 2004, 2 WORKSH CONT ED NEU; Rao S. L., 2004, NIMHANS NEUROPSYCHOL; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Said PZ, 2018, ARCH MENT HLTH, V19, P97; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Srivastav D., 2013, INDIAN J HLTH WELLBE, V4, P1357; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; World Health Organization, 2018, Global status report on alcohol and health 2018	40	0	0	1	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	APR	2021	12	02					295	301		10.1055/s-0041-1722817		APR 2021	7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RU5MX	WOS:000639601400003	33927520	gold, Green Published			2022-02-07	
J	Gelinas, C; Berube, M; Puntillo, KA; Boitor, M; Richard-Lalonde, M; Bernard, F; Williams, V; Joffe, AM; Steiner, C; Marsh, R; Rose, L; Dale, CM; Tsoller, DM; Choiniere, M; Streiner, DL				Gelinas, Celine; Berube, Melanie; Puntillo, Kathleen A.; Boitor, Madalina; Richard-Lalonde, Melissa; Bernard, Francis; Williams, Virginie; Joffe, Aaron M.; Steiner, Craig; Marsh, Rebekah; Rose, Louise; Dale, Craig M.; Tsoller, Darina M.; Choiniere, Manon; Streiner, David L.			Validation of the Critical-Care Pain Observation Tool-Neuro in brain-injured adults in the intensive care unit: a prospective cohort study	CRITICAL CARE			English	Article						Validation; Pain; Assessment; Brain injury; Critical care		Background Pain assessment in brain-injured patients in the intensive care unit (ICU) is challenging and existing scales may not be representative of behavioral reactions expressed by this specific group. This study aimed to validate the French-Canadian and English revised versions of the Critical-Care Pain Observation Tool (CPOT-Neuro) for brain-injured ICU patients. Methods A prospective cohort study was conducted in three Canadian and one American sites. Patients with a traumatic or a non-traumatic brain injury were assessed with the CPOT-Neuro by trained raters (i.e., research staff and ICU nurses) before, during, and after nociceptive procedures (i.e., turning and other) and non-nociceptive procedures (i.e., non-invasive blood pressure, soft touch). Patients who were conscious and delirium-free were asked to provide their self-report of pain intensity (0-10). A first data set was completed for all participants (n = 226), and a second data set (n = 87) was obtained when a change in the level of consciousness (LOC) was observed after study enrollment. Three LOC groups were included: (a) unconscious (Glasgow Coma Scale or GCS 4-8); (b) altered LOC (GCS 9-12); and (c) conscious (GCS 13-15). Results Higher CPOT-Neuro scores were found during nociceptive procedures compared to rest and non-nociceptive procedures in both data sets (p < 0.001). CPOT-Neuro scores were not different across LOC groups. Moderate correlations between CPOT-Neuro and self-reported pain intensity scores were found at rest and during nociceptive procedures (Spearman rho > 0.40 and > 0.60, respectively). CPOT-Neuro cut-off scores >= 2 and >= 3 were found to adequately classify mild to severe self-reported pain >= 1 and moderate to severe self-reported pain >= 5, respectively. Interrater reliability of raters' CPOT-Neuro scores was supported with intraclass correlation coefficients > 0.69. Conclusions The CPOT-Neuro was found to be valid in this multi-site sample of brain-injured ICU patients at various LOC. Implementation studies are necessary to evaluate the tool's performance in clinical practice.	[Gelinas, Celine; Richard-Lalonde, Melissa] McGill Univ, Ingram Sch Nursing, 680 Sherbrooke West St,Suite 1800, Montreal, PQ H3A 2M7, Canada; [Gelinas, Celine; Richard-Lalonde, Melissa; Tsoller, Darina M.] Jewish Gen Hosp, Ctr Nursing Res, CIUSSS West Cent Montreal, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada; [Gelinas, Celine; Richard-Lalonde, Melissa; Tsoller, Darina M.] Jewish Gen Hosp, Lady Davis Inst, CIUSSS West Cent Montreal, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada; [Berube, Melanie] Univ Laval, Fac Nursing, 1050 Ave Med,Room 3486, Quebec City, PQ G1V 0A6, Canada; [Berube, Melanie] Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Ctr Rech, Trauma Emergency Crit Care Med,CHU Quebec, 1401,18e Rue,Room Z-243, Quebec City, PQ G1J 1Z4, Canada; [Puntillo, Kathleen A.] Univ Calif San Francisco, Physiol Nursing, 2 Koret Way, San Francisco, CA 94143 USA; [Boitor, Madalina] McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 0C7, Canada; [Bernard, Francis; Williams, Virginie] Hop Sacre Coeur Montreal, Res Ctr, Equipe Rech Soins Intensifs ERESI, Ctr Integre Univ Sante & Serv Sociaux Nord Lile M, 5400 Blvd Gouin Ouest,K-3000, Montreal, PQ H4J 1C4, Canada; [Bernard, Francis] Univ Montreal, Dept Med, Succursale Ctr Ville,CP 6128, Montreal, PQ H3C 3J7, Canada; [Joffe, Aaron M.; Steiner, Craig] Univ Washington, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Joffe, Aaron M.; Marsh, Rebekah] Univ Washington Med, Harborview Med Ctr, 325 9th Ave, Seattle, WA 98104 USA; [Rose, Louise] Kings Coll London, Florence Nightingale Fac Nursing Midwifery & Pall, 57 Waterloo Rd, London SE1 8WA, England; [Rose, Louise; Dale, Craig M.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, 155 Coll St,Suite 130, Toronto, ON M5T 1P8, Canada; [Dale, Craig M.] Sunnybrook Hlth Sci Ctr, Tory Trauma Program, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Choiniere, Manon] Univ Montreal, Fac Med, Dept Anesthesiol & Pain Med, Succursale Ctr Ville,CP 6128, Montreal, PQ H3C 3J7, Canada; [Choiniere, Manon] Ctr Hosp Univ Montreal, Res Ctr, St Antoine Bldg,Room S01-126,850 St Denis St, Montreal, PQ H2X 0A9, Canada; [Streiner, David L.] McMaster Univ, Dept Psychiat & Behav Neurosci, St Josephs Healthcare, 100 West 5th St,Box 585, Hamilton, ON L8N 3K7, Canada		Gelinas, C (corresponding author), McGill Univ, Ingram Sch Nursing, 680 Sherbrooke West St,Suite 1800, Montreal, PQ H3A 2M7, Canada.; Gelinas, C (corresponding author), Jewish Gen Hosp, Ctr Nursing Res, CIUSSS West Cent Montreal, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.; Gelinas, C (corresponding author), Jewish Gen Hosp, Lady Davis Inst, CIUSSS West Cent Montreal, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	celine.gelinas@mcgill.ca		Dale, Craig/0000-0002-5042-0332; Gelinas, Celine/0000-0001-7948-5570	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [119486]; Fonds de Recherche du Quebec en Sante (FRQS) [25094]; Reseau de recherche en interventions en sciences infirmieres du Quebec (RRISIQ); FRQS	This study was supported by funding from the Canadian Institutes of Health Research (CIHR Funding #119486) and Fonds de Recherche du Quebec en Sante (FRQS Funding #25094). Funding from the Reseau de recherche en interventions en sciences infirmieres du Quebec (RRISIQ) was also obtained to help cover open access fees. The principal investigator (CG) and co-author (MB) hold a research career award from FRQS. The funding agencies were not involved in the design of the study, collection, analysis, and interpretation of data and in writing the manuscript.	Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Arbour C, 2014, CLIN J PAIN, V30, P960, DOI 10.1097/AJP.0000000000000061; Azevedo-Santos IF, 2016, PAIN PRACT, V16, P451, DOI 10.1111/papr.12287; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bernard C, 2019, PAIN, V160, P2535, DOI 10.1097/j.pain.0000000000001637; Boitor M, 2016, J CARDIOVASC NURS, V31, P425, DOI 10.1097/JCN.0000000000000250; Bouajram RH, 2020, J INTENSIVE CARE MED, V35, P453, DOI 10.1177/0885066618757450; Buttes P, 2014, DIMENS CRIT CARE NUR, V33, P78, DOI 10.1097/DCC.0000000000000021; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Chen J, 2019, J CLIN NURS, V28, P2824, DOI 10.1111/jocn.14862; Chookalayia H, 2018, INTENS CRIT CARE NUR, V44, P123, DOI 10.1016/j.iccn.2017.07.012; Dehghani H, 2014, ARCH TRAUMA RES, V3, DOI 10.5812/atr.18608; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Echegaray-Benites C, 2014, INTENS CRIT CARE NUR, V30, P257, DOI 10.1016/j.iccn.2014.04.002; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Gelinas Celine, 2007, Perspect Infirm, V4, P12; Gelinas C, 2007, CLIN J PAIN, V23, P497, DOI 10.1097/ajp.0b013e31806a23fb; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Gelinas C, 2019, AACN ADV CRIT CARE, V30, P365, DOI 10.4037/aacnacc2019952; Gelinas C, 2019, J PAIN SYMPTOM MANAG, V57, P761, DOI 10.1016/j.jpainsymman.2018.12.333; Gelinas C, 2018, AUST CRIT CARE, V31, P145, DOI 10.1016/j.aucc.2017.10.002; Gelinas C, 2018, CRIT CARE NURSE, V38, P38, DOI 10.4037/ccn2018633; Gelinas C, 2011, INT J NURS STUD, V48, P1495, DOI 10.1016/j.ijnurstu.2011.03.012; Gelinas C, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.01.013; Gelinas C, 2010, PAIN MANAG NURS, V11, P115, DOI 10.1016/j.pmn.2009.05.002; Gelinas C, 2009, J PAIN SYMPTOM MANAG, V37, P58, DOI 10.1016/j.jpainsymman.2007.12.022; Haidet KK, 2009, RES NURS HEALTH, V32, P465, DOI 10.1002/nur.20334; Herr K, 2019, PAIN MANAG NURS, V20, P404, DOI 10.1016/j.pmn.2019.07.005; International Association for the Study of Pain, IASP TERMINOLOGY; Jendoubi A, 2017, INDIAN J CRIT CARE M, V21, P585, DOI 10.4103/ijccm.IJCCM_419_16; Joffe AM, 2016, J CRIT CARE, V36, P76, DOI 10.1016/j.jcrc.2016.05.011; Kapoustina O, 2014, J ADV NURS, V70, P2562, DOI 10.1111/jan.12409; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016; Lawrence M, 1995, Am J Crit Care, V4, P227; Lee K, 2013, PAIN MANAG NURS, V14, P259, DOI 10.1016/j.pmn.2011.05.005; Li D, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.07.005; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Ribeiro CJN, 2019, PAIN MANAG NURS, V20, P152, DOI 10.1016/j.pmn.2018.09.004; Ribeiro Caíque Jordan Nunes, 2018, Rev. bras. ter. intensiva, V30, P42, DOI 10.5935/0103-507x.20180009; Ribeiro Caíque Jordan Nunes, 2017, Rev. dor, V18, P332, DOI 10.5935/1806-0013.20170125; Richard-Lalonde M., 2019, SCI NURS HLTH PRACTI, V2, P2; Roulin MJ, 2014, INTENS CARE MED, V40, P1115, DOI 10.1007/s00134-014-3380-y; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shan K, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010985; Sulla Francesco, 2017, Acta Biomed, V88, P48, DOI 10.23750/abm.v88i5-S.6858; TEASDALE G, 1974, LANCET, V2, P81; Topolovec-Vranic J, 2013, PAIN RES MANAG, V18, pE107, DOI 10.1155/2013/263104; Tosch P, 1988, J Neurosci Nurs, V20, P223	54	0	0	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	APR 13	2021	25	1							142	10.1186/s13054-021-03561-1			15	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN3GC	WOS:000640238900002	33849619	Green Published, gold			2022-02-07	
J	Meiches, B				Meiches, Benjamin			Genocide and the Brain: Neuroscience, Mental Harm, and International Law	JOURNAL OF GENOCIDE RESEARCH			English	Article; Early Access						Genocide; mass atrocity; traumatic brain injury; international law; mental harm; PTSD; Catherine Malabou; destructive plasticity; colonial genocide	PSYCHOLOGICAL TRAUMA; CONSEQUENCES; VIOLENCE; CHALLENGE; SELF	Genocide scholarship rarely gives direct consideration to the Genocide Convention's description of "causing serious bodily and mental harm" as an act of genocide. This article examines the historical rationales for including this act in the international legal definition of genocide. It shows that mental harm was included because of a concern for the impact of narcotics and other substances on cognitive functioning and brain health. Building off this observation, the article draws genocide research into a conversation with emerging neuroscience on brain injury, cognitive stress, and brain development. When the Genocide Convention was first written nearly eighty years ago, neuroscience did not exist, and politicians could not have anticipated the now well-demonstrated importance of environmental, social, nutritional, and linguistic enrichment for brain development and health. Contemporary neuroscience has revealed the profound vulnerability of the brain and body to multiple techniques of violence and observed that long-term damage to both an individual and their capacity to function in a social group may result from even low-levels of brain injury. As such, this article argues that genocide studies should to be more attuned to emerging neuroscientific literature because it has the potential to drastically change our understanding of the form, intensity, scale, and regularity of events of genocide. Moreover, emerging brain science greatly strengthens claims about the damaging, genocidal effects of cultural violence, intoxication, and residential schools in the context of colonial and indigenous genocide.	[Meiches, Benjamin] Univ Washington, Sch Interdisciplinary Arts & Sci, 1900 Commerce St, Tacoma, WA 98402 USA		Meiches, B (corresponding author), Univ Washington, Sch Interdisciplinary Arts & Sci, 1900 Commerce St, Tacoma, WA 98402 USA.	bmeiches@uw.edu		Meiches, Benjamin/0000-0002-2791-7244			Abed Mohammed, 2015, SOCIAL THEORY PRACTI, V41, P328; Abtahi Hirad, 2008, GENOCIDE CONVENTION, P1125; Abtahi Hirad, 2008, GENOCIDE CONVENTION, P1359; Akhavan, 2012, REDUCING GENOCIDE LA; Allen, 1996, RAPE WARFARE HIDDEN; Bachman Jeffrey, 2020, GENOCIDE STUDIES PRE, V14, P11; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BASSO AR, 2016, GENOCIDE STUDIES PRE, V0010, P00005, DOI DOI 10.5038/1911-9933.10.1.1297; Bercovich E, 2014, ISR MED ASSOC J, V16, P203; Bezo Brent, 2015, SOC SCI MED, V134, P87; Brook Timothy, 2000, OPIUM REGIMES CHINA; Card, 2010, CONFRONTING EVILS TE; Carpenter Charli, 2002, INT J HUM RIGHTS, V6, P77, DOI [10.1080/714003779, DOI 10.1080/714003779]; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Connolly, 2002, NEUROPOLITICS THINKI; Cooper J, 2008, RAPHAEL LEMKIN AND THE STRUGGLE FOR THE GENOCIDE CONVENTION, P151; COVER RM, 1986, YALE LAW J, V95, P1601, DOI 10.2307/796468; Crook M, 2021, J GENOCIDE RES, V23, P162, DOI 10.1080/14623528.2020.1853914; DAMASIO Antonio, 2003, LOOKING SPINOZA JOY; Dawson G, 2000, DEV PSYCHOPATHOL, V12, P695, DOI 10.1017/S0954579400004089; Evans A, 2014, EXPLOR MENT HEAL, P1; Fanon F., 2005, WRETCHED EARTH; Farah MJ, 2017, NEURON, V96, P56, DOI 10.1016/j.neuron.2017.08.034; Fein H., 1997, HLTH HUMAN RIGHTS, V2, P10; Felman Shoshana, 1991, TESTIMONY CRISES WIT; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; Frost Samantha, 2016, BIOCULTURAL CREATURE, P8; Gerlach Christian, 2010, EXTREMELY VIOLENT SO; Gorove Stephen, 1951, WASHINGTON U LAW Q, V2, P183; Grosz Elizabeth, 1994, VOLATILE BODIES CORP, P3; Hagen K.T., 2010, INT J PSYCHOL STUDIE, V2, P14; HARFF B, 1955, AM POLITICAL SCI REV, V0097, P00057; Harrison K. David, 2007, LANGUAGES DIE EXTINC, P181; Harvey MR, 1996, J TRAUMA STRESS, V9, P3, DOI 10.1002/jts.2490090103; Heyes Cressida J., 2007, SELF TRANSFORMATIONS, P15; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hinton A. L., 2013, HIDDEN GENOCIDES POW; Hinton Devon E., 2015, GENOCIDE MASS VIOLEN, P33; Irvin-Erickson Douglas, 2017, R LEMKIN CONCEPT GEN; Jenkins L., 2005, POLITICS, V25, P1; Jennings J., 1997, OPIUM EMPIRE JAPANES; Joshi PT, 2003, CLIN CHILD FAM PSYCH, V6, P275, DOI 10.1023/B:CCFP.0000006294.88201.68; Kellermann NPF, 2013, ISR J PSYCHIATR REL, V50, P33; King C, 2004, WORLD POLIT, V56, P431, DOI 10.1353/wp.2004.0016; Kotef H, 2020, POLIT THEORY, V48, P4, DOI 10.1177/0090591719861714; Kuper Leo, 1981, GENOCIDE, P32; La Capra Dominick, 2014, WRITING HIST WRITING; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lemkin Raphael, 1944, AXIS RULE OCCUPIED E, P85; Lennox C, 2016, ROUT INT HANDB, P1; Lesley Elena, 2019, GENOCIDE STUDIES PRE, V13, P91; Leys Ruth, 2002, TRAUMA GENEALOGY; Lindert J, 2017, INT J EPIDEMIOL, V46, P246, DOI 10.1093/ije/dyw161; Lindert Jutta, 2018, MULTIDISCIPLINARY PE, P81; MacDonald DB, 2012, CAN J POLIT SCI, V45, P427, DOI 10.1017/S000842391200039X; MacDonald David B., 2019, SLEEPING GIANT AWAKE, P157; Malabou C, 2012, FORM LIVING, P1; Malabou C., 2012, ONTOLOGY ACCIDENT ES; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Massumi Brian, 2002, PARABLES VIRTUAL, P229; May Larry, 2010, GENOCIDE NORMATIVE A, P88; Meger S, 2016, INT STUD QUART, V60, P149, DOI 10.1093/isq/sqw003; Meger Sara, 2016, RAPE LOOT PILLAGE PO, P5; Meiches Benjamin, 2019, POLITICS ANNIHILATIO; Meierhenrich J, 2007, J GENOCIDE RES, V9, P549, DOI 10.1080/14623520701643327; Milania Nema, 2018, VANDERBILT J TRANSNA, V51, P1381; Miller A, 2017, J PHILOS EDUC, V51, P785, DOI 10.1111/1467-9752.12266; Miller KE, 2015, GENOCIDE AND MASS VIOLENCE: MEMORY, SYMPTOM, AND RECOVERY, P359; Moix B., 2016, GENOCIDE STUDIES PRE, V9, P59, DOI DOI 10.5038/1911-9933.9.3.1313; Moses AD, 2002, PATTERNS PREJUDICE, V36, P7, DOI 10.1080/003132202128811538; Moshman D, 2001, J Genocide Res, V3, P431, DOI 10.1080/14623520120097224; Nixon Rob., 2011, SLOW VIOLENCE ENV PO; Oscar-Berman M, 2003, ALCOHOL RES HEALTH, V27, P125; Panzer A, 2008, Afr J Psychiatry (Johannesbg), V11, P29; Pearlman LA, 2013, J SOC ISSUES, V69, P111, DOI 10.1111/josi.12006; Prilleltensky I, 2008, LIBERATORY PSYCHIATRY: PHILOSOPHY, POLITICS, AND MENTAL HEALTH, P105; Protevi John, 2009, POLITICAL AFFECT CON, P130; Reid-Cunningham A. R., 2008, GENOCIDE STUDIES PRE, V3, P279, DOI [10.1353/gsp.2011.0043, DOI 10.1353/GSP.2011.0043]; Rinck Peter A, 2008, Spectroscopy Europe, V20, P7; Robison Nehemiah, 1960, GENOCIDE CONVENTION; Roscigno R, 2019, EDUC STUD-AESA, V55, P405, DOI 10.1080/00131946.2019.1629929; Rosenberg S., 2012, GENOCIDE STUDIES PRE, V7, P16, DOI 10.3138/gsp.7.1.16; Rothberg Michael, 2019, IMPLICATED SUBJECT V, P8; Rothberg Michael, 2019, IMPLICATED SUBJECT V; Roudinesco Elizabeth, 2003, WHY PSYCHOANALYSIS; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Schabas William, 2012, GENOCIDE INT LAW CRI; Scheffer D., 2006, GENOCIDE STUDIES PRE, V1, P229, DOI DOI 10.3138/E832-0314-6712-60H3; Scheffer David, 2006, GENOCIDE STUDIES PRE, V1, P246; Seth S, 2009, POSTCOLONIAL STUD-UK, V12, P373, DOI 10.1080/13688790903350633; SHAW B, 2007, WHAT IS GENOCIDE, P39; Shaw Martin., 2007, WHAT IS GENOCIDE; Short, 2016, REDEFINING GENOCIDE; Skejelsbaek Inger, 2012, POLITICAL PSYCHOL WA, P98; Smail DL, 2008, ON DEEP HISTORY AND THE BRAIN, P1; Staub E, 2006, POLIT PSYCHOL, V27, P867, DOI 10.1111/j.1467-9221.2006.00541.x; Straus, 2001, J GENOCIDE RES, P349, DOI DOI 10.1080/14623520120097189; Straus Scott., 2015, MAKING UNMAKING NATI; Szutorisz H, 2016, BIOL PSYCHIAT, V80, P730, DOI 10.1016/j.biopsych.2016.08.032; Teicher MH, 2002, SCI AM, V286, P68, DOI 10.1038/scientificamerican0302-68; Theriault HC, 2010, METAPHILOSOPHY, V41, P481, DOI 10.1111/j.1467-9973.2010.01658.x; Viebach J, 2019, INT REV VICT, V25, P277, DOI 10.1177/0269758019833281; Volkan V.D., 2001, GROUP ANAL, V34, P79, DOI [10.1177/05333160122077730, DOI 10.1177/05333160122077730]; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; Weiss B, 2000, ENVIRON HEALTH PERSP, V108, P373, DOI 10.1289/ehp.00108s3373; Weiss -Wendt Anton, 2017, SOVIET UNION GUTTING; Wickens AP, 2015, HIST BRAIN STONE AGE; Williams R, 2007, INT REV PSYCHIATR, V19, P263, DOI 10.1080/09540260701349480; Wise Louise, 2020, INT POLITICAL SOCIOL, DOI [10.1093/ips/olz032, DOI 10.1093/IPS/0LZ032]; Woolford Andrew, 2015, THIS BENEVOLENT EXPT, P261	110	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1462-3528	1469-9494		J GENOCIDE RES	J. Genocide Res.												10.1080/14623528.2021.1911131		APR 2021	22	Political Science	Emerging Sources Citation Index (ESCI)	Government & Law	RY8NU	WOS:000648162800001					2022-02-07	
J	Bian, TY; Meng, W; Qiu, MH; Zhong, ZG; Lin, ZR; Zou, JJ; Wang, YB; Huang, XW; Xu, LS; Yuan, TF; Huang, ZL; Niu, LL; Meng, L; Zheng, HR				Bian, Tianyuan; Meng, Wen; Qiu, Meihong; Zhong, Zhigang; Lin, Zhengrong; Zou, Junjie; Wang, Yibo; Huang, Xiaowei; Xu, Lisheng; Yuan, Tifei; Huang, Zhili; Niu, Lili; Meng, Long; Zheng, Hairong			Noninvasive Ultrasound Stimulation of Ventral Tegmental Area Induces Reanimation from General Anaesthesia in Mice	RESEARCH			English	Article							TRANSCRANIAL FOCUSED ULTRASOUND; LOCUS-COERULEUS; VEGETATIVE STATE; NEURONS; EMERGENCE; THALAMUS; RELEASE; AROUSAL; CORTEX; RATS	Evidence in animals suggests that deep brain stimulation or optogenetics can be used for recovery from disorders of consciousness (DOC). However, these treatments require invasive procedures. This report presents a noninvasive strategy to stimulate central nervous system neurons selectively for recovery from DOC in mice. Through the delivery of ultrasound energy to the ventral tegmental area, mice were aroused from an unconscious, anaesthetized state in this study, and this process was controlled by adjusting the ultrasound parameters. The mice in the sham group under isoflurane-induced, continuous, steady-state general anaesthesia did not regain their righting reflex. On insonation, the emergence time from inhaled isoflurane anaesthesia decreased (sham: 13.63 +/- 0.53 min, ultrasound: 1.5 +/- 0.19 min, p < 0.001). Further, the induction time (sham: 12.0 +/- 0.6 min, ultrasound: 17.88 +/- 0.64 min, p < 0.001) and the concentration for 50% of the maximal effect (EC50) of isoflurane (sham: 0.6%, ultrasound: 0.7%) increased. In addition, ultrasound stimulation reduced the recovery time in mice with traumatic brain injury (sham: 30.38 +/- 1.9 min, ultrasound: 7.38 +/- 1.02 min, p < 0.01). This noninvasive strategy could be used on demand to promote emergence from DOC and may be a potential treatment for such disorders.	[Bian, Tianyuan; Meng, Wen; Lin, Zhengrong; Zou, Junjie; Wang, Yibo; Huang, Xiaowei; Niu, Lili; Meng, Long; Zheng, Hairong] Chinese Acad Sci, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, 1068 Xueyuan Ave, Shenzhen 518055, Peoples R China; [Qiu, Meihong; Zhong, Zhigang; Huang, Zhili] Fudan Univ, Sch Basic Med Sci, Dept Pharmacol, Shanghai 200032, Peoples R China; [Xu, Lisheng] Northeastern Univ, Coll Med & Biol Informat Engn, 195 Innovat Rd, Shenyang 110016, Peoples R China; [Yuan, Tifei] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China		Niu, LL; Meng, L; Zheng, HR (corresponding author), Chinese Acad Sci, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, 1068 Xueyuan Ave, Shenzhen 518055, Peoples R China.	lili.niu@siat.ac.cn; long.meng@siat.ac.cn; hr.zheng@siat.ac.cn	Qiu, Mei-Hong/AAX-4362-2021	Qiu, Mei-Hong/0000-0002-3462-1724	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11904380, 81771430]; Guangdong Grant "Key Technologies for Treatment of Brain Disorders" [2018B030332001, 2018B030331001]; Shenzhen Basic Science Research [JCYJ20200109105622824, JCYJ20200109110006136]; Youth Innovation Promotion Association CAS [2018393, 2020358]	This work was supported by the National Natural Science Foundation of China (Grant No. 11904380, No. 81771430), Guangdong Grant "Key Technologies for Treatment of Brain Disorders" (No. 2018B030332001, No. 2018B030331001), Shenzhen Basic Science Research (JCYJ20200109105622824, JCYJ20200109110006136), and Youth Innovation Promotion Association CAS (2018393, 2020358).	ASTONJONES G, 1981, J NEUROSCI, V1, P876; Au-McCarren H. S., 2013, JOVE-J VIS EXP; Blanchet PJ, 2018, PROG NEURO-PSYCHOPH, V87, P200, DOI 10.1016/j.pnpbp.2017.10.010; Chen SG, 2020, BRAIN STIMUL, V13, P35, DOI 10.1016/j.brs.2019.09.011; Dahan L, 2007, NEUROPSYCHOPHARMACOL, V32, P1232, DOI 10.1038/sj.npp.1301251; Deffieux T, 2013, CURR BIOL, V23, P2430, DOI 10.1016/j.cub.2013.10.029; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Eban-Rothschild A, 2016, NAT NEUROSCI, V19, P1356, DOI 10.1038/nn.4377; F. a. D. A. U.S. Department of Health and Human Services Center for Devices and Radiological Health, 2017, DRAFT GUID IND FOOD; Folloni D., 2018, BIORXIV; Folloni D, 2019, NEURON, V101, P1109, DOI 10.1016/j.neuron.2019.01.019; Fouragnan EF, 2019, NAT NEUROSCI, V22, P797, DOI 10.1038/s41593-019-0375-6; Guo H., 2018, NEURON, V98; Hayat H, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4232; Heffner HE, 2007, J AM ASSOC LAB ANIM, V46, P20; Huang X., 2017, IEEE T ULTRASON FERR, V66, P930; Huang XW, 2019, ULTRASOUND MED BIOL, V45, P1274, DOI 10.1016/j.ultrasmedbio.2018.12.012; Ibsen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9264; Illing RB, 2005, HEARING RES, V206, P185, DOI 10.1016/j.heares.2005.01.016; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kirouac GJ, 2000, AM J PHYSIOL-REG I, V278, pR1643, DOI 10.1152/ajpregu.2000.278.6.R1643; Korotkova TM, 2006, EUR J NEUROSCI, V23, P2677, DOI 10.1111/j.1460-9568.2006.04792.x; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Kubanek J, 2018, J NEUROSCI, V38, P3081, DOI 10.1523/JNEUROSCI.1458-17.2018; Kubanek J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24170; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Legon W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28320-1; Legon W, 2018, HUM BRAIN MAPP, V39, P1995, DOI 10.1002/hbm.23981; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Lin WT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09671; Lin ZR, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201800041; Luo T, 2011, ANESTHESIOLOGY, V115, P36, DOI 10.1097/ALN.0b013e3182207655; Luo T, 2009, ANESTHESIOLOGY, V111, P725, DOI 10.1097/ALN.0b013e3181b061a0; Magnain C, 2014, NEUROIMAGE, V84, P524, DOI 10.1016/j.neuroimage.2013.08.072; Martens G., 2011, BRAIN STIMUL, V11, P982; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Nitz D, 1997, NEUROSCIENCE, V78, P795, DOI 10.1016/S0306-4522(96)00549-0; Niu XD, 2018, CURR OPIN BIOMED ENG, V8, P61, DOI 10.1016/j.cobme.2018.10.004; Nutt DJ, 2007, J CLIN PSYCHIAT, V68, P42; Pillay S, 2011, ANESTHESIOLOGY, V115, P733, DOI 10.1097/ALN.0b013e31822c5ee1; Reed SJ, 2013, BRIT J ANAESTH, V110, P646, DOI 10.1093/bja/aes432; Sato T, 2018, NEURON, V98, P1031, DOI 10.1016/j.neuron.2018.05.009; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Solt K, 2014, ANESTHESIOLOGY, V121, P311, DOI 10.1097/ALN.0000000000000117; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; Taylor NE, 2016, P NATL ACAD SCI USA, V113, P12826, DOI 10.1073/pnas.1614340113; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2010, NAT REV NEUROL, V6, P13, DOI 10.1038/nrneurol.2009.211; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Van Dort CJ, 2009, J NEUROSCI, V29, P871, DOI 10.1523/JNEUROSCI.4111-08.2009; White PJ, 2006, PHYS MED BIOL, V51, P2293, DOI 10.1088/0031-9155/51/9/013; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Ye J, 2018, NANO LETT, V18, P4148, DOI 10.1021/acs.nanolett.8b00935; Yoo SS, 2011, NEUROREPORT, V22, P783, DOI 10.1097/WNR.0b013e32834b2957; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058; Zhang DQ, 2019, IEEE T BIO-MED ENG, V66, P411, DOI 10.1109/TBME.2018.2845689; Zhou H, 2019, IEEE T BIO-MED ENG, V66, P3006, DOI 10.1109/TBME.2019.2899631	61	0	0	6	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA		2639-5274		RESEARCH-CHINA	Research	APR 12	2021	2021								2674692	10.34133/2021/2674692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RQ7YB	WOS:000642629400001	33954291	gold, Green Published			2022-02-07	
J	Li, Y; Huang, JR; Huang, T; Tang, J; Zhang, WY; Xu, WL; Wang, N; Deng, YB; Yu, X; Xu, L				Li, Ye; Huang, Jingrui; Huang, Tao; Tang, Jie; Zhang, Wenyao; Xu, Wenlong; Wang, Ning; Deng, Yongbing; Yu, Xing; Xu, Lei			Wearable Mixed-Reality Holographic Navigation Guiding the Management of Penetrating Intracranial Injury Caused by a Nail	JOURNAL OF DIGITAL IMAGING			English	Article						3D slicer; Mixed-reality; Navigation; Penetrating foreign body		Penetrating brain injury caused by a nail is an extremely rare neurosurgical emergency that poses a challenge for neurosurgeons. Nail entering the brain from the orbit and lodging within the cranial cavity is even more unusual. A 53-year-old male was found unconscious at a construction site, and brain CT revealed not only the presence of a nail beneath the inner table of the parietal bone, but also traumatic intracerebral hematoma. Consequently, accurate localization of the nail and hematoma was mandatory for surgical plan. During surgical planning, computational model reconstruction and trajectory calculation were completed using preoperative CT in 3D Slicer. Under the guidance of a head-mounted mixed-reality holographic computer, the neurosurgeon was able to visualize and interact with the hologram of the surgical plan, and intraoperative findings demonstrated that our low-cost portable wearable mixed-reality holographic navigation assisted precise localization of the nail and intracerebral hematoma, assuring less injury to the already compromised brain. After the surgery, the patient could obey commands, and postoperative imaging ruled out the possibility of brain abscess during follow-up. To the best of our knowledge, this is the first report on using a low-cost wearable mixed-reality holographic navigation to guide the management of penetrating intracranial injury caused by a nail.	[Li, Ye; Tang, Jie; Xu, Wenlong; Wang, Ning] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China; [Huang, Jingrui; Huang, Tao; Deng, Yongbing; Yu, Xing; Xu, Lei] Chongqing Emergency Med Ctr, Dept Neurosurg, Chongqing, Peoples R China; [Zhang, Wenyao] Beijing Inst Technol, Sch Comp Sci, Beijing Key Lab Intelligent Informat Technol, Beijing, Peoples R China		Wang, N (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.	ningjing_wd@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701796]; Capital Health Research and Development of Special [2020-2Z-2019]; China Scholarship Council (CSC)China Scholarship Council [201406200059]; Chongqing Science and Health Joint Medical Research Project [2020MSXM078]	This work was supported by the National Natural Science Foundation of China (81701796), Capital Health Research and Development of Special (2020-2Z-2019), the China Scholarship Council (CSC No. 201406200059), and Chongqing Science and Health Joint Medical Research Project (2020MSXM078).	Boubacar A, 2017, J NEUROLOGY STROKE, V7; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Li Y, 2020, J TRANSP SAF SECUR, V12, P358, DOI 10.1080/19439962.2018.1483989; Miki K, 2019, WORLD NEUROSURG, V127, P442, DOI 10.1016/j.wneu.2019.04.161; Nussbaum ES, 2019, BRIT J NEUROSURG, DOI 10.1080/02688697.2019.1698013; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Wu RH, 2018, WORLD NEUROSURG, V112, P143, DOI [10.1016/J.WNEU.2018.01.127, 10.1016/j.wneu.2018.01.127]	7	0	1	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0897-1889	1618-727X		J DIGIT IMAGING	J. Digit. Imaging	APR	2021	34	2			SI		362	366		10.1007/s10278-021-00436-3		APR 2021	5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	TL2BE	WOS:000639501900001	33846887				2022-02-07	
J	Morin, A; Mouzon, B; Ferguson, S; Paris, D; Saltiel, N; Browning, M; Mullan, M; Crawford, F				Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Saltiel, Nicole; Browning, Mackenzie; Mullan, Mike; Crawford, Fiona			A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice	SCIENTIFIC REPORTS			English	Article							WHITE-MATTER DEGENERATION; TAU PATHOLOGY; AXONAL INJURY; GRAY-MATTER; MEMORY; DAMAGE; CONSEQUENCES; PREVENTION; DEFICITS	To date, an overwhelming number of preclinical studies have addressed acute treatment in mild TBI (mTBI) and repetitive mTBI (r-mTBI), whereas, in humans, there often exists a significant time gap between the injury and the first medical intervention. Our study focused on a delayed treatment with anatabine, an anti-inflammatory compound, in hTau mice using two different models of r-mTBI. The rationale for using two models of the same impact but different frequencies (5 hit mTBI over 9 days and 24 hit mTBI over 90 days) was chosen to address the heterogeneity of r-mTBI in clinical population. Following the last injury in each model, three months elapsed before the initiation of treatment. Anatabine was administered in drinking water for 3 months thereafter. Our data demonstrated that a 3-month delayed treatment with anatabine mitigated astrogliosis in both TBI paradigms but improved cognitive functions only in more-frequently-injured mice (24 hit mTBI). We also found that anatabine decreased the phosphorylation of tau protein and NF kappa B, which were increased after r-mTBI in both models. The ability of anatabine to suppress these mechanisms suggests that delayed treatment can be effective for clinical population of r-mTBI. The discrepancy between the two models with regard to changes in cognitive performance suggests that r-mTBI heterogeneity may influence treatment efficiency and should be considered in therapeutic development.	[Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Saltiel, Nicole; Browning, Mackenzie; Mullan, Mike; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Mullan, Mike; Crawford, Fiona] Open Univ, Milton Keynes, Bucks, England; [Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Saltiel, Nicole; Crawford, Fiona] James A Haley Vet Adm, Tampa, FL 33612 USA		Morin, A (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.; Morin, A (corresponding author), Open Univ, Milton Keynes, Bucks, England.; Morin, A (corresponding author), James A Haley Vet Adm, Tampa, FL 33612 USA.	amorin@roskampinstitute.net		Morin, Alexander/0000-0002-2895-985X	Department of Veterans Affairs VA MeritUS Department of Veterans Affairs [I01RX002334]; Roskamp Institute	This work was supported by the Department of Veterans Affairs VA Merit [I01RX002334 (PI: F. Crawford)] and by the Roskamp Institute. The contents do not represent the views of the Department of Veterans Affairs, or the United States Government.	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Levin ED, 2014, J PSYCHOPHARMACOL, V28, P915, DOI 10.1177/0269881114543721; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meythaler J, 2019, BRAIN INJURY, V33, P679, DOI 10.1080/02699052.2019.1566968; Morin A, 2020, THERAPEUTIC TARGET I, DOI [10.1038/s41598-021-87161-7, DOI 10.1038/S41598-021-87161-7]; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nennig SE, 2017, ALCOHOL ALCOHOLISM, V52, P172, DOI 10.1093/alcalc/agw098; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Paris D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055392; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Robertson CS, 2017, J NEUROTRAUM, V34, P1394, DOI 10.1089/neu.2016.4717; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Verma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134776; Zalcman G, 2015, NEUROBIOL LEARN MEM, V119, P10, DOI 10.1016/j.nlm.2014.12.013	47	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 12	2021	11	1							7900	10.1038/s41598-021-87161-7			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN6AP	WOS:000640434400033	33846461	Green Published, gold			2022-02-07	
J	Sameh, G; Islem, F; Samar, A; Hedi, C; Mounir, B; Habib, EM				Sameh, Ghroubi; Islem, Feki; Samar, Alila; Hedi, Chelly; Mounir, Bouaziz; Habib, Elleuch Mohamed			Neuropsychological and behavioral disorders, functional outcomes and quality of life in traumatic brain injury victims	PAN AFRICAN MEDICAL JOURNAL			English	Article						Traumatic brain injury; neuropsychological disorders; behavioral disorders; functional outcomes; patients	HEAD-INJURY; FOLLOW-UP; SCALE; REHABILITATION; CLASSIFICATION; CONCUSSION; COGNITION; RECOVERY; DAMAGE; TIME	Introduction: the assessment of neuropsychological and behavioral disorders outcomes, functional outcomes and quality of life in traumatic brain injury victims. It was also to evaluate initial means of care provided to these patients. Finally, to study correlations between neuropsychological and behavioral disorders with demographic characteristics, injury severity, functional status and quality of life. Methods: it was a cross-sectional study including 50 patients with traumatic brain injury conducted in the physical medicine and rehabilitation department of Sfax. Memory disorders were tested by the mini mental state and the Glaveston orientation and amnesia tests. Executive functions were evaluated by the dysexecutive function scale. The psychological profile was evaluated using the hospital anxiety and depression scale and behavioral disorders were tested by the agitated behavior scale. Glasgow outcome scale has allowed the assessment of traumatic brain injury severity in terms of disability. Otherwise, functional capacity was measured by functional independence measure scale. Finally, health-related quality of life was measured using a generic measure (short-form-36) and the QOLIBRI scales. Results: abnormal executive functions were noted in 41 patients (82%) with a dysexcutive function average score of 33.20 +/- 22.74. About psychological profile, depressive symptoms were found in 32 patients (64%). Moreover anxiety was noted in 20 patients (40%). Behavioral disorders such as aggressiveness and agitation were noted respectively in 32 (64%) and 8 patients (16%). The global social functional evolution was considered as unfavorable in 42% of the patients and favorable in 58%. Regarding to functional independence measure scale, 92% of the victims showed impairment. Memory impairment and abnormal executive functions were statistically correlated with traumatic brain injury severity. Elementary brain injury lesions shown on computed tomography were correlated with memory disorders especially for temporal, cortical brain contusion and diffuse axonal injury. Our study showed that patients with severe memory impairment, abnormal executive functions and depressive mood had significant functional. Conclusion: the executive function disorders, depressed mood and the memory disorders seemed to be the most frequent among neuropsychological disorders in traumatic brain injury. We noted that it is so important to evaluate neuropsychological disorders in traumatic brain injury because they were underestimated. We have already started this experience despite the lack of means in our department. The evaluation of the executive function in addition to the classic neuropsychological assessment is essential to propose efficient means of rehabilitation.	[Sameh, Ghroubi; Islem, Feki; Samar, Alila; Habib, Elleuch Mohamed] Univ Hosp Ctr Habib Bourguiba, Phys Med & Rehabil Dept, Sfax, Tunisia; [Hedi, Chelly; Mounir, Bouaziz] Univ Hosp Ctr Habib Bourguiba, Reanimat Dept, Sfax, Tunisia		Habib, EM (corresponding author), Univ Hosp Ctr Habib Bourguiba, Phys Med & Rehabil Dept, Sfax, Tunisia.	habib.eleuch@ymail.com					Alaoui P., 1998, Annales de Readaptation et de Medecine Physique, V41, P171, DOI 10.1016/S0168-6054(98)80001-9; Allouche C, 2007, INDICE SF36 QUALITE; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Annoni JM, 2002, ARCH NEURO PSYCHIATR, V153, P354; Azouvi P, 2007, PRISE CHARGE TRAUMAT; Azouvi P, 2008, FONCTIONS EXECUTIVES, P65; Bedjaoui M, 1986, REEDUCATION TRAUMATI; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Chevignard M., 2008, Annales de Readaptation et de Medecine Physique, V51, P74, DOI 10.1016/j.annrmp.2007.10.008; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Coyette F., 2007, PRISE CHARGE TRAUMAT, P94; Darnoux E, 2011, ANN PHYS REHABIL MED, V54, P20; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Deb S, 1999, AM J PSYCHIAT, V156, P374; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; JENNETT B, 1975, LANCET, V1, P480; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kozlowski O., 2002, Annales de Readaptation et de Medecine Physique, V45, P466, DOI 10.1016/S0168-6054(02)00297-0; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Gall C., 2007, Annales de Readaptation et de Medecine Physique, V50, P5, DOI 10.1016/j.annrmp.2006.06.007; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; MINAIRE P, 1986, Annales de Readaptation et de Medecine Physique, V28, P409; Peskine A, 2007, FONCTIONS EXECUTIVES, P65; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Vallat-Azouvi C, 2007, REV NEUROL-FRANCE, V163, P210; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	0	0	1	1	AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET	KAMPALA	PO BOX 12874, KAMPALA, 00000, UGANDA	1937-8688			PAN AFR MED J	Pan Afr. Med. J.	APR 11	2021	38								346	10.11604/pamj.2021.38.346.16120			17	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	UO6LL	WOS:000694804700001	34367425	gold, Green Published			2022-02-07	
J	Anwer, F; Oliveri, F; Kakargias, F; Panday, P; Franchini, APA; Iskander, B; Hamid, P				Anwer, Fatima; Oliveri, Federico; Kakargias, Fotios; Panday, Priyanka; Franchini, Ana P. Arcia; Iskander, Beshoy; Hamid, Pousette			Post-Traumatic Seizures: A Deep-Dive Into Pathogenesis	CUREUS			English	Article						trauma and epilepsy; brain injury and seizure; head injury and epilepsy; post-traumatic epilepsy; motor vehicle accident and epilepsy; post-traumatic seizure	TRAUMATIC BRAIN-INJURY; ACTIVATION; ASTROCYTES; EXPRESSION; EPILEPSY	Post-traumatic seizures (PTS) have become an emerging challenge for neurologists worldwide with the rise of brain injuries. Trauma can lead to various outcomes, ranging from naive spasms to debilitating post-traumatic epilepsy (PTE). In this article, we will explore the pathogenesis of convulsions following a concussion. We will look at multiple studies to explain the various structural, metabolic, and inflammatory changes leading to seizures. Additionally, we will explore the association between severity and location of injury and PTE. PTE's pathophysiology is not entirely implicit, and we are still in the dark as to which anti-epileptic drugs will be useful in circumventing these attacks. The purpose of this narrative review is to explain the post-traumatic brain changes in detail so that such attacks can be either thwarted or treated more resourcefully in the future.	[Anwer, Fatima; Kakargias, Fotios; Panday, Priyanka; Franchini, Ana P. Arcia] Calif Inst Behav Neurosci & Psychol, Res, Fairfield, CT USA; [Oliveri, Federico] Calif Inst Behav Neurosci & Psychol, Cardiol, Fairfield, CT USA; [Iskander, Beshoy] Calif Inst Behav Neurosci & Psychol, Internal Med, Fairfield, CT USA; [Hamid, Pousette] Calif Inst Behav Neurosci & Psychol, Neurol, Fairfield, CT USA		Anwer, F (corresponding author), Calif Inst Behav Neurosci & Psychol, Res, Fairfield, CT USA.	fatimaanwar47@gmail.com					Agoston DV, 2019, NEUROBIOL DIS, V123, P59, DOI 10.1016/j.nbd.2018.07.017; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Dadas A, 2019, NEUROBIOL DIS, V123, P20, DOI 10.1016/j.nbd.2018.06.022; Danzer SC, 2019, EPILEPSY CURR, V19, P261, DOI 10.1177/1535759719854758; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Fang WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01868-0; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Jackson EK, 2016, J NEUROCHEM, V137, P142, DOI 10.1111/jnc.13551; Jarero-Basulto JJ, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010017; Jiang JX, 2019, NEUROPHARMACOLOGY, V149, P149, DOI 10.1016/j.neuropharm.2019.02.011; Kim SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07394-3; Koenig JB, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126506; Koenig JB, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00350; Lutkenhoff ES, 2020, J NEUROL NEUROSUR PS, V91, P1154, DOI 10.1136/jnnp-2020-322780; Newell EA, 2015, BRAIN RES, V1594, P27, DOI 10.1016/j.brainres.2014.10.059; Newell-Rogers MK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207448; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Sharma R, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110318; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Spencer R, 2019, SEIZURE-EUR J EPILEP, V69, P11, DOI 10.1016/j.seizure.2019.03.014; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Vielhaber S, 2003, EPILEPSIA, V44, P193, DOI 10.1046/j.1528-1157.2003.38102.x; Viviani B, 2003, J NEUROSCI, V23, P8692; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Xu SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01149; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651	30	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	APR 10	2021	13	4							e14395	10.7759/cureus.14395			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RL9NZ	WOS:000639291500001	33987052	Green Published, gold			2022-02-07	
J	Matveychuk, D; MacKenzie, EM; Kumpula, D; Song, MS; Holt, A; Kar, S; Todd, KG; Wood, PL; Baker, GB				Matveychuk, Dmitriy; MacKenzie, Erin M.; Kumpula, David; Song, Mee-Sook; Holt, Andrew; Kar, Satyabrata; Todd, Kathryn G.; Wood, Paul L.; Baker, Glen B.			Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Phenelzine; Monoamine oxidase; &#946; -Phenylethylidenehydrazine; Neuroprotection; &#947; -Aminobutyric acid; Reactive aldehydes	REACTIVE ALDEHYDES; LOAD	Phenelzine (PLZ) is a monoamine oxidase (MAO)-inhibiting antidepressant with anxiolytic properties. This multifaceted drug has a number of pharmacological and neurochemical effects in addition to inhibition of MAO, and findings on these effects have contributed to a body of evidence indicating that PLZ also has neuroprotective/neurorescue properties. These attributes are reviewed in this paper and include catabolism to the active metabolite beta-phenylethylidenehydrazine (PEH) and effects of PLZ and PEH on the GABA-glutamate balance in brain, sequestration of reactive aldehydes, and inhibition of primary amine oxidase. Also discussed are the encouraging findings of the effects of PLZ in animal models of stroke, spinal cord injury, traumatic brain injury, and multiple sclerosis, as well other actions such as reduction of nitrative stress, reduction of the effects of a toxin on dopaminergic neurons, potential anticonvulsant actions, and effects on brain-derived neurotrophic factor, neural cell adhesion molecules, an anti-apoptotic factor, and brain levels of ornithine and N-acetylamino acids.	[Matveychuk, Dmitriy; MacKenzie, Erin M.; Kumpula, David; Song, Mee-Sook; Holt, Andrew; Kar, Satyabrata; Todd, Kathryn G.; Baker, Glen B.] Univ Alberta, Dept Psychiat, Neurochem Res Unit, 12-105B Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada; [Song, Mee-Sook] Altos Biol, Seoul, South Korea; [Kar, Satyabrata] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Wood, Paul L.] Lincoln Mem Univ, Coll Vet Med, Harrogate, TN USA		Baker, GB (corresponding author), Univ Alberta, Dept Psychiat, Neurochem Res Unit, 12-105B Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada.	glen.baker@ualberta.ca		Baker, Glen/0000-0003-1581-6486	CIHRCanadian Institutes of Health Research (CIHR) [MOP86712]; University of AlbertaUniversity of Alberta; CIHR Doctoral Research AwardCanadian Institutes of Health Research (CIHR)	The authors are grateful for funding from CIHR (MOP86712, Phenylalkylhydrazine Drugs and Neuroprotection, GBB and KGT) and the University of Alberta. GBB held a TRIP Research Allowance from the Faculty of Medicine and Dentistry. DM held a CIHR Doctoral Research Award.	Aarre TF, 2003, NORD J PSYCHIAT, V57, P313, DOI 10.1080/08039480310002110; ADOLFSSON R, 1980, LIFE SCI, V27, P1029, DOI 10.1016/0024-3205(80)90025-9; Agostinelli E, 2010, AMINO ACIDS, V38, P353, DOI 10.1007/s00726-009-0431-8; Airas L, 2008, NEUROPATH APPL NEURO, V34, P394, DOI 10.1111/j.1365-2990.2007.00911.x; Al-Nuaimi SK, 2012, AM J THER, V19, P436, DOI 10.1097/MJT.0b013e31825b9eb5; Baillet A, 2010, NEUROCHEM RES, V35, P1530, DOI 10.1007/s11064-010-0212-5; Baker G, 2010, P JOINT ANN M CAND C; BAKER GB, 1991, J AFFECT DISORDERS, V21, P207, DOI 10.1016/0165-0327(91)90041-P; Baker GB, 2002, P 23 C COLL INT NEIU; Baker G, 2019, CHEM-BIOL INTERACT, V304, P139, DOI 10.1016/j.cbi.2019.03.003; Baker GB, 2012, KLIN PSIKOFARMAKOL B, V22, P293, DOI 10.5455/bcp.20121030014051; Balu DT, 2008, BRAIN RES, V1211, P37, DOI 10.1016/j.brainres.2008.03.023; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benson CA, 2013, BEHAV BRAIN RES, V252, P302, DOI 10.1016/j.bbr.2013.06.019; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Blier Pierre, 2016, J Clin Psychiatry, V77, pe319, DOI 10.4088/JCP.13097tx3c; Bourdon AK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29511-6; Bradley MA, 2010, FREE RADICAL BIO MED, V48, P1570, DOI 10.1016/j.freeradbiomed.2010.02.016; Buckley PF, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1050-z; BUIGUES J, 1987, J CLIN PSYCHIAT, V48, P55; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Butler B, 2017, J NEUROL SCI, V379, P29, DOI 10.1016/j.jns.2017.05.039; Cagle Brianna S., 2019, Current Opinion in Toxicology, V13, P16, DOI 10.1016/j.cotox.2018.12.002; Cai ZY, 2014, MOL MED REP, V9, P1533, DOI 10.3892/mmr.2014.2040; CALABRESE V, 1994, INT J CLIN PHARM RES, V14, P119; Cardenas-Rodriguez N, 2013, INT J MOL SCI, V14, P1455, DOI 10.3390/ijms14011455; Casado A, 2008, NEUROCHEM RES, V33, P450, DOI 10.1007/s11064-007-9453-3; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chen AT, 2019, SCHIZOPHR RES, V208, P1, DOI 10.1016/j.schres.2019.04.009; Chen Che-Hong, 2016, Acta Neurol Taiwan, V25(4), P111; Chen CM, 2009, NEUROBIOL DIS, V33, P429, DOI 10.1016/j.nbd.2008.11.011; Chen K, 2006, J NEUROCHEM, V99, P1413, DOI 10.1111/j.1471-4159.2006.04181.x; Chen Z, 2016, J NEUROCHEM, V138, P328, DOI 10.1111/jnc.13639; CLINESCHMIDT BV, 1969, BIOCHEM PHARMACOL, V18, P1021, DOI 10.1016/0006-2952(69)90105-1; CLINESCHMIDT BV, 1969, BIOCHEM PHARMACOL, V18, P1011, DOI 10.1016/0006-2952(69)90104-X; Cohen SM, 2015, SCHIZOPHR RES, V167, P98, DOI 10.1016/j.schres.2014.12.026; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Dalfo E, 2008, NEUROBIOL AGING, V29, P408, DOI 10.1016/j.neurobiolaging.2006.10.022; Dang Thanh Nam, 2010, Curr Mol Pharmacol, V3, P66; DAVIDSON J, 1987, J CLIN PSYCHIAT, V48, P143; DELMAR HM, 2005, NEUROSCI LETT, V384, P183; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Dewhurst WG., 1985, PHARMACOTHERAPY AFFE, P1; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Dodd S, 2008, INT J NEUROPSYCHOPH, V11, P179; Due MR, 2014, J NEUROCHEM, V128, P776, DOI 10.1111/jnc.12500; Duffy S, 2004, NEUROSCIENCE, V126, P423, DOI 10.1016/j.neuroscience.2004.03.007; Dwivedi Y, 2006, NEUROSCIENCE, V139, P1017, DOI 10.1016/j.neuroscience.2005.12.058; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foerster BR, 2013, JAMA NEUROL, V70, P1009, DOI 10.1001/jamaneurol.2013.234; Fowler JS, 1997, NEUROBIOL AGING, V18, P431, DOI 10.1016/S0197-4580(97)00037-7; Fowler JS, 2002, METHODS, V27, P263, DOI 10.1016/S1046-2023(02)00083-X; Fred SM, 2019, J BIOL CHEM, V294, P18150, DOI 10.1074/jbc.RA119.008837; Gerlach M, 1996, NEUROLOGY, V47, pS137, DOI 10.1212/WNL.47.6_Suppl_3.137S; Gillman PK, 2018, J NEURAL TRANSM, V125, P1707, DOI 10.1007/s00702-018-1932-y; Gomez-Ramos A, 2003, J NEUROSCI RES, V71, P863, DOI 10.1002/jnr.10525; Green AR, 2000, NEUROPHARMACOLOGY, V39, P1483, DOI 10.1016/S0028-3908(99)00233-6; Greilberger J, 2008, FREE RADICAL RES, V42, P633, DOI 10.1080/10715760802255764; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Gubisne-Haberle D, 2004, J PHARMACOL EXP THER, V310, P1125, DOI 10.1124/jpet.104.068601; Gunther L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120891; Gustaw-Rothenberg K, 2010, GERIATR GERONTOL INT, V10, P161, DOI 10.1111/j.1447-0594.2009.00571.x; Hill RL, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113322; Hill RL, 2019, J NEUROTRAUM, V36, P1231, DOI 10.1089/neu.2018.5946; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hogard ML, 2017, ANAL METHODS-UK, V9, P1848, DOI 10.1039/c6ay03327j; Holt A, 2004, NEUROTOXICOLOGY, V25, P251, DOI 10.1016/S0161-813X(03)00104-9; Holt A, 2006, NAT PROTOC, V1, P2498, DOI 10.1038/nprot.2006.402; HORITA A, 1965, BRIT J PHARM CHEMOTH, V24, P245, DOI 10.1111/j.1476-5381.1965.tb02100.x; Horvath A, 2017, SCI REP-UK, V7, DOI 10.1038/srep39863; HOUEN G, 1994, ACTA CHEM SCAND, V48, P52, DOI 10.3891/acta.chem.scand.48-0052; Huang YJ, 2013, TOXICOL LETT, V217, P184, DOI 10.1016/j.toxlet.2012.12.023; Hunsberger Joshua, 2009, Dialogues Clin Neurosci, V11, P333; HUNTER MIS, 1985, NEUROCHEM RES, V10, P1645, DOI 10.1007/BF00988606; Ilic TV, 1999, FUNCT NEUROL, V14, P141; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; Jarnicki AG, 2016, BRIT J PHARMACOL, V173, P3161, DOI 10.1111/bph.13573; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Jiang ZJ, 2008, NEUROPATH APPL NEURO, V34, P194, DOI 10.1111/j.1365-2990.2007.00886.x; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Joseph TP, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00458; JOSSAN SS, 1989, BRAIN RES, V476, P291, DOI 10.1016/0006-8993(89)91249-3; JOSSAN SS, 1991, NEUROSCIENCE, V45, P1, DOI 10.1016/0306-4522(91)90098-9; Garcia-Fuster MJ, 2016, PSYCHOPHARMACOLOGY, V233, P2955, DOI 10.1007/s00213-016-4342-6; Ketter TA, 2003, J CLIN PSYCHIAT, V64, P15; Khoramjouy M, 2021, NEUROTOX RES, V39, P277, DOI 10.1007/s12640-020-00278-x; Kim YS, 2017, EXP NEUROBIOL, V26, P122, DOI 10.5607/en.2017.26.3.122; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Kuhla B, 2007, J BIOL CHEM, V282, P6984, DOI 10.1074/jbc.M609521200; Kulbe JR, 2018, J NEUROTRAUM, V35, P1280, DOI 10.1089/neu.2017.5353; Lee CS, 2003, NEUROCHEM RES, V28, P1833, DOI 10.1023/A:1026119708124; Lee SE, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/629028; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Li R, 2018, PHARMACOL BIOCHEM BE, V171, P30, DOI 10.1016/j.pbb.2018.05.013; Li XH, 2012, NEUROMOL MED, V14, P338, DOI 10.1007/s12017-012-8191-0; Li XM, 2007, INT REV NEUROBIOL, V77, P107, DOI 10.1016/S0074-7742(06)77004-0; Lieberman JA, 2008, PHARMACOL REV, V60, P358, DOI 10.1124/pr.107.00107; LIEBOWITZ MR, 1988, J CLIN PSYCHIAT, V49, P252; Lin YZ, 2018, NEUROSCIENCE, V384, P120, DOI 10.1016/j.neuroscience.2018.05.029; Liu XY, 1996, DEMENTIA, V7, P128, DOI 10.1159/000106867; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P219, DOI 10.1002/jnr.20862; Lizcano JM, 1996, BIOCHEM PHARMACOL, V52, P187, DOI 10.1016/0006-2952(96)00132-3; Pedre LL, 2018, BEHAV SCI, V8, DOI 10.3390/bs8060059; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; LYLES G A, 1990, Journal of Pharmacy and Pharmacology, V42, P332; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Lyles GA, 1996, INT J BIOCHEM CELL B, V28, P259, DOI 10.1016/1357-2725(95)00130-1; Ma QY, 2011, J CEREBR BLOOD F MET, V31, P881, DOI 10.1038/jcbfm.2010.167; MacKenzie EM, 2009, NEUROCHEMICAL NEUROP; MacKenzie EM, 2008, BIOORGAN MED CHEM, V16, P8254, DOI 10.1016/j.bmc.2008.07.027; MacKenzie EM, 2008, NEUROCHEM RES, V33, P430, DOI 10.1007/s11064-007-9448-0; MacKenzie EM, 2010, KLIN PSIKOFARMAKOL B, V20, P179, DOI 10.1080/10177833.2010.11790656; Magyar K, 2004, NEUROTOXICOLOGY, V25, P233, DOI 10.1016/S0161-813X(03)00102-5; Manzoor S, 2020, EUR J MED CHEM, V206, DOI 10.1016/j.ejmech.2020.112787; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Martin-Aragon S, 2009, NEUROCHEM RES, V34, P373, DOI 10.1007/s11064-008-9789-3; Masato A, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0332-6; Matveychuk D, 2015, NOVEL PROPERTIES MUL; Matveychuk D, 2013, J NEURAL TRANSM, V120, P987, DOI 10.1007/s00702-013-0978-0; Matveychuk D, 2011, KLIN PSIKOFARMAKOL B, V21, P277, DOI 10.5455/bcp.19691231040000; MCGRATH PJ, 1986, J CLIN PSYCHIAT, V47, P420; McKenna K F, 1994, J Neural Transm Suppl, V41, P115; Mifflin KA, 2016, J PAIN, V17, P483, DOI 10.1016/j.jpain.2015.12.013; Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233; Musgrave T, 2011, BRAIN BEHAV IMMUN, V25, P1677, DOI 10.1016/j.bbi.2011.06.011; Mustafa AG, 2018, EXP THER MED, V16, P2132, DOI 10.3892/etm.2018.6419; Mustafa AG, 2018, ARCH PHYSIOL BIOCHEM, V124, P418, DOI 10.1080/13813455.2017.1415939; Naylor DE, 2010, EPILEPSIA, V51, P106, DOI 10.1111/j.1528-1167.2010.02622.x; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Niemann B, 2017, J AM COLL CARDIOL, V70, P230, DOI 10.1016/j.jacc.2017.05.043; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; O'Rourke AM, 2007, J NEURAL TRANSM, V114, P845, DOI 10.1007/s00702-007-0699-3; Olowe R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100990; ORELAND L, 1986, PROG NEURO-PSYCHOPH, V10, P533, DOI 10.1016/0278-5846(86)90023-0; Ou JJ, 2002, EXP NEUROL, V175, P363, DOI 10.1006/exnr.2002.7923; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; Pannecoeck R, 2015, CRIT REV CL LAB SCI, V52, P284, DOI 10.3109/10408363.2015.1050714; Panneton WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015251; Park JH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0316; Park J, 2015, J NEUROCHEM, V135, P987, DOI 10.1111/jnc.13352; Paslawski T, 2001, DRUG DEVELOP RES, V54, P35, DOI 10.1002/ddr.1202; Paslawski TM, 1995, PROG BRAIN RES, V106, P181; PATEK DR, 1974, J BIOL CHEM, V249, P2373; Perluigi M, 2012, ANTIOXID REDOX SIGN, V17, P1590, DOI 10.1089/ars.2011.4406; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; POPOV N, 1969, J NEUROCHEM, V16, P899, DOI 10.1111/j.1471-4159.1969.tb08978.x; Potter LE, 2018, NEUROSCIENCE, V383, P205, DOI 10.1016/j.neuroscience.2018.04.047; Potter LE, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0609-4; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Quartey MO, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00419; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; REINIKAINEN KJ, 1988, NEUROBIOL AGING, V9, P245, DOI 10.1016/S0197-4580(88)80061-7; Ribaudo G, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080714; Riederer P, 2004, NEUROTOXICOLOGY, V25, P271, DOI 10.1016/S0161-813X(03)00106-2; Riederer P, 1987, Adv Neurol, V45, P111; ROBINSON DS, 1985, J CLIN PSYCHOPHARM, V5, P333, DOI 10.1097/00004714-198505060-00005; Romano A, 2017, FREE RADICAL BIO MED, V111, P281, DOI 10.1016/j.freeradbiomed.2016.12.046; Ruiz P., 2009, KAPLAN SADOCKS COMPR, P3154; Sa JM, 2019, NEUROSCI LETT, V694, P51, DOI 10.1016/j.neulet.2018.11.023; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SAURA J, 1994, NEUROSCIENCE, V62, P15, DOI 10.1016/0306-4522(94)90311-5; Schain M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0733-2; Schedin-Weiss S, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0279-1; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serra JA, 2009, NEUROCHEM RES, V34, P2122, DOI 10.1007/s11064-009-9997-5; Shadfar S, 2018, MOL NEUROBIOL, V55, P554, DOI 10.1007/s12035-016-0342-0; Shamoto-Nagai M, 2007, J NEURAL TRANSM, V114, P1559, DOI 10.1007/s00702-007-0789-2; Shanahan P, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12697; SHEEHAN DV, 1980, ARCH GEN PSYCHIAT, V37, P51; Shemyakov SE, 2001, B EXP BIOL MED+, V131, P586, DOI 10.1023/A:1012371106766; SHERIF F, 1992, J NEURAL TRANSM-PARK, V4, P227, DOI 10.1007/BF02260906; Shi R, 2015, FREE RADICAL RES, V49, P888, DOI 10.3109/10715762.2015.1021696; Shi YZ, 2011, J NEUROCHEM, V117, P554, DOI 10.1111/j.1471-4159.2011.07226.x; Shuaib A, 1997, HISTOL HISTOPATHOL, V12, P185; SHUAIB A, 1992, BRAIN RES, V590, P13, DOI 10.1016/0006-8993(92)91076-Q; Shuaib A, 1997, EXP NEUROL, V147, P311, DOI 10.1006/exnr.1997.6588; Sinem F, 2010, CURR ALZHEIMER RES, V7, P463, DOI 10.2174/156720510791383822; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Song MS, 2013, PROG NEURO-PSYCHOPH, V44, P118, DOI 10.1016/j.pnpbp.2013.02.001; Song MS, 2010, J NEUROCHEM, V114, P1405, DOI 10.1111/j.1471-4159.2010.06857.x; Sowa B, 2005, BIOORGAN MED CHEM, V13, P4389, DOI 10.1016/j.bmc.2005.04.072; Sowa Bernard N., 2004, Current Neuropharmacology, V2, P153, DOI 10.2174/1570159043476800; Sowa BN, 2003, J NEUROCHEM, V85, P10; SPARKS DL, 1991, ARCH NEUROL-CHICAGO, V48, P718, DOI 10.1001/archneur.1991.00530190064017; Stolen CM, 2004, CIRC RES, V95, P50, DOI 10.1161/01.RES.0000134630.68877.2F; Stumm RK, 2001, J NEUROSCI, V21, P798, DOI 10.1523/JNEUROSCI.21-03-00798.2001; Sturm S, 2017, EUR J NUCL MED MOL I, V44, P382, DOI 10.1007/s00259-016-3510-6; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Sydserff SG, 2000, BRAIN RES, V862, P59, DOI 10.1016/S0006-8993(00)02071-0; Szoko E, 2018, J NEURAL TRANSM, V125, P1735, DOI 10.1007/s00702-018-1853-9; Tabi T, 2020, J NEURAL TRANSM, V127, P831, DOI 10.1007/s00702-019-02082-0; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Taso O.V., 2019, ANN RES HOSP, V3, P1, DOI [10.21037/arh.2018.12.02, DOI 10.21037/ARH.2018.12.02]; Tatton W, 2003, J NEURAL TRANSM, V110, P509, DOI 10.1007/s00702-002-0827-z; TIPTON KF, 1972, BIOCHEM PHARMACOL, V21, P268, DOI 10.1016/0006-2952(72)90278-X; TIPTON KF, 1972, BIOCHEM J, V128, P913, DOI 10.1042/bj1280913; TIPTON KF, 1971, BIOCHEM J, V121, pP33, DOI 10.1042/bj1210033P; Todd KG, 2008, J PHARM PHARM SCI, V11, P14, DOI 10.18433/J34S38; Todd KG, 1995, J AFFECT DISORDERS, V35, P125, DOI 10.1016/0165-0327(95)00056-9; Todd KG, 1999, J NEUROCHEM, V73, pS202; Troubat R, 2021, EUR J NEUROSCI, V53, P151, DOI 10.1111/ejn.14720; Tully M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00420; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Unzeta M, 2007, J NEURAL TRANSM, V114, P857, DOI 10.1007/s00702-007-0701-0; Valente T, 2012, J NEUROSCI RES, V90, P1989, DOI 10.1002/jnr.23092; Volchegorskii IA, 2001, B EXP BIOL MED+, V132, P760, DOI 10.1023/A:1013081912452; Wang W, 2004, ACTA PHARMACOL SIN, V25, P630; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Williams T, 2020, ACTA NEUROPSYCHIATR, V32, P169, DOI 10.1017/neu.2020.6; Williams TI, 2006, NEUROBIOL AGING, V27, P1094, DOI 10.1016/j.neurobiolaging.2005.06.004; Wood, 2020, NEUROL NEUROBIOL, DOI [10.31487/j.NNB.2020.03.03, DOI 10.31487/J.NNB.2020.03.03]; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Wood PL, 2007, BRAIN RES, V1158, P158, DOI 10.1016/j.brainres.2007.05.007; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood Paul L., 2003, P3; Wood PL, 2006, J PSYCHIATR NEUROSCI, V31, P296; Wood PL, 2013, CURR PSYCHIATRY REV, V9, P136, DOI 10.2174/1573400511309020008; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Xiao MQ, 2017, FREE RADICAL BIO MED, V111, P316, DOI 10.1016/j.freeradbiomed.2017.04.363; Xu LY, 2003, IMMUNOLOGY, V110, P141, DOI 10.1046/j.1365-2567.2003.01713.x; Xu WC, 2000, BRAIN RES, V874, P75, DOI 10.1016/S0006-8993(00)02554-3; Yadav UCS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/690545; Yang L, 2004, NEUROSCI LETT, V357, P73, DOI 10.1016/j.neulet.2003.12.032; Yang L, 2003, J NEUROCHEM, V87, P791, DOI 10.1046/j.1471-4159.2003.02069.x; Yoon BE, 2014, J PHYSIOL-LONDON, V592, P4951, DOI 10.1113/jphysiol.2014.278754; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Youdim MBH, 2006, NEUROTOX RES, V10, P181, DOI 10.1007/BF03033355; Young LT, 2002, J PSYCHIATR NEUROSCI, V27, P8; Yu PH, 2003, BBA-PROTEINS PROTEOM, V1647, P193, DOI 10.1016/S1570-9639(03)00101-8; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4; Zhang W, 2007, EXPERT OPIN PHARMACO, V8, P1861, DOI 10.1517/14656566.8.12.1861; Zuliani G, 2007, J PSYCHIATR RES, V41, P686, DOI 10.1016/j.jpsychires.2006.02.008	246	0	0	1	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JAN	2022	42	1			SI		225	242		10.1007/s10571-021-01078-3		APR 2021	18	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	YC1MI	WOS:000638828100001	33839994	hybrid, Green Published			2022-02-07	
J	Rucker, JC; Rizzo, JR; Hudson, TE; Horn, AKE; Buettner-Ennever, JA; Leigh, RJ; Optican, LM				Rucker, Janet C.; Rizzo, John-Ross; Hudson, Todd E.; Horn, Anja K. E.; Buettner-Ennever, Jean A.; Leigh, R. John; Optican, Lance M.			Dysfunctional mode switching between fixation and saccades: collaborative insights into two unusual clinical disorders	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Saccade termination; Late-onset Tay Sachs; Concussion; Opsoclonus; Eye position-dependence	OMNIPAUSE NEURONS	Voluntary rapid eye movements (saccades) redirect the fovea toward objects of visual interest. The saccadic system can be considered as a dual-mode system: in one mode the eye is fixating, in the other it is making a saccade. In this review, we consider two examples of dysfunctional saccades, interrupted saccades in late-onset Tay-Sachs disease and gaze-position dependent opsoclonus after concussion, which fail to properly shift between fixation and saccade modes. Insights and benefits gained from bi-directional collaborative exchange between clinical and basic scientists are emphasized. In the case of interrupted saccades, existing mathematical models were sufficiently detailed to provide support for the cause of interrupted saccades. In the case of gaze-position dependent opsoclonus, existing models could not explain the behavior, but further development provided a reasonable hypothesis for the mechanism underlying the behavior. Collaboration between clinical and basic science is a rich source of progress for developing biologically plausible models and understanding neurological disease. Approaching a clinical problem with a specific hypothesis (model) in mind often prompts new experimental tests and provides insights into basic mechanisms.	[Rucker, Janet C.; Rizzo, John-Ross; Hudson, Todd E.] NYU, Grossman Sch Med, Dept Neurol, New York, NY 10016 USA; [Rucker, Janet C.] NYU, Dept Ophthalmol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Rizzo, John-Ross; Hudson, Todd E.] NYU, Grossman Sch Med, Dept Rehabil Med, New York, NY USA; [Rizzo, John-Ross] NYU, Tandon Sch Engn, Dept Biomed Engn, New York, NY USA; [Rizzo, John-Ross] NYU, Tandon Sch Engn, Dept Mech Engn, New York, NY USA; [Rizzo, John-Ross] NYU, Tandon Sch Engn, Dept Aerosp Engn, New York, NY USA; [Horn, Anja K. E.; Buettner-Ennever, Jean A.] Ludwig Maximilians Univ Munchen, Dept Anat & Cell Biol 1, Munich, Germany; [Leigh, R. John] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Optican, Lance M.] NEI, Lab Sensorimotor Res, DHHS, NIH, Bethesda, MD 20892 USA		Rucker, JC (corresponding author), NYU, Grossman Sch Med, Dept Neurol, New York, NY 10016 USA.; Rucker, JC (corresponding author), NYU, Dept Ophthalmol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.	janet.rucker@nyulangone.org		Rucker, Janet/0000-0002-0397-0999; Rizzo, John-Ross/0000-0002-4084-0085	NEI, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)	This research was supported, in part, by the Intramural Research Program of the NEI, NIH.	Bertolini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061389; Bockisch CJ, 2013, EXP BRAIN RES, V226, P175, DOI 10.1007/s00221-013-3423-6; BUTTNERENNEVER JA, 1988, J COMP NEUROL, V267, P307, DOI 10.1002/cne.902670302; Chan WWP, 2008, IEEE T BIO-MED ENG, V55, P1946, DOI 10.1109/TBME.2007.912429; Chan WWP, 2010, IEEE T BIO-MED ENG, V57, P1012, DOI 10.1109/TBME.2009.2016112; Chan WWP, 2005, J NEUROPHYSIOL, V93, P3709, DOI 10.1152/jn.00814.2004; CRAWFORD JD, 1993, EXP BRAIN RES, V96, P443; Cullen KE, 1997, J NEUROPHYSIOL, V78, P3283, DOI 10.1152/jn.1997.78.6.3283; Daye PM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-125; EVINGER C, 1982, J NEUROPHYSIOL, V47, P827, DOI 10.1152/jn.1982.47.5.827; HAIN TC, 1986, ANN NEUROL, V19, P299, DOI 10.1002/ana.410190315; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; HELMCHEN C, 1994, EXP BRAIN RES, V98, P474; HORN AKE, 1994, J NEUROSCI, V14, P2032; HORN AKE, 1995, J COMP NEUROL, V359, P350, DOI 10.1002/cne.903590212; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Kaneko CRS, 1996, J NEUROPHYSIOL, V75, P2229, DOI 10.1152/jn.1996.75.6.2229; Keller EL, 1996, VISUAL NEUROSCI, V13, P1059, DOI 10.1017/S0952523800007719; Keller EL, 2003, ANN NY ACAD SCI, V1004, P29, DOI 10.1196/annals.1303.004; Keller EL, 2000, EXP BRAIN RES, V130, P227, DOI 10.1007/s002219900239; Kepski A, 1983, Neurol Neurochir Pol, V17, P239; Khojasteh E, 2013, EUR J NEUROSCI, V37, P141, DOI 10.1111/ejn.12030; Lefevre P, 1998, NEURAL NETWORKS, V11, P1175, DOI 10.1016/S0893-6080(98)00071-9; Leigh R. J., 2015, NEUROLOGY EYE MOVEME; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Missal M, 2002, J NEUROPHYSIOL, V88, P1880, DOI 10.1152/jn.2002.88.4.1880; Missal M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0200; Miura K, 2006, J COMPUT NEUROSCI, V20, P25, DOI 10.1007/s10827-006-4258-y; OHTSUKA K, 1995, J NEUROPHYSIOL, V74, P1828, DOI 10.1152/jn.1995.74.5.1828; Optican LM, 2019, PROG BRAIN RES, V249, P35, DOI 10.1016/bs.pbr.2019.01.002; Optican LM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00372; Optican LM, 2008, PROG BRAIN RES, V171, P567, DOI 10.1016/S0079-6123(08)00681-X; Optican LM, 2002, ANN NY ACAD SCI, V956, P164, DOI 10.1111/j.1749-6632.2002.tb02817.x; Pretegiani E, 2017, CLIN NEUROPHYSIOL, V128, P408, DOI 10.1016/j.clinph.2016.12.014; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999; Ramat S, 2005, EXP BRAIN RES, V160, P89, DOI 10.1007/s00221-004-1989-8; Ramat S, 2008, PROG BRAIN RES, V171, P123, DOI 10.1016/S0079-6123(08)00616-X; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Rizzo JR, 2019, PROG BRAIN RES, V249, P65, DOI 10.1016/bs.pbr.2019.04.016; Rucker JC, 2011, ANN NY ACAD SCI, V1233, P48, DOI 10.1111/j.1749-6632.2011.06170.x; Rucker JC, 2008, PROG BRAIN RES, V171, P563, DOI 10.1016/S0079-6123(08)00680-8; Rucker JC, 2004, NEUROLOGY, V63, P1918, DOI 10.1212/01.WNL.0000144275.76658.F4; SEGRAVES MA, 1992, J NEUROPHYSIOL, V68, P1967, DOI 10.1152/jn.1992.68.6.1967; Shinoda Y, 2011, ANN NY ACAD SCI, V1233, P100, DOI 10.1111/j.1749-6632.2011.06171.x; SHOOK BL, 1990, J COMP NEUROL, V301, P618, DOI 10.1002/cne.903010410; SHOOK BL, 1988, EXP BRAIN RES, V73, P215, DOI 10.1007/BF00279675; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P679, DOI 10.1152/jn.00886.2000; STANTON GB, 1988, J COMP NEUROL, V271, P493, DOI 10.1002/cne.902710403; STRASSMAN A, 1986, J COMP NEUROL, V249, P358, DOI 10.1002/cne.902490304; Thier P, 2002, ANN NY ACAD SCI, V978, P50, DOI 10.1111/j.1749-6632.2002.tb07555.x; Thier P, 2000, NATURE, V405, P72, DOI 10.1038/35011062; TUSA RJ, 1986, J NEUROPHYSIOL, V56, P1590, DOI 10.1152/jn.1986.56.6.1590; Van Horn MR, 2008, J NEUROPHYSIOL, V99, P2602, DOI 10.1152/jn.01379.2007; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; Waitzman DM, 1996, J NEUROPHYSIOL, V75, P1546, DOI 10.1152/jn.1996.75.4.1546; Yoshida K, 1999, J NEUROPHYSIOL, V82, P1198, DOI 10.1152/jn.1999.82.3.1198; ZEE DS, 1979, ANN NEUROL, V5, P405, DOI 10.1002/ana.410050502; 2003, NEUROLOGY, V61, P412, DOI DOI 10.1212/01.WNL.0000073271.66866.51	60	0	0	0	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	AUG	2021	49	3			SI		283	293		10.1007/s10827-021-00785-6		APR 2021	11	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	TU3MO	WOS:000638873900001	33839988				2022-02-07	
J	Esterov, D; Bellamkonda, E; Mandrekar, J; Ransom, JE; Brown, AW				Esterov, Dmitry; Bellamkonda, Erica; Mandrekar, Jay; Ransom, Jeanine E.; Brown, Allen W.			Cause of Death after Traumatic Brain Injury: A Population-Based Health Record Review Analysis Referenced for Nonhead Trauma	NEUROEPIDEMIOLOGY			English	Article						Cause of death; Life expectancy; Long-term survival; Mortality; Traumatic brain injury		Introduction: Traumatic brain injury (TBI) is a leading cause of disability and is associated with decreased survival. Although it is generally accepted that TBI increases risk of death in acute and postacute periods after injury, causes of premature death after TBI in the long term are less clear. Methods: A cohort sample of Olmsted County, Minnesota, residents with confirmed TBI from January 1987 through December 1999 was identified. Each case was assigned an age- and sex-matched non-TBI referent case, called regular referent. Confirmed TBI cases with simultaneous nonhead injuries were identified, labeled special cases. These were assigned 2 age- and sex-matched special referents with nonhead injuries of similar severity. Underlying causes of death in each case were categorized using death certificates, International Classification of Diseases, Ninth Revision, International Statistical Classification of Diseases, Tenth Revision, and manual health record review. Comparisons were made over the study period and among 6-month survivors. Results: Case-regular referent pairs (n = 1,257) were identified over the study period, and 221 were special cases. In total, 237 deaths occurred among these pairs. A statistically significant difference was observed between total number of deaths among all cases (n = 139, 11%) and regular referents (n = 98, 8%) (p = 0.006) over the entire period. This outcome was not true for special cases (32/221, 14%) and special referents (61/441, 14%) (p = 0.81). A greater proportion of deaths by external cause than all other causes was observed in all cases (52/139, 37%) versus regular referents (3/98, 3%) and in special cases (13/32, 41%) versus special referents (5/61, 8%) (p < 0.001 for both). Among all case-referent pairs surviving 6 months, no difference was found between total number of deaths (p = 0.82). The underlying cause of death between these 2 groups was significantly different for external causes only (p < 0.01). For special cases surviving 6 months versus special referents, no difference was observed in total number of deaths (p = 0.24) or underlying causes of death (p = 1.00) between groups. Discussion/Conclusion: This population-based case-matched referent study showed that increased risk of death after TBI existed only during the first 6 months after injury, and the difference was due to external causes.	[Esterov, Dmitry; Bellamkonda, Erica; Brown, Allen W.] Dept Phys Med & Rehabil, Rochester, MN USA; [Mandrekar, Jay; Ransom, Jeanine E.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Mandrekar, Jay] Mayo Clin, Dept Neurol, Rochester, MN USA		Esterov, D (corresponding author), Dept Phys Med & Rehabil, Rochester, MN USA.	esterov.dmitry@mayo.edu	Esterov, Dmitry/AAR-6991-2021		National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; Mayo Clinic Center for Clinical and Translational Science - National Institutes of Health (NIH) Clinical and Translational Science Awards program; National Institute on Aging of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034676]	This research was supported by Grant No. UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS) and by the Mayo Clinic Center for Clinical and Translational Science, which is funded by the National Institutes of Health (NIH) Clinical and Translational Science Awards program. This project was made possible with use of the resources of REP, which is supported by the National Institute on Aging of the NIH under Award No. R01AG034676. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	ANNEGERS J, NEUROLOGY, V30, P912; ANNEGERS J, NEUROLOGY, V30, P683; ANNEGERS J, NEW ENGL J MED, V338, P20; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Barker-Collo S, 2016, NEUROEPIDEMIOLOGY, V47, P46, DOI 10.1159/000448403; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Chang CH., 2019, WORLD NEUROSURG, V122, P740, DOI 10.1016/j.wneu.2018.10.130; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Commission on Professional and Hospital Activities National Center for Health Statistics (U.S.), 1973, H ICDA HOSP ADAPTATI; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; JONES M, AM J EPIDEMIOL, V148, P1012; KRAUS J, AM J EPIDEMIOL, V119, P186; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Lystad RP, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000445; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Rodriguez SR, 2006, PUBLIC HEALTH REP, V121, P282, DOI 10.1177/003335490612100310; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; SHAVELLE R, AM J PHYS MED REHAB, V80, P510; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Swain GR, 2005, AM FAM PHYSICIAN, V71, P652; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE T, J NEUROL NEUROSUR PS, V71, P436; Ulfarsson T, 2014, BRAIN INJURY, V28, P1675, DOI 10.3109/02699052.2014.947625; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Yawn BP., 2012, INT J EPIDEMIOL, V41, P1614, DOI 10.1093/ije/dys195	45	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology	JUN	2021	55	3					180	187		10.1159/000514807		APR 2021	8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	SU2OD	WOS:000640293700001	33839727				2022-02-07	
J	Garcia, GGP; Schumb, CM; Lavieri, MS; Koffijberg, H; McAllister, TW; McCrea, MA; Broglio, SP				Garcia, Gian-Gabriel P.; Schumb, Caroline M.; Lavieri, Mariel S.; Koffijberg, Hendrik; McAllister, Thomas W.; McCrea, Michael A.; Broglio, Steven P.		Concussion Assessment Res Educ Con	Developing Insights for Possible and Probable Acute Concussions Using Cluster Analysis	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						clustering; concussion; possible; probable concussion; Sport Concussion Assessment Tool		Few studies have analyzed the Sport Concussion Assessment Tool's (SCAT) utility among athletes whose concussion assessment is challenging. Using a previously published algorithm, we identified possible and probable concussions at <6 h (n = 393 males, n = 265 females) and 24-48 h (n = 323 males, n = 236 females) post-injury within collegiate student-athletes and cadets from the Concussion Assessment, Research, and Education (CARE) Consortium. We applied cluster analysis to characterize performance on the Standard Assessment of Concussion (SAC), Balance Error Scoring System (BESS), and the SCAT symptom checklist for these athletes. Among the cluster sets that best separated acute concussions and normal performances, total symptom number raw score and change and post-traumatic migraine raw score and change score were the most frequent clustering variables across males and females at <6 h and 24-48 h. Similarly, total symptom number raw score and change score and post-traumatic migraine raw score and change score were most significantly different between clusters for males and females at <6 h and 24-48 h. Our results suggest that clinicians should focus on total symptom number, post-traumatic migraine symptoms, and cognitive-fatigue symptoms when assessing possible and probable concussions, followed by the SAC and BESS scores.	[Garcia, Gian-Gabriel P.] Harvard Med Sch, MGH Inst Technol Assessment, Boston, MA 02114 USA; [Schumb, Caroline M.; Lavieri, Mariel S.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Koffijberg, Hendrik] Univ Twente, Tech Med Ctr, Dept Hlth Technol & Serv Res, Enschede, Netherlands; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Garcia, GGP (corresponding author), Harvard Med Sch, MGH Inst Technol Assessment, Boston, MA 02114 USA.	ggarcia16@mgh.harvard.edu			National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE 1256260]; Grand Alliance CARE Consortium - NCAA; Grand Alliance CARE Consortium - Department of Defense (DOD); United States Army Medical Research Acquisition Activity, Fort Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This material is based on work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1256260. This publication was made possible, in part, with support from the Grand Alliance CARE Consortium, funded, in part, by the NCAA and the Department of Defense (DOD). The United States Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the author(s) and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Centers for Disease Control and Prevention, 2016, CTR DIS CONTROL PREV; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cowell F.A., 2000, ELSEVIER SCI TECHNOL, P87; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Echemendia RJ, 2017, BRIT J SPORT MED, V51, DOI DOI 10.1136/BJSPORTS-2017-097506; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Efron B., 1993, INTRO BOOTSTRAP; Formann A.K., 1984, LATENT CLASS ANAL EI; Garcia GGP, 2020, NEUROSURGERY, V87, P971, DOI 10.1093/neuros/nyaa150; Garcia GGP, 2020, IISE TRANS, V52, P1098, DOI 10.1080/24725854.2020.1725254; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kontos AP, 2020, NEUROSURGERY, V87, P348, DOI 10.1093/neuros/nyz545; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; Moran RN, 2020, BRAIN INJURY, V34, P20, DOI 10.1080/02699052.2019.1669824; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Royston P, 2004, STATA J, V4, P224; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb	46	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7399		APR 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RL5UQ	WOS:000639038300001	33677994				2022-02-07	
J	Liu, HY; Liao, KM; Liang, FW; Hung, YC; Wang, JJ; Shen, TC; Ho, CH				Liu, Hsin-Yueh; Liao, Kuang-Ming; Liang, Fu-Wen; Hung, Yi-Chieh; Wang, Jhi-Joung; Shen, Te-Chun; Ho, Chung-Han			The risk of pulmonary tuberculosis after traumatic brain injury	SCIENTIFIC REPORTS			English	Article								After traumatic brain injury (TBI), an inflammatory response in the brain might affect the immune system. The risk of pulmonary infection reportedly increases in patients with TBI. We aimed to evaluate the risk of tuberculosis (TB) in patients with TBI in Taiwan. All participants were selected from the intensive care unit (ICU). Patients with TBI were defined as patients in ICU with intracranial injury, and comparison cohort were patients in ICU without TBI diagnosis. There was a significant difference in TB risk between the patients with TBI and the comparison cohort according to age and the Charlson's comorbidity index (CCI) score. Thus, we divided patients based on CCI into three groups for further analysis: mild (CCI = 0), moderate (CCI = 1/2), severe (CCI > 2). Mild-CCI group had a lower TB incidence rate (0.74%) and longer time to TB development (median: 2.43) than the other two groups. Moderate-CCI group had 1.52-fold increased risk of TB infection (p < 0.0001) compared with mild-CCI group. In the severe-CCI group, patients aged >= 80 years had 1.91-fold risk of TB compared with mild-CCI group (p = 0.0481). Severe-CCI group had significantly higher mortality than the mild-CCI group (p = 0.0366). Patients with TBI and more comorbidities had higher risk of TB infection with higher mortality rate.	[Liu, Hsin-Yueh; Liao, Kuang-Ming] Chi Mei Med Ctr, Dept Internal Med, Chiali, Taiwan; [Liang, Fu-Wen] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Liang, Fu-Wen] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Liang, Fu-Wen] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Hung, Yi-Chieh] Chi Mei Med Ctr, Dept Surg, Dept Neurosurg, Tainan, Taiwan; [Hung, Yi-Chieh] Chia Nan Univ Pharm & Sci, Dept Recreat & Healthcare Management, Tainan, Taiwan; [Wang, Jhi-Joung; Ho, Chung-Han] Chi Mei Med Ctr, Dept Med Res, 901 Zhonghua Rd, Tainan 710, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Wang, Jhi-Joung] Southern Taiwan Univ Sci & Technol, AI Biomed Ctr, Tainan, Taiwan; [Shen, Te-Chun] China Med Univ, Sch Med, Taichung, Taiwan; [Shen, Te-Chun] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, 2 Yude Rd, Taichung 404, Taiwan		Ho, CH (corresponding author), Chi Mei Med Ctr, Dept Med Res, 901 Zhonghua Rd, Tainan 710, Taiwan.; Shen, TC (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.; Shen, TC (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, 2 Yude Rd, Taichung 404, Taiwan.	chestshen@gmail.com; ho.c.hank@gmail.com			Chi Mei Medical Center [CMFHR108120]	This study was funded by Chi Mei Medical Center (Grant No. CMFHR108120).	Akan H, 2006, J HOSP INFECT, V62, P421, DOI 10.1016/j.jhin.2005.09.020; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; BRUCE RM, 1977, ANN INTERN MED, V87, P574, DOI 10.7326/0003-4819-87-5-574; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577; Dong YH, 2014, CHEST, V145, P1286, DOI 10.1378/chest.13-2137; Heunis JC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3972-2; Ho CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190683; Hochberg NS, 2013, CLIN INFECT DIS, V56, P1240, DOI 10.1093/cid/cit027; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Kamboj M, 2006, CLIN INFECT DIS, V42, P1592, DOI 10.1086/503917; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lee CH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-194; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Munno I, 1996, IMMUNOPHARM IMMUNOT, V18, P549, DOI 10.3109/08923979609052753; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Oeltmann JE, 2009, ARCH INTERN MED, V169, P189, DOI 10.1001/archinternmed.2008.535; Pien FD, 2001, INFECT DIS CLIN N AM, V15, P851, DOI 10.1016/S0891-5520(05)70176-8; Taiwan Centers for Disease Control Department of Health., 2020, TAIW TUB CONTR REP; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Thulstrup AM, 2000, EPIDEMIOL INFECT, V124, P221, DOI 10.1017/S0950268899003593; WOLACH B, 1993, BRAIN INJURY, V7, P401, DOI 10.3109/02699059309029683; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; World Health Organization, 2020, TUBERCULOSIS; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Yang YX, 2019, NEUROIMMUNOMODULAT, V26, P43, DOI 10.1159/000495465; Yulu Miao, 2007, Neural Regeneration Research, V2, P126; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0	33	0	0	2	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 9	2021	11	1							7840	10.1038/s41598-021-87332-6			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM3MY	WOS:000639568600030	33837282	Green Published, gold			2022-02-07	
J	Straughan, AJ; Pasick, LJ; Gupta, V; Benito, DA; Goodman, JF; Zapanta, PE				Straughan, Alexander J.; Pasick, Luke J.; Gupta, Vrinda; Benito, Daniel A.; Goodman, Joseph F.; Zapanta, Philip E.			Feel the Burn! Fireworks-related Otolaryngologic Trauma	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						public health; otolaryngology; trauma; hearing loss	RISK-FACTORS; INJURIES; FIRECRACKERS	Objectives: Fireworks are used commonly for celebrations in the United States, but can lead to severe injury to the head and neck. We aim to assess the incidence, types, and mechanisms of head and neck injuries associated with fireworks use from 2010 to 2019. Methods: A retrospective cross-sectional study, using data from the National Electronic Injury Surveillance System, of individuals presenting to United States Emergency Departments with head and neck injuries caused by fireworks and flares from 2010 to 2019. Incidence, types, and mechanisms of injury related to fireworks use in the US population were assessed. Results: A total of 541 patients (349 [64.5%] male, and 294 [54%] under 18 years of age) presented to emergency departments with fireworks-related head and neck injuries; the estimated national total was 20 584 patients (13 279 male, 9170 white, and 11 186 under 18 years of age). The most common injury diagnoses were burns (44.7% of injuries), laceration/avulsion/penetrating trauma (21.1%), and otologic injury (15.2%), which included hearing loss, otalgia, tinnitus, unspecified acoustic trauma, and tympanic membrane perforation. The remaining 19% of injuries were a mix, including contusion, abrasion, hematoma, fracture, and closed head injury. Associations between fireworks type and injury diagnosis (chi-square P < .001), as well as fireworks type by age group (chi-square P < .001) were found. Similarly, associations were found between age groups and injury diagnoses (chi-square P < .001); these included children 5 years and younger and adults older than 30 years. Conclusions: Fireworks-related head and neck injuries are more likely to occur in young, white, and male individuals. Burns are the most common injury, while otologic injury is a significant contributor. Annual rates of fireworks-related head and neck injuries have not changed or improved significantly in the United States in the past decade, suggesting efforts to identify and prevent these injuries are insufficient.	[Straughan, Alexander J.; Gupta, Vrinda; Benito, Daniel A.; Goodman, Joseph F.; Zapanta, Philip E.] George Washington Univ, Sch Med & Hlth Sci, Div Otolaryngol Head & Neck Surg, Dept Surg, 2300 M St NW, Washington, DC 20037 USA; [Pasick, Luke J.] Univ Miami Miller, Sch Med, Dept Otolaryngol Head & Neck Surg, Miami, FL USA		Straughan, AJ (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Div Otolaryngol Head & Neck Surg, Dept Surg, 2300 M St NW, Washington, DC 20037 USA.	astraughan@gwu.edu		Pasick, Luke/0000-0003-1776-1730; Gupta, Vrinda/0000-0002-6743-8395; Straughan, Alexander/0000-0001-9967-546X; Zapanta, Phil/0000-0003-2290-0571			Billock RM, 2017, CLIN PEDIATR, V56, P535, DOI 10.1177/0009922816664063; Bull N, 2011, ACTA OPHTHALMOL, V89, pe654, DOI 10.1111/j.1755-3768.2010.02061.x; Consumer Product Safety Commision, FIR INF CTR; Di Benedetto Giovanni, 2009, J Plast Reconstr Aesthet Surg, V62, pe145, DOI 10.1016/j.bjps.2008.06.074; GUPTA D, 1989, LARYNGOSCOPE, V99, P330; Haseen MA, 2015, INDIAN J PLAST SURG, V48, P225, DOI 10.4103/0970-0358.163082; Hlavaty L, 2019, AM J FOREN MED PATH, V40, P49, DOI 10.1097/PAF.0000000000000441; HUBBARD TJ, 1992, J TRAUMA, V33, P767, DOI 10.1097/00005373-199211000-00030; Jeyabal P, 2019, INT OPHTHALMOL, V39, P2407, DOI 10.1007/s10792-018-1054-4; MCFARLAND LV, 1984, JAMA-J AM MED ASSOC, V251, P3251; Molendijk J, 2016, CRANIOMAX TRAUM REC, V9, P175, DOI 10.1055/s-0035-1566164; Moore JX, 2014, INJURY, V45, P1704, DOI 10.1016/j.injury.2014.06.024; Nam SM, 2013, J CRANIOFAC SURG, V24, pE510, DOI 10.1097/SCS.0b013e31829aca1f; Ng J, 2019, 2018 FIREWORKS ANN R; Peng CZ, 2012, INTERN EMERG MED, V7, P85, DOI 10.1007/s11739-011-0632-5; Plontke SKR, 2002, EUR ARCH OTO-RHINO-L, V259, P247, DOI 10.1007/s00405-002-0451-4; Puri V, 2009, J PLAST RECONSTR AES, V62, P1103, DOI 10.1016/j.bjps.2007.12.080; Rad EH, 2019, BURNS, V45, P466, DOI 10.1016/j.burns.2018.07.011; Romano F, 2008, J CRANIOFAC SURG, V19, P322, DOI 10.1097/SCS.0b013e3180690237; Saadat S, 2012, PUBLIC HEALTH, V126, P40, DOI 10.1016/j.puhe.2011.09.010; Saadat S, 2010, AM J HEALTH BEHAV, V34, P525; Schroeder T., 2001, NEISS SAMPLE DESIGN; SHELLER JP, 1995, BURNS, V21, P50, DOI 10.1016/0305-4179(95)90782-U; Shiuey EJ, 2020, JAMA OPHTHALMOL, V138, P618, DOI 10.1001/jamaophthalmol.2020.0832; Singh S, 1997, BURNS, V23, P369, DOI 10.1016/S0305-4179(96)00128-3; Smith GA, 1996, PEDIATRICS, V98, P1; SMOORENBURG GF, 1993, AUDIOLOGY, V32, P333; Tadisina KK, 2014, WEST J EMERG MED, V15, P387, DOI 10.5811/westjem.2014.1.19857; United States Consumer Product Safety Commision, 2020, NEISS FREQ ASK QUEST; United States Consumer Product Safety Commision, 2020, NEISS COD MAN JAN 20; US Census Bureau, 2020, QUICKFACTS US; Wang C, 2014, BURNS, V40, P305, DOI 10.1016/j.burns.2013.06.007; Wisse RPL, 2010, BRIT J OPHTHALMOL, V94, P1586, DOI 10.1136/bjo.2009.168419; Zwirner J, 2017, INT J LEGAL MED, V131, P1581, DOI 10.1007/s00414-017-1580-z	34	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	DEC	2021	130	12					1369	1377	00034894211008100	10.1177/00034894211008100		APR 2021	9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	WO4QU	WOS:000679702100001	33834893				2022-02-07	
J	Worley, ML; O'Leary, MC; Sackett, JR; Schlader, ZJ; Willer, B; Leddy, JJ; Johnson, BD				Worley, Morgan L.; O'Leary, Morgan C.; Sackett, James R.; Schlader, Zachary J.; Willer, Barry; Leddy, John J.; Johnson, Blair D.			Preliminary Evidence of Orthostatic Intolerance and Altered Cerebral Vascular Control Following Sport-Related Concussion	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; cerebral blood flow; blood pressure; baroreflex; autonomic function		Concussions have been shown to result in autonomic dysfunction and altered cerebral vascular function. We tested the hypothesis that concussed athletes (CA) would have altered cerebral vascular function during acute decreases and increases in blood pressure compared to healthy controls (HC). Ten CA (age: 20 +/- 2 y, 7 females) and 10 HC (age: 21 +/- 2 y, 6 females) completed 5 min of lower body negative pressure (LBNP; -40 mmHg) and 5 min of lower body positive pressure (LBPP; 20 mmHg). Protocols were randomized and separated by 10 min. Mean arterial pressure (MAP) and middle cerebral artery blood velocity (MCAv) were continuously recorded. Cerebral vascular resistance (CVR) was calculated as MAP/MCAv. Values are reported as change from baseline to the last minute achieved (LBNP) or 5 min (LBPP). There were no differences in baseline values between groups. During LBNP, there were no differences in the change for MAP (CA: -23 +/- 18 vs. HC: -21 +/- 17 cm/s; P = 0.80) or MCAv (CA: -13 +/- 8 vs. HC: -18 +/- 9 cm/s; P = 0.19). The change in CVR was different between groups (CA: -0.08 +/- 0.26 vs. HC: 0.18 +/- 0.24 mmHg/cm/s; P = 0.04). Total LBNP time was lower for CA (204 +/- 92 s) vs. HC (297 +/- 64 s; P = 0.04). During LBPP, the change in MAP was not different between groups (CA: 13 +/- 6 vs. HC: 10 +/- 7 mmHg; P = 0.32). The change in MCAv (CA: 7 +/- 6 vs. HC: -4 +/- 13 cm/s; P = 0.04) and CVR (CA: -0.06 +/- 0.27 vs. HC: 0.38 +/- 0.41 mmHg/cm/s; P = 0.03) were different between groups. CA exhibited impaired tolerance to LBNP and had a different cerebral vascular response to LBPP compared to HC.	[Worley, Morgan L.; O'Leary, Morgan C.; Sackett, James R.; Schlader, Zachary J.; Johnson, Blair D.] SUNY Buffalo, Ctr Res & Educ Special Environm, Dept Exercise & Nutr Sci, Sch Publ Hlth & Hlth Profess, Buffalo, NY 14260 USA; [Schlader, Zachary J.; Johnson, Blair D.] Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Human Integrat Physiol Lab, Bloomington, IN 47405 USA; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Leddy, John J.] SUNY Buffalo, UBMD Dept Orthopaed & Sports Med, Buffalo, NY USA		Johnson, BD (corresponding author), SUNY Buffalo, Ctr Res & Educ Special Environm, Dept Exercise & Nutr Sci, Sch Publ Hlth & Hlth Profess, Buffalo, NY 14260 USA.; Johnson, BD (corresponding author), Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Human Integrat Physiol Lab, Bloomington, IN 47405 USA.	bj33@indiana.edu		Johnson, Blair/0000-0002-1731-4415	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]	This study was supported by Grant No. UL1TR001412 from the National Center for Advancing Translational Sciences of the National Institutes of Health Pilot Grants Award Program BJ and Grant No. 1R01NS094444 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health JL.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Abidi S, 2017, J APPL PHYSIOL, V123, P375, DOI 10.1152/japplphysiol.00035.2017; ANDERSON EA, 1991, HYPERTENSION, V17, pS43; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Barlow K., 2016, NEUROLOGY, V86; Becelewski J, 2002, NEUROL NEUROCHIR POL, V36, P1146; Becelewski Janusz, 2002, Neurol Neurochir Pol, V36, P1135; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; BILL A, 1976, ACTA PHYSIOL SCAND, V96, P114, DOI 10.1111/j.1748-1716.1976.tb10176.x; CALLISTER R, 1992, J PHYSIOL-LONDON, V454, P373, DOI 10.1113/jphysiol.1992.sp019269; Carter JR, 2009, AM J PHYSIOL-HEART C, V296, pH847, DOI 10.1152/ajpheart.01234.2008; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gross V, 2002, HYPERTENSION, V40, P207, DOI 10.1161/01.HYP.0000027279.69240.75; Haider MN, 2019, SPORTS HEALTH, V11, P492, DOI 10.1177/1941738119870189; Haider MN, 2020, CLIN J SPORT MED, V30, P513, DOI 10.1097/JSM.0000000000000687; Haider MN, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.547126; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hinojosa-Laborde C, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00085; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; HOFFLER GW, 1974, AEROSPACE MED, V45, P807; Hoiland RL, 2019, COMPR PHYSIOL, V9, P1101, DOI 10.1002/cphy.c180021; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; Ide K, 1985, J APPL PHYSIOL, V2003, P129; Johnson BD, 2020, J ATHL TRAINING, V55, P124, DOI 10.4085/1062-6050-573-18; Johnson BD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13694; Johnson BD, 2014, J APPL PHYSIOL, V117, P131, DOI 10.1152/japplphysiol.00070.2014; JULIUS S, 1988, J HYPERTENS, V6, P177, DOI 10.1097/00004872-198803000-00001; JULIUS S, 1986, J HYPERTENS, V4, pS54; JULIUS S, 1982, HYPERTENSION, V4, P782, DOI 10.1161/01.HYP.4.6.782; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; King ML, 1997, BRAIN INJURY, V11, P445; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2019, MED SCI SPORT EXER, V51, P792, DOI 10.1249/MSS.0000000000001833; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Laude D, 2009, IEEE ENG MED BIOL, V28, P30, DOI 10.1109/MEMB.2009.934630; Le VV, 2008, PROG CARDIOVASC DIS, V51, P135, DOI 10.1016/j.pcad.2008.07.001; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LEVINE BD, 1991, CIRCULATION, V84, P1016, DOI 10.1161/01.CIR.84.3.1016; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; MCCLOSKE.DI, 1972, J PHYSIOL-LONDON, V224, P173, DOI 10.1113/jphysiol.1972.sp009887; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; MCWILLIAM PN, 1991, AM J PHYSIOL, V260, pH730, DOI 10.1152/ajpheart.1991.260.3.H730; MITCHELL JH, 1983, ANNU REV PHYSIOL, V45, P229, DOI 10.1146/annurev.ph.45.030183.001305; Moir ME, 2018, MED SCI SPORT EXER, V50, P2192, DOI 10.1249/MSS.0000000000001695; Mucha A, 2018, HAND CLINIC, V158, P135, DOI 10.1016/B978-0-444-63954-7.00014-8; Nishiyasu T, 1998, J APPL PHYSIOL, V85, P160, DOI 10.1152/jappl.1998.85.1.160; Ogoh S, 2003, J PHYSIOL-LONDON, V551, P601, DOI 10.1113/jphysiol.2003.046029; Osterziel K J, 1984, J Hypertens, V2, P411; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; Peltonen GL, 2016, AM J PHYSIOL-REG I, V311, pR222, DOI 10.1152/ajpregu.00106.2016; Perry BG, 2013, CLIN PHYSIOL FUNCT I, V33, P483, DOI 10.1111/cpf.12046; Pinna GD, 2001, MED BIOL ENG COMPUT, V39, P338, DOI 10.1007/BF02345289; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; Querido JS, 2007, SPORTS MED, V37, P765, DOI 10.2165/00007256-200737090-00002; Rickards CA, 2015, J APPL PHYSIOL, V119, P677, DOI 10.1152/japplphysiol.00127.2015; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; SHI XR, 1993, AM J PHYSIOL, V265, pH69, DOI 10.1152/ajpheart.1993.265.1.H69; STEVENS PM, 1965, AM J CARDIOL, V16, P506, DOI 10.1016/0002-9149(65)90027-5; Tanaka M, 2003, AM J PHYSIOL-REG I, V285, pR1091, DOI 10.1152/ajpregu.00162.2003; Tybout A, 2001, J CONSUM PSYCHOL, V10, P9; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; WOLTHUIS RA, 1974, PHYSIOL REV, V54, P566, DOI 10.1152/physrev.1974.54.3.566; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196; Xiang LS, 2018, AM J PHYSIOL-REG I, V315, pR408, DOI 10.1152/ajpregu.00361.2017; Yoshida H, 2018, J APPL PHYSIOL, V124, P321, DOI 10.1152/japplphysiol.00700.2017	79	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 9	2021	12								620757	10.3389/fneur.2021.620757			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RQ4YD	WOS:000642424100001	33897587	gold, Green Published			2022-02-07	
J	Baker, HP; Satinsky, A; Lee, CS; Seidel, H; Dwyer, E; Athiviraham, A				Baker, Hayden P.; Satinsky, Alexander; Lee, Cody S.; Seidel, Henry; Dwyer, Emma; Athiviraham, Aravind			The targeting rule does not increase the rate of lower extremity injuries in NFL players over two seasons	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Concussion; sports medicine; lower extremity injuries; football; nfl		Objectives: In 2018 the NFL instituted playing rule article 8, which aimed to help decrease sport related concussion (SRC) by broadening the helmet-hit rule, making it a foul when a player lowers his head to make contact with his helmet against an opponent. Previous studies have demonstrated that the rate of lower extremity injuries increased following the institution of the targeting rule in NCAA football. The objective of this study was to determine if playing rule article 8 unintentionally led to a significant increase in the rate of lower extremity injuries sustained by NFL players during regular season games. Methods: This study was a retrospective review of all NFL players who were placed on the publically available injury reports for a lower extremity injury from the 2016-2017 through 2019-2020 regular seasons. With article 8 taking effect starting with the 2018-2019 season, players were assigned to a pre- or post-rule cohort based on date of injury for purposes of injury rate comparison. Injury rates were calculated per 1000 athletic exposures (AE). Incidence rate ratio (RR) with 95% confidence intervals (CI) compared injury rates between the two cohorts. Results: There was a 3% decrease in the lower extremity injury rate in 2018-2019 to 2019-2020 compared with 2016-2017 to 2017-2018, however this was not statistically significant (33.6 versus 34.3/1000 AEs, respectively; RR, 0.97; 95% CI 0.92-1.04). There was a 40% decrease in the SRC rate when comparing the post- to the pre-article-8 cohort (3.3 vs. 5.5/1000 AEs, respectively; RR 0.60; 95% CI 0.50-0.73). Conclusions: The rate of lower extremity injuries and players placed on the injury reserve over the past two NFL seasons following the enactment of playing rule article 8 has not significantly increased. However, the average games missed due to lower extremity injuries significantly increased under playing rule article 8, which suggests that the severity of lower extremity injuries possibly increased.	[Baker, Hayden P.; Satinsky, Alexander; Lee, Cody S.; Seidel, Henry; Dwyer, Emma; Athiviraham, Aravind] Univ Chicago, Dept Orthopaed Surg, 5758 S Maryland Ave,4B, Chicago, IL 60637 USA		Baker, HP (corresponding author), Univ Chicago, Dept Orthopaed Surg, 5758 S Maryland Ave,4B, Chicago, IL 60637 USA.	hpbaker65@gmail.com		Satinsky, Alexander/0000-0002-7052-3734; Baker, Hayden/0000-0002-9306-7006; Dwyer, Emma/0000-0002-6978-6860			[Anonymous], 2020, INJURY DATA IQVIA; Baker HP, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118768446; Barzilai P., 2014, US TODAY SPORTS; Conte SA, 2012, AM J SPORT MED, V40, P650, DOI 10.1177/0363546511433030; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Erdtmann F, 2015, MIL MED, V180, P123, DOI 10.7205/MILMED-D-14-00516; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Gibson BW, 2007, AM J SPORT MED, V35, P575, DOI 10.1177/0363546506296737; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Knoblauch A., 2020, NFL EXPANDS HELMET H; Makhni EC, 2014, AM J SPORT MED, V42, P1323, DOI 10.1177/0363546514528864; Marshall NE, 2018, ARTHROSCOPY, V34, P473, DOI 10.1016/j.arthro.2017.08.298; National Collegiate Athletic Association , NCAA FOOTB RUL INT S; Smith MD., 2015, NBC SPORTS      1130; TORG JS, 1987, CLIN SPORT MED, V6, P61; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290	16	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1910873		APR 2021	5	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	RI4SQ	WOS:000636899500001	33784939				2022-02-07	
J	Kumar, SM; Simm, PJ; De Silva, ML; Gorelik, A; Freeman, JL; Mackay, MT; Ahmad, BS; Petty, SJ; Wark, JD				Kumar, Sunita M.; Simm, Peter J.; De Silva, Manikkuwadura L.; Gorelik, Alexandra; Freeman, Jeremy L.; Mackay, Mark T.; Ahmad, Baemisla Shiek; Petty, Sandra J.; Wark, John D.			Risk of Fractures and Other Injuries in Children Treated with Antiseizure Medications for Epilepsy	CALCIFIED TISSUE INTERNATIONAL			English	Article						Pediatric; Epilepsy; Fractures and antiseizure medications		This study aimed to investigate the prevalence of fractures and non-fracture injuries, including associated risk factors, in children with epilepsy prescribed antiseizure medications (ASM). A controlled, cross-sectional study was conducted in a hospital outpatient setting, comparing children with epilepsy prescribed ASMs with their non-epileptic siblings. Information was collected by questionnaire included history of fractures, non-fracture injuries and epilepsy, comorbidities and ASM use. 261 participants completed the questionnaire, 133 children with epilepsy (aged 10.7 +/- 3.5 years, mean +/- SD) and 128 siblings (10.1 +/- 3.7 years). There were 49 non-seizure-related fractures in 34 ASM patients while prescribed ASMs, compared with 21 lifetime fractures in 15 controls, giving a 2.7 (95% CI 1.3-5.3, p = 0.007) times greater fracture prevalence in children treated with ASMs compared to healthy siblings. The rates of non-fracture injuries were similar across groups, except that concussion was more common in children taking ASMs (9.0% vs 1.6%, p = 0.026). Duration of ASM use and generalized tonic-clonic seizures (GTCS) were independent predictors of fractures (OR 1.55; 95% CI 1.03-2.31, p = 0.03; OR 2.50; 95% CI 1.05-5.94, p = 0.04, respectively). Fewer than 20% of participants and/or their families were aware that ASM use was related to bone health. Children with epilepsy treated with ASMs had a higher fracture prevalence than their sibling controls. Duration of ASM treatment and GTCS were associated with fracture risk. Longitudinal prospective studies are required to further explore risk and the direct impact of epilepsy on bone health.	[Kumar, Sunita M.; De Silva, Manikkuwadura L.] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Simm, Peter J.] Royal Childrens Hosp, Dept Endocrinol & Diabet, 50 Flemington Rd, Parkville, Vic 3052, Australia; [Simm, Peter J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Simm, Peter J.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Gorelik, Alexandra] Cabrini Hlth, Cabrini Inst, Monash Dept Epidemiol, Malvern, Australia; [Gorelik, Alexandra] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia; [Gorelik, Alexandra; Ahmad, Baemisla Shiek; Wark, John D.] Univ Melbourne, Dept Med RMH, Melbourne, Vic, Australia; [Freeman, Jeremy L.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; [Freeman, Jeremy L.; Mackay, Mark T.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Petty, Sandra J.] Ctr Biomed Res Transparency, New York, NY USA; [Petty, Sandra J.] Monash Univ, CCS, Melbourne, Vic, Australia; [Petty, Sandra J.] Alfred Hlth, Dept Neurol, Melbourne, Vic, Australia; [Petty, Sandra J.] St Vincents Hosp, Dept Neurosci, Melbourne, Vic, Australia; [Wark, John D.] Royal Melbourne Hosp, Bone & Mineral Med, Melbourne, Vic, Australia; [Wark, John D.] Royal Melbourne Hosp, Dept Diabet & Endocrinol, Melbourne, Vic, Australia		Simm, PJ (corresponding author), Royal Childrens Hosp, Dept Endocrinol & Diabet, 50 Flemington Rd, Parkville, Vic 3052, Australia.; Simm, PJ (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Simm, PJ (corresponding author), Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia.	peter.simm@rch.org.au		Freeman, Jeremy/0000-0002-4184-3683			Ahmad BS, 2012, NEUROLOGY, V79, P145, DOI 10.1212/WNL.0b013e31825f0466; Appleton RE, 2002, EPILEPSIA, V43, P764, DOI 10.1046/j.1528-1157.2002.41101.x; Barkley R. A., 2014, ADHD REP, V22, P1, DOI DOI 10.1521/adhd.2014.22.2.1; Coppola G, 2009, EPILEPSIA, V50, P2140, DOI 10.1111/j.1528-1167.2009.02082.x; Dimic M, 2013, SRP ARK CELOK LEK, V141, P329, DOI 10.2298/SARH1306329D; Dworetzky BA, 2012, EPILEPSIA, V53, pe1, DOI 10.1111/j.1528-1167.2011.03308.x; Fraser L-A, 2015, NEUROLOGY, V84; Gniatkowska-Nowakowska A, 2010, SEIZURE-EUR J EPILEP, V19, P324, DOI 10.1016/j.seizure.2010.04.013; Goldberg-Stern H, 2015, HORM RES PAEDIAT, V83, P332, DOI 10.1159/000375374; Hakami T, 2016, CALCIFIED TISSUE INT, V98, P556, DOI 10.1007/s00223-016-0109-7; Henneicke H, 2014, TRENDS ENDOCRIN MET, V25, P197, DOI 10.1016/j.tem.2013.12.006; Herzog AG, 2019, SEIZURE-EUR J EPILEP, V69, P1, DOI 10.1016/j.seizure.2019.03.018; LIDGREN L, 1977, ACTA ORTHOP SCAND, V48, P356, DOI 10.3109/17453677708992008; LIDGREN L, 1979, CALCIFIED TISSUE INT, V28, P99, DOI 10.1007/BF02441226; Miller J, 2011, JAMA-J AM MED ASSOC, V305, P1140, DOI [10.1001/jama.2011.328, DOI 10.1001/JAMA.2011.328]; Pack AM, 2011, CURR TREAT OPTION NE, V13, P346, DOI 10.1007/s11940-011-0133-x; Pack AM, 2004, EPILEPSY BEHAV, V5, pS24, DOI 10.1016/j.yebeh.2003.11.029; Panayiotopoulos CP, 1997, J NEUROL NEUROSUR PS, V63, P622, DOI 10.1136/jnnp.63.5.622; Petty SJ, 2007, OSTEOPOROSIS INT, V18, P129, DOI 10.1007/s00198-006-0185-z; Petty SJ, 2010, EPILEPSIA, V51, P280, DOI 10.1111/j.1528-1167.2009.02254.x; Shen CH, 2014, BONE, V64, P246, DOI 10.1016/j.bone.2014.04.018; Sheth RD, 2008, NEUROLOGY, V70, P170, DOI 10.1212/01.wnl.0000284595.45880.93; Simm PJ, 2017, EPILEPSIA, V58, P1931, DOI 10.1111/epi.13893; Svalheim S, 2011, ACTA NEUROL SCAND, V124, P89, DOI 10.1111/j.1600-0404.2011.01551.x; Van Staa TP, 2001, BONE, V29, P517, DOI 10.1016/S8756-3282(01)00614-7; Verrotti A, 2002, EPILEPSIA, V43, P1488, DOI 10.1046/j.1528-1157.2002.13002.x; Wood E, 2000, DEV MED CHILD NEUROL, V42, P292, DOI 10.1017/S0012162200000529	27	0	0	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	AUG	2021	109	2					139	146		10.1007/s00223-021-00842-3		APR 2021	8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	TH0IL	WOS:000637641300001	33829290				2022-02-07	
J	Zhaba, WD; Deji, QZ; Gao, SQ; Han, YL; Gao, CC; Deng, HJ; Liu, XL; Li, T; Zhou, ML				Zhaba, Wang-Dui; Deji, Qu-Zhen; Gao, Sheng-Qing; Han, Yan-Ling; Gao, Chao-Chao; Deng, Hong-Ji; Liu, Xi-Lin; Li, Tao; Zhou, Meng-Liang			Deferoxamine reduces amyloid-beta peptides genesis and alleviates neural apoptosis after traumatic brain injury	NEUROREPORT			English	Article						amyloid &#946; deferoxamine; ferritin; traumatic brain injury		Traumatic brain injury (TBI) is recognized as the most influential risk factor for neurodegenerative diseases later in life, including Alzheimer's disease. The aberrant genesis of amyloid-beta peptides, which is triggered by TBI, is associated with the development of Alzheimer's disease. Evidence suggests that iron plays a role in both the production of amyloid-beta and its neurotoxicity, and iron overload has been noted in the brain after TBI. We therefore investigated the effects of an iron-chelating treatment on amyloid-beta genesis in a weight-drop model of TBI in mice. Human brain samples were obtained from patients undergoing surgery for severe brain trauma. The Institute of Cancer Research mice were treated with deferoxamine by intraperitoneal injection after TBI induction. Changes in amyloid-beta((1-42)) were assessed using western blot and immunohistochemical staining. Ferritin was also detected using western blot to investigate iron deposition in the mice brain. Immunofluorescent terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling was also performed to evaluate neural apoptosis. The amyloid-beta((1-42)) was markedly elevated after TBI in both humans and mice. Deferoxamine treatment in mice significantly decreased the levels of both amyloid-beta((1-42)) and ferritin in the brain, and reduced TBI-induced neural cell apoptosis. The iron chelator deferoxamine can alleviate the increase of amyloid-beta((1-42)) in the brain after TBI, and may therefore be a potential therapeutic strategy to prevent TBI patients from undergoing neurodegenerative processes.	[Zhaba, Wang-Dui; Deji, Qu-Zhen; Gao, Sheng-Qing; Han, Yan-Ling; Zhou, Meng-Liang] Nanjing Univ, Affiliated Jinling Hosp, Dept Neurosurg, Med Sch, Nanjing, Jiangsu, Peoples R China; [Gao, Chao-Chao; Li, Tao] Nanjing Med Univ, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Deng, Hong-Ji] Guangxi Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanning, Guangxi, Peoples R China; [Liu, Xi-Lin] Wannan Med Coll, Grad Sch, Wuhu, Anhui, Peoples R China; [Zhou, Meng-Liang] Southern Med Univ, Sch Clin Med 1, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China		Zhou, ML (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhoangshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	mengliangzhou@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771292, 81571162]	This work was supported by grants from National Natural Science Foundation of China: No. 81771292 and 81571162 to Meng-Liang Zhou.	Abu Hamdeh S, 2018, BRAIN PATHOL, V28, P451, DOI 10.1111/bpa.12532; Almutairi MMA, 2019, ADV EXP MED BIOL, V1173, P105, DOI 10.1007/978-981-13-9589-5_6; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chen GF, 2017, ACTA PHARMACOL SIN, V38, P1205, DOI 10.1038/aps.2017.28; Chen XQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00659; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Guo X, 2019, WORLD NEUROSURG, V128, pE895, DOI 10.1016/j.wneu.2019.05.024; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Uranga RM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2850341; Peng DG, 2020, EXP CELL RES, V390, DOI 10.1016/j.yexcr.2020.111926; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Spangler B, 2016, NAT CHEM BIOL, V12, P680, DOI 10.1038/nchembio.2116; Spotorno N, 2020, BRAIN, V143, P1341, DOI 10.1093/brain/awaa089; Tang GQ, 2020, J MOL NEUROSCI, V70, P1437, DOI 10.1007/s12031-020-01564-1; Zhang Y, 2017, BRAIN RES, V1677, P86, DOI 10.1016/j.brainres.2017.09.019; Zhao Zhongwei, 2019, Aging Med (Milton), V2, P82, DOI 10.1002/agm2.12074	24	0	0	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 7	2021	32	6					472	478		10.1097/WNR.0000000000001619			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RL9QC	WOS:000639297000009	33788818				2022-02-07	
J	Zhang, GZ; Lang, ZY; Yang, QF; Nie, Y; Wang, ZH; Gao, M; Zhang, N; Xu, X				Zhang, Guangzheng; Lang, Zhenyuan; Yang, Qifan; Nie, You; Wang, Zhihan; Gao, Ming; Zhang, Nan; Xu, Xia			UPLC-Q-TOF/MS-based plasma metabolome to identify biomarkers and time of injury in traumatic brain injured rats	NEUROREPORT			English	Article						biomarkers; differential metabolites; metabolomics; traumatic brain injury; UPLC-Q-TOF; MS		Background To identify the potent metabolic biomarkers and time of injury of traumatic brain injured (TBI). Methods A total of 70 Sprague-Dawley rats were used to establish the TBI model in this study. The serum was collected at 3 h, 6 h, 12 h, 24 h, 3 days and 7 days after surgery. Ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry was performed to analyze metabolic changes in the serum of the TBI rats from different groups. The differences between the metabolic profiles of the rats in seven groups were analyzed using partial least squares discriminant analysis. Results Metabolic profiling revealed significant differences between the sham-operated and other groups. A total of 49 potential TBI metabolite biomarkers were identified between the sham-operated group and the model groups at different time points. Among them, six metabolites (methionine sulfone, kynurenine, 3-hydroxyanthranilic acid, 3-Indolepropionic acid, citric acid and glycocholic acid) were identified as biomarkers of TBI to estimate the injury time. Conclusion Using metabolomic analysis, we identified new TBI serum biomarkers for accurate detection and determination of the timing of TBI injury.	[Zhang, Guangzheng; Lang, Zhenyuan; Yang, Qifan; Nie, You] Zhengzhou Univ, Dept Forens Med, Basic Med Coll, Zhengzhou, Peoples R China; [Wang, Zhihan; Gao, Ming; Xu, Xia] Zhengzhou Univ, Dept Med Anal, Zhengzhou, Peoples R China; [Zhang, Nan] Zhengzhou Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Zhengzhou, Peoples R China		Xu, X (corresponding author), Zhengzhou Univ, Zhengzhou 450001, Peoples R China.	xuxia@zzu.edu.cn			Key Scientific Research Projects of Higher Education Institutions in Henan Province; School of Pharmacy Zhengzhou University	This work was supported by Key Scientific Research Projects of Higher Education Institutions in Henan Province and School of Pharmacy Zhengzhou University.	Anderson G, 2011, J NEUROTRAUM, V28, pA113; Bravo-Merodio L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1912-5; Chen JJ, 2015, J PROTEOME RES, V14, P3382, DOI 10.1021/acs.jproteome.5b00434; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; Figueroa JD, 2013, NEUROSCIENCE, V255, P1, DOI 10.1016/j.neuroscience.2013.09.012; Gao SY, 2015, J ETHNOPHARMACOL, V166, P323, DOI 10.1016/j.jep.2015.03.025; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Kang DZ, 2008, NEURAL REGEN RES, V3, P1161; Koehler PJ, 2008, J HIST NEUROSCI, V17, P46, DOI 10.1080/09647040600820050; Liu Y, 2014, MOL MED REP, V9, P333, DOI 10.3892/mmr.2013.1803; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; O'Rourke L, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2017.69; Pan XB, 2016, NEUROBIOL AGING, V38, P151, DOI 10.1016/j.neurobiolaging.2015.11.014; Peng B, 2015, PROTEIN CELL, V6, P628, DOI 10.1007/s13238-015-0185-x; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Posti JP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00398; Ristagno G, 2013, RESUSCITATION, V84, P1604, DOI 10.1016/j.resuscitation.2013.06.002; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Speziali G, 2018, J PROTEOMICS, V181, P118, DOI 10.1016/j.jprot.2018.04.008; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Wang Z, 2019, ARTERIOSCL THROM VAS, V39, P1475, DOI 10.1161/ATVBAHA.118.312236; Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181; Zhang Z, 2019, J NEUROTRAUM, V36, P74, DOI 10.1089/neu.2017.5450	27	0	0	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 7	2021	32	6					415	422		10.1097/WNR.0000000000001576			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RL9QC	WOS:000639297000001	33788810				2022-02-07	
J	Zorick, T; Gaines, KD; Berenji, GR; Mandelkern, MA; Smith, J				Zorick, Todd; Gaines, Katy D.; Berenji, Gholam R.; Mandelkern, Mark A.; Smith, Jason			Information Transfer and Multifractal Analysis of EEG in Mild Blast-Induced TBI	COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE			English	Article								Mild, blast-induced traumatic brain injury (mbTBI) is a common combat brain injury characterized by typically normal neuroimaging findings, with unpredictable future cognitive recovery. Traditional methods of electroencephalography (EEG) analysis (e.g., spectral analysis) have not been successful in detecting the degree of cognitive and functional impairment in mbTBI. We therefore collected resting state EEG (5 minutes, 64 leads) from twelve patients with a history of mbTBI, along with repeat neuropsychological testing (D-KEFS Tower test) to compare two new methods for analyzing EEG (multifractal detrended fluctuation analysis (MF-DFA) and information transfer modeling (ITM)) with spectral analysis. For MF-DFA, we extracted relevant parameters from the resultant multifractal spectrum from all leads and compared with traditional power by frequency band for spectral analysis. For ITM, because the number of parameters from each lead far exceeded the number of subjects, we utilized a reduced set of 10 leads which were compared with spectral analysis. We utilized separate 30 second EEG segments for training and testing statistical models based upon regression tree analysis. ITM and MF-DFA models both generally had improved accuracy at correlating with relevant measures of cognitive performance as compared to spectral analytic models ITM and MF-DFA both merit additional research as analytic tools for EEG and cognition in TBI.	[Zorick, Todd] Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA; [Zorick, Todd] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA 90024 USA; [Gaines, Katy D.] Univ Calif Irvine, Neuro Hlth Inc, Irvine, CA USA; [Berenji, Gholam R.; Mandelkern, Mark A.] Univ Calif Irvine, Greater Los Angeles VA Dept Nucl Imaging, Irvine, CA USA; [Mandelkern, Mark A.] Univ Calif Irvine, Dept Phys, Irvine, CA 92717 USA; [Smith, Jason] Boeing Co, Seattle, WA 29208 USA		Zorick, T (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA.; Zorick, T (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA 90024 USA.	tzorick@mednet.ucla.edu			Veterans Administration Career Development Award (CDA-2) [IK1 BX007080]	We thank Irina Arnold, M.D., and Zach Erickson for technical assistance. T.Z. was supported by a Veterans Administration Career Development Award (CDA-2; IK1 BX007080) during this study.	Auguie B., 2017, MISCELLANEOUS FUNCTI; Beck A., 1996, MANUAL BDI 2; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Cai SM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061903; Fielitz P, 2011, PHYS ESSAYS, V24, P350, DOI 10.4006/1.3601352; Fielitz P., 2014, ARXIV09050610; Gaines KD, 2016, APPL NEUROPSYCH-ADUL, V23, P115, DOI 10.1080/23279095.2015.1012762; Hastie T., 2009, ELEMENTS STAT LEARNI; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Millborrow S., 2018, rpart.plot: plot 'rpart' models: an enhanced version of 'plot. rpart; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Oswiecimka P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016103; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Prevention C f D C a, 2019, SURVEILLANCE REPORT; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rapp PE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00177; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shunk A.W., 2006, NEUROPSYCHOLOGY, V13, P275; SPITZ HH, 1985, AM J MENT DEF, V90, P46; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Therneau TM, 2018, RPART RECURSIVE PART; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; Werner G, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00015; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669; Zorick T, 2020, J CLIN NEUROSCI, V76, P195, DOI 10.1016/j.jocn.2020.04.003; Zorick T, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6450126; Zorick T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068360	28	0	0	1	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1748-670X	1748-6718		COMPUT MATH METHOD M	Comput. Math. Method Med.	APR 7	2021	2021								6638724	10.1155/2021/6638724			8	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	RQ7VG	WOS:000642622100001	33927783	Green Published, gold			2022-02-07	
J	Beebe, KE; Reynolds, E; Driver, S				Beebe, Kelzie E.; Reynolds, Erin; Driver, Simon			One size fits none: neurobiologic-specific modifications for the assessment, diagnosis, and treatment of sport-related concussion (SRC)	BRAIN INJURY			English	Article						sport-related concussion (SRC); clinical profiles; Vestibular; Ocular Motor Screening (VOMS); Physical Exertion Rehabilitation		Primary objective - To discuss how the underlying neuroanatomy and neurobiology of five sport-related concussion (SRC) clinical profiles impacts assessment and treatment. Research design - Narrative review. Methods and procedures - Based on the current literature and clinical experience, arguments against the traditional SRC protocol and for a clinical profiles-based SRC protocol are made. Main outcomes and results - While the clinical profiles-based SRC protocol is widely used and accepted, there has been little published regarding the link to the underlying neuropathology. Our narrative review describes the five SRC clinical profiles: vestibular, ocular, mood, post-traumatic migraine, and cognitive/fatigue. For these profiles, the underlying neuroanatomy and neurobiology is outlined, as well as how that anatomy and biology impact the profiles' etiology, assessment, and treatment. The cervical and sleep modifiers are also briefly covered. Conclusions - Utilizing this model, clinicians are able to provide an individualized assessment, conceptualization, and treatment plan for SRC, leading to improved outcomes and clinical experiences for athletes.	[Beebe, Kelzie E.] Univ North Texas, Dept Psychol, Denton, TX 76203 USA; [Reynolds, Erin] Baylor Scott & White Sports Concuss Program, Frisco, TX USA; [Driver, Simon] Baylor Scott & White Res Inst, Frisco, TX USA		Beebe, KE (corresponding author), Dept Psychol, Denton, TX 76203 USA.	kelziebeebe@my.unt.edu		driver, simon/0000-0003-2356-432X			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Chang A, 2013, OPTOM VIS PERF, V1, P48; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Kontos A. P., 2018, CONCUSSION CLIN PROF; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; SEL N, 2017, SPORT EXERC PERFORM, V6, DOI DOI 10.1037/spy0000098; SHERRY N, 2019, CLIN J SPORT MED, P1, DOI DOI 10.1097/JSM.0000000000000740; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010	37	0	0	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2021	35	5					505	510		10.1080/02699052.2020.1837957		APR 2021	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO8QM	WOS:000637237900001	33822673				2022-02-07	
J	Ganson, KT; O'Connor, J; Benabou, SE; Nagata, JM				Ganson, Kyle T.; O'Connor, Julia; Benabou, Samuel E.; Nagata, Jason M.			Associations between interpersonal violence victimisation and concussions among US college students	HEALTH & SOCIAL CARE IN THE COMMUNITY			English	Article						college students; concussions; mild traumatic brain injury; sexual assault; victimisation; violence		Interpersonal violence is common on college campuses and is associated with many adverse health outcomes; however, it remains unknown whether experiencing interpersonal violence victimisation is associated with concussions. The aim of this study was to estimate the associations between interpersonal violence, including emotional abuse, physical abuse and sexual assault, and concussions among a large, diverse sample of college students. We analysed cross-sectional data from the 2018-2019 national (US) Healthy Minds Study (N = 1,478). Multiple logistic regression analyses were conducted to estimate the association between interpersonal violence victimisation (any violence victimisation, emotional abuse, physical abuse and sexual assault) and concussion history (any concussion, diagnosed concussion and undiagnosed concussion), while adjusting for potential confounders. Analyses were conducted among the overall sample and separately by male and female participants. Results showed patterns of significant associations between interpersonal violence victimisation and concussions among the overall sample and among male and female participants. Among the overall sample, any interpersonal violence victimisation (adjusted odds ratio [AOR] 1.45, 95% confidence interval [CI] 1.13-1.88), emotional abuse (AOR 1.36, 95% CI 1.06-1.76), physical abuse (AOR 1.61, 95% CI 1.07-2.44) and sexual assault (AOR 2.17, 95% CI 1.44-3.26) were associated with higher odds of any concussion history. Sexual assault victimisation had the strongest association with any concussion history among male (AOR 1.96, 95% CI 1.04-3.71) and female (AOR 2.96, 95% CI 1.62-5.43) participants. These results expand on prior interpersonal violence and concussion research by showing an association with multiple victimisation measures among a large and diverse sample of college students. Medical professionals should screen for concussions among college students who experience emotional abuse, physical abuse and sexual assault to provide appropriate guidance. Information on the symptoms of concussions should be incorporated into campus violence awareness and prevention efforts.	[Ganson, Kyle T.] Univ Toronto, Factor Inwentash Fac Social Work, 246 Bloor St W, Toronto, ON M5S 1V4, Canada; [O'Connor, Julia] Univ Cent Florida, Coll Hlth Profess & Sci, Sch Social Work, Orlando, FL 32816 USA; [Benabou, Samuel E.; Nagata, Jason M.] Univ Calif San Francisco, Dept Pediat, Div Adolescent & Young Adult Med, San Francisco, CA USA		Ganson, KT (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, 246 Bloor St W, Toronto, ON M5S 1V4, Canada.	kyle.ganson@utoronto.ca		O'Connor, Julia/0000-0003-2400-9125; Nagata, Jason/0000-0002-6541-0604			Ackard DM, 2007, J PEDIATR-US, V151, P476, DOI 10.1016/j.jpeds.2007.04.034; Alcock Bradey, 2018, Addict Behav Rep, V7, P58, DOI 10.1016/j.abrep.2018.02.001; Amar AF, 2005, NURS RES, V54, P235; American College Health Association, 2008, SHIFT PAR PRIM PREV, DOI [10.1093/infdis/jis911, DOI 10.1093/INFDIS/JIS911]; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Banyard VL, 2020, J INTERPERS VIOLENCE, V35, P4375, DOI 10.1177/0886260517715022; Barone RP, 2007, J COLL STUDENT DEV, V48, P585, DOI 10.1353/csd.2007.0045; Baugh C.M., 2016, CONCUSSION, V1, P1, DOI [DOI 10.2217/CNC.15.6, 10.2217/cnc.15.6]; Black MC., 2014, INTIMATE PARTNER VIO; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley L, 2017, J PUBLIC HEALTH-UK, V39, P52, DOI 10.1093/pubmed/fdw009; Burczycka M., 2020, STUDENTSEXPERIENCES; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Casey E, 2018, TRAUMA VIOLENCE ABUS, V19, P231, DOI 10.1177/1524838016650191; Chang EC, 2015, J SOC CLIN PSYCHOL, V34, P221, DOI 10.1521/jscp.2015.34.3.221; Coulter RWS, 2017, PREV SCI, V18, P726, DOI 10.1007/s11121-017-0762-8; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Cybulska B, 2013, BEST PRACT RES CL OB, V27, P141, DOI 10.1016/j.bpobgyn.2012.08.013; Davies M, 2002, AGGRESS VIOLENT BEH, V7, P203, DOI 10.1016/S1359-1789(00)00043-4; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Edwards KM, 2015, J INTERPERS VIOLENCE, V30, P580, DOI 10.1177/0886260514535260; Fedina L, 2018, TRAUMA VIOLENCE ABUS, V19, P76, DOI 10.1177/1524838016631129; Fisher B. S., 2000, NCJ182369 DEP JUST; Fisher BS, 2003, BRIT J CRIMINOL, V43, P526, DOI 10.1093/bjc/azg526; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Glass N, 2003, JOGNN-J OBST GYN NEO, V32, P227, DOI 10.1177/0884217503252033; Halstead V, 2017, J CLIN NURS, V26, P2137, DOI 10.1111/jocn.13735; IVANY A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI DOI 10.1097/FCH.0000000000000094; Jordan CE, 2014, TRAUMA VIOLENCE ABUS, V15, P191, DOI 10.1177/1524838014520637; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kilpatrick D. G., 2007, DRUG FACILITATED INC; Knowledge Networks, 2011, COLL DAT VIOL AB POL; KOSS MP, 1985, J CONSULT CLIN PSYCH, V53, P422, DOI 10.1037/0022-006X.53.3.422; KOSS MP, 1987, J CONSULT CLIN PSYCH, V55, P162, DOI 10.1037/0022-006X.55.2.162; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lifshitz J, 2019, J AGGRESS MALTREAT T, V28, P655, DOI 10.1080/10926771.2019.1644693; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Martin Ryan J, 2018, J Dual Diagn, P1, DOI 10.1080/15504263.2018.1473906; McCauley JL, 2010, J INTERPERS VIOLENCE, V25, P1655, DOI 10.1177/0886260509354580; Mengo C, 2016, J COLL STUD RETENT-R, V18, P234, DOI 10.1177/1521025115584750; Mosti C, 2018, J NEUROPSYCH CLIN N, V30, P220, DOI 10.1176/appi.neuropsych.17070141; National Institute of Neurological Disorders and Stroke, 2019, TRAUMATIC BRAIN INJU; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Ray CM, 2021, J INTERPERS VIOLENCE, V36, P2241, DOI 10.1177/0886260518758332; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Sabina C, 2014, TRAUMA VIOLENCE ABUS, V15, P201, DOI 10.1177/1524838014521322; Senn CY, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0135-4; Sharkey TC, 2021, NETWORKS, V77, P225, DOI 10.1002/net.21996; Shorey RC, 2008, AGGRESS VIOLENT BEH, V13, P185, DOI 10.1016/j.avb.2008.03.003; Smith PH, 2003, AM J PUBLIC HEALTH, V93, P1104, DOI 10.2105/AJPH.93.7.1104; StataCorp L.L.C, 2020, STAT 15; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Sutherland MA, 2016, WOMEN HEALTH ISS, V26, P217, DOI 10.1016/j.whi.2015.07.008; Testa M, 2004, J INTERPERS VIOLENCE, V19, P1494, DOI 10.1177/0886260504269701; Tolman R M, 1999, Violence Vict, V14, P25; Trenchard SO, 2013, BRAIN INJURY, V27, P1217, DOI 10.3109/02699052.2013.812240; Vrees R.A, 2017, OBSTET GYNECOL SURV, V33, P792, DOI [10.1097/01.pec.0000526609.89886.37, DOI 10.1097/01.PEC.0000526609.89886.37]; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Weiss KG, 2010, MEN MASC, V12, P275, DOI 10.1177/1097184X08322632	63	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0410	1365-2524		HEALTH SOC CARE COMM	Health Soc. Care Community	JAN	2022	30	1					175	183		10.1111/hsc.13387		APR 2021	9	Public, Environmental & Occupational Health; Social Work	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Work	XK3IA	WOS:000637225000001	33825248				2022-02-07	
J	Pugh, M; Perrin, PB; Arango-Lasprilla, JC				Pugh, Mickeal, Jr.; Perrin, Paul B.; Arango-Lasprilla, Juan Carlos			Predicting caregiver burden over the first 4 months after acute traumatic brain injury in Latin America: a multi-country study	BRAIN INJURY			English	Article						Traumatic brain injury; caregiver; burden; latin america		Background: Traumatic brain injury (TBI) rates and outcomes are worse in Latin American countries relative to high-income countries. This study examined whether cognitive dysfunction, depressive mood, and poor social and emotional self-regulation in individuals with an acute TBI in Latin America predict longitudinal trajectories of caregiver burden during the first 4 months post-discharge. Method: A sample of 109 caregivers of individuals with a new TBI from Colombia and Mexico completed the observer European Brain Injury Questionnaire before hospital discharge and the Zarit Burden Inventory at the same time and again at 2 and 4 months after discharge. A hierarchical linear model (HLM) was used to assess whether cognitive dysfunction, depressive mood, and poor social and emotional self-regulation at hospital discharge predicted longitudinal trajectories of caregiver burden. Results: Results suggested that burden trajectories decreased over time and men reported higher burden than women. Additionally, results showed that poor patient social and emotional self-regulation predicted higher burden trajectories. Conclusions: Men and caregivers providing care for those experiencing poor social and emotional self-regulation may be at risk for burden. Culturally sensitive interventions focusing on social functioning of individuals with TBI and gender-informed caregiver interventions aimed at burden should be implemented in Latin America.	[Pugh, Mickeal, Jr.; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Arango-Lasprilla, Juan Carlos] Cruces Univ Hosp Barakaldo, BioCruces Bizkaia Hlth Res Inst, Baracaldo, Spain; [Arango-Lasprilla, Juan Carlos] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Arango-Lasprilla, Juan Carlos] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Ikerbasque, Basque Fdn Sci, BioCruces Bizkaia Hlth Res Inst, Plaza Cruces S-N, Barakaldo Bizkaia 48903, Spain.	jcalasprilla@gmail.com			Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW009746]	This study was funded by grant #R21TW009746 from Fogarty International Center of the National Institutes of Health [R21TW009746];	Akpinar B, 2011, J NURS SCHOLARSHIP, V43, P248, DOI 10.1111/j.1547-5069.2011.01402.x; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Beer J. S., 2007, HDB EMOTION REGULATI; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Boutoleau-Bretonniere C, 2008, DEMENT GERIATR COGN, V25, P272, DOI 10.1159/000117394; Caracuel A, 2011, J HEAD TRAUMA REHAB, V26, P478, DOI 10.1097/HTR.0b013e3181fc042c; Christensen, 2000, INT HDB NEUROPSYCHOL, P81; DAVID DS, 1983, CONTEMP SOCIOL, V12, P102, DOI 10.2307/2068233; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; GERVASIO A, 1997, J HEAD TRAUMA REHAB, V12; Gross J.J., 2007, EMOTION REGULATION C, V1st; Gururaj G., 1995, NEUROL INDIA, V43, P95; Hammer JH, 2013, PSYCHOL MEN MASCULIN, V14, P65, DOI 10.1037/a0026813; Hawley LA, 2010, BRAIN INJURY, V24, P1292, DOI 10.3109/02699052.2010.506866; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Judy M zarit, 1985, HIDDEN VICTIMS ALZHE; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Oliver MI, 2005, BRIT J PSYCHIAT, V186, P297, DOI 10.1192/bjp.186.4.297; Perrin PB, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/283958; Perrin PB, 2013, NEUROREHABILITATION, V32, P679, DOI 10.3233/NRE-130891; PLATA CMD, 2007, J HEAD TRAUMA REHAB, V22; Pradilla A Gustavo, 2003, Rev Panam Salud Publica, V14, P104, DOI 10.1590/S1020-49892003000700005; PUVANACHRA P, 2008, SALUD PUBLICA MEXICO, V50; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Yudofsky, 2007, REV 2005; Zniga Carrasco, 2008, VIGILANCIA EPIDEMIOL, V26, P1	45	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					769	777		10.1080/02699052.2021.1907861		APR 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000637234600001	33822684				2022-02-07	
J	Nys, C; Vankelecom, H				Nys, Charlotte; Vankelecom, Hugo			Pituitary disease and recovery: How are stem cells involved?	MOLECULAR AND CELLULAR ENDOCRINOLOGY			English	Article						Pituitary; Stem cells; Injury; Regeneration; Ageing; Tumour	TRAUMATIC BRAIN-INJURY; IN-VITRO EXPANSION; HORMONE DEFICIENCY; STEM/PROGENITOR CELL; SIDE POPULATION; REGENERATION; MECHANISMS; TUMORS; PROP1; PITX2	The pituitary gland embodies our endocrine hub and rigorously regulates hormone balances in the body, thereby ruling over vital developmental and physiological processes. Pituitary dysfunction and disease strongly impact the organism's biology. Physical damage, tumour development and ageing all negatively affect pituitary state and functionality. On top of its hormone-producing cells, the pituitary contains a population of stem cells. Not only their physiological role is still largely unknown, also whether or how these stem cells are involved in pituitary disease and recovery from defective functionality remains enigmatic. Here, we summarize what is known on the phenotypical and functional behaviour of pituitary stem cells in diseased or dysfunctional gland, as particularly caused by injury, tumourigenesis and ageing.	[Nys, Charlotte; Vankelecom, Hugo] Univ Leuven, Dept Dev & Regenerat, Lab Tissue Plast Hlth & Dis, Cluster Stem Cell & Dev Biol,KU Leuven, Herestr 49, B-3000 Leuven, Belgium		Vankelecom, H (corresponding author), Univ Leuven, Dept Dev & Regenerat, Lab Tissue Plast Hlth & Dis, Cluster Stem Cell & Dev Biol,KU Leuven, Herestr 49, B-3000 Leuven, Belgium.	hugo.vankelecom@kuleuven.be		Vankelecom, Hugo/0000-0002-2251-7284	KU Leuven (Research Fund)KU Leuven; Fund for Scientific Research (FWO) - Flanders (Belgium)FWO; FWOFWO	We would like to thank the funding agencies as this work was supported by grants from the KU Leuven (Research Fund) and from the Fund for Scientific Research (FWO) - Flanders (Belgium). C.N is supported by a PhD Fellowship from the FWO.	Ahmed Abu Shufian Ishtiaq, 2017, World J Exp Med, V7, P1, DOI 10.5493/wjem.v7.i1.1; Ajdzanovic V, 2018, EXCLI J, V17, P279, DOI 10.17179/excli2017-956; Alexandraki KI, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122153; Andoniadou C, 2007, GENET RES, V89, P182, DOI 10.1242/dev.02829; Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9; Andoniadou CL, 2013, CELL STEM CELL, V13, P433, DOI 10.1016/j.stem.2013.07.004; Barkhoudarian G, 2017, CUSHING'S DISEASE: AN OFTEN MISDIAGNOSED AND NOT SO RARE DISORDER, P1, DOI 10.1016/B978-0-12-804340-0.00001-2; Bartke A, 2002, NEUROPEPTIDES, V36, P201, DOI 10.1054/npep.2002.0889; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Bertko E, 2017, J HUM GENET, V62, P755, DOI 10.1038/jhg.2017.34; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Caimari F, 2016, CLIN CANCER RES, V22, P5030, DOI 10.1158/1078-0432.CCR-16-0452; Capp JP, 2017, INT J CANCER, V140, P2408, DOI 10.1002/ijc.30596; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chang CV, 2017, NEUROENDOCRINOLOGY, V104, P183, DOI 10.1159/000446072; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Chen JH, 2006, MOL ENDOCRINOL, V20, P3293, DOI 10.1210/me.2006-0293; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Chen LF, 2018, J MED CHEM, V61, P4290, DOI 10.1021/acs.jmedchem.7b01310; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Cox B, 2019, J ENDOCRINOL, V240, P287, DOI 10.1530/JOE-18-0462; Cox B, 2017, J ENDOCRINOL, V234, pR135, DOI 10.1530/JOE-17-0083; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Fang Q, 2016, ENDOCR REV, V37, P636, DOI 10.1210/er.2016-1101; Fang Q, 2016, CLIN ENDOCRINOL, V85, P408, DOI 10.1111/cen.13067; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fu QL, 2012, STEM CELLS DEV, V21, P3245, DOI 10.1089/scd.2012.0290; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Gangat M, 2017, ENDOCRIN METAB CLIN, V46, P247, DOI 10.1016/j.ecl.2017.01.003; Gaston-Massuet C, 2011, P NATL ACAD SCI USA, V108, P11482, DOI 10.1073/pnas.1101553108; Ghosh M, 2018, AM J RESP CRIT CARE, V197, P885, DOI 10.1164/rccm.201704-0667OC; Goldsmith S, 2016, DEVELOPMENT, V143, P2376, DOI 10.1242/dev.137984; Guereda V., 2009, PLOS ONE, V4, P1, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; Hegab AE, 2019, J TISSUE ENG REGEN M, V13, P295, DOI 10.1002/term.2792; Hill M, 2003, J ANAT, V203, P89, DOI 10.1046/j.1469-7580.2003.00195.x; Hiraishi N, 2018, TISSUE CELL, V53, P1, DOI 10.1016/j.tice.2018.05.008; Holsken A, 2014, PITUITARY, V17, P546, DOI 10.1007/s11102-013-0543-8; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jayakody SA, 2012, J CLIN INVEST, V122, P3635, DOI 10.1172/JCI64311; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; LANDOLT AM, 1973, J NEUROSURG, V39, P35, DOI 10.3171/jns.1973.39.1.0035; Levy A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740147; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lin E, 2012, CLIN ENDOCRINOL, V77, P430, DOI 10.1111/j.1365-2265.2012.04361.x; Locatelli V, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/235060; Manoranjan B, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0394-4; Gonzalez-Meljem JM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01992-5; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Melmed S, 2020, NEW ENGL J MED, V382, P937, DOI 10.1056/NEJMra1810772; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Mertens F, 2015, ENDOCR-RELAT CANCER, V22, P481, DOI 10.1530/ERC-14-0546; Mete O, 2017, ENDOCR PATHOL, V28, P228, DOI 10.1007/s12022-017-9498-z; Nielsen EH, 2011, J NEURO-ONCOL, V104, P755, DOI 10.1007/s11060-011-0540-6; Nolan LA, 2006, J NEUROENDOCRINOL, V18, P655, DOI 10.1111/j.1365-2826.2006.01459.x; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Olivieri F, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9076485; Prieto R, 2018, PITUITARY, V21, P431, DOI 10.1007/s11102-018-0890-6; Raetzman LT, 2002, DEVELOPMENT, V129, P4229; Ren RT, 2017, CELL METAB, V26, P460, DOI 10.1016/j.cmet.2017.07.019; Rizzoti K, 2013, CELL STEM CELL, V13, P419, DOI 10.1016/j.stem.2013.07.006; SAEGER W, 1980, VIRCHOWS ARCH A, V387, P279, DOI 10.1007/BF00454831; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sierra A, 2015, CELL STEM CELL, V16, P488, DOI 10.1016/j.stem.2015.04.003; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Sousa-Victor P, 2018, INT J DEV BIOL, V62, P583, DOI 10.1387/ijdb.180041pm; Straub RH, 2001, MECH AGEING DEV, V122, P1591, DOI 10.1016/S0047-6374(01)00289-5; Suh H, 2002, DEVELOPMENT, V129, P329; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; Trouillas J, 2020, CANCERS, V12, DOI 10.3390/cancers12020514; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Vankelecom H, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00339; Vankelecom H, 2016, RES PERSPECT END INT, P81, DOI 10.1007/978-3-319-41603-8_7; Vankelecom H, 2014, MOL CELL ENDOCRINOL, V385, P2, DOI 10.1016/j.mce.2013.08.018; Vankelecom H, 2012, CURR STEM CELL RES T, V7, P36, DOI 10.2174/157488812798483467; Veldhuis JD, 2013, NAT REV ENDOCRINOL, V9, P205, DOI 10.1038/nrendo.2013.38; Vennekens A, 2019, PITUITARY, V22, P212, DOI 10.1007/s11102-019-00961-z; Vijayakumar Archana, 2011, Front Endocrinol (Lausanne), V2, P32, DOI 10.3389/fendo.2011.00032; Vitale G, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00027; Ward RD, 2005, MOL ENDOCRINOL, V19, P698, DOI 10.1210/me.2004-0341; Willems C, 2016, ENDOCRINOLOGY, V157, P705, DOI 10.1210/en.2015-1741; Willems C, 2014, REGEN MED, V9, P513, DOI [10.2217/RME.14.19, 10.2217/rme.14.19]; Wurth R, 2017, MOL NEUROBIOL, V54, P4879, DOI 10.1007/s12035-016-0025-x; Xatzipsalti M, 2019, HORM METAB RES, V51, P81, DOI 10.1055/a-0822-3637; Xu Q, 2009, BRIT J CANCER, V101, P303, DOI 10.1038/sj.bjc.6605142	92	0	0	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0303-7207	1872-8057		MOL CELL ENDOCRINOL	Mol. Cell. Endocrinol.	APR 5	2021	525								111176	10.1016/j.mce.2021.111176			8	Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Endocrinology & Metabolism	QT5BM	WOS:000626602900005	33503464	Green Accepted			2022-02-07	
J	Su, YP; DePasquale, M; Liao, GL; Buchler, I; Zhang, GL; Byers, S; Carr, GV; Barrow, J; Wei, HJ				Su, Yupin; DePasquale, Michael; Liao, Gangling; Buchler, Ingrid; Zhang, Gongliang; Byers, Spencer; Carr, Gregory V.; Barrow, James; Wei, Huijun			Membrane bound catechol-O-methytransferase is the dominant isoform for dopamine metabolism in PC12 cells and rat brain	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Catechol-O-Methyltransfease; Dopamine; Cognition		Impaired dopamine activity in the dorsolateral prefrontal cortex (DLPFC) is thought to contribute to cognitive deficits in diseases such as schizophrenia, attention deficit hyperactivity disorder (ADHD) and traumatic brain injury. Catechol-O-methyltransfease (COMT) metabolizes dopamine and is an important regulator of dopamine signaling in the DLPFC. In mammalian species, two isoforms of COMT protein, membrane-bound COMT (MBCOMT) and soluble COMT (S-COMT), are encoded by one COMT gene and expressed widely. While S-COMT is thought to play a dominant role in the peripheral tissues, MB-COMT is suggested to have a greater role in dopamine metabolism in the brain. However, whether a selective inhibitor for MB-COMT may effectively block dopamine metabolism remains unknown. We generated a knockout of MB-COMT in PC12 cells using CRISPRcas9 technology to evaluate the effect of both MB and S-COMT on dopamine metabolism. Deletion of MBCOMT in PC12 cells significantly decreased homovanillic acid (HVA), completely depleted 3-methyoxytyramine (3-MT), and significantly increased 3,4-dihydroxyphenylacetic acid (DOPAC) levels. Comparison of the effect of a MB-COMT selective inhibitor LI-1141 on dopamine metabolism in wild type and MB-COMT knockout PC12 cells allowed us to confirm the selectivity of LI-1141 with respect to MB-COMT in cells. Under conditions in which LI1141 was shown to inhibit only MB-COMT but not S-COMT, it effectively changed dopamine metabolites similar to the effect induced by tolcapone, a non-selective COMT inhibitor, suggesting that selective inhibition of MBCOMT will be effective in blocking dopamine metabolism, providing an attractive therapeutic approach in improving cognition for patients.	[Su, Yupin; DePasquale, Michael; Liao, Gangling; Buchler, Ingrid; Zhang, Gongliang; Byers, Spencer; Carr, Gregory V.; Barrow, James; Wei, Huijun] Lieber Inst Brain Dev, 855 N Wolfe St, Baltimore, MD 21205 USA; [Carr, Gregory V.; Barrow, James; Wei, Huijun] Johns Hopkins Univ, Dept Pharmacol, Baltimore, MD 21205 USA; [Su, Yupin] 5 Res Ct, Rockville, MD 20850 USA; [Zhang, Gongliang] MedStar Hlth Res Inst, Baltimore, MD 21218 USA; [Byers, Spencer] Boston Univ, Dept Biol, Boston, MD 21218 USA; [Wei, Huijun] Johns Hopkins Univ, Brain Sci Inst, Dept Neurol, 855 N Wolfe St, Baltimore, MD 21205 USA		Wei, HJ (corresponding author), Lieber Inst Brain Dev, 855 N Wolfe St, Baltimore, MD 21205 USA.	hwei11@jhmi.edu		Barrow, James/0000-0001-5115-9300	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH107126]; Lieber Institute for Brain Development	This work was supported by the National Institutes of Health [R01 MH107126] and the Lieber Institute for Brain Development.	Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Buchler I, 2018, J MED CHEM, V61, P9647, DOI 10.1021/acs.jmedchem.8b01126; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Ciszek BP, 2016, ANESTHESIOLOGY, V124, P1122, DOI 10.1097/ALN.0000000000001070; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ernst G, 2019, ACS MED CHEM LETT, V10, P1573, DOI 10.1021/acsmedchemlett.9b00345; Ferreira JJ, 2019, EUR J NEUROL, V26, P953, DOI 10.1111/ene.13914; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; LEWITT PA, 1993, ADV NEUROL, V60, P544; Magarkar A, 2018, CHEM COMMUN, V54, P3440, DOI 10.1039/c8cc00221e; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Nirogi R, 2009, J NEUROSCI METH, V178, P116, DOI 10.1016/j.jneumeth.2008.12.001; Parkkila P, 2020, ACS CHEM NEUROSCI, V11, P969, DOI 10.1021/acschemneuro.0c00049; RIVETT AJ, 1982, BIOCHEMISTRY-US, V21, P1740, DOI 10.1021/bi00537a006; Robinson RG, 2012, ACS CHEM NEUROSCI, V3, P129, DOI 10.1021/cn200109w; ROTH JA, 1992, REV PHYSIOL BIOCH P, V120, P1, DOI 10.1007/BFb0036121; Salamon A, 2019, EXPERT OPIN PHARMACO, V20, P2201, DOI 10.1080/14656566.2019.1681971; TENHUNEN J, 1993, DNA CELL BIOL, V12, P253, DOI 10.1089/dna.1993.12.253; TENHUNEN J, 1994, EUR J BIOCHEM, V223, P1049, DOI 10.1111/j.1432-1033.1994.tb19083.x; Tenhunen J, 1996, DNA CELL BIOL, V15, P461, DOI 10.1089/dna.1996.15.461; Ulmanen I, 1997, EUR J BIOCHEM, V243, P452, DOI 10.1111/j.1432-1033.1997.0452a.x; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Zhang GL, 2019, ACS CHEM NEUROSCI, V10, P4221, DOI 10.1021/acschemneuro.9b00395	24	0	0	8	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	APR 5	2021	896								173909	10.1016/j.ejphar.2021.173909			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QP5UV	WOS:000623902800010	33503461				2022-02-07	
J	Wen, PS; Mackey, J; Rose, D; Waid-Ebbs, JK				Wen, Pey-Shan; Mackey, Jordan; Rose, Dorian; Waid-Ebbs, J. Kay			Smartphone Application for Measuring Community Participation in Veterans With Traumatic Brain Injury	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						brain injury; smartphone; community participation; veterans; measurement		The goal in the rehabilitation of veterans with mild traumatic brain injury (mTBI) is to improve community participation. A tool that can objectively measure community participation is lacking. The aims of this study are to evaluate the feasibility of a smartphone application (app) called MOVES to objectively measure community participation; and compare MOVES with a self-report questionnaire, and differences between veterans with mTBI and civilians without TBI. It is a 6-week parallel observational study, which included seven veterans with blast-related mTBI and five civilians without TBI. The measures include MOVES, Participation Assessment with Recombined Tools-Objective (self-report participation measure), Satisfaction Questionnaire, and Perceived Accuracy Daily Logs. Participants were mostly satisfied using the MOVES app with 75% retention rate. Perceived accuracy of the MOVES app was 90%, while the two groups showed similar discrepancies between the PART-O and the MOVES (52% vs. 53%). The MOVES app is a feasible option to objectively measure community participation. Self-report was discrepant from the MOVES app for both groups.	[Wen, Pey-Shan] Georgia State Univ, Atlanta, GA 30303 USA; [Mackey, Jordan; Rose, Dorian] Univ Florida, Gainesville, FL USA; [Rose, Dorian; Waid-Ebbs, J. Kay] Malcom Randall VAMC, Brain Rehabil Res Ctr, Gainesville, FL USA		Wen, PS (corresponding author), Georgia State Univ, Byrdine F Lewis Coll Nursing & Hlth Profess, Dept Occupat Therapy, 140 Decatur St, Atlanta, GA 30303 USA.	pwen@gsu.edu		Wen, Pey-Shan/0000-0002-8921-8801	Department of Veterans Affairs, Rehabilitation and Development Office, BRRC Center GrantUS Department of Veterans Affairs [B9256-C]; BRRC Innovation Award [0115BRRC-01]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Department of Veterans Affairs, Rehabilitation and Development Office, BRRC Center Grant B9256-C and BRRC Innovation Award No. 0115BRRC-01.	[Anonymous], 2016, VADOD CLIN PRACTICE; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Christopher E, 2019, CUREUS, V11, DOI 10.7759/cureus.5120; Connolly SL, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10748; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Fjeldsoe BS, 2013, HEALTH PROMOT J AUST, V24, P26, DOI 10.1071/HE12912; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Garcia SF, 2015, ARCH PHYS MED REHAB, V96, P596, DOI 10.1016/j.apmr.2014.06.019; Hurst FG, 2020, DISABIL REHABIL, V42, P651, DOI 10.1080/09638288.2018.1504993; Jamieson M, 2017, NEUROPSYCHOL REHABIL, V27, P919, DOI 10.1080/09602011.2015.1103760; Kirwan M, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1950; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Luxton DD, 2012, TELEMED E-HEALTH, V18, P409, DOI 10.1089/tmj.2011.0219; McCluskey A., 2012, ISRN REHABILITATION, V2012; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Nolan KJ, 2013, PHYS MED REH CLIN N, V24, P247, DOI 10.1016/j.pmr.2012.12.001; Oyesanya TO, 2021, DISABIL REHABIL, V43, P685, DOI 10.1080/09638288.2019.1638456; Oyesanya TO, 2019, ASSIST TECHNOL, DOI 10.1080/10400435.2019.1612798; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; ProtoGeo, 2018, MOVES MOBILE APP; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Vos L, 2020, J HEAD TRAUMA REHAB, V35, pE382, DOI 10.1097/HTR.0000000000000557; Wang J, 2016, MIL MED, V181, P560, DOI 10.7205/MILMED-D-14-00704; Wen PS, 2018, ARCH PHYS MED REHAB, V99, pS86, DOI 10.1016/j.apmr.2017.04.026; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434	34	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	JUL	2021	41	3					196	205	15394492211004159	10.1177/15394492211004159		APR 2021	10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	SU8GY	WOS:000637139100001	33813950				2022-02-07	
J	Zhuo, JC; Jiang, L; Rhodes, CS; Roys, S; Shanmuganathan, K; Chen, HG; Prince, JL; Badjatia, N; Gullapalli, RP				Zhuo, Jiachen; Jiang, Li; Sours Rhodes, Chandler; Roys, Steven; Shanmuganathan, Karthikamanthan; Chen, Hegang; Prince, Jerry L.; Badjatia, Neeraj; Gullapalli, Rao P.			Early Stage Longitudinal Subcortical Volumetric Changes following Mild Traumatic Brain Injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; volumetric analysis; post concussive symptoms; magnetic resonance imaging		Objective: To investigate early brain volumetric changes from acute to 6 months following mild traumatic brain injury (mTBI) in deep gray matter regions and their association with patient 6-month outcome. Methods: Fifty-six patients with mTBI underwent MRI and behavioral evaluation at acute (<10 days) and approximately 1 and 6 months post injury. Regional volume changes were investigated in key gray matter regions: thalamus, hippocampus, putamen, caudate, pallidum, and amygdala, and compared with volumes from 34 healthy control subjects. In patients with mTBI, we further assessed associations between longitudinal regional volume changes with patient outcome measures at 6 months including post-concussive symptoms, cognitive performance, and overall satisfaction with life. Results: Reduction in thalamic and hippocampal volumes was observed at 1 month among patients with mTBI. Such volume reduction persisted in the thalamus until 6 months. Changes in thalamic volumes also correlated with multiple symptom and functional outcome measures in patients at 6 months. Conclusion: Our results indicate that the thalamus may be differentially affected among patients with mTBI, resulting in both structural and functional deficits with subsequent post-concussive sequelae and may serve as a biomarker for the assessment of efficacy of novel therapeutic interventions.	[Zhuo, Jiachen; Jiang, Li; Sours Rhodes, Chandler; Roys, Steven; Shanmuganathan, Karthikamanthan; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Ctr Adv Imaging Res, Baltimore, MD 21201 USA; [Sours Rhodes, Chandler] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Prince, Jerry L.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Badjatia, Neeraj] Univ Maryland, Sch Med, Dept Neurol, Program Trauma, Baltimore, MD 21201 USA		Zhuo, JC (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Ctr Adv Imaging Res, Baltimore, MD 21201 USA.	jzhuo@som.umaryland.edu	Badjatia, Neeraj/AAS-4855-2021	Badjatia, Neeraj/0000-0003-1509-9034; Zhuo, Jiachen/0000-0001-6637-701X	Department of DefenseUnited States Department of Defense [W81XWH-08-1-0725]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS10550]	This work was supported by the Department of Defense [W81XWH-08-1-0725]; National Institute of Neurological Disorders and Stroke [5R01NS10550].	Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Clark AL, 2018, J HEAD TRAUMA REHAB, V33, P382, DOI 10.1097/HTR.0000000000000377; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Guild EB, 2015, J INT NEUROPSYCH SOC, V21, P650, DOI 10.1017/S1355617715000600; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kril JJ, 2004, NEUROSCI LETT, V361, P9, DOI 10.1016/j.neulet.2004.02.001; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; LYE T, 2000, NEUROPSYCHOL REV, V10; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; NEMETZ P, 1999, AM J EPIDEMIOL, V149; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; REEVES D, 2006, MIL MED, V171; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Ryan-Gonzalez C, 2019, J NEUROTRAUM, V36, P1584, DOI 10.1089/neu.2017.5590; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stenberg J, 2020, NEUROPSYCHOLOGY, V34, P560, DOI 10.1037/neu0000632; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; TEASDALE G, 1998, J NEUROTRAUM, V15; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA., 2007, ANALYSIS-UK, P294; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037; World Health Organisation, 1992, ICD 10 CLASSIFICATIO; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	43	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2021	35	6					725	733		10.1080/02699052.2021.1906445		APR 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SB4DP	WOS:000637257300001	33822686				2022-02-07	
J	Pienmunne, J; Batchelor, J; De Wit, B; Sowman, P				Pienmunne, Joel; Batchelor, Jennifer; De Wit, Bianca; Sowman, Paul			Rates of false positive outcomes on the A-WPTAS picture items in a sample of non-concussed athletes	BRAIN INJURY			English	Article						Sports-related concussion; post-traumatic amnesia; PTA; Westmead Post Traumatic Amnesia Scale	POSTTRAUMATIC AMNESIA SCALE	Accurate diagnosis of sports related concussion ensures that athletes are removed from play if concussed and prevents incorrect removal when a concussion has not occurred. Although various screening tools are currently in use, there is no gold standard measure with which to diagnose sports related concussion. Objective: The current study aimed to investigate the diagnostic accuracy of the Abbreviated Westmead Post Traumatic Amnesia Scale (A-WPTAS) picture task, a neurocognitive measure used to assess mild traumatic brain injury. The incidence of false positive classifications and the potential confounding effect of exercise on scores on the A-WPTAS picture items were examined. Methods: The study included an athlete group comprising 33 players and a control group comprising 37 subjects. The A-WPTAS picture task was completed on three testing occasions, separated by three week intervals. Results: Results revealed that the A-WPTAS picture task was highly accurate (>95%) in correctly classifying participants with no concussion across all three testing occasions. There was no significant difference between the two groups in relation to false positive outcomes on any testing occasion, suggesting that exercise was not a confounding factor. Conclusions: Findings provide preliminary evidence to support the use of the A-WPTAS picture task in a sporting context	[Pienmunne, Joel; Batchelor, Jennifer] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [De Wit, Bianca; Sowman, Paul] Macquarie Univ, Dept Cognit Sci, Sydney, NSW, Australia		Pienmunne, J (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW, Australia.	joelpienmunne1@hotmail.comm		De Wit, Bianca/0000-0002-3731-1887; Batchelor, Jennifer/0000-0003-4438-4993; Sowman, Paul/0000-0002-3863-6675			Borg G., 1998, BORGS PERCEIVED EXER; Elkington L., 2016, AUSTR I SPORT AUSTR; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; Hayter C, 2017, APPL NEUROPSYCH-ADUL, V24, P30, DOI 10.1080/23279095.2015.1081200; Hinson HE, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P334; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meares S, 2015, ARCH PHYS MED REHAB, V96, P956, DOI 10.1016/j.apmr.2014.12.014; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Scherr J, 2013, EUR J APPL PHYSIOL, V113, P147, DOI 10.1007/s00421-012-2421-x; Watson CE, 2017, SCAND J SURG, V106, P356, DOI 10.1177/1457496917698642	11	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					783	787		10.1080/02699052.2021.1911000		APR 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000648767600001	33971108				2022-02-07	
J	Schatz, P; Frees, A; Bilke, C; Brennan, N; Elbin, R				Schatz, Philip; Frees, Anastasia; Bilke, Clayton; Brennan, Neve; Elbin, Rj			Compliance with State Concussion Legislation in Non-School-Affiliated Youth Sport Leagues	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CDC HEADS; LAWS	Youth league administrators (N = 172) documented knowledge of/compliance with state concussion legislation, and were assigned to groups based on whether their state concussion legislation extended to non-school-affiliated (NSA) youth sport leagues: EXTEND (50.6%) or NOT EXTEND (49.4%). Administrators within the EXTEND group were 2.7x more likely to report having a formal concussion policy. Only 90.7% confirmed a policy for removing concussed athletes from play, and 75% required independent medical clearance, and 82% mandated education for coaches, 49.1% for parents, and 35.9% for athletes. These results raise questions regarding compliance with state concussion legislation, especially for NSA youth sports leagues.	[Schatz, Philip; Frees, Anastasia] St Josephs Univ, Dept Psychol, 222 Post Hall, Philadelphia, PA 19131 USA; [Bilke, Clayton; Elbin, Rj] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [Brennan, Neve] Dickinson Coll, Dept Psychol, Carlisle, PA 17013 USA		Schatz, P (corresponding author), St Josephs Univ, Dept Psychol, 222 Post Hall, Philadelphia, PA 19131 USA.	pschatz@sju.edu					Boufous S, 2004, AUST NZ J PUBL HEAL, V28, P482, DOI 10.1111/j.1467-842X.2004.tb00032.x; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Hanson Holly R, 2019, Inj Epidemiol, V6, P23, DOI 10.1186/s40621-019-0207-x; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Howland J, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-000959; Inst A., 2018, STATE PLAY 2018 TREN; Kajankova M, 2017, J SCHOOL HEALTH, V87, P409, DOI 10.1111/josh.12508; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; Morrissey D, 2014, J TRAUMA ACUTE CARE, V77, pS8, DOI 10.1097/TA.0000000000000331; O'Hara K, 2020, CUREUS, V12, DOI 10.7759/cureus.7691; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Schatz P, 2020, DEV NEUROPSYCHOL, V45, P110, DOI 10.1080/87565641.2020.1766464; Schmidt Julianne D, 2020, J Clin Transl Res, V5, P215; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019	18	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	APR 3	2021	46	3					184	191		10.1080/87565641.2021.1924721			8	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	RZ2ND	WOS:000648434300002	33969766				2022-02-07	
J	Jang, SH; Seo, YS				Jang, Sung Ho; Seo, You Sung			Neurogenic fever due to injury of the hypothalamus in a stroke patient Case report	MEDICINE			English	Article						diffusion tensor imaging; hypothalamus; intracerebral hemorrhage; intraventricular hemorrhage; neurogenic fever	TRAUMATIC BRAIN-INJURY	Rationale: Neurogenic fever is a non-infectious source of fever in a patient with brain injury, especially hypothalamic injury. We report on a stroke patient with neurogenic fever due to injury of hypothalamus, demonstrated by using diffusion tensor imaging (DTI). Patient concerns: A 28-year-old male patient was admitted to the rehabilitation department of university hospital at 30 months after onset. Brain MRI showed leukomalactic lesions in hypothalamus, bilateral medial temporal lobe, and bilateral basal ganglia. He showed intermittent high body temperature (maximum:39.5 degrees C, range:38.5-39.2 degrees C), but did not show any infection signs upon physical examination or after assessing his white blood cell count and inflammatory enzyme levels such as erythrocyte sedimentation rate and C-reactive protein. In addition, 8 age-matched normal (control) subjects (4 male, mean age: 26.6 years, range: 21-29years) were enrolled in the study. Diagnosis: Intraventricular hemorrhage and intracerebral hemorrhage in the left basal ganglia. Interventions: He underwent extraventricular drainage and ventriculoperitoneal shunting for hydrocephalus. Outcomes: DTI was performed at 30 months after onset, fractional anisotropy (FA) and apparent diffusion coefficient (ADC) values were obtained for hypothalamus. The FA and ADC values of patient were lower and higher, respectively, by more than two standard deviations from control values. Injury of hypothalamus was demonstrated in a stroke patient with neurogenic fever. Lessions: Our results suggest that evaluation of hypothalamus using DTI would be helpful in patients show unexplained fever following brain injury.	[Jang, Sung Ho; Seo, You Sung] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea		Seo, YS (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	yousung1008@hanmail.net			National Research Foundation (NRF) of Korea - Korean Government (MSIP) [2018R1A2B6000996]	DY This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MSIP) (2018R1A2B6000996).	Afifi AK, 2005, FUNCTIONAL NEUROANAT; Agrawal A., 2007, SMJ Singapore Medical Journal, V48, P492; Chua CO, 2009, STROKE, V40, P3369, DOI 10.1161/STROKEAHA.109.549212; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Goyal Keshav, 2020, Journal of Neurocritical Care, V13, P19, DOI 10.18700/jnc.190090; Hanken K, 2015, MULT SCLER RELAT DIS, V4, P39, DOI 10.1016/j.msard.2014.11.006; Jang SH, 2018, AM J PHYS MED REHAB, V97, P160, DOI 10.1097/PHM.0000000000000813; Jang SH, 2016, J NEUROL NEUROSUR PS, V87, P1260, DOI 10.1136/jnnp-2016-313093; Kasper, 2008, HARRISONS PRINCIPLES, P117; Meier K, 2017, J INTENSIVE CARE MED, V32, P124, DOI 10.1177/0885066615625194; Menzler K, 2012, SLEEP MED, V13, P736, DOI 10.1016/j.sleep.2012.02.013; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Shen YJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/148465; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Yeo SS, 2011, EUR NEUROL, V66, P235, DOI 10.1159/000330942; Zhao ZD, 2017, P NATL ACAD SCI USA, V114, P2042, DOI 10.1073/pnas.1616255114	18	0	0	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	APR 2	2021	100	13							e24053	10.1097/MD.0000000000024053			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SO4RD	WOS:000658960700003	33787568	Green Published, gold			2022-02-07	
J	Arroyo-Ferrer, A; Sanchez-Cuesta, FJ; Gonzalez-Zamorano, Y; del Castillo, MD; Sastre-Barrios, C; Rios-Lago, M; Romero, JP				Arroyo-Ferrer, Aida; Jose Sanchez-Cuesta, Francisco; Gonzalez-Zamorano, Yeray; Dolores del Castillo, Maria; Sastre-Barrios, Carolina; Rios-Lago, Marcos; Pablo Romero, Juan			Validation of Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients with Parkinson's Disease: Study Protocol for a Randomized Controlled Trial	MEDICINA-LITHUANIA			English	Article						Parkinson&#8217; s disease; balance; information processing speed; attention; cognitive rehabilitation	IMPAIRED EXECUTIVE FUNCTION; TRAUMATIC BRAIN-INJURY; DYNAMIC BALANCE; GO TEST; FALLS; GAIT; ATTENTION; SCALE; SPEED	Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder. This disease is characterized by motor symptoms, such as bradykinesia, tremor, and rigidity. Although balance impairment is characteristic of advanced stages, it can be present with less intensity since the beginning of the disease. Approximately 60% of PD patients fall once a year and 40% recurrently. On the other hand, cognitive symptoms affect up to 20% of patients with PD in early stages and can even precede the onset of motor symptoms. There are cognitive requirements for balance and can be challenged when attention is diverted or reduced, linking a worse balance and a higher probability of falls with a slower cognitive processing speed and attentional problems. Cognitive rehabilitation of attention and processing speed can lead to an improvement in postural stability in patients with Parkinson's. Methods: We present a parallel and controlled randomized clinical trial (RCT) to assess the impact on balance of a protocol based on cognitive rehabilitation focused on sustained attention through the NeuronUP platform (Neuronup SI, La Rioja, Spain) in patients with PD. For 4 weeks, patients in the experimental group will receive cognitive therapy three days a week while the control group will not receive any therapy. The protocol has been registered at trials.gov NCT04730466. Conclusions: Cognitive therapy efficacy on balance improvement may open the possibility of new rehabilitation strategies for prevention of falls in PD, reducing morbidity, and saving costs to the health care system.	[Arroyo-Ferrer, Aida; Jose Sanchez-Cuesta, Francisco; Gonzalez-Zamorano, Yeray; Pablo Romero, Juan] Univ Francisco Vitoria, Fac Ciencias Expt, Madrid 28223, Spain; [Gonzalez-Zamorano, Yeray] Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Escuela Int Doctorado, Madrid 28933, Spain; [Dolores del Castillo, Maria] Spanish Natl Res Council Arganda Rey, Ctr Automat & Robot, Neural & Cognit Engn Grp, Madrid 28500, Spain; [Sastre-Barrios, Carolina] Neuronup SL, Logrono 26006, Spain; [Rios-Lago, Marcos] UNED, Basic Psychol Dept 2, Madrid 28040, Spain; [Rios-Lago, Marcos; Pablo Romero, Juan] Hosp Beata Maria Ana, Brain Damage Unit, Madrid 28007, Spain		Romero, JP (corresponding author), Univ Francisco Vitoria, Fac Ciencias Expt, Madrid 28223, Spain.; Romero, JP (corresponding author), Hosp Beata Maria Ana, Brain Damage Unit, Madrid 28007, Spain.	aida.arroyo@ufv.es; fjose.sanchez@ufv.es; y.gonzalezz@alumnos.urjc.es; md.delcastillo@csic.es; carolina@neuronup.com; mrios@psi.uned.es; p.romero.prof@ufv.es	Rios-Lago, Marcos/P-6930-2019; Romero, Juan Pablo/Y-6765-2018	Rios-Lago, Marcos/0000-0003-0187-5047; Romero, Juan Pablo/0000-0002-3190-1296; del Castillo-Sobrino/0000-0002-9366-4484; Sanchez Cuesta, Francisco Jose/0000-0001-6202-7071; Arroyo, Aida/0000-0001-8704-242X			Allcock LM, 2009, PARKINSONISM RELAT D, V15, P110, DOI 10.1016/j.parkreldis.2008.03.010; Arroyo A, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.2031; Biundo R, 2017, ARCH CLIN NEUROPSYCH, V32, P840, DOI 10.1093/arclin/acx092; Bowman Thomas, 2018, Arch Physiother, V8, P10, DOI 10.1186/s40945-018-0051-2; Canning CG, 2020, NAT REV NEUROL, V16, P409, DOI 10.1038/s41582-020-0370-2; Canning CG, 2015, NEUROLOGY, V84, P304, DOI 10.1212/WNL.0000000000001155; Caronni A, 2018, GAIT POSTURE, V61, P287, DOI 10.1016/j.gaitpost.2018.01.015; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Clark S, 1997, ARCH PHYS MED REHAB, V78, P1078, DOI 10.1016/S0003-9993(97)90131-3; Diez-Cirarda M., NEUROREHABILITATION; Dona F, 2016, PHYSIOTHERAPY, V102, P272, DOI 10.1016/j.physio.2015.08.009; Edwards JD, 2013, NEUROLOGY, V81, P1284, DOI 10.1212/WNL.0b013e3182a823ba; Garg D., 2020, ANN MOV DISORD, V3, P79, DOI [10.4103/AOMD.AOMD_1_20, DOI 10.4103/AOMD.AOMD_1_20]; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Golden C.J., 2020, STROOP TEST COLORES, V6; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Heinzel S, 2016, PARKINSONISM RELAT D, V26, P73, DOI 10.1016/j.parkreldis.2016.03.007; Hulsdunker T, 2015, NEUROSCI LETT, V592, P1, DOI 10.1016/j.neulet.2015.02.049; Johnson D.K., ONSET MILD COGNITIVE; Kataoka H, 2015, J NEUROL, V262, P2049, DOI 10.1007/s00415-015-7814-4; Leung IHK, 2015, NEUROLOGY, V85, P1843, DOI 10.1212/WNL.0000000000002145; Lubrini G, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.90; Mak MK, 2014, ARCH PHYS MED REHAB, V95, P2390, DOI 10.1016/j.apmr.2014.08.006; Nocera JR, 2010, ADAPT PHYS ACT Q, V27, P87, DOI 10.1123/apaq.27.2.87; Opara JA, 2017, ANN AGR ENV MED, V24, P411, DOI 10.5604/12321966.1232774; Pal G, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0205-y; Pantall A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01044; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Petrelli A, 2014, PARKINSONISM RELAT D, V20, P1196, DOI 10.1016/j.parkreldis.2014.08.023; Picardi M, 2020, CLIN BIOMECH, V80, DOI 10.1016/j.clinbiomech.2020.105177; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Paris AP, 2011, MOVEMENT DISORD, V26, P1251, DOI 10.1002/mds.23688; Qutubuddin AA, 2005, ARCH PHYS MED REHAB, V86, P789, DOI 10.1016/j.apmr.2004.11.005; Rodriguez-Violante M, 2017, ARCH MED RES, V48, P221, DOI 10.1016/j.arcmed.2017.08.005; Ryan JJ, 2001, PERSP INDIV, P19; Shipley BA, 2002, NEUROPSYCHOLOGIA, V40, P1488, DOI 10.1016/S0028-3932(01)00195-6; Stacy MA, 2008, PARKINSONISM RELAT D, V14, P205, DOI 10.1016/j.parkreldis.2007.07.013; Stegemoller EL, 2014, PHYS THER, V94, P757, DOI 10.2522/ptj.20130251; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Varalta V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/365959; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Xu D, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/684758	45	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.	APR	2021	57	4							314	10.3390/medicina57040314			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RR7DM	WOS:000643253900001	33810477	Green Published, gold			2022-02-07	
J	Astuti, AK; Rahmayanti, F				Astuti, Ambar Kusuma; Rahmayanti, Febrina			Multiple Oral Ulcerations in a Seizure Patient with Undiagnosed Brain Arteriovenous Malformation	JOURNAL OF DENTISTRY INDONESIA			English	Article						brain arteriovenous malformation; oral ulceration; seizure; traumatic event	EPILEPSY; TRAUMA	Multiple ulcerations are rarely caused by a traumatic event, but seizures can induce repeated injury to the oral mucosa. A patient with a seizure history possesses a challenge in their dental management. Objective: In order to describe a case of multiple oral ulceration in a post-seizure patient with undiagnosed arteriovenous malformation (AVM) in the left parietal lobe and provide short guidelines for dentists in managing patient with a seizure history. Case report: A 23-years old female had multiple oral ulceration in the right and left buccal mucosa and her tongue. She reported having a seizure attack six days before. The patient never had a history of seizures or recurrent oral ulceration. During the seizure, improper placement of the spoon caused further damage to her oral mucosa. The trigger of her seizure is unknown. Based on the neurological consultation, she had an AVM on the left temporal lobe. In order to relieve pain, mouthwash containing aloe vera, sodium hyaluronate, glycyrhettinic acid, and polyvinylpyrrolidone (PVP) was prescribed. Conclusion: Dentists should be aware that oral mucosal injury can be related to a seizure disorder. A proper history and examination are essential to make an appropriate diagnosis. A safe dental treatment in seizure patients can be delivered accordingly.	[Astuti, Ambar Kusuma; Rahmayanti, Febrina] Univ Indonesia, Dept Oral Med, Fac Dent, Jakarta 10430, Indonesia		Rahmayanti, F (corresponding author), Univ Indonesia, Dept Oral Med, Fac Dent, Jakarta 10430, Indonesia.	febrina_r@ui.ac.id					Ajiboye N, 2014, SCI WORLD J, V2014, P1; Aragon CE, 2007, J CAN DENT ASSOC, V73, P71; Baranoski JF, 2014, J NEUROINTERV SURG, V6, P684, DOI 10.1136/neurintsurg-2013-010945; Casale M, 2016, INT J IMMUNOPATH PH, V29, P572, DOI 10.1177/0394632016652906; Casf N, 2019, J VASC ENDOVASC THER, V1, P1; Cho YW, 2019, J NEUROINTENSIVE CAR, V2, P1, DOI [10.32587/jnic.2019.00094, DOI 10.32587/JNIC.2019.00094]; Dalessandri D, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0850-1; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fitzpatrick SG, 2019, HEAD NECK PATHOL, V13, P91, DOI 10.1007/s12105-018-0981-8; Gerreth K, 2014, EUR J PAEDIATR DENT, V15, P13; Jacobsen Peter L, 2008, J Contemp Dent Pract, V9, P54; Joshi Sourabh Ramesh, 2013, Dent Res J (Isfahan), V10, P562; Kannan K, 2018, J DENT ORAL DISORD, V4, P2; Kapoor Pranav, 2011, Indian J Dermatol, V56, P300, DOI 10.4103/0019-5154.82485; Karolyhazy K, 2003, EPILEPSIA, V44, P1103, DOI 10.1046/j.1528-1157.2003.04003.x; Khan MA, 2015, PAKISTAN ORAL DENT J, V35, P3; Mehmet Y, 2012, SURG SCI, V3, P47; Mortazavi H, 2016, INT J DENT, V2016, DOI 10.1155/2016/7278925; Nair GR, 2016, J CLIN DIAGN RES, V10, pZE1, DOI 10.7860/JCDR/2016/18142.8222; Nonato ER, 2011, ARQ NEURO-PSIQUIAT, V69, P491, DOI 10.1590/S0004-282X2011000400016; Salman RA, 2012, EPILEPSIA, V53, P34, DOI 10.1111/j.1528-1167.2012.03611.x; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Stafstorm C.E., 2015, CSH PERSPECT MED, P1; Turner MD, 2005, J ORAL MAXIL SURG, V63, P996, DOI 10.1016/j.joms.2004.04.038	24	0	0	0	0	UNIV INDONESIA, FAC DENTISTRY	JAKARTA PUSAT	JALAN SALEMBA 6, JAKARTA PUSAT, 10430, INDONESIA	1693-9697	2355-4800		J DENT INDONES	J. DENT. INDONES.	APR	2021	28	1					54	58		10.14693/jdi.v28i1.1214			5	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	TP4OP	WOS:000677575300009		gold			2022-02-07	
J	Ayubcha, C; Moghbel, M; Borja, AJ; Newberg, A; Werner, TJ; Alavi, A; Revheim, ME				Ayubcha, Cyrus; Moghbel, Mateen; Borja, Austin J.; Newberg, Andrew; Werner, Thomas J.; Alavi, Abass; Revheim, Mona-Elisabeth			Tau Imaging in Head Injury	PET CLINICS			English	Article						Tau; Chronic traumatic encephalopathy; PET; Neurodegeneration; Imaging; CTE	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; AXONAL-TRANSPORT; BIOMARKERS; PROTEIN; ISOFORMS; FLUID	In reviewing this literature, there are several apparent takeaways. There are variations in the binding patterns between different tau radio-tracers. Nevertheless, there is consistently uptake in certain regions across studies; aberrant binding is expected given the variation in small studies and potential off-site radiotracer binding. However, the literature suggests that larger studies may be more consistent in finding uptake in regions where tau aggregates are normally observed in CTE populations. Overall, the evidence suggests that tau-PET imaging will continue to play a significant role in TBI and CTE. These studies have shown considerable promise in the imaging of tau and prospective larger studies may substantiate the use of a particular radiotracer in the assessment of long-term TBI ramifications and the diagnosis of CTE. In particular, there is a notable need for future studies that incorporate in vivo imaging and postmortem pathologic study.	[Ayubcha, Cyrus] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA; [Moghbel, Mateen] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Borja, Austin J.; Werner, Thomas J.; Alavi, Abass] Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Borja, Austin J.] Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Newberg, Andrew] Thomas Jefferson Univ, Marcus Inst Integrat Hlth, Dept Integrat Med & Nutr Sci, Philadelphia, PA 19107 USA; [Newberg, Andrew] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Revheim, Mona-Elisabeth] Oslo Univ Hosp, Div Radiol & Nucl Med, Sognsvannsveien 20, N-0372 Oslo, Norway; [Revheim, Mona-Elisabeth] Univ Oslo, Fac Med, Inst Clin Med, Problemveien 7, N-0315 Oslo, Norway		Revheim, ME (corresponding author), Oslo Univ Hosp, Div Radiol & Nucl Med, Sognsvannsveien 20, N-0372 Oslo, Norway.	monar@ous-hf.no		Ayubcha, Cyrus/0000-0001-8347-9173			Ayubcha C, 2021, EUR J NUCL MED MOL I, V48, P623, DOI 10.1007/s00259-020-04926-4; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Chen ST, 2018, J ALZHEIMERS DIS, V65, P79, DOI 10.3233/JAD-171152; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hall B, 2017, AGEING RES REV, V36, P50, DOI 10.1016/j.arr.2017.03.002; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Irwin DJ, 2016, PARKINSONISM RELAT D, V22, pS29, DOI 10.1016/j.parkreldis.2015.09.020; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Mantyh WG, 2020, JAMA NEUROL, V77, P517, DOI 10.1001/jamaneurol.2019.4509; Marquie M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0808-1; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Melkova K, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9030105; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Muller R, 1997, CELL TISSUE RES, V288, P239, DOI 10.1007/s004410050809; Okonkwo DO, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00831; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Qiang L, 2018, CURR BIOL, V28, P2181, DOI 10.1016/j.cub.2018.05.045; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Soto C, 2018, NAT NEUROSCI, V21, P1332, DOI 10.1038/s41593-018-0235-9; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Takahata K, 2019, BRAIN, V142, P3265, DOI 10.1093/brain/awz238; Vasilevskaya A, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102212; Wooten DW, 2019, J NEUROTRAUM, V36, P3233, DOI 10.1089/neu.2018.6178; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102	35	0	0	4	4	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1556-8598	1559-7814		PET CLIN	PET Clin.	APR	2021	16	2					249	260		10.1016/j.cpet.2020.12.009			12	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	SS0KB	WOS:000661430200009	33648666	hybrid			2022-02-07	
J	Aziz, PA; Pathan, S; Rauf, A; Ahmed, S; Raja, RA; Nasir, Z				Aziz, Peer Asad; Pathan, Sanaullah; Rauf, Abdul; Ahmed, Suhail; Raja, Riaz Ahmed; Nasir, Zeeshan			Outcomes of Conventional Craniotomy under Local Anesthesia in Traumatic Brian Injury Using Peer Regimen	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						Outcome; Conventional craniotomy; Traumatic brain injury	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; SUBDURAL-HEMATOMA; EPIDEMIOLOGY; HYPERTENSION; MANAGEMENT	Objective: To see the efficacy or safety of managing traumatic brain injury under local anesthesia. Study Design: Retrospective cohort study. Place and Duration of Study: Department of Neurosurgery, Liaquat University Hospital Hyderabad from 1st December 2017 to 31st December 2018. Methodology: Ten patients of all males between 20 to 55 years of age were included. The data was collected from the patients that went through emergency surgery or showed drop of more than three GCS. The data was collected through questionnaire based approach in three phases of whole time duration.i.e. preoperative, post operative with three month follow up. Results: The extra-dural hematoma (80%) and combination of extra-dural hematoma with acute subdural hematoma (20%). Improvement of GCS from initial moderate to severe GCS (90%), improvement of nonradiological vitals, systolic blood pressure (70%), heart rate (90%), respiration rate (80%), eye pupil size (70%), improvement of neurological deficit (33%) with improvement in radiological variables, midline line shift reversal (100%), removal of hematoma (100%), improvement in volume on scan (100%) and reversal of Cisterns and sulci (100%). Post-operative complication includes iatrogenic pnemocephalus (100%), new hematoma or contusion (10%) and ischemia or infarct (20%) which was resolved within 5 to 7 days post operatively.i.e. pnemocephalus (90%), hematoma (100%) and ischemia or infarct (50%) with total of (90%) clinical and functional outcome. At the time of discharge, headache (50%), numbness (20 %), pain at surgical side (70%) and vertigo (50%), which were subsequently improvement of headache (100%), numbness (100%), pain at surgical side (57%) and vertigo (50%) due to conservative management up to three month follows up. Conclusion: Conventional craniotomy under local anesthesia should be initial approach for early relive in extradural hematoma with or without acute subdural hematoma.	[Aziz, Peer Asad; Pathan, Sanaullah; Rauf, Abdul; Ahmed, Suhail; Raja, Riaz Ahmed; Nasir, Zeeshan] Liaquat Univ Hosp, Dept Neurosurg, Hyderabad, Pakistan		Aziz, PA (corresponding author), Liaquat Univ Hosp, Dept Neurosurg, Hyderabad, Pakistan.	pirasadaziz@hotmail.com					Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Danks RA, 1998, NEUROSURGERY, V42, P28, DOI 10.1097/00006123-199801000-00006; Di Rienzo A, 2017, J NEUROL SURG PART A, V78, P535, DOI 10.1055/s-0037-1599054; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; GOLDMAN L, 1979, ANESTHESIOLOGY, V50, P285, DOI 10.1097/00000542-197904000-00002; Hannay J. H., 2004, NEUROPSYCHOLOGICAL A, P133; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lotfy M, 2010, EGYPT J NEUROL PSYCH, V47, P255; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mehan ND, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0151-4; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Poon WS, 2005, ACT NEUR S, V93, P207; Qureshi PAA, 2017, SURG EVACUATION EXTR, P34; Qureshi PAA, 2017, ACUTE SUBDURAL HEMAT, P23; Rayan N, 2012, J TRAUMA ACUTE CARE, V72, P585, DOI 10.1097/TA.0b013e318243da4d; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Tao J, 2013, J DIABETES METAB, V4, P4172	27	0	0	0	0	LAHORE MEDICAL & DENTAL COLL	LAHORE	CANAL BANK N, TULSPURA, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	APR	2021	15	4					1488	1491					4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SV4DU	WOS:000663771700077					2022-02-07	
J	Beydoun, HA; Beydoun, MA; Weiss, J; Hossain, S; Huang, SY; Alemu, BT; Zonderman, AB				Beydoun, Hind A.; Beydoun, May A.; Weiss, Jordan; Hossain, Sharmin; Huang, Shuyan; Alemu, Brook T.; Zonderman, Alan B.			Insomnia as a predictor of diagnosed memory problems: 2006-2016 Health and Retirement Study	SLEEP MEDICINE			English	Article						Aging; Alzheimer's disease; Insomnia; Dementia; Neurodegenerative; Sleep	COMMUNITY-DWELLING MEN; TRAUMATIC BRAIN-INJURY; COGNITIVE FUNCTION; OSTEOPOROTIC FRACTURES; SLEEP DURATION; OLDER-ADULTS; POOR SLEEP; ASSOCIATIONS; PERFORMANCE; DEMENTIA	Objective: To evaluate the longitudinal relationship in insomnia symptoms over time with incident memory problems and dementia diagnoses among U.S. adults aged 65 years and older. Methods: Secondary analyses were performed on 9518 elderly participants (>= 65 years) who completed the 2006 wave of the Health and Retirement Study (HRS) and were followed-up to determine if insomnia symptom scores (2006-2014) were associated with time- to-onset of [1] physician-diagnosed "memory-related disease", "Alzheimer's disease" and/or "dementia, senility or any other serious memory impairment" and [2] diagnosis of dementia based on HRS-specific criteria. Cox proportional hazards models were constructed adjusting for socio-demographic, lifestyle, and health characteristics. Results: In fully adjusted models, severe insomnia symptoms were associated with increased risk of physician-diagnosed memory problems. Individuals reporting any change (increase or decrease) in insomnia symptoms during the 2006-2010 period were more likely to be diagnosed with dementia based on HRS criteria. Finally, those who experienced an increase in the severity of insomnia symptoms over time exhibited 41-72% increased risks of physician-diagnosed memory problems and 45-58% increased risks of dementia diagnosis based on HRS criteria. Conclusions: When severe insomnia symptoms increased over time, physician-diagnosed memory problems and dementia diagnoses also increased among U.S. elderly people over a 10-year follow-up period. More studies are required to confirm these findings using large prospective cohort designs and validated tools. (C) 2021 Elsevier B.V. All rights reserved.	[Beydoun, Hind A.] Ft Belvoir Community Hosp, Dept Res Programs, 9300 Dewitt Loop, Ft Belvoir, VA 22060 USA; [Beydoun, May A.; Hossain, Sharmin; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, NIH, IRP, Baltimore, MD 21225 USA; [Weiss, Jordan] Univ Calif Berkeley, Dept Demog, Berkeley, CA USA; [Huang, Shuyan] Ft Belvoir Troop Command, Ft Belvoir, VA 22060 USA; [Alemu, Brook T.] Western Carolina Univ, Sch Hlth Sci, Hlth Sci Program, Cullowhee, NC 28723 USA		Beydoun, HA (corresponding author), Ft Belvoir Community Hosp, Dept Res Programs, 9300 Dewitt Loop, Ft Belvoir, VA 22060 USA.	Hind.a.Baydoun.civ@mail.mil; baydounm@mail.nih.gov; jordanmnw@gmail.com; sharmin.hossain@nih.gov; shuyanh@yahoo.com; balemu@email.wcu.edu; zondermana@mail.nih.gov		Weiss, Jordan/0000-0002-0392-3535			Al-Qassabi A, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0458-1; Andre C, 2020, JAMA NEUROL, V77, P716, DOI 10.1001/jamaneurol.2020.0311; Aoun R, 2019, NAT SCI SLEEP, V11, P131, DOI 10.2147/NSS.S182158; Aurora RN, 2019, J CLIN SLEEP MED, V15, P749, DOI 10.5664/jcsm.7768; Bergmans RS, 2021, J HEALTH PSYCHOL, V26, P1913, DOI 10.1177/1359105319891650; Blackwell T, 2006, J GERONTOL A-BIOL, V61, P405, DOI 10.1093/gerona/61.4.405; Blackwell T, 2015, J AM GERIATR SOC, V63, P453, DOI 10.1111/jgs.13321; Blackwell T, 2014, SLEEP, V37, P655, DOI 10.5665/sleep.3562; Blackwell T, 2011, J AM GERIATR SOC, V59, P2217, DOI 10.1111/j.1532-5415.2011.03731.x; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; Brenner R, 2019, RESPIRATION, V97, P15, DOI 10.1159/000486577; Bubu OM, 2020, SLEEP MED REV, V50, DOI 10.1016/j.smrv.2019.101250; Capobianco DM, 2014, LARYNGOSCOPE, V124, P320, DOI 10.1002/lary.24207; Choe YM, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0536-6; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Davydow DS, 2015, PSYCHOSOM MED, V77, P200, DOI 10.1097/PSY.0000000000000136; Gildner TE, 2019, ARCH GERONTOL GERIAT, V83, P161, DOI 10.1016/j.archger.2019.04.014; Gronewold J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050863; Hahn EA, 2014, AM J GERIAT PSYCHIAT, V22, P1262, DOI 10.1016/j.jagp.2013.04.015; Herring WJ, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12782; Hery CMB, 2020, SLEEP HEALTH, V6, P48, DOI 10.1016/j.sleh.2019.09.005; Hunter JC, 2018, ALZHEIMERS DEMENT, V14, P454, DOI 10.1016/j.jalz.2017.10.007; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Kamble N, 2019, SLEEP MED, V62, P1, DOI 10.1016/j.sleep.2019.04.001; Kaufmann CN, 2016, AM J GERIAT PSYCHIAT, V24, P575, DOI 10.1016/j.jagp.2016.02.049; Kaufmann CN, 2013, J GERONTOL A-BIOL, V68, P1512, DOI 10.1093/gerona/glt050; Kim ES, 2015, J BEHAV MED, V38, P590, DOI 10.1007/s10865-015-9635-4; Kuehn BM, 2019, CIRCULATION, V139, P2483, DOI 10.1161/CIRCULATIONAHA.119.041278; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Lee JH, 2017, J BEHAV MED, V40, P821, DOI 10.1007/s10865-017-9850-2; Leggett A, 2016, J GERONTOL A-BIOL, V71, P954, DOI 10.1093/gerona/glv227; Leggett AN, 2018, INT J GERIATR PSYCH, V33, P1265, DOI 10.1002/gps.4923; Li YJ, 2019, SLEEP MED, V60, P211, DOI 10.1016/j.sleep.2019.03.026; Liao J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24778-1; Low DV, 2019, AM J GERIAT PSYCHIAT, V27, P1386, DOI 10.1016/j.jagp.2019.07.001; Ludka Ondrej, 2019, Cas Lek Cesk, V158, P178; McGrath R, 2020, J AM MED DIR ASSOC, V21, P634, DOI 10.1016/j.jamda.2019.08.032; McGrath RP, 2019, J AM MED DIR ASSOC, V20, P730, DOI 10.1016/j.jamda.2018.10.014; McKeon AB, 2019, NEUROREHABILITATION, V45, P163, DOI 10.3233/NRE-192804; Seijo LM, 2019, SLEEP MED, V63, P41, DOI 10.1016/j.sleep.2019.05.011; Min Yaena, 2016, J Aging Res, V2016, P3685789, DOI 10.1155/2016/3685789; Musiek ES, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.121; Ojile J, 2017, SLEEP HEALTH, V3, P226, DOI 10.1016/j.sleh.2017.05.009; Ownby RL, 2014, AM J GERIAT PSYCHIAT, V22, P148, DOI 10.1016/j.jagp.2012.08.001; Santoro JD, 2018, J CLIN SLEEP MED, V14, P1187, DOI 10.5664/jcsm.7222; Sateia M J, 2000, Semin Clin Neuropsychiatry, V5, P227, DOI 10.1053/scnp.2000.9556; Sharma A, 2019, PROG BRAIN RES, V245, P1, DOI 10.1016/bs.pbr.2019.03.002; Shih YC, 2019, ANN BEHAV MED, V53, P345, DOI 10.1093/abm/kay048; Short MA, 2019, PROG BRAIN RES, V246, P55, DOI 10.1016/bs.pbr.2019.02.008; Sillah A, 2019, PREV MED REP, V15, DOI 10.1016/j.pmedr.2019.100886; Song YS, 2015, SLEEP, V38, P411, DOI 10.5665/sleep.4500; Spiegelhalder K, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0364-5; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; Stone CR, 2019, CANCER CAUSE CONTROL, V30, P501, DOI 10.1007/s10552-019-01156-4; Tall AR, 2019, NATURE, V566, P329, DOI 10.1038/d41586-019-00393-6; Targa ADS, 2017, ONCOTARGET, V8, P5654, DOI 10.18632/oncotarget.14000; Tranah GJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191281; Vaghela P, 2016, SLEEP HEALTH, V2, P100, DOI 10.1016/j.sleh.2016.02.003; Wang F, 2019, PERSPECT PSYCHIATR C, V55, P344, DOI 10.1111/ppc.12353; Wei MY, 2018, J GERONTOL A-BIOL, V73, P225, DOI 10.1093/gerona/glx114; Weir D, 2011, LONGITUD LIFE COURSE, V2, P170; Winkelman JW, 2020, NEUROPSYCHOPHARMACOL, V45, P1, DOI 10.1038/s41386-019-0514-5; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yaffe K, 2007, NEUROLOGY, V69, P237, DOI 10.1212/01.wnl.0000265814.69163.da; Yan B, 2020, J DIABETES, V12, P215, DOI 10.1111/1753-0407.12987; Zeitzer JM, 2018, J GERONTOL A-BIOL, V73, P682, DOI 10.1093/gerona/glw250; Zhou GY, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018405	67	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	APR	2021	80						158	166		10.1016/j.sleep.2021.01.038			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WO3ZM	WOS:000712396300021	33601227				2022-02-07	
J	Breton, JM; George, KM; Riesenburger, RI				Breton, Jeffrey M.; George, Keith M.; Riesenburger, Ron, I			Diagnosis of a chronic spinal cord injury via televisit in a patient from an underserved community	JOURNAL OF SURGICAL CASE REPORTS			English	Article							TELEMEDICINE	A 42-year-old woman from a medically underserved community in rural New England was referred by her primary care provider (PCP) for televisit during the coronavirus disease 2019 (COVID-19) pandemic following 2 years of chronic neck pain and numbness in her left hand that was initially concerning for demyelinating disease. Upon further evaluation, it was revealed that she had experienced a traumatic fall with a concussion and symptoms consistent with central cord syndrome but had refused magnetic resonance imaging (MRI) at her initial medical evaluation. On MRI conducted 1 month prior to neurosurgical evaluation she was found to have a disc bulge and 4-mm T2-hyperintense lesion at the C4-C5 level that was consistent with a chronic spinal cord injury secondary to spinal trauma with associated vertebrogenic injury. This televisit confirmed the diagnosis of chronic spinal cord injury for this patient and allowed for discussion of future interventions, avoided further unnecessary referrals, and increased access to care.	[Breton, Jeffrey M.; George, Keith M.; Riesenburger, Ron, I] Tufts Univ, Sch Med, Dept Neurosurg, Boston, MA 02111 USA; [Riesenburger, Ron, I] Tufts Med Ctr, Dept Neurosurg, 800 Washington St,Box 178, Boston, MA 02111 USA		Riesenburger, RI (corresponding author), Tufts Med Ctr, Dept Neurosurg, 800 Washington St,Box 178, Boston, MA 02111 USA.	RRiesenburger@TuftsMedicalCenter.org		Breton, Jeffrey/0000-0002-7125-8303			Cremades M, 2020, AM J SURG, V219, P882, DOI 10.1016/j.amjsurg.2020.03.023; Dallolio L, 2008, ARCH PHYS MED REHAB, V89, P2332, DOI 10.1016/j.apmr.2008.06.012; Hakim AA, 2020, AM J SURG, V220, P48, DOI 10.1016/j.amjsurg.2020.04.026; Irgens I, 2018, SPINAL CORD, V56, P643, DOI 10.1038/s41393-017-0033-3; Reyes AJ, 2016, BMJ CASE REP, V2016; Ryken TC, 2013, NEUROSURGERY, V72, P54, DOI 10.1227/NEU.0b013e318276edee; Shank CD, 2019, NEUROCRIT CARE, V30, P261, DOI 10.1007/s12028-018-0537-5; Sundgren PC, 2016, DIS BRAIN HEAD NECK, P187; Walker WC, 2020, CONCUSSION, P37	9	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2042-8812			J SURG CASE REP	J. Surg. Case Rep.	APR	2021		4							rjab090	10.1093/jscr/rjab090			3	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	TX9CK	WOS:000683382900027	33927849	gold, Green Published			2022-02-07	
J	Burton, L				Burton, Leslie			METACOGNITION AND FRONTAL LOBE FUNCTIONING	CLINICAL NEUROPSYCHIATRY			English	Article						metacognition; frontal lobes; Wisconsin Card Sorting Test; traumatic brain injury; executive functions	CARD SORTING TEST; EXECUTIVE FUNCTION; TEST-PERFORMANCE; ACCURACY; SENSITIVITY; RECOGNITION; IMPAIRMENT; LESIONS; MEMORY; DAMAGE	Objective: The frontal lobes have been reported to play in important role in metacognition. The present study evaluated metacognition in a group of neurological patients. Method: Twenty-one neurological (traumatic brain injury and cerebral vascular accident) patients were administered a metacognitive test and neuropsychological tests including a well-known index of frontal lobe functioning, the Wisconsin Card Sorting Test (WCST). After each trial, the participants were asked to evaluate their own performance on a face recognition test by rating their confidence about their accuracy on a scale of 1 (not very confident) to 3 (very confident). Results: A point biserial correlation between accuracy on each trial and confidence was calculated for each participant as a measure of metacognition, Mcog. Mcog was significantly associated with the index of executive/frontal lobe functioning, WCST number of categories. Mcog was not associated with Full Scale IQ, General Memory Quotient, or Benton Facial Recognition Test score (short form, which did not include the experimental trials). Conclusions: These data add support to the idea that the frontal lobes have a special role in metacognition.	[Burton, Leslie] Univ Connecticut, Stamford, CT 06901 USA		Burton, L (corresponding author), Univ Connecticut, Dept Psychol Sci, One Univ Pl, Stamford, CT 06901 USA.	Leslie.Burton@UConn.edu					Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; AXELROD BN, 1992, CLIN NEUROPSYCHOL, V6, P16; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Benton A., 1994, CONTRIBUTIONS NEUROP; Beran M. J., 2012, FDN METACOGNITION; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; DRICKER J, 1978, NEUROPSYCHOLOGIA, V16, P683, DOI 10.1016/0028-3932(78)90003-9; Duffy J. D., 2001, FRONTAL LOBES NEUROP, P113; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming SM, 2014, BRAIN, V137, P2811, DOI 10.1093/brain/awu221; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Fleming Stephen M, 2014, COGNITIVE NEUROSCIEN; Gomez-de-Regil L, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10100699; Grimaldi P, 2015, NEUROSCI BIOBEHAV R, V55, P88, DOI 10.1016/j.neubiorev.2015.04.006; HAMSHER KD, 1979, ARCH NEUROL-CHICAGO, V36, P837, DOI 10.1001/archneur.1979.00500490051008; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R., 2000, WISCONSIN CARD SORTI; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; Jastrow, 1885, MEMOIRS NATIONAL ACA, V3, P73; Kopp B, 2021, ASSESSMENT, V28, P248, DOI 10.1177/1073191119866257; Lange F, 2018, NEUROSCI BIOBEHAV R, V93, P38, DOI 10.1016/j.neubiorev.2018.06.014; Maniscalco B., 2012, COGNITIVE NEUROSCIEN; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; McCurdy LY, 2013, J NEUROSCI, V33, P1897, DOI 10.1523/JNEUROSCI.1890-12.2013; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MULDER JL, 1995, CORTEX, V31, P487; Prigatano G., 1990, CLIN NEUROPSYCHOL, V4, P1; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rhodes MG, 2004, PSYCHOL AGING, V19, P482, DOI 10.1037/0882-7974.19.3.482; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D., 1991, AWARENESS DEFICITS F; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Van Allen MW, 1968, CORTEX, V93, P38, DOI [10.1016/S0010-9452(68)80018-8, DOI 10.1016/S0010-9452(68)80018, 10.1016/S0010-9452(68)80018]; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED	42	0	0	8	10	GIOVANNI FIORITI EDITORE	ROME	VIA ARCHIMEDE 179, ROME, 00197, ITALY	1724-4935	2385-0787		CLIN NEUROPSYCHIATR	Clin. Neuropsychiatr.	APR	2021	18	2					86	90		10.36131/cnfioritieditore20210202			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RT0QS	WOS:000644173700002	34909023				2022-02-07	
J	Chaudhari, PP; Pineda, JA; Bachur, RG; Khemani, RG				Chaudhari, Pradip P.; Pineda, Jose A.; Bachur, Richard G.; Khemani, Robinder G.			Trends and variation in repeat neuroimaging for children with traumatic intracranial hemorrhage	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						brain injuries; diagnostic imaging; hospitals; intracranial hemorrhages; neuroimaging; pediatric emergency medicine; pediatrics; traumatic; wounds and injuries	HEAD COMPUTED-TOMOGRAPHY; BRAIN-INJURY; MILD; CT; MANAGEMENT; MRI	Objectives We aimed to determine trends and institutional variation in repeat neuroimaging in children with traumatic intracranial hemorrhage and to identify factors associated with neuroimaging modality (subsequent magnetic resonance imaging [MRI] vs computed tomography [CT]). Methods We conducted a retrospective cross-sectional study of 35 hospitals in the Pediatric Health Information System database. We included children <18 years of age hospitalized from 2010-2019 with intracranial hemorrhage and who underwent a brain CT. We calculated repeat neuroimaging rates by modality and used regression analyses to examine temporal trends. We used hierarchical logistic regression to identify factors associated with subsequent MRI versus repeat CT, controlling for hospital. Results We identified 12,714 children with intracranial hemorrhage, of which 5072 with repeat neuroimaging were studied. Of the 5072 children with repeat neuroimaging, repeat CT was performed in 67.6% (n = 3429) and subsequent MRI in 32.4% (n = 1643). Overall repeat neuroimaging with either a CT or MRI remained similar from 2010-2019 (P = 0.431); however, repeat CT scans significantly decreased (P = 0.001); whereas, MRIs significantly increased (P < 0.001). Repeat neuroimaging by hospital ranged from 20%-80%. After controlling for institution, subsequent MRI was more likely to be used in younger children and children who did not receive hyperosmotic agents, neurosurgical interventions, or intensive care unit admission (all P-values <0.001). Conclusions We found that repeat neuroimaging rates for children with intracranial hemorrhage vary substantially by institution. We also found that although MRI was increasingly used to re-image these children, overall repeat neuroimaging rates (CT or MRI) have not decreased over the past decade. Future work to implement optimal utilization of neuroimaging in these children is needed.	[Chaudhari, Pradip P.] Childrens Hosp Los Angeles, Div Emergency & Transport Med, 4650 Sunset Blvd Mail Stop 113, Los Angeles, CA 90027 USA; [Chaudhari, Pradip P.; Pineda, Jose A.; Khemani, Robinder G.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Pineda, Jose A.; Khemani, Robinder G.] Childrens Hosp Los Angeles, Dept Anesthesia & Crit Care Med, Los Angeles, CA 90027 USA; [Bachur, Richard G.] Boston Childrens Hosp, Div Emergency, Boston, MA USA; [Bachur, Richard G.] Harvard Med Sch, Boston, MA 02115 USA		Chaudhari, PP (corresponding author), Childrens Hosp Los Angeles, Div Emergency & Transport Med, 4650 Sunset Blvd Mail Stop 113, Los Angeles, CA 90027 USA.	pchaudhari@chla.usc.edu		Chaudhari, Pradip/0000-0002-7732-632X			Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; Boyle TP, 2014, PEDIATRICS, V134, pE47, DOI 10.1542/peds.2013-3739; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Dawson EC, 2012, PEDIATR NEUROSURG, V48, P221, DOI 10.1159/000346697; Epstein D, 2011, PEDIATRICS, V127, pE588, DOI 10.1542/peds.2010-0394; Faul M, 2010, TRAUMATIC BRAIN INJU; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Flaherty BF, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0385; Greenberg JK, 2019, J NEUROSURG-PEDIATR, V23, P227, DOI 10.3171/2018.7.PEDS18263; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Hill EP, 2017, J TRAUMA ACUTE CARE, V82, P896, DOI 10.1097/TA.0000000000001406; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; Khemani RG, 2019, LANCET RESP MED, V7, P115, DOI 10.1016/S2213-2600(18)30344-8; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Lumba-Brown A, 2020, JACEP OPEN, V1, P994, DOI 10.1002/emp2.12055; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Murray BL, 2013, ANN EMERG MED, V62, pS67; Patel SK, 2018, J PEDIATR SURG, V53, P2048, DOI 10.1016/j.jpedsurg.2018.04.027; Sheridan DC, 2020, JACEP OPEN, V1, P965, DOI 10.1002/emp2.12113; WONG GY, 1985, J AM STAT ASSOC, V80, P513, DOI 10.2307/2288464	24	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	APR	2021	2	2							e12400	10.1002/emp2.12400			9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RV1OW	WOS:000645611000010	33733248	gold, Green Published			2022-02-07	
J	Chaudhari, PP; Pineda, J; Bachur, RG; Khemani, RG				Chaudhari, Pradip P.; Pineda, Jose; Bachur, Richard G.; Khemani, Robinder G.			Epidemiology of Critical Interventions in Children With Traumatic Intracranial Hemorrhage	PEDIATRIC EMERGENCY CARE			English	Article						critical intervention; intracranial hemorrhage; traumatic brain injury		Objective To estimate rates of critical medical and neurosurgical interventions and resource utilization for children with traumatic intracranial hemorrhage (ICH). Methods This was a retrospective study of children younger than 18 years hospitalized in 1 of 35 hospitals in the Pediatric Health Information System from 2009 to 2019 for ICH. We defined critical intervention as a critical medical (hyperosmotic agents and intubation) or neurosurgical intervention. We determined rates of critical interventions, intensive care unit (ICU) admission, and repeat neuroimaging. We used hierarchical logistic regression to identify high-level factors associated with undergoing critical interventions, controlling for hospital-level effects. Results There were 12,714 children with ICH included in the study. Median (interquartile range) age was 4.3 (0.7-11.0) years. Twelve percent (n = 1470) of children underwent a critical clinical intervention. Critical medical interventions occurred in 10% (n = 1219), and neurosurgical interventions occurred in 3% (n = 419). Intensive care unit admission occurred in 44% (n = 5565), whereas repeat neuroimaging occurred in 40% (n = 5072). Among ICU patients, 79% (n = 4366) did not undergo a critical intervention. Of the 11,244 children with no critical interventions, 39% (n = 4366) underwent ICU admission, and 37% (n = 4099) repeat neuroimaging. After controlling for hospital, children with isolated subdural (P = 0.013) and isolated subarachnoid (P < 0.001) hemorrhage were less likely to receive critical interventions. Conclusions Critical medical interventions occurred in 10% of children with ICH, and neurosurgical interventions occurred in 3%. Intensive care unit admission and repeat neuroimaging are common, even among those who did not undergo critical interventions. Selective utilization of ICU admission and repeat neuroimaging in children who are at low risk of requiring critical interventions could improve overall quality of care and decrease unnecessary resource utilization.	[Chaudhari, Pradip P.] Childrens Hosp Los Angeles, Div Emergency & Transport Med, 4650 Sunset Blvd,Mail Stop 113, Los Angeles, CA 90027 USA; [Chaudhari, Pradip P.; Pineda, Jose; Khemani, Robinder G.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA; [Pineda, Jose; Khemani, Robinder G.] Childrens Hosp Los Angeles, Dept Anesthesia & Crit Care Med, Los Angeles, CA 90027 USA; [Bachur, Richard G.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Bachur, Richard G.] Harvard Med Sch, Boston, MA 02115 USA		Chaudhari, PP (corresponding author), Childrens Hosp Los Angeles, Div Emergency & Transport Med, 4650 Sunset Blvd,Mail Stop 113, Los Angeles, CA 90027 USA.	pchaudhari@chla.usc.edu		Chaudhari, Pradip/0000-0002-7732-632X			Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; Dawson EC, 2012, PEDIATR NEUROSURG, V48, P221, DOI 10.1159/000346697; Epstein D, 2011, PEDIATRICS, V127, pE588, DOI 10.1542/peds.2010-0394; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Flaherty BF, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0385; Greenberg JK, 2019, J NEUROSURG-PEDIATR, V23, P227, DOI 10.3171/2018.7.PEDS18263; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Hill EP, 2017, J TRAUMA ACUTE CARE, V82, P896, DOI 10.1097/TA.0000000000001406; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; Khemani RG, 2019, LANCET RESP MED, V7, P115, DOI 10.1016/S2213-2600(18)30344-8; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Murray BL, 2013, ANN EMERG MED, V62, pS67; Patel SK, 2018, J PEDIATR SURG, V53, P2048, DOI 10.1016/j.jpedsurg.2018.04.027; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; WONG GY, 1985, J AM STAT ASSOC, V80, P513, DOI 10.2307/2288464	18	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	APR	2021	37	4					E196	E202		10.1097/PEC.0000000000002352			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	RL6QQ	WOS:000639095500010	33780412				2022-02-07	
J	Chen, FY; Komisarow, JM; Mills, B; Vavilala, M; Hernandez, A; Laskowitz, DT; Mathew, JP; James, ML; Haines, KL; Raghunathan, K; Fuller, M; Bartz, RR; Krishnamoorthy, V				Chen, Fangyu; Komisarow, Jordan M.; Mills, Brianna; Vavilala, Monica; Hernandez, Adrian; Laskowitz, Daniel T.; Mathew, Joseph P.; James, Michael L.; Haines, Krista L.; Raghunathan, Karthik; Fuller, Matt; Bartz, Raquel R.; Krishnamoorthy, Vijay			Echocardiogram Utilization Patterns and Association With Mortality Following Severe Traumatic Brain Injury	ANESTHESIA AND ANALGESIA			English	Article								BACKGROUND: Severe traumatic brain injury (TBI) can result in left ventricular dysfunction, which can lead to hypotension and secondary brain injuries. Although echocardiography is often used to examine cardiovascular function in multiple clinical settings, its use and association with outcomes following severe TBI are not known. To address this gap, we used the National Trauma Data Bank (NTDB) to describe utilization patterns of echocardiography and examine its association with mortality following severe TBI. METHODS: A retrospective cohort study was conducted using a large administrative trauma registry maintained by the NTDB from 2007 to 2014. Patients >18 years with isolated severe TBI, and without concurrent severe polytrauma, were included in the study. We examined echocardiogram utilization patterns (including overall utilization, factors associated with utilization, and variation in utilization) and the association of echocardiography utilization with hospital mortality, using multivariable logistic regression models. RESULTS: Among 47,808 patients, echocardiogram was utilized as part of clinical care in 2548 patients (5.3%). Clinical factors including vascular comorbidities and hemodynamic instability were associated with increased use of echocardiograms. Nearly half (46.0%, 95% confidence interval [CI], 40.3%-51.7%) of the variation in echocardiogram utilization was explained at the individual hospital level, above and beyond patient and injury factors. Exposure to an echocardiogram was associated with decreased odds of in-hospital mortality following severe TBI (adjusted odds ratio [OR] = 0.77; 95% CI, 0.69-0.87; P < .001). CONCLUSIONS: Echocardiogram utilization following severe TBI is relatively low, with wide variation in use at the hospital level. The association with decreased in-hospital mortality suggests that the information derived from echocardiography may be relevant to improving patient outcomes but will require confirmation in further prospective studies.	[Chen, Fangyu] Duke Univ, Sch Med, Durham, NC 27710 USA; [Chen, Fangyu; Komisarow, Jordan M.; James, Michael L.; Haines, Krista L.; Raghunathan, Karthik; Fuller, Matt; Bartz, Raquel R.; Krishnamoorthy, Vijay] Duke Univ, Crit Care & Perioperat Epidemiol Res CAPER Unit, Dept Anesthesiol, Durham, NC 27710 USA; [Komisarow, Jordan M.] Duke Univ, Dept Neurosurg, Durham, NC 27710 USA; [Mills, Brianna; Vavilala, Monica] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Vavilala, Monica] Univ Washington, Dept Anesthesiol & Pain Med, Washington, DC 98195 USA; [Hernandez, Adrian] Duke Univ, Dept Med, Durham, NC 27710 USA; [Laskowitz, Daniel T.] Duke Univ, Dept Neurol, Durham, NC 27710 USA; [Mathew, Joseph P.; James, Michael L.; Raghunathan, Karthik; Fuller, Matt; Bartz, Raquel R.; Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Durham, NC 27710 USA; [Haines, Krista L.] Duke Univ, Dept Surg, Durham, NC 27710 USA		Krishnamoorthy, V (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, DUMC 3094, Durham, NC 27710 USA.	vijay.krishnamoorthy@duke.edu		Komisarow, Jordan/0000-0003-3919-7931	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS109274] Funding Source: Medline		Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Feng ML, 2018, INTENS CARE MED, V44, P884, DOI 10.1007/s00134-018-5208-7; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Ghany R, 2017, ECHOCARDIOGR-J CARD, V34, P1152, DOI 10.1111/echo.13615; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Hasanin A., 2016, J NEUROL NEUROMED, V1, P41; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Kozak PM, 2019, INT J CARDIOVAS IMAG, V35, P1259, DOI 10.1007/s10554-019-01572-2; Krishnamoorthy V, 2019, J NEUROSURG ANESTH, V31, P173, DOI 10.1097/ANA.0000000000000577; Krishnamoorthy V, 2018, CRIT CARE MED, V46, P965, DOI 10.1097/CCM.0000000000003052; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Lang SM, 2017, AM J CARDIOL, V120, P1209, DOI 10.1016/j.amjcard.2017.06.065; Mathur MB, 2018, EPIDEMIOLOGY, V29, pE45, DOI 10.1097/EDE.0000000000000864; Matulevicius SA, 2013, JAMA INTERN MED, V173, P1600, DOI 10.1001/jamainternmed.2013.8972; Papolos A, 2016, J AM COLL CARDIOL, V67, P502, DOI 10.1016/j.jacc.2015.10.090; Richard C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-39; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Suttorp MM, 2015, NEPHROL DIAL TRANSPL, V30, P1418, DOI 10.1093/ndt/gfu325; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Urdaneta AE, 2017, J INTENSIVE CARE MED, V32, P151, DOI 10.1177/0885066615616907; van Diepen S, 2017, CIRCULATION, V136, pE232, DOI 10.1161/CIR.0000000000000525; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Virnig BA, 2011, TRENDS USE ECHOCARDI	24	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	APR	2021	132	4					1060	1066		10.1213/ANE.0000000000005110			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	RL9TO	WOS:000639306100019	32815871				2022-02-07	
J	Chen, P; Yu, X; Huang, T; Deng, YB; Huang, JR				Chen Peng; Yu Xing; Huang Tao; Deng Yongbing; Huang Jingrui			Role of Diffusion Tensor Imaging Combined with Neuron-Specific Enolase and S100 Calcium-binding Protein B Detection in Predicting the Prognosis of Moderate and Severe Traumatic Brain Injury	IRANIAN RED CRESCENT MEDICAL JOURNAL			English	Article						Diffusion tensor imaging; Neuron-specific enolase; Prognosis evaluation; S100B Protein; Traumatic brain injury	UTILITY; MILD; TBI; NSE	Background: Traumatic brain injury (TBI) seriously affects the quality of life of patients. The present study evaluated the role of diffusion tensor imaging (DTI) combined with Neuron-Specific Enolase (NSE) and 5100 calcium-binding protein B (S100B) protein in predicting the prognosis of moderate and severe TBI. Methods: The TBI patients were divided into moderate TBI (TBIm) and severe TBI (TBIs) groups according to the Glasgow Coma Scale (GCS) after admission. The patients were then divided into good and poor prognosis groups according to the Glasgow Outcome Scale (GOS); moreover, their follow-ups were recorded at 3 and 6 months after injury. This study also included 65 healthy individuals with matched age and gender as the control group. The fractional anisotropy (FA) values of DTI, serum neuron-specific enolase (NSE), and S100B protein levels were detected in this study. The data were analyzed in SPSS software (version 22.0) to evaluate the role of DTI combined with NSE and S100B protein in predicting the prognosis in TBIm and TBIs. Results: After TBI, the FA values of DTI in the TBI group were lower than those in the control group (P<0.05); moreover, the serum NSE and S100B values in the TBI group were higher than those in the control group (P<0.05). In the TBIm patients, the FA values of the corpus callosum in the good prognosis group were higher than that in the poor prognosis group (P<0.05); however, there was no significant difference between the two groups regarding the FA values of the internal capsule and the cerebral peduncle (P>0.05). The serum levels of NSE and S100B in the good prognosis group were significantly lower than those in the poor prognosis group (P<0.05). In the TBIs patients, the FA value of all areas in the good prognosis group was significantly higher than that in the poor prognosis group (P<0.05). However, there was no significant difference between the two prognosis groups regarding the serum levels of NSE and S100B (P>0.05). Conclusion: Although DTI combined with NSE and S100B protein can effectively predict the prognosis of patients with moderate and severe TBI in the early stages, various other measures have been used in the studies to predict the prognosis of TBI patients. Accordingly, comparison with other measures is essential in further studies.	[Chen Peng; Yu Xing; Huang Tao; Deng Yongbing; Huang Jingrui] Chongqing Univ, Chongqing Emergency Med Ctr, Dept Neurosurg, Cent Hosp, Chongqing, Peoples R China		Huang, T (corresponding author), Chongqing Univ, Chongqing Emergency Med Ctr, Dept Neurosurg, Cent Hosp, Chongqing, Peoples R China.	sunny.hjr@163.com			Medical Research Centre of Health and Family Planning Commission of Chongqing, China [2017ZDXM024]	This study was financially supported by the Medical Research Centre of Health and Family Planning Commission of Chongqing, China (2017ZDXM024).	Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Guo H, 2019, WORLD NEUROSURG, V121, pE630, DOI 10.1016/j.wneu.2018.09.178; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Main KL, 2017, NEUROIMAGE-CLIN, V16, P1, DOI 10.1016/j.nicl.2017.06.031; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Mercier E, 2018, BRAIN INJURY, V32, P29, DOI 10.1080/02699052.2017.1385097; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Park DW, 2019, CHILD NERV SYST, V35, P343, DOI 10.1007/s00381-018-3955-y; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Shinozaki K, 2009, CRIT CARE, V13, DOI 10.1186/cc7973; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Vogt N, 2018, SHOCK, V49, P164, DOI 10.1097/SHK.0000000000000943; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2	20	0	0	0	0	ZAMENSALAMATI PUBL CO	MASHHAD	KHORASAN, MASHHAD, SANABAD-EBNE SINA ST, MASHHAD, IRAN	2074-1804	2074-1812		IRAN RED CRESCENT ME	Iran. Red Crescent Med. J.	APR	2021	23	4							e261	10.32592/ircmj.2021.23.4.261			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UM0NN	WOS:000693037600007		hybrid			2022-02-07	
J	Ciccia, A; Lundine, JP; O'Brien, KH; Salley, J; Krusen, S; Wilson, B; Kunz, J; Haarbauer-Krupa, J				Ciccia, Angela; Lundine, Jennifer P.; O'Brien, Katy H.; Salley, Jessica; Krusen, Sarah; Wilson, Bethany; Kunz, Jasmin; Haarbauer-Krupa, Juliet			Understanding Cognitive Communication Needs in Pediatric Traumatic Brain Injury: Issues Identified at the 2020 International Cognitive-Communication Disorders Conference	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: In early 2020, the second International Cognitive-Communication Disorders Conference was held to provide an opportunity for researchers and clinician-scientists to discuss the most recent advances and pressing issues in the care of individuals with cognitive-communication disorders (CCDs). Presentations and discussions resulted in the identification of four areas in need of attention: (a) terminology, (b) training, (c) interdisciplinary teams, and (d) pediatrics. We will explore the four themes identified at ICCDC, specifically expanding on how terminology, training, and teams intersect in pediatric traumatic brain injury care. Additionally, we will provide two case studies to highlight the integration of these themes and suggest ways to advance clinical service provision across medical and educational settings for persons with CCDs through the lens of pediatrics. Conclusion: While speech-language pathology has come a long way since the original discussion of CCD over 30 years ago, clinicians and researchers have ongoing opportunities to help advance the ways in which speech-language pathologists offer support to persons, specifically children, with CCDs and to continue to advance the profession.	[Ciccia, Angela; Salley, Jessica] Case Western Reserve Univ, Dept Psychol Sci, Commun Sci Program, Cleveland, OH 44106 USA; [Lundine, Jennifer P.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH USA; [O'Brien, Katy H.] Univ Georgia, Dept Commun Sci & Special Educ, Athens, GA 30602 USA; [Krusen, Sarah] Bucks Cty Intermediate Unit 22, Doylestown, PA USA; [Wilson, Bethany] Riverview Intermediate Unit 6, Clarion, PA USA; [Kunz, Jasmin] Papill La Vista Community Sch, Omaha, NE USA; [Haarbauer-Krupa, Juliet] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA		Ciccia, A (corresponding author), Case Western Reserve Univ, Dept Psychol Sci, Commun Sci Program, Cleveland, OH 44106 USA.	Angela.ciccia@case.edu		Ciccia, Angela/0000-0003-2189-4827			American Speech-Language-Hearing Association, 1990, INTERDISCIPLINARY AP; American Speech-Language-Hearing Association, 1987, ASHA, V29, P53; American Speech-Language-Hearing Association, 2003, EV TREAT COMM COGN D; American Speech-Language-Hearing Association, 2018, 2018 SCH SURV REP SL; American Speech-Language-Hearing Association, 2004, PREF PRACT PATT PROF; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Bailey C, 2019, J HEAD TRAUMA REHAB, V34, P375, DOI 10.1097/HTR.0000000000000527; Bazarian JJ, 2019, J HEAD TRAUMA REHAB, V34, P371, DOI 10.1097/HTR.0000000000000548; Bishop DVM, 2017, J CHILD PSYCHOL PSYC, V58, P1068, DOI 10.1111/jcpp.12721; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Cermak CA, 2019, J HEAD TRAUMA REHAB, V34, pE13, DOI 10.1097/HTR.0000000000000419; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Coreno A, 2020, SEMIN SPEECH LANG, V41, P161, DOI 10.1055/s-0040-1701684; Dachtyl SA, 2017, AM J SPEECH-LANG PAT, V26, P716, DOI 10.1044/2017_AJSLP-16-0138; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Ehren Barbara J., 2001, Seminars in Speech and Language, V22, P233, DOI 10.1055/s-2001-16146; Ehren BJ, 2006, TOP LANG DISORD, V26, P42, DOI 10.1097/00011363-200601000-00005; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Haarbauer-Krupa J, 2019, J HEAD TRAUMA REHAB, V34, P111, DOI 10.1097/HTR.0000000000000414; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Homer Emily M, 2000, Lang Speech Hear Serv Sch, V31, P62, DOI 10.1044/0161-1461.3101.62; Ketcham C. J., 2017, CURRENT RES CONCUSSI, V4, P8, DOI [10.1055/s-0037-1603645, DOI 10.1055/S-0037-1603645]; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Leonard, 2020, PERSPECTIVES ASHA SP, V5, P6, DOI [10.1044/2019_PERS-SIG1-2019-0007, DOI 10.1044/2019_PERS-SIG1-2019-0007]; Linden MA, 2018, NEUROREHABILITATION, V42, P311, DOI 10.3233/NRE-172357; Lundine JP, 2020, SEMIN SPEECH LANG, V41, P170, DOI 10.1055/s-0040-1701685; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCarty J, 2013, ASHA LEADER, V18, P22, DOI [10.1044/leader.pa2.18022013.22, DOI 10.1044/LEADER.PA2.18022013.22]; McCarty J., 2015, ASHA LEADER, V20, P28, DOI [10.1044/leader.bml.20052015.28, DOI 10.1044/LEADER.BML.20052015.28]; Mitchell M., 2020, PERSPECTIVES ASHA SP, V5, P732, DOI [10.1044/2020_PERSP-19-00125, DOI 10.1044/2020_PERSP-19-00125]; Morrow EL, 2021, AM J SPEECH-LANG PAT, V30, P986, DOI 10.1044/2020_AJSLP-20-00073; Myers RK, 2018, CLIN PEDIATR, V57, P645, DOI 10.1177/0009922817732146; Nagele D., 2019, J PHYS HLTH MULTIPLE, V38, P10, DOI [10.14434/pders.v38i1.26850, DOI 10.14434/PDERS.V38I1.26850]; Pelatti CY, 2019, AM J SPEECH-LANG PAT, V28, P1611, DOI 10.1044/2019_AJSLP-19-0029; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Scratch SE, 2019, J HEAD TRAUMA REHAB, V34, P385, DOI 10.1097/HTR.0000000000000542; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Stockbridge MD, 2019, AM J SPEECH-LANG PAT, V28, P1554, DOI 10.1044/2019_AJSLP-18-0196; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Welsh JA, 2010, J EDUC PSYCHOL, V102, P43, DOI 10.1037/a0016738; Wiseman-Hakes C, 2020, SEMIN SPEECH LANG, V41, P143, DOI 10.1055/s-0040-1701683; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	48	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		853	862		10.1044/2020_AJSLP-20-00077			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400001	33621119				2022-02-07	
J	Collins, G; Lundine, JP; Kaizar, E				Collins, Gavin; Lundine, Jennifer P.; Kaizar, Eloise			Bayesian Generalized Linear Mixed-Model Analysis of Language Samples: Detecting Patterns in Expository and Narrative Discourse of Adolescents With Traumatic Brain Injury	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							CLOSED-HEAD-INJURY; LEXICAL DIVERSITY; CHILDREN; SPOKEN; AGE; IMPAIRMENT; PREDICTORS; CHILDHOOD; ABILITIES; OUTCOMES	Purpose: Generalized linear mixed-model (GLMM) and Bayesian methods together provide a framework capable of handling a wide variety of complex data commonly encountered across the communication sciences. Using language sample analysis, we demonstrate the utility of these methods in answering specific questions regarding the differences between discourse patterns of children who have experienced a traumatic brain injury (TBI), as compared to those with typical development. Method: Language samples were collected from 55 adolescents ages 13-18 years, five of whom had experienced a TBI. We describe parameters relating to the productivity, syntactic complexity, and lexical diversity of language samples. A Bayesian GLMM is developed for each parameter of interest, relating these parameters to age, sex, prior history (TBI or typical development), and socioeconomic status, as well as the type of discourse sample (compare-contrast, cause-effect, or narrative). Statistical models are thoroughly described. Results: Comparing the discourse of adolescents with TBI to those with typical development, substantial differences are detected in productivity and lexical diversity, while differences in syntactic complexity are more moderate. Female adolescents exhibited greater syntactic complexity, while male adolescents exhibited greater productivity and lexical diversity. Generally, our models suggest more advanced discourse among adolescents who are older or who have indicators of higher socioeconomic status. Differences relating to lecture type were also detected. Conclusions: Bayesian and GLMM methods yield more informative and intuitive results than traditional statistical analyses, with a greater degree of confidence in model assumptions. We recommend that these methods be used more widely in language sample analysis. Supplemental Material: https://doi.org/10.23641/asha. 14226959	[Collins, Gavin; Kaizar, Eloise] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH 43205 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH 43205 USA		Lundine, JP (corresponding author), Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA.; Lundine, JP (corresponding author), Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH 43205 USA.; Lundine, JP (corresponding author), Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH 43205 USA.	lundine.4@osu.edu	Lundine, Jennifer/P-5184-2018	Lundine, Jennifer/0000-0002-9113-7875	Alumni Grant for Graduate Research and Scholarship; Ohio State UniversityOhio State University	This research was supported in part by the Alumni Grant for Graduate Research and Scholarship and a laboratory start-up seed grant from The Ohio State University to the second author.	Aguilar JM, 2019, J HEAD TRAUMA REHAB, V34, P65, DOI 10.1097/HTR.0000000000000443; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Betz SK, 2013, LANG SPEECH HEAR SER, V44, P133, DOI 10.1044/0161-1461(2012/12-0093); Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Champion T. B., 2010, COMMUNICATION DISORD, V31, P162, DOI [10.1177/1525740109344218, DOI 10.1177/1525740109344218]; Channell MM, 2018, AM J SPEECH-LANG PAT, V27, P123, DOI 10.1044/2017_AJSLP-17-0046; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Charest M, 2020, AM J SPEECH-LANG PAT, V29, P1866, DOI 10.1044/2020_AJSLP-19-00176; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; Durber CM, 2017, NEUROPSYCHOLOGY, V31, P499, DOI 10.1037/neu0000351; Fergadiotis G, 2015, J SPEECH LANG HEAR R, V58, P840, DOI 10.1044/2015_JSLHR-L-14-0280; Finestack LH, 2014, J SPEECH LANG HEAR R, V57, P2274, DOI 10.1044/2014_JSLHR-L-14-0093; Gordon KR, 2019, J SPEECH LANG HEAR R, V62, P507, DOI 10.1044/2018_JSLHR-L-ASTM-18-0240; Greenhalgh KS, 2001, LANG SPEECH HEAR SER, V32, P114, DOI 10.1044/0161-1461(2001/010); Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); HEMPHILL L, 1994, J COMMUN DISORD, V27, P107, DOI 10.1016/0021-9924(94)90037-X; Hunt K. W., 1965, GRAMMATICAL STRUCTUR; Jacobson PF, 2013, AM J SPEECH-LANG PAT, V22, P554, DOI 10.1044/1058-0360(2013/11-0055); JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; Kateri, 2011, INT ENCY STAT SCI, P206, DOI [10.1007/978-3-642-04898-2_161, DOI 10.1007/978-3-642-04898-2]; Loban Walter, 1976, LANGUAGE DEV KINDERG; Lundine JP, 2019, AM J SPEECH-LANG PAT, V28, P1638, DOI 10.1044/2019_AJSLP-19-0012; Lundine JP, 2018, LANG SPEECH HEAR SER, V49, P551, DOI 10.1044/2018_LSHSS-17-0105; Lundine JP, 2018, AM J SPEECH-LANG PAT, V27, P247, DOI 10.1044/2017_AJSLP-16-0131; McMillan GP, 2019, J SPEECH LANG HEAR R, V62, P577, DOI 10.1044/2018_JSLHR-H-ASTM-18-0228; Miller J. F., 2010, SYSTEMATIC ANAL LANG; Mills MT, 2013, LANG SPEECH HEAR SER, V44, P211, DOI 10.1044/0161-1461(2012/12-0021); Moran C, 2012, LANG SPEECH HEAR SER, V43, P264, DOI 10.1044/0161-1461(2011/10-0114); Nalborczyk L, 2019, J SPEECH LANG HEAR R, V62, P1225, DOI 10.1044/2018_JSLHR-S-18-0006; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nippold, 2014, LANGUAGE SAMPLING AD; Nippold MA, 2008, AM J SPEECH-LANG PAT, V17, P356, DOI 10.1044/1058-0360(2008/07-0049); Oleson JJ, 2019, J SPEECH LANG HEAR R, V62, P489, DOI 10.1044/2018_JSLHR-S-ASTM-18-0239; Owen AJ, 2002, J SPEECH LANG HEAR R, V45, P927, DOI 10.1044/1092-4388(2002/075); Perry LK, 2019, J SPEECH LANG HEAR R, V62, P554, DOI 10.1044/2019_JSLHR-L-ASTM-18-0234; R Development Core Team, 2012, R LANG ENV STAT COMP; R Studio Team, 2020, RSTUDIO INT DEV R; Rashid M, 2014, J PEDIATR REHAB MED, V7, P241, DOI 10.3233/PRM-140293; Rice ML, 2015, J SPEECH LANG HEAR R, V58, P345, DOI 10.1044/2015_JSLHR-L-14-0150; RICHARDS B, 1987, J CHILD LANG, V14, P201, DOI 10.1017/S0305000900012885; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Scott CM, 2000, J SPEECH LANG HEAR R, V43, P324, DOI 10.1044/jslhr.4302.324; Stan Development Team, 2018, RSTAN R INT STAN 2 1; Stan Development Team, 2018, STAN COR LIB 2 18 0; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Ward-Lonergan JM, 1999, J LEARN DISABIL-US, V32, P213, DOI 10.1177/002221949903200303; Westby C, 2010, TOP LANG DISORD, V30, P275, DOI 10.1097/TLD.0b013e3181ff5a88; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	51	0	0	1	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	APR	2021	64	4					1256	1270		10.1044/2020_JSLHR-20-00471			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RN8NB	WOS:000640606600012	33784201				2022-02-07	
J	Collins, SM; Lininger, MR; Bowman, TG				Collins, Sean M.; Lininger, Monica R.; Bowman, Thomas G.			The Effect Of Mild Exercise Induced Dehydration On Sport Concussion Assessment Tool 3 (SCAT3) Scores: A within-subjects design.	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						balance; cognition; concussion management; movement system	ERROR SCORING SYSTEM; TESTING ENVIRONMENT; FLUID INGESTION; HIGH-SCHOOL; PERFORMANCE; SIDELINE; STATEMENT; SYMPTOMS; HEAT; MOOD	Background Sports-related concussions are prevalent in the United States. Various diagnostic tools are utilized in order to monitor deviations from baseline in memory, reaction time, symptoms, and balance. Evidence indicates that dehydration may also alter the results of diagnostic tests. Purpose The purpose was to determine the effect of exercise-induced dehydration on performance related to concussion examination tools. Study Design Repeated measures design. Methods Seventeen recreationally competitive, non-concussed participants (age: 23.1 +/- 3.1 years, height:168.93 +/- 10.71 cm, mass: 66.16 +/- 6.91 kg) performed three thermoneutral, counterbalanced sessions (rested control, euhydrated, dehydrated). Participants were either restricted (0.0 L/hr) or provided fluids (1.0 L/hr) while treadmill running for 60 min at an intensity equal to 65-70% age-predicted maximum heart rate (APMHR). The Sport Concussion Assessment Tool 3 (SCAT3) was utilized to assess symptoms, memory, balance, and coordination. Results Statistically significant differences were seen among sessions for symptom severity and symptom total. The rested control session had significantly lower values when compared to the dehydrated session. Additionally, the symptom total in the rested control was significantly lower than the euhydrated condition as well. No statistically significant differences were seen for the BESS or memory scores. Conclusions Mild exercise-induced dehydration results in increased self-reported symptoms associated with concussions. Clinicians tasked with monitoring and accurately diagnosing head trauma should take factors such as hydration status into account when assessing patients for concussion with the SCAT3. Clinicians should proceed with caution and not assume concussion as primary cause for symptom change.	[Collins, Sean M.] Univ Lynchburg, Exercise Physiol Dept, Lynchburg, VA 24501 USA; [Lininger, Monica R.] No Arizona Univ, Athlet Training Program, Flagstaff, AZ 86011 USA; [Bowman, Thomas G.] Univ Lynchburg, Athlet Training Dept, Lynchburg, VA 24501 USA		Collins, SM (corresponding author), Univ Lynchburg, Exercise Physiol Dept, Lynchburg, VA 24501 USA.	collins.s@lynchburg.edu					Benton D, 2015, NUTR REV, V73, P83, DOI 10.1093/nutrit/nuv045; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cian C, 2001, INT J PSYCHOPHYSIOL, V42, P243, DOI 10.1016/S0167-8760(01)00142-8; Cortes N, 2013, J ATHL TRAINING, V48, P306, DOI 10.4085/1062-6050-48.2.03; Engstrom E, 2012, EUR J PHYSIOTHER, V14, P115, DOI 10.3109/14038196.2012.694118; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Landers DM, 2001, J SPORT EXERCISE PSY, V23, P307, DOI 10.1123/jsep.23.4.307; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mclean SG, 2009, MED SCI SPORT EXER, V41, P1661, DOI 10.1249/MSS.0b013e31819ca07b; Onate JA, 2000, J ATHL TRAINING, V35, P155; Onate JA, 2007, J ATHL TRAINING, V42, P446; Patel AV, 2007, J ATHL TRAINING, V42, P66; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Schneiders AG, 2010, J SCI MED SPORT, V13, P382, DOI 10.1016/j.jsams.2010.01.003; Sell TC, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114532780; Smith DH, 2016, ATHL TRAIN SPORTS HL, V8, P193, DOI [10.3928/19425864-20160510-01, DOI 10.3928/19425864-20160510-01]; Susco TM, 2004, J ATHL TRAINING, V39, P241; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Tomporowski PD, 2007, INT J SPORTS MED, V28, P891, DOI 10.1055/s-2007-965004; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Wilson MMG, 2003, EUR J CLIN NUTR, V57, pS24, DOI 10.1038/sj.ejcn.1601898; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	30	0	0	0	0	NORTH AMER SPORTS MEDICINE INST-NASMI	NASHVILLE	6011 HILLSBORO PIKE, NASHVILLE, TN, UNITED STATES	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	APR	2021	16	2							21534	10.26603/001c.21534			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	RM4AH	WOS:000639604500024	33842047	Green Published, gold			2022-02-07	
J	Connolly, DM; Lupa, HT				Connolly, Desmond M.; Lupa, Henry T.			Prospective Study of White Matter Health for an Altitude Chamber Research Program	AEROSPACE MEDICINE AND HUMAN PERFORMANCE			English	Article						white matter hyperintensity; altitude; decompression; magnetic resonance imaging; head injury; mild traumatic brain injury		INTRODUCTION: Hypobaric decompression has been associated with brain white matter injury. Relevant exposure limits are unknown, raising ethical concerns over safety of volunteers for altitude chamber research. To inform this, a prospective study of white matter status using brain Magnetic Resonance Imaging (MRI) was conducted before and after a 9-mo program of hypobaric research. METHODS: Volunteers underwent 3-D, volumetric, fluid attenuated inversion recovery (FLAIR) MRI at the University of Nottingham, UK, on study entry and again after their final exposure. MRI data were analyzed and reported independently at the University of Maryland, Baltimore, MD, USA. Entry criteria were < 5 subcortical white matter hyperintensities (WMH) of total volume <= 0.08 mL. RESULTS: One volunteer failed screening with 63 WMH (total volume 2.38 mL). Eleven individuals completed 160 short-duration (< 1h) exposures (range 3 to 26) to. 18,000 ft pressure altitude (maximum 40,000 ft), no more often than twice weekly. The cohort exhibited eight total WMH on study entry (total volume 0.166 mL) and five (mostly different) total WMH on exit (0.184 mL). Just one WMH (frontal lobe) was present on both entry and exit scans. Excess background WMH on MRI screening were associated with past mild traumatic brain injury (MTBI). CONCLUSIONS: One hypoxia familiarization plus multiple, brief, infrequent, nonhypoxic hypobaric exposures (with denitrogenation) have not promoted WMH in this small cohort. Less intensive programs of decompression stress do not warrant MRI screening. A negative past history of MTBI has strong negative predictive value for excess WMH in young healthy subjects (N = 33).	[Connolly, Desmond M.; Lupa, Henry T.] QinetiQ Plc, Cody Technol Pk,Ively Rd, Farnborough GU14 0LX, Hants, England; [Connolly, Desmond M.] Kings Coll London, Ctr Human & Appl Physiol Sci, London, England		Connolly, DM (corresponding author), QinetiQ Plc, Cody Technol Pk,Ively Rd, Farnborough GU14 0LX, Hants, England.				UK Ministry of Defence	This work was funded by the UK Ministry of Defence. The authors have no competing interests to disclose.	Baum KA, 1996, NEURORADIOLOGY, V38, P755, DOI 10.1007/s002340050342; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Connolly DM, 2018, AEROSP MED HUM PERF, V89, P777, DOI 10.3357/AMHP.5090.2018; Connolly DM, 2015, AEROSP MED HUM PERF, V86, P928, DOI 10.3357/AMHP.4392.2015; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McGuire S, 2013, NEUROLOGY, V81, P729, DOI 10.1212/WNL.0b013e3182a1ab12; McGuire SA, 2016, AEROSP MED HUM PERF, V87, P983, DOI 10.3357/AMHP.4585.2016; McGuire SA, 2014, ANN NEUROL, V76, P719, DOI 10.1002/ana.24264; McGuire SA, 2014, NEUROLOGY, V83, P638, DOI 10.1212/WNL.0000000000000694; McGuire SA, 2012, AVIAT SPACE ENVIR MD, V83, P1117, DOI 10.3357/ASEM.3395.2012	12	0	0	0	1	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	2375-6314	2375-6322		AEROSP MED HUM PERF	Aerosp. Med.Hum. Perform.	APR	2021	92	4					215	222		10.3357/AMHP.5730.2021			8	Biophysics; Public, Environmental & Occupational Health; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Research & Experimental Medicine	RB2CD	WOS:000631921500002	33752784				2022-02-07	
J	Considine, CM; Huber, DL; Niemuth, A; Thomas, D; McCrea, MA; Nelson, LD				Considine, Ciaran M.; Huber, Daniel L.; Niemuth, Anna; Thomas, Danny; McCrea, Michael A.; Nelson, Lindsay D.			Relationship between Sport-Related Concussion and Sleep Based on Self-Report and Commercial Actigraph Measurement	NEUROTRAUMA REPORTS			English	Article						actigraphy; football; mHealth mobile health technology; sleep; sport-related concussion	TRAUMATIC BRAIN-INJURY; RISK; ADOLESCENTS; INSOMNIA	Sleep-wake disturbance (SWD) results from sport-related concussion (SRC) and may increase risk of protracted post-injury symptoms. However, methodological limitations in the extant literature limit our understanding of the role of SWD in SRC. This study examined the association between acute/subacute SRC and two sleep behaviors-sleep duration and efficiency-as measured by self-report and commercially available actigraphy (CA) in a sample of football players enrolled in a larger prospective longitudinal study of concussion. Fifty-seven high school and Division 3 male football players with SRC (mean [M] age = 18.00 years, standard deviation [SD] = 1.44) and 26 male teammate controls (M age = 18.54 years, SD = 2.21) were enrolled in this prospective pilot study. Sleep duration and sleep efficiency were recorded nightly for 2 weeks (starting 24-48 h post-injury in the SRC group) via CA and survey delivered via mobile application. There was no significant relationship between SRC and objectively recorded sleep measures, a null finding. However, the SRC group reported a brief (3-day) reduction in sleep efficiency after injury (M SRC = 82.18, SD = 12.24; M control = 89.2, SD = 4.25; p = 0.013; Cohen's d = 0.77), with no change in sleep duration. Self-reported and actigraph-assessed hours of sleep were weakly and insignificantly correlated in the SRC group (r = -0.21, p = 0.145), whereas they were robustly correlated in the non-injured control group (r = 0.65, p = 0.004). SWD post-SRC was not observed in objectively measured sleep duration or sleep efficiency and was modest and time-limited based on self-reported sleep efficiency. The weak correlation between self-reported and objective sleep behavior measures implies that subjective experience of SWD post-SRC may be due to factors other than actual changes in these observable sleep behaviors. Clinically, SWD in the early-subacute stages of recovery from SRC may not be adequately measurable via current CA. Subjective SWD may require alternative methods of evaluation (e.g., clinical actigraph or sleep study).	[Considine, Ciaran M.] Vanderbilt Univ, Dept Neurol, Med Ctr, Nashville, TN USA; [Huber, Daniel L.; Niemuth, Anna; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Thomas, Danny] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu			Research and Educa-tion Program Fund, Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin [UL1TR001436]; Clinical and Transla-tional Sciences (CTSA) program of the National Cen-ter for Research Resources [W81XWH-14-1-0561]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); Department of Defense Broad Agency Announcement for Extramural Medical Research	This project was funded by the Research and Educa-tion Program Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. This award was supported by grant UL1TR001436 from the Clinical and Transla-tional Sciences (CTSA) program of the National Cen-ter for Research Resources and the National Center for Advancing Translational Sciences, as well as the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research (W81XWH-14-1-0561). The content is solely the responsibility of the authors, and it does not necessarily represent the official views of the National Institutes of Health and is not necessarily endorsed by the Department of Defense.	Bei B, 2016, SLEEP MED REV, V28, P108, DOI 10.1016/j.smrv.2015.06.003; Berger Ivona, 2017, Glob Pediatr Health, V4, p2333794X17745973, DOI 10.1177/2333794X17745973; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; Helmick K., DEFENSE VET BRAIN IN; Huber DL, 2019, J ATHL TRAINING, V54, P929, DOI 10.4085/1062-6050-93-18; Jackowska M, 2011, PSYCHOSOM MED, V73, P810, DOI 10.1097/PSY.0b013e3182359e77; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Lee HA, 2017, PSYCHIAT INVEST, V14, P179, DOI [10.4306/pi.2017.14.2.179, 10.4306/0.2017.14.2.179]; Lee XK, 2019, J CLIN SLEEP MED, V15, P1337, DOI 10.5664/jcsm.7932; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Mollayeva T, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0657-2; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Stocker RPJ, 2017, ARCH CLIN NEUROPSYCH, V32, P349, DOI 10.1093/arclin/acx003; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zuzuarregui J.R.P., 2018, SLEEP SCI PRACT, V2, P2, DOI [10.1186/s41606-018-0020-4, DOI 10.1186/S41606-018-0020-4]	24	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	APR 1	2021	2	1					214	223		10.1089/neur.2021.0008			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WU6YA	WOS:000716687500001	33937913	Green Published, gold			2022-02-07	
J	Crodelle, J; Maia, PD				Crodelle, Jennifer; Maia, Pedro D.			A Computational Model for Pain Processing in the Dorsal Horn Following Axonal Damage to Receptor Fibers	BRAIN SCIENCES			English	Article						pain processing; dorsal horn; neuronal dynamics; computational model; axonal damage; painful neuropathies	TRAUMATIC BRAIN-INJURIES; SPINAL-CORD; NEURODEGENERATIVE DISEASES; MECHANISMS; NOCICEPTORS; MANAGEMENT; NEURONS; SYSTEM	Computational modeling of the neural activity in the human spinal cord may help elucidate the underlying mechanisms involved in the complex processing of painful stimuli. In this study, we use a biologically-plausible model of the dorsal horn circuitry as a platform to simulate pain processing under healthy and pathological conditions. Specifically, we distort signals in the receptor fibers akin to what is observed in axonal damage and monitor the corresponding changes in five quantitative markers associated with the pain response. Axonal damage may lead to spike-train delays, evoked potentials, an increase in the refractoriness of the system, and intermittent blockage of spikes. We demonstrate how such effects applied to mechanoreceptor and nociceptor fibers in the pain processing circuit can give rise to dramatically distinct responses at the network/population level. The computational modeling of damaged neuronal assemblies may help unravel the myriad of responses observed in painful neuropathies and improve diagnostics and treatment protocols.	[Crodelle, Jennifer] Middlebury Coll, Dept Math, Middlebury, VT 05753 USA; [Maia, Pedro D.] Univ Texas Arlington, Dept Math, Arlington, TX 76019 USA		Crodelle, J (corresponding author), Middlebury Coll, Dept Math, Middlebury, VT 05753 USA.	jcrodelle@middlebury.edu; pedro.maia@uta.edu		Crodelle, Jennifer/0000-0002-3402-4372; D. Maia, Pedro/0000-0002-3335-4257			Aguiar P, 2010, J NEUROPHYSIOL, V104, P1155, DOI 10.1152/jn.00834.2009; Baron R, 2013, ANN NEUROL, V74, P630, DOI 10.1002/ana.24017; BRITTON NF, 1989, J THEOR BIOL, V137, P91, DOI 10.1016/S0022-5193(89)80151-1; Caro XJ, 2018, EUR J RHEUMATOL, V5, P104, DOI 10.5152/eurjrheum.2018.17109; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Crodelle J.A., 2016, WOMEN MATH BIOL; Crodelle J, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007106; Duan B, 2018, NEUROSCI BULL, V34, P186, DOI 10.1007/s12264-017-0136-z; Ermentrout G., 2010, MATH FDN NEUROSCIENC; Fields HL, 1998, NEUROBIOL DIS, V5, P209, DOI 10.1006/nbdi.1998.0204; Finnerup NB, 2016, PAIN, V157, P1599, DOI 10.1097/j.pain.0000000000000492; Garland EL, 2012, PRIMARY CARE, V39, P561, DOI 10.1016/j.pop.2012.06.013; Gu C, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.610857; Hulse R, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.10.001; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kleggetveit IP, 2012, PAIN, V153, P2040, DOI 10.1016/j.pain.2012.05.017; Kunert JM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005261; Le Bars D, 2001, PHARMACOL REV, V53, P597; Le Franc Y, 2010, J NEUROPHYSIOL, V104, P1978, DOI 10.1152/jn.00919.2009; Loeser JD, 1999, LANCET, V353, P1607, DOI 10.1016/S0140-6736(99)01311-2; Lusch B, 2018, BRAIN COGNITION, V123, P154, DOI 10.1016/j.bandc.2018.02.012; Maia PD, 2019, J COMPUT NEUROSCI, V47, P1, DOI 10.1007/s10827-019-00714-8; Maia PD, 2017, J COMPUT NEUROSCI, V42, P323, DOI 10.1007/s10827-017-0643-y; Maia PD, 2015, J NEUROSCI METH, V253, P233, DOI 10.1016/j.jneumeth.2015.06.022; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Mendell LM, 2014, PAIN, V155, P210, DOI 10.1016/j.pain.2013.12.010; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Moayedi M, 2013, J NEUROPHYSIOL, V109, P5, DOI 10.1152/jn.00457.2012; Morrison M, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/6102494; Peirs C, 2020, J NEURAL TRANSM, V127, P505, DOI 10.1007/s00702-020-02159-1; PEYRONNARD JM, 1986, BRAIN RES, V373, P288, DOI 10.1016/0006-8993(86)90343-4; Reeve AJ, 2000, NEUROSCI LETT, V295, P25, DOI 10.1016/S0304-3940(00)01576-7; Rudy S., 2016, J SYST INT NEUROSCI, DOI [10.15761/JSIN.1000120, DOI 10.15761/JSIN.1000120]; Serra J, 2012, PAIN, V153, P42, DOI 10.1016/j.pain.2011.08.015; SMITH KJ, 1994, EYE, V8, P224, DOI 10.1038/eye.1994.51; Stavros K, 2014, CURR HIV-AIDS REP, V11, P195, DOI 10.1007/s11904-014-0211-2; Tesfaye S, 2013, DIABETES CARE, V36, P2456, DOI 10.2337/dc12-1964; Thakur S, 2015, PAIN, V156, P998, DOI 10.1097/j.pain.0000000000000178; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Weber M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00623; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zhang TC, 2014, J NEUROPHYSIOL, V112, P552, DOI 10.1152/jn.00254.2014; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	46	0	0	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	APR	2021	11	4							505	10.3390/brainsci11040505			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR0CL	WOS:000642777200001	33923490	Green Published, gold			2022-02-07	
J	D'Angelo, EC; Ober, BA; Shenaut, GK				D'Angelo, Elisabeth Cochran; Ober, Beth A.; Shenaut, Gregory K.			Combined Memory Training: An Approach for Episodic Memory Deficits in Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: The study aimed to test a combination of semantic memory and traditional episodic memory therapies on episodic memory deficits in adults with traumatic brain injury. Method: Twenty-five participants who had been diagnosed with traumatic brain injury and had episodic memory deficits were randomly assigned either to a combined memory treatment group (n = 16) or to a wait-list control group (n = 9). Before and after treatment, they completed standardized neuropsychological testing for episodic memory and related cognitive domains, including the California Verbal Learning Test-Second Edition, the Controlled Oral Word Association Test, the University of Southern California Repeatable Episodic Memory Test, the Wechsler Abbreviated Scale of Intelligence-Second Edition Matrices, the Test of Everyday Attention, the Memory Assessment Clinics Self-Rating Scale, the Expressive Vocabulary Test-Second Edition, and the Story Recall subtest from the Rivermead Behavioural Memory Test. In addition to a traditional episodic memory therapy, the treatment group received a novel semantic memory-focused therapy, which involved participants finding meaningful connections between diverse concepts represented by sets of two or three words. Results: The treatment group demonstrated statistically significant improvement in memory for list learning tasks, and there was a significant difference from pretest to posttest between the treatment group and the wait-list control group. Clinical significance was demonstrated for the treatment group using minimally important difference calculations. Conclusion: Combined memory therapy resulted in significant improvements in episodic memory, semantic memory, and attention, in comparison to no treatment.	[D'Angelo, Elisabeth Cochran] Calif State Univ Sacramento, Dept Commun Sci & Disorders, Sacramento, CA 95819 USA; [Ober, Beth A.; Shenaut, Gregory K.] Univ Calif Davis, Dept Human Ecol, Davis, CA 95616 USA		D'Angelo, EC (corresponding author), Calif State Univ Sacramento, Dept Commun Sci & Disorders, Sacramento, CA 95819 USA.	dangelo@csus.edu	Shenaut, Gregory/I-2014-2013	Shenaut, Gregory/0000-0002-2238-0900	Sacramento State Research and Creative Activity Faculty Awards Program	Funding was provided to the primary investigator by the Sacramento State Research and Creative Activity Faculty Awards Program. Thank you to Jerome Braun for his statistics assistance. We would like to thank the dedicated students in the Cognitive-Communication Lab at California State University, Sacramento and the amazing participants who were survivors of traumatic brain injury and their families.	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Andreou G, 2013, ADHD-ATTEND DEFICIT, V5, P343, DOI 10.1007/s12402-013-0112-z; Angelo E. C., 2016, PUBLICATIONS, V10124284; BADDELEY A, 1992, J COGNITIVE NEUROSCI, V4, P281, DOI 10.1162/jocn.1992.4.3.281; Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; BOWER GH, 1974, J EXP PSYCHOL, V103, P751, DOI 10.1037/h0037190; Cabeza R, 2003, NEUROPSYCHOLOGIA, V41, P390, DOI 10.1016/S0028-3932(02)00170-7; CERMAK LS, 1978, J EXP PSYCHOL-HUM L, V4, P165, DOI 10.1037/0278-7393.4.2.165; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Chiaravalloti ND, 2015, J HEAD TRAUMA REHAB, V30, P261, DOI 10.1097/HTR.0000000000000164; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CROOK TH, 1990, PSYCHOL AGING, V5, P48, DOI 10.1037/0882-7974.5.1.48; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; D'Angelo E, 2012, PROCD SOC BEHV, V61, P157, DOI 10.1016/j.sbspro.2012.10.125; Das Nair R, 2008, STROKE, V39, P516, DOI 10.1161/STROKEAHA.107.496935; Delis D.C., 2000, CALIFORNIA VERBAL LE; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; FitzGerald M. C., 2012, IRISH J PSYCHOL, V33, P78, DOI [10.1080/03033910.2012.708898, DOI 10.1080/03033910.2012.708898]; Foley N, 2012, DISABIL REHABIL, V34, P2132, DOI 10.3109/09638288.2012.676145; Garcia-Lazaro HG, 2012, NEUROL INDIA, V60, P613, DOI 10.4103/0028-3886.105196; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Greenberg DL, 2010, J INT NEUROPSYCH SOC, V16, P748, DOI 10.1017/S1355617710000676; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; KOPELMAN MD, 1995, BRIT J PSYCHIAT, V166, P154, DOI 10.1192/bjp.166.2.154; Lang CE, 2015, CURR OPIN NEUROL, V28, P549, DOI 10.1097/WCO.0000000000000256; Lepping Rebecca J, 2015, Int J Phys Med Rehabil, V3, DOI 10.4172/2329-9096.1000254; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; McRae K, 2005, BEHAV RES METHODS, V37, P547, DOI 10.3758/BF03192726; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; Mioni G., 2014, TRAUMATIC BRAIN INJU, P401, DOI [10.5772/5730, DOI 10.5772/57307]; MOSCOVITCH M, 1976, J VERB LEARN VERB BE, V15, P447, DOI 10.1016/S0022-5371(76)90040-2; Musselman KE, 2007, PHYS THER REV, V12, P287, DOI 10.1179/108331907X223128; Nelson D, 2013, MEM COGNITION, V41, P797, DOI 10.3758/s13421-013-0312-y; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Novack TA, 2000, BRAIN INJURY, V14, P987; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Page P, 2014, INT J SPORTS PHYS TH, V9, P726; Parker ES, 1995, J CLIN EXP NEUROPSYC, V17, P926, DOI 10.1080/01688639508402441; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; RANKIN JL, 1983, J GERONTOL, V38, P593, DOI 10.1093/geronj/38.5.593; Robertson I., 1994, TEST EVERYDAY ATTENT; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Tulving E., 1972, ORG MEMORY, P381; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wambaugh JL, 2013, AM J SPEECH-LANG PAT, V22, pS334, DOI 10.1044/1058-0360(2013/12-0070); Wechsler D, 2011, WECHSLER ABBREVIATED, V2nd, DOI [10.1037/t15171-000, DOI 10.1037/T15171-000]; Williams K.T., 1997, J AM ACAD CHILD PSY, V42, P864; Wilson BA, 1999, RIVERMEAD BEHAV MEMO; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328	68	0	0	4	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		920	932		10.1044/2020_AJSLP-20-00075			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400006	33630662				2022-02-07	
J	Delahunt, CB; Maia, PD; Kutz, JN				Delahunt, Charles B.; Maia, Pedro D.; Kutz, J. Nathan			Built to Last: Functional and Structural Mechanisms in the Moth Olfactory Network Mitigate Effects of Neural Injury	BRAIN SCIENCES			English	Article						neuronal injury; injury mitigation; focal axonal swellings (FAS); moth olfactory network		Most organisms suffer neuronal damage throughout their lives, which can impair performance of core behaviors. Their neural circuits need to maintain function despite injury, which in particular requires preserving key system outputs. In this work, we explore whether and how certain structural and functional neuronal network motifs act as injury mitigation mechanisms. Specifically, we examine how (i) Hebbian learning, (ii) high levels of noise, and (iii) parallel inhibitory and excitatory connections contribute to the robustness of the olfactory system in the Manduca sexta moth. We simulate injuries on a detailed computational model of the moth olfactory network calibrated to data. The injuries are modeled on focal axonal swellings, a ubiquitous form of axonal pathology observed in traumatic brain injuries and other brain disorders. Axonal swellings effectively compromise spike train propagation along the axon, reducing the effective neural firing rate delivered to downstream neurons. All three of the network motifs examined significantly mitigate the effects of injury on readout neurons, either by reducing injury's impact on readout neuron responses or by restoring these responses to pre-injury levels. These motifs may thus be partially explained by their value as adaptive mechanisms to minimize the functional effects of neural injury. More generally, robustness to injury is a vital design principle to consider when analyzing neural systems.	[Delahunt, Charles B.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Maia, Pedro D.] Univ Texas Arlington, Dept Math, Arlington, TX 76019 USA		Delahunt, CB (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.; Maia, PD (corresponding author), Univ Texas Arlington, Dept Math, Arlington, TX 76019 USA.	delahunt@uw.edu; pedro.maia@uta.edu; kutz@uw.edu		D. Maia, Pedro/0000-0002-3335-4257	Swartz Foundation; Air Force Office of Scientific ResearchUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9550-19-1-0011]	C.B.D. was partially supported by the Swartz Foundation. J.N.K. acknowledges support from the Air Force Office of Scientific Research (FA9550-19-1-0011).	Bazhenov M, 2010, NEURON, V67, P357, DOI 10.1016/j.neuron.2010.07.023; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Campbell RAA, 2013, J NEUROSCI, V33, P10568, DOI 10.1523/JNEUROSCI.0682-12.2013; Campbell RAA, 2010, CURR BIOL, V20, pR11, DOI 10.1016/j.cub.2009.10.031; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; CAYRE M, 1994, NATURE, V368, P57, DOI 10.1038/368057a0; Dayan P., 2001, THEORETICAL NEUROSCI; Delahunt CB, 2018, FRONT COMPUT NEUROSC, V12, DOI 10.3389/fncom.2018.00102; Eisthen HL, 2002, BRAIN BEHAV EVOLUT, V59, P273, DOI 10.1159/000063564; Galizia CG, 2014, EUR J NEUROSCI, V39, P1784, DOI 10.1111/ejn.12558; Ganguli S, 2012, ANNU REV NEUROSCI, V35, P485, DOI 10.1146/annurev-neuro-062111-150410; Gupta N, 2012, J NEUROSCI, V32, P8138, DOI 10.1523/JNEUROSCI.1066-12.2012; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hige T, 2015, NATURE, V526, P258, DOI 10.1038/nature15396; Higginson A. D., 2011, Psyche: A Journal of Entomology, V2011, P419793, DOI 10.1155/2011/419793; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; Kunert JM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005261; Kvello P, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.014.2009; Lin AC, 2014, NAT NEUROSCI, V17, P559, DOI 10.1038/nn.3660; Lofaldli BB, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.005.2010; Lusch B, 2018, BRAIN COGNITION, V123, P154, DOI 10.1016/j.bandc.2018.02.012; Maia PD, 2019, J COMPUT NEUROSCI, V47, P1, DOI 10.1007/s10827-019-00714-8; Maia PD, 2017, J COMPUT NEUROSCI, V42, P323, DOI 10.1007/s10827-017-0643-y; Maia PD, 2015, J NEUROSCI METH, V253, P233, DOI 10.1016/j.jneumeth.2015.06.022; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; Perisse E, 2013, CURR BIOL, V23, pR752, DOI 10.1016/j.cub.2013.07.060; Pouget Alexandre, 2014, Cold Spring Harb Symp Quant Biol, V79, P285, DOI 10.1101/sqb.2014.79.14; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Roberts JC, 2015, CAN J ZOOL, V93, P531, DOI 10.1139/cjz-2014-0317; Roelfsema PR, 2018, NAT REV NEUROSCI, V19, P166, DOI 10.1038/nrn.2018.6; Rouyar A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00148; Rudy S., 2016, J SYST INT NEUROSCI, DOI [10.15761/JSIN.1000120, DOI 10.15761/JSIN.1000120]; SMITH KJ, 1994, EYE, V8, P224, DOI 10.1038/eye.1994.51; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Weber M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00623; Wilson RI, 2008, CURR OPIN NEUROBIOL, V18, P408, DOI 10.1016/j.conb.2008.08.015; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005	46	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	APR	2021	11	4							462	10.3390/brainsci11040462			26	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR0OU	WOS:000642809300001	33916469	gold, Green Published, Green Submitted			2022-02-07	
J	Dos Santos, AA; Sorce, J; Schonning, A; Bevill, G				Dos Santos, Arthur Alves; Sorce, James; Schonning, Alexandra; Bevill, Grant			The Influence of Hard Hat Design Features on Head Acceleration Attenuation	JOURNAL OF APPLIED BIOMECHANICS			English	Article						construction safety; mild traumatic brain injury; personal protective equipment		This study evaluated the performance of 6 commercially available hard hat designs-differentiated by shell design, number of suspension points, and suspension tightening system-in regard to their ability to attenuate accelerations during vertical impacts to the head. Tests were conducted with impactor materials of steel, wood, and lead shot (resembling commonly seen materials in a construction site), weighing 1.8 and 3.6 kg and dropped from 1.83 m onto a Hybrid III head/neck assembly. All hard hats appreciably reduced head acceleration to the unprotected condition. However, neither the addition of extra suspension points nor variations in suspension tightening mechanism appreciably influenced performance. Therefore, these results indicate that additional features available in current hard hat designs do not improve protective capacity as related to head acceleration metrics.	[Dos Santos, Arthur Alves; Schonning, Alexandra; Bevill, Grant] Univ North Florida, Dept Engn, Jacksonville, FL 32224 USA; [Sorce, James] Univ North Florida, Dept Construct Management, Jacksonville, FL USA		Bevill, G (corresponding author), Univ North Florida, Dept Engn, Jacksonville, FL 32224 USA.	grant.bevill@unf.edu					Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; American National Standards Institute, 2014, AM NATL STANDARD IND; Caserta GD, 2011, COMPOS STRUCT, V93, P2748, DOI 10.1016/j.compstruct.2011.05.029; Cline M, 1985, REPORT 605, P17; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; ERB safety, HEAD PROTECTION HARD; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Hexa Research, 2017, SAFETY HELMETS MARKE; Hulme A, 1995, P 1995 IRCOBI C BIOM; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; Menard MR, 1996, J OCCUP ENVIRON MED, V38, P1161, DOI 10.1097/00043764-199611000-00017; Mittelmann M, 1991, J Insur Med, V23, P55; Moriguchi CS, 2013, APPL ERGON, V44, P86, DOI 10.1016/j.apergo.2012.05.002; MSA safety, HEAD PROTECTION HARD; Ommaya AK, 1984, INT CTR TRANSP STUD; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pinnoji PK, 2010, MATER DESIGN, V31, P3716, DOI 10.1016/j.matdes.2010.03.011; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; PROCTOR TD, 1986, J OCCUP ACCID, V8, P181, DOI 10.1016/0376-6349(86)90004-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schmitt KU, 2010, TRAUMA BIOMECHANICS: ACCIDENTAL INJURY IN TRAFFIC AND SPORTS, THIRD EDITION, P1, DOI 10.1007/978-3-642-03713-9; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Strickland J, 2019, J APPL BIOMECH, V35, P202, DOI 10.1123/jab.2018-0262; Suderman BL, 2014, ACCIDENT ANAL PREV, V73, P116, DOI 10.1016/j.aap.2014.08.011; Thibault L.E., 1972, SAE TECHNICAL PAPER, P720970, DOI [10.4271/720970, DOI 10.4271/720970]; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; United States Bureau of Labor Statistics, 2016, INJ ILLN FAT; US Bureau of Labor Statistics, 2016, CASE DEMOGRAPHIC CHA; US Bureau of Labor Statistics, 2019, TABLE R27 NUMBER NON; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327; Wu JZ, 2019, ENG FAIL ANAL, V96, P330, DOI 10.1016/j.engfailanal.2018.10.015; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	42	0	0	0	13	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	APR	2021	37	2					80	86		10.1123/jab.2020-0182			7	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Sport Sciences	RB0YZ	WOS:000631844800003	33373975				2022-02-07	
J	Eagle, SR; Kontos, AP; Collins, MW; Connaboy, C; Flanagan, SD				Eagle, Shawn R.; Kontos, Anthony P.; Collins, Michael W.; Connaboy, Chris; Flanagan, Shawn D.			Network Analysis of Sport-Related Concussion Research During the Past Decade (2010-2019)	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; assessment; rehabilitation	FOOTBALL PLAYERS; STATEMENT	Context: Research into sport-related concussion (SRC) has grown substantially over the past decade, yet no authors to date have synthesized developments over this critical time period. Objective: To apply a network-analysis approach in evaluating trends in the SRC literature using a comprehensive search of original, peer-reviewed research articles involving human participants published between January 1, 2010, and December 15, 2019. Design: Narrative review. Main Outcome Measure(s): Bibliometric maps were derived from a comprehensive search of all published, peer-reviewed SRC articles in the Web of Science database. A clustering algorithm was used to evaluate associations among journals, organizations or institutions, authors, and key words. The online search yielded 6130 articles, 528 journals, 7598 authors, 1966 organizations, and 3293 key words. Results: The analysis supported 5 thematic clusters of journals: (1) biomechanics/sports medicine (n = 15), (2) pediatrics/rehabilitation (n = 15), (3) neurotrauma/neurology/neurosurgery (n = 11), (4) general sports medicine (n = 11), and (5) neuropsychology (n = 7). The analysis identified 4 organizational clusters of hub institutions: (1) University of North Carolina (n = 19), (2) University of Toronto (n = 19), (3) University of Michigan (n = 11), and (4) University of Pittsburgh (n = 10). Network analysis revealed 8 clusters for SRC key words, each with a central topic area: (1) epidemiology (n = 14), (2) rehabilitation (n = 12), (3) biomechanics (n = 11), (4) imaging (n = 10), (5) assessment (n = 9), (6) mental health/chronic traumatic encephalopathy (n = 9), (7) neurocognition (n = 8), and (8) symptoms/impairments (n = 5). Conclusions: The findings suggest that during the past decade, SRC research has (1) been published primarily in sports medicine, pediatric, and neuro-focused journals, (2) involved a select group of researchers from several key institutions, and (3) concentrated on new topical areas, including treatment or rehabilitation and mental health.	[Eagle, Shawn R.; Kontos, Anthony P.; Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, 3850 South Water St, Pittsburgh, PA 15203 USA; [Connaboy, Chris; Flanagan, Shawn D.] Univ Pittsburgh, Neuromuscular Res Lab, Pittsburgh, PA 15203 USA		Eagle, SR (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, 3850 South Water St, Pittsburgh, PA 15203 USA.	seagle@pitt.edu	Flanagan, Shawn/AAC-6018-2021	Flanagan, Shawn/0000-0002-6531-4567; Connaboy, Christopher/0000-0002-9031-2192			Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; DeMatteo CA, 2021, CLIN J SPORT MED, V31, pE406, DOI 10.1097/JSM.0000000000000800; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Haarbauer-Krupa JK, 2018, BRAIN INJURY, V32, P1337, DOI 10.1080/02699052.2018.1482426; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Ledoux AA, 2019, BRIT J SPORT MED, V53, P195, DOI 10.1136/bjsports-2017-097981; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Panwar J, 2020, J NEUROTRAUM, V37, P1190, DOI 10.1089/neu.2019.6809; Register-Mihalik JK, 2020, MIL MED, V185, pE403, DOI 10.1093/milmed/usz414; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; van Eck NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062395; van Eck NJ, 2010, J AM SOC INF SCI TEC, V61, P2405, DOI 10.1002/asi.21421; Womble MN, 2021, CLIN J SPORT MED, V31, pE193, DOI 10.1097/JSM.0000000000000761	39	0	0	2	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2021	56	4					396	403		10.4085/1062-6050-0280.20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	RP8YP	WOS:000642009800007	33543307	gold			2022-02-07	
J	El-Khatib, H; Sanchez, E; Arbour, C; Van der Maren, S; Duclos, C; Blais, H; Carrier, J; Simonelli, G; Hendryckx, C; Paquet, J; Gosselin, N				El-Khatib, Hejar; Sanchez, Erlan; Arbour, Caroline; Van der Maren, Solenne; Duclos, Catherine; Blais, Helene; Carrier, Julie; Simonelli, Guido; Hendryckx, Charlotte; Paquet, Jean; Gosselin, Nadia			Slow wave activity moderates the association between new learning and traumatic brain injury severity	SLEEP			English	Article						polysomnography; sleep; slow wave activity; episodic memory; brain injury; cognition	POSTTRAUMATIC AMNESIA; DAYTIME SLEEPINESS; MEMORY; STIMULATION; DISORDERS; RECOVERY; FATIGUE; CONSCIOUSNESS; PERFORMANCE; COGNITION	Study objectives: Sleep-wake complaints and difficulties in making new learning are among the most persistent and challenging long-term sequelea following moderate to severe traumatic brain injury (TBI). Yet, it is unclear whether, and to what extent, sleep characteristics during the chronic stage of TBI contribute to sleep-wake and cognitive complaints. We aimed to characterize sleep architecture in chronic moderate to severe TBI adults and assess whether non-rapid eye movement slow wave activity (SWA) is associated to next day performance in episodic memory tasks according to TBI severity. Methods: Forty-two moderate to severe TBI participants, 12-47 months post-injury, and 38 healthy controls were tested with one night of in-laboratory polysomnography, followed the next morning by questionnaires (sleep quality, fatigue, and sleepiness) and neuropsychological assessment. We used multiple regression analyses to assess the moderator effect of SWA power on TBI severity and next-day memory performance. Results: We found that TBI participants reported worse sleep quality and fatigue, and had worse cognitive performance than controls. No between group differences were found on macro- and micro-architecture of sleep. However, SWA significantly interacted with TBI severity to explain next-day memory performance: higher SWA was more strongly associated to better memory performance in more severe TBI compared to milder TBI. Conclusions: This study provides evidence that the injured brain is able to produce macro- and micro-architecture of sleep comparable to what is seen in healthy controls. However, with increasing TBI severity, lower non-rapid eye movement SWA power is associated with reduced ability to learn and memorise new information the following day.	[El-Khatib, Hejar; Sanchez, Erlan; Arbour, Caroline; Van der Maren, Solenne; Duclos, Catherine; Blais, Helene; Carrier, Julie; Simonelli, Guido; Hendryckx, Charlotte; Paquet, Jean; Gosselin, Nadia] Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, Ctr Rech CIUSSS NIM, Montreal, PQ, Canada; [El-Khatib, Hejar; Van der Maren, Solenne; Carrier, Julie; Simonelli, Guido; Hendryckx, Charlotte; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Sanchez, Erlan] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Arbour, Caroline] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Duclos, Catherine] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada		Gosselin, N (corresponding author), Ctr Integre Univ Sante & Serv Sociaux Nord Ille d, Ctr Adv Res Sleep Med, Hop Sacre Coeur Montreal, 5400 Boul Gouin Ouest,J-5135, Montreal, PQ H4J 1C5, Canada.	nadia.gosselin@umontreal.ca		Van der Maren, Solenne/0000-0002-6689-089X	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP115172, FDN154291]; Fonds de Recherche Sante-Quebec (FRQS, Consortium pour le developpement de la recherche en traumatologie -Volet 1) [34851]; CIHRCanadian Institutes of Health Research (CIHR); FRQS	Financial disclosure: This study was funded by government granting agencies by grants to N.G. as a principal investigator: Canadian Institutes of Health Research (CIHR, MOP115172 and FDN154291) and Fonds de Recherche Sante-Quebec (FRQS, Consortium pour le developpement de la recherche en traumatologie -Volet 1 #34851). E.S. S.V.D.M. and C.D. received scholarships from the CIHR and FRQS. C.A. and N.G. received a salary award from the FRQS.	Antonenko D, 2013, EUR J NEUROSCI, V37, P1142, DOI 10.1111/ejn.12118; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baril AA, 2015, SLEEP, V38, P1439, DOI 10.5665/sleep.4986; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Borbely AA, 2016, J SLEEP RES, V25, P131, DOI 10.1111/jsr.12371; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Campbell IG, 2006, NEUROSCIENCE, V140, P1395, DOI 10.1016/j.neuroscience.2006.03.005; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cote KA, 2015, AIMS NEUROSCI, V2, P203, DOI 10.3934/Neuroscience.2015.4.203; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dornbierer DA, 2019, NEUROPSYCHOPHARMACOL, V44, P1985, DOI 10.1038/s41386-019-0382-z; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; El-Khatib H, 2019, SLEEP MED, V59, P67, DOI 10.1016/j.sleep.2018.11.012; Fattinger S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15405; Feld GB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00622; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Gao B, 2008, CEREBROVASC DIS, V26, P413, DOI 10.1159/000151683; Goeder R, 2006, J NEUROPSYCH CLIN N, V18, P529, DOI 10.1176/jnp.2006.18.4.529; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hayes, 2018, INTRO MEDIATION MODE; Hodor A, 2015, NEUROSCIENCE, V284, P18, DOI 10.1016/j.neuroscience.2014.08.061; Iber C., 2007, AASM MANUAL SCORING, P7; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Jaar O, 2010, SLEEP, V33, P1511, DOI 10.1093/sleep/33.11.1511; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Latreille V, 2019, NEUROBIOL AGING, V76, P106, DOI 10.1016/j.neurobiolaging.2018.12.012; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mander BA, 2013, NAT NEUROSCI, V16, P357, DOI 10.1038/nn.3324; Mantua J, 2018, SLEEP MED REV, V41, P61, DOI 10.1016/j.smrv.2018.01.004; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2013, ENCY SLEEP, V2, P330; Mondino M, 2015, CURR PHARM DESIGN, V21, P3373, DOI 10.2174/1381612821666150619093648; Norimoto H, 2018, SCIENCE, V359, P1524, DOI 10.1126/science.aao0702; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ragland JD, 2017, NEUROIMAGE-CLIN, V13, P82, DOI 10.1016/j.nicl.2016.11.017; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Robillard R, 2010, J SLEEP RES, V19, P455, DOI 10.1111/j.1365-2869.2010.00820.x; Sanchez E, 2019, BRAIN, V142, P674, DOI 10.1093/brain/awy348; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; Van Der Werf YD, 2009, NAT NEUROSCI, V12, P122, DOI 10.1038/nn.2253; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2009, WMS 4 WECHSLER MEMOR; Westerberg CE, 2015, NEUROBIOL AGING, V36, P2577, DOI 10.1016/j.neurobiolaging.2015.05.014; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Williams ET, 2019, J NEUROSCI NURS, V51, P134, DOI 10.1097/JNN.0000000000000441; Wiseman-Hakes C, 2016, J SLEEP DISORD THER, V5; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132	72	0	0	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	APR	2021	44	4							zsaa242	10.1093/sleep/zsaa242			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	SA5ZK	WOS:000649381900023	33211874	Green Published			2022-02-07	
J	Ferreira, A; Iramain, R; Bogado, N; Jara, A; Cardozo, L; Ortiz, J; Garcete, J; Guillen, MJ; Sandoval, J				Ferreira, Adriana; Iramain, Ricardo; Bogado, Norma; Jara, Alfredo; Cardozo, Laura; Ortiz, Jorge; Garcete, Jorge; Guillen, Ma Jose; Sandoval, Jose			Mild head injury in the pediatric emergency department of the San Lorenzo Clinical Hospital: clinical-epidemiological characteristics and frequency	PEDIATRIA-ASUNCION			Spanish	Article						Head trauma; epidemiology; simple tomography emergencies; pediatrics	TRAUMATIC BRAIN-INJURY	Introduction: Traumatic brain injury occurs commonly in childhood. Most head injuries in children are mild and are not associated with long-term brain injuries or sequelae. However, a small number of children who appear to be at low risk may have a clinically important TBI. Objective: to determine the frequency, clinical and epidemiological characteristics of mild head trauma in the pediatric emergency department of the San Lorenzo Clinical Hospital. Materials and Methods: this was an observational, descriptive, retrospective and cross-sectional study that included patients under 18 years of age with a diagnosis of mild head injury who were admitted to the observation room of the Emergency Department of the Clinical Hospital from November 2017 to November 2019. Results: 55 patients with a diagnosis of mild TB! were admitted, 53% male, 36% were older infants, the majority came from the metropolitan area. Regarding the trauma mechanism, 62% was due to a fall from their own height with an average of 0.9 +/- 0.91 m, 20% presented loss of consciousness. All patients were admitted to the emergency department awake and with a Glasgow 15/15, regarding the radiological findings, a skull fracture was confirmed in 5%. Imaging studies were performed in 55% of the patients, more than 60% of these were normal. Conclusion: in patients with mild head injury, doctors must decide whether the patient will undergo a tomography based on clinical judgment and internationally standardized guidelines for this purpose, since they expose them to ionizing radiation that increases the long-term risks of lethal neoplasms. This allows low to intermediate risk children to not be unnecessarily exposed to radiation.	[Ferreira, Adriana; Iramain, Ricardo; Bogado, Norma; Jara, Alfredo; Cardozo, Laura; Ortiz, Jorge; Garcete, Jorge; Guillen, Ma Jose; Sandoval, Jose] Univ Nacl Asuncion, Hosp Clin, Dept Urgencias Pediat, San Lorenzo, Paraguay		Ferreira, A (corresponding author), Univ Nacl Asuncion, Hosp Clin, Dept Urgencias Pediat, San Lorenzo, Paraguay.	adrilferreirap@gmail.com		Sandoval, Jose/0000-0002-4737-1816; Ortiz Rolon, Jorge/0000-0001-5078-2029; Ferreira Pascottini, Adriana/0000-0002-9754-4084			Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Jennett B, 1990, HDB CLIN NEUROLOGY, V13; Kelly JP, 1997, NEUROLOGY, V48, P581; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Nigrovic LE, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1495; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	10	0	0	0	0	SOC PARAGUAYA PEDIATRIA	ASUNCION	MCAL ESTIGARRIBIA 1764, C RCA FRANCESA, ASUNCION, 00000, PARAGUAY	1683-979X	1683-9803		PEDIATRIA-ASUNCION	Pediatria-Asuncion	APR	2021	48	1					59	64		10.31698/ped.48012021010			6	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	RP5YD	WOS:000641803500010		gold, Green Submitted			2022-02-07	
J	Fisher, AP; Aguilar, JM; Zhang, NH; Yeates, KO; Taylor, HG; Kurowski, BG; Narad, ME; Wade, SL				Fisher, Allison P.; Aguilar, Jessica M.; Zhang, Nanhua; Yeates, Keith Owen; Taylor, H. Gerry; Kurowski, Brad G.; Narad, Megan E.; Wade, Shari L.			Caregiver and Child Behavioral Health Service Utilization Following Pediatric Traumatic Brain Injury	RESEARCH ON CHILD AND ADOLESCENT PSYCHOPATHOLOGY			English	Article						Service utilization; Pediatric TBI; Unmet need; Behavioral health	LONG-TERM; EXECUTIVE FUNCTION; PARENTAL DISTRESS; RANDOMIZED-TRIAL; CARE UTILIZATION; SUPPORT NEEDS; OUTCOMES; ADOLESCENTS; TBI; RELIABILITY	Given sparse literature examining receipt of behavioral health service in children and caregivers following traumatic brain injury (TBI), we sought to identify predictors of unmet need. We performed an individual participant data meta-analysis using generalized linear mixed-effect models to examine predictors of behavioral health service use and unmet need. We included 572 children, ages 3 to 18, who were hospitalized overnight following complicated mild to severe TBI between 2002 and 2015. Caregivers completed ratings of depression and distress, child behavior problems, family functioning, and behavioral health service utilization. For children, unmet behavioral health service need was defined as an elevation on one or more child behavior problem scales without receipt of behavioral health services. For caregivers, unmet need was defined as an elevation on either a depression or distress scale without behavioral health service utilization. Among those with behavioral health needs, rates of unmet need were high for both children (77.8%) and caregivers (71.4%). Poorer family functioning was related to more unmet need in children (F(1, 497) = 6.57, p = 0.01; OR = 1.8) and caregivers (F(1, 492) = 17.54, p < 0.001; OR = 2.7). Children with unmarried caregivers also had more unmet behavioral health service need than those with married caregivers (F(1, 497) = 12.14, p < 0.001; OR = 2.2). In conclusion, unmet needs are common after pediatric TBI and relate to family factors. The findings underscore the importance of monitoring service needs following pediatric TBI and point to disparities in service use.	[Fisher, Allison P.; Aguilar, Jessica M.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Fisher, Allison P.; Aguilar, Jessica M.; Wade, Shari L.] Univ Cincinnati, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Dept Pediat, Cincinnati, OH 45229 USA; [Zhang, Nanhua] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Ohio State Univ, Abigail Wexner Res Inst, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Kurowski, Brad G.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Coll Med,Div Pediat Rehabil Med, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Coll Med,Div Pediat Rehabil Med, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Rehabil Med, Coll Med,Div Pediat Rehabil Med, Cincinnati, OH USA; [Narad, Megan E.] Univ Cincinnati, Behav Med & Clin Psychol Dept Pediat, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA		Fisher, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Fisher, AP (corresponding author), Univ Cincinnati, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	allison.fisher@cchmc.org			 [1R21HD089076-01]	1R21HD089076-01	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE, V4; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Benevides TW, 2016, MATERN CHILD HLTH J, V20, P878, DOI 10.1007/s10995-015-1876-x; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Chiri G, 2012, MATERN CHILD HLTH J, V16, P1081, DOI 10.1007/s10995-011-0833-6; Coker TR, 2009, ACAD PEDIATR, V9, P89, DOI 10.1016/j.acap.2008.11.007; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; DeRigne L, 2009, MATERN CHILD HLTH J, V13, P176, DOI 10.1007/s10995-008-0346-0; Derogatis L. R., 1999, USE PSYCHOL TESTING, P679, DOI DOI 10.1037/T07502-000; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Huebner ARS, 2018, PM&R, V10, P462, DOI 10.1016/j.pmrj.2017.10.004; Isquith PK, 2005, MENT RETARD DEV D R, V11, P209, DOI 10.1002/mrdd.20075; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Merikangas KR, 2011, J AM ACAD CHILD PSY, V50, P32, DOI 10.1016/j.jaac.2010.10.006; Merrell K. W., 2001, VALIDITY HOME COMMUN, P313; Merrell K. W., 1999, SOCIAL BEHAV ASSESSM, P36; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Moore M, 2018, J HEAD TRAUMA REHAB, V33, P177, DOI 10.1097/HTR.0000000000000348; Narad ME, 2019, J DEV BEHAV PEDIATR, V40, P451, DOI 10.1097/DBP.0000000000000681; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2018, J HEAD TRAUMA REHAB, V33, P158, DOI 10.1097/HTR.0000000000000331; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Simon AE, 2015, PSYCHIAT SERV, V66, P930, DOI 10.1176/appi.ps.201400342; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2020, J HEAD TRAUMA REHAB, V35, pE393, DOI 10.1097/HTR.0000000000000567; Wade SL, 2019, J INT NEUROPSYCH SOC, V25, P941, DOI 10.1017/S1355617719000778; Wade SL, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0422; Wade SL, 2018, J DEV BEHAV PEDIATR, V39, P154, DOI 10.1097/DBP.0000000000000519; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028	60	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2730-7166	2730-7174		RES CHILD ADOLES PSY	Res. Child Adolesc. Psychopathol.	APR	2021	49	4					491	501		10.1007/s10802-020-00737-1			11	Psychology, Clinical; Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	QT8LV	WOS:000626840900006	33404944				2022-02-07	
J	Fong, DH; Cohen, AJ; Mahony, DE; Simon, NG; Herrera, JE; Baron, RB; Putrino, D				Fong, Daryl H.; Cohen, Adrian J.; Mahony, Dylan E.; Simon, Neil G.; Herrera, Joseph E.; Baron, Rebecca B.; Putrino, David			Objectively Assessing Sports Concussion utilizing Visual Evoked Potentials	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article							DIAGNOSIS; FOOTBALL	A portable system capable of measuring steady-state visual-evoked potentials (SSVEP) was developed to provide an objective, quantifiable method of electroencephalogram (EEG) testing following a traumatic event. In this study, the portable system was used on 65 healthy rugby players throughout a season to determine whether SSVEP are a reliable electrophysiological biomarker for concussion. Preceding the competition season, all players underwent a baseline SSVEP assessment. During the season, players were re-tested within 72 h of a match for either test-retest reliability or post-injury assessment. In the case of a medically diagnosed concussion, players were reassessed again once deemed recovered by a physician. The SSVEP system consisted of a smartphone housed in a VR-frame delivering a 15 Hz flicker stimulus, while a wireless EEG headset recorded occipital activity. Players were instructed to stare at the screen's fixation point while remaining seated and quiet. Electrodes were arranged according to the 10-20 EEG-positioning nomenclature, with O1-O2 being the recording channels while P1-P2 the references and bias, respectively. All EEG data was processed using a Butterworth bandpass filter, Fourier transformation, and normalization to convert data for frequency analysis. Players SSVEP responses were quantified into a signal-to-noise ratio (SNR), with 15 Hz being the desired signal, and summarized into respective study groups for comparison. Concussed players were seen to have a significantly lower SNR compared to their baseline; however, post-recovery, their SNR was not significantly different from the baseline. Test-retest indicated high device reliability for the portable system. An improved portable SSVEP system was also validated against an established EEG amplifier to ensure the investigative design is capable of obtaining research quality EEG measurements. This is the first study to identify differences in SSVEP responses in amateur athletes following a concussion and indicates the potential for SSVEP as an aid in concussion assessment and management.	[Fong, Daryl H.] Univ Sydney, Fac Engn & Informat Technol, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW, Australia; [Cohen, Adrian J.; Mahony, Dylan E.] HeadsafeIP, Sydney, NSW, Australia; [Herrera, Joseph E.; Baron, Rebecca B.; Putrino, David] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Simon, Neil G.] Univ New South Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia		Mahony, DE (corresponding author), HeadsafeIP, Sydney, NSW, Australia.	dylan@headsafe.com					Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Australia Rugby, 2021, RUGBY AU CODES POLIC; Bey T, 2009, WEST J EMERG MED, V10, P6; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Dreyer AM, 2015, J NEUROSCI METH, V241, P1, DOI 10.1016/j.jneumeth.2014.12.004; Drislane F. W, 2007, CLINCAL NEUROPHYSIOL, P461; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fong DHC, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00171; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Handy TC, 2005, EVENT RELATED POTENT; Herbst S., 2012, J VISION, V12, P141; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Kothari R, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/9852194; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Luck S. J, 2012, OXFORD HDB EVENT REL; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Moyer JT, 2017, EPILEPSIA, V58, P53, DOI 10.1111/epi.13909; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Partridge B, 2015, NEUROETHICS-NETH, V8, P39, DOI 10.1007/s12152-014-9217-0; Phurailatpam J., 2014, J MED SOC, V28, P140; Ragan BG, 2009, ATHLETIC TRAIN SPORT, V1, P180; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Semyon M, 2014, CONCUSSIONS ATHLETIC; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Vander Werff KR, 2019, J SPEECH LANG HEAR R, V62, P2501, DOI 10.1044/2019_JSLHR-H-18-0281; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Yadav NK, 2015, BRAIN INJURY, V29, P352, DOI 10.3109/02699052.2014.979229; Yue Liu, 2012, 2012 IEEE International Conference on Virtual Environments Human-Computer Interfaces and Measurement Systems (VECIMS), P34	38	0	0	5	6	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2021		170							e62082	10.3791/62082			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RW0LW	WOS:000646217000045	33999030	Bronze			2022-02-07	
J	Guillaume, S; Lincoln, AE; Hepburn, L; Caswell, SV; Kerr, ZY				Guillaume, Stanley; Lincoln, Andrew E.; Hepburn, Lisa; Caswell, Shane, V; Kerr, Zachary Y.			Rule Modifications to Reduce Checking-Related Injuries in High School Boys' Lacrosse	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiology; body checking; concussion; injury rate ratio; injury prevention	FOR-DISEASE-CONTROL; ICE HOCKEY; EPIDEMIOLOGY; CONCUSSION; HEADS; SPORTS	Context: The National Federation of State High School Associations previously implemented 2 lacrosse rule modifications: Rule 5.4 in the 2012-2013 academic year to heighten the penalty for a head or neck hit to the head, face, or neck (HFN) and Rule 5.3.5 in the 2013-2014 academic year to minimize body checking. Objective: To determine if the rates of overall injury, HFN injuries, and concussions due to intentional contact (checking) differed for boys' high school lacrosse players after Rule 5.4 and 5.3.5 modifications were enacted. Design: Descriptive epidemiology study. Setting: Web-based online surveillance system. Patients or Other Participants: Boys' high school lacrosse players during the 2008-2009 to 2016-2017 seasons whose teams involved athletic trainers participating in the High School Reporting Information Online sports injury-surveillance system. Intervention(s): Rule 5.4 in the 2012-2013 academic year increased the penalty for any intentional hits to the HFN, and Rule 5.3.5 in the 2013-2014 year eliminated body checking to a player in a defenseless position. Main Outcome Measure(s): Overall, HFN, and concussion injury rate ratios (IRRs) by checking mechanism; overall and checking-related injury ratios by competitions and practices. Results: A decrease was shown in checking-related HFN injuries (IRR = 0.29, 95% CI = 0.13, 0.65) and checking-related concussions (IRR = 0.29, 95% CI = 0.12, 0.70) during practices in the seasons after both rule modifications were imposed, but no decreases occurred in any checking-related injuries during competitions. By injury mechanism, no decreases were evident after the Rule 5.4 modification. When both rule modifications (Rules 5.4 and 5.3.5) were enacted together, concussion rates due to delivering body checks (IRR = 0.51, 95% CI = 0.29, 0.91) and overall injury risk due to being body checked (IRR = 0.72, 95% CI = 0.53, 0.97) decreased. Conclusions: When both Rule 5.4 and 5.3.5 modifications were in effect, concussion and overall injury risks decreased for the body checker and the player being body checked, respectively.	[Guillaume, Stanley] Shirley Ryan Abil Lab, Dept Phys Med & Rehabil, 355 East Erie St, Chicago, IL 60611 USA; [Lincoln, Andrew E.; Hepburn, Lisa] MedStar Sports Med Res Ctr, Sports Med Res Ctr, Baltimore, MD USA; [Caswell, Shane, V] George Mason Univ, Sch Recreat Hlth & Tourism, Manassas, VA USA; [Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA		Guillaume, S (corresponding author), Shirley Ryan Abil Lab, Dept Phys Med & Rehabil, 355 East Erie St, Chicago, IL 60611 USA.	stanguil6@gmail.com					[Anonymous], 2017, US LACR WEB SIT; [Anonymous], CENS REG DIV US; [Anonymous], HIGH SCH SPORTS PART; Bartley JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740887; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Certification, US LACROSSE WEB SITE; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Foss KDB, 2017, PHYSICIAN SPORTSMED, V45, P224, DOI 10.1080/00913847.2017.1355209; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kindschi Kari, 2017, BMJ Open Sport Exerc Med, V3, pe000165, DOI 10.1136/bmjsem-2016-000165; Kraeutler MJ, 2018, SPORTS HEALTH, V10, P85, DOI 10.1177/1941738117709764; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; National Federation of State High School Associations, 2013, 2013 NFHS BOYS LACR; PCA courses, PCA COURS; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Trofa DP, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117741647; Vincent HK, 2015, SPORTS HEALTH, V7, P448, DOI 10.1177/1941738114552990; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Yard EE, 2006, J ATHL TRAINING, V41, P441	28	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2021	56	4					437	445		10.4085/1062-6050-0489.19			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	RP8YP	WOS:000642009800012	33878178	gold			2022-02-07	
J	Hoepner, JK; Sievert, A; Guenther, K				Hoepner, Jerry K.; Sievert, Alexis; Guenther, Kaitlin			Joint Video Self-Modeling for Persons With Traumatic Brain Injury and Their Partners: A Case Series	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: Individuals with traumatic brain injury (TBI) experience impairments to self-regulation and social communication that strain relationships. Video self-modeling (VSM) provides visible and audible, tangible evidence of what they do well and what could improve. Conducting such training in the context of authentic exchanges with their everyday partners may support positive change in social communication. The present investigation sought to evaluate indices of improved social communication. Method: A mixed-methods design was employed for this case series investigation. Quantitative measures include pre- and postoutcomes on goal attainment scales (GASs) and measures of conversational effectiveness. Qualitative measures include responsiveness to video-supported prompts, conversational behaviors, and metacognitive statements. Results: Participants perceived gains on GAS of 3-4 SDs, as well as perceived improvements on the La Trobe Communication Questionnaire. Those gains were validated by gains on the adapted Measure of Participation in Conversation and Measure of Skill in Supported Conversation. Individuals with TBI and their partners reached consensus on most goals and postintervention La Trobe Communication Questionnaire ratings. Participants made accurate judgments about their behaviors at a high rate, given video review. Conversational behaviors and use of metacognitive statements varied across participants and conversational contexts. Field notes and session transcripts provide evidence that both dyads increased internalization of VSM goals and purpose. Conclusions: Joint VSM shows promise as a method for eliciting accurate self-assessments among individuals with TBI and their close partners. Both dyads perceived positive gains in interactions within and outside their dyads. Furthermore, joint VSM and GAS appear to improve self-awareness and internalization of VSM goals and purpose.	[Hoepner, Jerry K.; Sievert, Alexis; Guenther, Kaitlin] Univ Wisconsin, Dept Commun Sci & Disorders, Eau Claire, WI 54701 USA		Hoepner, JK (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, Eau Claire, WI 54701 USA.	hoepnejk@uwec.edu		Hoepner, Jerry/0000-0002-0312-5410			American Speech-Language-Hearing Association, 2013, NATL OUTCOMES MEASUR; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Buggey T, 2012, PSYCHOL SCHOOLS, V49, P52, DOI 10.1002/pits.20618; Chia AA, 2019, BRAIN INJURY, V33, P690, DOI 10.1080/02699052.2019.1571632; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cools C, 1998, INT J REHABIL RES, V21, P323, DOI 10.1097/00004356-199809000-00007; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2019, NEUROPSYCHOL REHABIL, V29, P73, DOI 10.1080/09602011.2016.1259114; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; FISKE ST, 1980, J PERS SOC PSYCHOL, V38, P889, DOI 10.1037/0022-3514.38.6.889; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GODFREY H P D, 1991, Brain Injury, V5, P207, DOI 10.3109/02699059109008091; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Halford WK, 2002, COGNITIVE THER RES, V26, P759, DOI 10.1023/A:1021289400436; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hoepner J. K., 2010, CHARACTERISTICS EFFE; Hoepner JK, 2013, BRAIN INJURY, V27, P464, DOI 10.3109/02699052.2013.765600; Hoepner JK, 2018, CLIN ARCH COMMUN DIS, V3, P22, DOI [10.21849/cacd.2018.00262, DOI 10.21849/CACD.2018.00262]; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kiresuk TJ, 2014, GOAL ATTAINMENT SCAL; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Lewis T. F., 2017, J MENTAL HLTH COUNSE, V39, P195, DOI [10.17744/mehc.39.3.02, DOI 10.17744/MEHC.39.3.02]; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Milton S. B., 1986, CLIN NEUROPSYCHOLOGY, P223, DOI [10.1007/978-1-4613-2291-7_11, DOI 10.1007/978-1-4613-2291-7_11]; Murray Laura L., 2001, Seminars in Speech and Language, V22, P127; Oliver I, 2012, IEEE IC COMP COM NET; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2019, BRIT J CLIN PSYCHOL, V58, P35, DOI 10.1111/bjc.12185; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Pollock N, 1998, CANADIAN OCCUPATIONA; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigatano G., 1986, PATIENT COMPETENCY R; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rietdijk R., 2019, TBICONNECT CONNECTIN; Rietdijk R, 2020, BRAIN IMPAIR, V21, P110, DOI 10.1017/BrImp.2019.9; Rietdijk R, 2020, J HEAD TRAUMA REHAB, V35, P241, DOI 10.1097/HTR.0000000000000554; Rietdijk R, 2019, BRAIN INJURY, V33, P94, DOI 10.1080/02699052.2018.1531313; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M., 2004, INTRO AWARENESS QUES; Snow PC, 2000, BRAIN INJURY, V14, P397; Strauss A., 1990, BASICS QUALITATIVE R; Tate R. L., 2015, RISK BIAS N OF 1 TRI; Tate Robyn L, 2016, Phys Ther, V96, pe1, DOI 10.2522/ptj.2016.96.7.e1; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J.P., 2011, COGNITION OCCUPATION, P116; Tran S, 2018, BRAIN INJURY, V32, P1700, DOI 10.1080/02699052.2018.1537006; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Turner-Stokes L., 2017, GOAL ATTAINMENT SCAL; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]	82	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		863	882		10.1044/2021_AJSLP-20-00074			20	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400002	33784468				2022-02-07	
J	Jayan, M; Shukla, D; Devi, BI; Bhat, DI; Konar, SK				Jayan, Mini; Shukla, Dhaval; Devi, Bhagavatula Indira; Bhat, Dhananjaya I.; Konar, Subhas K.			Development of a Prognostic Model to Predict Mortality after Traumatic Brain Injury in Intensive Care Setting in a Developing Country	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						traumatic brain injury; outcome prediction; intensive care unit		Objectives We aimed to develop a prognostic model for the prediction of in-hospital mortality in patients with traumatic brain injury (TBI) admitted to the neurosurgery intensive care unit (ICU) of our institute. Materials and Methods The clinical and computed tomography scan data of consecutive patients admitted after a diagnosis TBI in ICU were reviewed. Construction of the model was done by using all the variables of Corticosteroid Randomization after Significant Head Injury and International Mission on Prognosis and Analysis of Clinical Trials in TBI models. The endpoint was in-hospital mortality. Results A total of 243 patients with TBI were admitted to ICU during the study period. The in-hospital mortality was 15.3%. On multivariate analysis, the Glasgow coma scale (GCS) at admission, hypoxia, hypotension, and obliteration of the third ventricle/basal cisterns were significantly associated with mortality. Patients with hypoxia had eight times, with hypotensions 22 times, and with obliteration of the third ventricle/basal cisterns three times more chance of death. The TBI score was developed as a sum of individual points assigned as follows: GCS score 3 to 4 (+2 points), 5 to 12 (+1), hypoxia (+1), hypotension (+1), and obliteration third ventricle/basal cistern (+1). The mortality was 0% for a score of "0" and 85% for a score of "4." Conclusion The outcome of patients treated in ICU was based on common admission variables. A simple clinical grading score allows risk stratification of patients with TBI admitted in ICU.	[Jayan, Mini; Shukla, Dhaval; Devi, Bhagavatula Indira; Konar, Subhas K.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Shukla, Dhaval; Devi, Bhagavatula Indira] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Bhat, Dhananjaya I.] RV Aster Hosp, Dept Neurosurg, Bangalore, Karnataka, India		Devi, BI (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	bidevidr@gmail.com		Shukla, Dhaval/0000-0001-7613-1929	National Institute of Health Research using Official Development Assistance (ODA) [16/137/105]	B.I.D. is a member of the National Institute of Health Research Global Health Research Group on Neurotrauma. The latter is supported by the National Institute of Health Research using Official Development Assistance (ODA) funding (16/137/105).	Bakhshi-Raiez F, 2007, CRIT CARE MED, V35, P2553, DOI 10.1097/01.CCM.0000288123.29559.5A; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; CRASH, CLIN RAND ANT SIGN H; Dean A, OPENEPI OPEN SOURCE; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; IMPACT, INT MISS PROGN AN CL; Maas AIR, 2008, ACTA NEUROCHIR SUPPL, V101, P119; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec	20	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	APR	2021	12	02					368	375		10.1055/s-0041-1726623		APR 2021	8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RU5MX	WOS:000637020800008	33927526	gold, Green Published			2022-02-07	
J	Jiang, T; Zhou, XQ; Jiang, HF; Ying, RB; Zhang, ZR; Cai, DL; Wu, Y; Fang, HJ; Wang, LC				Jiang Tao; Zhou Xiaqing; Jiang Huifang; Ying Rongbiao; Zhang Zhirong; Cai Danli; Wu Yu; Fang Hai-jun; Wang Lingcong			Efficacy of Sanqi (Radix Notoginseng) in treating cerebral hemorrhage in rats with traumatic brain injury	JOURNAL OF TRADITIONAL CHINESE MEDICINE			English	Article						Sanqi (Radix Notoginseng); Brain injuries; traumatic; Plasminogen activator inhibitor-1; Tissue-type plasminogen activator; p-p65	NF-KAPPA-B; INTRACEREBRAL HEMORRHAGE; CELLS; ATHEROSCLEROSIS; SUPPRESSION; INOS; R1	OBJECTIVE: To evaluate the protective efficacy of Sanqi (Radix Notoginseng) on cerebral hemorrhage in a rat model of traumatic brain injury (TBI) by investigating plasminogen activator inhibitor-1 (PAI-1), tissue-type plasminogen activator (t-PA), nuclear factor-kappa B (NF-kappa B, p-p65), nitric oxide (NO), endothelin (ET), cluster differentiation (CD61CD62), and coagulation. METHODS: The free-fall method was used to create a rat model of TBI. Forty-eight rats were randomly divided into six groups: the blank group, sham group, model group, low-dose Sanqi (Radix Notoginseng) group, middle-dose Sanqi (Radix Notoginseng) group, and high-dose Sanqi (Radix Notoginseng) group. At 24 h after the model was created, we investigated brain MRI, brain tissue morphology using HE staining, flow cytometry, and immunohistochemical changes. RESULTS: Cerebral hemorrhage was aggravated in TBI rats (observed in brain specimens, brain MRI, and brain tissue HE). Cerebral immunohistochemistry results demonstrated that the expression of t-PA, PAI-1 and p-p65 increased significantly in TBI rats, while t-PA/PAI-1 had a significant decrease. In addition, CD61CD62, D2D, and ET were significantly increased in TBI rats, and PT and APTT were significantly prolonged; in contrast, NO was significantly decreased. Sanqi (Radix Notoginseng) decreased cerebral hemorrhage in TBI rats (observed in brain MRI and brain tissue HE), and increased t-PA/PAI-1, CD61CD62 significantly. It also significantly decreased the expression of t-PA, PAI-1, and p-p65 in brain immunohistochemistry and significantly decreased PT, APTT, D2D, and ET. However, there were no differences in NO between the model group and the Sanqi (Radix Notoginseng) group. CONCLUSION: Sanqi (Radix Notoginseng) can decrease the expression of p-p65, increase t-PA/PAI-1, and stem traumatic intracranial hemorrhage in a TBI rat model. (C) 2021 JTCM. All rights reserved.	[Jiang Tao] Zhejiang Chinese Med Univ, Dept Neurosurg, Affiliated Hosp 1, Hangzhou 310006, Peoples R China; [Zhou Xiaqing; Zhang Zhirong; Cai Danli; Wu Yu; Fang Hai-jun] Zhejiang Chinese Med Univ, Dept Intens Care Unit, Affiliated Hosp 1, Hangzhou 310006, Peoples R China; [Jiang Huifang] Tongde Hosp Zhejiang Prov, Dept Hematol, Hangzhou 310012, Peoples R China; [Ying Rongbiao] Tumor Hosp Taizhou, Dept Surg Oncol, Wenling 317502, Peoples R China		Wang, LC (corresponding author), Zhejiang Chinese Med Univ, Affiliated Rehabil Hosp 1, Dept Intens Care Unit, Affiliated Hosp 1, Hangzhou 310023, Peoples R China.	wlc501@139.com			Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LQY19H080001, LS20C110001, LY17H290006]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents [2014-108]; Zhejiang Science and Technology Program of Traditional Chinese Medicine [2019ZA053]; Wenling City Key Discipline Group of Oncology [2016-127]	Supported by the Zhejiang Provincial Natural Science Foundation of China under Grant No. LQY19H080001, LS20C110001, LY17H290006), the Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents (No. 2014-108), the Zhejiang Science and Technology Program of Traditional Chinese Medicine (No. 2019ZA053), and the Wenling City Key Discipline Group of Oncology (No. 2016-127)	Bie XD, 2010, J ASIAN NAT PROD RES, V12, P239, DOI 10.1080/10286020903510636; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Frendl I, 2017, J NEUROTRAUM, V34, P3238, DOI 10.1089/neu.2017.5198; Fu Jian-hua, 2006, Zhongguo Zhong Yao Za Zhi, V31, P62; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Lee BS, 1997, HEPATOLOGY, V25, P913, DOI 10.1002/hep.510250421; Mahr S, 2000, GASTROENTEROLOGY, V118, P515, DOI 10.1016/S0016-5085(00)70257-5; Peng XX, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0045-x; Simard B, 2013, CYTOKINE, V61, P104, DOI 10.1016/j.cyto.2012.08.035; Teng ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06932-3; Trauma Quality Improvement Program (TQIP), 2015, BEST PRACT MAN TRAUM; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Wang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.66; Xu DY, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00274; Yang X, 2015, INT J CLIN EXP MED, V8, P15630; Yuan ZM, 2011, J ETHNOPHARMACOL, V138, P150, DOI 10.1016/j.jep.2011.08.066; Zhang HS, 2006, VASC PHARMACOL, V44, P224, DOI 10.1016/j.vph.2005.12.002; Zhang WJ, 1997, CELL MOL BIOL, V43, P581	20	0	0	7	9	JOURNAL TRADITIONAL CHINESE MED	BEIJING	16 NANXIAOJIE, DONGZHIMEN NEI, BEIJING, 100700, PEOPLES R CHINA	0255-2922	1577-7014		J TRADIT CHIN MED	J. Tradit. Chin. Med.	APR	2021	41	2					262	269		10.19852/j.cnki.jtcm.2021.02.006			8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	RH9WP	WOS:000636562900010	33825406				2022-02-07	
J	Kanthimathinathan, HK; Mehta, H; Scholefield, BR; Morris, KP				Kanthimathinathan, Hari Krishnan; Mehta, Hiren; Scholefield, Barnaby R.; Morris, Kevin P.			Traumatic Brain Injury Practice Guidelines: Variability in UK PICUs	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injuries; traumatic; Brain Trauma Foundation; child; guidelines; intensive care units; pediatric	CHILDREN; MANAGEMENT; CONSENSUS	Objectives: Traumatic brain injury in children is a leading cause of morbidity and mortality. Lack of high-quality evidence may lead to variation in management within and between PICUs. We examined U.K. pediatric traumatic brain injury management guidelines for extent of variability. Design: Analysis of U.K. PICU traumatic brain injury guidelines for areas of consistency and variation among each other and against the second edition of Brain Trauma Foundation pediatric traumatic brain injury guidelines. SETTING: Not applicable. SUBJECTS: Not applicable. INTERVENTIONS: Textual analysis of U.K. PICU guidelines. Measurements and Main Results: Twelve key clinical topics in three traumatic brain injury management domains were identified. We performed textual analysis of recommendations from anonymized local guidelines and compared them against each other and the Brain Trauma Foundation pediatric traumatic brain injury guidelines. Fifteen guidelines used by 16 of the 20 U.K. PICUs that manage traumatic brain injury were analyzed. Relatively better consistency was observed for intracranial pressure treatment thresholds (10/15), avoiding prophylactic hyperventilation (15/15), cerebrospinal fluid drainage (13/15), barbiturate (14/15), and decompressive craniectomy (12/15) for intracranial hypertension. There was less consistency in indications for intracranial pressure monitoring (3/15), cerebral perfusion pressure targets (2/15), target osmolarities (7/15), and hyperventilation for intracranial hypertension (2/15). Variability in choice and hierarchy of the interventions for intracranial hypertension were observed, albeit with some points of consistency. Conclusions: Significant variability in pediatric traumatic brain injury management guidelines exists. Despite the heterogeneity, we have highlighted a few points of consistency within the key topic areas of pediatric traumatic brain injury management. We anticipate that this provides impetus for further work around standardization.	[Kanthimathinathan, Hari Krishnan; Mehta, Hiren; Scholefield, Barnaby R.; Morris, Kevin P.] Birmingham Childrens Hosp, Paediat Intens Care Unit, Birmingham, W Midlands, England; [Kanthimathinathan, Hari Krishnan] Univ Birmingham, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Scholefield, Barnaby R.] Univ Birmingham, Inst Inflammat & Ageing, Birmingham Acute Care Res Grp, Birmingham, W Midlands, England; [Morris, Kevin P.] Univ Birmingham, Paediat Crit Care Med, Birmingham, W Midlands, England; [Kanthimathinathan, Hari Krishnan; Mehta, Hiren; Scholefield, Barnaby R.; Morris, Kevin P.] Birmingham Childrens Hosp, Birmingham, W Midlands, England		Kanthimathinathan, HK (corresponding author), Birmingham Childrens Hosp, Paediat Intens Care Unit, Birmingham, W Midlands, England.; Kanthimathinathan, HK (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Birmingham, W Midlands, England.	dr.h.krishnan@gmail.com	Scholefield, Barney/ABG-7312-2021; Krishnan, Hari/ABH-5848-2020	Krishnan, Hari/0000-0001-5170-1534; Scholefield, Barney/0000-0002-6198-4985	Department of HealthEuropean Commission [CS-2015-15-016] Funding Source: Medline		Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Appavu B, 2019, J NEUROSURG-PEDIATR, V23, P661, DOI 10.3171/2019.2.PEDS18384; Bell MJ, 2017, CHILD NERV SYST, V33, P1663, DOI 10.1007/s00381-017-3530-y; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Thomas LH, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000349; Vavilala MS, 2019, LANCET CHILD ADOLESC, V3, P23, DOI 10.1016/S2352-4642(18)30341-9; Wijayatilake DS, 2015, J NEUROSURG ANESTH, V27, P241, DOI 10.1097/ANA.0000000000000143; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	15	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	APR	2021	22	4					E270	E274		10.1097/PCC.0000000000002574			5	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	RL9TW	WOS:000639306900005	33009356				2022-02-07	
J	Keegan, LC; Suger, C; Togher, L				Keegan, Louise C.; Suger, Caitlin; Togher, Leanne			Discourse Analysis of Humor After Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: Individuals with cognitive communication difficulties after traumatic brain injury (TBI) often experience difficulties with social communication. Humor is a sociolinguistic skill that requires social, cognitive, emotional, and behavioral skills and, when used effectively, may serve to enhance one's social relationships. There is a paucity of research related to the use of humor in individuals with TBI. This study categorizes humor use in individuals with cognitive communication difficulties after TBI and examines the linguistic construction of these humorous exchanges. Method: The humorous exchanges of nine individuals who had cognitive communication difficulties after a moderate-to-severe TBI were examined. Conversations were collected from a community-based communication skills group, categorized using thematic analysis methods, and examined linguistically using the discourse analysis tools of systemic functional linguistics. Results: All participants demonstrated the ability to use a variety of categories of humor, and discourse analysis methods revealed humor use as a strength for engaging with others. Examples of such engagement include use of humor to elicit attention, assert authority, share information, acknowledge shared difficulties, and demonstrate affiliation toward their communication partners. Conclusions: Discourse analysis of humor can provide speech-language pathologists with important information about the linguistic strengths of individuals with cognitive communication difficulties. This has important implications for clinical service provision.	[Keegan, Louise C.] Moravian Coll, Dept Rehabil Sci, Bethlehem, PA 18018 USA; [Suger, Caitlin] Duke LifePoint Hlth, Frye Reg Med Ctr, Hickory, NC USA; [Togher, Leanne] Univ Sydney, Dept Speech Pathol, Sydney, NSW, Australia		Keegan, LC (corresponding author), Moravian Coll, Dept Rehabil Sci, Bethlehem, PA 18018 USA.	keeganl@moravian.edu			Appalachian State University's Graduate Research Mentorship award; American Speech-Language-Hearing Association's Advancing Academic Research Careers award	This work was supported by the Appalachian State University's Graduate Research Mentorship award and the American Speech-Language-Hearing Association's Advancing Academic Research Careers award. The authors would like to first acknowledge the participants who took part in this study, as well as Appalachian State University, where this research was carried out. Finally, much thanks are due to the team of undergraduate communication sciences and disorders students at Appalachian State University involved in coding these data.	Allain P, 2019, BRAIN INJURY, V33, P1, DOI 10.1080/02699052.2018.1533143; Bartell, 2011, DEMENTIA-LONDON, V10, P341, DOI DOI 10.1177/1471301211407805; Brassel S, 2016, BRAIN INJURY, V30, P1329, DOI 10.1080/02699052.2016.1187288; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Dynel M., 2013, DEV LINGUISTIC HUMOU, P105, DOI DOI 10.1075/THR.1.07DYN; Eckert P., 1997, LINGUIST VAR; Eggins S., 2005, ANAL CASUAL CONVERSA; Elbourn E, 2019, BRAIN INJURY, V33, P143, DOI 10.1080/02699052.2018.1539246; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Glenwright M, 2017, J SPEECH LANG HEAR R, V60, P3295, DOI 10.1044/2017_JSLHR-L-17-0058; Haire N, 2019, NORD J MUSIC THER, V28, P273, DOI 10.1080/08098131.2019.1577288; Halliday, 2014, INTRO FUNCTIONAL GRA, DOI [10.4324/9780203783771, DOI 10.4324/9780203783771]; Hanks RA, 2014, ARCH PHYS MED REHAB, V95, P2096, DOI 10.1016/j.apmr.2014.06.017; Heath RL, 2005, BRAIN LANG, V93, P267, DOI 10.1016/j.bandl.2004.10.006; Hill E, 2018, INT J LANG COMM DIS, V53, P689, DOI 10.1111/1460-6984.12394; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Keegan L. C., 2018, PERSPECTIVES AM SPEE, V3, P21, DOI [10.1044/persp3.SIG2.21, DOI 10.1044/PERSP3.SIG2.21]; Keegan LC, 2020, NEUROPSYCHOL REHABIL, V30, P1497, DOI 10.1080/09602011.2019.1591464; Keegan LC, 2017, BRAIN INJURY, V31, P1632, DOI 10.1080/02699052.2017.1332389; Keegan LC, 2016, J INTERACT RES COM D, V7, P101, DOI 10.1558/jircd.v7i1.21570; Kovarsky Dana, 2007, Commun Med, V4, P53, DOI 10.1515/CAM.2007.029; Kovarsky D, 2011, TOP LANG DISORD, V31, P325, DOI 10.1097/TLD.0b013e3182358e98; Kovarsky Dana, 2009, Seminars in Speech and Language, V30, P27, DOI 10.1055/s-0028-1104532; Lurie A, 2015, SOC WORK MENT HEALTH, V13, P82, DOI 10.1080/15332985.2014.884519; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Maddy KM, 2015, J INTERACT RES COM D, V6, P211, DOI 10.1558/jircd.v7i1.25519; McCreaddie M, 2014, HEALTH EXPECT, V17, P332, DOI 10.1111/j.1369-7625.2011.00758.x; McCreaddie M, 2009, INT J NURS STUD, V46, P1079, DOI 10.1016/j.ijnurstu.2009.01.008; McDonald S., SOCIAL COMMUNICATION, V2nd, P119; Merz EL, 2009, PSYCHOL HEALTH MED, V14, P553, DOI 10.1080/13548500903111798; Meulenbroek P, 2019, J SPEECH LANG HEAR R, V62, P3367, DOI 10.1044/2019_JSLHR-L-18-0466; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Ownsworth T., 2014, SELF IDENTITY BRAIN; POYNTON C, 1989, LANGUAGE GENDER MAKI; Reilly K., 2017, REHABILITATION NURSI, V42, P230, DOI [10.1097/rnj.0000000000000015, DOI 10.1097/RNJ.0000000000000015]; Roaldsen BL, 2015, SCAND J CARING SCI, V29, P724, DOI 10.1111/scs.12203; Sabat S., 1999, POSITIONING THEORY, P87; Sherratt S, 2016, APHASIOLOGY, V30, P1039, DOI 10.1080/02687038.2015.1092495; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Simmons-Mackie Nina, 2009, Seminars in Speech and Language, V30, P5, DOI 10.1055/s-0028-1104529; Steel J, 2019, BRAIN INJURY, V33, P48, DOI 10.1080/02699052.2018.1531304; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tompkins C.A., 2017, APHASIA RELATED NEUR, V2nd ed, P353; Westerhof-Evers HJ, 2019, BRAIN INJURY, V33, P78, DOI 10.1080/02699052.2018.1531303; Williams C, 2019, BRAIN INJURY, V33, P69, DOI 10.1080/02699052.2018.1531302; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	54	0	0	0	3	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		949	961		10.1044/2020_AJSLP-20-00059			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400008	33556258				2022-02-07	
J	Kiyohira, M; Suehiro, E; Shinoyama, M; Fujiyama, Y; Haji, K; Suzuki, M				Kiyohira, Miwa; Suehiro, Eiichi; Shinoyama, Mizuya; Fujiyama, Yuichi; Haji, Kohei; Suzuki, Michiyasu			Combined Strategy of Burr Hole Surgery and Elective Craniotomy under Intracranial Pressure Monitoring for Severe Acute Subdural Hematoma	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						severe acute subdural hematoma; burr hole surgery; large craniotomy; intercranial pressure; posttraumatic coagulopathy	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; MORTALITY; TRANSFUSION; MANAGEMENT	Burr hole surgery in the emergency room can be life saving for patients with acute subdural hematoma (ASDH). In the first part of this study, a strategy of combined burr hole surgery, a period of intracranial pressure (ICP) monitoring, and then craniotomy was examined for safe and effective treatment of ASDH. Since 2012, 16 patients with severe ASDH with indications for burr hole surgery were admitted to Kenwakai Otemachi Hospital. From 2012 to 2016, craniotomy was performed immediately after burr hole surgery (emergency [EM] group, n = 10). From 2017, an ICP sensor was placed before burr hole surgery. After a period for correction of traumatic coagulopathy, craniotomy was performed when ICP increased (elective [EL] group, n = 6). Patient background, bleeding tendency, intraoperative blood transfusion, and outcomes were compared between the groups. In the second part of the study, ICP was measured before and after burr hole surgery in seven patients (including two of the six in the EL group) to assess the effect of this surgery. Activated partial thromboplastin time (APTT) and prothrombin time-international normalized ratio (PT-INR) were significantly prolonged after craniotomy in the EM group, but not in the EL group, and the EM group tended to require a higher intraoperative transfusion volume. The rate of good outcomes was significantly higher in the EL group, and ICP was significantly decreased after burr hole surgery. These results suggest the value of burr hole surgery followed by ICP monitoring in patients with severe ASDH. Craniotomy can be performed safely using this method, and this may contribute to improved outcomes.	[Kiyohira, Miwa; Fujiyama, Yuichi; Haji, Kohei] Yamaguchi Univ, Dept Neurosurg, Sch Med, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan; [Suehiro, Eiichi] Int Univ Hlth & Welf, Sch Med, Dept Neurosurg, Narita, Chiba, Japan; [Shinoyama, Mizuya] Kenwakai Otemachi Hosp, Dept Neurosurg, Kitakyushu, Fukuoka, Japan; [Fujiyama, Yuichi; Suzuki, Michiyasu] Shinyurigaoka Gen Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Suzuki, Michiyasu] Yamaguchi Univ, Dept Adv ThermoNeuroBiol, Sch Med, Ube, Yamaguchi, Japan		Kiyohira, M (corresponding author), Yamaguchi Univ, Dept Neurosurg, Sch Med, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	miwakiyohira@outlook.com					Boutin A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014472; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Di Rienzo A, 2017, J NEUROL SURG PART A, V78, P535, DOI 10.1055/s-0037-1599054; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Leal-Noval SR, 2016, NEUROCRIT CARE, V24, P371, DOI 10.1007/s12028-015-0220-z; Liu XM, 2018, WORLD NEUROSURG, V120, pE1024, DOI 10.1016/j.wneu.2018.08.219; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Mihara Y, 2010, NEUROL MED-CHIR, V50, P1039, DOI 10.2176/nmc.50.1039; Mizumoto A, 2010, I STAT MATH COOPERAT, P1; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Suehiro E, 2019, NEUROL MED-CHIR, V59, P63, DOI 10.2176/nmc.oa.2018-0254; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yanagawa Y, 2012, TURK NEUROSURG, V22, P196, DOI 10.5137/1019-5149.JTN.5206-11.0; Yokobori S, 2018, BEHAV BRAIN RES, V340, P23, DOI 10.1016/j.bbr.2016.05.055; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140	21	0	0	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2021	61	4					253	259		10.2176/nmc.oa.2020-0266			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SD4ZM	WOS:000651382300002	33597319	Green Published, gold			2022-02-07	
J	Klaphajone, J; Wattanapan, P; Tunwattanapong, P; Wangno, W; Kuptniratsaikul, V				Klaphajone, Jakkrit; Wattanapan, Pattra; Tunwattanapong, Punjama; Wangno, Wuttiganok; Kuptniratsaikul, Vilai		KPI Team Rehabil Serv Indicator	Complications During the Inpatient Rehabilitation Period in Neurological Subjects A Multicenter Study	TOPICS IN GERIATRIC REHABILITATION			English	Article						complications; factors; pain; rehabilitation; urinary tract infection	SPINAL-CORD-INJURY; URINARY-TRACT-INFECTIONS; MEDICAL COMPLICATIONS; STROKE REHABILITATION; SHOULDER PAIN; RISK-FACTORS; MORTALITY	Objective To explore common complications in people with neurological conditions during rehabilitation admission. Methods: All neurological subjects, including those with stroke, spinal cord injury (SCI), and traumatic brain injury, who were admitted for intensive and less-intensive rehabilitation programs during January to December 2012 were recruited. Both avoidable and unavoidable complications and related factors were assessed. Results: Among 1146 subjects, 65% was male with a mean age of 54.5 years. Almost 90% were admitted for intensive rehabilitation. The common avoidable complications that occurred were urinary tract infection (UTI) (12.8%), musculoskeletal pain (7.0%), neuropathic pain (2.3%), pneumonia (1.5%), and pressure injury (1.2%). Spasticity, which is an unavoidable complication, occurred in 2.1% of subjects. Older age, male gender, diagnosis of SCI, and longer stay were important factors related to complications. Conclusions: Most of the common complications during rehabilitation were avoidable complications, especially UTI and pain. A heightened level of awareness and vigilance should be exercised in older male subjects, those with prolonged hospital stay, and those with a diagnosis of SCI.	[Klaphajone, Jakkrit] Chiang Mai Univ, Fac Med, Dept Rehabil Med, Chiang Mai, Thailand; [Wattanapan, Pattra] Khon Kaen Univ, Fac Med, Dept Rehabil Med, Khon Kaen, Thailand; [Tunwattanapong, Punjama] Minist Publ Hlth, Sunpasitthiprasong Hosp, Dept Rehabil Med, Ubon Ratchathani, Thailand; [Wangno, Wuttiganok] Minist Publ Hlth, Rattanaburi Hosp, Surin, Thailand; [Kuptniratsaikul, Vilai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Rehabil Med, 2 Wanglang Rd, Bangkok 10700, Thailand		Kuptniratsaikul, V (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Rehabil Med, 2 Wanglang Rd, Bangkok 10700, Thailand.	vilai.kup@mahidol.ac.th			Royal College of Physiatrists of Thailand; Faculty of Medicine Siriraj Hospital, Mahidol University	The authors thank Ms Daranee Prukshyajiva for her assistance with the coordination of data collection, and Mr Suthipol Udompunturak and Ms Julaporn Poolium for statistical analyses. This study was supported by the Royal College of Physiatrists of Thailand and partly supported by the Faculty of Medicine Siriraj Hospital, Mahidol University.	Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Barczak C A, 1997, Adv Wound Care, V10, P18; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; CARDENAS DD, 1995, ARCH PHYS MED REHAB, V76, P272, DOI 10.1016/S0003-9993(95)80615-6; Chen CM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-41; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; Domka E., 2005, NEUROL NEUROCHIR POL, V39, P30; Doshi V. S., 2003, SMJ Singapore Medical Journal, V44, P643; DROMERICK A, 1994, STROKE, V25, P358, DOI 10.1161/01.STR.25.2.358; European Association of Urology, EAU EUR ASS UR GUID; Haisma JA, 2007, J REHABIL MED, V39, P393, DOI 10.2340/16501977-0067; Hung Jen-Wen, 2005, Chang Gung Med J, V28, P31; Kitisomprayoonkul Wasuwat, 2010, Journal of the Medical Association of Thailand, V93, P594; Korner M, 2018, J INTERPROF CARE, V32, P123, DOI 10.1080/13561820.2017.1357542; Kovindha A, 2004, SPINAL CORD, V42, P638, DOI 10.1038/sj.sc.3101646; Kuptniratsaikul V., 2016, Rehab Process Outcome, V5, P13; Kuptniratsaikul V, 2009, AM J PHYS MED REHAB, V88, P92, DOI 10.1097/PHM.0b013e3181909d5f; Liguori PA, 1997, ARCH PHYS MED REHAB, V78, P156, DOI 10.1016/S0003-9993(97)90257-4; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P1402, DOI 10.1016/S0003-9993(99)90251-4; Nilchaikovit T., 1996, J PSYCHIAT ASS THAI, V41, P18; Putzke JD, 2002, SPINAL CORD, V40, P118, DOI 10.1038/sj.sc.3101269; Rinkaewkan P, 2015, SPINAL CORD, V53, P591, DOI 10.1038/sc.2015.8; Culleres GR, 2010, ACTAS UROL ESP, V34, P251, DOI 10.1016/j.acuro.2009.11.003; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Royal Colleges of Physicians of Ireland, REHABILITATION MED; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; Suethanapornkul Sumalee, 2008, Journal of the Medical Association of Thailand, V91, P1885; Turner JA, 2001, ARCH PHYS MED REHAB, V82, P501, DOI 10.1053/apmr.2001.21855; Wade D T, 1988, Int Disabil Stud, V10, P64; Walsh K, 2001, POSTGRAD MED J, V77, P645, DOI 10.1136/pmj.77.912.645; Wannapakhe J, 2015, J SPINAL CORD MED, V38, P84, DOI 10.1179/2045772313Y.0000000173; Woratyla S P, 1995, Conn Med, V59, P643; World Medical Association, 2011, WMA DECL HELS ETH PR	34	0	0	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0882-7524	1550-2414		TOP GERIATR REHABIL	Top. Geriatr. Rehabil.	APR-JUN	2021	37	2					82	88		10.1097/TGR.0000000000000308			7	Gerontology; Rehabilitation	Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Rehabilitation	SM2EA	WOS:000657421700005					2022-02-07	
J	Lacitignola, L; Samarelli, R; Zizzo, N; Circella, E; Acquafredda, C; Stabile, M; Lombardi, R; Staffieri, F; Camarda, A				Lacitignola, Luca; Samarelli, Rossella; Zizzo, Nicola; Circella, Elena; Acquafredda, Claudia; Stabile, Marzia; Lombardi, Roberto; Staffieri, Francesco; Camarda, Antonio			CT Findings and Histological Evaluation of Red Foxes (Vulpes vulpes) with Chronic Head Trauma Injury: A Retrospective Study	ANIMALS			English	Article						head trauma; hydrocephalus; chronic brain injury; neurologic disorders; brain atrophy; survival rate; CT; red foxes; road traffic accident; wild carnivores	GLASGOW COMA SCALE; BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; COMPUTED-TOMOGRAPHY; PROGNOSTIC VALUE; DOGS; PREDICTORS; SCORE; CATS	Simple Summary Large numbers of wild animals are injured every year in road traffic accidents (RTA) and need first aid and assistance procedures, depending on the severity of the trauma and lesions. Head trauma may lead to traumatic brain injury (TBI), which causes neurologic and behavioral disorders. In this study, we retrospectively evaluated the clinical records of red foxes rescued and clinically evaluated to characterize computed tomography (CT) findings in a cohort of foxes with chronic head trauma and identify survival rates. On average, CT scans were performed 260 days after fox rescue. We speculate that persisting clinical signs could be attributed to TBI. CT scan helped diagnose chronic lesion and their effect on prognostic judgment for animals that should be released to wildlife environments. Large numbers of wild animals are injured every year in road traffic accidents. Scant data are available for rescued wild carnivores, in particular for red foxes. Cases of foxes with head trauma were retrospectively considered for inclusion in this study. Clinical examination, modified Glasgow coma scale (MGCS), computed tomography (CT) examination, therapy, outcome, and post mortem findings of the brain were investigated. In all foxes, cranial vaults lesion occurred in single (67%) or multiple sites (33%). Midline shift and hydrocephalus were observed in this population. The mean survival was 290 (+/- 176) days. In our study, we performed CT scans on average 260 days after fox rescue, and we speculate that persisting clinical signs could be attributed to TBI. In our study, only two foxes were alive at the time of writing. Other foxes were euthanized due to the severity of the clinical signs. CT scans help diagnose chronic lesions and their effect on prognostic judgment for animals released to wildlife environments.	[Lacitignola, Luca; Staffieri, Francesco] Univ Bari, Dipartimento Emergenze & Trapianti Organo Sez Cli, Str Prov Casamassima Km 3, I-70010 Valenzano, Italy; [Samarelli, Rossella; Circella, Elena; Lombardi, Roberto; Camarda, Antonio] Univ Bari, Patol Aviare, Dipartimento Med Vet, Sez, Str Prov Casamassima Km 3, I-70010 Valenzano, Italy; [Zizzo, Nicola] Univ Bari, Anat Patol, Sez, Dipartimento Med Vet, Str Prov Casamassima Km 3, I-70010 Valenzano, Italy; [Circella, Elena; Lombardi, Roberto; Camarda, Antonio] Osservatorio Faunist Reg Puglia, Via Gen Palmiotti, I-70020 Bitetto, Italy; [Acquafredda, Claudia; Stabile, Marzia] Univ Bari Aldo Moro, Dottorato Ric Trapianti Tessuti & Organi & Terapi, Dipartimento Emergenza & Trapianti Organi DETO, I-70100 Bari, Italy		Lacitignola, L; Staffieri, F (corresponding author), Univ Bari, Dipartimento Emergenze & Trapianti Organo Sez Cli, Str Prov Casamassima Km 3, I-70010 Valenzano, Italy.	luca.lacitignola@uniba.it; rossella.samarelli@uniba.it; nicola.zizzo@uniba.it; elena.circella@uniba.it; claudia.acquafredda@uniba.it; marzia.stabile@uniba.it; roberto.lombardi.vet@gmail.com; francesco.staffieri@uniba.it; antonio.camarda@uniba.it	; Staffieri, Francesco/K-4230-2016	Lacitignola, Luca/0000-0003-4963-8673; Staffieri, Francesco/0000-0002-2085-376X; NICOLA, ZIZZO/0000-0002-1434-415X; Samarelli, Rossella/0000-0002-4415-1690			Ash K, 2018, J VET EMERG CRIT CAR, V28, P192, DOI 10.1111/vec.12717; Atkinson M.W., 1997, ZOO BIOL, V16, P355, DOI 10.1002/(SICI)1098-2361(1997)16:43.0.CO;2-9; Baker PJ, 2007, BEHAV ECOL, V18, P716, DOI 10.1093/beheco/arm035; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Chai O, 2017, AM J VET RES, V78, P1085, DOI 10.2460/ajvr.78.9.1085; Davies ESS, 2012, VET REC, V170, P179, DOI 10.1136/vr.100109; De Lahunta A., 1983, VET NEUROANATOMY CLI, P30; Dos Santos LO, 2018, VET MED-CZECH, V63, P345, DOI 10.17221/20/2017-VETMED; Flegel T, 2007, J SMALL ANIM PRACT, V48, P462, DOI 10.1111/j.1748-5827.2006.00257.x; Gielen I, 2013, JAVMA-J AM VET MED A, V243, P367, DOI 10.2460/javma.243.3.367; HARRIS S, 1987, J APPL ECOL, V24, P75, DOI 10.2307/2403788; Hodgson N, 2018, CAN VET J, V59, P31; Hu QX, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00337; Kuo KW, 2018, VET CLIN N AM-SMALL, V48, P111, DOI 10.1016/j.cvsm.2017.08.005; Liao CC, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/4303161; Machado GF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-246; MacKillop E, 2011, VET RADIOL ULTRASOUN, V52, pS42, DOI 10.1111/j.1740-8261.2010.01784.x; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Nykamp S, 2001, VET RADIOL ULTRASOUN, V42, P511, DOI 10.1111/j.1740-8261.2001.tb00978.x; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Platt SR, 2002, VET REC, V151, P243, DOI 10.1136/vr.151.8.243; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Rapoport K, 2020, VET J, V266, DOI 10.1016/j.tvjl.2020.105563; Ricciardi M, 2017, OPEN VET J, V7, P197, DOI 10.4314/ovj.v7i2.19; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Schmidt MJ, 2012, VET RADIOL ULTRASOUN, V53, P142, DOI 10.1111/j.1740-8261.2011.01887.x; Seiler A, 2004, WILDLIFE BIOL, V10, P225, DOI 10.2981/wlb.2004.028; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; Thomas WB, 2010, VET CLIN N AM-SMALL, V40, P143, DOI 10.1016/j.cvsm.2009.09.008	30	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-2615			ANIMALS-BASEL	Animals	APR	2021	11	4							1010	10.3390/ani11041010			13	Agriculture, Dairy & Animal Science; Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Veterinary Sciences; Zoology	RQ8FZ	WOS:000642650900001	33916753	Green Published, gold			2022-02-07	
J	Lecuyer, JB; Mercier, E; Tardif, PA; Archambault, PM; Chauny, JM; Berthelot, S; Frenette, J; Perry, J; Stiell, I; Emond, M; Lee, J; Lang, E; McRae, A; Boucher, V; Le Sage, N				Lecuyer, Julien Blais; Mercier, Eric; Tardif, Pier-Alexandre; Archambault, Patrick M.; Chauny, Jean-Marc; Berthelot, Simon; Frenette, Jerome; Perry, Jeff; Stiell, Ian; Emond, Marcel; Lee, Jacques; Lang, Eddy; McRae, Andrew; Boucher, Valerie; Le Sage, Natalie			S100B protein level for the detection of clinically significant intracranial haemorrhage in patients with mild traumatic brain injury: a subanalysis of a prospective cohort study	EMERGENCY MEDICINE JOURNAL			English	Article							MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; SERUM; VALIDATION; ACCURACY; MODERATE; RELEASE; DAMAGE; RULE	Background Clinical assessment of patients with mild traumatic brain injury (mTBI) is challenging and overuse of head CT in the ED is a major problem. Several studies have attempted to reduce unnecessary head CTs following a mTBI by identifying new tools aiming to predict intracranial bleeding. Higher levels of S100B protein have been associated with intracranial haemorrhage following a mTBI in previous literature. The main objective of this study is to assess whether plasma S100B protein level is associated with clinically significant brain injury and could be used to reduce the number of head CT post-mTBI. Methods Study design: secondary analysis of a prospective multicentre cohort study conducted between 2013 and 2016 in five Canadian EDs. Inclusion criteria: non-hospitalised patients with mTBI with a GCS score of 13-15 in the ED and a blood sample drawn within 24 hours after the injury. Data collected: sociodemographic and clinical data were collected in the ED. S100B protein was analysed using ELISA. All CT scans were reviewed by a radiologist blinded to the biomarker results. Main outcome: the presence of clinically important brain injury. Results 476 patients were included. Mean age was 41 +/- 18 years old and 150 (31.5%) were women. Twenty-four (5.0%) patients had a clinically significant intracranial haemorrhage. Thirteen patients (2.7%) presented a non-clinically significant brain injury. A total of 37 (7.8%) brain injured patients were included in our study. S100B median value (Q1-Q3) was: 0.043 mu g/L (0.008-0.080) for patients with clinically important brain injury versus 0.039 mu g/L (0.023-0.059) for patients without clinically important brain injury. Sensitivity and specificity of the S100B protein level, if used alone to detect clinically important brain injury, were 16.7% (95% CI 4.7% to 37.4%) and 88.5% (95% CI 85.2% to 91.3%), respectively. Conclusion Plasma S100B protein level was not associated with clinically significant intracranial lesion in patients with mTBI.	[Lecuyer, Julien Blais; Mercier, Eric; Frenette, Jerome; Perry, Jeff; Emond, Marcel; Le Sage, Natalie] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Lecuyer, Julien Blais; Mercier, Eric; Tardif, Pier-Alexandre; Berthelot, Simon; Emond, Marcel; Boucher, Valerie; Le Sage, Natalie] Univ Laval, Axe Rech Sante Populat & Prat Optimales Sante, CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Archambault, Patrick M.] Univ Laval, Dept Anesthesiol & Crit Care Med, Quebec City, PQ, Canada; [Archambault, Patrick M.] Chaudiere Appalaches Integrated Hlth & Social Ser, Levis, PQ, Canada; [Chauny, Jean-Marc] Univ Montreal, Dept Family Med & Emergency Med, Montreal, PQ, Canada; [Perry, Jeff; Stiell, Ian] Ottawa Hosp, Dept Emergency Med, Res Inst, Ottawa, ON, Canada; [Lee, Jacques] Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [Lang, Eddy; McRae, Andrew] Univ Calgary, Dept Emergency Med, Calgary, AB, Canada		Le Sage, N (corresponding author), Univ Laval, Dept Family Med & Emergency Med, Fac Med, Quebec City, PQ G1J 1Z4, Canada.	natalie.lesage@fmed.ulaval.ca	; Le Sage, Natalie/G-7063-2016	Berthelot, Simon/0000-0002-0372-0586; Boucher, Valerie/0000-0002-3117-2177; Le Sage, Natalie/0000-0003-4762-8156	Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec [35334]	Fonds de Recherche du Quebec-Sante (#35334).	Aaronson EL, 2019, INTERN EMERG MED, V14, P777, DOI 10.1007/s11739-019-02051-1; Allouchery G, 2018, CLIN CHEM LAB MED, V56, P1897, DOI 10.1515/cclm-2018-0471; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Cheng I, 2019, EMERG MED AUSTRALAS, V31, P605, DOI 10.1111/1742-6723.13247; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; EPA US, 2000, QAG9 US EPA QUW; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Mercier E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017848; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	24	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	APR	2021	38	4					285	289		10.1136/emermed-2020-209583			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RB1IB	WOS:000631868900008	33355233	Green Published, hybrid			2022-02-07	
J	Lee, HY; Youk, H; Kim, OH; Kang, CY; Kong, JS; Choo, YI; Choi, DR; Lee, HJ; Kang, DK; Lee, KH				Lee, Hee Young; Youk, Hyun; Kim, Oh Hyun; Kang, Chan Young; Kong, Joon Seok; Choo, Yeon Il; Choi, Doo Ruh; Lee, Hae Ju; Kang, Dong Ku; Lee, Kang Hyun			A Predictive Model to Analyze the Factors Affecting the Presence of Traumatic Brain Injury in the Elderly Occupants of Motor Vehicle Crashes Based on Korean In-Depth Accident Study (KIDAS) Database	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; the elderly; predictive model; validation analysis; KIDAS database	EPIDEMIOLOGY	Traumatic brain injury (TBI), also known as intracranial injury, occurs when an external force injures the brain. This study aimed to analyze the factors affecting the presence of TBI in the elderly occupants of motor vehicle crashes. We defined elderly occupants as those more than 55 years old. Damage to the vehicle was presented using the Collision Deformation Classification (CDC) code by evaluation of photos of the damaged vehicle, and a trauma score was used for evaluation of the severity of the patient's injury. A logistic regression model was used to identify factors affecting TBI in elderly occupants and a predictive model was constructed. We performed this study retrospectively and gathered all the data under the Korean In-Depth Accident Study (KIDAS) investigation system. Among 3697 patients who visited the emergency room in the regional emergency medical center due to motor vehicle crashes from 2011 to 2018, we analyzed the data of 822 elderly occupants, which were divided into two groups: the TBI patients (N = 357) and the non-TBI patients (N = 465). According to multiple logistic regression analysis, the probabilities of TBI in the elderly caused by rear-end (OR = 1.833) and multiple collisions (OR = 1.897) were higher than in frontal collision. Furthermore, the probability of TBI in the elderly was 1.677 times higher in those with unfastened seatbelts compared to those with fastened seatbelts (OR = 1.677). This study was meaningful in that it incorporated several indicators that affected the occurrence of the TBI in the elderly occupants. In addition, it was performed to determine the probability of TBI according to sex, vehicle type, seating position, seatbelt status, collision type, and crush extent using logistic regression analysis. In order to derive more precise predictive models, it would be needed to analyze more factors for vehicle damage, environment, and occupant injury in future studies.	[Lee, Hee Young; Youk, Hyun; Kim, Oh Hyun; Kang, Chan Young; Kong, Joon Seok; Choo, Yeon Il; Choi, Doo Ruh; Lee, Hae Ju; Kang, Dong Ku; Lee, Kang Hyun] Yonsei Univ, Wonju Coll Med, Automot Med Sci Res Inst, Wonju 26426, South Korea; [Youk, Hyun; Kim, Oh Hyun; Kang, Chan Young; Kong, Joon Seok; Lee, Kang Hyun] Yonsei Univ, Wonju Coll Med, Dept Emergency Med, Wonju 26426, South Korea		Lee, KH (corresponding author), Yonsei Univ, Wonju Coll Med, Automot Med Sci Res Inst, Wonju 26426, South Korea.; Lee, KH (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Emergency Med, Wonju 26426, South Korea.	hylee3971@yonsei.ac.kr; yhmentor@gmail.com; ardentem@gmail.com; chlrhkcy@naver.com; jskong4208@gmail.com; yg1tym@naver.com; dooruh78@naver.com; emt_hju@naver.com; gound333@nate.com; ed119@yonsei.ac.kr	Lee, Hee-Young/ABF-9167-2021; LEE, HEE YOUNG/ABG-7710-2021	LEE, HEE YOUNG/0000-0003-3254-2261; LEE, HAEJU/0000-0003-0548-6153	National Research Foundation of KOREANational Research Foundation of Korea [NRF-2019R1I1A1A01058960]	This research was supported by the National Research Foundation of KOREA (Project No.: NRF-2019R1I1A1A01058960).	[Anonymous], 2008, ABBREVIATED INJURY S; Ashok J., 2016, INT J RES MED SCI, V4, P649; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bum Kim Kyung, 2014, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V14, P151, DOI 10.5392/JKCA.2014.14.07.151; Campbell K.L., 1974, EN BAS COLL SEV, P2114; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; EVANS L, 1990, ACCIDENT ANAL PREV, V22, P167, DOI 10.1016/0001-4575(90)90067-U; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Holt M.P., 2016, CONCISE ENCY BIOSTAT; Mayrose J, 2005, ACAD EMERG MED, V12, P130, DOI 10.1197/j.aem.2004.09.017; MORI Y, 1995, ACCIDENT ANAL PREV, V27, P391, DOI 10.1016/0001-4575(94)00077-Y; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Papadakaki M, 2017, TRAUMA, V19, P264, DOI 10.1177/1460408616677564; Papadakaki M, 2017, INJURY, V48, P297, DOI 10.1016/j.injury.2016.11.011; Park S.D., 2010, THESIS HAN YANG U SE; Peden M., 2004, WORLD REPORT ROAD TR; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peschman J, 2011, J TRAUMA, V70, P1331, DOI 10.1097/TA.0b013e31821693e2; Popescu C, 2015, J Med Life, V8, P272; Promidor A., 2016, CLIN GUID ASS COUNS, V3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Society of Automotive Engineers International, 2017, COLL DEF CLASS J224; United Nations, LIF EXP BIRTH BOTH S; United Nations, 2015, 2015 WORLD POP AG; Young Lee， Hee, 2019, [Journal Of Auto-Vehicle Safety Association, 자동차안전학회지], V11, P43, DOI 10.22680/kasa2019.11.3.043	31	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2021	18	8							3975	10.3390/ijerph18083975			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	RT0AO	WOS:000644131700001	33918843	Green Published, gold			2022-02-07	
J	Lee, J; Anderson, LJ; Migula, D; Yuen, KCJ; McPeak, L; Garcia, JM				Lee, Jonathan; Anderson, Lindsey J.; Migula, Dorota; Yuen, Kevin C. J.; McPeak, Lisa; Garcia, Jose M.			Experience of a Pituitary Clinic for US Military Veterans With Traumatic Brain Injury	JOURNAL OF THE ENDOCRINE SOCIETY			English	Article						TBI; head trauma; hypopituitarism; GH; adrenal insufficiency; growth hormone deficiency	GROWTH-HORMONE DEFICIENCY; INSULIN TOLERANCE-TEST; CHRONIC HYPOPITUITARISM; STIMULATION TEST; GH DEFICIENCY; ADRENAL AXIS; DIAGNOSIS; MILD; REPLACEMENT; ACCURACY	Context: Traumatic brain injury (TBI) is considered the "signature" injury of veterans returning from wartime conflicts in Iraq and Afghanistan. While moderate/severe TBI is associated with pituitary dysfunction, this association has not been well established in the military setting and in mild TBI (mTBI). Screening for pituitary dysfunction resulting from TBI in veteran populations is inconsistent across Veterans Affairs (VA) institutions, and such dysfunction often goes unrecognized and untreated. Objective: This work aims to report the experience of a pituitary clinic in screening for and diagnosis of pituitary dysfunction. Methods: A retrospective analysis was conducted in a US tertiary care center of veterans referred to the VA Puget Sound Healthcare System pituitary clinic with a history of TBI at least 12 months prior. Main outcome measures included demographics, medical history, symptom burden, baseline hormonal evaluation, brain imaging, and provocative testing for adrenal insufficiency (AI) and adult-onset growth hormone deficiency (AGHD). Results: Fatigue, cognitive/memory problems, insomnia, and posttraumatic stress disorder were reported in at least two-thirds of the 58 patients evaluated. Twenty-two (37.9%) were diagnosed with at least one pituitary hormone deficiency, including 13 (22.4%) AI, 12 (20.7%) AGHD, 2 (3.4%) secondary hypogonadism, and 5 (8.6%) hyperprolactinemia diagnoses; there were no cases of thyrotropin deficiency. Conclusion: A high prevalence of chronic AI and AGHD was observed among veterans with TBI. Prospective, larger studies are needed to confirm these results and determine the effects of hormone replacement on long-term outcomes in this setting.	[Lee, Jonathan; Anderson, Lindsey J.; Migula, Dorota; Garcia, Jose M.] Univ Washington, Sch Med, Geriatr Res Educ & Clin Ctr GRECC, VA Puget Sound Hlth Care Syst, Washington, WA 98108 USA; [Lee, Jonathan; Anderson, Lindsey J.; Migula, Dorota; Garcia, Jose M.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Washington, WA 98108 USA; [Yuen, Kevin C. J.] Univ Arizona, Barrow Pituitary Ctr, Barrow Neurol Inst, Coll Med, Phoenix, AZ 85013 USA; [Yuen, Kevin C. J.] Univ Arizona, Coll Med, St Josephs Hosp & Med Ctr, Phoenix, AZ 85013 USA; [Yuen, Kevin C. J.] Creighton Sch Med, Phoenix, AZ 85013 USA; [McPeak, Lisa] VA Puget Sound Hlth Care Syst, Rehabil Care Serv, Ctr Polytrauma Care, Seattle, WA 98108 USA		Garcia, JM (corresponding author), Univ Washington, Geriatr Res Educ & Clin Ctr, VA Puget Sound Hlth Care Syst, 1660 S Columbian Way,S-182 GRECC, Seattle, WA 98108 USA.	jose.garcia@va.gov		Anderson, Lindsey/0000-0003-3810-2427; Lee, Jonathan/0000-0003-2163-8348	U.S. Department of Veterans AffairsUS Department of Veterans Affairs [BX002807]	This work was supported by grants from the U.S. Department of Veterans Affairs (BX002807).	[Anonymous], 2015, 649013 DI DEP DEF; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bernard F, 2006, NEUROCRIT CARE, V5, P176, DOI 10.1385/NCC:5:3:176; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bowles AO, 2016, VA DOD CLIN PRACTICE; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Chanson P, 2010, J CLIN ENDOCR METAB, V95, P3684, DOI 10.1210/jc.2010-0295; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Defense and Veterans Brain Injury Center, DOD WORLD WID NUMB T; Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dokmetas HS, 2000, J CLIN ENDOCR METAB, V85, P3713, DOI 10.1210/jc.85.10.3713; Dubiel R, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00520; Emelifeonwu JA, 2020, J NEUROTRAUM, V37, P217, DOI 10.1089/neu.2018.6349; Erturk E, 1998, J CLIN ENDOCR METAB, V83, P2350, DOI 10.1210/jc.83.7.2350; Fleseriu M, 2016, J CLIN ENDOCR METAB, V101, P3888, DOI 10.1210/jc.2016-2118; Garcia JM, 2018, J CLIN ENDOCR METAB, V103, P3083, DOI 10.1210/jc.2018-00665; Glynn N, 2019, PITUITARY, V22, P249, DOI 10.1007/s11102-019-00938-y; HAGG E, 1987, CLIN ENDOCRINOL, V26, P221, DOI 10.1111/j.1365-2265.1987.tb00780.x; Hamrahian AH, 2016, PITUITARY, V19, P332, DOI 10.1007/s11102-016-0712-7; Hazem A, 2011, EUR J ENDOCRINOL, V165, P841, DOI 10.1530/EJE-11-0476; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ioachimescu AG, 2015, PITUITARY, V18, P535, DOI 10.1007/s11102-014-0606-5; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kim SY, 2015, ENDOCRINOL METAB, V30, P443, DOI 10.3803/EnM.2015.30.4.443; Klose M, 2015, J CLIN MED, V4, P1480, DOI 10.3390/jcm4071480; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Lithgow K, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0247-1; Maghnie M, 2005, EUR J ENDOCRINOL, V152, P589, DOI 10.1530/eje.1.01873; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Mossberg KA, 2017, J NEUROTRAUM, V34, P845, DOI 10.1089/neu.2016.4552; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Summerall EL, 2018, TRAUMATIC BRAIN INJU; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Undurti A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00072; Veterans Affairs, MANAGEMENT CONCUSSIO; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Wright T, 2020, J NEUROTRAUM, V37, P1052, DOI 10.1089/neu.2019.6690; Yuen KCJ, 2016, ENDOCR PRACT, V22, P1235, DOI 10.4158/EP161407.DSCR	41	0	0	1	1	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA		2472-1972		J ENDOCR SOC	J. Endocr. Soc.	APR	2021	5	4							bvab005	10.1210/jendso/bvab005			14	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	SA0HA	WOS:000648979800004	33655093	Green Published, gold			2022-02-07	
J	Li, DJ; Chen, YL; Chen, YY; Hsiao, RC; Lu, WH; Yen, CF				Li, Dian-Jeng; Chen, Yi-Lung; Chen, Ying-Yeh; Hsiao, Ray C.; Lu, Wei-Hsin; Yen, Cheng-Fang			Increased Risk of Traumatic Injuries among Parents of Children with Attention Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						attention-deficit; hyperactivity disorder; parents; children; traumatic injuries		Children with attention deficit/hyperactivity disorder (ADHD) are vulnerable to traumatic injuries. Parents of children with ADHD experience undesirable impacts more frequently than parents of children without ADHD. The aim of this study was to evaluate whether traumatic injuries are more prevalent in parents of children with ADHD than in parents of children without ADHD. We compared the prevalence of traumatic injuries between parents of children with and without ADHD by using data from the Taiwan Maternal and Child Health Database from 2004 to 2017. The Cox proportional-hazards regression model was used to examine differences in burn injury, fracture, and traumatic brain injury between parents of children with and without ADHD after adjustment for age, urbanicity, and income level. In total, 81,401 fathers and 87,549 mothers who had at least one offspring with ADHD and 1,646,100 fathers and 1,730,941 mothers with no offspring with ADHD were included in the analysis. The results indicated that both fathers and mothers of children with ADHD had higher risks of burn injury, fracture, and traumatic brain injury than fathers and mothers of children without ADHD. Mothers of children with ADHD had higher risks for all kinds of traumatic events than fathers of children with ADHD.	[Li, Dian-Jeng] Kaohsiung Municipal Kai Syuan Psychiat Hosp, Dept Addict Sci, Kaohsiung 80276, Taiwan; [Li, Dian-Jeng] Meiho Univ, Dept Nursing, Pingtung 91200, Taiwan; [Li, Dian-Jeng; Yen, Cheng-Fang] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 80708, Taiwan; [Li, Dian-Jeng; Yen, Cheng-Fang] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung 80708, Taiwan; [Chen, Yi-Lung] Asia Univ, Dept Psychol, Taichung 41354, Taiwan; [Chen, Yi-Lung] Asia Univ, Dept Healthcare Adm, Taichung 41354, Taiwan; [Chen, Ying-Yeh] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei 107, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Hsiao, Ray C.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98105 USA; [Hsiao, Ray C.] Childrens Hosp, Dept Psychiat, Seattle, WA 98105 USA; [Hsiao, Ray C.] Reg Med Ctr, Seattle, WA 98105 USA; [Lu, Wei-Hsin] Ditmanson Med Fdn, Dept Psychiat, Chia Yi Christian Hosp, Chiayi, Taiwan; [Yen, Cheng-Fang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung 80708, Taiwan		Yen, CF (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 80708, Taiwan.; Yen, CF (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung 80708, Taiwan.; Lu, WH (corresponding author), Ditmanson Med Fdn, Dept Psychiat, Chia Yi Christian Hosp, Chiayi, Taiwan.; Yen, CF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung 80708, Taiwan.	u108800004@kmu.edu.tw; elong@asia.edu.tw; ychen@tpech.gov.tw; rhsiao@u.washington.edu; wiiseen@gmail.com; chfaye@cc.kmu.edu.tw	Li, Dian‐Jeng/T-7571-2019; Chen, Ying-Yeh/AAY-1478-2021	Li, Dian‐Jeng/0000-0002-6036-045X; Hsiao, Ray/0000-0003-2351-2335; Chen, Yi-Lung/0000-0003-2934-5814; Lu, Wei-hsin/0000-0002-6294-8820; Chen, Ying-Yeh/0000-0001-5543-5704; Yen, Cheng-Fang/0000-0003-1156-4939	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST: 109-2314-B-468-001-MY2]	This work was supported by grants from the Ministry of Science and Technology [MOST: 109-2314-B-468-001-MY2], Taiwan.	Allison PD, 1999, SOCIOL METHOD RES, V28, P186, DOI 10.1177/0049124199028002003; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Asherson P, 2016, LANCET PSYCHIAT, V3, P568, DOI 10.1016/S2215-0366(16)30032-3; Babinski DE, 2018, J ATTEN DISORD, V22, P1289, DOI 10.1177/1087054715580843; Boxhoorn S, 2019, EUR ARCH PSY CLIN N, V269, P627, DOI 10.1007/s00406-019-00993-3; Chen VCH, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796020000608; Chen CCH, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8714; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Doshi JA, 2012, J AM ACAD CHILD PSY, V51, P990, DOI 10.1016/j.jaac.2012.07.008; DuPaul GJ, 2001, J AM ACAD CHILD PSY, V40, P508, DOI 10.1097/00004583-200105000-00009; Epstein JN, 2000, J ABNORM CHILD PSYCH, V28, P585, DOI 10.1023/A:1005187216138; Fang XM, 2010, ARCH GEN PSYCHIAT, V67, P1179, DOI 10.1001/archgenpsychiatry.2010.137; Faraone SV, 2019, MOL PSYCHIATR, V24, P562, DOI 10.1038/s41380-018-0070-0; Frias A, 2015, J AFFECT DISORDERS, V174, P378, DOI 10.1016/j.jad.2014.12.008; Fridman M, 2017, NEUROPSYCH DIS TREAT, V13, P373, DOI 10.2147/NDT.S121391; Galera C, 2009, PSYCHOL MED, V39, P1895, DOI 10.1017/S0033291709005510; Ginsberg Ylva, 2014, Prim Care Companion CNS Disord, V16, DOI 10.4088/PCC.13r01600; Gonzalez RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075575; Grygiel P, 2018, J ATTEN DISORD, V22, P738, DOI 10.1177/1087054714563791; Herguner A, 2015, DENT TRAUMATOL, V31, P140, DOI 10.1111/edt.12153; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Javalkar K, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4050039; Kendrick D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006020.pub2; Li CY, 2016, TAIWAN J PUBLIC HLTH, V35, P209; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Margari F, 2013, RES DEV DISABIL, V34, P1036, DOI 10.1016/j.ridd.2012.12.001; Oerlemans AM, 2015, J CHILD PSYCHOL PSYC, V56, P782, DOI 10.1111/jcpp.12349; Peasgood T, 2016, EUR CHILD ADOLES PSY, V25, P1217, DOI 10.1007/s00787-016-0841-6; Perera H, 2009, INT J PEDIATR OTORHI, V73, P1362, DOI 10.1016/j.ijporl.2009.06.011; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Rice F, 2019, J AFFECT DISORDERS, V243, P175, DOI 10.1016/j.jad.2018.09.015; Rogers MA, 2009, J SCHOOL PSYCHOL, V47, P167, DOI 10.1016/j.jsp.2009.02.001; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Starck M, 2016, NEUROPSYCH DIS TREAT, V12, P581, DOI 10.2147/NDT.S100238; Steinhausen HC, 2013, J ATTEN DISORD, V17, P38, DOI 10.1177/1087054711427562; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Thissen AJAM, 2014, PSYCHOL MED, V44, P881, DOI 10.1017/S0033291713001153; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; van Dongen EV, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0043-y; van Emmerik-van Oortmerssen K, 2012, DRUG ALCOHOL DEPEN, V122, P11, DOI 10.1016/j.drugalcdep.2011.12.007; Wang LJ, 2017, EPIDEMIOL PSYCH SCI, V26, P624, DOI 10.1017/S2045796016000500; Wehmeier PM, 2010, J ADOLESCENT HEALTH, V46, P209, DOI 10.1016/j.jadohealth.2009.09.009; Wei HT, 2019, J AFFECT DISORDERS, V245, P335, DOI 10.1016/j.jad.2018.11.057; Wundersitz L, 2019, TRAFFIC INJ PREV, V20, P696, DOI 10.1080/15389588.2019.1644627; Wymbs B, 2012, J ATTEN DISORD, V16, P373, DOI 10.1177/1087054710389987	48	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2021	18	7							3586	10.3390/ijerph18073586			9	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	RK9AW	WOS:000638580700001	33808366	Green Published, gold			2022-02-07	
J	Mahmood, A; Needham, K; Shakur-Still, H; Harris, T; Jamaluddin, SF; Davies, D; Belli, A; Mohamed, FL; Leech, C; Lotfi, HM; Moss, P; Lecky, F; Hopkins, P; Wong, D; Boyle, A; Wilson, M; Darwent, M; Roberts, I				Mahmood, Abda; Needham, Kelly; Shakur-Still, Haleema; Harris, Tim; Jamaluddin, Sabariah Faizah; Davies, David; Belli, Antonio; Mohamed, Fatahul Laham; Leech, Caroline; Lotfi, Hamzah Mohd; Moss, Phil; Lecky, Fiona; Hopkins, Philip; Wong, Darin; Boyle, Adrian; Wilson, Mark; Darwent, Melanie; Roberts, Ian			Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients	EMERGENCY MEDICINE JOURNAL			English	Article								Background Early tranexamic acid (TXA) treatment reduces head injury deaths after traumatic brain injury (TBI). We used brain scans that were acquired as part of the routine clinical practice during the CRASH-3 trial (before unblinding) to examine the mechanism of action of TXA in TBI. Specifically, we explored the potential effects of TXA on intracranial haemorrhage and infarction. Methods This is a prospective substudy nested within the CRASH-3 trial, a randomised placebo-controlled trial of TXA (loading dose 1 g over 10 min, then 1 g infusion over 8 hours) in patients with isolated head injury. CRASH-3 trial patients were recruited between July 2012 and January 2019. Participants in the current substudy were a subset of trial patients enrolled at 10 hospitals in the UK and 4 in Malaysia, who had at least one CT head scan performed as part of the routine clinical practice within 28 days of randomisation. The primary outcome was the volume of intraparenchymal haemorrhage (ie, contusion) measured on a CT scan done after randomisation. Secondary outcomes were progressive intracranial haemorrhage (post-randomisation CT shows >25% of volume seen on pre-randomisation CT), new intracranial haemorrhage (any haemorrhage seen on post-randomisation CT but not on pre-randomisation CT), cerebral infarction (any infarction seen on any type of brain scan done post-randomisation, excluding infarction seen pre-randomisation) and intracranial haemorrhage volume (intraparenchymal + intraventricular + subdural + epidural) in those who underwent neurosurgical haemorrhage evacuation. We planned to conduct sensitivity analyses excluding patients who were severely injured at baseline. Dichotomous outcomes were analysed using relative risks (RR) or hazard ratios (HR), and continuous outcomes using a linear mixed model. Results 1767 patients were included in this substudy. One-third of the patients had a baseline GCS (Glasgow Coma Score) of 3 (n=579) and 24% had unilateral or bilateral unreactive pupils. 46% of patients were scanned pre-randomisation and post-randomisation (n=812/1767), 19% were scanned only pre-randomisation (n=341/1767) and 35% were scanned only post-randomisation (n=614/1767). In all patients, there was no evidence that TXA of an increase in infarction with TXA (adjusted HR=1.28, 95% CI 0.93 to 1.76). A larger proportion of patients without (vs with) a post-randomisation scan died from head injury (38% vs 19%: RR=1.97, 95% CI 1.66 to 2.34, p<0.0001). Conclusion TXA may prevent new haemorrhage in patients with reactive pupils at baseline. This is consistent with the results of the CRASH-3 trial which found that TXA reduced head injury death in patients with at least one reactive pupil at baseline. However, the large number of patients without post-randomisation scans and the possibility that the availability of scan data depends on whether a patient received TXA, challenges the validity of inferences made using routinely collected scan data. This study highlights the limitations of using routinely collected scan data to examine the effects of TBI treatments.	[Mahmood, Abda; Needham, Kelly; Shakur-Still, Haleema; Roberts, Ian] London Sch Hyg & Trop Med, Clin Trials Unit, Fac Epidemiol & Populat Hlth, London, England; [Harris, Tim] Barts Hlth NHS Trust, Royal London Hosp, Dept Emergency Med, London, England; [Jamaluddin, Sabariah Faizah] Hosp Sungai Buloh, Emergency Dept, Sungai Buloh, Malaysia; [Davies, David; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Mohamed, Fatahul Laham] Hosp Sultanah Bahiyah, Emergency Dept, Alor Setar, Malaysia; [Leech, Caroline] Univ Hosp Coventry & Warwickshire NHS Trust, Emergency Dept, Coventry, W Midlands, England; [Lotfi, Hamzah Mohd] Hosp Sultanah Nur Zahirah, Emergency Dept, Kuala Terengganu, Malaysia; [Moss, Phil] St Georges Univ Hosp NHS Fdn Trust, Clin Res Unit, Emergency Dept, London, England; [Lecky, Fiona] Salford Royal NHS Fdn Trust, Accid & Emergency, Salford, Lancs, England; [Hopkins, Philip] Kings Coll Hosp NHS Fdn Trust, Emergency Dept, London, England; [Wong, Darin] Penang Gen Hosp, Emergency Dept, Georgetown, Malaysia; [Boyle, Adrian] Addenbrookes Hosp Cambridge Univ Hosp NHS Fdn Tru, Emergency Dept, Cambridge, England; [Wilson, Mark] Imperial Coll Healthcare NHS Trust, Neurosurg Emergencies & Trauma, Div Med, Med St Marys Hosp, London, England; [Darwent, Melanie] Oxford Univ Hosp NHS Fdn Trust, Emergency Dept, Oxford, England		Mahmood, A (corresponding author), London Sch Hyg & Trop Med, Clin Trials Unit, Fac Epidemiol & Populat Hlth, London, England.	Abda.Mahmood@LSHTM.ac.uk	; Belli, Antonio/I-3799-2015	Leech, Caroline/0000-0002-5301-9798; Shakur-Still, Haleema/0000-0002-6511-109X; Boyle, Adrian/0000-0002-9009-5423; Belli, Antonio/0000-0002-3211-9933	London School of Hygiene & Tropical Medicine [EPAA6020]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M009211/1] Funding Source: UKRI	This study is fully funded by the London School of Hygiene & Tropical Medicine (Grant reference EPAA6020). The design, management and interpretation of this study is entirely independent of the manufacturers of TXA and the funders.	Altman Douglas G, 2009, Open Med, V3, pe51; Brenner A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03243-4; Cook JA, 2015, BRIT J SURG, V102, pE93, DOI 10.1002/bjs.9723; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; Haller S, 2018, RADIOLOGY, V287, P11, DOI 10.1148/radiol.2018170803; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hemostasis Clinical Trial Outcomes Working Group, 2019, HEMOSTASIS OUTCOMES; Hinson HE, 2010, CURR NEUROL NEUROSCI, V10, P73, DOI 10.1007/s11910-010-0086-6; Hu TT, 2016, BIOL RES NURS, V18, P5, DOI 10.1177/1099800415577634; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Liu GHF, 2009, STAT MED, V28, P2509, DOI 10.1002/sim.3639; Mahmood A, 2021, EUR J TRAUMA EMERG S, V47, P261, DOI 10.1007/s00068-020-01316-1; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; Mahmood A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4814; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Roberts I, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0056-1; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Su Z, 2006, PRELIMINARY RESULTS; Tatlisumak T, 2002, STROKE, V33, P2144, DOI 10.1161/01.STR.0000026862.42440.AA; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Williams JG, 2003, HEALTH TECHNOL ASSES, V7, p[iii, 1, v]; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	26	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	APR	2021	38	4					270	278		10.1136/emermed-2020-210424			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RB1IB	WOS:000631868900006	33262252	Green Accepted, Green Published, hybrid			2022-02-07	
J	Marcatti, M; Saada, J; Okereke, I; Wade, CE; Bossmann, SH; Motamedi, M; Szczesny, B				Marcatti, Michela; Saada, Jamal; Okereke, Ikenna; Wade, Charles E.; Bossmann, Stefan H.; Motamedi, Massoud; Szczesny, Bartosz			Quantification of Circulating Cell Free Mitochondrial DNA in Extracellular Vesicles with PicoGreen (TM) in Liquid Biopsies: Fast Assessment of Disease/Trauma Severity	CELLS			English	Article						circulating cell free DNA; traumatic brain injury; trauma severity; extracellular veciscles; PicoGreen(TM) staining; mitochondrial DNA		The analysis of circulating cell free DNA (ccf-DNA) is an emerging diagnostic tool for the detection and monitoring of tissue injury, disease progression, and potential treatment effects. Currently, most of ccf-DNA in tissue and liquid biopsies is analysed with real-time quantitative PCR (qPCR) that is primer- and template-specific, labour intensive and cost-inefficient. In this report we directly compare the amounts of ccf-DNA in serum of healthy volunteers, and subjects presenting with various stages of lung adenocarcinoma, and survivors of traumatic brain injury using qPCR and quantitative PicoGreen (TM) fluorescence assay. A significant increase of ccf-DNA in lung adenocarcinoma and traumatic brain injury patients, in comparison to the group of healthy human subjects, was found using both analytical methods. However, the direct correlation between PicoGreen (TM) fluorescence and qPCR was found only when mitochondrial DNA (mtDNA)-specific primers were used. Further analysis of the location of ccf-DNA indicated that the majority of DNA is located within lumen of extracellular vesicles (EVs) and is easily detected with mtDNA-specific primers. We have concluded that due to the presence of active DNases in the blood, the analysis of DNA within EVs has the potential of providing rapid diagnostic outcomes. Moreover, we speculate that accurate and rapid quantification of ccf-DNA with PicoGreen (TM) fluorescent probe used as a point of care approach could facilitate immediate assessment and treatment of critically ill patients.	[Marcatti, Michela] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Saada, Jamal; Szczesny, Bartosz] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Okereke, Ikenna] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77003 USA; [Bossmann, Stefan H.] Univ Kansas Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA; [Motamedi, Massoud; Szczesny, Bartosz] Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX 77555 USA; [Szczesny, Bartosz] Univ Texas Med Branch, Dept Visual Sci, Galveston, TX 77555 USA		Szczesny, B (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.; Szczesny, B (corresponding author), Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX 77555 USA.; Szczesny, B (corresponding author), Univ Texas Med Branch, Dept Visual Sci, Galveston, TX 77555 USA.	mimarcat@utmb.edu; jsaada@utmb.edu; ikokerek@utmb.edu; charles.e.wade@uth.tmc.edu; sbossmann@kumc.edu; mmotamed@utmb.edu; baszczes@utmb.edu		MARCATTI, MICHELA/0000-0003-1921-4626; Bossmann, Stefan/0000-0002-0058-0127	National Science Foundation ProjectNational Science Foundation (NSF) [1804422]; Department of Ophthalmology and Visual Sciences, UTMB	This work was supported by a grant from the National Science Foundation Project 1804422 (to MM and SHB) and start-up funds from the Department of Ophthalmology and Visual Sciences, UTMB (to BS).	Aarthy R, 2015, MOL DIAGN THER, V19, P339, DOI 10.1007/s40291-015-0167-y; Agassi R, 2015, AM J CLIN PATHOL, V143, P18, DOI 10.1309/AJCPI5YHG0OGFAHM; Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Anker P, 2001, CLIN CHIM ACTA, V313, P143, DOI 10.1016/S0009-8981(01)00666-0; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Biro O, 2018, BIOMARK MED, V12, P891, DOI 10.2217/bmm-2017-0386; Bronkhorst Abel Jacobus, 2019, Biomol Detect Quantif, V17, P100087, DOI 10.1016/j.bdq.2019.100087; Bronkhorst AJ, 2016, BBA-MOL CELL RES, V1863, P157, DOI 10.1016/j.bbamcr.2015.10.022; Chen Q, 2019, ONCOTARGETS THER, V12, P11517, DOI 10.2147/OTT.S227156; Dong L, 2020, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12044; Fang CJ, 2021, CELL MOL IMMUNOL, V18, P2211, DOI 10.1038/s41423-020-0456-1; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fernando MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183915; Flors C, 2013, J MICROSC-OXFORD, V251, P1, DOI 10.1111/jmi.12054; Garcia-Romero N, 2017, ONCOTARGET, V8, P1416, DOI 10.18632/oncotarget.13635; Giacomini E, 2020, CURR OPIN OBSTET GYN, V32, P179, DOI 10.1097/GCO.0000000000000621; Glebova KV, 2018, CRIT REV CL LAB SCI, V55, P55, DOI 10.1080/10408363.2017.1420032; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Huang LL, 2020, J THORAC DIS, V12, P1320, DOI 10.21037/jtd.2020.02.49; Jahr S, 2001, CANCER RES, V61, P1659; Jayaseelan VP, 2020, CANCER GENE THER, V27, P395, DOI 10.1038/s41417-019-0136-4; Kisurina-Evgenieva OP, 2016, BIOCHEMISTRY-MOSCOW+, V81, P453, DOI 10.1134/S0006297916050035; Koessler T, 2019, ADV CLIN CHEM, V89, P131, DOI 10.1016/bs.acc.2018.12.004; Kustanovich A, 2019, CANCER BIOL THER, V20, P1057, DOI 10.1080/15384047.2019.1598759; LOVE JD, 1979, J BIOL CHEM, V254, P2588; Margolis L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000363; Murphy DE, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0223-5; Nasim F, 2019, MED CLIN N AM, V103, P463, DOI 10.1016/j.mcna.2018.12.006; Okereke IC, 2019, J THORAC DIS, V11, P873, DOI 10.21037/jtd.2019.01.105; Parsons HA, 2016, ADV EXP MED BIOL, V882, P259, DOI 10.1007/978-3-319-22909-6_11; Pathak AK, 2006, CLIN CHEM, V52, P1833, DOI 10.1373/clinchem.2005.062893; Regner A, 2018, EXPERT REV MOL DIAGN, V18, P925, DOI 10.1080/14737159.2018.1535904; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Sundling KE, 2019, ADV ANAT PATHOL, V26, P56, DOI 10.1097/PAP.0000000000000217; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Szczesny B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19216-1; Tang ZY, 2020, INT J CANCER, V146, P2946, DOI 10.1002/ijc.32762; Tavasolian F, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102511; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; Torralba D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05077-9; Vaidyanathan R, 2019, LAB CHIP, V19, P11, DOI 10.1039/c8lc00684a; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Wang Y, 2017, EUR BIOPHYS J BIOPHY, V46, P561, DOI 10.1007/s00249-017-1204-z; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wiklander OPB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8521; Yokoi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax8849; Zhang SB, 2015, RADIAT RES, V183, P188, DOI 10.1667/RR13556.1	51	0	0	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	APR	2021	10	4							819	10.3390/cells10040819			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	RR1FJ	WOS:000642852400001	33917426	gold, Green Published			2022-02-07	
J	Matthews, M; Johnston, W; Bleakley, CM; Davies, RJ; Rankin, AT; Webb, M; Caulfield, BC; Archbold, HAP				Matthews, Mark; Johnston, William; Bleakley, Chris M.; Davies, Richard J.; Rankin, Alan T.; Webb, Michael; Caulfield, Brian C.; Archbold, H. A. P.			Concussion History and Balance Performance in Adolescent Rugby Union Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						sports-related concussion; balance; adolescent; dual tasking		Background: Sports-related concussion is a worldwide problem. There is a concern that an initial concussion can cause prolonged subclinical disturbances to sensorimotor function that increase the risk of subsequent injury. The primary aim of this study was to examine whether a history of sports-related concussion has effects on static and dynamic balance performance in adolescent rugby players. Hypothesis: Dynamic balance would be worse in players with a history of concussion compared with those with no history of concussion. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Male adolescent rugby players aged 14 to 18 years from 5 schools were recruited before the start of the 2018-2019 playing season. Participants completed questionnaires and physical tests, including dynamic Y balance and single-leg static balance (eyes closed) tests, while performing single and dual tasks. Dynamic balance was assessed using inertial sensor instrumentation. Dependent variables were normalized reach distance and the sample entropy (SEn) of the 3 axes (x, y, and z). Results: Of the 195 participants, 100 reported a history of concussion. Those with a history of concussion demonstrated higher SEn in all directions, with highest values during anterior (standardized mean difference [SMD], 0.4; 95% CI, 0.0-0.7; P = .027) and posteromedial (SMD, 0.5; 95% CI, 0.2-0.9; P = .004) reach directions compared with those with no history. There was no difference between groups (concussion history vs control) in traditional Y balance reach distances in the anterior or posteromedial directions or single-leg static balance during both single- (P = .47) and dual-task (P = .67) conditions. Conclusion: Adolescent rugby union athletes with a history of concussion had poorer dynamic balance during performance tasks compared with healthy controls. Static single-leg balance tests, either single or dual task, may not be sensitive enough to detect sensorimotor deficits in those with a history of concussion.	[Matthews, Mark; Johnston, William; Bleakley, Chris M.; Davies, Richard J.; Rankin, Alan T.; Webb, Michael; Caulfield, Brian C.; Archbold, H. A. P.] Ulster Univ, Belfast, Antrim, North Ireland; [Matthews, Mark] Ulster Univ, Sports & Exercise Sci Res Inst, Belfast BT37 0QB, Antrim, North Ireland; [Johnston, William; Caulfield, Brian C.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Johnston, William; Caulfield, Brian C.] Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland; [Bleakley, Chris M.] Ulster Univ, Sch Hlth Sci, Belfast, Antrim, North Ireland; [Davies, Richard J.] Ulster Univ, Sch Comp & Engn, Belfast, Antrim, North Ireland; [Rankin, Alan T.] Sports Med NI, Belfast, Antrim, North Ireland; [Webb, Michael] Ulster Rugby, Kingspan Stadium, Belfast, Antrim, North Ireland; [Archbold, H. A. P.] Royal Victoria Hosp, Belfast, Antrim, North Ireland		Matthews, M (corresponding author), Ulster Univ, Sports & Exercise Sci Res Inst, Belfast BT37 0QB, Antrim, North Ireland.	m.matthews@ulster.ac.uk					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Colquhoun D, 2019, AM STAT, V73, P192, DOI 10.1080/00031305.2018.1529622; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller CW, 2007, CLIN J SPORT MED, V17, P177, DOI 10.1097/JSM.0b013e31803220b3; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; IRFU, GUID CONC RUGB UN; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnston W., 6 INT C SPORTS SCI R, V1 2018, P63; Johnston W, 2020, J NEUROTRAUM, V37, P2549, DOI 10.1089/neu.2020.7040; Johnston W, 2020, SCAND J MED SCI SPOR, V30, P1497, DOI 10.1111/sms.13691; Johnston W, 2019, IEEE ENG MED BIO, P2063, DOI 10.1109/EMBC.2019.8857628; Johnston W, 2019, SPORTS MED, V49, P783, DOI 10.1007/s40279-019-01095-9; Johnston William, 2017, Digit Biomark, V1, P106, DOI 10.1159/000485470; Johnston W, 2017, QJM-INT J MED, V110, P779, DOI 10.1093/qjmed/hcw228; Longstaff C, FALSE POSITIVE RISK; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Parrington L, 2019, J ATHL TRAINING, V54, P429, DOI 10.4085/1062-6050-46-18; Rafferty J, 2019, BRIT J SPORT MED, V53, P969, DOI 10.1136/bjsports-2017-098417; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Shaffer SW, 2013, MIL MED, V178, P1264, DOI 10.7205/MILMED-D-13-00222; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002	35	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	APR	2021	49	5					1348	1354		10.1177/0363546521998709			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	RH1FP	WOS:000635972600026	33729858	Green Published, hybrid			2022-02-07	
J	McDuff, K; Benaim, A; Wong, M; Burley, A; Gandhi, P; Wallace, A; Brooks, D; Vaughan-Graham, J; Patterson, KK				McDuff, Kiera; Benaim, Amanda; Wong, Mark; Burley, Andrea; Gandhi, Payal; Wallace, Aaron; Brooks, Dina; Vaughan-Graham, Julie; Patterson, Kara K.			Analyzing the Eye Gaze Behaviour of Students and Experienced Physiotherapists during Observational Movement Analysis	PHYSIOTHERAPY CANADA			English	Article						fixation; ocular; movement; neurological rehabilitation; observation; students	GAIT-ANALYSIS; RELIABILITY; PERFORMANCE; ACCURACY	Purpose: Physiotherapists use observational movement analysis (OMA) to inform clinical reasoning. This study aimed to (1) determine the feasibility of characterizing eye gaze behaviour during OMA with eye-tracking technology, (2) characterize experienced neurological physiotherapists' and physiotherapy students' eye gaze behaviour during OMA, and (3) investigate differences in eye gaze behaviour during OMA between physiotherapy students and experienced physiotherapists. Method: Eight students and eight physiotherapists wore an eye-tracking device while watching a video of a person with a history of stroke and subsequent concussion perform sit to stand. Feasibility criteria were (1) successful calibration of the eye tracker, and successful collection of data, for 80% of the participants and (2) moderate interrater reliability of the investigators, measured by intra-class correlation coefficients (ICCs). Three investigators independently recorded the participants' foveal fixations. Differences between physiotherapists and students in number of fixations, duration per fixation, and total duration of fixations were evaluated using unpaired t-tests, mean differences, and 95% CIs. Results: Data were collected for all participants. ICCs ranged from 0.64 to 0.78. Fixations by physiotherapists were shorter (mean 368.5 [SD 80.8] ms) and greater in number (mean 18.9 [SD 2.2]) than those by students (mean 459.0 [SD 64.2] ms, p = 0.03, and mean 15.9 [SD 2.7], p = 0.03), respectively. Conclusions: Measuring eye gaze behaviour during OMA using eye tracker technology is feasible. Physiotherapists made more fixations of shorter duration than students. Further investigation of how experienced therapists perform OMA and apply it to clinical reasoning may inform the instruction of OMA.	[McDuff, Kiera; Benaim, Amanda; Wong, Mark; Burley, Andrea; Gandhi, Payal; Brooks, Dina; Vaughan-Graham, Julie; Patterson, Kara K.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Wallace, Aaron; Brooks, Dina; Vaughan-Graham, Julie; Patterson, Kara K.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Brooks, Dina; Patterson, Kara K.] Univ Hlth Network, KITE Res Inst, Toronto, ON, Canada; [Brooks, Dina] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Patterson, KK (corresponding author), Univ Toronto, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	kara.patterson@utoronto.ca	Brooks, Dina/ABB-3281-2021	Brooks, Dina/0000-0001-6080-5052	Heart and Stroke FoundationHeart & Stroke Foundation of Canada	Kara K. Patterson is supported by a personnel award from the Heart and Stroke Foundation.	Bernhardt J, 1998, PHYS THER, V78, P259, DOI 10.1093/ptj/78.3.259; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Carr JH., 2010, NEUROLOGICAL REHABIL, V2nd; Case K, 2000, PHYSIOTHERAPY, V86, P14, DOI DOI 10.1016/S0031-9406(05)61321-1; Doody C, 2002, PHYSIOTHERAPY, V88, P258, DOI DOI 10.1016/S0031-9406(05)61417-4; Duchowski AT, 2007, THEORY PRACTICE, P328, DOI [10.1007/978-3-319-57883-5, DOI 10.1007/978-3-319-57883-5]; EASTLACK ME, 1991, PHYS THER, V71, P465, DOI 10.1093/ptj/71.6.465; El-Sayyad M., 1995, GAIT POSTURE, V3, P174, DOI [10.1016/0966-6362(95)99082-v, DOI 10.1016/0966-6362(95)99082-V]; Hessels RS, 2015, INFANCY, V20, P601, DOI 10.1111/infa.12093; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; JENG SF, 1990, PHYS THER, V70, P511, DOI 10.1093/ptj/70.8.511; Khan RSA, 2012, SURG ENDOSC, V26, P3536, DOI 10.1007/s00464-012-2400-7; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; KREBS DE, 1985, PHYS THER, V65, P1027, DOI 10.1093/ptj/65.7.1027; Laboratories AS, Eye Tracker Systems Manual: Mobile Eye XG 1.5; Law B, 2003, STUD HEALTH TECHNOL, V94, P184; Le Meur O, 2007, VISION RES, V47, P2483, DOI 10.1016/j.visres.2007.06.015; MacKenzie DE, 2013, CAN J OCCUP THER, V80, P92, DOI 10.1177/0008417413484885; Manning D, 2006, RADIOGRAPHY, V12, P134, DOI 10.1016/j.radi.2005.02.003; McGinley JL, 2003, PHYS THER, V83, P146, DOI 10.1093/ptj/83.2.146; Skjaerven Liv H., 2008, Physiotherapy Theory and Practice, V24, P13, DOI 10.1080/01460860701378042; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Underwood G., 2002, TRANSPORT RES F-TRAF, V5, P87, DOI [10.1016/S1369-8478(02)00008-6, DOI 10.1016/S1369-8478(02)00008-6]; Vaughan-Graham J, 2017, J EVAL CLIN PRACT, V23, P1153, DOI 10.1111/jep.12742; Vine SJ, 2010, J APPL SPORT PSYCHOL, V22, P361, DOI 10.1080/10413200.2010.495106; Weeks BK, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-207; Wikstrom-Grotell Camilla, 2012, Physiotherapy Theory and Practice, V28, P428, DOI 10.3109/09593985.2012.692582; Wilson MR, 2011, SURG ENDOSC, V25, P3731, DOI 10.1007/s00464-011-1802-2	28	0	0	4	4	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA	0300-0508	1708-8313		PHYSIOTHER CAN	Physiother. Can.	APR 1	2021	73	2					129	135		10.3138/ptc-2019-0047			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	RX3OR	WOS:000647137000005	34456422				2022-02-07	
J	Miyai, K; Kawauchi, S; Kato, T; Yamamoto, T; Mukai, Y; Yamamoto, T; Sato, S				Miyai, Kosuke; Kawauchi, Satoko; Kato, Tamaki; Yamamoto, Tetsuo; Mukai, Yasuo; Yamamoto, Taisuke; Sato, Shunichi			Axonal damage and behavioral deficits in rats with repetitive exposure of the brain to laser-induced shock waves: Effects of inter-exposure time	NEUROSCIENCE LETTERS			English	Article						Repetitive blast-induced traumatic brain injury; Inter-Exposure time; Laser-Induced shock wave; Axonal injury; motor dysfunction; Anxiety		Much attention has been given to effects of repeated exposure to a shock wave as a possible factor causing severe higher brain dysfunction and post-traumatic stress disorder (PTSD)-like symptoms in patients with mild to moderate blast-induced traumatic brain injury (bTBI). However, it is unclear how the repeated exposure and the inter-exposure time affect the brain. In this study, we topically applied low-impulse (similar to 54 Pa.s) laser-induced shock waves (LISWs; peak pressure, similar to 75.7 MPa) to the rat brain once or twice with the different inter-exposure times (15 min, 1 h, 3 h, 24 h and 7 days) and examined anxiety-related behavior and motor dysfunction in the rats as well as expression of beta-amyloid precursor protein (APP) as an axonal damage marker in the brains of the rats. The averaged APP expression scores for the rat brains doubly-exposed to LISWs with inter-exposure times from 15 min to 24 h were significantly higher than those for rats with a single exposure (P < 0.0001). The rats with double exposure to LISWs showed significantly more frequent anxiety-related behavior (P < 0.05) and poorer motor function (P < 0.01) than those of rats with a single exposure. When the inter-exposure time was extended to 7 days, however, the rats showed no significant differences either in axonal damage score or level of motor dysfunction. The results suggest that the cumulative effects of shock wave-related brain injury can be avoided with an appropriate inter-exposure time. However, clinical bTBI occurs in much more complex environments than those in our model. Further study considering other factors, such as the effects of acceleration, is needed to know the clinically-relevant, necessary inter-exposure time.	[Miyai, Kosuke; Kato, Tamaki; Yamamoto, Tetsuo; Mukai, Yasuo; Yamamoto, Taisuke] Japan Ground Self Def Force, Mil Med Res Unit, Setagaya Ku, Tokyo, Japan; [Kawauchi, Satoko; Sato, Shunichi] Natl Def Med Coll Res Inst, Div Biomed Informat Sci, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan; [Miyai, Kosuke] Natl Def Med Coll, Dept Basic Pathol, Taipei, Taiwan; [Kato, Tamaki] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan; [Yamamoto, Tetsuo] Minist Def Clin, Tokyo, Japan; [Mukai, Yasuo] Japan Ground Selfdef Force, Headquarters Ground Component Command, Tokyo, Japan; [Yamamoto, Taisuke] Japan Ground Selfdef Force, Western Army Headquarters, Tokyo, Japan		Sato, S (corresponding author), Natl Def Med Coll Res Inst, Div Biomed Informat Sci, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	ssato-bits@ndmc.ac.jp	Miyai, Kosuke/AAQ-8566-2020	Miyai, Kosuke/0000-0003-1776-3541	Ministry of Defense Advanced Defense Medicine Research Program in Japan	This work was supported by the Ministry of Defense Advanced Defense Medicine Research Program in Japan.	Agoston DV, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00092; Alley M., 2009, EXPLOSIVE BLAST LOAD; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Callahan ML, 2019, APPL NEUROPSYCH-ADUL, V26, P365, DOI 10.1080/23279095.2018.1433179; Cernak Ibolja, 2017, Concussion, V2, pCNC42, DOI 10.2217/cnc-2017-0006; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; Fitzmaurice S., 2019, P 4 INT FOR BLAST IN; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Good CH, 2020, NEUROPSYCHOPHARMACOL, V45, P176, DOI 10.1038/s41386-019-0431-7; Guo WS, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190645; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Imai H, 2002, J CEREBR BLOOD F MET, V22, P1080, DOI 10.1097/00004647-200209000-00005; Kalsbeek A, 2014, FRONT HORM RES, V42, P1, DOI 10.1159/000358312; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kawauchi S, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.3.035005; Krall SC, 2015, BRAIN STRUCT FUNCT, V220, P587, DOI 10.1007/s00429-014-0803-z; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Maekawa T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230774; Magnus D, 2018, DEF TECHNOL, V14, P469, DOI 10.1016/j.dt.2018.07.014; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nelson N.W., BRAIN NEUROTRAUMA MO, pCH32; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sajja VSSS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00891; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01015; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Tomura S, 2020, NEUROSCI LETT, V721, DOI 10.1016/j.neulet.2020.134827; UA Army Asia-Pacific Counter-IED Fusion Center, 2020, IED MONTHLY REPORT J; Yamamoto S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020245; Yin WL, 2010, ANN NY ACAD SCI, V1204, P113, DOI 10.1111/j.1749-6632.2010.05518.x	50	0	0	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 1	2021	749								135722	10.1016/j.neulet.2021.135722			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RC3GL	WOS:000632691800009	33592306				2022-02-07	
J	Morelli, N; Heebner, NR; DeFeo, CJ; Hoch, MC				Morelli, Nathan; Heebner, Nicholas R.; DeFeo, Courtney J.; Hoch, Matthew C.			The Influence of Cognitive Dual Tasks on Concussion Balance Test Performance	MOTOR CONTROL			English	Article						concussion balance test; cognitive-motor interference; dual task; postural control		Objective: To determine the influence of a cognitive dual task on postural sway and balance errors during the Concussion Balance Test (COBALT). Methods: Twenty healthy adults (12 females, eight males; aged 21.95 +/- 3.77 years; height = 169.95 +/- 9.95 cm; weight = 69.58 +/- 15.03 kg) partook in this study and completed single- and dual-task versions of a reduced COBALT. Results: Sway velocity decreased during dual-task head rotations on foam condition (p = .021, ES = -0.57). A greater number of movement errors occurred during dual-task head rotations on firm surface (p =.005, ES = 0.71), visual field flow on firm surface (p = .008, ES = 0.68), and head rotations on foam surface (p < .001, ES = 1.61) compared with single-task conditions. Cognitive performance was preserved throughout different sensory conditions of the COBALT (p = .985). Discussion: Cognitive dual tasks influenced postural control and destabilized movements during conditions requiring advanced sensory integration and reweighting demands. Dual-task versions of the COBALT should be explored as a clinical tool to identify residual deficits past the acute stages of concussion recovery.	[Morelli, Nathan; Heebner, Nicholas R.; DeFeo, Courtney J.; Hoch, Matthew C.] Univ Kentucky, Sports Med Res Inst, Coll Hlth Sci, Lexington, KY 40506 USA		Morelli, N (corresponding author), Univ Kentucky, Sports Med Res Inst, Coll Hlth Sci, Lexington, KY 40506 USA.	nathan.morelli@uky.edu					Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Bayot M, 2018, NEUROPHYSIOL CLIN, V48, P361, DOI 10.1016/j.neucli.2018.10.003; Bekkers EMJ, 2018, NEUROREHAB NEURAL RE, V32, P166, DOI 10.1177/1545968318761121; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bolton DAE, 2015, NEUROSCI BIOBEHAV R, V57, P142, DOI 10.1016/j.neubiorev.2015.08.014; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Comber L, 2018, GAIT POSTURE, V61, P445, DOI 10.1016/j.gaitpost.2018.02.018; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fritz NE, 2015, J NEUROL PHYS THER, V39, P142, DOI 10.1097/NPT.0000000000000090; Ghai S, 2017, CLIN INTERV AGING, V12, P557, DOI 10.2147/CIA.S125201; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Howell DR, 2020, GAIT POSTURE, V79, P53, DOI 10.1016/j.gaitpost.2020.04.013; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kandel E.R., 2013, PRINCIPLES NEURAL SC, V5th; Ketcham C., 2019, ATHLETIC TRAINING SP, V11, P90, DOI [10.3928/19425864-20180313-02, DOI 10.3928/19425864-20180313-02]; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Massingale S, 2018, J NEUROL PHYS THER, V42, P149, DOI 10.1097/NPT.0000000000000225; Massingale SL, 2018, INT J ATHL THER TRAI, V23, DOI 10.1123/ijatt.2017-0042; Morelli N, 2020, PHYSIOL MEAS, V41, DOI 10.1088/1361-6579/ab8050; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Prosperini L, 2015, GAIT POSTURE, V41, P780, DOI 10.1016/j.gaitpost.2015.02.002; Remaud A, 2013, EXP BRAIN RES, V231, P219, DOI 10.1007/s00221-013-3684-0; Remaud A, 2012, J MOTOR BEHAV, V44, P329, DOI 10.1080/00222895.2012.708680; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Scholz JP, 2012, EXP BRAIN RES, V222, P229, DOI 10.1007/s00221-012-3210-9; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	33	0	0	1	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1087-1640	1543-2696		MOTOR CONTROL	Motor Control	APR	2021	25	2					252	263		10.1123/mc.2020-0075			12	Neurosciences; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Sport Sciences	RI1SY	WOS:000636691700007	33567406				2022-02-07	
J	Neustadtl, AL; Bukowski, WK; Neustadtl, A; Milzman, D				Neustadtl, Aidan L.; Bukowski, William K.; Neustadtl, Alan; Milzman, David			Performance After Concussion in National Hockey League Players	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; recovery; return to play	BATTING PERFORMANCE; NHL; RECOVERY; RETURN; TIME	Context: Concussions in ice hockey players are an interesting area of study due to the fast-paced and high-impact nature of the sport. Recently, researchers have focused on player performance after return from concussion to evaluate subclinical deficits that were previously missed. Objective: To examine National Hockey League (NHL) player performance from 2013 to 2019 and compare performance before a concussion with performance immediately after recovering to assess the current NHL return-to-play protocol. Design: Cross-sectional study. Setting: The NHL Injury Viz and sports reporting websites. Patients or Other Participants: Players in the NHL who sustained concussions from 2013 to 2019. Main Outcome Measure(s): Goals, assists, points, plus-minus, time on ice (TOI), and hits. Results: When goals, assists, points, plus-minus, TOI, and hits were examined, only TOI was different after the players returned from injury, and this TOI difference was not substantively important. Conclusions: After concussion, NHL player performance did not change.	[Neustadtl, Aidan L.; Bukowski, William K.] Georgetown Univ, Sch Med, 3900 Reservoir Rd North West, Washington, DC 20007 USA; [Neustadtl, Alan] Univ Maryland, Dept Sociol, College Pk, MD 20742 USA; [Milzman, David] Univ Maryland, Sch Med, Baltimore, MD 21201 USA		Neustadtl, AL (corresponding author), Georgetown Univ, Sch Med, 3900 Reservoir Rd North West, Washington, DC 20007 USA.	an344@georgetown.edu					[Anonymous], 2016, CONC EV MAN PROT 201; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Buckley TA, 2019, J ATHL TRAINING, V54, P527, DOI 10.4085/1062-6050-200-18; Chow BH, 2019, OPEN ACCESS J SPORTS, V10, P41, DOI 10.2147/OAJSM.S192338; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; Reams N, 2017, INT J SPORT PHYSIOL, V12, P1100, DOI 10.1123/ijspp.2016-0508; Sabesan VJ, 2018, OPEN ACCESS J SPORTS, V9, P253, DOI 10.2147/OAJSM.S157433; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Van Pelt KL, 2019, J ATHL TRAINING, V54, P534, DOI 10.4085/1062-6050-218-18; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956	17	0	0	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2021	56	4					404	407		10.4085/1062-6050-126.20			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	RP8YP	WOS:000642009800008	33878175	gold			2022-02-07	
J	Ni, QB; Yang, X; Pan, ZQ; Wang, JP				Ni, Qubo; Yang, Xu; Pan, Zhengqi; Wang, Jianping			The pronator teres and the flexor carpi radialis interval approach for operative fixation of ulna coronoid process fractures	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Ulna coronoid process fracture; Operative approach; The pronator teres; The flexor carpi radialis	ANTEROMEDIAL FACET; INTERNAL-FIXATION; TERRIBLE TRIAD; ELBOW; ANTERIOR; INJURY; HEAD	Background: The optimal approach for the fixation of coronoid process fractures is unknown. We present the advantages and the clinical effect of the pronator teres and the flexor carpi radialis interval approach for the treatment of ulna coronoid process fractures. Methods: The patients, who had operative treatment of closed ulna coronoid process fracture by the pronator teres and the flexor carpi radialis interval approach between January 2011 to December 2016, were studied retrospectively. Seventeen consecutive patients had received surgical fixation by screws or a mini-plate through the above approach, of whom were 16 males and one female with an average age of 36.7 years (range, 21-58 years). There were 11 cases of type II and 6 cases of type III according to the O'Driscoll classification, of which, 6 patients had combined elbow dislocation, 2 patients showed elbow instability after fixation, and one had another incision to repair the lateral collateral ligament, and received a hinged external fixator. The other patient only received a hinged external fixator for 4 weeks. Mayo Elbow Performance Score (MEPS) was used to assess the function of elbow for each patient at the final follow-up. Results: Mean follow-up was 28.7 months (range, 24-38 months). Fracture union was achieved in each patient; the average time to radiologic union was 14.2 weeks (range, 12-16 weeks). At the final followup, the elbow extension degree of the affected side was (3.88 +/- 2.96 degrees), reaching 98.1% of the normal side, and the flexion degree was (131.59 +/- 4.93 degrees), reaching 98.16% of the normal side. The forearm pronation was (82.94 +/- 3.86 degrees), reaching 94.31% of the normal side, and the supination activity was (82.12 +/- 3.82 degrees), reaching 93% of the normal side. According to the MEPS, the functional recovery of the injured arm was assessed as excellent in 16 cases, and good in one. None of the patients showed any neurovascular or deep infections and no heterotopic ossification was found. Conclusions: The pronator teres and the flexor carpi radialis interval approach has the advantages of simplicity, safety, minimal invasion, excellent exposure, and good postoperative function recovery for ulna coronoid process fracture. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Ni, Qubo; Yang, Xu; Pan, Zhengqi; Wang, Jianping] Wuhan Univ, Zhongnan Hosp, Dept Orthopaed Surg, 169 Donghu Rd, Wuhan 430071, Peoples R China		Wang, JP (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Orthopaed Surg, 169 Donghu Rd, Wuhan 430071, Peoples R China.	wjptg16@163.com			Natural Science Foundation of Hubei ProvinceNatural Science Foundation of Hubei Province [WJ2017M029]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81803275]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2042017kf0086, 2042018kf0111]; Health commission of Hubei Province scientific research project [WJ2019H016]	This work was financially supported by "Natural Science Foundation of Hubei Province (Project no. WJ2017M029)" directed by Dr. Jianping Wang; the "National Natural Science Foundation of China (Project no. 81803275)" and "Fundamental Research Funds for the Central Universities (Project no. 2042017kf0086)" directed by Dr. Qubo Ni; the "Fundamental Research Fund for the Central Universities (Project no. 2042018kf0111)" and "Health commission of Hubei Province scientific research project (Project no. WJ2019H016)" directed by Dr. Xu Yang.	Chemama B, 2010, ORTHOP TRAUMATOL-SUR, V96, P147, DOI [10.1016/j.rcot.2010.02.008, 10.1016/j.otsr.2009.11.009]; Chen ACY, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2162-z; Chen HW, 2018, EUR J MED RES, V23, DOI 10.1186/s40001-018-0336-7; Chen HW, 2015, INT J CLIN EXP MED, V8, P19607; Doornberg JN, 2007, J SHOULDER ELB SURG, V16, P667, DOI 10.1016/j.jse.2007.03.013; Garrigues GE, 2011, J BONE JOINT SURG AM, V93A, P1873, DOI 10.2106/JBJS.I.01673; Han Soo-Hong, 2013, Eur J Orthop Surg Traumatol, V23, P395, DOI 10.1007/s00590-012-1007-y; Huh J, 2013, J ORTHOP TRAUMA, V27, P730, DOI 10.1097/BOT.0b013e31828ba91c; Kasparyan NG, 1997, HAND CLIN, V13, P643; Manidakis N, 2012, INJURY, V43, P989, DOI 10.1016/j.injury.2011.08.030; Mathew PK, 2009, J AM ACAD ORTHOP SUR, V17, P137, DOI 10.5435/00124635-200903000-00003; MORREY BF, 1990, J BONE JOINT SURG AM, V72A, P601, DOI 10.2106/00004623-199072040-00019; O'Driscoll Shawn W, 2003, Instr Course Lect, V52, P113; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; Reichel Lee M, 2012, Tech Hand Up Extrem Surg, V16, P98, DOI 10.1097/BTH.0b013e31824e6a74; Rhyou IH, 2017, CLIN ORTHOP RELAT R, V475, P2308, DOI 10.1007/s11999-017-5348-z; Ring D, 2006, J HAND SURG-AM, V31A, P1679, DOI 10.1016/j.jhsa.2006.08.020; Ring David, 2007, J Bone Joint Surg Am, V89 Suppl 2 Pt.2, P267; Ring D, 2015, J ORTHOP TRAUMA, V29, P437, DOI 10.1097/BOT.0000000000000326; Sukegawa K, 2016, J HAND SURG-AM, V41, P819, DOI 10.1016/j.jhsa.2016.05.004; TAYLOR TKF, 1969, J TRAUM, V9, P594, DOI 10.1097/00005373-196907000-00004; Yang X, 2017, ORTHOP TRAUMATOL-SUR, V103, P899, DOI 10.1016/j.otsr.2017.05.020; Zhang C, 2014, INJURY, V45, P942, DOI 10.1016/j.injury.2013.12.012; Zhou CW, 2018, INT J SURG, V51, P49, DOI 10.1016/j.ijsu.2018.01.012	24	0	0	0	0	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	APR	2021	107	2							102610	10.1016/j.otsr.2020.04.004			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	RL9OY	WOS:000639294000012	32418740				2022-02-07	
J	O'Brien, KH; Wallace, T; Kemp, A				O'Brien, Katy H.; Wallace, Tracey; Kemp, Amy			Student Perspectives on the Role of Peer Support Following Concussion: Development of the SUCCESS Peer Mentoring Program	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: College students with concussion are often ill-equipped to manage their health and learning needs, and college campuses are slow to react. We present the development of a peer mentoring program for college students with concussion: Success in College after Concussion with Effective Student Supports ( SUCCESS), focusing on the process by which student needs and preferences drove development of the program for testing. Method: Principles of person-centered design were used to guide program development, engaging stakeholders at each stage of development and resulting in the intervention package presented to student participants here. A series of interviews and focus groups with 11 students with concussion addressed student needs after concussion, student perceptions of the role of peers in recovery, and feedback on program development. Results: Findings indicate students have limited knowledge about concussion, and concussion impacts extend beyond school, although students are most concerned about their studies. Students reported struggling to communicate with professors and find resources on campus to aid in their reentry to learning. Regarding peer mentoring, students report benefiting from hearing about other's successes and sharing personal narratives of injury and recovery. Students reported high acceptability of a peer mentoring program, both for psychosocial support and access to resources. Conclusions: College students with concussion have unmet needs as they return to learn. The SUCCESS peer mentoring program is highly acceptable to students, who report that they would expect such a program to be engaging and to meet their needs. The program's impact on student academic and psychosocial outcomes should be investigated through comparative efficacy trials.	[O'Brien, Katy H.; Kemp, Amy] Univ Georgia, Dept Commun Sci & Special Educ, Athens, GA 30602 USA; [Wallace, Tracey] Shepherd Ctr, Crawford Res Inst, Complex Concuss Clin, Atlanta, GA USA		O'Brien, KH (corresponding author), Univ Georgia, Dept Commun Sci & Special Educ, Athens, GA 30602 USA.	khobrien@uga.edu		Wallace, Tracey/0000-0002-6820-4363; O'Brien, Katy/0000-0001-9437-5193	Andee's Army Foundation	Funding for the current work was provided through a grant from the Andee's Army Foundation awarded to Tracey Wallace and Katy O'Brien. We would like to acknowledge the contributions of Kathryn Y. Hardin and Penny Welch-West in providing guidance on this project. We also thank our participants for sharing their experiences and knowledge with us.	Acord-Vira A, 2019, J POSTSECOND EDUC DI, V32, P35; Belch H. A., 2004, J COLL STUDENT RETEN, V1, P3, DOI DOI 10.2190/MC5A-DHRV-1GHM-N0CD; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Breck J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17626; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cancelliere C, 2019, J ORTHOP SPORT PHYS, V49, P842, DOI 10.2519/jospt.2019.8849; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Childers C, 2016, J POSTSECOND EDUC DI, V29, P389; Fichten CS, 2014, J POSTSECOND EDUC DI, V27, P273; Gassaway J, 2017, ARCH PHYS MED REHAB, V98, P1526, DOI 10.1016/j.apmr.2017.02.018; Groh DR, 2008, CLIN PSYCHOL REV, V28, P430, DOI 10.1016/j.cpr.2007.07.014; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hux K., 2017, CURRENT RES CONCUSSI, V4, pE14, DOI [10.1055/s-0037-1606578, DOI 10.1055/S-0037-1606578]; Jerant A, 2008, CHRONIC ILLN, V4, P173, DOI 10.1177/1742395308089057; Kennedy MRT, 2014, BRAIN INJURY, V28, P1748, DOI 10.3109/02699052.2014.955883; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; LORIG K, 1992, HEALTH EDUC QUART, V19, P355, DOI 10.1177/109019819201900307; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCrea M, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2846; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Money N., 2011, BEST PRACTICES IDENT; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; Morris RPG, 2017, CLIN REHABIL, V31, P1030, DOI 10.1177/0269215516676303; O'Brien K, 2019, BRAIN INJURY, V33, P139; O'Brien KH, 2018, NEUROREHABILITATION, V42, P365, DOI 10.3233/NRE-172413; Palmer C, 2000, J REHABIL, V66, P38; Patient -Centered Outcomes Research Institute, 2015, PCORI ENG RUBR PCORI; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sheridan S, 2017, ANN FAM MED, V15, P165, DOI 10.1370/afm.2042; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Venville A, 2016, INT J DISABIL DEV ED, V63, P571, DOI 10.1080/1034912X.2016.1153050; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Weber ML, 2019, BRAIN INJURY, V33, P592, DOI 10.1080/02699052.2019.1568573; Wobma R, 2016, J REHABIL MED, V48, P837, DOI 10.2340/16501977-2160; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	45	0	0	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		933	948		10.1044/2020_AJSLP-20-00076			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400007	33556263				2022-02-07	
J	Palafox-Sanchez, V; Ying, Z; Royes, LFF; Gomez-Pinilla, F				Palafox-Sanchez, Victoria; Ying, Zhe; Royes, Luiz Fernando Freire; Gomez-Pinilla, Fernando			The interaction between brain and liver regulates lipid metabolism in the TBI pathology	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Lysophosphatidylcholine; cPLA2; Liver; Fructose; Traumatic brain injury; Cognition		To shed light on the impact of systemic physiology on the pathology of traumatic brain injury (TBI), we examine the effects of TBI (concussive injury) and dietary fructose on critical aspects of lipid homeostasis in the brain and liver of young-adult rats. Lipids are integral components of brain structure and function, and the liver has a role on the synthesis and metabolism of lipids. Fructose is mainly metabolized in the liver with potential implications for brain function. Lipidomic analysis accompanied by unbiased sparse partial least squares discriminant analysis (sPLS-DA) identified lysophosphatidylcholine (LPC) and cholesterol ester (CE) as the top lipid families impacted by TBI and fructose in the hippocampus, and only LPC (16:0) was associated with hippocampal-dependent memory performance. Fructose and TBI elevated liver pro-inflammatory markers, interleukin-1 alpha (IL-1 alpha), Interferon-gamma (IFN-gamma) that correlated with hippocampal-dependent memory dysfunction, and monocyte chemo-attractant protein-1 (MCP-1) positively correlated with LPC levels in the hippocampus. The effects of fructose were more pronounced in the liver, in agreement with the role of liver on fructose metabolism and suggest that fructose could exacerbate liver inflammation caused by TBI. The overall results indicate that TBI and fructose interact to influence systemic and central inflammation by engaging liver lipids. The impact of TBI and fructose diet on the periphery provides a therapeutic target to counteract the TBI pathogenesis.	[Palafox-Sanchez, Victoria; Ying, Zhe; Royes, Luiz Fernando Freire; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Royes, Luiz Fernando Freire] Fed Univ Santa Maria UFSM, Ctr Phys Educ & Sports, Exercise Biochem Lab, Santa Maria, RS, Brazil		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Neurosurg & Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS50465, R01NS111378]; UC MEXUS-CONACYT Program 2019-2020	This research was supported by NIH R01NS50465 (F.G.P), R01NS111378 (F.G.P).; Dr. Victoria Palafox-Sanchez was supported by a fellowship from UC MEXUS-CONACYT Program 2019-2020.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abe-Dohmae S, 2006, J LIPID RES, V47, P1542, DOI 10.1194/jlr.M600145-JLR200; Agrawal R, 2016, J CEREBR BLOOD F MET, V36, P941, DOI 10.1177/0271678X15606719; Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Banks WA, 2018, INT J OBESITY, V42, P391, DOI 10.1038/ijo.2017.231; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Bruce KD, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00060; Cermenati G, 2015, BBA-MOL CELL BIOL L, V1851, P51, DOI 10.1016/j.bbalip.2014.08.011; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Correa R, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02927; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Dorninger F, 2018, J ALZHEIMERS DIS, V62, P841, DOI 10.3233/JAD-171036; Drzazga A, 2018, MOL CELL ENDOCRINOL, V472, P117, DOI 10.1016/j.mce.2017.12.002; Faeh D, 2005, DIABETES, V54, P1907, DOI 10.2337/diabetes.54.7.1907; Filipovic B, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/9638797; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gomez-Pinilla F, 2020, BIOCH BIOPHYS ACTA M; Grimm MOW, 2011, J CHROMATOGR A, V1218, P7713, DOI 10.1016/j.chroma.2011.07.073; Hollie NI, 2011, J LIPID RES, V52, P2005, DOI 10.1194/jlr.M019463; Hu Y, 2021, J NEUROTRAUM, V38, P399, DOI 10.1089/neu.2020.7271; Inose Y, 2015, NEUROPATHOLOGY, V35, P209, DOI 10.1111/neup.12182; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Johnson RJ, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.560865; Kakisaka K, 2019, J GASTROEN HEPATOL, V34, P1256, DOI 10.1111/jgh.14461; Kim H, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-0565-x; Krishna G, 2017, BBA-MOL BASIS DIS, V1863, P1204, DOI 10.1016/j.bbadis.2017.03.007; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lamade AM, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113307; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Li ZQ, 2012, J BIOL CHEM, V287, P20122, DOI 10.1074/jbc.M111.334664; Liu L, 2017, CELL METAB, V26, P719, DOI 10.1016/j.cmet.2017.08.024; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Lu CQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22452-0; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Majd AM, 2018, BEHAV BRAIN RES, V336, P111, DOI 10.1016/j.bbr.2017.08.046; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; Hung ND, 2012, INFLAMM RES, V61, P473, DOI 10.1007/s00011-012-0434-x; Nizamutdinov D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40112; Petta S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003446; Pflugrad H, 2015, LIVER INT, V35, P1816, DOI 10.1111/liv.12771; Pincon A, 2019, METABOLITES, V9, DOI 10.3390/metabo9050104; Rege SD, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801054; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Stonik JA, 2004, BIOCHEM BIOPH RES CO, V321, P936, DOI 10.1016/j.bbrc.2004.07.052; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taher J, 2017, CURR OPIN LIPIDOL, V28, P32, DOI 10.1097/MOL.0000000000000373; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Wang GH, 2019, NEUROPHARMACOLOGY, V146, P39, DOI 10.1016/j.neuropharm.2018.11.025; Wicker E, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5967816; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhang DM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040335; Zhang SY, 2018, EBIOMEDICINE, V31, P202, DOI 10.1016/j.ebiom.2018.04.022; Zhou XS, 2019, EUR J VASC ENDOVASC, V57, P434, DOI 10.1016/j.ejvs.2018.07.004; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	66	0	0	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	APR 1	2021	1867	4							166078	10.1016/j.bbadis.2021.166078			9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	QC1QW	WOS:000614609600016	33444711				2022-02-07	
J	Campos, MCP; Venzel, R; de Oliveira, LP; Reis, F; de Amorim, RLO				Paulino Campos, Maria Clara; Venzel, Raphaelly; de Oliveira, Larissa Pessoa; Reis, Franklin; Oliveira de Amorim, Robson Luis			Management of Traumatic Brain Injury at a Medium Complexity Hospital in a Remote Area of Amazonas, 2017-2019	WORLD NEUROSURGERY			English	Article						Epidemiology; Public health; Traumatic brain injury		OBJECTIVE: To describe the traumatic brain injury (TBI) care in the city of Coari, Amazonas, from 2017-2019. METHODS: Ecological study based on the analysis of the data obtained by the Epidemiology Service of the Regional Hospital of Coari regarding TBI attendances in the emergency room from January 2017 to October 2019. According to the GlasgowComa Scale, TBI was classified asmild, moderate, or severe. Other variables analyzed were sex, age, main causes of TBI, hospitalizations at the admission unit, and transfers to another health center and means of transport used. RESULTS: One hundred ten admissions were registered: 24 mild TBI, 51 moderate, and 35 severe; higher prevalence among men (70%); and age between 20 and 29 years (29%). The main causes were motorcycle accidents (42.7%), falls (29%), and physical aggression (21%). Some 69% of the patients admitted required to be transferred to another health center, with aerial intensive care unit (ICU) as the most significant means of transport (48.7%). Thirty patients hospitalized at the admission unit progressed with hospital discharge and 4 died. CONCLUSIONS: The profile of patients affected by TBI in the city of Coari was characterized by male victims of motorcycle accidents with age between 20 and 29 years. The high transfer rates indicates the need for a better neurotrauma assistance. Further investigations and studies associated with regional specificities are essential to recommend changes on the scope of public health and therefore decrease the incidence of TBI.	[Paulino Campos, Maria Clara; Venzel, Raphaelly; de Oliveira, Larissa Pessoa] Univ Fed Amazonas, Fac Med, Manaus, Amazonas, Brazil; [Reis, Franklin; Oliveira de Amorim, Robson Luis] Univ Fed Amazonas, Dept Neurosurg, Manaus, Amazonas, Brazil		Campos, MCP (corresponding author), Univ Fed Amazonas, Fac Med, Manaus, Amazonas, Brazil.	mccampos.2790@gmail.com		, Maria Clara Paulino Campos/0000-0002-6219-2031; Reis, Franklin/0000-0002-6052-440X			Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dunne J, 2020, J NEUROSCI RURAL PRA, V11, P287, DOI 10.1055/s-0040-1709363; Eloia SC, 2011, REV SANARE, V10, P34; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Instituto Brasileiro de Geografia e Estatistica, 2017, PAN MUN COAR; Instituto De Desenvolvimento Agropecuario E Florestal Sustentavel Do Estado Do Amazonas, 2013, COAR FID GEOGR; Lopes RD, 2013, REV BRASILEIRA NEURO, V7, P80; Marinho CDSR, 2017, BIOSCI J, V33, P779; Fernandes RNR, 2013, BRAZ NEUROSURG, V32, P136; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Salvarani CP, 2009, SURG NEUROL, V72, P6, DOI 10.1016/j.surneu.2007.10.008; Scheffer M, 2018, DEMOGRAFIA MED BRAS	15	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2021	148						E151	E154		10.1016/j.wneu.2020.12.088			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA9IO	WOS:000631732900019	33373738				2022-02-07	
J	Pengpid, S; Hinneh, JT; Peltzer, K				Pengpid, Supa; Hinneh, Johnson Tekay; Peltzer, Karl			Prevalence and correlates of single and multiple unintentional non-fatal injuries among school-going adolescents in Liberia	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Psychological distress; School adolescents; Substance use; Injury; Liberia	SOCIAL DETERMINANTS; HEALTH	Objective: This investigation aims to report on single and multiple unintentional nonfatal injuries among in-school adolescents in Liberia. Methods: Nationally representative cross-sectional data were statistically analysed from 2,744 adolescents (median age = 18 years) that participated in the 2017 Liberia Global School-Based Student Health Survey (GSHS). Results: The prevalence of single or multiple serious injuries (past 12 months) was 71.6% (31.8% once and 39.7% two or more times). Struck or hit by an object (10.6%), fall (9.0%), and motor vehicle crashes (8.6%) were the most frequent causes of injury, and cuts or open wounds (13.6%), fractures or dislocation (8.2%), and concussion (5.0%) were the most prevalent types of injury. In adjusted multinomial logistic regression analysis, experience of hunger (or food insecurity), passive smoking, frequent school truancy, psychological distress, and current cannabis use were associated with multiple and/or single injury. In addition, in unadjusted analysis, current tobacco use, ever drunk, ever amphetamine use, physically inactive and sedentary and walking and biking to school were associated with single and/or multiple injuries. In a separate multinomial logistic regression model, victims of physically assault, involvement in physical fighting, and bullying victimization were associated with both single and multiple injuries. Conclusion: A high prevalence of unintentional single and multiple injuries was discovered and several factors were found that can be utilized in targeting programmes aimed at injury prevention among ado-lescents. (C) 2020 Elsevier Ltd. All rights reserved.	[Pengpid, Supa] Mahidol Univ, ASEAN Inst Hlth Dev, Phutthamonthon, Nakhon Pathom, Thailand; [Pengpid, Supa] Univ Limpopo, Dept Res Adm & Dev, Turfloop, South Africa; [Hinneh, Johnson Tekay] Minist Educ, Sch Hlth, Monrovia, Liberia; [Peltzer, Karl] Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam; [Peltzer, Karl] Ton Duc Thang Univ, Fac Pharm, Ho Chi Minh City, Vietnam		Peltzer, K (corresponding author), Ton Duc Thang Univ, Ho Chi Minh City, Vietnam.	karl.peltzer@tdtu.edu.vn	Peltzer, Karl/Q-7334-2019	Peltzer, Karl/0000-0002-5980-0876			Asbridge M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-190; Guthold R, 2010, J PEDIATR-US, V157, P43, DOI 10.1016/j.jpeds.2010.01.019; Han LY, 2019, LANCET CHILD ADOLESC, V3, P616, DOI 10.1016/S2352-4642(19)30195-6; Johnson K, 2008, JAMA-J AM MED ASSOC, V300, P676, DOI 10.1001/jama.300.6.676; Mytton J, 2009, INJURY PREV, V15, P111, DOI 10.1136/ip.2008.019471; NCDI POVERTY Commission Liberia, 2018, LIB NONC DIS INJ NCD; Nkengbeza D., 2014, BUILDING PROFESSIONA; Peltzer K, 2008, INJURY PREV, V14, P381, DOI 10.1136/ip.2008.018598; Peltzer K, 2015, INT J ENV RES PUB HE, V12, P14936, DOI 10.3390/ijerph121114936; Peltzer K, 2012, INT J ENV RES PUB HE, V9, P2851, DOI 10.3390/ijerph9082851; Pengpid S, 2019, INT J GEN MED, V12, P263, DOI 10.2147/IJGM.S212350; Pengpid S, 2018, J PSYCHOL AFR, V28, P212, DOI 10.1080/14330237.2017.1409481; Pickett W, 2005, INJURY PREV, V11, P213, DOI 10.1136/ip.2004.007021; Sleet DA, 2010, ANNU REV PUBL HEALTH, V31, P195, DOI 10.1146/annurev.publhealth.012809.103616; Starkuviene Skirmante, 2005, Medicina (Kaunas), V41, P73; Street EJ, 2016, INJURY PREV, V22, P432, DOI 10.1136/injuryprev-2015-041786; Tradingeconomics, 2020, CAUS DEATH INJ TOT; WHO, 2020, GLOB SCH BAS STUD HL; Wilson M.L., 2012, AFR SAF PROMOT A, V10, P41	19	0	0	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	APR	2021	52	4					787	792		10.1016/j.injury.2020.11.048			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	RS3IZ	WOS:000643674700023	33250183				2022-02-07	
J	Pettemeridou, E; Constantinidou, F				Pettemeridou, Eva; Constantinidou, Fofi			The Association Between Brain Reserve, Cognitive Reserve, and Neuropsychological and Functional Outcomes in Males With Chronic Moderate-to-Severe Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: Moderate-to-severe traumatic brain injury (TBI) leads to significant neural and cognitive impairment, affecting functional outcome. This study investigated the chronic effects of moderate-to-severe TBI on brain reserve (BR), cognitive reserve (CR), and neuropsychological and functional outcome. Method: The group with TBI consisted of 41 male participants with a primary diagnosis of moderate-to-severe closed head injury (time since injury [TSI], M = 6.12 years, range: 1-23, SD = 5.99, Mdn = 4). TBI survivors were compared to 24 neurotypical male participants, matched on age and education. Magnetic resonance imaging T1 anatomical images were used to calculate gray and white matter and cerebrospinal fluid volume. BR was calculated using the ventricle-to-brain ratio. CR was assessed using two hold measures: the Peabody Picture Vocabulary Test and the Pseudowords task. Functional outcome was measured using the Glasgow Outcome Scale-Extended. Results: Neuropsychological performance of TBI survivors was significantly lower than their neurotypical controls, as measured by theoretically driven composites of verbal and visual memory, executive functions, attention, and CR. They presented greater ventricle-to-brain ratio volume, compared to noninjured controls, with higher scores indicating lower BR levels. Both BR and TSI were significantly associated with CR. Also, a median-split analysis revealed a TSI effect on CR. Significant associations were evident between the Glasgow Outcome Scale-Extended and the BR and CR measures. Conclusions: Lingering neuropsychological deficits in chronic TBI support the role of BR and CR in functional outcome. Furthermore, TSI interferes with CR supporting the notion that TBI sets off a chronic neurodegenerative and progressive course that interferes with semantic knowledge.	[Pettemeridou, Eva; Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus; [Pettemeridou, Eva] Univ Cyprus, KIOS Innovat & Res Ctr Excellence, Nicosia, Cyprus; [Constantinidou, Fofi] Univ Cyprus, Dept Psychol, Nicosia, Cyprus		Pettemeridou, E (corresponding author), Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus.; Pettemeridou, E (corresponding author), Univ Cyprus, KIOS Innovat & Res Ctr Excellence, Nicosia, Cyprus.	epette01@ucy.ac.cy		PETTEMERIDOU, EVA/0000-0001-5081-0042	Nicosia General Hospital Intensive Care Unit	The authors would like to thank the Nicosia General Hospital Intensive Care Unit and the Melathron Agoniston EOKA for the referrals and all participants and their families for their participation.	Betjemann RS, 2010, BEHAV GENET, V40, P135, DOI 10.1007/s10519-009-9328-2; Bigler E D, 1999, Appl Neuropsychol, V6, P217, DOI 10.1207/s15324826an0604_4; Cahn DA, 1998, ARCH CLIN NEUROPSYCH, V13, P575, DOI 10.1016/S0887-6177(98)00024-9; Chiaravalloti N. D., 2016, CHANGES BRAIN IMPACT; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cohen J., 2003, APPL MULTIPLE REGRES, V3; Constantinidou F., 2017, APHASIA RELATED NEUR, P421; Constantinidou F., 2017, TRAUMATICBRAIN INJUR, V4th, P513; Constantinidou F., 2008, PSYCHOLOGIA, V15, P342, DOI [10.12681/psy_hps.23842, DOI 10.12681/PSY_HPS.23842]; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Constantinidou F, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/9785319; Constantinidou F, 2012, CHILD NEUROPSYCHOL, V18, P256, DOI 10.1080/09297049.2011.602013; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Erickson KI, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.011.2008; Garcia-Molina A, 2013, MED CLIN-BARCELONA, V140, P527, DOI 10.1016/j.medcli.2012.09.047; Giogkaraki E, 2013, J CLIN EXP NEUROPSYC, V35, P1024, DOI 10.1080/13803395.2013.847906; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Knollman-Porter K, 2019, TOP LANG DISORD, V39, P257, DOI 10.1097/TLD.0000000000000187; Kokkinou M, 2020, NEUROREHABILITATION, V47, P143, DOI 10.3233/NRE-203111; Konstantinou N, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01163; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Lee JH, 2003, J CLIN EXP NEUROPSYC, V25, P594, DOI 10.1076/jcen.25.5.594.14582; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Pettemeridou E, 2020, NEUROREHABILITATION, V46, P109, DOI 10.3233/NRE-192963; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rey A., 1993, CLIN NEUROPSYCHOL, V7, P4; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Simos PG, 2013, J INT NEUROPSYCH SOC, V19, P355, DOI 10.1017/S1355617712001518; Simos PG, 2011, APHASIOLOGY, V25, P492, DOI 10.1080/02687038.2010.512120; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Wechsler D., 1997, WECHSLER ADULT INTEL, DOI [10.1037/t49755-000, DOI 10.1037/T49755-000]; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Yiannakkaras C, 2019, J INTEGR NEUROSCI, V18, P95, DOI 10.31083/j.jin.2019.02.144; Zalonis I, 2008, CLIN NEUROPSYCHOL, V22, P842, DOI 10.1080/13854040701629301; Zheng P, 2014, NEUROL INDIA, V62, P280, DOI 10.4103/0028-3886.136922	55	0	0	0	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		883	893		10.1044/2020_AJSLP-20-00053			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400003	33630655				2022-02-07	
J	Radin, A; Ganz, PA; Van Dyk, K; Stanton, AL; Bower, JE				Radin, Arielle; Ganz, Patricia A.; Van Dyk, Kathleen; Stanton, Annette L.; Bower, Julienne E.			Executive Functioning and Depressive Symptoms After Cancer: The Mediating Role of Coping	PSYCHOSOMATIC MEDICINE			English	Article						executive functioning; coping; depression; breast cancer; cognitive dysfunction; emotion regulation; BDI = Beck Depression Inventory; CI = confidence interval; EF = executive functioning; MBS = Mind-Body Study; PAOFI-HLC = Patient&#8217; s Assessment of Own Functioning&#8211; Higher Level Cognitive Complains Subscale; TBI = traumatic brain injury		Objective Cognitive difficulties are a common complaint among patients with breast cancer and may adversely affect psychological well-being. In particular, problems with executive functioning (EF) may interfere with coping, which is known to influence depressive symptoms. The current study was designed to examine correlations between EF, coping, and depressive symptoms in breast cancer survivors and to longitudinally test the hypothesis that coping mediates the relationship between EF and depressive symptoms. Methods Participants included 171 women with early-stage breast cancer assessed at the end of primary treatment with surgery, radiation, and/or chemotherapy and at 6 months, 1 year, and 2 years after treatment follow-ups as part of the Mind-Body Study. Participants completed questionnaires to assess subjective EF, approach and avoidant coping, and depressive symptoms, and neuropsychological testing was conducted to assess objective EF. Bivariate correlations were used to examine associations between EF, coping, and depressive symptoms. Mediation analyses were conducted using a bootstrapping approach (PROCESS). Results At 1 year after treatment, objective and subjective EFs were correlated with avoidant coping (r = -0.172 [p = .024] and r = 0.297 [p < .001], respectively). In longitudinal analyses, use of the avoidant strategy behavioral disengagement at 1 year mediated the association between objective (95% bootstrap confidence interval = -0.282 to -0.042) and subjective (95% bootstrap confidence interval = 0.020 to 0.254) EFs at 6 months and depressive symptoms at 2 years. Conclusions This study highlights how problems with EF during survivorship are associated with avoidant coping and depressive symptoms. Thus, these findings identify potential cognitive and affective targets for depression intervention in this population.	[Radin, Arielle; Stanton, Annette L.; Bower, Julienne E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; [Ganz, Patricia A.; Van Dyk, Kathleen; Stanton, Annette L.; Bower, Julienne E.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Van Dyk, Kathleen; Stanton, Annette L.; Bower, Julienne E.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Stanton, Annette L.; Bower, Julienne E.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA 90095 USA		Radin, A (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	radina02@ucla.edu			National Institutes of Health/National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA 109650]; Breast Cancer Research Foundation; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH015750]	This study was supported by funding from National Institutes of Health/National Cancer Institute R01 CA 109650 and the Breast Cancer Research Foundation, and by National Institute of Mental Health T32 MH015750 to A.R.	Arndt J, 2014, PSYCHO-ONCOLOGY, V23, P1, DOI 10.1002/pon.3351; Austenfeld JL, 2004, J PERS, V72, P1335, DOI 10.1111/j.1467-6494.2004.00299.x; Bauer MR, 2016, ANN BEHAV MED, V50, P370, DOI 10.1007/s12160-015-9763-7; Beck Aaron T., 1996, MENTAL MEASUREMENTS; Boykoff N, 2009, J CANCER SURVIV, V3, P223, DOI 10.1007/s11764-009-0098-x; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chelune GJ, 1986, ADV CLIN NEUROPSYCHO, V3, P95, DOI [10.1007/978-1-4613-2211-5_4, DOI 10.1007/978-1-4613-2211-5_4]; Compas B.E., 1997, PL S STRESS, P105; Compas BE, 2017, PSYCHOL BULL, V143, P939, DOI 10.1037/bul0000110; Culver JL, 2002, PSYCHO-ONCOL, V11, P495, DOI 10.1002/pon.615; Demick J., 1997, ROLE COGNITIVE STYLE; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Ercoli LM, 2015, PSYCHO-ONCOLOGY, V24, P1360, DOI 10.1002/pon.3769; FOLKMAN S, 1987, PSYCHOL AGING, V2, P171, DOI 10.1037/0882-7974.2.2.171; Folkman S., 1984, STRESS; Ganz PA, 2016, J CLIN ONCOL, V34, P816, DOI 10.1200/JCO.2015.64.3866; Ganz PA, 2014, J CLIN ONCOL, V32, P3559, DOI 10.1200/JCO.2014.56.1662; Ganz PA, 2013, JNCI-J NATL CANCER I, V105, P791, DOI 10.1093/jnci/djt073; Ganz PA, 2013, BRAIN BEHAV IMMUN, V30, pS99, DOI 10.1016/j.bbi.2012.07.015; Giesbrecht G., 2010, SELF SOCIAL REGULATI, P337; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gregorio GW, 2015, BRIT J CLIN PSYCHOL, V54, P291, DOI 10.1111/bjc.12074; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Hayes A.F., 2017, INTRO MEDIATION MODE; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Hoyt MA, 2014, PSYCHONEUROENDOCRINO, V49, P182, DOI 10.1016/j.psyneuen.2014.07.007; Janelsins MC, 2017, J CLIN ONCOL, V35, P506, DOI 10.1200/JCO.2016.68.5826; Jim HSL, 2013, HEALTH PSYCHOL, V32, P768, DOI 10.1037/a0031322; Joormann J, 2014, CLIN PSYCHOL SCI, V2, P402, DOI 10.1177/2167702614536163; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Parke C., 2013, ESSENTIAL 1 STEPS DA, P81, DOI [https://doi.org/10.4135/9781506335148.n5, DOI 10.4135/9781506335148.N5]; Pullens MJJ, 2010, PSYCHO-ONCOLOGY, V19, P1127, DOI 10.1002/pon.1673; Quinn ME, 2020, STRESS, V23, P60, DOI 10.1080/10253890.2019.1641079; Reid-Arndt SA, 2012, J CLIN PSYCHOL MED S, V19, P127, DOI 10.1007/s10880-011-9274-z; Villegas ALR, 2015, APPL NEUROPSYCH-ADUL, V22, P124, DOI 10.1080/23279095.2013.864972; Ryan J. J., 2001, UNDERSTANDING PSYCHO; Savard J, 2016, JAMA ONCOL, V2, P1263, DOI 10.1001/jamaoncol.2016.2047; Schmeichel BJ., 2014, CONTROL MOTIVATION I, P151; Schmeichel BJ, 2015, CURR DIR PSYCHOL SCI, V24, P93, DOI 10.1177/0963721414555178; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; Schweizer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024372; Smith JA, 2002, ANN BEHAV MED, V24, P326, DOI 10.1207/S15324796ABM2404_09; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Stanton, 2018, HDB CANC SURVIVORSHI, P29, DOI [10.1007/978-3-319-77432-9_3, DOI 10.1007/978-3-319-77432-9_3]; Stanton A.L., 2017, HAPPY MIND COGNITIVE, P253, DOI [10.1007/978-3-319-58763-9_14, DOI 10.1007/978-3-319-58763-9_14]; Stanton AL, 2002, PSYCHO-ONCOLOGY, V11, P93, DOI 10.1002/pon.574; Stanton AL, 2000, J PERS SOC PSYCHOL, V78, P1150, DOI 10.1037//0022-3514.78.6.1150; Stanton AL, 2018, J CONSULT CLIN PSYCH, V86, P820, DOI 10.1037/ccp0000328; Stanton AL, 2015, ADV EXP MED BIOL, V862, P231, DOI 10.1007/978-3-319-16366-6_15; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Troy AS, 2018, EMOTION, V18, P58, DOI 10.1037/emo0000371; Van den Bergh N, 2018, EXPERT REV NEUROTHER, V18, P907, DOI 10.1080/14737175.2018.1537783; Van Dyk K, 2017, BREAST CANCER RES TR, V166, P157, DOI 10.1007/s10549-017-4390-6; Van Dyk K, 2016, SUPPORT CARE CANCER, V24, P4939, DOI 10.1007/s00520-016-3352-6; Van Dyk K, 2016, JAMA ONCOL, V2, P964, DOI 10.1001/jamaoncol.2016.0350; Vance DE, 2017, CANCER NURS, V40, pE11, DOI 10.1097/NCC.0000000000000349; Von Ah D, 2013, EUR J ONCOL NURS, V17, P236, DOI 10.1016/j.ejon.2012.06.002; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; Yao C, 2017, BREAST CANCER RES TR, V166, P15, DOI 10.1007/s10549-017-4376-4; Zelazo P, 2007, HDB EMOTION REGULATI, P135, DOI DOI 10.1177/1545968309354536	68	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	APR	2021	83	3					291	299		10.1097/PSY.0000000000000926			9	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	RM1CN	WOS:000639398400011	33657085	Green Accepted			2022-02-07	
J	Raju, B; Kanmani, TR; Konar, S; Shukla, D; Kukkehalli, R				Raju, Birudu; Kanmani, T. R.; Konar, Subhas; Shukla, Dhaval; Kukkehalli, Raghavendra			Prehospital Impact on Family Members of Road Traffic Accident	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						prehospital care; family members; psychosocial problems		Background Prehospital care is nonexistent in most rural and semiurban areas. The implementation of golden hour care is still unachieved. The psychosocial problems of family members who accompany the traumatic brain injury (TBI) survivors after road traffic accidents (RTA) are not given attention during prehospital care. Therefore, the current study was aimed to understand the prehospital psychosocial impact on family members. Methodology A cross-sectional study was conducted at the Emergency and Trauma Care Centre at National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru between July 2017 to April 2018. Forty-five (n = 45) referred family members providing care for trauma survivors were purposively recruited in the study. Structured checklists were administered to measure the psychological reactions and psychosocial problems experienced by the family members during prehospital care. Data analysis was analyzed using the R software 3.0.1 version. Results TBI survivor's mean age was found to be 33 years (33.09 +/- 13.20), of which males were 23 (51.1%) and females were 22 (48.9%), respectively. The result depicted first aid was provided by unskilled people after an average of 41 minutes (41 +/- 30). The results further showed that family members had experienced agitation (100%), shock (82.2%), fatigue and headache (75.6%), depression (66.7%), feeling of hopelessness (55.6%) helplessness, and lack of support from family and financial constraints (48.9%) during prehospital care. Conclusion Psychosocial interventions need to be provided during prehospital care by trained medical and psychiatric social work professionals to address the need of family members during the crisis.	[Raju, Birudu] Kristu Jayanti Coll, Dept Social Work, Bengaluru, India; [Kanmani, T. R.; Kukkehalli, Raghavendra] Natl Inst Mental Hlth & Neurosci, Dept Psychiat Social Work, Bengaluru, India; [Konar, Subhas; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru, India		Kanmani, TR (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Psychiat Social Work, Bengaluru, India.	kanmani.raju@gmail.com					Agrawal A, 2013, INDIAN J NEUROTRAUM, V10, P38, DOI 10.1016/j.ijnt.2013.05.006; Agrawal Amit, 2016, Int J Crit Illn Inj Sci, V6, P65, DOI 10.4103/2229-5151.183025; Ahl C, 2012, INT EMERG NURS, V20, P33, DOI 10.1016/j.ienj.2011.03.001; Ahlenius M, 2017, INT EMERG NURS, V30, P25, DOI 10.1016/j.ienj.2016.07.004; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bhatoe HS, 2009, INDIAN J NEUROTRAUM, V6, P5, DOI 10.1016/S0973-0508(09)80020-8; Cartin-Ceba R, 2010, AM J RESP CRIT CARE, V181, P1279, DOI 10.1164/rccm.201004-0676ED; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Fusenig E., 2012, SOC WORK MASTERS CLI; Joshipura MK, 2008, WORLD J SURG, V32, P1613, DOI 10.1007/s00268-008-9634-5; Joshipura MK., 2004, INDIAN J CRIT CARE M, V8; Kanmani TR, 2019, J NEUROSCI RURAL PRA, V10, P54, DOI 10.4103/jnrp.jnrp_129_18; Meena Ugan Singh, 2018, Asian J Neurosurg, V13, P636, DOI 10.4103/1793-5482.238011; Raju Birudu, 2016, Int J Crit Illn Inj Sci, V6, P206, DOI 10.4103/2229-5151.195452; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sa T., 2019, EMERGEN MED, DOI [10.4172/2165-7548.1000229, DOI 10.4172/2165-7548.1000229]; Samabasivan, 1991, NEUROL INDIA S, V43, P9; Sankar J, 2015, INDIAN J CRIT CARE M, V19, P474, DOI 10.4103/0972-5229.162469; Schiller William R, 2003, J Trauma Nurs, V10, P93; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Subrahmanyam BV, 2016, MED J DR DY PATIL U, V9, P465; Uthkarsh Pallavi S, 2012, Int J Crit Illn Inj Sci, V2, P108, DOI 10.4103/2229-5151.97278	23	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	APR	2021	12	02					350	355		10.1055/s-0041-1723063		APR 2021	6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RZ6IR	WOS:000637020800001	34103880	gold, Green Published			2022-02-07	
J	Rasmus, A; Orlowska, E				Rasmus, Anna; Orlowska, Edyta			Communication Abilities of Children with DoC after Severe Brain Injury in ICF Frames	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						functional diagnosis; ICF; minimally conscious state (MCS); TBI; communication		Introduction: The ability to communicate is one of the fundamental factors underlying human relationships. Severe brain damage and disorders of consciousness may indispose a person to participate in everyday social and family life. In spite of this fact, however, the issue of holistic approach to communication in the context of severe traumatic brain injury is still not well explained and described. The goal of this article is to introduce a profile of nonverbal behavior of children with disorders of consciousness. Materials and methods: The study included 30 children with minimal conscious state after severe brain trauma, aged between 7 and 16 years old. Research was conducted using the Coma Recovery Scale-Revised and the Bykova-Lukyanov Scale of Communication Activity. Results: Significant differences in communication level between investigated groups were demonstrated, both in Body Function (F = 9.184; p < 0.001) and Activity and Participation (F = 13.100; p < 0.001). Conclusions: It is possible to map and classify communication ability of children with minimal conscious state by using International Classification of Functioning, Disability and Health (ICF) protocol and the Bykova-Lukyanov Scale of Communication Activity, with specific consideration of Activities and Participation factors. This approach reveals differences in communication and disability level between children with minimal conscious state plus (MSC+) and minimal conscious state minus (MSC-).	[Rasmus, Anna] Uniwersytet Kazimierza Wielkiego UKW, Inst Psychol, PL-85064 Bydgoszcz, Poland; [Orlowska, Edyta] Uniwersytet Gdanski UG, Inst Psychol, PL-80309 Gdansk, Poland		Rasmus, A (corresponding author), Uniwersytet Kazimierza Wielkiego UKW, Inst Psychol, PL-85064 Bydgoszcz, Poland.	arasmus@ukw.edu.pl; psyeo@ug.edu.pl		Rasmus, Anna/0000-0001-5125-3081; Orlowska, Edyta/0000-0002-2278-4091			Binder M, 2018, BRAIN INJURY, V32, P242, DOI 10.1080/02699052.2017.1406991; Bodart O, 2013, SEMIN NEUROL, V33, P83, DOI 10.1055/s-0033-1348965; Bykova VI, 2014, ACTA NEUROPSYCHOL, V12, P429, DOI 10.5604/17307503.1132370; Davidson B., 2002, NEUROGENIC COMMUNICA, P19; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; Hughes J, 2007, CAN J SPEECH-LANG PA, V31, P134; Kaczmarek B., 2009, MISTERNE GRY WKOMUNI; Larkins B., 2000, NEUROGENIC COMMUNICA, P206; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Leonardi M, 2014, INT J REHABIL RES, V37, P197, DOI 10.1097/MRR.0000000000000051; Leonardi M, 2012, INT J REHABIL RES, V35, P352, DOI 10.1097/MRR.0b013e328356425d; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; Ostensjo S, 2006, DISABIL REHABIL, V28, P489, DOI 10.1080/09638280500212013; Pachalska M., 2014, SKALA OCENY KOMUNIKA; PACHALSKA M, 2014, NEUROPSYCHOLOGIA KLI; Pundole A, 2018, NEUROPSYCHOL REHABIL, V28, P1285, DOI 10.1080/09602011.2017.1307766; Rasmus A, 2019, ANN AGR ENV MED, V26, P304, DOI 10.26444/aaem/91911; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Sitnik-Warchulska K, 2019, PSYCHIATR PSYCHOL KL, V19, P54, DOI 10.15557/PiPK.2019.0008; Stender J., 2014, BRAIN DISORD, V3, P115, DOI [10.4172/2329-8790.1000e115, DOI 10.4172/2329-8790.1000E115]; Threats T, 2004, ADV SPEECH LANGUAGE, V6, P53, DOI DOI 10.1080/14417040410001669426; Threats T.T., CONCEPTUAL FRAMEWORK; Willems M, 2015, INT J ENV RES PUB HE, V12, P3707, DOI 10.3390/ijerph120403707; World Health Organization, 2007, INT CLASS FUNCT DIS	26	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2021	18	8							4267	10.3390/ijerph18084267			11	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	RT0BZ	WOS:000644135400001	33920568	Green Published, gold			2022-02-07	
J	Reid, SA; Fornasier, J; Redrup, D; McLeod, S				Reid, Susan A.; Fornasier, Johnathan; Redrup, Daniel; McLeod, Shreya			Cervical spine range of motion and joint position sense in elite male cricketers: An observational study	INTERNATIONAL JOURNAL OF HEALTH AND ALLIED SCIENCES			English	Article						Cervical spine; cricketers; joint position sense; range of motion	SPORT-RELATED CONCUSSION; NECK-PAIN; MUSCLE MORPHOMETRY; PACE BOWLERS; HIGH-SCHOOL; INJURY; HEAD; DIZZINESS; REHABILITATION; EXERCISE	OBJECTIVE: The aims of the current study were to (1) establish baseline data for cervical range of motion (CROM) and joint position sense (JPS) in elite male cricketers, (2) determine whether these players had differences when compared to healthy adults, and (3) establish a reference set of values for future investigations. MATERIALS AND METHODS: Design: Repeated measures, observational study. Participants: Thirty-one elite cricketers, aged 18-35 years. Setting: Cricket New South Wales at the Sydney Cricket Ground, Sydney, Australia. Outcome measures: Cervical rotation was measured with a CROM device and JPS using the joint position error (JPE) laser method with two protocols: repositioning to straight ahead and to 80% of maximum rotation. RESULTS: Mean right and left rotation were less than healthy normals by 6.5 degrees (P < 0.001) and 4.2 degrees (P < 0.001), respectively. In the preseason, 26% of cricketers had JPE >4.5 degrees repositioning to straight ahead, which is 11% greater than the general population and 87% had JPE >4.5 degrees when repositioning to 80% rotation. Postseason, deficits in CROM were unchanged. Fewer players (22%) had JPE >4.5 degrees when repositioning to straight ahead however JPE when repositioning to 80% of rotation increased 1 degrees for both directions (P < 0.05). CONCLUSIONS: Contrary to the authors' hypothesis, preliminary findings from this study demonstrated that elite male cricketers in this cohort had deficits in CROM and JPS, compared to normal healthy adults. This has clinical implications for the use of physical therapies targeting JPS and restoring CROM pre- and post-head and neck injury. Therapists should account for preexisting, baseline asymmetries in the range of motion and JPE in male cricketers. Further research needs to validate these findings across adolescent and female cricketers and explore the interaction between cervical spine parameters, cricket biomechanics, and head or neck injury risk.	[Reid, Susan A.; Fornasier, Johnathan; McLeod, Shreya] Australian Catholic Univ, Sch Allied Hlth, Discipline Physiotherapy, 33 Berry St, Sydney, NSW 2060, Australia; [Redrup, Daniel] Cricket New South Wales, Sydney, NSW, Australia		McLeod, S (corresponding author), Australian Catholic Univ, Sch Allied Hlth, Discipline Physiotherapy, 33 Berry St, Sydney, NSW 2060, Australia.	shreya.mcleod@acu.edu.au			Australian Catholic University Faculty of Health Sciences Student Support Scheme	Funds were provided to Johnathon Fornasier by the Australian Catholic University Faculty of Health Sciences Student Support Scheme (FHSSS).	Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P779, DOI 10.2519/jospt.2019.8760; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Armstrong BS, 2005, CLIN BIOMECH, V20, P675, DOI 10.1016/j.clinbiomech.2005.03.009; Bonfield CM, 2015, PHYSICIAN SPORTSMED, V43, P236, DOI 10.1080/00913847.2015.1039922; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Chen XQ, 2013, MANUAL THER, V18, P562, DOI 10.1016/j.math.2013.05.015; Croft JL, 2010, HUM MOVEMENT SCI, V29, P751, DOI 10.1016/j.humov.2009.10.004; Dall'Alba PT, 2001, SPINE, V26, P2090, DOI 10.1097/00007632-200110010-00009; Falla D, 2013, EUR J PAIN, V17, P1517, DOI 10.1002/j.1532-2149.2013.00321.x; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gray J, 2016, J SCI MED SPORT, V19, P222, DOI 10.1016/j.jsams.2015.04.009; Hides J, 2008, BRIT J SPORT MED, V42, P809, DOI 10.1136/bjsm.2007.044024; Hides JA, 2010, SCAND J MED SCI SPOR, V20, P834, DOI 10.1111/j.1600-0838.2009.01019.x; Hides JA, 2017, MED SCI SPORT EXER, V49, P2385, DOI 10.1249/MSS.0000000000001372; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Hill T, 2019, SPORTS HEALTH, V11, P180, DOI 10.1177/1941738118811315; Jull GA, 2009, MANUAL THER, V14, P696, DOI 10.1016/j.math.2009.05.004; Jull G, 2007, J ORTHOP RES, V25, P404, DOI 10.1002/jor.20220; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Kiefer AW, 2018, J SCI MED SPORT, V21, P4, DOI 10.1016/j.jsams.2017.06.016; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kountouris A, 2012, J SCI MED SPORT, V15, P393, DOI 10.1016/j.jsams.2012.03.012; Kristjansson E, 2003, CLIN REHABIL, V17, P768, DOI 10.1191/0269215503cr676oa; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; Martin C, 2017, J SPORT REHABIL, V26, P386, DOI 10.1123/jsr.2016-0073; Martin C, 2017, PHYS THER SPORT, V28, P34, DOI 10.1016/j.ptsp.2017.08.078; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Orchard J, 2012, SPORTS PHYSL, V4, P20; Orchard JW, 2016, OPEN ACCESS J SPORTS, V7, P187, DOI 10.2147/OAJSM.S117497; Pandey CR, 2015, SPORT INJURY CRICKET; Pinsault N, 2010, PHYS THER SPORT, V11, P66, DOI 10.1016/j.ptsp.2010.02.004; Portelli A, 2018, J MANIP PHYSIOL THER, V41, P123, DOI 10.1016/j.jmpt.2017.10.004; Ranson C, 2008, CLIN J SPORT MED, V18, P31, DOI 10.1097/JSM.0b013e3181618aa2; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Roren A, 2009, MANUAL THER, V14, P270, DOI 10.1016/j.math.2008.03.002; Saw AE, 2019, SPORTS MED, V49, P553, DOI 10.1007/s40279-019-01066-0; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P140, DOI 10.1016/j.msksp.2019.05.007; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Stretch R., 2014, BR J SPORTS MED, V48, P663, DOI [10.1136/bjsports-2014-093494.275, DOI 10.1136/BJSPORTS-2014-093494.275]; Strimpakos N, 2011, J BODYW MOV THER, V15, P114, DOI 10.1016/j.jbmt.2009.06.003; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Tripathi M, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15341; Wibault J, 2013, MANUAL THER, V18, P403, DOI 10.1016/j.math.2013.02.004; YOUDAS JW, 1991, PHYS THER, V71, P98, DOI 10.1093/ptj/71.2.98	53	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2278-4292	2278-344X		INT J HLTH ALLIED SC	Int. J. Health Allied Sci.	APR-JUN	2021	10	2					134	140		10.4103/ijhas.IJHAS_111_19			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SM0XM	WOS:000657336000006					2022-02-07	
J	Ritter, J; Dawson, J; Singh, RK				Ritter, Jonathan; Dawson, Jeremy; Singh, Rajiv K.			Functional recovery after brain injury: Independent predictors of psychosocial outcome one year after TBI	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; Functional outcome; Rivermead head injury follow up questionnaire; Prognosis; Neurorehabilitation		Introduction: Traumatic Brain Injury (TBI) is the leading cause of death and disability in people aged under 40 in the UK. Many patients suffer residual deficits, which limits their functional recovery. The aim of this study was to determine independent predictors of functional outcome at 1-year post-TBI. Methods: Utilising a prospective observational cohort design, 1131 consecutive adult admissions with nonrecurrent TBI were recruited from the ED (Emergency Department). Using routine consultant-led follow up clinics, data was collected between August 2011 and July 2015. The Rivermead Head Injury Follow Up Questionnaire (RHFUQ) was used to measure psychosocial function at 1 year. Results: A multiple linear regression model showed that previous psychiatric history (p < 0.001), lower Glasgow Coma Scale (p < 0.001), a severe CT scan (p = 0.002), aetiology of assault compared to sport (p = 0.011) and falls (p = 0.005), initial unemployment (p < 0.001) and no job at 8?10 weeks (p 0.001) after TBI had a significant association with a worse RHFUQ score at 1 year. Follow up rate was 90 %. Conclusions: This study adds valuable information on the prognostic indicators of TBI recovery and possible targets for intervention. Future development of a validated prognostic model to predict long term functional outcomes after TBI will help improve long-term treatment of the condition.	[Ritter, Jonathan; Singh, Rajiv K.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Dawson, Jeremy] Univ Sheffield, Inst Work Psychol, Management Sch, Sheffield, S Yorkshire, England; [Singh, Rajiv K.] Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield S5 7AU, S Yorkshire, England		Ritter, J (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.	jmr1g16@soton.ac.uk		Ritter, Jonathan/0000-0002-9118-1112			Booker J, 2019, BRAIN INJURY, V33, P1158, DOI 10.1080/02699052.2019.1629626; Booker James, 2019, Br J Neurosurg, V33, P367, DOI 10.1080/02688697.2019.1598542; Brown AW, 2019, BRAIN INJURY, V33, P610, DOI 10.1080/02699052.2019.1566970; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chakroun-Walha O, 2017, EUR J TRAUMA EMERG S, V43, P747, DOI 10.1007/s00068-016-0656-7; Chandola T, 2000, J PUBLIC HEALTH MED, V22, P182, DOI 10.1093/pubmed/22.2.182; Charry JD, 2019, NEUROL NEUROCHIR POL, V53, P55, DOI 10.5603/PJNNS.a2018.0003; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lin HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104266; Lingsma HF, 2017, LANCET NEUROL, V16, P494, DOI 10.1016/S1474-4422(17)30171-0; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Pedersen AR, 2015, NEUROREHAB NEURAL RE, V29, P299, DOI 10.1177/1545968314545171; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Singh R, 2019, CLIN NEUROL NEUROSUR, V186, DOI 10.1016/j.clineuro.2019.105526; Singh R, 2019, BRAIN INJURY, V33, P584, DOI 10.1080/02699052.2019.1566837; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Zeldovich M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061931	53	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2021	203								106561	10.1016/j.clineuro.2021.106561			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RH8HY	WOS:000636453700009	33618172				2022-02-07	
J	Roberts, I; Shakur-Still, H; Aeron-Thomas, A; Beaumont, D; Belli, A; Brenner, A; Cargill, M; Chaudhri, R; Douglas, N; Frimley, L; Gilliam, C; Geer, A; Jamal, Z; Jooma, R; Mansukhani, R; Miners, A; Pott, J; Prowse, D; Shokunbi, T; Williams, J				Roberts, Ian; Shakur-Still, Haleema; Aeron-Thomas, Amy; Beaumont, Danielle; Belli, Antonio; Brenner, Amy; Cargill, Madeleine; Chaudhri, Rizwana; Douglas, Nicolas; Frimley, Lauren; Gilliam, Catherine; Geer, Amber; Jamal, Zahra; Jooma, Rashid; Mansukhani, Raoul; Miners, Alec; Pott, Jason; Prowse, Danielle; Shokunbi, Temitayo; Williams, Jack			Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT	HEALTH TECHNOLOGY ASSESSMENT			English	Article							INTRACEREBRAL HEMORRHAGE; EDEMA FORMATION; MRC CRASH; ADULTS; TRIAL; SCALE; COAGULOPATHY; COMA; TPA	Background: Tranexamic acid safely reduces mortality in traumatic extracranial bleeding. Intracranial bleeding is common after traumatic brain injury and can cause brain herniation and death. We assessed the effects of tranexamic acid in traumatic brain injury patients. Objective: To assess the effects of tranexamic acid on death, disability and vascular occlusive events in traumatic brain injury patients. We also assessed cost-effectiveness. Design: Randomised trial and economic evaluation. Patients were assigned by selecting a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients, caregivers and those assessing outcomes were masked to allocation. All analyses were by intention to treat. We assessed the cost-effectiveness of tranexamic acid versus no treatment from a UK NHS perspective using the trial results and a Markov model. Setting: 175 hospitals in 29 countries. Participants: Adults with traumatic brain injury within 3 hours of injury with a Glasgow Coma Scale score of <= 12 or any intracranial bleeding on computerised tomography scan, and no major extracranial bleeding, were eligible. Intervention: Tranexamic acid (loading dose 1 g over 10 minutes then infusion of 1 g over 8 hours) or matching placebo. Main outcome measures: Head injury death in hospital within 28 days of injury in patients treated within 3 hours of injury. Secondary outcomes were early head injury deaths, all-cause and cause-specific mortality, disability, vascular occlusive events, seizures, complications and adverse events. Results: Among patients treated within 3 hours of injury (n = 9127), the risk of head injury death was 18.5% in the tranexamic acid group versus 19.8% in the placebo group (855/4613 vs. 892/4514; risk ratio 0.94, 95% confidence interval 0.86 to 1.02). In a prespecified analysis excluding patients with a Glasgow Coma Scale score of 3 or bilateral unreactive pupils at baseline, the results were 12.5% in the tranexamic acid group versus 14.0% in the placebo group (485/3880 vs. 525/3757; risk ratio 0.89, 95% confidence interval 0.80 to 1.00). There was a reduction in the risk of head injury death with tranexamic acid in those with mild to moderate head injury (166/2846 vs. 207/2769; risk ratio 0.78, 95% confidence interval 0.64 to 0.95), but in those with severe head injury (689/1739 vs. 685/1710; risk ratio 0.99, 95% confidence interval 0.91 to 1.07) there was no apparent reduction (p-value for heterogeneity = 0.030). Early treatment was more effective in mild and moderate head injury (p = 0.005), but there was no obvious impact of time to treatment in cases of severe head injury (p = 0.73). The risk of disability, vascular occlusive events and seizures was similar in both groups. Tranexamic acid is highly cost-effective for mild and moderate traumatic brain injury (base case of 4288 pound per quality-adjusted life-year gained). Conclusion: Early tranexamic acid treatment reduces head injury deaths. Treatment is cost-effective for patients with mild or moderate traumatic brain injury, or those with both pupils reactive. Future work: Further trials should examine early tranexamic acid treatment in mild head injury. Research on alternative routes of administration is needed. Future work: Further trials should examine early tranexamic acid treatment in mild head injury. Research on alternative routes of administration is needed.	[Roberts, Ian; Shakur-Still, Haleema; Beaumont, Danielle; Brenner, Amy; Cargill, Madeleine; Frimley, Lauren; Gilliam, Catherine; Geer, Amber; Jamal, Zahra; Mansukhani, Raoul; Prowse, Danielle] London Sch Hyg & Trop Med, Clin Trials Unit, London, England; [Aeron-Thomas, Amy] RoadPeace, London, England; [Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct, Birmingham, W Midlands, England; [Belli, Antonio] Queen Elizabeth Hosp, Microbiol Res Ctr, Birmingham, W Midlands, England; [Chaudhri, Rizwana] Rawalpindi Med Univ, Dept Obstet & Gynaecol, Rawalpinidi, Pakistan; [Douglas, Nicolas; Miners, Alec; Williams, Jack] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Jooma, Rashid] Aga Khan Univ, Dept Surg, Med Coll, Karachi, Pakistan; [Pott, Jason] Barts Hlth NHS Trust, Royal London Hosp, Emergency Dept, London, England; [Shokunbi, Temitayo] Univ Ibadan, Dept Anat & Surg, Ibadan, Nigeria		Roberts, I (corresponding author), London Sch Hyg & Trop Med, Clin Trials Unit, London, England.	Ian.Roberts@lshtm.ac.uk	Brenner, Amy/ABB-8133-2021; Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Shakur-Still, Haleema/0000-0002-6511-109X; Shokunbi, Temitayo/0000-0002-7819-6862; Chaudhri, Rizwana/0000-0002-5428-3988; Brenner, Amy/0000-0003-2017-5994; Roberts, Ian/0000-0003-1596-6054	National Institute for Health Research (NIHR) Health Technology Assessment programmeNational Institute for Health Research (NIHR); JP Moulton Charitable Trust; Joint Global Health Trials (Medical Research Council); Joint Global Health Trials (Department for International Development); Joint Global Health Trials (Wellcome Trust)Wellcome Trust; NIHR Global Health Trials programme	The project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 26. See the NIHR Journals Library website for further project information. In addition, funding was provided by JP Moulton Charitable Trust, Joint Global Health Trials (Medical Research Council, Department for International Development and theWellcome Trust). This project was funded by the NIHR Global Health Trials programme.	Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; [Anonymous], 2019, BRIT NATL FORMULARY; [Anonymous], 2019, H SHAK 17 ANN M NEUR; Barton BL, 1998, DRUG INF J, V32, P1143, DOI 10.1177/009286159803200434; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Beecham J, 2009, BRAIN INJURY, V23, P30, DOI 10.1080/02699050802590338; Born K, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0966-z; Carley S, 1998, J EPIDEMIOL COMMUN H, V52, P392, DOI 10.1136/jech.52.6.392; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Coats TJ, 2019, EMERG MED J, V36, P78, DOI 10.1136/emermed-2018-207693; Curtis LA, 2018, UNIT COSTS HLTH SOCI; Department of Health and Social Care (DHSC), 2018, NHS REF COSTS 2017 1; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Edwards P, 2005, LANCET, V365, P1957; Electronic Medicines Compendium, 2018, TRAN AC 100 MG ML SO; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; Fuller GW, 2017, VALUE HEALTH, V20, P141, DOI 10.1016/j.jval.2016.09.2398; Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Guthrie Susan, 2016, Rand Health Q, V5, P5; Haljamae H, 1984, Am J Emerg Med, V2, P100, DOI 10.1016/0735-6757(84)90117-7; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Haydel M., 2018, BMJ BEST PRACTICE; HENRY DA, 2011, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001886.PUB3; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; HORROW JC, 1995, ANESTHESIOLOGY, V82, P383, DOI 10.1097/00000542-199502000-00009; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Joint Royal Colleges Ambulance Liaison Committee Association of Ambulance Chief Executives, 2019, JRCALC CLIN GUID 201; Kind P, 1999, UK POPULATION NORMS; Lecky F, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20010; Mahmood A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4814; May S, 2019, POWER OF CUTE, P19; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Moore EE, 2015, J TRAUMA ACUTE CARE, V78, pS65, DOI 10.1097/TA.0000000000000634; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence (NICE), 2018, QS166 NICE; National Institute for Health and Care Excellence (NICE), 2014, COST STAT NEEDL SYR; NICE, 2019, HEAD INJ ASS EARL MA; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Office for National Statistics, 2019, NAT LIF TABL UK 2016; Peden N, 2004, WORLD REPORT ROAD TR; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; PUIGDELLIVOL E, 1985, INT J CLIN PHARM TH, V23, P298; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts Ian, 1800, Wellcome Open Res, V3, P86, DOI 10.12688/wellcomeopenres.14700.1; Roberts I, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0685-8; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roberts Ian, 2019, I ROB WORLD C INT CA; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; Rodriguez-Boto G, 2015, NEUROLOGIA, V30, P16, DOI 10.1016/j.nrl.2012.09.002; Sano M, 1976, RINSHO YAKURI JPN J, V7, P375, DOI [10.3999/jscpt.7.375, DOI 10.3999/JSCPT.7.375]; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thiex R, 2004, EXP NEUROL, V189, P25, DOI 10.1016/j.expneurol.2004.05.021; Thiex R, 2003, NEUROL RES, V25, P254, DOI 10.1179/016164103101201463; Weijer C, 2000, BMJ-BRIT MED J, V321, P756, DOI 10.1136/bmj.321.7263.756; Williams J, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002716; World Health Organization, 2019, WHO MOD LIST ESS MED; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Wright C, 2014, J ROY ARMY MED CORPS, V160, P271, DOI 10.1136/jramc-2013-000152; Wu XW, 2016, AM J PHYSIOL-REG I, V310, pR323, DOI 10.1152/ajpregu.00401.2015; Yost Jonathan, 2015, Am J Disaster Med, V10, P217, DOI 10.5055/ajdm.2015.0204; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; 2011, BMJ-BRIT MED J, V343, DOI DOI 10.1136/BMJ.D3795	75	0	0	1	2	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	APR	2021	25	26					1	+		10.3310/hta25260			78	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	RW3CP	WOS:000646404300001	33928903	Green Published, Green Accepted, gold			2022-02-07	
J	Russell-Schulz, B; Vavasour, IM; Zhang, J; MacKay, AL; Purcell, V; Muller, AM; Brucar, LR; Torres, IJ; Panenka, WJ; Virji-Babul, N				Russell-Schulz, Bretta; Vavasour, Irene M.; Zhang, Jing; MacKay, Alex L.; Purcell, Victoria; Muller, Angela M.; Brucar, Leyla R.; Torres, Ivan J.; Panenka, William J.; Virji-Babul, Naznin			Myelin water fraction decrease in individuals with chronic mild traumatic brain injury and persistent symptoms	HELIYON			English	Article						Magnetic resonance imaging; Mild traumatic brain injury; Cognition; Myelin water fraction; Chronic injury	WHITE-MATTER; IN-VIVO; MULTIPLE-SCLEROSIS; T-2; MRI; DEMYELINATION; PATHOLOGY; PATHOPHYSIOLOGY; DISTRIBUTIONS; DAMAGE	The diffuse and continually evolving secondary changes after mild traumatic brain injury (mTBI) make it challenging to assess alterations in brain-behaviour relationships. In this study we used myelin water imaging to evaluate changes in myelin water fraction (MWF) in individuals with chronic mTBI and persistent symptoms and measured their cognitive status using the NIH Toolbox Cognitive Battery. Fifteen adults with mTBI with persistent symptoms and twelve age, gender and education matched healthy controls took part in this study. We found a significant decrease in global white matter MWF in patients compared to the healthy controls. Significantly lower MWF was evident in most white matter region of interest (ROIs) examined including the corpus callosum (separated into genu, body and splenium), minor forceps, right anterior thalamic radiation, left inferior longitudinal fasciculus; and right and left superior longitudinal fasciculus and corticospinal tract. Although patients showed lower cognitive functioning, no significant correlations were found between MWF and cognitive measures. These results suggest that individuals with chronic mTBI who have persistent symptoms have reduced MWF.	[Russell-Schulz, Bretta; Vavasour, Irene M.; MacKay, Alex L.] Univ British Columbia, UBC MRI Res Ctr, Dept Radiol, Vancouver, BC, Canada; [Zhang, Jing; Panenka, William J.] BC Childrens Hosp, Res Inst, Vancouver, BC, Canada; [MacKay, Alex L.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada; [Purcell, Victoria; Torres, Ivan J.; Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Muller, Angela M.; Brucar, Leyla R.; Virji-Babul, Naznin] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Torres, Ivan J.] BC Mental Hlth & Subst Use Serv, Vancouver, BC, Canada; [Virji-Babul, Naznin] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada		Virji-Babul, N (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.; Virji-Babul, N (corresponding author), Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada.	nvb31@mail.ubc.ca		Brucar, Leyla/0000-0002-5852-3088; Virji-Babul, Naznin/0000-0002-8984-5848	MITACS [F15-04819]	This work was supported by MITACS in partnership with the EatonArrowsmith group (Grant Reference Number: F15-04819).	Abel S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14220; Abel S, 2020, J NEUROIMAGING, V30, P205, DOI 10.1111/jon.12679; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alonso-Ortiz E., 2015, TECH REV, V81, P70; Arshad M, 2016, NEUROIMAGE, V143, P26, DOI 10.1016/j.neuroimage.2016.08.047; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J.D., 2014, SYSTEMATIC REV SELF, P95; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Choi J.Y., 2017, ISMRM 25 ANN M EXH 2; Choi JY, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101785; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Diaz-Arrastia R., 2014, REPORT DEP DEFENSE, V31, P135; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faizy T.D., 2016, HETEROGENEITY MULTIP, P1; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flynn SW, 2003, MOL PSYCHIATR, V8, P811, DOI 10.1038/sj.mp.4001337; Gareau PJ, 1999, MAGN RESON IMAGING, V17, P1319, DOI 10.1016/S0730-725X(99)00064-8; Giza CC, 2001, J ATHL TRAINING, V36, P228; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Grin N.M., 2013, REVERSIBLE BEHAV DEF, V8; Heaton R.K., 2015, TOOLBOX COGNITION BA, V20, P588; Hennig J., 1991, CONCEPT MAGNETIC RES, V3, P179, DOI [10.1002/cmr.1820030402, DOI 10.1002/CMR.1820030402]; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Koerte IK, 2016, TRANSLATIONAL RES TR; Kozlowski P, 2008, MAGN RESON MED, V59, P796, DOI 10.1002/mrm.21527; Kozlowski P, 2014, MAGN RESON IMAGING, V32, P250, DOI 10.1016/j.mri.2013.12.006; Lang DJM, 2014, NEUROIMAGE-CLIN, V6, P408, DOI 10.1016/j.nicl.2014.10.006; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Laule C., 2006, MYELIN WATER IMAGING; Laule C, 2008, NEUROIMAGE, V40, P1575, DOI 10.1016/j.neuroimage.2007.12.008; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Laule C, 2016, MULT SCLER J, V22, P1485, DOI 10.1177/1352458515624559; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lee Bruce, 2005, NeuroRx, V2, P372; Levesque IR, 2010, MAGN RESON MED, V63, P633, DOI 10.1002/mrm.22244; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; MacKay Alex L, 2016, Brain Plast, V2, P71, DOI 10.3233/BPL-160033; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCreary CR, 2009, NEUROIMAGE, V45, P1173, DOI 10.1016/j.neuroimage.2008.12.071; MENON RS, 1991, MAGNET RESON MED, V20, P214, DOI 10.1002/mrm.1910200205; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Moore GRW, 2000, NEUROLOGY, V55, P1506, DOI 10.1212/WNL.55.10.1506; Mori S, 2005, MRI ATLAS HUMAN WHIT, P276; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Odrobina EE, 2005, NMR BIOMED, V18, P277, DOI 10.1002/nbm.951; Oh J, 2007, J NEUROIMAGING, V17, P156, DOI 10.1111/j.1552-6569.2007.00098.x; Porter S, 2017, Heliyon, V3, pe00373, DOI 10.1016/j.heliyon.2017.e00373; Prasloski T, 2012, NEUROIMAGE, V63, P533, DOI 10.1016/j.neuroimage.2012.06.064; Prasloski T, 2012, MAGN RESON MED, V67, P1803, DOI 10.1002/mrm.23157; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Pun TWC, 2005, J PERIPHER NERV SYST, V10, P38, DOI 10.1111/j.1085-9489.2005.10107.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stanisz GJ, 2004, MAGNET RESON MED, V51, P473, DOI 10.1002/mrm.20008; SWIFT TJ, 1969, BIOPHYS J, V9, P54, DOI 10.1016/S0006-3495(69)86368-X; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; Valentine HL, 2007, NEUROTOXICOLOGY, V28, P645, DOI 10.1016/j.neuro.2007.01.009; VASILESCU V, 1978, EXPERIENTIA, V34, P1443, DOI 10.1007/BF01932339; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Webb S, 2003, MAGNET RESON MED, V49, P638, DOI 10.1002/mrm.10411; Weber AM, 2018, NEUROIMAG CLIN N AM, V28, P83, DOI 10.1016/j.nic.2017.09.005; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wintermark M., 2015, IMAGING EVIDENCE REC, P1; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624; Zhang J., ISMRM 23 ANN M EXH 3	80	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	APR	2021	7	4							e06709	10.1016/j.heliyon.2021.e06709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RX9TI	WOS:000647558500032	33898831	gold, Green Published			2022-02-07	
J	Saadi, A; Anand, P; Kimball, SL				Saadi, Altaf; Anand, Pria; Kimball, Sarah L.			Traumatic brain injury and forensic evaluations: Three case studies of US asylum-seekers	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Traumatic brain injury; Head trauma; Forensic evaluations; Torture; Human rights; Asylum medicine	INTIMATE PARTNER VIOLENCE; COGNITIVE SEQUELAE; CONCUSSION; PREVALENCE; DISORDERS; OUTCOMES; PTSD	Traumatic brain injuries are common among refugees and asylum-seekers and can result from a range of etiologies, including intimate partner violence, gang violence, war-related trauma, and torture. Regardless of the cause, these injuries often result in a host of neuropsychiatric and other symptoms that may complicate individuals' subsequent health outcomes. For asylum-seekers, documenting prior head trauma is essential to the legal process, since traumatic brain injuries and their subsequent effects on memory and cognition may affect the ability to provide thorough testimony. Using three case vignettes, we explore how to approach the forensic evaluation of asylum-seekers with a history of traumatic brain injury, illustrating the range of etiologies and sequelae of traumatic brain injury in this complex population.	[Saadi, Altaf] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 100 Cambridge St,Suite 2000, Boston, MA 02114 USA; [Anand, Pria] Boston Med Ctr, Dept Neurol, 72 E Concord St, Boston, MA 02118 USA; [Kimball, Sarah L.] Boston Univ, Dept Med, Immigrant & Refugee Hlth Ctr, Boston Med Ctr,Sch Med, 725 Albany St,Suite 5b, Boston, MA 02118 USA		Saadi, A (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 100 Cambridge St,Suite 2000, Boston, MA 02114 USA.	asaadi@mgh.harvard.edu		Saadi, Altaf/0000-0001-7522-6942; Anand, Pria/0000-0002-7421-7750			Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Brinckmann MP, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01088; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Doherty SM, 2016, GLOB MENT HEALTH, V3, DOI 10.1017/gmh.2016.23; Duzkoylu Y, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/8626275; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Ferdowsian H., 2019, ASYLUM MED STANDARD; Grassi S, 2018, INT J LEGAL MED, V132, P1225, DOI 10.1007/s00414-017-1704-5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harden C, 2017, NEUROLOGY, V88, P1674, DOI 10.1212/WNL.0000000000003685; Herlihy J, 2002, BMJ-BRIT MED J, V324, P324, DOI 10.1136/bmj.324.7333.324; Herlihy Jane, 2006, Torture, V16, P81; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kane JC, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0228-9; Kanemoto Kousuke, 2017, Epilepsia Open, V2, P307, DOI 10.1002/epi4.12060; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Keatley E, 2013, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0b013-3182776a70, DOI 10.1097/HTR.0B013-3182776A70]; Keatley E, 2015, J HEAD TRAUMA REHAB; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kimerling R, 2006, J GEN INTERN MED, V21, P65, DOI 10.1111/j.1525-1497.2005.00292.x; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Li SSY, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0723-0; Mateen FJ, 2012, J NEUROL, V259, P694, DOI 10.1007/s00415-011-6248-x; Mateen FJ, 2012, NEUROLOGY, DOI [10.1212/WNL.0b013-318266fcf1, DOI 10.1212/WNL.0B013-318266FCF1]; McMillan TM., 2014, J NEUROL NEUROSURG P, DOI [10.1136/jnnp-2013, DOI 10.1136/JNNP-2013]; McPherson JI, 2019, DISABIL REHABIL, V41, P1238, DOI 10.1080/09638288.2017.1422038; Mollica R, 1992, APA PsycTests; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Motzkin Julian C, 2015, Handb Clin Neurol, V128, P633, DOI 10.1016/B978-0-444-63521-1.00039-X; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ostergaard LS, 2020, EUR J PUBLIC HEALTH, V30, P1163, DOI 10.1093/eurpub/ckaa138; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pettorruso M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10080519; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Pricard M, HELPS BRAIN INJURY S; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; Raymont V, 2010, NEUROLOGY, DOI [10.1212/WNL.0b013-3181e8e6d0, DOI 10.1212/WNL.0B013-3181E8E6D0]; Saadi A, 2020, HLTH HUMAN RIGHTS J; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schneider ALC, 2018, NEW ENGL J MED, V379, P1176, DOI 10.1056/NEJMc1808550; Shannon Patricia, 2012, Ment Health Fam Med, V9, P47; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797	57	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	APR	2021	79								102139	10.1016/j.jflm.2021.102139			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	SU7TH	WOS:000663334400009	33740607				2022-02-07	
J	Scher, AI; McGinley, JS; Wirth, RJ; Lipton, RB; Terrio, H; Brenner, LA; Cole, WR; Schwab, K				Scher, Ann, I; McGinley, James S.; Wirth, R. J.; Lipton, Richard B.; Terrio, Heidi; Brenner, Lisa A.; Cole, Wesley R.; Schwab, Karen			Headache complexity (number of symptom features) differentiates post-traumatic from non-traumatic headaches	CEPHALALGIA			English	Article						Concussion; traumatic brain injury; post-traumatic headache; cohort study; epidemiology	TRAUMATIC BRAIN-INJURY; MILITARY PERSONNEL; NATURAL-HISTORY; MIGRAINE; CONCUSSION; EPIDEMIOLOGY; PREVALENCE; DIAGNOSIS; CRITERIA; SOLDIERS	Background Post-traumatic headaches are a common sequela of mild traumatic brain injury (concussion). It is unclear whether or how these headaches differ phenotypically from primary headaches. Objective Determine whether there is an overarching unobserved latent trait that drives the expression of observed features of post-traumatic headache and other headaches. Methods Data from this post-hoc analysis come from the Warrior Strong Cohort Study conducted from 2010 through 2015. Approximately 25,000 soldiers were screened for concussion history at routine post-deployment health assessments. A random sample was invited to participate, enrolling 1567. Twelve observed headache phenotypic features were used to measure "headache complexity", the latent trait of clinical interest, using single factor confirmatory factor analysis. We compared headache complexity between groups and determined whether headache complexity predicted accessing medical care for headache. Results Of 1094 soldiers with headaches, 198 were classified as having post-traumatic headache. These headaches were compared to those in the other soldiers (647 without concussion history and 249 with concussion history). Soldiers with post-traumatic headache had greater endorsement of all 12 headache features compared to the soldiers with non-concussive headaches. The confirmatory factor analysis showed good model fit (chi(2) (51) = 95.59, p = 0.0002, RMSEA = 0.03, comparative fit index = 0.99, and Tucker-Lewis index = 0.99), providing empirical support for the headache complexity construct. Soldier groups differed in their mean headache complexity level (p < 0.001) such that post-traumatic headache soldiers had greater headache complexity compared to non-concussed soldiers (standardized mean difference = 0.91, 95% confidence interval: 0.72-1.09, p < 0.001 and to concussed soldiers with coincidental headaches standardized mean difference = 0.75, 95% confidence interval: 0.53-0.96, p < 0.001). Increasing headache complexity predicted medical encounters for headache (odds ratio = 1.87, 95% confidence interval: 1.49-2.35, p < 0.001) and migraine (odds ratio = 3.74, 95% confidence interval: 2.33-5.98, p < 0.001) during the year following deployment. Conclusions and relevance: The current study provided support for a single latent trait, characterized by observed headache symptoms, that differentiates between concussive and non-concussive headaches and predicts use of medical care for headache. The single trait confirmatory factor analysis suggests that post-traumatic headaches differ from non-concussive headaches by severity more than kind, based on the symptoms assessed. ClinicalTrials.gov identifier NCT01847040	[Scher, Ann, I; Schwab, Karen] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [McGinley, James S.; Wirth, R. J.] Vector Psychometr Grp LLC, Chapel Hill, NC USA; [Lipton, Richard B.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Terrio, Heidi] Evans Army Community Hosp, Colorado Springs, CO USA; [Terrio, Heidi] VA Vet Affairs Puget Sound Hlth Syst, Seattle, WA USA; [Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] VA Vet Affairs Rocky Mt Mental Illness Res Educ &, Aurora, CO USA; [Cole, Wesley R.] Womack Army Med Ctr, Intrepid Spirit Ctr, Ft Bragg, NC USA		Scher, AI (corresponding author), Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	ann.scher@usuhs.edu	Lipton, Richard Bruce/AAY-2818-2021	Scher, Ann/0000-0003-4599-9834			Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Asparouhov T., 2010, MPLUS TECHNICAL APPE; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Bruehl S, 1999, HEADACHE, V39, P181, DOI 10.1046/j.1526-4610.1999.3903181.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; DRUMMOND PD, 1984, J NEUROL NEUROSUR PS, V47, P128, DOI 10.1136/jnnp.47.2.128; Ferdosi H, 2019, AM J EPIDEMIOL, V188, P77, DOI 10.1093/aje/kwy199; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kamins J, 2018, HEADACHE, V58, P811, DOI 10.1111/head.13312; Labastida-Ramirez A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01122-5; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Metti A, 2020, NEUROLOGY, V94, pE1137, DOI 10.1212/WNL.0000000000008935; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; Scher AI, 2019, CEPHALALGIA, V39, P296, DOI 10.1177/0333102418786266; Schurks M, 2011, CEPHALALGIA, V31, P861, DOI 10.1177/0333102411401635; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Seifert T, 2018, HAND CLINIC, V158, P119, DOI 10.1016/B978-0-444-63954-7.00012-4; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Steiger JH, 2016, STRUCT EQU MODELING, V23, P777, DOI 10.1080/10705511.2016.1217487; Stewart WF, 1996, NEUROLOGY, V47, P52, DOI 10.1212/WNL.47.1.52; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wang JW, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0973-4; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	40	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	APR	2021	41	5					582	592		10.1177/0333102420974352			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RN3JG	WOS:000640247200007	33242991				2022-02-07	
J	Soberg, HL; Andelic, N; Langhammer, B; Tamber, AU; Bruusgaard, KA; Kleffelgaard, I				Soberg, Helene L.; Andelic, Nada; Langhammer, Birgitta; Tamber, Anne-Use; Bruusgaard, Kari A.; Kleffelgaard, Ingerid			EFFECT OF VESTIBULAR REHABILITATION ON CHANGE IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH DIZZINESS AND BALANCE PROBLEMS AFTER TRAUMATIC BRAIN INJURY: A RANDOMIZED CONTROLLED TRIAL	JOURNAL OF REHABILITATION MEDICINE			English	Article						quality of life; traumatic brain injury; dizziness; randomized controlled trial; psychological distress; patient-reported outcome measure	POST-CONCUSSION SYMPTOMS; HOSPITAL ANXIETY; HEAD-INJURY; HANDICAP; SCALE; QOLIBRI	Objective: Secondary analysis, testing the effect on change in health-related quality of life of group based vestibular rehabilitation in patients with mild-moderate traumatic brain injury, dizziness and balance problems. Design: A single-blind randomized controlled trial. Subjects: A total of 65 patients aged 16-60 years with a Rivermead Post-concussion Symptoms Questionnaire dizziness score >= 2, and Dizziness Handicap Inventory score >15 points. Data collection was performed at baseline 3.5 (standard deviation (SD) 2.1) months post-injury, end of intervention, and 4.4 (SD 1.0) months after baseline. Methods: Quality of Life after Brain Injury was the main outcome. Independent variables were demographic and injury variables, Hospital Anxiety and Depression Scale, changes on the Rivermead Post concussion Symptoms Questionnaire (RPQ3 physical and RPQ13 psychological/cognitive), and Vertigo Symptom Scale-Short Form. Results: Mean age of participants was 39.4 years (SD 13.0); 70.3% women. Predictors of change in the Quality of Life after Brain Injury were receiving the vestibular rehabilitation (p = 0.049), baseline psychological distress (p = 0.020), and change in RPQ3 physical (p = 0.047) and RPQ13 psychological/cognitive (p = 0.047). Adjusted R2 was 0.399, F=6.13, p < 0.001. Conclusion: There was an effect in favour of the intervention group in improvement in health-related quality of life. Changes on the Rivermead Post -concussion Symptoms Questionnaire were also associated with change on the Quality of Life after Brain Injury.	[Soberg, Helene L.; Langhammer, Birgitta; Tamber, Anne-Use; Bruusgaard, Kari A.] OsloMet, Fac Hlth Sci, Oslo, Norway; [Soberg, Helene L.; Andelic, Nada; Kleffelgaard, Ingerid] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada; Kleffelgaard, Ingerid] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Langhammer, Birgitta] Sunnaas Rehabil Hosp, Nesodden, Norway		Soberg, HL (corresponding author), Oslo Metropolitan Univ, Fac Hlth Sci, OsloMet, POB 4 St Oiays Plass, N-0130 Oslo, Norway.	helus@oslomet.no					Arshad Q, 2017, CLIN NEUROL NEUROSUR, V155, P17, DOI 10.1016/j.clineuro.2017.01.021; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Howe EI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.561400; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Karr JE, 2020, J NEUROTRAUM, V37, P1183, DOI 10.1089/neu.2019.6834; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleffelgaard I, 2017, BRAIN INJURY, V31, P1436, DOI 10.1080/02699052.2017.1377348; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Lopez-Escamez JA, 2003, OTOL NEUROTOL, V24, P637, DOI 10.1097/00129492-200307000-00018; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mucha A, 2018, HAND CLINIC, V158, P135, DOI 10.1016/B978-0-444-63954-7.00014-8; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; O'Carroll GC, 2020, BRAIN INJURY, V34, P1701, DOI 10.1080/02699052.2020.1812117; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Soberg HL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0589-9; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; TEASDALE G, 1974, LANCET, V2, P81; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Weidt S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-317; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Wilhelmsen K, 2008, BMC EAR NOSE THROAT, V8, DOI 10.1186/1472-6815-8-2; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wu YJ, 2020, J CLIN MED, V9; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	0	0	2	2	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2021	53	4							jrm00181	10.2340/16501977-2823			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	RY1AB	WOS:000647648100005	33842981	gold			2022-02-07	
J	Taipale, J; Hautamaki, L				Taipale, Jaakko; Hautamaki, Lotta			Clinical practice guidelines in courts' representation of medical evidence and testimony	SOCIAL SCIENCE & MEDICINE			English	Article						Finland; Clinical practice guidelines; Expertise; Law and science; Traumatic brain injury	SCIENCE; EXPERIENCE; KNOWLEDGE; LAW	This article examines clinical practice guidelines (CPG) in the courtroom. The guidelines in question are Finnish national current care guidelines for brain injuries, and the case context is traffic insurance compensation cases contested in the Helsinki district court. We analyse 11 case verdicts qualitatively, drawing from earlier sociological and theoretical accounts of clinical practice guidelines and evidence-based medicine. What makes the case-type relevant for studying clinical practice guidelines is the fact that the cases, which feature a medical dispute concerning traumatic brain injury, involve highly specialized expertise and contradictory expert claims, but the cases are decided in a generalist court by non-expert judges. What we show in the article is how the guidelines structure, sequence and initiate temporal reworking in the judges? representation of medical evidence and testimony, and how the plaintiffs? delayed diagnoses complicate the application of the CPG in the evaluation. We further discuss the guidelines? epistemic authority in the verdicts and finish by comparing the 2008 and 2017 editions of Finnish CPGs for brain injuries, suggesting a multifaceted, courtroom-mediated feedback loop between the patient-plaintiffs and the clinical practice guidelines.	[Taipale, Jaakko] Univ Helsinki, Helsinki, Finland; [Hautamaki, Lotta] Tampere Univ, Tampere, Finland		Taipale, J (corresponding author), Univ Helsinki, Fac Law, POB 4,Yliopistonkatu 3, FI-00014 Helsinki, Finland.	Jaakko.taipale@helsinki.fi; lotta.hautamaki@tuni.fi		Taipale, Jaakko/0000-0003-1590-2499; Hautamaki, Lotta/0000-0002-8344-1439			[Anonymous], 2007, P BRIT ACAD, V151, P285, DOI DOI 10.5871/BACAD/9780197264249.003.0010; Armstrong D., 2007, BIOSOCIETIES, V2, P73, DOI DOI 10.1017/S1745855207005066; Aspers P, 2019, QUAL SOCIOL, V42, P139, DOI 10.1007/s11133-019-9413-7; Baran D, 2017, NAT MATER, V16, P363, DOI [10.1038/NMAT4797, 10.1038/nmat4797]; Becker H.S., 2017, EVIDENCE; Brain injuries: CPG, 2008, CURRENT CARE GUIDELI; Brain injuries: CPG, 2017, CURRENT CARE GUIDELI; Cambrosio A, 2006, SOC SCI MED, V63, P189, DOI 10.1016/j.socscimed.2005.12.007; Cartwright N, 2011, LANCET, V377, P1400, DOI 10.1016/S0140-6736(11)60563-1; Castel P, 2009, SOC STUD SCI, V39, P743, DOI 10.1177/0306312709104435; COLLINS HM, 1981, SOC STUD SCI, V11, P3, DOI 10.1177/030631278101100101; de Jong JD, 2010, SOC SCI MED, V70, P209, DOI 10.1016/j.socscimed.2009.10.016; Deaton A, 2018, SOC SCI MED, V210, P2, DOI 10.1016/j.socscimed.2017.12.005; Dumit J, 1999, SCI CONTEXT, V12, P173, DOI 10.1017/S0269889700003355; Duodecim, 2018, DUODECIM; Eddy DM, 2005, HEALTH AFFAIR, V24, P9, DOI 10.1377/hlthaff.24.1.9; Edmond G, 2000, SOC STUD SCI, V30, P265, DOI 10.1177/030631200030002003; Edmond G, 1997, PUBLIC UNDERST SCI, V6, P329, DOI 10.1088/0963-6625/6/4/003; Edmond G., 2000, MOD LAW REV, V63, P251, DOI DOI 10.1111/MLR.2000.63.ISSUE-2; Filippi C.G., 2014, AM J BIOETHICS AJOB, V5, P9; GARFIELD E, 1978, CURR CONTENTS, P5; HACKING Ian, 2002, HIST ONTOLOGY; Hautamaki L, 2018, HEALTH RISK SOC, V20, P43, DOI 10.1080/13698575.2018.1442918; Helen P., 2017, SUOM LAAKARILEHTI, V72, P1700; Helsingin Sanomat, 2018, VAARIN DIAGNOSOITU; Huttunen J, 2006, DUODECIM, V122, P393; Jasanoff S, 2005, AM J PUBLIC HEALTH, V95, pS49, DOI 10.2105/AJPH.2004.045732; Jasanoff S., 2004, STATES KNOWLEDGE COP, DOI DOI 10.4324/9780203413845; Jasanoff S, 2015, TEX LAW REV, V93, P1723; Katz DI, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P2; Kelly M, 2010, SOC SCI MED, V71, P1056, DOI 10.1016/j.socscimed.2010.06.032; Kirkland A, 2012, SOC STUD SCI, V42, P237, DOI 10.1177/0306312711435832; Knaapen L, 2014, SOCIOL COMPASS, V8, P823, DOI 10.1111/soc4.12184; Knaapen L, 2013, SOC STUD SCI, V43, P681, DOI 10.1177/0306312713483679; Knaapen L, 2010, SOC SCI MED, V71, P685, DOI 10.1016/j.socscimed.2010.05.019; Lambert H, 2006, SOC SCI MED, V62, P2633, DOI 10.1016/j.socscimed.2005.11.023; Louhiala Pekka, 2005, Duodecim, V121, P1317; Lynch M, 2007, SPONTANEOUS GENER, V1, P17; Mediuutiset, 2018, ALMA TALENT OY FEBRU; Mitrano M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.117801; Moreira T, 2005, SOC SCI MED, V60, P1975, DOI 10.1016/j.socscimed.2004.08.062; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; Samanta Ash, 2006, Med Law Rev, V14, P321, DOI 10.1093/medlaw/fwl010; Shank G, 2006, HOBBS WRIGHT SAGE HD, P22; Suomen Kuvalehti, 2016, SUOMEN KUVALEHTI; Taipale J, 2020, PUBLICATIONS FACULTY, V158; Taipale J, 2019, PUBLIC UNDERST SCI, V28, P883, DOI 10.1177/0963662519881338; Taipale J, 2019, SOC STUD SCI, V49, P310, DOI 10.1177/0306312719854538; Tenovuo O, 2006, DUODECIM, V122, P844; Timmermans S, 2005, PERSPECT BIOL MED, V48, P490, DOI 10.1353/pbm.2005.0096; Timmermans S, 2005, HEALTH AFFAIR, V24, P18, DOI 10.1377/hlthaff.24.1.18; Timmermans S, 2003, GOLD STANDARD CHALLE; Timmermans S, 2010, ANNU REV SOCIOL, V36, P69, DOI 10.1146/annurev.soc.012809.102629; Tonelli MR, 1998, ACAD MED, V73, P1234, DOI 10.1097/00001888-199812000-00011; Turun Sanomat, 2018, TURUN SANOMAT; Valanne Leena, 2013, Duodecim, V129, P1449; van Loon E., 2014, VAL STUD, V2, P43; Ware JB, 2015, ACAD RADIOL, V22, P1038, DOI 10.1016/j.acra.2015.05.004; Weisz G, 2007, MILBANK Q, V85, P691, DOI 10.1111/j.1468-0009.2007.00505.x; YLE, 2017, INSURANCE CO DENIGRA; Ylinen A., 2016, SUOMEN LAAK RILEHTI, V71, P1951	61	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536	1873-5347		SOC SCI MED	Soc. Sci. Med.	APR	2021	275								113805	10.1016/j.socscimed.2021.113805			9	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	RF9MW	WOS:000635163000017	33721744	hybrid, Green Published			2022-02-07	
J	Tsai, YC; Liu, CJ; Huang, HC; Lin, JH; Chen, PY; Su, YK; Chen, CT; Chiu, HY				Tsai, Ying-Chieh; Liu, Chin-Jung; Huang, Hui-Chuan; Lin, Jiann-Her; Chen, Pin-Yuan; Su, Yu-Kai; Chen, Chun-Ting; Chiu, Hsiao-Yean			A Meta-analysis of Dynamic Prevalence of Cognitive Deficits in the Acute, Subacute, and Chronic Phases After Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						adults; cognitive deficits; prevalence; traumatic brain injury	POST-CONCUSSION SYMPTOMS; FOLLOW-UP; QUESTIONNAIRE; PARTICIPATION; POPULATION; MODERATE; CARE	BACKGROUND: Reports regarding prevalence of post-traumatic brain injury (TBI) cognitive deficits were inconsistent. We aimed to synthesize the prevalence of cognitive deficits after TBI in the acute, subacute, and chronic phases. METHODS: PubMed, EMBASE, and ProQuest Dissertations and Theses A&I databases were searched from the inception to April 27, 2020. Studies with prospective, retrospective, and cross-sectional designs reporting the prevalence of cognitive deficits after TBI in adults were included. RESULTS: A total of 15 articles were included for prevalence estimation. The pooled prevalence of memory and attention deficits after mild TBI was 31% and 20% in the acute phase and 26% and 18% in the subacute phase, respectively, and 49% and 54% in the subacute phase and 21% and 50% in the chronic phase after moderate-to-severe TBI. The overall prevalence of information processing speed deficits after mild TBI in the acute and subacute phases was 21% and 17%, respectively, and 57% in the chronic phase after moderate-to-severe TBI. The overall prevalence of executive dysfunction in the subacute and chronic phases was 48% and 38%, respectively, after moderate-to-severe TBI. CONCLUSION: Cognitive deficits are prevalent in the acute to chronic phases after TBI. Healthcare providers should design effective intervention targeting cognitive impairment after TBI as early as possible.	[Tsai, Ying-Chieh; Liu, Chin-Jung; Huang, Hui-Chuan; Chiu, Hsiao-Yean] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Chiu, Hsiao-Yean] Taipei Med Univ, Res Ctr Sleep Med, Coll Med, Taipei, Taiwan; [Tsai, Ying-Chieh; Liu, Chin-Jung] Cathay Gen Hosp, Dept Nursing, Taipei, Taiwan; [Lin, Jiann-Her] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chen, Pin-Yuan] Chang Gung Mem Hosp, Dept Neurosurg, Keelung, Taiwan; [Su, Yu-Kai] Taipei Med Univ, Dept Neurosurg, Shuang Ho Hosp, New Taipei, Taiwan; [Chen, Chun-Ting] Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan		Chiu, HY (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.; Chiu, HY (corresponding author), Taipei Med Univ, Res Ctr Sleep Med, Coll Med, Taipei, Taiwan.	tsai1229@cgh.org.tw; happyone680315@hotmail.com; huichuan@tmu.edu.tw; jiannher@me.com; pinyuanc@gmail.com; 10463@s.tmu.edu.tw; b9002055@cgmh.org.tw; hychiu0315@tmu.edu.tw			Cathay General Hospital [CGH-MR-B10810]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 106-2314-B-038-058-MY3]	This study was supported by a grant to Y.C.T. from Cathay General Hospital (CGH-MR-B10810) and to H.Y.C. from the Ministry of Science and Technology, Taiwan C MOST 106-2314-B-038-058-MY3).	Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Chakroun-Walha O, 2017, EUR J TRAUMA EMERG S, V43, P747, DOI 10.1007/s00068-016-0656-7; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Hall EC, 2014, J TRAUMA ACUTE CARE, V76, P859, DOI 10.1097/TA.0000000000000148; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Marsh NV, 2018, NEUROREHABILITATION, V43, P377, DOI 10.3233/NRE-182457; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Olson DM, 2019, J NEUROSCI NURS, V51, P43, DOI 10.1097/JNN.0000000000000426; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Provencio JJ, 2020, NEUROCRIT CARE, V33, P1, DOI 10.1007/s12028-020-01028-9; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sinha S, 2013, NEUROL INDIA, V61, P501, DOI 10.4103/0028-3886.121920; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; The Joanna Briggs Institute Institute, 2016, JOANN BRIGGS I REV M; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009	31	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2021	53	2					63	68		10.1097/JNN.0000000000000570			6	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	SK9ED	WOS:000656520900004	33538456				2022-02-07	
J	Tunthanathip, T; Oearsakul, T; Tanvejsilp, P; Sae-heng, S; Kaewborisutsakul, A; Madteng, S; Inkate, S				Tunthanathip, Thara; Oearsakul, Thakul; Tanvejsilp, Pimwara; Sae-heng, Sakchai; Kaewborisutsakul, Anukoon; Madteng, Suphavadee; Inkate, Srirat			Predicting the Health-related Quality of Life in Patients Following Traumatic Brain Injury	SURGERY JOURNAL			English	Article						traumatic brain injury; heath-related quality of life; EQ-5D-5L	GLASGOW COMA SCALE; OUTCOMES; SCORE; POPULATION; PROGNOSIS; SYMPTOMS; MODERATE; TRIAL; EQ-5D	Background Traumatic brain injury (TBI) commonly causes death and disability that can result in productivity loss and economic burden. The health-related quality of life (HRQoL) has been measured in patients suffering from TBI, both in clinical and socioeconomic perspectives. The study aimed to assess the HRQoL in patients following TBI using the European quality of life measure-5 domain-5 level (EQ-5D-5L) questionnaire and develop models for predicting the EQ-5D-5L index score in patients with TBI. Method A cross-sectional study was performed with 193 TBI patients who had completed the EQ-5D-5L questionnaire. The clinical characteristics, Glasgow coma scale (GCS) score, treatment, and Glasgow outcome scale (GOS) were collected. The total data was divided into training data (80%) and testing data (20%); hence, the factors affecting the EQ-5D-5L index scores were used to develop the predictive model with linear and nonlinear regression. The performances of the predictive models were estimated with the adjusted coefficient of determination (R-2) and the root mean square error (RMSE). Results A good recovery was found at 96.4%, while 2.1% displayed an unfavorable outcome. Moreover, the mean EQ-5D-5L index scores were 0.91558 (standard deviation [SD] 1.09639). GCS score, pupillary light reflex, surgery, and GOS score significantly correlated with the HRQoL scores. The multiple linear regression model had a high adjusted R-2 of 0.6971 and a low RMSE of 0.06701, while the polynomial regression developed a nonlinear model that had the highest adjusted R-2 of 0.6843 and the lowest RMSE of 0.06748. Conclusions A strong positive correlation between the physician-based outcome as GOS and HRQoL was observed. Furthermore, both the linear and nonlinear regression models were acceptable approaches to predict the HRQoL of patients after TBI. There would be limitations for estimating the HRQoL in unconscious or intubated patients. The HRQoL obtained from the predictive models would be an alternative method to resolve this problem.	[Tunthanathip, Thara; Oearsakul, Thakul; Sae-heng, Sakchai; Kaewborisutsakul, Anukoon; Madteng, Suphavadee; Inkate, Srirat] Prince Songkla Univ, Fac Med, Dept Surg, Div Neurosurg, Hat Yai 90110, Songkhla, Thailand; [Tanvejsilp, Pimwara] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharm Adm, Hat Yai, Songkhla, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Fac Med, Dept Surg, Div Neurosurg, Hat Yai 90110, Songkhla, Thailand.	tsus4@hotmail.com					[Anonymous], 2018, LANCET, V391, P813, DOI 10.1016/S0140-6736(18)30547-6; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Born K, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0966-z; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, CDC NEWSROOM; Chaitanya K, 2018, CHILD NERV SYST, V34, P1119, DOI 10.1007/s00381-018-3784-z; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Edwards P, 2005, LANCET, V365, P1957; EuroQol Research Foundation, EQ 5D 5L; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Fuller GW, 2017, VALUE HEALTH, V20, P141, DOI 10.1016/j.jval.2016.09.2398; Golicki D, 2017, ARCH MED SCI, V13, P191, DOI 10.5114/aoms.2015.52126; Jakola AS, 2011, J NEUROSURG, V114, P1622, DOI 10.3171/2011.1.JNS101657; Jansson KA, 2009, J BONE JOINT SURG BR, V91B, P210, DOI 10.1302/0301-620X.91B2.21119; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johnson JA, 2005, MED CARE, V43, P221, DOI 10.1097/00005650-200503000-00004; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kavosi Z, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.22594; Kim JH, 2019, KOREAN J ANESTHESIOL, V72, P558, DOI 10.4097/kja.19087; Kodliwadmath HB., CORRELATION GLASGOW; Kosty J, 2012, J NEUROTRAUM, V29, P1322, DOI 10.1089/neu.2011.2222; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mayo clinic, POSTC SYNDR; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Owolabi MO, 2008, THESCIENTIFICWORLDJO, V8, P357, DOI 10.1100/tsw.2008.54; Parik Paresh C, 2019, Indian J Endocrinol Metab, V23, P407, DOI 10.4103/ijem.IJEM_29_19; Pattanaphesaj J., 2014, THESIS; Pattanaphesaj J, 2018, EXPERT REV PHARM OUT, V18, P551, DOI 10.1080/14737167.2018.1494574; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perry Edward C 3rd, 2014, Handb Clin Neurol, V121, P1751, DOI 10.1016/B978-0-7020-4088-7.00113-9; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Suskauer SJ, 2018, ARCH PHYS MED REHAB, V99, P2389, DOI 10.1016/j.apmr.2018.05.012; Tajima R, 2010, CLIN EXP NEPHROL, V14, P340, DOI 10.1007/s10157-010-0304-1; ThaiRoads Foundation and Thailand Accident Research Center (TARC) Asian Institute of Technology, KEY FACTS ROAD SAFET; Tsauo JY, 1999, ACCIDENT ANAL PREV, V31, P253, DOI 10.1016/S0001-4575(98)00078-5; Tunthanathip T, 2020, CLIN NEUROL NEUROSUR, V191, DOI 10.1016/j.clineuro.2020.105712; Tunthanathip T, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.5.FOCUS19241; Tunthanathip T, 2017, J NEUROSCI RURAL PRA, V8, P601, DOI 10.4103/jnrp.jnrp_381_17; Verdugo MA, 2019, INT J CLIN HLTH PSYC, V19, P189, DOI 10.1016/j.ijchp.2019.06.004; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Weber KT, 2016, ARQ NEURO-PSIQUIAT, V74, P409, DOI 10.1590/0004-282X20160053; World Health Organization, The World Health Organization Quality of Life (WHOQOL).; Yang ZH, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1036-2; Yoo Wonsuk, 2014, Int J Appl Sci Technol, V4, P9; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	49	0	0	5	5	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2378-5128	2378-5136		SURG J-NY	Surg. J.	APR	2021	07	02					E100	E110		10.1055/s-0041-1726426			11	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	ST7IT	WOS:000662614100001	34159258	gold, Green Published			2022-02-07	
J	van Erp, IA; Gaitanidis, A; El Moheb, M; Kaafarani, HMA; Saillant, N; Duhaime, AC; Mendoza, AE				van Erp, Inge A.; Gaitanidis, Apostolos; El Moheb, Mohamad; Kaafarani, Haytham M. A.; Saillant, Noelle; Duhaime, Ann-Christine; Mendoza, April E.			Low-molecular-weight heparin versus unfractionated heparin in pediatric traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						venous thromboembolism; VTE prophylaxis; pediatrics; traumatic brain injury; low-molecular-weight heparin; unfractionated heparin; trauma	VENOUS THROMBOEMBOLISM PROPHYLAXIS; ENOXAPARIN; CHILDREN; EDEMA; RISK; ANTICOAGULATION; PREVENTION; SAFETY	OBJECTIVE The incidence of venous thromboembolism (VTE) in patients with traumatic brain injury (TBI) has in-creased significantly. The Eastern Association for the Surgery of Trauma recommends using low-molecular-weight hepa- rin (LMWH) over unfractionated heparin (UH) in pediatric patients requiring VTE prophylaxis, although this strategy is unsupported by the literature. In this study, the authors compare the outcomes of pediatric TBI patients receiving LMWH versus UH. METHODS The authors performed a 4-year (2014-2017) analysis of the pediatric American College of Surgeons Trau-ma Quality Improvement Program. All trauma patients (age <= 18 years) with TBI requiring thromboprophylaxis with UH or LMWH were potentially eligible for inclusion. Patients who had been transferred, had died in the emergency department, or had penetrating trauma were excluded. Patients were stratified into either the LMWH or the UH group on the basis of the prophylaxis they had received. Patients were matched on the basis of demographics, injury characteristics, vital signs, and transfusion requirements using propensity score matching (PSM). The study endpoints were VTE, death, and craniotomy after initiation of prophylaxis. Univariate analysis was performed after PSM to compare outcomes. RESULTS A total of 2479 patients met the inclusion criteria (mean age 15.5 +/- 3.7 years and 32.0% female), of which 1570 (63.3%) had received LMWH and 909 (36.7%) had received UH. Before PSM, patients receiving UH were younger, had a lower Glasgow Coma Scale score, and had a higher Injury Severity Score. Patients treated in pediatric hospitals were more likely to receive UH (12.9% vs 9.0%, p < 0.001) than patients treated in adult hospitals. Matched patients re-ceiving UH had a higher incidence of VTE (5.1% vs 2.9%, p = 0.03). CONCLUSIONS LMWH prophylaxis in pediatric TBI appears to be more effective than UH in preventing VTE. Large, multicenter prospective studies are warranted to confirm the superiority of LMWH over UH in pediatric patients with TBI. Moreover, outcomes of VTE prophylaxis in the very young remain understudied; therefore, dedicated studies to evaluate this are needed.	[van Erp, Inge A.; Gaitanidis, Apostolos; El Moheb, Mohamad; Kaafarani, Haytham M. A.; Saillant, Noelle; Mendoza, April E.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [van Erp, Inge A.; Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Pediat Neurosurg, Boston, MA 02114 USA; [van Erp, Inge A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands		Mendoza, AE (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	aemendoza@mgh.harvard.edu	Moheb, Mohamad El/AAN-3487-2021				Benjamin E, 2017, ANN SURG, V266, P463, DOI 10.1097/SLA.0000000000002359; Bidlingmaier C, 2011, SEMIN THROMB HEMOST, V37, P814, DOI 10.1055/s-0031-1297173; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Carrillo LA, 2019, PEDIATR SURG INT, V35, P487, DOI 10.1007/s00383-018-4418-y; Connelly CR, 2016, JAMA SURG, V151, P50, DOI 10.1001/jamasurg.2015.2670; Cunningham AJ, 2020, PEDIATR SURG INT, V36, P373, DOI 10.1007/s00383-019-04613-y; Cyr C, 2006, ACTA HAEMATOL-BASEL, V115, P198, DOI 10.1159/000090935; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Faustino EVS, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00009; Hanson SJ, 2010, J TRAUMA, V68, P52, DOI 10.1097/TA.0b013e3181a74652; Ignjatovic V, 2010, BRIT J HAEMATOL, V149, P734, DOI 10.1111/j.1365-2141.2010.08163.x; Landisch RM, 2017, J TRAUMA ACUTE CARE, V82, P836, DOI 10.1097/TA.0000000000001404; Leeper CM, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26415; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahajerin A, 2017, J TRAUMA ACUTE CARE, V82, P627, DOI 10.1097/TA.0000000000001359; Margolick J, 2018, CAN J NEUROL SCI, V45, P432, DOI 10.1017/cjn.2017.275; Petty JK, 2017, SEMIN PEDIATR SURG, V26, P14, DOI 10.1053/j.sempedsurg.2017.01.001; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Stem J, 2013, J PEDIAT HEMATOL ONC, V35, pE287, DOI 10.1097/MPH.0b013e31829b7f92; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Thompson AJ, 2013, J PEDIATR SURG, V48, P1413, DOI 10.1016/j.jpedsurg.2013.02.059; Van Arendonk KJ, 2013, JAMA SURG, V148, P1123, DOI 10.1001/jamasurg.2013.3558; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055	25	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2021	27	4					469	474		10.3171/2020.9.PEDS20615			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RI2KM	WOS:000636738500003	33578391				2022-02-07	
J	Venkatesan, UM; Rabinowitz, AR; Riccitello, RM				Venkatesan, Umesh M.; Rabinowitz, Amanda R.; Riccitello, Rachael M.			Breaking the Percent Memory Retention Ceiling using Bayesian Statistics	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Episodic memory; Memory consolidation; Neuropsychological assessment; Psychometrics; Traumatic brain injury; Dementia		Objectives: Neuropsychological tests of episodic memory often include a measure of memory retention to facilitate the diagnosis of memory disorders. However, the traditional percent retention (PR) score has limited interpretability when smaller amounts of information are both initially learned and later recalled, creating a pseudo-ceiling effect. To improve psychometrics of PR, we investigated a scoring procedure that incorporates levels of certainty into estimates of memory retention based on learning level. Methods: Word-list recall data from adults with traumatic brain injury were modeled using a uniform prior in the Bayesian framework. From the resultant posterior probability distributions, we derived a measure referred to as retention probability (RPr), which distinguishes the retention of relatively good and poor learners. PR and RPr scores were compared on their distributional properties and associations with theoretically related memory measures. Results: Significant distributional differences between PR and RPr were observed. RPr removed the conspicuous ceiling of PR, resulting in stronger correlational and predictive relationships with other memory measures. Conclusion: A Bayesian procedure for quantifying memory retention has psychometric advantages and potentially widespread applicability for measuring the change in behavioral features over time. Future directions are briefly discussed. A sample RPr calculator is provided for interactive exploration of the method.	[Venkatesan, Umesh M.; Rabinowitz, Amanda R.; Riccitello, Rachael M.] Moss Rehabil Res Inst, 50 Township Line Rd,Suite 100, Elkins Pk, PA 19027 USA		Venkatesan, UM (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd,Suite 100, Elkins Pk, PA 19027 USA.	venkateu@einstein.edu		Venkatesan, Umesh/0000-0003-1869-8083	Pennsylvania Department of Health [4100077082]	This work was supported by the Pennsylvania Department of Health (A.R.R., grant number 4100077082). The authors thank Sean Falconer, Ph.D., and Frank Hillary, Ph.D., for methodological consultation and manuscript review.	Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Elliott G, 2014, CORTEX, V54, P16, DOI 10.1016/j.cortex.2014.02.001; Gelman A., 2003, BAYESIAN DATA ANAL, V2nd; Lee I. A., 2013, CALCULATION TEST DIF; LOFTUS GR, 1985, J EXP PSYCHOL LEARN, V11, P397, DOI 10.1037/0278-7393.11.2.397; Lynch SM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-71265-9; Myers L, 2006, DIFFER ENCY STAT SCI, DOI [10.1002/0471667196.ESS5050.PUB2, DOI 10.1002/0471667196.ESS5050.PUB2, 10.1002/0471667196.ess5050, DOI 10.1002/0471667196.ESS5050]; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Squire LR, 2006, LEARN MEMORY, V13, P522, DOI 10.1101/lm.310306; Squire LR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021766; The jamovi project, 2019, JAMOVI VERSION 09; Tuyl F, 2009, BAYESIAN ANAL, V4, P151, DOI 10.1214/09-BA405; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; Weissberger GH, 2017, NEUROPSYCHOL REV, V27, P354, DOI 10.1007/s11065-017-9360-6	15	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2021	27	4					396	400	PII S1355617720000892	10.1017/S1355617720000892			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	RI2QN	WOS:000636754200009	33012298				2022-02-07	
J	Wang, BB; Lin, WD; Zhu, HP				Wang, Bingbin; Lin, Wendong; Zhu, Haiping			Minocycline improves the recovery of nerve function and alleviates blood-brain barrier damage by inhibiting endoplasmic reticulum in traumatic brain injury mice model	EUROPEAN JOURNAL OF INFLAMMATION			English	Article						blood-brain barrier; inflammatory response; minocycline; traumatic brain injury		Traumatic brain injury (TBI) is a clinical emergency with a very high incidence, disability, and fatality rate. Minocycline, a widely used semisynthetic second-generation tetracycline antibiotic, has anti-inflammatory and bactericidal effects. However, minocycline has not been explored as a therapeutic drug in TBI and if effective, the related molecular mechanism is also unclear. In this study, we examined the neuroprotective effect and possible mechanism of minocycline, in mice TBI model by studying the trauma-related functional and morphological changes. Also, in vitro cell studies were carried out to verify the animal model data. We found that minocycline significantly improved the neurobehavioral score, inhibited apoptosis, repaired the blood-brain barrier, and reduced the levels of inflammatory factors Interleukin-6 and tumor necrosis factor-alpha in TBI mice. In vitro, upon oxygen and glucose deprivation, minocycline reduced the levels of cellular inflammatory factors and increased the levels of tight junction and adherens junction proteins, thereby significantly improving the cell viability. Moreover, Mino treatment prevented the loss of tight junction and adherens junction proteins which were markedly reversed by an ER stress activator (tunicamycin) both in vivo and in vitro. Our findings set an effective basis for the clinical use of Mino to treat Traumatic brain injury-induced neurological deficits.	[Wang, Bingbin; Lin, Wendong] Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zhu, Haiping] Wenzhou Med Univ, Dept Intens Care Unit, Affiliated Hosp 1, 2 Fuxue Lane, Wenzhou 325000, Peoples R China		Zhu, HP (corresponding author), Wenzhou Med Univ, Dept Intens Care Unit, Affiliated Hosp 1, 2 Fuxue Lane, Wenzhou 325000, Peoples R China.	misszhp@126.com			program of Wenzhou Municipal Science and Technology Bureau [2016Y0394]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding from the program of Wenzhou Municipal Science and Technology Bureau (No. 2016Y0394).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Arvanitis CD, 2020, NAT REV CANCER, V20, P26, DOI 10.1038/s41568-019-0205-x; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Cronin A, 2017, NEUROSCIENCE, V367, P34, DOI 10.1016/j.neuroscience.2017.10.018; Dai CS, 2017, J ANTIMICROB CHEMOTH, V72, P1635, DOI 10.1093/jac/dkx037; Dai SH, 2019, NEUROBIOL DIS, V126, P76, DOI 10.1016/j.nbd.2018.06.001; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Hahn JN, 2016, J IMMUNOL, V197, P3850, DOI 10.4049/jimmunol.1600436; Keep RF, 2018, J CEREBR BLOOD F MET, V38, P1255, DOI 10.1177/0271678X18774666; Kempuraj D, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00703; Killen MJ, 2019, EXPERT REV NEUROTHER, V19, P227, DOI 10.1080/14737175.2019.1582332; Langen UH, 2019, ANNU REV CELL DEV BI, V35, P591, DOI 10.1146/annurev-cellbio-100617-062608; Liebner S, 2018, ACTA NEUROPATHOL, V135, P311, DOI 10.1007/s00401-018-1815-1; Mehra A, 2020, J NEUROSCI, V40, P1778, DOI 10.1523/JNEUROSCI.0969-19.2019; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Neves KB, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131344; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Rana SVS, 2020, BIOL TRACE ELEM RES, V196, P10, DOI 10.1007/s12011-019-01903-3; Ruth MM, 2019, J ANTIMICROB CHEMOTH, V74, P1952, DOI 10.1093/jac/dkz143; Sen T, 2020, J NEUROSCI, V40, P424, DOI 10.1523/JNEUROSCI.0718-19.2019; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Szeto GL, 2011, J BIOL CHEM, V286, P11275, DOI 10.1074/jbc.M110.210518; Wan HD, 2020, AUTOPHAGY, V16, P531, DOI 10.1080/15548627.2019.1630224; Wang GQ, 2019, NEUROSCIENCE, V415, P135, DOI 10.1016/j.neuroscience.2019.06.038; Wang YW, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00222; Wegleiter K, 2014, EXP NEUROL, V261, P501, DOI 10.1016/j.expneurol.2014.07.022; Xu WQ, 2020, EXP EYE RES, V190, DOI 10.1016/j.exer.2019.107887; Yi NX, 2019, NEURAL REGEN RES, V14, P1919, DOI 10.4103/1673-5374.259619; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhang LJ, 2020, ARCH BIOCHEM BIOPHYS, V682, DOI 10.1016/j.abb.2020.108302; Zheng W, 2019, J PSYCHOPHARMACOL, V33, P1215, DOI 10.1177/0269881119858286; Zhou Y., PHARMACOL RES, V134, P305	36	0	0	2	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1721-727X	2058-7392		EUR J INFLAMM	Eur. J. Inflamm.	APR	2021	19								20587392211010898	10.1177/20587392211010898			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RP8JP	WOS:000641969700001		gold			2022-02-07	
J	Wong, AWK; Garcia, SF; Hahn, EA; Semik, P; Lai, JS; Magasi, S; Hammel, J; Nitsch, KP; Miskovic, A; Heinemann, AW				Wong, Alex W. K.; Garcia, Sofia F.; Hahn, Elizabeth A.; Semik, Patrick; Lai, Jin-Shei; Magasi, Susan; Hammel, Joy; Nitsch, Kristian P.; Miskovic, Ana; Heinemann, Allen W.			Rasch Analysis of Social Attitude Barriers and Facilitators to Participation for Individuals with Disabilities	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Attitude; Brain injuries; traumatic; Community participation; Environment; Patient reported outcome measures; Rehabilitation; Spinal cord injuries; Stroke		Objectives: To develop item banks of social attitude barriers and facilitators to participation and validate them with established instruments. Design: We used the Rasch model to identify misfitting items and rating scale problems, calibrate items, and develop KeyForms and short forms. Correlations between the Social Attitude Barriers and Facilitators item banks with the Patient-Reported Outcomes Measurement Information System (PROMIS) Social Health domain and National Institutes of Health Toolbox Emotional Battery Social Relationships domain were computed to evaluate convergent and divergent validity. Setting: Community-dwelling individuals traveled to 3 academic medical centers for testing. Participants: Participants (NZ558) who had a primary impairment of stroke, spinal cord injury, or traumatic brain injury (mean age, 47.0 +/- 16.0y) completed 31 social attitude facilitator and 51 barrier items using a 5-point rating scale. Interventions: Not applicable. Main Outcome Measures: Item banks to measure social attitude barriers and facilitators for individuals with disabilities. Results: After combining the "never" and "rarely" rating scale categories, 30 Facilitator items fit the Rasch model and demonstrated person reliability of 0.93. After collapsing the "never" and "rarely" rating scale categories, 45 Barrier items fit the Rasch model and demonstrated person reliability of 0.95. Ceiling and floor effects were negligible for both item banks. Facilitators and Barriers item banks were negatively correlated, and these banks were moderately correlated with PROMIS and Toolbox measures, providing evidence of convergent and divergent validity. Conclusions: Findings support the reliability and validity of the Social Attitude Facilitators and Barriers item banks. These item banks allow investigators and clinicians to measure perceptions of social attitudes, providing information that can guide individual interventions to reduce barriers and promote facilitators. Moderate correlations between the Social Attitude banks and PROMIS and Toolbox variables provide support for the measurement and theory of environmental influences on social health and participation. (C) 2020 by the American Congress of Rehabilitation Medicine	[Wong, Alex W. K.] Washington Univ, Sch Med, Program Occupat Therapy, 600 South Taylor Ave,MSC8505-94-01, St Louis, MO 63110 USA; [Wong, Alex W. K.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wong, Alex W. K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Wong, Alex W. K.; Semik, Patrick; Nitsch, Kristian P.; Miskovic, Ana; Heinemann, Allen W.] Shirley Ryan AbilityLab, Ctr Rehabil Outcomes Res, Chicago, IL USA; [Garcia, Sofia F.; Hahn, Elizabeth A.; Lai, Jin-Shei] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Magasi, Susan; Hammel, Joy] Univ Illinois, Dept Occupat Therapy, Chicago, IL USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Wong, AWK (corresponding author), Washington Univ, Sch Med, Program Occupat Therapy, 600 South Taylor Ave,MSC8505-94-01, St Louis, MO 63110 USA.	wongal@wustl.edu			National Institute on Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant [H133B090024]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01HD095388]; Craig H. Neilsen Foundation [542448]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant awarded to the Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago) (grant no. H133B090024). The National Institutes of Health (grant no. K01HD095388) and Craig H. Neilsen Foundation (grant no. 542448) supported a portion of Dr Wong's effort for developing this manuscript. The contents do not necessarily represent the policy of the funding agencies. We certify that all financial and material support for this research and work are clearly identified in the manuscript.	Babakhanyan I, 2018, PATIENT-RELAT OUTCOM, V9, P115, DOI 10.2147/PROM.S151658; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Boone W.J., 2013, RASCH ANAL HUMAN SCI; Castel LD, 2008, QUAL LIFE RES, V17, P737, DOI 10.1007/s11136-008-9352-3; Charles EP, 2005, PSYCHOL METHODS, V10, P206, DOI 10.1037/1082-989X.10.2.206; Daruwalla P, 2005, ANN TOURISM RES, V32, P549, DOI 10.1016/j.annals.2004.10.008; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Dunn DS, 2013, REHABIL PSYCHOL, V58, P148, DOI 10.1037/a0031691; Enderby P M, 1987, Int Rehabil Med, V8, P166; Field M.J., 2007, FUTURE DISABILITY AM; Fougeyrollas P., 1988, QUEBEC CLASSIFICATIO; Garcia SF, 2015, ARCH PHYS MED REHAB, V96, P596, DOI 10.1016/j.apmr.2014.06.019; Gill Carol J., 1997, J VOCATIONAL REHABIL, V9, P39, DOI DOI 10.1016/S1052-2263(97)00020-2; Haddock G, 2004, CONTEMPORARY PERSPECTIVES ON THE PSYCHOLOGY OF ATTITUDES, P1; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Keller C, 2010, J APPL SOC PSYCHOL, V40, P389, DOI 10.1111/j.1559-1816.2009.00579.x; Keller RM., 2010, MICROAGGRESSIVE EXPE; Kimberlin SE, 2009, J HUM BEHAV SOC ENVI, V19, P26, DOI 10.1080/10911350802619870; Linacre JM, 2013, RASCH MEAS T, V26, P1399; Linacre John M, 2002, J Appl Meas, V3, P85; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Office of Disease Prevention and Health Promotion, HLTH PEOPL 2020; Oliver M., 1990, POLITICS DISABLEMENT; Olkin R, 2003, AM PSYCHOL, V58, P296, DOI 10.1037/0003-066X.58.4.296; Schmidt FL, 1999, INTELLIGENCE, V27, P183, DOI 10.1016/S0160-2896(99)00024-0; Sue D.W., 2010, MICROAGGRESSIONS EVE; United Nations, CONVENTION RIGHTS PE; Velozo CA, 2011, J REHABIL RES DEV, V48, P1211, DOI 10.1682/JRRD.2010.10.0203; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; WHO, 2008, COMMISSION SOCIAL DE; Wilkinson GaryS, 2006, WRAT4 WIDE RANGE ACH; Wong AWK, 2017, QUAL LIFE RES, V26, P2633, DOI 10.1007/s11136-017-1586-5; WorldHealthOrganization, 2002, COMM LANG FUNCT DIS; Wright BD., 1998, RASCH MEASUREMENT T, V12, P641; YUKER HE, 1960, SCALE MEASURE ATTITU	40	0	0	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2021	102	4					675	686		10.1016/j.apmr.2020.09.390			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	RI8YM	WOS:000637192600014	33223007				2022-02-07	
J	Wooten, T; Sullivan, DR; Logue, MW; Fonda, JR; Fortier, CB; DeGutis, J; McGlinchey, R; Milberg, W; Esterman, M				Wooten, Thomas; Sullivan, Danielle R.; Logue, Mark W.; Fonda, Jennifer R.; Fortier, Catherine B.; DeGutis, Joseph; McGlinchey, Regina; Milberg, William; Esterman, Michael			Apolipoprotein E (APOE) epsilon 4 Status Moderates the Relationship Between Close-Range Blast Exposure and Cognitive Functioning	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						APOE; Blast; Memory; Concussive; Genetic; Veterans; Mild traumatic brain injury		Objectives: Recent studies suggest that close-range blast exposure (CBE), regardless of acute concussive symptoms, may have negative long-term effects on brain health and cognition; however, these effects are highly variable across individuals. One potential genetic risk factor that may impact recovery and explain the heterogeneity of blast injury's long-term cognitive outcomes is the inheritance of an apolipoprotein (APOE) epsilon 4 allele, a well-known genetic risk factor for Alzheimer's disease. We hypothesized that APOE epsilon 4 carrier status would moderate the impact of CBE on long-term cognitive outcomes. Methods: To test this hypothesis, we examined 488 post-9/11 veterans who completed assessments of neuropsychological functioning, psychiatric diagnoses, history of blast exposure, military and non-military mild traumatic brain injuries (mTBIs), and available APOE genotypes. We separately examined the effects of CBE on attention, memory, and executive functioning in individuals with and without the APOE epsilon 4 allele. Results: As predicted, we observed a differential impact of CBE status on cognition as a function of APOE epsilon 4 status, in which CBE epsilon 4 carriers displayed significantly worse neuropsychological performance, specifically in the domain of memory. These results persisted after adjusting for clinical, demographic, and genetic factors and were not observed when examining other neurotrauma variables (i.e., lifetime or military mTBI, distant blast exposure), though these variables displayed similar trends. Conclusions: These results suggest APOE epsilon 4 carriers are more vulnerable to the impact of CBE on cognition and highlight the importance of considering genetic risk when studying cognitive effects of neurotrauma.	[Wooten, Thomas] Tufts Univ, Boston, MA 02155 USA; [Wooten, Thomas; Fonda, Jennifer R.; Fortier, Catherine B.; DeGutis, Joseph; McGlinchey, Regina; Milberg, William; Esterman, Michael] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA 02130 USA; [Wooten, Thomas; Fonda, Jennifer R.; Fortier, Catherine B.; DeGutis, Joseph; McGlinchey, Regina; Milberg, William; Esterman, Michael] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA 02130 USA; [Wooten, Thomas; DeGutis, Joseph; Esterman, Michael] VA Boston Healthcare Syst, Boston Attent & Learning Lab, Boston, MA 02130 USA; [Sullivan, Danielle R.; Logue, Mark W.; Esterman, Michael] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Sullivan, Danielle R.; Logue, Mark W.; Fonda, Jennifer R.; Esterman, Michael] Boston Univ, Dept Psychiat, Sch Med, Boston, MA 02118 USA; [Logue, Mark W.] Boston Univ, Biomed Genet, Sch Med, Boston, MA 02118 USA; [Logue, Mark W.] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02118 USA; [Fonda, Jennifer R.; Fortier, Catherine B.; DeGutis, Joseph; McGlinchey, Regina; Milberg, William] Harvard Med Sch, Dept Psychiat, Boston, MA 02215 USA		Wooten, T (corresponding author), Tufts Univ, Dept Psychol, 490 Boston Ave, Medford, MA 02155 USA.	thomas.wooten@tufts.edu	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904; Sullivan, Danielle R./0000-0002-0141-5887; Wooten, Thomas/0000-0002-8968-3324	United States Department of Veterans Affairs Clinical Sciences Research and Development [I01CX001653]; United States Department of Veterans Affairs, Clinical Science Research and Development Service [1 IK2 CX001772-01]; Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Network Research Center [B9254-C]	This work was supported by Merit Review Award from the United States Department of Veterans Affairs Clinical Sciences Research and Development (I01CX001653) awarded to ME, a Career Development Award (grant number: 1 IK2 CX001772-01) from the United States Department of Veterans Affairs, Clinical Science Research and Development Service awarded to DRS and the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Network Research Center (B9254-C). This work was further supported with resources and the use of facilities at the National Center for PTSD, the Neuroimaging Research for Veterans Center, VA Boston Healthcare System, and the Pharmacogenomics Analysis Laboratory Research and Development Service, Central Arkansas VA Healthcare System, Little Rock, Arkansas. The authors thank the team of investigators at TRACTS for their assistance with data collection and management and the team at the Pharmacogenomics Analysis Laboratory Research and Development Service. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Borghesani PR, 2008, NEUROBIOL AGING, V29, P981, DOI 10.1016/j.neurobiolaging.2007.01.012; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chao LDL, 2017, MIL MED, V182, pE1625, DOI 10.7205/MILMED-D-16-00309; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; Clark AL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00873; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delis D., 2001, D KEFS EXAMINERS TEC; Delis D.C., 1999, CALIFORNIA VERBAL LE, VSecond; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Friedland D, 2016, J NEUROL NEUROSUR PS, V87, P1068, DOI 10.1136/jnnp-2015-312193; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graff-Radford NR, 2002, ARCH NEUROL-CHICAGO, V59, P594, DOI 10.1001/archneur.59.4.594; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Green P., 2004, MED SYMPTOM VALIDITY; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hayes, 2018, INTRO MEDIATION MODE; Hayes A.F., 2012, PROCESS VERSATILE CO; Henry GK, 2005, CLIN NEUROPSYCHOL, V19, P121, DOI 10.1080/13854040490516604; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kukolja J, 2010, NEUROSCIENCE, V168, P487, DOI 10.1016/j.neuroscience.2010.03.044; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Logue MW, 2013, MOL PSYCHIATR, V18, P937, DOI 10.1038/mp.2012.113; Logue MW, 2015, NEUROPSYCHOPHARMACOL, V40, P2287, DOI 10.1038/npp.2015.118; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P1050, DOI 10.1080/13803395.2018.1508555; Miller MW, 2015, PSYCHONEUROENDOCRINO, V62, P359, DOI 10.1016/j.psyneuen.2015.09.003; Miyashita A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058618; Nievergelt CM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12576-w; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Padgett CR, 2016, NEUROPSYCHOLOGY, V30, P775, DOI 10.1037/neu0000270; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Roberts NA, 2020, PSYCHOL SERV, V17, P33, DOI 10.1037/ser0000279; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Sullivan DR, 2019, J NEUROTRAUM, V36, P3264, DOI 10.1089/neu.2019.6489; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wechsler D., 2008, WECHSLER ADULT INTEL; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	82	0	0	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2021	27	4					315	328	PII S1355617720001034	10.1017/S1355617720001034			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	RI2QN	WOS:000636754200002	33138883				2022-02-07	
J	Yang, C; Zhang, JR; Zhu, G; Guo, H; Gao, F; Wang, B; Cui, WX; Shi, YW; Du, Y; Li, ZH; Wang, L; Ma, LT; Qu, Y; Ge, SN				Yang, Chen; Zhang, Jia-Rui; Zhu, Gang; Guo, Hao; Gao, Fei; Wang, Bao; Cui, Wen-Xing; Shi, Ying-Wu; Du, Yong; Li, Zhi-Hong; Wang, Liang; Ma, Lian-Ting; Qu, Yan; Ge, Shun-Nan			Effects of Primary Decompressive Craniectomy on the Outcomes of Serious Traumatic Brain Injury with Mass Lesions, and Independent Predictors of Operation Decision	WORLD NEUROSURGERY			English	Article						Basal cisterns; Craniotomy; Decompressive craniectomy; Pupillary light reflex; Traumatic brain injury		BACKGROUND: Although operative indications for traumatic brain injury (TBI) are known, neurosurgeons are unsure whether to remove the bone flap after mass lesion extraction, and an efficient scoring system for predicting which patients should undergo decompressive craniectomy (DC) does not exist. METHODS: Nine parameters were assessed. In total, 245 patients with severe TBI were retrospectively assessed from June 2015 to May 2019, who underwent DC or craniotomy to remove mass lesions. The 6-month mortality and Extended Glasgow Outcome Scale scores were compared between the DC and craniotomy groups. Using univariable and multivariable logistic regression equations, receiver operating characteristic curves were obtained for predicting the decision for DC. RESULTS: The overall 6-month mortality in the entire cohort was 11.43% (28/245). Patients undergoing DC had lower mean preoperative Glasgow Coma Scale scores (P= 0.01), and higher amounts of individuals with a Glasgow Coma Scale score of 6 (P = 0.007), unresponsive pupillary light reflex (P < 0.001), closed basal cisterns (P < 0.001), and diffuse injury (P = 0.025), compared with the craniotomy group. Because of high disease severity, individuals administered primary DC showed increased 6-month mortality compared with the craniotomy group. However, in surviving patients, favorable Extended Glasgow Outcome Scale rates were similar in both groups. Pupillary light reflex and basal cisterns were independent predictors of the DC decision. Based on receiver operating characteristic curves, the model had sensitivity and specificity of 81.6% and 84.9%, respectively, in predicting the probability of DC. CONCLUSIONS: These preliminary data showed that primary DC may benefit some patients with severe TBI with mass lesions. In addition, unresponsive preoperative pupil reaction and closed basal cistern could predict the DC decision.	[Yang, Chen; Zhu, Gang; Guo, Hao; Gao, Fei; Wang, Bao; Cui, Wen-Xing; Shi, Ying-Wu; Du, Yong; Li, Zhi-Hong; Wang, Liang; Qu, Yan; Ge, Shun-Nan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China; [Yang, Chen; Ma, Lian-Ting] Gen Hosp Cent Theater Command Chinese Peoples Lib, Postdoctoral Res Stn Neurosurg, Wuhan, Hubei, Peoples R China; [Zhang, Jia-Rui] Fourth Mil Med Univ, Tangdu Hosp, Dept Pathol, Helmholtz Sino German Lab Canc Res, Xian, Shaanxi, Peoples R China		Ge, SN (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China.				National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701304]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M623432]	This work was supported by the National Natural Science Foundation of China (grant number 81701304), the China Postdoctoral Science Foundation (grant number 2017M623432).	Bales JW, 2019, NEUROCRIT CARE, V31, P11, DOI 10.1007/s12028-019-00712-9; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Feng JF, 2020, J NEUROTRAUM, V37, P1806, DOI 10.1089/neu.2019.6900; Gao GY, 2020, LANCET NEUROL, V19, P670, DOI 10.1016/S1474-4422(20)30182-4; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2020, LANCET NEUROL, V19, P637, DOI 10.1016/S1474-4422(20)30208-8; Marion DW, 2006, NEUROSURGERY, V58, P655; Miller K, 2016, WORLD NEUROSURG, V95, P441, DOI 10.1016/j.wneu.2016.08.061; Sahuquillo J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub3; Singounas E G, 1992, J Neurosurg Sci, V36, P201; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Zhao HX, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0524-9; ZWEIG MH, 1993, CLIN CHEM, V39, P561	36	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2021	148						E396	E405		10.1016/j.wneu.2020.12.158			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA9IO	WOS:000631732900046	33422716				2022-02-07	
J	Yengo-Kahn, AM; Akinnusotu, O; Wiseman, AL; Ghani, MOA; Shannon, CN; Golinko, MS; Bonfield, CM				Yengo-Kahn, Aaron M.; Akinnusotu, Oluwatoyin; Wiseman, Alyssa L.; Ghani, Muhammad Owais Abdul; Shannon, Chevis N.; Golinko, Michael S.; Bonfield, Christopher M.			Sport participation and related head injuries following craniosynostosis correction: a survey study	NEUROSURGICAL FOCUS			English	Article						craniosynostosis; craniofacial reconstruction; sport participation; sport-related head injury	CHILDREN; DEFECTS; RECONSTRUCTION; MULTICENTER; OUTCOMES; REPAIR; AGE	OBJECTIVE Craniosynostosis (CS) affects about 1 in 2500 infants and is predominantly treated by surgical intervention in infancy. Later in childhood, many of these children wish to participate in sports. However, the safety of participation is largely anecdotal and based on surgeon experience. The objective of this survey study was to describe sport participation and sport-related head injury in CS patients. METHODS A 16-question survey related to child/parent demographics, CS surgery history, sport history, and sport induced head injury history was made available to patients/parents in the United States through a series of synostosis organization listservs, as well as synostosis-focused Facebook groups, between October 2019 and June 2020. Sports were categorized based on the American Academy of Pediatrics groupings. Pearson's chi-square test, Fisher's exact test, and the independent-samples t-test were used in the analysis. RESULTS Overall, 187 CS patients were described as 63% male, 89% White, and 88% non-Hispanic, and 89% underwent surgery at 1 year or younger. The majority (74%) had participated in sports starting at an average age of 5 years (SD 2.2). Of those participating in sports, contact/collision sport participation was most common (77%), and 71% participated in multiple sports. Those that played sports were less frequently Hispanic (2.2% vs 22.9%, p < 0.001) and more frequently had undergone a second surgery (44% vs 25%, p = 0.021). Only 9 of 139 (6.5%) sport-participating CS patients suffered head injuries; 6 (67%) were concussions and the remaining 3 were nondescript but did not mention any surgical needs. CONCLUSIONS In this nationwide survey of postsurgical CS patients and parents, sport participation was exceedingly common, with contact sports being the most common sport category. Few head injuries (mostly concussions) were reported as related to sport participation. Although this is a selective sample of CS patients, the initial data suggest that sport participation, even in contact sports, and typically beginning a few years after CS correction, is safe and commonplace.	[Yengo-Kahn, Aaron M.; Shannon, Chevis N.; Bonfield, Christopher M.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Ghani, Muhammad Owais Abdul; Golinko, Michael S.] Vanderbilt Univ, Med Ctr, Dept Plast Surg, Nashville, TN USA; [Yengo-Kahn, Aaron M.; Akinnusotu, Oluwatoyin; Wiseman, Alyssa L.; Ghani, Muhammad Owais Abdul; Shannon, Chevis N.; Bonfield, Christopher M.] Vanderbilt Univ, Surg Outcomes Ctr Kids, Monroe Caret Jr Childrens Hosp, 221 Kirkland Hall, Nashville, TN 37235 USA; [Akinnusotu, Oluwatoyin] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA		Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.	a.yengo@vumc.org			NCATS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]	This study utilized REDCap, which is funded through NCATS/NIH grant support (UL1 TR000445) , for survey and data management. There was no direct funding received or utilized for this study.	Anantheswar YN, 2009, J PEDIATR NEUROSCI, V4, P86, DOI 10.4103/1817-1745.57327; Boulet SL, 2008, AM J MED GENET A, V146A, P984, DOI 10.1002/ajmg.a.32208; Bruce WJ, 2018, CLEFT PALATE-CRAN J, V55, P649, DOI 10.1177/1055665617725215; Chieffo D, 2010, J NEUROS-PEDIATR, V5, P232, DOI 10.3171/2009.10.PEDS09231; FACES, NAT CRAN ASS; Gilardino MS, 2011, J CRANIOFAC SURG, V22, P1284, DOI 10.1097/SCS.0b013e31821c6b2d; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Logan K, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2019-0997; National Federation of State High School Associations, NAT FED STAT HIGH SC; Paige KT, 2006, PLAST RECONSTR SURG, V118, P977, DOI 10.1097/01.prs.0000232353.44086.af; POSNICK JC, 1993, NEUROSURGERY, V32, P785, DOI 10.1227/00006123-199305000-00011; Project Play, STAT PLAY 2019 TREND; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rotimi O, 2021, CHILD NERV SYST, V37, P287, DOI 10.1007/s00381-020-04723-2; Sacks GN, 2019, J CRANIOFAC SURG, V30, P2526, DOI 10.1097/SCS.0000000000006009; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Skolnick GB, 2019, ANN PLAS SURG, V82, P679, DOI 10.1097/SAP.0000000000001906; Stricker PA, 2017, ANESTHESIOLOGY, V126, P276, DOI 10.1097/ALN.0000000000001481; Thompson DR, 2018, ANESTH ANALG, V126, P968, DOI 10.1213/ANE.0000000000002454	20	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2021	50	4							E15	10.3171/2021.1.FOCUS20970			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RI2ED	WOS:000636721900002	33794495	gold			2022-02-07	
J	Yin, JW; Julius, AA; Wen, JT; Hanifin, JP; Warfield, B; Brainard, GC				Yin, Jiawei; Julius, A. Agung; Wen, John T.; Hanifin, John P.; Warfield, Benjamin; Brainard, George C.			Automatic sleeping time estimation and mild traumatic brain injury (mTBI) detection using actigraphy data	BIOMEDICAL SIGNAL PROCESSING AND CONTROL			English	Article						Actigraphy; Circadian rhythm; Sleep; Traumatic brain injury (TBI); Concussion detection		Sleep schedule and circadian phase irregularity are associated with some health problems and diseases, e.g., narcolepsy, circadian disorder, and concussion. Actigraphy has been widely used in the study of sleep and circadian rhythms. This paper presents a method for estimating the sleep/wake state based on the minute-byminute actigraphy data measured by wrist actigraphy and its associated scoring software. The circadian phase shift is estimated from actigraphy data using an adaptive notch filter algorithm. Compared with the scoring methods used in wrist actigraphy, the estimated wake-onset time from our method is more consistent with the sleep logs reported by the subjects. Concussion detection based on the sleep-related features calculated from actigraphy data is also presented, with detection accuracy up to about 90%. This result implies that the concussion is closely related to sleep and circadian disruption.	[Yin, Jiawei] Qilu Univ Technol, Shandong Acad Sci, Inst Oceanog Instrumentat, Qingdao, Peoples R China; [Yin, Jiawei] Shandong Prov Key Lab Ocean Environm Monitoring T, Qingdao, Peoples R China; [Yin, Jiawei] Natl Engn & Technol Res Ctr Marine Monitoring Equ, Qingdao, Peoples R China; [Julius, A. Agung; Wen, John T.] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Hanifin, John P.; Warfield, Benjamin; Brainard, George C.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA		Julius, AA (corresponding author), Rensselaer Polytech Inst, Troy, NY 12180 USA.	agung@eese.rpi.edu	Yin, Jiawei/AAT-8712-2021; Wen, John/B-4474-2008	Wen, John/0000-0002-5123-5411; Yin, Jiawei/0000-0003-4227-3448	National Science Foundation (NSF) through the Smart Lighting Engineering Research CenterNational Science Foundation (NSF) [EEC-0812056]; Army Research Office [W911NF-17-1-0562]; New York State under NYSTAR [C130145]; Thomas Jefferson University Dean's Transformatio-nal Science Award	This work was primarily supported by the National Science Foundation (NSF) through the Smart Lighting Engineering Research Center (EEC-0812056) and in part by the Army Research Office through Grant number W911NF-17-1-0562, New York State under NYSTAR contract C130145 and the Thomas Jefferson University Dean's Transformatio-nal Science Award. The authors would like to thank Dr. Wei Qiao for his contribution to the initial portion of this research as part of his postdoctoral research. We are grateful to Kimberly Atkinson, M.D., and the physicians at the Jefferson Comprehensive Concussion Center as well as the staff lead by Melanie McKendry for patient recruitment. In addition, we thank the research efforts of Samar Jasser, M.D., Sreeramya Kanumilli, M.D. and Leanna Panepinto, D.O. for entering patients in the protocol.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Burgess HJ, 2005, J SLEEP RES, V14, P229, DOI 10.1111/j.1365-2869.2005.00470.x; Chae KY, 2009, SLEEP MED, V10, P621, DOI 10.1016/j.sleep.2008.07.009; Crespo C, 2012, MED BIOL ENG COMPUT, V50, P329, DOI 10.1007/s11517-012-0875-y; Crivello A, 2019, IEEE ACCESS, V7, P167374, DOI 10.1109/ACCESS.2019.2953835; Gleason JD, 2019, BIOMED SIGNAL PROCES, V54, DOI 10.1016/j.bspc.2019.101610; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Ibanez V, 2018, PEERJ, V6, DOI 10.7717/peerj.4849; Jean-Louis G, 2001, PHYSIOL BEHAV, V72, P21, DOI 10.1016/S0031-9384(00)00355-3; JeanLouis G, 1996, SLEEP, V19, P739; Julius A, 2016, INT J ADAPT CONTROL, V30, P1375, DOI 10.1002/acs.2659; Kapella MC, 2017, SLEEP MED, V37, P124, DOI 10.1016/j.sleep.2017.06.012; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; LaRovere KL, 2019, SEMIN PEDIATR NEUROL, V30, P54, DOI 10.1016/j.spen.2019.03.009; McNamara P, 2010, INT REV NEUROBIOL, V92, P69, DOI 10.1016/S0074-7742(10)92004-7; Meltzer LJ, 2011, SLEEP MED, V12, P793, DOI 10.1016/j.sleep.2011.03.011; Mendonca F, 2019, IEEE ACCESS, V7, P24527, DOI 10.1109/ACCESS.2019.2900345; Mojiri M, 2004, IEEE T AUTOMAT CONTR, V49, P314, DOI 10.1109/TAC.2003.821414; Mojiri M, 2007, IEEE T SIGNAL PROCES, V55, P85, DOI 10.1109/TSP.2006.885686; Mosti C, 2016, NEUROL-CLIN PRACT, V6, P129, DOI 10.1212/CPJ.0000000000000225; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; RIEDLE BD, 1986, IEEE T AUTOMAT CONTR, V31, P316, DOI 10.1109/TAC.1986.1104263; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Shapley L.S., 1951, NOTES N PERSON GAME; Shrivastava D, 2014, J COMMUNITY HOSP INT, V4, DOI 10.3402/jchimp.v4.24983; Smith MT, 2018, J CLIN SLEEP MED, V14, P1209, DOI 10.5664/jcsm.7228; Zee Phyllis C, 2013, Continuum (Minneap Minn), V19, P132, DOI 10.1212/01.CON.0000427209.21177.aa; Zhang J., 2013, THESIS RENSSELAER PO; Zhang JX, 2012, IEEE SIG PROC MED; Zhang JX, 2013, P AMER CONTR CONF, P2295	33	0	0	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1746-8094	1746-8108		BIOMED SIGNAL PROCES	Biomed. Signal Process. Control	APR	2021	66								102430	10.1016/j.bspc.2021.102430			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	RH5DX	WOS:000636240200041					2022-02-07	
J	Zalesky, CC; Moran, TP; Koval, RR; Usher, J; Ratcliff, JJ; Wu, D; Wright, DW				Zalesky, C. Christopher; Moran, Tim P.; Koval, Rachel R.; Usher, Jasmine; Ratcliff, Jonathan J.; Wu, Daniel; Wright, David W.			A prospective cross-sectional study examining the documented evaluation of patients at high risk for mild traumatic brain injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article								Objectives: Annually, the CDC reports that 2.5 million Emergency Department (ED) visits occur due to Traumatic Brain Injuries (TBI) with nearly 75% classified as mild TBI (mTBI). Generally, these injuries are thought to be under recognized. This study was done to determine the proportion of patients, who were considered high risk for an mTBI, that had documentation of an mTBI evaluation. Methods: A prospective cross-section of patients was identified using a 3-question screen at the time of triage: did an injury occur; was the mechanism consistent with mTBI; and was there a period of altered mental status. Chart review was completed for these patients who were thought to meet a minimum threshold warranting an evaluation for mTBI. Results: 38,621 patients were screened over 16 weeks, of whom 441 (1.14%) were identified as being high risk for having an mTBI and met inclusion criteria. Recommended portions of an mTBI evaluation occurred in fewer than 50% of patients. In total, 98 subjects were diagnosed with an mIBI, and 49 received mTBI discharge instructions. The odds ratio for the subgroup of patients who had documented criteria sufficient for diagnosis revealed that an isolated head injury increased a patient's odds of a documented diagnosis by 2.1 times (95%, 13-3.4). Conclusions: Many patients with a possible mTBI did not have significant portions of an mTBI evaluation documented, and roughly half of the patients with a documented mTBI diagnosis did not receive discharge education. Changes in clinicians' approach to mTBI must occur to ensure patients receive appropriate evaluations, management, and education. (C) 2020 Elsevier Inc. All rights reserved.	[Zalesky, C. Christopher] Univ Cincinnati, Dept Emergency Med, Coll Med, Cincinnati, OH 45267 USA; [Moran, Tim P.; Koval, Rachel R.; Ratcliff, Jonathan J.; Wu, Daniel; Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Usher, Jasmine; Wu, Daniel] Grady Mem Hosp, Atlanta, GA USA		Zalesky, CC (corresponding author), Univ Cincinnati, Dept Emergency Med, Coll Med, Cincinnati, OH 45267 USA.	Zaleskcc@ucmail.uc.edu		Moore, Jasmine/0000-0002-5265-9574	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002378]	CZ was supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. Support also from UL1TR000424 for REDCap Support.	[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control, 2008, MTBI PATIENT INSTRUC; Centers for disease control, NATL HOSP DISCHARGE; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; for Disease Control C. Prevention, 2003, REPORT C MILD TRAUMA, P45; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Koval RR, 2019, ANN EMERG MED, DOI [10.1016/j.annemergmed, DOI 10.1016/J.ANNEMERGMED]; Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACTICE; Mann A, 2017, CAN FAM PHYSICIAN, V63, P460; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; MTBI Guidelines Development Team, 2018, GUIDELINE CONCUSSION; Patrick Sean P, 2017, AEM Educ Train, V1, P346, DOI 10.1002/aet2.10053; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rowe BH, 2018, AM J EMERG MED, V36, P2144, DOI 10.1016/j.ajem.2018.03.040; Shahaf DB, 2018, BRAIN INJURY, V32, P331, DOI 10.1080/02699052.2018.1425914; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Walls R.M., 2018, ROSENS EMERGENCY MED; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zinman R, 1996, PEDIATR EMERG CARE, V12, P78, DOI 10.1097/00006565-199604000-00002; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	35	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	APR	2021	42						150	160		10.1016/j.ajem.2020.02.016			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RC3LB	WOS:000632704200026	32165070				2022-02-07	
J	Zambetti, BR; Huang, DD; Lewis, RH; Fischer, PE; Croce, MA; Magnotti, LJ				Zambetti, Benjamin R.; Huang, Dih-Dih; Lewis, Richard H., Jr.; Fischer, Peter E.; Croce, Martin A.; Magnotti, Louis J.			Use of Thoracic Endovascular Aortic Repair in Patients with Concomitant Blunt Aortic and Traumatic Brain Injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article								BACKGROUND: Blunt aortic injury (BAI) and traumatic brain injury (TBI) represent the 2 leading causes of death after blunt trauma. The goal of this study was to examine the impact of TBI and use of thoracic endovascular aortic repair (TEVAR) on patients with BAI, using a large, national dataset. STUDY DESIGN: Patients with BAI were identified from the Trauma Quality Improvement Program (TQIP) database over 10 years, ending in 2016. Patients with BAI were stratified by the presence of concomitant TBI and compared. Multivariable logistic regression (MLR) analysis was performed to determine independent predictors of mortality in BAI patients with and without TBI. Youdens index was used to identify the optimal time to TEVAR in these patients. RESULTS: 17,040 patients with BAI were identified, with 4,748 (28%) having a TBI. Patients with BAI and TBI were predominantly male, with a higher injury burden and greater severity of shock at presentation, underwent fewer TEVAR procedures, and had increased mortality compared with BAI patients without TBI. The optimal time for TEVAR was 9 hours. Mortality was significantly increased in patients undergoing TEVAR before 9 hours (12.9% vs 6.5%, p = 0.003). For BAI patients with and without TBI, MLR identified use of TEVAR as the only modifiable risk factor significantly associated with reduced mortality (odds ratio [OR] 0.41; 95%CI 0.32-0.54, p < 0.0001). CONCLUSIONS: TBI significantly increases mortality in BAI patients. TEVAR and delayed repair both significantly reduced mortality. So, for patients with both BAI and TBI, an endovascular repair performed in a delayed fashion should be the preferred approach. (C) 2020 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.	[Zambetti, Benjamin R.; Huang, Dih-Dih; Lewis, Richard H., Jr.; Fischer, Peter E.; Croce, Martin A.; Magnotti, Louis J.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Div Trauma & Surg Crit Care, 910 Madison Ave,Second Floor, Memphis, TN 38163 USA		Magnotti, LJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Surg, Div Trauma & Surg Crit Care, 910 Madison Ave,Second Floor, Memphis, TN 38163 USA.	lmagnott@uthsc.edu					Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Alarhayem AQ, 2020, J VASC SURG; Demetriades D, 2008, J TRAUMA, V64, P561, DOI 10.1097/TA.0b013e3181641bb3; Fabian TC, 1998, ANN SURG, V227, P666, DOI 10.1097/00000658-199805000-00007; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Gianfrancesco M, 2021, ANN RHEUM DIS, V80, DOI [10.1136/annrheumdis-2020-218713, 10.1136/annrheumdis-2020-217871, 10.1136/annrheumdis-2020-218328]; Gombert A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171837; Jacob-Brassard J, 2019, J VASC SURG, V70, P1675, DOI 10.1016/j.jvs.2019.02.023; Kenel-Pierre S, 2019, J VASC SURG, V70, P1809, DOI 10.1016/j.jvs.2019.01.065; Khoynezhad A, 2013, J VASC SURG, V57, P899, DOI 10.1016/j.jvs.2012.10.099; Kitagawa RS, 2013, J NEUROSURG, V119, P324, DOI 10.3171/2013.5.JNS1397; Lee WA, 2011, J VASC SURG, V53, P187, DOI 10.1016/j.jvs.2010.08.027; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Marcaccio CL, 2018, J VASC SURG, V68, P64, DOI 10.1016/j.jvs.2017.10.084; Martinelli O, 2013, J VASC SURG, V58, P832, DOI 10.1016/j.jvs.2013.02.243; McCurdy CM, 2020, ANN THORAC SURG, V110, P524, DOI 10.1016/j.athoracsur.2019.11.046; Mohapatra A, 2020, J VASC SURG, V71, P768, DOI 10.1016/j.jvs.2019.07.059; Neschis DG, 2008, NEW ENGL J MED, V359, P1708, DOI 10.1056/NEJMra0706159; Rabin J, 2014, ANN THORAC SURG, V98, P46, DOI 10.1016/j.athoracsur.2014.04.025; Scalea TM, 2019, J AM COLL SURGEONS, V228, P605, DOI 10.1016/j.jamcollsurg.2018.12.022; Smeds MR, 2016, J TRAUMA ACUTE CARE, V80, P947, DOI 10.1097/TA.0000000000001027; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Starnes BW, 2020, J VASC SURG, V71, P1851, DOI 10.1016/j.jvs.2019.05.070	23	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	APR	2021	232	4					416	422		10.1016/j.jamcollsurg.2020.12.007			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RC2CE	WOS:000632610800018	33348014				2022-02-07	
J	Zheng, K; Zhu, L; Ding, YW; Zhang, XX; Chen, N; Liu, G; He, QS				Zheng, Kai; Zhu, Liang; Ding, Yiwei; Zhang, Xixi; Chen, Ning; Liu, Gang; He, Qiushui			Serum cytokine profile of pediatric patients with laboratory confirmed pneumococcal meningitis	JOURNAL OF INFECTION AND PUBLIC HEALTH			English	Article						Meningitis; Streptococcus pneumoniae; Cytokines; Luminex; Children	TRAUMATIC BRAIN-INJURY; STREPTOCOCCUS-PNEUMONIAE; CELLS; ACTIVATION; IL-1-BETA; EDEMA	Background: Streptococcus pneumoniae infection is a leading cause of bacterial meningitis in children with severe sequelae. Cytokines are important molecules in regulating of host inflammatory and antiinflammatory responses. So far, the cytokine profile of bacterial meningitis caused by single pathogen has been rarely reported. The aim of this study was to explore serum cytokine profile in pediatric patients with pneumococcal meningitis (PM) and its clinical relevance which could be considered as a valuable tool for differential diagnosis of PM. Methods: During 2015-2018, 95 children with laboratory-confirmed PM were included. Of them, 63 had serum samples at admission. Ten cytokines including TNF-a, IL-12p40, IL-17A, IL-1(3, IFN-eta, GM-CSF, IL-10, CXCL-1, IL-8 and IL-13 were measured by multiplex immunoassay in sera of 63 PM patients and 55 age-matched healthy controls (HCs). Level of serum cytokines was compared with different clinical features of patients. Results: Significantly higher level of IL-10 was observed in patients than HCs (median, 2.19 vs. 1.92 pg/mL, p = 0.017). Significantly lower levels of serum IL-12p40, IL-17A and IL-1 beta were observed in patients than HCs (median, 0.68 vs. 10.12 pg/mL, p < 0.0001; 1.14 vs. 1.14 pg/mL, p = 0.004; 1.00 vs. 5.09 pg/mL, p < 0.0001, respectively). No difference was found in levels of other cytokines between patients and controls. A negative correlation was noticed between percentages of blood neutrophils and concentrations of IL-10 (p = 0.048, r = & minus;0.25). Significantly lower levels of IL-12p40 and CXCL-1 were observed in PM patients with sepsis than those without (median 0.68 vs. 1.64 pg/mL, p = 0.026; 7.25 vs. 12.84 pg/mL, p = 0.043, respectively). Conclusions: Our results suggested that there might be significant changes in serum pro-inflammatory and anti-inflammatory cytokines in PM children and that the determination of these cytokines may have limited value for evaluation of clinical outcome of pediatric PM. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).	[Zheng, Kai; Ding, Yiwei; Chen, Ning; He, Qiushui] Capital Med Univ, Dept Med Microbiol, Beijing 100069, Peoples R China; [Zhu, Liang; Zhang, Xixi; Liu, Gang] Capital Med Univ, Beijing Childrens Hosp, Dept Infect Dis, Minist Educ,Key Lab Major Dis Children, Beijing 100045, Peoples R China; [Ding, Yiwei] Chinese Peoples Liberat Army Gen Hosp, Dept Med Ctr 6, Beijing, Peoples R China; [He, Qiushui] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland		He, QS (corresponding author), Capital Med Univ, Dept Med Microbiol, Beijing 100069, Peoples R China.; Liu, G (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Dept Infect Dis, Minist Educ,Key Lab Major Dis Children, Beijing 100045, Peoples R China.	liugang10@hotmail.com; qiushui.he@utu.fi		Zheng, Kai/0000-0002-0840-2798	Program for the 13th Five-year Plan of China [2017ZX10202101004]	This work was partly supported by the Program for the 13th Five-year Plan of China [2017ZX10202101004]. The funding body had no role in study design, data collection, data analysis or interpretation or writing of the report.	Amatya N, 2017, TRENDS IMMUNOL, V38, P310, DOI 10.1016/j.it.2017.01.006; Atehortua L, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-018-1796-4; Barbaro NR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/631594; Barichello T, 2010, J NEUROIMMUNOL, V221, P42, DOI 10.1016/j.jneuroim.2010.02.009; Baumgartner D, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0777-5; Birkl D, 2019, MUCOSAL IMMUNOL, V12, P909, DOI 10.1038/s41385-019-0150-8; Burmeister AR, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00458; Butters C, 2019, JAMA PEDIATR, V173, P1084, DOI 10.1001/jamapediatrics.2019.3203; Cui T, 2015, CELL BIOCHEM BIOPHYS, V71, P595, DOI 10.1007/s12013-014-0239-3; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; JR AAB, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1293, DOI DOI 10.1134/S0006297916110079; Karmakar M, 2015, J IMMUNOL, V194, P1763, DOI 10.4049/jimmunol.1401624; Kolbinger F, 2016, CURR DRUG TARGETS, V17, P1882, DOI 10.2174/1389450117666160307144027; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; LEONAM GC, 2013, BMC INFECT DIS, V13, P326, DOI DOI 10.1186/1471-2334-13-326; Penaloza HF, 2015, IMMUNOLOGY, V146, P100, DOI 10.1111/imm.12486; Roh YS, 2018, TOX RESEARCH, V34, P241, DOI 10.5487/TR.2018.34.3.241; Srinivasan L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0181449; Srinivasan L, 2016, PEDIATR RES, V80, P566, DOI 10.1038/pr.2016.117; Valeri M, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw111; Vazquez MI, 2015, CYTOKINE, V74, P318, DOI 10.1016/j.cyto.2015.02.007; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Wang C Y, 2019, Zhonghua Er Ke Za Zhi, V57, P355, DOI 10.3760/cma.j.issn.0578-1310.2019.05.008; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; World Health Organization, 2003, WHO RECOMMENDED STAN; Xu JL, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23198; Yau B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113555; Ye Q, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003222; Yin J, 2018, MED SCI MONITOR, V24, P1863, DOI 10.12659/MSM.907212	29	0	0	0	0	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1876-0341	1876-035X		J INFECT PUBLIC HEAL	J. Infect. Public Health	APR	2021	14	4					514	520		10.1016/j.jiph.2021.01.010			7	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	RJ0XH	WOS:000637326500013	33743374	gold			2022-02-07	
J	Zhou, J; Liu, YL; Shah, SZA				Zhou, Jing; Liu, Yali; Shah, Sayed Zulfiqar Ali			Hypertrophic olivary degeneration following cerebral trauma managed with rehabilitation-A case report	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article						MRI; Neurological rehabilitation; Olivary nucleus; Olivopontocerebellar atrophies		Hypertrophic olivary degeneration is a kind of trans-synaptic degeneration, caused by the interruption of dentato rubro olivary pathway. Magnetic resonance imaging (MRI) has been the best modality to show the signals of olivary nucleus hypertrophy. It appears on T2-weighted magnetic resonance imaging as hyper-intensities. Here we present a unique case of a 27-year-old male with traumatic brain injury causing multiple intracranial haemorrhages and functional impairment, which was revealed on computerised tomography. Tracheotomy and thoracic drainage were performed immediately. Anti-infection therapy, brain protection, and comprehensive arousal therapy were part of the intervention along with a comprehensive rehabilitation programme including occupational therapy, balance training, coordination, bed mobility training, and strengthening exercises. A holistic diagnostic approach can reduce the chances of misdiagnosing post-traumatic Hypertrophic Olivary Degeneration cases. We concluded that a comprehensive physical rehabilitation programme and medical treatment works best to heal the lesion and its resulting traumatic symptoms in cases of Hypertrophic Olivary Degeneration cases.	[Zhou, Jing; Liu, Yali; Shah, Sayed Zulfiqar Ali] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rehabil Med, Wuhan, Peoples R China		Liu, YL (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rehabil Med, Wuhan, Peoples R China.	liuyali74@126.com	Shah, Sayed Zulfiqar Ali/AAT-2804-2021				Bruno MK, 2012, ARCH NEUROL-CHICAGO, V69, P274, DOI 10.1001/archneurol.2011.657; GOTO N, 1988, CLIN NEUROPATHOL, V7, P39; Goyal M, 2000, AM J NEURORADIOL, V21, P1073; Krings T, 2003, J NEUROL NEUROSUR PS, V74, P797, DOI 10.1136/jnnp.74.6.797; Mossuto-Agatiello L, 2006, NEUROLOGY, V66, P1668, DOI 10.1212/01.wnl.0000218180.03127.11; Salamon-Murayama N, 1999, RADIOLOGY, V213, P814, DOI 10.1148/radiology.213.3.r99dc43814; Sanverdi SE, 2012, BRIT J RADIOL, V85, P511, DOI 10.1259/bjr/60727602; Sarawagi R, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.150454; Tilikete C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00302	9	0	0	1	2	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	APR	2021	71	4					1252	1254		10.47391/JPMA.1124			3	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	SD7YL	WOS:000651592000040	34125782				2022-02-07	
J	Ziegenhain, F; Scherer, J; Kalbas, Y; Neuhaus, V; Lefering, R; Teuben, M; Sprengel, K; Pape, HC; Jensen, KO				Ziegenhain, Franziska; Scherer, Julian; Kalbas, Yannik; Neuhaus, Valentin; Lefering, Rolf; Teuben, Michel; Sprengel, Kai; Pape, Hans-Christoph; Jensen, Kai Oliver		TraumaRegister DGU	Age-Dependent Patient and Trauma Characteristics and Hospital Resource Requirements-Can Improvement Be Made? An Analysis from the German Trauma Registry	MEDICINA-LITHUANIA			English	Article						geriatric trauma; interdisciplinary; polytrauma; epidemiology		Background and objectives: The burden of geriatric trauma patients continues to rise in Western society. Injury patterns and outcomes differ from those seen in younger adults. Getting a better understanding of these differences helps medical staff to provide a better care for the elderly. The aim of this study was to determine epidemiological differences between geriatric trauma patients and their younger counterparts. To do so, we used data of polytraumatized patients from the TraumaRegister DGU(R). Materials and Methods: All adult patients that were admitted between 1 January 2013 and 31 December 2017 were included from the TraumaRegister DGU(R). Patients aged 55 and above were defined as the elderly patient group. Patients aged 18-54 were included as control group. Patient and trauma characteristics, as well as treatment and outcome were compared between groups. Results: A total of 114,169 severely injured trauma patients were included, of whom 55,404 were considered as elderly patients and 58,765 younger patients were selected for group 2. Older patients were more likely to be admitted to a Level II or III trauma center. Older age was associated with a higher occurrence of low energy trauma and isolated traumatic brain injury. More restricted utilization of CT-imaging at admission was observed in older patients. While the mean Injury Severity Score (ISS) throughout the age groups stayed consistent, mortality rates increased with age: the overall mortality in young trauma patients was 7.0%, and a mortality rate of 40.2% was found in patients >90 years of age. Conclusions: This study shows that geriatric trauma patients are more frequently injured due to low energy trauma, and more often diagnosed with isolated craniocerebral injuries than younger patients. Furthermore, utilization of diagnostic tools as well as outcome differ between both groups. Given the aging society in Western Europe, upcoming studies should focus on the right application of resources and optimizing trauma care for the geriatric trauma patient.	[Ziegenhain, Franziska; Scherer, Julian; Kalbas, Yannik; Neuhaus, Valentin; Teuben, Michel; Sprengel, Kai; Pape, Hans-Christoph; Jensen, Kai Oliver] Univ Hosp Zurich, Dept Trauma, CH-8091 Zurich, Switzerland; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; [TraumaRegister DGU] German Trauma Soc DGU, Comm Emergency Med Intens Care & Trauma Managemen, D-10623 Berlin, Germany		Ziegenhain, F (corresponding author), Univ Hosp Zurich, Dept Trauma, CH-8091 Zurich, Switzerland.	Franziska.Ziegenhain@usz.ch; julian.scherer@usz.ch; yannik.kalbas@usz.ch; valentin.neuhaus@usz.ch; rolf.lefering@uni-wh.de; michel.teuben@usz.ch; kai.sprengel@usz.ch; hans-christoph.pape@usz.ch; kaioliver.jensen@usz.ch	; Sprengel, Kai/G-4780-2014	Pape, Hans-Christoph/0000-0002-2059-4980; Scherer, Julian/0000-0001-8943-5817; Neuhaus, Valentin/0000-0003-4012-5628; Sprengel, Kai/0000-0001-5921-8272			Bass RR, 2009, ARCH SURG-CHICAGO, V144, P91, DOI 10.1001/archsurg.2008.521; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Brooks SE, 2017, SURG CLIN N AM, V97, P1157, DOI 10.1016/j.suc.2017.06.006; Brown CVR, 2016, AM SURGEON, V82, P1055; Chen CL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55459-2; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Con J, 2014, J SURG RES, V191, P262, DOI 10.1016/j.jss.2014.05.072; Daabiss M, 2011, INDIAN J ANAESTH, V55, P111, DOI 10.4103/0019-5049.79879; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Fuster V, 2017, J AM COLL CARDIOL, V69, P3002, DOI 10.1016/j.jacc.2017.05.013; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gennarelli TA., 2008, ABBREVIATED INJURY S; Haustein T., 2015, OLDER PEOPLE GERMANY; Hildebrand F, 2016, EUR J TRAUMA EMERG S, V42, P317, DOI 10.1007/s00068-015-0557-1; Kocuvan S, 2016, WIEN KLIN WOCHENSCHR, V128, P535, DOI 10.1007/s00508-016-1140-4; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Liener UCBCRK., 2018, WEISSBUCH ALTERSTRAU; Mende A, 2019, DTSCH ARZTEBL INT, V116, P73, DOI 10.3238/arztebl.2019.0073; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Peterer L, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1380-z; Shamliyan T, 2013, AGEING RES REV, V12, P719, DOI 10.1016/j.arr.2012.03.001; Spering C, 2020, EUR J TRAUMA EMERG S, V46, P487, DOI 10.1007/s00068-019-01229-8; Statistisches Bundesamt Wiesbaden, 2019, BEV WAND; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; vanderSluis CK, 1996, J TRAUMA, V40, P78, DOI 10.1097/00005373-199601000-00015; World Health Organization, 2020, AG HLTH; Wutzler S, 2008, UNFALLCHIRURG, V111, P592, DOI 10.1007/s00113-008-1448-2; Zhao FZ, 2015, J PALLIAT MED, V18, P677, DOI 10.1089/jpm.2015.0027	29	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.	APR	2021	57	4							330	10.3390/medicina57040330			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RR7AD	WOS:000643245200001	33915888	Green Accepted, gold, Green Published			2022-02-07	
J	Brakenridge, CL; Leow, CKL; Kendall, M; Turner, B; Valiant, D; Quinn, R; Johnston, V				Brakenridge, Charlotte L.; Leow, Charmaine Kai Ling; Kendall, Melissa; Turner, Ben; Valiant, Donna; Quinn, Ray; Johnston, Venerina			Exploring the lived return-to-work experience of individuals with acquired brain injury: use of vocational services and environmental, personal and injury-related influences	DISABILITY AND REHABILITATION			English	Article; Early Access						Acquired brain injury; stroke; traumatic brain injury; return to work; vocational rehabilitation; qualitative research		Purpose To explore work outcomes, vocational services, barriers and facilitators for returning to work in individuals with acquired brain injury (ABI) in Queensland, Australia and to identify areas for improvement. Design and methods Ten semi-structured interviews were conducted with individuals with ABI (stroke, traumatic brain injury, tumour). Interviews were analysed using a realist thematic analysis approach. Results Participants either returned to the same work, different work, did not maintain work or did not have any work since their injury. Use of vocational services depended on participants' needs and insurance. Facilitators for return to work (RTW) were a supportive workplace and family, vocational rehabilitation that met the individual's needs, insurance coverage and self-motivation. Workplaces that were not understanding of brain injury, employment service providers who were unable to find work for participants, and physical and cognitive deficits were barriers to RTW. Workplaces, employment service providers and individuals require more information about the deficits associated with brain injury. Conclusions The use and effectiveness of vocational services were variable across participants and depended on insurance coverage and needs. Barriers and facilitators for RTW were affected by both the environment and the individual. Implications for vocational rehabilitation were identified.	[Brakenridge, Charlotte L.; Valiant, Donna; Johnston, Venerina] Univ Queensland, RECOVER Injury Res Ctr, Brisbane, Qld, Australia; [Leow, Charmaine Kai Ling] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Kendall, Melissa; Turner, Ben; Quinn, Ray] Princess Alexandra Hosp, Hopkins Ctr, Acquired Brain Injury Outreach Serv, Brisbane, Qld, Australia		Brakenridge, CL (corresponding author), Univ Queensland, RECOVER Injury Res Ctr, Brisbane, Qld, Australia.	c.brakenridge@uq.edu.au		Johnston, Venerina/0000-0003-0911-0866	Motor Accident Insurance Commission (MAIC)	This work is supported by funding from the Motor Accident Insurance Commission (MAIC). MAIC had no role in the design, analysis or writing of this manuscript.	Alaszewski A, 2007, DISABIL REHABIL, V29, P1858, DOI 10.1080/09638280601143356; Alves DE, 2020, OCCUP ENVIRON MED, V77, P122, DOI 10.1136/oemed-2019-106102; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Australian Bureau of Statistics, 2015, DISABILITY LABOUR FO; Australian Institute of Health and Welfare, 2014, NAT COMM SERV DAT DI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Collie A, 2019, J OCCUP REHABIL, V29, P526, DOI 10.1007/s10926-018-9816-4; Donker-Cools BHPM, 2018, DISABIL REHABIL, V40, P185, DOI 10.1080/09638288.2016.1250118; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Donker-Cools BHPM, 2016, DISABIL REHABIL, V38, P733, DOI 10.3109/09638288.2015.1061608; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Grigorovich A, 2017, BRAIN INJURY, V31, P607, DOI 10.1080/02699052.2017.1280855; Hackett ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041795; Hall A, 2012, BRAIN IMPAIR, V13, P85, DOI 10.1017/BrImp.2012.7; Hartke RJ, 2011, TOP STROKE REHABIL, V18, P341, DOI 10.1310/tsr1804-341; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kim J, 2020, INT J STROKE, V15, P819, DOI 10.1177/1747493020909545; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; Krishnamurthi RV, 2015, NEUROEPIDEMIOLOGY, V45, P190, DOI 10.1159/000441098; Liaset IF, 2016, SCAND J OCCUP THER, V23, P446, DOI 10.3109/11038128.2016.1152294; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; Lundqvist A, 2012, BRAIN INJURY, V26, P1574, DOI 10.3109/02699052.2012.698363; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; Mcrae P, 2016, AUST J REHABIL COUNS, V22, P76, DOI 10.1017/jrc.2016.14; Palstam A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021182; Possl O, 2001, BRAIN INJURY, V15, P15; Safe Work Australia, 2019, COMP WORKERSCOMPENSA; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Schwarz B, 2018, J OCCUP REHABIL, V28, P28, DOI 10.1007/s10926-017-9713-2; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Soeker MS, 2019, WORK, V64, P355, DOI 10.3233/WOR-192997; Soeker MS, 2012, WORK, V43, P171, DOI 10.3233/WOR-2012-1413; State of Queensland (Queensland Health), 2016, STATEWIDE ADULT BRAI; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Wolfenden B, 2012, BRAIN IMPAIR, V13, P203, DOI 10.1017/BrImp.2012.16; World Health Organization, 2001, INT CLASSIFICATION F	46	0	0	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1903101		MAR 2021	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	RG9FN	WOS:000635836800001	33794118				2022-02-07	
J	Plekhova, NG; Radkov, IV; Zinoviev, SV; Dyuizen, IV; Baryshev, AN; Shumatov, VB				Plekhova, N. G.; Radkov, I. V.; Zinoviev, S. V.; Dyuizen, I. V.; Baryshev, A. N.; Shumatov, V. B.			Effect of Mild Traumatic Brain Injury on Behavioral Reactions and Neocortical Morphology in Rats	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						traumatic brain injury; experimental model; behavioral phenotype; neocortex; rats		The original weight-drop model was employed to examine the effect of mild traumatic brain injury (TBI) on behavioral phenotype and neocortical morphology in rats. The neurological examination of rats with moderate TBI revealed the focal symptoms corresponding to pronounced neurological disorders, whereas in rats after mild TBI, there were only minor coordination disorders. On day 7 after injury, the rats with mild TBI demonstrated enhanced anxiety assessed by conditioned passive avoidance response. The morphometric analysis of the brain tissues revealed narrowing of the capillaries and increased score of hyperchromic neocortical neurons, which attested to cerebral hypoxia. The manifestations of mild TBI in original rat model demonstrated a close similarity to the symptoms of TBI in humans.	[Plekhova, N. G.; Radkov, I. V.; Zinoviev, S. V.; Shumatov, V. B.] Pacific State Med Univ, Minist Hlth Russian Federat, Vladivostok, Russia; [Dyuizen, I. V.; Baryshev, A. N.] Russian Acad Sci, Far Eastern Div, AV Zhirmunsky Inst Marine Biol, Vladivostok, Russia		Plekhova, NG (corresponding author), Pacific State Med Univ, Minist Hlth Russian Federat, Vladivostok, Russia.	pl_nat@hotmail.com	Plekhova, Natalia G/E-1553-2014	Plekhova, Natalia G/0000-0002-8701-7213			Baryshev AN., Patent RU, Patent No. 2725287; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Ngamdee K, 2011, SENSOR ACTUAT B-CHEM, V160, P129, DOI 10.1016/j.snb.2011.07.023; Pascual JM, 2012, SCHMIDEK SWEET OPERA, P1513; SAVCHENKO YN, 1993, ZH NEVROPATOL PSIKH, V93, P3; Skottnik L, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00779; Smith Douglas H, 2016, Bridge (Wash D C), V46, P79; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624	15	0	0	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	MAR	2021	170	5					672	676		10.1007/s10517-021-05130-6		MAR 2021	5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	RJ7JZ	WOS:000635494300001	33788107				2022-02-07	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Disturbances in Brain Physiology Due to Season Play: A Multi-Sport Study of Male and Female University Athletes	FRONTIERS IN PHYSIOLOGY			English	Article						exercise; season play; cerebral blood flow; white matter; brain activity		High-performance university athletes experience frequent exertion, resulting in disrupted biological homeostasis, but it is unclear to what extent brain physiology is affected. We examined whether athletes without overtraining symptoms show signs of increased neurophysiological stress over the course of a single athletic season, and whether the effects are modified by demographic factors of age, sex and concussion history, and sport-related factors of contact exposure and season length. Fifty-three university-level athletes were recruited from multiple sports at a single institution and followed longitudinally from beginning of season (BOS) to end of season (EOS) and 1 month afterwards, with a subset followed up at the subsequent beginning of season. MRI was used to comprehensively assess white matter (WM) diffusivity, cerebral blood flow (CBF), and brain activity, while overtraining symptoms were assessed with Hooper's Index (HI). Although athletes did not report increased HI scores, they showed significantly increased white matter diffusivity and decreased CBF at EOS and 1 month afterwards, with recovery at follow-up. Global brain activity was not significantly altered though, highlighting the ability of the brain to adapt to exercise-related stressors. Male athletes had greater white matter diffusivity at EOS, but female athletes had greater declines in CBF at 1 month afterwards. Post-season changes in MRI measures were not related to change in HI score, age, concussion history, contact exposure, or length of athletic season. Hence, the brain shows substantial but reversible neurophysiological changes due to season play in the absence of overtraining symptoms, with effects that are sex-dependent but otherwise insensitive to demographic variations. These findings provide new insights into the effects of training and competitive play on brain health.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.	nchurchill.research@gmail.com			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN356342-401065, RN294001-367456]; Canadian Institute for Military and Veterans Health Research (CIMVHR) [W7714-145967]; Siemens Healthineers Canada	This work was supported by the Canadian Institutes of Health Research (CIHR; grant numbers RN356342-401065 and RN294001-367456), the Canadian Institute for Military and Veterans Health Research (CIMVHR; grant number W7714-145967), and Siemens Healthineers Canada.	Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Ayus JC, 2000, ANN INTERN MED, V132, P711, DOI 10.7326/0003-4819-132-9-200005020-00005; Bailey DM, 2011, EXP PHYSIOL, V96, P1196, DOI 10.1113/expphysiol.2011.060178; Balsalobre-Fernandez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106066; Brown AD, 2010, NEUROBIOL AGING, V31, P2047, DOI 10.1016/j.neurobiolaging.2008.11.002; Carfagno DG, 2014, CURR SPORT MED REP, V13, P45, DOI 10.1249/JSR.0000000000000027; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cotman CW, 2002, EXERC SPORT SCI REV, V30, P75, DOI 10.1097/00003677-200204000-00006; Erickson KI, 2015, CURR OPIN BEHAV SCI, V4, P27, DOI 10.1016/j.cobeha.2015.01.005; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Freire L., 2020, J PHYS ED SPORT, V20, P1279, DOI [10.7752/jpes.2020.03178, DOI 10.7752/JPES.2020.03178]; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guiney H, 2015, NEUROPSYCHOLOGY, V29, P1, DOI 10.1037/neu0000124; Gurney KJ, 2006, NEUROBIOL DIS, V23, P87, DOI 10.1016/j.nbd.2006.02.006; Herting MM, 2014, DEV COGN NEUROS-NETH, V7, P65, DOI 10.1016/j.dcn.2013.11.003; Hooper SL, 1999, MED SCI SPORT EXER, V31, P1205, DOI 10.1097/00005768-199908000-00019; HOOPER SL, 1995, SPORTS MED, V20, P321, DOI 10.2165/00007256-199520050-00003; Joo M, 2004, EUR J APPL PHYSIOL, V93, P82, DOI 10.1007/s00421-004-1168-4; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; Kreher JB, 2012, SPORTS HEALTH, V4, P128, DOI 10.1177/1941738111434406; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marks BL, 2007, ANN NY ACAD SCI, V1097, P171, DOI 10.1196/annals.1379.022; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meeusen R, 2006, EUR J SPORT SCI, V6, P263, DOI 10.1080/17461390601151302; Meeusen R, 2013, EUR J SPORT SCI, V13, P1, DOI 10.1080/17461391.2012.730061; Murrell CJ, 2013, AGE, V35, P905, DOI 10.1007/s11357-012-9414-x; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Poulin MJ, 1999, J APPL PHYSIOL, V86, P1632, DOI 10.1152/jappl.1999.86.5.1632; Purvis D, 2010, PM&R, V2, P442, DOI 10.1016/j.pmrj.2010.03.025; Querido JS, 2007, SPORTS MED, V37, P765, DOI 10.2165/00007256-200737090-00002; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Robson-Ansley PJ, 2007, EUR J APPL PHYSIOL, V99, P353, DOI 10.1007/s00421-006-0354-y; Ruegsegger GN, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029694; Smith LL, 2003, SPORTS MED, V33, P347, DOI 10.2165/00007256-200333050-00002; Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Svensson M, 2015, NEUROREHAB NEURAL RE, V29, P577, DOI 10.1177/1545968314562108; Tallon CM, 2020, EXP PHYSIOL, V105, P1090, DOI 10.1113/EP088293; Tan H, 2009, J MAGN RESON IMAGING, V29, P1134, DOI 10.1002/jmri.21721; Tanskanen M, 2010, J SPORT SCI, V28, P309, DOI 10.1080/02640410903473844; THOMAS SN, 1989, J APPL PHYSIOL, V67, P744, DOI 10.1152/jappl.1989.67.2.744; Tiidus PM, 1998, CAN J PHYSIOL PHARM, V76, P533, DOI 10.1139/cjpp-76-5-533; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; WAHL M, 1993, ACTA NEUROCHIR, P3; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Yanguas-Casas N., 2020, NEUROIMMUNOL NEUROIN, V7, P13, DOI 10.20517/2347-8659.2019.31	57	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	MAR 30	2021	12								653603	10.3389/fphys.2021.653603			11	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	RM1MG	WOS:000639423800001	33868020	Green Published, gold			2022-02-07	
J	Jannotta, GE; Gulek, BG; Dempsey, JS; Blissitt, PA; Sullivan, HC; Tran, K; Joffe, A; Lele, AV				Jannotta, Gemi E.; Gulek, Bernice G.; Dempsey, John S.; Blissitt, Patricia A.; Sullivan, Helen C.; Tran, Kim; Joffe, Aaron; Lele, Abhijit V.			Administration of 3% Sodium Chloride Through Peripheral Intravenous Access: Development and Implementation of a Protocol for Clinical Practice	WORLDVIEWS ON EVIDENCE-BASED NURSING			English	Article						evidence&#8208; based practice; neurology; patient safety; education; curriculum; learning		Background Patients with traumatic brain injury, cerebral edema, and severe hyponatremia require rapid augmentation of serum sodium levels. Three percent sodium chloride is commonly used to normalize or augment serum sodium level, yet there are limited data available concerning the most appropriate route of administration. Traditionally, 3% sodium chloride is administered through a central venous catheter (CVC) due to the attributed theoretical risk of phlebitis and extravasation injuries when hyperosmolar solution is administered peripherally. CVCs are associated with numerous complications, including arterial puncture, pneumothorax, infection, thrombosis, and air embolus. Peripherally infused 3% sodium chloride may bypass these concerns. Aims To explore the evidence for peripherally infused 3% sodium chloride and to implement the findings. Methods The Iowa Model of Evidence-Based Practice (EBP) was used to guide the project. A multidisciplinary team was established, and they developed an evidence-based protocol for the administration of 3% sodium chloride using peripheral intravenous catheters (PIVs), identified potential barriers to implementation, and developed targeted education to implement this practice change in a large academic medical center. Results Of the 103 patients in this project, only three (2.9%) identified adverse events. Two were associated with continuous infusions, and one was associated with a bolus infusion. Linking Action to Evidence This is the first study to describe a multidisciplinary protocol development and implementation process for the administration of 3% sodium chloride peripherally. Utilizing a multidisciplinary team is critical to the success of an EBP project. Implementing an evidence-based PIV protocol with stringent monitoring criteria for the administration of 3% sodium chloride has the potential to reduce adverse events related to CVC injury.	[Jannotta, Gemi E.; Gulek, Bernice G.] Univ Washington, Harborview Med Ctr, Neurocrit Care Serv, 325 9Th Ave, Seattle, WA 98104 USA; [Gulek, Bernice G.] Washington State Univ, Coll Nursing, Grad Sch, Spokane, WA USA; [Dempsey, John S.] Harborview Med Ctr, Dept Pharm, Seattle, WA USA; [Blissitt, Patricia A.] Harborview Med Ctr, Profess Dev & Nursing Excellence, Seattle, WA USA; [Blissitt, Patricia A.] Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Sullivan, Helen C.] Harborview Med Ctr, Profess Dev & Nursing Excellence, Seattle, WA USA; [Tran, Kim] Harborview Med Ctr, Dept Pharm, Seattle, WA USA; [Joffe, Aaron; Lele, Abhijit V.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave, Seattle, WA 98104 USA		Jannotta, GE (corresponding author), Univ Washington, Harborview Med Ctr, Neurocrit Care Serv, 325 9Th Ave, Seattle, WA 98104 USA.	jannotta@uw.edu		Jannotta, Gemi/0000-0002-2344-2894			Dillon RC, 2018, J INTENSIVE CARE MED, V33, P48, DOI 10.1177/0885066617702590; Groll D, 2010, J INFUS MURS, V33, P385, DOI 10.1097/NAN.0b013e3181f85a73; Infusion Nursing Society, 2016, INF THER STAND PRACT; Jones GM, 2017, AM J CRIT CARE, V26, P37, DOI 10.4037/ajcc2017439; Kang H, 2016, KOREAN J ANESTHESIOL, V69, P435, DOI 10.4097/kjae.2016.69.5.435; Luu JL, 2011, PEDIATR EMERG CARE, V27, P1113, DOI 10.1097/PEC.0b013e31823aff59; Meng LN, 2018, AM J HEALTH-SYST PH, V75, P284, DOI 10.2146/ajhp161028; Nagler EV, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0231-1; Parienti JJ, 2015, NEW ENGL J MED, V373, P1220, DOI 10.1056/NEJMoa1500964; Perez CA, 2017, J NEUROSCI NURS, V49, P191, DOI 10.1097/JNN.0000000000000286; Reynolds PM, 2014, PHARMACOTHERAPY, V34, P617, DOI 10.1002/phar.1396; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; TIMMER JG, 1991, CLIN NUTR, V10, P71, DOI 10.1016/0261-5614(91)90090-Y; Titler M G, 2001, Crit Care Nurs Clin North Am, V13, P497	14	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-102X	1741-6787		WORLDV EVID-BASED NU	Worldviews Evid.-Based Nurs.	APR	2021	18	2			SI		147	153		10.1111/wvn.12501		MAR 2021	7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	RN2WD	WOS:000634753900001	33783949				2022-02-07	
J	Skilbeck, L; Spanton, C; Roylance, I				Skilbeck, Lilian; Spanton, Christopher; Roylance, Ian			Integrated Trauma-Focused Cognitive Behavioral Therapy for Comorbid Combat-Related Posttraumatic Stress Disorder: A Case Study with a Military Veteran	CLINICAL CASE STUDIES			English	Article						trauma; PTSD; trauma-focused CBT; veteran; military		Individual Trauma-focused CBT has been shown to be effective for treating posttraumatic stress disorder in military veterans. Treatment challenges are common including the presence of dissociation and comorbidities including depression, traumatic brain injury symptoms, substance misuse, and social transition difficulties. There are currently no standard psychological therapy guidelines for veterans with comorbid presentations. However, as recommended by the National Institute for Health and Care Excellence treatment guidelines, adapting existing treatments can improve the chances of successfully treating trauma cases. In line with these recommendations, the current case study describes how the existing individual trauma-focused CBT model was integrated to treat posttraumatic stress disorder with comorbid depression, persistent mild-traumatic brain injury migraine, and social transition difficulties in a 38-year-old male combat veteran. The client attended 16-sessions of trauma-focused CBT. This model integrated his comorbidities and involved his spouse and multidisciplinary discussions with his general practitioner, and neurorehabilitation team and the Veterans' Transition Service. At the end of treatment, the client no longer met the diagnostic criteria for posttraumatic stress disorder. This case illustrates how trauma-focused CBT can be integrated to treat comorbid posttraumatic stress disorder in veterans.	[Skilbeck, Lilian; Spanton, Christopher; Roylance, Ian] East London NHS Fdn Trust, 10 Vicarage Lane, London E15 4ES, England		Skilbeck, L (corresponding author), East London NHS Fdn Trust, 10 Vicarage Lane, London E15 4ES, England.	l.skilbeck@nhs.net					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Braehler C., 2020, EMOTION POSTTRAUMATI, P567, DOI [10.1016/B978-0-12-816022-0.00020-X, DOI 10.1016/B978-0-12-816022-0.00020-X]; Carlstrom LP, 2020, J NEUROSURG, V133, P736, DOI 10.3171/2019.4.JNS19201; Clohessy S, 1999, BRIT J CLIN PSYCHOL, V38, P251, DOI 10.1348/014466599162836; de Kleine RA, 2019, EUR J PSYCHOTRAUMATO, V10, DOI 10.1080/20008198.2019.1625690; Dedert EA, 2019, BEHAV SLEEP MED, V17, P595, DOI 10.1080/15402002.2018.1435544; Denby E., 2019, ARCH PHYS MED REHAB, V100, pE189; Department of Health, 2008, IMPRG ACC PSYCH THER; Donachie TC, 2019, J SPORT EXERCISE PSY, V41, P309, DOI 10.1123/jsep.2018-0317; Dunmore E, 1999, BEHAV RES THER, V37, P809, DOI 10.1016/S0005-7967(98)00181-8; Ehlers A, 2005, BEHAV RES THER, V43, P413, DOI 10.1016/j.brat.2004.03.006; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fear NT, 2018, BRIT J PSYCHIAT, V212, P347, DOI 10.1192/bjp.2017.16; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Forbes D, 2019, INT REV PSYCHIATR, V31, P95, DOI 10.1080/09540261.2019.1595545; Harden L, 2018, J ROY ARMY MED CORPS, V164, P352, DOI 10.1136/jramc-2018-000921; Hendrikx LJ, 2021, J HEAD TRAUMA REHAB, V36, P34, DOI 10.1097/HTR.0000000000000599; Hendrikx LJ, 2020, TELEMED E-HEALTH, V26, P1475, DOI 10.1089/tmj.2019.0309; Improving Access to Psychological Therapies, 2014, MEAS IMPR REC AD SER; Kar N, 2011, NEUROPSYCH DIS TREAT, V7, P167, DOI 10.2147/NDT.S10389; Kazantzis N, 2017, PSYCHIAT CLIN N AM, V40, P625, DOI 10.1016/j.psc.2017.08.001; Kleim B, 2013, J CONSULT CLIN PSYCH, V81, P383, DOI 10.1037/a0031290; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Manfield P, 2017, J EMDR PRACT RES, V11, P195, DOI 10.1891/1933-3196.11.4.195; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meyer E., 2019, MINDFULNESS VALUES B; Miao XR, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0179-0; Ministry of Defence, 2017, VET KEY FACTS; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Murphy D., 2017, J MIL VETERAN FAM HL, V3, P52, DOI [DOI 10.3138/JMVFH.4011, 10.3138/jmvfh.4011]; Murphy D, 2018, J TRAUMA STRESS, V31, P753, DOI 10.1002/jts.22333; Murphy D, 2015, J ROY ARMY MED CORPS, V161, P322, DOI 10.1136/jramc-2014-000344; Murphy D, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.21759; National Institute for Health and Care Excellence, 2018, POSTTRAUMATIC STRESS; Park J, 2016, EMOTION, V16, P349, DOI 10.1037/emo0000121; Reisman Miriam, 2016, P T, V41, P623; Sharp ML, 2019, J MIL VETERAN FAM HL, V5, P75, DOI 10.3138/jmvfh.2018-0051; Siegel D., 1999, DEV MIND RELATIONSHI; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steenkamp MM, 2011, COGN BEHAV PRACT, V18, P98, DOI 10.1016/j.cbpra.2009.08.006; Stevelink SAM, 2019, BRIT J PSYCHIAT, V214, P175, DOI 10.1192/bjp.2018.235; Turgoose D, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6030086; Veterans' Health Administration and Department of Defense, 2017, CLIN PRACTICE GUIDEL; Weiss Daniel S., 1997, P399; White J, 2015, EPIDEMIOL PSYCH SCI, V24, P249, DOI 10.1017/S2045796014000110	47	0	0	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1534-6501	1552-3802		CLIN CASE STUD	Clin. Case Stud.	OCT	2021	20	5					385	401	15346501211006922	10.1177/15346501211006922		MAR 2021	17	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	UI6UE	WOS:000635330100001					2022-02-07	
J	Sun, H; Shu, LY; Sherrier, MC; Zhu, Y; Liu, JW; Zhang, W				Sun, Hui; Shu, Lin-Yuan; Sherrier, Matthew C.; Zhu, Yi; Liu, Jing-Wen; Zhang, Wei			Decreased complications but a distinctive fixation loosening mechanism of fully threaded headless cannulated screw fixation for femoral neck fractures in young adults	JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH			English	Article						Femoral neck fracture; Internal fixation; Fully threaded headless cannulated screws; Complication; Fixation failure		Background Despite being a commonly encountered injury in orthopedic practice, controversy surrounds the methods of optimal internal fixation for femoral neck fractures (FNF) in young patients. The objective of the present study is to compare complication rates and failure mechanisms for surgical fixation of FNF using fully threaded headless cannulated screws (FTHCS) versus partial threaded cannulated screws (PTS) in young adults. Methods A total of 75 patients (18-65 years old) with FNF were prospectively treated with close reduction and internal fixation using three parallel FTHCS and compared to a historical control case-matched group (75 patients) with FNF treated by PTS fixation. After 2 years follow-up, rates of fixation failure (including varus collapse, fracture displacement, and femoral neck shortening), nonunion, and avascular necrosis of the femoral head (ANFH) were compared between the two cohorts. The demographic, follow-up information, and radiological images were assessed by independent blinded investigators. Results Patient demographics and fracture patterns were similar in the two patient groups. The overall fixation failure rates were 8% (6/75) in the FTHCS cohort, which was significantly lower than the 25.3% (19/75) seen in the PTS group. Rates of nonunion and ANFH were significantly lower in the FTHCS group when compared to the PTS control group. When stratified by injury severity (high-energy vs. low-energy fractures), the rate of fixation failure was significant lower with the use of FTHCS when compared with PTS for high-energy fractures while there was no difference in the rates of nonunion or ANFH for high or low-energy fracture patterns. Unique to the FTHCS cohort was an atypical screw migration pattern with varus collapse (6/75, 8%). Conclusions The results show that FTHCS fixation could significantly reduce the complication rate of young patients with FNF, especially in high-energy fracture patterns (Garden III-IV, Pauwels III, or vertical of the neck axis (VN) angle >= 15 degrees). There was also confirmation that the modes of fixation loosening in the FTCHS group, including screw "medial migration" and superior cutout, were different from the screw withdrawal pattern seen in the PTS cohort.	[Sun, Hui; Zhu, Yi; Liu, Jing-Wen; Zhang, Wei] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Orthopaed Surg, 600 YiShan Rd, Shanghai 200233, Peoples R China; [Shu, Lin-Yuan] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Emergency Med, 600 YiShan Rd, Shanghai 200233, Peoples R China; [Sherrier, Matthew C.] Univ Pittsburgh, Dept Phys Med & Rehabil, Med Ctr, Pittsburgh, PA 15219 USA		Zhang, W (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Orthopaed Surg, 600 YiShan Rd, Shanghai 200233, Peoples R China.	orthozhangwei@163.com					Bhandari M, 2017, LANCET, V389, P1519, DOI 10.1016/S0140-6736(17)30066-1; Bhandari M, 2009, J ORTHOP TRAUMA, V23, P403, DOI 10.1097/BOT.0b013e318176191f; Boraiah S, 2010, J TRAUMA, V69, P142, DOI 10.1097/TA.0b013e3181bba236; Chiang MH, 2019, ASIAN J SURG, V42, P320, DOI 10.1016/j.asjsur.2018.05.009; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; Dexter S, 2018, AM J OBSTET GYNECOL, V218, P360, DOI 10.1016/j.ajog.2017.11.581; FICAT P, 1973, REV CHIR ORTHOP, V59, P26; Florschutz AV, 2015, J ORTHOP TRAUMA, V29, P121, DOI 10.1097/BOT.0000000000000291; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; Huang TW, 2011, INJURY, V42, P217, DOI 10.1016/j.injury.2010.10.005; Kellam JF, 2018, J ORTHOP TRAUMA, V32, pS1, DOI [10.1097/BOT.0000000000001063, 10.1097/BOT.0000000000001062]; Levack AE, 2019, J ORTHOP TRAUMA, V33, pS33, DOI 10.1097/BOT.0000000000001368; Luttrell K, 2014, J ORTHOP TRAUMA, V28, pE221, DOI 10.1097/BOT.0000000000000080; Ma Z, 2013, INJURY, V44, P1661, DOI 10.1016/j.injury.2013.03.023; Okcu G, 2015, INJURY, V46, pS24, DOI 10.1016/j.injury.2015.05.028; Simmermacher RK, 2018, AO PRINCIPLES FRACTU, V3rd, P773; Singh JA, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1106-8; Wang SH, 2015, INJURY, V46, P1969, DOI 10.1016/j.injury.2015.06.016; Weil YA, 2018, ARCH ORTHOP TRAUM SU, V138, P661, DOI 10.1007/s00402-018-2896-y; Zhang BK, 2018, INT ORTHOP, V42, P1949, DOI 10.1007/s00264-018-3798-x; Zhang BK, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4898301; Zhang YL, 2017, ORTHOP TRAUMATOL-SUR, V103, P229, DOI 10.1016/j.otsr.2016.11.019; Zielinski SM, 2014, OSTEOPOROSIS INT, V25, P875, DOI 10.1007/s00198-013-2487-2; Zlowodzki M, 2008, J BONE JOINT SURG BR, V90B, P1487, DOI 10.1302/0301-620X.90B11.20582; Zlowodzki M, 2008, J TRAUMA, V64, P163, DOI 10.1097/01.ta.0000241143.71274.63; Zlowodzki M, 2007, CLIN ORTHOP RELAT R, P213, DOI 10.1097/BLO.0b013e31805b7ec4	27	0	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-799X			J ORTHOP SURG RES	J. Orthop. Surg. Res.	MAR 30	2021	16	1							234	10.1186/s13018-021-02335-3			13	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	RH4WT	WOS:000636221600004	33785020	Green Published, gold, Green Submitted			2022-02-07	
J	Zou, TF; Liu, ZZ; Wang, DQ; Chen, T; Liu, L				Zou, Tiefang; Liu, Zhuzi; Wang, Danqi; Chen, Tao; Liu, Lin			Methods, upper limit and reason for reducing pedestrian ground contact injury by controlling vehicle braking	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article; Early Access						Pedestrian vehicle collision; ground related injury; controlled vehicle braking; vehicle related injury; weighted injury cost		In order to access the maximum benefits of controlled vehicle braking in reducing ground related injury, based on a basic simulation test sample, which include 24 simulations with three velocities, four pedestrian sizes and two pedestrian gaits, 10176 simulations were conducted by Madymo. After comparative study, we found that the vehicle caused injury will not increase if the vehicle braking is starting to reduce at the time the pedestrian head first contact the vehicle and the ground related WIC/HIC can be maximally reduced 88.9% and 75.6% respectively by controlling the vehicle braking efficiently. Through a further analysis we found that the optimal time at which the vehicle was to fully brake again (t2) is not hard to obtain because the optimal t2 is not an isolated point and hence it is easy to obtain a simple controlling method for a specific car shape but it may be impossible to find one way to control the braking of vehicles with different shapes. And the possible reason that the ground related injury can be reduced is the change of the landing mechanism. Not all ground related injury can be reduced because in some fully braked cases the WIC/HIC is already equal or close to 0; and two danger situations for controlling the vehicle braking were found, which are the pedestrian fall to the ground from the vehicle side and the controlled vehicle cannot contact the pedestrian's main body in the controlling braking process. Research results will enhance our confidence.	[Zou, Tiefang; Wang, Danqi] Changsha Univ Sci & Technol, Sch Automobile & Mech Engn, Changsha, Peoples R China; [Zou, Tiefang; Liu, Zhuzi; Wang, Danqi] Key Lab Safety Design & Reliabil Technol Engn Veh, Changsha, Hunan, Peoples R China; [Zou, Tiefang; Chen, Tao] Changan Univ, Minist Commun, Key Lab Automot Transportat Safety Enhancement Te, Xian, Peoples R China; [Liu, Lin] Cent South Univ, Xiangya Hosp 3, Changsha, Peoples R China		Zou, TF (corresponding author), Changsha Univ Sci & Technol, Sch Automobile & Mech Engn, Changsha, Peoples R China.; Zou, TF (corresponding author), Key Lab Safety Design & Reliabil Technol Engn Veh, Changsha, Hunan, Peoples R China.; Zou, TF (corresponding author), Changan Univ, Minist Commun, Key Lab Automot Transportat Safety Enhancement Te, Xian, Peoples R China.	tiefang@163.com		Zou, Tiefang/0000-0002-2972-5502	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51775056]; Excellent Youth Project of Hunan Education Department [19B035]	This work was supported by the National Natural Science Foundation of China (51775056) and the Excellent Youth Project of Hunan Education Department (19B035).	Badea-Romero A, 2013, ACCIDENT ANAL PREV, V50, P1140, DOI 10.1016/j.aap.2012.09.024; Crocetta G, 2015, ACCIDENT ANAL PREV, V79, P56, DOI 10.1016/j.aap.2015.03.009; Han Y, 2019, INT J CRASHWORTHINES, V24, P211, DOI 10.1080/13588265.2018.1429520; Hu L, 2021, P I MECH ENG D-J AUT, V235, P2176, DOI 10.1177/0954407020985972; Hu L, 2020, TRAFFIC INJ PREV, V21, P283, DOI 10.1080/15389588.2020.1747614; Huang Y, 2020, ACCIDENT ANAL PREV, V134, DOI 10.1016/j.aap.2019.105336; Li, 2017, THESIS TRINITY COLL; Li G., 2017, ACCIDENT ANAL PREV, V100; Li G., 2016, TRAFFIC INJ PREV, V17; Li QQ, 2021, THIN WALL STRUCT, V162, DOI 10.1016/j.tws.2021.107588; Nie BB, 2016, TRAFFIC INJ PREV, V17, P712, DOI 10.1080/15389588.2016.1143096; Pohlemann T., 2001, P INT RES COUNC BIOM; Shang S, 2021, ACCIDENT ANAL PREV, V149, DOI 10.1016/j.aap.2020.105803; Shang S, 2020, SAFETY SCI, V127, DOI 10.1016/j.ssci.2020.104684; Shang S, 2018, ACCIDENT ANAL PREV, V110, P9, DOI 10.1016/j.aap.2017.10.011; Shi L., 2019, P I MECH ENG D-J AUT, V233; Simms C., 2006, INT J CRASHWORTHINES, V11; Sun J, 2018, J FORENSIC LEG MED, V56, P99, DOI 10.1016/j.jflm.2018.03.014; Tamura A., 2015, IJVS, V8; Tierney G., 2017, BRAIN INJURY, V31; Tierney GJ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040726; Wang F., 2018, BIOMECH MODEL MECHAN, V17; Wang F, 2020, TRAFFIC INJ PREV, V21, P102, DOI 10.1080/15389588.2019.1680837; Zou T., 2019, ACCIDENT ANAL PREV, V129; Zou TF, 2020, INT J CRASHWORTHINES, DOI 10.1080/13588265.2020.1827848; Zou TF, 2022, INT J CRASHWORTHINES, V27, P1, DOI 10.1080/13588265.2020.1769455	26	0	0	5	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness												10.1080/13588265.2021.1910399		MAR 2021	12	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	RN8ED	WOS:000640583400001					2022-02-07	
J	Frisso, PLC; Ellakkis, RFE; Silva, EG; Farina, EMG; El Sarraf, RA				Capelini Frisso, Paulo Lucas; El Hossain Ellakkis, Richam Faissal; Silva, Elton Gomes; Garcete Farina, Edgar Manuel; El Sarraf, Raymond Assad			Multiple Brain Abscesses Secondary to Odontogenic Infection: A Clinical Case Report	BRAZILIAN NEUROSURGERY-ARQUIVOS BRASILEIROS DE NEUROCIRURGIA			English	Article						cerebral abscess; dental infection; Streptoccocus intermedius		Introduction Cerebral abscess is a suppurative infection of the cerebral parenchyma, which may occur due to contiguity, hematogenous dissemination of distant foci, secondary to open traumatic brain injuries, or be idiopathic. Clinical Case A 63- year-old male patient sought assistance due to a severe headache in the frontal region associated with chills and lack of appetite that started four days before. Clinical examination of the patient showed no significant changes. Imaging and laboratory tests on admission showed only nonspecific changes, such as leukocytes 18,540, platelets 517,000, and c-reactive protein 2,0. In such case, magnetic resonance imaging (MRI) of the skull was performed with contrast, showing the presence of expansive lesions compatible with multiple brain abscesses in the right parietooccipital region. Discussion After excluding the main focus of hematogenous dissemination and in view of the identification of the agent Streptococcus intermedius by means of secretion culture collected through a surgical method, the hypothesis of abscess due to contiguous dental pyogenic foci was pointed out. Conclusion Dental evaluation showed multiple foci of infection with periodontitis and dental abscess, which were treated along with the use of antibiotics directed to the etiologic agent.	[Capelini Frisso, Paulo Lucas; Silva, Elton Gomes] Inst Latino Americano Ciencias Vida & Nat ILACVN, Univ Fed Integracao Latino Amer, Med Course, Foz Do Iguacu, PR USA; [El Hossain Ellakkis, Richam Faissal; Silva, Elton Gomes; Garcete Farina, Edgar Manuel; El Sarraf, Raymond Assad] Hosp Municipal Padre Germano Lauck, Foz Do Iguacu, Brazil		Frisso, PLC (corresponding author), Univ Fed Integracao Latino Amer, Foz Do Iguacu, Brazil.	plc.frisso.2016@unila.edu.br		Garcete Farina, Edgar Manuel/0000-0003-4052-010X			Alves ON., 2018, REV PATOLOGIA TOCANT, V5, P23; Cantiera M, 2019, REV NEUROL-FRANCE, V175, P469, DOI 10.1016/j.neurol.2019.07.002; Correia FCS., 2017, ABCESSO CEREBRAL SEC, P11; Darlow CA, 2020, J INFECTION, V80, P623, DOI 10.1016/j.jinf.2020.03.011; Frosch MP, 2010, ROBBINS COTRAN PATHO, P1279; Hasegawa N, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00886-16; Kichenbrand C, 2020, INT J SURG CASE REP, V69, P35, DOI 10.1016/j.ijscr.2020.03.025; Livingston LV, 2014, CASE REP INFECT DIS, V2014, DOI 10.1155/2014/954046; Lurdes M, 2014, NASCER CRESCER, V23, P30; Manresa C, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009376.pub2; Mombelli Andrea, 2019, Swiss Dent J, V129, P835; Nath A., 2014, GOLDMAN CECIL MED, P2731; Oliveira Renata Lanzoni de, 2020, Rev Bras Ter Intensiva, V32, P161, DOI 10.5935/0103-507x.20200025; Phumat P, 2018, DRUG DISCOV THER, V12, P133, DOI 10.5582/ddt.2018.01021; Pittella JEH., 2016, BOGLIOLO PATOLOGIA, P1253; Rams TE, 2014, J PERIODONTOL, V85, P1792, DOI 10.1902/jop.2014.130291; Roos KL., 2017, HARRISON MED INTERNA, P3892; Souza MNP., 2019, MED EMERGENCIA ABORD, P317; Speciali JG., 2018, PROTOCOLO NACL DIAGN; Sveinsson OA, 2013, LAEKNABLADID, V99, P25, DOI 10.17992/lbl.2013.01.478; UFSC, 2013, EV AG AT BAS CEF; Lopez AJV, 2019, NEUROCIRUGIA, V30, P305, DOI 10.1016/j.neucir.2019.05.004	22	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0103-5355	2359-5922		BRAZ NEUROSURG	Braz. Neurosurg.	JUN	2021	40	02					E162	E166		10.1055/s-0040-1722242		MAR 2021	5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	WI8MV	WOS:000634500900003		gold			2022-02-07	
J	Goulet, J; Audrit, H; Tinawi, S; Lague-Beauvais, M; De Guise, E				Goulet, Justine; Audrit, Helene; Tinawi, Simon; Lague-Beauvais, Maude; De Guise, Elaine			Relationship between depression, community integration and life satisfaction following mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; concussion; community integration; depression; life satisfaction		Purpose: Compared to studies on moderate and severe traumatic brain injury (TBI), less literature exists concerning the consequences of mild traumatic brain injury (mTBI) on community integration and life satisfaction, especially in the early phase of recovery. Moreover, a better understanding of the variables that contribute to community integration and life satisfaction is still needed. The aim of the study was to assess the association of mood, fatigue and post-concussive symptoms with community integration and life satisfaction early following mTBI. Research method: A total of 85 participants aged between 18 and 61 years who sustained mTBI were included. Participants answered web-based questionnaires measuring anxiety and depression symptoms, fatigue, post-concussive symptoms, community integration and life satisfaction in the first three months post mTBI. Results: Post-concussive symptoms, fatigue and anxiety were not associated with community integration or life satisfaction. However, depressive symptoms were negatively associated with community integration and life satisfaction. Conclusions: Among all acute post-concussive symptoms following mTBI, depressive symptoms seem to have strongest relationship with community integration and life satisfaction. Acute psychological intervention targeting these symptoms is strongly recommended.	[Goulet, Justine; Audrit, Helene; De Guise, Elaine] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Goulet, Justine; Audrit, Helene; De Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Tinawi, Simon; Lague-Beauvais, Maude] McGill Univ, Traumat Brain Injury Program, Hlth Ctr, Montreal, PQ, Canada; [Lague-Beauvais, Maude; De Guise, Elaine] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [De Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada		De Guise, E (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	elaine.de.guise@umontreal.ca			MUHC-MGH TBI clinic	We would like to acknowledge the support provided by Mrs. Mitra Feyz, who was the TBI program director at the McGill University Health Center, and the mild MUHC-MGH TBI clinic for their support in this study. We also like to thank Sabrina Beaulieu-Benoit for her assistance in recruiting participants. Finally, we are grateful for the participation of all patients in this study	Agtarap SD, 2021, J NEUROTRAUM, V38, P546, DOI 10.1089/neu.2020.7055; ALEXER M, 1995, NEUROLOGY, V45; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Brown KL, 2003, CRIT CARE MED, V31, P28, DOI 10.1097/00003246-200301000-00004; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE K, 2007, J HEAD TRAUMA REHAB, V22; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; De Guise E., 2012, ISRN REHABIL, V2012, P1, DOI [10.5402/2012/534856, DOI 10.5402/2012/534856]; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Giummarra MJ, 2018, CLIN PSYCHOL REV, V62, P11, DOI 10.1016/j.cpr.2018.05.001; Haagsma JA., 2015, J NEUROTRAUM, V32, DOI 10.1089/neu.2013.3283; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Mollayeva T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0432-z; Perroux M, 2013, SANTE PUBLIQUE, V25, P719, DOI 10.3917/spub.136.0719; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; RAPOPORT M, 2005, J NEUROPSYCH CLIN N, V17; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; SMETS E, 1995, J PSYCHOSOM RES, V39; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					751	759		10.1080/02699052.2021.1906950		MAR 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000634582900001	33780305				2022-02-07	
J	Mott, RE; von Reyn, CR; Firestein, BL; Meaney, DF				Mott, Rosalind E.; von Reyn, Catherine R.; Firestein, Bonnie L.; Meaney, David F.			Regional Neurodegeneration in vitro: The Protective Role of Neural Activity	FRONTIERS IN COMPUTATIONAL NEUROSCIENCE			English	Article						traumatic brain injury; neural networks; repair; microtrauma; recovery		Traumatic brain injury is a devastating public health problem, the eighth leading cause of death across the world. To improve our understanding of how injury at the cellular scale affects neural circuit function, we developed a protocol to precisely injure individual neurons within an in vitro neural network. We used high speed calcium imaging to estimate alterations in neural activity and connectivity that occur followed targeted microtrauma. Our studies show that mechanically injured neurons inactivate following microtrauma and eventually re-integrate into the network. Single neuron re-integration is dependent on its activity prior to injury and initial connections in the network: more active and integrated neurons are more resistant to microtrauma and more likely to re-integrate into the network. Micromechanical injury leads to neuronal death 6 h post-injury in a subset of both injured and uninjured neurons. Interestingly, neural activity and network participation after injury were associated with survival in linear discriminate analysis (77.3% correct prediction, Wilks' Lambda = 0.838). Based on this observation, we modulated neuronal activity to rescue neurons after microtrauma. Inhibition of neuronal activity provided much greater survivability than did activation of neurons (ANOVA, p < 0.01 with post-hoc Tukey HSD, p < 0.01). Rescue of neurons by blocking activity in the post-acute period is partially mediated by mitochondrial energetics, as we observed silencing neurons after micromechanical injury led to a significant reduction in mitochondrial calcium accumulation. Overall, the present study provides deeper insight into the propagation of injury within networks, demonstrating that together the initial activity, network structure, and post-injury activity levels contribute to the progressive changes in a neural circuit after mechanical trauma.	[Mott, Rosalind E.] Cell Press, Cambridge, MA USA; [von Reyn, Catherine R.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [von Reyn, Catherine R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Meaney, DF (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Firestein, Bonnie/0000-0002-1679-3565; von Reyn, Catherine/0000-0002-5753-2134	New Jersey Commission on Brain Injury Research [CBIR14IRG019, CBIR17IRG006, CBIR20IRG003]; Rutgers University Brain Health Institute Pilot Grant; Rutgers University Vice Chancellor for Research and Innovation Seed Fund; Paul G. Allen Frontiers Group grant [12347]	This work was funded in part by New Jersey Commission on Brain Injury Research grants #CBIR14IRG019, #CBIR17IRG006, and #CBIR20IRG003 (to BF and DM), a Rutgers University Brain Health Institute Pilot Grant (to BF), a Rutgers University Vice Chancellor for Research and Innovation Seed Funding (to BF), and the Paul G. Allen Frontiers Group grant #12347.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Bas-Orth C, 2013, MECH DEVELOP, V130, P396, DOI 10.1016/j.mod.2012.09.008; Beyder A, 2010, J PHYSIOL-LONDON, V588, P4969, DOI 10.1113/jphysiol.2010.199034; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fujikawa K, 2012, J PHARMACOL SCI, V119, P20, DOI 10.1254/jphs.12034FP; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Graham D.I., 2006, NEUROLOGY TRAUMA NEU, V2nd; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hasel P, 2015, BBA-MOL CELL RES, V1853, P2066, DOI 10.1016/j.bbamcr.2014.12.021; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Kakizawa S, 2012, EMBO J, V31, P417, DOI 10.1038/emboj.2011.386; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Labus KM, 2016, J MECH BEHAV BIOMED, V62, P195, DOI 10.1016/j.jmbbm.2016.05.003; Lamade AM, 2019, NEUROPHARMACOLOGY, V145, P209, DOI 10.1016/j.neuropharm.2018.07.014; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Li XL, 2007, J NEUROPHYSIOL, V98, P3341, DOI 10.1152/jn.00977.2007; Lonardoni D, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005672; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; MURPHY TH, 1993, J NEUROSCI, V13, P2672, DOI 10.1523/JNEUROSCI.13-06-02672.1993; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nigam S, 2016, J NEUROSCI, V36, P670, DOI 10.1523/JNEUROSCI.2177-15.2016; Omelchenko A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1908-3; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pankratov Y, 2009, NEUROSCIENCE, V158, P137, DOI 10.1016/j.neuroscience.2008.03.076; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Patel TP, 2015, J NEUROSCI METH, V243, P26, DOI 10.1016/j.jneumeth.2015.01.020; Patel TP, 2012, ANN BIOMED ENG, V40, P23, DOI 10.1007/s10439-011-0390-6; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Schmeltzer C, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012116; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; Singh S, 2015, BIOMECH MODEL MECHAN, V14, P1303, DOI 10.1007/s10237-015-0675-z; Sniadecki NJ, 2007, METHOD CELL BIOL, V83, P313, DOI 10.1016/S0091-679X(07)83013-5; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tumulty JS, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.022408; Vegue M, 2017, J NEUROSCI, V37, P8498, DOI 10.1523/JNEUROSCI.0984-17.2017; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Yousefsani SA, 2018, J MECH BEHAV BIOMED, V88, P288, DOI 10.1016/j.jmbbm.2018.08.042; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	70	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5188		FRONT COMPUT NEUROSC	Front. Comput. Neurosci.	MAR 29	2021	15								580107	10.3389/fncom.2021.580107			18	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	RL7EU	WOS:000639132400001	33854425	gold, Green Published			2022-02-07	
J	Luo, JM; Xia, ZY; Che, YJ; Zhou, K				Luo, Jiemin; Xia, Zhiyuan; Che, Yanjun; Zhou, Ke			Characteristics, treatments, and prognosis of a critical illness polyneuromyopathy patient with positive anti-GM1 after severe traumatic brain injury: A case report	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						anti&#8208; ganglioside GM1 antibody; critical illness polyneuromyopathy; severe traumatic brain injury		To investigate the clinical features, treatment and prognosis of critical illness polyneuromyopathy (CIPNM) in patients with severe traumatic brain injury (sTBI) who had positive anti-ganglioside GM1 (anti-GM1) antibody IgG. A case of CIPNM with positive anti-GM1 antibody IgG was retrospectively analysed and followed-up for 30 months. After 1 week of treatment with large dose of short-term glucocorticoid and human immunoglobulin, the muscle strength of both lower extremities was restored to grade 1. Three months later, the muscle strength and muscle tension of the patient's limbs returned to normal except for grade 3 of bilateral dorsal extensor muscle strength. In addition, the patient can walk alone with a waddling gait. After 30 months, there was no recurrence. The application of large dose of short-term glucocorticoid and human immunoglobulin to CIPNM that are positive for anti-GM1 antibodies may be an effective treatment.	[Luo, Jiemin; Xia, Zhiyuan; Che, Yanjun; Zhou, Ke] Jingjiang Peoples Hosp, Dept Neurosurg, 28 Zhongzhou Rd, Jingjiang 214500, Peoples R China; [Che, Yanjun] Jingjiang Peoples Hosp, Dept NSICU, 28 Zhongzhou Rd, Jingjiang 214500, Peoples R China		Che, YJ; Zhou, K (corresponding author), Jingjiang Peoples Hosp, Dept Neurosurg, 28 Zhongzhou Rd, Jingjiang 214500, Peoples R China.; Che, YJ (corresponding author), Jingjiang Peoples Hosp, Dept NSICU, 28 Zhongzhou Rd, Jingjiang 214500, Peoples R China.	cheyj2003@163.com; jjrynwkzk@163.com					ALA TA, 1994, ANN NEUROL, V36, P455, DOI 10.1002/ana.410360332; Aureli M, 2016, MOL NEUROBIOL, V53, P1824, DOI 10.1007/s12035-015-9136-z; Bolton CF, 2005, MUSCLE NERVE, V32, P140, DOI 10.1002/mus.20304; BOLTON CF, 1984, J NEUROL NEUROSUR PS, V47, P1223, DOI 10.1136/jnnp.47.11.1223; Cunningham C, 2016, CAN MED ASSOC J, V188, P1104, DOI 10.1503/cmaj.151272; de Jonghe Bernard, 2009, Crit Care Med, V37, pS309, DOI 10.1097/CCM.0b013e3181b6e64c; Druschky A, 2001, INTENS CARE MED, V27, P686, DOI 10.1007/s001340100890; Fan CG, 2017, MUSCLE NERVE, V55, P470, DOI 10.1002/mus.25266; Galban-Horcajo Francesc, 2015, J Neuromuscul Dis, V2, P157; Grimm A, 2012, MED KLIN-INTENSIVMED, V107, P649, DOI 10.1007/s00063-012-0186-y; Hotta S, 2014, NEUROL SCI, V35, P205, DOI 10.1007/s10072-013-1480-z; Hund E, 2001, J NEUROL, V248, P929, DOI 10.1007/s004150170043; Intiso D, 2017, EUR J PHYS REHAB MED, V53, P910, DOI 10.23736/S1973-9087.17.04595-6; Kelmenson DA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2281-9; Khan J, 2008, CRIT CARE CLIN, V24, P165, DOI 10.1016/j.ccc.2007.10.004; Kieseier BC, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0027-2; Korinthenberg R, 2020, EUR J PAEDIATR NEURO, V25, P5, DOI 10.1016/j.ejpn.2020.01.003; Lardone RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19901; Latronico N, 1996, LANCET, V347, P1579, DOI 10.1016/S0140-6736(96)91074-0; Lopate G, 2011, CURR TREAT OPTION NE, V13, P131, DOI 10.1007/s11940-011-0114-0; Magistretti PJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00859; Mahashabde M, 2020, INDIAN J CRIT CARE M, V24, P133, DOI 10.5005/jp-journals-10071-23346; Naik GS, 2017, NEUROL INDIA, V65, P1001, DOI 10.4103/neuroindia.NI_1226_15; Novak KR, 2009, J CLIN INVEST, V119, P1150, DOI 10.1172/JCI36570; Rich MM, 2003, J PHYSIOL-LONDON, V547, P555, DOI 10.1113/jphysiol.2002.035188; Shepherd S, 2017, NEUROHOSPITALIST, V7, P41, DOI 10.1177/1941874416663279; Stevens RD, 2007, INTENS CARE MED, V33, P1876, DOI 10.1007/s00134-007-0772-2; Tennila A, 2000, INTENS CARE MED, V26, P1360, DOI 10.1007/s001340000586; Wu XJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001898	29	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1870	1440-1681		CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	JUN	2021	48	6					831	836		10.1111/1440-1681.13496		MAR 2021	6	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	RZ2SR	WOS:000634118900001	33715175				2022-02-07	
J	George, AK; Behera, J; Homme, RP; Tyagi, N; Tyagi, SC; Singh, M				George, Akash K.; Behera, Jyotirmaya; Homme, Rubens P.; Tyagi, Neetu; Tyagi, Suresh C.; Singh, Mahavir			Rebuilding Microbiome for Mitigating Traumatic Brain Injury: Importance of Restructuring the Gut-Microbiome-Brain Axis	MOLECULAR NEUROBIOLOGY			English	Article						1-Carbon metabolism; Central nervous system; Ocular function; Retinal remodeling; Brain trauma	CENTRAL-NERVOUS-SYSTEM; BONE MORPHOGENETIC PROTEIN-6; PITUITARY-ADRENAL AXIS; LONG-TERM DISABILITY; ALZHEIMERS-DISEASE; UNITED-STATES; TGF-BETA; INTESTINAL MICROBIOTA; MATERNAL SEPARATION; TRANSFORMING GROWTH-FACTOR-BETA-1	Traumatic brain injury (TBI) is a damage to the brain from an external force that results in temporary or permanent impairment in brain functions. Unfortunately, not many treatment options are available to TBI patients. Therefore, knowledge of the complex interplay between gut microbiome (GM) and brain health may shed novel insights as it is a rapidly expanding field of research around the world. Recent studies show that GM plays important roles in shaping neurogenerative processes such as blood-brain-barrier (BBB), myelination, neurogenesis, and microglial maturation. In addition, GM is also known to modulate many aspects of neurological behavior and cognition; however, not much is known about the role of GM in brain injuries. Since GM has been shown to improve cellular and molecular functions via mitigating TBI-induced pathologies such as BBB permeability, neuroinflammation, astroglia activation, and mitochondrial dysfunction, herein we discuss how a dysbiotic gut environment, which in fact, contributes to central nervous system (CNS) disorders during brain injury and how to potentially ward off these harmful effects. We further opine that a better understanding of GM-brain (GMB) axis could help assist in designing better treatment and management strategies in future for the patients who are faced with limited options.	[George, Akash K.; Homme, Rubens P.; Singh, Mahavir] Univ Louisville, Sch Med, Dept Physiol, Eye & Vis Sci Lab, Louisville, KY 40202 USA; [George, Akash K.; Homme, Rubens P.; Tyagi, Suresh C.; Singh, Mahavir] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA; [Behera, Jyotirmaya; Tyagi, Neetu] Univ Louisville, Sch Med, Dept Physiol, Bone Biol Lab, Louisville, KY 40202 USA		Singh, M (corresponding author), Univ Louisville, Sch Med, Dept Physiol, Eye & Vis Sci Lab, Louisville, KY 40202 USA.; Singh, M (corresponding author), Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA.	mahavir.singh@louisville.edu		Singh, Mahavir/0000-0002-2415-3314	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AR-71789, HL139047, DK116591]	A part of this work was supported by NIH grants AR-71789, HL139047, and DK116591.	Aguilar-Valles A, 2015, NEUROPHARMACOLOGY, V96, P124, DOI 10.1016/j.neuropharm.2014.12.023; Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Atarashi K, 2011, CURR OPIN IMMUNOL, V23, P761, DOI 10.1016/j.coi.2011.11.002; Axer-Siegel R, 2004, AM J OPHTHALMOL, V137, P84, DOI 10.1016/S0002-9394(03)00864-X; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Behera J, 2017, J CELL PHYSIOL, V232, P2704, DOI 10.1002/jcp.25693; Beli E, 2018, DIABETES, V67, P1867, DOI 10.2337/db18-0158; Berg M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08379-8; Bhattacharjee S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00153; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bibbo S, 2017, ANN MED, V49, P11, DOI 10.1080/07853890.2016.1222449; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Byrne ML, 2015, CHILD PSYCHIAT HUM D, V46, P839, DOI 10.1007/s10578-014-0524-9; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Caracciolo B, 2014, MECH AGEING DEV, V136, P59, DOI 10.1016/j.mad.2013.11.011; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cavaleri F, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/7195760; Chen J, 2018, J NEUROSCI, V38, P3840, DOI 10.1523/JNEUROSCI.2031-17.2018; Cheng FS, 2020, WORLD J CLIN CASES, V8, P1361, DOI 10.12998/wjcc.v8.i8.1361; Chervonsky AV, 2012, CURR OPIN IMMUNOL, V24, P255, DOI 10.1016/j.coi.2012.03.002; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clark JF, 2018, G3-GENES GENOM GENET, V8, P343, DOI 10.1534/g3.117.300416; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cowan CSM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.94; Cristoni S, 2019, RAPID COMMUN MASS SP, V33, P1221, DOI 10.1002/rcm.8461; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dalfo D, 2012, CURR BIOL, V22, P712, DOI 10.1016/j.cub.2012.02.064; De Palma G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8735; de Theije CGM, 2014, BRAIN BEHAV IMMUN, V37, P197, DOI 10.1016/j.bbi.2013.12.005; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dewan S, 2018, EXPERT OPIN BIOL TH, V18, P515, DOI 10.1080/14712598.2018.1439473; Dinan TG, 2017, PSYCHOSOM MED, V79, P920, DOI 10.1097/PSY.0000000000000519; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Douglas-Escobar M, 2013, JAMA PEDIATR, V167, P374, DOI 10.1001/jamapediatrics.2013.497; Duan YQ, 2019, CIRC RES, V125, P969, DOI 10.1161/CIRCRESAHA.119.315743; Durgan DJ, 2019, STROKE, V50, P2270, DOI 10.1161/STROKEAHA.119.025140; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Floyd JL, 2020, OPHTHALMOL THER, V9, P499, DOI 10.1007/s40123-020-00278-2; Fond G, 2015, PATHOL BIOL, V63, P35, DOI 10.1016/j.patbio.2014.10.003; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Garcia A, 2004, CAN MED ASSOC J, V171, P897, DOI 10.1503/cmaj.1031586; Gavin PG, 2018, DIABETES CARE, V41, P2178, DOI 10.2337/dc18-0777; George AK, 2020, J CELL PHYSIOL, V235, P2590, DOI 10.1002/jcp.29163; George AK, 2020, CAN J PHYSIOL PHARM, V98, P51, DOI 10.1139/cjpp-2019-0236; Gerth C, 2008, J AAPOS, V12, P591, DOI 10.1016/j.jaapos.2008.06.008; Ghaisas S, 2016, PHARMACOL THERAPEUT, V158, P52, DOI 10.1016/j.pharmthera.2015.11.012; Ghorbanihaghjo A, 2008, MOL VIS, V14, P1692; Goldsworthy MR, 2013, J NEUROSCI, V33, P12910, DOI 10.1523/JNEUROSCI.2252-13.2013; Goszczynski B, 2016, DEV BIOL, V413, P112, DOI 10.1016/j.ydbio.2016.02.031; Gumienny Tina L, 2013, WormBook, P1, DOI 10.1895/wormbook.1.22.2; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Han B, 2017, CELL, V169, P1249, DOI 10.1016/j.cell.2017.05.036; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Heissigerova J, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5065703; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hill JM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00127; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Howard Benjamin M, 2017, Trauma Surg Acute Care Open, V2, pe000108, DOI 10.1136/tsaco-2017-000108; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huang RQ, 2010, NEUROSCI LETT, V473, P22, DOI 10.1016/j.neulet.2010.02.011; Huang XY, 2018, INVEST OPHTH VIS SCI, V59, P1523, DOI 10.1167/iovs.17-22677; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hyland NP, 2015, NEUROGASTROENT MOTIL, V27, P105, DOI 10.1111/nmo.12486; Hylin MJ, 2018, DEV NEUROSCI-BASEL, V40, P175, DOI 10.1159/000488343; Jacobs SM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0389-5; Janowitz C, 2019, INVEST OPHTH VIS SCI, V60, P420, DOI 10.1167/iovs.18-24813; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Javadzadeh A, 2010, MOL VIS, V16, P2578; Jogia T, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00704; Kade Grzegorz, 2012, Med Sci Monit, V18, pCR771; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Kasselman LJ, 2018, ATHEROSCLEROSIS, V271, P203, DOI 10.1016/j.atherosclerosis.2018.02.036; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Khorjahani A, 2020, BASIC CLIN NEUROSCI, V11, P69, DOI 10.32598/bcn.9.10.450; Kigerl KA, 2018, NEUROTHERAPEUTICS, V15, P60, DOI 10.1007/s13311-017-0583-2; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Klimova A, 2016, BIOMED PAP, V160, P140, DOI 10.5507/bp.2015.056; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kobeissy, 2015, BRAIN NEUROTRAUMA MO; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Komuta Y, 2010, CELL MOL NEUROBIOL, V30, P101, DOI 10.1007/s10571-009-9435-x; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Kumar KP, 2020, CURR OPIN NEUROBIOL, V62, P10, DOI 10.1016/j.conb.2019.10.002; Kumar M, 2017, AM J PHYSIOL-GASTR L, V312, pG34, DOI 10.1152/ajpgi.00298.2016; Laha A, 2018, CAN J PHYSIOL PHARM, V96, P971, DOI 10.1139/cjpp-2018-0037; Lewen A, 1997, NEUROREPORT, V8, P475, DOI 10.1097/00001756-199701200-00020; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Liang J, 2007, DEV BIOL, V305, P714, DOI 10.1016/j.ydbio.2007.02.038; Lin P, 2019, CLIN EXP OPHTHALMOL, V47, P418, DOI 10.1111/ceo.13493; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Ma QQ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1434-3; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260; Madaan U, 2018, GENETICS, V210, P1355, DOI 10.1534/genetics.118.301631; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Maltsev AV, 2011, AGEING RES REV, V10, P440, DOI 10.1016/j.arr.2011.03.002; Martinez G, 2001, BRAIN RES, V894, P1, DOI 10.1016/S0006-8993(00)03140-1; Mattson MP, 2003, ANN INTERN MED, V139, P441, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00012; Mattson MP, 2002, AGEING RES REV, V1, P95, DOI 10.1016/S0047-6374(01)00365-7; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Micheal S, 2009, MOL VIS, V15, P2268; Mohajeri MH, 2018, NUTR REV, V76, P481, DOI 10.1093/nutrit/nuy009; Molnar J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01730; Moos WH, 2016, BIORESEARCH OPEN ACC, V5, P137, DOI 10.1089/biores.2016.0010; Mulle JG, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0337-0; Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030; Nakamura YK, 2016, INVEST OPHTH VIS SCI, V57, P3747, DOI 10.1167/iovs.16-19733; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Nilsson K, 2007, DEMENT GERIATR COGN, V24, P162, DOI 10.1159/000105562; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; O'Mahony SM, 2011, PSYCHOPHARMACOLOGY, V214, P71, DOI 10.1007/s00213-010-2010-9; Ozdemir V, 2007, J INVEST MED, V55, P315, DOI 10.2310/6650.2007.00014; Paun A, 2015, CURR OPIN IMMUNOL, V37, P34, DOI 10.1016/j.coi.2015.09.004; Pavelescu D., 2014, CRIT CARE, V18, P472, DOI [10.1186/cc13662, DOI 10.1186/CC13662]; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Pirbaglou M, 2016, NUTR RES, V36, P889, DOI 10.1016/j.nutres.2016.06.009; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Rice MW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00875; Rincel M, 2020, P NUTR SOC, V79, P113, DOI 10.1017/S0029665119000958; Rizowy GM, 2020, BIOCHIMIE, V173, P3, DOI 10.1016/j.biochi.2020.02.013; Rodriguez-Fandino O, 2013, NEUROGASTROENT MOTIL, V25, P872, DOI 10.1111/nmo.12204; Salthouse TA, 2009, J INT NEUROPSYCH SOC, V15, P650, DOI 10.1017/S1355617709990385; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Savage-Dunn C, 2001, CYTOKINE GROWTH F R, V12, P305, DOI 10.1016/S1359-6101(01)00015-6; Savage-Dunn C, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022178; Savage-Dunn C, 2011, GENET RES, V93, P427, DOI 10.1017/S0016672311000310; Savignac HM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00013; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schaffer S, 2012, MOL NEUROBIOL, V46, P161, DOI 10.1007/s12035-012-8282-9; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Severance EG, 2012, SCHIZOPHR RES, V138, P48, DOI 10.1016/j.schres.2012.02.025; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Singh M, 2021, CAN J PHYSIOL PHARM, V99, P56, DOI 10.1139/cjpp-2020-0093; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Sohail MU, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/9631435; Stanisic D, 2021, CAN J PHYSIOL PHARM, V99, P115, DOI 10.1139/cjpp-2020-0224; Stanisic D, 2021, CAN J PHYSIOL PHARM, V99, P9, DOI 10.1139/cjpp-2020-0215; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sun J, 2016, BRAIN RES, V1642, P180, DOI 10.1016/j.brainres.2016.03.042; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tan BYQ, 2020, ANN INDIAN ACAD NEUR, V23, P155, DOI 10.4103/aian.AIAN_483_19; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tchantchou F, 2021, CELL MOL NEUROBIOL, V41, P487, DOI 10.1007/s10571-020-00866-7; Tengeler AC, 2018, NUTR REV, V76, P603, DOI 10.1093/nutrit/nuy016; Tjiattas L, 2004, AGING CELL, V3, P71, DOI 10.1111/j.1474-9728.2004.00086.x; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Tyagi SC, 2021, MOL CELL BIOCHEM, V476, P507, DOI 10.1007/s11010-020-03895-4; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; Viano DC, 2017, TRAFFIC INJ PREV, V18, P616, DOI 10.1080/15389588.2017.1285023; Wang HX, 2016, CHINESE MED J-PEKING, V129, P2373, DOI 10.4103/0366-6999.190667; Wang HY, 2016, J NEUROGASTROENTEROL, V22, P589, DOI 10.5056/jnm16018; Wang JJ, 2005, DEVELOPMENT, V132, P3505, DOI 10.1242/dev.01930; Wen SW, 2017, GUT MICROBES, V8, P601, DOI 10.1080/19490976.2017.1344809; Winek K, 2016, J CEREBR BLOOD F MET, V36, P891, DOI 10.1177/0271678X16636890; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Ye Z, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0520-6; Yi LJ, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000015426, 10.1097/md.0000000000015426]; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang YX, 2021, EXP NEUROL, V337, DOI 10.1016/j.expneurol.2020.113585; Zhang Z, 2006, NEUROSCIENCE, V138, P47, DOI 10.1016/j.neuroscience.2005.11.036; Zhao YL, 2015, J APPL ANAL COMPUT, V5, P177; Zhu SB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1705-z; Zinno P, 2020, EUR J NUTR, V59, P345, DOI 10.1007/s00394-019-01911-y; Zou CG, 2010, NEUROBIOL AGING, V31, P2069, DOI 10.1016/j.neurobiolaging.2008.11.007; [No title captured], DOI DOI 10.1895/WORMB00K.1.22.1	194	0	0	2	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2021	58	8					3614	3627		10.1007/s12035-021-02357-2		MAR 2021	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TJ4YM	WOS:000633772000001	33774742	Green Published, Bronze			2022-02-07	
J	Lin, CH; Chou, C; Hong, YY				Lin, Chien-Heng; Chou, I-Ching; Hong, Syuan-Yu			Genetic factors and the risk of drug-resistant epilepsy in young children with epilepsy and neurodevelopment disability A prospective study and updated meta-analysis	MEDICINE			English	Article						children; drug-resistant epilepsy; genetic; infant; neurodevelopmental disability	TRAUMATIC BRAIN-INJURY; MECHANISMS; ONSET; PATHOGENESIS; POPULATION; PREDICTORS; MUTATIONS; PROGNOSIS; SEIZURES; AGE	Drug-resistant epilepsy (DRE) affects 7% to 20% of children with epilepsy. Although some risk factors for DRE have been identified, the results have not been consistent. Moreover, data regarding the risk factors for epilepsy and its seizure outcome in the first 2 years of life are limited. We analyzed data for children aged 0 to 2 years with epilepsy and neurodevelopmental disability from January, 2013, through December, 2017. These patients were followed up to compare the risk of DRE in patients with genetic defect (genetic group) with that without genetic defect (nongenetic group). Additionally, we conducted a meta-analysis to identify the pooled prevalence of genetic factors in children with DRE. A total of 96 patients were enrolled. A total of 68 patients were enrolled in the nongenetic group, whereas 28 patients were enrolled in the genetic group. The overall DRE risk in the genetic group was 6.5 times (95% confidence interval [CI], 2.15-19.6; p = 0.03) higher than that in the nongenetic group. Separately, a total of 1308 DRE patients were participated in the meta-analysis. The pooled prevalence of these patients with genetic factors was 22.8% (95% CI 17.4-29.3). The genetic defect plays a crucial role in the development of DRE in younger children with epilepsy and neurodevelopmental disability. The results can serve as a reference for further studies of epilepsy panel design and may also assist in the development of improved treatments and prevention strategies for DRE.	[Lin, Chien-Heng] China Med Univ, Childrens Hosp, Div Pediat Pulmonol, Taichung, Taiwan; [Lin, Chien-Heng] China Med Univ, Coll Med, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Chou, I-Ching; Hong, Syuan-Yu] China Med Univ, Childrens Hosp, Div Pediat Neurol, Taichung, Taiwan; [Chou, I-Ching] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan		Hong, YY (corresponding author), China Med Univ Hosp, Dept Pediat, 2 Yuh Der Rd, Taichung 404, Taiwan.	dazingdog@hotmail.com					Ambrogini P, 2019, BBA-MOL BASIS DIS, V1865, P1098, DOI 10.1016/j.bbadis.2019.01.026; Berg AT, 2012, NEUROLOGY, V79, P1384, DOI 10.1212/WNL.0b013e31826c1b55; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; BRORSON LO, 1987, EPILEPSIA, V28, P324, DOI 10.1111/j.1528-1157.1987.tb03651.x; Bui TT, 2002, AM J EMERG MED, V20, P518, DOI 10.1053/ajem.2002.34796; Callaghan BC, 2007, ANN NEUROL, V62, P382, DOI 10.1002/ana.21166; Chawla S, 2002, PEDIATR NEUROL, V27, P186, DOI 10.1016/S0887-8994(02)00416-2; Chen T, 2017, NEUROPSYCH DIS TREAT, V13, P1841, DOI 10.2147/NDT.S142032; Cormack F, 2007, EPILEPSIA, V48, P201, DOI 10.1111/j.1528-1167.2006.00904.x; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; Depondt C, 2006, EUR J PAEDIATR NEURO, V10, P57, DOI 10.1016/j.ejpn.2005.11.009; Dlugos DJ, 2001, NEUROLOGY, V57, P2259, DOI 10.1212/WNL.57.12.2259; Fangsaad T, 2019, J CLIN NEUROSCI, V59, P119, DOI 10.1016/j.jocn.2018.10.117; Fujikawa DG, 2015, COMPUT STRUCT BIOTEC, V13, P212, DOI 10.1016/j.csbj.2015.03.004; Glass HC, 2011, PEDIATR RES, V70, P535, DOI 10.1203/PDR.0b013e31822f24c7; Grass B., 2019, J MATERN-FETAL NEO M, V34, P1020; Hermann BP, 2006, ANN NEUROL, V60, P80, DOI 10.1002/ana.20872; Ho MH, 2018, EPILEPSIA OPEN, V4, P63; Howell KB, 2018, EPILEPSIA, V59, P1177, DOI 10.1111/epi.14087; Hughes DM, 2018, NEUROLOGY, V91, pE2035, DOI 10.1212/WNL.0000000000006564; Kalilani L, 2018, EPILEPSIA, V59, P2179, DOI 10.1111/epi.14596; Kang KW, 2019, PEERJ, V7, DOI 10.7717/peerj.8278; Kwan P, 2004, CNS SPECTRUMS, V9, P110, DOI 10.1017/S1092852900008476; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Levite M, 2014, J NEURAL TRANSM, V121, P1029, DOI 10.1007/s00702-014-1193-3; Liu J, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0392-5; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Margineanu DG, 2009, EXPERT OPIN DRUG DIS, V4, P23, DOI 10.1517/17460440802611729; Marsh ED, 2006, EPILEPSIA, V47, P1999, DOI 10.1111/j.1528-1167.2006.00894.x; Mhatre D., 2018, CHILD NEUROL OPEN, V5; MONAGHAN DT, 1983, NATURE, V306, P176, DOI 10.1038/306176a0; Myers KA, 2019, CLIN GENET, V95, P95, DOI 10.1111/cge.13414; Nalivaeva NN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00825; Oates S, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0052-9; Parrini E, 2017, HUM MUTAT, V38, P216, DOI 10.1002/humu.23149; Peng J, 2019, CNS NEUROSCI THER, V25, P14, DOI 10.1111/cns.12869; Poudel P, 2016, IRAN J CHILD NEUROL, V10, P48; Ream MA, 2014, EPILEPSY BEHAV, V37, P241, DOI 10.1016/j.yebeh.2014.06.018; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Segal E, 2016, PEDIATR NEUROL, V64, P66, DOI 10.1016/j.pediatrneurol.2016.06.019; Singh R, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8781725; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Stafstrom CE, 2016, EPILEPSY CURR, V16, DOI 10.5698/1535-7511-16.4.273; Symonds JD, 2019, BRAIN, V142, P2303, DOI 10.1093/brain/awz195; Tang F, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00301; Vasconcellos E, 2001, EPILEPSIA, V42, P268; Vitaliti G, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00118; Voll A, 2015, EPILEPSY BEHAV, V53, P126, DOI 10.1016/j.yebeh.2015.09.027; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Wang J, 2017, SEIZURE-EUR J EPILEP, V44, P11, DOI 10.1016/j.seizure.2016.11.030; Wang XP, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016402; Westover MB, 2012, EPILEPSIA, V53, P368, DOI 10.1111/j.1528-1167.2011.03355.x; Wu CC, 2020, EPILEPSY BEHAV, V106, DOI 10.1016/j.yebeh.2020.107003	54	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR 26	2021	100	12							e25277	10.1097/MD.0000000000025277			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SP2WP	WOS:000659535100107	33761731	Green Published, gold			2022-02-07	
J	Tranter-Entwistle, I; Evans, M; Johns, S; Fleischer, D; Wakeman, C				Tranter-Entwistle, Isaac; Evans, Melissa; Johns, Simon; Fleischer, Dominic; Wakeman, Christopher			What a headache! Reviewing mild traumatic brain injury management in a new trauma service	NEW ZEALAND MEDICAL JOURNAL			English	Article							GLASGOW COMA SCALE; POSTTRAUMATIC AMNESIA; INTERVENTIONS	AIM: Mild traumatic brain injury (mild TBI) is a common, poorly managed condition with an underestimated impact and inadequate follow-up. This study aimed to assess local practice in terms of assessment and follow-up. METHODS: A retrospective review of all patients presenting to Christchurch Hospital between 1 August 2019 and 30 September 2019 with ICD-10 coded diagnosis of head trauma was conducted. Patients younger than 16 or older than 80 years who had a concurrent medical illness or who did not meet diagnostic criteria for mild TBI were excluded. This was to minimise diagnostic uncertainty where patients may have had mild TBI like symptoms due to alternate pathology. Primary outcomes included documentation of post-traumatic amnesia (PTA) with the Abbreviated Westmead Post-Traumatic Amnesia Scale (A-WPTAS), provision of mild TBI information, the proportion referred for follow-up and the proportion followed up at the mild TBI clinic. Demographic data included age, sex, ethnicity, mechanism of injury, admission service and rate of admission. RESULTS: A total of 525 patients were identified, with 239 patients included. Median age was 29 years (IQR 22-50) and 65.3% (n=156) were male. The most common mechanisms of injury were falls (25.5%, n=61) and assault (25.5%, n=61). The most-commonly recorded diagnosis was head injury (41.4%, n=99), followed by concussion (34.3%, n=82). A-WPTAS was documented for 4.2% of patients (n=10). The provision of written mild TBI advice to patients was documented in 61.5% of cases (n=147). On discharge, no follow-up was documented for 63.6% of patients (n=152). In those with documented follow-up, 23.4% (n=56) was with a general practitioner (GP) and 5.4% (n=13) were referred to mild TBI clinic. Review of Accident Corporation Commission (ACC) records identified claims for 80.3% (n=192) of the cohort. Of these, 11.5% (n=22) received a payment for mild TBI services and 2.1% (n=4) had their service provided by Christchurch Hospital. CONCLUSION: The results suggest that current management of mild TBI at Christchurch Hospital needs improvement. Accurate diagnostic coding allows patients to access ACC-funded clinics. The utilisation rates of these clinics confirm that the frequency of specialist follow-up is low, which is in keeping with the international literature. Furthermore, given the strongly predictive nature of post-traumatic amnesia for outcomes, the low rate of A-WPTAS assessment is concerning. These results suggest that a mild TBI protocol is needed to standardise assessment, management and follow-up.	[Tranter-Entwistle, Isaac; Evans, Melissa; Johns, Simon; Wakeman, Christopher] Canterbury Dist Hlth Board, Christchurch Hosp, Christchurch, New Zealand; [Fleischer, Dominic] Canterbury Dist Hlth Board, Christchurch Hosp, Emergency Med, Christchurch, New Zealand		Tranter-Entwistle, I (corresponding author), Christchurch Hosp, 2 Riccarton Ave, Christchurch, New Zealand.	tranter.isaac@gmail.com					Accenture Global Credit Data and the Institute of International Finance, 2019, CONCUSSION SERVICE, P1; Accident Compensation Corporation, 2017, TRAUMATIC BRAIN INJU, P1; [Anonymous], 2016, ICD10 WHO; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bosch M, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-018-0841-7; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; Leathem, 2004, NZ MED J, V10, P1201; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2015, ARCH PHYS MED REHAB, V96, P956, DOI 10.1016/j.apmr.2014.12.014; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Snell D, 2006, NEW ZEAL MED J, V119, P66; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Watson CE, 2017, SCAND J SURG, V106, P356, DOI 10.1177/1457496917698642	29	0	0	0	0	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	MAR 26	2021	134	1532					59	66					8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RF2AC	WOS:000634646000007	33767477				2022-02-07	
J	Wang, D; Zhou, ZL; Zhang, BJ; Zhang, B; Yang, HF				Wang, Dan; Zhou, Zhulin; Zhang, Bingjie; Zhang, Bo; Yang, Hongfa			Effects of STC on postoperative recovery of disturbance of consciousness in traumatic multiple intracranial hematoma patients	MEDICINE			English	Article						consciousness; disturbance; postoperative recovery; standard trauma craniectomy; traumatic multiple intracranial hematoma	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; PROGNOSTIC VALUE; MANAGEMENT	Objective: The study explored the therapeutic value of standard trauma craniectomy (STC) for the treatment of traumatic multiple intracranial hematoma. Methods: Clinical data of traumatic multiple intracranial hematoma patients who underwent surgical treatment in 2014 and 2015 were collected. The STC group and a control group according to the surgical mode, 48 and 30 cases were randomly selected from each group, respectively. Statistical analysis was performed on the change in the Glasgow coma scale (GCS) score from before the operation to 1 day, 1 week and 1 month postoperatively through repeated analysis of variance and Wilcoxon rank-sum analysis. Results: Significant differences in the GCS were observed at different time points for the two operative modes (P < .01), and an interaction was observed between time and treatment groups (P < .05). The rates of change of the GCS score for the two surgical modes were most obviously different at 3 days and 1 week postoperatively (P <= .001, P < .01). No statistically significant differences were observed in the rates of change of the GCS at 1 month postoperatively (P > .05). Conclusions: Compared to conventional craniotomy, STC has obvious effects on the recovery after disturbance of consciousness at 1 week postoperatively but does not result in a significant improvement in recovery at 1 month postoperatively.	[Wang, Dan; Zhang, Bingjie] First Hosp Jilin Univ, Dept Ophthalmol, Changchun, Jilin, Peoples R China; [Wang, Dan; Zhou, Zhulin; Zhang, Bo] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Neurobiol Care Sci & Soc, Div Neurodegernerat, Stockholm, Sweden; [Zhang, Bo; Yang, Hongfa] First Hosp Jilin Univ, Dept Neurosurg, 1 Xinmin Ave, Changchun 130021, Jilin, Peoples R China		Yang, HF (corresponding author), First Hosp Jilin Univ, Dept Neurosurg, 1 Xinmin Ave, Changchun 130021, Jilin, Peoples R China.	yhf@jlu.edu.cn			Noninvasive ultrasonic intracranial pressure detector project - Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences [2016220101000791]; Science and Technology Department of Jilin Province [20200404161YY, YDZJ202101ZYTS098]	The author(s) received the financial support for the Noninvasive ultrasonic intracranial pressure detector project (No. 2016220101000791) supported by Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences. And the financial also support for the development of mini high frequency intervention ultrasound navigation system and its application in diagnosis and treatment of puncture project (No. 20200404161YY) supported by Science and Technology Department of Jilin Province and Science and Technology Department of Jilin Province (Collaborative Fund project); (YDZJ202101ZYTS098).	Alexander E, 2001, NEUROSURGERY, V48, P704, DOI 10.1097/00006123-200103000-00065; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Motohashi O, 2003, NEUROL SURG TOKYO, V31, P529; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Romodanov A P, 1975, Vopr Neirokhir, P3; Schneider GH, 2002, ACT NEUR S, V81, P77; Vigue B, 2003, NEUROCHIRURGIE, V49, P583; Yang CH, 2014, NEUROSCIENCES, V19, P306	17	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR 26	2021	100	12							e25032	10.1097/MD.0000000000025032			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SP2WP	WOS:000659535100036	33761660	gold			2022-02-07	
J	Chhiber, SS; Gu, A; Arif, S; Wani, AA; Ramzan, AU				Chhiber, Sarbjit Singh; Gu, Adfer; Arif, Sajad; Wani, Abrar Ahad; Ramzan, Altaf Umar			Serum Progesterone Levels as Predictor of Outcome in Severe Traumatic Brain Injury: Analysis of Cohort of 100 Patients	INDIAN JOURNAL OF NEUROSURGERY			English	Article						severe traumatic brain injury; progesterone; biochemical marker; outcome		Despite advances in research and improved neurological intensive care in recent years, the clinical outcome of severely head injured patients is still poor. Primary insult is followed by a complex cascade of molecular and biochemical events that lead to neuroinflammation, brain edema, and delayed neuronal death. No specific pharmacological therapy is currently available which prevents the development of secondary brain injuries, and most therapeutic strategies have failed in translation from bench to bedside. There are limitations of clinical and radiological methods in delineating the exact severity and prognosis of traumatic brain injury (TBI). A myriad complex biochemical markers are under investigation to delineate the extent of brain tissue damage and to independently predict the outcome, but a search for simple biomarker still eludes the research. Progesterone, a gonadal hormone and a neurosteroid, although controversial as a neuroprotective agent, may hold promise as a simple biochemical marker of the outcome in severe TBI.	[Chhiber, Sarbjit Singh; Arif, Sajad; Wani, Abrar Ahad; Ramzan, Altaf Umar] Sher E Kashmir Inst Med Sci, Dept Neurosurg, Srinagar 190011, Jammu & Kashmir, India; [Gu, Adfer] Sher E Kashmir Inst Med Sci, Dept Plast Surg, Srinagar, Jammu & Kashmir, India		Chhiber, SS (corresponding author), Sher E Kashmir Inst Med Sci, Dept Neurosurg, Srinagar 190011, Jammu & Kashmir, India.	sarabjitchhiber@gmall.com					Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V7, P125, DOI 10.1016/0891-5849(89)90003-8; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; CLARK WM, 1995, DRUGS, V50, P971, DOI 10.2165/00003495-199550060-00005; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dasgupta A., 2012, J NEUROL RES, V2, P44; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; Dhandapani SS, 2010, INDIAN J NEUROTRAUM, V7, P23, DOI 10.1016/S0973-0508(10)80007-3; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Woolhandler S, 2007, MED CARE, V45, P699, DOI 10.1097/MLR.0b013e3180f62b9f; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; 2007, J NEUROTRAUM, V24, pS1, DOI DOI doi:10.1089/neu.2007.9998	37	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.	DEC	2021	10	03					230	235		10.1055/s-0041-1726610		MAR 2021	6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	XV0EH	WOS:000632602500002		gold			2022-02-07	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, N. W.; Hutchison, M. G.; Graham, S. J.; Schweizer, T. A.			Long-term changes in the small-world organization of brain networks after concussion	SCIENTIFIC REPORTS			English	Article							DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; RECURRENT CONCUSSION; WHITE-MATTER; EFFICIENCY; INJURY; SPORT; INDIVIDUALS	There is a growing body of literature using functional MRI to study the acute and long-term effects of concussion on functional brain networks. To date, studies have largely focused on changes in pairwise connectivity strength between brain regions. Less is known about how concussion affects whole-brain network topology, particularly the "small-world" organization which facilitates efficient communication at both local and global scales. The present study addressed this knowledge gap by measuring local and global efficiency of 26 concussed athletes at acute injury, return to play (RTP) and one year post-RTP, along with a cohort of 167 athletic controls. On average, concussed athletes showed no alterations in local efficiency but had elevated global efficiency at acute injury, which had resolved by RTP. Athletes with atypically long recovery, however, had reduced global efficiency at 1 year post-RTP, suggesting long-term functional abnormalities for this subgroup. Analyses of nodal efficiency further indicated that global network changes were driven by high-efficiency visual and sensorimotor regions and low-efficiency frontal and subcortical regions. This study provides evidence that concussion causes subtle acute and long-term changes in the small-world organization of the brain, with effects that are related to the clinical profile of recovery.	[Churchill, N. W.; Hutchison, M. G.; Schweizer, T. A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Churchill, N. W.; Schweizer, T. A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, M. G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, S. J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Graham, S. J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schweizer, T. A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, T. A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.	nchurchill.research@gmail.com			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN356342-401065, RN294001-367456]; Canadian Institute for Military and Veterans Health Research (CIMVHR) [W7714-145967]; Siemens Healthineers Canada	This work was supported by the Canadian Institutes of Health Research (CIHR) [Grant numbers RN356342-401065, RN294001-367456]; the Canadian Institute for Military and Veterans Health Research (CIMVHR) [Grant number W7714-145967]; and Siemens Healthineers Canada.	ABBAS K, 2015, J APPL PHYSIOL, V5, P91, DOI DOI 10.1089/BRAIN.2014.0279; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bailey DM, 2011, EXP PHYSIOL, V96, P1196, DOI 10.1113/expphysiol.2011.060178; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; BULLMORE E, 2012, JAMA-J AM MED ASSOC, V13, P336, DOI DOI 10.1038/NRN3214; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; CHURCHILL N, 2020, BRAIN IMAGING BEHAV, V2, P10; Churchill NW, 2020, HUM BRAIN MAPP, V41, P2567, DOI 10.1002/hbm.24962; Churchill NW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58073-9; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2016, NEURAL COMPUT, V28, P2250, DOI 10.1162/NECO_a_00877; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; HILLARY F, 2017, PHYS REV LETT, V21, P385, DOI DOI 10.1016/J.TICS.2017.03.003; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; PIT A, 2013, NEUROLOGY, V80, P1826, DOI DOI 10.1212/WNL.0B013E3182929F38; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Simard D, 2005, PHYS LETT A, V336, P8, DOI 10.1016/j.physleta.2004.12.078; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; SPORNS O, 2007, NAT REV NEUROSCI, V2, DOI DOI 10.1371/JOURNAL.PONE.0001049; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011; Tarlochan F., 2013, INT, V2, P17; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; VIANO D, 2005, TRENDS COGN SCI, V57, P891, DOI DOI 10.1227/01.NEU.0000186950.54075.3B; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	60	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAR 25	2021	11	1							6862	10.1038/s41598-021-85811-4			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RG7FJ	WOS:000635699600023	33767293	gold, Green Published			2022-02-07	
J	Selveindran, SM; Samarutilake, GDN; Vera, DS; Brayne, C; Hill, C; Kolias, A; Joannides, AJ; Hutchinson, PJA; Rubiano, AM				Selveindran, Santhani M.; Samarutilake, Gurusinghe D. N.; Vera, David Santiago; Brayne, Carol; Hill, Christine; Kolias, Angelos; Joannides, Alexis J.; Hutchinson, Peter J. A.; Rubiano, Andres M.			Prevention of road traffic collisions and associated neurotrauma in Colombia: An exploratory qualitative study	PLOS ONE			English	Article								Introduction Neurotrauma is an important but preventable cause of death and disability worldwide, with the majority being associated with road traffic collisions (RTCs). The greatest burden is seen in low -and middle- income countries (LMICs) where variations in the environment, infrastructure, population and habits can challenge the success of conventional preventative approaches. It is therefore necessary to understand local perspectives to allow for the development and implementation of context-specific strategies which are effective and sustainable. Methods This study took place in Colombia where qualitative data collection was carried out with ten key informants between October and November 2019. Semi-structured interviews were conducted and explored perceptions on RTCs and neurotrauma, preventative strategies and interventions, and the role of research in prevention. Interview transcripts were analysed by thematic analysis using a framework approach. Results Participants' confirmed that RTCs are a significant problem in Colombia with neurotrauma as an important outcome. Human and organisational factors were identified as key causes of the high rates of RTCs. Participants described the current local preventative strategies, but were quick to discuss limitations and challenges to their success. Key barriers reported were poor attitudes and knowledge, particularly in the community. Suggestions were provided on ways to improve prevention through better education and awareness, stricter enforcement and new policies on prevention, proper budgeting and resource allocation, as well as through collaboration and changes in attitudes and leadership. Participants identified four key research areas they felt would influence prevention of RTCs and associated neurotrauma: causes of RTCs; consequences and impact of RTCs; public involvement in research; improving prevention. Conclusion RTCs are a major problem in Colombia despite the current preventative strategies and interventions. Findings from this study have a potential to influence policy, practice and research by illustrating different solutions to the challenges surrounding prevention and by highlighting areas for further research.	[Selveindran, Santhani M.; Kolias, Angelos; Joannides, Alexis J.; Hutchinson, Peter J. A.] Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England; [Selveindran, Santhani M.; Vera, David Santiago; Brayne, Carol; Hill, Christine; Kolias, Angelos; Joannides, Alexis J.; Hutchinson, Peter J. A.; Rubiano, Andres M.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Samarutilake, Gurusinghe D. N.] Minist Hlth, Directorate Healthcare Qual & Safety, Colombo, Sri Lanka; [Samarutilake, Gurusinghe D. N.; Brayne, Carol; Hill, Christine] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Vera, David Santiago; Rubiano, Andres M.] Meditech Fdn, Cali, Colombia; [Rubiano, Andres M.] Univ El Bosque, Neurosci Inst, Bogota, Colombia		Selveindran, SM (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England.; Selveindran, SM (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.	ss2604@medschl.cam.ac.uk		M Selveindran, Santhani/0000-0002-3734-1189; Brayne, Carol/0000-0001-5307-663X	National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [RG89187]; UK Government	This research was commissioned by the National Institute for Health Research (NIHR) (Grant Number: RG89187) using UK aid from the UK Government. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Alonso F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122828; Asaba E, 2018, SCAND J OCCUP THER, V25, P309, DOI 10.1080/11038128.2018.1541224; Astbury NM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238645; Bradshaw C, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617742282; Centers for Disase Control and Prevention, 2014, REPORT C TRAUMATIC B; Coles E, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0566-8; Cook N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026514; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhibi M, 2019, INT J INJ CONTROL SA, V26, P99, DOI 10.1080/17457300.2018.1482926; Dijkink S, 2017, J TRAUMA ACUTE CARE, V83, P917, DOI 10.1097/TA.0000000000001633; DiPietro G., 2009, 4 IRTAD C; Elliott B., 2003, P AUSTRALASIAN ROAD, V7, P246; Elmendorf W. F., 2006, Arboriculture & Urban Forestry, V32, P54; Essex R, 2019, J ROY SOC MED, V112, P456, DOI 10.1177/0141076819865867; European Transport Safety Council, 2019, STATUS TRAFFIC SAFET; Federacion de Aseguaradores Colombianos, 2018, COSTOS ACCIDENTALIDA; Federation Internationale de l'Automobile (FIA), 2017, 3500LIVES CAMPAIGN G; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gopalakrishnan S, 2012, J Family Med Prim Care, V1, P144, DOI 10.4103/2249-4863.104987; GOTTESMAN II, 1989, SCHIZOPHRENIA BULL, V15, P5, DOI 10.1093/schbul/15.1.5; Gururaj G., 2005, NATL I MENTAL HLTH N; Hackett A, 2018, NURSE RES, V26, P8, DOI 10.7748/nr.2018.e1580; Heydari S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11226249; Hispanics In Philanthropy (HIP) Give, 2014, 5 FAMOUS COLOMBIANS; Holmes BD, 2019, INT J INJ CONTROL SA, V26, P194, DOI 10.1080/17457300.2018.1535512; Howat P, 2001, J COMMUN HEALTH, V26, P257, DOI 10.1023/A:1010304511244; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jull J, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0696-3; Khorasani-Zavareh D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-486; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Kiragu AW, 2017, J PEDIATR INTENSIVE, V6, P52, DOI 10.1055/s-0036-1584676; Knoll J, 2017, J ACAD MARKET SCI, V45, P55, DOI 10.1007/s11747-016-0503-8; Kwon SC, 2018, TRANSL BEHAV MED, V8, P683, DOI 10.1093/tbm/ibx026; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McKenna F., 2010, ROAD SAFETY ED ARE W; McKenna SA, 2013, ACTION RES-LONDON, V11, P113, DOI 10.1177/1476750312473342; Ministerio de Transporte, 2015, PLAN NACL SEGURIDAD; Mohan D., ROAD TRAFFIC INJURY; Parsons JA., 2019, ENCY SURVEY RES METH, P406; Pratt B, 2019, HEALTH POLICY PLANN, V34, P346, DOI 10.1093/heapol/czz041; Quitian-Reyes H, 2017, J CLIN EPIDEMIOL, V86, P101, DOI 10.1016/j.jclinepi.2016.04.017; Razmkon Ali, 2013, Bull Emerg Trauma, V1, P5; Reynolds TA, 2017, ANNU REV PUBL HEALTH, V38, P507, DOI 10.1146/annurev-publhealth-032315-021412; Rodriguez Deysi Yasmin, 2003, Inj Control Saf Promot, V10, P29; Hernandez JMR, 2016, CIENC SAUDE COLETIVA, V21, P3793, DOI 10.1590/1413-812320152112.06732015; Rodriguez-Hernandez JM., 2017, ARCH MED, V9, DOI [10.21767/1989-5216.1000228, DOI 10.21767/1989-5216.1000228]; Rojas IC, 2019, P 13 WORLD C; Rolison JJ, 2018, ACCIDENT ANAL PREV, V115, P11, DOI 10.1016/j.aap.2018.02.025; Saatian Mohamadreza, 2018, Bull Emerg Trauma, V6, P45, DOI 10.29252/beat-060107; Stange KC., 2013, ARHQ PUBLICATION NO; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Synnot A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019481; Tetali S, 2013, INJURY, V44, pS17, DOI 10.1016/S0020-1383(13)70208-0; The British Institute of Traffic Education Research (BITER) and The Transport Research Laboratory (TRL), ROAD SAFETY ED SECON; The World Bank, 2019, WORLD INCOME REGION; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vergel-Tovar E., 2018, PAVING PATHWAYS CHAN; Ward DJ, 2013, J ADV NURS, V69, P2423, DOI 10.1111/jan.12127; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2004, WORLD REPORT ROAD TR; Yue JK, 2017, BRAIN INJURY, V31, P1820, DOI 10.1080/02699052.2017.1351000	63	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249004	10.1371/journal.pone.0249004			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	WOS:000634832800003	33765057	gold, Green Published			2022-02-07	
J	Vidhate, S; Willis, AM; Mejia-Alvarez, R				Vidhate, S.; Willis, A. M.; Mejia-Alvarez, R.			Experimental Technique to Generate Complex Pressure Cycles in TBI-related In-vitro or Ex-vivo Samples	EXPERIMENTAL TECHNIQUES			English	Article						Blast-induced traumatic brain injury; Piezoelectric actuator; Complex pressure profiles; Blast loading; Feedforward controller		Blast-induced traumatic brain injury (bTBI) has been widely accepted as a "signature" wound affecting service members in modern conflicts, yet the mechanisms that cause bTBI still remain poorly understood. One of the main reasons for such poor understanding is the technical challenge of reproducing under controlled laboratory conditions the typical time-varying loading cycles induced on brain tissue after a blast event. Blast events have a sub-millisecond onset of high pressure followed by complex dynamics resulting from interaction between the blast wave and the complex anatomical structure of the human head. To tackle these experimental challenges, our group developed a novel apparatus using a water-filled piston-cylinder assembly driven by a piezoelectric actuator to generate complex and fast-varying pressure profiles. The versatility of our apparatus in producing complex pressure profiles was demonstrated by generating a single pressure pulse with various pulse-widths and magnitudes, an approximate Friedlander waveform, and a multi-modal waveform. A feedforward controller was also designed for the apparatus enhancing its capabilities to generate custom, user-defined pressure profiles. The apparatus successfully generated pressures up to 450 kPa at frequencies up to 5 kHz. The designed apparatus is compact, easily portable, and highly controllable, making it well suited for biomedical applications. This apparatus can be used to conduct ex-vivo and in-vitro experiments involving animal brain tissue specimens, cell cultures, and organoids to explore their response to the complex pressure loadings observed during a bTBI event.	[Vidhate, S.; Mejia-Alvarez, R.] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA; [Willis, A. M.] Brooke Army Med Ctr, Dept Neurol, Ft Sam Houston, TX 78234 USA; [Willis, A. M.] Univ Texas Southwestern, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA		Mejia-Alvarez, R (corresponding author), Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA.	rimejal@egr.msu.edu			Michigan State University; Air Force Research Laboratory [FA8650-18-2-6880]	This work was sponsored in part by Michigan State University and in part by the Air Force Research Laboratory (award No. FA8650-18-2-6880).	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bedford A., 1994, INTRO ELASTIC WAVE P; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bustamante MC, 2018, EXP MECH, V58, P55, DOI 10.1007/s11340-017-0323-x; Campos-Pires R, 2018, JOVE-J VIS EXP, DOI 10.3791/58400; Canchi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175396; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chen WNW, 2011, MECH ENG SER, P1, DOI 10.1007/978-1-4419-7982-7; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Dewey J.M., 2010, P 21 INT S MIL ASP B, P1; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Fischer H, 2013, LIB C WASH DC C RES; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Graff KF, 1991, DOVER BOOKS PHYS SER; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Kfoury R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212566; Khalil H.K, 2002, NONLINEAR SYSTEMS, V3rd; Kolsky H, 1963, DOVER BOOKS PHYS; Koo B, 2019, MOL CELLS, V42, P617, DOI 10.14348/molcells.2019.0162; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Logan NJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55618; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meyers MA., 1994, DYNAMIC BEHAV MAT, V2nd ed.; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Nienaber M, 2011, JOVE-J VIS EXP, DOI 10.3791/2723; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Przekwas A, 2019, MIL MED, V184, P195, DOI 10.1093/milmed/usy344; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Sadd MH, 2009, ELASTICITY: THEORY, APPLICATIONS, AND NUMERICS, 2ND EDITION, P1; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Williams PR, 1998, PHYS MED BIOL, V43, P3101, DOI 10.1088/0031-9155/43/10/028; Zander N, 2017, BIOEFFECTS IN VITRO	45	0	0	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0732-8818	1747-1567		EXP TECHNIQUES	Exp. Tech.	DEC	2021	45	6					795	808		10.1007/s40799-021-00453-5		MAR 2021	14	Engineering, Mechanical; Mechanics; Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics; Materials Science	WQ2BA	WOS:000632758300001					2022-02-07	
J	Santos, BFD; Paz, DD; Fernandes, VM; dos Santos, JC; Chaddad-Neto, FEA; Sousa, ACS; Oliveira, JLM				Fernandes de Oliveira Santos, Bruno; de Araujo Paz, Daniel; Fernandes, Victor Miranda; dos Santos, Jose Calasans; Chaddad-Neto, Feres Eduardo Aparecido; Sousa, Antonio Carlos Sobral; Oliveira, Joselina Luzia Menezes			Minimally invasive supratentorial neurosurgical approaches guided by Smartphone app and compass	SCIENTIFIC REPORTS			English	Article								The precise location in the scalp of specifically planned points can help to achieve less invasive approaches. This study aims to develop a smartphone app, evaluate the precision and accuracy of the developed tool, and describe a series of cases using the referred technique. The application was developed with the React Native framework for Android and iOS. A phantom was printed based on the patient's CT scan, which was used for the calculation of accuracy and precision of the method. The points of interest were marked with an "x" on the patient's head, with the aid of the app and a compass attached to a skin marker pen. Then, two experienced neurosurgeons checked the plausibility of the demarcations based on the anatomical references. Both evaluators marked the frontal, temporal and parietal targets with a difference of less than 5 mm from the corresponding intended point, in all cases. The overall average accuracy observed was 1.6 +/- 1.0 mm. The app was used in the surgical planning of trepanations for ventriculoperitoneal (VP) shunts and for drainage of abscesses, and in the definition of craniotomies for meningiomas, gliomas, brain metastases, intracranial hematomas, cavernomas, and arteriovenous malformation. The sample consisted of 88 volunteers who exhibited the following pathologies: 41 (46.6%) had brain tumors, 17 (19.3%) had traumatic brain injuries, 16 (18.2%) had spontaneous intracerebral hemorrhages, 2 (2.3%) had cavernomas, 1 (1.1%) had arteriovenous malformation (AVM), 4 (4.5%) had brain abscesses, and 7 (7.9%) had a VP shunt placement. In cases approached by craniotomy, with the exception of AVM, straight incisions and minicraniotomy were performed. Surgical planning with the aid of the NeuroKeypoint app is feasible and reliable. It has enabled neurological surgeries by craniotomy and trepanation in an accurate, precise, and less invasive manner.	[Fernandes de Oliveira Santos, Bruno; Sousa, Antonio Carlos Sobral; Oliveira, Joselina Luzia Menezes] Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, SE, Brazil; [de Araujo Paz, Daniel; Chaddad-Neto, Feres Eduardo Aparecido] Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Sao Paulo, SP, Brazil; [Fernandes, Victor Miranda] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil; [Fernandes de Oliveira Santos, Bruno; dos Santos, Jose Calasans] Unimed Sergipe Hosp, Aracaju, SE, Brazil; [Sousa, Antonio Carlos Sobral; Oliveira, Joselina Luzia Menezes] Univ Fed Sergipe, Dept Internal Med, Aracaju, SE, Brazil; [Sousa, Antonio Carlos Sobral; Oliveira, Joselina Luzia Menezes] Univ Fed Sergipe, Univ Hosp, Div Cardiol, Aracaju, SE, Brazil; [Fernandes de Oliveira Santos, Bruno; Sousa, Antonio Carlos Sobral; Oliveira, Joselina Luzia Menezes] Clin & Hosp Sao Lucas Rede Sao Luiz, Aracaju, SE, Brazil; [Fernandes de Oliveira Santos, Bruno] Hosp Cirurgia, Dept Neurosurg, Aracaju, SE, Brazil		Santos, BFD (corresponding author), Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, SE, Brazil.; Santos, BFD (corresponding author), Unimed Sergipe Hosp, Aracaju, SE, Brazil.; Santos, BFD (corresponding author), Clin & Hosp Sao Lucas Rede Sao Luiz, Aracaju, SE, Brazil.; Santos, BFD (corresponding author), Hosp Cirurgia, Dept Neurosurg, Aracaju, SE, Brazil.	brunofernandes.se@gmail.com		Sobral Sousa, Antonio Carlos/0000-0002-4158-9726; Santos, Bruno Fernandes de Oliveira/0000-0003-0101-2815; OLIVEIRA, JOSELINA LUZIA/0000-0002-4325-0590			Askeland C, 2016, INT J COMPUT ASS RAD, V11, P505, DOI 10.1007/s11548-015-1292-0; CAIL WS, 1979, SURG NEUROL, V11, P35; Chabrerie A, 1998, NEUROSURG FOCUS, V4, pE7, DOI [10.3171/foc.1998.4.4.10, DOI 10.3171/FOC.1998.4.4.10]; Chen JG, 2017, WORLD NEUROSURG, V106, P193, DOI [10.1016/j.wneu.2017.06.146, 10.1016/j.WNEU.2017.06.146]; Santos BFD, 2018, WORLD NEUROSURG, V110, pE864, DOI 10.1016/j.wneu.2017.11.123; Deza M.M, 2009, ENCY DISTANCES, P1, DOI [10.1007/978-3-642-00234-2, DOI 10.1007/978-3-642-00234-2]; Dias-Filho L.C., 2003, TECHNICAL NOTE J BRA, V14, P41; Drouin S, 2017, INT J COMPUT ASS RAD, V12, P363, DOI 10.1007/s11548-016-1478-0; Eftekhar B, 2016, WORLD NEUROSURG, V85, P359, DOI 10.1016/j.wneu.2015.09.091; Esposito V, 2008, ACTA NEUROCHIR, V150, P537, DOI 10.1007/s00701-008-1592-z; Ferroli P, 2013, NEUROSURGERY, V72, pA54, DOI 10.1227/NEU.0b013e3182748ee8; Ganslandt O, 2002, NEUROL INDIA, V50, P244; Gong XY, 2008, STEREOT FUNCT NEUROS, V86, P345, DOI 10.1159/000163555; Harput MV, 2014, OPER NEUROSURG, V10, P426, DOI 10.1227/NEU.0000000000000355; Hattingen E, 2005, J NEUROSURG, V102, P302, DOI 10.3171/jns.2005.102.2.0302; HIRSCHBERG H, 1989, J NEUROSURG, V70, P280, DOI 10.3171/jns.1989.70.2.0280; Hou YZ, 2016, WORLD NEUROSURG, V94, P480, DOI 10.1016/j.wneu.2016.07.047; Hou YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159185; KANDEL EI, 1972, J NEUROSURG, V37, P407, DOI 10.3171/jns.1972.37.4.0407; Kikinis R, 1996, NEUROSURGERY, V38, P640, DOI 10.1227/00006123-199604000-00003; KING JS, 1980, NEUROSURGERY, V6, P160; Kockro RA, 2000, NEUROSURGERY, V46, P118, DOI 10.1093/neurosurgery/46.1.118; Leger E, 2020, INT J COMPUT ASS RAD, V15, P1013, DOI 10.1007/s11548-020-02155-6; Maruyama K, 2018, OPER NEUROSURG, V15, P551, DOI 10.1093/ons/opx279; Nakajima S, 1997, NEUROSURGERY, V40, P1201, DOI 10.1097/00006123-199706000-00018; NORMAN D, 1975, AM J ROENTGENOL, V125, P961, DOI 10.2214/ajr.125.4.961; OLEARY DH, 1978, J NEUROSURG, V49, P71, DOI 10.3171/jns.1978.49.1.0071; Paraskevopoulos D, 2011, NEUROSURG REV, V34, P217, DOI 10.1007/s10143-010-0302-5; PENNING L, 1987, J NEUROSURG, V66, P474, DOI 10.3171/jns.1987.66.3.0474; Pfisterer WK, 2008, NEUROSURGERY, V63, P201, DOI [10.1227/01.neu.0000317394.14303.99, 10.1227/01.NEU.0000297007.04975.C6]; Schultke E, 2009, NEUROSURGERY, V64, P1001, DOI 10.1227/01.NEU.0000344003.72056.7F; Serletis D, 2016, J NEUROSURG, V124, P1867, DOI 10.3171/2015.6.JNS15424; SPIEGEL EA, 1947, SCIENCE, V106, P349, DOI 10.1126/science.106.2754.349; Spivak CJ, 2005, J NEUROSURG, V103, P424, DOI 10.3171/jns.2005.103.3.0424; Sun GC, 2017, J NEUROSURG, V127, P537, DOI 10.3171/2016.7.JNS16932; Teo C, 2010, NEUROSURG CLIN N AM, V21, P583, DOI 10.1016/j.nec.2010.07.001; van Doormaal TPC, 2019, OPER NEUROSURG, V17, P588, DOI 10.1093/ons/opz094; Wagner W, 2000, MINIM INVAS NEUROSUR, V43, P124, DOI 10.1055/s-2000-8332; Watanabe E, 2016, WORLD NEUROSURG, V87, P399, DOI 10.1016/j.wneu.2015.11.084	39	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAR 24	2021	11	1							6778	10.1038/s41598-021-85472-3			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF6SN	WOS:000634972100028	33762597	gold, Green Published			2022-02-07	
J	Kanmani, TR; Raju, B; Konar, S; Shukla, D; Kukkehalli, R				Kanmani, T. R.; Raju, Birudu; Konar, Subhas; Shukla, Dhaval; Kukkehalli, Raghavendra			Tailor-Made Psychosocial Intervention for the Caregivers in Emergency and Trauma Care Center	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						caregivers; psychosocial problems; intervention		Introduction The caregiver's psychosocial problems are unnoticed in the emergency and trauma care center. Therefore, the study objective was to understand the impact of psychoeducation and psychosocial intervention on traumatic brain injury (TBI) care-givers during hospitalization. Methodology The study adopted a descriptive research design. Sixty-three (n = 63) consented caregivers were recruited by using a cross-sectional survey method. Two separate checklists were used to collect the psychosocial problems in emergency and trauma care as well as to know the satisfaction levels of caregivers after the intervention. R free 3.0.1 software was used to calculate the frequency and percentage. Results The caregiver's mean age was 39 years (39.46 +/- 16.22). The majority of the caregivers were males (45; 71.4%) working as daily wagers (42; 66.7%). Caregivers experienced psychosocial problems, that is, depression, anxiety, stress, unable to handle crisis, grief, lack of coping skills (57; 90.5%), emotional distress (57; 90.5%), financial constraints (45; 71.1%), and need for referral services (45; 71.1%). Tailor-made psychosocial interventions were provided to the caregivers. Conclusion To conclude, there is a greater need to provide psychosocial intervention and train the caregivers to provide care for TBI survivors during hospitalization. There is a need to develop the uniform standard operating procedure for medical and psychiatric social workers in providing psychosocial care in emergency and trauma care setting.	[Kanmani, T. R.; Kukkehalli, Raghavendra] Natl Inst Mental Hlth & Neurosci, Dept Psychiat Social Work, Bengaluru, Karnataka, India; [Raju, Birudu] Kristu Jayanti Coll, Dept Social Work, Bengaluru, Karnataka, India; [Konar, Subhas; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru, Karnataka, India		Kanmani, TR (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Psychiat Social Work, Bengaluru, Karnataka, India.	kanmani.raju@gmail.com		Shukla, Dhaval/0000-0001-7613-1929			Agrawal Amit, 2016, Int J Crit Illn Inj Sci, V6, P65, DOI 10.4103/2229-5151.183025; Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; Birudu R, 2018, INT J HLTH ALLIED SC, V7, P120, DOI 10.4103/ijhas.IJHAS_142_1; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Das A, 2012, NEUROLOGY, V79, P2146, DOI 10.1212/WNL.0b013e3182752cdb; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Harding A, 2009, J EMERG NURS, V35, P352, DOI 10.1016/j.jen.2009.01.011; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Nebhinani N., 2016, INDIAN J SOC PSYCHIA, V32, P1; Raju Birudu, 2016, Int J Crit Illn Inj Sci, V6, P206, DOI 10.4103/2229-5151.195452; Raju B, 2017, J NEUROSCI RURAL PRA, V8, P114, DOI 10.4103/0976-3147.193551; Ramasamy J., 2014, INT J HLTH SYST DISA, V2, P130; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Vra, 2012, DISABIL CBR INCL DEV, V23, P137	21	0	0	3	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	APR	2021	12	02					290	294		10.1055/s-0041-1722815		MAR 2021	5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RU5MX	WOS:000632203600004	33927519	gold, Green Published			2022-02-07	
J	Shaughness, M; Byrnes, K				Shaughness, Mike; Byrnes, Kimberly			Assessment of the Effects of Stretch-Injury on Primary Rat Microglia	MOLECULAR NEUROBIOLOGY			English	Article						Microglia; Mechanical stretch-injury; in vitro; Inflammation; TBI		Mechanical stretch-injury is a prominent force involved in the etiology of traumatic brain injury (TBI). It is known to directly cause damage and dysfunction in neurons, astrocytes, and endothelial cells. However, the deleterious effects of stretch-injury on microglia, the brain's primary immunocompetent cell, are currently unknown. The Cell Injury Controller II (CICII), a validated cellular neurotrauma model, was used to induce a mechanical stretch-injury in primary rat microglia. Statistical analysis utilized Student's t test and one- and two-way ANOVAs with Tukey's and Sidak's multiple comparisons, respectively. Cells exposed to stretch-injury showed no signs of membrane permeability, necrosis, or apoptosis, as measured by media-derived lactate dehydrogenase (LDH) and cleaved-caspase 3 immunocytochemistry, respectively. Interestingly, injured cells displayed a functional deficit in nitric oxide production (NO), identified by media assay and immunocytochemistry, at 6, 12, 18, and 48 h post-injury. Furthermore, gene expression analysis revealed the expression of inflammatory cytokines IL-6 and IL-10, and enzyme arginase-1 was significantly downregulated at 12 h post-injury. Time course evaluation of migration, using a cell exclusion zone assay, showed stretch-injured cells display decreased migration into the exclusion zone at 48- and 72-h post-stretch. Lastly, coinciding with the functional immune deficits was a significant change in morphology, with process length decreasing and cell diameter increasing following an injury at 12 h. Taken together, the data demonstrate that stretch-injury produces significant alterations in microglial function, which may have a marked impact on their response to injury or their interaction with other cells.	[Shaughness, Mike; Byrnes, Kimberly] Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Byrnes, Kimberly] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Shaughness, M (corresponding author), Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Michael.shaughness.ctr@usuhs.edu		Byrnes, Kimberly/0000-0002-7501-7734; Shaughness, Michael/0000-0003-4138-3311	Defense Health Program, Congressionally Directed Medical Research Programs through the Spinal Cord Injury Research Program [SC170244]; Center for the Study of Traumatic Stress (CSTS) at USUHS	This work was supported by the Defense Health Program, Congressionally Directed Medical Research Programs through the Spinal Cord Injury Research Program under Award No. SC170244. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Defense Health Program, Congressionally Directed Medical Research Programs, the Department of Defense, or the Uniformed Services University. Additional funding was provided by the Center for the Study of Traumatic Stress (CSTS) at USUHS.	Augustine C, 2014, NEUROSCIENCE, V274, P1, DOI 10.1016/j.neuroscience.2014.05.009; Benson BA, 2015, XENOTRANSPLANTATION, V22, P295, DOI 10.1111/xen.12172; Brabazon F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201878; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Caplan HW, 2020, ASN NEURO, V12, DOI 10.1177/1759091420911770; CASTRO A, 1974, CLIN BIOCHEM, V7, P64, DOI 10.1016/S0009-9120(74)90464-0; CHAMAK B, 1991, NEUROSCIENCE, V45, P513, DOI 10.1016/0306-4522(91)90267-R; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chuang DY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0419-0; Ciacci-Zanella J, 1999, J VIROL, V73, P9734, DOI 10.1128/JVI.73.12.9734-9740.1999; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fan Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00309; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Gao TL, 2018, BIOCHEM BIOPH RES CO, V497, P430, DOI 10.1016/j.bbrc.2018.02.102; Gunther M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0335-17.2018; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Herzog C, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174698; Hornik TC, 2016, J CELL SCI, V129, P65, DOI 10.1242/jcs.174631; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kumar A, 2019, J PHARMACOL EXP THER, V368, P338, DOI 10.1124/jpet.118.253955; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lobo-Silva D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0763-8; Lopez-Garcia I, 2018, BRIT J PHARMACOL, V175, P284, DOI 10.1111/bph.13642; Lucke-Wold BP, 2017, J NEUROTRAUM, V34, pS62, DOI 10.1089/neu.2016.4680; Qu WS, 2015, NEUROCHEM INT, V90, P85, DOI 10.1016/j.neuint.2015.07.007; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Saykally JN, 2017, CELL TRANSPLANT, V26, P1193, DOI 10.1177/0963689717714320; Shin N, 2019, ANTIOXID REDOX SIGN, V30, P1601, DOI 10.1089/ars.2017.7280; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Vainchtein ID, 2020, TRENDS NEUROSCI, V43, P144, DOI 10.1016/j.tins.2020.01.003; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; Xu ZM, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0378-8; Yauger YJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1430-7; Yi SN, 2020, CYTOTECHNOLOGY, V72, P589, DOI 10.1007/s10616-020-00409-4; Yu JT, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-0554-0; Ziaja M, 2007, J NEUROTRAUM, V24, P1845, DOI 10.1089/neu.2007.0303	55	0	0	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2021	58	7					3545	3560		10.1007/s12035-021-02362-5		MAR 2021	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TE3YU	WOS:000632295500001	33763772	Green Submitted			2022-02-07	
J	Kinnunen, J; Satopaa, J; Niemela, M; Putaala, J				Kinnunen, Janne; Satopaa, Jarno; Niemela, Mika; Putaala, Jukka			Coagulopathy and its effect on treatment and mortality in patients with traumatic intracranial hemorrhage	ACTA NEUROCHIRURGICA			English	Article						Anticoagulation; Coagulopathy; Mortality; Outcome; Surgical treatment; Traumatic intracranial hemorrhage		Background The role of coagulopathy in patients with traumatic brain injury has remained elusive. In the present study, we aim to assess the prevalence of coagulopathy in patients with traumatic intracranial hemorrhage, their clinical features, and the effect of coagulopathy on treatment and mortality. Methods An observational, retrospective single-center cohort of consecutive patients with traumatic intracranial hemorrhage treated at Helsinki University Hospital between 01 January and 31 December 2010. We compared clinical and radiological parameters in patients with and without coagulopathy defined as drug- or disease-induced, i.e., antiplatelet or anticoagulant medication at a therapeutic dose, thrombocytopenia (platelet count < 100 E9/L), international normalized ratio > 1.2, or thromboplastin time < 60%. Primary outcome was 30-day all-cause mortality. Logistic regression analysis allowed to assess for factors associated with coagulopathy and mortality. Results Of our 505 patients (median age 61 years, 65.5% male), 206 (40.8%) had coagulopathy. Compared to non-coagulopathy patients, coagulopathy patients had larger hemorrhage volumes (mean 140.0 mL vs. 98.4 mL, p < 0.001) and higher 30-day mortality (18.9% vs. 9.7%, p = 0.003). In multivariable analysis, older age, lower admission Glasgow Coma Scale score, larger hemorrhage volume, and conservative treatment were independently associated with mortality. Surgical treatment was associated with lower mortality in both patients with and without coagulopathy. Conclusions Coagulopathy was more frequent in patients with traumatic intracranial hemorrhage presenting larger hemorrhage volumes compared to non-coagulopathy patients but was not independently associated with higher 30-day mortality. Hematoma evacuation, in turn, was associated with lower mortality irrespective of coagulopathy.	[Kinnunen, Janne; Putaala, Jukka] Helsinki Univ Hosp, Dept Neurol, Haartmaninkatu 4, Helsinki 00290, Finland; [Kinnunen, Janne; Putaala, Jukka] Univ Helsinki, Haartmaninkatu 4, Helsinki 00290, Finland; [Satopaa, Jarno; Niemela, Mika] Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5, Helsinki 00260, Finland; [Satopaa, Jarno; Niemela, Mika] Univ Helsinki, Topeliuksenkatu 5, Helsinki 00260, Finland		Kinnunen, J (corresponding author), Helsinki Univ Hosp, Dept Neurol, Haartmaninkatu 4, Helsinki 00290, Finland.; Kinnunen, J (corresponding author), Univ Helsinki, Haartmaninkatu 4, Helsinki 00290, Finland.	ext-janne.kinnunen@hus.fi			University of Helsinki; Maire Taponen foundation; Helsinki and Uusimaa Hospital District's competitive research funding (2019); Helsinki University Central Hospital	Open access funding provided by University of Helsinki including Helsinki University Central Hospital. Janne Kinnunen has received personal funding from Maire Taponen foundation grant (2016) and from Helsinki and Uusimaa Hospital District's competitive research funding (2019). These supporting sources had no involvement or restrictions regarding the publication.	Albrecht JS, 2018, AM J EPIDEMIOL, V187, P233, DOI 10.1093/aje/kwx254; Balendran CA, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-016-0332-2; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Bullock MR, 2006, NEUROSURGERY, V58, pS7, DOI 10.1227/01.NEU.0000210365.36914.E3; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Das SK, 2011, SINGAP MED J; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Ezzati M., 2004, COMP QUANTIFICATION, P1200; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gozal Yair M, 2017, Surg Neurol Int, V8, P48, DOI 10.4103/sni.sni_265_16; Greuter L, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19546; Grysiewicz R, 2014, J STROKE CEREBROVASC, V23, P2479, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.031; Hsiao KY, 2015, INJURY, V46, P859, DOI 10.1016/j.injury.2014.11.025; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lega BC, 2010, J NEUROSURG, V113, P615, DOI 10.3171/2009.9.JNS08825; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Makela P, 2015, ALCOHOL ALCOHOLISM, V50, P661, DOI 10.1093/alcalc/agv068; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Powers AY, 2020, J NEUROSURG, V132, P552, DOI 10.3171/2018.11.JNS182199; Ragni MV, 1982, ALCOHOL CLIN EXP RES; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; SAUAIA A, 1995, J TRAUMA; Schoechl, 2012, SHOCK, DOI [10.1007/978-3-642-18081-1, DOI 10.1007/978-3-642-18081-1]; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Shield KD, 2017, ADDICTION, V112, P1535, DOI 10.1111/add.13827; Smith AR, 2020, J SURG RES, V251, P107, DOI 10.1016/j.jss.2020.01.013; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; TurMart?nez, 2018, CIR ESP ENGL ED, DOI [10.1016/j.cireng.2018.07.012, DOI 10.1016/J.CIRENG.2018.07.012]; Van Essen TA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033513; WEIGEL R, 2003, J NEUROL NEUROSUR PS; Whaley CC, 2019, WORLD NEUROSURG, V130, P454, DOI 10.1016/j.wneu.2019.06.124; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825; Zuckerman A.J., 1995, J CLIN PATHOL, V48, P691, DOI DOI 10.1136/JCP.48.7.691-A	38	0	0	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2021	163	5					1391	1401		10.1007/s00701-021-04808-0		MAR 2021	11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RO5GJ	WOS:000631752800001	33759013	Green Published, hybrid			2022-02-07	
J	Lorente, L; Martin, MM; Perez-Cejas, A; Gonzalez-Rivero, AF; Ramos-Gomez, L; Sole-Violan, J; Caceres, JJ; Ferrer-Moure, C; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.; Ramos-Gomez, Luis; Sole-Violan, Jordi; Caceres, Juan J.; Ferrer-Moure, Carmen; Jimenez, Alejandro			Low blood caspase-8 levels in survivor patients of traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article						Caspase-8; Patients; Mortality; Trauma; Injury; Brain	FATAL HEAD-INJURY; APOPTOSIS; MATTER; DEATH; CONTUSIONS; SEVERITY; OCCURS; DAMAGE; WHITE	Objective High concentrations of caspase-8 (main initiator caspase of the extrinsic pathway of apoptosis) have been found in brain tissue of patients with traumatic brain injury (TBI) and in the blood of patients with different diseases. However, blood caspase-8 concentrations in TBI patients have not been reported. Therefore, our aim was to analyze whether blood caspase-8 concentrations are associated with mortality in TBI patients. Method Patients with isolated and severe TBI were included. TBI was considered isolated if it showed an Injury Severity Score (ISS) <10 points on non-cranial aspects. TBI was considered severe if it showed a Glasgow Coma Scale (GCS) Results Surviving patients (n=59) had lower age (p=0.004), higher GCS (p=0.001), lower APACHE-II score (p<0.001), lower high-risk-of-death computed tomography (CT) findings (p=0.02), lower intracranial pressure (ICP) (p=0.01), and lower serum caspase-8 concentrations (p<0.001) than non-surviving patients (n=24). An association was found between serum caspase-8 levels and mortality after controlling for CT findings, GCS, and age (OR=1.037; 95% CI=1.013-1.062; p=0.002), and after controlling for CT findings, APACHE-II, and ICP (OR=1.042; 95% CI=1.013-1.071; p=0.004) in multiple logistic regression. Conclusions To our knowledge, this is the first series describing blood caspase-8 concentrations in patients with TBI. The association of high blood caspase-8 concentrations with mortality was the main new finding of the study. However, further investigations are needed to validate the preliminary results of our study.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38010, Spain; [Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.; Caceres, Juan J.; Ferrer-Moure, Carmen] Hosp Univ Canarias, Dept Lab, S-N La Laguna, Santa Cruz De Tenerife 38320, Spain; [Ramos-Gomez, Luis] Hosp Gen La Palma, Intens Care Unit, Buenavista Arriba S-N, Brena Alta 38713, La Palma, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Barranco Ballena S-N, Las Palmas Gran Canaria 35010, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur S-N, Las Palmas Gran Canaria 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain.	lorentemartin@msn.com; mar.martinvelasco@gmail.com; aperezcejas@gmail.com; agonriv@hotmail.com; lramosgomez@gmail.com; jsolvio@gobiernodecanarias.org; juanjose.caceresagra@gobiernodecanarias.org; carmenferrermoure@gmail.com; ajimenezsosa@gmail.com		Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI-18-00500]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	This study was supported by a grant from Instituto de Salud Carlos III (PI-18-00500) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Drapkina OM, 2015, TERAPEVT ARKH, V87, P76, DOI 10.17116/terarkh201587576-83; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Glushakova Olena Y, 2017, Brain Circ, V3, P87, DOI 10.4103/bc.bc_27_16; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lorente L, 2020, Med Intensiva (Engl Ed), DOI 10.1016/j.medin.2020.06.016; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Petrackova A, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9167-8; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; TEASDALE G, 1974, LANCET, V2, P81; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Yang XF, 2015, J BIOMED RES, V29, P232, DOI 10.7555/JBR.29.20130037; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje; 2007, J NEUROTRAUM, V24, pS1, DOI DOI doi:10.1089/neu.2007.9998	23	0	0	1	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	DEC	2021	42	12					5065	5070		10.1007/s10072-021-05205-2		MAR 2021	6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XI4QV	WOS:000631732400002	33759054				2022-02-07	
J	Kim, JH; Jung, HG; Kim, A; Shim, HS; Hyeon, SJ; Lee, YS; Han, J; Jung, JH; Lee, J; Ryu, H; Park, JY; Hwang, EM; Suk, K				Kim, Jong-Heon; Jung, Hyun-Gug; Kim, Ajung; Shim, Hyun Soo; Hyeon, Seung Jae; Lee, Young-Sun; Han, Jin; Jung, Jong Hoon; Lee, Jaekwang; Ryu, Hoon; Park, Jae-Yong; Hwang, Eun Mi; Suk, Kyoungho			Hevin-calcyon interaction promotes synaptic reorganization after brain injury	CELL DEATH AND DIFFERENTIATION			English	Article								Hevin, also known as SPARC-like protein 1 (SPARCL1 or SC1), is a synaptogenic protein secreted by astrocytes and modulates the formation of glutamatergic synapses in the developing brain by interacting with synaptic adhesion proteins, such as neurexin and neuroligin. Here, we identified the neuron-specific vesicular protein calcyon as a novel interaction partner of hevin and demonstrated that this interaction played a pivotal role in synaptic reorganization after an injury in the mature brain. Astrocytic hevin was upregulated post-injury in a photothrombotic stroke model. Hevin was fragmented by MMP3 induced during the acute stage of brain injury, and this process was associated with severe gliosis. At the late stage, the functional hevin level was restored as MMP3 expression decreased. The C-terminus of hevin interacted with the N-terminus of calcyon. By using RNAi and binding competitor peptides in an ischemic brain injury model, we showed that this interaction was crucial in synaptic and functional recoveries in the sensory-motor cortex, based on histological and electrophysiological analyses. Regulated expression of hevin and calcyon and interaction between them were confirmed in a mouse model of traumatic brain injury and patients with chronic traumatic encephalopathy. Our study provides direct evidence for the causal relationship between the hevin-calcyon interaction and synaptic reorganization after brain injury. This neuron-glia interaction can be exploited to modulate synaptic reorganization under various neurological conditions.	[Kim, Jong-Heon; Suk, Kyoungho] Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea; [Jung, Hyun-Gug; Kim, Ajung; Hwang, Eun Mi] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Funct Connect, Seoul, South Korea; [Jung, Hyun-Gug; Lee, Young-Sun; Park, Jae-Yong] Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Seoul, South Korea; [Shim, Hyun Soo; Hyeon, Seung Jae; Ryu, Hoon] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neurosci, Seoul, South Korea; [Han, Jin; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu, South Korea; [Han, Jin; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, Daegu, South Korea; [Jung, Jong Hoon; Lee, Jaekwang] Korea Food Res Inst, Res Grp Funct Food Mat, Wonju, South Korea; [Ryu, Hoon] VA Boston Healthcare Syst, Boston, MA USA; [Ryu, Hoon] Boston Univ, Alzheimers Dis Ctr, Boston, MA USA; [Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Suk, K (corresponding author), Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea.; Hwang, EM (corresponding author), Korea Inst Sci & Technol, Brain Sci Inst, Ctr Funct Connect, Seoul, South Korea.; Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu, South Korea.; Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, Daegu, South Korea.	emhwang@kist.re.kr; ksuk@knu.ac.kr		Kim, Ajung/0000-0002-1867-6493	Basic Science Research Program through the National Research Foundation (NRF) - Korean government (Ministry of Science, ICT and Future Planning, MSIP) [2016M3C7A1904148, 2017M3C7A1043842, NRF-2020M3E5D9079764]	This work was supported by a grant from the Basic Science Research Program through the National Research Foundation (NRF), which is funded by the Korean government (Ministry of Science, ICT and Future Planning, MSIP) (2016M3C7A1904148, 2017M3C7A1043842, and NRF-2020M3E5D9079764).	Adams JC, 2004, INT J BIOCHEM CELL B, V36, P1102, DOI 10.1016/j.biocel.2004.01.022; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Davidson HT, 2009, EUR J NEUROSCI, V29, P42, DOI 10.1111/j.1460-9568.2008.06563.x; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; Delpech JC, 2015, NEUROPHARMACOLOGY, V96, P19, DOI 10.1016/j.neuropharm.2014.12.034; Gan KJ, 2020, J NEUROSCI, V40, P8088, DOI 10.1523/JNEUROSCI.0454-20.2020; Gottschall PE, 2015, MATRIX BIOL, V44-46, P70, DOI 10.1016/j.matbio.2015.01.014; Ha CM, 2012, J BIOL CHEM, V287, P31813, DOI 10.1074/jbc.M112.370601; Ikeshima-Kataoka H, 2008, IN VIVO, V22, P409; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Jo M, 2017, J NEUROSCI, V37, P2878, DOI 10.1523/JNEUROSCI.2534-16.2017; Jones EV, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/321209; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lee J, 2018, AGING CELL, V17, DOI 10.1111/acel.12679; Lemarchant S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-133; Li T, 2019, NEUROSCI LETT, V712, DOI 10.1016/j.neulet.2019.134485; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lloyd-Burton SM, 2013, J NEUROSCI, V33, P4468, DOI 10.1523/JNEUROSCI.3585-12.2013; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Nishio T, 2003, BRAIN RES, V990, P129, DOI 10.1016/S0006-8993(03)03448-6; Perucca P, 2019, NEUROBIOL DIS, V123, P69, DOI 10.1016/j.nbd.2018.06.002; Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schwab JM, 2001, J NEUROTRAUM, V18, P377, DOI 10.1089/089771501750170930; Seo JS, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.56; Singh SK, 2016, CELL, V164, P183, DOI 10.1016/j.cell.2015.11.034; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strekalova T, 2002, MOL CELL NEUROSCI, V21, P173, DOI 10.1006/mcne.2002.1172; Vonsattel JPG, 2008, CELL TISSUE BANK, V9, P247, DOI 10.1007/s10561-008-9079-y; Weaver M, 2011, J CELL BIOCHEM, V112, P3093, DOI 10.1002/jcb.23235; Weaver MS, 2010, J BIOL CHEM, V285, P5868, DOI 10.1074/jbc.M109.070318; Xiao JP, 2006, J BIOL CHEM, V281, P15182, DOI 10.1074/jbc.M600265200; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Yin DM, 2015, MOL PSYCHIATR, V20, P1251, DOI 10.1038/mp.2014.131	41	0	0	3	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	SEP	2021	28	9					2571	2588		10.1038/s41418-021-00772-5		MAR 2021	18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	UM5IU	WOS:000631489600002	33753902				2022-02-07	
J	Roby, PR; Duquette, PJ; Kerr, ZY; Register-Mihalik, JK; Stoner, L; Mihalik, JP				Roby, Patricia R.; Duquette, Peter J.; Kerr, Zachary Y.; Register-Mihalik, Johna K.; Stoner, Lee; Mihalik, Jason P.			Preseason Cerebrovascular Function in Adolescent Athletes	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Cerebral blood flow; Football; High school; neural activation; Subconcussion; Concussion; Age of first exposure		The purpose of this study was to investigate the effects of sport participation, concussion history, and age of first exposure to football on preseason cerebrovascular function in adolescent athletes. Athletes (n = 53, age = 15.8 +/- 1.2 years) were examined based on three exposure groupings: (1) sport participation (football vs. non-collision), (2) concussion history (none vs. >= 1), and (3) age of first exposure (football participants only). Transcranial Doppler assessed cerebrovascular reactivity (CVR) and neurovascular coupling (NVC), and separate independent samples t-tests evaluated group differences in CVR and NVC outcomes. Separate univariate linear regressions determined how age of first exposure related to CVR and NVC outcomes. Linear mixed effects models assessed group differences in CVR and NVC relative response curves. Differential response to NVC visual task response was significantly greater in non-collision sport athletes (F-1,F-2946 = 38.69, p < 0.0001) and athletes without a concussion history (F-1,F-2946 = 25.23, p < 0.0001). Older age of first exposure significantly predicted reduced breath-holding CVR response (F-1,F-1560 = 2.92, p = 0.03). Healthy adolescent athletes have similar pre-season cerebrovascular function despite different sport participation and concussion history. However, age of first exposure may predict CVR in adolescent football athletes. Developmental literature identifies cerebrovascular function as dynamically changing throughout adolescence. Our study provides fundamental data informing the clinical meaningfulness of short- and long-term physiological function changes.	[Roby, Patricia R.; Duquette, Peter J.; Kerr, Zachary Y.; Register-Mihalik, Johna K.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Ctr, 2207 Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA; [Roby, Patricia R.; Kerr, Zachary Y.; Register-Mihalik, Johna K.; Stoner, Lee; Mihalik, Jason P.] Univ N Carolina, Dept Allied Hlth Sci, Human Movement Sci Curriculum, Sch Med, Chapel Hill, NC 27515 USA; [Duquette, Peter J.] Univ N Carolina, Sch Med, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA; [Stoner, Lee] Univ N Carolina, Dept Exercise & Sport Sci, UNC Cardiometab Lab, Chapel Hill, NC 27515 USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Ctr, 2207 Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu	Stoner, Lee/C-8504-2011	Stoner, Lee/0000-0002-0682-2270			AASLID R, STROKE; ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; ADAMS RJ, 1998, NEW ENGL J MED, V339, P5, DOI [DOI 10.1056/NEJM199807023390102, 10.1056/NEJM199807023390102]; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Barthel H, 1997, EUR J NUCL MED, V24, P1245, DOI 10.1007/s002590050148; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Caccese JB, 2020, NEUROLOGY, V95, pE2935, DOI 10.1212/WNL.0000000000010672; Champagne AA, 2019, BRAIN INJURY, V33, P1479, DOI 10.1080/02699052.2019.1644375; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; CHIRON C, 1992, J NUCL MED, V33, P696; Claassen JAHR, 2007, J APPL PHYSIOL, V102, P870, DOI 10.1152/japplphysiol.00906.2006; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Macedo-Campos RD, 2018, J STROKE CEREBROVASC, V27, P2703, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.042; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moses P, 2014, HUM BRAIN MAPP, V35, P3188, DOI 10.1002/hbm.22394; NCAA, 2019, ESTIMATED PROBABILIT; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Purkayastha S, 2019, J NEUROTRAUM, V36, P2385, DOI 10.1089/neu.2018.5861; Rayner K, 1996, PSYCHON B REV, V3, P245, DOI 10.3758/BF03212426; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Roby PR, 2021, ANN BIOMED ENG, V49, P793, DOI 10.1007/s10439-020-02604-y; Roby PR, 2020, ANN BIOMED ENG, V48, P1651, DOI 10.1007/s10439-020-02514-z; Satterthwaite TD, 2014, P NATL ACAD SCI USA, V111, P8643, DOI 10.1073/pnas.1400178111; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Staszewski J, 2019, J ULTRAS MED, V38, P975, DOI 10.1002/jum.14782; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Thibeault CM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00590; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Totaro R, 1999, CEREBROVASC DIS, V9, P142, DOI 10.1159/000015943; Valadi N, 2006, NEUROLOGY, V67, P572, DOI 10.1212/01.wnl.0000230150.39429.8e; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Wright AD, 2020, CLIN J SPORT MED, V30, pS53, DOI 10.1097/JSM.0000000000000578; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	45	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2734	2746		10.1007/s10439-021-02764-5		MAR 2021	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	WH8FD	WOS:000631320300002	33754253				2022-02-07	
J	Turner, S; Lazarus, R; Marion, D; Main, KL				Turner, Stephanie; Lazarus, Rachel; Marion, Donald; Main, Keith L.			Molecular and Diffusion Tensor Imaging Biomarkers of Traumatic Brain Injury: Principles for Investigation and Integration	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; concussion; diffusion tensor imaging; molecular assays; traumatic brain injury		The last 20 years have seen the advent of new technologies that enhance the diagnosis and prognosis of traumatic brain injury (TBI). There is recognition that TBI affects the brain beyond initial injury, in some cases inciting a progressive neuropathology that leads to chronic impairments. Medical researchers are now searching for biomarkers to detect and monitor this condition. Perhaps the most promising developments are in the biomolecular and neuroimaging domains. Molecular assays can identify proteins indicative of neuronal injury and/or degeneration. Diffusion imaging now allows sensitive evaluations of the brain's cellular microstructure. As the pace of discovery accelerates, it is important to survey the research landscape and identify promising avenues of investigation. In this review, we discuss the potential of molecular and diffusion tensor imaging (DTI) biomarkers in TBI research. Integration of these technologies could advance models of disease prognosis, ultimately improving care. To date, however, few studies have explored relationships between molecular and DTI variables in patients with TBI. Here, we provide a short primer on each technology, review the latest research, and discuss how these biomarkers may be incorporated in future studies.	[Turner, Stephanie; Lazarus, Rachel; Marion, Donald; Main, Keith L.] Def & Vet Brain Injury Ctr, 1335 East West Highway,Suite 6-100, Silver Spring, MD 20910 USA; [Turner, Stephanie; Lazarus, Rachel; Marion, Donald; Main, Keith L.] Gen Dynam Informat Technol, Falls Church, VA USA		Main, KL (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway,Suite 6-100, Silver Spring, MD 20910 USA.	Keith.l.main3.ctr@mail.mil			DHA Contracting Office (CO-NCR) [HT0014-19-C-0004, HT0014]	The views expressed in this manuscript are those of the authors and do not necessarily represent the official policy or position of the Defense Health Agency, Department of Defense, or any other U.S. government agency. This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C.x101. Per Title 17 U.S.C.x105, copyright protection is not available for any work of the U.S. Government. For more information, please contact dha.DVBICinfo@mail.mil.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Agoston Denes V, 2017, Concussion, V2, pCNC45, DOI 10.2217/cnc-2016-0013; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Albayram Onder, 2018, J Alzheimers Dis Parkinsonism, V8, DOI 10.4172/2161-0460.1000443; Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Aronson JK, 2005, BRIT J CLIN PHARMACO, V59, P491, DOI 10.1111/j.1365-2125.2005.02435.x; Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Baliyan V, 2016, WORLD J RADIOL, V8, P785, DOI 10.4329/wjr.v8.i9.785; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Coleman MP, 2004, CNS NEUROL DISORD-DR, V3, P227, DOI 10.2174/1568007043337436; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Colom Roberto, 2010, Dialogues Clin Neurosci, V12, P489; Cox SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13629; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cruz JA, 2006, CANCER INFORM, V2, P59; Cummings, 2017, J CONCUSSION, V1, P1; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Duits FH, 2016, ALZHEIMERS DEMENT, V12, P154, DOI 10.1016/j.jalz.2015.08.003; Edwards LJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00720; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Essayed WI, 2017, NEUROIMAGE-CLIN, V15, P659, DOI 10.1016/j.nicl.2017.06.011; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Fridriksson T, 2000, ACAD EMERG MED, V7, P816, DOI 10.1111/j.1553-2712.2000.tb02276.x; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; GILLESPIE MJ, 1983, BRAIN RES, V259, P41, DOI 10.1016/0006-8993(83)91065-X; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goggio AF, 1941, J NEUROL PSYCHIATRY, V4, P11, DOI 10.1136/jnnp.4.1.11; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Greenberg J., 2009, J LIB METADATA, V9, P194, DOI [10.1080/19386380903405090, DOI 10.1080/19386380903405090]; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hansen B, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00040; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hayes JP, 2018, GENES BRAIN BEHAV, V17, P107, DOI 10.1111/gbb.12403; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hunter LE, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01297; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Jenkins S, 2002, COMP FUNCT GENOM, V3, P57, DOI 10.1002/cfg.130; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones Derek K, 2010, Top Magn Reson Imaging, V21, P87, DOI 10.1097/RMR.0b013e31821e56ac; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Kirchhoff C, 2009, CRIT CARE, V13, DOI 10.1186/cc7914; Kotsiantis SB, 2006, ARTIF INTELL REV, V26, P159, DOI 10.1007/S10462-007-9052-3; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Le Bihan D, 1991, Magn Reson Q, V7, P1; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Leclercq M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00452; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Leyden KM, 2015, QUANT IMAG MED SURG, V5, P247, DOI 10.3978/j.issn.2223-4292.2015.02.01; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Linsenmaier U, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150827; Lippa SM, 2019, J NEUROTRAUM, V36, P2190, DOI 10.1089/neu.2018.6269; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Machnicka B, 2014, BBA-BIOMEMBRANES, V1838, P620, DOI 10.1016/j.bbamem.2013.05.002; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Main KL, 2017, NEUROIMAGE-CLIN, V16, P1, DOI 10.1016/j.nicl.2017.06.031; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martinez BI, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0145-8; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathew AS, 2018, MOL DIAGN THER, V22, P729, DOI 10.1007/s40291-018-0365-5; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; Missler U, 1999, CLIN CHEM, V45, P138; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Moradi E, 2015, NEUROIMAGE, V104, P398, DOI 10.1016/j.neuroimage.2014.10.002; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Nazeri A, 2015, NEUROBIOL AGING, V36, P2094, DOI 10.1016/j.neurobiolaging.2015.02.022; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Netto CBO, 2006, CLIN CHIM ACTA, V364, P275, DOI 10.1016/j.cca.2005.07.028; Ni H, 2006, AM J NEURORADIOL, V27, P1776; Oh EJ, 2007, J CLIN LAB ANAL, V21, P387, DOI 10.1002/jcla.20201; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Orr ME, 2017, TRENDS PHARMACOL SCI, V38, P637, DOI 10.1016/j.tips.2017.03.011; Orringer DA, 2012, EXPERT REV MED DEVIC, V9, P491, DOI [10.1586/erd.12.42, 10.1586/ERD.12.42]; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Palacios EM, 2017, AM J NEURORADIOL, V38, P537, DOI 10.3174/ajnr.A5025; Pan S, 2005, MOL CELL PROTEOMICS, V4, P182, DOI 10.1074/mcp.M400161-MCP200; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pinto MS, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00396; Pohl KM, 2016, NEUROIMAGE, V130, P194, DOI 10.1016/j.neuroimage.2016.01.061; Poldrack RA, 2017, NEUROIMAGE, V144, P259, DOI 10.1016/j.neuroimage.2015.05.073; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Qin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041441; Quinn JP, 2018, J ALZHEIMERS DIS, V63, P13, DOI 10.3233/JAD-170959; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raad M, 2014, NEUROSCIENCE, V281, P16, DOI 10.1016/j.neuroscience.2014.08.045; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Ristevski B, 2018, J INTEGR BIOINFORMAT, V15, DOI 10.1515/jib-2017-0030; Rizk-Jackson A, 2011, NEUROIMAGE, V56, P788, DOI 10.1016/j.neuroimage.2010.04.273; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Rogatzki M.J., 2016, J NEUROL NEUROPHYSIO, V7, P3; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sandsmark DK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00246; Sbardella E, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/671730; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Soylu-Kucharz R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14179-1; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Su, 2016, TRANSLATIONAL RES TR, P1; Su YS, 2019, J NEUROTRAUM, V36, P2083, DOI 10.1089/neu.2018.6020; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Sun DQ, 2009, BIOL PSYCHIAT, V66, P1055, DOI 10.1016/j.biopsych.2009.07.019; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Suvak MK, 2009, J TRAUMA STRESS, V22, P622, DOI 10.1002/jts.20476; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Thomas D G, 1979, Acta Neurochir Suppl (Wien), V28, P93; THOMAS DGT, 1977, LANCET, V1, P113; Tomita K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214381; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; U.S. Food and Drug Administration, 2018, AUTHORIZES MARKETING; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vakhtin AA, 2020, J NEUROTRAUM, V37, P373, DOI 10.1089/neu.2019.6487; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Van Essen D. C., 2016, CEREBRUM, V2016; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wald M.M., 2021, TRAUMATIC BRAIN INJU; Wallace C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206466; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Ware JB, 2017, J NEUROTRAUM, V34, P2243, DOI 10.1089/neu.2016.4817; Wasserthal J, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101559; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Wheeler AL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00653; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; ZELENIKA D, 1993, J NEUROCHEM, V60, P1574, DOI 10.1111/j.1471-4159.1993.tb03325.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg Henrik, 2016, Concussion, V1, pCNC12, DOI 10.2217/cnc-2015-0002; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2; 2001, CLIN PHARMACOL THER, V69, P89, DOI DOI 10.1067/mcp.2000.113989	275	0	0	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1762	1782		10.1089/neu.2020.7259		MAR 2021	21	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000631711900001	33446015				2022-02-07	
J	Fitzpatrick, D; Thompson, P; Kipps, C; Webborn, N				Fitzpatrick, Daniel; Thompson, Peter; Kipps, Courtney; Webborn, Nick			Head impact forces in blind football are greater in competition than training and increased cervical strength may reduce impact magnitude	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						Concussion; blind football; cervical strength; injury prevention		Paralympic Blind Association Football has the highest rate of injury of any Paralympic sport and head injuries are common. This study aims to quantify head impact incidence and magnitude in Blind Football, and to examine contributing factors. This Observational study based on a Blind Football Team comprising seven male athletes 28.63 years (SD 9.74, range 16-46) over 6 months. Head mounted impact sensors were used to measure the frequency and location of impacts, as well as their linear acceleration and rotational velocity. Cervical isometric strength and proprioception was measured. There were 374 impacts recorded in 212.5 athlete hours. There was a higher rate of impacts in matches than training (Incidence Risk Ratio 2.58, 95% CI 2.01-3.30). Greater cervical strength was associated with reduced linear acceleration of impacts (R (2) = 0.1912, p = .020). Blind Football players are exposed to a greater number of head impacts in matches than training. Neck muscle strength may influence magnitude of head impact forces in this sport but further study is required to further investigate.	[Fitzpatrick, Daniel; Webborn, Nick] Univ Brighton, Ctr Sport & Exercise Sci & Med, Brighton, E Sussex, England; [Fitzpatrick, Daniel; Kipps, Courtney] UCL, Inst Sport Exercise & Hlth, London, England; [Thompson, Peter] Football Assoc, London, England		Fitzpatrick, D (corresponding author), Univ Brighton, Ctr Sport & Exercise Sci & Med, Brighton, E Sussex, England.; Fitzpatrick, D (corresponding author), UCL, Inst Sport Exercise & Hlth, London, England.	dfitzpatrick@doctors.org.uk		Webborn, Nick/0000-0003-3636-5557	British Association of Sport and Exercise Medicine	Funding was received from the British Association of Sport and Exercise Medicine.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Derman W, 2018, BRIT J SPORT MED, V52, P24, DOI 10.1136/bjsports-2017-098039; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Honda J, 2018, J EXERC REHABIL, V14, P706, DOI 10.12965/jer.1836416.208; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; International Blind Sports Federation, 2017, FOOTBALL 5 A SIDE RU; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Strimpakos N, 2006, GAIT POSTURE, V23, P22, DOI 10.1016/j.gaitpost.2004.11.019; Versteegh T, 2015, PHYSIOTHER CAN, V67, P58, DOI 10.3138/ptc.2013-66; Webborn N, 2018, BRIT J SPORT MED, V52, P1157, DOI 10.1136/bjsports-2016-097236; Webborn N, 2016, PM&R, V8, P545, DOI 10.1016/j.pmrj.2015.09.025; Willick SE, 2013, BRIT J SPORT MED, V47, P426, DOI 10.1136/bjsports-2013-092374	31	0	0	4	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.	APR 3	2021	28	2					194	200		10.1080/17457300.2021.1905667		MAR 2021	7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	SH2WS	WOS:000634981200001	33781178				2022-02-07	
J	Zou, YK; Zhu, WB; Yang, HC; Jang, I; Vike, NL; Svaldi, DO; Shenk, TE; Poole, VN; Breedlove, EL; Tamer, GG; Leverenz, LJ; Dydak, U; Nauman, EA; Tong, YJ; Talavage, TM; Rispoli, JV				Zou, Yukai; Zhu, Wenbin; Yang, Ho-Ching; Jang, Ikbeom; Vike, Nicole L.; Svaldi, Diana O.; Shenk, Trey E.; Poole, Victoria N.; Breedlove, Evan L.; Tamer, Gregory G., Jr.; Leverenz, Larry J.; Dydak, Ulrike; Nauman, Eric A.; Tong, Yunjie; Talavage, Thomas M.; Rispoli, Joseph V.			Development of brain atlases for early-to-middle adolescent collision-sport athletes	SCIENTIFIC REPORTS			English	Article								Human brains develop across the life span and largely vary in morphology. Adolescent collision-sport athletes undergo repetitive head impacts over years of practices and competitions, and therefore may exhibit a neuroanatomical trajectory different from healthy adolescents in general. However, an unbiased brain atlas targeting these individuals does not exist. Although standardized brain atlases facilitate spatial normalization and voxel-wise analysis at the group level, when the underlying neuroanatomy does not represent the study population, greater biases and errors can be introduced during spatial normalization, confounding subsequent voxel-wise analysis and statistical findings. In this work, targeting early-to-middle adolescent (EMA, ages 13-19) collision-sport athletes, we developed population-specific brain atlases that include templates (T1-weighted and diffusion tensor magnetic resonance imaging) and semantic labels (cortical and white matter parcellations). Compared to standardized adult or age-appropriate templates, our templates better characterized the neuroanatomy of the EMA collision-sport athletes, reduced biases introduced during spatial normalization, and exhibited higher sensitivity in diffusion tensor imaging analysis. In summary, these results suggest the population-specific brain atlases are more appropriate towards reproducible and meaningful statistical results, which better clarify mechanisms of traumatic brain injury and monitor brain health for EMA collision-sport athletes.	[Zou, Yukai; Yang, Ho-Ching; Svaldi, Diana O.; Poole, Victoria N.; Tamer, Gregory G., Jr.; Nauman, Eric A.; Tong, Yunjie; Talavage, Thomas M.; Rispoli, Joseph V.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Zou, Yukai] Purdue Univ, Coll Vet Med, W Lafayette, IN 47907 USA; [Zhu, Wenbin] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Jang, Ikbeom; Shenk, Trey E.; Talavage, Thomas M.; Rispoli, Joseph V.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Vike, Nicole L.; Poole, Victoria N.; Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Leverenz, Larry J.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Dydak, Ulrike] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA		Rispoli, JV (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	jrispoli@purdue.edu	Rispoli, Joseph Vincent/AAB-1655-2019; Zou, Yukai/AAX-4642-2021	Rispoli, Joseph Vincent/0000-0003-4514-3390; Zou, Yukai/0000-0002-9924-5926; Talavage, Thomas/0000-0003-4977-6398	Purdue University Libraries Open Access Publishing Fund	Publication of this article was funded in part by Purdue University Libraries Open Access Publishing Fund.	Akakpo L, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3793; Ashby, 2011, STAT ANAL FMRI DATA, DOI [10.7551/mitpress/8764.001.0001, DOI 10.7551/MITPRESS/8764.001.0001]; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.3; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Cabeen RP, 2017, NEUROIMAGE, V146, P100, DOI 10.1016/j.neuroimage.2016.11.020; CARPENTER MB, 1983, HUMAN NEUROANATOMY; Cercignani M, 2002, J NEUROL, V249, P875, DOI 10.1007/s00415-002-0752-y; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Coupe P, 2012, IET IMAGE PROCESS, V6, P558, DOI 10.1049/iet-ipr.2011.0161; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickie DA, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00001; Douet V, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00343; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Gogtay N., 2004, PNAS, V98, P11650, DOI [10.1073/pnas.201243998, DOI 10.1073/PNAS.0402680101]; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Guillemaud R, 1997, IEEE T MED IMAGING, V16, P238, DOI 10.1109/42.585758; Irfanoglu MO, 2016, NEUROIMAGE, V132, P439, DOI 10.1016/j.neuroimage.2016.02.066; Jang I, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101930; Jenkinson M., 2005, 11 ANN M ORG HUM BRA; JERNIGAN TL, 1990, DEV MED CHILD NEUROL, V32, P379; Jin Y, 2015, I S BIOMED IMAGING, P140, DOI 10.1109/ISBI.2015.7163835; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Jung KJ, 2014, MAGN RESON IMAGING, V32, P619, DOI 10.1016/j.mri.2014.02.020; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lebel C, 2012, J NEUROSCI, V32, P15243, DOI 10.1523/JNEUROSCI.1161-12.2012; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Mori S., 2005, AM J NEURORADIOL; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Narvacan K, 2017, HUM BRAIN MAPP, V38, P3771, DOI 10.1002/hbm.23604; Nauman EA, 2020, ANNU REV BIOMED ENG, V22, P387, DOI 10.1146/annurev-bioeng-091219-053447; Nauman EA, 2018, HAND CLINIC, V158, P245, DOI 10.1016/B978-0-444-63954-7.00024-0; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nilsson KJ, 2019, SPORTS HEALTH, V11, P507, DOI 10.1177/1941738119865264; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Park HJ, 2003, NEUROIMAGE, V20, P1995, DOI 10.1016/j.neuroimage.2003.08.008; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Picciotto M, 2018, J NEUROSCI, V38, P3375, DOI 10.1523/JNEUROSCI.0424-18.2018; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Pordes R, 2007, J PHYS CONF SER, V78, DOI 10.1088/1742-6596/78/1/012057; R Core Team, 2019, R LANG ENV STAT COMP; Richards JE, 2015, ADV CHILD DEV BEHAV, V48, P1, DOI 10.1016/bs.acdb.2014.11.001; Rohlfing T, 2010, HUM BRAIN MAPP, V31, P798, DOI 10.1002/hbm.20906; Sanchez CE, 2012, DEV NEUROPSYCHOL, V37, P379, DOI 10.1080/87565641.2012.688900; Satchell EK, 2019, MUSCULOSKEL SCI PRAC, V42, P162, DOI 10.1016/j.msksp.2019.05.002; Sbardella E, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/671730; Sfiligoi Igor, 2009, 2009 WRI World Congress on Computer Science and Information Engineering, CSIE, P428, DOI 10.1109/CSIE.2009.950; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talairach J., 1988, COPLANAR STEREOTAXIC; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Treit S, 2018, NEUROIMAGE, V182, P479, DOI 10.1016/j.neuroimage.2018.01.034; van Hecke W, 2016, DIFFUSION TENSOR IMA, P183; Van Hecke W, 2007, IEEE T MED IMAGING, V26, P1598, DOI 10.1109/TMI.2007.906786; Van Hecke W, 2011, NEUROIMAGE, V55, P566, DOI 10.1016/j.neuroimage.2010.12.005; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wu D, 2016, NEUROIMAGE, V125, P120, DOI 10.1016/j.neuroimage.2015.10.042; Wu GR, 2011, NEUROIMAGE, V56, P1968, DOI 10.1016/j.neuroimage.2011.03.050; Xu DR, 2003, MAGN RESON MED, V50, P175, DOI 10.1002/mrm.10489; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang SW, 2018, NEUROIMAGE, V172, P40, DOI 10.1016/j.neuroimage.2018.01.046; Zhang SW, 2013, J MAGN RESON IMAGING, V37, P372, DOI 10.1002/jmri.23842; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhao TD, 2019, NEUROIMAGE, V189, P55, DOI 10.1016/j.neuroimage.2019.01.006; Zou Y., 2020, Purdue Univ. Res. Repos., DOI 10.4231/RTXE-0Q70; Zou Y., 2017, BIOM ENG SOC 2017 AN; Zou YK, 2018, J NEUROTRAUM, V35, pA23	101	0	0	4	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAR 19	2021	11	1							6440	10.1038/s41598-021-85518-6			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RB3XK	WOS:000632047400011	33742031	gold, Green Accepted, Green Published			2022-02-07	
J	Johnson, AM; McCarty, CA; Marcynyszyn, LA; Zatzick, DF; Chrisman, SPD; Rivara, FP				Johnson, Ashleigh M.; McCarty, Carolyn A.; Marcynyszyn, Lyscha A.; Zatzick, Douglas F.; Chrisman, Sara P. D.; Rivara, Frederick P.			Child- compared with parent-report ratings on psychosocial measures following a mild traumatic brain injury among youth with persistent post-concussion symptoms	BRAIN INJURY			English	Article						Concussion; parent&#8211; child agreement; quality of life; anxiety; depression		Primary Objective: To compare child- and parent-report ratings on the Health Behavior Inventory, Revised Child Anxiety and Depression Scale-Short Version (anxiety subscale), Patient Health Questionnaire-9, and Pediatric Quality of Life Inventory(TM) among children with persistent post-concussive symptoms following a sports- or recreation-related concussion, overall and by child age and gender. Research Design: Cross-sectional study examining baseline data from a randomized, comparative effectiveness trial. Methods and Procedures: Inter-rater reliability was assessed using two-way random effects model (absolute agreement) intraclass correlations, correlations were examined using Spearman's rho, mean differences were determined using paired t-tests, and agreement was examined using Bland-Altman plots. Main Outcomes and Results: The final analytic sample was 200 parent-child dyads [child M-age = 14.7 (95% CI: 14.5, 15.0)]. Reliability and correlations were modest overall. When considering child age and gender, reliability ranged from poor to excellent (-1.01-0.95) and correlations ranged from weak to strong (-0.64-0.94). Overall, children reported more symptoms but better functioning than parents, and mean differences in scores were greater among females (versus males) and ages 16-18 (versus younger groups). Conclusions: Findings should inform the use and interpretation of psychosocial measures when developing appropriate youth concussion treatment plans.	[Johnson, Ashleigh M.; McCarty, Carolyn A.; Marcynyszyn, Lyscha A.; Chrisman, Sara P. D.; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA; [McCarty, Carolyn A.; Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Zatzick, Douglas F.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Johnson, AM (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA.	ashleigh.johnson@seattlechildrens.org	Johnson, Ashleigh/ABG-6095-2021	Johnson, Ashleigh/0000-0001-6638-9352; Chrisman, Sara/0000-0001-5373-7223; McCarty, Carolyn/0000-0002-9747-0927	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD090230]	This work was supported by the National Institute of Child Health and Human Development [R01 HD090230].	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; BARTKO J, 1966, PSYCHOL REP, V19; Becker-Haimes EM, 2018, CLIN CHILD PSYCHOL P, V23, P42, DOI 10.1177/1359104516689586; Berg-Nielsen TS, 2003, CHILD CARE HLTH DEV, V29, P207, DOI 10.1046/j.1365-2214.2003.00332.x; BL J, 1986, LANCET, V327; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carlston DL, 2009, J CHILD FAM STUD, V18, P125, DOI 10.1007/s10826-008-9213-2; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Clacy A, 2020, AUST J PSYCHOL, V72, P50, DOI 10.1111/ajpy.12266; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Cremeens J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-58; Curtis AC., 2015, J ADOLESC FAMILY HLT, V2; Dancey C., 2020, STAT MATHS PSYCHOL, V8th edition; De Los Reyes A, 2011, J CLIN CHILD ADOLESC, V40, P1, DOI 10.1080/15374416.2011.533405; DEROSS R, 2002, BEHAV CHANGE, V19; EDELBROCK C, 1986, J CHILD PSYCHOL PSYC, V27, P181, DOI 10.1111/j.1469-7610.1986.tb02329.x; Eiser C, 2013, EUR J PEDIATR, V172, P1299, DOI 10.1007/s00431-013-2049-9; FRICK P, 2000, J CLIN CHILD PSYCHOL, V29; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; HODGES K, 1990, J CHILD PSYCHOL PSYC, V31, P427, DOI 10.1111/j.1469-7610.1990.tb01579.x; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Howell DR, 2019, CLIN PEDIATR, V58, P42, DOI 10.1177/0009922818806308; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnston C, 2003, PSYCHOL ASSESSMENT, V15, P496, DOI 10.1037/1040-3590.15.4.496; Jones KM, 2018, BRAIN INJURY, V32, P1397, DOI 10.1080/02699052.2018.1496477; Joseph, 2017, BR J SPORTS MED, V51, DOI 10.1136/bjsports-2016-097270.89; KOLKO D, 1993, J CHILD PSYCHOL PSYC, V34; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Mac Donald CL, 2019, J NEUROTRAUM, V36, P264, DOI 10.1089/neu.2018.5629; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Martin SR., 2019, J PEDIATR PSYCHOL, V44, P645, DOI [10.1093/jpep/jsz007, DOI 10.1093/JPEP/JSZ007]; Mason Spicer C., 2014, SPORTS RELATED CONCU, P181; Mathyssek CM, 2013, INT J METH PSYCH RES, V22, P27, DOI 10.1002/mpr.1380; McCarty CA, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3662-3; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Milan S, 2017, J ABNORM CHILD PSYCH, V45, P171, DOI 10.1007/s10802-016-0156-6; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Muris P, 2003, PERS INDIV DIFFER, V34, P759, DOI 10.1016/S0191-8869(02)00069-7; MYERS K, 2002, J AM ACAD CHILD PSY, V41; Ogles B. M., 2001, J CHILD FAM STUD, V10, P199, DOI [DOI 10.1023/A:1016651508801, 10.1023/A:1016651508801]; Patsimas T, 2020, J ATHL TRAINING, V55, P1020, DOI 10.4085/1062-6050-200-19; PIACENTINI JC, 1992, J ABNORM CHILD PSYCH, V20, P51, DOI 10.1007/BF00927116; Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712; Rowhani-Rahbar A, 2016, J NEUROTRAUM, V33, P784, DOI 10.1089/neu.2015.4100; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Seiffge-Krenke I, 1998, J CHILD PSYCHOL PSYC, V39, P687, DOI 10.1111/1469-7610.00368; Sin B., 2010, REV PSICOPATOL PSICO, V15, P165, DOI [10.5944/rppc.vol.15.num.3.2010.4095, DOI 10.5944/RPPC.VOL.15.NUM.3.2010.4095, DOI 10.5944/RPPC.V0L.15.NUM.3.2010.4095]; Spano S., 2004, STAGES ADOLESCENT DE, DOI 13/19311/StagesAdol_chart.pdf?sequence=2; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	67	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2021	35	5					574	586		10.1080/02699052.2021.1889663		MAR 2021	13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO8QM	WOS:000630315300001	33733955				2022-02-07	
J	Li, Y; Liu, KJ; Li, C; Guo, Y; Fang, JQ; Tong, HP; Tang, Y; Zhang, JF; Sun, JJ; Jiao, FY; Zhang, QH; Jin, RB; Xiong, KL; Chen, X				Li, Yang; Liu, Kaijun; Li, Chang; Guo, Yu; Fang, Jingqin; Tong, Haipeng; Tang, Yi; Zhang, Junfeng; Sun, Jinju; Jiao, Fangyang; Zhang, Qianhui; Jin, Rongbing; Xiong, Kunlin; Chen, Xiao			F-18-FDG PET Combined With MR Spectroscopy Elucidates the Progressive Metabolic Cerebral Alterations After Blast-Induced Mild Traumatic Brain Injury in Rats	FRONTIERS IN NEUROSCIENCE			English	Article						blast injury; mild traumatic brain injury; positron emission tomography; fluorodeoxyglucose; magnetic resonance spectroscopy		A majority of blast-induced mild traumatic brain injury (mTBI) patients experience persistent neurological dysfunction with no findings on conventional structural MR imaging. It is urgent to develop advanced imaging modalities to detect and understand the pathophysiology of blast-induced mTBI. Fluorine-18 fluorodeoxyglucose positron emission tomography (F-18-FDG PET) could detect neuronal function and activity of the injured brain, while MR spectroscopy provides complementary information and assesses metabolic irregularities following injury. This study aims to investigate the effectiveness of combining F-18-FDG PET with MR spectroscopy to evaluate acute and subacute metabolic cerebral alterations caused by blast-induced mTBI. Thirty-two adult male Sprague-Dawley rats were exposed to a single blast (mTBI group) and 32 rats were not exposed to the blast (sham group), followed by F-18-FDG PET, MRI, and histological evaluation at baseline, 1-3 h, 1 day, and 7 days post-injury in three separate cohorts. F-18-FDG uptake showed a transient increase in the amygdala and somatosensory cortex, followed by a gradual return to baseline from day 1 to 7 days post-injury and a continuous rise in the motor cortex. In contrast, decreased F-18-FDG uptake was seen in the midbrain structures (inferior and superior colliculus). Analysis of MR spectroscopy showed that inflammation marker myo-inositol (Ins), oxidative stress marker glutamine + glutamate (Glx), and hypoxia marker lactate (Lac) levels markedly elevated over time in the somatosensory cortex, while the major osmolyte taurine (Tau) level immediately increased at 1-3 h and 1 day, and then returned to sham level on 7 days post-injury, which could be due to the disruption of the blood-brain barrier. Increased F-18-FDG uptake and elevated Ins and Glx levels over time were confirmed	[Li, Yang; Tang, Yi; Sun, Jinju; Jiao, Fangyang; Jin, Rongbing; Chen, Xiao] Army Med Univ, Daping Hosp, Dept Nucl Med, Chongqing, Peoples R China; [Li, Yang; Li, Chang; Guo, Yu; Fang, Jingqin; Tong, Haipeng; Zhang, Junfeng; Xiong, Kunlin] Army Med Univ, Daping Hosp, Dept Radiol, Chongqing, Peoples R China; [Li, Yang] Air Force Hosp Western Theater Command, Dept Med Imaging, Chengdu, Peoples R China; [Liu, Kaijun] Army Med Univ, Daping Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Zhang, Qianhui] Army Med Univ, Dept Foreign Language, Chongqing, Peoples R China; [Jin, Rongbing; Xiong, Kunlin; Chen, Xiao] Chongqing Clin Res Ctr Imaging & Nucl Med, Chongqing, Peoples R China		Jin, RB; Chen, X (corresponding author), Army Med Univ, Daping Hosp, Dept Nucl Med, Chongqing, Peoples R China.; Xiong, KL (corresponding author), Army Med Univ, Daping Hosp, Dept Radiol, Chongqing, Peoples R China.; Jin, RB; Xiong, KL; Chen, X (corresponding author), Chongqing Clin Res Ctr Imaging & Nucl Med, Chongqing, Peoples R China.	jinrb99@126.com; 109948969@qq.com; xiaochen229@foxmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801672, 81571889]; Natural Science Foundation of ChongqingNatural Science Foundation of Chongqing [cstc2019jcyj-msxmX0123]; Science and Technology Innovation Ability Enhancement Project of Army Medical University [2019XLC3054]; Talent Innovation Ability Training Program of Daping Hospital [2019CXLCC010]; Chongqing Clinical Research Centre of Imaging and Nuclear Medicine [CSTC2015YFPT-gcjsyjzx0175]	This work was supported by grants from the National Natural Science Foundation of China (81801672 and 81571889), the Natural Science Foundation of Chongqing (cstc2019jcyj-msxmX0123), Science and Technology Innovation Ability Enhancement Project of Army Medical University (2019XLC3054), Talent Innovation Ability Training Program of Daping Hospital (2019CXLCC010), and Chongqing Clinical Research Centre of Imaging and Nuclear Medicine (CSTC2015YFPT-gcjsyjzx0175).	Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Brabazon F, 2017, J NEUROTRAUM, V34, P1074, DOI 10.1089/neu.2016.4540; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Honce JM, 2016, PHYS MED REH CLIN N, V27, P411, DOI 10.1016/j.pmr.2016.01.002; Jaiswal S, 2019, BRAIN RES, V1723, DOI 10.1016/j.brainres.2019.146400; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Ning YL, 2019, TOXICOL LETT, V301, P90, DOI 10.1016/j.toxlet.2018.11.004; Park JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50681-4; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Singh K, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3764; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Tang SY, 2017, J NEUROTRAUM, V34, P1972, DOI 10.1089/neu.2016.4650; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Venkatasubramanian PN, 2020, ASN NEURO, V12, DOI 10.1177/1759091420922929; Walls MK, 2016, J NEUROSURG, V124, P675, DOI 10.3171/2015.1.JNS141571; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhuo JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136151	51	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAR 18	2021	15								593723	10.3389/fnins.2021.593723			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RG5OO	WOS:000635587600001	33815036	Green Published, gold			2022-02-07	
J	Mohan, M; Horsfall, HL; Solla, DJF; Robertson, FC; Adeleye, AO; Teklemariam, TL; Khan, MM; Servadei, F; Khan, T; Karekezi, C; Rubiano, AM; Hutchinson, PJ; Paiva, WS; Kolias, AG; Devi, BI				Mohan, Midhun; Layard Horsfall, Hugo; Solla, Davi Jorge Fontoura; Robertson, Faith C.; Adeleye, Amos O.; Teklemariam, Tsegazeab Laeke; Khan, Muhammad Mukhtar; Servadei, Franco; Khan, Tariq; Karekezi, Claire; Rubiano, Andres M.; Hutchinson, Peter J.; Paiva, Wellingson Silva; Kolias, Angelos G.; Devi, B. Indira		NIHR Global Health Research Grp N	Decompressive craniotomy: an international survey of practice	ACTA NEUROCHIRURGICA			English	Article						Neurosurgery; Decompressive craniectomy; Decompressive craniotomy; Hinge craniotomy; Floating craniotomy; Traumatic brain injury; Stroke		Background Traumatic brain injury (TBI) and stroke have devastating consequences and are major global public health issues. For patients that require a cerebral decompression after suffering a TBI or stroke, a decompressive craniectomy (DC) is the most commonly performed operation. However, retrospective non-randomized studies suggest that a decompressive craniotomy (DCO; also known as hinge or floating craniotomy), where a bone flap is replaced but not rigidly fixed, has comparable outcomes to DC. The primary aim of this project was to understand the current extent of usage of DC and DCO for TBI and stroke worldwide. Method A questionnaire was designed and disseminated globally via emailing lists and social media to practicing neurosurgeons between June and November 2019. Results We received 208 responses from 60 countries [40 low- and middle-income countries (LMICs)]. DC is used more frequently than DCO, however, about one-quarter of respondents are using a DCO in more than 25% of their patients. The three top indications for a DCO were an acute subdural hematoma (ASDH) and a GCS of 9-12, ASDH with contusions and a GCS of 3-8, and ASDH with contusions and a GCS of 9-12. There were 8 DCO techniques used with the majority (60/125) loosely tying sutures to the bone flap. The majority (82%) stated that they were interested in collaborating on a randomized trial of DCO vs. DC. Conclusion Our results show that DCO is a procedure carried out for TBI and stroke, especially in LMICs, and most commonly for an ASDH. The majority of the respondents were interested in collaborating on a is a future randomized trial.	[Mohan, Midhun; Layard Horsfall, Hugo; Hutchinson, Peter J.; Kolias, Angelos G.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Biomed Campus,Box 167, Cambridge CB2 0QQ, England; [Mohan, Midhun; Layard Horsfall, Hugo; Hutchinson, Peter J.; Kolias, Angelos G.] Univ Cambridge, Biomed Campus,Box 167, Cambridge CB2 0QQ, England; [Mohan, Midhun; Layard Horsfall, Hugo; Adeleye, Amos O.; Teklemariam, Tsegazeab Laeke; Khan, Muhammad Mukhtar; Khan, Tariq; Rubiano, Andres M.; Hutchinson, Peter J.; Kolias, Angelos G.; Devi, B. Indira] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Solla, Davi Jorge Fontoura; Paiva, Wellingson Silva] Univ Sao Paulo, Dept Neurosurg, Sao Paulo, Brazil; [Robertson, Faith C.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Adeleye, Amos O.] Univ Ibadan, Div Neurol Surg, Dept Surg, Coll Med, Ibadan, Nigeria; [Adeleye, Amos O.] Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria; [Teklemariam, Tsegazeab Laeke] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia; [Khan, Muhammad Mukhtar; Khan, Tariq] North West Gen Hosp & Res Ctr, Dept Neurosurg, Peshawar, Pakistan; [Servadei, Franco] Humanitas Univ, Dept Neurosurg, Dept Biomed Sci, Milan, Italy; [Servadei, Franco] Humanitas Clin & Res Ctr IRCCS, Milan, Italy; [Karekezi, Claire] Rwanda Mil Hosp, Dept Surg, Neurosurg Unit, Kigali, Rwanda; [Rubiano, Andres M.] El Bosque Univ, INUB MEDITECH Res Grp, Bogota, Colombia; [Rubiano, Andres M.] MEDITECH Fdn, Clin Res, Cali, Colombia; [Devi, B. Indira] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India		Mohan, M (corresponding author), Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Biomed Campus,Box 167, Cambridge CB2 0QQ, England.; Mohan, M (corresponding author), Univ Cambridge, Biomed Campus,Box 167, Cambridge CB2 0QQ, England.; Mohan, M (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.	mm2446@cam.ac.uk	Robertson, Faith/AAO-9914-2020; Paiva, Wellingson S/G-5517-2013; Karekezi, Claire/AAR-9283-2021	Paiva, Wellingson S/0000-0002-5165-7040; Karekezi, Claire/0000-0002-7183-899X; Layard Horsfall, Hugo/0000-0001-7848-5325	National Institute for Health Research (NIHR) Global Health Research Group on Neurotrauma using UK aid from the UK GovernmentNational Institute for Health Research (NIHR) [16/137/105]; NIHR Academic Clinical Fellowship at the University of Cambridge; NIHRNational Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research Center; European Union Seventh Framework Program grant (CENTER-TBI) [602150]; Clinical Lectureship, School of Clinical Medicine, University of Cambridge; Royal College of Surgeons of England	This research was commissioned by the National Institute for Health Research (NIHR) Global Health Research Group on Neurotrauma (16/137/105) using UK aid from the UK Government. Midhun Mohan is supported by the NIHR Academic Clinical Fellowship at the University of Cambridge. Peter Hutchinson is supported by a Research Professorship and Senior Investigator award from the NIHR, the NIHR Cambridge Biomedical Research Center, a European Union Seventh Framework Program grant (CENTER-TBI; grant no. 602150), and Angelos Kolias is supported by a Clinical Lectureship, School of Clinical Medicine, University of Cambridge and the Royal College of Surgeons of England.	Adeleye A Olufemi, 2011, Surg Neurol Int, V2, P150, DOI 10.4103/2152-7806.86227; Adeleye AO, 2012, WORLD NEUROSURG, V78, DOI [10.1016/j.wneu.2011.07.015, 10.1016/J.WNEU.2011.07.015]; Adeleye Amos Olufemi, 2016, Surg Neurol Int, V7, P54, DOI 10.4103/2152-7806.181905; Alexander P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-014390; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gorelick PB, 2019, LANCET NEUROL, V18, P417, DOI 10.1016/S1474-4422(19)30030-4; Gutman Matthew J, 2017, Surg Neurol Int, V8, P130, DOI 10.4103/sni.sni_460_16; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Horsfall HL, 2020, NEUROSURG REV, V43, P1493, DOI 10.1007/s10143-019-01180-7; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kano T, 2012, NEUROL MED-CHIR, V52, P816, DOI 10.2176/nmc.52.816; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Meara JG, 2015, SURGERY, V157, P834, DOI 10.1016/j.surg.2015.02.009; Posti JP, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00223; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	20	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2021	163	5					1415	1422		10.1007/s00701-021-04783-6		MAR 2021	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RO5GJ	WOS:000630274500001	33738561	Green Published, hybrid			2022-02-07	
J	Deana, C; Vetrugno, L; Stefani, F; Bassi, F; Bove, T				Deana, Cristian; Vetrugno, Luigi; Stefani, Francesca; Bassi, Flavio; Bove, Tiziana			Transcranial Doppler in a child: A most valuable imaging modality	ULTRASOUND			English	Article; Early Access						Head injury; transcranial Doppler ultrasound; neurocritical care; children; radiology		Introduction: Pediatric brain injury is a common cause of emergency department (ED) referral. Although severe traumatic brain damage is less frequent, it could be primarily managed by non-pediatric critical care physicians called in for advice. Clinical evaluation is important, but radiology is of particular value in the case of severe brain injury. Transcranial Doppler may help the physician through neuromonitoring. Case Report: We report the case of a 3-year-old male child brought into the pediatric ED for a moderate head injury. His neurological status deteriorated rapidly, making endotracheal intubation and mechanical ventilation necessary. Computed tomography (CT) of the head revealed brain contusion and post-traumatic subarachnoidal hemorrhage. Discussion: Transcranial Doppler was performed at the standard transtemporal evaluation window, and it showed normal vascularization of the entire anterior brain. This result permitted performance of the control CT scan to be postponed. In this case, basic knowledge of transcranial ultrasound proved to be useful, and we believe it could also be useful to other colleagues faced with similar situations even if they are not dedicated to pediatric critically ill patients. Conclusion: Doppler ultrasound in the pediatric population is a valuable bedside tool. Together with clinical evaluation and radiology, it completes the set of techniques necessary for continuous neuromonitoring.	[Deana, Cristian; Vetrugno, Luigi; Stefani, Francesca; Bassi, Flavio; Bove, Tiziana] Acad Hosp Udine, Dept Anesthesia & Intens Care, Udine, Italy; [Vetrugno, Luigi; Bove, Tiziana] Univ Udine, Dept Med, Udine, Italy		Deana, C (corresponding author), Acad Hosp S Maria della Misericordia, Azienda Sanit Univ Friuli Cent, Anesthesia & Intens Care Dept, Anesthesia & Intens Care 1, Piazzale S M della Misericordia 15, I-33100 Udine, Italy.	deana.cristian@gmail.com	Bassi, Flavio/AAC-8684-2022	Bassi, Flavio/0000-0002-2174-2316; DEANA, CRISTIAN/0000-0002-1626-3177			Appavu B, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01261; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Deana C., 2020, J ULTRAS MED, V9999, P1, DOI [10.1002/(ISSN)1550-9613, DOI 10.1002/(ISSN)1550-9613]; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LaRovere KL, 2015, J ULTRAS MED, V34, P2121, DOI 10.7863/ultra.15.02016; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Narayan V, 2018, WORLD NEUROSURG, V114, P293, DOI 10.1016/j.wneu.2018.02.159; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Reuter-Rice Karin, 2017, J Radiol Nurs, V36, P3, DOI 10.1016/j.jradnu.2016.11.003; Melo JRT, 2011, CHILD NERV SYST, V27, P979, DOI 10.1007/s00381-010-1367-8; Verlhac S, 2011, PEDIATR RADIOL, V41, pS153, DOI 10.1007/s00247-011-2038-y	12	0	0	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1742-271X	1743-1344		ULTRASOUND	Ultrasound												10.1177/1742271X21998059		MAR 2021	6	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	QZ2MK	WOS:000630566900001					2022-02-07	
J	Finneran, MM; Marotta, DA; Nardone, EM				Finneran, Megan M.; Marotta, Dario A.; Nardone, Emilio M.			Nonmissile penetrating head injury with a wooden table leg: An illustrative case	CLINICAL CASE REPORTS			English	Article						intraparenchymal hemorrhage; penetrating head injury; traumatic brain injury		Penetrating head injuries are relatively uncommon and require a unique approach. This report highlights a previously unreported mechanism of injury with a table leg and the steps required to evaluate and promptly treat the patient.	[Finneran, Megan M.] Carle BroMenn Med Ctr, Neurol Surg, Normal, IL USA; [Marotta, Dario A.] Alabama Coll Osteopath Med, Dothan, AL USA; [Marotta, Dario A.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Nardone, Emilio M.] Cent Illinois Neuro Hlth Sci, Neurol Surg, Bloomington, IL USA		Finneran, MM (corresponding author), Carle BroMenn Med Ctr, 1304 Franklin Ave,Suite 110, Normal, IL 61761 USA.	megan.finneran@carle.com		Marotta, Dario/0000-0002-0852-2327; Finneran, Megan/0000-0001-5629-0711	National Center for Osteopathic Principles and Practice Education	Financial support was provided by The National Center for Osteopathic Principles and Practice Education. Published with written consent of the patient.	Aarabi B, 2000, Neurosurg Focus, V8, pe1; Chowdhury FH, 2016, WORLD NEUROSURG, V94, P529, DOI 10.1016/j.wneu.2016.06.062; Clement MO, 2019, RADIOL CLIN N AM, V57, P733, DOI 10.1016/j.rcl.2019.02.008; D'Agostino Robyn, 2021, J Surg Res, V257, P101, DOI 10.1016/j.jss.2020.07.046; DIMAIO VJM, 1982, J FORENSIC SCI, V27, P894; Estebanez G, 2015, CRANIOMAX TRAUM REC, V8, P356, DOI 10.1055/s-0035-1546813; Exadaktylos AK, 2002, AM J EMERG MED, V20, P295, DOI 10.1053/ajem.2002.33784; Fahde Y, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.305.10376; Finneran MM., 2021, CLIN CASE REP, P1; Harrington BM, 2021, J NEUROSURG, V134, P1658, DOI 10.3171/2020.4.JNS20122; Kataria Rashim, 2011, Asian J Neurosurg, V6, P39, DOI 10.4103/1793-5482.85635; Li DD, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008523; Marklund N, 2019, J INTERN MED, V285, P608, DOI 10.1111/joim.12900; Mendez MF, 2013, BRAIN INJURY, V27, P10, DOI 10.3109/02699052.2012.722252; Moreira-Gonzalez A, 2006, PLAST RECONSTR SURG, V117, P1964, DOI 10.1097/01.prs.0000209933.78532.a7; Moussa WMM, 2016, ACTA NEUROCHIR, V158, P895, DOI 10.1007/s00701-016-2764-x; Nathoo N., 1999, Central African Journal of Medicine, V45, P213; Skoch J, 2013, J NEUROL SURG REP, V74, P23, DOI 10.1055/s-0033-1346976; Solumsmoen S., 2018, UGESKR LAEGER, V180; Yarandi K Karimi, 2018, Asian J Neurosurg, V13, P754, DOI 10.4103/ajns.AJNS_29_18; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Young M, 2020, CUREUS, V12, DOI 10.7759/cureus.7388	22	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2050-0904			CLIN CASE REP	Clin. Case Rep.	APR	2021	9	4					2424	2428		10.1002/ccr3.4057		MAR 2021	5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RT5AC	WOS:000629605400001	33936708	gold, Green Published			2022-02-07	
J	Sokol-Randell, D; Rotundo, MP; Tierney, G; Deasy, C; Cusimano, MD				Sokol-Randell, Darek; Rotundo, Mario Pasquale; Tierney, Gregory; Deasy, Conor; Cusimano, Michael D.			Characteristics of potential concussive events in elite male gaelic football players: A descriptive video-analysis	JOURNAL OF SPORTS SCIENCES			English	Article						Sport-Related Concussion; Gaelic athletic association; video analysis; SCAT-5; concussion management; return to play		Gaelic football (GF) is a high-impact sport and Sport-Related Concussion (SRC) is an issue within the game. Our aim was to evaluate the characteristics of Potential Concussive Events (PCEs) that occur in the Gaelic Athletic Association National Football League and extrapolate this data to reduce the incidence and severity of SRC. PCEs may or may not lead to a clinical diagnosis of SRC, but represent high-risk events and therefore may be a useful indicator. A video-analysis approach was undertaken to identify PCEs throughout two seasons of play using broadcast footage, and characteristics of each PCE were measured based on previously validated methods. A total of 242 PCEs were identified over 111 matches (2.18 per match, 58.14 per 1000 hours of exposure). PCEs were frequently not anticipated by the player (40.5%, n = 98). The most common impact locations were the mandibular region (33.1%, n = 80) and the temporal region (21.1%, n = 51), and the most frequently observed mechanism was hand/fist to head (27.3%, n = 66). A second-hit was observed in 34 PCEs (14.0%). The findings provide initial guidance for the development of player protection strategies to reduce the incidence and severity of SRC in Gaelic Football.	[Sokol-Randell, Darek; Rotundo, Mario Pasquale] Univ Coll Cork, Brookfield Hlth Sci Complex, Cork, Ireland; [Tierney, Gregory] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Deasy, Conor] Univ Coll Cork, Cork Univ Hosp Emergency Dept, Cork, Ireland; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada		Sokol-Randell, D (corresponding author), Univ Coll Cork, Brookfield Hlth Sci Complex, Cork, Ireland.	117105165@umail.ucc.ie		Rotundo, Mario/0000-0002-7516-1023; Tierney, Gregory/0000-0002-4666-4473; Deasy, Conor/0000-0001-6613-0076; Cusimano, Michael/0000-0002-9989-0650; Sokol-Randell, Darek/0000-0002-6751-5645			[Anonymous], 2019, GUARDIAN; Armstrong N, 2020, INJURY PREV, V26, P334, DOI 10.1136/injuryprev-2019-043242; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Bjorneboe J, 2013, BRIT J SPORT MED, V47, P508, DOI 10.1136/bjsports-2012-091522; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gaelic Athletic Association, 2020, GAA REF HDB PEN; Gaelic Athletic Association , 2020, GAEL GAM CAN; Gaelic Athletic Association, 2015, OFF GUID 2; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; GUSKIEWICZ KM, 2006, FDN SPORT RELATED BR; Hanson E, 2014, CLIN PEDIATR, V53, P1221, DOI 10.1177/0009922813518429; Hardy, 2003, P INT RES C BIOM IMP; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; JUNGE A, 2000, AM J SPORT MED, V28; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; LIS JR, 1977, BIOMETRICS, V33; Ly N., 2015, RULES GAELIC FOOTBAL; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Makdissi M., 2016, J SCI MED SPORT SPOR; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MCHUGH ML, 2012, BIOCHEM MEDICA; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Murphy JC, 2012, AM J SPORT MED, V40, P2113, DOI 10.1177/0363546512455315; National Hockey League, 2010, RUL PROH LAT BACK PR; NFL, 2019, NFL SEES SIGN CONC 2; NHL, 2013, NHL RUL 481 WHY BLIN; O'Connor S, 2019, SPORTS HEALTH, V11, P498, DOI 10.1177/1941738119875978; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P45; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sokol-Randell D, 2021, IRISH J MED SCI, V190, P787, DOI 10.1007/s11845-020-02390-5; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stubberman M., 2019, NCAA FOOTBALL RULES, V2019; Sullivan L., 2017, INT J ADOLESC MED HL, V29, P1, DOI [10.1515/ijamh-2015-0084, DOI 10.1515/IJAMH-2015-0084, 10.1515/ijamh-2017-3001]; Tarzi C, 2020, INJURY PREV, V26, P536, DOI 10.1136/injuryprev-2019-043397; Tierney G.J., 2017, RES MED, V24, P87, DOI [10.2218/resmedica.v24i1.2507, DOI 10.2218/RESMEDICA.V24I1.2507]; Wikipedia, 2009, NTR; Wilson F, 2007, BRIT J SPORT MED, V41, P317, DOI 10.1136/bjsm.2006.033167	55	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	AUG 3	2021	39	15					1700	1708		10.1080/02640414.2021.1896455		MAR 2021	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL7OM	WOS:000629409700001	33722171				2022-02-07	
J	Liu, PF; Chen, SB; Wang, YF; Chen, XM; Guo, YP; Liu, CH; Wang, HT; Zhao, YF; Wu, D; Shan, YL; Zhang, J; Wu, CM; Li, DW; Zhang, YM; Zhou, TC; Chen, YY; Liu, XB; Li, CX; Wang, LH; Jia, B; Liu, J; Feng, B; Cai, JL; Pei, DQ				Liu, Pengfei; Chen, Shubin; Wang, Yaofeng; Chen, Xiaoming; Guo, Yiping; Liu, Chunhua; Wang, Haitao; Zhao, Yifan; Wu, Di; Shan, Yongli; Zhang, Jian; Wu, Chuman; Li, Dongwei; Zhang, Yanmei; Zhou, Tiancheng; Chen, Yaoyu; Liu, Xiaobo; Li, Chenxu; Wang, Lihui; Jia, Bei; Liu, Jie; Feng, Bo; Cai, Jinglei; Pei, Duanqing			Efficient induction of neural progenitor cells from human ESC/iPSCs on Type I Collagen	SCIENCE CHINA-LIFE SCIENCES			English	Article						ESCs; iPSCs; NPCs; neural differentiation; Type I Collagen		A stable, rapid and effective neural differentiation method is essential for the clinical applications of human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) in treating neurological disorders and diseases. Herein, we established a novel and robust monolayer differentiation method to produce functional neural progenitor cells (NPCs) from human ESC/iPSCs on Type I Collagen. The derived cells not only displayed the requisite markers, but also behaved similarly to classic NPCs both in vitro and in vivo. Upon transplantation into traumatic brain injury model, the derived NPCs facilitated recovery from injury. We also found that SMAD signaling stayed down throughout the differentiation process on Type I Collagen, and the pluripotent signals were rapidly downregulated along with raising up of neural early markers on the third day. Meanwhile, ATAC-seq data showed the related mediation of distinct transcriptome and global chromatin dynamics during NPC induction. Totally, our results thus provide a convenient way to generate NPCs from human ESC/iPSCs for neural diseases' treatment.	[Liu, Pengfei; Chen, Shubin; Wang, Yaofeng; Chen, Xiaoming; Guo, Yiping; Liu, Chunhua; Wang, Haitao; Zhao, Yifan; Wu, Di; Shan, Yongli; Zhang, Jian; Wu, Chuman; Li, Dongwei; Zhang, Yanmei; Zhou, Tiancheng; Chen, Yaoyu; Liu, Xiaobo; Li, Chenxu; Wang, Lihui; Cai, Jinglei; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou 510530, Peoples R China; [Liu, Pengfei] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp, Affiliated Hosp 1,Clin Med Coll 2,Ambulatory Surg, Shenzhen 518020, Peoples R China; [Liu, Pengfei] Jinan Univ, Integrated Chinese & Western Med Postdoctoral Re, Guangzhou 510632, Peoples R China; [Chen, Shubin; Wang, Yaofeng; Chen, Xiaoming; Liu, Chunhua; Zhao, Yifan; Zhang, Yanmei; Pei, Duanqing] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou 510005, Peoples R China; [Wang, Yaofeng; Feng, Bo] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Wang, Yaofeng; Cai, Jinglei; Pei, Duanqing] Chinese Acad Sci, Hong Kong Inst Sci & Innovat, Ctr Regenerat Med & Hlth, Hong Kong, Peoples R China; [Chen, Yaoyu; Liu, Xiaobo; Li, Chenxu] Jilin Univ, Sch Pharmaceut Sci, Dept Regenerat Med, Changchun 130012, Peoples R China; [Wang, Lihui] Jinan Univ, Med Coll, Dept Pathol, Guangzhou 510632, Peoples R China; [Jia, Bei] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Peoples R China; [Liu, Jie] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou 510515, Peoples R China; [Cai, Jinglei; Pei, Duanqing] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China		Cai, JL; Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou 510530, Peoples R China.; Pei, DQ (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou 510005, Peoples R China.; Cai, JL; Pei, DQ (corresponding author), Chinese Acad Sci, Hong Kong Inst Sci & Innovat, Ctr Regenerat Med & Hlth, Hong Kong, Peoples R China.; Cai, JL; Pei, DQ (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China.	cai_jinglei@gibh.ac.cn; pei_duanqing@gibh.ac.cn		Guo, Yiping/0000-0003-1628-8312	National Key Research and Development Program of China [2017YFA0104800]; "Strategic Priority Research Program" of the Chinese Academy of SciencesChinese Academy of Sciences [XDA16010505]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81570944, 31300901, 31900547]; Fountain-Valley Life Sciences Fund of University of Chinese Academy of Sciences Education Foundation, Science and Technology Planning Project of Guangdong Province, China [2017B030314056]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [2017A030310098, 2016A030313165, 2015A030310026, 2014A030313732]; Science and Technology Planning Project of Guangzhou, China [201904010474]; Shenzhen Peacock Plan [KQTD2016113015442590]	This work was supported by the National Key Research and Development Program of China (2017YFA0104800), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA16010505), the National Natural Science Foundation of China (81570944, 31300901, and 31900547), Fountain-Valley Life Sciences Fund of University of Chinese Academy of Sciences Education Foundation, Science and Technology Planning Project of Guangdong Province, China (2017B030314056), Natural Science Foundation of Guangdong Province, China (2017A030310098, 2016A030313165, 2015A030310026, and 2014A030313732), Science and Technology Planning Project of Guangzhou, China (201904010474) and Shenzhen Peacock Plan (KQTD2016113015442590). We are grateful to Dr. Xiaodong Shu, Dr. Jiekai Chen, Dr. Jing Liu, and Dr. Guangjin Pan for valuable suggestions.	Burke EE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14266-z; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cai JL, 2013, DEV BIOL, V376, P62, DOI 10.1016/j.ydbio.2013.01.012; Cao ST, 2018, CELL STEM CELL, V22, P529, DOI 10.1016/j.stem.2018.03.005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cui CP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07025-z; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Fujimori K, 2017, STEM CELL REP, V9, P1675, DOI 10.1016/j.stemcr.2017.09.024; Huang K, 2014, SCI CHINA LIFE SCI, V57, P162, DOI 10.1007/s11427-013-4598-6; Hutchins Andrew Paul, 2014, Cell Regen, V3, P1, DOI 10.1186/2045-9769-3-1; Ishii S, 2010, J NEUROSCI RES, V88, P722, DOI 10.1002/jnr.22250; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kamishibahara Y, 2014, NEUROSCI LETT, V579, P58, DOI 10.1016/j.neulet.2014.07.011; Kang HC, 2010, BRAIN DEV-JPN, V32, P658, DOI 10.1016/j.braindev.2009.09.010; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; Lee DH, 2009, CHILD NERV SYST, V25, P1547, DOI 10.1007/s00381-009-0973-9; Li DW, 2017, CELL STEM CELL, V21, P819, DOI 10.1016/j.stem.2017.10.012; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lippmann ES, 2014, STEM CELLS, V32, P1032, DOI 10.1002/stem.1622; Liu PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069617; Lukovic D, 2017, STEM CELL TRANSL MED, V6, P1217, DOI 10.1002/sctm.16-0371; Luo K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022137; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Otsu Masahiro, 2014, World J Stem Cells, V6, P651, DOI 10.4252/wjsc.v6.i5.651; Poh YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5000; Qin YR, 2015, CELL REPROGRAM, V17, P221, DOI 10.1089/cell.2015.0001; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Rowland TJ, 2010, STEM CELLS DEV, V19, P1231, DOI 10.1089/scd.2009.0328; Shao Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00236-w; Surmacz B, 2012, STEM CELLS, V30, P1875, DOI 10.1002/stem.1166; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Wang B, 2019, CELL REP, V27, P3473, DOI 10.1016/j.celrep.2019.05.068; Wang LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22484; Wang LH, 2013, NAT METHODS, V10, P84, DOI [10.1038/NMETH.2283, 10.1038/nmeth.2283]; Wen Y, 2014, J BIOTECHNOL, V188, P122, DOI 10.1016/j.jbiotec.2014.07.453; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yamazoe H, 2005, BIOMATERIALS, V26, P5746, DOI 10.1016/j.biomaterials.2005.02.021; Yan YP, 2013, STEM CELL TRANSL MED, V2, P862, DOI [10.5966/sctm.2013-0080, 10.5966/sctm.2013-0080erratum]; Yang JY, 2010, J BIOL CHEM, V285, P40303, DOI 10.1074/jbc.M110.183392; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zerti D, 2020, STEM CELLS, V38, P45, DOI 10.1002/stem.3082; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115; Zhu LL, 2016, J CELL BIOL, V215, P187, DOI 10.1083/jcb.201601061	46	0	0	5	10	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	DEC	2021	64	12			SI		2100	2113		10.1007/s11427-020-1897-0		MAR 2021	14	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	XV2IR	WOS:000630689400001	33740188				2022-02-07	
J	Wettervik, TS; Howells, T; Hanell, A; Ronne-Engstrom, E; Lewen, A; Enblad, P				Svedung Wettervik, Teodor; Howells, Timothy; Hanell, Anders; Ronne-Engstrom, Elisabeth; Lewen, Anders; Enblad, Per			Low intracranial pressure variability is associated with delayed cerebral ischemia and unfavorable outcome in aneurysmal subarachnoid hemorrhage	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article; Early Access						Aneurysmal subarachnoid hemorrhage; Clinical outcome; Delayed cerebral ischemia; Intracranial pressure variability; Vasospasm		Purpose High intracranial pressure variability (ICPV) is associated with favorable outcome in traumatic brain injury, by mechanisms likely involving better cerebral blood flow regulation. However, less is known about ICPV in aneurysmal subarachnoid hemorrhage (aSAH). In this study, we investigated the explanatory variables for ICPV in aSAH and its association with delayed cerebral ischemia (DCI) and clinical outcome. Methods In this retrospective study, 242 aSAH patients, treated at the neurointensive care, Uppsala, Sweden, 2008-2018, with ICP monitoring the first ten days post-ictus were included. ICPV was evaluated on three time scales: (1) ICPV-1 m-ICP slow wave amplitude of wavelengths between 55 and 15 s, (2) ICPV-30 m-the deviation from the mean ICP averaged over 30 min, and (3) ICPV-4 h-the deviation from the mean ICP averaged over 4 h. The ICPV measures were analyzed in the early phase (day 1-3), in the early vasospasm phase (day 4-6.5), and the late vasospasm phase (day 6.5-10). Results High ICPV was associated with younger age, reduced intracranial pressure/volume reserve (high RAP), and high blood pressure variability in multiple linear regression analyses for all ICPV measures. DCI was associated with reduced ICPV in both vasospasm phases. High ICPV-1 m in the post-ictal early phase and the early vasospasm phase predicted favorable outcome in multiple logistic regressions, whereas ICPV-30 m and ICPV-4 h in the late vasospasm phase had a similar association. Conclusions Higher ICPV may reflect more optimal cerebral vessel activity, as reduced values are associated with an increased risk of DCI and unfavorable outcome after aSAH.	[Svedung Wettervik, Teodor; Howells, Timothy; Hanell, Anders; Ronne-Engstrom, Elisabeth; Lewen, Anders; Enblad, Per] Uppsala Univ, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se		Svedung Wettervik, Teodor/0000-0002-4556-5721	Uppsala University; Uppsala University Hospital (ALF Grant, Swedish Research Council)	Open access funding provided by Uppsala University.. The study was supported financially by the Uppsala University Hospital (ALF Grant, i.e. Swedish Research Council funding for clinical research in medicine).	Aries MJH, 2015, NEUROCRIT CARE, V23, P347, DOI 10.1007/s12028-015-0107-z; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; Engquist H, 2018, NEUROCRIT CARE, V28, P143, DOI 10.1007/s12028-017-0439-y; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; Hockel K, 2018, ACTA NEUROCHIR SUPPL, V126, P281, DOI 10.1007/978-3-319-65798-1_55; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2017, J CLIN MONIT COMPUT, V31, P469, DOI 10.1007/s10877-016-9863-3; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; Johnson U, 2016, NEUROCRIT CARE, V25, P47, DOI 10.1007/s12028-016-0240-3; Kirkness CJ, 2009, AM J CRIT CARE, V18, P241, DOI 10.4037/ajcc2009743; Kirkness CJ, 2008, ACTA NEUROCHIR SUPPL, V102, P105, DOI 10.1007/978-3-211-85578-2_21; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Rosner M., 1986, INTRACRANIAL PRESSUR, P137, DOI [10.1007/978-3-642-70971-5_25, DOI 10.1007/978-3-642-70971-5_25]; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Soehle M, 2013, J CLIN MONIT COMPUT, V27, P395, DOI 10.1007/s10877-012-9427-0; Spiegelberg A, 2016, INTERDISCIP NEUROSUR, V6, P13, DOI 10.1016/j.inat.2016.03.004; Wettervik TS, 2021, NEUROCRIT CARE, V34, P390, DOI 10.1007/s12028-020-01162-4; Wettervik TS, 2020, J CLIN MONIT COMPUT, V34, P733, DOI 10.1007/s10877-019-00387-9; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Wettervik TS, 2020, NEUROSURGERY, V86, pE300, DOI 10.1093/neuros/nyz515; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zeiler FA, 2021, J NEUROTRAUM, V38, P272, DOI 10.1089/neu.2020.7249	39	0	0	4	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.												10.1007/s10877-021-00688-y		MAR 2021	10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	QX7FJ	WOS:000629510000001	33728586	Green Published, hybrid			2022-02-07	
J	Gamboa, J; Horvath, J; Simon, A; Islam, MS; Gao, SJ; Perk, D; Thoman, A; Calderon, DP				Gamboa, Jasmine; Horvath, Jessica; Simon, Amanda; Islam, Md Safiqul; Gao, Sijia; Perk, Dror; Thoman, Amy; Calderon, Diany Paola			Secondary-blast injury in rodents produces cognitive sequelae and distinct motor recovery trajectories	BRAIN RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; MOUSE MODEL; DEFICITS		[Gamboa, Jasmine; Horvath, Jessica; Simon, Amanda; Islam, Md Safiqul; Gao, Sijia; Perk, Dror; Thoman, Amy; Calderon, Diany Paola] Weill Cornell Med Coll, Dept Anesthesiol, 1300 York Ave A Bldg 1033, New York, NY 10065 USA		Calderon, DP (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, 1300 York Ave A Bldg 1033, New York, NY 10065 USA.	dpc2003@med.cornell.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS094655]	We thank S. Gurunsinghe, S. Krebs and Heiken S. for helping to perform behavioral studies and histology. This work was supported by the National Institute of Neurological Disorders and Stroke awarded to DPC (NINDS, NS094655)	Aldag M, 2017, J NEUROTRAUM, V34, pS26, DOI 10.1089/neu.2017.5218; Andersen CR, 2021, J NEUROTRAUM, V38, P435, DOI 10.1089/neu.2020.7089; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fremont R, 2014, J NEUROSCI, V34, P11723, DOI 10.1523/JNEUROSCI.1409-14.2014; Furth D, 2018, NAT NEUROSCI, V21, P139, DOI 10.1038/s41593-017-0027-7; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Hoschneider DP, 2007, BRAIN RES, V1184, P96, DOI 10.1016/j.brainres.2007.09.081; Hughes JR, 2010, EPILEPSY BEHAV, V17, P147, DOI 10.1016/j.yebeh.2009.12.014; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Keller MW, 2015, MIL MED, V180, P315, DOI 10.7205/MILMED-D-14-00345; Kochanek P.M, 2019, J NEUROTRAUM; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Li YH, 2017, FRONT BEHAV NEUROSCI, V11, P1, DOI 10.3389/fnbeh.2017.00031; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Nakagawa H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.62; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Perez-Garcia G, 2019, BLAST INDUCED PTSD E; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Scherer M, 2007, BRAIN INJURY, V21, P93, DOI 10.1080/02699050601149104; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Scholz J, 2015, NEUROIMAGE, V107, P182, DOI 10.1016/j.neuroimage.2014.12.003; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Seif-Naraghi AH, 1999, J HEAD TRAUMA REHAB, V14, P146, DOI 10.1097/00001199-199904000-00005; Shi QX, 2020, BRAIN RES BULL, V157, P149, DOI 10.1016/j.brainresbull.2020.02.002; Singh AK, 2016, RADIOGRAPHICS, V36, P295, DOI 10.1148/rg.2016150114; Singh AK, 2014, AM J ROENTGENOL, V203, P235, DOI 10.2214/AJR.14.12549; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Sugihara I, 2018, CEREBELLUM, V17, P49, DOI 10.1007/s12311-017-0911-4; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tahtabasi M, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102489; Wang Y., 2020, SCI REP-UK, V10; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080058; Zhou Y, 2018, CHINESE MED J-PEKING, V131, P2447, DOI 10.4103/0366-6999.243558	43	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 15	2021	1755								147275	10.1016/j.brainres.2020.147275			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QG0NF	WOS:000617282400005	33422537				2022-02-07	
J	Dijkink, S; van Zwet, EW; Krijnen, P; Leenen, LPH; Bloemers, FW; Edwards, MJR; Den Hartog, D; Leenhouts, PA; Poeze, M; Spanjersberg, WR; Wendt, KW; De Wit, RJ; Van Zuthpen, SWAM; Schipper, IB				Dijkink, Suzan; van Zwet, Erik W.; Krijnen, Pieta; Leenen, Luke P. H.; Bloemers, Frank W.; Edwards, Michael J. R.; Den Hartog, Dennis; Leenhouts, Peter A.; Poeze, Martijn; Spanjersberg, W. Richard; Wendt, Klaus W.; De Wit, Ralph J.; Van Zuthpen, Stefan W. A. M.; Schipper, Inger B.			The impact of regionalized trauma care on the distribution of severely injured patients in the Netherlands	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Trauma system; The Netherlands; Regionalization of care; Trauma care		Background Twenty years ago, an inclusive trauma system was implemented in the Netherlands. The goal of this study was to evaluate the impact of structured trauma care on the concentration of severely injured patients over time. Methods All severely injured patients (Injury Severity Score [ISS] >= 16) documented in the Dutch Trauma Registry (DTR) in the calendar period 2008-2018 were included for analysis. We compared severely injured patients, with and without severe neurotrauma, directly brought to trauma centers (TC) and non-trauma centers (NTC). The proportion of patients being directly transported to a trauma center was determined, as was the total Abbreviated Injury Score (AIS), and ISS. Results The documented number of severely injured patients increased from 2350 in 2008 to 4694 in 2018. During this period, on average, 70% of these patients were directly admitted to a TC (range 63-74%). Patients without severe neurotrauma had a lower chance of being brought to a TC compared to those with severe neurotrauma. Patients directly presented to a TC were more severely injured, reflected by a higher total AIS and ISS, than those directly transported to a NTC. Conclusion Since the introduction of a well-organized trauma system in the Netherlands, trauma care has become progressively centralized, with more severely injured patients being directly presented to a TC. However, still 30% of these patients is initially brought to a NTC. Future research should focus on improving pre-hospital triage to facilitate swift transfer of the right patient to the right hospital.	[Dijkink, Suzan; Krijnen, Pieta; Schipper, Inger B.] Leiden Univ, Med Ctr, Dept Trauma Surg, Post Zone K6-R,POB 9600, NL-2300 RC Leiden, Netherlands; [van Zwet, Erik W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Leenen, Luke P. H.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Bloemers, Frank W.] Vrije Univ Amsterdam Med Ctr, Dept Surg, Amsterdam, Netherlands; [Edwards, Michael J. R.] Radboud Univ Nijmegen, Med Ctr, Dept Trauma Surg, Nijmegen, Netherlands; [Den Hartog, Dennis] Erasmus MC, Univ Med Ctr Rotterdam, Dept Surg, Trauma Res Unit, Rotterdam, Netherlands; [Leenhouts, Peter A.] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands; [Poeze, Martijn] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Spanjersberg, W. Richard] Isala Klin, Dept Trauma Surg, Zwolle, Netherlands; [Wendt, Klaus W.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands; [De Wit, Ralph J.] Med Spectrum Twente, Dept Trauma Surg, Enschede, Netherlands; [Van Zuthpen, Stefan W. A. M.] Elisabeth Tweesteden Ziekenhuis, Dept Surg, Tilburg, Netherlands		Dijkink, S (corresponding author), Leiden Univ, Med Ctr, Dept Trauma Surg, Post Zone K6-R,POB 9600, NL-2300 RC Leiden, Netherlands.	s.dijkink@lumc.nl	Schipper, Inger/ABE-7796-2021	Schipper, Inger/0000-0001-9952-3079			American College of Surgeons Committee on Trauma, 1999, RESOURCES OPTIMAL CA; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Barrington I, 1998, ADV AUTOMOT MED; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Gennarelli TA, 2008, UPDATE; Goris RJADJ, 1984, MEDISCH CONTACT, V39, P301; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Jeppesen E., 2020, RESUSCITATION EMERG, V28, P34; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Maduz R, 2017, INJURY, V48, P885, DOI 10.1016/j.injury.2017.02.015; Mills EHA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023049; Mimasaka S, 2006, INT J LEGAL MED, V120, P265, DOI 10.1007/s00414-006-0081-2; Ministerie van Volksgezondheid Welzijn en Sport, 1997, MET ZORG VERB; Nederlandse Vereniging voorTraumatologie, 1997, TRAUM ONZ ZORG; Newgard CD, 2018, JAMA SURG, V153, P328, DOI 10.1001/jamasurg.2017.4499; Newgard CD, 2016, J AM COLL SURGEONS, V222, P146, DOI 10.1016/j.jamcollsurg.2015.10.016; Newgard CD, 2011, J TRAUMA, V70, P1345, DOI 10.1097/TA.0b013e3182191a1b; Pal C., 2017, INT J AUTOM ENG, V8, P71; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-29; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-1; Ringdal KG, 2013, INJURY, V44, P691, DOI 10.1016/j.injury.2012.06.032; Sturms L, 2015, DUTCH TRAUMA REGISTR; Team RC, 2013, RA LANG ENV STAT COM; ten Duis HJ, 2003, INJURY, V34, P722, DOI 10.1016/S0020-1383(03)00162-1; Twijnstra MJ, 2010, ANN SURG, V251, P339, DOI 10.1097/SLA.0b013e3181c0e910; Uleberg O, 2007, ACTA ANAESTH SCAND, V51, P1178, DOI 10.1111/j.1399-6576.2007.01414.x; van Rein EAJ, 2019, EUR J NEUROL, V26, P274, DOI 10.1111/ene.13804; van Rein EAJ, 2018, AM J EMERG MED, V36, P1060, DOI 10.1016/j.ajem.2018.01.055; van Rein EAJ, 2017, J TRAUMA ACUTE CARE, V83, P328, DOI 10.1097/TA.0000000000001516; Vickers BP, 2015, AM J EMERG MED, V33, P1158, DOI 10.1016/j.ajem.2015.05.010; Voskens FJ, 2018, JAMA SURG, V153, P322, DOI 10.1001/jamasurg.2017.4472; Xiang HY, 2014, AM J EMERG MED, V32, P997, DOI 10.1016/j.ajem.2014.05.038; Zorg LNA, 2017, LANDELIJKE TRAUMAREG	35	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01615-1		MAR 2021	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	QV6MU	WOS:000628083900002	33712892	hybrid			2022-02-07	
J	Braun, D; Schoniger, C; Pyrc, J; Petrowski, K				Braun, Desiree; Schoeniger, Christian; Pyrc, Jaroslaw; Petrowski, Katja			Traumatic brain injury as vulnerability factor for the development of psychological disorders in a prospective single-event trauma traffic accident sample	BRAIN INJURY			English	Article						Acute concussion; traumatic brain injury (TBI); dexamethasone-suppression-test (DST); psychological disorders; traffic accident		Primary Objective: Traumatic brain injuries (TBIs) present a relevant problem among individuals involved in traffic accidents. The aim of this study was to investigate the impact of TBI on the development of psychological symptoms after a traffic accident. Research Design: This cohort study investigates, whether individuals involved in traffic accidents with TBI are more likely to develop psychological illness than those without TBI. Measures and Procedures: 59 men (patients: n= 19, controls: n= 40) and 64 women (patients: n= 21, controls n= 43) participated in the study (Mean age: M= 40.23; SD = 13.19; Injury severity score ISS: M= 6.48, SD = 5.99). The psychological distress was compared between the two groups using t-tests. The impact of ISS, number and duration of surgeries were regarded using regression analyses. Main Outcomes and Results: No indications for a heightened risk of psychological disorders in patients with TBI were found. The treatment at the hospital had no measurable influence on the development of psychological disorders. Nevertheless, in the Dexamethasone-suppression-test there was an increased stress load of patients with TBI caused by injury severity and operations. Conclusions: TBIs do not seem to cause psychological illness directly but the number of surgeries and the injury severity can influence the stress load which is associated with psychological symptoms.	[Braun, Desiree] Univ Witten, Dept Psychol & Psychotherapy, Herdecke, Germany; [Braun, Desiree; Schoeniger, Christian; Petrowski, Katja] Univ Med, Clin & Policlin Psychosomat Med & Psychotherapy, Med Psychol & Med Sociol, Mainz, Germany; [Pyrc, Jaroslaw] Univ Hosp Carl Gustav Carus, Clin Orthopaed & Traumatol, Dresden, Germany; [Petrowski, Katja] Tech Univ Dresden, Dept Internal Med 3, Dresden, Germany		Petrowski, K (corresponding author), Univ Med Mainz, Clin & Policlin Psychosomat Med & Psychotherapy, Med Psychol & Med Sociol, Duesbergweg 6, D-55128 Mainz, Germany.	Kpetrows@uni-mainz.de					[Anonymous], DTSCH GESELLSCHAFT; Baker S. P., 1974, J TRAUMA, V14; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Derogatis LR, 2000, BSI 18 BRIEF SYMPTOM; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Elbert T., 2003, ESTSSB, V10; FANN J, 2004, ARCH GEN PSYCHIAT, V61; Federal Statistical Office Germany (Statistisches Bundesamt), 2018, UNF VER STRASS; Franke G.H., 2000, BRIEF SYMPTOM INVENT; Fydrich T, 1997, STRUKTURIERTES KLINI; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; HARTWIG E, 1993, UNFALLCHIRURG, V96, P564; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lopez-Duran NL, 2015, STRESS, V18, P545, DOI 10.3109/10253890.2015.1053455; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; PARKER R, 1996, BRAIN INJURY, V10; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wenzlaff, 2006, EPIDEMIOLOGIE VERSOR; Wichmann S, 2017, PSYCHONEUROENDOCRINO, V83, P135, DOI 10.1016/j.psyneuen.2017.06.005; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	32	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2021	35	5					604	608		10.1080/02699052.2021.1894480		MAR 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO8QM	WOS:000627228100001	33719837				2022-02-07	
J	Choudhary, A; Kumar, A; Sharma, RK; Varshney, R; Munjal, SS; Kaushik, K; Gupta, LN				Choudhary, Ajay; Kumar, Ashok; Sharma, Rajesh Kumar; Varshney, Rahul; Munjal, Satya Shiva; Kaushik, Kaviraj; Gupta, Laxmi Narayan			Emergency Department Management of Mild Traumatic Brain Injury in New Delhi-A Single Institute Cohort Management Data	INDIAN JOURNAL OF NEUROSURGERY			English	Article; Early Access						mild traumatic brain injury; emergency care; clinical management		Introduction The purpose of this study is to compare the current clinical management practices and decision guidelines of the Brain Trauma Foundation (BTF) for mild traumatic brain insult with line of treatment followed at our center to identify the clinically significant treatment outcome in pediatric to elderly patients. Materials and Methods This is a questionnaire-based prospective observational study at the emergency department of neurosurgery in Dr. Ram Manohar Lohia (RML) Hospital, New Delhi. A registry questionnaire was administered to all the eligible subjects by the neurosurgery resident in emergency department (ED) to correlate clinical status, severity of traumatic brain injury (TBI) and associated comorbid conditions and its outcome after management. Results Out of 154 mild TBI cases attending ED, 115 (74.7%) were males and 39 (25.3%) were females, with average age of 27 years. Of the patients with mild TBI, road traffic accidents (RTA) were the main cause (50.6%), followed by fall from height (42.9%), assault and sports-related injury (6.4%). Of the total, 96.1% underwent CT. Of these, 31.8% found abnormal CT results, 27.5% received wound treatment care, and 9.1% received emergency care. Nearly 30.5% were admitted and 1.3% patients were died in the hospital, 75.3% patients were discharged and 23.4% were referred to other department for associated co morbid conditions. Conclusion The present study identified deficiencies in and variation around several important aspects of ED care. The development of BTF guidelines specific for mild TBI could reduce variation and improve emergency care for this injury.	[Choudhary, Ajay; Kumar, Ashok; Sharma, Rajesh Kumar; Varshney, Rahul; Munjal, Satya Shiva; Kaushik, Kaviraj; Gupta, Laxmi Narayan] Dr Ram Manohar Lohia Hosp, Atal Bihari Vajpayee Inst Med Sci, Dept Neurosurg, New Delhi 110001, India		Sharma, RK (corresponding author), Dr Ram Manohar Lohia Hosp, Atal Bihari Vajpayee Inst Med Sci, Dept Neurosurg, New Delhi 110001, India.	drsrk22@gmail.com	Varshney, Rahul/AAP-3666-2020	Varshney, Rahul/0000-0002-8280-7662; Kaushik, Kaviraj/0000-0001-7131-4849; sharma, rajesh/0000-0002-2741-740X; Kumar, Dr. Ashok/0000-0001-5735-3067			Bazarian J, 2000, BRAIN INJURY, V14, P285; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention. National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Gutu V, 2000, J EMERG MED, V18, P7, DOI 10.1016/S0736-4679(99)00153-5; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Jay G W, 1996, J Insur Med, V27, P262; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Petrack EM, 1997, PEDIATRICS, V99, P711, DOI 10.1542/peds.99.5.711; Phillips DM, 2000, JAMA-J AM MED ASSOC, V284, P428, DOI 10.1001/jama.284.4.428; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177	24	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.												10.1055/s-0040-1719236		MAR 2021	5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	QU8XI	WOS:000627561300001		gold			2022-02-07	
J	Kashyap, S; Brazdzionis, J; Savla, P; Berry, JA; Farr, S; Patchana, T; Majeed, G; Ghanchi, H; Bowen, I; Wacker, MR; Miulli, DE				Kashyap, Samir; Brazdzionis, James; Savla, Paras; Berry, James A.; Farr, Saman; Patchana, Tye; Majeed, Gohar; Ghanchi, Hammad; Bowen, Ira; Wacker, Margaret Rose; Miulli, Dan E.			Osteopathic Manipulative Treatment to Optimize the Glymphatic Environment in Severe Traumatic Brain Injury Measured With Optic Nerve Sheath Diameter, Intracranial Pressure Monitoring, and Neurological Pupil Index	CUREUS			English	Article						omt; glymphatic; onsd; tbi; osteopathic; optic nerve sheath	BIOMARKERS; RECOVERY	Background Traumatic brain injury (TBI) has a complex pathophysiology that has historically been poorly understood. New evidence on the pathophysiology, molecular biology, and diagnostic studies involved in TBI have shed new light on optimizing rehabilitation and recovery. The goal of this study was to assess the effect of osteopathic manipulative treatment (OMT) on peripheral and central glial lymphatics in patients with severe TBI, brain edema, and elevated intracranial pressure (ICP) by measuring changes in several parameters regularly used in management. Methodology This was a retrospective study at a level II trauma center that occurred in 2018. The study enrolled patients with TBI, increased ICP, or brain edema who had an external ventricular drain placed. Patients previously underwent a 51-minute treatment with OMT with an established protocol. Patients received 51 minutes of OMT to the head, neck, and peripheral lymphatics. The ICP, cerebrospinal fluid (CSF) drainage, optic nerve sheath diameter (ONSD) measured by ultrasonography, and Neurological Pupil Index (NPi) measured by pupillometer were recorded before, during, and after receiving OMT. Results A total of 11 patients were included in the study, and 21 points of data were collected from the patients meeting inclusion criteria who received OMT. There was a mean decrease in the ONSD of 0.62 mm from 6.24 mm to 5.62 mm (P = 0.0001). The mean increase in NPi was 0.18 (P = 0.01). The mean decrease in ICP was 3.33 mmHg (P = 0.0001). There was a significant decrease in CSF output after treatment (P = 0.0001). Each measurement of ICP, ONSD, and NPi demonstrated a decrease in overall CSF volume and pressure after OMT compared to CSF output and ICP prior to OMT. Conclusions This study demonstrates that OMT may help optimize glial lymphatic clearance of CSF and improve brain edema, interstitial waste product removal, NPi, ICP, CSF volume, and ONSD. A holistic approach including OMT may be considered to enhance management in TBI patients. As TBI is a spectrum of disease, utilizing similar techniques may be considered for all forms of TBI including concussions and other diseases with brain edema. The results of this study can better inform future trials to specifically study the effectiveness of OMT in post-concussive treatment and in those with mild-to-moderate TBI.	[Kashyap, Samir; Brazdzionis, James; Savla, Paras; Berry, James A.; Farr, Saman; Patchana, Tye; Majeed, Gohar; Ghanchi, Hammad; Bowen, Ira] Riverside Univ Hlth Syst, Med Ctr, Neurosurg, Moreno Valley, CA 92555 USA; [Wacker, Margaret Rose; Miulli, Dan E.] Arrowhead Reg Med Ctr, Neurosurg, Colton, CA USA		Brazdzionis, J (corresponding author), Riverside Univ Hlth Syst, Med Ctr, Neurosurg, Moreno Valley, CA 92555 USA.	jbrazdzionis@une.edu		Brazdzionis, James/0000-0002-1336-4810			Abbott NJ, 2018, ACTA NEUROPATHOL, V135, P387, DOI 10.1007/s00401-018-1812-4; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; COHADON F, 1976, NEUROCHIRURGIA, V19, P33; Cramer D, 2010, J AM OSTEOPATH ASSOC, V110, P232; Dreyer J, 2012, J AM ORG NEUROL SURG, V12, P1; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Jakel A, 2011, J AM OSTEOPATH ASSOC, V111, P685; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Joshua SP, 2011, CLIN NEUROL NEUROSUR, V113, P635, DOI 10.1016/j.clineuro.2011.05.012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Morais N, 2013, ONCOL LETT, V5, P992, DOI 10.3892/ol.2012.1076; Patel KG, 2018, J AM OSTEOPATH ASSOC, V118, P403, DOI 10.7556/jaoa.2018.061; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Smith AJ, 2017, ELIFE, V6, DOI [10.7554/elife.27679, 10.7554/eLife.27679]; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016	23	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAR 11	2021	13	3							e13823	10.7759/cureus.13823			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QW4UI	WOS:000628646000008	33859888	gold, Green Published			2022-02-07	
J	Lah, S; Bodanov, S; Brookes, N; Epps, A; Phillips, NL; Teng, A; Naismith, SL				Lah, Suncica; Bodanov, Stefan; Brookes, Naomi; Epps, Adrienne; Phillips, Natalie Lynette; Teng, Arthur; Naismith, Sharon L.			Children who sustained traumatic brain injury take longer to fall asleep compared to children who sustained orthopedic injuries: actigraphy findings	BRAIN INJURY			English	Article						Sleep disturbance; insomnia; traumatic brain injuries; head injury; children; actigraphy		Objective: Primary: to examine objective sleep outcomes in children who sustained moderate to severe traumatic brain injury (TBI). Secondary: to examine the relation of objective sleep with subjective sleep, fatigue, and injury variables. Setting: A single tertiary brain injury unit. Participants: Children (5-15 years) with moderate to severe TBI (n = 23) or orthopedic injury (OI; n = 13). Design: Cohort study. Measures: Primary: objective sleep measure (actigraphy watch). Secondary: subjective sleep measure (questionnaire), fatigue questionnaire, and injury variables. Results: On actigraphy, children with TBI had longer sleep onset latency compared to children with OI. On the sleep questionnaire, children with TBI obtained higher scores for total sleep disturbance, initiating and maintaining sleep, and excessive somnolence. On the fatigue questionnaire, greater difficulties were found for total, sleep/rest, and cognitive fatigue for the TBI group. In the TBI group, actigraphy data did not correlate with sleep questionnaire, fatigue, or injury variables. Conclusion: Our study showed evidence of objective and subjective sleep disturbance in children with moderate to severe TBI, but these two types of sleep measures were not related. It is possible that distinct mechanisms underpin objective and subjective sleep disturbance, which may require different interventions.	[Lah, Suncica; Bodanov, Stefan; Phillips, Natalie Lynette; Naismith, Sharon L.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Brookes, Naomi; Epps, Adrienne] Sydney Childrens Hosp Randwick, Rehab2Kids Rehabil Unit, Randwick, NSW, Australia; [Teng, Arthur] Sydney Childrens Hosp Randwick, Dept Sleep Med, Randwick, NSW, Australia; [Teng, Arthur] Univ New South Wales, Sch Paediat & Womens Hlth, Kensington, NSW, Australia; [Naismith, Sharon L.] Univ Sydney, Brain & Mind Ctr, Charles Perkins Ctr, Camperdown, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Camperdown, NSW 2050, Australia.	suncica.lah@sydney.edu.au			Research Infrastructure Block Grant: Top Slice by the School of Psychology, University of Sydney	The study was in-part funded by the Research Infrastructure Block Grant: Top Slice awarded to SL & SLN by the School of Psychology, University of Sydney.	ACEBO C, 1999, SLEEP, V22; Australian Bureau of Statistics, TECHINICAL PAPER; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bogdanov S, 2021, J HEAD TRAUMA REHAB, V36, pE108, DOI 10.1097/HTR.0000000000000585; Bogdanov S, 2019, J HEAD TRAUMA REHAB, V34, P122, DOI 10.1097/HTR.0000000000000426; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; Corkum P, 2001, SLEEP, V24, P303, DOI 10.1093/sleep/24.3.303; Crichton A, 2018, J INT NEUROPSYCH SOC, V24, P224, DOI 10.1017/S1355617717000893; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Fischer JT, 2018, NEUROPSYCHOLOGY, V32, P161, DOI 10.1037/neu0000420; Goldstone A, 2020, J ADOLESCENT HEALTH, V66, P567, DOI 10.1016/j.jadohealth.2019.12.005; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hvolby A, 2008, ARCH PEDIAT ADOL MED, V162, P323, DOI 10.1001/archpedi.162.4.323; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Lah S., 2021, PEDIAT SLEEP MED; Lah S., FEASIBILITY ACCEPTAB; Lewandowski AS, 2011, J PEDIATR PSYCHOL, V36, P780, DOI 10.1093/jpepsy/jsq119; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Owens JA, 2000, SLEEP, V23, P1043; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; Stickgold R, 2013, TRENDS COGN SCI, V17, P261, DOI 10.1016/j.tics.2013.04.006; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; TEASDALE G, 1974, LANCET, V2, P81; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Wei YN, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006322; Williams CN, 2018, NAT SCI SLEEP, V10, P225, DOI 10.2147/NSS.S174608; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhu B, 2012, NEUROBIOL DIS, V48, P348, DOI 10.1016/j.nbd.2012.06.022	47	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2021	35	6					682	689		10.1080/02699052.2021.1895314		MAR 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SB4DP	WOS:000627224700001	33689527				2022-02-07	
J	Mitchell, T; du Preez, E; Theadom, A				Mitchell, Tracey; du Preez, Elizabeth; Theadom, Alice			An intervention to improve coping strategies in adult male prisoners with a history of traumatic brain injury: A pilot randomised clinical trial	CLINICAL REHABILITATION			English	Article						Traumatic brain injury; prison; cognitive behaviour therapy; rehabilitation; mindfulness		Objective: To determine whether a psychological intervention improves coping, post-concussion symptoms and decreases in-prison infractions in adult males with a history of traumatic brain injury. Design: A single centre, randomised, wait-list, pilot study. Setting: A high security prison in New Zealand. Subjects: Fifty-five adult male participants who had experienced at least one traumatic brain injury in their lifetime (mean age 37.29 +/-9.81 years). Intervention: A manualised ten session, in-person, group based combined Cognitive Behavioural Therapy /Mindfulness Based Stress Reduction intervention versus wait list control. Main measures: The Negative Affect Repair Questionnaire and Rivermead Post-concussion Symptom Questionnaire were completed at baseline, post-intervention (five weeks) and at 12 week follow up. In-prison misconduct charges and negative file notes were reviewed for the previous five weeks at each assessment time point. Results: There was an improvement in the use of calming and distraction strategies in the intervention group from baseline (x = 17.38, SD = 3.57) to post-intervention (x = 18.67, SD = 3.84) and 12-week follow up (x = 18.13, SD = 2.63). Participants in the intervention group had significantly higher negative affect repair on the calming and distractive strategies subscale following completion of the intervention, compared to wait-list controls (F = 4.69, P = 0.04) with a moderate effect size (eta(2)(p) = 0.11). Improvements in use of calming and distractive strategies was not sustained at the twelve-week follow-up (F = 0.87, P = 0.36). There was no-significant improvement on other negative affect subscales or for post-concussion symptoms or decrease in-prison infractions. Conclusion: A manualised psychological intervention may have the potential to facilitate the development of positive coping strategies in prisoners with a history of traumatic brain injury.	[Mitchell, Tracey] Serco New Zealand Ltd, Auckland, New Zealand; [du Preez, Elizabeth; Theadom, Alice] Auckland Univ Technol, Dept Psychol, Sch Clin Sci, Fac Hlth & Environm Studies, Auckland, New Zealand; [Theadom, Alice] Auckland Univ Technol, Fac Hlth & Environm Studies, TBI Network, AR238,AUT North Campus,Private Bag 92006, Auckland 1142, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Studies, TBI Network, AR238,AUT North Campus,Private Bag 92006, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz		Theadom, Alice/0000-0003-0351-6216	Rutherford Discovery Fellowship	The authors wish to thank Auckland South Corrections Facility for their support in facilitating the intervention delivery within their service. The authors also wish thank the participants who took part in the study. AT is supported by a Rutherford Discovery Fellowship from government funding, administered by the Royal Society Te Aparangi.	Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Backhaus S, 2016, ARCH PHYS MED REHAB, V97, P281, DOI 10.1016/j.apmr.2015.10.097; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bench Suzanne, 2013, Nurse Res, V20, P38; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Department of C, 2017, PRIS FACTS STAT; Ferguson SD, 2009, J PERS DISORD, V23, P230, DOI 10.1521/pedi.2009.23.3.230; Fix RL, 2013, AGGRESS VIOLENT BEH, V18, P219, DOI 10.1016/j.avb.2012.11.009; Gomez-de-Regil L, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/6937832; Hart T, 2015, CONTEMP CLIN TRIALS, V40, P180, DOI 10.1016/j.cct.2014.12.005; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Kelly, 2007, THESIS PHILADELPHIA; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Medvedev ON, 2018, PEERJ, V6, DOI 10.7717/peerj.5676; Mitchell T, 2017, NEUROEPIDEMIOLOGY, V48, P164, DOI 10.1159/000479520; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Scherer A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-16; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Stalder-Luthy F, 2013, ARCH PHYS MED REHAB, V94, P1386, DOI 10.1016/j.apmr.2013.02.013; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thomas M, 2018, BRAIN IMPAIR, V19, P166, DOI 10.1017/Brimp.2017.26; Trimble TJ, 2015, J CRIM PSYCHOL, V5, P124, DOI 10.1108/JCP-02-2015-0006; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wehman PH, 2017, PHYS MED REH CLIN N, V28, P351, DOI 10.1016/j.pmr.2016.12.010; Whitehead AL, 2016, STAT METHODS MED RES, V25, P1057, DOI 10.1177/0962280215588241; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134	36	0	0	2	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	AUG	2021	35	8					1185	1195	0269215521998535	10.1177/0269215521998535		MAR 2021	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	TG8OX	WOS:000631215900001	33706573				2022-02-07	
J	Wu, QQ; Chen, ZB; Xiong, J; Wang, ZY; Yang, CL				Wu, Qianqian; Chen, Zongbing; Xiong, Jian; Wang, Zhenyu; Yang, Chenglin			Computational Studies of Porous Head Protection Structures for Human Cranium under Impact Loading	ACTA MECHANICA SOLIDA SINICA			English	Article						Protective helmet; Porous shell structures; Negative Poisson&#8217; s ratio effect; Impact resistance; Numerical simulation	ENERGY-ABSORPTION; HELMET; PERFORMANCE; FRACTURE; MODEL	This paper looks into the effects of various porous structures used in the construction of the shell of a protective helmet on the energy absorption capacity and their efficacy in protecting the head/skull against impact force. It is well known that porous structures are very effective for energy absorption; hence, they have been widely used to reduce the negative effects of impact and explosion loads on the human skull. Porous shell structures, made from titanium alloy (Ti-6Al-4V) and, comprised of several periodic topological configurations, namely the more common rectangle and hexagonal honeycomb, as well as those having auxetic properties, namely the concave honeycomb and double-arrow, are studied by means of numerical modeling. The reliability of the numerical model is validated with the published experimental results. For the double-arrow configurations, the study involves three different densities, and the structural energy absorption capacity of the double-arrow shells increases with density. For the same density, the energy absorption capacity of the rectangular shell is the best, and that of the honeycomb is the worst. The superior performance of the rectangular configuration is partly derived from the fact that the orientation of the struts in this structure is aligned along the direction of the impact force. Further comparison of energy absorption capacity is made between the porous shell and a shell having a traditional titanium monolayer. The severe plastic deformation in the solid titanium shell (traditional monolayer shell) is detrimental to the overall effectiveness of head protection gear. Apart from this, compared with the Kevlar composite laminated shell of the same mass, both the solid and porous titanium shells provide considerable protection to the human head. The comprehensive comparisons show that the porous design on the titanium shell is beneficial for mitigating the risks of traumatic brain injuries (TBIs).	[Wu, Qianqian; Chen, Zongbing; Xiong, Jian] Harbin Inst Technol, Ctr Composite Mat & Struct, Harbin 150001, Peoples R China; [Wang, Zhenyu] Harbin Med Univ, Affiliated Hosp 2, Neurosurg Dept, Harbin 150001, Peoples R China; [Yang, Chenglin] Harbin Med Univ, Affiliated Hosp 1, Orthoped Dept, Harbin 150001, Peoples R China		Xiong, J (corresponding author), Harbin Inst Technol, Ctr Composite Mat & Struct, Harbin 150001, Peoples R China.; Wang, ZY (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Neurosurg Dept, Harbin 150001, Peoples R China.	jx@hit.edu.cn; wangzhenyuhmu@126.com		Xiong, Jian/0000-0003-1755-1338	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [12002107]; National Postdoctoral Program for Innovative Talents [BX20190101]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019M661268]; Heilongjiang Postdoctoral Financial Assistance [LBH-Z19061]; von Humboldt FoundationAlexander von Humboldt Foundation [1155520]; Science and Technology on Advanced Composites in Special Environment Laboratory, Young Elite Scientist Sponsorship Program by CAST [YESS20160190]	This study was funded in part by the National Natural Science Foundation of China (12002107), the National Postdoctoral Program for Innovative Talents (Grant No.: BX20190101), the China Postdoctoral Science Foundation (Grant No.: 2019M661268) and the Heilongjiang Postdoctoral Financial Assistance (Grant No.: LBH-Z19061). The present work was also supported by the von Humboldt Foundation under grant award 1155520 (University of Siegen, Germany) and the Science and Technology on Advanced Composites in Special Environment Laboratory, Young Elite Scientist Sponsorship Program by CAST (YESS20160190).	Chen XW, 2002, INT J IMPACT ENG, V27, P619, DOI 10.1016/S0734-743X(02)00005-2; Deck C, 2008, 7 EUR LS DYNA C SALZ; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; Erhardt T, 2016, ACCIDENT ANAL PREV, V86, P23, DOI 10.1016/j.aap.2015.10.004; Furusu K, 2001, JSAE REV, V22, P195, DOI 10.1016/S0389-4304(01)00084-4; Gibson L. J., 1999, CELLULAR SOLIDS STRU; GURDJIAN ES, 1950, J NEUROSURG, V7, P106, DOI 10.3171/jns.1950.7.2.0106; Halldin P, 2013, P INT C HELM PERF DE; Hou XH, 2016, ACTA MECH SOLIDA SIN, V29, P490, DOI 10.1016/S0894-9166(16)30267-1; Khosroshahi SF, 2018, MATER TODAY COMMUN, V14, P312, DOI 10.1016/j.mtcomm.2018.02.002; Khosroshahi SF, 2019, J BIOMECH, V97, DOI 10.1016/j.jbiomech.2019.109376; Li WW, 2019, ACTA MECH SOLIDA SIN, V32, P713, DOI 10.1007/s10338-019-00097-4; Liu YP, 2010, SCI RES ESSAYS, V5, P1052; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Roberts Jack C, 2013, Front Bioeng Biotechnol, V1, P13; SAHA S, 1976, J BIOMECH, V9, P243, DOI 10.1016/0021-9290(76)90010-5; Sahoo D, 2013, J MECH BEHAV BIOMED, V28, P340, DOI 10.1016/j.jmbbm.2013.08.010; Shuaeib FM, 2007, MATER DESIGN, V28, P182, DOI 10.1016/j.matdes.2005.04.015; Soe SP, 2015, INT J ADV MANUF TECH, V79, P1975, DOI 10.1007/s00170-015-6972-y; Thompson D C, 2001, Nurs Times, V97, P41; Tinard V, 2011, MATER DESIGN, V32, P3112, DOI 10.1016/j.matdes.2010.12.019; WHO, 2006, HELM ROAD SAF MAN DE; Wu QQ, 2018, J MECH BEHAV BIOMED, V81, P106, DOI 10.1016/j.jmbbm.2018.02.018; Yang F, 2015, ACTA MECH SOLIDA SIN, V28, P735, DOI 10.1016/S0894-9166(16)30013-1; Zahid B, 2014, J COMPOS MATER, V48, P761, DOI 10.1177/0021998313477173; Zhao J, 2005, 19 INT TECHN C ENH S	26	0	0	12	16	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0894-9166	1860-2134		ACTA MECH SOLIDA SIN	Acta Mech. Solida Sin.	AUG	2021	34	4					477	493		10.1007/s10338-021-00222-2		MAR 2021	17	Materials Science, Multidisciplinary; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics	TJ2LV	WOS:000627659600001					2022-02-07	
J	Zachar-Tirado, CN; Donders, J				Zachar-Tirado, Christopher N.; Donders, Jacobus			Clinical utility of the GAD-7 in identifying anxiety disorders after traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; GAD-7; concussion; premorbid mental health; anxiety disorder		To determine if the GAD-7 provides incremental value, predicting a final diagnosis of an anxiety disorder after traumatic brain injury (TBI). Retrospective analysis of archival data of 100 patients with TBI, who underwent neuropsychological evaluation 1-12 months after injury. Receiver Operating Characteristic analysis determined the optimal cutoff point for clinically significant symptoms on the GAD-7. Hierarchical logistic regression analyses determined the relative contributions of premorbid psychiatric history, injury severity, and GAD-7 results in predicting a final diagnosis of anxiety disorder. GAD-7 cutoff point of >= 7 yielded the best combination of sensitivity and specificity regarding a final diagnosis of anxiety disorder. Within hierarchical logistic regression models, injury severity did not statistically significantly add to prior psychiatric history in predicting a final diagnosis of anxiety disorder. When GAD-7 was added, it made a statistically significant contribution in accounting for such a diagnosis and increased sensitivity from 71% to 91%. The GAD-7 holds diagnostic utility as a screening measure for anxiety disorders in patients with TBI. It should not be used in isolation but as part of a more comprehensive interview and history. The GAD-7 can benefit clinicians in assisting with timelier identification and treatment of symptoms of anxiety.	[Zachar-Tirado, Christopher N.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI USA		Zachar-Tirado, CN (corresponding author), Mary Free Bed Rehabil Hosp, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	christopher.zachar-tirado@maryfreebed.com			Campbell Foundation [MFB-JD 2019]; Mary Free Bed Fund [191]	This work was supported by the Campbell Foundation [MFB-JD 2019]; Mary Free Bed Fund [191].	Allanson F, 2017, NEUROPSYCHOL REV, V27, P187, DOI 10.1007/s11065-017-9353-5; Austin PC, 2017, STAT METHODS MED RES, V26, P796, DOI 10.1177/0962280214558972; Budikayanti A, 2019, NEUROL RES INT, V2019, DOI 10.1155/2019/5902610; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Donders J, 2017, ARCH PHYS MED REHAB, V98, P2514, DOI 10.1016/j.apmr.2017.05.019; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; FANN J, 2004, ARCH GEN PSYCHIAT, V61; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Jordan P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182162; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Moran TP, 2016, PSYCHOL BULL, V142, P831, DOI 10.1037/bul0000051; Morey L.C., 2007, PERSONALITY ASSESSME; Morris R, 2017, APHASIOLOGY, V31, P1410, DOI 10.1080/02687038.2017.1304633; Ober, 2017, CALIFORNIA VERBAL LE; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rutter LA, 2017, J PSYCHOPATHOL BEHAV, V39, P140, DOI 10.1007/s10862-016-9571-9; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Sharma A, 2015, INDIAN J NEUROTRAUM, V12, P2, DOI 10.1055/s-0035-1554948; Spitzer R.L., 2016, STRUCTURED CLIN INTE; Terrill Alexandra L, 2015, Int J MS Care, V17, P49, DOI 10.7224/1537-2073.2014-008; Tombaugh, 2002, TEST MEMORY MALINGER; Tully PJ, 2015, DISABIL REHABIL, V37, P585, DOI 10.3109/09638288.2014.935493; van Gils A, 2020, PRACT NEUROL, V20, P213, DOI 10.1136/practneurol-2018-002087; Wechsler D., 2014, WECHSLER ADULT INTEL, Vfourth; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	39	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2021	35	6					655	660		10.1080/02699052.2021.1895315		MAR 2021	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SB4DP	WOS:000627271200001	33689521				2022-02-07	
J	Guvenc, Y; Sakar, M; Niftaliyev, S; Guliyev, A; Simsek, I; Dagcinar, A				Guvenc, Yahya; Sakar, Mustafa; Niftaliyev, Seymur; Guliyev, Abdulmammad; Simsek, Ismail; Dagcinar, Adnan			Penetrating Craniocerebral Injury by the Hook of a School Desk	PEDIATRIC NEUROSURGERY			English	Article						Gigantic foreign body; Seizure; Surgery; Head injury		Introduction: Although penetrating cranial injuries are rare in pediatric patients, these injuries can lead to morbidity and mortality. Removal of a gigantic foreign body from the cranium requires proper management as it has high risk of further brain damage and seizures. Case Presentation: We report the case of a patient with cranial injury caused by hitting the head to the hook of a school desk. Due to the extreme nature of the injury, the following additional steps were necessary: taking help from a local firefighter team to cut the desk, surgical removal of the foreign body, and cranioplasty after 6 months. Following this, he was discharged without neurological deficits. Discussion/Conclusion: Neurotrauma is one of the major causes of death in children. The damage and effect of the injuring foreign body depends on its size, shape, velocity, trajectory, and entry point. It should be kept in mind that any high-frequency processes applied on the extracranial parts of conductive objects, such as metal bars, may trigger seizures. Preoperative extracranial intervention for huge penetrating foreign bodies should be performed under anticonvulsant administration and intubation to decrease the risk of epileptic seizures and its complications.	[Guvenc, Yahya; Sakar, Mustafa; Niftaliyev, Seymur; Guliyev, Abdulmammad; Simsek, Ismail; Dagcinar, Adnan] Marmara Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey; [Guvenc, Yahya; Sakar, Mustafa; Niftaliyev, Seymur; Guliyev, Abdulmammad; Simsek, Ismail; Dagcinar, Adnan] Marmara Univ, Neurol Sci Inst, Istanbul, Turkey		Guvenc, Y (corresponding author), Marmara Univ, Neurol Sci Inst, Dept Neurosurg, Sch Med, Basibuyuk Yolu 9-2, TR-34854 Istanbul, Turkey.	dr.yahyaguvenc@gmail.com	dagcinar, adnan/AAD-6890-2022	Niftaliyev, Seymur/0000-0003-4267-505X; Simsek, Ismail/0000-0002-5087-5863			Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; RIVARA F, PEDIATR ANN, V23, P12; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512	6	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	APR	2021	56	2					152	156		10.1159/000512863		MAR 2021	5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RN4LI	WOS:000627439100001	33691329				2022-02-07	
J	Pandya, JD; Leung, LY; Hwang, HM; Yang, XF; Deng-Bryant, Y; Shear, DA				Pandya, Jignesh D.; Leung, Lai Yee; Hwang, Hye M.; Yang, Xiaofang; Deng-Bryant, Ying; Shear, Deborah A.			Time-Course Evaluation of Brain Regional Mitochondrial Bioenergetics in a Pre-Clinical Model of Severe Penetrating Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain energy metabolism; mitochondrial dysfunction; penetrating traumatic brain injury (PTBI); seahorse analyzer; TBI therapeutics; time course		Mitochondrial dysfunction is a pivotal target for neuroprotection strategies for traumatic brain injury (TBI). However, comprehensive time-course evaluations of mitochondrial dysfunction are lacking in the pre-clinical penetrating TBI (PTBI) model. The current study was designed to characterize temporal responses of mitochondrial dysfunction from 30 min to 2 weeks post-injury after PTBI. Anesthetized adult male rats were subjected to either PTBI or sham craniectomy (n = 6 animals per group x 7 time points). Animals were euthanized at 30 min, 3 h, 6 h, 24 h, 3 days, 7 days, and 14 days post-PTBI, and mitochondria were isolated from the ipsilateral hemisphere of brain regions near the injury core (i.e., frontal cortex [FC] and striatum [ST]) and a more distant region from the injury core (i.e., hippocampus [HIP]). Mitochondrial bioenergetics parameters were measured in real time using the high-throughput procedures of the Seahorse Flux Analyzer (Agilent Technologies, Santa Clara, CA). The post-injury time course of FC + ST showed a biphasic mitochondrial bioenergetics dysfunction response, indicative of reduced adenosine triphosphate synthesis rate and maximal respiratory capacity after PTBI. An initial phase of energy crisis was detected at 30 min (-42%; p < 0.05 vs. sham), which resolved to baseline levels between 3 and 6 h (non-significant vs. sham). This was followed by a second and more robust phase of bioenergetics dysregulation detected at 24 h that remained unresolved out to 14 days post-injury (-55% to -90%; p < 0.05 vs. sham). In contrast, HIP mitochondria showed a delayed onset of mitochondrial dysfunction at 7 days (-74%; p < 0.05 vs. sham) that remained evident out to 14 days (-51%; p < 0.05 vs. sham) post-PTBI. Collectively, PTBI-induced mitochondrial dysfunction responses were time and region specific, evident differentially at the injury core and distant region of PTBI. The current results provide the basis that mitochondrial dysfunction may be targeted differentially based on region specificity post-PTBI. Even more important, these results suggest that therapeutic interventions targeting mitochondrial dysfunction may require extended dosing regimens to achieve clinical efficacy after TBI.	[Pandya, Jignesh D.; Leung, Lai Yee; Hwang, Hye M.; Yang, Xiaofang; Deng-Bryant, Ying; Shear, Deborah A.] Walter Reed Army Inst Res WRAIR, Ctr Mil Psychiat & Neurosci CMPN, Brain Trauma Neuroprotect BTN Branch, Silver Spring, MD USA; [Leung, Lai Yee] Uniformed Serv Univ Hlth Sci USUHS, Dept Surg, Bethesda, MD USA		Pandya, JD (corresponding author), Walter Reed Army Inst Res WRAIR, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	jignesh.d.pandya.civ@mail.mil			US Army Combat Casualty Care Research Program (CCCRP)United States Department of Defense [H_001_2018_WRAIR]	This work was supported by the US Army Combat Casualty Care Research Program (CCCRP; H_001_2018_WRAIR).	Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dave KR, 2001, J CEREBR BLOOD F MET, V21, P1401, DOI 10.1097/00004647-200112000-00004; de Castro IP, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001456; Deng-Bryant Y, 2016, J NEUROTRAUM, V33, pA54; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU; Fecher C, 2019, NAT NEUROSCI, V22, P1731, DOI 10.1038/s41593-019-0479-z; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gajavelli S, 2015, J CEREBR BLOOD F MET, V35, P773, DOI 10.1038/jcbfm.2014.243; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Gimeno-Bayon J, 2014, J NEUROSCI RES, V92, P723, DOI 10.1002/jnr.23356; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1289, DOI 10.1016/j.bbabio.2009.07.011; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kaiser EE, 2020, NEURAL REGEN RES, V15, P1377, DOI 10.4103/1673-5374.274324; Keller JN, 1998, J NEUROSCI, V18, P687; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kim DK, 2019, BMB REP, V52, P679, DOI 10.5483/BMBRep.2019.52.12.282; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kozlov AV, 2017, BBA-MOL BASIS DIS, V1863, P2627, DOI 10.1016/j.bbadis.2016.12.020; Kubik LL, 2015, TOXICOL SCI, V144, P7, DOI 10.1093/toxsci/kfu254; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Leung LY, 2016, J TRAUMA ACUTE CARE, V81, P860, DOI 10.1097/TA.0000000000001206; Leung Lai Yee, 2015, J Trauma Acute Care Surg, V79, pS130, DOI 10.1097/TA.0000000000000785; Li FH, 1999, ANN NEUROL, V46, P333, DOI 10.1002/1531-8249(199909)46:3<333::AID-ANA9>3.0.CO;2-X; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McCafferty R., 2016, JOINT TRAUMA SYSTEM; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya Jignesh D, 2020, J Aging Res, V2020, P7232614, DOI 10.1155/2020/7232614; Pandya JD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00605; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Pandya JD, 2011, BRAIN RES, V1384, P151, DOI 10.1016/j.brainres.2011.01.102; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Racay P, 2009, NEUROCHEM RES, V34, P1469, DOI 10.1007/s11064-009-9934-7; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rose J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.536682; Rose J, 2017, TOXICOLOGY, V391, P109, DOI 10.1016/j.tox.2017.06.011; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Sicard Kenneth M, 2009, Exp Transl Stroke Med, V1, P7, DOI 10.1186/2040-7378-1-7; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Yonutas HM, 2015, J BIOENERG BIOMEMBR, V47, P149, DOI 10.1007/s10863-014-9593-5; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	99	0	0	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2323	2334		10.1089/neu.2020.7379		MAR 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000628696200001	33544034				2022-02-07	
J	Silva, MA; Finn, JA; Dillahunt-Aspillaga, C; Cotner, BA; Stevens, LF; Nakase-Richardson, R				Silva, Marc A.; Finn, Jacob A.; Dillahunt-Aspillaga, Christina; Cotner, Bridget A.; Stevens, Lillian F.; Nakase-Richardson, Risa			Development of the traumatic brain injury Rehabilitation Needs Survey: a Veterans Affairs TBI Model Systems study	DISABILITY AND REHABILITATION			English	Article; Early Access						Brain injuries; traumatic; health service needs and demand; health care surveys; military personnel; rehabilitation; surveys and questionnaires; veterans		Purpose To describe the development of the Rehabilitation Needs Survey (RNS) for persons in the chronic phase of traumatic brain injury (TBI) recovery. Materials and methods RNS items were generated following a literature review (January - March 2015) on the topic of rehabilitation needs and revised via consensus from an expert panel of TBI clinicians and researchers. The RNS was added to the VA TBI Model Systems longitudinal study; data collection occurred between 2015-2019. Needs were classified as current (if endorsed) or absent; if current, needs were classified as unmet if no help was received. Need frequency and association with rehabilitation outcomes were presented. Results Eight studies examined rehabilitation needs and formed the initial item pool of 42 needs. This was reduced to form the 21-item RNS which was administered at year 1 (n = 260) and year 2 (n = 297) post-TBI. Number of needs endorsed was 8-9, and number of unmet needs was 1-2, on average. Number of needs was correlated with functional status, neurobehavioral symptoms, and mental health symptoms (p < 0.05) suggesting support for convergent validity of the RNS. Conclusion The RNS is a new measure of rehabilitation needs following TBI. Further investigation into its psychometrics and clinical utility is recommended.	[Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Sect MHBSS, Tampa, FL 33612 USA; [Silva, Marc A.; Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA; [Silva, Marc A.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Finn, Jacob A.] Minneapolis VA Hlth Care Syst, Extended Care & Rehabil EC&R Patient Serv Line, Minneapolis, MN USA; [Finn, Jacob A.] Univ Minnesota Twin Cities, Dept Psychiat & Behav Sci, Minneapolis, MN USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Child & Family Studies, Tampa, FL 33620 USA; [Cotner, Bridget A.] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Cotner, Bridget A.] Univ S Florida, Dept Anthropol, Tampa, FL 33620 USA; [Stevens, Lillian F.] Hunter Holmes McGuire VA Med Ctr, Mental Hlth Serv, Richmond, VA USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, TBI Ctr Excellence TBICoE, Tampa, FL 33612 USA		Silva, MA (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci, 13000 Bruce B Downs Blvd 116-B, Tampa, FL 33612 USA.	marc.silva1@va.gov		Dillahunt-Aspillaga, Christina/0000-0002-1231-2023	Defense and Veterans Brain Injury Center subcontract from General Dynamics Information Technology [HT0014-19-C-0004, W91YTZ-13-C-0015]	This work was supported by the Defense and Veterans Brain Injury Center subcontract from General Dynamics Information Technology (HT0014-19-C-0004,W91YTZ-13-C-0015).	Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; [Anonymous], 2020, TRAUMATIC BRAIN INJU; Beatty PC, 2007, PUBLIC OPIN QUART, V71, P287, DOI 10.1093/poq/nfm006; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Centers for Disease Control and Prevention, 2019, SURVEILLANCE REPORT; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cooney MT, 2016, CLIN MED, V16, P109, DOI 10.7861/clinmedicine.16-2-109; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Cotner BA., 2020, ARCH PHYS MED REHAB, V101; Cotner BA., 2020, ARCH PHYS MED REHAB, V101; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Harrison-Felix C., 2018, ONE 5 YEAR OUTCOMES; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Heiden SM, 2018, ERGONOMICS, V61, P134, DOI 10.1080/00140139.2017.1349932; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hurst H, 2004, J MANIP PHYSIOL THER, V27, P26, DOI 10.1016/j.jmpt.2003.11.003; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Levin H.S., 2014, UNDERSTANDING TRAUMA; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Linstone H.A., 1975, DELPHI METHOD TECHNI; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Mahoney EJ, 2021, J HEAD TRAUMA REHAB, V36, P175, DOI 10.1097/HTR.0000000000000629; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Purc-Stephenson RJ, 2014, REHABIL PSYCHOL, V59, P10, DOI 10.1037/a0035353; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reed K, 1999, ARCH CLIN NEUROPSYCH, V14, P795; Ropacki S, 2018, ARCH PHYS MED REHAB, V99, P952, DOI 10.1016/j.apmr.2017.12.035; Silva MA, 2021, ARCH PHYS MED REHAB, V102, P58, DOI 10.1016/j.apmr.2020.08.012; Soo C, 2010, ARCH PHYS MED REHAB, V91, P905, DOI 10.1016/j.apmr.2009.11.033; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; U.S. Department of Veterans Affairs, 2015, POLYTRAUMATBI SYSTEM; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Zamanzadeh Vahid, 2015, J Caring Sci, V4, P165, DOI 10.15171/jcs.2015.017	48	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1900930		MAR 2021	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	RB2JU	WOS:000631941700001	33756089				2022-02-07	
J	Dickson, KH; Straw, CM; Thoms, AW; Carson, TD; Sorochan, JC				Dickson, Kyley H.; Straw, Chase M.; Thoms, Adam W.; Carson, Troy D.; Sorochan, John C.			Impact of third generation synthetic turf athletic field age on surface hardness and infill depth spatial variability	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article; Early Access						Surface hardness; concussion; synthetic turf; spatial variability; Gmax	ARTIFICIAL TURF; MAINTENANCE; PERFORMANCE; INJURY	The use of synthetic turf (ST) has become a popular option for many athletic fields. Little is known about how surface hardness and infill depth spatial variability changes over time on third generation (3G) ST athletic fields. A research study was conducted to investigate the impact of field age on surface hardness and infill depth spatial variability from 12 3G ST athletic fields in Tennessee and Georgia (USA) between March 5, 2014 and April 8, 2014. The 3G ST athletic fields tested varied in fiber type including monofilament, slit film, and a combination of monofilament with slit film fibers. All 3G ST athletic fields were directly over gravel with no shockpad present. Surface hardness and infill depth were collected in the same location on all fields. Surface hardness was collected with the Toro Mobile Tester (400-450 samples/field) and infill depth was collected manually with a three-prong infill depth gauge (200-225 samples/field). As field age increased, surface hardness and spatial variability of the surface hardness increased significantly. Surface hardness and infill depth also had a significant negative relationship with one another. The increase in mean surface hardness and variability is partially attributed to infill depth loss and compaction of the remaining infill. Infill depth did not have a significant relationship with age, unless plots were outside the manufacturer's recommendation for infill depth. Considering the nearly 3000 samples collected in this study, maintaining a minimum infill depth between 30 and 35 mm kept 90% of surface hardness data points below the National Football League limit of 100 Gmax. Results from this study highlight how 3G ST athletic fields can change with age, which may indicate the need for targeted infill applications and decompaction to improve field uniformity over time.	[Dickson, Kyley H.; Sorochan, John C.] Univ Tennessee, Dept Plant Sci, 2431 Joe Johnson Dr, Knoxville, TN 37996 USA; [Straw, Chase M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Thoms, Adam W.] Iowa State Univ, Dept Hort, Ames, IA USA; [Carson, Troy D.] Toro Co, Ctr Technol Res & Innovat, Bloomington, MN USA		Dickson, KH (corresponding author), Univ Tennessee, Dept Plant Sci, 2431 Joe Johnson Dr, Knoxville, TN 37996 USA.	kdickso1@utk.edu	Thoms, Adam/AAW-4469-2021	Thoms, Adam/0000-0003-3779-3027; Dickson, Kyley/0000-0003-1064-9367	AstroTurf USA	The authors would like to thank Matthew Boggs, Eric Reasor, James Adams, Tyler Mulling, Kris Brown, and Cory Yurisik for their assistance in this research, as well as AstroTurf USA for partially funding this project. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the University of Tennessee Institute of Agriculture, Iowa State University, or Texas A&M University. They declare no conflict of interest in this study.	Alcantara E, 2009, P I MECH ENG P-J SPO, V223, P1, DOI 10.1243/17543371JSET27; [Anonymous], 2012, Patent, Patent No. [8,327,693, US, 8327693]; ASTM, 2000, ASTM STANDARDS, V15, P1; Cockerham S. T., 1989, California Turfgrass Culture, V39, P9; Cressie N, 2015, STAT SPATIAL DATA, P105; Dickson K, 2020, MULTIDISCIP DIGITAL, V49, P2; Felipe, 2012, SCI RES ESSAYS, V7, P2457, DOI DOI 10.5897/SRE11.1454; Fleming P, 2011, P I MECH ENG P-J SPO, V225, P43, DOI 10.1177/1754337111401688; Fleming PR, 2015, P I MECH ENG P-J SPO, V229, P169, DOI 10.1177/1754337114566480; Forrester SE, 2014, P I MECH ENG P-J SPO, V228, P213, DOI 10.1177/1754337114523756; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Jastifer JR, 2019, SPORTS HEALTH, V11, P84, DOI 10.1177/1941738118793378; MCNITT A, 2004, ACTA HORTIC, V661, P559; Meyers MC, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119832878; R Development Core Team, 2012, R LANG ENV STAT COMP; Sharma P, 2016, PROCEDIA ENGINEER, V147, P830, DOI 10.1016/j.proeng.2016.06.298; Straw CM, 2018, J TEST EVAL, V46, P714, DOI 10.1520/JTE20160467; Straw CM, 2020, AGRON J, V112, P2401, DOI 10.1002/agj2.20193; Straw CM, 2019, PRECIS AGRIC, V20, P118, DOI 10.1007/s11119-018-9585-2; Straw CM, 2018, EUR J SPORT SCI, V18, P893, DOI 10.1080/17461391.2018.1457083; Thomson A, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094478; Twomey DM, 2012, J SCI MED SPORT, V15, P305, DOI 10.1016/j.jsams.2011.12.003	22	0	0	2	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.											17543371211002947	10.1177/17543371211002947		MAR 2021	8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	QU2GN	WOS:000627100100001					2022-02-07	
J	Kim, WC; Campbell, AR				Kim, Woon Cho; Campbell, Andre R.			Common Injury Patterns from Standing Motorized Scooter Crashes	CURRENT SURGERY REPORTS			English	Article						Traumatic brain injury; Standing motorized scooter; Electric scooter; e-scooter; Micromobility; Injury prevention		Purpose of Review With the rising popularity of standing motorized scooters in major cities in the United States, many hospitals are experiencing a surge of traumatic injuries associated with this new mode of transportation. The impact and characteristics of injuries associated with standing motorized scooters are evolving, and safety regulations for the riders are poorly defined. There is a need for a review for healthcare providers and policy makers on this topic. Recent Findings Since its market introduction of rentable standing motorized scooters in late 2017, there has been an exponential rise in emergency department visits and hospitalization due to scooter-related trauma in urban hospitals. There have been a number of independent hospital-based and national-level studies describing demographics and trends of injury patterns in the last 2 years. Patients presenting to the hospital with injuries tend to be young male between 20 and 40 years of age, presenting at night. Head and extremity injuries are common, and patients often do not comply with helmets and other protective gears. Intoxication is a major risk factor for injuries requiring hospital admission and surgical interventions. These findings increase awareness for (1) healthcare providers to recognize and triage high-energy injuries, and (2) policy makers to advocate universal helmet use, increase public safety education, and enforce road safety regulations to minimize the impact of these injuries.	[Kim, Woon Cho; Campbell, Andre R.] Univ Calif San Francisco, Dept Surg, Div Trauma & Crit Care, Campus Box 0807, San Francisco, CA 94143 USA		Campbell, AR (corresponding author), Univ Calif San Francisco, Dept Surg, Div Trauma & Crit Care, Campus Box 0807, San Francisco, CA 94143 USA.	Wooncho.kim@ucsf.edu; Andre.Campbell@ucsf.edu		Kim, Woon Cho/0000-0003-3106-4317			Aizpuru M, 2019, AM J EMERG MED, V37, P1133, DOI 10.1016/j.ajem.2019.03.049; Badeau A, 2019, AM J EMERG MED, V37, P1531, DOI 10.1016/j.ajem.2019.05.003; Bauer F, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1925; Bekhit MNZ, 2020, INJURY, V51, P271, DOI 10.1016/j.injury.2019.10.026; Carter PM, 2017, AM J PUBLIC HEALTH, V107, P166, DOI 10.2105/AJPH.2016.303525; Caspi O, 2020, TRANSPORT RES D-TR E, V86, DOI 10.1016/j.trd.2020.102396; Centers for Disease Control and Prevention, 2020, COVID 19 RACIAL ETHN; Dhillon NK, 2020, J AM COLL SURGEONS, V231, P133, DOI 10.1016/j.jamcollsurg.2020.02.047; DiMaggio CJ, 2020, INJURY PREV, V26, P524, DOI 10.1136/injuryprev-2019-043418; Eltorai AEM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2914-3; Farley KX, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14500; Flora HC, 2018, AB 2989 MOTORIZED SC; Hollister S, 2018, CNET; Hoye A, 2018, ACCIDENT ANAL PREV, V120, P239, DOI 10.1016/j.aap.2018.08.001; Ishmael CR, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.19.00390; Kobayashi LM, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000337; Lazo L., 2020, WASHINGTON POST 0912; Namiri NK, 2020, JAMA SURG, V155, P357, DOI 10.1001/jamasurg.2019.5423; National Association of City Transportation Officials, 2019, SHAR MICR US 2019; Schneider B, 2020, BLOOMBERG CITYLAB; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Siow MY, 2020, J ORTHOP TRAUMA, V34, pE424, DOI 10.1097/BOT.0000000000001803; Trivedi B, 2019, J ORAL MAXIL SURG, V77, P2292, DOI 10.1016/j.joms.2019.07.014; Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7381; Vernon N, 2020, EMERG RADIOL, V27, P469, DOI 10.1007/s10140-020-01783-4	25	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2167-4817			CURR SURG REP	Curr. Surg. Rep.	MAR 9	2021	9	4							8	10.1007/s40137-021-00283-9			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	QT9WQ	WOS:000626937800001	33717660	Bronze, Green Published			2022-02-07	
J	Pearce, AJ; Kidgell, DJ; Tommerdahl, MA; Frazer, AK; Rist, B; Mobbs, R; Batchelor, J; Buckland, ME				Pearce, Alan J.; Kidgell, Dawson J.; Tommerdahl, Mark A.; Frazer, Ashlyn K.; Rist, Billymo; Mobbs, Rowena; Batchelor, Jennifer; Buckland, Michael E.			Chronic Neurophysiological Effects of Repeated Head Trauma in Retired Australian Male Sport Athletes	FRONTIERS IN NEUROLOGY			English	Article						concussion; sports; transcranial magnetic stimulation; somatosensory; mental fatigue; motor cortex	TRANSCRANIAL MAGNETIC STIMULATION; NEUROSENSORY ASSESSMENTS; SILENT PERIOD; MOTOR CORTEX; CONCUSSION; ENCEPHALOPATHY; EXCITABILITY; INHIBITION; CHILDREN; DECLINE	Aim: This study investigated the somatosensory and corticomotor physiology of retired contact sport athletes with a history of repeated concussion/subconcussion head trauma. Methods: Retired male athletes with a history of playing contact sports and repeated head trauma (n = 122) were divided into two groups: those who expressed concerns regarding their mental and cognitive health ("symptomatic": n = 83), and those who did not express any ongoing concerns ("asymptomatic": n = 39). Both groups were compared to age-matched male controls (n = 50) with no history of concussions or participation in contact sports, an absence of self-reported cognitive, or mood impairments. Transcranial magnetic stimulation (TMS) and vibrotactile stimulation were used to assess corticomotor and somatosensory pathways respectively. TMS and vibrotactile stimulation were correlated to self-reported responses using the Fatigue and Related Symptom Survey. Linear regression was used to associate concussion history with TMS, somatosensory variables. Results: Significant differences were found in symptom survey scores between all groups (p < 0.001). TMS showed significant differences between the "symptomatic" and control groups for intracortical inhibition and paired pulse TMS measures. Somatosensory measures showed significant differences for reaction time (p < 0.01) and reaction time variability (p < 0.01) between the "symptomatic" group to the "asymptomatic" and control groups. For other somatosensory measures, the "symptomatic" measures showed differences to the "control" group. Correlations showed significant associations between severity of symptom reporting with TMS and somatosensory measure, and regression revealed the number of concussions reported was shown to have significant relationships to increased intracortical inhibition and poorer somatosensory performance. Conclusion: This study shows that retired contact sport athletes expressing chronic symptoms showed significant pathophysiology compared to those with no ongoing concerns and non-concussed controls. Further, there is a linear dose-response relationship between number of reported concussions and abnormal neurophysiology. Neurophysiological assessments such as TMS and somatosensory measures represent useful and objective biomarkers to assess cortical impairments and progression of neuropsychological impairment in individuals with a history of repeated head trauma.	[Pearce, Alan J.; Rist, Billymo] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia; [Kidgell, Dawson J.; Frazer, Ashlyn K.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Physiotherapy, Melbourne, Vic, Australia; [Tommerdahl, Mark A.] Univ N Carolina, Dept Biomed Engn, Chappell Hill, NC USA; [Tommerdahl, Mark A.] Cort Metr, Carrboro, NC USA; [Mobbs, Rowena] Macquarie Univ, Macquarie Univ Hosp, Dept Neurol, Sydney, NSW, Australia; [Batchelor, Jennifer] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Buckland, Michael E.] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Buckland, Michael E.] Univ Sydney, Brain & Mind Ctr, Camperdown, NSW, Australia		Pearce, AJ (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia.	alan.pearce@latrobe.edu.au	Frazer, Ashlyn/ABA-7461-2021	Mobbs, Rowena/0000-0002-7353-7883; Batchelor, Jennifer/0000-0003-4438-4993			Belson K, 2019, CONCUSSION CRISIS AU; Benussi A, 2020, BRAIN STIMUL, V13, P386, DOI 10.1016/j.brs.2019.11.009; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buckland ME, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0751-1; Carlisle W, 2018, AFLS CONCUSSION PROB; Cohen J., 2013, STAT POWER ANAL BEHA; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Faraone Stephen V, 2008, P T, V33, P700; Folger SE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-87; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Greenwood PM, 2007, NEUROPSYCHOLOGY, V21, P657, DOI 10.1037/0894-4105.21.6.657; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hermens HJ., 1999, EUROPEAN RECOMMENDAT; Holden J, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.509091; Holden JK, 2012, J NEUROSCI METH, V204, P215, DOI 10.1016/j.jneumeth.2011.11.007; Johansson B., 2014, TRAUMA BRAIN INJ, P491, DOI [10.5772/57311, DOI 10.5772/57311]; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Lee KGH, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-89; Lewis GN, 2017, NEW ZEAL MED J, V130, P34; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGinley M, 2010, EXP GERONTOL, V45, P671, DOI 10.1016/j.exger.2010.04.005; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mikkelsen M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63208-z; Motta C, 2018, J NEUROL NEUROSUR PS, V89, P1237, DOI 10.1136/jnnp-2017-317879; Nguyen RH, 2013, BRAIN RES, V1498, P50, DOI 10.1016/j.brainres.2012.12.043; Opie GM, 2019, J NEUROTRAUM, V36, P2774, DOI 10.1089/neu.2018.6353; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Padovani A, 2018, J ALZHEIMERS DIS, V65, P221, DOI 10.3233/JAD-180293; Pearce A., 2018, J SPORT SCI, V36, P68, DOI [10.1080/02640414.2018.1521633, DOI 10.1080/02640414.2018.1521633]; Pearce AJ, 2000, EXP BRAIN RES, V130, P238, DOI 10.1007/s002219900236; Pearce AJ, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0895-z; Pearce AJ, 2020, SOMATOSENS MOT RES, V37, P14, DOI 10.1080/08990220.2019.1699045; Pearce AJ, 2019, NEUROSCIENCE, V408, P272, DOI 10.1016/j.neuroscience.2019.04.019; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pearce AJ, 2013, BRAIN STIMUL, V6, P306, DOI 10.1016/j.brs.2012.05.010; Pearce AJ, 2010, J SCI MED SPORT, V13, P167, DOI 10.1016/j.jsams.2008.12.632; Pearce AJ, 2009, J SCI MED SPORT, V12, P280, DOI 10.1016/j.jsams.2007.12.005; Puts NAJ, 2017, AUTISM RES, V10, P608, DOI 10.1002/aur.1691; Puts NAJ, 2015, J NEUROPHYSIOL, V114, P808, DOI 10.1152/jn.00060.2015; Scott E, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00306; Skarabot J, 2019, EXP PHYSIOL, V104, P635, DOI 10.1113/EP087557; Stenberg J, 2020, NEUROPSYCHOLOGY, V34, P560, DOI 10.1037/neu0000632; Tommerdahl M, 2016, MIL MED, V181, P45, DOI 10.7205/MILMED-D-15-00172; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; WILSON SA, 1995, ELECTROMYOGR MOTOR C, V97, P246, DOI 10.1016/0924-980X(95)80001-8; Wright DK, 2021, J NEUROTRAUM, V38, P983, DOI 10.1089/neu.2019.6886; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018; Zhang Z, 2011, CLIN J PAIN, V27, P755, DOI 10.1097/AJP.0b013e31821c98ec; Ziemann U., 2008, OXFORD HDB TRANSCRAN, P135	54	0	0	3	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 9	2021	12								633320	10.3389/fneur.2021.633320			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RA4MH	WOS:000631391300001	33767661	Green Published, gold			2022-02-07	
J	Vyas, K; Singh, KM				Vyas, Khongbantabam; Singh, Khaidem Mani			Outcome of Cranioplasty Done within and Beyond 2 Months after Decompressive Craniectomy for Traumatic Brain Injury	JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS			English	Article						Traumatic Brain Injury; Decompressive Craniectomy; Outcome; Cranioplasty		BACKGROUND Cranioplasty although a simple elective neurosurgical procedure is burdened by considerable morbidity. The timing of doing cranioplasty and a good outcome remains a topic of much debate. We wanted to compare the outcome of doing cranioplasty within (early) and beyond (late) 2 months after decompressive craniectomy for traumatic brain injury. METHODS The study was carried out in a tertiary care hospital. A 5-year retrospective study of patient records was analysed. Consecutive series of traumatic brain injury patients who underwent cranioplasty after decompressive craniectomy from a tertiary care hospital operated by a single neurosurgeon, were studied. Data was analysed using SPSS version 21, IBM. Associations of categorical variables were compared using chisquare test and of continuous variables by using unpaired 2-tailed Student t-test. RESULTS Altogether 90 patients were identified who had undergone cranioplasty after decompressive craniectomy for traumatic brain injury and were grouped into early (within 2 months; 44 patients) and late (beyond 2 months; 46 patients). Cranioplasty operative time was significantly shorter in the early (59.39 mins) than the late (77.28 mins) with a P value of 0.001. Infection rates were significantly higher in the early (4.55 %) than late (0 %), with P value 0.144. Other complication rates were postoperative haematoma (0 % early, 2.17 % late, P = 0.325), hydrocephalus (0 % early, 6.52 % late, P = 0.085), sunken brain (0 % early, 4.35 % late, P = 0.162), and bone graft resorption (0 % early, 2.17 % late, P = 0.325). These differences were not statistically significant though. CONCLUSIONS Early cranioplasty performed within 2 months of decompressive craniectomy has better outcome in the form of reduced hospital stay, decreased cost, and fewer complications.	[Vyas, Khongbantabam] Jawaharlal Inst Med Sci JNIMS, Dept Surg, Imphal, Manipur, India; [Singh, Khaidem Mani] Jawaharlal Inst Med Sci JNIMS, Dept Radiodiag, Imphal, Manipur, India		Vyas, K (corresponding author), Jawaharlal Inst Med Sci JNIMS, Dept Surg, Imphal, Manipur, India.	kvyas98@yahoo.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bhat AR, 2011, INDIAN J NEUROTRAUM, V8, P105, DOI 10.1016/S0973-0508(11)80009-2; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Huang YH, 2013, INT J SURG, V11, P886, DOI 10.1016/j.ijsu.2013.07.013; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Zanaty Mario, 2014, ScientificWorldJournal, V2014, P356042, DOI 10.1155/2014/356042	22	0	0	0	0	JOURNAL EVOLUTION MEDICAL & DENTAL SCIENCES	KARNATAKA	C/O AKSHANTALA ENTERPRISES, NO 65, 1ST FL, SAHUKAR CHENNIAH RD, MYSORE, KARNATAKA, 570 009, INDIA	2278-4748	2278-4802		J EVOL MED DENT SCI-	J. Evol. Med. Dent. Sci.-JEMDS	MAR 8	2021	10	10					711	714		10.14260/jemds/2021/152			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RB1YR	WOS:000631912400010		gold			2022-02-07	
J	Whiting, DL; Simpson, GK; Deane, FP; Chuah, SL; Maitz, M; Weaver, J				Whiting, Diane L.; Simpson, Grahame K.; Deane, Frank P.; Chuah, Sarah L.; Maitz, Michelle; Weaver, Jerre			Protocol for a Phase Two, Parallel Three-Armed Non-inferiority Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT-Adjust) Comparing Face-to-Face and Video Conferencing Delivery to Individuals With Traumatic Brain Injury Experiencing Psychological Distress	FRONTIERS IN PSYCHOLOGY			English	Article						traumatic brain injury; acceptance and commitment therapy; video conferencing; randomized control trial; telehealth; psychological distress		Background: People with traumatic brain injury (TBI) face a range of mental health challenges during the adjustment process post-injury, but access to treatment can be difficult, particularly for those who live in regional and remote regions. eHealth provides the potential to improve access to evidence-based psychological therapy for people with a severe TBI. The aim of the current study is to assess the efficacy of a psychological intervention delivered via video consulting to reduce psychological distress in people with TBI. Methods: This paper outlines the protocol for a multi-center, three-arm, parallel, non-inferiority randomized controlled trial (RCT) of an evidence-based manualized psychological intervention, ACT-Adjust. ACT-Adjust provides nine sessions for adults with a moderate to severe TBI experiencing clinical levels of psychological distress. Fifty-six participants referred from Brain Injury Rehabilitation Units across New South Wales (NSW) and the NSW icare scheme will be randomly allocated to three conditions; (1) video consulting (VC), (2) face-to-face (FtF) and, (3) a waitlist control (WL). Discussion: This is the first RCT to evaluate the efficacy of a psychological therapy (ACT-Adjust) delivered via video consulting for individuals with a moderate to severe TBI.	[Whiting, Diane L.; Simpson, Grahame K.; Chuah, Sarah L.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool, NSW, Australia; [Whiting, Diane L.; Deane, Frank P.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Sch Med, St Leonards, NSW, Australia; [Maitz, Michelle] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Liverpool, NSW, Australia; [Weaver, Jerre] Midwestern Brain Injury Rehabil Unit, Bathurst, NSW, Australia		Whiting, DL (corresponding author), Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool, NSW, Australia.; Whiting, DL (corresponding author), Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia.	diane.whiting@health.nsw.gov.au	Whiting, Diane/AAN-2522-2021	Simpson, Grahame/0000-0001-8156-9060; Chuah, Sarah/0000-0002-5446-3874	icare Foundation [46000002342]; South Western Sydney Local Health District (SWSLHD), 13 Elizabeth Street, Liverpool, NSW, Australia	The project was funded by the icare Foundation (Funding Agreement 46000002342) and the trial is sponsored by South Western Sydney Local Health District (SWSLHD), 13 Elizabeth Street, Liverpool, NSW, Australia, 2170. The funding body and sponsor play no role in the design of the study, the collection, analysis, and interpretation of data, and in writing themanuscript and submitting for publication.	Abel EA, 2017, J TECHNOL BEHAV SCI, V2, P28, DOI DOI 10.1007/S41347-016-0003-1; Backhaus A, 2012, PSYCHOL SERV, V9, P111, DOI 10.1037/a0027924; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bourne K., 2017, PILLARS COMMUNITIES; Brenner LA, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000351; Chan AW, 2013, LANCET, V381, P91, DOI 10.1016/S0140-6736(12)62160-6; Ciarrochi J., 2009, SURVEY GUIDING PRINC; Coviu, 2020, HEALTHDIRECT VIDEO C; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dindo L, 2020, CONTEMP CLIN TRIALS, V90, DOI 10.1016/j.cct.2020.105954; Duncan Barry L., 2003, J BRIEF THERAPY, V3, P3; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Freedland KE, 2011, PSYCHOSOM MED, V73, P323, DOI 10.1097/PSY.0b013e318218e1fb; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; IBM Corp, 2019, IBM SPSS STAT WINDOW; Kreitzer NP, 2019, J HEAD TRAUMA REHAB, V34, pE10, DOI 10.1097/HTR.0000000000000457; Lovibond SH., 1996, MANUAL DEPRESSION AN, DOI [10.1037/t01004-000, DOI 10.1037/T01004-000]; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Montgomery P, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2733-1; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; O'Connor M, 2018, BEHAV THER, V49, P459, DOI 10.1016/j.beth.2017.07.007; O'Neill L, 2019, J CONTEXT BEHAV SCI, V14, P111, DOI 10.1016/j.jcbs.2019.08.008; Ownsworth T, 2020, J INT NEUROPSYCH SOC, V26, P47, DOI 10.1017/S135561771900078X; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Randolph C., 1998, RBANS MANUAL REPEATA, DOI [10.1037/t15149-000, DOI 10.1037/T15149-000]; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Sealed Envelope Ltd, 2019, CREATE BLOCKED RANDO; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [DOI 10.1375/BRIM.5.1.81.35408, 10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408]; Tran V, 2017, BRAIN INJURY, V31, P1701, DOI 10.1080/02699052.2017.1387932; Trompetter HR, 2013, PSYCHOL ASSESSMENT, V25, P1235, DOI 10.1037/a0033813; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Whiting DL, 2015, PSYCHOL ASSESSMENT, V27, P415, DOI 10.1037/pas0000050; Whiting DL, 2012, BRAIN IMPAIR, V13, P360, DOI 10.1017/BrImp.2012.28	45	0	0	4	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAR 8	2021	12								652323	10.3389/fpsyg.2021.652323			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	QZ9QX	WOS:000631055300001	33763008	gold, Green Published			2022-02-07	
J	Ahluwalia, R; Miller, S; Dawoud, FM; Malave, JO; Tyson, H; Bonfield, CM; Yengo-Kahn, AM				Ahluwalia, Ranbir; Miller, Scott; Dawoud, Fakhry M.; Malave, Jose O.; Tyson, Heidi; Bonfield, Christopher M.; Yengo-Kahn, Aaron M.			A Pilot Study Evaluating the Timing of Vestibular Therapy After Sport-Related Concussion: Is Earlier Better?	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						vestibular rehabilitation therapy (VRT); sport-related concussion (SRC); pediatric concussion; vestibular dysfunction		Background: Vestibular dysfunction, characterized by nausea, dizziness, imbalance, and/or gait disturbance, represents an important sport-related concussion (SRC) subtype associated with prolonged recovery. Vestibular physical therapy promotes recovery; however, the benefit of earlier therapy is unclear. Hypothesis: Earlier vestibular therapy for young athletes with SRC is associated with earlier return to play (RTP), return to learn (RTL), and symptom resolution. Study Design: Retrospective cohort study. Methods: Patients aged 5 to 23 years with SRC who initiated vestibular rehabilitation therapy (VRT) from January 2019 to December 2019 were included and patient records were reviewed. Therapy initiation was defined as either early, <= 30 days postinjury, or late (>30 days). Univariate comparisons between groups, Kaplan-Meier plots, and multivariate Cox proportional hazard modeling were performed. Results: Overall, 23 patients (10 early, 13 late) aged 16.14 +/- 2.98 years and 43.5% were male patients. There was no difference between group demographics or medical history. Median initial total and vestibular symptom scores were comparable between groups. The late therapy group required additional time to RTP (110 days [61.3, 150.8] vs 31 days [22.5, 74.5], P = 0.03) and to achieve symptom resolution (121.5 days [71, 222.8] vs 54 days [27, 91], P = 0.02), but not to RTL (12 days [3.5, 26.5] vs 17.5 days [8, 20.75], P = 0.09). Adjusting for age and initial total symptom score, earlier therapy was protective against delayed symptom resolution (P = 0.01). Conclusion: This pilot study suggests that initiating VRT within the first 30 days after SRC is associated with earlier RTP and symptom resolution. Further prospective trials to evaluate if even earlier VRT should be pursued to further improve recovery time.	[Ahluwalia, Ranbir] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; [Ahluwalia, Ranbir; Dawoud, Fakhry M.; Bonfield, Christopher M.; Yengo-Kahn, Aaron M.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA; [Ahluwalia, Ranbir; Miller, Scott; Dawoud, Fakhry M.; Bonfield, Christopher M.; Yengo-Kahn, Aaron M.] Vanderbilt Univ, Med Ctr, Vanderbilt Sport Concuss Ctr, Nashville, TN USA; [Miller, Scott; Malave, Jose O.] Vanderbilt Univ, Med Ctr, Dept Phys Med & Rehabil, Nashville, TN USA; [Dawoud, Fakhry M.] East Tennessee State Univ, Quillen Coll Med, Mountain Home, TN USA; [Tyson, Heidi] Vanderbilt Univ, Med Ctr, Dept Orthoped Surg & Rehabil, Nashville, TN USA		Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA.	a.yengo@vumc.org			NCATS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]	REDCap, used for study data management, is supported by NCATS/NIH grant UL1 TR000445.	Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Brown L, 2019, SEMIN PEDIATR NEUROL, V30, P68, DOI 10.1016/j.spen.2019.03.011; Cardenache R., 2009, THESIS PEPPERDINE U; Cheever KM, 2018, INT J SPORTS MED, V39, P141, DOI 10.1055/s-0043-118339; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Ianof Jéssica Natuline, 2014, Dement. neuropsychol., V8, P14, DOI 10.1590/S1980-57642014DN81000003; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Mucha A, 2018, HAND CLINIC, V158, P135, DOI 10.1016/B978-0-444-63954-7.00014-8; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Nagib S, 2019, J SPORT REHABIL, V28, P764, DOI 10.1123/jsr.2018-0021; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Whitney SL, 2016, HAND CLINIC, V137, P187, DOI 10.1016/B978-0-444-63437-5.00013-3	25	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2021	13	6					573	579	1941738121998687	10.1177/1941738121998687		MAR 2021	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WP1FK	WOS:000626251900001	33682532				2022-02-07	
J	Langenderfer, M; Williams, K; Douglas, A; Rutter, B; Johnson, CE				Langenderfer, M.; Williams, K.; Douglas, A.; Rutter, B.; Johnson, C. E.			An evaluation of measured and predicted air blast parameters from partially confined blast waves	SHOCK WAVES			English	Article						Wearable blast sensors; Air blast; Shock pressure measurement; Traumatic brain injury; Reflected blast waves		Understanding the physical mechanisms by which blast waves interact with their surroundings is paramount to protecting the safety of armed service personnel and equipment. This study evaluates and discusses modern technology used in blast pressure measurement as it relates to primary blast injuries such as traumatic brain injury. Factors influencing primary blast injury were established as peak overpressure, impulse, number, and frequency of shock impacts based on a literature review. A simulated confined-corridor breaching environment was used to establish the potential for variability in these key parameters depending on location in a confined blast environment. Wearable blast pressure monitors were compared experimentally to not only laboratory grade pressure transducers but also simulated and empirically modeled blast pressure and impulse predictions at scaled distances between 3.1 and 13.6m/kg(1/3) from 100-g and 200-g suspended Composition C-4 detonations partially confined by the ground. surface ground reflection. Each measurement and predictive technique is detailed and comparatively summarized. Average deviation from the mean in collected pressure and impulse data ranged between 10 and 15%. The disparity in the measured data was lowest in the static pressure range where mild traumatic brain injury is reported to occur.	[Langenderfer, M.; Williams, K.; Douglas, A.; Rutter, B.; Johnson, C. E.] Missouri Univ Sci & Technol, Energet Res Grp, 290 McNutt Hall,1400 North Bishop, Rolla, MO 65409 USA		Johnson, CE (corresponding author), Missouri Univ Sci & Technol, Energet Res Grp, 290 McNutt Hall,1400 North Bishop, Rolla, MO 65409 USA.	johnsonce@mst.edu					[Anonymous], 2010, PCB PIEZOTRONICS PCB; [Anonymous], 2019, USMC BLAST OVERPRESS; [Anonymous], 2014, UFC 3 340 02 STRUCTU; [Anonymous], 2015, PCB PIEZOTRONICS PCB; Aref A.J, 2010, MCEER100009, DOI [10.13140/RG.2.1.3978.4565, DOI 10.13140/RG.2.1.3978.4565]; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Borkholder D.A., 2015, 18 INT C SOL STAT SE, DOI [10.1109/TRANSDUCERS.2015.7180916, DOI 10.1109/TRANSDUCERS.2015.7180916]; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Bulmash G., 1984, ARBRLTR02555; Cernak I, 2015, BRAIN NEUROTRAUMA MO, P631, DOI DOI 10.1201/B18126-53; Chen HJ, 2015, CHIN J TRAUMATOL, V18, P267, DOI 10.1016/j.cjtee.2015.11.006; Committee on Gulf War and Health:, 2014, GULF WAR HLTH LONG T, V9; Cooper PW., 1996, EXPLOSIVES ENG; Cormie D., 2014, MCEER140006, DOI [10.13140/RG.2.1.3454.1686, DOI 10.13140/RG.2.1.3454.1686]; Cranz C., 1926, LEURBUCH BALLISTIK, DOI [10.1007/978-3-642-52612-1, DOI 10.1007/978-3-642-52612-1]; DDESB, 1999, 60559STD DDESB DOD; Dewey JM, 2018, SHOCK WAVE HIGH PRES, P37, DOI 10.1007/978-3-319-70831-7_3; Dobratz B.M.:, 1981, URCL52997; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P322, DOI 10.1098/rspa.1946.0046; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hopkinson B., 1915, BRIT ORDNANCE BOARD; Hosseini-Farid M, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25020021; Johnson C, 2018, AIP CONF PROC, V1979, DOI 10.1063/1.5044977; Jorolemon MR., 2020, EXPLOSIONS BLAST INJ; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Karlos V., 2013, JRC TECHNICAL REPORT, DOI [10.2788/61866, DOI 10.2788/61866]; Kim M.:, 2020, MECH TBI; Knowles BM, 2017, ANN BIOMED ENG, V45, P2146, DOI 10.1007/s10439-017-1848-y; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Misistia A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240262; Needham C.E., 2018, BLAST WAVES, P197, DOI [10.1007/978-3-319-65382-2_13, DOI 10.1007/978-3-319-65382-2_13]; Needham C.E., 2018, BLAST WAVES, P227, DOI [10.1007/978-3-319-65382-2_14, DOI 10.1007/978-3-319-65382-2_14]; Needham CE, 2010, SHOCK WAVE HIGH PRES, P9, DOI 10.1007/978-3-642-05288-0_3; Nyquist H., 1928, T AIEE, V47, P617, DOI [10.1109/T-AIEE.1928.5055024, DOI 10.1109/T-AIEE.1928.5055024]; Ostertag MH, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2013, VOL 3A; Oswald C., 2018, IMPROVED METHOD CALC; Peters P, 2011, MIL MED, V176, P110, DOI 10.7205/MILMED-D-10-00300; Rao S.(, 2019, DIRECT NUMERICAL SIM, DOI [10.5772/intechopen.87190, DOI 10.5772/INTECHOPEN.87190]; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Robinson N., 2011, CARL GUSTAV RECOILLE; Rutter B., 2019, PRESSURE VERSUS IMPU; Sajja VSSS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00891; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Skotak M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00052; Snow H.:, 2018, ARMY TIMES; Sochet I, 2018, SHOCK WAVE HIGH PRES, P89, DOI 10.1007/978-3-319-70831-7_6; Song HL, 2018, NEURAL REGEN RES, V13, P1516, DOI 10.4103/1673-5374.237110; Swisdak M.M., 1975, NSWCWOLTR75116; U. S. Army, 2008, EXPLOSIVES DEMOLITIO; U. S. Army, 2002, COMBINED ARMS OPERAT; Walter P.L.:, 2019, AIRBLAST SCI DYNAMIC; Walter PL., 2012, PHYSL MEASUREMENT EX; Wiri S, 2016, SHOCK WAVES, V26, P279, DOI 10.1007/s00193-016-0644-1; Yamamoto S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020245	57	0	0	1	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	MAR	2021	31	2					175	192		10.1007/s00193-021-00993-0		MAR 2021	18	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	SB1CN	WOS:000625747000001					2022-02-07	
J	Diaz, CR; Mayoral, LPC; Huerta, MTH; Majluf-Cruz, AS; Mora, SEP; Mayoral, EPC; Andrade, GM; Cruz, MM; Zenteno, E; Cervantes, CAM; Martinez, GV; Cruz, RM; Franco, MAR; Parada, EC; Canseco, SP; Perez-Campos, E				Romero Diaz, Carlos; Perez-Campos Mayoral, Laura; Hernandez Huerta, Maria Teresa; Majluf-Cruz, Abraham Salvador; Plascencia Mora, Stephanie Elizabeth; Perez-Campos Mayoral, Eduardo; Mayoral Andrade, Gabriel; Martinez Cruz, Margarito; Zenteno, Edgar; Matias Cervantes, Carlos Alberto; Vasquez Martinez, Gabriela; Martinez Cruz, Ruth; Reyes Franco, Miguel Angel; Cruz Parada, Eli; Pina Canseco, Socorro; Perez-Campos, Eduardo			The influence of hydrogen ions on coagulation in traumatic brain injury, explored by molecular dynamics	BRAIN INJURY			English	Article						Traumatic brain injury; coagulation; molecular dynamics	FIBRINOGEN	Background: Patients in intensive care units with traumatic brain injuries (TBI) frequently present acid-base abnormalities and coagulability disorders, which complicate their condition. Objective: To identify protonation through in silico simulations of molecules involved in the process of coagulation in standard laboratory tests. Materials and methods: Ten patients with TBI were selected from the intensive care unit in addition to ten "healthy control subjects", and another nine patients as "disease control subjects"; the latter being a comparative group, corresponding to subjects with diabetes mellitus 2 (DM2). Fibrinogen, FVII, FVIII, FIX, FX, and D-dimer in the presence of acidification were evaluated in 20 healthy subjects in order to compare clinical results with molecular dynamics (MD), and to explain proton interactions and coagulation molecules. Results: The TBI group presented a slight, non-significant increase in D-dimer; but this was not present in "disease control subjects". Levels of fibrinogen, FVII, FIX, FX, and D-dimer were affected in the presence of acidification. We observed that various specific residues of coagulation factors "trap" ions. Conclusion: Protonation of tissue factor and factor VIIa may favor anticoagulant mechanisms, and protonation does not affect ligand binding sites of GPIIb/IIIa (PAC1) suggesting other causes for the low affinity to PAC1.	[Romero Diaz, Carlos; Martinez Cruz, Margarito; Vasquez Martinez, Gabriela; Cruz Parada, Eli; Perez-Campos, Eduardo] Natl Technol Mexico ITOaxaca, Oaxaca, Oaxaca, Mexico; [Perez-Campos Mayoral, Laura; Perez-Campos Mayoral, Eduardo; Mayoral Andrade, Gabriel; Martinez Cruz, Ruth; Pina Canseco, Socorro] Benito Juarez Autonomous Univ Oaxaca, Res Ctr Med UNAM UABJO, Fac Med, Oaxaca, Oaxaca, Mexico; [Hernandez Huerta, Maria Teresa; Matias Cervantes, Carlos Alberto] Benito Juarez Autonomous Univ Oaxaca, CONACyT Fac Med, Oaxaca, Oaxaca, Mexico; [Majluf-Cruz, Abraham Salvador] Mexican Inst Social Secur IMSS, Med Res Unit Thrombosis Haemostasis & Atherogenes, Mexico City, DF, Mexico; [Plascencia Mora, Stephanie Elizabeth; Reyes Franco, Miguel Angel] Dr Aurelio Valdivieso Gen Hosp, Internal Med Unit, Oaxaca, Oaxaca, Mexico; [Zenteno, Edgar] Univ Nacl Autonoma Mexico, Sch Med, Mexico City, DF, Mexico; [Perez-Campos, Eduardo] Dr Eduardo Perez Ortega, Clin Pathol Lab, Oaxaca, Oaxaca, Mexico		Mayoral, EPC (corresponding author), Natl Technol Mexico ITOaxaca, Oaxaca, Oaxaca, Mexico.	pcampos@itoaxaca.edu.mx	Mayoral, Laura Perez-Campos/G-2014-2018; Perez-Campos, Eduardo/AAH-1263-2019; majluf-cruz, abraham/B-8830-2018	Mayoral, Laura Perez-Campos/0000-0003-4140-4661; Perez Campos Mayoral, Eduardo/0000-0002-6032-7609; majluf-cruz, abraham/0000-0002-7697-5790; Matias Cervantes, Carlos Alberto/0000-0002-3476-1743; Zenteno, Edgar/0000-0001-5603-4072; HERNANDEZ HUERTA, MARIA TERESA/0000-0003-2182-2540; Mayoral-Andrade, Gabriel/0000-0002-2957-8565; Romero, Carlos/0000-0002-7524-067X	Clinical Pathology Laboratory "Dr Eduardo Perez Ortega" in Oaxaca, Mexico; UABJO; National Institute of Technology in Mexico, (TecNM) [5302.19-P, 8703.20-P]	This work was supported by the Clinical Pathology Laboratory "Dr Eduardo Perez Ortega" in Oaxaca, Mexico. The authors would like to thank Charlotte Grundy for her support throughout the work, and also UABJO and National Institute of Technology in Mexico, (TecNM) project 5302.19-P and 8703.20-P for financial support.	Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Behnen M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00184; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Case D.A., 2018, AMBER 2018; CHARO IF, 1991, J BIOL CHEM, V266, P1415; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; CHO D, 1997, INTENS CARE MED, V23; Darlington DN, 2011, J TRAUMA, V71, P1271, DOI 10.1097/TA.0b013e318214f522; Daskalakis M, 2014, CYTOM PART B-CLIN CY, V86, P397, DOI [10.1002/cyto.b.21157, 10.1002/cytob.21157]; Ellingson BM, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101736; Emsley J, 2010, BLOOD, V115, P2569, DOI 10.1182/blood-2009-09-199182; Feiner John R, 2017, Crit Care Med, V45, pe40; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HEMKER H, 1989, BIOCHIM BIOPHYS ACTA, V992; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Johansson PI, 2011, CRIT CARE, V15, DOI 10.1186/cc10553; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamikubo Y, 2017, BLOOD, V130, P1661, DOI 10.1182/blood-2017-02-767079; Khoshfetrat M, 2020, BIOMED RES THER, V7, P3614, DOI 10.15419/bmrat.v7i2.588; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Levy JH, 2014, CLIN LAB MED, V34, P453, DOI 10.1016/j.cll.2014.06.005; Liang F, 2020, CELL STRESS CHAPERON, V25, P1013, DOI 10.1007/s12192-020-01137-6; LU Q, 2011, ARTIF ORGANS, V35, DOI DOI 10.1111/j.1525-1594.2010.01051.x; McKinley BA, 1998, ACT NEUR S, V71, P177; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877; Mirsaiedi M., 2012, ANN BIOL RES, V3; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Pin-on P, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013081; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; SHAPIRO M, 2000, J TRAUMA, V49; Sirunyan AM, 2018, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2018)003; Sorensen AB, 2016, J BIOL CHEM, V291, P4671, DOI 10.1074/jbc.M115.698613; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Thachil J, 2017, METHODS MOL BIOL, V1646, P91, DOI 10.1007/978-1-4939-7196-1_7; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Verni CC, 2019, J TRAUMA ACUTE CARE, V86, P250, DOI 10.1097/TA.0000000000002140; Wong SS, 2016, BLOOD, V127, P2915, DOI 10.1182/blood-2015-10-676122; Yang Z, 2002, BIOCHEMISTRY-US, V41, P15610, DOI 10.1021/bi026666i; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011774; Zhao ZL, 2017, PROTEIN CELL, V8, P801, DOI 10.1007/s13238-017-0414-6; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]	49	0	0	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					842	849		10.1080/02699052.2021.1895312		MAR 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000625994900001	33678100				2022-02-07	
J	Saarinen, M; Erkinjuntti, N; Koskinen, S; Himanen, L; Vahlberg, T; Tenovuo, O; Lahdesmaki, T				Saarinen, M.; Erkinjuntti, N.; Koskinen, S.; Himanen, L.; Vahlberg, T.; Tenovuo, O.; Lahdesmaki, T.			Prolonged injury symptoms and later visits to psychiatric care after mild traumatic brain injury in school-age	BRAIN INJURY			English	Article						Mild traumatic brain injury; pediatric; pre-injury learning; psychiatric care		Objective To investigate demographic and pre-injury factors in Finnish school-aged children admitted to pediatric neurology services after mild traumatic brain injury (mTBI). The relation of these factors to prolonged injury symptoms and later visits into psychiatric care was assessed. Methods Demographic information, pre-injury learning status, and neuropsychological test results of 120 patients aged 7-16 years were retrospectively collected from the hospital medical records. Data were compared with self- or parent-reported injury symptoms at 1-3 months post-injury and later visits to psychiatric care. Results According to medical records, 14.2% of the children with mTBI had a diagnosed neurobehavioral or psychiatric condition pre-injury. Additionally, 53.3% of the children had some neurobehavioral or psychiatric concerns or traits prior to the injury. Over half (56.7%) of the children studied were symptomatic at 1-3 months following the injury. Female gender and presence of prolonged symptoms were predictive for later visit into psychiatric care. Conclusions Pre-injury neurobehavioral or psychiatric problems may predict prolonged injury symptoms following pediatric mTBI. In this retrospective patient series, prolonged symptoms and female gender seem to predict the need for later psychiatric care. Monitoring the recovery of children with mTBI and pre-injury risk factors is important for timely interventions.	[Saarinen, M.; Erkinjuntti, N.; Lahdesmaki, T.] Univ Turku, Dept Pediat Neurol, Turku 20521, Finland; [Erkinjuntti, N.; Lahdesmaki, T.] Turku Univ Hosp, Dept Pediat Neurol, Turku, Finland; [Koskinen, S.] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Himanen, L.] Univ Turku, Dept Psychol, Turku, Finland; [Vahlberg, T.] Univ Turku, Dept Biostat, Turku, Finland; [Vahlberg, T.] Turku Univ Hosp, Turku, Finland; [Tenovuo, O.] Turku Univ Hosp, Dept Clin Neurosci, Turku, Finland; [Tenovuo, O.] Univ Turku, Turku, Finland		Saarinen, M (corresponding author), Univ Turku, Dept Pediat Neurol, Turku 20521, Finland.	mari.saarinen@attentio.fi		Lahdesmaki, Tuire/0000-0002-8447-2958; Saarinen, Mari/0000-0002-5437-1670; Vahlberg, Tero/0000-0002-4935-3056; Koskinen, Sanna/0000-0002-3453-5084	Turku University Foundation [11-211]; Finnish Cultural foundationFinnish Cultural FoundationFinnish IT center for science [00190926]	This work was supported by the Turku University Foundation [11-211] and Finnish Cultural foundation [00190926].	Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bernard CO, 2017, J HEAD TRAUMA REHAB, V32, P413, DOI 10.1097/HTR.0000000000000298; BOLL T, 1983, J CLIN CHILD PSYCHOL, V12; Cassidy J. David, 2004, Journal of Rehabilitation Medicine Supplement, P28; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; FARMER J, 2002, DEV NEUROPSYCHOL, V22; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; LANGLOIS J, 2006, J HEAD TRAUMA REHAB, V21; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manzanero S., 2017, J CONCUSSION, DOI [10.1177/2059700217726874, DOI 10.1177/2059700217726874]; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Peden M, 2008, WORLD REPORT CHILD I; Pennington BF., 2010, PEDIAT NEUROPSYCHOLO; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Simpson TS., 2017, CLIN PRACTISE PEDIAT, V5, DOI [10.1037/cpp0000195, DOI 10.1037/CPP0000195]; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 2011, FINLAND PSYKOLOGIEN; Wilson ML, 2017, EUR J PAEDIATR NEURO, V21, P374, DOI 10.1016/j.ejpn.2016.10.008; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO., 2010, NEUROPSYCHOLOGY, V24, DOI 10.1037/a0018112; Yeates KO., 2012, MILD TRAUMATIC BRAIN	36	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2021	35	6					690	697		10.1080/02699052.2021.1895316		MAR 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SB4DP	WOS:000626050200001	33678108				2022-02-07	
J	Begonia, MT; Knapp, AM; Prabhu, RK; Liao, J; Williams, LN				Begonia, Mark T.; Knapp, Alexander M.; Prabhu, R. K.; Liao, Jun; Williams, Lakiesha N.			Shear-deformation based continuum-damage constitutive modeling of brain tissue	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury; Constitutive modeling; Brain; Stress state	MECHANICAL CHARACTERIZATION; INJURY; STRAIN	Traumatic brain injury (TBI) isa leading cause of death in the United States. Depending on the severity of injury, complications such as memory loss and emotional changes are common. While the exact mechanisms are still unclear, these cognitive deficiencies are thought to arise from microstructural damages to the brain tissue, such as in diffuse-axonal injury where neuron fibers are sheared. Constitutive models can predict such damage at a microstructural level and allow for insight into the mechanisms of injury initiating at lower length scales. In this study, we developed a continuum damage model of brain tissue that is validated by experimental quasi-static stress-strain tests in tension, compression, and shear. The present work shows that damage is most present in the shear stress state, making the tissue suitable for damage modeling via shear interaction terms. Using this model, new insights into microstructural breakdown due to shear stresses and strains can be gained by application to simulations. (c) 2021 Elsevier Ltd. All rights reserved.	[Begonia, Mark T.] Virginia Polytech Inst & State Univ, Virginia Tech Helmet Lab, Inst Crit Technol & Appl Sci ICTAS, Blacksburg, VA 24061 USA; [Knapp, Alexander M.; Williams, Lakiesha N.] Univ Florida, Dept Biomed Engn, Tissue Mech Microstruct & Modeling Lab, Gainesville, FL 32611 USA; [Prabhu, R. K.] Ctr Adv Vehicular Syst, Res Blvd, Starkville, MS 39762 USA; [Liao, Jun] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76010 USA		Williams, LN (corresponding author), Univ Florida, Dept Biomed Engn, Tissue Mech Microstruct & Modeling Lab, Gainesville, FL 32611 USA.	lwilliams@bme.ufl.edu	Liao, Jun/AAW-3591-2021	Liao, Jun/0000-0003-1049-5783; Knapp, Alexander/0000-0002-5275-1493	MSU Department of Agricultural and Biological Engineering; University of Florida J. Crayton Pruitt Family Department of Biomedical Engineering	This research was supported by the MSU Department of Agricultural and Biological Engineering and the University of Florida J. Crayton Pruitt Family Department of Biomedical Engineering.	Appelboom G, 2012, WORLD NEUROSURG, V78, P646, DOI 10.1016/j.wneu.2011.12.001; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Begonia MT, 2010, ANN BIOMED ENG, V38, P3043, DOI 10.1007/s10439-010-0072-9; Bigler E.D., 2009, NEUROPATHOLOGY MILD, DOI [10.1007/S11682-011-9145-0, DOI 10.1007/S11682-011-9145-0]; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Chaboche J.L., 1988, CONTINUUM DAMAGE M 1; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Donnelly B.R., 1997, SHEAR PROPERTIES HUM; Faul M, 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gasser TC, 2011, ACTA BIOMATER, V7, P2457, DOI 10.1016/j.actbio.2011.02.015; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Giordano C., 2013, CONNECTING FRACTIONA, DOI [10.1098/RSIF.2013.0914, DOI 10.1098/RSIF.2013.0914]; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Li HL, 2006, J APPL PHYS, V100, DOI 10.1063/1.2375015; Li WG, 2016, J MED BIOL ENG, V36, P285, DOI 10.1007/s40846-016-0132-1; MacManus DB, 2018, J MECH BEHAV BIOMED, V87, P256, DOI 10.1016/j.jmbbm.2018.07.025; Miller K, 2005, J BIOMECH, V38, P153, DOI 10.1016/j.jbiomech.2004.03.004; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Natali A. N., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P329; Natali AN, 2005, MED ENG PHYS, V27, P209, DOI 10.1016/j.medengphy.2004.10.011; Nicolle S., 2004, SAE TECHNICAL PAPERS, DOI [10.4271/2004-22-0011, DOI 10.4271/2004-22-0011]; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Prabhu RK, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6020040; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007	31	0	0	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAR 5	2021	117									10.1016/j.jbiomech.2021.110260			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	QT0ET	WOS:000626266300004	33515903				2022-02-07	
J	Li, YS; He, JH; Yang, B; Zhang, H; Yang, ZH; Fu, JH; Huang, L; Chen, H; Yang, XF; Bao, YJ				Li, Yusheng; He, Jianghong; Yang, Bo; Zhang, Hui; Yang, Zhonghua; Fu, Jianhui; Huang, Lian; Chen, Hong; Yang, Xiaofeng; Bao, Yijun		Chinese Assoc Neurorestoratology P; Int Assoc Neurorestoratology	Clinical diagnosis guidelines and neurorestorative treatment for chronic disorders of consciousness (2021 China version)	JOURNAL OF NEURORESTORATOLOGY			English	Article						chronic disorders of consciousness; neurorestoration; clinical guideline	DIRECT-CURRENT STIMULATION; HYPERBARIC-OXYGEN THERAPY; TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; THALAMIC-STIMULATION; EXPERIENCE; SPASTICITY; STANDARDS; TRIAL; EEG	Chronic disorders of consciousness (DOC) include the vegetative state and the minimally consciousness state. The DOC diagnosis mainly relies on the evaluation of clinical behavioral scales, electrophysiological testing, and neuroimaging examinations. No specifically effective neurorestorative methods for chronic DOC currently exist. Any valuable exploration therapies of being able to repair functions and/or structures in the consciousness loop (e.g., drugs, hyperbaric medicines, noninvasive neurostimulation, sensory and environmental stimulation, invasive neuromodulation therapy, and cell transplantation) may become effective neurorestorative strategies for chronic DOC. In the viewpoint of Neurorestoratology, this guideline proposes the diagnostic and neurorestorative therapeutic suggestions and future exploration direction for this disease following the review of the existing treatment exploration achievements for chronic DOC.	[Li, Yusheng; Yang, Bo] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [He, Jianghong; Yang, Zhonghua] Capital Med Univ, Tiantan Hosp, Beijing 100070, Peoples R China; [Zhang, Hui] Zhengzhou Cent Hosp, Zhengzhou 450007, Henan, Peoples R China; [Fu, Jianhui] Shanghai Huashan Hosp, Shanghai 200040, Peoples R China; [Huang, Lian] Jinan Univ, Affiliated Hosp 1, Guangzhou 510630, Guangdong, Peoples R China; [Chen, Hong] Huazhong Univ Sci & Technol, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China; [Yang, Xiaofeng] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Bao, Yijun] China Med Univ, Hosp 4, Shenyang 110084, Liaoning, Peoples R China		Li, YS (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China.	yushengli1970@163.com					Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Bai Y, 2018, INT J NEUROSCI, V128, P587, DOI 10.1080/00207454.2017.1403440; Brenner RP, 2005, NEUROLOGIST, V11, P271, DOI 10.1097/01.nrl.0000178756.44055.f6; Briand MM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00933; Cai KH, 2008, CHIN J NEUROMEDICINE, V7, P1174; Canavero S, 2009, J NEUROL, V256, P834, DOI 10.1007/s00415-009-5019-4; Carriere M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10070469; Cheng LJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00826; Chudy D, 2018, J NEUROSURG, V128, P1189; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Corazzol M, 2017, CURR BIOL, V27, pR994, DOI 10.1016/j.cub.2017.07.060; Daly S, 2018, J NEUROTRAUM, V35, P623, DOI 10.1089/neu.2017.5225; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Formaggio E, 2016, BRAIN TOPOGR, V29, P322, DOI 10.1007/s10548-015-0461-3; Functional Neurosurgery Group in Neurosurgery Branch of Chinese Medical Association Chinese Neuromodulation Society of Chinese Medical Doctor Association Consciousness and Disturbance of Consciousness Branch of Chinese Neuroscience Society, 2019, CHIN J NEUROSURG, V35, P433; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gummadavelli A, 2015, EPILEPSIA, V56, P114, DOI 10.1111/epi.12872; Haddad AR, 2019, NEUROMODULATION, V22, P373, DOI 10.1111/ner.12944; Hakon J, 2020, NEUROMODULATION, V23, P859, DOI 10.1111/ner.13148; Hirsch L., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Huang HY, 2020, J NEURORESTORATOLOGY, V8, P217, DOI 10.26599/JNR.2020.9040023; Huang HY, 2020, J NEURORESTORATOLOGY, V8, P61, DOI 10.26599/JNR.2020.9040009; Huang HY., 2007, OLFACTORY ENSHEATHIN, P124; Kanno T, 2009, NEUROMODULATION, V12, P33, DOI 10.1111/j.1525-1403.2009.00185.x; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Krewer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143180; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Liang ZH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01511; Liu P, 2016, EUR NEUROL, V76, P1, DOI 10.1159/000447325; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Lotze M, 2011, J REHABIL MED, V43, P230, DOI 10.2340/16501977-0653; Ma HM, 2020, BRAIN INJURY, V34, P299, DOI 10.1080/02699052.2020.1723697; Magrassi L, 2016, J NEUROSURG, V125, P972, DOI 10.3171/2015.7.JNS15700; Margetis K, 2014, NEUROMODULATION, V17, P699, DOI 10.1111/ner.12147; Moattari M, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.23531; Noe E, 2020, BRAIN STIMUL, V13, P427, DOI 10.1016/j.brs.2019.12.005; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2014, COMA DISORDERS CONSC, P5; Schnakers C, 2014, COMA DISORDERS CONSC, P66; Septien S, 2018, SEMIN NEUROL, V38, P548, DOI 10.1055/s-0038-1667384; Song HJ, 2018, FRONT MED-PRC, V12, P334, DOI 10.1007/s11684-017-0539-2; The Professional Group of Craniocerebral Injury Neurosurgery Branch of Chinese Medical Association The Professional Group of Neurotrauma Branch of Chinese Medical Association, 2015, CHIN J NEUROSURG, V31, P757; Thibaut A, 2018, NEUROREHABILITATION, V42, P199, DOI 10.3233/NRE-172229; Thibaut A, 2019, ANN PHYS REHABIL MED, V62, P418, DOI 10.1016/j.rehab.2019.05.009; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Wang P, 2008, COMA VEGETATIVE STAT; Wang XY, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00381; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Wu J., 2010, NEUROLOGY, V2nd, P62; Wu M, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/7089543; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182; Xiang SL, 2020, J NEURORESTORATOLOGY, V8, P197, DOI 10.26599/JNR.2020.9040021; Yamamoto T, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.04.010; Yamamoto T, 2012, NEUROL MED-CHIR, V52, P475, DOI 10.2176/nmc.52.475; Yu YT, 2017, BRAIN STIMUL, V10, P328, DOI 10.1016/j.brs.2016.12.004; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263; Zhao JZ., 2020, J CLIN NEUROSURG, V17, P1; Zmigrod S, 2013, CLIN NEUROPHYSIOL, V124, pE132	62	0	0	2	2	TSINGHUA UNIV PRESS	BEIJING	B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA	2324-2426			J NEURORESTORATOLOGY	J. NEURORESSTORATOLOGY	MAR 5	2021	9	1					50	59		10.26599/JNR.2021.9040006			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	UB2ZV	WOS:000685720500004		gold			2022-02-07	
J	Nie, QM; Hui, PQ; Ding, HT; Wang, ZW				Nie, Quanmin; Hui, Peiquan; Ding, Haitao; Wang, Zengwu			Rectal chloral hydrate sedation for computed tomography in young children with head trauma	MEDICINE			English	Article						chloral hydrate; computed tomography; pediatric sedation; traumatic brain injury	PROCEDURAL SEDATION; PEDIATRIC OPHTHALMOLOGY; EFFICACY; SAFETY; INJURY	Children evaluated in the emergency department for head trauma often undergo computed tomography (CT), with some uncooperative children requiring pharmacological sedation. Chloral hydrate (CH) is a sedative that has been widely used, but its rectal use for child sedation after head trauma has rarely been studied. The objective of this study was to document the safety and efficacy of rectal CH sedation for cranial CT in young children. We retrospectively studied all the children with head trauma who received rectal CH sedation for CT in the emergency department from 2016 to 2019. CH was administered rectally at a dose of 50 mg/kg body weight. When sedation was achieved, CT scanning was performed, and the children were monitored until recovery. The sedative safety and efficacy were analyzed. A total of 135 children were enrolled in the study group, and the mean age was 16.05 months. The mean onset time was 16.41 minutes. Successful sedation occurred in 97.0% of children. The mean recovery time was 71.59 minutes. All of the vital signs were within normal limits after sedation, except 1 (0.7%) with transient hypoxia. There was no drug-related vomiting reaction in the study group. Adverse effects occurred in 11 patients (8.1%), but all recovered completely. Compared with oral CH sedation, rectal CH sedation was associated with quicker onset (P < .01), higher success rate (P < .01), and lower adverse event rate (P < .01). Rectal CH sedation can be a safe and effective method for CT imaging of young children with head trauma in the emergency department.	[Nie, Quanmin; Hui, Peiquan; Wang, Zengwu] Weifang Peoples Hosp, Dept Neurosurg, 151 Guangwen Rd, Weifang 261041, Peoples R China; [Ding, Haitao] Linyi Cent Hosp, Dept Neurosurg, Yishui, Shandong, Peoples R China		Wang, ZW (corresponding author), Weifang Peoples Hosp, Dept Neurosurg, 151 Guangwen Rd, Weifang 261041, Peoples R China.	zengwuw2016@163.com					Alp H, 2019, CARDIOL YOUNG, V29, P1189, DOI 10.1017/S1047951119001835; Anderson Jordan, 2018, J Pediatr Pharmacol Ther, V23, P460, DOI 10.5863/1551-6776-23.6.460; Avlonitou E, 2011, INT J PEDIATR OTORHI, V75, P760, DOI 10.1016/j.ijporl.2011.02.010; Bellolio MF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011384; Berkenbosch JW, 2015, PEDIATR DRUGS, V17, P385, DOI 10.1007/s40272-015-0140-6; Burnett HF, 2015, BRIT J OPHTHALMOL, V99, P1565, DOI 10.1136/bjophthalmol-2015-306604; Chaitanya K, 2018, CHILD NERV SYST, V34, P1119, DOI 10.1007/s00381-018-3784-z; Chawla N, 2017, CURR OPIN ANESTHESIO, V30, P507, DOI 10.1097/ACO.0000000000000487; Chen ML, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005842; Chen Z, 2019, DRUG DES DEV THER, V13, P2643, DOI 10.2147/DDDT.S201820; Cote CJ, 2000, PEDIATRICS, V106, P633, DOI 10.1542/peds.106.4.633; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dirani M, 2017, CLIN EEG NEUROSCI, V48, P41, DOI 10.1177/1550059415621830; Horeczko T, 2016, CURR OPIN ANESTHESIO, V29, pS48, DOI 10.1097/ACO.0000000000000320; Hoyle JD, 2014, PEDIATR EMERG CARE, V30, P1, DOI 10.1097/PEC.0000000000000059; Ives-Deliperi VL, 2015, PEDIATR NEUROL, V53, P478, DOI 10.1016/j.pediatrneurol.2015.08.015; Karaoui M, 2018, AM J OPHTHALMOL, V192, P39, DOI 10.1016/j.ajo.2018.05.003; Li BL, 2018, PEDIATR ANESTH, V28, P1022, DOI 10.1111/pan.13498; Mataftsi A, 2017, BRIT J OPHTHALMOL, V101, P1423, DOI 10.1136/bjophthalmol-2016-309449; Necula V, 2019, INT J PEDIATR OTORHI, V126, DOI 10.1016/j.ijporl.2019.109605; Pomeranz ES, 2000, PEDIATRICS, V105, P1110, DOI 10.1542/peds.105.5.1110; Seder DB, 2017, HAND CLINIC, V140, P15, DOI 10.1016/B978-0-444-63600-3.00002-7; Sturm JJ, 2013, AM J EMERG MED, V31, P166, DOI 10.1016/j.ajem.2012.07.002; Varadaraj V, 2018, AM J OPHTHALMOL, V194, P126, DOI 10.1016/j.ajo.2018.07.023; West SK, 2013, BRIT J OPHTHALMOL, V97, P1437, DOI 10.1136/bjophthalmol-2013-303818; Yuen VMY, 2019, HONG KONG MED J, V25, P27	26	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR 5	2021	100	9							e25033	10.1097/MD.0000000000025033			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SO5WT	WOS:000659043000073	33655976	gold, Green Published			2022-02-07	
J	Peach, RK; Hanna, LE				Peach, Richard K.; Hanna, Lindsey E.			Sentence-level processing predicts narrative coherence following traumatic brain injury: evidence in support of a resource model of discourse processing	LANGUAGE COGNITION AND NEUROSCIENCE			English	Article						Traumatic brain injury; cognition; language disorders; discourse; executive function		Research suggests that coherence processing of narratives produced by speakers with traumatic brain injury is dissociated from processing of inter-sentential cohesion and intra-sentential production. The goal of this study was to investigate the relationships between microlinguistic abilities and macrolinguistic operations in narratives produced by individuals with TBI. Narratives with variable story grammar were analysed for co-occurring instances of correct and erroneous cohesive ties, sentence pausing, and mazing to determine the relationships among global coherence, inter-sentential cohesion, and intra-sentential production. Story grammar was predicted by both increased inter-sentential cohesion and increased pausing within sentences. Logistic regression classified the completeness of the story episodes with 94% accuracy based on inter-sentential cohesion and sentence pausing. The results support a resource model of discourse processing where executive disturbances that impair the way individuals with TBI recruit and control cognitive resources result in deficits in multiple levels of discourse processing during narrative construction.	[Peach, Richard K.; Hanna, Lindsey E.] Rush Univ, Med Ctr, Dept Commun Disorders & Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA		Peach, RK (corresponding author), Rush Univ, Med Ctr, Dept Commun Disorders & Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA.	richard_k_peach@rush.edu					Adornetti I, 2014, WAYS PROTOLANGUAGE, V3; AGAR M, 1982, DISCOURSE PROCESS, V5, P1, DOI 10.1080/01638538209544529; Armstrong E, 2000, APHASIOLOGY, V14, P875, DOI 10.1080/02687030050127685; Baker H., 1967, DETROIT TESTS LEARNI; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Barwood CHS, 2013, BRAIN INJURY, V27, P671, DOI 10.3109/02699052.2013.775500; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Boersma P., 2012, PRAAT DOING PHONETIC; Cannizzaro M, 2012, COGNITION ACQUIRED L; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Chapman, 2008, SYSTEMATIC ANAL LANG; Coelho C.A, 1998, ANAL DISCOURSE COMMU; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Delis DC., 2001, DELIS KAPLAN EXECUTI; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Fergadiotis G, 2011, APHASIOLOGY, V25, P1414, DOI 10.1080/02687038.2011.603898; Fergadiotis G, 2011, APHASIOLOGY, V25, P1261, DOI 10.1080/02687038.2011.606974; Fischler I, 2000, SCI PRACT NEUROPSYCH, P348; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Goldman-Eisler F., 1968, PSYCHOLINGUISTICS EX; GRANIER JP, 2000, APHASIOLOGY, V14; GRANT DA, 1948, J EXP PSYCHOL, V38; Griffin Z.M, 2012, CAMBRIDGE HDB PSYCHO; GROSJEAN F, 1979, PHONETICA, V36, P98, DOI 10.1159/000259950; Hagen C., 1972, LEVELS COGNITIVE FUN; Halliday M. K., 1976, COHESION ENGLISH; Haravon A, 1994, DISCOURSE ANAL APPL; Harley TA, 2014, PSYCHOL LANGUAGE; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hobbs J.R., 1985, J LANG SOC PSYCHOL, V4, DOI 10.1177/0261927X8543004; Hollingshead A., 1972, 4 FACTOR INDEX SOCIA; Hough MS, 2008, APHASIOLOGY, V22, P644, DOI 10.1080/02687030701541024; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kertesz A., 2007, WAB R W APHASIA BATT; Kertesz A., 1982, W APHASIA BATTERY TE; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kintsch W, 1978, PSYCHOL REV, V85; Kirsner K., 2002, P 9 AUSTR INT SPEECH, P52; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); Levelt W.J.M., 1989, SPEAKING INTENTION A; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Liles B.Z., 1998, ANAL DISCOURSE COMMU; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Lundine JP, 2019, AM J SPEECH-LANG PAT, V28, P1638, DOI 10.1044/2019_AJSLP-19-0012; MacWhinney B, 2007, CREATING AND DIGITIZING LANGUAGE CORPORA VOLUME 1: SYNCHRONIC DATABASES, P163; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Matsuoka K, 2012, BRAIN INJURY, V26, P1723, DOI 10.3109/02699052.2012.698789; Mattis S, 1988, DEMENTIA RATING SCAL; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1999, COMMUNICATION DISORD; Meister, 2013, 2013 WORKSH COMP MOD, DOI [10.4230/OASIcs.CMN.2013.61, DOI 10.4230/OASICS.CMN.2013.61]; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; NAVARRORUIZ MI, 2009, CLIN LINGUIST PHONET, V15; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Peach R.K., 1990, AM SPEECH LANG HEAR; Peach R. K., 2012, COGNITION ACQUIRED L; Peach R.K, 1993, APHASIA TREATMENT WO; Peach RK, 2019, J SPEECH LANG HEAR R, V62, P2785, DOI 10.1044/2019_JSLHR-L-18-0504; Peach RK, 2017, SEMIN SPEECH LANG, V38, P5, DOI 10.1055/s-0036-1597260; Peach RK, 2016, NEUROPSYCHOLOGIA, V80, P157, DOI 10.1016/j.neuropsychologia.2015.11.015; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); PEACH RK, 1992, J SPEECH HEAR RES, V35, P810, DOI 10.1044/jshr.3504.810; Raven J., 1965, RAVENS COLOURED PROG; Reitan R, 1985, HALSTEAD REITAN NEUR; Rispoli M, 2008, J SPEECH LANG HEAR R, V51, P953, DOI 10.1044/1092-4388(2008/070); Schaude B.A., 1986, AM SPEECH LANG HEAR; Simonet M, 2019, NEUROIMAGE, V197, P457, DOI 10.1016/j.neuroimage.2019.04.010; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Spierer L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00427; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Thordardottir ET, 2002, BRAIN COGNITION, V48, P587, DOI 10.1006/brcg.2001.1422; Togher L., 2012, COGNITION ACQUIRED L; Van Belle G., 2008, STAT RULES THUMB, V2nd ed.; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; VANDIJK TA, 1995, DISCOURSE COMPREHENSION, P383; Verschueren J., 2011, DISCURSIVE PRAGMATIC; Wechsler, 1997, WECHSLER ADULT INTEL; Willems RM, 2020, TRENDS NEUROSCI, V43, P271, DOI 10.1016/j.tins.2020.03.003; WINTER P, 1976, BEAR FLY; Wright HH, 2014, AGING NEUROPSYCHOL C, V21, P174, DOI 10.1080/13825585.2013.794894; Zimmermann N, 2015, BRAIN INJURY, V29, P1071, DOI 10.3109/02699052.2015.1015613	98	0	0	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-3798	2327-3801		LANG COGN NEUROSCI	Lang. Cogn. Neurosci.	JUL 1	2021	36	6					694	710		10.1080/23273798.2021.1894346		MAR 2021	17	Audiology & Speech-Language Pathology; Behavioral Sciences; Linguistics; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Behavioral Sciences; Linguistics; Psychology	SX0OS	WOS:000625997000001					2022-02-07	
J	Arch, A; Ferraro, FR				Arch, Autumn; Ferraro, F. Richard			Performance on the repeatable battery for the assessment of neuropsychological status in college students with mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						College students; mild traumatic brain injury; Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)		College students recovering from mild traumatic brain injury (MTBI) often experience a constellation of symptoms including cognitive and emotional difficulties. While these symptoms may interfere with academic performance, few students seek supportive services. Assessment of MTBI symptoms may be important to help identify students with symptoms that may interfere with academic performance and assist them in obtaining appropriate treatment and support services. The purpose of this study was to evaluate cognitive performance of college students with a history of MTBI on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) as well as symptoms of anxiety and depression. A total of seventy college students participated in this study. Participants were divided into two groups based on self-reported history of MTBI. Participants with a history of MTBI (n = 22) performed significantly higher (p < .05) on the RBANS Delayed Memory Index and endorsed significantly fewer (p < .05) trait anxiety symptoms on the State-Trait Anxiety Inventory (STAI) than students without a history of head injury (n = 48). Students with a history of MTBI displayed few impairments on the RBANS and are more likely to endorse fewer symptoms of trait anxiety (but not state anxiety or depression) than peers without a history of head injury.	[Arch, Autumn] Univ North Dakota, Grand Forks, ND USA; [Ferraro, F. Richard] Univ North Dakota, Dept Psychol, Stop 8380, Grand Forks, ND 58202 USA		Ferraro, FR (corresponding author), Univ North Dakota, Dept Psychol, Stop 8380, Grand Forks, ND 58202 USA.	f.ferraro@und.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Binder S, 2003, REPORT C MILD TRAUMA; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention. National Center for Injury Prevention and Control, 2007, FACTS PHYS HEADS UP; Childers C, 2016, J POSTSECOND EDUC DI, V29, P389; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Hux K., 2017, CURRENT RES CONCUSSI, V4, pE14, DOI [10.1055/s-0037-1606578, DOI 10.1055/S-0037-1606578]; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kosaka B., 2006, BRIT COLOMBIA MEDICA, V48, P447; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Lippa SM, 2013, BRAIN INJURY, V27, P689, DOI 10.3109/02699052.2013.771793; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Triplett G, 1996, PERCEPT MOTOR SKILL, V83, P1344, DOI 10.2466/pms.1996.83.3f.1344	43	0	0	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2021	28	2					220	229		10.1080/23279095.2019.1626236			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QJ4GT	WOS:000619650700004	31230481				2022-02-07	
J	Baugh, CM; Foster, CA; Johnson, BR; D'Lauro, C				Baugh, Christine M.; Foster, Craig A.; Johnson, Brian R.; D'Lauro, Christopher			Pluralistic Ignorance as a Contributing Factor to Concussion Underreporting	HEALTH EDUCATION & BEHAVIOR			English	Article; Early Access						pluralistic ignorance; concussion reporting; social norms; young adult; disclosure; concussion		Background Concussion underreporting is endemic, and social norms are an established predictor of concussion reporting behavior. However, pluralistic ignorance-a situation in which most individuals in a group hold the belief that their peers' views differ from their own, despite views actually being similar-has not been studied in this context. Aim To assess whether pluralistic ignorance contributes to concussion underreporting. Method We surveyed 2,504 military service academy cadets. Each cadet was presented with a survey asking about their willingness to self-report a concussion, their perception of other cadets' willingness to report a concussion, and personal and demographic factors. Results Most cadets viewed themselves as more willing to report a concussion than others (mean difference = 1.12, 95% CI [1.02, 1.21]), a belief consistent with pluralistic ignorance. Demographic characteristics were associated with holding this belief. For example, female cadets and upper-class cadets were more likely to show this disparity than male or under-class cadets, respectively. Collegiate athletes not only showed similar willingness to report concussion as nonathletes but also perceived other cadets as less likely to report concussions. Meanwhile, future pilots showed less self-report willingness and perceived that others were similarly unwilling to report concussions. Discussion A majority of this economically and geographically diverse population displays characteristics of pluralistic ignorance: They largely share proconcussion reporting sentiments but incorrectly perceive that others do not. This belief is not held uniformly in all subpopulations, which may inform how these beliefs are developed and maintained. Conclusions Pluralistic ignorance is an important consideration in concussion education efforts.	[Baugh, Christine M.] Univ Colorado Denver, Anschutz Med Campus, Aurora, CO USA; [Foster, Craig A.; D'Lauro, Christopher] US Air Force Acad, Colorado Springs, CO 80840 USA; [Foster, Craig A.] SUNY Coll Cortland, Cortland, NY USA; [Johnson, Brian R.] Walter Reed Army Inst Res, Silver Spring, MD USA		Baugh, CM (corresponding author), Univ Colorado Denver, Ctr Bioeth & Humanities, Anschutz Med Campus,13080 East 19th Ave,CB B137, Aurora, CO 80045 USA.	christine.baugh@cuanschutz.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; D'Lauro, Christopher/0000-0003-0894-6602	NCAA; Department of Defense through a Mind Matters Challenge Award	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work received partial financial and logistical support from the NCAA and Department of Defense through a Mind Matters Challenge Award.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bandura A, 1986, SOCIAL FDN THOUGHT A; Baugh CM, 2019, J NEUROTRAUM, V36, P2065, DOI 10.1089/neu.2018.6161; Baugh CM, 2020, J LAW MED ETHICS, V48, P307, DOI 10.1177/1073110520935342; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Bjerring JC, 2014, SYNTHESE, V191, P2445, DOI 10.1007/s11229-014-0434-1; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cook N, 2020, J SPORT REHABIL, V29, P1019, DOI 10.1123/jsr.2019-0419; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Grant D, 2009, SOCIOL PERSPECT, V52, P59, DOI 10.1525/sop.2009.52.1.59; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lewis MA, 2006, J AM COLL HEALTH, V54, P213, DOI 10.3200/JACH.54.4.213-218; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Perkins HW, 2005, J STUD ALCOHOL, V66, P470, DOI 10.15288/jsa.2005.66.470; Register-Mihalik JK, 2021, RES SPORTS MED, V29, P1, DOI 10.1080/15438627.2020.1719493; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; United States Air Force Academy, 2015, DEMOGRAPHIC PROFILE; Warmath D, 2019, SPORTS HEALTH, V11, P416, DOI 10.1177/1941738119856609	30	0	0	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.											1090198121995732	10.1177/1090198121995732		MAR 2021	7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	QS9YU	WOS:000626249200001	33660553				2022-02-07	
J	Madurski, C; Jarvis, JM; Beers, SR; Houtrow, AJ; Wagner, AK; Fabio, A; Wang, CY; Smith, CM; Doughty, L; Janesko-Feldman, K; Rubin, P; Pollon, D; Treble-Barna, A; Kochanek, PM; Fink, EL				Madurski, Catherine; Jarvis, Jessica M.; Beers, Sue R.; Houtrow, Amy J.; Wagner, Amy K.; Fabio, Anthony; Wang, Chunyan; Smith, Craig M.; Doughty, Lesley; Janesko-Feldman, Keri; Rubin, Pamela; Pollon, Dorothy; Treble-Barna, Amery; Kochanek, Patrick M.; Fink, Ericka L.		PICU-Rehabil Study Grp	Serum Biomarkers of Regeneration and Plasticity are Associated with Functional Outcome in Pediatric Neurocritical Illness: An Exploratory Study	NEUROCRITICAL CARE			English	Article						Brain injury; Biomarkers; Pediatrics; Critical care; Rehabilitation	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; CRITICALLY-ILL CHILDREN; NEUROTROPHIC FACTOR; INTENSIVE-CARE; TRANSLATIONAL REHABILITATION; REHABILOMICS RESEARCH; INFLAMMATORY MARKERS; PROGNOSTIC VALUE; S100B PROTEIN	Background/Objective Pediatric neurocritical care survivorship is frequently accompanied by functional impairments. Lack of prognostic biomarkers is a barrier to early identification and management of impairment. We explored the association between blood biomarkers and functional impairment in children with acute acquired brain injury. Methods This study is a secondary analysis of a randomized control trial evaluating early versus usual care rehabilitation in the pediatric intensive care unit (PICU). Forty-four children (17 [39%] female, median age 11 [interquartile range 6-13] years) with acute acquired brain injury admitted to the PICU were studied. A single center obtained serum samples on admission days 0, 1, 3, 5, and the day closest to hospital discharge. Biomarkers relevant to brain injury (neuron specific enolase [NSE], S100b), inflammation (interleukin [IL-6], C-reactive protein), and regeneration (brain-derived neurotrophic factor [BDNF], vascular endothelial growth factor [VEGF]) were collected. Biomarkers were analyzed using a Luminex (R) bioassay. Functional status scale (FSS) scores were abstracted from the medical record. New functional impairment was defined as a (worse) FSS score at hospital discharge compared to pre-PICU (baseline). Individual biomarker fluorescence index (FI) values for each sample collection day were correlated with new functional impairment using Spearman rank correlation coefficient (rho). Trends in repeated measures of biomarker FI over time were explored graphically, and the association between repeated measures of biomarker FI and new functional impairment was analyzed using covariate adjusted linear mixed-effect models. Results Functional impairment was inversely correlated with markers of regeneration and plasticity including BDNF at day 3 (rho = - 0.404, p = .015), day 5 (rho = - 0.549, p = 0.005) and hospital discharge (rho = - 0.420, p = 0.026) and VEGF at day 1 (rho = - 0.282, p = 0.008) and hospital discharge (rho = - 0.378, p = 0.047), such that lower levels of both markers at each time point were associated with greater impairment. Similarly, repeated measures of BDNF and VEGF were inversely correlated with new functional impairment (B = - 0.001, p = 0.001 and B = - 0.001, p = 0.003, respectively). NSE, a biomarker of acute brain injury, showed a positive correlation between day 0 levels and new functional impairment (rho = 0.320, p = 0.044). Conclusions Blood-based biomarkers of regeneration and plasticity may hold prognostic utility for functional impairment among pediatric patients with neurocritical illness and warrant further investigation.	[Madurski, Catherine; Janesko-Feldman, Keri; Rubin, Pamela; Kochanek, Patrick M.; Fink, Ericka L.] UPMC Childrens Hosp Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Madurski, Catherine] Nemours Alfred I DuPont Hosp Children, Div Crit Care Med, Wilmington, DE USA; [Jarvis, Jessica M.; Houtrow, Amy J.; Wagner, Amy K.; Treble-Barna, Amery] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Beers, Sue R.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Wagner, Amy K.; Kochanek, Patrick M.; Fink, Ericka L.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Fabio, Anthony; Wang, Chunyan] Univ Pittsburgh, Epidemiol Data Ctr, Pittsburgh, PA USA; [Smith, Craig M.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Crit Care, Chicago, IL 60611 USA; [Doughty, Lesley] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Pollon, Dorothy] Special Needs Child Advocate & Study Stakeholder, Pittsburgh, PA USA; [Fink, Ericka L.] UPMC Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, 4401 Penn Ave,Fac Pavil,2nd Floor, Pittsburgh, PA 15224 USA		Fink, EL (corresponding author), UPMC Childrens Hosp Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15224 USA.; Fink, EL (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA.; Fink, EL (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, 4401 Penn Ave,Fac Pavil,2nd Floor, Pittsburgh, PA 15224 USA.	finkel@ccm.upmc.edu	Fink, Ericka/AAU-9792-2021		Patient Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [CER-1310-08343]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD040686, K01 HD097030, NS096714];  [P30CA047904]	This study received funding from Patient Centered Outcomes Research Institute CER-1310-08343 (E.L.F.) and the National Institutes of Health T32 HD040686 (J.M.J.), K01 HD097030 (A.T-B.) and NS096714 (E.L.F.). Luminex bioassay used UPCI Cancer Biomarkers Facility: Luminex Core Laboratory, which is supported in part by award P30CA047904.	Au AK, 2017, NEUROCRIT CARE, V28, P1; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bembea MM, 2015, CRIT CARE MED, V43, P2202, DOI 10.1097/CCM.0000000000001145; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bone MF, 2014, PEDIATR CRIT CARE ME, V15, P640, DOI 10.1097/PCC.0000000000000199; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Buerki SE, 2016, EUR J PAEDIATR NEURO, V20, P252, DOI 10.1016/j.ejpn.2015.12.006; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Choong K, 2018, PEDIATR CRIT CARE ME, V19, P145, DOI 10.1097/PCC.0000000000001421; Choong K, 2017, PEDIATR CRIT CARE ME, V18, pE546, DOI 10.1097/PCC.0000000000001329; Coelho FM, 2012, ARCH GERONTOL GERIAT, V54, P415, DOI 10.1016/j.archger.2011.05.014; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; El-Tamawy MS, 2014, NEUROREHABILITATION, V34, P209, DOI 10.3233/NRE-131020; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Fink EL, 2020, CRIT CARE MED, V48, P1819, DOI 10.1097/CCM.0000000000004660; Fink EL, 2020, CONTEMP CLIN TRIALS, V91, DOI 10.1016/j.cct.2020.105968; Fink EL, 2019, PEDIATR CRIT CARE ME, V20, P540, DOI 10.1097/PCC.0000000000001881; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Fink EL, 2014, CRIT CARE MED, V42, P664, DOI 10.1097/01.ccm.0000435668.53188.80; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Griffith DM, 2016, THORAX, V71, P820, DOI 10.1136/thoraxjnl-2015-208114; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Holden JE, 2008, AM J NEPHROL, V28, P792, DOI 10.1159/000131102; Jarvis JM, 2020, DEV MED CHILD NEUROL, V62, P954, DOI 10.1111/dmcn.14535; Jarvis JM, 2019, ARCH PHYS MED REHAB, V100, P2144, DOI 10.1016/j.apmr.2019.05.034; Jarvis JM, 2019, ARCH PHYS MED REHAB, V100, P703, DOI 10.1016/j.apmr.2018.11.017; Jarvis JM, 2018, DISABIL REHABIL, V41, P13; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kudchadkar SR, 2020, CRIT CARE MED, V48, P634, DOI 10.1097/CCM.0000000000004291; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Lone NI, 2013, CRIT CARE MED, V41, P1832, DOI 10.1097/CCM.0b013e31828a409c; Maddux AB, 2020, CRIT CARE MED, V48, pE1313, DOI 10.1097/CCM.0000000000004595; Manning JC, 2018, PEDIATR CRIT CARE ME, V19, P298, DOI 10.1097/PCC.0000000000001476; Mehta Tejas, 2020, Open Access J Neurol Neurosurg, V12, P86; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Muszynski JA, 2016, CURR OPIN PEDIATR, V28, P267, DOI 10.1097/MOP.0000000000000352; Park SH, 2018, WORLD NEUROSURG, V118, pE534, DOI 10.1016/j.wneu.2018.06.234; Peberdy MA, 2016, RESUSCITATION, V103, P117, DOI 10.1016/j.resuscitation.2016.01.006; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Rahmani F, 2019, BRAIN RES, V1704, P127, DOI 10.1016/j.brainres.2018.10.006; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Seale GS, 2010, REHABIL PSYCHOL, V55, P33, DOI 10.1037/a0018744; Seymour CW, 2019, JAMA-J AM MED ASSOC, V321, P2003, DOI 10.1001/jama.2019.5791; Spadaro S, 2019, J INFLAMM-LOND, V16, DOI 10.1186/s12950-018-0202-y; Stanne TM, 2016, STROKE, V47, P1943, DOI 10.1161/STROKEAHA.115.012383; Taylor JM, 2015, BRAIN RES, V1622, P414, DOI 10.1016/j.brainres.2015.07.009; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thomaz A, 2016, J MOL NEUROSCI, V59, P326, DOI 10.1007/s12031-015-0689-0; Topjian AA, 2009, PEDIATR CRIT CARE ME, V10, P479, DOI 10.1097/PCC.0b013e318198bdb5; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0791-5; Wagner AK, 2014, AM J PHYS MED REHAB, V93, P913, DOI 10.1097/PHM.0000000000000114; Walker T, 2018, J PEDIATR-US, V203, P10, DOI 10.1016/j.jpeds.2018.08.058; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Wong AW, 2013, J NEUROSCI, V33, P4947, DOI 10.1523/JNEUROSCI.3990-12.2013; World Health Organization, 2007, INT CLASS FUNCT DIS; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xu JP, 2010, HEALTH PSYCHOL, V29, P9, DOI 10.1037/a0016767; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Zhou S, 2018, NEURAL REGEN RES, V13, P2134, DOI 10.4103/1673-5374.241462	75	0	0	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	2					457	467		10.1007/s12028-021-01199-z		MAR 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	WU3OH	WOS:000626919900001	33665769				2022-02-07	
J	Rao, HM; Yuditskaya, S; Williamson, JR; Vian, TR; Lacirignola, JJ; Shenk, TE; Talavage, TM; Heaton, KJ; Quatieri, TF				Rao, Hrishikesh M.; Yuditskaya, Sophia; Williamson, James R.; Vian, Trina R.; Lacirignola, Joseph J.; Shenk, Trey E.; Talavage, Thomas M.; Heaton, Kristin J.; Quatieri, Thomas F.			Using Oculomotor Features to Predict Changes in Optic Nerve Sheath Diameter and ImPACT Scores From Contact-Sport Athletes	FRONTIERS IN NEUROLOGY			English	Article						eye movements; optic nerve sheath diameter; neurocognitive testing; contact sports; athletic season		There is mounting evidence linking the cumulative effects of repetitive head impacts to neuro-degenerative conditions. Robust clinical assessment tools to identify mild traumatic brain injuries are needed to assist with timely diagnosis for return-to-field decisions and appropriately guide rehabilitation. The focus of the present study is to investigate the potential for oculomotor features to complement existing diagnostic tools, such as measurements of Optic Nerve Sheath Diameter (ONSD) and Immediate Post-concussion Assessment and Cognitive Testing (ImPACT). Thirty-one high school American football and soccer athletes were tracked through the course of a sports season. Given the high risk of repetitive head impacts associated with both soccer and football, our hypotheses were that (1) ONSD and ImPACT scores would worsen through the season and (2) oculomotor features would effectively capture both neurophysiological changes reflected by ONSD and neuro-functional status assessed via ImPACT. Oculomotor features were used as input to Linear Mixed-Effects Regression models to predict ONSD and ImPACT scores as outcomes. Prediction accuracy was evaluated to identify explicit relationships between eye movements, ONSD, and ImPACT scores. Significant Pearson correlations were observed between predicted and actual outcomes for ONSD (Raw = 0.70; Normalized = 0.45) and for ImPACT (Raw = 0.86; Normalized = 0.71), demonstrating the capability of oculomotor features to capture neurological changes detected by both ONSD and ImPACT. The most predictive features were found to relate to motor control and visual-motor processing. In future work, oculomotor models, linking neural structures to oculomotor function, can be built to gain extended mechanistic insights into neurophysiological changes observed through seasons of participation in contact sports.	[Rao, Hrishikesh M.; Yuditskaya, Sophia; Williamson, James R.; Quatieri, Thomas F.] MIT, Lincoln Lab, Human Hlth & Performance Syst Grp, 244 Wood St, Lexington, MA 02173 USA; [Vian, Trina R.; Lacirignola, Joseph J.] MIT, Lincoln Lab, Counter Weapons Mass Destruct Syst Grp, 244 Wood St, Lexington, MA 02173 USA; [Shenk, Trey E.] MIT, Lincoln Lab, Adv Radio Frequency Tech & Syst Grp, 244 Wood St, Lexington, MA 02173 USA; [Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, Dept Biomed Engn, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Purdue Univ, Dept Elect & Comp Engn, W Lafayette, IN 47907 USA; [Heaton, Kristin J.] US Army, Res Inst Environm Med, Mil Performance Div, Natick, MA 01760 USA		Rao, HM (corresponding author), MIT, Lincoln Lab, Human Hlth & Performance Syst Grp, 244 Wood St, Lexington, MA 02173 USA.	hrishikesh.rao@ll.mit.edu		Talavage, Thomas/0000-0003-4977-6398	Department of the Army under Air Force [FA8702-15-D-0001]	This material was based upon work supported by the Under Secretary of Defense for Research & Engineering [USD(R&E)] and the Department of the Army under Air Force Contract No. FA8702-15-D-0001.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Bueno APA, 2019, NEUROPSYCHOLOGIA, V133, DOI 10.1016/j.neuropsychologia.2019.107191; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Cook RD, 1982, RESIDUALS INFLUENCE; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Defense and Veterans Brain Injury Center , 2020, DOD WORLDWIDE NUMBER; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; GALETTA S, 1989, J CLIN NEURO-OPHTHAL, V9, P79; Ganslandt O, 2018, J NEUROSURG, V128, P1653, DOI 10.3171/2016.11.JNS152268; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Helfer BS, 2014, INTERSPEECH, P485; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kim DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16173-z; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawley JS, 2017, J PHYSIOL-LONDON, V595, P2115, DOI 10.1113/JP273557; Lee SH, 2019, HONG KONG J EMERG ME, DOI 10.1177/1024907919892775; Lefevre P, 1998, NEURAL NETWORKS, V11, P1175, DOI 10.1016/S0893-6080(98)00071-9; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Lochner P, 2016, J ULTRASOUND, V19, P41, DOI 10.1007/s40477-014-0144-z; Lovell MR., 2007, IMPACT CLIN INTERPRE; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall-Bowman K, 2013, ACTA ASTRONAUT, V87, P77, DOI 10.1016/j.actaastro.2013.01.014; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Michael AP, 2015, AEROSP MED HUM PERF, V86, P557, DOI 10.3357/AMHP.4284.2015; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Mustari MJ, 2009, ANN NY ACAD SCI, V1164, P147, DOI 10.1111/j.1749-6632.2009.03859.x; Nauman EA, 2018, HAND CLINIC, V158, P245, DOI 10.1016/B978-0-444-63954-7.00024-0; Nuding U, 2008, J NEUROPHYSIOL, V99, P2798, DOI 10.1152/jn.90237.2008; Orey SA, 2000, ARCH CLIN NEUROPSYCH, V15, P335, DOI 10.1016/S0887-6177(99)00024-4; Padayachy LC, 2016, CHILD NERV SYST, V32, P1769, DOI 10.1007/s00381-016-3067-5; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Rao HM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71611-9; ROBERTS RJ, 1994, J EXP PSYCHOL GEN, V123, P374, DOI 10.1037/0096-3445.123.4.374; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Scheer D, 2015, PROCEDIA ENGINEER, V112, P556, DOI 10.1016/j.proeng.2015.07.244; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Spenceley LM., 2012, IMPACT INCENTIVES NE; Svaldi DO, 2020, BRAIN IMAGING BEHAV, V14, P164, DOI 10.1007/s11682-018-9983-0; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Talavage TM., 2016, BRIDGE LINKING ENG S, V46, P91; Talkar T., 2020, P INTERSPEECH 2020 S, V2020, P135, DOI [10.21437/Interspeech.2020-2651, DOI 10.21437/INTERSPEECH.2020-2651]; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tong JL, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00090; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	68	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 4	2021	12								584684	10.3389/fneur.2021.584684			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QY3XA	WOS:000629975300001	33746869	Green Published, gold			2022-02-07	
J	Thomsen, AH; Leth, PM; Hougen, HP; Villesen, P				Thomsen, Asser H.; Leth, Peter M.; Hougen, Hans Petter; Villesen, Palle			Gunshot homicides in Denmark 1992-2016	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Homicide; Gunshot injuries; Firearms; Forensic autopsy; Gun violence; Interpersonal violence		The majority of homicides in the world are caused by firearms and a good understanding of gunshot wounds is important for the forensic pathologist. We have analyzed all 315 homicides by gunshots in Denmark during 1992-2016 with focus on information relevant to forensic pathologists. Of the 1417 homicides in Denmark in 1992-2016, 315 (22.2%) had gunshot trauma as the primary homicide method. During 1992-2016, there has been a significant decrease in the number of gunshot homicides overall, of homicides committed with hunting weapons, and of domestic gunshot homicides. Most victims (70.5%) and offenders (93.7% of homicides with known offenders) were males. Male victims were significantly younger than female victims. Most victims were killed with handguns (43.8%) or shotguns (41.0%). Compared to all other weapons, the victims killed with shotguns had fewer entry wounds, a higher New Injury Severity Score (NISS), and a higher proportion of contact/close-range entry wounds. The head (58.1%) and thorax (46.7%) were often injured, with injuries to the head being more common in contact/close-range entry wounds. The results show that gunshot injuries in homicides are different from suicides and accidents and clearly are affected by the homicide type, the sex of the victim, and the weapon used and that these entities are intertwined. Our findings provide an evidence-based foundation for use in death investigations and for policy development in the area of interpersonal violence.	[Thomsen, Asser H.] Aarhus Univ, Dept Forens Med, Palle Juul Jensen Blvd 99, DK-8200 Aarhus N, Denmark; [Leth, Peter M.] Univ Southern Denmark, Dept Forens Med, JB Winsloews Vej 17, DK-5000 Odense C, Denmark; [Hougen, Hans Petter] Univ Copenhagen, Fac Hlth Sci, Dept Forens Med, Frederik Vs Vej 11, DK-2100 Copenhagen, Denmark; [Villesen, Palle] Aarhus Univ, Bioinformat Res Ctr, CF Moellers Alle 8, DK-8000 Aarhus C, Denmark; [Villesen, Palle] Aarhus Univ, Dept Clin Med, Aarhus, Denmark		Thomsen, AH (corresponding author), Aarhus Univ, Dept Forens Med, Palle Juul Jensen Blvd 99, DK-8200 Aarhus N, Denmark.	aht@forens.au.dk; pleth@health.sdu.dk; hougen@sund.ku.dk; palle@birc.au.dk	Leth, Peter Mygind/AAU-6748-2021	Leth, Peter Mygind/0000-0002-8685-0246; Villesen, Palle/0000-0001-7589-8781	Brodrene Hartmanns Fond [A26707]	Asser Hedegard Thomsen has received funding from Brodrene Hartmanns Fond (A26707).	Castro-Espicalsky TL, 2020, J FORENSIC LEG MED, V69, DOI 10.1016/j.jflm.2019.101888; Cave R, 2014, AM J FOREN MED PATH, V35, P118, DOI 10.1097/PAF.0000000000000085; Chmieliauskas S, 2019, J FORENSIC LEG MED, V65, P27, DOI 10.1016/j.jflm.2019.04.010; Denton JS, 2006, ARCH PATHOL LAB MED, V130, P1283; Doucette ML, 2019, AM J PUBLIC HEALTH, V109, P1747, DOI 10.2105/AJPH.2019.305307; Druid H, 1997, FORENSIC SCI INT, V88, P147, DOI 10.1016/S0379-0738(97)00104-7; Ganpat S.M., 2011, HOMICIDE FINLAND NET; Gennarelli TA, 2008, ASS ADV AUTOMOTIVE M; Gjertsen F, 2014, INT J ENV RES PUB HE, V11, P487, DOI 10.3390/ijerph110100487; Hepburn LM, 2004, AGGRESS VIOLENT BEH, V9, P417, DOI 10.1016/S1359-1789(03)00044-2; Hideg G, 2017, GLOBAL VIOLENT DEATH; Hougen HP, 2000, AM J FOREN MED PATH, V21, P281, DOI 10.1097/00000433-200009000-00021; Jeffery A, 2007, Forensic Sci Med Pathol, V3, P252, DOI 10.1007/s12024-007-0035-0; Junuzovic M, 2019, EUR J PUBLIC HEALTH, V29, P351, DOI 10.1093/eurpub/cky137; Justitsministeriet, 2019, DANISH FIREARM ACT; Kalesan B, 2017, INJURY PREV, V23, P321, DOI 10.1136/injuryprev-2016-042162; Karger B, 2002, INT J LEGAL MED, V116, P350, DOI 10.1007/s00414-002-0337-4; Karger B, 2002, INT J LEGAL MED, V116, P273, DOI 10.1007/s00414-002-0325-8; Khoshnood A, 2019, FOREN SCI RES, V4, P88, DOI 10.1080/20961790.2019.1570665; Knight B., 2016, KNIGHTS FORENSIC PAT; Lee LK, 2017, JAMA INTERN MED, V177, P106, DOI 10.1001/jamainternmed.2016.7051; Maghin F, 2019, INT J LEGAL MED, V133, P1469, DOI 10.1007/s00414-019-02085-2; Maiden NR, 2016, J FORENSIC SCI, V61, P87, DOI 10.1111/1556-4029.12901; Molina DK, 2007, AM J FOREN MED PATH, V28, P99, DOI 10.1097/01.paf.0000257415.82728.d7; Molina DK, 2013, AM J FOREN MED PATH, V34, P366, DOI 10.1097/PAF.0000000000000065; Molina DK, 2013, AM J FOREN MED PATH, V34, P342, DOI 10.1097/PAF.0000000000000048; Naghavi M, 2018, JAMA-J AM MED ASSOC, V320, P792, DOI 10.1001/jama.2018.10060; Ptaszynska-Sarosiek Iwona, 2016, Arch Med Sadowej Kryminol, V66, P211, DOI 10.5114/amsik.2016.68097; Rowell SE, 2011, J TRAUMA, V71, pS384, DOI 10.1097/TA.0b013e3182287c8d; Santaella-Tenorio J, 2016, EPIDEMIOL REV, V38, P140, DOI 10.1093/epirev/mxv012; Siegel M, 2014, AM J PUBLIC HEALTH, V104, P1912, DOI 10.2105/AJPH.2014.302042; Siegel M, 2013, AM J PUBLIC HEALTH, V103, P2098, DOI 10.2105/AJPH.2013.301409; Sollid SJM, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-3; Stefanopoulos PK, 2019, J TRAUMA ACUTE CARE, V87, P690, DOI 10.1097/TA.0000000000002290; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; SUWANJUTHA T, 1988, FORENSIC SCI INT, V37, P223, DOI 10.1016/0379-0738(88)90188-0; Thomsen Asser H, 2019, Forensic Sci Int, V1, P275, DOI 10.1016/j.fsisyn.2019.07.001; Thomsen AH, 2020, FORENSIC SCI MED PAT, V16, P415, DOI 10.1007/s12024-020-00246-z; Thomsen AH, 2020, J FORENSIC SCI, V65, P833, DOI 10.1111/1556-4029.14244; THOMSEN JL, 1991, MED SCI LAW, V31, P162, DOI 10.1177/002580249103100213; Tresson P, 2017, ANN VASC SURG, V40, P44, DOI 10.1016/j.avsg.2016.09.011; (UNODC) TUNOoDaC, 2019, GLOB STUD HOM 2019	42	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2021	135	4					1507	1514		10.1007/s00414-021-02548-5		MAR 2021	8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	SS7YK	WOS:000626940300003	33661341				2022-02-07	
J	Ucal, M; Maurer, C; Etschmaier, V; Hamberger, D; Grunbacher, G; Togl, L; Roosen, MJ; Molcanyi, M; Vorholt, D; Hatay, FF; Hescheler, J; Pallasch, C; Schafer, U; Patz, S				Uecal, Muammer; Maurer, Christa; Etschmaier, Vanessa; Hamberger, Daniel; Gruenbacher, Gerda; Toegl, Lennart; Roosen, Marvin J.; Molcanyi, Marek; Vorholt, Daniela; Hatay, F. Fulya; Hescheler, Juergen; Pallasch, Christian; Schaefer, Ute; Patz, Silke			Inflammatory Pre-Conditioning of Adipose-Derived Stem Cells with Cerebrospinal Fluid from Traumatic Brain Injury Patients Alters the Immunomodulatory Potential of ADSC Secretomes	JOURNAL OF NEUROTRAUMA			English	Article						adipose-derived stem cells; conditioning; inflammation; secretome; traumatic brain injury; immunomodulation		Immunomodulation by adipose-tissue-derived stem cells (ADSCs) is of special interest for the alleviation of damaging inflammatory responses in central nervous system injuries. The present study explored the effects of cerebrospinal fluid (CSF) from traumatic brain injury (TBI) patients on this immunomodulatory potential of ADSCs. CSF conditioning of ADSCs increased messenger RNA levels of both pro- and anti-inflammatory genes compared to controls. Exposure of phorbol-12-myristate-13-acetate-differentiated THP1 macrophages to the secretome of CSF-conditioned ADSCs downregulated both proinflammatory (cyclooxygenase-2, tumor necrosis factor alpha) and anti-inflammatory (suppressor of cytokine signaling 3, interleukin-1 receptor antagonist, and transforming growth factor beta) genes in these cells. Interleukin-10 expression was elevated in both naive and conditioned secretomes. ADSC secretome treatment, further, induced macrophage maturation of THP1 cells and increased the percentage of CD11b(+), CD14(+), CD86(+), and, to a lesser extent, CD206(+) cells. This, moreover, enhanced the phagocytic activity of CD14(+) and CD86(+) cells, though independently of pre-conditioning. Secretome exposure, finally, also induced a reduction in the percentage of CD192(+) adherent cells in cultures of peripheral blood mononuclear cells (PBMCs) from both healthy subjects and TBI patients. This limited efficacy (of both naive and pre-conditioned secretomes) suggests that the effects of lymphocyte-monocyte paracrine signaling on the fate of cultured PBMCs are strongest upon adherent cell populations.	[Uecal, Muammer; Maurer, Christa; Etschmaier, Vanessa; Hamberger, Daniel; Gruenbacher, Gerda; Toegl, Lennart; Roosen, Marvin J.; Molcanyi, Marek; Schaefer, Ute; Patz, Silke] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Molcanyi, Marek; Hatay, F. Fulya; Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, Fac Med, Cologne, Germany; [Vorholt, Daniela; Pallasch, Christian] Univ Cologne, CECAD Ctr Excellence Cellular Stress Responses Ag, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Dept Internal Med,Ctr Mol Med Cologne CMMC, Cologne, Germany; [Maurer, Christa] Heidelberg Univ, Inst Anat & Cell Biol, Div Med Cell Biol, Heidelberg, Germany; [Hamberger, Daniel] Univ Hosp Heidelberg, Natl Ctr Tumour Dis NCT, Heidelberg, Germany; [Vorholt, Daniela] Miltenyi Biotec BV & Co KG, Bergisch Gladbach, Germany		Patz, S (corresponding author), Med Univ Graz, Inst Neurosurg, Res Unit Expt Neurotraumatol, Stiftingtalstr 24, A-8010 Graz, Austria.	silke.patz@medunigraz.at		Pallasch, Christian P./0000-0001-5675-6905; Roosen, Marvin Johannes/0000-0003-2994-0840			Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Birrell MA, 2015, THORAX, V70, P740, DOI 10.1136/thoraxjnl-2014-206592; Bromander S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-242; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cavanagh LL, 1998, BLOOD, V92, P1598, DOI 10.1182/blood.V92.5.1598.417k33_1598_1607; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Cossetti C, 2012, CELL TISSUE RES, V349, P321, DOI 10.1007/s00441-012-1341-8; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; Domenis R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31707-9; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Erickson MA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071632; Franquesa M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00212; Frolov A, 2013, PROSTAG LEUKOTR ESS, V89, P351, DOI 10.1016/j.plefa.2013.08.003; Glavaski-Joksimovic A, 2009, CELL TRANSPLANT, V18, P801, DOI 10.3727/096368909X470801; Gu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08733; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hestad KA, 2016, NEUROPSYCH DIS TREAT, V12, P817, DOI 10.2147/NDT.S101925; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Ivanova-Todorova E, 2009, IMMUNOL LETT, V126, P37, DOI 10.1016/j.imlet.2009.07.010; Jiang JX, 2013, TRENDS PHARMACOL SCI, V34, P413, DOI 10.1016/j.tips.2013.05.003; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kim SJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-317; Lambert C, 2017, CYTOM PART B-CLIN CY, V92, P180, DOI 10.1002/cyto.b.21280; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Mittal M, 2016, P NATL ACAD SCI USA, V113, pE8151, DOI 10.1073/pnas.1614935113; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Pattison MJ, 2012, J IMMUNOL, V189, P2784, DOI 10.4049/jimmunol.1200310; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2013, GLIA, V61, P1379, DOI 10.1002/glia.22500; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Salehi H, 2016, STEM CELL REV REP, V12, P26, DOI 10.1007/s12015-015-9631-7; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Trombetta AC, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0891-z; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; Vasilevko V, 2002, DNA CELL BIOL, V21, P137, DOI 10.1089/10445490252925404; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Watanabe Rena, 2016, JACC Basic Transl Sci, V1, P494, DOI 10.1016/j.jacbts.2016.07.008; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zeng W, 2015, EXP THER MED, V9, P283, DOI 10.3892/etm.2014.2133; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061	73	0	0	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2311	2322		10.1089/neu.2020.7017		MAR 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000626774200001	33514282				2022-02-07	
J	Al Saffar, MMA; Verdonschot, RJCG; Stassen, HS; Wolvius, EB; Rozeboom, AVJ				Al Saffar, M. M. A.; Verdonschot, R. J. C. G.; Stassen, H. S.; Wolvius, E. B.; Rozeboom, A. V. J.			The Association of Helmet Use with the Occurrence of Maxillofacial Injuries Following Bicycle or Scooter Accidents: A Retrospective Cohort Study	CRANIOMAXILLOFACIAL TRAUMA & RECONSTRUCTION			English	Article; Early Access						traffic accidents; helmet use; maxillofacial fractures; facial injury; bicycle; scooter	TRAUMATIC BRAIN-INJURY; MOTORCYCLE HELMET; FACIAL INJURY; HEAD-INJURY; IMPACT; COLLISIONS; RIDERS; LAW	Study Design: Retrospective Cohort Study. Objective: Yearly, bicycle and scooter accidents in the Netherlands amount to 90 thousand emergency department visits. Maxillofacial injuries are common after cycling or scooter accidents. To prevent these injuries, helmet use might be beneficial. However, the effect of helmet use on maxillofacial injuries remains unclear. The aim of this retrospective study is to assess the effect of helmet use on maxillofacial injuries in patients who had a bicycle or scooter accident. Methods: We collected data from the emergency department of the Erasmus Medical Center in the period from October 2017 to October 2019. Patients that were involved in a bicycle or scooter accident and subsequently received a CT scan of the head were included. We compared the incidence of maxillofacial injuries in helmeted cyclists and scooter users to nonhelmeted users. Descriptive and analytic statistics were computed. Level of statistical significance was set at p < 0.05. Results: Helmet use among scooter users was associated with a significant reduction in maxillofacial fractures (p < 0.001) and soft tissue injuries (p < 0.001). Helmet use among cyclists was not associated with a reduction in maxillofacial fractures (p = 0.17) or soft tissue injuries (p = 0.30). Helmet use was not associated with a reduction in soft tissue injuries of the lower face in both cyclists (p = 0.47) and scooter users (p = 0.24) Conclusions: Helmet use should be considered among cyclists and scooter users to prevent maxillofacial injuries. Especially unhelmeted scooter users might benefit from helmet use as this is associated with a lower incidence of maxillofacial injuries.	[Al Saffar, M. M. A.; Stassen, H. S.; Wolvius, E. B.; Rozeboom, A. V. J.] Erasmus MC, Dept Oral & Maxillofacial Surg, Rotterdam, Netherlands; [Verdonschot, R. J. C. G.] Erasmus MC, Dept Emergency Med, Rotterdam, Netherlands		Al Saffar, MMA (corresponding author), Erasmus MC, Dept Maxillofacial Surg, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	m.alsaffar@hotmail.com					Benjamin T, 2019, JAMA OTOLARYNGOL, V145, P140, DOI 10.1001/jamaoto.2018.3351; Boffano P, 2013, OR SURG OR MED OR PA, V116, P275, DOI 10.1016/j.oooo.2013.03.004; BOVAG-RAI, 2019, FIETS STAT 2011 2018; BOVAG-RAI, 2018, MOBILITEIT CIJFERS T; Brewer BL, 2013, J TRAUMA ACUTE CARE, V75, P88, DOI 10.1097/TA.0b013e3182988b59; Cavalcante JR, 2012, J CRANIOFAC SURG, V23, P982, DOI 10.1097/SCS.0b013e31824e5b04; Christian JM, 2014, J ORAL MAXIL SURG, V72, P2503, DOI 10.1016/j.joms.2014.07.015; Crompton JG, 2012, ARCH SURG-CHICAGO, V147, P674, DOI 10.1001/archsurg.2012.894; Dinh MM, 2015, EMERG MED AUSTRALAS, V27, P323, DOI 10.1111/1742-6723.12407; Does Hvd., 2019, VERKEERSONGEVALLEN 2; Dupaix John P, 2019, Hawaii J Health Soc Welf, V78, P311; Erhardt T, 2016, ACCIDENT ANAL PREV, V86, P23, DOI 10.1016/j.aap.2015.10.004; European Commission, 2018, TRAFF SAF BAS FACTS; Gopalakrishna G, 1998, ANN EMERG MED, V32, P425, DOI 10.1016/S0196-0644(98)70170-2; Hothem Z, 2017, AM J SURG, V214, P407, DOI 10.1016/j.amjsurg.2016.09.052; Houte Wv., 2018, DEELSCOOTER RUKT FEL; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; La Torre G, 2007, EUR J PUBLIC HEALTH, V17, P607, DOI 10.1093/eurpub/ckm028; LEE MC, 1995, INJURY, V26, P467, DOI 10.1016/0020-1383(95)00071-G; Levine E, 2005, ANN PLAS SURG, V54, P502, DOI 10.1097/01.sap.0000155282.48465.94; McCarty JC, 2020, J CRANIOFAC SURG, V31, P1182, DOI 10.1097/SCS.0000000000006379; Morris LM, 2013, FACIAL PLAST SURG CL, V21, P605, DOI 10.1016/j.fsc.2013.07.005; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Paes Jefferson Viapiana, 2012, Indian J Dent Res, V23, P80, DOI 10.4103/0970-9290.99045; Patel PB, 2019, J SURG RES, V242, P177, DOI 10.1016/j.jss.2019.03.023; Poos H P A M, 2017, Ned Tijdschr Geneeskd, V161, pD1520; Pucher J, 2008, TRANSPORT RES REC, P58, DOI 10.3141/2074-08; Ramli R, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-17; Roden KS, 2012, ANN PLAS SURG, V68, P461, DOI 10.1097/SAP.0b013e31823b69dd; Sahni V, 2018, CRANIOMAX TRAUM REC, V11, P15, DOI 10.1055/s-0037-1603464; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Thompson D C, 2000, Cochrane Database Syst Rev, pCD001855; Wentzel JL, 2017, AM SURGEON, V83, pE311; Zhou SA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007395	37	0	0	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1943-3875	1943-3883		CRANIOMAX TRAUM REC	Craniomaxillofacial Trauma Reconstr.												10.1177/1943387521998199		MAR 2021	7	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	QU3XG	WOS:000627215000001					2022-02-07	
J	Lugo, GJ; Beletanga, M; Goldstein, L; Rana, M; Jonas, R; Torres, AR				Lugo, Giancarlo J.; Beletanga, Maria; Goldstein, Laura; Rana, Mandeep; Jonas, Rinat; Torres, Alcy R.			Assessment and Treatment of Concussion in the Pediatric Population	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; concussion; children		Traumatic brain injury (TBI) is common in children. The evaluation and management of children with TBI is based on the research performed in adults. There is a relative paucity of research in the literature involving children and many of the practice recommendations for this age are based on expert opinion in the absence of good research studies in both sports and non-sports-related injuries. The pediatric population is heterogeneous and the approach might be specific for infants, preschoolers, school age children, and adolescents. Children may also suffer from neurodevelopmental disabilities, making their evaluation even more challenging. Adult neurologists are often asked to see children due to increasing demands. This review will focus on specific issues related to TBI in children that might be useful to adult neurologists. Science, however, is evolving rapidly and physicians should make sure to remain up to date to offer evidence-based services to their patients.	[Lugo, Giancarlo J.; Beletanga, Maria; Rana, Mandeep; Jonas, Rinat; Torres, Alcy R.] Boston Med Ctr, Dept Pediat, Div Pediat Neurol, 801 Albany St, Boston, MA 02215 USA; [Goldstein, Laura] Boston Med Ctr, Dept Psychiat, Div Child Psychiat, Boston, MA USA; [Torres, Alcy R.] Boston Univ, Sch Med, Pediat Brain Injury Program, Boston, MA 02118 USA		Torres, AR (corresponding author), Boston Med Ctr, Dept Pediat, Div Pediat Neurol, 801 Albany St, Boston, MA 02215 USA.	artorres@bu.edu					ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babaee A, 2015, IRAN J BASIC MED SCI, V18, P867; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bale JF, 2009, J PEDIATR-US, V154, P602, DOI 10.1016/j.jpeds.2008.10.021; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Borghol Amne, 2018, Innov Clin Neurosci, V15, P17; Botchway EN, 2019, J HEAD TRAUMA REHAB, V34, P241, DOI 10.1097/HTR.0000000000000446; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Chendrasekhar A, 2019, PEDIATR HEALTH MED T, V10, P57, DOI 10.2147/PHMT.S206388; Chung JS, 2019, J CHILD NEUROL, V34, P639, DOI 10.1177/0883073819849741; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corti SJ, 2019, J CHILD NEUROL, V34, P262, DOI 10.1177/0883073818825031; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Dahm KT, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007612.pub2; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Hsu AC, 2012, MED SCI SPORT EXER, V44, P178, DOI 10.1249/MSS.0b013e318275044f; Iaccarino MA, 2019, NEW ENGL J MED, V381, P863, DOI 10.1056/NEJMcpc1900590; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kirschen MP, 2019, PEDIATR CRIT CARE ME, V20, P660, DOI 10.1097/PCC.0000000000001938; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Liu XX, 2017, J NEUROTRAUM, V34, P2445, DOI 10.1089/neu.2016.4823; Lovell M., 2004, IMPACT VERSION 20 CL; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Magalhaes R, 2016, BMJ OPEN SPORT EXERC, V2; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mallinson AI, 1998, AM J OTOL, V19, P814; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McClain R, 2015, PRIMARY CARE, V42, P77, DOI 10.1016/j.pop.2014.09.005; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P., 2013, PHYS THER SPORT, V14; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Melonie Heron, NATL VITALS STAT REP; Moran B, 2015, SOUTH MED J, V108, P553, DOI 10.14423/SMJ.0000000000000340; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; National Clinical Guideline Centre (UK), 2014, NICE CLIN GUIDELINES, V176; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Oyegbile TO, 2017, SLEEP MED, V40, P110, DOI 10.1016/j.sleep.2017.09.026; Park JT, 2015, PEDIATR NEUROL, V52, P174, DOI 10.1016/j.pediatrneurol.2014.09.013; Pearl PL, 2013, EPILEPSIA, V54, pe135, DOI 10.1111/epi.12326; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Piantino J, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0799-4; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Seifert T, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0568-6; Shafer JS, 2009, WEST J EMERG MED, V10, P74; Sheehy JP, 2019, SEMIN PEDIATR NEUROL, V30, P40, DOI 10.1016/j.spen.2019.03.007; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stillman A, 2017, CLEV CLIN J MED, V84, P623, DOI 10.3949/ccjm.84a.16013; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tham SW, 2019, BRAIN INJURY, V33, P1413, DOI 10.1080/02699052.2019.1643921; Torres AR, 2019, CUREUS, V11, DOI 10.7759/cureus.3937; van Markus-Doornbosch F, 2019, EUR J PAEDIATR NEURO, V23, P53, DOI 10.1016/j.ejpn.2018.11.002; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Volovici V, 2019, J NEUROTRAUM, V36, P3183, DOI 10.1089/neu.2019.6474; Wat R, 2019, WORLD NEUROSURG, V122, P433, DOI 10.1016/j.wneu.2018.11.076; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Wiseman-Hakes C, 2019, ASN NEURO, V11, DOI 10.1177/1759091418822405; Yoon Jae Eon, 2017, Korean J Neurotrauma, V13, P167, DOI 10.13004/kjnt.2017.13.2.167; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	111	0	0	1	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	APR	2021	41	02					132	146		10.1055/s-0041-1725135		MAR 2021	15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RJ9NH	WOS:000624907900001	33657625				2022-02-07	
J	Mohatt, NV; Kreisel, CJ; Brenner, LA				Mohatt, Nathaniel, V; Kreisel, Carlee J.; Brenner, Lisa A.		CRITICAL Team	Engaging Those Living With Moderate to Severe TBI and Their Caregivers in Research	JOURNAL OF PATIENT EXPERIENCE			English	Article						patient engagement; traumatic brain injury; patient-centered outcomes research; participatory research	TRAUMATIC BRAIN-INJURY; PATIENT ENGAGEMENT; HEALTH; DISABILITY; DEMENTIA	Despite the fact that millions of individuals living in the United States are coping with disabilities associated with traumatic brain injury (TBI), limited work has explored strategies for patient engagement in research among those with such injuries. The Coalition for Recovery and Innovation in Traumatic Brain Injury Care Across the Lifespan (CRITICAL) brought together those living with TBI, caregivers, clinicians, researchers, and advocates with the goal of developing a new patient-centered research agenda. This platform was also used to explore strategies to engage those with moderate to severe TBI in the research process. The CRITICAL was formed of 6 survivors of moderate to severe TBI, 2 caregivers of survivors of moderate to severe TBI, and 8 TBI professionals. The CRITICAL identified 3 priority topic areas: Relationship Quality, Caregiver Needs, and Thriving. Furthermore, strategies associated with Communication, Preparation, and the Environment facilitated research engagement. Employing the strategies outlined in this article is expected to promote patient engagement in clinical research, which can improve patient-centered interventions and outcomes for individuals living with TBI.	[Mohatt, Nathaniel, V; Kreisel, Carlee J.; Brenner, Lisa A.] VA Rocky Mt Mental Illness Res Educ & Clin Ctr Su, 1700 N Wheeling St,G3-116M, Aurora, CO 80045 USA; [Mohatt, Nathaniel, V; Kreisel, Carlee J.; Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Phys Med & Rehabil, Aurora, CO USA; [Mohatt, Nathaniel, V] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Neurol, Aurora, CO USA		Mohatt, NV (corresponding author), VA Rocky Mt Mental Illness Res Educ & Clin Ctr Su, 1700 N Wheeling St,G3-116M, Aurora, CO 80045 USA.	Nathaniel.Mohatt@va.gov		Kreisel, Carlee/0000-0002-6128-1147	Patient-Centered Outcomes Research Institute (R) (PCORI(R)) Eugene Washington PCORI Engagement Award [3908-UCD]; Department of Veterans AffairsUS Department of Veterans Affairs	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was funded through a Patient-Centered Outcomes Research Institute (R) (PCORI (R)) Eugene Washington PCORI Engagement Award (3908-UCD), and is based on work supported, in part, by the Department of Veterans Affairs.	Bethell J, 2018, DEMENTIA-LONDON, V17, P944, DOI 10.1177/1471301218789292; Bombard Y, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0784-z; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Centers for Disease Control, PREV NAT CTR INJ PRE; Centers for Disease Control and Prevention, BAS INF TRAUM BRAIN; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; CU Anschutz Medical Campus, 2018, COAL REC INN TRAUM B; Ehde DM, 2013, ARCH PHYS MED REHAB, V94, pS30, DOI 10.1016/j.apmr.2012.10.025; Frieden T.R., 2015, CDC NIH REP C, P1, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Jones SP, 2008, J CLIN NURS, V17, P1270, DOI 10.1111/j.1365-2702.2007.02259.x; Kirwan JR, 2017, VALUE HEALTH, V20, P481, DOI 10.1016/j.jval.2016.10.003; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Peterson DB, 2005, REHABIL PSYCHOL, V50, P105, DOI 10.1037/0090-5550.50.2.105; Rimmer JH., 2001, CTR HLTH PROMOTION R; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Seekins T, 2013, ARCH PHYS MED REHAB, V94, pS20, DOI 10.1016/j.apmr.2012.07.033; Thomson A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0773-8; Tooke J, 2013, QUAL AGEING OLDER AD, V14, P56, DOI 10.1108/14717791311311111; Wallerstein NB, 2006, HEALTH PROMOT PRACT, V7, P312, DOI 10.1177/1524839906289376; World Health Organization, 2021, INT CLASS FUNCT DIS; Wu M, 2004, P PART DES C 2004, P214, DOI DOI 10.1145/1011870.1011895	25	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2374-3743	2374-3735		J PATIENT EXPERIENCE	J. Patient Experience	MAR 3	2021	8								2374373521998852	10.1177/2374373521998852			7	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	SA3JS	WOS:000649195300001	34179408	Green Published, gold			2022-02-07	
J	Prior, A; Fiaschi, P; Iaccarino, C; Stefini, R; Battaglini, D; Balestrino, A; Anania, P; Prior, E; Zona, G				Prior, Alessandro; Fiaschi, Pietro; Iaccarino, Corrado; Stefini, Roberto; Battaglini, Denise; Balestrino, Alberto; Anania, Pasquale; Prior, Enrico; Zona, Gianluigi			How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH)	BMC NEUROLOGY			English	Article						Anticoagulant; Reversal therapy; Neurosurgery; Traumatic brain injury; Spontaneous intracerebral hemorrhage	PROTHROMBIN COMPLEX CONCENTRATE; RECOMBINANT FACTOR-VIIA; CEREBRAL AMYLOID ANGIOPATHY; RAPID WARFARIN REVERSAL; TRAUMATIC BRAIN-INJURY; VITAMIN-K ANTAGONIST; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; INTRACEREBRAL HEMORRHAGE; EXCESSIVE ANTICOAGULATION	Background Anticoagulant assumption is a concern in neurosurgical patient that implies a delicate balance between the risk of thromboembolism versus the risk of peri- and postoperative hemorrhage. Methods We performed a survey among 129 different neurosurgical departments in Italy to evaluate practice patterns regarding the management of neurosurgical patients taking anticoagulant drugs. Furthermore, we reviewed the available literature, with the aim of providing a comprehensive but practical summary of current recommendations. Results Our survey revealed that there is a lack of knowledge, mostly regarding the indication and the strategies of anticoagulant reversal in neurosurgical clinical practice. This may be due a lack of national and international guidelines for the care of anticoagulated neurosurgical patients, along with the fact that coagulation and hemostasis are not simple topics for a neurosurgeon. Conclusions To overcome this issue, establishment of hospital-wide policy concerning management of anticoagulated patients and developed in an interdisciplinary manner are strongly recommended.	[Prior, Alessandro; Fiaschi, Pietro; Balestrino, Alberto; Anania, Pasquale; Zona, Gianluigi] IRCCS, Osped Policlin San Martino, Dept Neurosci DINOGMI, Sect Neurosurg, Genoa, Italy; [Fiaschi, Pietro; Zona, Gianluigi] Univ Genoa, IRCCS, Osped Policlin San Martino, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, I-1016132 Genoa, Italy; [Iaccarino, Corrado] Univ Hosp, Dept Neurosurg, Parma, Italy; [Stefini, Roberto] Osped Civile Legnano, Dept Neurosurg, Milan, Italy; [Battaglini, Denise] IRCCS Oncol & Neurosci, Policlin San Martino Hosp, Anesthesia & Intens Care, Genoa, Italy; [Battaglini, Denise] Univ Barcelona, Dept Med, Barcelona, Spain; [Prior, Enrico] Univ Verona, Dept Med, Div Cardiol, Verona, Italy		Fiaschi, P (corresponding author), IRCCS, Osped Policlin San Martino, Dept Neurosci DINOGMI, Sect Neurosurg, Genoa, Italy.; Fiaschi, P (corresponding author), Univ Genoa, IRCCS, Osped Policlin San Martino, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, I-1016132 Genoa, Italy.	pietro.fiaschi@alice.it	Prior, Alessandro/AAA-8253-2021; Iaccarino, Corrado/L-3190-2013; Battaglini, Denise/X-6446-2019	Prior, Alessandro/0000-0003-2995-8709; Iaccarino, Corrado/0000-0002-5133-6327; Battaglini, Denise/0000-0002-6895-6442; ZONA, GIANLUIGI/0000-0002-3577-7894; Fiaschi, Pietro/0000-0002-6034-5524	IRCCS Ospedale Policlinico San Martino	IRCCS Ospedale Policlinico San Martino financial support permitted to cover publication fees.	Ageno W, 2002, THROMB HAEMOSTASIS, V88, P48; Al-Majzoub O, 2016, J EMERG MED; Albaladejo P, 2017, ANAESTH CRIT CARE PA, V36, P73, DOI 10.1016/j.accpm.2016.09.002; Albrecht JS, 2014, JAMA INTERN MED; Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Andrews H, 2017, J TRAUMA NURS; Ansell JE, 2014, NEW ENGL J MED; Awad NI, 2013, ACTIVATED PROTHROMBI; Banerjee G, 2017, J NEUROL NEUROSUR PS, V88, P982, DOI 10.1136/jnnp-2016-314697; Beshay JE, 2010, J NEUROSURG; Boi-Mijovski M, 2015, ANN CLIN BIOCHEM; Boulouis G, 2018, J NEUROL NEUROSUR PS; Brody DL, 2005, NEUROCRIT CARE, V2, P263, DOI 10.1385/NCC:2:3:263; Butenas S, 2002, BLOOD; Caldeira D, 2015, J NEUROL, V262, P516, DOI 10.1007/s00415-014-7462-0; Collins CE, 2014, AM J SURG; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Connolly SJ, 2016, NEW ENGL J MED; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Croci DM, 2017, WORLD NEUROSURG, V105, P841, DOI 10.1016/j.wneu.2017.06.105; Crowther MA, 2003, J THROMB THROMBOLYS; Cucchiara B, 2008, STROKE, V39, P2993, DOI 10.1161/STROKEAHA.108.520668; David CA, 2011, J TRAUMA; Dogliotti A, 2013, CLIN CARDIOL, V36, P61, DOI 10.1002/clc.22081; Doherty JU, 2017, J AM COLL CARDIOL, V69, P871, DOI 10.1016/j.jacc.2016.11.024; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298; Douketis JD, 2016, NEW ENGL J MED; Douxfils J, 2012, THROMB HAEMOSTASIS; Ducruet AF, 2012, NEUROSURG REV; Eikelboom JW, 2017, BRIT J ANAESTH; Endres M, 2015, JAMA J AM MED ASS; Faraoni D, 2018, EUR J ANAESTH, V35, P90, DOI 10.1097/EJA.0000000000000710; Farooqui A, 2013, J NEUROSURG; Fiaschi P, 2020, NEUROSURG REV; Fiaschi P., 2020, WORLD NEUROSURG; Flaherty ML, 2007, NEUROLOGY; Flibotte JJ, 2004, NEUROLOGY; Franke CL, 1990, STROKE; Frontera JA, 2016, NEUROCRIT CARE; Gaist D, 2017, JAMA J AM MED ASS; Gerner ST, 2018, ANN NEUROL; Gillespie L, 2002, ACP J CLUB; Giugliano RP, 2013, NEW ENGL J MED; Goldstein JN, 2015, LANCET, V385, P2077, DOI 10.1016/S0140-6736(14)61685-8; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guha D, 2016, J NEUROSURG; Hacke W, 2016, EUR HEART J; Hankey GJ, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0480-9; He L, 2017, THROMB RES; Horstmann S., 2013, SEMIN THROMB HEMOST; Hu Y-F, 2018, CIRCULATION; Hung A, 2000, BRIT J HAEMATOL; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Inohara T, 2018, JAMA-J AM MED ASSOC, V319, P463, DOI 10.1001/jama.2017.21917; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jones CA, 2016, EXPERT REV PHARMACOE; Khan NR, 2017, J NEUROSURG; Kissela BM, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-17; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Korber MK, 2017, TRANSFUS MED HEMOTH; Kurogi R, 2018, NEUROLOGY; Lavoie A, 2004, J TRAUMA; Lazio BE, 1999, NEUROSURGERY, V45, P838, DOI 10.1097/00006123-199910000-00022; Le Roux P, 2014, J NEUROSURG, V121, P1, DOI 10.3171/2014.8.paradigm; Lip GYH, 2018, CHEST, V154, P1121, DOI 10.1016/j.chest.2018.07.040; Loftus CM., 2016, ANTICOAGULATION HEMO; Lubetsky A, 2004, THROMB RES, V113, P371, DOI 10.1016/j.thromres.2004.04.004; Lubetsky A, 2003, ARCH INTERN MED, V163, P2469, DOI 10.1001/archinte.163.20.2469; Makris M, 1997, THROMB HAEMOSTASIS, V77, P477; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mountain D, 2010, MED J AUSTRALIA, V193, P202, DOI 10.5694/j.1326-5377.2010.tb03868.x; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Pollack CV, 2017, NEW ENGL J MED; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Prange HW., 1991, J NEUROL NEUROSUR PS; Puckett Y, 2018, CUREUS, V10, DOI 10.7759/cureus.2920; Purrucker JC, 2015, JAMA NEUROL; Raval AN, 2017, CIRCULATION; Rosand J, 2004, ARCH INTERN MED; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Samama MM, 2014, CLIN LAB MED; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Sarode R, 2012, J NEUROSURG, V116, P491, DOI 10.3171/2011.11.JNS11836; Schulman S, 2007, TRANSFUS MED REV, V21, P37, DOI 10.1016/j.tmrv.2006.08.002; Schwab K, 2017, ANN NEUROL; SHETTY HGM, 1992, THROMB HAEMOSTASIS, V67, P13; Sindet-Pedersen C, 2018, EUR HEART J; Skardelly M, 2018, ACTA NEUROCHIR, V160, P2077, DOI 10.1007/s00701-018-3679-5; Smith K, 2012, JBI LIB SYST REV; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Steiner T, 2006, STROKE, V37, P256, DOI 10.1161/01.STR.0000196989.09900.f8; Steiner T, 2016, LANCET NEUROL; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Studt JD, 2017, J THROMB HAEMOST; Testa S, 2016, J THROMB HAEMOST; Tsivgoulis G, 2017, NEUROLOGY; Tykocki T, 2016, WORLD NEUROSURG; Verma A, 2018, JAMA SURG, V153, P577, DOI 10.1001/jamasurg.2018.0374; Viswanathan A., 2012, AM AC NEUR M; von der Brelie C, 2017, ACTA NEUROCHIR, V159, P101, DOI 10.1007/s00701-016-3026-7; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x; Watson VL, 2017, NEUROSURGERY; Wiegele M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2352-6; Won S-Y, 2017, NEUROSURG FOCUS; Woo CH, 2014, WORLD NEUROSURG; Yasaka M, 2002, THROMB RES, V108, P25, DOI 10.1016/S0049-3848(02)00402-4; Yasaka M, 2006, THROMB RES	110	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	MAR 3	2021	21	1							98	10.1186/s12883-021-02126-7			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QS0VG	WOS:000625626100002	33658003	Green Published, gold			2022-02-07	
J	Pushchina, EV; Marinina, KS; Myasoyedov, SD				Pushchina, E. V.; Marinina, K. S.; Myasoyedov, S. D.			Hydrogen Sulfide and Pathophysiology of the CNS	NEUROPHYSIOLOGY			English	Article						hydrogen sulfide; traumatic brain injury; stroke; oxidative stress; cerebral edema; neural stem cells; constitutive and reparative neurogenesis		The literature data and results of our research team concerning the physiological and pathological effects of hydrogen sulfide, a gas transmitter that has recently attracted significant and increasing attention of neurophysiologists, are analyzed. Hydrogen sulfide is a gaseous signaling molecule, the effects of which were discovered later than those of NO and CO; H2S was found to play great pathophysiological roles in various diseases. This compound is synthesized in the body by enzymatic and non-enzymatic pathways from cysteine, using the pyridoxal 5'-phosphate-dependent enzymes cystathionine beta-synthase (CBS) or cystathionine gamma-lyase (CSE); 3-mercaptopyruvate sulfurtransferase (3MST) plays a considerable role in H2S catabolism. Abnormal deviations in H2S metabolism are important factors involved in the development of a number of dangerous neurological pathologies, in particular of Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), and Down's syndrome (DS). This compound was also demonstrated to be involved in various biological and pathophysiological processes in the brain resulting from traumatic brain injury (TBI), stroke, oxidative stress, and cerebral edema. In the case of traumatic injury in the trout brain, the activation of CBS expression in the radial glia phenotypes occurs in the aNSC.	[Pushchina, E. V.; Marinina, K. S.] Russian Acad Sci NSCMB FEB RAS, Far Eastern Branch, Zhirmunsky Natl Sci Ctr Marine Biol, Vladivostok, Russia; [Pushchina, E. V.] Natl Acad Sci Ukraine, Bogomolets Inst Physiol, Kiev, Ukraine; [Myasoyedov, S. D.] Shupyk Natl Med Acad Postgrad Educ NMAPE, Kiev, Ukraine		Pushchina, EV (corresponding author), Russian Acad Sci NSCMB FEB RAS, Far Eastern Branch, Zhirmunsky Natl Sci Ctr Marine Biol, Vladivostok, Russia.; Pushchina, EV (corresponding author), Natl Acad Sci Ukraine, Bogomolets Inst Physiol, Kiev, Ukraine.	puschina@mail.ru	Pushchina, Evgeniya/P-9789-2015	Pushchina, Evgeniya/0000-0003-0388-3147			Abe K, 1996, J NEUROSCI, V16, P1066; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Alunni A, 2005, EUR J HISTOCHEM, V49, P157; Arochena M, 2004, J COMP NEUROL, V469, P413, DOI 10.1002/cne.11021; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Beltowski J, 2014, MOLECULES, V19, P21183, DOI 10.3390/molecules191221183; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Cai W, 2017, TRANSL STROKE RES, V8, P107, DOI 10.1007/s12975-016-0504-4; Cao X, 2018, MOL NEUROBIOL, V55, P3789, DOI 10.1007/s12035-017-0617-0; Chan SJ, 2015, ASN NEURO, V7, DOI 10.1177/1759091415578711; Che XR, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00392; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Cheung NS, 2007, NEUROPHARMACOLOGY, V53, P505, DOI 10.1016/j.neuropharm.2007.06.014; Chu QJ, 2013, J SURG RES, V183, P330, DOI 10.1016/j.jss.2012.12.003; Cirino G, 2017, BRIT J PHARMACOL, V174, P4021, DOI 10.1111/bph.13815; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Cuoghi B, 2009, CELL TISSUE RES, V338, P319, DOI 10.1007/s00441-009-0870-2; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; Than-Trong E, 2015, GLIA, V63, P1406, DOI 10.1002/glia.22856; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; FURCHGOTT RF, 1991, BLOOD VESSELS, V28, P52; GALEA E, 1992, P NATL ACAD SCI USA, V89, P10945, DOI 10.1073/pnas.89.22.10945; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Giuliani D, 2013, NEUROBIOL LEARN MEM, V104, P82, DOI 10.1016/j.nlm.2013.05.006; Gopalakrishnan Priya, 2019, Pathophysiology, V26, P1, DOI 10.1016/j.pathophys.2018.10.005; Hermann, 2012, GASOTRANSMITTERS PHY, P163; Hu YY, 2015, J STROKE CEREBROVASC, V24, P601, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.006; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI 10.1089/ARS.2008.2132; Islam KN, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001986; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Jiang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117982; Kalman M, 1998, ANAT EMBRYOL, V198, P409, DOI 10.1007/s004290050193; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Karimi SA, 2017, BRAIN RES BULL, V134, P177, DOI 10.1016/j.brainresbull.2017.07.014; Kida K, 2015, HANDB EXP PHARMACOL, V230, P181, DOI 10.1007/978-3-319-18144-8_9; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P795, DOI 10.1089/ars.2005.7.795; Kimura H, 2013, NEUROCHEM INT, V63, P492, DOI 10.1016/j.neuint.2013.09.003; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2013, FASEB J, V27, P2451, DOI 10.1096/fj.12-226415; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Leffler CW, 2011, AM J PHYSIOL-HEART C, V300, pH440, DOI 10.1152/ajpheart.00722.2010; Liang GH, 2011, AM J PHYSIOL-HEART C, V300, pH2088, DOI 10.1152/ajpheart.01290.2010; Liu H, 2016, TRANSL STROKE RES, V7, P209, DOI 10.1007/s12975-016-0459-5; Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005; Lowicka E, 2007, PHARMACOL REP, V59, P4; Luo YG, 2013, NEUROCHEM INT, V63, P826, DOI 10.1016/j.neuint.2013.06.004; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Nagy P, 2010, CHEM RES TOXICOL, V23, P1541, DOI 10.1021/tx100266a; Olivenza R, 2000, J NEUROCHEM, V74, P785, DOI 10.1046/j.1471-4159.2000.740785.x; Panthi S, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0108-x; Panthi S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9049782; Parfenova H, 2008, CURR PHARM DESIGN, V14, P443, DOI 10.2174/138161208783597380; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; Pushchina EV, 2019, RUSS J DEV BIOL+, V50, P39, DOI 10.1134/S1062360419020048; Pushchina EV, 2016, RUSS J DEV BIOL+, V47, P11, DOI 10.1134/S1062360416010057; Pushchina EV, 2011, NEUROCHEM J+, V5, P24, DOI 10.1134/S1819712411010090; Pushchina EV., 2011, NEUROPHYSIOLOGY, V43, P109; Pushchina EV, 2020, NEURAL REGEN RES, V15, P1867, DOI 10.4103/1673-5374.280320; Pushchina EV, 2016, NEURAL REGEN RES, V11, P578, DOI 10.4103/1673-5374.180742; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Samhan-Arias AK, 2009, BIOCHEM BIOPH RES CO, V388, P718, DOI 10.1016/j.bbrc.2009.08.076; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Tang S, 2016, NEUROGASTROENT MOTIL, V28, P687, DOI 10.1111/nmo.12765; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2012, P NATL ACAD SCI USA, V109, P8801, DOI 10.1073/pnas.1206646109; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wei X, 2015, BRAIN RES, V1622, P292, DOI 10.1016/j.brainres.2015.07.001; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Wu J, 2007, J NEUROSCI, V27, P6510, DOI 10.1523/JNEUROSCI.1256-07.2007; Xiao LC, 2012, INT J MOL MED, V30, P1126, DOI 10.3892/ijmm.2012.1090; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060200; Xuan AG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-202; Yu Q, 2015, CELL PHYSIOL BIOCHEM, V36, P1539, DOI 10.1159/000430317; Zhang JY, 2017, MED GAS RES, V7, P113, DOI 10.4103/2045-9912.208517; Zhang LM, 2009, NEUROCHEM RES, V34, P1984, DOI 10.1007/s11064-009-0006-9; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhou J, 2012, CLIN EXP PHARMACOL P, V39, P566, DOI 10.1111/j.1440-1681.2011.05654.x; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	94	0	0	2	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-2977	1573-9007		NEUROPHYSIOLOGY+	Neurophysiology	JUL	2020	52	4					308	321		10.1007/s11062-021-09887-4		MAR 2021	14	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	QT5YV	WOS:000624392400001					2022-02-07	
J	Weaver, DF				Weaver, Donald F.			Inter-individual variability in disease expression: the Tudor-Churchill spectrum	NEUROLOGICAL SCIENCES			English	Article						Dementia; Alzheimer&#8217; s disease; Brain trauma; Chronic traumatic encephalopathy; Concussion; Henry VIII; Winston Churchill		Henry VIII and Winston Churchill are clinically instructive when appreciating inter-individual variability in disease expression. Both were illustrious English leaders who as young men sustained multiple traumatic brain injuries, which may (or may not) have profoundly influenced their successes and failures of later years. Both men were admired and castigated; both struggled at various times with their bodies and their minds. Ultimately, one was initially a great man who descended as a flawed leader; the other was initially a flawed man who ascended as a great leader. Their similar yet contrasting case histories define the full spectrum ("Tudor-Churchill Spectrum") of inter-individual variability in response to brain disease or injury. The Tudor-Churchill spectrum is the immense variability between individual patients and reminds us that every person is unique, deserving of individualized thought, personalized diagnosis and tailored treatment.	[Weaver, Donald F.] Univ Hlth Network, Krembil Brain Inst, Toronto, ON M5T 0S8, Canada; [Weaver, Donald F.] Univ Toronto, Toronto, ON M5T 0S8, Canada; [Weaver, Donald F.] Univ Hlth Network, Toronto Western Hosp, Krembil Res Inst, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 0S8, Canada		Weaver, DF (corresponding author), Univ Hlth Network, Krembil Brain Inst, Toronto, ON M5T 0S8, Canada.; Weaver, DF (corresponding author), Univ Toronto, Toronto, ON M5T 0S8, Canada.; Weaver, DF (corresponding author), Univ Hlth Network, Toronto Western Hosp, Krembil Res Inst, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.	donald.weaver@uhnresearch.ca			Canada Research Chair, Tier 1Canada Research Chairs	This study had no external funding. D. Weaver acknowledges funding support from a Canada Research Chair, Tier 1.	[Anonymous], 1920, TIMES OF LONDON, P11; [Anonymous], 1931, NEW YORK TIMES, P1; [Anonymous], 1922, TIMES OF LONDON, P12; [Anonymous], 1926, TIMES LONDON    0608, P13; [Anonymous], 1931, TIMES LONDON    1215, P12; [Anonymous], 1914, CHICAGO DAILY TRIBUN, P1; Arciniega H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-80995-1; BOYLE MO, 1978, RENAISSANCE QUART, V31, P161, DOI 10.2307/2860126; Brewer JS, 1894, LETT PAPERS FOREIGN, V14; Brewer JS, 1887, LETT PAPERS FOREIGN, V10; BRINCH O, 1958, Centaurus, V5, P339; Carey WB., 2009, J WINSTON CHURCHILL, V145, P22; Chalmers CR, 2009, J ROY SOC MED, V102, P513, DOI 10.1258/jrsm.2009.090286; Chamberlin FC., 1931, PRIVATE CHARACTER HE; Churchill, 1975, CHURCHILL, VIV, P208; Churchill WS., 1930, ROVING COMMISSION, P30; cMenamin, 2018, MYTH CHURCHILL ALCOH; Dickens C, 1854, CHILDS HIST ENGLAND, V3, P59; Ikram MQ, 2016, J CLIN NEUROSCI, V28, P16, DOI 10.1016/j.jocn.2015.10.035; International Churchill Society, 2012, CHURCHILL B B, V45; Keynes Milo, 2005, J Med Biogr, V13, P174; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; McMenamin M., 2014, J WINSTON CHURCHILL, V63, P38; Moran L., 1966, WINSTON CHURCHILL ST, P167; Soames M., 1999, SPEAKING THEMSELVES, P53; Sykes C., 1967, CROSS ROADS ISRAEL P, P66; Whibley, 1904, UNION 2 NOBLE ILLUST, V2, P266; Zuckerman SL, 2018, J ALZHEIMERS DIS, V66, P37, DOI 10.3233/JAD-180218	28	0	0	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	DEC	2021	42	12					5407	5411		10.1007/s10072-021-05129-x		MAR 2021	5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XI4QV	WOS:000625023700001	33660158	Green Published, Bronze			2022-02-07	
J	Thomas, E; Chih, H; Gabbe, B; Fitzgerald, M; Cowen, G				Thomas, Elizabeth; Chih, HuiJun; Gabbe, Belinda; Fitzgerald, Melinda; Cowen, Gill			A cross-sectional study reporting concussion exposure, assessment and management in Western Australian general practice	BMC FAMILY PRACTICE			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; POSITION STATEMENT; COST-EFFECTIVENESS; FAMILY PHYSICIANS; KNOWLEDGE; CHILDREN; EPIDEMIOLOGY; STRATEGIES; PREDICTORS	Background General Practitioners (GPs) may be called upon to assess patients who have sustained a concussion despite limited information being available at this assessment. Information relating to how concussion is actually being assessed and managed in General Practice is scarce. This study aimed to identify characteristics of current Western Australian (WA) GP exposure to patients with concussion, factors associated with GPs' knowledge of concussion, confidence of GPs in diagnosing and managing patients with concussion, typical referral practices and familiarity of GPs with guidelines. Methods In this cross-sectional study, GPs in WA were recruited via the RACGP WA newsletter and shareGP and the consented GPs completed an electronic survey. Associations were performed using Chi-squared tests or Fisher's Exact test. Results Sixty-six GPs in WA responded to the survey (response rate = 1.7%). Demographics, usual practice, knowledge, confidence, identification of prolonged recovery as well as guideline and resource awareness of GPs who practised in regional and metropolitan areas were comparable (p > 0.05). Characteristics of GPs were similar between those who identified all symptoms of concussion and distractors correctly and those who did not (p > 0.05). However, 84% of the respondents who had never heard of concussion guidelines were less likely to answer all symptoms and distractors correctly (p = 0.039). Whilst 78% of the GPs who were confident in their diagnoses had heard of guidelines (p = 0.029), confidence in managing concussion was not significantly associated with GPs exposure to guidelines. It should be noted that none of the respondents correctly identified signs of concussion and excluded the distractors. Conclusions Knowledge surrounding concussion guidelines, diagnosis and management varied across GPs in WA. Promotion of available concussion guidelines may assist GPs who lack confidence in making a diagnosis. The lack of association between GPs exposure to guidelines and confidence managing concussion highlights that concussion management may be an area where GPs could benefit from additional education and support.	[Cowen, Gill] Curtin Univ, Curtin Med Sch, Bentley, WA, Australia; [Thomas, Elizabeth; Chih, HuiJun] Curtin Univ, Sch Publ Hlth, Bentley, WA, Australia; [Thomas, Elizabeth] Univ Western Australia, Fac Hlth & Med Sci, Div Surg, Perth, WA, Australia; [Chih, HuiJun] Curtin Univ, Ctr Clin Res Excellence, Bentley, WA, Australia; [Gabbe, Belinda] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Gabbe, Belinda] Swansea Univ, Med Sch, Hlth Data Res UK, Swansea, W Glam, Wales; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia; [Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg, Nedlands, WA, Australia		Cowen, G (corresponding author), Curtin Univ, Curtin Med Sch, Bentley, WA, Australia.	gill.cowen@curtin.edu.au		Cowen, Gill/0000-0002-7092-4589	Curtin Medical School	This study was funded by Curtin Medical School.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; [Anonymous], 2013, Br J Sports Med, V47, P259; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Damodaran O, 2014, CLIN ANAT, V27, P25, DOI 10.1002/ca.22336; Davis GA., 2017, BRIT J SPORT MED, P1, DOI [DOI 10.1136/BJSPORTS-2017-097506SCAT5, 10.1136/bjsports-2017-097506SCAT5]; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Elkington LJ, 2018, MED J AUSTRALIA, V208, P246, DOI 10.5694/mja17.01180; Ellis MJ, 2019, PAED CHILD HEALT-CAN, V24, P137, DOI 10.1093/pch/pxy171; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Herceg M, 2018, CONCUSSION KNOWLEDGE, V3, DOI [10.2217/cnc-2018-0002, DOI 10.2217/CNC-2018-0002]; Herceg Marko, 2018, Concussion, V3, pCNC59, DOI 10.2217/cnc-2018-0002; Holmes MW, 2013, ARCH DIS CHILD, V98, P939, DOI 10.1136/archdischild-2012-302820; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Itriyeva Khalida, 2017, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2017-0070; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jackson WT, 2019, MED CLIN N AM, V103, P251, DOI 10.1016/j.mcna.2018.10.005; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Luff C, 2020, BRIT J SPORT MED, V54, P1438, DOI 10.1136/bjsports-2019-101848; Mann A, 2017, CAN FAM PHYSICIAN, V63, P460; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Manzanero S., 2017, J CONCUSSION, DOI [10.1177/2059700217726874, DOI 10.1177/2059700217726874]; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01034; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Parkinson A, 2015, AUST J PRIM HEALTH, V21, P254, DOI 10.1071/PY13129; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	53	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2296		BMC FAM PRACT	BMC Fam. Pract.	MAR 2	2021	22	1							46	10.1186/s12875-021-01384-1			11	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ4WP	WOS:000624524600001	33653287	Green Published, gold			2022-02-07	
J	Abdelaziz, I; Aljondi, R; Alhailiy, AB; Mahmoud, MZ				Abdelaziz, Ikhlas; Aljondi, Rowa; Alhailiy, Ali B.; Mahmoud, Mustafa Z.			Detection of Midline Shift from CT Scans to Predict Outcome in Patients with Head Injuries	INTERNATIONAL JOURNAL OF BIOMEDICINE			English	Article						brain midline shift; Glasgow Coma Scale; intracerebral hemorrhage; intracranial pressure; subdural hematoma		Background: The present study aimed to detect the degree of midline shift from CT scans and the clinical status of the patient, to evaluate the relationship between the degree of midline shift found by the CT scan and Glasgow Coma Scale (GCS) score as a predictor of clinical outcome in head injury patients. Furthermore, we aimed to assess the relationship between midline shift and age, sex, and causes. Methods and Results: The study included 50 subjects (36 males and 14 females). The age range of the patients in this study was 18-95 years old (mean age of 48.34 +/- 17.02 years). The inclusion criteria were patients with traumatic brain injury (TBI) or patients evaluated for level of consciousness by a neurosurgeon. Toshiba 16 Slice CT Scanner (Toshiba Medical Systems, Nasu, Japan 2003) was used to scan all patients in the supine, head first position. Contiguous 2 mm slices were obtained using the Toshiba 16-slice machine spiral technique (pitch 1.25-1.5, 0.75 s rotation time, 120 KvP, 2 mm reconstruction interval). The results indicated that the degree of midline shift in patients with brain injuries was statistically significant as a determinant of clinical outcome. It appeared that the probability of poor clinical outcome was higher when there was a combination of midline shift and other types of intracranial hemorrhage, clinical factors, such as sex, age, and GCS score, and associated injuries. The worst outcome was seen in patients with midline shift and subdural hematoma, when compared with other lesions in patients with brain injuries. Conclusion: This study suggests that the degree of midline shift may be predictive of clinical outcome in patients with head injuries.	[Abdelaziz, Ikhlas; Aljondi, Rowa] Univ Jeddah, Dept Med Imaging & Radiat Sci, Coll Appl Med Sci, Jeddah, Saudi Arabia; [Abdelaziz, Ikhlas] Sudan Univ Sci & Technol, Diagnost Radiol Dept, Coll Med Radiol Sci, Khartoum, Sudan; [Alhailiy, Ali B.; Mahmoud, Mustafa Z.] Prince Sattam bin Abdulaziz Univ, Radiol & Med Imaging Dept, Coll Appl Med Sci, POB 422, Al Kharj 11942, Saudi Arabia		Mahmoud, MZ (corresponding author), Prince Sattam bin Abdulaziz Univ, Radiol & Med Imaging Dept, Coll Appl Med Sci, POB 422, Al Kharj 11942, Saudi Arabia.	m.alhassen@psau.edu.sa	Mahmoud, Mustafa Z./AAD-4833-2022		Deanship of Scientific Research at Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia	This publication was supported by the Deanship of Scientific Research at Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia.	Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Chiewvit Pipat, 2010, Journal of the Medical Association of Thailand, V93, P99; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jain S, 2019, J NEUROTRAUM, V36, P1794, DOI 10.1089/neu.2018.6183; Liao CC, 2006, BIOMED ENG-APP BAS C, V18, DOI 10.4015/S1016237206000452; Liao CC, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/4303161; Liao CC, 2010, COMPUT BIOL MED, V40, P331, DOI 10.1016/j.compbiomed.2010.01.004; Liu RZ, 2009, 2009 16TH IEEE INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOLS 1-6, P2637, DOI 10.1109/ICIP.2009.5414092; Liu RZ, 2014, COMPUT MED IMAG GRAP, V38, P1, DOI 10.1016/j.compmedimag.2013.11.001; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Pillai SV, 2003, NEUROL INDIA, V51, P345; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Xiao FR, 2010, CLIN NEUROL NEUROSUR, V112, P785, DOI 10.1016/j.clineuro.2010.06.020	17	0	0	2	2	INT MEDICAL RESEARCH & DEVELOPMENT CORP	NEW YORK	6308 12TH AVE, NEW YORK, NY 11219 USA	2158-0510	2158-0529		INT J BIOMED	Int. J. Biomed.	MAR	2021	11	1					18	23		10.21103/Article11(1)_OA3			6	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	RE2VE	WOS:000634017700003		gold			2022-02-07	
J	Amirkhosravi, L; Khaksari, M; Sheibani, V; Shahrokhi, N; Ebrahimi, MN; Amiresmaili, S; Salmani, N				Amirkhosravi, Ladan; Khaksari, Mohammad; Sheibani, Vahid; Shahrokhi, Nader; Ebrahimi, Mohammad Navid; Amiresmaili, Sedigheh; Salmani, Neda			Improved spatial memory, neurobehavioral outcomes, and neuroprotective effect after progesterone administration in ovariectomized rats with traumatic brain injury: Role of RU486 progesterone receptor antagonist	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Behavioral disorders; Mifepristone; Neuroprotection; Progesterone; Spatial memory; TBI	SEX STEROID-HORMONES; FOCAL CEREBRAL-ISCHEMIA; INTRACRANIAL-PRESSURE; CELL-DEATH; INFLAMMATORY CYTOKINES; FUNCTIONAL DEFICITS; NEUROLOGIC OUTCOMES; COGNITIVE DEFICITS; BARRIER DISRUPTION; NEURONAL LOSS	Objective(s): The contribution of classic progesterone receptors (PR) in interceding the neuroprotective efficacy of progesterone (P4) on the prevention of brain edema and long-time behavioral disturbances was assessed in traumatic brain injury (TBI). Materials and Methods: Female Wistar rats were ovariectomized and apportioned into 6 groups: sham, TBI, oil, P4, vehicle, and RU486. P4 or oil was injected following TBI. The antagonist of PR (RU486) or DMSO was administered before TBI. The brain edema and destruction of the blood-brain barrier (BBB) were determined. Intracranial pressure (ICP), cerebral perfusion pressure (CPP), and beam walk (BW) task were evaluated previously and at various times post-trauma. Long-time locomotor and cognitive consequences were measured one day before and on days 3, 7, 14, and 21 after the trauma. Results: RU486 eliminated the inhibitory effects of P4 on brain edema and BBB leakage (P<0.05, P<0.001, respectively). RU486 inhibited the decremental effect of P4 on ICP as well as the increasing effect of P4 on CPP (P<0.001) after TBI. Also, RU486 inhibited the effect of P4 on the increase in traversal time and reduction in vestibulomotor score in the BW task (P<0.001). TBI induced motor, cognitive, and anxiety-like disorders, which lasted for 3 weeks after TBI; but, P4 prevented these cognitive and behavioral abnormalities (P<0.05), and RU486 opposed this P4 effect (P<0.001). Conclusion: The classic progesterone receptors have neuroprotective effects and prevent long-time behavioral and memory deficiency after brain trauma.	[Amirkhosravi, Ladan; Ebrahimi, Mohammad Navid] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran; [Amirkhosravi, Ladan; Sheibani, Vahid; Ebrahimi, Mohammad Navid] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran; [Amirkhosravi, Ladan; Khaksari, Mohammad] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Physiol Res Ctr, Kerman, Iran; [Amiresmaili, Sedigheh] Bam Univ Med Sci, Dept Physiol, Bam, Iran; [Salmani, Neda] Islamic Azad Univ, Genet Inst, Dept Psychol, Zarand Branch, Kerman, Iran		Khaksari, M (corresponding author), Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran.	mkhaksari@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019; Amirkhosravi, Ladan/AAW-9036-2021	Haddad, Mohammad Khaksari/0000-0003-0770-4281; 			Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Amirkhosravi L., 2014, Iranian Journal of Veterinary Science and Technology, V6, P62; An CR, 2016, TRANSL STROKE RES, V7, P512, DOI 10.1007/s12975-016-0483-5; [Anonymous], 2014, BRAIN RES, V1545, P23; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Bashiri H, 2016, NEUROPHARMACOLOGY, V105, P478, DOI 10.1016/j.neuropharm.2016.02.010; Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; BENZEL EC, 1988, NEUROSURGERY, V23, P169, DOI 10.1227/00006123-198808000-00007; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Chang Chi-Wu, 2014, Biomed Res Int, V2014, P141582, DOI 10.1155/2014/141582; Crandall C, 2006, J WOMENS HEALTH, V15, P14, DOI 10.1089/jwh.2006.15.14; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Espinosa-Garcia C, 2014, BRAIN RES, V1545, P23, DOI 10.1016/j.brainres.2013.11.030; Feng YZ, 2015, INT J DEV NEUROSCI, V44, P6, DOI 10.1016/j.ijdevneu.2015.04.010; Frye CA, 2004, BRAIN RES, V1004, P116, DOI 10.1016/j.brainres.2004.01.020; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; Geddes RI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146419; Gilkes CE., 2009, NEUROSURGERY, V27, P139; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guennoun R, 2019, CELL MOL NEUROBIOL, V39, P551, DOI 10.1007/s10571-018-0627-0; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Impellizzeri D., 2017, FRONT NEUROSCI-SWITZ, V11, P1; Ishihara Y, 2016, STEROIDS, V113, P71, DOI 10.1016/j.steroids.2016.06.004; Jiang C, 2017, MOL NEUROBIOL, V54, P571, DOI 10.1007/s12035-015-9651-y; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Krause DN, 2002, INT CONGR SER, V1235, P395, DOI 10.1016/S0531-5131(02)00211-X; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Li XJ, 2014, EXP THER MED, V7, P1311, DOI 10.3892/etm.2014.1589; Li Xin-Juan, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P472; Liu R, 2005, BRAIN RES, V1060, P55, DOI 10.1016/j.brainres.2005.08.048; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Marik P, 1999, J EMERG MED, V17, P711, DOI 10.1016/S0736-4679(99)00055-4; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; Marschner L, 2019, BEHAV BRAIN RES, V365, P222, DOI 10.1016/j.bbr.2018.02.040; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Newell AJ, 2018, J COMP NEUROL, V526, P2285, DOI 10.1002/cne.24485; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Petersen SL, 2013, J NEUROENDOCRINOL, V25, P991, DOI 10.1111/jne.12060; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Sehajpal J, 2014, J SURG RES, V191, P441, DOI 10.1016/j.jss.2014.04.025; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Sugo N, 2002, STROKE, V33, P1660, DOI 10.1161/01.STR.0000016967.76805.BF; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Walter B, 2004, J NEUROTRAUM, V21, P1076, DOI 10.1089/0897715041651024; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wise PM, 2001, FRONT NEUROENDOCRIN, V22, P33, DOI 10.1006/frne.2000.0207; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x; Zhang Z, 2010, NEUROPHARMACOLOGY, V58, P930, DOI 10.1016/j.neuropharm.2010.01.002; Zhu XY, 2019, J STEROID BIOCHEM, V185, P90, DOI 10.1016/j.jsbmb.2018.07.014; Zhu XY, 2017, J NEUROSCI, V37, P10998, DOI 10.1523/JNEUROSCI.3874-16.2017; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	82	0	0	0	0	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	MAR	2021	24	3					349	359		10.22038/ijbms.2021.50973.11591			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	QP2RC	WOS:000623684900010	33995946				2022-02-07	
J	Avsenik, J; Bajrovic, FF; Gradisek, P; Kejzar, N; Surlan, PK				Avsenik, Jernej; Bajrovic, Fajko F.; Gradisek, Primoz; Kejzar, Natasa; Surlan Popovic, Katarina			Prognostic value of CT perfusion and permeability imaging in traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; prediction models; perfusion computed tomography; permeability imaging		BACKGROUND Currently established prognostic models in traumatic brain injury (TBI) include noncontrast computed tomography (CT) which is insensitive to early perfusion alterations associated with secondary brain injury. Perfusion CT (PCT) on the other hand offers insight into early perfusion abnormalities. We hypothesized that adding CT perfusion and permeability data to the established outcome predictors improves the performance of the prognostic model. METHODS A prospective cohort study of consecutive 50 adult patients with head injury and Glasgow Coma Scale score of 12 or less was performed at a single Level 1 Trauma Centre. Perfusion CT was added to routine control CT 12 hours to 24 hours after admission. Region of interest analysis was performed in six major vascular territories on perfusion and permeability parametric maps. Glasgow Outcome Scale (GOS) was used 6 months later to categorize patients' functional outcomes to favorable (GOS score > 3) or unfavorable (GOS score <= 3). We defined core prognostic model, consisting of age, motor Glasgow Coma Scale score, pupillary reactivity, and CT Rotterdam Score. Next, we added perfusion and permeability data as predictors and compared updated models to the core model using cross-validated areas under the receiver operator curves (cv-AUC). RESULTS Significant advantage over core model was shown by the model, containing both mean cerebral extravascular-extracellular volume per unit of tissue volume and cerebral blood volume of the least perfused arterial territory in addition to core predictors (cv-AUC, 0.75; 95% confidence interval, 0.51-0.84 vs. 0.6; 95% confidence interval, 0.37-0.74). CONCLUSION The development of cerebral ischemia and traumatic cerebral edema constitutes the secondary brain injury and represents the target for therapeutic interventions. Our results suggest that adding CT perfusion and permeability data to the established outcome predictors improves the performance of the prognostic model in the setting of moderate and severe TBI.	[Avsenik, Jernej; Surlan Popovic, Katarina] Univ Med Ctr Ljubljana, Clin Inst Radiol, Zaloska Cesta 7, Ljubljana 1000, Slovenia; [Avsenik, Jernej; Surlan Popovic, Katarina] Univ Ljubljana, Fac Med, Dept Radiol, Ljubljana, Slovenia; [Bajrovic, Fajko F.] Univ Med Ctr Ljubljana, Div Neurol, Ljubljana, Slovenia; [Bajrovic, Fajko F.] Univ Ljubljana, Fac Med, Inst Pathophysiol, Ljubljana, Slovenia; [Gradisek, Primoz] Univ Ctr Ljubljana, Ctr Intens Therapy, Clin Dept Anaesthesiol & Intens Therapy, Ljubljana, Slovenia; [Gradisek, Primoz] Univ Ljubljana, Dept Anaesthesiol Reanimatol, Ljubljana, Slovenia; [Kejzar, Natasa] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia		Avsenik, J (corresponding author), Univ Med Ctr Ljubljana, Clin Inst Radiol, Zaloska Cesta 7, Ljubljana 1000, Slovenia.	jernej.avsenik@kclj.si; fajko.bajrovic@mf.uni-lj.si; primoz.gradisek@kclj.si; natasa.kejzar@mf.uni-lj.si; katarina.surlan@kclj.si			 [20150039]	Study was supported by tertiary research funding of University Medical Centre Ljubljana - research project No. 20150039.	Amorim RL, 2012, J NEURORADIOLOGY, V39, P346, DOI 10.1016/j.neurad.2012.02.006; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bendinelli C, 2017, WORLD J SURG, V41, P2512, DOI 10.1007/s00268-017-4030-7; Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; Bisdas S, 2006, EUR RADIOL, V16, P2220, DOI 10.1007/s00330-006-0209-2; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Celli P, 1997, Minerva Chir, V52, P1467; Chai WY, 2014, J CONTROL RELEASE, V192, P1, DOI 10.1016/j.jconrel.2014.06.023; Cuenod C A, 2013, Diagn Interv Imaging, V94, P1187, DOI 10.1016/j.diii.2013.10.010; Dankbaar JW, 2008, AM J NEURORADIOL, V29, P1671, DOI 10.3174/ajnr.A1203; Douglas DB, 2018, NEUROIMAG CLIN N AM, V28, P55, DOI 10.1016/j.nic.2017.09.002; Escudero D, 2009, NEUROCRIT CARE, V11, P261, DOI 10.1007/s12028-009-9243-7; Etminan N, 2012, STROKE, V43, P759, DOI 10.1161/STROKEAHA.111.616730; Frontera JA, 2016, CRIT CARE MED, V44, P2251, DOI 10.1097/CCM.0000000000002057; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Ivanidze J, 2019, AM J NEURORADIOL, V40, P408, DOI 10.3174/ajnr.A5962; Ivanidze J, 2016, AM J NEURORADIOL, V37, P1599, DOI 10.3174/ajnr.A4784; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; Mills JN, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415960; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Nguyen GT, 2013, NEUROIMAGE-CLIN, V2, P658, DOI 10.1016/j.nicl.2013.04.004; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Roberts HC, 2002, AM J NEURORADIOL, V23, P828; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824	44	0	0	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2021	90	3					484	491		10.1097/TA.0000000000002964			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	QR7MW	WOS:000625400000014	33009337				2022-02-07	
J	Babaee, A; Vaghefi, SHE; Soltani, SD; Shekaari, MA; Shahrokhi, N; Basiri, M				Babaee, Abdolreza; Vaghefi, Seyed Hassan Eftekhar; Soltani, Samereh Dehghani; Shekaari, Majid Asadi; Shahrokhi, Nader; Basiri, Mohsen			Hippocampal Astrocyte Response to Melatonin Following Neural Damage Induction in Rats	BASIC AND CLINICAL NEUROSCIENCE			English	Article						Melatonin; Astrocyte; GFAP; Hippocampus	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; GLIAL-CELLS; ALZHEIMERS-DISEASE; NEURONAL DAMAGE; SPINAL-CORD; INFLAMMATION; ACTIVATION; PATHOPHYSIOLOGY; PROLIFERATION	Introduction. Brain injury induces an almost immediate response from glial cells, especially agtrocytes. Activation of astrocytes leads to the production of inflammatory cytokines and reactive oxygen species that may result in secondary neuronal damage. Melatonin is an anti-inflammatory and antioxidant agent, and it has been reported to exert neuroprotection through the prevention of neuronal death in several models of central nervous system injury. This study aimed to investigate the effect of melatonin on astrocyte activation induced by Traumatic Brain Injury (TBI) in rat hippocampus and dentate gyms. Methods: Animals were randomly divided into 5 groups; Sham group, TBI group, vehicle group, and melatonin-treated TBI groups (TBI+Mel5, TBI+Me120). Immunohisclochemical method (GFAP marker) and TUNEL assay were used to evaluate astrocyte reactivity and neuronal death, respectively. Results: The results demonstrated that the astrocyte number was reduced significantly in melatonin-treated groups compared to the vehicle group. Additionally, based on TUNEL results, melatonin administration noticeably reduced the number of apoptotic neurons in the rat hippocampus and dentate gyms. Conclusion: In general, our findings suggest that melatonin treatment after brain injury reduces astrocyte reactivity as well as neuronal cell apoptosis in rat hippocampus and dentate gyms.	[Babaee, Abdolreza; Vaghefi, Seyed Hassan Eftekhar] Kerman Univ Med Sci, Afzalipour Sch Med, Dept Anat, Kerman, Iran; [Soltani, Samereh Dehghani] Rafsanjan Univ Med Sci, Sch Med, Dept Anat, Rafsanjan, Iran; [Shekaari, Majid Asadi; Shahrokhi, Nader; Basiri, Mohsen] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran		Basiri, M (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran.	m_basiri@kmu.ac.ir	Dehghani-Soltani, Samereh/AAR-7297-2021; Vaghefi, Seyed Hassan Eftekhar/AAW-9916-2020	Dehghani-Soltani, Samereh/0000-0003-1074-3345; Vaghefi, Seyed Hassan Eftekhar/0000-0002-5083-9563	Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran [EC/KNRC/90-2]	This study was extracted from the MSc. thesis of Abdolreza Babaee, and financially supported by Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran (EC/KNRC/90-2).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; Ananth C, 2003, HIPPOCAMPUS, V13, P375, DOI 10.1002/hipo.10090; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Asadi-Shekaari M., 2014, SCI J KURDISTAN U ME, V19, P100; Babaee A, 2019, BIOCHEM BIOPH RES CO, V514, P239, DOI 10.1016/j.bbrc.2019.04.059; Babaee A, 2018, BIOCHEM BIOPH RES CO, V504, P871, DOI 10.1016/j.bbrc.2018.09.010; Babaee A, 2015, IRAN J BASIC MED SCI, V18, P867; Babaei-Balderlou F, 2010, IRAN J BASIC MED SCI, V13, P1; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; Boutin JA, 2005, TRENDS PHARMACOL SCI, V26, P412, DOI 10.1016/j.tips.2005.06.006; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chern CM, 2012, FREE RADICAL BIO MED, V52, P1634, DOI 10.1016/j.freeradbiomed.2012.01.030; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Dehghani-Soltani S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10655-w; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong YS, 2016, J PINEAL RES, V60, P253, DOI 10.1111/jpi.12300; Eftekhar-Vaghefi S. H., 2017, J BABOL U MED SCI, V19, P59, DOI [10.22088/jbums.19.3.59, DOI 10.22088/JBUMS.19.3.59]; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gee JR, 2005, INT J BIOCHEM CELL B, V37, P1145, DOI 10.1016/j.biocel.2004.10.004; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Gutierrez-Cuesta J, 2007, J PINEAL RES, V42, P394, DOI 10.1111/j.1600-079X.2007.00433.x; Hakemi SG, 2019, INT J FERTIL STERIL, V13, P57, DOI 10.22074/ijfs.2019.5520; Hald A, 2009, EUR J PAIN, V13, P138, DOI 10.1016/j.ejpain.2008.03.014; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hickie IB, 2011, LANCET, V378, P621, DOI 10.1016/S0140-6736(11)60095-0; Hostenbach S, 2014, NEUROSCI LETT, V565, P39, DOI 10.1016/j.neulet.2013.10.012; Hung MW, 2008, J PINEAL RES, V44, P214, DOI 10.1111/j.1600-079X.2007.00514.x; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Liang HW, 2008, NEUROSCI LETT, V438, P116, DOI 10.1016/j.neulet.2008.04.058; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mortavazi Seyed, 2009, Oman Med J, V24, P274, DOI 10.5001/omj.2009.56; Mortezazadeh F, 2018, J RES MED DENT SCI, V6, P133; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Pazar A, 2016, J PINEAL RES, V60, P74, DOI 10.1111/jpi.12292; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Pourhoseini S, 2017, J CARDIOVASC THORAC, V9, P108, DOI 10.15171/jcvtr.2017.18; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Seo JH, 2013, J CLIN INVEST, V123, P782, DOI 10.1172/JCI65863; Soltani SD, 2016, LASER MED SCI, V31, P255, DOI 10.1007/s10103-015-1846-y; Tsai MC, 2011, J PINEAL RES, V51, P233, DOI 10.1111/j.1600-079X.2011.00885.x; Varshosaz J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/816103; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	54	0	0	1	1	IRAN UNIV MEDICAL SCIENCES	TEHRAN	COOPERATION IRAN NEUROSCIENCE SOC, NEGAH INST SCIENTIFIC COMMUNICATION, SHAHID HEMMAT HIGHWAY, TEHRAN, 1449614535, IRAN	2008-126X	2228-7442		BASIC CLIN NEUROSCI	Basic Clin. Neurosci.	MAR-APR	2021	12	2					177	185		10.32598/bcn.12.2.986.1			9	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	SK8SV	WOS:000656489800002	34925714	gold, Green Published			2022-02-07	
J	Bagnato, S; Prestandrea, C; D'Agostino, T; Boccagni, C; Rubino, F				Bagnato, Sergio; Prestandrea, Caterina; D'Agostino, Tiziana; Boccagni, Cristina; Rubino, Francesca			Somatosensory evoked potential amplitudes correlate with long-term consciousness recovery in patients with unresponsive wakefulness syndrome	CLINICAL NEUROPHYSIOLOGY			English	Article						Vegetative state; Disorders of consciousness; SEPs; Traumatic brain injury; Hypoxic brain injury; Prognosis	VEGETATIVE STATE; CARDIAC-ARREST; DISORDERS; SCALE; COMA; NEUROPHYSIOLOGY; RECOMMENDATIONS; PREDICTION	Objective: To prospectively investigate relationships of cortical somatosensory evoked potential (SEP) amplitudes with consciousness recovery and disability in the year following brain injury in patients with vegetative state/unresponsive wakefulness syndrome (VS/UWS). Methods: SEPs of 42 patients with VS/UWS were recorded 51.7 +/- 23.3 days post-injury. N20-P25 amplitudes were compared between patients with and without consciousness recovery at 6 months and 1 year post-injury. Results: SEPs were present in 21 patients and bilaterally absent in 21 patients. N20-P25 amplitudes were significantly higher in patients who recovered consciousness than in those who died or did not recover consciousness at 6 months (median, 4.6 vs. 1.9 mu V; P = 0.004) and 1 year (median, 4.6 vs. 2.1 mu V; P = 0.02) after injury. The lowest N20-P25 amplitude in a patient who recovered consciousness was 2.15 mu V. N20-P25 amplitudes correlated significantly with Coma Recovery Scale-Revised and Disability Rating Scale scores at 6 months and 1 year post-injury (both P < 0.05). Conclusions: In patients with VS/UWS, SEP amplitudes are related to consciousness recovery and disability at 6 months and 1 year post-injury. Significance: The evaluation of SEP amplitudes can help to refine prognoses for patients with VS/UWS. (C) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.	[Bagnato, Sergio; Prestandrea, Caterina; D'Agostino, Tiziana; Boccagni, Cristina; Rubino, Francesca] Giuseppe Giglio Fdn, Rehabil Dept, Unit Neurophysiol, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy; [Bagnato, Sergio; Prestandrea, Caterina; D'Agostino, Tiziana; Boccagni, Cristina; Rubino, Francesca] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy		Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Rehabil Dept, Unit Neurophysiol, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy.; Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887			Annen J, 2019, BRAIN INJURY, V33, P1409, DOI 10.1080/02699052.2019.1644376; Avesani R, 2018, FUNCT NEUROL, V33, P97; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bagnato S, 2011, J PERIPHER NERV SYST, V16, P315, DOI 10.1111/j.1529-8027.2011.00363.x; Bruno M-A., 2012, COMA DISORDERS CONSC, P11, DOI [DOI 10.1007/978-1-4471-2440-5_2, 10.1007/978-1-4471-2440-5_2]; Carrai R, 2019, ACTA NEUROL SCAND, V139, P158, DOI 10.1111/ane.13030; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; CHU NS, 1986, J NEUROL SCI, V76, P199, DOI 10.1016/0022-510X(86)90169-3; Comanducci A, 2020, CLIN NEUROPHYSIOL, V131, P2736, DOI 10.1016/j.clinph.2020.07.015; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; Endisch C, 2015, NEUROLOGY, V85, P1752, DOI 10.1212/WNL.0000000000002123; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lucca LF, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1293-7; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Royal College of Physicians, 2013, PROLONGED DISORDERS; Sandroni C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2060-7; Scarpino M, 2020, RESUSCITATION, V147, P95, DOI 10.1016/j.resuscitation.2019.11.014; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; van Erp WS, 2014, EUR J NEUROL, V21, P1361, DOI 10.1111/ene.12483; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962	29	0	0	3	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2021	132	3					793	799		10.1016/j.clinph.2021.01.006			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QL5DQ	WOS:000621097800013	33578338				2022-02-07	
